PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	King, MA; Ganley, IG; Flemington, V				King, M. A.; Ganley, I. G.; Flemington, V.			Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells	ONCOGENE			English	Article							MEMBRANE PERMEABILIZATION; SELECTIVE INHIBITOR; AUTOPHAGY; APOPTOSIS; POTENT; RESISTANCE; DISCOVERY; COMPLEX; DEATH; EXPRESSION	Mutations to fibroblast growth factor receptor 3 (FGFR3) and phosphatase and tensin homologue (PTEN) signalling pathway components (for example, PTEN loss, PIK3CA, AKT1, TSC1/2) are common in bladder cancer, yet small-molecule inhibitors of these nodes (FGFR/PTENi) show only modest activity in preclinical models. As activation of autophagy is proposed to promote survival under FGFR/PTENi, we have investigated this relationship in a panel of 18 genetically diverse bladder cell lines. We found that autophagy inhibition does not sensitise bladder cell lines to FGFR/PTENi, but newly identify an autophagy-independent cell death synergy in FGFR3-mutant cell lines between mTOR (mammalian target of rapamycin) pathway inhibitors and chloroquine (CQ)-an anti-malarial drug used as a cancer therapy adjuvant in over 30 clinical trials. The mechanism of synergy is consistent with lysosomal cell death (LCD), including cathepsin-driven caspase activation, and correlates with suppression of cSREBP1 and cholesterol biosynthesis in sensitive cell lines. Remarkably, loss of viability can be rescued by saturating cellular membranes with cholesterol or recapitulated by statin-mediated inhibition, or small interfering RNA knockdown, of enzymes regulating cholesterol metabolism. Modulation of CQ-induced cell death by atorvastatin and cholesterol is reproduced across numerous cell lines, confirming a novel and fundamental role for cholesterol biosynthesis in regulating LCD. Thus, we have catalogued the molecular events underlying cell death induced by CQ in combination with an anticancer therapeutic. Moreover, by revealing a hitherto unknown aspect of lysosomal biology under stress, we propose that suppression of cholesterol metabolism in cancer cells should elicit synergy with CQ and define a novel approach to future cancer treatments.	[King, M. A.] AstraZeneca Oncol, Alderley Pk, Macclesfield, Cheshire, England; [Ganley, I. G.] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland; [Flemington, V.] AstraZeneca Oncol, CRUK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	AstraZeneca; University of Dundee; AstraZeneca; CRUK Cambridge Institute	King, MA; Flemington, V (corresponding author), AstraZeneca, Oncol IMED, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	matthew.king@astrazeneca.com; vikki.flemington@astrazeneca.com		Ganley, Ian/0000-0003-1481-9407	Medical Research Council [MC_UU_12016/4, MC_UP_A500_1019] Funding Source: Medline; MRC [MC_UU_12016/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Appelqvist H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050262; Barlaam B, 2015, J MED CHEM, V58, P943, DOI 10.1021/jm501629p; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Ch'ng JH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.265; Christian AE, 1997, J LIPID RES, V38, P2264; Cufi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02469; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Dickstein RJ, 2012, CANCER BIOL THER, V13, P1325, DOI 10.4161/cbt.21793; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Graham RM, 2014, ONCOTARGET, V5, P1162, DOI 10.18632/oncotarget.1699; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hao SJ, 2008, GEN PHYSIOL BIOPHYS, V27, P278; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Laforge M, 2007, J VIROL, V81, P11426, DOI 10.1128/JVI.00597-07; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; Li S, 2016, ONCOGENE, V35, P642, DOI 10.1038/onc.2015.123; MCGOWAN EB, 1989, BIOCHEM BIOPH RES CO, V158, P432, DOI 10.1016/S0006-291X(89)80065-8; Medina MW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003058; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Pike KG, 2013, BIOORG MED CHEM LETT, V23, P1212, DOI 10.1016/j.bmcl.2013.01.019; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Roth BD, 2002, PROGR MED CHEM, V40, P1, DOI 10.1016/S0079-6468(08)70080-8; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Seitz C, 2013, INT J CANCER, V132, P2682, DOI 10.1002/ijc.27935; SHOJIKASAI Y, 1988, P NATL ACAD SCI USA, V85, P146, DOI 10.1073/pnas.85.1.146; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Sun CH, 2011, HISTOPATHOLOGY, V58, P1054, DOI 10.1111/j.1365-2559.2011.03856.x; von Schwarzenberg K, 2013, J BIOL CHEM, V288, P1385, DOI 10.1074/jbc.M112.412007; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu XR, 2009, CANCER METAST REV, V28, P281, DOI 10.1007/s10555-009-9189-4; Xu CX, 2011, CANCER BIOL THER, V12, P549, DOI 10.4161/cbt.12.6.16397; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ye J RA, 2011, COLD SPRING HARBOR P, V3; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	57	39	41	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4518	4528		10.1038/onc.2015.511	http://dx.doi.org/10.1038/onc.2015.511			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26853465	Green Published, hybrid			2022-12-26	WOS:000382153100009
J	Wang, J; Sevier, CS				Wang, Jie; Sevier, Carolyn S.			Formation and Reversibility of BiP Protein Cysteine Oxidation Facilitate Cell Survival during and post Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-REGULATED PROTEIN; INDUCED S-GLUTATHIONYLATION; ENDOPLASMIC-RETICULUM; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; DISULFIDE-ISOMERASE; ADP-RIBOSYLATION; SACCHAROMYCES-CEREVISIAE; THIOL/DISULFIDE EXCHANGE; MONOTHIOL GLUTAREDOXINS; PROTEOMIC ANALYSIS	Redox fluctuations within cells can be detrimental to cell function. To gain insight into how cells normally buffer against redox changes to maintain cell function, we have focused on elucidating the signaling pathways that serve to sense and respond to oxidative redox stress within the endoplasmic reticulum (ER) using yeast as a model system. Previously, we have shown that a cysteine in the molecular chaperone BiP, a Hsp70 molecular chaperone within the ER, is susceptible to oxidation by peroxide during ER-derived oxidative stress, forming a sulfenic acid (-SOH) moiety. Here, we demonstrate that this same conserved BiP cysteine is susceptible also to glutathione modification (-SSG). Glutathionylated BiP is detected both as a consequence of enhanced levels of cellular peroxide and also as a by-product of increased levels of oxidized glutathione (GSSG). Similar to sulfenylation, we observe glutathionylation decouples BiP ATPase and peptide binding activities, turning BiP from an ATP-dependent foldase into an ATP-independent holdase. We show glutathionylation enhances cell proliferation during oxidative stress, which we suggest relates to modified BiP's increased ability to limit polypeptide aggregation. We propose the susceptibility of BiP to modification with glutathione may serve also to prevent irreversible oxidation of BiP by peroxide.	[Wang, Jie; Sevier, Carolyn S.] Cornell Univ, Dept Mol Med, VMC C4-141, Ithaca, NY 14853 USA	Cornell University	Sevier, CS (corresponding author), Cornell Univ, Dept Mol Med, VMC C4-141, Ithaca, NY 14853 USA.	css224@cornell.edu	Wang, Jie/GPT-0245-2022	Wang, Jie/0000-0002-4974-9587; Sevier, Carolyn/0000-0003-3245-6988	National Institutes of Health [1S10OD017992-01]; NATIONAL CANCER INSTITUTE [R01CA081554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105958] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017992] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank John O'Donnell and Heather Sickles for assistance with plasmid construction and technical expertise. We also thank Dante Lepore for help with fluorescence microscopy and Dr. Ruth Collins for the use of her lab microscope. We acknowledge the Cornell Proteomics and Mass Spectrometry Core Facility for processing and analysis of samples, and we thank the director of the core facility, Dr. Sheng Zhang, for providing the methods describing the mass spectrometry procedures. The proteomics core facility was supported by National Institutes of Health Grant 1S10OD017992-01, which provided instrument support.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Berndt C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00168; Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218; CARLSSON L, 1983, P NATL ACAD SCI-BIOL, V80, P4664, DOI 10.1073/pnas.80.15.4664; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Devarie-Baez NO, 2016, FREE RADICAL RES, V50, P172, DOI 10.3109/10715762.2015.1090571; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Galligan JJ, 2014, FREE RADICAL BIO MED, V73, P411, DOI 10.1016/j.freeradbiomed.2014.06.002; Grant CM, 1999, MOL CELL BIOL, V19, P2650; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Halloran M, 2013, Int J Cell Biol, V2013, P797914, DOI 10.1155/2013/797914; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; Hildebrandt T, 2015, BIOL CHEM, V396, P523, DOI 10.1515/hsz-2014-0295; Hochrainer K, 2012, CELL MOL LIFE SCI, V69, P2057, DOI 10.1007/s00018-011-0912-2; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Izquierdo A, 2008, EUKARYOT CELL, V7, P1415, DOI 10.1128/EC.00133-08; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kettenhofen NJ, 2010, CHEM RES TOXICOL, V23, P1633, DOI 10.1021/tx100237w; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; LEDFORD BE, 1994, MOL CELL BIOCHEM, V138, P141, DOI 10.1007/BF00928456; LENO GH, 1989, EUR J BIOCHEM, V186, P205, DOI 10.1111/j.1432-1033.1989.tb15196.x; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Lind C, 1998, BIOCHEM BIOPH RES CO, V247, P481, DOI 10.1006/bbrc.1998.8695; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Lundstrom-Ljung J, 1999, FEBS LETT, V443, P85, DOI 10.1016/S0014-5793(98)01698-6; Maller C, 2011, ANTIOXID REDOX SIGN, V14, P49, DOI 10.1089/ars.2010.3149; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; SIKORSKI RS, 1989, GENETICS, V122, P19; Uys JD, 2011, METHOD ENZYMOL, V490, P321, DOI 10.1016/B978-0-12-385114-7.00018-0; VEDIA LM, 1992, J BIOL CHEM, V267, P24929; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wei PC, 2012, MOL CELL, V48, P747, DOI 10.1016/j.molcel.2012.10.007; WELCH WJ, 1983, J BIOL CHEM, V258, P7102; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Xiao RY, 2005, J BIOL CHEM, V280, P21099, DOI 10.1074/jbc.M411476200; Xiong Y., 2012, INT J CELL BIOL, V2012, P273549, DOI 10.1155/2012/273549; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s	68	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7541	7557		10.1074/jbc.M115.694810	http://dx.doi.org/10.1074/jbc.M115.694810			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865632	Green Published, hybrid			2022-12-26	WOS:000383447600028
J	Tcheng, DK; Nayak, AK; Fowlkes, CC; Punyasena, SW				Tcheng, David K.; Nayak, Ashwin K.; Fowlkes, Charless C.; Punyasena, Surangi W.			Visual Recognition Software for Binary Classification and Its Application to Spruce Pollen Identification	PLOS ONE			English	Article							EASTERN NORTH-AMERICA; FEATURES; PLANT	Discriminating between black and white spruce (Picea mariana and Picea glauca) is a difficult palynological classification problem that, if solved, would provide valuable data for paleoclimate reconstructions. We developed an open-source visual recognition software (ARLO, Automated Recognition with Layered Optimization) capable of differentiating between these two species at an accuracy on par with human experts. The system applies pattern recognition and machine learning to the analysis of pollen images and discovers general-purpose image features, defined by simple features of lines and grids of pixels taken at different dimensions, size, spacing, and resolution. It adapts to a given problem by searching for the most effective combination of both feature representation and learning strategy. This results in a powerful and flexible framework for image classification. We worked with images acquired using an automated slide scanner. We first applied a hash-based "pollen spotting" model to segment pollen grains from the slide background. We next tested ARLO's ability to reconstruct black to white spruce pollen ratios using artificially constructed slides of known ratios. We then developed a more scalable hash-based method of image analysis that was able to distinguish between the pollen of black and white spruce with an estimated accuracy of 83.61%, comparable to human expert performance. Our results demonstrate the capability of machine learning systems to automate challenging taxonomic classifications in pollen analysis, and our success with simple image representations suggests that our approach is generalizable to many other object recognition problems.	[Tcheng, David K.] Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA; [Nayak, Ashwin K.] Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; [Fowlkes, Charless C.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Punyasena, Surangi W.] Univ Illinois, Sch Integrat Biol, Dept Plant Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Irvine; University of Illinois System; University of Illinois Urbana-Champaign	Punyasena, SW (corresponding author), Univ Illinois, Sch Integrat Biol, Dept Plant Biol, Urbana, IL 61801 USA.	punyasena@life.illinois.edu		Punyasena, Surangi/0000-0003-2110-5840; Fowlkes, Charless/0000-0002-2990-1780	National Science Foundation [NSF EF-1137396, NSF-DBI 1053036, NSF-DBI 1262547]; National Center for Supercomputing Applications Institute for Advanced Computing Applications and Technologies (NCSA IACAT) Fellowship; Research Experiences for Undergraduates (REU) from NSF Macrosystems Biology; Div Of Biological Infrastructure [1262547] Funding Source: National Science Foundation; Emerging Frontiers [1137396] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Center for Supercomputing Applications Institute for Advanced Computing Applications and Technologies (NCSA IACAT) Fellowship; Research Experiences for Undergraduates (REU) from NSF Macrosystems Biology(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation (NSF EF-1137396 to SWP and DKT; NSF-DBI 1053036 to CCF; NSF-DBI 1262547 to CCF) and a National Center for Supercomputing Applications Institute for Advanced Computing Applications and Technologies (NCSA IACAT) Fellowship awarded to SWP. AN was supported by Research Experiences for Undergraduates (REU) from NSF Macrosystems Biology awarded to SWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlein PJ, 1998, QUATERNARY SCI REV, V17, P549, DOI 10.1016/S0277-3791(98)00012-2; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; BIRKS HJB, 1980, CAN J BOT, V58, P2043, DOI 10.1139/b80-237; BRUBAKER LB, 1987, CAN J BOT, V65, P899, DOI 10.1139/b87-124; CAIN SA, 1948, SCIENCE, V108, P115, DOI 10.1126/science.108.2796.115; Dean T, 2013, PROC CVPR IEEE, P1814, DOI 10.1109/CVPR.2013.237; Erdtman G, 1931, SCIENCE, V73, P399, DOI 10.1126/science.73.1893.399; Faegri K, 1989, TXB POLLEN ANAL; HANSEN BCS, 1985, CAN J BOT, V63, P2159, DOI 10.1139/b85-305; Holt K, 2011, REV PALAEOBOT PALYNO, V167, P175, DOI 10.1016/j.revpalbo.2011.08.006; Holt KA, 2014, NEW PHYTOL, V203, P735, DOI 10.1111/nph.12848; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Iversen J, 1989, J BIOGEOGR; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jackson ST, 2007, ENCY QUATERNARY SCI, P2413; Kaya Y, 2013, GRANA, V52, P71, DOI 10.1080/00173134.2012.754050; Lighthill James, 1973, ARTIFICIAL INTELLIGE; Lindbladh M, 2009, MORPHOMETRIC ANAL PO, V89, P1459; Mander L, 2014, INT J PLANT SCI, V175, P931, DOI 10.1086/677680; Mander L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1905; Norvig P., 2015, ARTIFICIAL INTELLIGE; PRAGLOWS.J, 1970, REV PALAEOBOT PALYNO, V10, P203, DOI 10.1016/0034-6667(70)90003-5; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Punyasena SW, 2012, NEW PHYTOL, V196, P937, DOI 10.1111/j.1469-8137.2012.04291.x; REITSMA T, 1969, REV PALAEOBOT PALYNO, V9, P175, DOI 10.1016/0034-6667(69)90003-7; Richtarik P., 2012, MATH PROGRAM, P1; Stillman EC, 1996, QUATERNARY SCI REV, V15, P1, DOI 10.1016/0277-3791(95)00076-3	29	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148879	10.1371/journal.pone.0148879	http://dx.doi.org/10.1371/journal.pone.0148879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867017	Green Published, gold			2022-12-26	WOS:000370050700044
J	Cox, JA; Zhang, B; Pope, HM; Voigt, MM				Cox, Jane A.; Zhang, Bo; Pope, Holly M.; Voigt, Mark M.			Transcriptome Analysis of Chemically-Induced Sensory Neuron Ablation in Zebrafish	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; SCHWANN-CELL PHENOTYPE; C-JUN; NEGATIVE REGULATOR; SIGNALING PATHWAY; UP-REGULATION; TNF-ALPHA; EXPRESSION; FIBERS; QUANTIFICATION	Peripheral glia are known to have a critical role in the initial response to axon damage and degeneration. However, little is known about the cellular responses of non-myelinating glia to nerve injury. In this study, we analyzed the transcriptomes of wild-type and mutant (lacking peripheral glia) zebrafish larvae that were treated with metronidazole. This treatment allowed us to conditionally and selectively ablate cranial sensory neurons whose axons are ensheathed only by non-myelinating glia. While transcripts representing over 27,000 genes were detected by RNAseq, only a small fraction (similar to 1% of genes) were found to be differentially expressed in response to neuronal degeneration in either line at either 2 hrs or 5 hrs of metronidazole treatment. Analysis revealed that most expression changes (332 out of the total of 458 differentially expressed genes) occurred over a continuous period (from 2 to 5 hrs of metronidazole exposure), with a small number of genes showing changes limited to only the 2 hr (55 genes) or 5 hr (71 genes) time points. For genes with continuous alterations in expression, some of the most meaningful sets of enriched categories in the wild-type line were those involving the inflammatory TNF-alpha and IL6 signaling pathways, oxidoreductase activities and response to stress. Intriguingly, these changes were not observed in the mutant line. Indeed, cluster analysis indicated that the effects of metronidazole treatment on gene expression was heavily influenced by the presence or absence of glia, indicating that the peripheral non-myelinating glia play a significant role in the transcriptional response to sensory neuron degeneration. This is the first transcriptome study of metronidazole-induced neuronal death in zebrafish and the response of non-myelinating glia to sensory neuron degeneration. We believe this study provides important insight into the mechanisms by which non-myelinating glia react to neuronal death and degeneration in sensory circuits.	[Cox, Jane A.; Pope, Holly M.; Voigt, Mark M.] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO USA; [Cox, Jane A.; Voigt, Mark M.] St Louis Univ, Sch Med, Ctr Neurosci, St Louis, MO USA; [Zhang, Bo] Washington Univ, Sch Med, Ctr Regenerat Med, Dept Dev Biol, St Louis, MO USA	Saint Louis University; Saint Louis University; Washington University (WUSTL)	Voigt, MM (corresponding author), St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO USA.; Voigt, MM (corresponding author), St Louis Univ, Sch Med, Ctr Neurosci, St Louis, MO USA.	voigtm@slu.edu	zb, aber/A-6874-2011	zb, aber/0000-0003-2962-5314	National Institute for Neurological Disorders and Stroke [NS087574]; National Institute of General Medical Sciences [GM008306]; National Institute on Drug Abuse [DA027995]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NS087574, National Institute for Neurological Disorders and Stroke (http://www.ninds.nih.gov/) to MMV; GM008306, National Institute of General Medical Sciences (http://www.nigms.nih.gov/Pages/default.aspx) to HP; and DA027995, National Institute on Drug Abuse, (http://www.drugabuse.gov/) to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bennett GJ, 2014, NAT REV NEUROL, V10, P326, DOI 10.1038/nrneurol.2014.77; Brazda V, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-42; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Brushart TM, 2013, EXP NEUROL, V247, P272, DOI 10.1016/j.expneurol.2013.05.007; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Caron SJC, 2008, DEVELOPMENT, V135, P3259, DOI 10.1242/dev.023200; Cheepudomwit T, 2008, NEUROSCI LETT, V430, P230, DOI 10.1016/j.neulet.2007.11.003; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cox JA, 2011, DEV BIOL, V357, P305, DOI 10.1016/j.ydbio.2011.06.044; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; de Oliveira I, 2010, NITROREDUCTASE ENZYM; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Dubovy P, 2011, ANN ANAT, V193, P267, DOI 10.1016/j.aanat.2011.02.011; Geuna S, 2015, J NEUROSCI METH, V243, P39, DOI 10.1016/j.jneumeth.2015.01.021; Gibbons Christopher H, 2014, Continuum (Minneap Minn), V20, P1398, DOI 10.1212/01.CON.0000455874.68556.02; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Hansen A, 2002, DEV DYNAM, V223, P483, DOI 10.1002/dvdy.10074; Hantke J, 2014, BRAIN, V137, P2922, DOI 10.1093/brain/awu257; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487; Jonz MG, 2008, J EXP BIOL, V211, P2371, DOI 10.1242/jeb.010587; Jortner BS, 2000, TOXICOL PATHOL, V28, P54, DOI 10.1177/019262330002800108; Kaku M, 2014, CURR OPIN HIV AIDS, V9, P521, DOI 10.1097/COH.0000000000000103; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kotrschal K, 1997, CHEM SENSES, V22, P111, DOI 10.1093/chemse/22.2.111; Kucenas S, 2006, NEUROSCIENCE, V138, P641, DOI 10.1016/j.neuroscience.2005.11.058; Lamora A, 2009, NEUROSCIENCE, V159, P1175, DOI 10.1016/j.neuroscience.2009.01.049; Lara-Ramirez R, 2008, NEUROSCIENCE, V152, P601, DOI 10.1016/j.neuroscience.2008.01.014; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; Mathis S, 2015, J MED GENET, V52, P681, DOI 10.1136/jmedgenet-2015-103272; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Murinson BB, 2005, J NEUROSCI, V25, P1179, DOI 10.1523/JNEUROSCI.1372-04.2005; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Pereira V, 2014, PAIN, V155, P2534, DOI 10.1016/j.pain.2014.09.013; Perry TA, 2004, EXP NEUROL, V190, P133, DOI 10.1016/j.expneurol.2004.07.013; Pope HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103283; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Sagnelli A, 2013, J NEUROL, V260, P2684, DOI 10.1007/s00415-013-7113-x; Said G, 2013, HAND CLINIC, V115, P579, DOI 10.1016/B978-0-444-52902-2.00033-3; Shubayev VI, 2000, BRAIN RES, V855, P83, DOI 10.1016/S0006-8993(99)02321-5; Smith ES, 2012, J COMP NEUROL, V520, P2785, DOI 10.1002/cne.23133; Steiner I, 2013, HAND CLINIC, V115, P543, DOI 10.1016/B978-0-444-52902-2.00031-X; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Sundin L, 2002, J EXP ZOOL, V293, P232, DOI 10.1002/jez.10130; Uceyler N, 2013, AKTUEL NEUROL, V40, P96, DOI 10.1055/s-0033-1333767; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Xiao Y, 2015, DIS MODEL MECH, V8, P553, DOI 10.1242/dmm.018184; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Ydens E, 2013, NEUROBIOL DIS, V55, P95, DOI 10.1016/j.nbd.2013.03.005; Zrouri H, 2004, EUR J NEUROSCI, V20, P1811, DOI 10.1111/j.1460-9568.2004.03641.x	68	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148726	10.1371/journal.pone.0148726	http://dx.doi.org/10.1371/journal.pone.0148726			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863206	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600101
J	Alhaddad, H; Zhang, C; Rannala, B; Lyons, LA				Alhaddad, Hasan; Zhang, Chi; Rannala, Bruce; Lyons, Leslie A.			A Glance at Recombination Hotspots in the Domestic Cat	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; HUMAN GENOME; HOT-SPOTS; PRDM9; RATES; EVOLUTION; INFERENCE; HUMANS; MOUSE	Recombination has essential roles in increasing genetic variability within a population and in ensuring successful meiotic events. The objective of this study is to (i) infer the population-scaled recombination rate (rho), and (ii) identify and characterize regions of increased recombination rate for the domestic cat, Felis silvestris catus. SNPs (n = 701) were genotyped in twenty-two East Asian feral cats (random bred). The SNPs covered ten different chromosomal regions (A1, A2, B3, C2, D1, D2, D4, E2, F2, X) with an average region size of 850 Kb and an average SNP density of 70 SNPs/region. The Bayesian method in the program inferRho was used to infer regional population recombination rates and hotspots localities. The regions exhibited variable population recombination rates and four decisive recombination hotspots were identified on cat chromosome A2, D1, and E2 regions. As a description of the identified hotspots, no correlation was detected between the GC content and the locality of recombination spots, and the hotspots enclosed L2 LINE elements and MIR and tRNA-Lys SINE elements.	[Alhaddad, Hasan] Kuwait Univ, Coll Sci, Dept Biol Sci, Safat 13060, Kuwait; [Zhang, Chi] Swedish Museum Nat Hist, Dept Bioinformat & Genet, Box 50007, SE-10405 Stockholm, Sweden; [Rannala, Bruce] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Lyons, Leslie A.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA	Kuwait University; Swedish Museum of Natural History; University of California System; University of California Davis; University of Missouri System; University of Missouri Columbia	Alhaddad, H (corresponding author), Kuwait Univ, Coll Sci, Dept Biol Sci, Safat 13060, Kuwait.	hassan.alhaddad@ku.edu.kw		Lyons, Leslie/0000-0002-1628-7726	National Center for Research Resources [R24 RR016094]; Office of Research Infrastructure Programs [OD R24OD010928]; Winn Feline Foundation [W10-014, W11-041]; George and Phyllis Miller Feline Health Fund; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; Winn Feline Foundation; George and Phyllis Miller Feline Health Fund; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	LAL funding from National Center for Research Resources R24 RR016094 and is currently supported by the Office of Research Infrastructure Programs OD R24OD010928, the Winn Feline Foundation (W10-014, W11-041), the George and Phyllis Miller Feline Health Fund, and the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaddad H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053537; Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baker CL, 2014, GENOME RES, V24, P724, DOI 10.1101/gr.170167.113; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bighignoli B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-27; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Hellenthal G, 2006, CURR OPIN GENET DEV, V16, P565, DOI 10.1016/j.gde.2006.10.001; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Lee YS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-434; McVean G, 2002, GENETICS, V160, P1231; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond M, 2009, GENOMICS, V93, P305, DOI 10.1016/j.ygeno.2008.11.004; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; STEINMETZ M, 1982, NATURE, V300, P35, DOI 10.1038/300035a0; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Wang Y, 2008, PHILOS T R SOC B, V363, P3921, DOI 10.1098/rstb.2008.0172; Wang Y, 2009, P NATL ACAD SCI USA, V106, P6215, DOI 10.1073/pnas.0900418106; Wu ZK, 2010, NUCLEIC ACIDS RES, V38, P2346, DOI 10.1093/nar/gkp1251; Zheng J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r103	34	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148710	10.1371/journal.pone.0148710	http://dx.doi.org/10.1371/journal.pone.0148710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859385	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400067
J	Bonthala, VS; Mayes, K; Moreton, J; Blythe, M; Wright, V; May, ST; Massawe, F; Mayes, S; Twycross, J				Bonthala, Venkata Suresh; Mayes, Katie; Moreton, Joanna; Blythe, Martin; Wright, Victoria; May, Sean Tobias; Massawe, Festo; Mayes, Sean; Twycross, Jamie			Identification of Gene Modules Associated with Low Temperatures Response in Bambara Groundnut by Network-Based Analysis	PLOS ONE			English	Article							WRKY FAMILY GENES; TRANSCRIPTION FACTORS; EXPRESSION; ARABIDOPSIS; STRESS; CROP	Bambara groundnut (Vigna subterranea (L.) Verdc.) is an African legume and is a promising underutilized crop with good seed nutritional values. Low temperature stress in a number of African countries at night, such as Botswana, can effect the growth and development of bambara groundnut, leading to losses in potential crop yield. Therefore, in this study we developed a computational pipeline to identify and analyze the genes and genemodules associated with low temperature stress responses in bambara groundnut using the cross-species microarray technique (as bambara groundnut has nomicroarray chip) coupled with network-based analysis. Analyses of the bambara groundnut transcriptome using cross-species gene expression data resulted in the identification of 375 and 659 differentially expressed genes (p<0.01) under the sub-optimal (23 degrees C) and very sub-optimal (18 degrees C) temperatures, respectively, of which 110 genes are commonly shared between the two stress conditions. The construction of a Highest Reciprocal Rank-based gene co-expression network, followed by its partition using a Heuristic Cluster Chiseling Algorithm resulted in 6 and 7 gene modules in sub-optimal and very sub-optimal temperature stresses being identified, respectively. Modules of sub-optimal temperature stress are principally enriched with carbohydrate and lipid metabolic processes, while most of the modules of very sub-optimal temperature stress are significantly enriched with responses to stimuli and various metabolic processes. Several transcription factors (from MYB, NAC, WRKY, WHIRLY & GATA classes) that may regulate the down-streamgenes involved in response to stimulus in order for the plant to withstand very sub-optimal temperature stress were highlighted. The identified genemodules could be useful in breeding for low-temperature stress tolerant bambara groundnut varieties.	[Bonthala, Venkata Suresh] Univ Nottingham, Sch Comp Sci, Jubilee Campus, Nottingham NG7 2RD, England; [Bonthala, Venkata Suresh; Massawe, Festo] Univ Nottingham Malaysia Campus, Sch Biosci, Kuala Lumpur, Malaysia; [Bonthala, Venkata Suresh; Mayes, Sean] Crops Future, Jalan Broga, Semenyih 43500, Malaysia; [Mayes, Katie; May, Sean Tobias; Mayes, Sean] Sutton Bonington Campus, Plant & Crop Sci, Biosci, Loughborough, Leics, England; [Moreton, Joanna] Univ Nottingham, Adv Data Anal Ctr, Sutton Bonington Campus, Loughborough, Leics, England; [Moreton, Joanna] Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Moreton, Joanna; Blythe, Martin; Wright, Victoria] Univ Nottingham, Sch Med, Queens Med Ctr, Deep Seq,Sch Life Sci, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Bonthala, VS (corresponding author), Univ Nottingham, Sch Comp Sci, Jubilee Campus, Nottingham NG7 2RD, England.; Bonthala, VS (corresponding author), Univ Nottingham Malaysia Campus, Sch Biosci, Kuala Lumpur, Malaysia.; Bonthala, VS (corresponding author), Crops Future, Jalan Broga, Semenyih 43500, Malaysia.	psxvb@nottingham.ac.uk	may, sean t/B-6838-2012; Twycross, Jamie/N-9010-2016; Massawe, Festo/K-4555-2013; Bonthala, Venkata Suresh/G-9852-2013	may, sean t/0000-0001-5282-3250; Twycross, Jamie/0000-0002-1684-0886; Massawe, Festo/0000-0002-0744-4777; Bonthala, Venkata Suresh/0000-0001-6550-1648; Moreton, Joanna/0000-0003-3193-1812; Mayes, Sean/0000-0003-4770-3662	Crops for Future (CFF); University of Nottingham; BBSRC [BB/E022758/1, BB/L010100/1, BB/J018961/1, BB/I001271/1, BB/E01772X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G17764, BB/E01772X/1, BB/L010100/1, BB/E022758/1, BBS/B/1356X, BB/J018961/1, BB/I001271/1, G18881] Funding Source: researchfish	Crops for Future (CFF); University of Nottingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Crops for Future (CFF) and University of Nottingham.	Ahmad NS, 2013, BREEDING ACTA HORTIC, P979; Al Shareef I, 2014, EXP AGR, V50, P72, DOI 10.1017/S0014479713000379; Al-Whaibi Mohamed H., 2011, Journal of King Saud University Science, V23, P139, DOI 10.1016/j.jksus.2010.06.022; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Azam-Ali SN, 2001, EXP AGR, V37, P433, DOI 10.1017/S0014479701000412; Bagnaresi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-176; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095176; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Davey MW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-436; Desveaux D, 2004, DEV CELL, V6, P229, DOI 10.1016/S1534-5807(04)00028-0; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fabi JP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-242; Gao RH, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/972852; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GREGORY A, 2007, BRIEFINGS BIOINFORMA, V0008; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Kang YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6443; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kayum MA, 2015, MOL GENET GENOMICS, V290, P79, DOI 10.1007/s00438-014-0898-1; Kong FY, 2014, J EXP BOT, V65, P143, DOI 10.1093/jxb/ert357; Lata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113092; Linnemann AR, 1993, UNDERUTILIZED CROPS; Makanda I, 2009, AFRICAN CROP SCI J, V16, P175; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Muthamilarasan M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00910; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nguyen HT, 2009, PLANT PHYSIOL BIOCH, V47, P116, DOI 10.1016/j.plaphy.2008.10.010; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Ohnishi S, 2010, ENVIRON EXP BOT, V69, P56, DOI 10.1016/j.envexpbot.2010.02.007; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Singh M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0404-2; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Valliyodan B, 2014, INT J MOL SCI, V15, P17622, DOI 10.3390/ijms151017622; Wang LN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-103; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wang Z, 2015, BMC GENOMICS, V16, DOI [10.1186/s12864-015-1988-0, 10.1186/s12864-015-1216-y]; Wong DCJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-186; Wong DCJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-882; Yim WC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-83; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]; Zhu MK, 2014, PLANT CELL REP, V33, P1851, DOI 10.1007/s00299-014-1662-z; Zhu MZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-437	55	31	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148771	10.1371/journal.pone.0148771	http://dx.doi.org/10.1371/journal.pone.0148771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859686	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000370038400079
J	Le Roy, B; Tixier, L; Pereira, B; Sauvanet, P; Buc, E; Petorin, C; Dechelotte, P; Pezet, D; Balayssac, D				Le Roy, Bertrand; Tixier, Lucie; Pereira, Bruno; Sauvanet, Pierre; Buc, Emmanuel; Petorin, Caroline; Dechelotte, Pierre; Pezet, Denis; Balayssac, David			Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; 1ST-LINE TREATMENT; 3 SLC22A3; FLUOROURACIL; LEUCOVORIN; IRINOTECAN; SURVIVAL; PREDICTOR; MEMBRANE; OCT1	Background Adjuvant chemotherapy for colorectal cancer is mainly based on the combination of 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX-4). The pharmacological target of oxaliplatin remains intracellular and therefore dependent on its entry into cells. The intracellular distribution of oxaliplatin is mediated by organic cation transporters 1, 2 and 3 (OCT1, 2 and 3), copper transporter 1 (CTR1) and ATPase Cu2+ transporting beta polypeptide (ATP7B) and may modulate the efficacy of oxaliplatin-based chemotherapy. The aim of this study was to perform a retrospective study to assess the relation between the expression of oxaliplatin transporters in colorectal cancer before chemotherapy and the response to FOLFOX-4 adjuvant chemotherapy in responder and non-responder patients. Methods This retrospective study was conducted at a single center (University Hospital of ClermontFerrand, France). The target population was patients with resectable colorectal cancer operated between 2006 and 2013. Inclusion criteria were defined for the responder patients as no cancer recurrence 3 years after the end of chemotherapy, and for the non-responder patients as cancer recurrence within 1 year. Other inclusion criteria were stages IIb-IV cancers, first-line adjuvant FOLFOX-4 chemotherapy, and the availability of resected primary tumor samples. Exclusion criteria were preoperative chemotherapy and/or radiotherapy, a targeted therapy, other anticancer drugs, cancer recurrence between the first and the third year after the end of chemotherapy and follow-up < 3 years. Immunostaining of oxaliplatin transporters (OCT1, 2, 3, CTR1 and ATP7B) and Ki-67 was assessed in tumor samples. Results Retrospectively, 31 patients have been selected according to inclusion and exclusion criteria (15 responders and 16 non-responders). Before FOLFOX-4 regimen, OCT3 expression was significantly lower in responder patients compared to non-responders (p<0.001). According to multivariate analysis, OCT3 remains an independent criterion for adjuvant FOLFOX chemotherapy response (p = 0.039). No significant relation is reported between chemotherapy response and the expression of OCT1 (p = 0.49), OCT2 (p = 0.09), CTR1 (p = 0.45), ATP7B (p = 0.94) and Ki-67 (p = 0.34) in tumors. Conclusions High expression of OCT3 could be an independent factor related to resistance to FOLFOX-4 chemotherapy.	[Le Roy, Bertrand; Sauvanet, Pierre; Buc, Emmanuel; Petorin, Caroline; Pezet, Denis] CHU Clermont Ferrand, Serv Chirurg & Oncol Digest, F-63003 Clermont Ferrand, France; [Tixier, Lucie; Dechelotte, Pierre] CHU Clermont Ferrand, Serv Anatomopathol, F-63003 Clermont Ferrand, France; [Pereira, Bruno; Balayssac, David] CHU Clermont Ferrand, Delegat Rech Clin & Innovat, F-63003 Clermont Ferrand, France; [Sauvanet, Pierre; Buc, Emmanuel; Pezet, Denis] INRA, INSERM, UdA U1071, USC 2018,M2iSH, F-63001 Clermont Ferrand, France; [Dechelotte, Pierre] Univ Auvergne, R2D2, EA 7281, F-63001 Clermont Ferrand, France; [Balayssac, David] INSERM, U1107, Neurodol, F-63001 Clermont Ferrand, France	CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Balayssac, D (corresponding author), CHU Clermont Ferrand, Delegat Rech Clin & Innovat, F-63003 Clermont Ferrand, France.; Balayssac, D (corresponding author), INSERM, U1107, Neurodol, F-63001 Clermont Ferrand, France.	dbalayssac@chu-clermontferrand.fr	Balayssac, David/K-2265-2015; Balayssac, David/AAZ-3007-2020; Pezet, Denis/I-4423-2017	Balayssac, David/0000-0002-6126-6588; Pezet, Denis/0000-0001-9416-2876; Le Roy, Bertrand/0000-0002-4668-9275; Pereira, Bruno/0000-0003-3778-7161; Tixier, Lucie/0000-0002-1325-3141				COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Gallagher DJ, 2010, ONCOLOGY-BASEL, V78, P237, DOI 10.1159/000315730; Gupta S, 2012, J PHARMACOL EXP THER, V341, P16, DOI 10.1124/jpet.111.190561; Han T, 2013, MOL PHARMACOL, V84, P182, DOI 10.1124/mol.112.084517; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jennison C, 2000, GROUP SEQUENTIAL MET; Jonker JW, 2001, MOL CELL BIOL, V21, P5471, DOI 10.1128/MCB.21.16.5471-5477.2001; Kitada N, 2008, CANCER CHEMOTH PHARM, V62, P577, DOI 10.1007/s00280-007-0640-3; Lee N, 2014, J BIOL CHEM, V289, P27055, DOI 10.1074/jbc.M114.570564; Ma YL, 2010, MED ONCOL, V27, P304, DOI 10.1007/s12032-009-9210-3; Martinez-Balibrea E, 2009, INT J CANCER, V124, P2905, DOI 10.1002/ijc.24273; Mulgaonkar A, 2013, ANTIMICROB AGENTS CH, V57, P2705, DOI 10.1128/AAC.02289-12; Muller J, 2005, BIOCHEM PHARMACOL, V70, P1851, DOI 10.1016/j.bcp.2005.09.011; Nies AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022163; NOETHER GE, 1987, J AM STAT ASSOC, V82, P645, DOI 10.2307/2289477; Noordhuis P, 2008, BIOCHEM PHARMACOL, V76, P53, DOI 10.1016/j.bcp.2008.04.007; Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Phua LC, 2013, CANCER CHEMOTH PHARM, V71, P817, DOI 10.1007/s00280-012-2054-0; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Ray P, 2010, ANESTHESIOLOGY, V112, P1023, DOI 10.1097/ALN.0b013e3181d47604; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Tang SC, 2013, CURR OPIN PHARMACOL, V13, P853, DOI 10.1016/j.coph.2013.08.011; Tashiro A, 2014, AM J CANCER RES, V4, P528; Tatsumi S, 2014, INT J CLIN EXP PATHO, V7, P204; Tournigand C, 2012, J CLIN ONCOL, V30, P3353, DOI 10.1200/JCO.2012.42.5645; Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019; Yokoo S, 2008, DRUG METAB DISPOS, V36, P2299, DOI 10.1124/dmd.108.023168; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Zhang SZ, 2006, CANCER RES, V66, P8847, DOI 10.1158/0008-5472.CAN-06-0769	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148739	10.1371/journal.pone.0148739	http://dx.doi.org/10.1371/journal.pone.0148739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859833	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400072
J	Li, Z; Tan, Z; Hao, SY; Jin, B; Deng, XH; Hu, G; Liu, XD; Zhang, J; Jin, H; Huang, M; Kanegaye, JT; Tremoulet, AH; Burns, JC; Wu, JM; Cohen, HJ; Ling, XFB				Li, Zhen; Tan, Zhou; Hao, Shiying; Jin, Bo; Deng, Xiaohong; Hu, Guang; Liu, Xiaodan; Zhang, Jie; Jin, Hua; Huang, Min; Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.; Wu, Jianmin; Cohen, Harvey J.; Ling, Xuefeng B.		Emergency Med Kawasaki Dis Res Grp	Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses	PLOS ONE			English	Article							NITRIC-OXIDE; IDENTIFICATION; DIPHENYLAMINE; DIAGNOSIS	Objectives Kawasaki disease (KD) is an acute pediatric vasculitis of infants and young children with unknown etiology and no specific laboratory-based test to identify. A specific molecular diagnostic test is urgently needed to support the clinical decision of proper medical intervention, preventing subsequent complications of coronary artery aneurysms. We used a simple and low-cost colorimetric sensor array to address the lack of a specific diagnostic test to differentiate KD from febrile control (FC) patients with similar rash/fever illnesses. Study Design Demographic and clinical data were prospectively collected for subjects with KD and FCs under standard protocol. After screening using a genetic algorithm, eleven compounds including metalloporphyrins, pH indicators, redox indicators and solvatochromic dye categories, were selected from our chromatic compound library (n = 190) to construct a colorimetric sensor array for diagnosing KD. Quantitative color difference analysis led to a decision-tree-based KD diagnostic algorithm. Results This KD sensing array allowed the identification of 94% of KD subjects (receiver operating characteristic [ROC] area under the curve [AUC] 0.981) in the training set (33 KD, 33 FC) and 94% of KD subjects (ROC AUC: 0.873) in the testing set (16 KD, 17 FC). Color difference maps reconstructed from the digital images of the sensing compounds demonstrated distinctive patterns differentiating KD from FC patients. Conclusions The colorimetric sensor array, composed of common used chemical compounds, is an easily accessible, low-cost method to realize the discrimination of subjects with KD from other febrile illness.	[Li, Zhen; Wu, Jianmin] Zhejiang Univ, Inst Microanalyt Syst, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zhen; Tan, Zhou; Hao, Shiying; Jin, Bo; Deng, Xiaohong; Hu, Guang; Liu, Xiaodan; Zhang, Jie; Jin, Hua; Ling, Xuefeng B.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Huang, Min] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Cohen, Harvey J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Zhejiang University; Stanford University; Shanghai Jiao Tong University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Stanford University	Ling, XFB (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	bxling@stanford.edu		Hao, Shiying/0000-0002-7527-2460; Ling, Bruce/0000-0002-5386-3884	Stanford University Spark Program; American Heart Association [14GRNT20510026]; Chinese Scholarship Council (CSC)	Stanford University Spark Program(Stanford University); American Heart Association(American Heart Association); Chinese Scholarship Council (CSC)(China Scholarship Council)	This work was supported by Stanford University Spark Program (2013-2014) (URL: http://med.stanford.edu/sparkmed.html) to XBL and HJC, and American Heart Association (14GRNT20510026) (URL: www.heart.org) to XBL and HJC. This work was supported by the Chinese Scholarship Council (CSC) (URL: http://en.csc.edu.cn/) to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhimschi IA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008808; Feng LA, 2010, ANAL CHEM, V82, P9433, DOI 10.1021/ac1020886; Holman RC, 2003, PEDIATRICS, V112, P495, DOI 10.1542/peds.112.3.495; Iizuka T, 1997, ACTA PAEDIATR, V86, P470, DOI 10.1111/j.1651-2227.1997.tb08915.x; Ishwaran H, 2008, RANDOM SURVIVAL FORE, P841, DOI [DOI 10.1214/08-A0AS169, 10.1214/08-AOAS169]; Janzen MC, 2006, ANAL CHEM, V78, P3591, DOI 10.1021/ac052111s; Kentsis A, 2013, EMBO MOL MED, V5, P210, DOI 10.1002/emmm.201201494; Kolthoff IM, 1933, J AM CHEM SOC, V55, P1448, DOI 10.1021/ja01331a019; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Lin HW, 2011, J AM CHEM SOC, V133, P16786, DOI 10.1021/ja207718t; Ling XB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-130; Ling XB, 2010, ADV CLIN CHEM, V51, P181, DOI 10.1016/S0065-2423(10)51007-2; LUCASIUS CB, 1993, CHEMOMETR INTELL LAB, V19, P1, DOI 10.1016/0169-7439(93)80079-W; Lussier LS, 2000, PROPELL EXPLOS PYROT, V25, P117, DOI 10.1002/1521-4087(200006)25:3<117::AID-PREP117>3.3.CO;2-#; MAYATEPEK E, 1995, ARCH DIS CHILD, V72, P526, DOI 10.1136/adc.72.6.526; Mazzone PJ, 2007, THORAX, V62, P565, DOI 10.1136/thx.2006.072892; Mitchell M., 1996, INTRO GENETIC ALGORI; Musto CJ, 2009, ANAL CHEM, V81, P6526, DOI 10.1021/ac901019g; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; Rakow NA, 2005, ANGEW CHEM INT EDIT, V44, P4528, DOI 10.1002/anie.200500939; TAUBERT KA, 1991, J PEDIATR-US, V119, P279, DOI 10.1016/S0022-3476(05)80742-5; Tsukahara H, 1997, SCAND J CLIN LAB INV, V57, P43, DOI 10.3109/00365519709057817; Zhang C, 2005, J AM CHEM SOC, V127, P11548, DOI 10.1021/ja052606z; Zhang C, 2007, J AGR FOOD CHEM, V55, P237, DOI 10.1021/jf0624695	26	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0146733	10.1371/journal.pone.0146733	http://dx.doi.org/10.1371/journal.pone.0146733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859297	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400003
J	Marck, CH; Neate, SL; Taylor, KL; Weiland, TJ; Jelinek, GA				Marck, Claudia Helena; Neate, Sandra Leanne; Taylor, Keryn Louise; Weiland, Tracey Joy; Jelinek, George Alexander			Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADVERSE LIPID PROFILE; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; DISEASE-ACTIVITY; RELAPSE RATE; DISABILITY; RISK; MS; PROGRESSION	Multiple sclerosis (MS) is a chronic neurological disorder, often affecting young people. Comorbid disorders such as depression, anxiety and hypertension are common and can affect disease course, treatment, and quality of life (QOL) of people with MS (PwMS). The associations between comorbidities, body mass index (BMI) and health outcomes are not well studied in MS, although research shows most PwMS are overweight. Most data on the prevalence of comorbidities and obesity in PwMS comes from North American populations. This study describes the prevalence of comorbidities, overweight and obesity and associations with modifiable factors in an international sample of PwMS recruited online through social media, MS societies and websites. The online survey consisted of validated and researcher-devised instruments to assess self-reported health outcomes and lifestyle behaviors. Of the 2399 respondents, 22.5% were overweight, 19.4% were obese and 67.2% reported at least one comorbidity, with back pain (36.2%), depression (31.7%), anxiety (29.1%) and arthritis (13.7%) most prevalent and most limiting in daily activities. Obesity and most comorbid disorders were significantly more prevalent in North America. Obese participants were more likely to have comorbidities, especially diabetes (OR 4.8) and high blood pressure (OR 4.5) but also depression (OR 2.2). Being overweight, obese, or a former, or current smoker was associated with an increase in the number of comorbidities; while healthy diet, physical activity (borderline significant) and moderate alcohol consumption were associated with decreased number of comorbidities. Increasing number of comorbidities was related to worse QOL, increased odds of disability and prior relapse. Obese PwMS had higher odds of disability and lower QOL. The associations between BMI, comorbidities and health outcomes are likely to be bi-directional and associated with lifestyle behaviors. Preventing and treating comorbid disorders and obesity in PwMS is warranted, and advice regarding healthy and risky lifestyle may assist in improving health outcomes.	[Marck, Claudia Helena; Neate, Sandra Leanne; Taylor, Keryn Louise; Weiland, Tracey Joy; Jelinek, George Alexander] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Vic, Australia	University of Melbourne	Marck, CH (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Vic, Australia.	Claudia.marck@unimelb.edu.au	Weiland, Tracey/Y-2029-2018	Weiland, Tracey/0000-0002-4053-5507; Jelinek, George/0000-0001-6157-0910; TAYLOR, KERYN/0000-0001-7543-4362; Marck, Claudia/0000-0002-3173-1522	Bloom Foundation; Horne Family Charitable Trust	Bloom Foundation; Horne Family Charitable Trust	The study was funded by philanthropic funders the Bloom Foundation and the Horne Family Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth HP, 2014, FAM PRACT, V31, P38, DOI 10.1093/fampra/cmt061; Cambil-Martin J., 2014, NUTR NEUROSCI; Culpepper WJ, 2015, NEUROLOGY, V84, P335, DOI 10.1212/WNL.0000000000001194; Hadgkiss EJ, 2015, NEUROL SCI, V36, P845, DOI 10.1007/s10072-015-2089-1; Hadgkiss EJ, 2015, NUTR NEUROSCI, V18, P125, DOI 10.1179/1476830514Y.0000000117; Hadgkiss EJ, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/580596; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Holper L, 2010, J NEUROL, V257, P103, DOI 10.1007/s00415-009-5282-4; Jelinek GA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0394-1; Jelinek GA, 2015, NEUROL RES, V37, P662, DOI 10.1179/1743132815Y.0000000036; Jelinek GA, 2013, INT J NEUROSCI, V123, P792, DOI 10.3109/00207454.2013.803104; Khurana SR, 2009, AM J PHYS MED REHAB, V88, P83, DOI 10.1097/PHM.0b013e318194f8b5; Levin AB, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/916519; Marck CH, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-143; Marrie R, 2015, OVERVIEW, V21, P263, DOI DOI 10.1177/1352458514564491; Marrie RA, 2008, MULT SCLER J, V14, P1091, DOI 10.1177/1352458508092263; Marrie RA, 2012, ACTA NEUROL SCAND, V125, P180, DOI 10.1111/j.1600-0404.2011.01526.x; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Marrie RA, 2009, MULT SCLER J, V15, P105, DOI 10.1177/1352458508096680; Marrie RA, 2015, NEUROLOGY, V85, P240, DOI 10.1212/WNL.0000000000001718; Marrie RA, 2015, MULT SCLER J, V21, P332, DOI 10.1177/1352458514564488; Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487; Marrie RA, 2015, MULT SCLER J, V21, P318, DOI 10.1177/1352458514564485; Marrie RA, 2015, MULT SCLER J, V21, P294, DOI 10.1177/1352458514564489; Marrie RA, 2015, NEUROLOGY, V84, P350, DOI 10.1212/WNL.0000000000001187; Marrie RA, 2011, NEUROEPIDEMIOLOGY, V36, P85, DOI 10.1159/000323948; Merlino G, 2009, SLEEP MED, V10, P26, DOI 10.1016/j.sleep.2007.11.004; Midaglia L, 2012, MULT SCLER J, V18, P1644, DOI 10.1177/1352458512442262; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; Motl RW, 2011, NEUROEPIDEMIOLOGY, V36, P183, DOI 10.1159/000327749; Pilutti LA, 2012, MULT SCLER RELAT DIS, V1, P139, DOI 10.1016/j.msard.2012.02.004; Pilutti LA, 2012, J OBES, V2012, DOI 10.1155/2012/868256; Pinhas-Hamiel O, 2015, EUR J NEUROL, V22, P1275, DOI 10.1111/ene.12738; Renzaho A, 2010, QUAL LIFE RES, V19, P515, DOI 10.1007/s11136-010-9610-z; Salem R, 2014, DISABIL HEALTH J, V7, P124, DOI 10.1016/j.dhjo.2013.10.003; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Slawta JN, 2003, ARCH PHYS MED REHAB, V84, P1823, DOI 10.1016/S0003-9993(03)00466-0; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Sundh J, 2015, INT J CHRONIC OBSTR, V10, P173, DOI 10.2147/COPD.S74645; Taylor KL, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0327-3; Tettey P, 2014, J NEUROL SCI, V347, P23, DOI 10.1016/j.jns.2014.10.020; Tettey P, 2014, MULT SCLER J, V20, P1737, DOI 10.1177/1352458514533162; Tettey P, 2014, J NEUROL SCI, V340, P230, DOI 10.1016/j.jns.2014.02.038; Turpin KVL, 2007, MULT SCLER J, V13, P1038, DOI 10.1177/1352458507078393; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Weiland TJ, 2014, J NEUROL SCI, V336, P211, DOI 10.1016/j.jns.2013.10.046; World Health Organization, 2015, WORLD HEALTH STATIST	47	68	68	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148573	10.1371/journal.pone.0148573	http://dx.doi.org/10.1371/journal.pone.0148573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849357	gold, Green Published			2022-12-26	WOS:000369554000129
J	Sento, S; Sasabe, E; Yamamoto, T				Sento, Shinya; Sasabe, Eri; Yamamoto, Tetsuya			Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes	PLOS ONE			English	Article							CANCER METASTASIS; BREAST-CANCER; T-CELL; MICROVESICLES; PROGRESSION; APOPTOSIS; MICROENVIRONMENT; ANTICOAGULANTS; EXPRESSION; HEPARANASE	Exosomes are 30-100 nm-sized membranous vesicles, secreted from a variety of cell types into their surrounding extracellular space. Various exosome components including lipids, proteins, and nucleic acids are transferred to recipient cells and affect their function and activity. Numerous studies have showed that tumor cell-derived exosomes play important roles in tumor growth and progression. However, the effect of exosomes released from oral squamous cell carcinoma (OSCC) into the tumor microenvironment remains unclear. In the present study, we isolated exosomes from OSCC cells and investigated the influence of OSCC cell-derived exosomes on the tumor cell behavior associated with tumor development. We demonstrated that OSCC cell-derived exosomes were taken up by OSCC cells themselves and significantly promoted proliferation, migration, and invasion through the activation of the PI3K/Akt, MAPK/ERK, and JNK-1/2 pathways in vitro. These effects of OSCC cell-derived exosomes were obviously attenuated by treatment with PI3K, ERK-1/2, and JNK-1/2 pharmacological inhibitors. Furthermore, the growth rate of tumor xenografts implanted into nude mice was promoted by treatment with OSCC cell-derived exosomes. The uptake of exosomes by OSCC cells and subsequent tumor progression was abrogated in the presence of heparin. Taken together, these data suggest that OSCC cell-derived exosomes might be a novel therapeutic target and the use of heparin to inhibit the uptake of OSCC-derived exosomes by OSCC cells may be useful for treatment.	[Sento, Shinya; Sasabe, Eri; Yamamoto, Tetsuya] Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Kohoku Ku, Oko Cho, Nankoku, Kochi 7838505, Japan	Kochi University	Sento, S (corresponding author), Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Kohoku Ku, Oko Cho, Nankoku, Kochi 7838505, Japan.	jm-shinya-sento@kochi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26670867]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (26670867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The additional funding has come from internal organization (laboratory office expenses).	Altevogt P, 2014, SEMIN CANCER BIOL, V28, P51, DOI 10.1016/j.semcancer.2014.04.008; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Broek RV, 2015, ORAL DIS, V21, P815, DOI 10.1111/odi.12206; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Hall K, 2010, FRONT BIOSCI-LANDMRK, V15, P195, DOI 10.2741/3615; Henderson MC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00038; Jackson LL, 2007, LARYNGOSCOPE, V117, P868, DOI 10.1097/MLG.0b013e318033c810; Jiang HG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-34; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kawamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034045; Koga K, 2005, ANTICANCER RES, V25, P3703; Kosaka N, 2014, FUTURE ONCOL, V10, P671, DOI [10.2217/fon.13.222, 10.2217/FON.13.222]; Kuderer NM, 2007, CANCER-AM CANCER SOC, V110, P1149, DOI 10.1002/cncr.22892; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Lin RZ, 2013, MOL CELL BIOCHEM, V383, P13, DOI 10.1007/s11010-013-1746-z; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Melero-Martin JM, 2011, STEM CELLS, V29, P163, DOI 10.1002/stem.583; Mrizak D, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju363; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; OSAKI T, 1994, ORAL ONCOL, V30B, P296, DOI 10.1016/0964-1955(94)90028-0; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Principe S, 2013, PROTEOMICS, V13, P1608, DOI 10.1002/pmic.201200533; Qu JL, 2009, DIGEST LIVER DIS, V41, P875, DOI 10.1016/j.dld.2009.04.006; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ristorcelli E, 2008, FASEB J, V22, P3358, DOI 10.1096/fj.07-102855; Saleem SN, 2015, CELL MOL LIFE SCI, V72, P1, DOI 10.1007/s00018-014-1710-4; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; Somasundaram R, 2012, NAT MED, V18, P853, DOI 10.1038/nm.2775; Stevenson CE, 2012, FUTURE ONCOL, V8, P403, DOI [10.2217/FON.12.22, 10.2217/fon.12.22]; Sun Y, 2014, CLIN THER, V36, P863, DOI 10.1016/j.clinthera.2014.04.018; Tagalakis V, 2007, CANCER TREAT REV, V33, P358, DOI 10.1016/j.ctrv.2007.02.004; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Verderio C, 2012, ANN NEUROL, V72, P610, DOI 10.1002/ana.23627; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yang L, 2013, MOL MED REP, V8, P1272, DOI 10.3892/mmr.2013.1634; Ye SB, 2014, ONCOTARGET, V5, P5439, DOI 10.18632/oncotarget.2118; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647; Zhao L, 2015, CANCER LETT, V356, P339, DOI 10.1016/j.canlet.2014.10.027	51	50	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148454	10.1371/journal.pone.0148454	http://dx.doi.org/10.1371/journal.pone.0148454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849680	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000097
J	Wong, JGX; Thein, TL; Leo, YS; Pang, JX; Lye, DC				Wong, Joshua G. X.; Thein, Tun Linn; Leo, Yee-Sin; Pang, Junxiong; Lye, David C.			Identifying Adult Dengue Patients at Low Risk for Clinically Significant Bleeding	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SHOCK SYNDROME; INFECTION; CHILDREN; MANIFESTATIONS; VALIDATION; PREDICTORS; SINGAPORE	Background Clinically significant bleeding is important for subsequent optimal case management in dengue patients, but most studies have focused on dengue severity as an outcome. Our study objective was to identify differences in admission parameters between patients who developed clinically significant bleeding and those that did not. We sought to develop a model for discriminating between these patients. Methods We conducted a retrospective study of 4,383 adults aged > 18 years who were hospitalized with dengue infection at Tan Tock Seng Hospital, Singapore from 2005 to 2008. Patients were divided into those with clinically significant bleeding (n = 188), and those without (n = 4,195). Demographic, clinical, and laboratory variables on admission were compared between groups to determine factors associated with clinically significant bleeding during hospitalization. Results On admission, female gender (p< 0.001); temperature > 38 degrees C (p< 0.001); nausea/vomiting (p = 0.009) and abdominal pain/tenderness (p = 0.005); lower systolic blood pressure (p< 0.001); higher pulse rate (p< 0.001); increased absolute neutrophil count (ANC; p< 0.001); reduced absolute lymphocyte count (ALC; p< 0.001), haematocrit percentage (p< 0.001) and platelet count (p = 0.04), and increased prothrombin time (p = 0.003) were significantly associated with clinically significant bleeding on univariate analysis. Multivariate analysis showed that independent variables in the final model were female gender (aOR 2.85; 95% CI: 1.9-4.33); temperature > 38 degrees C (aOR 1.81; 95% CI: 1.27-2.61), nausea/vomiting (aOR 1.39; 95% CI: 0.94-2.12), ANC (aOR 1.3; 95% CI: 1.15-1.46), ALC (aOR 0.4; 95% CI: 0.25-0.64), hematocrit percentage (aOR 0.96; 95% CI: 0.92-1.002) and platelet count (aOR 0.993; 95% CI: 0.988-0.998). At the cutoff of -3.919, the model achieved an AUC of 0.758 (sensitivity: 0.87, specificity: 0.38, PPV: 0.06, NPV: 0.98). Conclusion Clinical risk factors associated with clinically significant bleeding were identified. This model may be useful to complement clinical judgement in triaging adult dengue patients given the dynamic nature of acute dengue, particularly in pre-identifying those less likely to develop clinically significant bleeding.	[Wong, Joshua G. X.; Thein, Tun Linn; Leo, Yee-Sin; Pang, Junxiong; Lye, David C.] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Wong, Joshua G. X.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Leo, Yee-Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Leo, Yee-Sin; Pang, Junxiong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Leo, Yee-Sin; Lye, David C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore	Wong, JGX (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.	Joshua_Gx_Wong@ttsh.com.sg	Pang, Junxiong/AAI-5115-2021; Thein, Tun-Linn/Y-9520-2018; Lye, David/ABF-4402-2021; Thein, Tun-Linn/K-5281-2019	Thein, Tun-Linn/0000-0002-5254-032X; Thein, Tun-Linn/0000-0002-5254-032X; Pang, Junxiong, Vincent/0000-0002-9788-701X; Wong, Joshua/0000-0001-8268-5610; Lye, David/0000-0003-0324-0205	National Medical Research Council Translational Clinical Research STOP-Dengue grant [NMRC/TCR/005/2008]	National Medical Research Council Translational Clinical Research STOP-Dengue grant	This work was supported by research funding from the National Medical Research Council Translational Clinical Research STOP-Dengue grant [NMRC/TCR/005/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz-Quijano FA, 2010, J CLIN VIROL, V49, P11, DOI 10.1016/j.jcv.2010.06.011; Almas A, 2010, SE ASIAN J TROP MED, V41, P333; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Carrasco L R, 2014, PLOS NEGLECT TROP D, V8, pe2972, DOI DOI 10.1371/J0URNAL.PNTD.0002972; Chamnanchanunt S, 2012, SE ASIAN J TROP MED, V43, P890; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003; Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090; Fariz-Safhan MN, 2014, TROP BIOMED, V31, P270; Branco MDFC, 2014, CLINICS, V69, P55, DOI 10.6061/clinics/2014(01)08; Gjenero-Margan I, 2011, EURO SURVEILL BULL E, P16; Gupta V, 2011, J TROP PEDIATRICS, V57, P451, DOI 10.1093/tropej/fmr020; Hanna JN, 1990, COMMUN DIS INTELL, P33; Huhtamo E, 2012, EUROSURVEILLANCE, P18; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; Larrieu S, 2012, RE EMERGENCE OF DENG; Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532; Lee LK, 2013, T ROY SOC TROP MED H, V107, P37, DOI 10.1093/trstmh/trs009; Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676; Lee VJ, 2008, J CLIN VIROL, V42, P34, DOI 10.1016/j.jcv.2007.12.017; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; National Enviroment Agency, 2014, FACTSHEET ON MANAGIN; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1; Orsi FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-350; Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004; R Core Team, 2013, R A LANGUAGE AND ENV; Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777; Shivbalan So., 2004, Indian Journal of Pediatrics, V71, P33, DOI 10.1007/BF02725653; Sousa CA, 2012, PRELIMINARY REPORT; Tee H P, 2009, Med J Malaysia, V64, P316; Thein TL, 2011, AM J TROP MED HYG, V85, P942, DOI 10.4269/ajtmh.2011.11-0149; 'Thein TL, 2014, AM J TROP MED HYG, V90, P984, DOI 10.4269/ajtmh.14-0004; Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060; The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679; Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370; WHO, DENGUE HAEMORRHAGIC; WHO, 2009, DENGUE GUIDELINES FO; WHO, DENGUE AND SEVERE DE; Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x; Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680; Yacoub S, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0147-9; Zhang H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/359308	43	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148579	10.1371/journal.pone.0148579	http://dx.doi.org/10.1371/journal.pone.0148579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849556	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000131
J	Fontana, C; Conde-Alvarez, R; Stahle, J; Holst, O; Iriarte, M; Zhao, Y; Arce-Gorvel, V; Hanniffy, S; Gorvel, JP; Moriyon, I; Widmalm, G				Fontana, Carolina; Conde-Alvarez, Raquel; Stahle, Jonas; Holst, Otto; Iriarte, Maite; Zhao, Yun; Arce-Gorvel, Vilma; Hanniffy, Sean; Gorvel, Jean-Pierre; Moriyon, Ignacio; Widmalm, Goran			Structural Studies of Lipopolysaccharide-defective Mutants from Brucella melitensis Identify a Core Oligosaccharide Critical in Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENUS-SPECIFIC EPITOPE; ESCHERICHIA-COLI K-12; CHLAMYDIA LIPOPOLYSACCHARIDE; PEROSAMINE SYNTHETASE; SALMONELLA-MINNESOTA; LIPID-A; NMR; SMOOTH; SPECTROSCOPY; ABORTUS	The structures of the lipooligosaccharides from Brucella melitensis mutants affected in the WbkD and ManB(core) proteins have been fully characterized using NMR spectroscopy. The results revealed that disruption of wbkD gives rise to a rough lipopolysaccharide (R-LPS) with a complete core structure (beta-D-Glcp-(1 -> 4)-alpha-Kdop-(2 -> 4)[beta-D-GlcpN-(1 -> 6)-beta-D-GlcpN-(1 -> 4)[beta-D-GlcpN-(1 -> 6)]-beta-D-GlcpN-(1 -> 3)-alpha-D-Manp-(1 -> 5)]-alpha-Kdop-(2 -> 6)-beta-D-GlcpN3N4P-(1 -> 6)-alpha-D-GlcpN3N1P), in addition to components lacking one of the terminal beta-D-GlcpN and/or the beta-D-Glcp residues (48 and 17%, respectively). These structures were identical to those of the R-LPS from B. melitensis EP, a strain simultaneously expressing both smooth and R-LPS, also studied herein. In contrast, disruption of man-B-core gives rise to a deep-rough pentasaccharide core (beta-D-Glcp-(1 -> 4)-alpha-Kdop-(2 -> 4)-alpha-Kdop-(2 -> 6)-beta-D-GlcpN3N4P-(1 -> 6)-alpha-D-GlcpN3N1P) as the major component (63%), as well as a minor tetrasaccharide component lacking the terminal beta-D-Glcp residue (37%). These results are in agreement with the predicted functions of the WbkD (glycosyltransferase involved in the biosynthesis of the O-antigen) and ManB(core) proteins (phosphomannomutase involved in the biosynthesis of a mannosyl precursor needed for the biosynthesis of the core and O-antigen). We also report that deletion of B. melitensis wadC removes the core oligosaccharide branch not linked to the O-antigen causing an increase in overall negative charge of the remaining LPS inner section. This is in agreement with the mannosyltransferase role predicted for WadC and the lack of GlcpN residues in the defective core oligosaccharide. Despite carrying the O-antigen essential in B. melitensis virulence, the core deficiency in the wadC mutant structure resulted in a more efficient detection by innate immunity and attenuation, proving the role of the beta-D-GlcpN-(1 -> 6)-beta-D-GlcpN-(1 -> 4)[beta-D-GlcpN-(1 -> 6)]-beta-D-GlcpN-(1 -> 3)-alpha-D-Manp-(1 -> 5) structure in virulence.	[Fontana, Carolina; Stahle, Jonas; Widmalm, Goran] Stockholm Univ, Dept Organ Chem, Arrhenius Lab, S-10691 Stockholm, Sweden; [Conde-Alvarez, Raquel; Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Inst Salud Trop, Inst Invest Sanitaria Navarra, C Irunlarrea 1, Pamplona 31008, Spain; [Conde-Alvarez, Raquel; Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, C Irunlarrea 1, Pamplona 31008, Spain; [Holst, Otto] Airway Res Ctr North, Div Struct Biochem, Leibniz Ctr Med & Biosci, Prior Area Asthma & Allergy,Res Ctr Borstel, D-23845 Borstel, Germany; [Holst, Otto] German Ctr Lung Res, D-23845 Borstel, Germany; [Zhao, Yun; Arce-Gorvel, Vilma; Hanniffy, Sean; Gorvel, Jean-Pierre] Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy, Marseille, France; [Arce-Gorvel, Vilma; Hanniffy, Sean; Gorvel, Jean-Pierre] INSERM, U1104, Marseille, France; [Arce-Gorvel, Vilma; Hanniffy, Sean; Gorvel, Jean-Pierre] CNRS, UMR7280, Marseille, France	Stockholm University; University of Navarra; University of Navarra; Forschungszentrum Borstel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Widmalm, G (corresponding author), Stockholm Univ, Dept Organ Chem, Arrhenius Lab, S-10691 Stockholm, Sweden.	goran.widmalm@su.se	IRIARTE, MAITE/L-9460-2014; Moriyon, Ignacio/N-4764-2016; Conde-Álvarez, Raquel/K-5854-2014; Gorvel, Jean-Pierre/O-1332-2018; Fontana, Carolina/AAA-3564-2022	IRIARTE, MAITE/0000-0002-6726-8920; Moriyon, Ignacio/0000-0002-4288-0195; Conde-Álvarez, Raquel/0000-0003-0046-3577; Gorvel, Jean-Pierre/0000-0002-2829-9804; Fontana, Carolina/0000-0002-7362-2180; Arce-Gorvel, Vilma/0000-0003-0090-837X; Widmalm, Goran/0000-0001-8303-4481	Swedish Research Council; Knut and Alice Wallenberg Foundation; Ministerio de Economia y Competitividad [AGL2011-30453-C04, AGL2014-58795-C4-1-R]; European Commission [215536]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ministerio de Economia y Competitividad(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Swedish Research Council, the Knut and Alice Wallenberg Foundation, and Ministerio de Economia y Competitividad Grants AGL2011-30453-C04 and AGL2014-58795-C4-1-R; the research that led to these results received funding from the European Commission's Seventh Framework Programme FP7/2007-2013 under Grant Agreement 215536. The authors declare that they have no conflicts of interest with the contents of this article.	Aragon V, 1996, J BACTERIOL, V178, P1070, DOI 10.1128/jb.178.4.1070-1079.1996; Ariza J, 1999, REV MED MICROBIOL, V10, P125; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BOHLEN JM, 1993, J MAGN RESON SER A, V102, P293, DOI 10.1006/jmra.1993.1107; BOWDEN RA, 1993, J MED MICROBIOL, V39, P363, DOI 10.1099/00222615-39-5-363; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Claridge TDW, 2003, ORG BIOMOL CHEM, V1, P3632, DOI 10.1039/b307122g; Conde-Alvarez R, 2013, MICROB PATHOGENESIS, V58, P29, DOI 10.1016/j.micpath.2012.11.011; Conde-Alvarez R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002675; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; DEBOER WR, 1976, EUR J BIOCHEM, V62, P1; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Godfroid F, 1998, INFECT IMMUN, V66, P5485, DOI 10.1128/IAI.66.11.5485-5493.1998; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; HOLST O, 1990, CARBOHYD RES, V204, P93, DOI 10.1016/0008-6215(90)84024-O; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iriarte M., 2004, Brucella: molecular and cellular biology, P159; KELLOGG GW, 1992, J MAGN RESON, V98, P176, DOI 10.1016/0022-2364(92)90122-N; Knirel YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P41, DOI 10.1007/978-3-7091-0733-1_3; Kubler-Kielb J, 2013, CARBOHYD RES, V366, P33, DOI 10.1016/j.carres.2012.11.004; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kupce E, 2001, METHOD ENZYMOL, V338, P82; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Mancilla M, 2012, J BACTERIOL, V194, P1860, DOI 10.1128/JB.06561-11; Mancilla M, 2010, J BACTERIOL, V192, P6346, DOI 10.1128/JB.00838-10; McDermott J, 2013, REV SCI TECH OIE, V32, P249; MUHLRADT PF, 1977, EUR J BIOCHEM, V81, P193, DOI 10.1111/j.1432-1033.1977.tb11941.x; Nyberg NT, 2005, J AM CHEM SOC, V127, P6154, DOI 10.1021/ja050878w; Posch G, 2013, CLIN VACCINE IMMUNOL, V20, P945, DOI 10.1128/CVI.00139-13; QURESHI N, 1994, J ENDOTOXIN RES, V1, P137; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Stewart A, 1998, CARBOHYD RES, V313, P193, DOI 10.1016/S0008-6215(98)00271-7; Tannus A, 1997, NMR BIOMED, V10, P423, DOI 10.1002/(SICI)1099-1492(199712)10:8<423::AID-NBM488>3.0.CO;2-X; Turse JE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00054; Valvano MA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P275, DOI 10.1007/978-3-7091-0733-1_9; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Zaccheus MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053941; Zartler ER, 2011, J BIOMOL NMR, V51, P357, DOI 10.1007/s10858-011-9563-8; Zhao G, 2007, BIOCHEM BIOPH RES CO, V363, P525, DOI 10.1016/j.bbrc.2007.08.184; Zygmunt MS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-92	47	32	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7727	7741		10.1074/jbc.M115.701540	http://dx.doi.org/10.1074/jbc.M115.701540			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26867577	Green Published, hybrid			2022-12-26	WOS:000383447600042
J	Qi, HL; Prabakaran, S; Cantrelle, FX; Chambraud, B; Gunawardena, J; Lippens, G; Landrieu, I				Qi, Haoling; Prabakaran, Sudhakaran; Cantrelle, Francois-Xavier; Chambraud, Beatrice; Gunawardena, Jeremy; Lippens, Guy; Landrieu, Isabelle			Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; CYCLIN-DEPENDENT KINASES; ALZHEIMER-LIKE STATE; MAP KINASE; ABNORMAL PHOSPHORYLATION; DOCKING INTERACTIONS; MICROTUBULE-BINDING; STRUCTURAL BASIS; HUMAN BRAIN; DISEASE	Tau neuronal protein has a central role in neurodegeneration and is implicated in Alzheimer disease development. Abnormal phosphorylation of Tau impairs its interaction with other proteins and is associated with its dysregulation in pathological conditions. Molecular mechanisms leading to hyperphosphorylation of Tau in pathological conditions are unknown. Here, we characterize phosphorylation of Tau by extracellular-regulated kinase (ERK2), a mitogen-activated kinase (MAPK) that responds to extracellular signals. Analysis of in vitro phosphorylated Tau by activated recombinant ERK2 with nuclear magnetic resonance spectroscopy (NMR) reveals phosphorylation of 15 Ser/Thr sites. In vitro phosphorylation of Tau using rat brain extract and subsequent NMR analysis identifies the same sites. Phosphorylation with rat brain extract is known to transform Tau into an Alzheimer disease-like state. Our results indicate that phosphorylation of Tau by ERK2 alone is sufficient to produce the same characteristics. We further investigate the mechanism of ERK2 phosphorylation of Tau. Kinases are known to recognize their protein substrates not only by their specificity for a targeted Ser or Thr phosphorylation site but also by binding to linear-peptide motifs called docking sites. We identify two main ERK2 docking sites in Tau sequence using NMR. Our results suggest that ERK2 dysregulation in Alzheimer disease could lead to abnormal phosphorylation of Tau resulting in the pathology of the disease.	[Qi, Haoling; Cantrelle, Francois-Xavier; Lippens, Guy; Landrieu, Isabelle] Univ Lille, CNRS, UMR8576, F-59000 Lille, France; [Prabakaran, Sudhakaran; Gunawardena, Jeremy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Chambraud, Beatrice] Univ Paris 11, INSERM, UMR1195, F-94276 Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Landrieu, I (corresponding author), CNRS, RMN, IRI Bldg,Parc Sci Haute Borne 50,Ave Halley, F-59650 Villeneuve Dascq, France.	isabelle.landrieu@univ-lille1.fr	Landrieu, Isabelle/AAF-8495-2019	Landrieu, Isabelle/0000-0002-4883-2637; Lippens, Guy/0000-0002-8236-0901; Prabakaran, Sudhakaran/0000-0002-6527-1085; cantrelle, francois-xavier/0000-0002-3413-5443	TGE RMN THC (France) [FR-3050]; FRABio (Lille University, CNRS) [FR 3688]; LabEx (Laboratory of Excellence); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); French government funding agency Agence Nationale de la Recherche TAF; National Institutes of Health [R01 GM081578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081578] Funding Source: NIH RePORTER	TGE RMN THC (France); FRABio (Lille University, CNRS); LabEx (Laboratory of Excellence); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); French government funding agency Agence Nationale de la Recherche TAF(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by TGE RMN THC (FR-3050, France) and FRABio (Lille University, CNRS, FR 3688) and also by a grant from the LabEx (Laboratory of Excellence), DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease), and in part by the French government funding agency Agence Nationale de la Recherche TAF. This work was supported by National Institutes of Health Grant R01 GM081578 (to S. P. and J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; ARENDT T, 1995, NEUROSCIENCE, V68, P5, DOI 10.1016/0306-4522(95)00146-A; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Fernandes N, 2007, ACS CHEM BIOL, V2, P665, DOI 10.1021/cb700158q; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gotz J, 2010, BBA-MOL BASIS DIS, V1802, P860, DOI 10.1016/j.bbadis.2009.09.008; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; KOBAYASHI S, 1993, FEBS LETT, V335, P171, DOI 10.1016/0014-5793(93)80723-8; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Leroy A, 2010, J BIOL CHEM, V285, P33435, DOI 10.1074/jbc.M110.149419; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Lippens G, 2012, BIOCHEM SOC T, V40, P698, DOI 10.1042/BST20120050; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Ma WF, 2010, STRUCTURE, V18, P1502, DOI 10.1016/j.str.2010.08.011; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Marsh ENG, 2014, ACS CHEM BIOL, V9, P1242, DOI 10.1021/cb500111u; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Prabakaran S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.15; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Stygelbout V, 2014, BRAIN, V137, P537, DOI 10.1093/brain/awt344; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tepper K, 2014, J BIOL CHEM, V289, P34389, DOI 10.1074/jbc.M114.611368; Theillet FX, 2013, NAT PROTOC, V8, P1416, DOI 10.1038/nprot.2013.083; Theillet FX, 2012, J BIOMOL NMR, V54, P217, DOI 10.1007/s10858-012-9674-x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	70	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7742	7753		10.1074/jbc.M115.700914	http://dx.doi.org/10.1074/jbc.M115.700914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858248	Green Published, hybrid			2022-12-26	WOS:000383447600043
J	Gosejacob, D; Jager, PS; vom Dorp, K; Frejno, M; Carstensen, AC; Kohnke, M; Degen, J; Dormann, P; Hoch, M				Gosejacob, Dominic; Jaeger, Philipp S.; vom Dorp, Katharina; Frejno, Martin; Carstensen, Anne C.; Koehnke, Monika; Degen, Joachim; Doermann, Peter; Hoch, Michael			Ceramide Synthase 5 Is Essential to Maintain C-16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue metabolism; ceramide; ceramide synthase; diabetes; gene knockout; insulin resistance; lipid metabolism; metabolism; obesity; sphingolipid	INDUCED INSULIN-RESISTANCE; HEPATIC STEATOSIS; CHAIN LENGTH; PPAR-GAMMA; FAT; METABOLISM; INHIBITION; INFLAMMATION; HOMEOSTASIS; ACTIVATION	Ceramides are bioactive sphingolipids, which are composed of sphingoid bases carrying acyl chains of various lengths. Ceramides are synthesized by a family of six ceramide synthases (CerS) in mammals, which produce ceramides with different N-linked acyl chains. Increased ceramide levels are known to contribute to the development of obesity and insulin resistance. Recently, it has been demonstrated that the ceramide acylation pattern is of particular importance for an organism to maintain energy homeostasis. However, which of the CerS family members are involved in this process is not yet completely known. Using newly developed CerS5 knock-out mice, we show here that CerS5 is essential to maintain cellular C-16:0 sphingolipid pools in lung, spleen, muscle, liver, and white adipose tissue. Glycerophospholipid levels in CerS5-deficient mice were not altered. We found a strong impact of CerS5-dependent ceramide synthesis in white adipose tissue after high fat diet feeding. In skeletal muscle, liver, and spleen, C-16:0-ceramide levels were altered independent of feeding conditions. The loss of CerS5 is associated with reduced weight gain and improved systemic health, including maintenance of glucose homeostasis and reduced white adipose tissue inflammation after high fat diet challenge. Our findings indicate that reduction of endogenous C-16:0-ceramide by genetic inhibition of CerS5 is sufficient to ameliorate obesity and its comorbidities.	[Gosejacob, Dominic; Jaeger, Philipp S.; Frejno, Martin; Carstensen, Anne C.; Koehnke, Monika; Degen, Joachim; Hoch, Michael] Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Mol Dev Biol, Carl Troll Str 31, D-53115 Bonn, Germany; [vom Dorp, Katharina; Doermann, Peter] Univ Bonn, IMBIO, Mol Biotechnol, Karlrobert Kreiten Str 13, D-53115 Bonn, Germany; [Jaeger, Philipp S.] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Frejno, Martin] Univ Oxford, Chem Biol Unit, NDM Res Bldg,Old Rd Campus, Headington OX3 7FZ, England; [Carstensen, Anne C.] Univ Wurzburg, Lehrstuhl Biochem & Mol Biol, D-97074 Wurzburg, Germany	University of Bonn; University of Bonn; Max Planck Society; University of Oxford; University of Wurzburg	Hoch, M (corresponding author), Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Mol Dev Biol, Carl Troll Str 31, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de			Deutsche Forschungsgemeinschaft DFG [SFB 645, SFB TR83]; Bayer-Schering scholarship	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Bayer-Schering scholarship	This work was supported in part by Deutsche Forschungsgemeinschaft DFG Grants SFB 645, TP B1 and SFB TR83, TP A7 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Bayer-Schering scholarship.	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chen JB, 2016, BBA-MOL CELL BIOL L, V1861, P138, DOI 10.1016/j.bbalip.2015.11.006; Ebel P, 2014, BIOCHEM J, V461, P147, DOI 10.1042/BJ20131242; Ebel P, 2013, J BIOL CHEM, V288, P21433, DOI 10.1074/jbc.M113.479907; Gaebler A, 2013, J LIPID RES, V54, P2282, DOI 10.1194/jlr.D038653; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Park WJ, 2015, BIOL CHEM, V396, P693, DOI 10.1515/hsz-2014-0310; Peters F, 2015, J INVEST DERMATOL, V135, P1501, DOI 10.1038/jid.2015.60; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Schiffmann S, 2012, BIOCHIMIE, V94, P558, DOI 10.1016/j.biochi.2011.09.007; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vazquez AI, 2010, J ANIM SCI, V88, P497, DOI 10.2527/jas.2009-1952; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; Xia JY, 2015, CELL METAB, V22, P266, DOI 10.1016/j.cmet.2015.06.007; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu ZW, 2005, J LIPID RES, V46, P1229, DOI 10.1194/jlr.M500001-JLR200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	70	74	77	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6989	7003		10.1074/jbc.M115.691212	http://dx.doi.org/10.1074/jbc.M115.691212			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26853464	Green Published, hybrid			2022-12-26	WOS:000373299700035
J	Cao, ZY; Ding, Y; Ke, ZP; Cao, L; Li, N; Ding, G; Wang, ZZ; Xiao, W				Cao, Zeyu; Ding, Yue; Ke, Zhipeng; Cao, Liang; Li, Na; Ding, Gang; Wang, Zhenzhong; Xiao, Wei			Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro	PLOS ONE			English	Article							LONICERA-JAPONICA; SUBSTITUTED FLAVANOIDS; ANTIVIRAL ACTIVITY; INFECTION; IDENTIFICATION; CELL; PHARMACOKINETICS; RHABDOMYOSARCOMA; REPLICATION; SEQUENCE	Luteoloside is a member of the flavonoids family that exhibits several bioactivities including anti-microbial and anti-cancer activities. However, the antiviral activity of luteoloside against enterovirus 71 (EV71) and the potential mechanism(s) responsible for this effect remain unknown. In this study, the antiviral potency of luteoloside against EV71 and its inhibitory effects on 3C protease activity were evaluated. First, we investigated the cytotoxicity of luteoloside against rhabdomyosarcoma (RD) cells, which was the cell line selected for an in vitro infection model. In a subsequent antiviral assay, the cytopathic effect of EV71 was significantly and dose-dependently relieved by the administration of luteoloside (EC50 = 0.43 mM, selection index = 5.3). Using a plaque reduction assay, we administered luteoloside at various time points and found that the compound reduced EV71 viability in RD cells rather than increasing defensive mobilization or viral absorption. Moreover, biochemical studies focused on VP1 (a key structural protein of EV71) mRNA transcript and protein levels also revealed the inhibitory effects of luteoloside on the EV71 viral yield. Finally, we performed inhibition assays using luteoloside to evaluate its effect on recombinant 3C protease activity. Our results demonstrated that luteoloside blocked 3C protease enzymatic activity in a dose-dependent manner (IC50 = 0.36 mM) that was similar to the effect of rutin, which is a well-known C3 protease inhibitor. Collectively, the results from this study indicate that luteoloside can block 3C protease activity and subsequently inhibit EV71 production in vitro.	[Cao, Zeyu; Ding, Yue; Ke, Zhipeng; Cao, Liang; Li, Na; Ding, Gang; Wang, Zhenzhong; Xiao, Wei] Jiangsu Kan Pharmaceut Co Ltd, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Jiangsu, Peoples R China		Xiao, W (corresponding author), Jiangsu Kan Pharmaceut Co Ltd, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Jiangsu, Peoples R China.	kanionlunwen@163.com			National Major New Drugs Innovation and Development Project by Ministry of Science and Technology [2013ZX09402203]; Jiangsu Kanion Pharmaceutical Co., Ltd.	National Major New Drugs Innovation and Development Project by Ministry of Science and Technology; Jiangsu Kanion Pharmaceutical Co., Ltd.	This work was supported by National Major New Drugs Innovation and Development Project by Ministry of Science and Technology (2013ZX09402203). Jiangsu Kanion Pharmaceutical Co., Ltd. provided support in the form of salaries for all authors and the research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Binford SL, 2007, ANTIMICROB AGENTS CH, V51, P4366, DOI 10.1128/AAC.00905-07; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chen TC, 2008, J ANTIMICROB CHEMOTH, V62, P1169, DOI 10.1093/jac/dkn424; Chen XQ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/504563; CONTI C, 1992, ANTIMICROB AGENTS CH, V36, P95, DOI 10.1128/AAC.36.1.95; CONTI C, 1990, ANTIMICROB AGENTS CH, V34, P460, DOI 10.1128/AAC.34.3.460; Dragovich PS, 1998, J MED CHEM, V41, P2819, DOI 10.1021/jm9800696; ESANU V, 1981, Revue Roumaine de Medecine Virologie, V32, P213; Fan SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089961; GENOVESE D, 1995, ANTIVIR RES, V27, P123, DOI 10.1016/0166-3542(95)00088-4; He L, 2013, PLOS ONE, V25; Hung HC, 2011, J INFECT DIS, V203, P1784, DOI 10.1093/infdis/jir174; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; KJELLEN L, 1985, J GEN VIROL, V66, P2279, DOI 10.1099/0022-1317-66-10-2279; Kok TW, 1998, J CLIN VIROL, V11, P61, DOI 10.1016/S0928-0197(98)00026-9; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076007; Li XJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-250; Lin YJ, J VIROL METHODS, V182, P93, DOI [10.1016/j.jviromet.2012.03.020, DOI 10.1016/J.JVIR0MET.2012.03.020]; Liu AL, 2008, PLANTA MED, V74, P847, DOI 10.1055/s-2008-1074558; Liu JN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-483; Lu J, 2011, WORLD J GASTROENTERO, V17, P4135, DOI 10.3748/wjg.v17.i36.4135; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Nakashima S, 2015, BIOORG MED CHEM LETT, V25, P2702, DOI 10.1016/j.bmcl.2015.04.052; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Patick AK, 1999, ANTIMICROB AGENTS CH, V43, P2444, DOI 10.1128/AAC.43.10.2444; Qiu F, 2013, BIOMED CHROMATOGR, V27, P311, DOI 10.1002/bmc.2793; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandoval IV, 1997, J VIROL, V71, P4679, DOI 10.1128/JVI.71.6.4679-4693.1997; Shang XF, 2011, J ETHNOPHARMACOL, V138, P1, DOI 10.1016/j.jep.2011.08.016; Shi WF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-327; Shih SR, 2004, MED RES REV, V24, P449, DOI 10.1002/med.10067; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; Sun YS, 2014, J SEP SCI, V37, P1703, DOI 10.1002/jssc.201400153; VRIJSEN R, 1987, ANTIVIR RES, V7, P35, DOI 10.1016/0166-3542(87)90037-4; Wang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052954; Wang Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0308-2; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Xi XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056966; Xiong JH, 2013, FOOD CHEM, V138, P327, DOI 10.1016/j.foodchem.2012.10.127; Xu L, 2014, VIRUSES-BASEL, V6, P2778, DOI 10.3390/v6072778; Yin YX, 2014, VIRUS GENES, V48, P538, DOI 10.1007/s11262-014-1046-z; Zandi K, 2011, J MED PLANTS RES, V5, P5534; Zhang JH, 2014, VIRUS RES, V189, P248, DOI 10.1016/j.virusres.2014.06.003; Zhou W, 2015, J CHROMATOGR A, V1376, P84, DOI 10.1016/j.chroma.2014.12.018	51	30	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148693	10.1371/journal.pone.0148693	http://dx.doi.org/10.1371/journal.pone.0148693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870944	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100050
J	le Feber, J; Pavlidou, ST; Erkamp, N; van Putten, MJAM; Hofmeijer, J				le Feber, Joost; Pavlidou, Stelina Tzafi; Erkamp, Niels; van Putten, Michel J. A. M.; Hofmeijer, Jeannette			Progression of Neuronal Damage in an In Vitro Model of the Ischemic Penumbra	PLOS ONE			English	Article							CEREBRAL-CORTEX; SPREADING DEPOLARIZATION; NETWORKS; CULTURES; HYPOXIA; PHOSPHORYLATION; INTERNEURONS; SYNAPSES; SURVIVAL; GROWTH	Improvement of neuronal recovery in the ischemic penumbra around a brain infarct has a large potential to advance clinical recovery of patients with acute ischemic stroke. However, pathophysiological mechanisms leading to either recovery or secondary damage in the penumbra are not completely understood. We studied neuronal dynamics in a model system of the penumbra consisting of networks of cultured cortical neurons exposed to controlled levels and durations of hypoxia. Short periods of hypoxia (pO(2) approximate to 20mmHg) reduced spontaneous activity, due to impeded synaptic function. After approximate to 6 hours, activity and connectivity partially recovered, even during continuing hypoxia. If the oxygen supply was restored within 12 hours, changes in network connectivity were completely reversible. For longer periods of hypoxia (12-30 h), activity levels initially increased, but eventually decreased and connectivity changes became partially irreversible. After approximate to 30 hours, all functional connections disappeared and no activity remained. Since this complete silence seemed unrelated to hypoxic depths, but always followed an extended period of low activity, we speculate that irreversible damage (at least partly) results from insufficient neuronal activation. This opens avenues for therapies to improve recovery by neuronal activation.	[le Feber, Joost; Pavlidou, Stelina Tzafi; Erkamp, Niels; van Putten, Michel J. A. M.; Hofmeijer, Jeannette] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Clin Neurophysiol, POB 217, NL-7500 AE Enschede, Netherlands; [van Putten, Michel J. A. M.] Med Spectrum Twente, Dept Clin Neurophysiol, Enschede, Netherlands; [Hofmeijer, Jeannette] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands	University of Twente; Medical Spectrum Twente; Rijnstate Hospital	le Feber, J (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Clin Neurophysiol, POB 217, NL-7500 AE Enschede, Netherlands.	j.lefeber@utwente.nl	van Putten, Michel J.A.M./D-6519-2018	van Putten, Michel J.A.M./0000-0001-8319-3626				Akanda N, 2009, J BIOMOL SCREEN, V14, P1228, DOI 10.1177/1087057109348378; Becchetti A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00063; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Butz M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003259; del Zoppo GJ, 2011, J CEREBR BLOOD F MET, V31, P1836, DOI 10.1038/jcbfm.2011.93; Doubal FN, 2011, J NEUROL NEUROSUR PS, V82, P540, DOI 10.1136/jnnp.2009.190298; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Grote J, 1996, J AUTONOM NERV SYST, V57, P168, DOI 10.1016/0165-1838(95)00096-8; Gualtieri F, 2013, NEUROMOL MED, V15, P133, DOI 10.1007/s12017-012-8203-0; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hofmeijer J, 2014, BRAIN RES, V1557, P180, DOI 10.1016/j.brainres.2014.02.027; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; KHAZIPOV R, 1995, J NEUROPHYSIOL, V74, P2138, DOI 10.1152/jn.1995.74.5.2138; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Law JKY, 2009, PHYSIOL MEAS, V30, P155, DOI 10.1088/0967-3334/30/2/004; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; le Feber J, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/3/036005; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; LIPTON P, 1982, J PHYSIOL-LONDON, V325, P51, DOI 10.1113/jphysiol.1982.sp014135; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; NAIR PK, 1987, STROKE, V18, P616, DOI 10.1161/01.STR.18.3.616; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; ROMIJN HJ, 1984, NEUROSCI BIOBEHAV R, V8, P301, DOI 10.1016/0149-7634(84)90055-1; Schmitz Y, 2009, J NEUROSCI, V29, P11973, DOI 10.1523/JNEUROSCI.2927-09.2009; Stegenga J, 2008, IEEE T BIO-MED ENG, V55, P1382, DOI 10.1109/TBME.2007.913987; Stoyanova II, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-49; Stoyanova II, 2013, REGUL PEPTIDES, V186, P43, DOI 10.1016/j.regpep.2013.07.004; Symon L, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P149; Tjepkema-Cloostermans MC, 2014, CLIN NEUROPHYSIOL, V125, P255, DOI 10.1016/j.clinph.2013.08.005; Toledo-Rodriguez M, 2003, NEOCORTEX BASIC NEUR, P719; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; Wagenaar D A, 2005, MEABENCH TOOLSET MUL; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu K, 2004, MOL BRAIN RES, V130, P178, DOI 10.1016/j.molbrainres.2004.07.019; Zandt BJ, 2013, J NEUROSCI, V33, P5915, DOI 10.1523/JNEUROSCI.5115-12.2013; Zandt BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022127	46	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147231	10.1371/journal.pone.0147231	http://dx.doi.org/10.1371/journal.pone.0147231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871437	gold, Green Published			2022-12-26	WOS:000370054100006
J	Monterroso, B; Reija, B; Jimenez, M; Zorrilla, S; Rivas, G				Monterroso, Begona; Reija, Belen; Jimenez, Mercedes; Zorrilla, Silvia; Rivas, German			Charged Molecules Modulate the Volume Exclusion Effects Exerted by Crowders on FtsZ Polymerization	PLOS ONE			English	Article							MACROMOLECULAR CROWDING AGENTS; STATIC LIGHT-SCATTERING; LINEAR SELF-ASSOCIATION; DIVISION PROTEIN FTSZ; QUANTITATIVE CHARACTERIZATION; SEDIMENTATION EQUILIBRIUM; ESCHERICHIA-COLI; STERIC EXCLUSION; DNA-REPLICATION; EGG-WHITE	We have studied the influence of protein crowders, either combined or individually, on the GTP-induced FtsZ cooperative assembly, crucial for the formation of the dynamic septal ring and, hence, for bacterial division. It was earlier demonstrated that high concentrations of inert polymers like Ficoll 70, used to mimic the crowded cellular interior, favor the assembly of FtsZ into bundles with slow depolymerization. We have found, by fluorescence anisotropy together with light scattering measurements, that the presence of protein crowders increases the tendency of FtsZ to polymerize at micromolar magnesium concentration, being the effect larger with ovomucoid, a negatively charged protein. Neutral polymers and a positively charged protein also diminished the critical concentration of assembly, the extent of the effect being compatible with that expected according to pure volume exclusion models. FtsZ polymerization was also observed to be strongly promoted by a negatively charged polymer, DNA, and by some unrelated polymers like PEGs at concentrations below the crowding regime. The influence of mixed crowders mimicking the heterogeneity of the intracellular environment on the tendency of FtsZ to assemble was also studied and nonadditive effects were found to prevail. Far from exactly reproducing the bacterial cytoplasm environment, this approach serves as a simplified model illustrating how its intrinsically crowded and heterogeneous nature may modulate FtsZ assembly into a functional Z-ring.	[Monterroso, Begona; Jimenez, Mercedes; Zorrilla, Silvia; Rivas, German] CSIC, Ctr Invest Biol, Madrid, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Monterroso, B; Zorrilla, S; Rivas, G (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.; Zorrilla, S (corresponding author), CSIC, Inst Quim Fis Rocasolano, Madrid, Spain.	monterroso@cib.csic.es; silvia@cib.csic.es; grivas@cib.csic.es	Rivas, German/AAG-7458-2022; Monterroso, Begoña/J-9748-2014; Rivas, German/AFL-7528-2022; Jimenez Sarmiento, Mercedes/K-2691-2014; Zorrilla, Silvia/J-9771-2014	Rivas, German/0000-0003-3450-7478; Monterroso, Begoña/0000-0003-2538-084X; Rivas, German/0000-0003-3450-7478; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903; Zorrilla, Silvia/0000-0002-6309-9058	Spanish government [BIO2011-28941-C03, BFU 2014-52070-C2-2-P]; European Commission [HEALTH-F3-2009-223432]; Human Frontiers Science Program [RGP0050/2010-C102]	Spanish government(Spanish GovernmentEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by Spanish government BIO2011-28941-C03 (GR and SZ) and BFU 2014-52070-C2-2-P (GR) (www.mineco.gob.es), European Commission HEALTH-F3-2009-223432 (GR) (http://ec.europa.eu/), and Human Frontiers Science Program RGP0050/2010-C102 (GR) (www.hfsp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahijado-Guzman R, 2013, J BIOL CHEM, V288, P27358, DOI 10.1074/jbc.M113.482943; Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425; BHAT R, 1992, PROTEIN SCI, V1, P1133, DOI 10.1002/pro.5560010907; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; DAVIS JG, 1971, BIOCHEMISTRY-US, V10, P39, DOI 10.1021/bi00777a006; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fan YQ, 2012, INT J BIOL MACROMOL, V51, P113, DOI 10.1016/j.ijbiomac.2012.04.014; Fernandez C, 2011, J PHYS CHEM B, V115, P1289, DOI 10.1021/jp110285b; Fernandez C, 2009, BIOPHYS J, V96, P1992, DOI 10.1016/j.bpj.2008.11.054; Fodeke AA, 2010, J PHYS CHEM B, V114, P10876, DOI 10.1021/jp104342f; Frederick KB, 2008, J MOL BIOL, V378, P540, DOI 10.1016/j.jmb.2008.02.022; FREDERICQ E, 1949, J BIOL CHEM, V181, P499; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Granath KA., 1958, J COLLOID SCI, V13, P308; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; KNOLL D, 1983, J BIOL CHEM, V258, P5710; Kornberg A, 2000, J BACTERIOL, V182, P3613, DOI 10.1128/JB.182.13.3613-3618.2000; LEE JC, 1981, J BIOL CHEM, V256, P7193; Liu YG, 2012, LANGMUIR, V28, P3831, DOI 10.1021/la204757z; Longsworth LG, 1940, J AM CHEM SOC, V62, P2580, DOI 10.1021/ja01867a002; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P6108, DOI 10.1021/bi300891q; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Phillip Y, 2013, FEBS LETT, V587, P1046, DOI 10.1016/j.febslet.2013.01.007; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Reddy MK, 1995, METHOD ENZYMOL, V262, P466; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Richards FM, 1971, ENZYMES; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Rivas German, 2013, Biophys Rev, V5, P63, DOI 10.1007/s12551-013-0115-1; ROSS PD, 1979, BIOCHEM BIOPH RES CO, V88, P1308, DOI 10.1016/0006-291X(79)91123-9; SUZUKI A, 1989, BIOCHEMISTRY-US, V28, P6513, DOI 10.1021/bi00441a052; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; TELLAM RL, 1983, BIOCHEM J, V213, P651, DOI 10.1042/bj2130651; UI N, 1971, BIOCHIM BIOPHYS ACTA, V229, P567; Weast R. C., 1984, HDB CHEM PHYS; Winzor DJ, 2006, BIOPHYS CHEM, V119, P186, DOI 10.1016/j.bpc.2005.08.001; Wu D, 2013, J PHYS CHEM B, V117, P111, DOI 10.1021/jp308880v; YI QM, 1985, GENE, V36, P241; Zhou BR, 2008, BBA-PROTEINS PROTEOM, V1784, P472, DOI 10.1016/j.bbapap.2008.01.004; Zhou HX, 2008, PROTEINS, V72, P1109, DOI 10.1002/prot.22111; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zorrilla S, 2004, BIOPHYS CHEM, V108, P89, DOI 10.1016/j.bpc.2003.10.012	47	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149060	10.1371/journal.pone.0149060	http://dx.doi.org/10.1371/journal.pone.0149060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870947	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100095
J	Asati, A; Kachurina, O; Karol, A; Dhir, V; Nguyen, M; Parkhill, R; Kouiavskaia, D; Chumakov, K; Warren, W; Kachurin, A				Asati, Atul; Kachurina, Olga; Karol, Alex; Dhir, Vipra; Nguyen, Michael; Parkhill, Robert; Kouiavskaia, Diana; Chumakov, Konstantin; Warren, William; Kachurin, Anatoly			Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced Antibodies	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; LINKED-IMMUNOSORBENT-ASSAY; FLOW-CYTOMETRY; IMMUNOFLUORESCENCE ASSAY; NEUTRALIZATION TEST; INFLUENZA-VIRUS; IGG ANTIBODIES; PROTEIN; ELISA; 17D	Neutralizing antibodies induced by vaccination or natural infection play a critically important role in protection against the viral diseases. In general, neutralization of the viral infection occurs via two major pathways: pre- and post-attachment modes, the first being the most important for such infections as influenza and polio, the latter being significant for filoviruses. Neutralizing capacity of antibodies is typically evaluated by virus neutralization assays that assess reduction of viral infectivity to the target cells in the presence of functional antibodies. Plaque reduction neutralization test, microneutralization and immunofluorescent assays are often used as gold standard virus neutralization assays. However, these methods are associated with several important prerequisites such as use of live virus requiring safety precautions, tedious evaluation procedure and long assessment time. Hence, there is a need for a robust, inexpensive high throughput functional assay that can be performed rapidly using inactivated virus, without extensive safety precautions. Herein, we report a novel high throughput Fluorescence Adherence Inhibition assay (fADI) using inactivated virus labeled with fluorescent secondary antibodies virus and Vero cells or erythrocytes as targets. It requires only few hours to assess pre-attachment neutralizing capacity of donor sera. fADI assay was tested successfully on donors immunized with polio, yellow fever and influenza vaccines. To further simplify and improve the throughput of the assay, we have developed a mathematical approach for calculating the 50% titers from a single sample dilution, without the need to analyze multi-point titration curves. Assessment of pre- and post-vaccination human sera from subjects immunized with IPOL (R), YF-VAX (R) and 2013-2014 Fluzone (R) vaccines demonstrated high efficiency of the assay. The results correlated very well with microneutralization assay performed independently by the FDA Center of Biologics Evaluation and Research, with plaque reduction neutralization test performed by Focus Diagnostics, and with hemaglutination inhibition assay performed in-house at Sanofi Pasteur. Taken together, fADI assay appears to be a useful high throughput functional immunoassay for assessment of antibody-related neutralization of the viral infections for which pre-attachment neutralization pathway is predominant, such as polio, influenza, yellow fever and dengue.	[Asati, Atul; Kachurina, Olga; Karol, Alex; Dhir, Vipra; Nguyen, Michael; Parkhill, Robert; Warren, William; Kachurin, Anatoly] Sanofi Pasteur VaxDesign Campus, 2501 Discovery Dr Suite 3000, Orlando, FL 32826 USA; [Kouiavskaia, Diana; Chumakov, Konstantin] US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Kachurin, A (corresponding author), Sanofi Pasteur VaxDesign Campus, 2501 Discovery Dr Suite 3000, Orlando, FL 32826 USA.	anatoly.kachurin@sanofipasteur.com			Defense Threat Reduction Agency (DTRA) [HDTRA1-13-C-00011]; Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services [HHSO100201000035C]; Sanofi Pasteur; CBER FDA	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services; Sanofi Pasteur; CBER FDA	This project has been funded in whole or in part with Federal funds from Defense Threat Reduction Agency (DTRA) and Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services, under Contract No. HDTRA1-13-C-00011 and HHSO100201000035C, respectively. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors Atul Asati, Olga Kachurina, Alex Karol, Vipra Dhir, Michael Nguyen, Robert Parkhill, William Warren and Anatoly Kachurin are employed by Sanofi Pasteur. The authors Diana Kouiavskaia and Konstantin Chumakov are employed by Center for Biologics Evaluation and Research within FDA (CBER FDA). Both Sanofi Pasteur and CBER FDA provided support in the form of salaries for authors AA, OK, A. Kachurin, VD, MN, RP, WW, A. Karol, DK, and KC respectively, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	[Anonymous], 1999, WHO M; BARRY M, 1991, AM J TROP MED HYG, V44, P79, DOI 10.4269/ajtmh.1991.44.79; Biacchesi S, 2005, J VIROL METHODS, V128, P192, DOI 10.1016/j.jviromet.2005.05.005; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; DEUBEL V, 1983, AM J TROP MED HYG, V32, P565, DOI 10.4269/ajtmh.1983.32.565; Devon J, 2010, VIROLOGY, V401, P228, DOI [10.1016/j.virol.2010.02.029, DOI 10.1016/J.VIROL.2010.02.029]; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; GROOT H, 1962, B WORLD HEALTH ORGAN, V27, P699; Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034; Kachurin A, 2014, Patent No. [US8778347 B2, 8778347B2]; Klingen Y, 2008, J VIROL, V82, P237, DOI 10.1128/JVI.01342-07; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Kremser L, 2004, ANAL CHEM, V76, P7360, DOI 10.1021/ac048999m; Lonsdale R, 2003, J VIROL METHODS, V110, P67, DOI 10.1016/S0166-0934(03)00102-2; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; NICHOLS JE, 1993, ARCH VIROL, V130, P441, DOI 10.1007/BF01309672; Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x; Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07; Plotkin S, 2008, VACCINES, P959; Roberson S, 1993, IMMUNOLOGICAL BASIS; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sliva K, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-14; Vazquez S, 2003, J VIROL METHODS, V110, P179, DOI 10.1016/S0166-0934(03)00128-9; Wang Z, 2004, J VIROL METHODS, V120, P207, DOI 10.1016/j.jviromet.2004.05.010; World Health Organization, 2007, GUID PLAQ RED NEUTR; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization (WHO), 1997, MAN VIR INV POL; You JO, 2006, INT J NANOMED, V1, P59, DOI 10.2147/nano.2006.1.1.59	29	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0144261	10.1371/journal.pone.0144261	http://dx.doi.org/10.1371/journal.pone.0144261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863313	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600003
J	Chomczynski, P; Wilfinger, WW; Eghbalnia, HR; Kennedy, A; Rymaszewski, M; Mackey, K				Chomczynski, Piotr; Wilfinger, William W.; Eghbalnia, Hamid R.; Kennedy, Amy; Rymaszewski, Michal; Mackey, Karol			Inter-Individual Differences in RNA Levels in Human Peripheral Blood	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; RIBOSOMAL-RNA; WHOLE-BLOOD; HOUSEKEEPING GENES; CELLS; STABILIZATION; VALIDATION	Relatively little is known about the range of RNA levels in human blood. This report provides assessment of peripheral blood RNA level and its inter-individual differences in a group of 35 healthy humans consisting of 25 females and 10 males ranging in age from 50 to 89 years. In this group, the average total RNA level was 14.59 mu g/ml of blood, with no statistically significant difference between females and males. The individual RNA level ranged from 6.7 to 22.7 mu g/ml of blood. In healthy subjects, the repeated sampling of an individual's blood showed that RNA level, whether high or low, was stable. The inter-individual differences in RNA level in blood can be attributed to both, differences in cell number and the amount of RNA per cell. The 3.4-fold range of inter-individual differences in total RNA levels, documented herein, should be taken into account when evaluating the results of quantitative RT-PCR and/or RNA sequencing studies of human blood. Based on the presented results, a comprehensive assessment of gene expression in blood should involve determination of both the amount of mRNA per unit of total RNA (U /ng RNA) and the amount of mRNA per unit of blood (U / ml blood) to assure a thorough interpretation of physiological or pathological relevance of study results.	[Chomczynski, Piotr; Wilfinger, William W.; Kennedy, Amy; Rymaszewski, Michal; Mackey, Karol] Mol Res Ctr Inc, Cincinnati, OH USA; [Eghbalnia, Hamid R.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati	Chomczynski, P (corresponding author), Mol Res Ctr Inc, Cincinnati, OH USA.	piotr@mrcgene.com		Wilfinger, William/0000-0002-7891-2232	Molecular research Center, Inc.	Molecular research Center, Inc.	This study was funded by Molecular research Center, Inc. All authors, except HE, are employees of Molecular Research center, Inc. and performed the following roles in the study: PCh, WWW, KM, study design, data collection and analysis, decision to publish, preparation of the manuscript. AK, MR, data collection and analysis. HE, statistical analysis and manuscript preparation.	Anderson R, 2008, QUANTITATIVE APPL SO, V152, P1; [Anonymous], 2014, TECHNICAL NOTE ANAL, P3; Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Bowyer JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133315; Chomczynski P, 2013, NAT METHODS, V10, pan1; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Hantzsch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113298; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Hiebeler D, 2014, MATLAB R REFERENCE; Kabanova S, 2009, INT J MED SCI, V6, P156; Mesko B, 2011, TRENDS MOL MED, V17, P223, DOI 10.1016/j.molmed.2010.12.004; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mostafavi S, 2014, MOL PSYCHIATR, V19, P1267, DOI 10.1038/mp.2013.161; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; O'Neil Dominic, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0419s103; Pahl A, 2002, CLIN CHEM, V48, P2251; Rainen L, 2002, CLIN CHEM, V48, P1883; Raval A, 2012, BLOOD, V120, P4812, DOI 10.1182/blood-2012-04-423111; Rouchka EC, 2013, OA BIOINFORMATICS, V1, P3; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Shin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091041; Stamova BS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-49; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; TRUDNOWSKI RJ, 1974, CLIN CHEM, V20, P615; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; Wang J, 2004, CLIN BIOCHEM, V37, P741, DOI 10.1016/j.clinbiochem.2004.03.013; Wehrens R, 1997, J CHEMOMETR, V11, P157, DOI 10.1002/(SICI)1099-128X(199703)11:2<157::AID-CEM471>3.0.CO;2-J; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020	33	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148260	10.1371/journal.pone.0148260	http://dx.doi.org/10.1371/journal.pone.0148260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863434	Green Submitted, gold, Green Published			2022-12-26	WOS:000370046600049
J	Fried, S; Tosun, S; Troost, G; Keil, S; Zaenker, KS; Dittmar, T				Fried, Sabrina; Tosun, Songuel; Troost, Gabriele; Keil, Silvia; Zaenker, Kurt S.; Dittmar, Thomas			Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial x Breast Cancer Hybrids, but Not in Parental Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MESENCHYMAL STEM-CELLS; NF-KAPPA-B; SPONTANEOUS FUSION; TUMOR-GROWTH; PROGRESSION; CHEMORESISTANCE; PROLIFERATION; GLIOBLASTOMA; NECROPTOSIS	Toll-like receptors (TLRs) belong to the group of pathogen recognition receptors known to play a crucial role in the innate immune system. In cancer, TLR expression is still debated controversially due to contradictory results reporting that both induction of apoptosis as well as tumor progression could depend on TLR signaling, whereby recent data rather indicate a pro-tumorigenic effect. The biological phenomenon of cell fusion has been associated with cancer progression due to findings revealing that fusion-derived hybrid cells could exhibit properties like an increased metastatogenic capacity and an increased drug resistance. Thus, M13MDA435 hybrid cell lines, which derived from spontaneous fusion events between human M13SV1-EGFP-Neo breast epithelial cells and human MDA-MB-435-Hyg breast cancer cells, were investigated. Cultivation of cells in the presence of the TLR4 ligand LPS potently induced apoptosis in all hybrid clones, but not in parental cells, which was most likely attributed to differential kinetics of the TLR4 signal transduction cascade. Activation of this pathway concomitant with NF-kappa B nuclear translocation and TNF-alpha expression was solely observed in hybrid cells. However, induction of LPS mediated apoptosis was not TNF-alpha dependent since TNF-alpha neutralization was not correlated to a decreased amount of dead cells. In addition to TNF-alpha, LPS also caused IFN-beta expression in hybrid clones 1 and 3. Interestingly, hybrid clones differ in the mode of LPS induced apoptosis. While neutralization of IFN-beta was sufficient to impair the LPS induced apoptosis in M13MDA435-1 and -3 hybrids, the amount of apoptotic M13MDA435-2 and -4 hybrid cells remained unchanged in the presence of neutralizing IFN-beta antibodies. In summary, the fusion of non-LPS susceptible parental human breast epithelial cells and human breast cancer cells gave rise to LPS susceptible hybrid cells, which is in view with the cell fusion hypothesis that hybrid cells could exhibit novel properties.	[Fried, Sabrina; Tosun, Songuel; Troost, Gabriele; Keil, Silvia; Zaenker, Kurt S.; Dittmar, Thomas] Univ Witten Herdecke, Inst Immunol & Expt Oncol, Ctr Biomed Educ & Res, Stockumer Str 10, Witten, Germany	Witten Herdecke University	Dittmar, T (corresponding author), Univ Witten Herdecke, Inst Immunol & Expt Oncol, Ctr Biomed Educ & Res, Stockumer Str 10, Witten, Germany.	thomas.dittmar@uni-wh.de	Dittmar, Thomas/X-3691-2019; Dittmar, Thomas/T-6679-2019		Fritz-Bender Foundation, Munich, Germany; Witten/Herdecke University	Fritz-Bender Foundation, Munich, Germany; Witten/Herdecke University	SF, ST, SK, GT and TD were supported by the Fritz-Bender Foundation, Munich, Germany. ST was supported by an Internal Grant of Witten/Herdecke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22945; Berndt B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063711; Berndt Benjamin, 2013, Critical Reviews in Oncogenesis, V18, P97; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Carloni V, 2013, ONCOGENE, V32, P2649, DOI 10.1038/onc.2012.268; Carpentier A, 2010, NEURO-ONCOLOGY, V12, P401, DOI 10.1093/neuonc/nop047; Chang CC, 2001, RADIAT RES, V155, P201, DOI 10.1667/0033-7587(2001)155[0201:AHBECT]2.0.CO;2; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Chen Q, 2001, BLOOD, V98, P2183, DOI 10.1182/blood.V98.7.2183; Chicoine MR, 2007, NEUROSURGERY, V60, P372, DOI 10.1227/01.NEU.0000249280.61761.2E; Dittmar T, 2000, ANTISENSE NUCLEIC A, V10, P401, DOI 10.1089/oli.1.2000.10.401; Dittmar T, 2013, CURR MOL MED, V13, P735, DOI 10.2174/1566524011313050005; Dittmar T, 2011, CELL FUSION HLTH DIS, P950; Dittmar T, 2015, INT J MOL SCI, V16, P30362, DOI 10.3390/ijms161226240; Dittmar T, 2011, CLIN EXP METASTAS, V28, P75, DOI 10.1007/s10585-010-9359-3; Dittmar T, 2009, MED HYPOTHESES, V73, P542, DOI 10.1016/j.mehy.2009.05.044; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; He XH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1027-1; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Islam MQ, 2006, STEM CELLS DEV, V15, P905, DOI 10.1089/scd.2006.15.905; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martin-Padura I, 2012, NEOPLASIA, V14, P1057, DOI 10.1593/neo.12736; Matijevic T, 2010, CURR PHARM DESIGN, V16, P1081, DOI 10.2174/138161210790963779; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; MILLER FR, 1989, CANCER RES, V49, P4316; MILLER FR, 1988, J CELL BIOCHEM, V36, P129, DOI 10.1002/jcb.240360204; Mohr M, 2015, METHODS MOL BIOL, P21, DOI 10.1007/978-1-4939-2703-6_2; Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860; Nagler C, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-21; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Neff SB, 2006, AM J PHYSIOL-LUNG C, V290, pL86, DOI 10.1152/ajplung.00391.2004; Ozel C, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-10; Otto F, 1996, EUR J CANCER, V32A, P1712, DOI 10.1016/0959-8049(96)00186-4; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ramakrishnan M, 2013, CANC RES; Razack AHA, 2007, ASIAN J SURG, V30, P302, DOI 10.1016/S1015-9584(08)60045-7; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834; Wang RF, 2008, ONCOGENE, V27, P181, DOI 10.1038/sj.onc.1210906; Xaus J, 2000, BLOOD, V95, P3823; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109980; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Zhou XF, 2015, AM J PATHOL, V185, P2049, DOI 10.1016/j.ajpath.2015.03.014	57	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148438	10.1371/journal.pone.0148438	http://dx.doi.org/10.1371/journal.pone.0148438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863029	gold, Green Published			2022-12-26	WOS:000370046600072
J	Fujimoto, Y; Urashima, T; Shimura, D; Ito, R; Kawachi, S; Kajimura, I; Akaike, T; Kusakari, Y; Fujiwara, M; Ogawa, K; Goda, N; Ida, H; Minamisawa, S				Fujimoto, Yoshitaka; Urashima, Takashi; Shimura, Daisuke; Ito, Reiji; Kawachi, Sadataka; Kajimura, Ichige; Akaike, Toru; Kusakari, Yoichiro; Fujiwara, Masako; Ogawa, Kiyoshi; Goda, Nobuhito; Ida, Hiroyuki; Minamisawa, Susumu			Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats	PLOS ONE			English	Article							LIVER; INDUCTION; HYPOXIA; DISEASE	Background Hepatic fibrosis progresses with right heart failure, and becomes cardiac cirrhosis in a severe case. Although its causal factor still remains unclear. Here we evaluated the progression of hepatic fibrosis using a pulmonary artery banding (PAB)-induced right heart failure model and investigated whether cardiac output (CO) is responsible for the progression of hepatic fibrosis. Methods and Results Five-week-old Sprague-Dawley rats divided into the PAB and sham-operated control groups. After 4 weeks from operation, we measured CO by echocardiography, and hepatic fibrosis ratio by pathological examination using a color analyzer. In the PAB group, CO was significantly lower by 48% than that in the control group (78.2 +/- 27.6 and 150.1 +/- 31.2 ml/min, P<0.01). Hepatic fibrosis ratio and serum hyaluronic acid, an index of hepatic fibrosis, were significantly increased in the PAB group than those in the control group (7.8 +/- 1.7 and 1.0 +/- 0.2%, P<0.01, 76.2 +/- 27.5 and 32.7 +/- 7.5 ng/ml, P<0.01). Notably, the degree of hepatic fibrosis significantly correlated a decrease in CO. Immunohistological analysis revealed that hepatic stellate cells were markedly activated in hypoxic areas, and HIF-1 alpha positive hepatic cells were increased in the PAB group. Furthermore, by real-time PCR analyses, transcripts of profibrotic and fibrotic factors (TGF-beta 1, CTGF, procollargen I, procollargen III, MMP 2, MMP 9, TIMP 1, TIMP 2) were significantly increased in the PAB group. In addition, western blot analyses revealed that the protein level of HIF-1 alpha was significantly increased in the PAB group than that in the control group (2.31 +/- 0.84 and 1.0 +/- 0.18 arbitrary units, P<0.05). Conclusions Our study demonstrated that low CO and tissue hypoxia were responsible for hepatic fibrosis in right failure heart model rats.	[Fujimoto, Yoshitaka; Shimura, Daisuke; Kajimura, Ichige; Akaike, Toru; Kusakari, Yoichiro; Minamisawa, Susumu] Jikei Univ, Sch Med, Dept Cell Physiol, Tokyo, Japan; [Fujimoto, Yoshitaka; Urashima, Takashi; Ito, Reiji; Fujiwara, Masako; Ida, Hiroyuki] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Kawachi, Sadataka; Ogawa, Kiyoshi] Saitama Childrens Med Ctr, Div Cardiol, Saitama, Japan; [Goda, Nobuhito] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan	Jikei University; Jikei University; Saitama Children's Medical Center; Waseda University	Urashima, T (corresponding author), Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan.	urashima-t@jikei.ac.jp	Shimura, Daisuke/ABB-8456-2021; Goda, Nobuhito/W-2468-2019; Shimura, Daisuke/ABA-3516-2021	Shimura, Daisuke/0000-0002-9954-2162; Minamisawa, Susumu/0000-0003-4728-2116; Goda, Nobuhito/0000-0003-0295-4257; Ito, Reiji/0000-0003-3016-8106	Grants-in-Aid for Scientific Research [13J05481] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abdellatif M.S, 2015, OPEN MICROBIOL J, V9, P136; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422; Asrani SK, 2012, HEPATOLOGY, V56, P1160, DOI 10.1002/hep.25692; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Camposilvan S, 2008, ANN THORAC SURG, V86, P177, DOI 10.1016/j.athoracsur.2008.03.077; Dai DF, 2014, MODERN PATHOL, V27, P1552, DOI 10.1038/modpathol.2014.79; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Hao CQ, 2014, CLIN EXP MED, V14, P141, DOI 10.1007/s10238-013-0229-6; Khan JA, 2007, JCPSP-J COLL PHYSICI, V17, P323; Kietzmann T, 1999, BLOOD, V94, P4177, DOI 10.1182/blood.V94.12.4177.424k14_4177_4185; Lambrecht J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00209; Leach RM, 2002, THORAX, V57, P170, DOI 10.1136/thorax.57.2.170; Lindsay I, 2015, AM J CARDIOL, V115, P249, DOI 10.1016/j.amjcard.2014.10.032; McCabe N, 2013, CONGENIT HEART DIS, V8, pE139, DOI 10.1111/j.1747-0803.2012.00700.x; Megalla S, 2011, MED SCI MONITOR, V17, pCR537, DOI 10.12659/MSM.881977; MILLER MJ, 1986, CIRCULATION, V73, P799, DOI 10.1161/01.CIR.73.4.799; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Myers RP, 2003, HEPATOLOGY, V37, P393, DOI 10.1053/jhep.2003.50062; Poelzl Gerhard, 2015, Curr Heart Fail Rep, V12, P68, DOI 10.1007/s11897-014-0238-0; Richter S, 2000, AM J PHYSIOL-GASTR L, V279, pG454, DOI 10.1152/ajpgi.2000.279.2.G454; Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; SHERLOCK S, 1951, BRIT HEART J, V13, P273; Shimura D, 2013, AM J PHYSIOL-HEART C, V305, pH494, DOI 10.1152/ajpheart.00867.2012; Simonetto DA, 2015, HEPATOLOGY, V61, P648, DOI 10.1002/hep.27387; Takeda Y, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-22; Wang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074051; Yoshida D, 2006, J NEURO-ONCOL, V76, P13, DOI 10.1007/s11060-005-3279-0; Zhan L, 2015, BIOCHIMIE, V108, P1, DOI 10.1016/j.biochi.2014.10.013	30	16	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148666	10.1371/journal.pone.0148666	http://dx.doi.org/10.1371/journal.pone.0148666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863419	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600094
J	Jiang, T; Qiao, H; Zheng, ZJ; Chu, QL; Li, X; Yong, Q; Ouyang, J				Jiang, Ting; Qiao, Hui; Zheng, Zhaojuan; Chu, Qiulu; Li, Xin; Yong, Qiang; Ouyang, Jia			Lactic Acid Production from Pretreated Hydrolysates of Corn Stover by a Newly Developed Bacillus coagulans Strain	PLOS ONE			English	Article							FUEL ETHANOL-PRODUCTION; BIOMASS-DERIVED XYLOSE; SACCHAROMYCES-CEREVISIAE; PICHIA-STIPITIS; LIGNOCELLULOSIC BIOMASS; ZYMOMONAS-MOBILIS; ESCHERICHIA-COLI; WHEAT-STRAW; INHIBITORS; FERMENTATION	An inhibitor-tolerance strain, Bacillus coagulans GKN316, was developed through atmospheric and room temperature plasma (ARTP) mutation and evolution experiment in condensed dilute-acid hydrolysate (CDH) of corn stover. The fermentabilities of other hydrolysates with B. coagulans GKN316 and the parental strain B. coagulans NL01 were assessed. When using condensed acid-catalyzed steam-exploded hydrolysate (CASEH), condensed acid-catalyzed liquid hot water hydrolysate (CALH) and condensed acid-catalyzed sulfite hydrolysate (CASH) as substrates, the concentration of lactic acid reached 45.39, 16.83, and 18.71 g/L by B. coagulans GKN316, respectively. But for B. coagulans NL01, only CASEH could be directly fermented to produce 15.47 g/L lactic acid. The individual inhibitory effect of furfural, 5-hydroxymethylfurfural (HMF), vanillin, syringaldehyde and p-hydroxybenzaldehyde (pHBal) on xylose utilization by B. coagulans GKN316 was also studied. The strain B. coagulans GKN316 could effectively convert these toxic inhibitors to the less toxic corresponding alcohols in situ. These results suggested that B. coagulans GKN316 was well suited to production of lactic acid from undetoxified lignocellulosic hydrolysates.	[Jiang, Ting; Qiao, Hui; Zheng, Zhaojuan; Chu, Qiulu; Li, Xin; Ouyang, Jia] Nanjing Forestry Univ, Coll Chem Engn, Nanjing 210037, Jiangsu, Peoples R China; [Yong, Qiang; Ouyang, Jia] Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing 210037, Jiangsu, Peoples R China	Nanjing Forestry University; Nanjing Forestry University	Ouyang, J (corresponding author), Nanjing Forestry Univ, Coll Chem Engn, Nanjing 210037, Jiangsu, Peoples R China.; Ouyang, J (corresponding author), Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing 210037, Jiangsu, Peoples R China.	hgouyj@njfu.edu.cn		Chu, Qiulu/0000-0003-4782-8668	National Natural Science Foundation of China [51561145015, 31200443]; Excellent Youth Foundation of Jiangsu Province of China [BK2012038]; Doctorate Fellowship Foundation of Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Jiangsu Province of China; Doctorate Fellowship Foundation of Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the National Natural Science Foundation of China (51561145015, 31200443), Excellent Youth Foundation of Jiangsu Province of China (BK2012038), and the Doctorate Fellowship Foundation of Nanjing Forestry University. The authors are also grateful to the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) for partial funding of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Baral NR, 2014, APPL MICROBIOL BIOT, V98, P9151, DOI 10.1007/s00253-014-6106-8; Bellido C, 2011, BIORESOURCE TECHNOL, V102, P10868, DOI 10.1016/j.biortech.2011.08.128; Bischoff KM, 2010, BIOTECHNOL LETT, V32, P823, DOI 10.1007/s10529-010-0222-z; Cardona CA, 2007, BIORESOURCE TECHNOL, V98, P2415, DOI 10.1016/j.biortech.2007.01.002; Chandel AK, 2013, BIOENERG RES, V6, P388, DOI 10.1007/s12155-012-9241-z; Chang Q, 2007, BBA-MOL CELL RES, V1773, P321, DOI 10.1016/j.bbamcr.2006.10.009; Delgenes JP, 1996, ENZYME MICROB TECH, V19, P220, DOI 10.1016/0141-0229(95)00237-5; Franden MA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-99; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Guo T, 2013, BIORESOURCE TECHNOL, V135, P379, DOI 10.1016/j.biortech.2012.08.029; Heer D, 2008, MICROB BIOTECHNOL, V1, P497, DOI 10.1111/j.1751-7915.2008.00050.x; Jiang M, 2014, J IND MICROBIOL BIOT, V41, P115, DOI 10.1007/s10295-013-1346-7; Jiang T, 2014, PROTEIN EXPRES PURIF, V95, P219, DOI 10.1016/j.pep.2013.12.014; Jonsson LJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-16; Klinke HB, 2003, BIOTECHNOL BIOENG, V81, P738, DOI 10.1002/bit.10523; Koppram R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-32; Larsson S, 2000, 21 S BIOT FUELS CHEM; Li XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095455; Limayem A, 2012, PROG ENERG COMBUST, V38, P449, DOI 10.1016/j.pecs.2012.03.002; Liu ZL, 2005, 26 S BIOT FUELS CHEM; Mussatto SI, 2004, BIORESOURCE TECHNOL, V93, P1, DOI 10.1016/j.biortech.2003.10.005; Oh H, 2005, BIORESOURCE TECHNOL, V96, P1492, DOI 10.1016/j.biortech.2004.11.020; Ou MS, 2011, J IND MICROBIOL BIOT, V38, P599, DOI 10.1007/s10295-010-0796-4; Ouyang J, 2013, BIORESOURCE TECHNOL, V135, P475, DOI 10.1016/j.biortech.2012.09.096; Ouyang J, 2012, APPL BIOCHEM BIOTECH, V168, P2387, DOI 10.1007/s12010-012-9944-9; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Parawira W, 2011, CRIT REV BIOTECHNOL, V31, P20, DOI 10.3109/07388551003757816; Parreiras LS, 2014, ENG 2 STAGE EVOLUTIO; Persson P, 2002, BIOTECHNOL BIOENG, V79, P694, DOI 10.1002/bit.10324; Petersson A, 2006, YEAST, V23, P455, DOI 10.1002/yea.1370; Taherzadeh MJ, 2011, BIOMASS BIOF BIOCHEM, P287; Ye LD, 2013, BIORESOURCE TECHNOL, V132, P38, DOI 10.1016/j.biortech.2013.01.011; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624; Zhang Y, 2012, NEW BIOTECHNOL, V29, P345, DOI 10.1016/j.nbt.2011.09.001; Zheng ZJ, 2014, APPL BIOCHEM BIOTECH, V173, P1896, DOI 10.1007/s12010-014-0975-2; Zhu JJ, 2014, BIOPROC BIOSYST ENG, V37, P2215, DOI 10.1007/s00449-014-1199-0	38	34	36	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149101	10.1371/journal.pone.0149101	http://dx.doi.org/10.1371/journal.pone.0149101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863012	Green Submitted, gold, Green Published			2022-12-26	WOS:000370046600153
J	Dua, TK; Dewanjee, S; Khanra, R; Joardar, S; Barma, S; Das, S; Zia-Ul-Haq, M; De Feo, V				Dua, Tarun K.; Dewanjee, Saikat; Khanra, Ritu; Joardar, Swarnalata; Barma, Sujata; Das, Shilpa; Zia-Ul-Haq, M.; De Feo, Vincenzo			Cytoprotective and Antioxidant Effects of an Edible Herb, Enhydra fluctuans Lour. (Asteraceae), against Experimentally Induced Lead Acetate Intoxication	PLOS ONE			English	Article							OXYGEN SPECIES ROS; OXIDATIVE STRESS; APOPTOSIS; CADMIUM; INVOLVEMENT; IMAGE; ACID; QUANTIFICATION; INJURY	Background Enhydra fluctuans Lour. (Asteraceae), an edible aquatic herb, is traditionally employed against toxic effects of heavy metals in India. The present study was planned to discover the protective effect of edible extract of E. fluctuans (AEEF) against Pb toxicity. Methods The cytoprotective role of AEEF was determined on murine hepatocytes employing MTT assay and Hoechst staining. The effects on lipid peroxidation, protein carbonylation, endogenous redox systems and the transcription levels of apoptotic proteins were studied after incubating the hepatocytes with AEEF (400 mu g/ml) + Pb-acetate (6.8 mu M). The defensive role of AEEF (100 mg/kg) against Pb-acetate (5 mg/kg) intoxication was measured in mice by in vivo assays. Biochemical, haematological and histological parameters, intracellular Pb burden and redox status were measured. Results AEEF exhibited a concentration dependent cytoprotective effect against Pb-induced cytotoxicity in vitro. Pb-acetate incubation significantly (p < 0.01) altered the extents of ROS production up arrow, protein carbonylation up arrow, lipid peroxidation up arrow, endogenous antioxidant enzymes down arrow and GSH down arrow in vitro. Besides, Pb-acetate significantly (p < 0.01) induced apoptosis in the hepatocytes apparent from the altered expressions of apoptotic proteins viz. Apaf-1 up arrow, Bad up arrow, Bcl-2 down arrow, Cyt C up arrow, cleaved caspases up arrow, Bid up arrow and Fas up arrow. However, AEEF (400 mu g/ml) could significantly (p < 0.05-0.01) attenuate the Pb-acetate mediated toxic manifestation in vitro. In in vivo assay, Pb-acetate (5 mg/kg) treated mice exhibited significantly (p < 0.01) high intracellular Pb content. A high Pb-burden within the tissues caused significant (p < 0.05-0.01) patho-physiological alterations viz. ROS production up arrow, protein carbonylation up arrow, lipid peroxidation up arrow, DNA fragmentation up arrow, ATPformation up arrow, mitochondrial co-enzymes Q down arrow, endogenous antioxidant enzymes down arrow and GSH down arrow within the selected tissues. The haematological and serum biochemical parameters were significantly (p < 0.05-0.01) different in the Pb-acetate treated mice. Finally, histological assessment imposed significant toxic occurrence within the organs of Pb-intoxicated animals. However, concurrent administration of AEEF (100 mg/kg) could significantly (p < 0.05-0.01) reinstate the Pb-acetate mediated toxicity. Conclusion Presence of metal chelators and phyto-antioxidants within AEEF would offer overall protection through promoting Pb clearance coupled with restoring redox balance.	[Dua, Tarun K.; Dewanjee, Saikat; Khanra, Ritu; Joardar, Swarnalata; Barma, Sujata; Das, Shilpa] Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata 700032, India; [Zia-Ul-Haq, M.] Patent Off, Karchi 75400, Pakistan; [De Feo, Vincenzo] Univ Salerno, Dept Pharm, I-84084 Salerno, Italy	Jadavpur University; University of Salerno	Dewanjee, S (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata 700032, India.; De Feo, V (corresponding author), Univ Salerno, Dept Pharm, I-84084 Salerno, Italy.	s.dewanjee@yahoo.com; defeo@unisa.it	Dewanjee, Saikat/U-9778-2017; De Feo, Vincenzo/AAF-2293-2019; KHANRA, RITU/AAV-4351-2021; Dua, Tarun Kumar/AAM-4891-2020	De Feo, Vincenzo/0000-0002-1070-3207; Dua, Tarun Kumar/0000-0001-5136-7564; Dewanjee, Saikat/0000-0001-9085-4226	Council for Scientific and Industrial Research (CSIR), New Delhi, India [09/096(773)/2013-EMR-I]	Council for Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	The financial support of the Council for Scientific and Industrial Research (CSIR), New Delhi, India is gratefully acknowledged through Senior Research Fellowship to Mr. Tarun K. Dua [Council for Scientific and Industrial Research-senior research fellowship Ref. No.: 09/096(773)/2013-EMR-I dated 15th March, 2013].; The financial support of the Council for Scientific and Industrial Research (CSIR), New Delhi, India is gratefully acknowledged through Senior Research Fellowship to Mr. Tarun K. Dua [Council for Scientific and Industrial Research-senior research fellowship Ref. No.: 09/096(773)/2013-EMR-I dated 15th March, 2013]. Authors are thankful to Jadavpur University, Kolkata, India for providing necessary facilities for this study. All authors are thankful to Prof. Biswajit Mukherjee, Department of Pharmaceutical Technology, Jadavpur University for his kind help for histological studies. Finally, the authors would like to say thanks to the reviewers for their time and valuable comments to improve the quality of this manuscript.	Ahmad RS, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0436-x; ALI E, 1972, TETRAHEDRON, V28, P2285, DOI 10.1016/S0040-4020(01)93572-0; Bolner A, 2011, CLIN LAB, V57, P859; Chander K, 2014, FOOD CHEM TOXICOL, V68, P297, DOI 10.1016/j.fct.2014.02.012; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Das AK, 2010, FOOD CHEM TOXICOL, V48, P1210, DOI 10.1016/j.fct.2010.02.012; Das AK, 2010, FOOD CHEM TOXICOL, V48, P326, DOI 10.1016/j.fct.2009.10.020; Das AK, 2010, ENVIRON TOXICOL PHAR, V29, P64, DOI 10.1016/j.etap.2009.10.002; DEFIGUEIREDO RJP, 1995, NEUROBIOL AGING, V16, P211, DOI 10.1016/0197-4580(94)00151-0; Dewanjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139831; Dewanjee S, 2014, ENZYME MICROB TECH, V66, P1, DOI 10.1016/j.enzmictec.2014.07.006; Dewanjee S, 2013, FOOD CHEM TOXICOL, V60, P188, DOI 10.1016/j.fct.2013.07.043; Dewanjee S, 2013, FOOD CHEM TOXICOL, V55, P78, DOI 10.1016/j.fct.2012.12.040; Dewanjee S, 2009, FOOD CHEM TOXICOL, V47, P2679, DOI 10.1016/j.fct.2009.07.038; Dua TK, 2016, REDOX REP, V21, P147, DOI 10.1179/1351000215Y.0000000021; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0598-6; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0430-3; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Gurer H, 2000, FREE RADICAL BIO MED, V29, P927, DOI 10.1016/S0891-5849(00)00413-5; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hong KJ, 2000, CHEMOSPHERE, V41, P345, DOI 10.1016/S0045-6535(99)00489-0; Hsu PC, 2002, TOXICOLOGY, V180, P33, DOI 10.1016/S0300-483X(02)00380-3; Jackie Tan, 2011, BMC Res Notes, V4, P67, DOI 10.1186/1756-0500-4-67; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Khanra R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0364-1; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; Kuri Sourov, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P299, DOI 10.12980/APJTB.4.2014C677; LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O; Lin KT, 1997, BIOCHEM BIOPH RES CO, V230, P115, DOI 10.1006/bbrc.1996.5897; Mansoor TA, 2013, J ETHNOPHARMACOL, V149, P463, DOI 10.1016/j.jep.2013.06.051; Matovic V, 2015, FOOD CHEM TOXICOL, V78, P130, DOI [10.1016/j.fct.2015.02.011, 10.1016/jict.2015.02.011]; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pal S, 2011, TOXICOLOGY, V283, P129, DOI 10.1016/j.tox.2011.03.006; PHS (Public Health Service), 1986, PUBL HLTH SERV POL H; Rahman MT, 2002, FITOTERAPIA, V73, P707, DOI 10.1016/S0367-326X(02)00212-5; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Ruegg MA, 2014, HISTOPATHOLOGY HEMAT; Saeed K, 2015, J PAK MED ASSOC, V65, P43; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sultan MT, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0853-7; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Wu DD, 2015, MED GAS RES, V5, DOI 10.1186/s13618-014-0022-y; ZHANG YY, 1995, J NUTR, V125, P446	47	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148757	10.1371/journal.pone.0148757	http://dx.doi.org/10.1371/journal.pone.0148757			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859407	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400076
J	Gaetano, J; van der Zwan, R; Oxner, M; Hayward, WG; Doring, N; Blair, D; Brooks, A				Gaetano, Justin; van der Zwan, Rick; Oxner, Matthew; Hayward, William G.; Doring, Natalie; Blair, Duncan; Brooks, Anna			Converging Evidence of Ubiquitous Male Bias in Human Sex Perception	PLOS ONE			English	Article							OWN-RACE BIAS; GENDER; FACES; CATEGORIZATION; RECOGNITION; CUES	Visually judging the sex of another can be achieved easily in most social encounters. When the signals that inform such judgements are weak (e.g. outdoors at night), observers tend to expect the presence of males-an expectation that may facilitate survival-critical decisions under uncertainty. The present aim was to examine whether this male bias depends on expertise. To that end, Caucasian and Asian observers targeted female and male hand images that were either the same or different to the observers' race (i.e. long term experience was varied) while concurrently, the proportion of targets changed across presentation blocks (i.e. short term experience change). It was thus found that: (i) observers of own-race stimuli were more likely to report the presence of males and absence of females, however (ii) observers of other-race stimuli-while still tending to accept stimuli as male-were not prone to rejecting female cues. Finally, (iii) male-biased measures did not track the relative frequency of targets or lures, disputing the notion that male bias derives from prior expectation about the number of male exemplars in a set. Findings are discussed in concert with the pan-stimulus model of human sex perception.	[Gaetano, Justin; van der Zwan, Rick; Doring, Natalie; Blair, Duncan; Brooks, Anna] So Cross Univ, Cognit Neurosci Res Cluster, Coffs Harbour, Australia; [Oxner, Matthew; Hayward, William G.] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Oxner, Matthew; Hayward, William G.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand	Southern Cross University; University of Hong Kong; University of Auckland	Gaetano, J (corresponding author), So Cross Univ, Cognit Neurosci Res Cluster, Coffs Harbour, Australia.	justin.gaetano@scu.edu.au	; Gaetano, Justin/E-9469-2012	Oxner, Matt/0000-0002-4419-6020; Gaetano, Justin/0000-0002-4200-163X; Doring, Natalie/0000-0001-5648-0160; Hayward, William/0000-0002-7248-0301				Barzut V, 2013, PSIHOLOGIJA, V46, P45, DOI 10.2298/PSI1301045B; Bird K. D., 2004, ANAL VARIANCE VIA CO; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bramwell S, 2014, PSYCHOPHYSIOLOGY, V51, P152, DOI 10.1111/psyp.12155; Brielmann AA, 2014, J VIS; Brielmann AA, 2014, VISION RES, V100, P105, DOI 10.1016/j.visres.2014.04.011; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Central Intelligence Agency, 2014, WORLD FACT BOOK; Chatterjee G, 2012, COGN NEUROPSYCHOL, V29, P482, DOI 10.1080/02643294.2012.756809; Chiroro PM, 2008, PSYCHON B REV, V15, P1089, DOI 10.3758/PBR.15.6.1089; Clifford CWG, CONSCIOUS C IN PRESS; Dahl CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep06654; Davidenko N, 2007, J VISION, V7, DOI 10.1167/7.4.6; DeGutis J, 2012, VIS COGN, V20, P1242, DOI 10.1080/13506285.2012.744788; Fitzgerald SA, 2014, I-PERCEPTION, V5, P120, DOI 10.1068/i0612; Freeman JB, 2011, PSYCHOL REV, V118, P247, DOI 10.1037/a0022327; Fu GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037688; Gaetano JM, 2012, CURRENT TRENDS EXPT, V1, P105; Gaetano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091032; Geniole SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030366; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; Golkar A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00123; Hacker Graeme, 2013, BMC Psychol, V1, P10, DOI 10.1186/2050-7283-1-10; Hall J, 2012, FRONT HUM NEUROSCI; Heenan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099902; HILDEBRANDT KA, 1977, PERCEPT MOTOR SKILL, V45, P472, DOI 10.2466/pms.1977.45.2.472; Ishak NI, 2012, FORENSIC SCI INT, V221, DOI 10.1016/j.forsciint.2012.04.017; Jaquet E, 2008, VIS COGN, V16, P734, DOI 10.1080/13506280701350647; Johnson KL, 2012, P ROY SOC B-BIOL SCI, V279, P4982, DOI 10.1098/rspb.2012.2060; Lai M, 2012, CORTEX, V48, P477, DOI 10.1016/j.cortex.2010.11.014; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Miellet S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00034; Millar JA, 1996, J HUM HYPERTENS, V10, P449; Nagy E, 2000, PERCEPT MOTOR SKILL, V90, P102, DOI 10.2466/PMS.90.1.102-104; Navarrete CD, 2009, PSYCHOL SCI, V20, P155, DOI 10.1111/j.1467-9280.2009.02273.x; Ng M, 2006, P NATL ACAD SCI USA, V103, P19552, DOI 10.1073/pnas.0605358104; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; OToole AJ, 1996, PERCEPTION, V25, P669, DOI 10.1068/p250669; Packer C, 2000, PHILOS T ROY SOC B, V355, P1627, DOI 10.1098/rstb.2000.0725; Palumbo R, 2013, VIS COGN, V21, P1, DOI 10.1080/13506285.2012.753970; Pedersen F A, 1991, Hum Nat, V2, P271, DOI 10.1007/BF02692189; Plant EA, 2011, PERS SOC PSYCHOL B, V37, P1274, DOI 10.1177/0146167211408617; Podrebarac SK, 2013, EXP BRAIN RES, V226, P241, DOI 10.1007/s00221-013-3429-0; Quek GL, 2014, ADV COGN PSYCHOL, V10, P131, DOI 10.5709/acp-0164-8; Quek GL, 2014, COGN AFFECT BEHAV NE, V14, P1407, DOI 10.3758/s13415-014-0282-y; ROBERTS T, 1988, PERCEPTION, V17, P475, DOI 10.1068/p170475; Rodger H, 2010, PERCEPTION, V39, P1491, DOI 10.1068/p6750; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Sigala R, 2011, J NEUROPHYSIOL, V105, P2740, DOI 10.1152/jn.00882.2010; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Troje NF, 2006, J VISION, V6, P850, DOI 10.1167/6.8.7; van der Zwan R, 2009, EXP BRAIN RES, V198, P373, DOI 10.1007/s00221-009-1800-y; Wallis J, 2012, ATTEN PERCEPT PSYCHO, P1; Weech S, 2014, J VISION, V14, DOI 10.1167/14.12.10; Wheeler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018621; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Winer B.J., 1962, STAT PRINCIPLES EXPT	61	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148623	10.1371/journal.pone.0148623	http://dx.doi.org/10.1371/journal.pone.0148623			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859570	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400060
J	Khan, SG; Melikian, N; Mushemi-Blake, S; Dennes, W; Jouhra, F; Monaghan, M; Shah, AM				Khan, Sitara G.; Melikian, Narbeh; Mushemi-Blake, Sitali; Dennes, William; Jouhra, Fadi; Monaghan, Mark; Shah, Ajay M.			Physiological Reduction in Left Ventricular Contractile Function in Healthy Postpartum Women: Potential Overlap with Peripartum Cardiomyopathy	PLOS ONE			English	Article							NORMAL HUMAN-PREGNANCY; ATRIAL-NATRIURETIC-PEPTIDE; HEART-FAILURE ASSOCIATION; CARDIOLOGY WORKING GROUP; 3D ECHOCARDIOGRAPHY; EUROPEAN-SOCIETY; CARDIAC-OUTPUT; RECOMMENDATIONS; PREECLAMPSIA; ADRENOMEDULLIN	Aims Peripartum cardiomyopathy is a potentially life-threatening cause of heart failure, commoner in Afro-Caribbean than Caucasian women. Its diagnosis can be challenging due to physiological changes in cardiac function that also occur in healthy women during the early postpartum period. This study aimed to (i) establish the overlap between normal cardiac physiology in the immediate postpartum period and pathological changes in peripartum cardiomyopathy ii) identify any ethnicity-specific changes in cardiac function and cardiac biomarkers in healthy postpartum women. Methods and Results We conducted a cross-sectional study of 58 healthy postpartum women within 48 hours of delivery and 18 matched non-pregnant controls. Participants underwent cardiac assessment by echocardiography and strain analysis, including 3D echocardiography in 40 postpartum women. Results were compared with 12 retrospectively studied peripartum cardiomyopathy patients. Healthy postpartum women had significantly higher left ventricular volumes and mass, and lower ejection fraction and global longitudinal strain than nonpregnant controls. These parameters were significantly more impaired in peripartum cardiomyopathy patients but with overlapping ranges of values. Healthy postpartum women had higher levels of adrenomedullin, placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1) compared to controls. The postpartum state, adrenomedullin, sFlt1 and the sFlt1: PlGF ratio were independent predictors of LV remodelling and function in healthy postpartum women. Conclusion Healthy postpartum women demonstrate several echocardiographic indicators of left ventricular remodelling and reduced function, which are associated with altered levels of angiogenic and cardiac biomarkers.	[Khan, Sitara G.; Melikian, Narbeh; Mushemi-Blake, Sitali; Monaghan, Mark; Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, Dept Cardiol, London, England; [Khan, Sitara G.; Melikian, Narbeh; Mushemi-Blake, Sitali; Jouhra, Fadi; Monaghan, Mark; Shah, Ajay M.] Kings Coll Hosp London, Dept Cardiol, London, England; [Dennes, William] Kings Coll Hosp London, Dept Obstet & Gynaecol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital	Shah, AM (corresponding author), Kings Coll London, British Heart Fdn Ctr, Dept Cardiol, London, England.; Shah, AM (corresponding author), Kings Coll Hosp London, Dept Cardiol, London, England.	ajay.shah@kcl.ac.uk		Shah, Ajay/0000-0002-6547-0631	Academy of Medical Science (UK); British Heart Foundation	Academy of Medical Science (UK); British Heart Foundation(British Heart Foundation)	Funded by grants from the Academy of Medical Science (UK), and British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamfo JEAK, 2007, ULTRASOUND OBST GYN, V29, P414, DOI 10.1002/uog.3966; Bamfo JEAK, 2007, EUR J ECHOCARDIOGR, V8, P360, DOI 10.1016/j.euje.2006.12.004; Belo L, 2005, EUR J OBSTET GYN R B, V123, P46, DOI 10.1016/j.ejogrb.2005.02.022; Belo L, 2004, ATHEROSCLEROSIS, V177, P391, DOI 10.1016/j.atherosclerosis.2004.07.023; Desai DK, 2004, OBSTET GYNECOL, V104, P20, DOI 10.1097/01.AOG.0000128170.15161.1d; Estensen ME, 2013, ULTRASOUND OBST GYN, V41, P659, DOI 10.1002/uog.12296; Estensen ME, 2012, ULTRASOUND OBST GYN, DOI [10.1002/uog.12296, DOI 10.1002/U0G.12296]; Feigenbaum H, 2012, CIRC J, V76, P1550, DOI 10.1253/circj.CJ-12-0665; Gati S, 2014, CIRCULATION, V130, P475, DOI 10.1161/CIRCULATIONAHA.114.008554; Geva T, 1997, AM HEART J, V133, P53, DOI 10.1016/S0002-8703(97)70247-3; Hilfiker-Kleiner D, 2014, NAT REV CARDIOL, V11, P364, DOI 10.1038/nrcardio.2014.37; JOUGASAKI M, 1995, CIRCULATION, V92, P286, DOI 10.1161/01.CIR.92.3.286; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lang RM, 2012, EUR HEART J-CARD IMG, V13, P1, DOI 10.1093/ehjci/jer316; MABIE WC, 1994, AM J OBSTET GYNECOL, V170, P849, DOI 10.1016/S0002-9378(94)70297-7; Mannaerts HFJ, 2004, EUR HEART J, V25, P680, DOI 10.1016/j.ehj.2004.02.030; Melchiorre K, 2014, CIRCULATION, V130, P703, DOI 10.1161/CIRCULATIONAHA.113.003664; Minegishi T, 1999, MOL HUM REPROD, V5, P767, DOI 10.1093/molehr/5.8.767; Monaghan MJ, 2006, HEART, V92, P131, DOI 10.1136/hrt.2004.058388; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nanno H, 1998, MOL HUM REPROD, V4, P609, DOI 10.1093/molehr/4.6.609; Ntusi NBA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133466; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; Sanghavi M, 2014, CIRCULATION, V130, P1003, DOI 10.1161/CIRCULATIONAHA.114.009029; Savu O, 2012, CIRC-CARDIOVASC IMAG, V5, P289, DOI 10.1161/CIRCIMAGING.111.970012; Sliwa K, 2014, EUR J HEART FAIL, V16, P583, DOI 10.1002/ejhf.68; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Verlohren S, 2014, HYPERTENSION, V63, P346, DOI 10.1161/HYPERTENSIONAHA.113.01787; YOSHIMURA T, 1994, J ENDOCRINOL, V140, P393, DOI 10.1677/joe.0.1400393	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147074	10.1371/journal.pone.0147074	http://dx.doi.org/10.1371/journal.pone.0147074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859567	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400006
J	Montminy, ML; Gauvin, V; Turcotte, S; Milot, A; Douville, Y; Bairati, I				Montminy, Myriam L.; Gauvin, Valerie; Turcotte, Stephane; Milot, Alain; Douville, Yvan; Bairati, Isabelle			Factors Influencing the Prescription of Cardiovascular Preventive Therapies in Patients with Peripheral Arterial Disease	PLOS ONE			English	Article							MISSED OPPORTUNITIES; HIGH-RISK; RAMIPRIL; CLAUDICATION; IMPROVEMENT; QUALITY; SOCIETY; IMPACT	Background Guidelines recommend that patients with peripheral arterial disease should be medically treated to reduce the occurrence of serious cardiovascular events. Despite these recommendations, studies conducted in the early 2000s reported that medical therapies for secondary cardiovascular prevention are not given systematically to patients with peripheral arterial disease (PAD). We identified factors associated with the prescription of preventive therapies in patients with symptomatic PAD. Methods and Findings Consecutive patients with symptomatic peripheral arterial disease (n = 362) treated between 2008 and 2010 in one tertiary care center (CHU de Quebec, Canada) were considered. Data were collected from the medical charts. The main outcome was the combined prescription of three therapies: 1) statins, 2) antiplatelets, 3) angiotensin-convertingenzyme inhibitors or angiotensin receptor blockers. The mean age was 70 years and 43% had a pre-existing coronary artery disease. Antiplatelet therapy was the most prescribed drug (83%). A total of 52% of the patients received the three combined therapies. Less than 10% of patients had a known contraindication to one class of medication. Having at least three cardiovascular risk factors (Odds Ratio (OR) = 4.51; 95% CI: 2.76-7.37) was the factor most strongly associated with the prescription of the combined therapies. Preexisting coronary artery disease (OR = 2.28; 95% CI: 1.43-3.65) and history of peripheral vascular surgery (OR = 2.30; 95% CI: 1.37-3.86) were two factors independently associated with the prescription of the combined therapies. However, peripheral arterial disease patients with chronic critical limb ischemia were less likely to receive the combined therapies (OR = 0.53; 95% CI: 0.32-0.87) than those with claudication. The retrospective nature of this study, not allowing for an exhaustive report of the contraindication to medication prescription, is the main limitation. Conclusion About half of the patients with peripheral arterial disease were not optimally managed. Patients with multiple cardiovascular risk factors were more likely to receive the combined therapies. We still need to better understand the barriers and facilitators to the application of the guidelines.	[Montminy, Myriam L.; Gauvin, Valerie; Douville, Yvan] Ctr Hosp Univ Quebec, Dept Vasc Surg, Quebec City, PQ, Canada; [Montminy, Myriam L.; Turcotte, Stephane] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Milot, Alain] Ctr Hosp Univ Quebec, Dept Vasc Med, Quebec City, PQ, Canada; [Bairati, Isabelle] Ctr Hosp Univ Quebec, Dept Publ Hlth, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Montminy, ML (corresponding author), Ctr Hosp Univ Quebec, Dept Vasc Surg, Quebec City, PQ, Canada.; Montminy, ML (corresponding author), Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada.	myriam.letourneau-montminy.1@ulaval.ca						Abramson BL, 2005, CAN J CARDIOL, V21, P997; Ardati AK, 2012, CIRC-CARDIOVASC INTE, V5, P850, DOI 10.1161/CIRCINTERVENTIONS.112.975862; Aronow WS, 2003, AM J CARDIOL, V92, P711, DOI 10.1016/S0002-9149(03)00833-6; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Cacoub Patrice P, 2009, Atherosclerosis, V204, pe86, DOI 10.1016/j.atherosclerosis.2008.10.023; Cassar K, 2003, EUR J VASC ENDOVASC, V26, P262, DOI 10.1053/ejvs.2002.1948; Charlson ME, 2002, NEW METHOD CLASSIFYI, P1; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P159, DOI [10.1136/bmj.308.6922.159, DOI 10.1136/BMJ.308.6922.159]; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; Heart Protection Study Collaborative Group, 2007, J VASC SURG, V45, P644; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hosmer DW, 2004, APPL LOGISTIC REGRES, P392; Khan S, 2007, EUR J VASC ENDOVASC, V33, P442, DOI 10.1016/j.ejvs.2006.11.010; Kidney disease outcomes quality initiative (KDOQI), KIDNEY DIS OUTCOMES, V39, pS46, DOI [10.1053/ajkd.2002.30943, DOI 10.1053/AJKD.2002.30943]; Kundhal KK, 2007, CAN J CARDIOL, V23, P357, DOI 10.1016/S0828-282X(07)70768-7; Mukherjee D, 2002, CIRCULATION, V106, P1909, DOI 10.1161/01.CIR.0000035649.39669.CE; Ostergren J, 2004, EUR HEART J, V25, P17, DOI 10.1016/j.ehj.2003.10.033; Pampalon R, 2000, Chronic Dis Can, V21, P104; Rooke TW, 2011, CATHETER CARDIOVASC; Subherwal S, 2012, CIRCULATION, V126, P1345, DOI 10.1161/CIRCULATIONAHA.112.108787; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Welten GMJM, 2008, J AM COLL CARDIOL, V51, P1588, DOI 10.1016/j.jacc.2007.11.077; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	25	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148069	10.1371/journal.pone.0148069	http://dx.doi.org/10.1371/journal.pone.0148069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849679	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000037
J	Peixoto, P; Blomme, A; Costanza, B; Ronca, R; Rezzola, S; Palacios, AP; Schoysman, L; Boutry, S; Goffart, N; Peulen, O; Maris, P; Di Valentin, E; Hennequiere, V; Bianchi, E; Henry, A; Meunier, P; Rogister, B; Muller, RN; Delvenne, P; Bellahcene, A; Castronovo, V; Turtoi, A				Peixoto, P.; Blomme, A.; Costanza, B.; Ronca, R.; Rezzola, S.; Palacios, A. P.; Schoysman, L.; Boutry, S.; Goffart, N.; Peulen, O.; Maris, P.; Di Valentin, E.; Hennequiere, V.; Bianchi, E.; Henry, A.; Meunier, P.; Rogister, B.; Muller, R. N.; Delvenne, P.; Bellahcene, A.; Castronovo, V.; Turtoi, A.			HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies	ONCOGENE			English	Article							HISTONE DEACETYLASE INHIBITORS; EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE GENES; NF-KAPPA-B; INTRATUMORAL HETEROGENEITY; TUMOR; CANCER; BRAIN; AMPLIFICATION; ANGIOGENESIS	To date, the mutational status of EGFR and PTEN has been shown as relevant for favoring pro-or anti-tumor functions of STAT3 in human glioblastoma multiforme (GBM). We have screened genomic data from 154 patients and have identified a strong positive correlation between STAT3 and HDAC7 expression. In the current work we show the existence of a subpopulation of patients overexpressing HDAC7 and STAT3 that has particularly poor clinical outcome. Surprisingly, the somatic mutation rate of both STAT3 and HDAC7 was insignificant in GBM comparing with EGFR, PTEN or TP53. Depletion of HDAC7 in a range of GBM cells induced the expression of tyrosine kinase JAK1 and the tumor suppressor AKAP12. Both proteins synergistically sustained the activity of STAT3 by inducing its phosphorylation (JAK1) and protein expression (AKAP12). In absence of HDAC7, activated STAT3 was responsible for significant imbalance of secreted pro-/anti-angiogenic factors. This inhibited the migration and sprouting of endothelial cells in paracrine fashion in vitro as well as angiogenesis in vivo. In a murine model of GBM, induced HDAC7-silencing decreased the tumor burden by threefold. The current data show for the first time that silencing HDAC7 can reset the tumor suppressor activity of STAT3, independently of the EGFR/PTEN/TP53 background of the GBM. This effect could be exploited to overcome tumor heterogeneity and provide a new rationale behind the development of specific HDAC7 inhibitors for clinical use.	[Peixoto, P.; Blomme, A.; Costanza, B.; Palacios, A. P.; Peulen, O.; Maris, P.; Hennequiere, V.; Henry, A.; Bellahcene, A.; Castronovo, V.; Turtoi, A.] Univ Liege, GIGA Canc, Metastasis Res Lab, Ave Hop 3,Tour Patho 4, B-4000 Liege, Belgium; [Ronca, R.; Rezzola, S.] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Schoysman, L.; Meunier, P.] Univ Hosp Liege, Dept Radiol, Liege, Belgium; [Boutry, S.; Muller, R. N.] Univ Mons, Dept Gen Organ & Biomed Chem, NMR & Mol Imaging Lab, Mons, Belgium; [Boutry, S.; Muller, R. N.] Ctr Microscopy & Mol Imaging, Charleroi, Belgium; [Goffart, N.; Rogister, B.] Univ Liege, GIGA Neurosci, Liege, Belgium; [Di Valentin, E.] Univ Liege, GIGA Viral Vectors Platform, Liege, Belgium; [Bianchi, E.; Delvenne, P.] Univ Hosp Liege, Dept Pathol, Liege, Belgium	University of Liege; University of Brescia; University of Liege; University of Mons; University of Liege; University of Liege; University of Liege	Turtoi, A (corresponding author), Univ Liege, GIGA Canc, Metastasis Res Lab, Ave Hop 3,Tour Patho 4, B-4000 Liege, Belgium.	a.turtoi@ulg.ac.be	Maris, Pamela/ABG-2488-2021; Rogister, Bernard/AAJ-9591-2020; Rezzola, Sara/AAA-2745-2019; Ronca, Roberto/AAC-6470-2022; Turtoi, Andrei/ABD-1271-2021; Blomme, Arnaud/AAM-1440-2020; Blomme, Arnaud/AGO-7915-2022; Rezzola, Sara/AAE-8980-2020; Peulen, Olivier/C-1250-2018	Rezzola, Sara/0000-0003-1193-8929; Ronca, Roberto/0000-0001-8979-7068; Turtoi, Andrei/0000-0003-3813-6635; Blomme, Arnaud/0000-0003-4183-8726; Peulen, Olivier/0000-0002-6933-0134; Costanza, Brunella/0000-0001-8279-805X; Di Valentin, Emmanuel/0000-0002-5287-7950; Maris, Pamela/0000-0002-4471-9717; Peixoto, Paul/0000-0001-6302-7823	University of Liege (Concerted Research Action Program (IDEA project)); National Fund for Scientific Research (FNRS/TELEVIE); European Regional Development Fund and Wallonia	University of Liege (Concerted Research Action Program (IDEA project)); National Fund for Scientific Research (FNRS/TELEVIE)(Fonds de la Recherche Scientifique - FNRS); European Regional Development Fund and Wallonia	The authors acknowledge the experimental support of Dr Chantal Humblet and Ms Alice Marquet (GIGA-histology platform, ULg), Dr Sandra Ormenese (GIGA-imaging platform, ULg) as well as of Evgenia Turtoi (Metastasis Research Laboratory) for the immunohistochemistry analysis and of Naima Maloujahmoum (Metastasis Research Laboratory) for the cell culture. The authors are also thankful to Dr Stephanie Gofflot from the institutional Biobank of the University Hospital Liege for providing GBM fresh tissues and to Dr Gilles Doumont (group of Prof Serge Goldman, Universite libre de Bruxelles) for help with animal experiments. The authors are grateful to Ms. Ana Turtoi for proofreading the manuscript. The results shown in this work are in part based on data generated by the TCGA Research Network: http://cancergenome.nih.gov/. This work was supported with grants from the University of Liege (Concerted Research Action Program (IDEA project)) and from the National Fund for Scientific Research (FNRS/TELEVIE). Andrei Turtoi is a post-doctoral research fellow (FNRS/TELEVIE) and Akeila Bellahcene is a senior research associate (FNRS). Arnaud Blomme is a post-doctoral research fellow (FNRS/TELEVIE). The Center for Microscopy and Molecular Imaging (CMMI) is supported by the European Regional Development Fund and Wallonia. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Bezecny P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0985-5; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gelman IH, 2012, CANCER METAST REV, V31, P493, DOI 10.1007/s10555-012-9360-1; Goeppert B, 2013, J NEUROPATH EXP NEUR, V72, P933, DOI 10.1097/NEN.0b013e3182a59a88; Hamer PCDW, 2010, NEURO-ONCOLOGY, V12, P304, DOI 10.1093/neuonc/nop068; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Inda MD, 2014, CANCERS, V6, P226, DOI 10.3390/cancers6010226; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; Lokker NA, 2002, CANCER RES, V62, P3729; LUNDJOHANSEN M, 1990, CANCER RES, V50, P6039; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Mottet D, 2007, CIRC RES, V101, P1237, DOI 10.1161/CIRCRESAHA.107.149377; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schneller D, 2011, HEPATOLOGY, V54, P164, DOI 10.1002/hep.24329; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Su B, 2013, ONCOGENE, V32, P2016, DOI 10.1038/onc.2012.218; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Talasila KM, 2013, ACTA NEUROPATHOL, V125, P683, DOI 10.1007/s00401-013-1101-1; Turtoi Andrei, 2015, Critical Reviews in Oncogenesis, V20, P119; Turtoi A, 2015, B CANCER, V102, P17, DOI 10.1016/j.bulcan.2014.12.006; Turtoi A, 2012, ANGIOGENESIS, V15, P543, DOI 10.1007/s10456-012-9279-8; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	47	21	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4481	4494		10.1038/onc.2015.506	http://dx.doi.org/10.1038/onc.2015.506			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26853466				2022-12-26	WOS:000382153100006
J	Baratchian, M; Davis, CA; Shimizu, A; Escors, D; Bagneris, C; Barrett, T; Collins, MK				Baratchian, Mehdi; Davis, Christopher A.; Shimizu, Akira; Escors, David; Bagneris, Claire; Barrett, Tracey; Collins, Mary K.			Distinct Activation Mechanisms of NF-kappa B Regulator Inhibitor of NF-kappa B Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KSHV VFLIP; C-FLIPR; COMPLEX; EXPRESSION; APOPTOSIS; GAMMA; LYMPHOMAS; PATHWAY; TAK1	The viral FLICE-like inhibitory protein (FLIP) protein from Kaposi sarcoma-associated herpesvirus activates the NF-kappa B pathway by forming a stable complex with a central region (amino acids 150-272) of the inhibitor of NF-kappa B kinase (IKK)gamma subunits, thereby activating IKK. Cellular FLIP (cFLIP) forms are also known to activate the NF-kappa B pathway via IKK activation. Here we demonstrate that cFLIP(L), cFLIP(S), and their proteolytic product p22-FLIP all require the C-terminal region of NEMO/IKK gamma (amino acids 272-419) and its ubiquitin binding function for activation of the IKK kinase (or kinase complex), but none form a stable complex with IKK gamma. Our results further reveal that cFLIPL requires the linear ubiquitin chain assembly complex and the kinase TAK1 for activation of the IKK kinase. Similarly, cFLIPS and p22-FLIP also require TAK1 but do not require LUBAC. In contrast, these isoforms are both components of complexes that incorporate Fas-associated death domain and RIP1, which appear essential for kinase activation. This conservation of IKK activation among the cFLIP family using different mechanisms suggests that the mechanism plays a critical role in their function.	[Baratchian, Mehdi; Davis, Christopher A.; Shimizu, Akira; Escors, David; Collins, Mary K.] UCL, Div Infect & Immun, MRC, Ctr Med Mol Virol, London WC1E 6BT, England; [Baratchian, Mehdi; Collins, Mary K.] Natl Inst Biol Stand & Controls, Div Adv Therapies, Blanche Lane, Potters Bar EN6 3QG, Herts, England; [Bagneris, Claire; Barrett, Tracey] Birkbeck Coll, Sch Biol Sci, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England	University of London; University College London; National Institute for Biological Standards & Control; University of London; Birkbeck University London	Collins, MK (corresponding author), UCL, Infect & Immun, Gower St, London WC1E 6BT, England.	mary.collins@ucl.ac.uk	Escors-Murugarren, David/ABG-1930-2020; Escors, David/C-1549-2008	Escors-Murugarren, David/0000-0003-2828-4458; Escors, David/0000-0003-2828-4458; davis, chris/0000-0002-7317-3266; Bagneris, Claire/0000-0002-0561-7574	Cancer Research UK; University College London Graduate School; MRC [G0701236] Funding Source: UKRI; Cancer Research UK [12595] Funding Source: researchfish; Medical Research Council [G0701236] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); University College London Graduate School; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from Cancer Research UK (to M. K. C and T. B.) and a scholarship from the University College London Graduate School (to M. B.). The authors declare they have no conflicts of interest with the contents of this article.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Keller SA, 2000, BLOOD, V96, P2537; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Matta H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036601; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mukherjee S, 2008, J BIOL CHEM, V283, P15127, DOI 10.1074/jbc.M704831200; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; O'Donnell MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041238; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Park YH, 2013, BBA-PROTEINS PROTEOM, V1834, P292, DOI 10.1016/j.bbapap.2012.08.013; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shimizu A, 2011, J VIROL, V85, P7444, DOI 10.1128/JVI.02337-10; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tolani B, 2014, J VIROL, V88, P6345, DOI 10.1128/JVI.00028-14; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314; Ullenhag GJ, 2007, CLIN CANCER RES, V13, P5070, DOI 10.1158/1078-0432.CCR-06-2547; Valente G, 2006, BRIT J HAEMATOL, V132, P560, DOI 10.1111/j.1365-2141.2005.05898.x; Valnet-Rabier MB, 2005, BRIT J HAEMATOL, V128, P767, DOI 10.1111/j.1365-2141.2005.05378.x; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu XF, 2007, EMBO REP, V8, P510, DOI 10.1038/sj.embor.7400931; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	49	17	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7608	7620		10.1074/jbc.M116.718122	http://dx.doi.org/10.1074/jbc.M116.718122			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865630	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000383447600033
J	Qu, CS; Bian, DD; Li, X; Xiao, J; Wu, CP; Li, Y; Jiang, T; Zhou, XT; Qu, J; Chen, JG				Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Li, Yue; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang			Transient Expression of Fez Family Zinc Finger 2 Protein Regulates the Brn3b Gene in Developing Retinal Ganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN FACTOR BRN-3B; TRANSCRIPTION FACTOR; FATE SPECIFICATION; COMPETENCE STATE; CEREBRAL-CORTEX; STEM-CELLS; MATH5; DIFFERENTIATION; NEURONS; LAYER	Retinal ganglion cells (RGCs) are projection neurons in the neural retina that relay visual information from the environment to the central nervous system. The early expression of MATH5 endows the post-mitotic precursors with RGC competence and leads to the activation of Brn3b that marks committed RGCs. Nevertheless, this fate commitment process and, specifically, regulation of Brn3b remain elusive. To explore the molecular mechanisms underlying RGC generation in the mouse retina, we analyzed the expression and function of Fez family zinc finger 2 (FEZF2), a transcription factor critical for the development of projection neurons in the cerebral cortex. Fezf2 mRNA and protein were transiently expressed at embryonic day 16.5 in the inner neuroblast layer and the prospective ganglion cell layer of the retina, respectively. Knockout of Fezf2 in the developing retina reduced BRN3B+ cells and increased apoptotic cell markers. Fezf2 knockdown by retinal in utero electroporation diminished BRN3B but not the coexpressed ISLET1 and BRN3A, indicating that the BRN3B decrease was the cause, not the result, of the overall reduction of BRN3B+ RGCs in the Fezf2 knockout retina. Moreover, the mRNA and promoter activity of Brn3b were increased in vitro by FEZF2, which bound to a 5' regulatory fragment in the Brn3b genomic locus. These results indicate that transient expression of Fezf2 in the retina modulates the transcription of Brn3b and the survival of RGCs. This study improves our understanding of the transcriptional cascade required for the specification of RGCs and provides novel insights into the molecular basis of retinal development.	[Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325000, Zhejiang, Peoples R China; [Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Wenzhou Med Univ, Hosp Eye, Wenzhou 325000, Zhejiang, Peoples R China; [Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Minist Hlth China, China State Key Lab Cultivat Base, Wenzhou 325000, Zhejiang, Peoples R China; [Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Minist Hlth China, Key Lab Vis Sci, Wenzhou 325000, Zhejiang, Peoples R China; [Qu, Chunsheng; Bian, Dandan; Li, Xue; Xiao, Jian; Wu, Chunping; Jiang, Tian; Zhou, Xiangtian; Qu, Jia; Chen, Jie-Guang] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou 325000, Zhejiang, Peoples R China; [Li, Yue] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Qu, Chunsheng] Wenzhou Med Univ, Affiliated Hosp 6, LiShui Peoples Hosp, Clin Lab, Lishui 323000, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Yale University; Wenzhou Medical University	Chen, JG (corresponding author), Wenzhou Med Univ, Key Lab Visual Sci, 270 Xueyuan Rd, Wenzhou 325003, Zhejiang, Peoples R China.; Chen, JG (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, 270 Xueyuan Rd, Wenzhou 325003, Zhejiang, Peoples R China.	jgchen@mail.eye.ac.cn	Xiao, Jian/GYU-4351-2022; zhou, xt/GWZ-9212-2022		National Natural Science Foundation of China [31500850, 81571096]; Zhejiang Provincial Natural Science Foundation of China [LQ16H120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The work was supported by National Natural Science Foundation of China Grants 31500850 (to C. Q.) and 81571096 (to J. G. C.) and Zhejiang Provincial Natural Science Foundation of China Grant LQ16H120001 (to C. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen LS, 2011, J BIOL CHEM, V286, P18641, DOI 10.1074/jbc.M111.236471; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Farah MH, 2005, J COMP NEUROL, V489, P120, DOI 10.1002/cne.20615; Farah MH, 2006, BRAIN RES REV, V52, P264, DOI 10.1016/j.brainresrev.2006.04.002; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Garcia-Frigola C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-103; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hutcheson DA, 2001, DEV BIOL, V232, P327, DOI 10.1006/dbio.2001.0178; Jiang Y, 2013, J BIOL CHEM, V288, P18429, DOI 10.1074/jbc.M113.478503; Liu W, 2001, P NATL ACAD SCI USA, V98, P1649, DOI 10.1073/pnas.98.4.1649; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Mu XQ, 2008, P NATL ACAD SCI USA, V105, P6942, DOI 10.1073/pnas.0802627105; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Shimizu T, 2010, DEVELOPMENT, V137, P1875, DOI 10.1242/dev.047167; Shu XS, 2013, CARCINOGENESIS, V34, P1984, DOI 10.1093/carcin/bgt165; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang ZB, 2011, CEREB CORTEX, V21, P2177, DOI 10.1093/cercor/bhr006; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005	34	1	1	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7661	7668		10.1074/jbc.M115.689448	http://dx.doi.org/10.1074/jbc.M115.689448			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26861874	Green Published, hybrid			2022-12-26	WOS:000383447600037
J	Zhao, YH; Luo, AP; Li, S; Zhang, W; Chen, HY; Li, Y; Ding, F; Huang, FR; Liu, ZH				Zhao, Yahui; Luo, Aiping; Li, Sheng; Zhang, Wei; Chen, Hongyan; Li, Yi; Ding, Fang; Huang, Furong; Liu, Zhihua			Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP-1 transcription factor (AP-1); apoptosis; c-Fos; chemoresistance; promoter; ID1; c-Jun; etoposide	SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL CANCER-CELLS; TRANSCRIPTION FACTOR; EXPRESSION; AP-1; PATHWAY; P53; ACTIVATION; GENES; CHEMORESISTANCE	ID1 (inhibitor of differentiation/DNA binding 1) acts an important role in metastasis, tumorigenesis, and maintenance of cell viability. It has been shown that the up-regulation of ID1 is correlated with poor prognosis and the resistance to chemotherapy of human cancers. However, the underlying molecular mechanism remains elusive. Here, we determined for the first time that up-regulating ID1 upon etoposide activation was mediated through AP-1 binding sites within the ID1 promoter and confirmed that ID1 enhanced cell resistance to DNA damage-induced apoptosis in esophageal squamous cell carcinoma cells. Ablation of c-Jun/c-Fos or ID1 expression enhanced etoposide-mediated apoptosis through increasing activity of caspase 3 and PARP cleavage. Moreover, c-Jun/c-Fos and ID1 were positively correlated in human cancers. More importantly, simultaneous high expression of ID1 and c-Jun or c-Fos was correlated with poor survival in cancer patients. Collectively, we demonstrate the importance of c-Jun/c-Fos-ID1 signaling pathway in chemoresistance of esophageal cancer cells and provide considerable insight into understanding the underlying molecular mechanisms in esophageal squamous cell carcinoma cell biology.	[Zhao, Yahui; Luo, Aiping; Zhang, Wei; Chen, Hongyan; Li, Yi; Ding, Fang; Huang, Furong; Liu, Zhihua] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Zhao, Yahui; Luo, Aiping; Zhang, Wei; Chen, Hongyan; Li, Yi; Ding, Fang; Huang, Furong; Liu, Zhihua] Peking Union Med Coll, Collaborat Innovat Ctr Canc Med, Beijing 100021, Peoples R China; [Li, Sheng] Peking Univ, Canc Hosp & Inst, Ctr Mol & Translat Med,Minist Educ, Dept Cell Biol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Liu, ZH (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.; Liu, ZH (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn		Li, Sheng/0000-0001-8080-9712; Zhao, Yahui/0000-0002-9613-1384	National Basic Research Program of China [2013CB911004]; National Natural Science Foundation of China [81130043, 81420108025, 81472791]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2013CB911004 and National Natural Science Foundation of China Grants 81130043, 81420108025, and 81472791. The authors declare that they have no conflicts of interest with the contents of this article.	Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Boeckx C, 2015, AM J CANCER RES, V5, P1921; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Castanon E, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-13; Chen HY, 2013, MOL CANCER RES, V11, P1542, DOI 10.1158/1541-7786.MCR-13-0317; di Pietro A, 2012, CELL CYCLE, V11, P4552, DOI 10.4161/cc.22803; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; He H, 2015, J BIOL CHEM, V290, P13567, DOI 10.1074/jbc.M114.629717; He H, 2014, J BIOL CHEM, V289, P9089, DOI 10.1074/jbc.M113.534271; Hernandez-Vargas H, 2006, INT J CANCER, V119, P1164, DOI 10.1002/ijc.21938; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hu YC, 2001, CLIN CANCER RES, V7, P3519; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Li B, 2016, CLIN CANCER RES, V22, P1243, DOI 10.1158/1078-0432.CCR-15-1196; Li B, 2014, CLIN CANCER RES, V20, P2651, DOI 10.1158/1078-0432.CCR-13-2735; Li B, 2009, INT J CANCER, V125, P2576, DOI 10.1002/ijc.24675; Li S, 2013, J BIOL CHEM, V288, P4076, DOI 10.1074/jbc.M111.317487; Ling F, 2014, CURR TOP DEV BIOL, V110, P189, DOI 10.1016/B978-0-12-405943-6.00005-1; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Liu JG, 2010, CANCER BIOMARK, V8, P67, DOI 10.3233/DMA-2011-0831; Luo AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096610; Luo AP, 2013, MOL ONCOL, V7, P955, DOI 10.1016/j.molonc.2013.05.005; Ma J, 2013, INT J ONCOL, V43, P1052, DOI 10.3892/ijo.2013.2043; McNeely SC, 2006, ENVIRON HEALTH PERSP, V114, P1401, DOI 10.1289/ehp.8969; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Subramanian D, 2015, J BIOL CHEM, V290, P18636, DOI 10.1074/jbc.M115.636548; Sun NK, 2015, ONCOTARGET, V6, P27065, DOI 10.18632/oncotarget.4824; Trevino JG, 2012, NEOPLASIA, V14, P1102, DOI 10.1593/neo.121044; Wu YZ, 2003, ONCOGENE, V22, P8891, DOI 10.1038/sj.onc.1206898; Yang H, 2015, ONCOTARGET, V6, P26079, DOI 10.18632/oncotarget.4581; Yap WN, 2010, CANCER LETT, V291, P187, DOI 10.1016/j.canlet.2009.10.012; Yu H. H., 2014, LASER PHOTONICS REV, V1, P1, DOI DOI 10.1080/09670874.2014.986560; Yu XF, 2006, BIOCHEM BIOPH RES CO, V342, P286, DOI 10.1016/j.bbrc.2006.01.147; Zhang S, 2014, ONCOTARGET, V5, P7183, DOI 10.18632/oncotarget.2293; Zhang XP, 2009, INT J CANCER, V124, P1980, DOI 10.1002/ijc.24139	40	25	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6831	6842		10.1074/jbc.M115.704361	http://dx.doi.org/10.1074/jbc.M115.704361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26858249	Green Published, hybrid			2022-12-26	WOS:000373299700022
J	Chen, BY; Gao, ET; Chen, HY; Yang, JL; Shi, F; Zheng, C; Zhu, WF; Xiang, DH; Chen, XJ; Zhang, MZ				Chen, Binyao; Gao, Enting; Chen, Haoyu; Yang, Jianling; Shi, Fei; Zheng, Ce; Zhu, Weifang; Xiang, Dehui; Chen, Xinjian; Zhang, Mingzhi			Profile and Determinants of Retinal Optical Intensity in Normal Eyes with Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							NERVE-FIBER LAYER; QUANTITATIVE-ANALYSIS; PIGMENT EPITHELIUM; 3-DIMENSIONAL PROFILE; MACULAR DISEASE; GANGLION-CELLS; AGE; THICKNESS; GLAUCOMA; DENSITY	Purpose To investigate the profile and determinants of retinal optical intensity in normal subjects using 3D spectral domain optical coherence tomography (SD OCT). Methods A total of 231 eyes from 231 healthy subjects ranging in age from 18 to 80 years were included and underwent a 3D OCT scan. Forty-four eyes were randomly chosen to be scanned by two operators for reproducibility analysis. Distribution of optical intensity of each layer and regions specified by the Early Treatment of Diabetic Retinopathy Study (ETDRS) were investigated by analyzing the OCT raw data with our automatic graph-based algorithm. Univariate and multivariate analyses were performed between retinal optical intensity and sex, age, height, weight, spherical equivalent (SE), axial length, image quality, disc area and rim/disc area ratio (R/D area ratio). Results For optical intensity measurements, the intraclass correlation coefficient of each layer ranged from 0.815 to 0.941, indicating good reproducibility. Optical intensity was lowest in the central area of retinal nerve fiber layer, ganglion cell layer, inner plexiform layer, inner nuclear layer, outer plexiform layer and photoreceptor layer, except for the retinal pigment epithelium (RPE). Optical intensity was positively correlated with image quality in all retinal layers (0.553<beta<0.851, p<0.01), and negatively correlated with age in most retinal layers (-0.362<beta<-0.179, p<0.01), except for the RPE (beta = 0.456, p<0.01), outer nuclear layer and photoreceptor layer (p>0.05). There was no relationship between retinal optical intensity and sex, height, weight, SE, axial length, disc area and R/D area ratio. Conclusions There was a specific pattern of distribution of retinal optical intensity in different regions. The optical intensity was affected by image quality and age. Image quality can be used as a reference for normalization. The effect of age needs to be taken into consideration when using OCT for diagnosis.	[Chen, Binyao; Chen, Haoyu; Yang, Jianling; Zheng, Ce; Zhang, Mingzhi] Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China; [Chen, Binyao; Chen, Haoyu; Yang, Jianling; Zheng, Ce; Zhang, Mingzhi] Chinese Univ Hong Kong, Shantou, Peoples R China; [Gao, Enting; Shi, Fei; Zhu, Weifang; Xiang, Dehui; Chen, Xinjian] Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China	Shantou University; Soochow University - China	Zhang, MZ (corresponding author), Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China.; Zhang, MZ (corresponding author), Chinese Univ Hong Kong, Shantou, Peoples R China.; Chen, XJ (corresponding author), Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China.	xjchen@suda.edu.cn; zmz@jsiec.org	Xiang, Dehui/B-1938-2016; Chen, Haoyu/A-7432-2013	Xiang, Dehui/0000-0001-7873-9778; Chen, Haoyu/0000-0003-0676-4610; Chen, Xinjian/0000-0002-0871-293X	National Nature Science Foundation of China [30901646, 81170853]; Innovation Training Program for the University Students of Guangdong Province [1056013105]; Joint Shantou International Eye Center [2012-18]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Training Program for the University Students of Guangdong Province; Joint Shantou International Eye Center	This work was funded by the National Nature Science Foundation of China (HC, 30901646 and 81170853, http://www.nsfc.gov.cn/), the Innovation Training Program for the University Students of Guangdong Province (BC, 1056013105, http://gjxx.edugd.cn/gdhe/), and the Research Grant of Joint Shantou International Eye Center (MZ, 2012-18, http://www.jsiec.org/). The funders played a role in data collection and analysis, and decision to publish.	Abignano G, 2013, ANN RHEUM DIS, V72, P1845, DOI 10.1136/annrheumdis-2012-202682; Aggarwal P, 2007, J BIOSCIENCES, V32, P293, DOI 10.1007/s12038-007-0029-9; Ahlers C, 2009, INVEST OPHTH VIS SCI, V50, P3417, DOI 10.1167/iovs.08-2759; Alasil T, 2013, J GLAUCOMA, V22, P532, DOI 10.1097/IJG.0b013e318255bb4a; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; Barbas Carlos F 3rd, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.ip47; Barthelmes D, 2006, INVEST OPHTH VIS SCI, V47, P1161, DOI 10.1167/iovs.05-0783; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P3529, DOI 10.1167/iovs.07-1320; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P2156, DOI 10.1167/iovs.07-0478; Baumann B, 2012, BIOMED OPT EXPRESS, V3, P1670, DOI 10.1364/BOE.3.001670; BOULTON M, 1990, VISION RES, V30, P1291, DOI 10.1016/0042-6989(90)90003-4; Bruno L, 2011, GUIDE INTERPRETING S, P8; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P6846, DOI 10.1167/iovs.13-12062; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; COLEMAN DJ, 1973, ARCH OPHTHALMOL-CHIC, V90, P29; Coscas G, 2013, OPHTHALMOLOGICA, V229, P32, DOI 10.1159/000342159; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Fukuchi T, 2001, GRAEF ARCH CLIN EXP, V239, P424, DOI 10.1007/s004170100296; Gao ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128925; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Geitzenauer W, 2011, BRIT J OPHTHALMOL, V95, P171, DOI 10.1136/bjo.2010.182170; Giani A, 2011, RETINA-J RET VIT DIS, V31, P942, DOI 10.1097/IAE.0b013e31820a68cc; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Horu T, 2012, OPHTHALMOLOGY, V119, P1047, DOI 10.1016/j.ophtha.2011.10.030; Hoye VJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1287; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; JONAS JB, 1990, INVEST OPHTH VIS SCI, V31, P736; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Kanamori A, 2003, AM J OPHTHALMOL, V135, P513, DOI 10.1016/S0002-9394(02)02003-2; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kozak I, 2007, OPHTHALMOLOGY, V114, P537, DOI 10.1016/j.ophtha.2006.06.054; Le PV, 2013, INVEST OPHTH VIS SCI, V54, P4287, DOI 10.1167/iovs.12-11388; Litts K, 2011, ARVO C MAY 2 FORT LA; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; MATSUMOTO C, 1994, CALCIFIED TISSUE INT, V55, P324, DOI 10.1007/BF00299308; Neudorfer M, 2012, INVEST OPHTH VIS SCI, V53, P3104, DOI 10.1167/iovs.11-8700; Nouri-Mahdavi K, 2013, AM J OPHTHALMOL, V156, P1297, DOI 10.1016/j.ajo.2013.08.001; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Ooto S, 2010, INVEST OPHTH VIS SCI, V51, P465, DOI 10.1167/iovs.09-4047; Otani T, 2011, RETINA-J RET VIT DIS, V31, P497, DOI 10.1097/IAE.0b013e3181ed8dae; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Polito A, 2002, AM J OPHTHALMOL, V134, P240, DOI 10.1016/S0002-9394(02)01528-3; Pons ME, 2000, ARCH OPHTHALMOL-CHIC, V118, P1044, DOI 10.1001/archopht.118.8.1044; REPKA MX, 1989, OPHTHALMOLOGY, V96, P26; Schmitt O, 2004, BRAIN RES PROTOC, V12, P157, DOI 10.1016/j.brainresprot.2003.10.003; SCHUMAN JS, 2004, OPTICAL COHERENCE TO, P21; Shi F, 2015, IEEE T MED IMAGING, V34, P441, DOI 10.1109/TMI.2014.2359980; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Sung KR, 2011, INVEST OPHTH VIS SCI, V52, P2634, DOI 10.1167/iovs.10-6246; Tappeiner C, 2008, INVEST OPHTH VIS SCI, V49, P1609, DOI 10.1167/iovs.07-1264; van der Schoot J, 2012, INVEST OPHTH VIS SCI, V53, P2424, DOI 10.1167/iovs.11-8436; Zhang QX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02644	58	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148183	10.1371/journal.pone.0148183	http://dx.doi.org/10.1371/journal.pone.0148183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863010	gold, Green Submitted, Green Published			2022-12-26	WOS:000370046600045
J	Choi, A; Fusch, G; Rochow, N; Fusch, C				Choi, Arum; Fusch, Gerhard; Rochow, Niels; Fusch, Christoph			Target Fortification of Breast Milk: Predicting the Final Osmolality of the Feeds	PLOS ONE			English	Article							PRETERM INFANTS; PROTEIN; OSMOLARITY; NUTRITION	For preterm infants, it is common practice to add human milk fortifiers to native breast milk to enhance protein and calorie supply because the growth rates and nutritional requirements of preterm infants are considerably higher than those of term infants. However, macronutrient intake may still be inadequate because the composition of native breast milk has individual inter-and intra-sample variation. Target fortification (TFO) of breast milk is a new nutritional regime aiming to reduce such variations by individually measuring and adding deficient macronutrients. Added TFO components contribute to the final osmolality of milk feeds. It is important to predict the final osmolality of TFO breast milk to ensure current osmolality recommendations are followed to minimize feeding intolerance and necrotizing enterocolitis. This study aims to develop and validate equations to predict the osmolality of TFO milk batches. To establish prediction models, the osmolalities of either native or supplemented breast milk with known amounts of fat, protein, and carbohydrates were analyzed. To validate prediction models, the osmolalities of each macronutrient and combinations of macronutrients were measured in an independent sample set. Additionally, osmolality was measured in TFO milk samples obtained from a previous clinical study and compared with predicted osmolality using the prediction equations. Following the addition of 1 g of carbohydrates (glucose polymer), 1 g of hydrolyzed protein, or 1 g of whey protein per 100 mL breast milk, the average increase in osmolality was 20, 38, and 4 mOsm/kg respectively. Adding fat decreased osmolality only marginally due to dilution effect. Measured and predicted osmolality of combinations of macronutrients as well as single macronutrient (R-2 = 0.93) were highly correlated. Using clinical data (n = 696), the average difference between the measured and predicted osmolality was 3 +/- 11 mOsm/kg and was not statistically significant. In conclusion, the prediction model can be utilized to estimate osmolality values after fortification.	[Choi, Arum; Fusch, Gerhard; Rochow, Niels; Fusch, Christoph] McMaster Univ, Dept Pediat, Div Neonatol, Hamilton, ON, Canada	McMaster University	Fusch, C (corresponding author), McMaster Univ, Dept Pediat, Div Neonatol, Hamilton, ON, Canada.	fusch@mcmaster.ca	Choi, Arum/R-7185-2019; Fusch, Gerhard/ABG-1096-2021; Rochow, Niels/A-9785-2011	Fusch, Gerhard/0000-0003-4026-3211; Rochow, Niels/0000-0001-7990-3904	Canadian Institute of Health Research (CIHR) [MOP-125883]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Christoph Fusch holds the Hamilton Health Sciences Foundation - Jack Sinclair Chair in Neonatology, Faculty of Health Sciences at McMaster University, Hamilton, Ontario, Canada. The study was funded by Canadian Institute of Health Research (CIHR) #MOP-125883.	Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; [Anonymous], 1976, PEDIATRICS, V57, P278; Arslanoglu S, 2006, J PERINATOL, V26, P614, DOI 10.1038/sj.jp.7211571; BOOK LS, 1975, J PEDIATR-US, V87, P602, DOI 10.1016/S0022-3476(75)80835-3; Chang WK, 2011, JPEN-PARENTER ENTER, V35, P412, DOI 10.1177/0148607110383864; Chauhan M, 2008, ARCH DIS CHILD-FETAL, V93, pF162, DOI 10.1136/adc.2007.115824; CHICA-Canada Paediatrics Interest Group, CHICA CAN POS STAT H; De Castro-Morel M, 2002, MILCHWISSENSCHAFT, V57, P367; De Curtis M, 1999, ARCH DIS CHILD-FETAL, V81, pF141, DOI 10.1136/fn.81.2.F141; Fenton TR, 2002, J PEDIATR GASTR NUTR, V35, P298, DOI 10.1097/00005176-200209000-00011; Fusch G, 2015, CLIN NUTR, V34, P465, DOI 10.1016/j.clnu.2014.05.005; Jocson MAL, 1997, PEDIATRICS, V100, P240, DOI 10.1542/peds.100.2.240; KOO WWK, 1991, JPEN-PARENTER ENTER, V15, P144, DOI 10.1177/0148607191015002144; Kreissl A, 2013, J PEDIATR GASTR NUTR, V57, P432, DOI 10.1097/MPG.0b013e3182a208c7; MAUER AM, 1985, PEDIATRICS, V75, P976; Pearson F, 2013, ARCH DIS CHILD-FETAL, V98, pF166, DOI 10.1136/adc.2011.300492; Polberger S, 2009, NESTLE NUTR WORKS SE, V63, P195, DOI 10.1159/000209982; Radmacher PG, 2012, J PERINATOL, V32, P227, DOI 10.1038/jp.2011.83; Rochow N, 2015, NUTRIENTS, V7, P2297, DOI 10.3390/nu7042297; Rochow N, 2013, J PEDIATR-US, V163, P1001, DOI 10.1016/j.jpeds.2013.04.052; Silkand V, 2011, J DAIRY SCI, V94, P6194, DOI [10.3168/jds.2011-4477, DOI 10.3168/JDS.2011-4477]; Slutzah M, 2010, J PEDIATR-US, V156, P26, DOI 10.1016/j.jpeds.2009.07.023; Srinivasan L, 2004, ARCH DIS CHILD-FETAL, V89, pF514, DOI 10.1136/adc.2003.037192	23	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148941	10.1371/journal.pone.0148941	http://dx.doi.org/10.1371/journal.pone.0148941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863130	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600127
J	Muller, CA; Riemer, S; Viranyi, Z; Huber, L; Range, F				Mueller, Corsin A.; Riemer, Stefanie; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike			Inhibitory Control, but Not Prolonged Object-Related Experience Appears to Affect Physical Problem-Solving Performance of Pet Dogs	PLOS ONE			English	Article							CANIS-LUPUS-FAMILIARIS; CORVIDS CORVUS-CORAX; SELF-CONTROL; TOOL-USE; PAN-TROGLODYTES; GORILLA-GORILLA; BEHAVIORAL FLEXIBILITY; PONGO-PYGMAEUS; COGNITION; APES	Human infants develop an understanding of their physical environment through playful interactions with objects. Similar processes may influence also the performance of non-human animals in physical problem-solving tasks, but to date there is little empirical data to evaluate this hypothesis. In addition or alternatively to prior experiences, inhibitory control has been suggested as a factor underlying the considerable individual differences in performance reported for many species. Here we report a study in which we manipulated the extent of object-related experience for a cohort of dogs (Canis familiaris) of the breed Border Collie over a period of 18 months, and assessed their level of inhibitory control, prior to testing them in a series of four physical problem-solving tasks. We found no evidence that differences in object-related experience explain variability in performance in these tasks. It thus appears that dogs do not transfer knowledge about physical rules from one physical problem-solving task to another, but rather approach each task as a novel problem. Our results, however, suggest that individual performance in these tasks is influenced in a complex way by the subject's level of inhibitory control. Depending on the task, inhibitory control had a positive or a negative effect on performance and different aspects of inhibitory control turned out to be the best predictors of individual performance in the different tasks. Therefore, studying the interplay between inhibitory control and problem-solving performance will make an important contribution to our understanding of individual and species differences in physical problem-solving performance.	[Mueller, Corsin A.; Riemer, Stefanie; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Mueller, Corsin A.; Riemer, Stefanie; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike] Univ Vienna, Vienna, Austria; [Mueller, Corsin A.; Riemer, Stefanie] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Riemer, Stefanie] Lincoln Univ, Sch Life Sci, Anim Behav Cognit & Welf Res Grp, Lincoln, England	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Vienna; University of Lincoln	Muller, CA (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria.; Muller, CA (corresponding author), Univ Vienna, Vienna, Austria.; Muller, CA (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	corsin.mueller@vetmeduni.ac.at		Huber, Ludwig/0000-0002-0217-136X; Riemer, Stefanie/0000-0001-8008-5291; Range, Friederike/0000-0003-3127-5536	Austrian Science Fund [P21418]; DK CogCom Program (FWF) [W1234]; Vienna Science and Technology Fund [CS11-005, CS11-026]; Clever Dog Lab from Royal Canin	Austrian Science Fund(Austrian Science Fund (FWF)); DK CogCom Program (FWF); Vienna Science and Technology Fund; Clever Dog Lab from Royal Canin	This work was funded by the Austrian Science Fund (http://www.fwf.ac.at/) grant P21418 to LH and FR. In addition, SR received support from the DK CogCom Program (FWF Doctoral Programs W1234), LH and ZV from the Vienna Science and Technology Fund (http://www.wwtf.at/) grants CS11-005 and CS11-026, and the Clever Dog Lab from Royal Canin and a private sponsor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiach-Serrano A, 2012, J COMP PSYCHOL, V126, P355, DOI 10.1037/a0028050; Albiach-Serrano A, 2012, APPL ANIM BEHAV SCI, V141, P25, DOI 10.1016/j.applanim.2012.07.005; Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; [Anonymous], 2014, R LANG ENV STAT COMP; Auersperg AMI, 2015, J COMP PSYCHOL, V129, P62, DOI 10.1037/a0038314; Auersperg AMI, 2011, BIOL LETTERS, V7, P825, DOI 10.1098/rsbl.2011.0388; Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Auersperg AMI, 2009, BIOL LETTERS, V5, P455, DOI 10.1098/rsbl.2009.0114; Baillargeon R., 2002, BLACKWELL HDB CHILDH, P47, DOI DOI 10.1002/9780470996652.CH3; Bania AE, 2009, ANIM COGN, V12, P85, DOI 10.1007/s10071-008-0173-0; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Bensky MK, 2013, ADV STUD BEHAV, V45, P209, DOI 10.1016/B978-0-12-407186-5.00005-7; Bezdjian S, 2011, CLIN PSYCHOL REV, V31, P1209, DOI 10.1016/j.cpr.2011.07.005; Boesch C, 2012, WILD CULTURES: A COMPARISON BETWEEN CHIMPANZEE AND HUMAN CULTURES, P1, DOI 10.1017/CBO9781139178532; Bonawitz EB, 2012, COGNITIVE PSYCHOL, V64, P215, DOI 10.1016/j.cogpsych.2011.12.002; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Bray EE, 2014, ANIM COGN, V17, P15, DOI 10.1007/s10071-013-0633-z; BRENT L, 1995, PRIMATES, V36, P265, DOI 10.1007/BF02381352; BROWN AL, 1990, COGNITIVE SCI, V14, P107, DOI 10.1016/0364-0213(90)90028-U; Byrne R. W., 1997, MACHIAVELLIAN INTELL, P289, DOI DOI 10.1017/CBO9780511525636.012; Cacchione T, 2009, J COMP PSYCHOL, V123, P168, DOI 10.1037/a0013580; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Cunningham C, 2011, ANIM COGN, V14, P599, DOI 10.1007/s10071-011-0380-y; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P637, DOI 10.1111/j.1749-6632.1990.tb48913.x; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Duckworth AL, 2010, APPETITE, V54, P304, DOI 10.1016/j.appet.2009.11.016; Fiset S, 2013, J COMP PSYCHOL, V127, P115, DOI 10.1037/a0030595; FRANK H, 1982, ANIM BEHAV, V30, P95, DOI 10.1016/S0003-3472(82)80241-8; FRANK H, 1980, Z TIERPSYCHOL, V53, P389; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Gagne JR, 2010, BEHAV GENET, V40, P327, DOI 10.1007/s10519-009-9316-6; Gajdon G. K., 2014, Open Journal of Animal Sciences, V4, P51, DOI 10.4236/ojas.2014.42008; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; Graham KL, 2010, Q REV BIOL, V85, P393, DOI 10.1086/656903; Hanus D, 2011, ANIM COGN, V14, P871, DOI 10.1007/s10071-011-0421-6; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hauser MD, 2002, ANIM BEHAV, V64, P387, DOI 10.1006/anbe.2002.3066; Herrmann E, 2008, J COMP PSYCHOL, V122, P220, DOI 10.1037/0735-7036.122.2.220; Herrmann E, 2012, PHILOS T R SOC B, V367, P2753, DOI 10.1098/rstb.2012.0191; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Irie-Sugimoto N, 2008, ANIM COGN, V11, P359, DOI 10.1007/s10071-007-0126-z; Johnson SP, 2010, COGNITIVE SCI, V34, P1158, DOI 10.1111/j.1551-6709.2010.01127.x; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kundey SMA, 2010, ANIM COGN, V13, P497, DOI 10.1007/s10071-009-0300-6; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; Liedtke J, 2011, ANIM COGN, V14, P143, DOI 10.1007/s10071-010-0347-4; LIMONGELLI L, 1995, J COMP PSYCHOL, V109, P18, DOI 10.1037/0735-7036.109.1.18; Lockman JJ, 2000, CHILD DEV, V71, P137, DOI 10.1111/1467-8624.00127; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Manrique HM, 2011, ANIM COGN, V14, P213, DOI 10.1007/s10071-010-0355-4; Marshall-Pescini S, 2011, ANIM COGN, V14, P137, DOI 10.1007/s10071-010-0340-y; Marshall-Pescini S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118469; Marshall-Pescini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035437; Martin-Ordas G, 2012, ANIM COGN, V15, P1007, DOI 10.1007/s10071-012-0504-z; Miklosi A., 2007, DOG BEHAV EVOLUTION; Miller HC, 2010, PSYCHOL SCI, V21, P534, DOI 10.1177/0956797610364968; MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037/0022-3514.54.4.687; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Montgomery SH, 2014, ANIM BEHAV, V90, P281, DOI 10.1016/j.anbehav.2014.02.004; Muller CA, 2014, ANIM COGN, V17, P1071, DOI 10.1007/s10071-014-0739-y; Muller CA, 2014, ANIM COGN, V17, P821, DOI 10.1007/s10071-013-0709-9; Muller CA, 2011, BIOL LETTERS, V7, P689, DOI 10.1098/rsbl.2011.0287; Mulcahy NJ, 2006, ANIM COGN, V9, P193, DOI 10.1007/s10071-006-0019-6; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Oaten M, 2006, BRIT J HEALTH PSYCH, V11, P717, DOI 10.1348/135910706X96481; Osthaus B, 2005, ANIM COGN, V8, P37, DOI 10.1007/s10071-004-0230-2; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Range F, 2012, ANIM COGN, V15, P597, DOI 10.1007/s10071-012-0488-8; Range F, 2011, ANIM COGN, V14, P575, DOI 10.1007/s10071-011-0394-5; Reaux JE, 2000, FOLK PHYS APES CHIMP, P108; Riemer S, 2014, ANIM COGN, V17, P815, DOI 10.1007/s10071-013-0701-4; Riemer S, 2014, J COMP PSYCHOL, V128, P31, DOI 10.1037/a0033202; Santos LR, 2006, INFANCY, V9, P147, DOI 10.1207/s15327078in0902_4; Santos LR, 2004, DEVELOPMENTAL SCI, V7, P167, DOI 10.1111/j.1467-7687.2004.00335.x; Seed AM, 2006, CURR BIOL, V16, P697, DOI 10.1016/j.cub.2006.02.066; Seed A, 2009, ETHOLOGY, V115, P401, DOI 10.1111/j.1439-0310.2009.01644.x; Seed AM, 2009, J EXP PSYCHOL ANIM B, V35, P23, DOI 10.1037/a0012925; Silva FJ, 2005, LEARN BEHAV, V33, P47; Spelke ES, 2000, AM PSYCHOL, V55, P1233, DOI 10.1037/0003-066X.55.11.1233; Stahl AE, 2015, SCIENCE, V348, P91, DOI 10.1126/science.aaa3799; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Tebbich S, 2007, ANIM COGN, V10, P225, DOI 10.1007/s10071-006-0061-4; Teschke I, 2011, ANIM COGN, V14, P555, DOI 10.1007/s10071-011-0390-9; Thompson WR, 1954, CAN J PSYCHOLOGY, V8, P17, DOI 10.1037/h0083595; Tsukayama E, 2013, DEVELOPMENTAL SCI, V16, P879, DOI 10.1111/desc.12067; Tsukayama E, 2012, EUR J PERSONALITY, V26, P318, DOI 10.1002/per.841; Tsukayama E, 2010, JUDGM DECIS MAK, V5, P72; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Wallis LJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00071; Yamazaki Y, 2011, ANIM COGN, V14, P175, DOI 10.1007/s10071-010-0351-8; [No title captured]	98	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147753	10.1371/journal.pone.0147753	http://dx.doi.org/10.1371/journal.pone.0147753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863141	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600037
J	Owocki, K; Kremer, B; Wrzosek, B; Krolikowska, A; Kazmierczak, J				Owocki, Krzysztof; Kremer, Barbara; Wrzosek, Beata; Krolikowska, Agata; Kazmierczak, Jozef			Fungal Ferromanganese Mineralisation in Cretaceous Dinosaur Bones from the Gobi Desert, Mongolia	PLOS ONE			English	Article							BIOGENIC MANGANESE OXIDES; RAMAN-SPECTROSCOPY; STRAIN KR21-2; IRON-OXIDES; MN OXIDES; MINERALS; TODOROKITE; MECHANISMS; AMBER; IDENTIFICATION	Well-preserved mycelia of fungal- or saprolegnia-like biota mineralised by ferromanganese oxides were found for the first time in long bones of Late Cretaceous dinosaurs from the Gobi Desert (Nemegt Valley, Mongolia). The mycelia formed a biofilm on the wall of the bone marrow cavity and penetrated the osteon channels of the nearby bone tissue. Optical microscopy, Raman, SEM/EDS, SEM/BSE, electron microprobe and cathodoluminescence analyses revealed that the mineralisation of the mycelia proceeded in two stages. The first stage was early post-mortem mineralisation of the hyphae by Fe/Mn-oxide coatings and microconcretions. Probably this proceeded in a mildly acidic to circumneutral environment, predominantly due to heterotrophic bacteria degrading the mycelial necromass and liberating Fe and Mn sorbed by the mycelia during its lifetime. The second stage of mineralisation, which proceeded much later following the final burial of the bones in an alkaline environment, resulted from the massive precipitation of calcite and occasionally barite on the iron/manganeseoxide-coated mycelia. The ineral phases produced by fungal biofilms colonising the interiors of decaying dinosaur bones not only enhance the preservation (fossilisation) of fungal remains but can also be used as indicators of the geochemistry of the dinosaur burial sites.	[Owocki, Krzysztof; Kremer, Barbara; Kazmierczak, Jozef] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Wrzosek, Beata; Krolikowska, Agata] Warsaw Univ, Fac Chem, Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Warsaw	Owocki, K (corresponding author), Polish Acad Sci, Inst Paleobiol, Warsaw, Poland.	kowoc@twarda.pan.pl	Królikowska, Agata/D-9594-2014; Królikowska, Agata/AAH-3944-2019; Wrzosek, Beata/I-9473-2016; Owocki, Krzysztof/ABA-4558-2020; Kremer, Barbara/ABB-1201-2020	Królikowska, Agata/0000-0001-7245-2709; Królikowska, Agata/0000-0001-7245-2709; Owocki, Krzysztof/0000-0002-1270-3622; Kremer, Barbara/0000-0002-0464-1265	Polish Ministry of Science and Higher Education [N N307 24293]; European Regional Development Fund within Innovation Economy Operational Programme [POIG.02.02.00-00-025/09]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Regional Development Fund within Innovation Economy Operational Programme	The study was supported by the grant N N307 24293 of the Polish Ministry of Science and Higher Education for KO. Cathodoluminescence analyses were performed at the NanoFun laboratories co-financed by the European Regional Development Fund within the Innovation Economy Operational Programme POIG.02.02.00-00-025/09.	[Anonymous], 1974, OCCASIONAL PAPERS FA; [Anonymous], 1970, PALAENTOL POL; Ascaso C, 2005, MICROPALEONTOLOGY, V51, P59, DOI 10.2113/51.1.59; Bargar JR, 2009, GEOCHIM COSMOCHIM AC, V73, P889, DOI 10.1016/j.gca.2008.10.036; Beckner GJ, 2009, CARBONATE CEMENTATIO, P27; BEHRENSMEYER AK, 1982, PALEOBIOLOGY, V8, P211, DOI 10.1017/S0094837300006941; BERNARD MC, 1993, J ELECTROCHEM SOC, V140, P3065, DOI 10.1149/1.2220986; BISCHOFF WD, 1985, AM MINERAL, V70, P581; BRIGGS DEG, 1993, SCIENCE, V259, P1439, DOI 10.1126/science.259.5100.1439; BRIGGS DEG, 1994, PALAIOS, V9, P431, DOI 10.2307/3515135; Brock-Hon AL, 2012, GEODERMA, V179, P1, DOI 10.1016/j.geoderma.2012.02.012; Buciuman F, 1999, PHYS CHEM CHEM PHYS, V1, P185, DOI 10.1039/a807821a; Carpenter K, 2005, NEUES JAHRB GEOL P-M, P83; Carpenter K., 1999, J VERTEBR PALEONTOL, V19, P36; Daniel JC, 2010, PALAIOS, V25, P507, DOI 10.2110/palo.2009.p09-120r; Davis PG, 1997, INT J OSTEOARCHAEOL, V7, P388, DOI 10.1002/(SICI)1099-1212(199707/08)7:4<388::AID-OA357>3.0.CO;2-H; De Luca NG, 2000, ADV MICROB PHYSIOL, V43, P39, DOI 10.1016/S0065-2911(00)43002-X; deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B; Ehrlich HL., 2015, GEOMICROBIOL J; Feng XH, 2010, GEOCHIM COSMOCHIM AC, V74, P3232, DOI 10.1016/j.gca.2010.03.005; Froment F, 2008, J RAMAN SPECTROSC, V39, P560, DOI 10.1002/jrs.1858; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; GRADZINSKI R, 1977, Acta Geologica Polonica, V27, P281; Grangeon S, 2010, AM MINERAL, V95, P1608, DOI 10.2138/am.2010.3516; HACKETT CJ, 1981, MED SCI LAW, V21, P243, DOI 10.1177/002580248102100403; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Hof CHJ, 1997, PALAIOS, V12, P420, DOI 10.2307/3515381; Isaac S, 1997, MYCOLOGIST 2, V4, P182; Jackson FD, 2009, PALAIOS, V24, P840, DOI 10.2110/palo.2009.p09-053r; Jans MME, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P397, DOI 10.1007/978-3-540-77598-0_20; Jans MME, 2004, J ARCHAEOL SCI, V31, P87, DOI 10.1016/j.jas.2003.07.007; Jerzykiewicz T, 1998, GEOSCI CAN, V25, P15; Jerzykiewicz Tom, 2000, P279; Julien C, 2002, J RAMAN SPECTROSC, V33, P223, DOI 10.1002/jrs.838; Julien CM, 2004, SPECTROCHIM ACTA A, V60, P689, DOI 10.1016/S1386-1425(03)00279-8; Kalgutkar RM, 2000, AASP FDN CONTRIBUTIO, V39, P1; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Kim HS, 2004, J PHYS CHEM B, V108, P17019, DOI 10.1021/jp048810a; Kim HS, 2003, J AM CHEM SOC, V125, P14284, DOI 10.1021/ja0375784; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Kremer B, 2012, PALAEOGEOGR PALAEOCL, V358, P51, DOI 10.1016/j.palaeo.2012.07.020; Kretzschmar M., 1982, FACIES, V7, P237, DOI [10.1007/BF02537228, DOI 10.1007/BF02537228]; Krings M, 2013, PERSOONIA, V30, P1, DOI 10.3767/003158513X664819; Marshall CP, 2013, ASTROBIOLOGY, V13, P920, DOI 10.1089/ast.2013.1034; Miller AZ, 2012, CHEM GEOL, V322, P181, DOI 10.1016/j.chemgeo.2012.07.005; Mironova-Ulmane N, 2009, J ALLOY COMPD, V480, P97, DOI 10.1016/j.jallcom.2008.10.056; Miyata N, 2004, FEMS MICROBIOL ECOL, V47, P101, DOI 10.1016/S0168-6496(03)00251-4; Miyata N, 2006, GEOMICROBIOL J, V23, P63, DOI 10.1080/01490450500533809; Miyata N, 2007, J BIOSCI BIOENG, V104, P1, DOI 10.1263/jbb.104.1; Miyata N, 2006, APPL ENVIRON MICROB, V72, P6467, DOI 10.1128/AEM.00417-06; Oh SJ, 1998, HYPERFINE INTERACT, V112, P59, DOI 10.1023/A:1011076308501; Pasteris J.D., 1991, CAN MINERAL, V29, P143; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; Pfretzschner HU, 2006, PALAEONTOGR ABT A, V278, P135, DOI 10.1127/pala/278/2006/135; Pfretzschner HU, 2011, PALAEOGEOGR PALAEOCL, V310, P117, DOI 10.1016/j.palaeo.2011.01.026; Poinar G, 2006, J INVERTEBR PATHOL, V93, P36, DOI 10.1016/j.jip.2006.04.006; Puceat E, 2004, CHEM GEOL, V205, P83, DOI 10.1016/j.chemgeo.2003.12.014; REMY W, 1994, AM J BOT, V81, P690, DOI 10.2307/2445647; Reynard B, 1999, CHEM GEOL, V155, P233, DOI 10.1016/S0009-2541(98)00169-7; Sagemann J, 1999, GEOCHIM COSMOCHIM AC, V63, P1083, DOI 10.1016/S0016-7037(99)00087-3; Santelli CM, 2011, GEOCHIM COSMOCHIM AC, V75, P2762, DOI 10.1016/j.gca.2011.02.022; Sawlowicz Z, 2000, PRACE MINERALOGICZNE; Sharma N, 2005, MICROPALEONTOLOGY, V51, P73, DOI 10.2113/51.1.73; SHERMAN DM, 1985, AM MINERAL, V70, P1262; Shuvalov Vladimir F., 2000, P256; SIEGEL SM, 1990, WATER AIR SOIL POLL, V53, P335; Speranza M, 2010, MICROSCOPY SCI TECHN, P1135; STOOPS GJ, 1978, GEODERMA, V20, P63, DOI 10.1016/0016-7061(78)90050-2; Talyor T.N., 2015, FOSSIL FUNGI; Taylor TN, 1997, REV PALAEOBOT PALYNO, V95, P83, DOI 10.1016/S0034-6667(96)00029-2; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349; Taylor TN, 2015, SYSTEMATICS EVOLUTIO, P259, DOI [10.1007/978-3-662-46011-5_10, DOI 10.1007/978-3-662-46011-5_10]; Taylor TN, 1993, FOSS REC, P9; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Thomas DB, 2011, PALAEOGEOGR PALAEOCL, V310, P62, DOI 10.1016/j.palaeo.2011.06.016; THOMAS GM, 1988, J PALEONTOL, V62, P141; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; Trueman CNG, 2004, J ARCHAEOL SCI, V31, P721, DOI 10.1016/j.jas.2003.11.003; Turner-Walker G, 2008, PALAEOGEOGR PALAEOCL, V266, P227, DOI 10.1016/j.palaeo.2008.03.024; Verrecchia EP, 2000, MICROBIAL SEDIMENTS, P68; Villalobos M, 2006, AM MINERAL, V91, P489, DOI 10.2138/am.2006.1925; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Webb SM, 2005, AM MINERAL, V90, P1342, DOI 10.2138/am.2005.1669; Wedl, 1864, AKAD WISSENSCHAFTEN, V50, P171; Weigelt Johannes, 1989, RECENT VERTEBRATE CA, DOI DOI 10.7208/CHICAGO/9780226881683.001.0001; White SN, 2009, CHEM GEOL, V259, P240, DOI 10.1016/j.chemgeo.2008.11.008; Wilby PR, 1996, J GEOLOGICAL SCI, V153, P665, DOI [10.1144/gsjgs.153.5.0665, DOI 10.1144/GSJGS.153.5.0665]; Winkelmann G, 1994, METAL IONS IN FUNGI; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Xiao F, 2012, INT J ELECTROCHEM SC, V7, P7440	91	14	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146293	10.1371/journal.pone.0146293	http://dx.doi.org/10.1371/journal.pone.0146293			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863014	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600009
J	Pfortmueller, CA; Schwetlick, M; Mueller, T; Lehmann, B; Exadaktylos, AK				Pfortmueller, Carmen Andrea; Schwetlick, Miriam; Mueller, Thomas; Lehmann, Beat; Exadaktylos, Aristomenis Konstantinos			Adult Asylum Seekers from the Middle East Including Syria in Central Europe: What Are Their Health Care Problems?	PLOS ONE			English	Article							BODILY DISTRESS; MULTIMORBIDITY; PREVALENCE; MORBIDITY; DISEASES	Background Forced displacement related to persecution and violent conflict has reached a new peak in recent years. The primary aim of this study is to provide an initial overview of the acute and chronic health care problems of asylum seekers from the Middle East, with special emphasis on asylum seekers from Syria. Methods Our retrospective data analysis comprised adult patients presenting to our emergency department between 01.11.2011 and 30.06.2014 with the official resident status of an "asylum seeker" or "refugee" from the Middle East. Results In total, 880 patients were included in the study. Of these, 625 (71.0%) were male and 255 (29.0%) female. The median age was 34 (range 16-84). 222 (25.2%) of our patients were from Syria. The most common reason for presentation was surgical (381, 43.3%), followed by medical (321, 36.5%) and psychiatric (137, 15.6%). In patients with surgical presentations, trauma-related problems were most common (n = 196, 50.6%). Within the group of patients with medical presentation, acute infectious diseases were most common (n = 141, 43.9%), followed by neurological problems (n = 70, 21.8%) and gastrointestinal problems (n = 47, 14.6%). There were no differences between Syrian and non-Syrian refugees concerning surgical or medical admissions. The most common chronic disorder of unclear significance was chronic gastrointestinal problems (n = 132, 15%), followed by chronic musculoskeletal problems (n = 108, 12.3%) and chronic headaches (n = 78, 8.9%). Patients from Syria were significantly younger and more often suffered from a post-traumatic stress disorder than patients of other nationalities (p<0.0001, and p = 0.05, respectively). Conclusion Overall a remarkable number of our very young group of patients suffered from psychiatric disorders and unspecified somatic symptoms. Asylum seekers should be carefully evaluated when presenting to a medical facility and physicians should be aware of the high incidence of unspecified somatic symptoms in this patient population. In general, there is no major difference between asylum seekers from Syria when compared to other nationalities of asylum seekers from the Middle East.	[Pfortmueller, Carmen Andrea] Med Univ Vienna, Dept Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria; [Schwetlick, Miriam; Lehmann, Beat; Exadaktylos, Aristomenis Konstantinos] Univ Hosp Bern, Univ Dept Emergency Med, CH-3010 Bern, Switzerland; [Schwetlick, Miriam; Mueller, Thomas; Lehmann, Beat; Exadaktylos, Aristomenis Konstantinos] Univ Bern, Bern, Switzerland; [Mueller, Thomas] Univ Hosp Psychiat, Bern, Switzerland	Medical University of Vienna; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Med Univ Vienna, Dept Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria.	cpfortmueller@gmail.com	Müller, Thomas/D-1212-2010	Müller, Thomas/0000-0001-9315-8138; Pfortmueller, Carmen/0000-0003-0326-2770				Aarts S, 2012, J PSYCHOSOM RES, V73, P211, DOI 10.1016/j.jpsychores.2012.05.014; Bischoff A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13252; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Buhmann Cacilie, 2015, Torture, V25, P1; Buhmann CB, 2014, DAN MED J, V61; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Cookson ST, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0044-7; Doocy Shannon, 2015, PLoS Curr, V7, DOI 10.1371/currents.dis.6b7587562e58cf965bf2d7be36f96de6; Fink P, 2007, PSYCHOSOM MED, V69, P30, DOI 10.1097/PSY.0b013e31802e46eb; Fink P, 2010, J PSYCHOSOM RES, V68, P415, DOI 10.1016/j.jpsychores.2010.02.004; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Harris MF, 2001, MED J AUSTRALIA, V175, P589, DOI 10.5694/j.1326-5377.2001.tb143739.x; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Laban CJ, 2008, SOC PSYCH PSYCH EPID, V43, P507, DOI 10.1007/s00127-008-0333-1; Maier T, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13110; McKenzie ED, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0038-5; Migration Bf, 2012, AS 2011 2011; Mohammad Y, 2012, J THORAC DIS, V4, P203, DOI 10.3978/j.issn.2072-1439.2011.11.07; Nickerson A, 2011, PSYCHIAT RES, V187, P267, DOI 10.1016/j.psychres.2010.12.015; Pfortmueller CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082671; Pfortmueller CA, 2012, WIEN KLIN WOCHENSCHR, V124, P647, DOI 10.1007/s00508-012-0227-9; Piette John D, 2008, J Diabetes Sci Technol, V2, P15; Starfield B, 2011, HEALTH POLICY, V103, P3, DOI 10.1016/j.healthpol.2011.09.004; Stone-Brown K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7375; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54	26	50	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148196	10.1371/journal.pone.0148196	http://dx.doi.org/10.1371/journal.pone.0148196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863216	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600047
J	Scannell, JW; Bosley, J				Scannell, Jack W.; Bosley, Jim			When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis	PLOS ONE			English	Article							COST EFFICIENCY; BIOMEDICAL-RESEARCH; SUCCESS RATES; PRODUCTIVITY; VALIDATION; IMPROVE; MODELS; CHALLENGES; QUESTIONS; OPTIMIZE	A striking contrast runs through the last 60 years of biopharmaceutical discovery, research, and development. Huge scientific and technological gains should have increased the quality of academic science and raised industrial R&D efficiency. However, academia faces a "reproducibility crisis"; inflation-adjusted industrial R&D costs per novel drug increased nearly 100 fold between 1950 and 2010; and drugs are more likely to fail in clinical development today than in the 1970s. The contrast is explicable only if powerful headwinds reversed the gains and/or if many "gains" have proved illusory. However, discussions of reproducibility and R&D productivity rarely address this point explicitly. The main objectives of the primary research in this paper are: (a) to provide quantitatively and historically plausible explanations of the contrast; and (b) identify factors to which R&D efficiency is sensitive. We present a quantitative decision-theoretic model of the R&D process. The model represents therapeutic candidates (e.g., putative drug targets, molecules in a screening library, etc.) within a "measurement space", with candidates' positions determined by their performance on a variety of assays (e.g., binding affinity, toxicity, in vivo efficacy, etc.) whose results correlate to a greater or lesser degree. We apply decision rules to segment the space, and assess the probability of correct R&D decisions. We find that when searching for rare positives (e.g., candidates that will successfully complete clinical development), changes in the predictive validity of screening and disease models that many people working in drug discovery would regard as small and/or unknowable (i.e., an 0.1 absolute change in correlation coefficient between model output and clinical outcomes in man) can offset large (e.g., 10 fold, even 100 fold) changes in models' brute-force efficiency. We also show how validity and reproducibility correlate across a population of simulated screening and disease models. We hypothesize that screening and disease models with high predictive validity are more likely to yield good answers and good treatments, so tend to render themselves and their diseases academically and commercially redundant. Perhaps there has also been too much enthusiasm for reductionist molecular models which have insufficient predictive validity. Thus we hypothesize that the average predictive validity of the stock of academically and industrially "interesting" screening and disease models has declined over time, with even small falls able to offset large gains in scientific knowledge and brute-force efficiency. The rate of creation of valid screening and disease models may be the major constraint on R&D productivity.	[Scannell, Jack W.] Univ Oxford, Ctr Adv Sustainable Med Innovat, Oxford, England; [Scannell, Jack W.] Univ Edinburgh, Innogen Inst, Sci Technol & Innovat Studies, Edinburgh, Midlothian, Scotland; [Scannell, Jack W.] JW Scannell Analyt Ltd, 32 Queens Crescent, Edinburgh, Midlothian, Scotland; [Bosley, Jim] Clerbos LLC, Kennett Sq, PA USA	University of Oxford; University of Edinburgh	Scannell, JW (corresponding author), Univ Oxford, Ctr Adv Sustainable Med Innovat, Oxford, England.; Scannell, JW (corresponding author), Univ Edinburgh, Innogen Inst, Sci Technol & Innovat Studies, Edinburgh, Midlothian, Scotland.; Scannell, JW (corresponding author), JW Scannell Analyt Ltd, 32 Queens Crescent, Edinburgh, Midlothian, Scotland.	jack.scannell@ed.ac.uk			JW Scannell Analytics Ltd; Clerbos LLC	JW Scannell Analytics Ltd; Clerbos LLC	The authors received funding from JW Scannell Analytics Ltd (JWS) and from Clerbos LLC (JB). JW Scannell Analytics Ltd provided research materials for JWS and paid the PLOS ONE Publication Fee for the paper. Clerbos LLC provided support in the form of salary for JB. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajay, 1998, J MED CHEM, V41, P3314, DOI 10.1021/jm970666c; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; [Anonymous], 2000, Nat Biotechnol, V18 Suppl, pIT50; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Bacchetti P, 2008, BIOMETRICS, V64, P577, DOI [10.1111/j.1541-0420.2008.01004.x, 10.1111/j.1541-0420.2008.01004_1.x]; Bacchetti P, 2008, BIOMETRICS, V64, P592, DOI 10.1111/j.1541-0420.2008.01004_5.x; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Bacchetti P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-17; Baker S, 1989, COMMUNICATIONS STAT, V20, P2739; Beck B, 2002, ENCY ENV, P1275; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-9; Bender A, 2008, CURR OPIN DRUG DISC, V11, P327; Benner SA, 2013, ASTROBIOLOGY, V13, P510, DOI 10.1089/ast.2012.0954; Berndt ER, 2015, HEALTH AFFAIR, V34, P245, DOI 10.1377/hlthaff.2014.1029; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Booth B, 2004, NAT REV DRUG DISCOV, V3, P451, DOI 10.1038/nrd1384; Brand D., 2004, YEARS HOURS CALCULAT; Brown CD, 2006, CHEMOMETR INTELL LAB, V80, P24, DOI 10.1016/j.chemolab.2005.05.004; Brunke S, 2015, DIS MODEL MECH, V8, P473, DOI 10.1242/dmm.019901; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Casadevall A, 2015, P NATL ACAD SCI US; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Coma I, 2009, J BIOMOL SCREEN, V14, P66, DOI 10.1177/1087057108326664; Cook D, 2014, NAT REV DRUG DISCOV; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Cumming JG, 2013, NAT REV DRUG DISCOV, V12, P948, DOI 10.1038/nrd4128; DeMonaco HJ, 2006, PHARMACOTHERAPY, V26, P323, DOI 10.1592/phco.26.3.323; DETSKY AS, 1990, STAT MED, V9, P173, DOI 10.1002/sim.4780090124; Dillon S, 2006, TARGET VALIDATION DR; DIMASI JA, 1995, CLIN PHARMACOL THER, V58, P1, DOI 10.1016/0009-9236(95)90066-7; Do CB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002973; Dolle RE, 2011, METHODS MOL BIOL, V685, P3, DOI 10.1007/978-1-60761-931-4_1; Dranchak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057888; Eder J, 2014, NAT REV DRUG DISCOV; Edwards W, 2007, ADVANCES IN DECISION ANALYSIS: FROM FOUNDATIONS TO APPLICATIONS, P1, DOI 10.1017/CBO9780511611308; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Funtowicz S. O., 1990, UNCERTAINTY QUALITY; GART JJ, 1966, AM J EPIDEMIOL, V83, P593, DOI 10.1093/oxfordjournals.aje.a120610; Gasparini M, 2013, EPIDEMIOL BIOSTAT PU, V10, DOI 10.2427/8760; Geysen HM, 2003, NAT REV DRUG DISCOV, V2, P222, DOI 10.1038/nrd10335; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hanley JA, 2008, BIOMETRICS, V64, P586, DOI 10.1111/j.1541-0420.2008.01004_2.x; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Healy D., 1997, ANTIDEPRESSANT ERA; Healy David, 2002, CREATION PSYCHOPHARM; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Hogan JC, 1997, NAT BIOTECHNOL, V15, P328, DOI 10.1038/nbt0497-328; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Horrobin D, 2011, NAT BIOTECHNOL, V19, P1099; Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012; Horrobin DF, 2000, J ROY SOC MED, V93, P341, DOI 10.1177/014107680009300702; Howard RA, 2007, ADVANCES IN DECISION ANALYSIS: FROM FOUNDATIONS TO APPLICATIONS, P32, DOI 10.1017/CBO9780511611308.004; Huang RL, 2006, J MED CHEM, V49, P1964, DOI 10.1021/jm051029m; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Joyner MJ, 2014, J PHYSIOL-LONDON, V592, P2381, DOI 10.1113/jphysiol.2014.272336; LaMattina J, 2012, FORBES; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Langer T, 2009, CURR OPIN PHARMACOL, V9, P589, DOI 10.1016/j.coph.2009.06.001; Le Fanu J., 1999, RISE FALL MODERN MED; Leach A. R., 2005, INTRO CHEMOINFORMATI; Lendrem DW, 2015, NAT REV DRUG DISCOV, V14, P220, DOI 10.1038/nrd4320-c1; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Mayr LM, 2008, J BIOMOL SCREEN, V13, P443, DOI 10.1177/1087057108319644; McArthur R A, 2008, ANIMAL TRANSLATIONAL, V1; Muller P, 2008, BIOMETRICS, V64, P587, DOI 10.1111/j.1541-0420.2008.01004_3.x; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; O'Hagan A, 2005, PHARM STAT, V4, P187, DOI 10.1002/pst.175; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pedro-Rosa L, 2015, J BIOMOL SCREEN, V20, P122, DOI 10.1177/1087057114548832; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Peterson M., 2009, INTRO DECISION THEOR; Petrone FM, 2012, ACS CHEM BIOL, V7, P1399, DOI 10.1021/cb3001028; Pickett SD, 2000, J CHEM INF COMP SCI, V40, P263, DOI 10.1021/ci990261w; Powledge TM, 2003, GENOME BIOL; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Sadowski J, 1998, J MED CHEM, V41, P3325, DOI 10.1021/jm9706776; Sams-Dodd F, 2006, DRUG DISCOV TODAY, V11, P355, DOI 10.1016/j.drudis.2006.02.005; Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1; Sams-Dodd F, 2013, DRUG DISCOV TODAY, V18, P211, DOI 10.1016/j.drudis.2012.10.010; SANGER F, 1988, ANNU REV BIOCHEM, V57, P1, DOI 10.1146/annurev.bi.57.070188.000245; Scannell JW, 2015, REV RECENT CLIN TRIA, V10, P28, DOI 10.2174/1574887110666150430151751; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Senn S., 2007, STAT ISSUES DRUG DEV; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Simon R, 2008, BIOMETRICS, V64, P589, DOI 10.1111/j.1541-0420.2008.01004_4.x; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; VANBRUNT J, 1986, BIO-TECHNOL, V4, P277; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; Willan AR, 2005, STAT MED, V24, P1791, DOI 10.1002/sim.2069; WILLNER P, 1984, PSYCHOPHARMACOLOGY, V83, P1, DOI 10.1007/BF00427414; Wong CC, 2012, J PHARMACOL EXP THER, V341, P572, DOI 10.1124/jpet.112.191957; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	105	141	145	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147215	10.1371/journal.pone.0147215	http://dx.doi.org/10.1371/journal.pone.0147215			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863229	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600020
J	Schlick, B; Massoner, P; Lueking, A; Charoentong, P; Blattner, M; Schaefer, G; Marquart, K; Theek, C; Amersdorfer, P; Zielinski, D; Kirchner, M; Trajanoski, Z; Rubin, MA; Mullner, S; Schulz-Knappe, P; Klocker, H				Schlick, Bettina; Massoner, Petra; Lueking, Angelika; Charoentong, Pornpimol; Blattner, Mirjam; Schaefer, Georg; Marquart, Klaus; Theek, Carmen; Amersdorfer, Peter; Zielinski, Dirk; Kirchner, Matthias; Trajanoski, Zlatko; Rubin, Mark A.; Muellner, Stefan; Schulz-Knappe, Peter; Klocker, Helmut			Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients	PLOS ONE			English	Article							INCREASED EXPRESSION; BIOMARKER DISCOVERY; ANTIGEN LEVELS; BENIGN; SPOP; IDENTIFICATION; HYPERPLASIA; ANTIBODIES; SIGNATURES; MUTATIONS	Background Chronic inflammation is frequently observed on histological analysis of malignant and nonmalignant prostate specimens. It is a suspected supporting factor for prostate diseases and their progression and a main cause of false positive PSA tests in cancer screening. We hypothesized that inflammation induces autoantibodies, which may be useful biomarkers. We aimed to identify and validate prostate inflammation associated serum autoantibodies in prostate cancer patients and evaluate the expression of corresponding autoantigens. Methods Radical prostatectomy specimens of prostate cancer patients (N = 70) were classified into high and low inflammation groups according to the amount of tissue infiltrating lymphocytes. The corresponding pre-surgery blood serum samples were scrutinized for autoantibodies using a low-density protein array. Selected autoantigens were identified in prostate tissue and their expression pattern analyzed by immunohistochemistry and qPCR. The identified autoantibody profile was cross-checked in an independent sample set (N = 63) using the Luminex-bead protein array technology. Results Protein array screening identified 165 autoantibodies differentially abundant in the serum of high compared to low inflammation patients. The expression pattern of three corresponding antigens were established in benign and cancer tissue by immunohistochemistry and qPCR: SPAST (Spastin), STX18 (Syntaxin 18) and SPOP (speckle-type POZ protein). Of these, SPAST was significantly increased in prostate tissue with high inflammation. All three autoantigens were differentially expressed in primary and/or castration resistant prostate tumors when analyzed in an inflammation-independent tissue microarray. Cross-validation of the inflammation autoantibody profile on an independent sample set using a Luminex-bead protein array, retrieved 51 of the significantly discriminating autoantibodies. Three autoantibodies were significantly upregulated in both screens, MUT, RAB11B and CSRP2 (p>0.05), two, SPOP and ZNF671, close to statistical significance (p = 0.051 and 0.076). Conclusions We provide evidence of an inflammation-specific autoantibody profile and confirm the expression of corresponding autoantigens in prostate tissue. This supports evaluation of autoantibodies as non-invasive markers for prostate inflammation.	[Schlick, Bettina; Massoner, Petra; Klocker, Helmut] Med Univ Innsbruck, Div Expt Urol, Dept Urol, A-6020 Innsbruck, Austria; [Schlick, Bettina; Massoner, Petra; Schaefer, Georg] Ctr Personalized Canc Med, ONCOTYROL, Innsbruck, Austria; [Lueking, Angelika; Marquart, Klaus; Theek, Carmen; Amersdorfer, Peter; Muellner, Stefan; Schulz-Knappe, Peter] Protagen AG, Dortmund, Germany; [Schaefer, Georg] Med Univ Innsbruck, Dept Pathol, A-6020 Innsbruck, Austria; [Charoentong, Pornpimol; Trajanoski, Zlatko] Med Univ Innsbruck, Div Bioinformat, A-6020 Innsbruck, Austria; [Blattner, Mirjam; Rubin, Mark A.] Cornell Univ, Dept Pathol & Lab Med, Inst Precis Med, Weill Med Coll, New York, NY 10021 USA; [Zielinski, Dirk; Kirchner, Matthias] TARGOS Mol Pathol GmbH, Kassel, Germany	Medical University of Innsbruck; Protagen Protein Services (PPS); Medical University of Innsbruck; Medical University of Innsbruck; Cornell University; Targos Molecular Pathology GmbH	Klocker, H (corresponding author), Med Univ Innsbruck, Div Expt Urol, Dept Urol, A-6020 Innsbruck, Austria.	helmut.klocker@i-med.ac.at	Klocker, Helmut/AAI-7130-2020; Trajanoski, Zlatko/AAT-6703-2021	Rubin, Mark/0000-0002-8321-9950; Amersdorfer, Peter/0000-0002-0983-5755	COMET K1 Center Oncotyrol-Center for Personalized Medicine - Austrian Research Promotion Agency (FFG); Future Foundation of the Country of Tyrol; Protagen AG; ONCOTYROL GmbH; TARGOS Molecular Pathology GmbH	COMET K1 Center Oncotyrol-Center for Personalized Medicine - Austrian Research Promotion Agency (FFG); Future Foundation of the Country of Tyrol; Protagen AG; ONCOTYROL GmbH; TARGOS Molecular Pathology GmbH	The study was supported by COMET K1 Center Oncotyrol-Center for Personalized Medicine, financed by the Austrian Research Promotion Agency (FFG) and the Future Foundation of the Country of Tyrol, and Protagen AG. ONCOTYROL GmbH, Protagen AG and TARGOS Molecular Pathology GmbH provided support in the form of salaries for authors [BS, PM, GS], [AL, KM, CT, PA, SM, PSK], [DZ, MK] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors declare no competing interest. The specific roles of these authors are articulated in the 'author contributions' section.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bartsch G, 2008, BJU INT, V101, P809, DOI 10.1111/j.1464-410X.2008.07502.x; Bassett T, 2008, CANCER LETT, V272, P167, DOI 10.1016/j.canlet.2008.07.014; Battikhi MNG, 2006, INT UROL NEPHROL, V38, P21, DOI 10.1007/s11255-005-1662-6; Bei R, 2009, CANCER LETT, V281, P8, DOI 10.1016/j.canlet.2008.11.009; Beyer NH, 2012, J NEUROIMMUNOL, V242, P26, DOI 10.1016/j.jneuroim.2011.08.013; Blattner M, 2014, NEOPLASIA, V16, P14, DOI 10.1593/neo.131704; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bostanci Y, 2013, CURR OPIN UROL, V23, P5, DOI 10.1097/MOU.0b013e32835abd4a; Bradford TJ, 2006, UROL ONCOL-SEMIN ORI, V24, P237, DOI 10.1016/j.urolonc.2005.11.033; Bul M, 2011, ACTA ONCOL, V50, P4, DOI 10.3109/0284186X.2010.522197; Caruso C, 2009, CANCER IMMUNOL IMMUN, V58, P1919, DOI 10.1007/s00262-009-0658-y; Carver BS, 2003, J UROLOGY, V169, P589, DOI 10.1016/S0022-5347(05)63959-6; Casiano CA, 2006, MOL CELL PROTEOMICS, V5, P1745, DOI 10.1074/mcp.R600010-MCP200; Croswell JM, 2011, ONCOLOGY-NY, V25, P452; Dancau AM, 2010, METHODS MOL BIOL, V576, P49, DOI 10.1007/978-1-59745-545-9_4; De Marzo AM, 2007, UROL ONCOL-SEMIN ORI, V25, P398, DOI 10.1016/j.urolonc.2007.05.007; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Draberova E, 2011, J NEUROPATH EXP NEUR, V70, P811, DOI 10.1097/NEN.0b013e31822c256d; Duffy MJ, 2015, ADV CLIN CHEM, V71, P1, DOI [10.1016/bs.acc.2015.05.001, 10.1016/B978-0-12-801401-1.00001-3]; Dunphy EJ, 2004, J CLIN IMMUNOL, V24, P492, DOI 10.1023/B:JOCI.0000040920.96065.5a; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fujita K, 2011, J UROLOGY, V185, P1722, DOI 10.1016/j.juro.2010.12.058; Gallon S, 2013, MATH BIOSCI, V242, P129, DOI 10.1016/j.mbs.2012.12.007; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Groves HK, 2013, PROSTATE CANCER P D, V16, P260, DOI 10.1038/pcan.2013.11; HASUI Y, 1994, PROSTATE, V25, P91, DOI 10.1002/pros.2990250206; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Horn S, 2006, PROTEOMICS, V6, P605, DOI 10.1002/pmic.200401293; Horta ES, 2014, CLIN CANCER RES, V20, P3862, DOI 10.1158/1078-0432.CCR-14-0652; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jia D, 2014, HEPATOLOGY; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jun BH, 2012, MOLECULES, V17, P2474, DOI 10.3390/molecules17032474; Karaman H, 2013, INT J MED SCI, V10, P1387, DOI 10.7150/ijms.6126; Kramer G, 2002, PROSTATE, V52, P43, DOI 10.1002/pros.10084; Lacombe J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/574981; Lepor H, 2004, REV UROL S9, V6, P3; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Lin HS, 2007, CANCER EPIDEM BIOMAR, V16, P2396, DOI 10.1158/1055-9965.EPI-07-0318; Liu YA, 2012, J IMMUNOTHER, V35, P299, DOI 10.1097/CJI.0b013e3182518e83; Lueking A, 2005, MOL CELL PROTEOMICS, V4, P1382, DOI 10.1074/mcp.T500004-MCP200; Mani RS, 2014, DRUG DISCOVERY TODAY; Maricque BB, 2011, PROSTATE, V71, P134, DOI 10.1002/pros.21229; Massoner P, 2012, PROSTATE, V72, P427, DOI 10.1002/pros.21444; MCCLINTON S, 1990, BRIT J CANCER, V61, P400, DOI 10.1038/bjc.1990.87; McDowell KL, 2010, PROSTATE, V70, P377, DOI 10.1002/pros.21071; Miah S, 2014, INDIAN J UROL, V30, P214, DOI 10.4103/0970-1591.126909; Narayanan NK, 2009, PROSTATE, V69, P133, DOI 10.1002/pros.20862; Nickel JC, 2001, BJU INT, V87, P797, DOI 10.1046/j.1464-410x.2001.02193.x; Nickel JC, 1999, BJU INT, V84, P976; O'Rourke DJ, 2012, CLIN CHIM ACTA, V413, P561, DOI 10.1016/j.cca.2011.11.027; Ozden C, 2007, INT UROL NEPHROL, V39, P859, DOI 10.1007/s11255-006-9125-2; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ran YL, 2008, CLIN CANCER RES, V14, P2696, DOI 10.1158/1078-0432.CCR-07-2021; Robert G, 2011, PROSTATE, V71, P1701, DOI 10.1002/pros.21387; Robert G, 2009, PROSTATE, V69, P1774, DOI 10.1002/pros.21027; Roehrborn CG, 2011, BJU INT, V108, P806, DOI 10.1111/j.1464-410X.2011.10365.x; Russo N, 2013, ONCOGENE, V32, P5026, DOI 10.1038/onc.2012.532; Salinas S, 2007, J NEUROSCI RES, V85, P2778, DOI 10.1002/jnr.21238; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Schaefer G, 2013, PROSTATE CANC PROSTA; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Soussi T, 2000, CANCER RES, V60, P1777; Storr SJ, 2006, EXPERT REV ANTICANC, V6, P1215, DOI 10.1586/14737140.6.8.1215; Taylor BS, 2008, MOL CELL PROTEOMICS, V7, P600, DOI 10.1074/mcp.M700263-MCP200; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wei QQ, 2014, PARKINSONISM RELAT D; Wu LL, 2010, CLIN CANCER RES, V16, P3760, DOI 10.1158/1078-0432.CCR-10-0193; Xu YW, 2014, AM J GASTROENTEROL, V109, P36, DOI 10.1038/ajg.2013.384; Zheng SL, 2006, PROSTATE, V66, P1556, DOI 10.1002/pros.20496	79	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147739	10.1371/journal.pone.0147739	http://dx.doi.org/10.1371/journal.pone.0147739			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863016	Green Submitted, gold, Green Published			2022-12-26	WOS:000370046600036
J	Christian, LM; Blair, LM; Porter, K; Lower, M; Cole, RM; Belury, MA				Christian, Lisa M.; Blair, Lisa M.; Porter, Kyle; Lower, Mary; Cole, Rachel M.; Belury, Martha A.			Polyunsaturated Fatty Acid (PUFA) Status in Pregnant Women: Associations with Sleep Quality, Inflammation, and Length of Gestation	PLOS ONE			English	Article							ACTIVATING PEPTIDE-1 INTERLEUKIN-8; FADS GENE VARIANTS; C-REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; PRETERM BIRTH; LONGITUDINAL CHANGES; DHA SUPPLEMENTATION; ARACHIDONIC-ACID; RISK PREGNANCIES; GROWTH MEASURES	Mechanistic pathways linking maternal polyunsaturated fatty acid (PUFA) status with gestational length are poorly delineated. This study examined whether inflammation and sleep quality serve as mediators, focusing on the antiinflammatory.-3 docosahexaenoic acid (DHA; 22:6n3) and proinflammatory omega-6 arachidonic acid (AA; 20:4n6). Pregnant women (n = 135) provided a blood sample and completed the Pittsburgh Sleep Quality Index (PSQI) at 20-27 weeks gestation. Red blood cell (RBC) fatty acid levels were determined by gas chromatography and serum inflammatory markers [interleukin (IL)-6, IL-8, tumor necrosis factor-a, IL-1 beta, and C-reactive protein] by electrochemiluminescence using high sensitivity kits. Both higher serum IL-8 (95% CI = 0.10,3.84) and poor sleep (95% CI = 0.03,0.28) served as significant mediators linking lower DHA: AA ratios with shorter gestation. Further, a serial mediation model moving from the DHA: AA ratio! sleep! IL-8! length of gestation was statistically significant (95% CI = 0.02, 0.79). These relationships remained after adjusting for depressive symptoms, age, BMI, income, race, and smoking. No interactions with race were observed in relation to length of gestation as a continuous variable. However, a significant interaction between race and the DHA: AA ratio in predicting preterm birth was observed (p = 0.049); among African Americans only, odds of preterm birth decreased as DHA: AA increased (p = 0.048). These data support a role for both inflammatory pathways and sleep quality in linking less optimal RBC PUFA status with shorter gestation in African American and European American women and suggest that African-Americans have greater risk for preterm birth in the context of a low DHA: AA ratio.	[Christian, Lisa M.; Lower, Mary] Ohio State Univ, Dept Psychiat & Behav Hlth, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.; Lower, Mary] Ohio State Univ, Inst Behav Med Res, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Blair, Lisa M.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Porter, Kyle] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Cole, Rachel M.; Belury, Martha A.] Ohio State Univ, Program Nutr, Dept Human Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Christian, LM (corresponding author), Ohio State Univ, Dept Psychiat & Behav Hlth, Wexner Med Ctr, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Inst Behav Med Res, Wexner Med Ctr, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH USA.	Lisa.Christian@osumc.edu	Blair, Lisa M./I-8088-2019; Christian, Lisa/E-2892-2011	Blair, Lisa M./0000-0002-6169-5876; Christian, Lisa/0000-0001-5571-050X	NICHD [HD061644, HD067670]; Ohio State University College of Dentistry; Ruth L. Kirschstein National Research Service Award [T32NR014225]; Ohio State University Clinical Research Center - National Center for Research Resources [UL1TR001070]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD067670] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061644] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR014225] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ohio State University College of Dentistry; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Clinical Research Center - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study and manuscript preparation was supported by NICHD (HD061644 and HD067670) and a seed grant from the Ohio State University College of Dentistry. Manuscript preparation by LMB was supported by a Ruth L. Kirschstein National Research Service Award (T32NR014225). The project described was supported by the Ohio State University Clinical Research Center, funded by the National Center for Research Resources (UL1TR001070). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2015, OM 3 FATT AC MAT CHI; Allen KGD, 2001, EXP BIOL MED, V226, P498, DOI 10.1177/153537020122600602; [Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bayer JK, 2007, J PAEDIATR CHILD H, V43, P66, DOI 10.1111/j.1440-1754.2007.01005.x; Belury MA, 1997, LIPIDS, V32, P199, DOI 10.1007/s11745-997-0025-0; Bhati S, 2015, JOGNN-J OBST GYN NEO, V44, P350, DOI 10.1111/1552-6909.12562; Blair LM, 2015, SLEEP, V38, P1259, DOI 10.5665/sleep.4904; Block Robert C, 2012, World J Cardiovasc Dis, V2, P14; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calcagni SC, 2012, BEHAV SLEEP MED, V10, P167, DOI 10.1080/15402002.2012.668147; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; CHEROUNY PH, 1993, AM J OBSTET GYNECOL, V169, P1299, DOI 10.1016/0002-9378(93)90297-V; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Combs CA, 2015, AM J OBSTET GYNECOL, V212, pe1, DOI DOI 10.1016/J.AJ0G.2015.02.007; Coussons-Read ME, 2012, BRAIN BEHAV IMMUN, V26, P650, DOI 10.1016/j.bbi.2012.02.009; Dennis CL, 2005, BIRTH-ISS PERINAT C, V32, P187, DOI 10.1111/j.0730-7659.2005.00368.x; Denomme J, 2005, J NUTR, V135, P206, DOI 10.1093/jn/135.2.206; Facco FL, 2010, OBSTET GYNECOL, V115, P77, DOI 10.1097/AOG.0b013e3181c4f8ec; FAGIOLI I, 1989, SLEEP, V12, P495; Frew L, 2013, PROSTAG LEUKOTR ESS, V89, P221, DOI 10.1016/j.plefa.2013.07.001; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Haghiac M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137309; Hall Martica H, 2015, F1000Prime Rep, V7, P63, DOI 10.12703/P7-63; Hall MH, 2009, SLEEP, V32, P73; Hall WL, 2013, INT J CARDIOL, V168, P4439, DOI 10.1016/j.ijcard.2013.06.153; Hayes AF, 2011, COMMUN SER, P434; Hiscock H, 2006, ARCH DIS CHILD; Hiscock H, 2008, PEDIATRICS, V122, pE621, DOI 10.1542/peds.2007-3783; Hong S, 2005, BRAIN BEHAV IMMUN, V19, P165, DOI 10.1016/j.bbi.2004.07.008; Horvath A, 2007, BRIT J NUTR, V98, P253, DOI 10.1017/S0007114507709078; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; Jackson CL, 2013, AM J EPIDEMIOL, V178, P1442, DOI 10.1093/aje/kwt159; Jia XM, 2015, APPL PHYSIOL NUTR ME, V40, P474, DOI 10.1139/apnm-2014-0313; Jorgensen MH, 2006, MATERN CHILD NUTR, V2, P29, DOI 10.1111/j.1740-8709.2006.00039.x; Judge MP, 2012, EARLY HUM DEV, V88, P531, DOI 10.1016/j.earlhumdev.2011.12.016; Kamysheva E, 2010, J AFFECT DISORDERS, V123, P317, DOI 10.1016/j.jad.2009.09.015; Kelley DS, 2009, J NUTR, V139, P495, DOI 10.3945/jn.108.100354; Ladesich JB, 2011, J CLIN SLEEP MED, V7, P391, DOI 10.5664/JCSM.1198; Lauritzen L, 2015, PEDIATR RES, V77, P263, DOI 10.1038/pr.2014.166; Lavialle M, 2008, J NUTR, V138, P1719, DOI 10.1093/jn/138.9.1719; Leung BMY, 2009, J AM DIET ASSOC, V109, P1566, DOI 10.1016/j.jada.2009.06.368; Lewis N. M., 1995, Journal of Agromedicine, V2, P49, DOI 10.1300/J096v02n04_05; Makrides M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub2; Medina AM, 2009, FAM SYST HEALTH, V27, P153, DOI 10.1037/a0015762; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miles EA, 2011, AM J CLIN NUTR, V94, p1986S, DOI 10.3945/ajcn.110.001636; Misra VK, 2009, PLACENTA, V30, P619, DOI 10.1016/j.placenta.2009.04.007; Mocellin MC, 2016, CLIN NUTR, V35, P359, DOI 10.1016/j.clnu.2015.04.013; Molto-Puigmarti C, 2014, J NUTR, V144, P1430, DOI 10.3945/jn.114.194035; Montgomery P, 2014, J SLEEP RES, V23, P364, DOI 10.1111/jsr.12135; Nadeem R, 2013, J CLIN SLEEP MED, V9, P1003, DOI 10.5664/jcsm.3070; Nordgren TM, 2014, NUTRIENTS, V6, P5434, DOI 10.3390/nu6125434; O'Brien LM, 2013, BMC PREGNANCY CHILDB, V13, DOI [10.1186/1471-2393-13-S1-S12, 10.1186/1471-2393-13-113]; Oken E, 2004, AM J EPIDEMIOL, V160, P774, DOI 10.1093/aje/kwh282; Okun ML, 2015, CURR OPIN PSYCHIATR, V28, P490, DOI 10.1097/YCO.0000000000000206; Okun ML, 2011, SLEEP, V34, P1493, DOI 10.5665/sleep.1384; Okun ML, 2011, DEPRESS ANXIETY, V28, P676, DOI 10.1002/da.20828; Okun ML, 2011, J AFFECT DISORDERS, V130, P378, DOI 10.1016/j.jad.2010.07.015; Palagini L, 2014, SLEEP MED, V15, P853, DOI 10.1016/j.sleep.2014.02.013; Papandreou C, 2013, J SLEEP RES, V22, P569, DOI 10.1111/jsr.12043; Prather AA, 2009, BRAIN BEHAV IMMUN, V23, P1109, DOI 10.1016/j.bbi.2009.07.001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rangel-Huerta OD, 2012, BRIT J NUTR, V107, pS159, DOI 10.1017/S0007114512001559; Reutrakul S, 2011, DIABETES CARE, V34, P2454, DOI 10.2337/dc11-0780; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P813, DOI 10.1016/0002-9378(91)90422-N; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Ruiter ME, 2011, SLEEP MED, V12, P209, DOI 10.1016/j.sleep.2010.12.010; Saccone G, 2016, J MATERN-FETAL NEO M, V29, P2389, DOI 10.3109/14767058.2015.1086742; Saccone G, 2015, AM J OBSTET GYNECOL, V213, P135, DOI 10.1016/j.ajog.2015.03.013; Saccone G, 2015, OBSTET GYNECOL, V125, P663, DOI 10.1097/AOG.0000000000000668; SAITO S, 1993, CYTOKINE, V5, P81, DOI 10.1016/1043-4666(93)90027-3; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Signal TL, 2014, SLEEP MED, V15, P1477, DOI 10.1016/j.sleep.2014.07.007; Simhan HN, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.038; Simopoulos AP, 2000, PROSTAG LEUKOTR ESS, V63, P119, DOI 10.1054/plef.2000.0176; Skouteris H, 2009, WOMEN HEALTH ISS, V19, P45, DOI 10.1016/j.whi.2008.10.004; Skulas-Ray AC, 2015, PROSTAG OTH LIPID M, V116, P104, DOI 10.1016/j.prostaglandins.2015.02.001; Storey A, 2005, J INVEST DERMATOL, V124, P248, DOI 10.1111/j.0022-202X.2004.23543.x; Sun Q, 2007, AM J CLIN NUTR, V86, P74, DOI 10.1093/ajcn/86.1.74; Szajewska H, 2006, AM J CLIN NUTR, V83, P1337, DOI 10.1093/ajcn/83.6.1337; Thomas KS, 2011, BRAIN BEHAV IMMUN, V25, P53, DOI 10.1016/j.bbi.2010.07.245; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-39; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Yee LD, 2010, AM J CLIN NUTR, V91, P1185, DOI 10.3945/ajcn.2009.29036; Yehuda S, 2011, EUR J CLIN NUTR, V65, P1167, DOI 10.1038/ejcn.2011.80; Zaslavsky O, 2015, SLEEP MED, V16, P364, DOI 10.1016/j.sleep.2014.11.008	90	32	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148752	10.1371/journal.pone.0148752	http://dx.doi.org/10.1371/journal.pone.0148752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859301	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400075
J	Park, AM; Kanai, K; Itoh, T; Sato, T; Tsukui, T; Inagaki, Y; Selman, M; Matsushima, K; Yoshie, O				Park, Ah-Mee; Kanai, Kyosuke; Itoh, Tatsuki; Sato, Takao; Tsukui, Tatsuya; Inagaki, Yutaka; Selman, Moises; Matsushima, Kouji; Yoshie, Osamu			Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis	PLOS ONE			English	Article							TGF-BETA; EXPRESSION; HSP27; PATHOGENESIS; INHIBITION; MECHANISMS; PROTEOMICS; EMT	Heat shock protein 27 (HSP27) is a member of the small molecular weight HSP family. Upon treatment with transforming growth factor beta 1 (TGF-beta 1), we observed upregulation of HSP27 along with that of alpha-smooth muscle actin (alpha-SMA), a marker of myofibroblast differentiation, in cultured human and mouse lung fibroblasts. Furthermore, by using siRNA knockdown, we demonstrated that HSP27 was involved in cell survival and upregulation of fibronectin, osteopontin (OPN) and type 1 collagen, all functional markers of myofibroblast differentiation, in TGF-beta 1-treated MRC-5 cells. In lung tissues of bleomycin-treated mice, HSP27 was strongly upregulated and substantially co-localized with alpha-SMA, OPN and type I collagen but not with proSP-C (a marker of type II alveolar epithelial cells), E-cadherin (a marker of epithelial cells) or F4/80 (a marker of macrophages). A similar co-localization of HSP27 and alpha-SMA was observed in lung tissues of patients with idiopathic pulmonary fibrosis. Furthermore, airway delivery of HSP27 siRNA effectively suppressed bleomycin-induced pulmonary fibrosis in mice. Collectively, our findings indicate that HSP27 is critically involved in myofibroblast differentiation of lung fibroblasts and may be a promising therapeutic target for lung fibrotic diseases.	[Park, Ah-Mee; Kanai, Kyosuke; Yoshie, Osamu] Dept Microbiol, Osaka, Japan; [Park, Ah-Mee; Kanai, Kyosuke; Yoshie, Osamu] Kindai Univ, Fac Med, Osaka, Japan; [Itoh, Tatsuki; Sato, Takao] Kindai Univ, Fac Med, Dept Pathol, Osaka, Japan; [Tsukui, Tatsuya; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Inagaki, Yutaka] Tokai Univ, Sch Med, Dept Regenerat Med, Sagamihara, Kanagawa, Japan; [Selman, Moises] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico	Kindai University (Kinki University); Kindai University (Kinki University); University of Tokyo; Tokai University	Yoshie, O (corresponding author), Dept Microbiol, Osaka, Japan.; Yoshie, O (corresponding author), Kindai Univ, Fac Med, Osaka, Japan.	o.yoshie@med.kindai.ac.jp	Park, Ah-Mee/AAS-2545-2020	Park, Ah-Mee/0000-0001-8453-3872; Yoshie, Osamu/0000-0003-4353-5809; Tsukui, Tatsuya/0000-0003-3100-6934	Ministry of Education, Culture, Sports, Science and Technology of Japan [22790772]; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25293179] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to AMP (22790772), and by a grant of Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency to OY.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bratt C, 2001, J CHROMATOGR A, V909, P279, DOI 10.1016/S0021-9673(00)01103-1; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Foster MW, 2015, J PROTEOME RES, V14, P1238, DOI 10.1021/pr501149m; Hagiwara S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-37; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Higashiyama R, 2009, GASTROENTEROLOGY, V137, P1459, DOI 10.1053/j.gastro.2009.07.006; Honda E, 2013, TOHOKU J EXP MED, V230, P67, DOI 10.1620/tjem.230.67; Honda E, 2010, TOHOKU J EXP MED, V220, P319, DOI 10.1620/tjem.220.319; Korfei M, 2011, J PROTEOME RES, V10, P2185, DOI 10.1021/pr1009355; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; Nakatani T, 2008, MOL CELL BIOCHEM, V308, P201, DOI 10.1007/s11010-007-9629-9; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Thakur SA, 2009, TOXICOL SCI, V108, P462, DOI 10.1093/toxsci/kfp011; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Valles P, 2003, PEDIATR NEPHROL, V18, P527, DOI 10.1007/s00467-003-1096-2; Vidyasagar A, 2008, AM J PHYSIOL-RENAL, V295, pF707, DOI 10.1152/ajprenal.90240.2008; Vidyasagar A, 2013, KIDNEY INT, V83, P84, DOI 10.1038/ki.2012.336; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang Y, 2002, CLIN EXP IMMUNOL, V128, P169, DOI 10.1046/j.1365-2249.2002.01811.x; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	34	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148998	10.1371/journal.pone.0148998	http://dx.doi.org/10.1371/journal.pone.0148998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859835	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400117
J	Pascual, V; Medrano, LM; Lopez-Palacios, N; Bodas, A; Dema, B; Fernandez-Arquero, M; Gonzalez-Perez, B; Salazar, I; Nunez, C				Pascual, V.; Medrano, L. M.; Lopez-Palacios, N.; Bodas, A.; Dema, B.; Fernandez-Arquero, M.; Gonzalez-Perez, B.; Salazar, I.; Nunez, C.			Different Gene Expression Signatures in Children and Adults with Celiac Disease	PLOS ONE			English	Article							TH17 CELLS; MULTIPLE COMMON; ASSOCIATION; RISK; INFLAMMATION; VARIANTS; MUCOSA	Celiac disease (CD) is developed after gluten ingestion in genetically susceptible individuals. It can appear at any time in life, but some differences are commonly observed between individuals with onset early in life or in adulthood. We aimed to investigate the molecular basis underlying those differences. We collected 19 duodenal biopsies of children and adults with CD and compared the expression of 38 selected genes between each other and with the observed in 13 non-CD controls matched by age. A Bayesian methodology was used to analyze the differences of gene expression between groups. We found seven genes with a similarly altered expression in children and adults with CD when compared to controls (C2orf74, CCR6, FASLG, JAK2, IL23A, TAGAP and UBE2L3). Differences were observed in 13 genes: six genes being altered only in adults (IL1RL1, CD28, STAT3, TMEM187, VAMP3 and ZFP36L1) and two only in children (TNFSF18 and ICOSLG); and four genes showing a significantly higher alteration in adults (CCR4, IL6, IL18RAP and PLEK) and one in children (C1orf106). This is the first extensive study comparing gene expression in children and adults with CD. Differences in the expression level of several genes were found between groups, being notorious the higher alteration observed in adults. Further research is needed to evaluate the possible genetic influence underlying these changes and the specific functional consequences of the reported differences.	[Pascual, V.; Medrano, L. M.; Dema, B.; Fernandez-Arquero, M.; Nunez, C.] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Serv Inmunol Clin, Madrid, Spain; [Bodas, A.] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Serv Pediat, Madrid, Spain; [Lopez-Palacios, N.] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Serv Aparato Digestivo, Madrid, Spain; [Gonzalez-Perez, B.] Univ Complutense Madrid, Fac Matemet, Dept Estadist & Invest Operativa 1, Madrid, Spain; [Salazar, I.] Univ Complutense Madrid, Fac Vet, Dept Anim Prod, Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Complutense University of Madrid	Nunez, C (corresponding author), Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Serv Inmunol Clin, Madrid, Spain.	conchita.npardo@gmail.com	Núñez, Concepción/H-8517-2017; de dios, luz maria medrano/K-1946-2016; Pérez, Beatriz González/ABG-2414-2020; Dema, Barbara/AAM-2354-2020; Palacios, Natalia Lopez/AAZ-7954-2020	de dios, luz maria medrano/0000-0003-3717-5384; Pérez, Beatriz González/0000-0003-2631-8503; SALAZAR MENDOZA/0000-0002-1605-5407	Fundacion Eugenio Rodriguez Pascual CN; de Investigaciones Sanitarias, Instituto de Salud Carlos III (AES)-Fondo Europeo de Desarrollo Regional (FEDER) [PI11/00614]	Fundacion Eugenio Rodriguez Pascual CN; de Investigaciones Sanitarias, Instituto de Salud Carlos III (AES)-Fondo Europeo de Desarrollo Regional (FEDER)	Ths work was supported by PI11/00614 (http://www.isciii.es/Fondo) de Investigaciones Sanitarias, Instituto de Salud Carlos III (AES 2011)-Fondo Europeo de Desarrollo Regional (FEDER) to CN, (https://www.fundacioneugeniorodriguezpascual.es/); Fundacion Eugenio Rodriguez Pascual CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, GASTROENTEROLOGY, V131, P1977, DOI 10.1053/j.gastro.2006.10.003; [Anonymous], 2005, NORMFINDER VERSION0; [Anonymous], 2007, GENORM VERSION3 5; Ausin MC, 2011, COMMUN STAT-THEOR M, V40, P2276, DOI 10.1080/03610921003778183; Burkett PR, 2015, J CLIN INVEST, V125, P2211, DOI 10.1172/JCI78085; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Ciccocioppo R, 2015, NUTRIENTS, V7, P8733, DOI 10.3390/nu7105426; Comani GB, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0482-2; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Fernandez-Jimenez N, 2014, HUM MOL GENET, V23, P1298, DOI 10.1093/hmg/ddt520; Galatola M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074747; Gomez-Villegas MA, 2014, STAT APPL GENET MOL, V13, P49, DOI 10.1515/sagmb-2012-0076; Gutierrez-Achury J, 2015, NAT GENET, V47, P577, DOI 10.1038/ng.3268; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jauregi-Miguel A, 2014, J PEDIATR GASTR NUTR, V58, P762, DOI 10.1097/MPG.0000000000000338; Kelly CP, 2015, GASTROENTEROLOGY, V148, P1175, DOI 10.1053/j.gastro.2015.01.044; Kumar V, 2015, HUM MOL GENET, V24, P397, DOI 10.1093/hmg/ddu453; Lahdenpera AI, 2014, SCAND J GASTROENTERO, V49, P145, DOI 10.3109/00365521.2013.863966; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Plaza-Izurieta L, 2015, EUR J HUM GENET, V23, P1100, DOI 10.1038/ejhg.2014.244; Plaza-Izurieta L, 2011, J MED GENET, V48, P493, DOI 10.1136/jmg.2011.089714; Poddar U, 2013, INDIAN J GASTROENTER, V32, P283, DOI 10.1007/s12664-013-0339-9; Saez LR, 2011, REV ESP ENFERM DIG, V103, P238; Singh RP, 2014, AUTOIMMUN REV, V13, P1174, DOI 10.1016/j.autrev.2014.08.019; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Leeuwen MA, 2013, MUCOSAL IMMUNOL, V6, P1202, DOI 10.1038/mi.2013.19; Vivas Santiago, 2015, World J Gastrointest Pharmacol Ther, V6, P207, DOI 10.4292/wjgpt.v6.i4.207; 1990, ARCH DIS CHILD, V65, P909	32	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0146276	10.1371/journal.pone.0146276	http://dx.doi.org/10.1371/journal.pone.0146276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859134	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400002
J	Quetglas, A; Rueda, L; Alvarez-Berastegui, D; Guijarro, B; Massut-, E				Quetglas, Antoni; Rueda, Lucia; Alvarez-Berastegui, Diego; Guijarro, Beatriz; Massut-, Enric			Contrasting Responses to Harvesting and Environmental Drivers of Fast and Slow Life History Species	PLOS ONE			English	Article							OCTOPUS ELEDONE-CIRRHOSA; BALEARIC-ISLANDS; REPRODUCTIVE-BIOLOGY; POPULATION-DYNAMICS; GALEUS-MELASTOMUS; CLIMATE-CHANGE; BODY-SIZE; SHARKS; CEPHALOPOD; FISHERIES	According to their main life history traits, organisms can be arranged in a continuum from fast (species with small body size, short lifespan and high fecundity) to slow (species with opposite characteristics). Life history determines the responses of organisms to natural and anthropogenic factors, as slow species are expected to be more sensitive than fast species to perturbations. Owing to their contrasting traits, cephalopods and elasmobranchs are typical examples of fast and slow strategies, respectively. We investigated the responses of these two contrasting strategies to fishing exploitation and environmental conditions (temperature, productivity and depth) using generalized additive models. Our results confirmed the foreseen contrasting responses of cephalopods and elasmobranchs to natural (environment) and anthropogenic (harvesting) influences. Even though a priori foreseen, we did expect neither the clear-cut differential responses between groups nor the homogeneous sensitivity to the same factors within the two taxonomic groups. Apart from depth, which affected both groups equally, cephalopods and elasmobranchs were exclusively affected by environmental conditions and fishing exploitation, respectively. Owing to its short, annual cycle, cephalopods do not have overlapping generations and consequently lack the buffering effects conferred by different age classes observed in multi-aged species such as elasmobranchs. We suggest that cephalopods are sensitive to short-term perturbations, such as seasonal environmental changes, because they lack this buffering effect but they are in turn not influenced by continuous, long-term moderate disturbances such as fishing because of its high population growth and turnover. The contrary would apply to elasmobranchs, whose multi-aged population structure would buffer the seasonal environmental effects, but they would display strong responses to uninterrupted harvesting due to its low population resilience. Besides providing empirical evidence to the theoretically predicted contrasting responses of cephalopods and elasmobranchs to disturbances, our results are useful for the sustainable exploitation of these resources.	[Quetglas, Antoni; Rueda, Lucia; Guijarro, Beatriz; Massut-, Enric] Ctr Oceanog Balears, Inst Espanol Oceanog, Palma De Mallorca, Spain; [Alvarez-Berastegui, Diego] SOCIB Balear Isl Coastal Observing & Forecast Sys, Palma De Mallorca, Spain	Spanish Institute of Oceanography	Quetglas, A (corresponding author), Ctr Oceanog Balears, Inst Espanol Oceanog, Palma De Mallorca, Spain.	toni.quetglas@ba.ieo.es	Quetglas, Antoni/K-9089-2014; Massutí, Enric/AAG-5117-2021; Guijarro, Beatriz/I-2480-2015	Quetglas, Antoni/0000-0002-1303-8003; Guijarro, Beatriz/0000-0002-2083-4681; Massuti, Enric/0000-0002-9524-5873; Alvarez-Berastegui, Diego/0000-0003-1304-7185; Rueda, Lucia/0000-0001-6105-6559	European Community [289257]; project ECLIPSAME (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean) - Spanish Ministry of Economy and Competitiveness [CTM2012-37701]; European Commission (EC); EC; Instituto Espanol de Oceanografia (IEO)	European Community(European Commission); project ECLIPSAME (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean) - Spanish Ministry of Economy and Competitiveness; European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); EC(European CommissionEuropean Commission Joint Research Centre); Instituto Espanol de Oceanografia (IEO)	The research leading to these results has received funding from: 1) the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement MYFISH no 289257; and 2) the project ECLIPSAME (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean, CTM2012-37701) co-financed by the Spanish Ministry of Economy and Competitiveness and the European Commission (EC). The article does not necessarily reflect the views of the EC. Spanish MEDITS surveys are co-financed by the EC and the Instituto Espanol de Oceanografia (IEO).	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Andre J, 2010, GLOBAL CHANGE BIOL, V16, P2866, DOI 10.1111/j.1365-2486.2010.02223.x; Barausse A, 2011, J FISH BIOL, V79, P1453, DOI 10.1111/j.1095-8649.2011.03139.x; Barausse A, 2014, ICES J MAR SCI, V71, P1593, DOI 10.1093/icesjms/fst222; Barnett LAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065000; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Bradley D, 2014, ELIFE, V3, DOI 10.7554/eLife.02199; Bromham L, 2011, PHILOS T R SOC B, V366, P2503, DOI 10.1098/rstb.2011.0014; Caddy JF, 1998, REV FISH BIOL FISHER, V8, P431, DOI 10.1023/A:1008807129366; Capape C, 2008, J MAR BIOL ASSOC UK, V88, P415, DOI 10.1017/S002531540800060X; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; Cuccu D, 2013, J MAR BIOL ASSOC UK, V93, P843, DOI 10.1017/S0025315412000203; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Eastwood PD, 2007, ICES J MAR SCI, V64, P453, DOI 10.1093/icesjms/fsm001; ELLIS JR, 1995, J FISH BIOL, V46, P903, DOI 10.1111/j.1095-8649.1995.tb01613.x; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01057; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Finley C, 2013, ICES J MAR SCI, V70, P245, DOI 10.1093/icesjms/fss192; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Gonzalez AF, 2013, ADV SQUID BIOL ECO 2, P49; Guijarro B, 2012, SCI MAR, V76, P87, DOI 10.3989/scimar.03432.22A; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hutchings JA, 2012, ECOL APPL, V22, P1061, DOI 10.1890/11-1313.1; Ivory P., 2005, Journal of Northwest Atlantic Fishery Science, V35, P89; Jackson GD, 2003, ICES J MAR SCI, V60, P290, DOI 10.1016/S1054-3139(03)00007-9; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 2011, FISH FISH, V12, P125, DOI 10.1111/j.1467-2979.2011.00409.x; Jeschke J.M., 2008, ENCY ECOLOGY, V4, P3113, DOI DOI 10.1016/B978-008045405-4.00648-0; Jeschke JM, 2009, EVOL ECOL, V23, P867, DOI 10.1007/s10682-008-9276-y; Juan-Jorda MJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0322; Kadri H, 2014, MAR BIOL RES, V10, P416, DOI 10.1080/17451000.2013.797584; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kousteni V, 2010, MAR BIOL RES, V6, P390, DOI 10.1080/17451000903233771; LARKIN PA, 1977, T AM FISH SOC, V106, P1, DOI 10.1577/1548-8659(1977)106<1:AEFTCO>2.0.CO;2; Le Quesne WJF, 2012, J APPL ECOL, V49, P20, DOI 10.1111/j.1365-2664.2011.02087.x; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Link JS, 2013, FISHERIES, V38, P463, DOI 10.1080/03632415.2013.851556; Lloret J, 2001, FISH OCEANOGR, V10, P33, DOI 10.1046/j.1365-2419.2001.00151.x; de Puelles MLF, 2007, PROG OCEANOGR, V74, P329, DOI 10.1016/j.pocean.2007.04.009; Mackinson S, 2009, CAN J FISH AQUAT SCI, V66, P1107, DOI 10.1139/F09-057; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Merino G, 2015, FISH RES, V161, P131, DOI 10.1016/j.fishres.2014.06.010; Moltschaniwskyj N, 2002, B MAR SCI, V71, P501; Moore DM, 2013, J MAR BIOL ASSOC UK, V93, P1941, DOI 10.1017/S0025315413000374; Mueter FJ, 2006, FISH RES, V81, P189, DOI 10.1016/j.fishres.2006.07.010; Nogueira A, 2015, ICES J MAR SCI, V72, P753, DOI 10.1093/icesjms/fsu182; Okie JG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1007; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Puerta P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133439; Puerta P, 2014, MAR ECOL PROG SER, V514, P105, DOI 10.3354/meps10972; Quetglas A, 2015, FISHERIES MANAG ECOL, V22, P349, DOI 10.1111/fme.12131; Quetglas A, 2012, SCI MAR, V76, P17, DOI 10.3989/scimar.2012.76n1017; Quetglas A, 2011, ACTA OECOL, V37, P476, DOI 10.1016/j.actao.2011.06.002; Ravard D, 2014, FISH RES, V157, P86, DOI 10.1016/j.fishres.2014.03.007; Regueira M, 2015, SCI MAR, V79, P71, DOI 10.3989/scimar.04137.23A; Regueira M, 2013, J MAR BIOL ASSOC UK, V93, P1641, DOI 10.1017/S0025315413000118; Reynolds John D., 2003, P195; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Rochet MJ, 2000, OIKOS, V91, P255, DOI 10.1034/j.1600-0706.2000.910206.x; Rodhouse PGK, 2014, ADV MAR BIOL, V67, P99, DOI 10.1016/B978-0-12-800287-2.00002-0; Roff Derek, 2002, pi; Rogers SI, 1999, J ANIM ECOL, V68, P769, DOI 10.1046/j.1365-2656.1999.00327.x; Rueffler C, 2006, AM NAT, V168, pE148, DOI 10.1086/508618; Saether BE, 2013, AM NAT, V182, P743, DOI 10.1086/673497; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; Schultner J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2090; Scott RD, 2011, MAR POLICY, V35, P79, DOI 10.1016/j.marpol.2010.08.005; Shelton AO, 2011, P NATL ACAD SCI USA, V108, P7075, DOI 10.1073/pnas.1100334108; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Silva L, 2002, B MAR SCI, V71, P837; Smith JM, 2005, AQUAT LIVING RESOUR, V18, P341, DOI 10.1051/alr:2005038; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Wiedmann MA, 2014, ECOL EVOL, V4, P3596, DOI 10.1002/ece3.1203; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	92	27	29	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148770	10.1371/journal.pone.0148770	http://dx.doi.org/10.1371/journal.pone.0148770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859577	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400078
J	Moriguchi, K; Yamamoto, S; Ohmine, Y; Suzuki, K				Moriguchi, Kazuki; Yamamoto, Shinji; Ohmine, Yuta; Suzuki, Katsunori			A Fast and Practical Yeast Transformation Method Mediated by Escherichia coli Based on a Trans-Kingdom Conjugal Transfer System: Just Mix Two Cultures and Wait One Hour	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ALKALI CATIONS; INCP PLASMIDS; DNA TRANSFER; CELLS; TOOL	Trans-kingdom conjugation is a phenomenon by which DNA is transferred into a eukaryotic cell by a bacterial conjugal transfer system. Improvement in this method to facilitate the rapid co-cultivation of donor bacterial and recipient eukaryotic cell cultures could make it the simplest transformation method, requiring neither isolation of vector DNA nor preparation of competent recipient cells. To evaluate this potential advantage of trans-kingdom conjugation, we examined this simple transformation method using vector combinations, helper plasmids, and recipient Saccharomyces cerevisiae strains. Mixing donor Escherichia coli and recipient S. cerevisiae overnight cultures (50 mu L each) consistently yielded on the order of 10(1) transformants using the popular experimental strain BY4742 derived from S288c and a shuttle vector for trans-kingdom conjugation. Transformation efficiency increased to the order of 10(2) using a high receptivity trans-kingdom conjugation strain. In addition, either increasing the amount of donor cells or pretreating the recipient cells with thiols such as dithiothreitol improved the transformation efficiency by one order of magnitude. This simple trans-kingdom conjugation-mediated transformation method could be used as a practical yeast transformation method upon enrichment of available vectors and donor E. coli strains.	[Moriguchi, Kazuki; Yamamoto, Shinji; Ohmine, Yuta; Suzuki, Katsunori] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan	Hiroshima University	Moriguchi, K (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	kmoriguc@hiroshima-u.ac.jp			JSPS [21510209, 25660007]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by JSPS KAKENHI (21510209 and 25660007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates S, 1998, J BACTERIOL, V180, P6538, DOI 10.1128/JB.180.24.6538-6543.1998; BRZOBOHATY B, 1986, J GEN MICROBIOL, V132, P3089; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; ITO H, 1984, AGR BIOL CHEM TOKYO, V48, P341, DOI 10.1080/00021369.1984.10866161; Kawai S, 2004, BIOCHEM BIOPH RES CO, V317, P100, DOI 10.1016/j.bbrc.2004.03.011; Mizuta M, 2012, MICROBIOL RES, V167, P311, DOI 10.1016/j.micres.2011.10.001; Moriguchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074590; Moriguchi K, 2013, APPL ENVIRON MICROB, V79, P4393, DOI 10.1128/AEM.00770-13; NISHIKAWA M, 1992, CURR GENET, V21, P101, DOI 10.1007/BF00318467; NISHIKAWA M, 1990, JPN J GENET, V65, P323, DOI 10.1266/jjg.65.323; Nishikawa M, 1998, GENET ANAL-BIOMOL E, V14, P65, DOI 10.1016/S1050-3862(97)10003-1; Simon R., 1983, NAT BIOTECHNOL, V1, P784, DOI [10.1038/nbt1183-784, DOI 10.1038/NBT1183-784]; SUZUKI K, 1986, PLANT CELL PHYSIOL, V27, P523; Thompson JR, 1998, YEAST, V14, P565, DOI 10.1002/(SICI)1097-0061(19980430)14:6<565::AID-YEA251>3.0.CO;2-B	16	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148989	10.1371/journal.pone.0148989	http://dx.doi.org/10.1371/journal.pone.0148989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849654	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000192
J	Stoner, DC; Sexton, JO; Nagol, J; Bernales, HH; Edwards, TC				Stoner, David C.; Sexton, Joseph O.; Nagol, Jyoteshwar; Bernales, Heather H.; Edwards, Thomas C., Jr.			Ungulate Reproductive Parameters Track Satellite Observations of Plant Phenology across Latitude and Climatological Regimes	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; POPULATION-DYNAMICS; CLIMATE-CHANGE; RED DEER; SYNCHRONY; HERBIVORE; NDVI; PRODUCTIVITY; PARTURITION; GRADIENTS	The effect of climatically-driven plant phenology on mammalian reproduction is one key to predicting species-specific demographic responses to climate change. Large ungulates face their greatest energetic demands from the later stages of pregnancy through weaning, and so in seasonal environments parturition dates should match periods of high primary productivity. Interannual variation in weather influences the quality and timing of forage availability, which can influence neonatal survival. Here, we evaluated macro-scale patterns in reproductive performance of a widely distributed ungulate (mule deer, Odocoileus hemionus) across contrasting climatological regimes using satellite-derived indices of primary productivity and plant phenology over eight degrees of latitude (890 km) in the American Southwest. The dataset comprised > 180,000 animal observations taken from 54 populations over eight years (2004-2011). Regionally, both the start and peak of growing season ("Start" and "Peak", respectively) are negatively and significantly correlated with latitude, an unusual pattern stemming from a change in the dominance of spring snowmelt in the north to the influence of the North American Monsoon in the south. Corresponding to the timing and variation in both the Start and Peak, mule deer reproduction was latest, lowest, and most variable at lower latitudes where plant phenology is timed to the onset of monsoonal moisture. Parturition dates closely tracked the growing season across space, lagging behind the Start and preceding the Peak by 27 and 23 days, respectively. Mean juvenile production increased, and variation decreased, with increasing latitude. Temporally, juvenile production was best predicted by primary productivity during summer, which encompassed late pregnancy, parturition, and early lactation. Our findings offer a parsimonious explanation of two key reproductive parameters in ungulate demography, timing of parturition and mean annual production, across latitude and changing climatological regimes. Practically, this demonstrates the potential for broad-scale modeling of couplings between climate, plant phenology, and animal populations using space-borne observations.	[Stoner, David C.; Edwards, Thomas C., Jr.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Sexton, Joseph O.; Nagol, Jyoteshwar] Univ Maryland, Global Landcover Facil, Dept Geog Sci, College Pk, MD 20742 USA; [Bernales, Heather H.] Utah Div Wildlife Resources, Salt Lake City, UT USA; [Edwards, Thomas C., Jr.] US Geol Survey, Utah Cooperat Fish & Wildlife Res Unit, Logan, UT USA	Utah System of Higher Education; Utah State University; University System of Maryland; University of Maryland College Park; United States Department of the Interior; United States Geological Survey	Stoner, DC (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	david.stoner@usu.edu			National Aeronautics and Space Administration, Biodiversity and Ecological Forecasting Program [NNH10ZDA001N]	National Aeronautics and Space Administration, Biodiversity and Ecological Forecasting Program	Funding for this work was provided by National Aeronautics and Space Administration, Biodiversity and Ecological Forecasting Program, Grant no. NNH10ZDA001N.	Adams DK, 1997, B AM METEOROL SOC, V78, P2197, DOI 10.1175/1520-0477(1997)078<2197:TNAM>2.0.CO;2; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Arizona Game and Fish Department, 2012, HUNG AR 2012 ED SURV; Bartlam-Brooks HLA, 2013, J GEOPHYS RES-BIOGEO, V118, P1427, DOI 10.1002/jgrg.20096; Bender LC, 2006, WILDLIFE SOC B, V34, P1225, DOI 10.2193/0091-7648(2006)34[1225:UOHCAA]2.0.CO;2; Bernales HH, 2013, UTAB DIVISION WILDLI, V13-21; Bernales HH, 2010, THESIS UTAH STATE U; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Bishop CJ, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2008-107; Bissonette John A., 2008, Human-Wildlife Conflicts, V2, P17; Bonenfant C, 2005, J APPL ECOL, V42, P361, DOI 10.1111/j.1365-2664.2005.01008.x; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; BOWYER RT, 1991, J MAMMAL, V72, P138, DOI 10.2307/1381988; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; Cayan DR, 2010, P NATL ACAD SCI USA, V107, P21271, DOI 10.1073/pnas.0912391107; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; Connolly GE, 1981, MULE BLACK TAILED DE, P245; Forrester TD, 2013, MAMMAL REV, V43, P292, DOI 10.1111/mam.12002; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Garel M, 2011, J MAMMAL, V92, P1112, DOI 10.1644/10-MAMM-A-056.1; Garrott RA, 2003, CAN J ZOOL, V81, P33, DOI 10.1139/Z02-218; GILBERT P F, 1970, Journal of Wildlife Management, V34, P15, DOI 10.2307/3799486; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hansen AJ, 2014, ECOL APPL, V24, P484, DOI 10.1890/13-0905.1; Harris NC, 2008, J WILDLIFE MANAGE, V60, P695; Hass CC, 1997, J MAMMAL, V78, P1251, DOI 10.2307/1383068; Heffelfinger J. R., 2006, DEER SW; Heffelfinger J.R., 2003, MULE DEER CONSERVATI, P63; Herfindal I, 2006, OECOLOGIA, V150, P213, DOI 10.1007/s00442-006-0519-8; Hurley MA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0196; Hurley MA, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.4; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Kerby J., 2013, PHENOLOGY INTEGRATIV, P467, DOI [10.1007/978-94-007-6925-0_25, DOI 10.1007/978-94-007-6925-0_25]; Lendrum PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064548; Linnell JDC, 1998, J ZOOL, V244, P497, DOI 10.1017/S0952836998004038; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; MacDonald GM, 2010, P NATL ACAD SCI USA, V107, P21256, DOI 10.1073/pnas.0909651107; Mackie R. J., 2003, WILD MAMMALS N AM BI, P889; Melis C, 2010, ECOSCIENCE, V17, P166, DOI 10.2980/17-2-3314; Monteith KL, 2014, WILDLIFE MONOGR, V186, P1, DOI 10.1002/wmon.1011; Monteith KL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00096.1; Morellet N, 2013, J ANIM ECOL, V82, P1326, DOI 10.1111/1365-2656.12105; Ogutu JO, 2013, WILDLIFE RES, V40, P698, DOI 10.1071/WR13117; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Peek J., 2003, WILD MAMMALS N AM, P877; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pettorelli N, 2014, J APPL ECOL, V51, P839, DOI 10.1111/1365-2664.12261; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pierce BM, 2012, J MAMMAL, V93, P977, DOI 10.1644/12-MAMM-A-014.1; Plard F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001828; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2005, ECOLOGY, V86, P2320, DOI 10.1890/04-0823; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabe MJ, 2002, WILDLIFE SOC B, V30, P46; Robinette WL, 1977, UTAH DIVISION WILDLI, V77-15; Rose RA, 2015, CONSERV BIOL, V29, P350, DOI 10.1111/cobi.12397; Rouse JW, 1973, 3 EARTH RES TECHN SA, VI; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; Sadleir RMFS, 1969, ECOLOGY REPROD DOMES; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Schwartz M. D., 2013, PHENOLOGY INTEGRATIV, P1, DOI DOI 10.1109/ICAT.2013.6684065; Seager R, 2013, NAT CLIM CHANGE, V3, P482, DOI [10.1038/nclimate1787, 10.1038/NCLIMATE1787]; Singh NJ, 2010, DIVERS DISTRIB, V16, P663, DOI 10.1111/j.1472-4642.2010.00671.x; Swetnam TW, 2010, ADV GLOB CHANGE RES, V41, P329, DOI 10.1007/978-90-481-8736-2_32; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Turner W, 2014, SCIENCE, V346, P301, DOI 10.1126/science.1256014; Tveraa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056450; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Vermote E, 2009, IEEE T GEOSCI REMOTE, V47, P898, DOI 10.1109/TGRS.2008.2005977; Vermote EF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009662; Wakeling B, 2000, P 5 BIENN C RES COL, P73; Western Association of Fish and Wildlife Agencies, 2004, W STAT PROV MUL DEER; Whiting JC, 2012, WILDLIFE RES, V39, P565, DOI 10.1071/WR12059	75	25	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148780	10.1371/journal.pone.0148780	http://dx.doi.org/10.1371/journal.pone.0148780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849642	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000168
J	Spanjer, AIR; Baarsma, HA; Oostenbrink, LM; Jansen, SR; Kuipers, CC; Lindner, M; Postma, DS; Meurs, H; Heijink, IH; Gosens, R; Konigshoff, M				Spanjer, Anita I. R.; Baarsma, Hoeke A.; Oostenbrink, Lisette M.; Jansen, Sepp R.; Kuipers, Christine C.; Lindner, Michael; Postma, Dirkje S.; Meurs, Herman; Heijink, Irene H.; Gosens, Reinoud; Koenigshoff, Melanie			TGF-beta-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8	FASEB JOURNAL			English	Article						airway remodeling; extracellular matrix; myofi-broblast; differentiation; WNT signaling	AIRWAY SMOOTH-MUSCLE; IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX PRODUCTION; MOLECULAR-MECHANISMS; RESPONSE ELEMENT; CATENIN; CELLS; EXPRESSION; MYOFIBROBLAST	TGF-beta is important in lung injury and remodeling processes. TGF-beta and Wingless/integrase-1 (WNT) signaling are interconnected; however, the WNT ligand-receptor complexes involved are unknown. Thus, we aimed to identify Frizzled (FZD) receptors that mediate TGF-beta-induced profibrotic signaling. MRC-5 and primary human lung fibroblasts were stimulated with TGF-beta(1), WNT-5A, or WNT-5B in the presence and absence of specific pathway inhibitors. Specific small interfering RNA was used to knock down FZD8. In vivo studies using bleomycin-induced lung fibrosis were performed in wildtype and FZD8-deficient mice. TGF-beta(1) induced FZD8 specifically via Smad3-dependent signaling in MRC-5 and primary human lung fibroblasts. It is noteworthy that FZD8 knockdown reduced TGF-beta(1)-induced collagen I alpha 1, fibronectin, versican, a-smooth muscle (sm)-actin, and connective tissue growth factor. Moreover, bleomycin-induced lung fibrosis was attenuated in FZD8-deficient mice in vivo. Although inhibition of canonical WNT signaling did not affect TGF-beta(1)-induced gene expression in vitro, noncanonical WNT-5B mimicked TGF-beta(1)-induced fibroblast activation. FZD8 knockdown reduced both WNT-5B-induced gene expression of fibronectin and alpha-sm-actin, as well as WNT-5B-induced changes in cellular impedance. Collectively, our findings demonstrate a role for FZD8 in TGF-beta-induced profibrotic signaling and imply that WNT-5B may be the ligand for FZD8 in these responses.	[Spanjer, Anita I. R.; Jansen, Sepp R.; Kuipers, Christine C.; Meurs, Herman; Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Baarsma, Hoeke A.; Oostenbrink, Lisette M.; Koenigshoff, Melanie] Univ Munich, Univ Hosp Grosshadern, German Ctr Lung Res DZL, Comprehens Pneumol Ctr,Helmholtz Ctr Munich, Munich, Germany; [Lindner, Michael] Asklepios Fachkliniken Munchen Gauting, Munich, Germany; [Postma, Dirkje S.; Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Expt Pulmonol & Inflammat Res, Groningen, Netherlands; [Spanjer, Anita I. R.; Jansen, Sepp R.; Kuipers, Christine C.; Postma, Dirkje S.; Meurs, Herman; Heijink, Irene H.; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands	University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Groningen; University of Groningen; University of Groningen	Gosens, R (corresponding author), Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.; Konigshoff, M (corresponding author), Max Lebsche Pl 31, D-81377 Munich, Germany.	r.gosens@rug.nl; melanie.koenigshoff@hemholtz-muenchen.de	lindner, michael/AAO-8653-2020	lindner, michael/0000-0002-2106-0286; Baarsma, Hoeke/0000-0002-0792-0374; Gosens, Reinoud/0000-0002-5595-152X	Netherlands Lung Foundation (NLF) [3.2.10.042]; European Respiratory Society [LTRF 79-2012]; Helmholtz Zentrum Germany [PFP PD-135]; European Research Council [ERC-StG-LS7, 261302]	Netherlands Lung Foundation (NLF); European Respiratory Society; Helmholtz Zentrum Germany; European Research Council(European Research Council (ERC)European Commission)	The authors thank E. Schmitt (Novartis Pharma AG) for the generous gift of the PKF 115-584. They also thank M. H. Menzen and A. van den Berg for technical assistance. This work was supported in part by the Netherlands Lung Foundation (NLF; Grant 3.2.10.042). H.A.B. is supported by a postdoctoral fellowship from the European Respiratory Society (LTRF 79-2012) and a fellowship from the Helmholtz Zentrum Germany (PFP PD-135). M.K. is supported by a European Research Council Starting Grant ERC-StG-LS7; Grant No. 261302.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Camoretti-Mercado B, 2005, CELL BIOCHEM BIOPHYS, V43, P131, DOI 10.1385/CBB:43:1:131; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Gauldie Jack, 2006, Proc Am Thorac Soc, V3, P696, DOI 10.1513/pats.200605-125SF; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lam AP, 2014, AM J RESP CRIT CARE, V190, P185, DOI 10.1164/rccm.201401-0079OC; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Minke KS, 2009, EUR J HAEMATOL, V82, P165, DOI 10.1111/j.1600-0609.2008.01188.x; Moore B, 2008, CURR MOL MED, V8, P427, DOI 10.2174/156652408785160943; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Schaafsma D, 2007, BRIT J PHARMACOL, V150, P136, DOI 10.1038/sj.bjp.0706985; Schaafsma D, 2007, AM J PHYSIOL-CELL PH, V293, pC429, DOI 10.1152/ajpcell.00502.2006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; White Eric S, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS30, DOI 10.1513/AnnalsATS.201406-240MG; Wojcik KA, 2012, POL ARCH MED WEWN, V122, P326, DOI 10.20452/pamw.1343; Yeganeh B, 2013, PULM PHARMACOL THER, V26, P50, DOI 10.1016/j.pupt.2012.07.006; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079	49	46	46	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1823	1835		10.1096/fj.201500129	http://dx.doi.org/10.1096/fj.201500129			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26849959	Green Submitted			2022-12-26	WOS:000374879400013
J	Liu, C; Song, XM; Nisbet, R; Gotz, J				Liu, Chang; Song, Xiaomin; Nisbet, Rebecca; Goetz, Juergen			Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; apolipoprotein; protein; protein interaction; Tau protein (Tau); Tauopathy	MICROTUBULE-ASSOCIATED PROTEINS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; PHOSPHORYLATED TAU; ALPHA-SYNUCLEIN; AMYLOID-BETA; MOUSE MODEL; ASSOCIATION; COMPLEXES; TRANSPORT	Alternative splicing generates multiple isoforms of the microtubule-associated protein Tau, but little is known about their specific function. In the adult mouse brain, three Tau isoforms are expressed that contain either 0, 1, or 2 N-terminal inserts (0N, 1N, and 2N). We generated Tau isoform-specific antibodies and performed co-immunoprecipitations followed by tandem mass tag multiplexed quantitative mass spectrometry. We identified novel Tau-interacting proteins of which one-half comprised membrane-bound proteins, localized to the plasma membrane, mitochondria, and other organelles. Tau was also found to interact with proteins involved in presynaptic signal transduction. MetaCore analysis revealed one major Tau interaction cluster that contained 33 Tau pulldown proteins. To explore the pathways in which these proteins are involved, we conducted an ingenuity pathway analysis that revealed two significant overlapping pathways, cell-to-cell signaling and interaction and neurological disease. The functional enrichment tool DAVID showed that in particular the 2N Tau-interacting proteins were specifically associated with neurological disease. Finally, for a subset of Tau interactions (apolipoprotein A1 (apoA1), apoE, mitochondrial creatine kinase U-type, -synuclein, synaptogyrin-3, synaptophysin, syntaxin 1B, synaptotagmin, and synapsin 1), we performed reverse co-immunoprecipitations, confirming the preferential interaction of specific isoforms. For example, apoA1 displayed a 5-fold preference for the interaction with 2N, whereas -synuclein showed preference for 0N. Remarkably, a reverse immunoprecipitation with apoA1 detected only the 2N isoform. This highlights distinct protein interactions of the different Tau isoforms, suggesting that they execute different functions in brain tissue.	[Liu, Chang] Univ Sydney, Brain & Mind Res Inst, Sydney Med Sch, Camperdown, NSW 2050, Australia; [Song, Xiaomin] Macquarie Univ Sydney, Australian Proteome Anal Facil, Sydney, NSW 2109, Australia; [Nisbet, Rebecca; Goetz, Juergen] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, St. Lucia Campus Brisbane, Brisbane, Qld 4072, Australia	University of Sydney; Macquarie University; University of Queensland	Gotz, J (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, St. Lucia Campus Brisbane, Brisbane, Qld 4072, Australia.	j.goetz@uq.edu.au	Nisbet, Rebecca/P-6492-2017; Götz, Jürgen/C-2448-2014	Nisbet, Rebecca/0000-0002-3751-9119; Götz, Jürgen/0000-0001-8501-7896	Estate of Dr. Clem Jones, Order of Australia; State Government of Queensland; Federal Government of Australia [ACT900116]; Australian Research Council [DP13300101932]; National Health and Medical Research Council of Australia [APP1037746, APP1003150]	Estate of Dr. Clem Jones, Order of Australia; State Government of Queensland; Federal Government of Australia; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Estate of Dr. Clem Jones, Order of Australia, the State Government of Queensland, Federal Government of Australia Grant ACT900116, Australian Research Council Grant DP13300101932, and National Health and Medical Research Council of Australia Grants APP1037746 and APP1003150 (to J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	ALLEN RD, 1985, J CELL BIOL, V100, P1736, DOI 10.1083/jcb.100.5.1736; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Benussi L, 2005, EXP CELL RES, V308, P78, DOI 10.1016/j.yexcr.2005.04.021; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Brandt Roland, 2004, Current Alzheimer Research, V1, P255, DOI 10.2174/1567205043332054; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Chen F, 2004, CURR DRUG TARGETS, V5, P503, DOI 10.2174/1389450043345236; David S, 1998, MOL BRAIN RES, V54, P276, DOI 10.1016/S0169-328X(97)00343-4; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; Dehmelt L, 2005, GENOME BIOL, V6; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Farah CA, 2005, J BIOL CHEM, V280, P9439, DOI 10.1074/jbc.M412304200; Farah CA, 2006, CELL MOTIL CYTOSKEL, V63, P710, DOI 10.1002/cm.20157; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Galas MC, 2000, J NEUROCHEM, V75, P1511, DOI 10.1046/j.1471-4159.2000.0751511.x; Garringer HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056426; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Gotz J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00072; Gotz J, 2001, EUR J NEUROSCI, V13, P2131, DOI 10.1046/j.0953-816x.2001.01604.x; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iijima-Ando K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002918; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Li JY, 2002, NEUROSCIENCE, V113, P463, DOI 10.1016/S0306-4522(02)00143-4; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; MATUS A, 1990, J PHYSIOL-PARIS, V84, P134; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Mishima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090004; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Pooler AM, 2010, BIOCHEM SOC T, V38, P1012, DOI 10.1042/BST0381012; Reddy PH, 2014, BBA-MOL BASIS DIS, V1842, P1167, DOI 10.1016/j.bbadis.2014.03.012; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Roher AE, 2009, BIOMARKERS, V14, P493, DOI 10.3109/13547500903108423; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Salminen A, 2011, PROG NEUROBIOL, V93, P99, DOI 10.1016/j.pneurobio.2010.10.006; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sontag JM, 2012, J BIOL CHEM, V287, P14984, DOI 10.1074/jbc.M111.338681; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Tashiro K, 1997, NEUROREPORT, V8, P2797, DOI 10.1097/00001756-199708180-00029; Trinczek B, 1999, J CELL SCI, V112, P2355; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Ullrich M, 2014, NAT PROTOC, V9, P2237, DOI 10.1038/nprot.2014.150; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; Xia D, 2015, BBA-MOL BASIS DIS, V1852, P913, DOI 10.1016/j.bbadis.2014.12.017; Xia D, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00040; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yoshiyama Y, 2013, J NEUROL NEUROSUR PS, V84, P784, DOI 10.1136/jnnp-2012-303144; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004	66	83	84	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8173	8188		10.1074/jbc.M115.641902	http://dx.doi.org/10.1074/jbc.M115.641902			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26861879	Green Published, hybrid			2022-12-26	WOS:000374056700034
J	Kolesar, P; Altmannova, V; Silva, S; Lisby, M; Krejci, L				Kolesar, Peter; Altmannova, Veronika; Silva, Sonia; Lisby, Michael; Krejci, Lumir			Pro-recombination Role of Srs2 Protein Requires SUMO (Small Ubiquitin-like Modifier) but Is Independent of PCNA (Proliferating Cell Nuclear Antigen) Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; YEAST SACCHAROMYCES-CEREVISIAE; RAD51 PRESYNAPTIC FILAMENT; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; ELEVATED RECOMBINATION; MITOTIC RECOMBINATION; MOLECULAR DISSECTION; CONJUGATING ENZYME; IN-VITRO	Srs2 plays many roles in DNA repair, the proper regulation and coordination of which is essential. Post-translational modification by small ubiquitin-like modifier (SUMO) is one such possible mechanism. Here, we investigate the role of SUMO in Srs2 regulation and show that the SUMO-interacting motif (SIM) of Srs2 is important for the interaction with several recombination factors. Lack of SIM, but not proliferating cell nuclear antigen (PCNA)-interacting motif (PIM), leads to increased cell death under circumstances requiring homologous recombination for DNA repair. Simultaneous mutation of SIM in a srs2 Delta PIM strain leads to a decrease in recombination, indicating a pro-recombination role of SUMO. Thus SIM has an ambivalent function in Srs2 regulation; it not only mediates interaction with SUMO-PCNA to promote the anti-recombination function but it also plays a PCNA-independent pro-recombination role, probably by stimulating the formation of recombination complexes. The fact that deletion of PIM suppresses the phenotypes of Srs2 lacking SIM suggests that proper balance between the anti-recombination PCNA-bound and pro-recombination pools of Srs2 is crucial. Notably, sumoylation of Srs2 itself specifically stimulates recombination at the rDNA locus.	[Kolesar, Peter; Altmannova, Veronika; Krejci, Lumir] Masaryk Univ, Dept Biol, Brno 62500, Czech Republic; [Kolesar, Peter; Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Silva, Sonia; Lisby, Michael] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Krejci, Lumir] St Annes Univ Hosp Brno, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno 60200, Czech Republic; [Kolesar, Peter] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Masaryk University Brno; Masaryk University Brno; University of Copenhagen; St Anne's University Hospital Brno (FNUSA-ICRC); University of Sussex	Krejci, L (corresponding author), Masaryk Univ, Dept Biol, Brno 62500, Czech Republic.; Krejci, L (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic.; Krejci, L (corresponding author), St Annes Univ Hosp Brno, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno 60200, Czech Republic.	lkrejci@chemi.muni.cz	da Silva, Sonia C Pinela/F-2447-2016; Krejci, Lumir/B-7842-2009; Kolesar, Peter/B-2580-2015; Lisby, Michael/K-9814-2014	da Silva, Sonia C Pinela/0000-0003-3700-3072; Krejci, Lumir/0000-0002-4732-1405; Kolesar, Peter/0000-0002-3315-3586; Lisby, Michael/0000-0002-4830-5247	Czech Science Foundation [GACR 13-26629S, P207/12/2323]; European Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Research Support Programme "Employment of Newly Graduated Doctors of Science for Scientific Excellence" - European Social Fund [GAMU-MUNI/M/1894/2014, CZ.1.07/2.3.00/30.0009, CZ.1.07/2.3.00/30.0037]; Faculty of Medicine, Masaryk University; Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation; Lundbeck Foundation; European Research Council (ERC); Fundacao para a Ciencia e Tecnologia (FCT); Villum Fonden [00011407] Funding Source: researchfish	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund-Project FNUSA-ICRC; Research Support Programme "Employment of Newly Graduated Doctors of Science for Scientific Excellence" - European Social Fund; Faculty of Medicine, Masaryk University; Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation(Villum Fonden); Lundbeck Foundation(Lundbeckfonden); European Research Council (ERC)(European Research Council (ERC)European Commission); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Villum Fonden(Villum Fonden)	This work was supported by the Czech Science Foundation (GACR 13-26629S and P207/12/2323; to L. K.), European Regional Development Fund-Project FNUSA-ICRC (CZ.1.05/1.1.00/02.0123; to L. K.) and Research Support Programme (GAMU-MUNI/M/1894/2014; to L. K), "Employment of Newly Graduated Doctors of Science for Scientific Excellence" co-financed from the European Social Fund (CZ.1.07/2.3.00/30.0009 (to V. A.) and CZ.1.07/2.3.00/30.0037 (to P. K.), funds from the Faculty of Medicine, Masaryk University to junior researcher (to V. A.), the Danish Agency for Science, Technology and Innovation, the Villum Kann Rasmussen Foundation, the Lundbeck Foundation, European Research Council (ERC) (to M. L.), and Fundacao para a Ciencia e Tecnologia (FCT; to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; AGUILERA A, 1988, GENETICS, V119, P779; Altmannova V, 2012, BIOMOLECULES, V2, P350, DOI 10.3390/biom2030350; Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Burkovics P, 2016, NUCLEIC ACIDS RES, V44, P3176, DOI 10.1093/nar/gkw024; Carter SD, 2009, P NATL ACAD SCI USA, V106, P12037, DOI 10.1073/pnas.0903869106; Chamankhah M, 1999, NUCLEIC ACIDS RES, V27, P2072, DOI 10.1093/nar/27.10.2072; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Chavdarova M, 2015, NUCLEIC ACIDS RES, V43, P3626, DOI 10.1093/nar/gkv198; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Davis AP, 2001, GENETICS, V159, P515; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Eckert-Boulet N, 2009, DNA REPAIR, V8, P507, DOI 10.1016/j.dnarep.2009.01.015; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hegde V, 2000, NUCLEIC ACIDS RES, V28, P2779, DOI 10.1093/nar/28.14.2779; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim SO, 2012, J MOL CELL BIOL, V4, P258, DOI 10.1093/jmcb/mjs026; Klein H, 2001, GENETICS, V157, P557; Kolesar P, 2012, NUCLEIC ACIDS RES, V40, P7831, DOI 10.1093/nar/gks484; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Le Breton C, 2008, NUCLEIC ACIDS RES, V36, P4964, DOI 10.1093/nar/gkn441; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Marini V, 2012, DNA REPAIR, V11, P789, DOI 10.1016/j.dnarep.2012.05.007; Marini V, 2010, DNA REPAIR, V9, P268, DOI 10.1016/j.dnarep.2010.01.007; Merker RJ, 2002, MOL CELL BIOL, V22, P421, DOI 10.1128/MCB.22.2.421-429.2002; Miura T, 2013, P NATL ACAD SCI USA, V110, P16067, DOI 10.1073/pnas.1303111110; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Mortensen UH, 2002, GENETICS, V161, P549; Paliwal S, 2014, NUCLEIC ACIDS RES, V42, P2380, DOI 10.1093/nar/gkt1263; PALLADINO F, 1992, GENETICS, V132, P23; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Burkovics P, 2013, EMBO J, V32, P742, DOI 10.1038/emboj.2013.9; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; RONG L, 1991, GENETICS, V127, P75; RONG L, 1993, J BIOL CHEM, V268, P1252; Ruiz JF, 2009, MOL CELL BIOL, V29, P5441, DOI 10.1128/MCB.00256-09; Saponaro M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000858; SCHIESTL RH, 1990, GENETICS, V124, P817; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; Sherman F., 1989, LAB COURSE MANUAL ME; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; SMITH J, 1995, MOL CELL BIOL, V15, P1632; Smith J, 1999, GENETICS, V151, P447; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Takahashi Y, 2003, J BIOCHEM, V133, P415, DOI 10.1093/jb/mvg054; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wilson TE, 2002, GENETICS, V162, P677; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	80	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7594	7607		10.1074/jbc.M115.685891	http://dx.doi.org/10.1074/jbc.M115.685891			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26861880	hybrid, Green Published			2022-12-26	WOS:000383447600032
J	Wasitthankasem, R; Posuwan, N; Vichaiwattana, P; Theamboonlers, A; Klinfueng, S; Vuthitanachot, V; Thanetkongtong, N; Saelao, S; Foonoi, M; Fakthongyoo, A; Makaroon, J; Srisingh, K; Asawarachun, D; Owatanapanich, S; Wutthiratkowit, N; Tohtubtiang, K; Yoocharoen, P; Vongpunsawad, S; Poovorawan, Y				Wasitthankasem, Rujipat; Posuwan, Nawarat; Vichaiwattana, Preeyaporn; Theamboonlers, Apiradee; Klinfueng, Sirapa; Vuthitanachot, Viboonsak; Thanetkongtong, Napha; Saelao, Siriporn; Foonoi, Monthana; Fakthongyoo, Apinya; Makaroon, Jamorn; Srisingh, Klaita; Asawarachun, Duangporn; Owatanapanich, Somchai; Wutthiratkowit, Norra; Tohtubtiang, Kraisorn; Yoocharoen, Pornsak; Vongpunsawad, Sompong; Poovorawan, Yong			Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey	PLOS ONE			English	Article							BLOOD-DONORS; RISK-FACTORS; GENOTYPE DISTRIBUTION; PEGYLATED INTERFERON; COST-EFFECTIVENESS; PREVALENCE; EPIDEMIOLOGY; SOFOSBUVIR; RIBAVIRIN; SEROEPIDEMIOLOGY	Hepatitis C virus (HCV) infection affects >= 180 million individuals worldwide especially those living in developing countries. Recent advances in direct-acting therapeutics promise effective treatments for chronic HCV carriers, but only if the affected individuals are identified. Good treatment coverage therefore requires accurate epidemiological data on HCV infection. In 2014, we determined the current prevalence of HCV in Thailand to assess whether over the past decade the significant number of chronic carriers had changed. In total, 5964 serum samples from Thai residents between 6 months and 71 years of age were obtained from 7 provinces representing all 4 geographical regions of Thailand and screened for the anti-HCV antibody. Positive samples were further analyzed using RT-PCR, sequencing, and phylogenetic analysis to identify the prevailing HCV genotypes. We found that 56 (0.94%) samples tested positive for anti-HCV antibody (mean age = 36.6 +/- 17.6 years), while HCV RNA of the core and NS5B subgenomic regions was detected in 23 (41%) and 19 (34%) of the samples, respectively. The seropositive rates appeared to increase with age and peaked in individuals 41-50 years old. These results suggested that approximately 759,000 individuals are currently anti-HCV-positive and that 357,000 individuals have viremic HCV infection. These numbers represent a significant decline in the prevalence of HCV infection. Interestingly, the frequency of genotype 6 variants increased from 8.9% to 34.8%, while the prevalence of genotype 1b declined from 27% to 13%. These most recent comprehensive estimates of HCV burden in Thailand are valuable towards evidence-based treatment coverage for specific population groups, appropriate allocation of resources, and improvement in the national public health policy.	[Wasitthankasem, Rujipat; Posuwan, Nawarat; Vichaiwattana, Preeyaporn; Theamboonlers, Apiradee; Klinfueng, Sirapa; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Vuthitanachot, Viboonsak; Thanetkongtong, Napha] Chumpare Hosp, Khon Kaen, Thailand; [Saelao, Siriporn; Foonoi, Monthana; Fakthongyoo, Apinya] Uttaradit Hosp, Mueang, Uttaradit, Thailand; [Makaroon, Jamorn] Lablae Hosp, Lablae, Uttaradit, Thailand; [Srisingh, Klaita] Naresuan Univ Hosp, Mueang, Phitsanulok, Thailand; [Asawarachun, Duangporn] Phra Nakhon Si Ayutthaya Hosp, Phra Nakhon Si Ayutthaya, Thailand; [Owatanapanich, Somchai] King Narai Hosp, Khao Sam Yot, Lop Buri, Thailand; [Wutthiratkowit, Norra] Narathiwat Ratchanakarin Hosp, Mueang, Narathiwat, Thailand; [Tohtubtiang, Kraisorn] Trang Hosp, Mueang, Trang, Thailand; [Yoocharoen, Pornsak] Minist Publ Hlth, Dept Dis Control, Bur Gen Communicable Dis, Nonthaburi, Thailand	Chulalongkorn University; Ministry of Public Health - Thailand	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807	National Research University Project, Office of Higher Education Commission [WCU-58-006-HR]; National Research Council of Thailand (NRCT); Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of Thailand Research Fund [DPG5480002]; Center of Excellence in Clinical Virology of Chulalongkorn University [GCE 58-014-30-004]; King Chulalongkorn Memorial Hospital; Rachadapisek Sompote Fund of Chulalongkorn University; National Science and Technology Development Agency	National Research University Project, Office of Higher Education Commission; National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of Thailand Research Fund; Center of Excellence in Clinical Virology of Chulalongkorn University; King Chulalongkorn Memorial Hospital(Chulalongkorn University); Rachadapisek Sompote Fund of Chulalongkorn University; National Science and Technology Development Agency	This work was supported by The National Research University Project, Office of Higher Education Commission (WCU-58-006-HR), The National Research Council of Thailand (NRCT), The Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), The Outstanding Professor of Thailand Research Fund (DPG5480002), and The Center of Excellence in Clinical Virology of Chulalongkorn University (GCE 58-014-30-004), King Chulalongkorn Memorial Hospital, and the Rachadapisek Sompote Fund of Chulalongkorn University for postdoctoral fellowship to Rujipat Wasitthankasem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2013, INTERVIROLOGY, V56, P284, DOI 10.1159/000351621; Akkarathamrongsin S, 2011, INTERVIROLOGY, V54, P10, DOI 10.1159/000318884; ARGUILLAS MO, 1991, GASTROENTEROL JPN, V26, P170; Baid-Agrawal S, 2014, J HEPATOL, V60, P928, DOI 10.1016/j.jhep.2014.01.012; Caruana SR, 2005, AUST NZ J PUBL HEAL, V29, P64, DOI 10.1111/j.1467-842X.2005.tb00751.x; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cure S, 2015, J MED ECON, V18, P678, DOI 10.3111/13696998.2015.1040024; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Comas LG, 2015, J MED VIROL, V87, P1697, DOI 10.1002/jmv.24219; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hart-Malloy R, 2013, AM J PUBLIC HEALTH, V103, P1402, DOI 10.2105/AJPH.2013.301231; Haslina MNN, 2012, SE ASIAN J TROP MED, V43, P668; Houghton M, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01925.x; Inoue Y, 2000, AM J TROP MED HYG, V62, P92, DOI 10.4269/ajtmh.2000.62.92; Ishida T, 2002, J CLIN VIROL, V24, P31, DOI 10.1016/S1386-6532(01)00222-0; Jittiwutikarn J, 2006, AM J TROP MED HYG, V74, P1111, DOI 10.4269/ajtmh.2006.74.1111; Kanistanon D, 1997, J CLIN MICROBIOL, V35, P1772, DOI 10.1128/JCM.35.7.1772-1776.1997; Kao HH, 2015, NEPHRON, V130, P127, DOI 10.1159/000430988; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Luksamijarulkul Pipat, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P272; Lwin AA, 2007, HEPATOL RES, V37, P337, DOI 10.1111/j.1872-034X.2007.00053.x; Ng KT, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00168-12; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Pfeil AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126984; PHANUPHAK P, 1985, ASIAN PAC J ALLERGY, V3, P195; Ratanasuwan Winai, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P416; Sawanpanyalert P, 1996, J EPIDEMIOL COMMUN H, V50, P174, DOI 10.1136/jech.50.2.174; Sistayanarain A, 2011, MOL BIOL REP, V38, P4287, DOI 10.1007/s11033-010-0552-x; Do SH, 2015, HEPATOL RES, V45, P259, DOI 10.1111/hepr.12350; Songsivilai S, 1997, AM J TROP MED HYG, V57, P66, DOI 10.4269/ajtmh.1997.57.66; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Suwanagool Surapol, 1995, Journal of the Medical Association of Thailand, V78, P611; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thaikruea L, 2004, TRANSFUSION, V44, P1433, DOI 10.1111/j.1537-2995.2004.04073.x; Verachai Viroj, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P849; Vidimliski PD, 2014, J MED VIROL, V86, P1491, DOI 10.1002/jmv.23979; Wang JEH, 1995, J PUBLIC HEALTH MED, V17, P387; World Health Organization, 2014, HEP C; Yamada H, 2015, HEPATOL RES, V45, P480, DOI 10.1111/hepr.12367; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082598	48	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149362	10.1371/journal.pone.0149362	http://dx.doi.org/10.1371/journal.pone.0149362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871561	Green Submitted, gold, Green Published			2022-12-26	WOS:000370054100151
J	Dierickx, S; Gryseels, C; Mwesigwa, J; O'Neill, S; Bannister-Tyrell, M; Ronse, M; Jaiteh, F; Gerrets, R; D'Alessandro, U; Grietens, KP				Dierickx, Susan; Gryseels, Charlotte; Mwesigwa, Julia; O'Neill, Sarah; Bannister-Tyrell, Melanie; Ronse, Maya; Jaiteh, Fatou; Gerrets, Rene; D'Alessandro, Umberto; Grietens, Koen Peeters			Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in The Gambia	PLOS ONE			English	Article							HEALTH-CARE; ELIMINATION; TRANSMISSION; COMBINATION; UGANDA; TRIAL	Introduction The potential benefits of Mass Drug Administration (MDA) for malaria elimination are being considered in several malaria endemic countries where a decline in malaria transmission has been reported. For this strategy to work, it is important that a large proportion of the target population participates, requiring an in-depth understanding of factors that may affect participation and adherence to MDA programs. Methodology This social science study was ancillary to a one-round directly observed MDA campaign with dihydroartemisinin-piperaquine, carried out in 12 villages in rural Gambia between June and August 2014. The social science study employed a mixed-methods approach combining qualitative methods (participant observation and in-depth interviewing) and quantitative methods (structured follow-up interviews among non-participating and non-adhering community members). Results Of 3942 people registered in the study villages, 67.9% adhered to the three consecutive daily doses. For the remaining villagers, 12.6% did not attend the screening, 3.5% was not eligible and 16% did not adhere to the treatment schedule. The main barriers for non-participation and adherence were long and short-term mobility of individuals and specific subgroups, perceived adverse drug reactions and rumors, inconveniences related to the logistics of MDA (e.g. waiting times) and the perceived lack of information about MDA. Conclusion While, there was no fundamental resistance from the target communities, adherence was 67.9%. This shows the necessity of understanding local perceptions and barriers to increase its effectiveness. Moreover, certain of the constraining factors were socio-spatially clustered which might prove problematic since focal areas of residual malaria transmission may remain allowing malaria to spread to adjacent areas where transmission had been temporarily interrupted.	[Dierickx, Susan; Gryseels, Charlotte; O'Neill, Sarah; Bannister-Tyrell, Melanie; Ronse, Maya; Jaiteh, Fatou; D'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Dierickx, Susan; Gryseels, Charlotte; Gerrets, Rene] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Dierickx, Susan] Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect, Rhea, Brussels, Belgium; [Mwesigwa, Julia; Jaiteh, Fatou; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Grietens, Koen Peeters] PASS Int, Tessenderlo, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan	Institute of Tropical Medicine (ITM); University of Amsterdam; Vrije Universiteit Brussel; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Nagasaki University	Dierickx, S (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.; Dierickx, S (corresponding author), Amsterdam Inst Social Sci Res, Amsterdam, Netherlands.; Dierickx, S (corresponding author), Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect, Rhea, Brussels, Belgium.	susan.dierickx@vub.ac.be	Peeters Grietens, Koen/G-7028-2019	Peeters Grietens, Koen/0000-0001-6570-9887; O'Neill, Sarah/0000-0001-8807-0991; Gryseels, Charlotte/0000-0002-8963-4469; Dierickx, Susan/0000-0003-3140-0771; Ronse, Maya/0000-0001-7182-6940; Mwesigwa, Julia/0000-0003-2452-3677	UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID; European Union; MRC [MC_EX_MR/J002364/1] Funding Source: UKRI; Medical Research Council [MC_EX_MR/J002364/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This award is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union.	Amazigo UV, 2002, ANN TROP MED PARASIT, V96, P41, DOI 10.1179/000349802125000646; Bhullar N, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-70; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Cassell JA, 2006, HEALTH POLICY PLANN, V21, P373, DOI 10.1093/heapol/czl020; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Crowell V, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-4; De Martin S, 2001, TROP MED INT HEALTH, V6, P442, DOI 10.1046/j.1365-3156.2001.00723.x; Dial NJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-47; GARFIELD RM, 1986, SOC SCI MED, V22, P869, DOI 10.1016/0277-9536(86)90241-8; Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Greenwood B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S2; Gryseels C, 2015, AM J TROP MED HYG, V93, P810, DOI 10.4269/ajtmh.15-0259; Katabarwa MN, 2001, ANN TROP MED PARASIT, V95, P275, DOI 10.1080/00034983.2001.11813639; Kingori P, 2013, SOC SCI MED, V98, P361, DOI 10.1016/j.socscimed.2013.10.013; Krentel A, 2012, HEALTH POLICY PLANN, V27, P384, DOI 10.1093/heapol/czr048; Marshall Martin N, 1996, FAMILY PRACTICE, P4; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Nichter M, 2008, INTRODUCING ZINC DIA; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; Poirot E, 2013, MASS DRUG A IN PRESS; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; Shekalaghe SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-247; Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108; Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800	28	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148627	10.1371/journal.pone.0148627	http://dx.doi.org/10.1371/journal.pone.0148627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866685	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000370050700023
J	Guo, HL; Liao, XH; Liu, Q; Zhang, L				Guo, Hui-Lin; Liao, Xiao-Hui; Liu, Qi; Zhang, Ling			Angiotensin II Type 2 Receptor Decreases Transforming Growth Factor-beta Type II Receptor Expression and Function in Human Renal Proximal Tubule Cells	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; AT(2) RECEPTORS; BLOOD-PRESSURE; TGF-BETA-1; NATRIURESIS; MECHANISM; OBESE; STIMULATION; INHIBITION; INCREASES	Transforming growth factor-beta (TGF-beta), via its receptors, induces epithelial-mesenchymal transition (EMT) and plays an important role in the development of renal tubulointersitial fibrosis. Angiotensin II type 2 receptor (AT(2)R), which mediates beneficial renal physiological functions, has received attention as a prospective therapeutic target for renoprotection. In this study, we investigated the effect and underlying mechanism of AT(2)R on the TGF-beta receptor II (TGF-beta RII) expression and function in human proximal tubular cells (HK-2). Here, we show that the AT(2)R agonist CGP42112A decreased TGF-beta RII protein expression in a concentration- and time-dependent manner in HK-2 cells. The inhibitory effect of the AT(2)R on TGF-beta RII expression was blocked by the AT(2)R antagonists PD123319 or PD123177. Stimulation with TGF-beta 1 enhanced EMT in HK-2 cells, which was prevented by pre-treatment with CGP42112A. One of mechanisms in this regulation is associated with the increased TGF-beta RII degradation after activation of AT(2)R. Furthermore, laser confocal immunofluorescence microscopy showed that AT(2)R and TGF-beta RII colocalized in HK-2 cells. AT(2)R and TGF-beta RII coimmunoprecipitated and this interaction was increased after AT(2)R agonist stimulation for 30 min. The inhibitory effect of the AT(2)R on TGF-beta RII expression was also blocked by the nitric oxide synthase inhibitor L-NAME, indicating that nitric oxide is involved in the signaling pathway. Taken together, our study indicates that the renal AT(2)R regulates TGF-beta RII expression and function via the nitric oxide pathway, which may be important in the control of renal tubulointerstitial fibrosis.	[Guo, Hui-Lin; Liao, Xiao-Hui; Zhang, Ling] Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400010, Peoples R China; [Liu, Qi] Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Inst Viral Hepatitis, Chongqing 400010, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zhang, L (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400010, Peoples R China.; Liu, Q (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Inst Viral Hepatitis, Chongqing 400010, Peoples R China.	txzzliuqi@163.com; lindazhang8508@sina.com			Chongqing Municipal Health and Family Planning Commission [20142031]; Chongqing Medical University [201404]	Chongqing Municipal Health and Family Planning Commission; Chongqing Medical University	These studies were supported in part by grants from medical scientific research projects of Chongqing Municipal Health and Family Planning Commission (No. 20142031), and the funding for fostering talents of Chongqing Medical University (No. 201404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadir PM, 2011, J INTERF CYTOK RES, V31, P471, DOI 10.1089/jir.2010.0043; Ali Q, 2013, KIDNEY INT, V84, P931, DOI 10.1038/ki.2013.193; Aurelie NDC, 2011, CURR HYPERTENS REP, V13, P122, DOI 10.1007/s11906-011-0187-x; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Carey RM, 2013, CLIN EXP PHARMACOL P, V40, P527, DOI 10.1111/1440-1681.12059; Castoldi G, 2014, AM J PHYSIOL-RENAL, V307, pF1123, DOI 10.1152/ajprenal.00247.2014; Dhande I, 2013, HYPERTENSION, V61, P1218, DOI 10.1161/HYPERTENSIONAHA.111.00422; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Giani JF, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0477-1; Hakam AC, 2006, AM J PHYSIOL-RENAL, V290, pF1430, DOI 10.1152/ajprenal.00218.2005; Hakam AC, 2006, HYPERTENSION, V47, P1117, DOI 10.1161/01.HYP.0000220112.91724.fc; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Ichiki T, 1998, HYPERTENSION, V31, P342, DOI 10.1161/01.HYP.31.1.342; Jin XQ, 2002, HYPERTENSION, V39, P1021, DOI 10.1161/01.HYP.0000016179.52601.B4; Kamitani S, 2011, INT ARCH ALLERGY IMM, V155, P119, DOI 10.1159/000318854; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kemp BA, 2014, CIRC RES, V115, P388, DOI 10.1161/CIRCRESAHA.115.304110; Li YK, 2010, MOL CELL BIOCHEM, V339, P263, DOI 10.1007/s11010-010-0389-6; Liu J., 2015, MOL NEUROBIOL; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Padia SH, 2013, PFLUG ARCH EUR J PHY, V465, P99, DOI 10.1007/s00424-012-1146-3; Padia SH, 2012, HYPERTENSION, V59, P437, DOI 10.1161/HYPERTENSIONAHA.111.184788; Painemal P, 2013, BIOFACTORS, V39, P467, DOI 10.1002/biof.1087; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Roulston CL, 2004, NEUROSCIENCE, V127, P753, DOI 10.1016/j.neuroscience.2004.04.062; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Salomone LJ, 2007, HYPERTENSION, V49, P155, DOI 10.1161/01.HYP.0000251881.89610.ee; Siragy HM, 2007, AM J PHYSIOL-REG I, V293, pR1461, DOI 10.1152/ajpregu.00014.2007; Su JZ, 2002, HYPERTENSION, V40, P853, DOI 10.1161/01.HYP.0000042096.17141.B1; Sumners C, 2015, CURR OPIN PHARMACOL, V21, P115, DOI 10.1016/j.coph.2015.01.004; Ulmasov B, 2009, AM J PHYSIOL-GASTR L, V296, pG284, DOI 10.1152/ajpgi.90409.2008; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu YF, 2012, INT J MOL MED, V29, P781, DOI 10.3892/ijmm.2012.911; Yang J, 2012, J HYPERTENS, V30, P1176, DOI 10.1097/HJH.0b013e3283532099; Yin RY, 2015, FREE RADICAL BIO MED, V89, P895, DOI 10.1016/j.freeradbiomed.2015.10.406; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zhang XH, 2012, ARTERIOSCL THROM VAS, V32, P1015, DOI 10.1161/ATVBAHA.111.244962	42	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148696	10.1371/journal.pone.0148696	http://dx.doi.org/10.1371/journal.pone.0148696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867007	Green Submitted, gold, Green Published			2022-12-26	WOS:000370050700026
J	Liu, G; Gao, Y; Huang, FF; Yuan, MY; Peng, SL				Liu, Gang; Gao, Yang; Huang, Fang-Fang; Yuan, Ming-Yue; Peng, Shao-Lin			The Invasion of Coastal Areas in South China by Ipomoea cairica May Be Accelerated by the Ecotype Being More Locally Adapted to Salt Stress	PLOS ONE			English	Article							PLANT PHENOTYPIC PLASTICITY; LEAF CONSTRUCTION COST; COMPETITIVE ABILITY; GENETIC DIVERSITY; CO2 ASSIMILATION; NITROGEN-CONTENT; ADAPTATION; EVOLUTION; SALINITY; ENVIRONMENTS	Local adaptation and phenotypic plasticity are two alternative mechanisms used by invasive plants for range expansion. We conducted a series of experiments to investigate the role of these mechanisms in the recent expansion of the invasive Ipomoea cairica from non-saline to salt-stressed coastal habitats. A comparison of the plant's photosynthetic traits and construction costs across habitats was conducted through a field survey. Meanwhile, a full factorial greenhouse experiment was conducted with two ecotypes (non-saline and coastal) of I. cairica and two salinity gradients (water and 4 g L-1 NaCl solution) to evaluate the roles of the two strategies by comparing their main traits. The results revealed that the construction cost and A(max) of I. cairica did not change with the habitat type. The ecotype and saline treatments, however, significantly influenced the plant growth. The non-saline ecotype (NE) generally showed higher or equal plasticity of biomass-allocation and functional traits compared to the coastal ecotype (CE). However, the fitness and biomass of the NE significantly decreased with salinity, whereas those aspects of the CE did not change. Our results indicate that the recent expansion of I. cairica into coastal areas may be accelerated by the local adaptation of the CE to salt stress. Additionally, in South China, the CE will most likely evolve adaptations to both saline and non-saline environments, which will further broaden the invasion range of I. cairica in the future.	[Liu, Gang] Shaanxi Normal Univ, Coll Life Sci, Xian 710119, Peoples R China; [Liu, Gang; Gao, Yang; Huang, Fang-Fang; Yuan, Ming-Yue; Peng, Shao-Lin] Sun Yat Sen Univ, Sch Life Sci, Guangdong Higher Educ Inst, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Gang; Gao, Yang; Huang, Fang-Fang; Yuan, Ming-Yue; Peng, Shao-Lin] Sun Yat Sen Univ, Sch Life Sci, Guangdong Higher Educ Inst, Guangdong Key Lab Plant Resources,Key Lab Biodive, Guangzhou 510275, Guangdong, Peoples R China	Shaanxi Normal University; Sun Yat Sen University; Sun Yat Sen University	Peng, SL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Higher Educ Inst, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.; Peng, SL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Higher Educ Inst, Guangdong Key Lab Plant Resources,Key Lab Biodive, Guangzhou 510275, Guangdong, Peoples R China.	lsspsl@mail.sysu.edu.cn		Liu, Gang/0000-0002-5633-4216	National Natural Science Foundation of China [31300401, 31030015]; international fund of 985 project, Sun Yat-Sen University; Scientific Research Fund of Hongda Zhang, Sun Yat-Sen University; fund of State Key Laboratory of Biocontrol, Sun Yat-sen University [SKLBC14KF04]; Fundamental Research Funds for the Central Universities [GK201503044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); international fund of 985 project, Sun Yat-Sen University; Scientific Research Fund of Hongda Zhang, Sun Yat-Sen University; fund of State Key Laboratory of Biocontrol, Sun Yat-sen University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (31300401 and 31030015), the international fund of 985 project, Sun Yat-Sen University and the Scientific Research Fund of Hongda Zhang, Sun Yat-Sen University, the fund of State Key Laboratory of Biocontrol, Sun Yat-sen University(SKLBC14KF04), and the Fundamental Research Funds for the Central Universities (GK201503044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka M, 2005, J VEG SCI, V16, P647, DOI 10.1111/j.1654-1103.2005.tb02407.x; Albacete A, 2008, J EXP BOT, V59, P4119, DOI 10.1093/jxb/ern251; Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Avolio ML, 2013, ECOLOGY, V94, P953, DOI 10.1890/12-1119.1; Baker H. G., 1965, The genetics of colonizing species., P147; Barthod S, 2005, ANN FOREST SCI, V62, P545, DOI 10.1051/forest:2005047; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Chen LY, 2013, PLOS ONE, V8; Cheng LL, 2001, J EXP BOT, V52, P1865, DOI 10.1093/jexbot/52.362.1865; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dawson W, 2011, GLOBAL ECOL BIOGEOGR, V20, P299, DOI 10.1111/j.1466-8238.2010.00599.x; DEVRIES FWT, 1974, J THEOR BIOL, V45, P339, DOI DOI 10.1016/0022-5193(74)90119-2; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Drenovsky RE, 2008, AM J BOT, V95, P681, DOI 10.3732/ajb.2007408; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; File AL, 2012, P ROY SOC B-BIOL SCI, V279, P209, DOI 10.1098/rspb.2011.1995; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Funk JL, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot026; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; Huang QQ, 2011, WEED RES, V51, P534, DOI 10.1111/j.1365-3180.2011.00868.x; Huang QQ, 2009, BIODIVERS CONSERV, V18, P305, DOI 10.1007/s10531-008-9485-2; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Liu G, 2015, BIOL INVASIONS, V17, P3479, DOI 10.1007/s10530-015-0972-6; Liu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048829; Mal TK, 2005, AM J BOT, V92, P819, DOI 10.3732/ajb.92.5.819; Matesanz S, 2013, ECOLOGY, V94, P2464, DOI 10.1890/12-1359.1; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; Meloni Diego Ariel, 2004, Brazilian Journal of Plant Physiology, V16, P39, DOI 10.1590/S1677-04202004000100006; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Nichols PGH, 2009, PLANT SOIL, V315, P241, DOI 10.1007/s11104-008-9747-5; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Phillips AJ, 2015, AM J BOT, V102, P73, DOI 10.3732/ajb.1400234; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; PUTZ FE, 1984, BIOTROPICA, V16, P19, DOI 10.2307/2387889; Putz FE., 2012, VINE ECOLOGY ECOLOGY; Rewald B, 2012, J EXP BOT, V63, P2717, DOI 10.1093/jxb/err457; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richards CL, 2010, ESTUAR COAST, V33, P840, DOI 10.1007/s12237-009-9186-4; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Ross C.A., 2009, INVASION SUCCESS PLA; Rozema J, 1988, PLANT POPULATION ECO, P137; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Shen XY, 2011, BIOL INVASIONS, V13, P869, DOI 10.1007/s10530-010-9875-8; Suarez N, 2005, BIOL PLANTARUM, V49, P111, DOI 10.1007/s10535-005-1116-0; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Sultan SE, 2004, PERSPECT PLANT ECOL, V6, P227, DOI 10.1078/1433-8319-00082; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Walls RL, 2010, ESTUAR COAST, V33, P902, DOI 10.1007/s12237-009-9190-8; WILLIAMS DG, 1993, FUNCT ECOL, V7, P623, DOI 10.2307/2390140; WILLIAMS K, 1987, PLANT CELL ENVIRON, V10, P725	65	12	14	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149262	10.1371/journal.pone.0149262	http://dx.doi.org/10.1371/journal.pone.0149262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867222	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700082
J	Szkaradkiewicz, A; Karpinski, TM; Linke, K; Majewski, P; Rozkiewicz, D; Goslinska-Kuzniarek, O				Szkaradkiewicz, Andrzej; Karpinski, Tomasz M.; Linke, Krzysztof; Majewski, Przemyslaw; Rozkiewicz, Dorota; Goslinska-Kuzniarek, Olga			Expression of cagA, virB/D Complex and/or vacA Genes in Helicobacter pylori Strains Originating from Patients with Gastric Diseases	PLOS ONE			English	Article							IV SECRETION SYSTEM; PATHOGENICITY ISLAND; VACUOLATING CYTOTOXIN; VIRULENCE FACTORS; EPITHELIAL-CELLS; CANCER; PATHOGENESIS; INFECTION; CARCINOGENESIS; DISRUPTION	In order to better understand pathogenicity of Helicobacter pylori, particularly in the context of its carcinogenic activity, we analysed expression of virulence genes: cagA, virB/D complex (virB4, virB7, virB8, virB9, virB10, virB11, virD4) and vacA in strains of the pathogen originating from persons with gastric diseases. The studies were conducted on 42 strains of H. pylori isolated from patients with histological diagnosis of non-atrophic gastritis-NAG (group 1, including subgroup 1 containing cagA(+) isolates and subgroup 2 containing cagA(-) strains), multifocal atrophic gastritis-MAG (group 2) and gastric adenocarcinoma-GC (group 3). Expression of H. pylori genes was studied using microarray technology. In group 1, in all strains of H. pylori cagA(+) (subgroup 1) high expression of the gene as well as of virB/D was disclosed, accompanied by moderate expression of vacA. In strains of subgroup 2 a moderate expression of vacA was detected. All strains in groups 2 and 3 carried cagA gene but they differed in its expression: a high expression was detected in isolates of group 2 and its hyperexpression in strains of group 3 (hypervirulent strains). In both groups high expression of virB/D and vacA was disclosed. Our results indicate that chronic active gastritis may be induced by both cagA(+) strains of H. pylori, manifesting high expression of virB/D complex but moderate activity of vacA, and cagA(-) strains with moderate expression of vacA gene. On the other hand, in progression of gastric pathology and carcinogenesis linked to H. pylori a significant role was played by hypervirulent strains, manifesting a very high expression of cagA and high activity of virB/D and vacA genes.	[Szkaradkiewicz, Andrzej; Karpinski, Tomasz M.; Goslinska-Kuzniarek, Olga] Poznan Univ Med Sci, Dept Med Microbiol, Wieniawskiego Str 3, PL-61712 Poznan, Poland; [Linke, Krzysztof] Poznan Univ Med Sci, Dept Gastroenterol Human Nutr & Internal Dis, Przybyszewskiego Str 49, PL-60355 Poznan, Poland; [Majewski, Przemyslaw] Poznan Univ Med Sci, Dept Clin Pathomorphol, Przybyszewskiego Str 49, PL-60355 Poznan, Poland; [Rozkiewicz, Dorota] Med Univ Bialystok, Dept Paediat Infect Dis, Univ Childrens Hosp, Waszyngtona Str 17, PL-15274 Bialystok, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Medical University of Bialystok	Szkaradkiewicz, A (corresponding author), Poznan Univ Med Sci, Dept Med Microbiol, Wieniawskiego Str 3, PL-61712 Poznan, Poland.	szkaradkiewicza@poczta.onet.pl	Rozkiewicz, Dorota/S-1101-2018; Majewski, Przemysław Wojciech/GLR-2179-2022; Karpiński, Tomasz M./G-5645-2011	Rozkiewicz, Dorota/0000-0002-8368-8706; Karpiński, Tomasz M./0000-0001-6599-9204; Goslinska-Pawlowska, Olga/0000-0002-2288-2812	Poznan University of Medical Sciences, Poland [502-01-02206316-02658]	Poznan University of Medical Sciences, Poland	The research was supported by a grant from Poznan University of Medical Sciences, Poland (502-01-02206316-02658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by a grant from Poznan University of Medical Sciences, Poland (502-01-02206316-02658).	Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Al-Ghoul L, 2004, BIOCHEM BIOPH RES CO, V322, P860, DOI 10.1016/j.bbrc.2004.07.199; Ali A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/139580; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Argent RH, 2008, J MED MICROBIOL, V57, P145, DOI 10.1099/jmm.0.47465-0; Aviles-Jimenez F, 2012, INFECT IMMUN, V80, P594, DOI 10.1128/IAI.05845-11; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; CORREA P, 1992, CANCER RES, V52, P6735; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; COVER TL, 1992, J BIOL CHEM, V267, P10570; CRABTREE JE, 1991, LANCET, V338, P332, DOI 10.1016/0140-6736(91)90477-7; de Bernard M, 2014, HELICOBACTER, V19, P11, DOI 10.1111/hel.12160; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Graham JE, 2002, GASTROENTEROLOGY, V123, P1637, DOI 10.1053/gast.2002.36589; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hocker M, 2003, LANCET, V362, P1231, DOI 10.1016/S0140-6736(03)14547-3; Ishikawa S, 2009, FEBS LETT, V583, P2414, DOI 10.1016/j.febslet.2009.06.043; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Kane MD, 2009, DRUG DISCOV SER, V11, P1; Karita M, 1998, J INFECT DIS, V178, P213, DOI 10.1086/515606; Ki MR, 2014, MOL CELL BIOCHEM, V396, P23, DOI 10.1007/s11010-014-2138-8; Kodama Masaaki, 2004, Journal of Infection and Chemotherapy, V10, P316, DOI 10.1007/s10156-004-0353-z; Konturek Peter C, 2003, Med Sci Monit, V9, pSR53; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Megraud F, 2015, CLIN MICROBIOL INFEC, V21, P984, DOI 10.1016/j.cmi.2015.06.004; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Memon AA, 2014, J CLIN MICROBIOL, V52, P2984, DOI 10.1128/JCM.00551-14; Noto Jennifer M, 2012, Methods Mol Biol, V921, P41; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Tamer E, 2013, ISRN GASTROENTEROLOG, V2013; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tsang YH, 2010, ONCOGENE, V29, P5643, DOI 10.1038/onc.2010.304; Vannini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098416; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Warburton VJ, 1998, J CLIN PATHOL, V51, P55, DOI 10.1136/jcp.51.1.55; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Winter JA, 2014, J INFECT DIS, V210, P954, DOI 10.1093/infdis/jiu154; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10	42	3	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148936	10.1371/journal.pone.0148936	http://dx.doi.org/10.1371/journal.pone.0148936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866365	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700047
J	Dimala, CA; Atashili, J; Mbuagbaw, JC; Wilfred, A; Monekosso, GL				Dimala, Christian Akem; Atashili, Julius; Mbuagbaw, Josephine C.; Wilfred, Akam; Monekosso, Gottlieb L.			Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naive Patients at the Limbe Regional Hospital, Cameroon	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; BLOOD-PRESSURE; INSULIN-RESISTANCE; GLUCOSE; INDIVIDUALS; INHIBITORS; COHORT; IMPACT	Background Highly active antiretroviral therapy (HAART) has greatly reduced the morbidity and mortality of HIV/AIDS patients but has also been associated with increased metabolic complications and cardiovascular diseases. Data on the association between HAART and hypertension (HTN) in Africa are scarce. Objectives Primarily to compare the prevalence of HTN in HIV/AIDS patients on HAART and HAART-naive patients in Limbe, Cameroon; and secondarily to assess other socio-demographic and clinical factors associated with HTN in this population. Methods A cross-sectional study was conducted at the Limbe Regional Hospital HIV treatment center between April and June 2013, involving 200 HIV/AIDS patients (100 on first-line HAART regimens for at least 12 months matched by age and sex to 100 HAART-naive patients). HTN was defined as a systolic blood pressure (BP) >= 140 mmHg and/or diastolic BP >= 90 mmHg. Results The prevalence of HTN in patients on HAART was twice (38%; 95% CI: 28.5-48.3) that of the HAART-naive patients (19%; 95% CI, 11.8-28.1), p = 0.003. In multivariate analyses adjusted for age, gender, smoking, family history of HTN, and BMI-defined overweight, HAART was associated with HTN, the adjusted odds ratio of the HAART-treated versus HAART-naive group was 2.20 (95% CI: 1.07-4.52), p = 0.032. HTN was associated with older age and male gender, in the HAART group and with BMI-defined overweight in the HAART-naive group. Conclusion The prevalence of hypertension in HIV/AIDS patients in Limbe stands out to be elevated, higher in patients on HAART compared to those not on treatment. Blood pressure and cardiovascular risk factors should be routinely monitored. Other factors such as diet, weight control and physical exercise should also be considered.	[Dimala, Christian Akem] London Sch Hyg & Trop Med, London WC1, England; [Atashili, Julius; Mbuagbaw, Josephine C.; Wilfred, Akam; Monekosso, Gottlieb L.] Univ Buea, Fac Hlth Sci, Buea, Cameroon	University of London; London School of Hygiene & Tropical Medicine	Dimala, CA (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	akdimch@yahoo.com		Akem Dimala, Christian/0000-0002-0064-0126				[Anonymous], 2009, FAST FACTS HIV TREAT; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Bergersen BM, 2003, EUR J CLIN MICROBIOL, V22, P731, DOI 10.1007/s10096-003-1034-z; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Brown TT, 2005, AIDS, V19, P1375, DOI 10.1097/01.aids.0000181011.62385.91; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Cattelan AM, 2001, AIDS, V15, P805, DOI 10.1097/00002030-200104130-00021; Chow DC, 2003, HIV CLIN TRIALS, V4, P411, DOI 10.1310/5E7Q-PGWB-16UE-J48U; Ekali LG, 2013, DIABETES METAB, V39, P71, DOI 10.1016/j.diabet.2012.08.012; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Fleischman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1666, DOI 10.1152/ajpendo.00550.2006; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; de la Serna JIB, 2010, ENFERM INFEC MICR CL, V28, P32, DOI 10.1016/j.eimc.2008.07.005; Institut National de la Statistique, 2011, RAPP PREL PREV VIH; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Jung O, 2004, NEPHROL DIAL TRANSPL, V19, P2250, DOI 10.1093/ndt/gfh393; Khatib OM., 2005, CLIN GUIDELINES MANA; Mateen FJ, 2013, J HYPERTENS, V31, P1372, DOI 10.1097/HJH.0b013e328360de1c; Muhammad Sanusi, 2013, Niger Med J, V54, P185, DOI 10.4103/0300-1652.114591; Palacios R, 2006, HIV MED, V7, P10, DOI 10.1111/j.1468-1293.2005.00333.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Sherer R., 2014, Journal of the International Association of Providers of AIDS Care, V13, P342, DOI 10.1177/2325957414530473; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Thiebaut R, 2005, ANTIVIR THER, V10, P811; Yone EWP, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-33	28	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148100	10.1371/journal.pone.0148100	http://dx.doi.org/10.1371/journal.pone.0148100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862763	gold, Green Published			2022-12-26	WOS:000370046600043
J	Pettis, JS; Rice, N; Joselow, K; vanEngelsdorp, D; Chaimanee, V				Pettis, Jeffery S.; Rice, Nathan; Joselow, Katie; vanEngelsdorp, Dennis; Chaimanee, Veeranan			Colony Failure Linked to Low Sperm Viability in Honey Bee (Apis mellifera) Queens and an Exploration of Potential Causative Factors	PLOS ONE			English	Article							HYMENOPTERA; APIDAE; FLUVALINATE; COUMAPHOS; MORTALITY; HISTORY; LOSSES; HEALTH; RACES	Queen health is closely linked to colony performance in honey bees as a single queen is normally responsible for all egg laying and brood production within the colony. In the U.S. in recent years, queens have been failing at a high rate; with 50% or greater of queens replaced in colonies within 6 months when historically a queen might live one to two years. This high rate of queen failure coincides with the high mortality rates of colonies in the US, some years with >50% of colonies dying. In the current study, surveys of sperm viability in US queens were made to determine if sperm viability plays a role in queen or colony failure. Wide variation was observed in sperm viability from four sets of queens removed from colonies that beekeepers rated as in good health (n = 12; average viability = 92%), were replacing as part of normal management (n = 28; 57%), or where rated as failing (n = 18 and 19; 54% and 55%). Two additional paired set of queens showed a statistically significant difference in viability between colonies rated by the beekeeper as failing or in good health from the same apiaries. Queens removed from colonies rated in good health averaged high viability (ca. 85%) while those rated as failing or in poor health had significantly lower viability (ca. 50%). Thus low sperm viability was indicative of, or linked to, colony performance. To explore the source of low sperm viability, six commercial queen breeders were surveyed and wide variation in viability (range 60-90%) was documented between breeders. This variability could originate from the drones the queens mate with or temperature extremes that queens are exposed to during shipment. The role of shipping temperature as a possible explanation for low sperm viability was explored. We documented that during shipment queens are exposed to temperature spikes (<8 and > 40 degrees C) and these spikes can kill 50% or more of the sperm stored in queen spermathecae in live queens. Clearly low sperm viability is linked to colony performance and laboratory and field data provide evidence that temperature extremes are a potential causative factor.	[Pettis, Jeffery S.; Rice, Nathan; Joselow, Katie] USDA ARS, Bee Res Lab, Beltsville, MD USA; [vanEngelsdorp, Dennis] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Chaimanee, Veeranan] Maejo Univ, Dept Biotechnol, Phrae Campus, Rong Kwang, Phrae, Thailand	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; Maejo University	Chaimanee, V (corresponding author), Maejo Univ, Dept Biotechnol, Phrae Campus, Rong Kwang, Phrae, Thailand.	chveeranan@gmail.com			USDA-ARS Areawide Program funds; ARS [ARS-0425645] Funding Source: Federal RePORTER	USDA-ARS Areawide Program funds; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-ARS Areawide Program funds supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, J INVERTEBR PATHOL, V106, P380, DOI 10.1016/j.jip.2010.12.005; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Buchler R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.07; Burley LM, 2008, J ECON ENTOMOL, V101, P1081, DOI 10.1603/0022-0493(2008)101[1081:SOHBHA]2.0.CO;2; Chaimanee V, 2014, APIDOLOGIE, V45, P451, DOI 10.1007/s13592-013-0258-x; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Collins AM, 1999, THERIOGENOLOGY, V51, P1513, DOI 10.1016/S0093-691X(99)00094-1; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; DeGrandi-Hoffman Gloria, 2013, Insects, V4, P71, DOI 10.3390/insects4010071; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Franck P, 1998, EVOLUTION, V52, P1119, DOI [10.2307/2411242, 10.1111/j.1558-5646.1998.tb01839.x]; FURGALA B, 1962, J INSECT PATHOL, V4, P429; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Guzman L. I. de, 1999, American Bee Journal, V139, P304; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; HARBO JR, 1984, J APICULT RES, V23, P31, DOI 10.1080/00218839.1984.11100606; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Higes M, 2009, ENV MICROBIOL REP, V1, P495, DOI 10.1111/j.1758-2229.2009.00052.x; Lodesani Marco, 2004, Italian Journal of Animal Science, V3, P385; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; PETTIS JS, 1991, APIDOLOGIE, V22, P1, DOI 10.1051/apido:19910101; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Rinderer TE, 1999, AM BEE J, V139, P134; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; SCHIFF NM, 1995, J ECON ENTOMOL, V88, P1216, DOI 10.1093/jee/88.5.1216; SCHIFF NM, 1994, ANN ENTOMOL SOC AM, V87, P842, DOI 10.1093/aesa/87.6.842; Schiff NM, 1996, APIDOLOGIE, V27, P77, DOI 10.1051/apido:19960202; SHEPPARD WS, 1989, AM BEE J, V129, P664; SHEPPARD WS, 1989, AM BEE J, V129, P617; Tarpy DR, 2012, J ECON ENTOMOL, V105, P20, DOI 10.1603/EC11276; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Winston M., 1987, The biology of the honey bee.; Woodward D., 2007, QUEEN BEE BIOL READI; Woyke J., 1971, J Apic Res, V10, P45; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yue C, 2006, J INVERTEBR PATHOL, V92, P105, DOI 10.1016/j.jip.2006.03.001	41	56	58	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147220	10.1371/journal.pone.0147220	http://dx.doi.org/10.1371/journal.pone.0147220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863438	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600022
J	Lin, C; Agnes, JT; Behrens, N; Shao, M; Tagawa, Y; Gershwin, LJ; Corbeil, LB				Lin, C.; Agnes, J. T.; Behrens, N.; Shao, M.; Tagawa, Y.; Gershwin, L. J.; Corbeil, L. B.			Histophilus somni Stimulates Expression of Antiviral Proteins and Inhibits BRSV Replication in Bovine Respiratory Epithelial Cells	PLOS ONE			English	Article							IMMUNOGLOBULIN BINDING-PROTEINS; HAEMOPHILUS-SOMNUS; SYNCYTIAL VIRUS; HEMOPHILUS-SOMNUS; GENE-EXPRESSION; DENDRITIC CELLS; CALVES; PNEUMONIA; CHALLENGE; INFECTION	Our previous studies showed that bovine respiratory syncytial virus (BRSV) followed by Histophilus somni causes more severe bovine respiratory disease and a more permeable alveolar barrier in vitro than either agent alone. However, microarray analysis revealed the treatment of bovine alveolar type 2 (BAT2) epithelial cells with H. somni concentrated culture supernatant (CCS) stimulated up-regulation of four antiviral protein genes as compared with BRSV infection or dual treatment. This suggested that inhibition of viral infection, rather than synergy, may occur if the bacterial infection occurred before the viral infection. Viperin (or radical S-adenosyl methionine domain containing 2-RSAD2) and ISG15 (IFN-stimulated gene 15-ubiquitin-like modifier) were most up-regulated. CCS dose and time course for up-regulation of viperin protein levels were determined in treated bovine turbinate (BT) upper respiratory cells and BAT2 lower respiratory cells by Western blotting. Treatment of BAT2 cells with H. somni culture supernatant before BRSV infection dramatically reduced viral replication as determined by qRT PCR, supporting the hypothesis that the bacterial infection may inhibit viral infection. Studies of the role of the two known H. somni cytotoxins showed that viperin protein expression was induced by endotoxin (lipooligosaccharide) but not by IbpA, which mediates alveolar permeability and H. somni invasion. A naturally occurring IbpA negative asymptomatic carrier strain of H. somni (129Pt) does not cause BAT2 cell retraction or permeability of alveolar cell monolayers, so lacks virulence in vitro. To investigate initial steps of pathogenesis, we showed that strain 129Pt attached to BT cells and induced a strong viperin response in vitro. Thus colonization of the bovine upper respiratory tract with an asymptomatic carrier strain lacking virulence may decrease viral infection and the subsequent enhancement of bacterial respiratory infection in vivo.	[Lin, C.; Agnes, J. T.; Corbeil, L. B.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Behrens, N.; Shao, M.; Gershwin, L. J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Tagawa, Y.] NARO, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Corbeil, L. B.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California Davis; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; University of California System; University of California Davis	Corbeil, LB (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.; Corbeil, LB (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	lcorbeil@ucsd.edu			United States Department of Agriculture, National Institute of Food and Agriculture [2011-67015-30177]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	The only grant funding for this work was provided by the United States Department of Agriculture, National Institute of Food and Agriculture, Award number 2011-67015-30177: LBC. URL: (http://nifa.usda.gov/program/afri-foundational-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnes JT, 2013, INFECT IMMUN, V81, P2592, DOI 10.1128/IAI.00108-13; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Caswell JL, 2014, VET PATHOL, V51, P393, DOI 10.1177/0300985813502821; Challacombe JF, 2007, J BACTERIOL, V189, P1890, DOI 10.1128/JB.01422-06; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; COLE SP, 1992, MOL MICROBIOL, V6, P1895, DOI 10.1111/j.1365-2958.1992.tb01362.x; COLE SP, 1993, J GEN MICROBIOL, V139, P2135, DOI 10.1099/00221287-139-9-2135; Corbeil LB, 1997, INFECT IMMUN, V65, P4250, DOI 10.1128/IAI.65.10.4250-4257.1997; CORBEIL LB, 1985, J CLIN MICROBIOL, V22, P192, DOI 10.1128/JCM.22.2.192-198.1985; CORBEIL LB, 1985, J CLIN MICROBIOL, V21, P803, DOI 10.1128/JCM.21.5.803-807.1985; Dieterich C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027535; Geertsema RS, 2011, VACCINE, V29, P4805, DOI 10.1016/j.vaccine.2011.04.075; Gershwin LJ, 2005, VET IMMUNOL IMMUNOP, V107, P119, DOI 10.1016/j.vetimm.2005.04.004; GOGOLEWSKI RP, 1989, J CLIN MICROBIOL, V27, P1767, DOI 10.1128/JCM.27.8.1767-1774.1989; GOGOLEWSKI RP, 1987, VET PATHOL, V24, P250, DOI 10.1177/030098588702400309; GOGOLEWSKI RP, 1987, INFECT IMMUN, V55, P1403, DOI 10.1128/IAI.55.6.1403-1411.1987; Gu XX, 1998, INFECT IMMUN, V66, P1891, DOI 10.1128/IAI.66.5.1891-1897.1998; Hoshinoo K, 2009, MICROB PATHOGENESIS, V46, P273, DOI 10.1016/j.micpath.2009.02.003; Humphrey J. D., 1983, Veterinary Bulletin, V53, P987; INZANA TJ, 1988, INFECT IMMUN, V56, P2830, DOI 10.1128/IAI.56.11.2830-2837.1988; Kalina WV, 2005, VACCINE, V23, P4625, DOI 10.1016/j.vaccine.2005.04.032; Kalina WV, 2004, VACCINE, V22, P1465, DOI 10.1016/j.vaccine.2003.10.024; Kandasamy S, 2012, J DAIRY SCI, V95, P3852, DOI 10.3168/jds.2011-5251; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, pS121, DOI 10.1097/INF.0b013e3181b6d7ec; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Proud D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040762; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sandal I, 2007, J BACTERIOL, V189, P8179, DOI 10.1128/JB.00479-07; Sandal I, 2009, MICROBES INFECT, V11, P254, DOI 10.1016/j.micinf.2008.11.011; Sanders JD, 2003, MICROB PATHOGENESIS, V34, P131, DOI 10.1016/S0882-4010(02)00188-2; Schmidt U, 2002, J VIROL, V76, P12355, DOI 10.1128/JVI.76.23.12355-12359.2002; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Smirnova NP, 2012, VIRUS RES, V167, P329, DOI 10.1016/j.virusres.2012.05.018; Sylte MJ, 2001, INFECT IMMUN, V69, P1650, DOI 10.1128/IAI.69.3.1650-1660.2001; Tagawa Y, 2005, MICROB PATHOGENESIS, V39, P159, DOI 10.1016/j.micpath.2005.08.002; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Woolums AR, 2004, COMP IMMUNOL MICROB, V27, P57, DOI 10.1016/S0147-9571(03)00036-5; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Zekarias B, 2011, VET MICROBIOL, V149, P177, DOI 10.1016/j.vetmic.2010.10.012; Zekarias B, 2010, INFECT IMMUN, V78, P1850, DOI 10.1128/IAI.01277-09; Zhao C, 2013, TRENDS MICROBIOL, V21, P181, DOI 10.1016/j.tim.2013.01.005	48	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148551	10.1371/journal.pone.0148551	http://dx.doi.org/10.1371/journal.pone.0148551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859677	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400052
J	Miller, GE; Engen, PA; Gillevet, PM; Shaikh, M; Sikaroodi, M; Forsyth, CB; Mutlu, E; Keshavarzian, A				Miller, Gregory E.; Engen, Phillip A.; Gillevet, Patrick M.; Shaikh, Maliha; Sikaroodi, Masoumeh; Forsyth, Christopher B.; Mutlu, Ece; Keshavarzian, Ali			Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; CARDIOVASCULAR HEALTH; UNITED-STATES; DISEASE; AGE; DISPARITIES; MORTALITY; US; PERMEABILITY	In the United States, there are persistent and widening socioeconomic gaps in morbidity and mortality from chronic diseases. Although most disparities research focuses on person-level socioeconomic-status, mounting evidence suggest that chronic diseases also pattern by the demographic characteristics of neighborhoods. Yet the biological mechanisms underlying these associations are poorly understood. There is increasing recognition that chronic diseases share common pathogenic features, some of which involve alterations in the composition, diversity, and functioning of the gut microbiota. This study examined whether socioeconomic-status was associated with alpha-diversity of the colonic microbiota. Forty-four healthy adults underwent un-prepped sigmoidoscopy, during which mucosal biopsies and fecal samples were collected. Subjects' zip codes were geocoded, and census data was used to form a composite indicator of neighborhood socioeconomic-status, reflecting household income, educational attainment, employment status, and home value. In unadjusted analyses, neighborhood socioeconomic-status explained 12-18 percent of the variability in alpha-diversity of colonic microbiota. The direction of these associations was positive, meaning that as neighborhood socioeconomic-status increased, so did alpha-diversity of both the colonic sigmoid mucosa and fecal microbiota. The strength of these associations persisted when models were expanded to include covariates reflecting potential demographic (age, gender, race/ethnicity) and lifestyle (adiposity, alcohol use, smoking) confounds. In these models neighborhood socioeconomic-status continued to explain 11-22 percent of the variability in diversity indicators. Further analyses suggested these patterns reflected socioeconomic variations in evenness, but not richness, of microbial communities residing in the sigmoid. We also found indications that residence in neighborhoods of higher socioeconomic-status was associated with a greater abundance of Bacteroides and a lower abundance of Prevotella, suggesting that diet potentially underlies differences in microbiota composition. These findings suggest the presence of socioeconomic variations in colonic microbiota diversity. Future research should explore whether these variations contribute to disparities in chronic disease outcomes.	[Miller, Gregory E.] Northwestern Univ, Dept Psychol, Evanston, IL USA; [Miller, Gregory E.] Northwestern Univ, Inst Policy Res, Evanston, IL USA; [Engen, Phillip A.; Shaikh, Maliha; Forsyth, Christopher B.; Mutlu, Ece; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Internal Med, Div Gastroenterol, Chicago, IL 60612 USA; [Gillevet, Patrick M.; Sikaroodi, Masoumeh] George Mason Univ, Microbiome Anal Ctr, Dept Environm Sci & Policy, Sci & Technol Campus, Manassas, VA USA	Northwestern University; Northwestern University; Rush University; George Mason University	Miller, GE (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL USA.; Miller, GE (corresponding author), Northwestern Univ, Inst Policy Res, Evanston, IL USA.	greg.miller@northwestern.edu			National Heart, Lung, and Blood Institute [HL122328]; National Institute on Drug Abuse [DA027827]; National Institutes of Health NIAAA [RC2AA019405, RO1AA013745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013745, RC2AA019405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA027827] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants to GEM from the National Heart, Lung, and Blood Institute (HL122328), the National Institute on Drug Abuse (DA027827), and to AK from the National Institutes of Health NIAAA (RC2AA019405 and RO1AA013745).	Abreu MT, 2014, GASTROENTEROLOGY, V146, P1534, DOI 10.1053/j.gastro.2014.01.001; Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Bailey MT, 2012, HORM BEHAV, V62, P286, DOI 10.1016/j.yhbeh.2012.02.006; Bengmark S, 2013, PHARMACOL RES, V69, P87, DOI 10.1016/j.phrs.2012.09.002; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Brown AF, 2011, STROKE, V42, P3363, DOI 10.1161/STROKEAHA.111.622134; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caricilli Andrea Moro, 2014, World J Gastrointest Pathophysiol, V5, P18, DOI 10.4291/wjgp.v5.i1.18; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Couch RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119362; Couch RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081163; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Fasano A, 2012, CLIN REV ALLERG IMMU, V42, P71, DOI 10.1007/s12016-011-8291-x; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gillevet P, 2010, CHEM BIODIVERS, V7, P1065, DOI 10.1002/cbdv.200900322; Gillevet PM, 2009, FUNGAL ECOL, V2, P160, DOI 10.1016/j.funeco.2009.04.001; Hansen TH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0157-z; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Krishnan S, 2010, AM J EPIDEMIOL, V171, P564, DOI 10.1093/aje/kwp443; Lotfipour S, 2013, J EMERG MED, V44, P861, DOI 10.1016/j.jemermed.2012.09.038; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Masters RK, 2012, AM SOCIOL REV, V77, P548, DOI 10.1177/0003122412451019; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Natividad JM, 2012, PHARM RES; O'Connor PG, 1998, NEW ENGL J MED, V338, P592, DOI 10.1056/NEJM199802263380907; Rehman Tayyab, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P361; Rook GAW, 2014, CLIN EXP IMMUNOL, V177, P1, DOI 10.1111/cei.12269; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shaikh M, 2015, CLIN CHIM ACTA, V442, P24, DOI 10.1016/j.cca.2014.12.040; Shankardass K, 2011, J EPIDEMIOL COMMUN H, V65, P859, DOI 10.1136/jech.2009.102806; Signorello LB, 2014, AM J PUBLIC HEALTH, V104, pE98, DOI 10.2105/AJPH.2014.302156; Sikaroodi M, 2012, BIOTECHNIQUES, V53, P381, DOI 10.2144/000113967; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; Swanson GR, 2015, AM J PHYSIOL-GASTR L, V308, pG1004, DOI 10.1152/ajpgi.00002.2015; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; World Health Organization, 2008, THE GLOBAL BURDEN OF; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493	69	81	82	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148952	10.1371/journal.pone.0148952	http://dx.doi.org/10.1371/journal.pone.0148952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859894	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400109
J	Andresen, L; Theodorou, K; Grunewald, S; Czech-Zechmeister, B; Konnecke, B; Luhder, F; Trendelenburg, G				Andresen, Lena; Theodorou, Konstantina; Gruenewald, Sarah; Czech-Zechmeister, Bozena; Koennecke, Birte; Luehder, Fred; Trendelenburg, George			Evaluation of the Therapeutic Potential of Anti-TLR4-Antibody MTS510 in Experimental Stroke and Significance of Different Routes of Application	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; BRAIN-INJURY; TOLL-LIKE-RECEPTOR-4; ACTIVATION; PROTECTS; ACCUMULATION; INFLAMMATION; IMMUNOLOGY; COMPLEX; GAMMA	Toll-like receptors (TLRs) are central sensors for the inflammatory response in ischemia-reperfusion injury. We therefore investigated whether TLR4 inhibition could be used to treat stroke in a standard model of focal cerebral ischemia. Anti-TLR4/MD2-antibody (mAb clone MTS510) blocked TLR4-induced cell activation in vitro, as reported previously. Here, different routes of MTS510 application in vivo were used to study the effects on stroke outcome up to 2d after occlusion of the middle cerebral artery (MCAO) for 45min in adult male C57Bl/6 wild-type mice. Improved neurological performance, reduced infarct volumes, and reduced brain swelling showed that intravascular application of MTS510 had a protective effect in the model of 45min MCAO. Evaluation of potential long-term adverse effects of anti-TLR4-mAb-treament revealed no significant deleterious effect on infarct volumes nor neurological deficit after 14d of reperfusion in a mild model of stroke (15min MCAO). Interestingly, inhibition of TLR4 resulted in an altered adaptive immune response at 48 hours after reperfusion. We conclude that blocking TLR4 by the use of specific mAb is a promising strategy for stroke therapy. However, long-term studies with increased functional sensitivity, larger sampling sizes and use of other species are required before a clinical use could be envisaged.	[Andresen, Lena; Theodorou, Konstantina; Gruenewald, Sarah; Czech-Zechmeister, Bozena; Koennecke, Birte; Trendelenburg, George] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Luehder, Fred] Hertie Fdn, Inst Multiple Sclerosis Res, Dept Neuroimmunol, Gottingen, Germany; [Luehder, Fred] MPI Expt Med, Gottingen, Germany	University of Gottingen	Trendelenburg, G (corresponding author), Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany.	george.trendelenburg@med.uni-goettingen.de			Deutsche Studienstiftung; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony; Deutsche Forschungsgemeinschaft [SFB-TRR43]; Georg-August-University Gottingen Foundation	Deutsche Studienstiftung; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-August-University Gottingen Foundation	This work was supported by the Deutsche Studienstiftung to LA, Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony and Deutsche Forschungsgemeinschaft SFB-TRR43 TP B11 to FL, and Georg-August-University Gottingen Foundation to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Baron JC, 2013, CEREBROVASC DIS, V36, P306, DOI 10.1159/000355027; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bell MT, 2013, CIRCULATION, V128, pS152, DOI 10.1161/CIRCULATIONAHA.112.000024; Bohacek I, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-191; Cao AT, 2014, J LEUKOCYTE BIOL, V96, P895, DOI 10.1189/jlb.3A0114-056RR; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chekhonin VP, 2004, B EXP BIOL MED+, V138, P343, DOI 10.1007/s10517-005-0037-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dunn-Siegrist I, 2007, J BIOL CHEM, V282, P34817, DOI 10.1074/jbc.M706440200; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Harhausen D, 2010, J IMMUNOL, V184, P6407, DOI 10.4049/jimmunol.0902342; Harhausen D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-15; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Lin YC, 2005, ATHEROSCLEROSIS, V180, P305, DOI 10.1016/j.atherosclerosis.2004.12.022; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Suzuki Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00896; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157; Ziegler G, 2011, J CEREBR BLOOD F MET, V31, P757, DOI 10.1038/jcbfm.2010.161	31	21	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148428	10.1371/journal.pone.0148428	http://dx.doi.org/10.1371/journal.pone.0148428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849209	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000092
J	Czyzewski, AM; Jenssen, H; Fjell, CD; Waldbrook, M; Chongsiriwatana, NP; Yuen, E; Hancock, REW; Barron, AE				Czyzewski, Ann M.; Jenssen, Havard; Fjell, Christopher D.; Waldbrook, Matt; Chongsiriwatana, Nathaniel P.; Yuen, Eddie; Hancock, Robert E. W.; Barron, Annelise E.			In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents	PLOS ONE			English	Article							N-SUBSTITUTED GLYCINES; HOST-DEFENSE PEPTIDES; PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; SIDE-CHAINS; ANTIBACTERIAL PEPTIDES; SECONDARY STRUCTURE; ANTIBIOTICS; LIPOPOLYSACCHARIDE; RESISTANCE	Bacterial resistance to conventional antibiotics is a global threat that has spurred the development of antimicrobial peptides (AMPs) and their mimetics as novel anti-infective agents. While the bioavailability of AMPs is often reduced due to protease activity, the non-natural structure of AMP mimetics renders them robust to proteolytic degradation, thus offering a distinct advantage for their clinical application. We explore the therapeutic potential of N-substituted glycines, or peptoids, as AMP mimics using a multi-faceted approach that includes in silico, in vitro, and in vivo techniques. We report a new QSAR model that we developed based on 27 diverse peptoid sequences, which accurately correlates antimicrobial peptoid structure with antimicrobial activity. We have identified a number of peptoids that have potent, broad-spectrum in vitro activity against multi-drug resistant bacterial strains. Lastly, using a murine model of invasive S. aureus infection, we demonstrate that one of the best candidate peptoids at 4 mg/kg significantly reduces with a two-log order the bacterial counts compared with saline-treated controls. Taken together, our results demonstrate the promising therapeutic potential of peptoids as antimicrobial agents.	[Czyzewski, Ann M.; Chongsiriwatana, Nathaniel P.; Barron, Annelise E.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Jenssen, Havard; Fjell, Christopher D.; Waldbrook, Matt; Yuen, Eddie; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V6T 1Z4, Canada; [Jenssen, Havard] Roskilde Univ, Dept Sci Syst & Models, DK-4000 Roskilde, Denmark; [Barron, Annelise E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Northwestern University; University of British Columbia; Roskilde University; Stanford University	Barron, AE (corresponding author), Univ British Columbia, Ctr Microbial Dis & Immun Res, 232-2259 Lower Mall Res Stn, Vancouver, BC V6T 1Z4, Canada.	bob@hancocklab.com; aebarron@stanford.edu	Hancock, Robert E. W./E-1145-2013; Czyzewski, Ann/R-3421-2019	Hancock, Robert E. W./0000-0001-5989-8503; Fjell, Christopher/0000-0001-6304-2628; Jenssen, Havard/0000-0003-0007-0335; Barron, Annelise/0000-0002-0735-6873	Northwestern University's Institute for Bioengineering and Nanoscience in Advanced Medicine; Dreyfus Foundation; DuPont Young Investigator award; NIH/NIAID [5R01-AI072666]; Canadian Institutes for Health Research (CIHR); Foundation of the National Institutes of Health; CIHR through the Grand Challenges in Global Health Initiative; 3M graduate research fellowship; Danish Council for Independent Research [10-085287]; Department of Homeland Security graduate fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072666] Funding Source: NIH RePORTER	Northwestern University's Institute for Bioengineering and Nanoscience in Advanced Medicine; Dreyfus Foundation; DuPont Young Investigator award; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation of the National Institutes of Health; CIHR through the Grand Challenges in Global Health Initiative(Canadian Institutes of Health Research (CIHR)); 3M graduate research fellowship(3M); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Department of Homeland Security graduate fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AEB acknowledges support from Northwestern University's Institute for Bioengineering and Nanoscience in Advanced Medicine, the Dreyfus Foundation, a DuPont Young Investigator award, and NIH/NIAID Grant 5R01-AI072666. REWH gratefully acknowledges financial support from the Canadian Institutes for Health Research (CIHR) and the Foundation of the National Institutes of Health and CIHR through the Grand Challenges in Global Health Initiative. REWH is the recipient of a Canada Research Chair. AMC was supported by a 3M graduate research fellowship. HJ acknowledges support from the Danish Council for Independent Research grant #10-085287. NPC was supported by a Department of Homeland Security graduate fellowship.	Armand P, 1997, FOLD DES, V2, P369, DOI 10.1016/S1359-0278(97)00051-5; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bowdish DME, 2005, J ENDOTOXIN RES, V11, P230, DOI 10.1179/096805105X37394; Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fidai S, 1997, Methods Mol Biol, V78, P187; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Fritsche TR, 2008, J ANTIMICROB CHEMOTH, V61, P1092, DOI 10.1093/jac/dkn074; Fritsche TR, 2008, DIAGN MICR INFEC DIS, V60, P399, DOI 10.1016/j.diagmicrobio.2007.11.004; Giacometti A, 2004, J ANTIMICROB CHEMOTH, V54, P654, DOI 10.1093/jac/dkh390; Godballe T, 2011, CHEM BIOL DRUG DES, V77, P107, DOI 10.1111/j.1747-0285.2010.01067.x; Goodson B, 1999, ANTIMICROB AGENTS CH, V43, P1429, DOI 10.1128/AAC.43.6.1429; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; HANCOCK REW, 1981, ANTIMICROB AGENTS CH, V19, P777, DOI 10.1128/AAC.19.5.777; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haug BE, 2008, J MED CHEM, V51, P4306, DOI 10.1021/jm701600a; Jacobs MR, 2007, FUTURE MICROBIOL, V2, P591, DOI 10.2217/17460913.2.6.591; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Jenssen H, 2006, CHEM BIOL DRUG DES, V68, P58, DOI 10.1111/j.1747-0285.2006.00412.x; Jenssen H, 2010, METHODS MOL BIOL, V618, P329, DOI 10.1007/978-1-60761-594-1_20; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaur KJ, 2008, PROTEIN SCI, V17, P545, DOI 10.1110/ps.073145008; Kirikae T, 1998, INFECT IMMUN, V66, P1861, DOI 10.1128/IAI.66.5.1861-1868.1998; Kirshenbaum K, 1998, P NATL ACAD SCI USA, V95, P4303, DOI 10.1073/pnas.95.8.4303; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Livermore DM, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1465-0691.2004.1004.x; Mojsoska B, 2015, PHARMACEUTICALS-BASE, V8, P366, DOI 10.3390/ph8030366; Mojsoska B, 2015, ANTIMICROB AGENTS CH, V59, P4112, DOI 10.1128/AAC.00237-15; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; Nahra R, 2008, CURR OPIN ANESTHESIO, V21, P98, DOI 10.1097/ACO.0b013e3282f5335c; Nemoto H, 2001, BLOOD PURIFICAT, V19, P361, DOI 10.1159/000046966; Overbye KM, 2005, DRUG DISCOV TODAY, V10, P45, DOI 10.1016/S1359-6446(04)03285-4; Patch JA, 2003, J AM CHEM SOC, V125, P12092, DOI 10.1021/ja037320d; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Sanborn TJ, 2002, BIOPOLYMERS, V63, P12, DOI 10.1002/bip.1058; Schurek KN, 2009, ANTIMICROB AGENTS CH, V53, P4345, DOI 10.1128/AAC.01267-08; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; STEINBERG IZ, 1960, J AM CHEM SOC, V82, P5263, DOI 10.1021/ja01505a001; Tew GN, 2006, BBA-BIOMEMBRANES, V1758, P1387, DOI 10.1016/j.bbamem.2006.03.001; Wu CW, 2003, J AM CHEM SOC, V125, P13525, DOI 10.1021/ja037540r; Wu CW, 2001, J AM CHEM SOC, V123, P2958, DOI 10.1021/ja003153v; Wu MH, 1999, ANTIMICROB AGENTS CH, V43, P1274, DOI 10.1128/AAC.43.5.1274; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076	54	61	62	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0135961	10.1371/journal.pone.0135961	http://dx.doi.org/10.1371/journal.pone.0135961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849681	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000001
J	Kariisa, AT; Weeks, K; Tamayo, R				Kariisa, Ankunda T.; Weeks, Kevin; Tamayo, Rita			The RNA Domain Vc1 Regulates Downstream Gene Expression in Response to Cyclic Diguanylate in Vibrio cholerae	PLOS ONE			English	Article							C-DI-GMP; CLOSTRIDIUM-DIFFICILE; BACTERIAL 2ND-MESSENGER; COLONIZATION FACTOR; BIOFILM FORMATION; LIGAND-BINDING; PROTEIN DOMAIN; PHOSPHODIESTERASE; RIBOSWITCH; SHAPE	In many bacterial species, including the aquatic bacterium and human pathogen Vibrio cholerae, the second messenger cyclic diguanylate (c-di-GMP) modulates processes such as biofilm formation, motility, and virulence factor production. By interacting with various effectors, c-di-GMP regulates gene expression or protein function. One type of c-di-GMP receptor is the class I riboswitch, representatives of which have been shown to bind c-di-GMP in vitro. Herein, we examined the in vitro and in vivo function of the putative class I riboswitch in Vibrio cholerae, Vc1, which lies upstream of the gene encoding GbpA, a colonization factor that contributes to attachment of V. cholerae to environmental and host surfaces containing N-acetylglucosamine moieties. We provide evidence that Vc1 RNA interacts directly with c-di-GMP in vitro, and that nucleotides conserved among this class of riboswitch are important for binding. Yet the mutation of these conserved residues individually in the V. cholerae chromosome inconsistently affects the expression of gbpA and production of the GbpA protein. By isolating the regulatory function of Vc1, we show that the Vc1 element positively regulates downstream gene expression in response to c-di-GMP. Together these data suggest that the Vc1 element responds to c-di-GMP in vivo. Positive regulation of gbpA expression by c-di-GMP via Vc1 may influence the ability of V. cholerae to associate with chitin in the aquatic environment and the host intestinal environment.	[Kariisa, Ankunda T.; Tamayo, Rita] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Weeks, Kevin] Univ N Carolina, Dept Chem, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tamayo, R (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.	rita_tamayo@med.unc.edu			American Society for Microbiology; UNC-CH; National Science Foundation [MCB-1121024]; ASM Robert D. Watkins Fellowship; NSF [MCB-1121024]; NIH [R01 AI107029]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107029] Funding Source: NIH RePORTER	American Society for Microbiology; UNC-CH; National Science Foundation(National Science Foundation (NSF)); ASM Robert D. Watkins Fellowship; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AK received a Robert D. Watkins Fellowship from the American Society for Microbiology; RT is supported by a Simmons Scholars Award from UNC-CH; KW is supported by award MCB-1121024 from the National Science Foundation. The funding bodies had no role in the experimental design, in the collection, analysis or interpretation of the data, in the preparation of the manuscript, or in the decision to submit the manuscript for publication.; We thank Robert W. McKee for his help with 5' RACE studies. This work was supported by an ASM Robert D. Watkins Fellowship to A.K and by NSF award MCB-1121024 to K.W. R.T. is supported by NIH award R01 AI107029. The funding bodies had no role in the experimental design, in the collection, analysis or interpretation of the data, in the preparation of the manuscript, or in the decision to submit the manuscript for publication.	Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Bordeleau E, 2015, J BACTERIOL, V197, P819, DOI 10.1128/JB.02340-14; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Gao XH, 2014, APPL ENVIRON MICROB, V80, P6167, DOI 10.1128/AEM.01638-14; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Kariisa AT, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0506-5; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Leonard CW, 2013, BIOCHEMISTRY-US, V52, P588, DOI 10.1021/bi300755u; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Marden JN, 2013, P NATL ACAD SCI USA, V110, P15055, DOI 10.1073/pnas.1307217110; McGinnis JL, 2012, J AM CHEM SOC, V134, P6617, DOI 10.1021/ja2104075; McKee RW, 2013, J BACTERIOL, V195, P5174, DOI 10.1128/JB.00501-13; Miller J.H., 1972, EXPT MOL GENETICS; Mudrak B, 2012, INFECT IMMUN, V80, P1794, DOI 10.1128/IAI.06277-11; Peltier J, 2015, J BIOL CHEM; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Purcell EB, 2015, J BACTERIOL; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Smith KD, 2010, BIOCHEMISTRY-US, V49, P7351, DOI 10.1021/bi100671e; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Stauder M, 2012, ENV MICROBIOL REP, V4, P439, DOI 10.1111/j.1758-2229.2012.00356.x; Steen KA, 2011, NAT PROTOC, V6, P1683, DOI 10.1038/nprot.2011.373; Steen KA, 2010, J AM CHEM SOC, V132, P9940, DOI 10.1021/ja103781u; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373	45	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148478	10.1371/journal.pone.0148478	http://dx.doi.org/10.1371/journal.pone.0148478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849223	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000104
J	Leung, NHL; Zhou, J; Chu, DKW; Yu, H; Lindsley, WG; Beezhold, DH; Yen, HL; Li, YG; Seto, WH; Peiris, JSM; Cowling, BJ				Leung, Nancy H. L.; Zhou, Jie; Chu, Daniel K. W.; Yu, Han; Lindsley, William G.; Beezhold, Donald H.; Yen, Hui-Ling; Li, Yuguo; Seto, Wing-Hong; Peiris, Joseph S. M.; Cowling, Benjamin J.			Quantification of Influenza Virus RNA in Aerosols in Patient Rooms	PLOS ONE			English	Article							TRANSMISSION; SEASONALITY; HUMIDITY	Background The potential for human influenza viruses to spread through fine particle aerosols remains controversial. The objective of our study was to determine whether influenza viruses could be detected in fine particles in hospital rooms. Methods and Findings We sampled the air in 2-bed patient isolation rooms for four hours, placing cyclone samplers at heights of 1.5m and 1.0m. We collected ten air samples each in the presence of at least one patient with confirmed influenza A virus infection, and tested the samples by reverse transcription polymerase chain reaction. We recovered influenza A virus RNA from 5/10 collections (50%); 4/5 were from particles> 4 mu m, 1/5 from 1-4 mu m, and none in particles< 1 mu m. Conclusions Detection of influenza virus RNA in aerosols at low concentrations in patient rooms suggests that healthcare workers and visitors might have frequent exposure to airborne influenza virus in proximity to infected patients. A limitation of our study was the small sample size. Further studies should be done to quantify the concentration of viable influenza virus in healthcare settings, and factors affecting the detection of influenza viruses in fine particles in the air.	[Leung, Nancy H. L.; Yen, Hui-Ling; Seto, Wing-Hong; Peiris, Joseph S. M.; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Zhou, Jie; Chu, Daniel K. W.; Yen, Hui-Ling; Peiris, Joseph S. M.] Univ Hong Kong, Li Ka Shing Fac Med, Influenza Res Ctr, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Yu, Han; Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Lindsley, William G.; Beezhold, Donald H.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA	University of Hong Kong; World Health Organization; University of Hong Kong; University of Hong Kong; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Yen, Hui-Ling/C-4501-2009; Yen, Hui-Ling/GNH-5083-2022; Li, Yuguo/A-9469-2010; Leung, Nancy Hiu Lan/M-9080-2016; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Yen, Hui-Ling/0000-0003-2493-3609; Li, Yuguo/0000-0002-2281-4529; Leung, Nancy Hiu Lan/0000-0001-7314-840X; Seto, Wing Hong/0000-0002-1139-9200; Lindsley, William/0000-0003-0720-5829; Beezhold, Donald/0000-0001-5543-5747; Zhou, Jie/0000-0002-6413-2454; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Chu, Daniel Ka Wing/0000-0002-9219-8979	Research Grants Council of the Hong Kong Special Administrative Region, China [T11-705/14N]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Theme-based Research Scheme from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. T11-705/14N), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), and a commissioned grant from the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010; Lindsley WG, 2006, J ENVIRON MONITOR, V8, P1136, DOI 10.1039/b609083d; Lindsley WG, 2015, J OCCUP ENVIRON HYG, V12, P107, DOI 10.1080/15459624.2014.973113; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Tang JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107338; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; World Health Organization (WHO), 2014, GUID VOL ORG VOL PRA	15	43	44	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148669	10.1371/journal.pone.0148669	http://dx.doi.org/10.1371/journal.pone.0148669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849130	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000151
J	Fluckiger, A; Dumont, A; Derangere, V; Rebe, C; de Rosny, C; Causse, S; Thomas, C; Apetoh, L; Hichami, A; Ghiringhelli, F; Rialland, M				Fluckiger, A.; Dumont, A.; Derangere, V.; Rebe, C.; de Rosny, C.; Causse, S.; Thomas, C.; Apetoh, L.; Hichami, A.; Ghiringhelli, F.; Rialland, M.			Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNF alpha	ONCOGENE			English	Article							POLYUNSATURATED FATTY-ACIDS; TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; PREVENTS BREAST-CANCER; CELL-PROLIFERATION; TUMORICIDAL ACTION; LIPID-METABOLISM; GENE-EXPRESSION; RIP1 KINASE; NF-KAPPAB	The omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) has anti-inflammatory and anti-cancer properties. Among pro-inflammatory mediators, tumor necrosis factor a (TNF alpha) plays a paradoxical role in cancer biology with induction of cancer cell death or survival depending on the cellular context. The objective of the study was to evaluate the role of TNFa in DHA-mediated tumor growth inhibition and colon cancer cell death. The treatment of human colorectal cancer cells, HCT-116 and HCT-8 cells, with DHA triggered apoptosis in autocrine TNF alpha-dependent manner. We demonstrated that DHA-induced increased content of TNF alpha mRNA occurred through a post-transcriptional regulation via the down-regulation of microRNA-21 (miR-21) expression. Treatment with DHA led to nuclear accumulation of Foxo3a that bounds to the miR-21 promoter triggering its transcriptional repression. Moreover, inhibition of RIP1 kinase and AMP-activated protein kinase a reduced Foxo3a nuclear-cytoplasmic shuttling and subsequent increase of TNFa expression through a decrease of miR-21 expression in DHA-treated colon cancer cells. Finally, we were able to show in HCT-116 xenograft tumor-bearing nude mice that a DHA-enriched diet induced a decrease of human miR-21 expression and an increase of human TNF alpha mRNA expression limiting tumor growth in a cancer cell-derived TNF alpha dependent manner. Altogether, the present work highlights a novel mechanism for anti-cancer action of DHA involving colon cancer cell death mediated through autocrine action of TNF alpha.	[Fluckiger, A.; Dumont, A.; Derangere, V.; Rebe, C.; de Rosny, C.; Causse, S.; Thomas, C.; Apetoh, L.; Hichami, A.; Ghiringhelli, F.; Rialland, M.] INSERM, UMR 866, Dijon, France; [Fluckiger, A.; Dumont, A.; de Rosny, C.; Thomas, C.; Hichami, A.; Rialland, M.] Univ Bourgogne, UFR Sci Vie Terre & Environm, Dijon, France; [Derangere, V.; Causse, S.; Apetoh, L.; Ghiringhelli, F.] Univ Bourgogne, UFR Sci Sante, Dijon, France; [Rebe, C.; Apetoh, L.; Ghiringhelli, F.] Ctr Georges Francois Leclerc, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc	Rialland, M (corresponding author), Univ Bourgogne, INSERM, UMR 866, 6 Bd Gabriel, F-21000 Dijon, Bourgogne, France.	mickael.rialland@u-bourgogne.fr	Thomas, charles/C-7130-2019; Causse, Sebastien Zwe/AAZ-7365-2021; REBE, Cédric/AAD-4316-2019; Apetoh, Lionel/AIC-2384-2022	Thomas, charles/0000-0001-9998-6698; REBE, Cédric/0000-0001-8831-145X; Apetoh, Lionel/0000-0002-2774-438X; Causse, Sebastien/0000-0003-3246-3491; ghiringhelli, francois/0000-0002-5465-8305; Rialland, Mickael/0000-0001-9693-9351	Ligue contre le cancer comite Grand-Est; French Government grant [ANR-11-LABX-0021]	Ligue contre le cancer comite Grand-Est; French Government grant	The authors would like to thank the lipidomic plateform and the flow cytometry plateform facilities of Universite de Bourgogne. The present work was supported by Ligue contre le cancer comite Grand-Est and by a French Government grant managed by the French National Research Agency under the program 'Investissements d'Avenir' with reference ANR-11-LABX-0021 (Lipstic Labex).	Al-Zoubi M, 2013, CELL CYCLE, V12, P480, DOI 10.4161/cc.23370; ANTI M, 1992, GASTROENTEROLOGY, V103, P883, DOI 10.1016/0016-5085(92)90021-P; ANTI M, 1994, GASTROENTEROLOGY, V107, P1709, DOI 10.1016/0016-5085(94)90811-7; BALKWILL FR, 1986, CANCER RES, V46, P3990; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; BARTOLI GM, 1993, MOL ASPECTS MED, V14, P247, DOI 10.1016/0098-2997(93)90011-2; Bartoli R, 2000, GUT, V46, P191, DOI 10.1136/gut.46.2.191; Bathen TF, 2008, ANTICANCER RES, V28, P3717; Beaugerie L, 2015, NEW ENGL J MED, V372, P1441, DOI 10.1056/NEJMra1403718; BEGIN ME, 1986, JNCI-J NATL CANCER I, V77, P1053; BEGIN ME, 1986, PROG LIPID RES, V25, P573, DOI 10.1016/0163-7827(86)90116-5; BEGIN ME, 1985, PROSTA LEUKOTR MED, V19, P177, DOI 10.1016/0262-1746(85)90084-8; Berger H, 2013, CANCER RES, V73, P3578, DOI 10.1158/0008-5472.CAN-12-4018; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Calviello G, 2007, CARCINOGENESIS, V28, P1202, DOI 10.1093/carcin/bgl254; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Chen Z, 2014, ONCOGENE, V33, P4548, DOI 10.1038/onc.2013.402; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Chou CC, 2014, CANCER RES, V74, P4783, DOI 10.1158/0008-5472.CAN-14-0135; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Chung H, 2015, ONCOGENE, V34, P3504, DOI 10.1038/onc.2014.283; Cianchi F, 2008, CLIN CANCER RES, V14, P7691, DOI 10.1158/1078-0432.CCR-08-0799; Cockbain AJ, 2012, GUT, V61, P135, DOI 10.1136/gut.2010.233718; DAS UN, 1991, CANCER LETT, V56, P235, DOI 10.1016/0304-3835(91)90008-6; Ding WQ, 2007, MOL CANCER THER, V6, P1467, DOI 10.1158/1535-7163.MCT-06-0608; Else PL, 2015, BBA-BIOMEMBRANES, V1848, P417, DOI 10.1016/j.bbamem.2014.10.039; Farago N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-173; Gattolliat CH, 2015, EUR J CANCER, V51, P409, DOI 10.1016/j.ejca.2014.12.007; Gil-Zamorano J, 2014, J NUTR, V144, P575, DOI 10.3945/jn.113.189050; Giros A, 2009, CANCER PREV RES, V2, P732, DOI 10.1158/1940-6207.CAPR-08-0197; Gravaghi C, 2011, J NUTR BIOCHEM, V22, P360, DOI 10.1016/j.jnutbio.2010.03.003; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gu ZN, 2013, CARCINOGENESIS, V34, P1968, DOI 10.1093/carcin/bgt147; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kreeger PK, 2009, CANCER RES, V69, P8191, DOI 10.1158/0008-5472.CAN-09-1921; Krzystek-Korpacka M, 2013, CANCER LETT, V337, P107, DOI 10.1016/j.canlet.2013.05.033; Bin L, 2008, WORLD J GASTROENTERO, V14, P2434, DOI 10.3748/wjg.14.2434; Maihofner C, 2003, CARCINOGENESIS, V24, P665, DOI 10.1093/carcin/bgg006; Martinasso G, 2007, PPAR RES, V2007, DOI 10.1155/2007/93416; Monjazeb AM, 2006, CARCINOGENESIS, V27, P1950, DOI 10.1093/carcin/bgl023; NAYLOR MS, 1990, CANCER RES, V50, P4436; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pierre AS, 2013, BBA-MOL CELL BIOL L, V1831, P759, DOI 10.1016/j.bbalip.2013.01.005; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shime H, 2012, P NATL ACAD SCI USA, V109, P2066, DOI 10.1073/pnas.1113099109; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Verbeke H, 2010, HUM PATHOL, V41, P990, DOI 10.1016/j.humpath.2009.09.021; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Yao L, 2015, CANCER RES, V75, P1388, DOI 10.1158/0008-5472.CAN-14-2561; Yu HN, 2015, ARCH MED SCI, V11, P282, DOI 10.5114/aoms.2015.50962; Yu XF, 2015, ONCOTARGET, V6, P1995, DOI 10.18632/oncotarget.3038; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zins K, 2007, CANCER RES, V67, P1038, DOI 10.1158/0008-5472.CAN-06-2295; Zou ZQ, 2013, J LIPID RES, V54, P3453, DOI 10.1194/jlr.M042754	67	31	33	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4611	4622		10.1038/onc.2015.523	http://dx.doi.org/10.1038/onc.2015.523			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26853468				2022-12-26	WOS:000382336300007
J	Baek, SH; Seok, HY; Koo, YS; Kim, BJ				Baek, Seol-Hee; Seok, Hung Youl; Koo, Yong Seo; Kim, Byung-Jo			Lengthened Cutaneous Silent Period in Fibromyalgia Suggesting Central Sensitization as a Pathogenesis	PLOS ONE			English	Article							SMALL FIBER NEUROPATHY; CARPAL-TUNNEL-SYNDROME; DIABETES-MELLITUS; PAIN; DISEASE; POLYNEUROPATHY; ABNORMALITIES; DISORDERS; DENSITY; REFLEX	The pathogenesis of fibromyalgia (FM) has not been clearly elucidated, but central sensitization, which plays an important role in the development of neuropathic pain, is considered to be the main mechanism. The cutaneous silent period (CSP), which is a spinal reflex mediated by A-delta cutaneous afferents, is useful for the evaluation of sensorimotor integration at the spinal and supraspinal levels. To understand the pathophysiology of FM, we compared CSP patterns between patients with FM and normal healthy subjects. Twenty-four patients with FM diagnosed in accordance with the 1990 American College of Rheumatology classification system and 24 age-and sex-matched healthy volunteers were recruited. The CSP was measured from the abductor pollicis brevis muscle. Demographic data, number of tender points, and visual analog scale and FM impact questionnaire scores were collected. The measured CSP and clinical parameters of the patient and control groups were compared. In addition, possible correlations between the CSP parameters and the other clinical characteristics were analyzed. Mean CSP latencies did not differ between patients (55.50 +/- 10.97 ms) and healthy controls (60.23 +/- 11.87 ms; p = 0.158), although the mean CSP duration was significantly longer in patients (73.75 +/- 15.67 ms) than in controls (63.50 +/- 14.05 ms; p = 0.021). CSP variables did not correlate with any clinical variables. The significantly longer CSP duration in FM patients suggests central dysregulation at the spinal and supraspinal levels, rather than peripheral small fiber dysfunction.	[Baek, Seol-Hee; Seok, Hung Youl; Koo, Yong Seo; Kim, Byung-Jo] Korea Univ, Coll Med, Med Ctr, Dept Neurol, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, BJ (corresponding author), Korea Univ, Coll Med, Med Ctr, Dept Neurol, Seoul 136705, South Korea.	nukbj@korea.ac.kr	Kim, Byung-Jo/A-5943-2012	Kim, Byung-Jo/0000-0002-0445-7185	National Research Foundation of Korea (NRF) - Korean Government (MSIP) [NRF-2015R1A5A7037674]; Technology Innovation Program - Ministry of Trade, Industry and Energy (MI, Korea) [10049743]	National Research Foundation of Korea (NRF) - Korean Government (MSIP); Technology Innovation Program - Ministry of Trade, Industry and Energy (MI, Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP; no. NRF-2015R1A5A7037674) and the Technology Innovation Program (or the Industrial Strategic Technology Development Program) (10049743, "Establishing a medical device development open platform, as a hub for accelerating close firm-hospital communication") funded by the Ministry of Trade, Industry and Energy (MI, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP; no. NRF-2015R1A5A7037674) and the Technology Innovation Program (or the Industrial Strategic Technology Development Program) (10049743, "Establishing a medical device development open platform, as a hub for accelerating close firm-hospital communication") funded by the Ministry of Trade, Industry and Energy (MI, Korea).	Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; Caro XJ, 2014, ARTHRITIS RHEUMATOL, V66, P1945, DOI 10.1002/art.38662; Desmeules JA, 2003, ARTHRITIS RHEUM-US, V48, P1420, DOI 10.1002/art.10893; Floeter MK, 2003, MUSCLE NERVE, V28, P391, DOI 10.1002/mus.10447; Giannoccaro MP, 2014, MUSCLE NERVE, V49, P757, DOI 10.1002/mus.24156; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Han JK, 2007, CLIN NEUROPHYSIOL, V118, P1705, DOI 10.1016/j.clinph.2007.04.024; Inghilleri M, 2002, MUSCLE NERVE, V25, P695, DOI 10.1002/mus.10101; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Kim BJ, 2010, J NEUROL SCI, V293, P1, DOI 10.1016/j.jns.2010.03.032; Kim YA, 2002, J KOREAN MED SCI, V17, P220, DOI 10.3346/jkms.2002.17.2.220; Koo YS, 2012, J CLIN NEUROL, V8, P1, DOI 10.3988/jcn.2012.8.1.1; Koo YS, 2010, CLIN NEUROPHYSIOL, V121, P1584, DOI 10.1016/j.clinph.2010.03.012; Kosmidis ML, 2014, J NEUROL SCI, V347, P143, DOI 10.1016/j.jns.2014.09.035; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Leis AA, 1998, MUSCLE NERVE, V21, P1243, DOI 10.1002/(SICI)1097-4598(199810)21:10<1243::AID-MUS1>3.0.CO;2-B; Low PA, 2013, J CLIN NEUROL, V9, P1, DOI 10.3988/jcn.2013.9.1.1; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Mhalla A, 2010, PAIN, V149, P495, DOI 10.1016/j.pain.2010.03.009; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Oaklander AL, 2006, PAIN, V120, P235, DOI 10.1016/j.pain.2005.09.036; Oaklander AL, 2013, PAIN, V154, P2310, DOI 10.1016/j.pain.2013.06.001; Oaklander AL, 2013, PEDIATRICS, V131, pE1091, DOI 10.1542/peds.2012-2597; Onal MR, 2010, CLIN NEUROPHYSIOL, V121, P714, DOI 10.1016/j.clinph.2009.12.024; Osio M, 2004, J PERIPHER NERV SYST, V9, P224, DOI 10.1111/j.1085-9489.2004.09400.x; Park SY, 2014, J CLIN NEUROL, V10, P334, DOI 10.3988/jcn.2014.10.4.334; Polydefkis M, 2000, NEUROLOGY, V55, P1115, DOI 10.1212/WNL.55.8.1115; Pullman SL, 1996, NEUROLOGY, V46, P503, DOI 10.1212/WNL.46.2.503; Ramirez M, 2015, SEMIN ARTHRITIS RHEU, V45, P214, DOI 10.1016/j.semarthrit.2015.03.003; Robinson ME, 2011, J PAIN, V12, P436, DOI 10.1016/j.jpain.2010.10.003; RUSSELL IJ, 1992, ARTHRITIS RHEUM, V35, P550, DOI 10.1002/art.1780350509; RUSSELL IJ, 1994, ARTHRITIS RHEUM-US, V37, P1593, DOI 10.1002/art.1780371106; Sahin O, 2011, NEUROL RES, V33, P339, DOI 10.1179/016164110X12767786356516; Samuelsson K, 2014, J CLIN NEUROL, V10, P108, DOI 10.3988/jcn.2014.10.2.108; Sarchielli P, 2007, J PAIN, V8, P737, DOI 10.1016/j.jpain.2007.05.002; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schwenkreis P, 2011, MUSCLE NERVE, V43, P479, DOI 10.1002/mus.21920; Serrao M, 2002, ACTA NEUROL SCAND, V105, P196, DOI 10.1034/j.1600-0404.2002.1o085.x; Smith HS, 2011, PAIN PHYSICIAN, V14, pE217; Stetkarova I, 2015, BIOMED PAP, V159, P327, DOI 10.5507/bp.2013.081; Svilpauskaite J, 2006, MUSCLE NERVE, V33, P487, DOI 10.1002/mus.20496; Svilpauskaite Jovita, 2006, Medicina (Kaunas), V42, P300; Thaisetthawatkul P, 2013, MUSCLE NERVE, V48, P883, DOI 10.1002/mus.23891; Tilki HE, 2014, J CLIN NEUROL, V10, P10, DOI 10.3988/jcn.2014.10.1.10; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Umay E, 2013, REV BRAS REUMATOL, V53, P288, DOI 10.1590/S0482-50042013000300007; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yaman M, 2007, NEUROSCI LETT, V419, P258, DOI 10.1016/j.neulet.2007.04.018; Yunus MB, 2007, SEMIN ARTHRITIS RHEU, V36, P339, DOI 10.1016/j.semarthrit.2006.12.009	49	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149248	10.1371/journal.pone.0149248	http://dx.doi.org/10.1371/journal.pone.0149248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871583	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100133
J	Ge, X; Tao, FB; Huang, K; Mao, LJ; Huang, SH; Niu, Y; Hao, JH; Sun, YL; Rutayisire, E				Ge, Xing; Tao, Fangbiao; Huang, Kun; Mao, Leijing; Huang, Sanhuan; Niu, Ying; Hao, Jiahu; Sun, Yanli; Rutayisire, Erigene			Maternal Snoring May Predict Adverse Pregnancy Outcomes: A Cohort Study in China	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; RISK-FACTORS; GLUCOSE-METABOLISM; BIRTH-WEIGHT; WOMEN; DISTURBANCES; PREVALENCE; HYPERTENSION; ASSOCIATION; POPULATION	Objective To examine the prevalence of snoring during pregnancy and its effects on key pregnancy outcomes. Methods Pregnant women were consecutively recruited in their first trimester. Habitual snoring was screened by using a questionnaire in the 1st and 3rd trimester, respectively. According to the time of snoring, participants were divided into pregnancy onset snorers, chronic snorers and non-snorers. Logistic regressions were performed to examine the associations between snoring and pregnancy outcomes. Results Of 3 079 pregnant women, 16.6% were habitual snorers, with 11.7% were pregnancy onset snorers and 4.9% were chronic snorers. After adjusting for potential confounders, chronic snorers were independently associated with gestational diabetes mellitus (GDM) (RR 1.66, 95% CI 1.09-2.53). Both pregnancy onset and chronic snorers were independently associated with placental adhesion (RR 1.96, 95% CI 1.17-3.27, and RR 2.33, 95% CI 1.22-4.46, respectively). Pregnancy onset snorers were at higher risk of caesarean delivery (RR 1.37, 95% CI 1.09-1.73) and having macrosomia (RR 1.54, 95% CI 1.05-2.27) and large for gestational age (LGA) (RR 1.71, 95% CI 1.31-2.24) infants. In addition, being overweight or obese before pregnancy plays an important role in mediating snoring and adverse pregnancy outcomes. Conclusions Maternal snoring may increase the risk of adverse pregnancy outcomes, and being overweight or obese before pregnancy with snoring is remarkable for researchers. Further studies are still needed to confirm our results.	[Ge, Xing; Tao, Fangbiao; Huang, Kun; Mao, Leijing; Huang, Sanhuan; Niu, Ying; Hao, Jiahu; Sun, Yanli; Rutayisire, Erigene] Anhui Med Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Ge, Xing; Tao, Fangbiao; Huang, Kun; Mao, Leijing; Huang, Sanhuan; Niu, Ying; Hao, Jiahu; Sun, Yanli; Rutayisire, Erigene] Anhui Prov Key Lab Populat Hlth & Aristogen, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China	Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.; Tao, FB (corresponding author), Anhui Prov Key Lab Populat Hlth & Aristogen, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	taofangbiao@126.com			National Natural Science Foundation of China, National Natural Science Funds Commission [81330068, 81373012]; Anhui Medical University [XJ201205]	National Natural Science Foundation of China, National Natural Science Funds Commission; Anhui Medical University	This work was supported by 1) the National Natural Science Foundation of China (No. 81330068, http://fund.sciencenet.cn/), which is supported by National Natural Science Funds Commission. This funding was received by FT; 2) the National Natural Science Foundation of China (No. 81373012, http://fund.sciencenet.cn/), which is supported by National Natural Science Funds Commission. This funding was received by KH; and 3) the Research Fund for the Doctor Program of Anhui Medical University (No: XJ201205), a fund to encourage doctor's scientific achievements of Anhui Medical University, which is supported by Anhui Medical University. There is no URL for this funding.	Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; BLIWISE DL, 1991, CHEST, V99, P600, DOI 10.1378/chest.99.3.600; Bourjeily G, 2010, EUR RESPIR J, V36, P849, DOI 10.1183/09031936.00021810; Bourjeily G, 2015, SLEEP BREATH, V19, P835, DOI 10.1007/s11325-014-1099-1; Bourjeily G, 2014, SLEEP MED, V15, P550, DOI 10.1016/j.sleep.2014.01.004; Cai XH, 2013, SLEEP BREATH, V17, P951, DOI 10.1007/s11325-012-0783-2; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen YH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.023; del Campo F, 2013, SLEEP BREATH, V17, P463, DOI 10.1007/s11325-012-0754-7; Domingo C, 2006, INT J GYNECOL OBSTET, V93, P57, DOI 10.1016/j.ijgo.2006.01.004; Facco FL, 2014, AM J PERINAT, V31, P899, DOI 10.1055/s-0033-1363768; Facco FL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.035; Facco FL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.041; Facco FL, 2010, OBSTET GYNECOL, V115, P77, DOI 10.1097/AOG.0b013e3181c4f8ec; Franklin KA, 2000, CHEST, V117, P137, DOI 10.1378/chest.117.1.137; Frederick IO, 2013, SLEEP BREATH, V17, P541, DOI 10.1007/s11325-012-0717-z; Hu FB, 1999, AM J EPIDEMIOL, V150, P806; Hung TH, 1999, OBSTET GYNECOL, V93, P545, DOI 10.1016/S0029-7844(98)00460-8; Hutchison BL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-144; Izci B, 2006, EUR RESPIR J, V27, P321, DOI 10.1183/09031936.06.00148204; Ko HS, 2013, ARCH GYNECOL OBSTET, V287, P429, DOI 10.1007/s00404-012-2602-1; Lash GE, 2007, PLACENTA, V28, P390, DOI 10.1016/j.placenta.2006.06.001; Leung PL, 2005, BJOG-INT J OBSTET GY, V112, P1568, DOI 10.1111/j.1471-0528.2005.00737.x; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; Luque-Fernandez MA, 2013, DIABETES CARE, V36, P3353, DOI 10.2337/dc13-0778; Macones GA, 2012, AM J OBSTET GYNECOL, V206, pE1, DOI 10.1016/j.ajog.2012.02.017; Micheli K, 2011, EPIDEMIOLOGY, V22, P738, DOI 10.1097/EDE.0b013e31822546fd; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Mindell JA, 2015, SLEEP MED, V16, P483, DOI 10.1016/j.sleep.2014.12.006; O'Brien LM, 2013, SLEEP, V36, P1625, DOI 10.5665/sleep.3112; O'Brien LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.034; O'Keeffe M, 2013, INT J OBESITY, V37, P765, DOI 10.1038/ijo.2012.142; Pamidi S, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.07.033; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Pien GW, 2014, THORAX, V69, P371, DOI 10.1136/thoraxjnl-2012-202718; Pijnenborg Robert, 2002, Reprod Biomed Online, V4 Suppl 3, P14; Qiu CF, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-17; Redhead K, 2014, THORAX, V69, P1048, DOI 10.1136/thoraxjnl-2014-205485; Sarberg M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-15; Schanz A, 2014, PLACENTA, V35, P1089, DOI 10.1016/j.placenta.2014.09.012; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Svensson M, 2006, CHEST, V129, P933, DOI 10.1378/chest.129.4.933; Tauman R, 2012, J MATERN-FETAL NEO M, V25, P1283, DOI 10.3109/14767058.2011.629255; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Ugur MG, 2012, CLIN EXP OBSTET GYN, V39, P214; Xiong X, 2000, AM J OBSTET GYNECOL, V183, P148, DOI 10.1067/mob.2000.105735; Yang Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep05549; Young T, 1996, SLEEP, V19, pS202, DOI 10.1093/sleep/19.suppl_10.S202; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	50	32	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148732	10.1371/journal.pone.0148732	http://dx.doi.org/10.1371/journal.pone.0148732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871434	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100051
J	Passlack, N; Schmiedchen, B; Raila, J; Schweigert, FJ; Stumpff, F; Kohn, B; Neumann, K; Zentek, J				Passlack, Nadine; Schmiedchen, Bettina; Raila, Jens; Schweigert, Florian J.; Stumpff, Friederike; Kohn, Barbara; Neumann, Konrad; Zentek, Juergen			Impact of Increasing Dietary Calcium Levels on Calcium Excretion and Vitamin D Metabolites in the Blood of Healthy Adult Cats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; PARATHYROID-HORMONE; URINARY PH; PHOSPHORUS; FGF23; DEFICIENCY; DOGS; HYPERCALCIURIA; SECRETION	Background Dietary calcium (Ca) concentrations might affect regulatory pathways within the Ca and vitamin D metabolism and consequently excretory mechanisms. Considering large variations in Ca concentrations of feline diets, the physiological impact on Ca homeostasis has not been evaluated to date. In the present study, diets with increasing concentrations of dicalcium phosphate were offered to ten healthy adult cats (Ca/phosphorus (P): 6.23/6.02, 7.77/7.56, 15.0/12.7, 19.0/17.3, 22.2/19.9, 24.3/21.6 g/kg dry matter). Each feeding period was divided into a 10-day adaptation and an 8-day sampling period in order to collect urine and faeces. On the last day of each feeding period, blood samples were taken. Results Urinary Ca concentrations remained unaffected, but faecal Ca concentrations increased (P < 0.001) with increasing dietary Ca levels. No effect on whole and intact parathyroid hormone levels, fibroblast growth factor 23 and calcitriol concentrations in the blood of the cats were observed. However, the calcitriol precursors 25(OH)D-2 and 25(OH)D-3, which are considered the most useful indicators for the vitamin D status, decreased with higher dietary Ca levels (P = 0.013 and P = 0.033). Increasing dietary levels of dicalcium phosphate revealed an acidifying effect on urinary fasting pH (6.02) and postprandial pH (6.01) (P < 0.001), possibly mediated by an increase of urinary phosphorus (P) concentrations (P < 0.001). Conclusions In conclusion, calcitriol precursors were linearly affected by increasing dietary Ca concentrations. The increase in faecal Ca excretion indicates that Ca homeostasis of cats is mainly regulated in the intestine and not by the kidneys. Long-term studies should investigate the physiological relevance of the acidifying effect observed when feeding diets high in Ca and P.	[Passlack, Nadine; Zentek, Juergen] Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Konigin Luise Str 49, D-14195 Berlin, Germany; [Schmiedchen, Bettina; Raila, Jens; Schweigert, Florian J.] Univ Potsdam, Inst Nutr Sci, Arthur Scheunert Allee 114-116, D-14558 Bergholz Rehbrucke, Germany; [Stumpff, Friederike] Free Univ Berlin, Inst Vet Physiol, Dept Vet Med, Oertzenweg 19b, D-14163 Berlin, Germany; [Kohn, Barbara] Free Univ Berlin, Dept Vet Med, Clin Small Anim, Oertzenweg 19b, D-14163 Berlin, Germany; [Neumann, Konrad] Charite, Inst Biometry & Clin Epidemiol, Hindenburgdamm 30, D-12203 Berlin, Germany	Free University of Berlin; University of Potsdam; Free University of Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Passlack, N (corresponding author), Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Konigin Luise Str 49, D-14195 Berlin, Germany.	nadine.passlack@fu-berlin.de		Zentek, Jurgen/0000-0003-2864-9250; Schweigert, Florian/0000-0001-7103-2438				AAFCO, 2014, AAFCO METHODS SUBSTA; Anderson PH, 2010, J STEROID BIOCHEM, V121, P288, DOI 10.1016/j.jsbmb.2010.03.022; Aronov PA, 2008, ANAL BIOANAL CHEM, V391, P1917, DOI 10.1007/s00216-008-2095-8; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Bihuniak JD, 2013, J ACAD NUTR DIET, V113, P447, DOI 10.1016/j.jand.2012.11.002; Burkholder WJ, 2000, J AM VET MED ASSOC, V216, P1730, DOI 10.2460/javma.2000.216.1730; Ceglia L, 2009, J CLIN ENDOCR METAB, V94, P645, DOI 10.1210/jc.2008-1796; CLEMENTS MR, 1987, NATURE, V325, P62, DOI 10.1038/325062a0; Cline J, 2012, TOP COMPANION ANIM M, V27, P159, DOI 10.1053/j.tcam.2012.09.004; de Morais HA, 2008, VET CLIN N AM-SMALL, V38, P559, DOI 10.1016/j.cvsm.2008.02.003; Dijcker JC, 2011, NUTR RES REV, V24, P96, DOI 10.1017/S0954422410000351; Dillitzer N, 2010, C P 14 C EUR SOC VET, P67; Dittmer KE, 2011, VET PATHOL, V48, P389, DOI 10.1177/0300985810375240; Federation europeenne de l'industrie des aliments pour animaux familiers The European Pet Food Federation (FEDIAF), 2014, NUTR GUID COMPL COMP; Felsenfeld AJ, 2007, CLIN J AM SOC NEPHRO, V2, P1283, DOI 10.2215/CJN.01520407; Finch NC, 2013, J VET INTERN MED, V27, P227, DOI 10.1111/jvim.12036; Galvao JFD, 2013, J VET EMERG CRIT CAR, V23, P134, DOI 10.1111/vec.12036; Geddes RF, 2013, J VET INTERN MED, V27, P234, DOI 10.1111/jvim.12044; Geddes RF, 2013, J VET EMERG CRIT CAR, V23, P122, DOI 10.1111/vec.12032; Hardcastle MR, 2015, VET PATHOL, V52, P770, DOI 10.1177/0300985815586222; IZQUIERDO JV, 1991, J NUTR, V121, pS89, DOI 10.1093/jn/121.suppl_11.S89; KIENZLE E, 1991, J NUTR, V121, pS87, DOI 10.1093/jn/121.suppl_11.S87; KIENZLE E, 1993, DEUT TIERARZTL WOCH, V100, P198; KIENZLE E, 1994, J NUTR PHILADELPHIA, V124, P2652, DOI DOI 10.1093/JN/124.SUPPL_12.2652S; KIRK CA, 1995, J AM VET MED ASSOC, V207, P1429; Lips P, 2012, SCAND J CLIN LAB INV, V72, P60, DOI 10.3109/00365513.2012.681960; Maalouf NM, 2011, J CLIN ENDOCR METAB, V96, P3733, DOI 10.1210/jc.2011-1531; Mack JK, 2015, J ANIM PHYSIOL AN N, V99, P801, DOI 10.1111/jpn.12294; Morris JG, 1999, J NUTR, V129, P909, DOI 10.1093/jn/129.4.909; National Research Council, 2006, NUTR REQ DOGS CATS; Osborne CA, 1995, P 13 ACVIM FOR, P487; Passlack N, 2014, BRIT J NUTR, V111, P785, DOI 10.1017/S0007114513003279; Passlack N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070530; Pastoor F., 1993, THESIS U UTRECHT; PASTOOR FJH, 1995, J NUTR, V125, P1334; PASTOOR FJH, 1994, J NUTR, V124, P2212, DOI 10.1093/jn/124.11.2212; Penniston KL, 2009, UROLOGY, V73, P484, DOI 10.1016/j.urology.2008.10.035; Pineda C, 2012, DOMEST ANIM ENDOCRIN, V42, P256, DOI 10.1016/j.domaniend.2012.01.003; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Schlesinger DP, 2011, CAN VET J, V52, P50; SCOTT P. PATRICIA, 1967, P163; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; SKOCH ER, 1991, J SMALL ANIM PRACT, V32, P413, DOI 10.1111/j.1748-5827.1991.tb00968.x; Stevenson AE, 2004, VET THER, V5, P218; Torres PU, 2006, KIDNEY INT, V70, P240, DOI 10.1038/sj.ki.5001658; Verbeke G, 2000, LINEAR MIXED MODELS, P20; Wesseling-Perry K, 2014, J CLIN ENDOCR METAB, V99, pE1951, DOI 10.1210/jc.2014-2125; ZEMEL MB, 1981, J NUTR, V111, P545, DOI 10.1093/jn/111.3.545	48	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149190	10.1371/journal.pone.0149190	http://dx.doi.org/10.1371/journal.pone.0149190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870965	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100122
J	Skipp, PJS; Hughes, C; McKenna, T; Edwards, R; Langridge, J; Thomson, NR; Clarke, IN				Skipp, Paul J. S.; Hughes, Chris; McKenna, Therese; Edwards, Richard; Langridge, James; Thomson, Nicholas R.; Clarke, Ian N.			Quantitative Proteomics of the Infectious and Replicative Forms of Chlamydia trachomatis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PELVIC-INFLAMMATORY-DISEASE; III SECRETION SYSTEM; LYMPHOGRANULOMA-VENEREUM; DEVELOPMENTAL CYCLE; RISK-FACTORS; PROTEIN; PNEUMONIAE; QUANTIFICATION; PREVALENCE	The obligate intracellular developmental cycle of Chlamydia trachomatis presents significant challenges in defining its proteome. In this study we have applied quantitative proteomics to both the intracellular reticulate body (RB) and the extracellular elementary body (EB) from C. trachomatis. We used C. trachomatis L2 as a model chlamydial isolate for our study since it has a high infectivity: particle ratio and there is an excellent quality genome sequence. EBs and RBs (>99% pure) were quantified by chromosomal and plasmid copy number using PCR, from which the concentrations of chlamydial proteins per bacterial cell/genome were determined. RBs harvested at 15h post infection (PI) were purified by three successive rounds of gradient centrifugation. This is the earliest possible time to obtain purified RBs, free from host cell components in quantity, within the constraints of the technology. EBs were purified at 48h PI. We then used two-dimensional reverse phase UPLC to fractionate RB or EB peptides before mass spectroscopic analysis, providing absolute amount estimates of chlamydial proteins. The ability to express the data as molecules per cell gave ranking in both abundance and energy requirements for synthesis, allowing meaningful identification of rate-limiting components. The study assigned 562 proteins with high confidence and provided absolute estimates of protein concentration for 489 proteins. Interestingly, the data showed an increase in TTS capacity at 15h PI. Most of the enzymes involved in peptidoglycan biosynthesis were detected along with high levels of muramidase (in EBs) suggesting breakdown of peptidoglycan occurs in the non-dividing form of the microorganism. All the genome-encoded enzymes for glycolysis, pentose phosphate pathway and tricarboxylic acid cycle were identified and quantified; these data supported the observation that the EB is metabolically active. The availability of detailed, accurate quantitative proteomic data will be invaluable for investigations into gene regulation and function.	[Skipp, Paul J. S.] Univ Southampton, Ctr Biol Sci, Ctr Prote Res, Southampton, Hants, England; [Hughes, Chris; McKenna, Therese; Langridge, James] Waters Corp, Stamford Ave, Wilmslow, Cheshire, England; [Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Pathogen Genom, Hinxton, England; [Clarke, Ian N.] Univ Southampton, Sch Med, Mol Microbiol Grp, Southampton, Hants, England; [Edwards, Richard] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Edwards, Richard] Univ Southampton, Sch Biol Sci, Southampton, Hants, England	University of Southampton; Waters UK; Wellcome Trust Sanger Institute; University of Southampton; University of New South Wales Sydney; University of Southampton	Skipp, PJS (corresponding author), Univ Southampton, Ctr Biol Sci, Ctr Prote Res, Southampton, Hants, England.	pjss@soton.ac.uk	Edwards, Richard/C-8755-2011; Thomson, Nicholas R/P-5988-2014	Edwards, Richard/0000-0002-3645-5539; Thomson, Nicholas R/0000-0002-4432-8505; Clarke, Ian/0000-0002-4938-1620	Wellcome Trust [057347]; Waters Corporation	Wellcome Trust(Wellcome TrustEuropean Commission); Waters Corporation	This study was supported by a grant from the Wellcome Trust (#057347). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. Waters Corporation provided support in the form of salaries for authors C.H.,T.M. and J.L. These authors had roles in data collection and analysis, preparation of the manuscript and contribution of analysis tools.	Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; [Anonymous], 2008, REPROD HLTH MATTERS, V20, P207; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662; de Vrieze NHN, 2013, SEX TRANSM INFECT, V89, P548, DOI 10.1136/sextrans-2012-050915; Falk L, 2005, SEX TRANSM INFECT, V81, P73, DOI 10.1136/sti.2004.010439; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Hefty PS, 2007, J BACTERIOL, V189, P198, DOI 10.1128/JB.01034-06; Herod MR, 2014, BIOCHEM J, V464, P461, DOI 10.1042/BJ20140959; Iliffe-Lee ER, 1999, MOL MICROBIOL, V33, P177, DOI 10.1046/j.1365-2958.1999.01464.x; Kong FYS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1030-9; Lambden PR, 2006, MICROBIOL-SGM, V152, P2573, DOI 10.1099/mic.0.29032-0; Lerat E, 2005, NUCLEIC ACIDS RES, V33, P3125, DOI 10.1093/nar/gki631; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Liu XY, 2010, J BACTERIOL, V192, P2852, DOI 10.1128/JB.01628-09; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moorhead AM, 2010, INFECT IMMUN, V78, P1990, DOI 10.1128/IAI.01340-09; Oakeshott P., 2010, BRIT MED J, V340, pc1642, DOI [10.1136/bmj.c1642, DOI 10.1136/BMJ.C1642]; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; Persson K, 2012, SEX TRANSM INFECT, V88, P451, DOI 10.1136/sextrans-2011-050409; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pickett MA, 2005, MICROBIOL-SGM, V151, P893, DOI 10.1099/mic.0.27625-0; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Salim O, 2008, VIROLOGY, V377, P440, DOI 10.1016/j.virol.2008.05.001; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Skilton RJ, 2007, J BACTERIOL, V189, P4957, DOI 10.1128/JB.00235-07; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200; Sun L, 2010, NATURE, V467, P163, DOI 10.1038/467163a; Szaflarski W, 2007, ORIGINS LIFE EVOL B, V37, P423, DOI 10.1007/s11084-007-9091-4; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Vandahl BB, 2001, ELECTROPHORESIS, V22, P1204, DOI 10.1002/1522-2683()22:6<1204::AID-ELPS1204>3.0.CO;2-M; Vissers JPC, 2007, MOL CELL PROTEOMICS, V6, P755, DOI 10.1074/mcp.M600303-MCP200; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WARD ME, 1983, BRIT MED BULL, V39, P109, DOI 10.1093/oxfordjournals.bmb.a071800	43	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149011	10.1371/journal.pone.0149011	http://dx.doi.org/10.1371/journal.pone.0149011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871455	Green Published, gold, Green Accepted			2022-12-26	WOS:000370054100087
J	Thanakun, S; Pornprasertsuk-Damrongsri, S; Gokyu, M; Kobayashi, H; Izumi, Y				Thanakun, Supanee; Pornprasertsuk-Damrongsri, Suchaya; Gokyu, Misa; Kobayashi, Hiroaki; Izumi, Yuichi			Inverse Association of Plasma IgG Antibody to Aggregatibacter actinomycetemcomitans and High C-Reactive Protein Levels in Patients with Metabolic Syndrome and Periodontitis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; REAL-TIME PCR; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; THAI POPULATION; PERIODONTOPATHIC BACTERIA; SYSTEMIC ANTIBODIES; SERUM ANTIBODIES; IMMUNE-RESPONSE; METAANALYSIS	The association between clinically diagnosed periodontitis, a common chronic oral infection, and metabolic syndrome has been previously reported. The aim of this study was to investigate the association of plasma IgG levels against Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia, C-reactive protein, and periodontal status with metabolic syndrome. Plasma IgG levels and C-reactive protein were measured by enzyme-linked immunosorbent assay, and salivary levels of A. actinomycetemcomitans and P. gingivalis were determined by quantitative real-time polymerase chain reaction. Among 127 individuals aged 35-76 years, 57 participants had metabolic syndrome and severe periodontitis, 25 had metabolic syndrome and an absence of severe periodontitis, 17 healthy individuals had severe periodontitis, and 28 healthy individuals were without severe periodontitis. Patients with metabolic syndrome had reduced humoral immune response to A. actinomycetemcomitans (p = 0.008), regardless of their salivary levels or periodontitis status compared with healthy participants. The IgG antibody response to P. gingivalis, regardless of their salivary levels or participants' health condition, was significantly higher in severe periodontitis patients (p < 0.001). Plasma IgG titers for P. intermedia were inconsistent among metabolic syndrome or periodontal participants. Our results indicate that the presence of lower levels of IgG antibodies to A. actinomycetemcomitans (OR = 0.1; 95% CI 0.0-0.7), but not P. gingivalis, a severe periodontitis status (OR = 7.8; 95% CI 1.1-57.0), high C-reactive protein levels (OR = 9.4; 95% CI 1.0-88.2) and body mass index (OR = 3.0; 95% CI 1.7-5.2), are associated with the presence of metabolic syndrome. The role of the decreased IgG antibody response to A. actinomycetemcomitans, increased C-reactive protein levels on the association between periodontal disease and metabolic syndrome in a group of Thai patients is suggested.	[Thanakun, Supanee] Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand; [Pornprasertsuk-Damrongsri, Suchaya] Mahidol Univ, Fac Dent, Dept Oral & Maxillofacial Radiol, Bangkok 10700, Thailand; [Gokyu, Misa; Kobayashi, Hiroaki; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Izumi, Yuichi] Tokyo Med & Dent Univ, Global Ctr Excellence Program Tooth & Bone Res, Tokyo, Japan	Mahidol University; Mahidol University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Thanakun, S (corresponding author), Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand.	supanee.tha@mahidol.ac.th	Kobayashi, Hiroaki/AAG-6812-2019	Thanakun, Supanee/0000-0002-2570-0658; Gokyu, Misa/0000-0003-1482-9218	Faculty of Dentistry, Mahidol University [2011]; Tokyo Medical and Dental University [25293424]; Ronpaku (JSPS) [NRCT-11123]	Faculty of Dentistry, Mahidol University; Tokyo Medical and Dental University; Ronpaku (JSPS)	This work was supported by the Faculty of Dentistry, Mahidol University (www.dt.mahidol.ac.th; grant number 2011; ST); Tokyo Medical and Dental University (www.tmd.ac.jp; grant number 25293424; YI); and Ronpaku (www.tmd.ac.jp; grant number NRCT-11123; ST JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alfakry H, 2011, SCAND J IMMUNOL, V74, P383, DOI 10.1111/j.1365-3083.2011.02584.x; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Atieh MA, 2008, J PERIODONTOL, V79, P1620, DOI [10.1902/jop.2008.070668, 10.1902/jop.2008.070668 ]; Beckstrom BW, 2007, ORAL SURG ORAL MED O, V103, P359, DOI 10.1016/j.tripleo.2006.08.016; Devaraj S, 2008, AM J CLIN PATHOL, V129, P815, DOI 10.1309/RN84K51B2JJY1Y0B; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Furuichi Y, 2003, J PERIODONTOL, V74, P1491, DOI 10.1902/jop.2003.74.10.1491; Gemmell E, 2002, CRIT REV ORAL BIOL M, V13, P17, DOI 10.1177/154411130201300104; Graswinckel JEM, 2004, J CLIN PERIODONTOL, V31, P562, DOI 10.1111/j.1600-051X.2004.00522.x; GUNSOLLEY JC, 1990, J PERIODONTOL, V61, P412, DOI 10.1902/jop.1990.61.7.412; Hayman L, 2011, CLIN EXP IMMUNOL, V164, P118, DOI 10.1111/j.1365-2249.2010.04314.x; He JY, 2012, CLIN ORAL INVEST, V16, P1579, DOI 10.1007/s00784-011-0654-4; Hyvarinen K, 2015, ACTA DIABETOL, V52, P179, DOI 10.1007/s00592-014-0586-y; Ishikawa I, 1988, Adv Dent Res, V2, P334; Iwasaki M, 2016, GERODONTOLOGY, V33, P193, DOI 10.1111/ger.12135; Johansson A, 2005, CEREBROVASC DIS, V20, P226, DOI 10.1159/000087703; Johansson A, 2005, EUR J ORAL SCI, V113, P197, DOI 10.1111/j.1600-0722.2005.00218.x; Karels AJ, 2007, INTERNET J ALLIED HE, V5; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Kinane DF, 2007, PERIODONTOL 2000, V43, P278, DOI 10.1111/j.1600-0757.2006.00169.x; Kinane DF, 1999, PERIODONTOL 2000, V20, P289, DOI 10.1111/j.1600-0757.1999.tb00164.x; Lakio L, 2009, J ORAL MICROBIOL, V1, DOI [10.3402/jom.v3401i3400.1979, DOI 10.3402/J0M.V3401I3400.1979]; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Miyashita H, 2012, ARCH ORAL BIOL, V57, P820, DOI 10.1016/j.archoralbio.2011.11.008; Moreno S, 2013, COLOMB MEDICA, V44, P51; Mustapha IZ, 2007, J PERIODONTOL, V78, P2289, DOI 10.1902/jop.2007.070140; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; OFFENBACHER S, 1993, J PERIODONTAL RES, V28, P523, DOI 10.1111/j.1600-0765.1993.tb02118.x; Offenbacher S, 2008, J PERIODONTOL, V79, P1577, DOI 10.1902/jop.2008.080220; Paju S, 2009, J CLIN MICROBIOL, V47, P235, DOI 10.1128/JCM.01824-08; Papapanou PN, 2004, J CLIN PERIODONTOL, V31, P985, DOI 10.1111/j.1600-051X.2004.00599.x; Papapanou PN, 2002, EUR J ORAL SCI, V110, P345, DOI 10.1034/j.1600-0722.2002.21361.x; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Pitiphat W, 2008, J CLIN PERIODONTOL, V35, P120, DOI 10.1111/j.1600-051X.2007.01179.x; Pussinen PJ, 2011, J CLIN PERIODONTOL, V38, P405, DOI 10.1111/j.1600-051X.2011.01703.x; Pussinen PJ, 2003, ARTERIOSCL THROM VAS, V23, P1250, DOI 10.1161/01.ATV.0000072969.71452.87; Rajakaruna GA, 2012, J MICROBIOL, V50, P827, DOI 10.1007/s12275-012-2030-8; Rams TE, 2006, J PERIODONTAL RES, V41, P228, DOI 10.1111/j.1600-0765.2005.00860.x; Sakamoto M, 2001, MICROBIOL IMMUNOL, V45, P39, DOI 10.1111/j.1348-0421.2001.tb01272.x; Saygun I, 2011, J PERIODONTAL RES, V46, P235, DOI 10.1111/j.1600-0765.2010.01335.x; Seymour GJ, 2001, ACTA ODONTOL SCAND, V59, P167, DOI 10.1080/000163501750266765; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; Tanaka S, 2006, J PERIODONTAL RES, V41, P1, DOI 10.1111/j.1600-0765.2005.00829.x; Thanakun S, 2014, J PERIODONTOL, V85, P1502, DOI 10.1902/jop.2014.140105; Torrungruang K, 2009, J PERIODONTOL, V80, P122, DOI [10.1902/jop.2009.080248, 10.1902/jop.2009.080248 ]; Ueno M, 2012, INT HEART J, V53, P209, DOI 10.1536/ihj.53.209; Wara-aswapati N, 2009, ORAL DIS, V15, P354, DOI 10.1111/j.1601-0825.2009.01562.x; WHISLER RL, 1986, CELL IMMUNOL, V102, P287, DOI 10.1016/0008-8749(86)90422-3; Zhang RX, 2006, EUR J IMMUNOL, V36, P2993, DOI 10.1002/eji.200635207	51	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148638	10.1371/journal.pone.0148638	http://dx.doi.org/10.1371/journal.pone.0148638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871443	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100042
J	NikNadia, NMN; Sam, IC; Khaidir, N; Ngui, R; Lim, YAL; Goh, XT; Choy, SH; Chan, YF				NikNadia, N. M. N.; Sam, I-Ching; Khaidir, Nasibah; Ngui, Romano; Lim, Yvonne A. L.; Goh, Xiang Ting; Choy, Seow Huey; Chan, Yoke Fun			Risk Factors for Enterovirus A71 Seropositivity in Rural Indigenous Populations in West Malaysia	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; EFFECTIVE CONTROL PROGRAM; MOUTH-DISEASE; ORANG ASLI; 71 VACCINE; HAND; FOOT; CHILDREN; CHINA; SEROEPIDEMIOLOGY	Enterovirus A71 (EV-A71), which is transmitted by the fecal-oral route, causes hand, foot and mouth disease and, rarely, severe neurological complications. In Malaysia, the indigenous rural community (Orang Asli) has a high prevalence of parasitic diseases due to poor sanitation, water supply and hygiene practices. This cross-sectional study compared the seroepidemiology of EV-A71 among rural Orang Asli and urban Kuala Lumpur populations in West Malaysia, and determined the risk factors associated with EV-A71 seropositivity in rural Orang Asli. Seropositive rates were determined by neutralization assay. EV-A71 seropositivity was strongly associated with increasing age in both populations. Rural Orang Asli children <= 12 years had significantly higher EV-A71 seropositivity rates than urban Kuala Lumpur children (95.5% vs 57.6%, P < 0.001), and also higher rates in the age groups of 1-3, 4-6 and 7-12 years. Multivariate analysis confirmed that age <= 12 years (adjusted OR 8.1, 95% CI 3.2-20.7, P < 0.001) and using untreated water (adjusted OR 6.2, 95% CI 2.3-16.6, P < 0.001) were independently associated with EV-A71 seropositivity in the Orang Asli population. Supply of clean drinking water may reduce the risk of EV-A71 infection. With significantly higher EV-A71 seropositive rates, younger rural children should be a priority target for future vaccination programs in Malaysia.	[NikNadia, N. M. N.; Sam, I-Ching; Khaidir, Nasibah; Chan, Yoke Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Ngui, Romano; Lim, Yvonne A. L.; Goh, Xiang Ting; Choy, Seow Huey] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chan, YF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	chanyf@um.edu.my	LIM, YVONNE AL/B-5276-2010; Sam, Jamal I-Ching/B-8688-2010; Ngui, Romano/H-9645-2015; Goh, Xiang Ting/AAD-7175-2020; Chan, Yoke Fun/B-5351-2010; Choy, Seow Huey/AAD-8828-2020	LIM, YVONNE AL/0000-0003-4050-6332; Sam, Jamal I-Ching/0000-0002-1296-7898; Ngui, Romano/0000-0002-3520-579X; Chan, Yoke Fun/0000-0001-7089-0510; Choy, Seow Huey/0000-0003-0020-871X; goh, xiang ting/0000-0002-2186-5447	University Malaya Research Grant Scheme [RG522-13HTM]; Postgraduate Research Fund from University Malaya [PG033-2014B]; Ministry of Higher Education, Malaysia [E000013-20001, FP022-2014A]	University Malaya Research Grant Scheme; Postgraduate Research Fund from University Malaya; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This study was supported by University Malaya Research Grant Scheme (RG522-13HTM) and Postgraduate Research Fund (PG033-2014B) from University Malaya, High Impact Research grant (E000013-20001) and Fundamental Research Grant Scheme (FP022-2014A) from the Ministry of Higher Education, Malaysia.	Ahmed A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-119; Ahmed A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-242; Al-Delaimy AK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003074; Al-Mekhlafi HM, 2011, ANN TROP MED PARASIT, V105, P135, DOI 10.1179/136485911X12899838683368; Al-Mekhlafi HM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002516; Al-Mekhlafi MH, 2008, ACTA TROP, V107, P200, DOI 10.1016/j.actatropica.2008.05.022; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bedford J, 2013, WHEN CULTURE IMPACTS HEALTH: GLOBAL LESSONS FOR EFFECTIVE HEALTH RESEARCH, P193, DOI 10.1016/B978-0-12-415921-1.00017-8; Chan YF, 2012, TROP BIOMED, V29, P451; Chan YF, 2011, NEUROL ASIA, V16, P1; Chang JL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0474-9; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Economic Planning Unit Prime Minister's Department Malaysia, 2013, PERCENTAGE DISTRIBUT; Fang QY, 2013, ARCH VIROL, V158, P895, DOI 10.1007/s00705-012-1566-6; Huang HI, 2012, FUTURE MICROBIOL, V7, P467, DOI [10.2217/FMB.12.22, 10.2217/fmb.12.22]; Huang KYA, 2015, J INFECT DIS, V212, P808, DOI 10.1093/infdis/jiv094; Huang WC, 2017, J MICROBIOL IMMUNOL, V50, P10, DOI 10.1016/j.jmii.2014.11.013; Jaafar J., 2004, J DEP STAT MALAYSIA, V1, P43; Ji H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-248; Leuridan E, 2011, CLIN INFECT DIS, V53, P68, DOI 10.1093/cid/cir270; Li L, 2015, VACCINE, V33, P1107, DOI 10.1016/j.vaccine.2014.10.081; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087603; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Lim PY, 2015, VACCINE, V33, P6017, DOI 10.1016/j.vaccine.2015.05.108; Lim YAL, 2009, TROP BIOMED, V26, P110; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Liu LD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0448-7; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Masron T., 2012, GEOGR MALAYS J SOC S, V8, P20; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-28; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-27; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Noor MAM, 2012, J INT COMP EDUC, V1, P90; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Peng LH, 1997, MALAYS J CHILD HLTH, V9, P104; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; The Government of Malaysia's Official Portal, IMM SCHED; Tran Chau Bich Nguyen, 2011, PLoS One, V6, pe21116, DOI 10.1371/journal.pone.0021116; Wang SM, 2012, EUR J CLIN MICROBIOL, V31, P1219, DOI 10.1007/s10096-011-1432-6; Xie YH, 2015, EPIDEMIOL INFECT, V143, P1432, DOI 10.1017/S0950268814002301; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang CF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-306; Yu HY, 2011, JPN J INFECT DIS, V64, P528; Zeng M, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.72; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148767	10.1371/journal.pone.0148767	http://dx.doi.org/10.1371/journal.pone.0148767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866912	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700034
J	Vivien, R; Lejzerowicz, F; Pawlowski, J				Vivien, Regis; Lejzerowicz, Franck; Pawlowski, Jan			Next-Generation Sequencing of Aquatic Oligochaetes: Comparison of Experimental Communities	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ENVIRONMENTAL DNA; WORMS ANNELIDA; BIODIVERSITY; CLITELLATA; AMPLIFICATION; ARTHROPODS; SEDIMENTS; ALIGNMENT; RECOVERY	Aquatic oligochaetes are a common group of freshwater benthic invertebrates known to be very sensitive to environmental changes and currently used as bioindicators in some countries. However, more extensive application of oligochaetes for assessing the ecological quality of sediments in watercourses and lakes would require overcoming the difficulties related to morphology-based identification of oligochaetes species. This study tested the Next-Generation Sequencing (NGS) of a standard cytochrome c oxydase I (COI) barcode as a tool for the rapid assessment of oligochaete diversity in environmental samples, based on mixed specimen samples. To know the composition of each sample we Sanger sequenced every specimen present in these samples. Our study showed that a large majority of OTUs (Operational Taxonomic Unit) could be detected by NGS analyses. We also observed congruence between the NGS and specimen abundance data for several but not all OTUs. Because the differences in sequence abundance data were consistent across samples, we exploited these variations to empirically design correction factors. We showed that such factors increased the congruence between the values of oligochaetes-based indices inferred from the NGS and the Sanger-sequenced specimen data. The validation of these correction factors by further experimental studies will be needed for the adaptation and use of NGS technology in biomonitoring studies based on oligochaete communities.	[Vivien, Regis] Eawag EPFL, Ecotox Ctr, Swiss Ctr Appl Ecotoxicol, CH-1015 Lausanne, Switzerland; [Lejzerowicz, Franck; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Geneva	Vivien, R (corresponding author), Eawag EPFL, Ecotox Ctr, Swiss Ctr Appl Ecotoxicol, CH-1015 Lausanne, Switzerland.	regis.vivien@centreecotox.ch	Pawlowski, Jan/AAO-3306-2021; Lejzerowicz, Franck/AAG-7812-2021; Vivien, Régis/AAN-2549-2020	Pawlowski, Jan/0000-0003-2421-388X; Lejzerowicz, Franck/0000-0002-3195-032X	SWISSBOL; UNITEC; Fondation Schmidheiny; Swiss National Science Foundation [316030_150817]	SWISSBOL; UNITEC; Fondation Schmidheiny; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by SWISSBOL (www.swissbol.ch), UNITEC (www.unige.ch/unitec/presentation.html), Fondation Schmidheiny (www.fondation-schmidheiny.ch/informations.html), and Swiss National Science Foundation grant 316030_150817. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armendariz L, 2012, LIMNOLOGICA, V42, P118, DOI 10.1016/j.limno.2011.09.005; Association Francaise de Normalisation (AFNOR), 2002, T90390 AFNOR NF; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Beauchamp KA, 2001, MOL PHYLOGENET EVOL, V19, P216, DOI 10.1006/mpev.2001.0923; Bely AE, 2004, MOL PHYLOGENET EVOL, V30, P50, DOI 10.1016/S1055-7903(03)00180-5; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Brinkhurst RO, 1966, WATER SEWAGE WORKS, V113, P434; Brodin Y, 2013, MOL ECOL RESOUR, V13, P996, DOI 10.1111/1755-0998.12053; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Deagle BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egge E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074371; Envall I, 2012, ZOOL J LINN SOC-LOND, V165, P495, DOI 10.1111/j.1096-3642.2012.00828.x; Erseus C, 2009, ANNELIDS IN MODERN BIOLOGY, P31; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gustafsson DR, 2009, MOL PHYLOGENET EVOL, V51, P182, DOI 10.1016/j.ympev.2008.12.016; Hajibabaei M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-28; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kermarrec L, 2013, MOL ECOL RESOUR, V13, P607, DOI 10.1111/1755-0998.12105; Kvist S, 2010, MOL PHYLOGENET EVOL, V57, P687, DOI 10.1016/j.ympev.2010.08.018; Lafont M, 2006, HYDROBIOLOGIA, V564, P171, DOI 10.1007/s10750-005-1717-9; Lafont M., 1989, THESIS U CLAUDE BERN; Lang C, 1997, AQUAT SCI, V59, P26, DOI 10.1007/PL00001303; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Martinsson S, 2013, ZOOL SCR, V42, P612, DOI 10.1111/zsc.12032; Morgan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071974; Prygiel J, 1999, HYDROBIOLOGIA, V410, P25, DOI 10.1023/A:1003799224961; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rodriguez P., 2011, POLLUTION BIOL AQUAT; Rougerie R, 2009, PESQUI AGROPECU BRAS, V44, P789, DOI 10.1590/S0100-204X2009000800002; Sarka J, 1994, HYDROBIOLOGIA, V322, P29, DOI DOI 10.1007/978-94-011-0842-3_26; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stein ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051273; Sturmbauer C, 1999, MOL BIOL EVOL, V16, P967, DOI 10.1093/oxfordjournals.molbev.a026186; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tkach V, 1999, ACTA PARASITOL, V44, P147; Vivien R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125485; Vivien Regis, 2014, Ecohydrology & Hydrobiology, V14, P142, DOI 10.1016/j.ecohyd.2014.03.003; Wessa P, 2014, OFFIC RES DEV ED, V1, P23; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037; Zhou H, 2010, ZOOL SCR, V39, P378, DOI 10.1111/j.1463-6409.2010.00429.x; Zhou X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	52	19	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148644	10.1371/journal.pone.0148644	http://dx.doi.org/10.1371/journal.pone.0148644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866802	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700024
J	Amon, M; Jager, F				Amon, Miha; Jager, Franc			Electrocardiogram ST-Segment Morphology Delineation Method Using Orthogonal Transformations	PLOS ONE			English	Article							ADAPTIVE ESTIMATION; EPISODES; COMPLEX; DATABASE	Differentiation between ischaemic and non-ischaemic transient ST segment events of long term ambulatory electrocardiograms is a persisting weakness in present ischaemia detection systems. Traditional ST segment level measuring is not a sufficiently precise technique due to the single point of measurement and severe noise which is often present. We developed a robust noise resistant orthogonal-transformation based delineation method, which allows tracing the shape of transient ST segment morphology changes from the entire ST segment in terms of diagnostic and morphologic feature-vector time series, and also allows further analysis. For these purposes, we developed a new Legendre Polynomials based Transformation (LPT) of ST segment. Its basis functions have similar shapes to typical transient changes of ST segment morphology categories during myocardial ischaemia (level, slope and scooping), thus providing direct insight into the types of time domain morphology changes through the LPT feature-vector space. We also generated new Karhunen and Loeve Transformation (KLT) ST segment basis functions using a robust covariance matrix constructed from the ST segment pattern vectors derived from the Long Term ST Database (LTST DB). As for the delineation of significant transient ischaemic and non-ischaemic ST segment episodes, we present a study on the representation of transient ST segment morphology categories, and an evaluation study on the classification power of the KLT- and LPT-based feature vectors to classify between ischaemic and non-ischaemic ST segment episodes of the LTST DB. Classification accuracy using the KLT and LPT feature vectors was 90% and 82%, respectively, when using the k-Nearest Neighbors (k = 3) classifier and 10-fold cross-validation. New sets of feature-vector time series for both transformations were derived for the records of the LTST DB which is freely available on the PhysioNet website and were contributed to the LTST DB. The KLT and LPT present new possibilities for human-expert diagnostics, and for automated ischaemia detection.	[Amon, Miha; Jager, Franc] Univ Ljubljana, Fac Comp & Informat Sci, Vecna Pot 113, Ljubljana 1000, Slovenia	University of Ljubljana	Jager, F (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Vecna Pot 113, Ljubljana 1000, Slovenia.	franc.jager@fri.uni-lj.si			Innovation Scheme grant; European Union; Republic of Slovenia; Slovenian Research Agency (ARRS) [P3-0124]	Innovation Scheme grant; European Union(European Commission); Republic of Slovenia; Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was financed by the Innovation Scheme grant for PhD study (http://www.uni-lj.si) to Miha Amon, financed by the European Union and by the Republic of Slovenia (MA). This work was financed in part by the Slovenian Research Agency (ARRS) (https://www.arrs.gov.si/) under the research project P3-0124 Metabolic and inborn factors of reproductive health, birth II (FJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buemi M., 1991, Proceedings. Computers in Cardiology (Cat. No.91CH3116-1), P385, DOI 10.1109/CIC.1991.169125; Clifford G, 2006, ADV METHODS TOOLS EC; Clifford GD, 2009, PHILOS T R SOC A, V367, P411, DOI 10.1098/rsta.2008.0157; DEVLIN SJ, 1981, J AM STAT ASSOC, V76, P354, DOI 10.2307/2287836; Faganeli J, 2010, PHYSIOL MEAS, V31, P323, DOI 10.1088/0967-3334/31/3/004; GALLINO A, 1984, J AM COLL CARDIOL, V4, P245, DOI 10.1016/S0735-1097(84)80209-0; Garcia J, 1998, COMPUT BIOMED RES, V31, P271, DOI 10.1006/cbmr.1998.1481; Garcia J, 1996, COMPUT CARDIOL, P249, DOI 10.1109/CIC.1996.542520; Georgiev G, 2012, PROCEDIA COMPUT SCI, V12, P426, DOI 10.1016/j.procs.2012.09.099; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Jager F, 2003, MED BIOL ENG COMPUT, V41, P172, DOI 10.1007/BF02344885; Jager F, 1998, COMPUT BIOMED RES, V31, P305, DOI 10.1006/cbmr.1998.1483; KITTLER J, 1973, PATTERN RECOGN, V5, P335, DOI 10.1016/0031-3203(73)90025-3; Lagerholm M, 2000, IEEE T BIO-MED ENG, V47, P838, DOI 10.1109/10.846677; Laguna P, 1996, MED BIOL ENG COMPUT, V34, P58, DOI 10.1007/BF02637023; Laguna P, 1999, MED BIOL ENG COMPUT, V37, P175, DOI 10.1007/BF02513285; Laguna P, 1994, COMPUT CARDIOL, P233; Minchole A, 2010, BIOMED SIGNAL PROCES, V5, P21, DOI 10.1016/j.bspc.2009.09.001; Moody G B, 1989, COMPUT CARDIOL, V16, P269; Moody GB., 1982, COMPUT CARDIOL, V9, P39; Oefinger MB, 2006, THESIS MIT; Radhakrishnan S, 2010, INT J COMPUT SCI ENG, V2, P1532; Smrdel A, 2004, MED BIOL ENG COMPUT, V42, P303, DOI 10.1007/BF02344704; TADDEI A, 1992, EUR HEART J, V13, P1164, DOI 10.1093/oxfordjournals.eurheartj.a060332; Taddei A, 1992, J AMB MONIT, V5, P167; Tou J. T., 1974, PATTERN RECOGN; Trefethen L. N., 1997, NUMERICAL LINEAR ALG, V50; Vilakazi CB, 2011, COMPUT CARDIOL CONF, V38, P633; Weisstein E. W., 2015, LEGENDRE POLYNOMIAL; Weisstein EW, 2015, GRAM SCHMIDT ORTHONO	30	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148814	10.1371/journal.pone.0148814	http://dx.doi.org/10.1371/journal.pone.0148814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863140	gold, Green Submitted, Green Published			2022-12-26	WOS:000370046600109
J	Silva, GAE; de Moura, L; Curado, MP; Gomes, FD; Otero, U; de Rezende, LFM; Daumas, RP; Guimaraes, RM; Meira, KC; Leite, ID; Valente, JG; Moreira, RI; Koifman, R; Malta, DC; Mello, MSD; Guedes, TWG; Boffetta, P				Azevedo e Silva, Gulnar; de Moura, Lenildo; Curado, Maria Paula; Gomes, Fabio da Silva; Otero, Ubirani; Machado de Rezende, Leandro Fornias; Daumas, Regina Paiva; Guimaraes, Raphael Mendonca; Meira, Karina Cardoso; Leite, Iuri da Costa; Valente, Joaquim Goncalves; Moreira, Ronaldo Ismerio; Koifman, Rosalina; Malta, Deborah Carvalho; de Campos Mello, Marcia Sarpa; Guimaraes Guedes, Thiago Wagnos; Boffetta, Paolo			The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; LUNG-CANCER; RISK; BURDEN; HEALTH; PREVALENCE; BEHAVIORS; EXPOSURE; SMOKING; STATE	Many human cancers develop as a result of exposure to risk factors related to the environment and ways of life. The aim of this study was to estimate attributable fractions of 25 types of cancers resulting from exposure to modifiable risk factors in Brazil. The prevalence of exposure to selected risk factors among adults was obtained from population-based surveys conducted from 2000 to 2008. Risk estimates were based on data drawn from meta-analyses or large, high quality studies. Population-attributable fractions (PAF) for a combination of risk factors, as well as the number of preventable deaths and cancer cases, were calculated for 2020. The known preventable risk factors studied will account for 34% of cancer cases among men and 35% among women in 2020, and for 46% and 39% deaths, respectively. The highest attributable fractions were estimated for tobacco smoking, infections, low consumption of fruits and vegetables, excess weight, reproductive factors, and physical inactivity. This is the first study to systematically estimate the fraction of cancer attributable to potentially modifiable risk factors in Brazil. Strategies for primary prevention of tobacco smoking and control of infection and the promotion of a healthy diet and physical activity should be the main priorities in policies for cancer prevention in the country.	[Azevedo e Silva, Gulnar; Guimaraes Guedes, Thiago Wagnos] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Rio De Janeiro, Brazil; [de Moura, Lenildo] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Curado, Maria Paula] Hosp AC Camargo Fund Antonio Prudente, AC Camargo Canc Ctr, Sao Paulo, SP, Brazil; [Curado, Maria Paula] Int Prevent Res Inst, Lyon, France; [Gomes, Fabio da Silva; Otero, Ubirani; de Campos Mello, Marcia Sarpa] Minist Hlth, Natl Canc Inst, Rio De Janeiro, Rio De Janeiro, Brazil; [Machado de Rezende, Leandro Fornias; Koifman, Rosalina] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, SP, Brazil; [Daumas, Regina Paiva; Leite, Iuri da Costa; Valente, Joaquim Goncalves] Minist Hlth, Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Rio De Janeiro, Brazil; [Guimaraes, Raphael Mendonca] Minist Hlth, Joaquim Venancio Polytech Sch Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Rio De Janeiro, Brazil; [Meira, Karina Cardoso] Univ Fed Rio Grande do Norte, Sch Nursing, BR-59072970 Natal, RN, Brazil; [Moreira, Ronaldo Ismerio] Minist Hlth, Oswaldo Cruz Fdn, Natl Inst Infectolgy, Rio De Janeiro, Rio De Janeiro, Brazil; [Malta, Deborah Carvalho] Minist Hlth, Hlth Surveillance Secretariat, Brasilia, DF, Brazil; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Universidade do Estado do Rio de Janeiro; Pan American Health Organization; A.C.Camargo Cancer Center; National Cancer Institute (Inca); Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Norte; Fundacao Oswaldo Cruz; Icahn School of Medicine at Mount Sinai	Silva, GAE (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Rio De Janeiro, Brazil.	gulnar@ims.uerj.br	Boffetta, Paolo/AAI-7767-2021; Malta, Deborah C/H-7880-2012; Rezende, Leandro F. M./C-1724-2012; Malta, Deborah Carvalho/GNM-8218-2022; GUIMARAES, RAPHAEL/ABH-8745-2020; Malta, Deborah Carvalho/L-2491-2019; DAUMAS, REGINA P/M-9387-2013; Curado, Maria Paula/M-6200-2013; MEIRA, KARINA KCM KARINA/C-8555-2018	Boffetta, Paolo/0000-0002-3811-2791; Malta, Deborah C/0000-0002-8214-5734; Rezende, Leandro F. M./0000-0002-7469-1399; Malta, Deborah Carvalho/0000-0002-8214-5734; Malta, Deborah Carvalho/0000-0002-8214-5734; DAUMAS, REGINA P/0000-0002-8923-7711; Curado, Maria Paula/0000-0001-8172-2483; Cardoso Meira, Karina/0000-0002-1722-5703; Sarpa de Campos Mello, Marcia/0000-0001-8976-4653				Silva Gulnar Azevedo e, 2011, Rev. Saúde Pública, V45, P1009, DOI 10.1590/S0034-89102011005000076; Bakos L, 2013, AN BRAS DERMATOL, V88, P226, DOI 10.1590/S0365-05962013000200007; Behrens G, 2013, BRIT J CANCER, V108, P798, DOI 10.1038/bjc.2013.37; Boffetta P, 2009, ANN ONCOL, V20, P550, DOI 10.1093/annonc/mdn597; Brasil. Instituto Brasileiro de Geografia e Estagistica (IBGE, 2009, PESQ ESP TAB PETAB; Brasil. Instituto Brasileiro de Geografia e Estatistica (IBGE), 2004, PESQ NAC AM DOM PNAD; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2009, VIG BRAS 2008 VIG FA; Brasil. Universidade de Pernambuco, 2010, EST PREV BAS POP INF; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Brenner DR, 2014, PREV MED, V66, P131, DOI 10.1016/j.ypmed.2014.06.018; [Censo Demografico Brasil. Instituto Brasileiro de Geografia e Estatistica (IBGE)], 2000, CENS DEM 2000 PESS O; Correa PCRP, 2009, BMC PUBLIC HEALTH, V9, P1; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; de Freitas CU, 2013, EPIDEMIOL SERV SAUDE, V22, P445, DOI 10.5123/S1679-49742013000300009; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Figueira-Silva Cecília M., 2004, Rev. Soc. Bras. Med. Trop., V37, P409; Girianelli VR, 2011, REV BRAS GINECOL OBS, V32, P39; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Gomes F. S., 2011, SCN News, P57; Hamra GB, 2014, ENVIRON HEALTH PERSP, V122, P906, DOI [10.1289/ehp.1408092, 10.1289/ehp/1408092]; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; *IARC, 1997, HDB CANC PREV, V1; IBGE, 2008, PESQ NAC AM DOM; Inoue M, 2012, ANN ONCOL, V23, P1362, DOI 10.1093/annonc/mdr437; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2010, PESQ ORC FAM 2008 20; [Instituto Nacional de Cancer Brasil. Ministerio da Saude], 2014, EST CANC REG CANC BA; International Agency for Research on Cancer, 1971, IARC MONOGRAPHS EVAL, V1-110, P1971; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Liu YP, 2011, EUR UROL, V60, P1029, DOI 10.1016/j.eururo.2011.07.007; Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI [10.5123/S1679-49742011000400002, DOI 10.5123/S1679-49742011000400002]; Menezes AMB, 2002, REV SAUDE PUBL, V36, P129, DOI 10.1590/S0034-89102002000200002; Milton K, 2014, GLOB PUBLIC HEALTH, V9, P369, DOI 10.1080/17441692.2014.894548; Ministerio da Saude (BR), 2014, SIST INF MORT; Ministerio da Saude (Brasil), 2009, PESQ NAC DEM SAUD CR; Moore SC, 2010, BRIT J CANCER, V103, P933, DOI 10.1038/sj.bjc.6605902; O'Rorke MA, 2010, INT J CANCER, V126, P2957, DOI 10.1002/ijc.24997; Oliveira AF, 2008, CLINICS, V63, P215, DOI 10.1590/S1807-59322008000200010; Olsen JH, 1997, APMIS, V105, P141; Park S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090871; Parkin DM, 2011, BRIT J CANCER, V105, pS77, DOI 10.1038/bjc.2011.489; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Pinto M, 2010, CAD SAUDE PUBLICA, V26, P1234, DOI 10.1590/S0102-311X2010000600016; Purdue MP, 2015, ANN EPIDEMIOL, V25, P188, DOI 10.1016/j.annepidem.2014.11.009; Rodrigues MN, 2005, REV SAUDE PUBL, V39, P847, DOI 10.1590/S0034-89102005000500022; Santana VS, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S10; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schottenfeld D, 2013, ANNU REV PUBL HEALTH, V34, P97, DOI 10.1146/annurev-publhealth-031912-114350; Shin A, 2011, ANN ONCOL, V22, P1435, DOI 10.1093/annonc/mdq592; Stahel RA, 2010, ANN ONCOL, V21, pv126, DOI 10.1093/annonc/mdq173; Szklo AS, 2007, CAD SAUDE PUBLICA, V23, P823, DOI 10.1590/S0102-311X2007000400010; Szwarcwald CL, 2014, CIENC SAUDE COLETIVA, V19, P333, DOI 10.1590/1413-81232014192.14072012; Valente VB, 2005, REV SOC BRAS MED TRO, V38, P488, DOI 10.1590/S0037-86822005000600008; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Wang JB, 2012, ANN ONCOL, V23, P2983, DOI 10.1093/annonc/mds139; Whiteman DC, 2015, AUST NZ J PUBL HEAL, V39, P477, DOI 10.1111/1753-6405.12471; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization & Food and Agriculture Organization, 2003, DIET NUTR PREV CHRON, V916; World Health Organization (WHO), GLOB HLTH OBS OV OB; World Health Organization (WHO), 2012, REC AMB AIR QUAL POL	61	47	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148761	10.1371/journal.pone.0148761	http://dx.doi.org/10.1371/journal.pone.0148761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863517	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600104
J	Cohen, A; Weindling, E; Rabinovich, E; Nachman, I; Fuchs, S; Chuartzman, S; Gal, L; Schuldiner, M; Bar-Nun, S				Cohen, Aviv; Weindling, Esther; Rabinovich, Efrat; Nachman, Iftach; Fuchs, Shai; Chuartzman, Silvia; Gal, Lihi; Schuldiner, Maya; Bar-Nun, Shoshana			Water-Transfer Slows Aging in Saccharomyces cerevisiae	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CHRONOLOGICAL LIFE-SPAN; CALORIE RESTRICTION; YEAST; DEGRADATION; ER; TRANSCRIPTION; POPULATIONS; LONGEVITY; ELEMENT	Transferring Saccharomyces cerevisiae cells to water is known to extend their lifespan. However, it is unclear whether this lifespan extension is due to slowing the aging process or merely keeping old yeast alive. Here we show that in water-transferred yeast, the toxicity of polyQ proteins is decreased and the aging biomarker 47Q aggregates at a reduced rate and to a lesser extent. These beneficial effects of water-transfer could not be reproduced by diluting the growth medium and depended on de novo protein synthesis and proteasomes levels. Interestingly, we found that upon water-transfer 27 proteins are downregulated, 4 proteins are upregulated and 81 proteins change their intracellular localization, hinting at an active genetic program enabling the lifespan extension. Furthermore, the aging-related deterioration of the heat shock response (HSR), the unfolded protein response (UPR) and the endoplasmic reticulum-associated protein degradation (ERAD), was largely prevented in water-transferred yeast, as the activities of these proteostatic network pathways remained nearly as robust as in young yeast. The characteristics of young yeast that are actively maintained upon water-transfer indicate that the extended lifespan is the outcome of slowing the rate of the aging process.	[Cohen, Aviv; Weindling, Esther; Rabinovich, Efrat; Nachman, Iftach; Bar-Nun, Shoshana] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Fuchs, Shai; Chuartzman, Silvia; Gal, Lihi; Schuldiner, Maya] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Tel Aviv University; Weizmann Institute of Science	Bar-Nun, S (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	shoshbn@tauex.tau.ac.il	Schuldiner, Maya/C-9488-2009; Nachman, Iftach/AAK-2051-2020; Nachman, Iftach/E-6750-2010	Schuldiner, Maya/0000-0001-9947-115X; Nachman, Iftach/0000-0002-4667-0398	Chief Scientist Office of the Ministry of Health, Israel [3-3211]; Israel Science Foundation [394/11]	Chief Scientist Office of the Ministry of Health, Israel; Israel Science Foundation(Israel Science Foundation)	Initial stages of this study were supported by a grant from the Chief Scientist Office of the Ministry of Health, Israel (grant no. 3-3211 to SB) and later by a grant from The Israel Science Foundation (grant no. 394/11 to SB).	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Aris JP, 2013, EXP GERONTOL, V48, P1107, DOI 10.1016/j.exger.2013.01.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bosis E, 2010, GENETICS, V184, P695, DOI 10.1534/genetics.109.111419; Brandes N, 2013, ELIFE, V2, DOI 10.7554/eLife.00306; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Breker M, 2013, J CELL BIOL, V200, P839, DOI 10.1083/jcb.201301120; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cohen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044785; Cohen Y, 2011, METHODS MOL BIOL, V781, P127, DOI 10.1007/978-1-61779-276-2_8; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; GRANOT D, 1993, YEAST, V9, P465, DOI 10.1002/yea.320090503; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jung PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119807; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kamei Y, 2014, J BIOL CHEM, V289, P32081, DOI 10.1074/jbc.M114.600528; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Ljubuncic P, 2009, GERONTOLOGY, V55, P205, DOI 10.1159/000200772; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mei SC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002048; Miller J. J., 1989, YEASTS, P489; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nussbaum I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111505; Ocampo A, 2011, MECH AGEING DEV, V132, P315, DOI 10.1016/j.mad.2011.06.007; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Richardson A, 1981, RELATIONSHIP AGING P; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Tollefsbol Trygve O, 2007, Methods Mol Biol, V371, P1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Weindling E, 2015, BIOCHEM BIOPH RES CO, V457, P473, DOI 10.1016/j.bbrc.2015.01.021; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639	48	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148650	10.1371/journal.pone.0148650	http://dx.doi.org/10.1371/journal.pone.0148650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862897	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600089
J	Henriquez, RA; Chica, AB; Billeke, P; Bartolomeo, P				Henriquez, Rodrigo A.; Chica, Ana B.; Billeke, Pablo; Bartolomeo, Paolo			Fluctuating Minds: Spontaneous Psychophysical Variability during Mind-Wandering	PLOS ONE			English	Article							TASK-UNRELATED THOUGHT; DEFAULT NETWORK; ATTENTION; BRAIN; EXPERIENCE	Mind-wandering is the occasional distraction we experience while performing a cognitive task. It arises without any external precedent, varies over time, and interferes with the processing of sensory information. Here, we asked whether the transition from the on-task state to mind-wandering is a gradual process or an abrupt event. We developed a new experimental approach, based on the continuous, online assessment of individual psychophysical performance. Probe questions were asked whenever response times (RTs) exceeded 2 standard deviations from the participant's average RT. Results showed that mind-wandering reports were generally preceded by slower RTs, as compared to trials preceding on-task reports. Mind-wandering episodes could be reliably predicted from the response time difference between the last and the second-to-last trials. Thus, mind-wandering reports follow an abrupt increase in behavioral variability, lasting between 2.5 and 10 seconds.	[Henriquez, Rodrigo A.; Bartolomeo, Paolo] Univ Paris 06, INSERM, U1127, F-75013 Paris, France; [Henriquez, Rodrigo A.; Bartolomeo, Paolo] Univ Paris 06, Sorbonne Univ, UMR S 1127, F-75013 Paris, France; [Henriquez, Rodrigo A.; Bartolomeo, Paolo] CNRS, UMR 7225, F-75013 Paris, France; [Henriquez, Rodrigo A.; Bartolomeo, Paolo] Inst Cerveau & Moelle Epiniere, ICM, F-75013 Paris, France; [Chica, Ana B.] Univ Granada, Dept Expt Psychol, Granada, Spain; [Chica, Ana B.] Univ Granada, Brain Mind & Behav Res Ctr, Granada, Spain; [Billeke, Pablo] Univ Desarrollo, Fac Govt, Res Ctr Social Complex, Santiago, Chile; [Bartolomeo, Paolo] Catholic Univ Milan, Dept Psychol, Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Granada; University of Granada; Universidad del Desarrollo; Catholic University of the Sacred Heart	Henriquez, RA (corresponding author), Univ Paris 06, INSERM, U1127, F-75013 Paris, France.; Henriquez, RA (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S 1127, F-75013 Paris, France.; Henriquez, RA (corresponding author), CNRS, UMR 7225, F-75013 Paris, France.; Henriquez, RA (corresponding author), Inst Cerveau & Moelle Epiniere, ICM, F-75013 Paris, France.	rhenriquezch@gmail.com	Henríquez, Rodrigo A./AAM-9515-2021; Bartolomeo, Paolo/B-3046-2009; Chica, Ana B./AAC-1677-2021; Billeke, Pablo/D-5311-2011	Henríquez, Rodrigo A./0000-0002-4970-8013; Bartolomeo, Paolo/0000-0002-2640-6426; Chica, Ana B./0000-0001-5804-1591; Billeke, Pablo/0000-0003-4261-0678	National Commission for Scientific and Technological Research - CONICYT, Chile [72120217]; Ramon y Cajal fellowship from Spanish Ministry of Education and Science [RYC-2011-09320]; program "Investissements d'Avenir" [ANR-10-IAIHU-06];  [PSI2011-22416];  [PSI2014-58681-P]	National Commission for Scientific and Technological Research - CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Ramon y Cajal fellowship from Spanish Ministry of Education and Science(German Research Foundation (DFG)); program "Investissements d'Avenir"(French National Research Agency (ANR)); ; 	This work was supported by a doctoral fellowship from the National Commission for Scientific and Technological Research - CONICYT 72120217, Chile to R.A.H, and A.B.C was supported by a Ramon y Cajal fellowship from the Spanish Ministry of Education and Science, RYC-2011-09320. This research was funded by research projects PSI2011-22416 and PSI2014-58681-P to A.B.C. This research also has received funding from the program "Investissements d'Avenir" ANR-10-IAIHU-06.	Axelrod V, 2015, P NATL ACAD SCI USA; Bastian M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00573; Braboszcz C, 2011, NEUROIMAGE, V54, P3040, DOI 10.1016/j.neuroimage.2010.10.008; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; GIAMBRA LM, 1989, PSYCHOL AGING, V4, P136, DOI 10.1037/0882-7974.4.2.136; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Le Van Quyen M, 2011, NEW IDEAS PSYCHOL, V29, P57, DOI 10.1016/j.newideapsych.2010.11.001; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Morin A., 2009, ENCY CONSCIOUSNESS, P389; Rastelli F, 2013, CORTEX, V49, P1989, DOI 10.1016/j.cortex.2013.04.001; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Seli P, 2013, FRONT PSYCHOL, V4, P1, DOI DOI 10.3389/FPSYG.2013; Seli P, 2013, J EXP PSYCHOL HUMAN, V39, P1, DOI 10.1037/a0030954; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2008, BRAIN COGNITION, V66, P50, DOI 10.1016/j.bandc.2007.05.004; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	28	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147174	10.1371/journal.pone.0147174	http://dx.doi.org/10.1371/journal.pone.0147174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863144	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600019
J	Reiter, T; Jagoda, E; Capellini, TD				Reiter, Taylor; Jagoda, Evelyn; Capellini, Terence D.			Dietary Variation and Evolution of Gene Copy Number among Dog Breeds	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; HUNTER-GATHERERS; REFSUM-DISEASE; PHYTANIC ACID; AMYLASE GENE; DOMESTICATION; DNA; SELECTION; ORIGINS; SITE	Prolonged human interactions and artificial selection have influenced the genotypic and phenotypic diversity among dog breeds. Because humans and dogs occupy diverse habitats, ecological contexts have likely contributed to breed-specific positive selection. Prior to the advent of modern dog-feeding practices, there was likely substantial variation in dietary landscapes among disparate dog breeds. As such, we investigated one type of genetic variant, copy number variation, in three metabolic genes: glucokinase regulatory protein (GCKR), phytanol-CoA 2-hydroxylase (PHYH), and pancreatic alpha-amylase 2B (AMY2B). These genes code for proteins that are responsible for metabolizing dietary products that originate from distinctly different food types: sugar, meat, and starch, respectively. After surveying copy number variation among dogs with diverse dietary histories, we found no correlation between diet and positive selection in either GCKR or PHYH. Although it has been previously demonstrated that dogs experienced a copy number increase in AMY2B relative to wolves during or after the dog domestication process, we demonstrate that positive selection continued to act on amylase copy number in dog breeds that consumed starch-rich diets in time periods after domestication. Furthermore, we found that introgression with wolves is not responsible for deterioration of positive selection on AMY2B among diverse dog breeds. Together, this supports the hypothesis that the amylase copy number expansion is found universally in dogs.	[Reiter, Taylor; Jagoda, Evelyn; Capellini, Terence D.] Harvard Univ, Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA	Harvard University	Capellini, TD (corresponding author), Harvard Univ, Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA.	tcapellini@fas.harvard.edu		Reiter, Taylor/0000-0002-7388-421X	Global Health and Health Policy Secondary Field, Harvard University; Cordiero Fellowship; Museum of Comparative Zoology, Harvard University; Grants-in-Aid for Scientific Research [26450433] Funding Source: KAKEN	Global Health and Health Policy Secondary Field, Harvard University; Cordiero Fellowship; Museum of Comparative Zoology, Harvard University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Global Health and Health Policy Secondary Field, Harvard University (TR), fellowship name: Cordiero Fellowship, http://ghhp.fas.harvard.edu/cordeiro-summer-research-fellowship; and Museum of Comparative Zoology, Harvard University (TR), grant name: Grants-in-aid of undergraduate research, http://www.mcz.harvard.edu/grants_and_funding/gur.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Arendt M, 2014, ANIM GENET, V45, P716, DOI 10.1111/age.12179; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bogoras W, 1901, AM ANTHROPOL, V3, P80, DOI 10.1525/aa.1901.3.1.02a00060; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Choy K, 2010, ARCHAEOL ANTHROP SCI, V2, P1, DOI 10.1007/s12520-010-0022-3; Clutton-Brock Juliet, 1995, P7; Coppinger L, 2001, DOGS A NEW UNDERSTAN; Croes K, 1996, EUR J BIOCHEM, V240, P674, DOI 10.1111/j.1432-1033.1996.0674h.x; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Esaka T, 1970, ARCHAEOL J, V40, P6; Feltovich N., 2003, Experimental Economics, V6, P273, DOI 10.1023/A:1026273319211; FLIGNER MA, 1976, J AM STAT ASSOC, V71, P210, DOI 10.2307/2285771; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; HABU J., 2004, ANCIENT JOMON JAPAN; Harrison JA, 1960, AINU NO JAPAN STUDY; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; HORII A, 1987, GENE, V60, P57; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; Kil DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012882; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Li Y, 2014, MOL BIOL EVOL, V31, P1200, DOI 10.1093/molbev/msu070; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Losey RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063740; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; Murdock GP, 2008, ONLINE CULTURAL MAT; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Okumura N, 1999, ANTHROPOL SCI, V107, P213, DOI 10.1537/ase.107.213; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pechenkina EA, 2005, J ARCHAEOL SCI, V32, P1176, DOI 10.1016/j.jas.2005.02.015; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Porsild AE, 1953, EDIBLE PLANTS ARCTIC, V1953, P6; Schluter A, 2002, BIOCHEM J, V362, P61, DOI 10.1042/0264-6021:3620061; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Strohle A, 2011, NUTR RES, V31, P429, DOI 10.1016/j.nutres.2011.05.003; Tsutaya T, 2014, ANTHROPOL SCI, V122, P89, DOI 10.1537/ase.140604; Usher CL, 2015, NAT GENET, V47, P921, DOI 10.1038/ng.3340; van den Brink DM, 2006, CELL MOL LIFE SCI, V63, P1752, DOI 10.1007/s00018-005-5463-y; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Weng Q., 2000, GeoJournal, V51, P191, DOI 10.1023/A:1012021520392; Wong AK, 2010, GENETICS, V184, P595, DOI 10.1534/genetics.109.106831; Yang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063148; Yang XY, 2009, SCI CHINA SER D, V52, P1164, DOI 10.1007/s11430-009-0089-9	54	21	21	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148899	10.1371/journal.pone.0148899	http://dx.doi.org/10.1371/journal.pone.0148899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863414	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600121
J	Kyrkjeeide, MO; Hassel, K; Flatberg, KI; Shaw, AJ; Yousefi, N; Stenoien, HK				Kyrkjeeide, Magni Olsen; Hassel, Kristian; Flatberg, Kjell Ivar; Shaw, A. Jonathan; Yousefi, Narjes; Stenoien, Hans K.			Spatial Genetic Structure of the Abundant and Widespread Peatmoss Sphagnum magellanicum Brid.	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; TIERRA-DEL-FUEGO; POPULATION-STRUCTURE; DIVERSITY; DIVERGENCE; INFERENCE; ALLOPOLYPLOIDY; BIOGEOGRAPHY; DISJUNCTIONS; BRYOPHYTES	Spore-producing organisms have small dispersal units enabling them to become widespread across continents. However, barriers to gene flow and cryptic speciation may exist. The common, haploid peatmoss Sphagnum magellanicum occurs in both the Northern and Southern hemisphere, and is commonly used as a model in studies of peatland ecology and peatmoss physiology. Even though it will likely act as a rich source in functional genomics studies in years to come, surprisingly little is known about levels of genetic variability and structuring in this species. Here, we assess for the first time how genetic variation in S. magellanicum is spatially structured across its full distribution range (Northern Hemisphere and South America). The morphologically similar species S. alaskense was included for comparison. In total, 195 plants were genotyped at 15 microsatellite loci. Sequences from two plastid loci (trnG and trnL) were obtained from 30 samples. Our results show that S. alaskense and almost all plants of S. magellanicum in the northern Pacific area are diploids and share the same gene pool. Haploid plants occur in South America, Europe, eastern North America, western North America, and southern Asia, and five genetically differentiated groups with different distribution ranges were found. Our results indicate that S. magellanicum consists of several distinct genetic groups, seemingly with little or no gene flow among them. Noteworthy, the geographical separation of diploids and haploids is strikingly similar to patterns found within other haploid Sphagnum species spanning the Northern Hemisphere. Our results confirm a genetic division between the Beringian and the Atlantic that seems to be a general pattern in Sphagnum taxa. The pattern of strong genetic population structuring throughout the distribution range of morphologically similar plants need to be considered in future functional genomic studies of S. magellanicum.	[Kyrkjeeide, Magni Olsen; Hassel, Kristian; Flatberg, Kjell Ivar; Yousefi, Narjes] Norwegian Univ Sci & Technol, NTNU Univ Museum, NO-7491 Trondheim, Norway; [Kyrkjeeide, Magni Olsen] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Shaw, A. Jonathan] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Stenoien, Hans K.] Norwegian Univ Sci & Technol, NTNU Univ Museum, Ctr Biodivers Dynam, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research; Duke University; Norwegian University of Science & Technology (NTNU)	Stenoien, HK (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Ctr Biodivers Dynam, NO-7491 Trondheim, Norway.	stenoien@ntnu.no	Hassel, Kristian/AAD-7241-2022	Hassel, Kristian/0000-0002-1906-8166	NTNU University Museum	NTNU University Museum	The funding source of this work has been NTNU University Museum. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L. E., 2009, PEAT MOSSES SE US; Andrus RE, 2003, BRYOLOGIST, V106, P435, DOI 10.1639/08; [Anonymous], 2008, BRYOPHYTE BIOL, DOI [10.1017/CBO9780511754807.010, DOI 10.1017/CBO9780511754807.010., DOI 10.1017/CBO9780511754807.010]; Bridel SE, 1798, MUSCOLOGIA RECENTIOR; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Buschbom J, 2007, MOL ECOL, V16, P1835, DOI 10.1111/j.1365-294X.2007.03258.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cuesta F, 2012, IMCG NEWSLETTER, P4; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Donoghue MJ, 2011, P NATL ACAD SCI USA, V108, P6341, DOI 10.1073/pnas.1103801108; Eddy A., 1985, B BRIT MUS NAT HIST, V12, P77; Eidesen PB, 2013, NEW PHYTOL, V200, P898, DOI 10.1111/nph.12412; Escudero M, 2010, FLORA, V205, P118, DOI 10.1016/j.flora.2009.01.005; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandez-Mendoza F, 2013, MOL ECOL, V22, P1961, DOI 10.1111/mec.12210; Flatberg K. I., 2013, NORGES TORVMOSER; Flatberg K. I., 2008, LINDBERGIA, V33, P2; Frahm JP, 2008, BIODIVERS CONSERV, V17, P277, DOI 10.1007/s10531-007-9251-x; FRAHM JP, 1993, NOVA HEDWIGIA, V56, P307; Geml J, 2010, J BIOGEOGR, V37, P1529, DOI 10.1111/j.1365-2699.2010.02287.x; Grootjans A, 2014, MIRES PEAT, V14; Grootjans A, 2010, MIRES PEAT, V6; Hajek T, 2014, ADV PHOTOSYNTH RESP, V37, P233, DOI 10.1007/978-94-007-6988-5_13; Hanssen L, 2000, BRYOLOGIST, V103, P93, DOI 10.1639/0007-2745(2000)103[0093:PSATOS]2.0.CO;2; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karlin EF, 2011, MOL ECOL, V20, P753, DOI 10.1111/j.1365-294X.2010.04982.x; Karlin EF, 2012, NEW PHYTOL, V193, P1088, DOI 10.1111/j.1469-8137.2011.03999.x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kyrkjeeide MO, 2015, THESIS; Kyrkjeeide MO, J BRYOLOGY IN PRESS; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Lewis Lily R, 2014, PeerJ, V2, pe424, DOI 10.7717/peerj.424; Lewis LR, 2014, J BIOGEOGR, V41, P2385, DOI 10.1111/jbi.12385; Lucking R, 2003, LICHENOLOGIST, V35, P33, DOI 10.1006/lich.2002.0430; [Максимов А.И. Maksimov Anatoly I.], 2008, [Arctoa, Arctoa], V17, P109; McQueen C. B., 1997, Tropical Bryology, P65; McQueen C. B., 2007, FLORA N AM N MEXICO, V27, P45; MCQUEEN CB, 1991, BRYOLOGIST, V94, P39, DOI 10.2307/3243715; McQueen CB, 1995, TROP BRYOL, V11, P119; Medina NG., 2011, BIOGEOGRAPHY MICROSC, P209, DOI [10.1017/CBO9780511974878.012, DOI 10.1017/CBO9780511974878.012]; Ochyra R, 2003, BRYOLOGIST, V106, P532, DOI 10.1639/0007-2745(2003)106[532:AFNTTD]2.0.CO;2; Pante E, 2015, MOL ECOL, V24, P525, DOI 10.1111/mec.13048; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PENTECOST A, 1981, NEW PHYTOL, V89, P667, DOI 10.1111/j.1469-8137.1981.tb02345.x; Pineiro R, 2012, J BIOGEOGR, V39, P2041, DOI 10.1111/j.1365-2699.2012.02765.x; Popp M, 2011, P NATL ACAD SCI USA, V108, P6520, DOI 10.1073/pnas.1012249108; Printzen C, 2008, PLANT ECOL DIVERS, V1, P265, DOI 10.1080/17550870802328702; Pritchard JK, 2000, GENETICS, V155, P945; Proches S, 2013, J BIOGEOGR, V40, P1819, DOI 10.1111/jbi.12125; R Core Team, 2021, R LANGUAGE ENV STAT; Ramaiya M, 2010, AM J BOT, V97, P1707, DOI 10.3732/ajb.1000171; Ricca M, 2008, AM J BOT, V95, P1606, DOI 10.3732/ajb.0800148; Ricca M, 2010, BIOL J LINN SOC, V99, P135; Rydin H, 2013, BIO HABIT, P65; SCHOFIELD WB, 1988, BOT J LINN SOC, V98, P211, DOI 10.1111/j.1095-8339.1988.tb02425.x; Shaw AJ, 2008, MOL PHYLOGENET EVOL, V49, P304, DOI 10.1016/j.ympev.2008.06.009; Shaw AJ, 2008, BRYOLOGIST, V111, P271, DOI 10.1639/0007-2745(2008)111[271:GVITCP]2.0.CO;2; Shaw AJ, 2014, BIOL J LINN SOC, V111, P17, DOI 10.1111/bij.12200; Shaw AJ, 2010, MOL PHYLOGENET EVOL, V55, P1139, DOI 10.1016/j.ympev.2010.01.020; Shaw AJ, 2001, J BIOGEOGR, V28, P253; Shaw AJ, 2003, AM J BOT, V90, P1777, DOI 10.3732/ajb.90.12.1777; Shepherd LD, 2009, J BIOGEOGR, V36, P1972, DOI 10.1111/j.1365-2699.2009.02120.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stech M, 2011, TAXON, V60, P79, DOI 10.1002/tax.601007; Stenoien HK, 2011, HEREDITY, V106, P370, DOI 10.1038/hdy.2010.96; Stenoien HK, 2014, BRYOLOGIST, V117, P95, DOI 10.1639/0007-2745-117.2.095; Stenoien HK, 2011, EVOLUTION, V65, P1181, DOI 10.1111/j.1558-5646.2010.01191.x; Sundberg S, 2002, J ECOL, V90, P268, DOI 10.1046/j.1365-2745.2001.00653.x; Szovenyi P, 2008, MOL ECOL, V17, P5364, DOI 10.1111/j.1365-294X.2008.04003.x; Szweykowski J, 2005, PLANT SYST EVOL, V253, P133, DOI 10.1007/s00606-005-0301-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Temsch EM, 1998, BOT ACTA, V111, P325, DOI 10.1111/j.1438-8677.1998.tb00716.x; Thingsgaard K, 2001, HEREDITY, V87, P485, DOI 10.1046/j.1365-2540.2001.00939.x; Villarreal JC, 2014, MOL PHYLOGENET EVOL, V78, P25, DOI 10.1016/j.ympev.2014.04.014; Villaverde T, 2015, J BIOGEOGR, V42, P1514, DOI 10.1111/jbi.12521; Wang JY, 2008, HEREDITY, V101, P145, DOI 10.1038/hdy.2008.40; Werth S., 2011, BIOGEOGRAPHY MICROSC, P191, DOI [DOI 10.1017/CBO9780511974878.011, 10.1017/CBO9780511974878.011]; Wolfe J, 1992, TROPICAL BRYOLOGY, V5, P73; Xiang JY, 2015, J SYST EVOL, V53, P2, DOI 10.1111/jse.12141	85	28	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148447	10.1371/journal.pone.0148447	http://dx.doi.org/10.1371/journal.pone.0148447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859563	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400042
J	Wotschofsky, Z; Gummlich, L; Liep, J; Stephan, C; Kilic, E; Jung, K; Billaud, JN; Meyer, HA				Wotschofsky, Zofia; Gummlich, Linda; Liep, Julia; Stephan, Carsten; Kilic, Ergin; Jung, Klaus; Billaud, Jean-Noel; Meyer, Hellmuth-Alexander			Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CLINICAL-SIGNIFICANCE; TUMOR-SUPPRESSOR; PROSTATE-CANCER; REFERENCE GENES; UP-REGULATION; EXPRESSION; UHRF1; IDENTIFICATION	Background MicroRNAs (miRNAs) regulate gene expression by interfering translation or stability of target transcripts. This interplay between miRNA and their mRNA has been proposed as an important process in cancer development and progression. We have investigated molecular networks impacted by predicted mRNA targets of differentially expressed miRNAs in patients with clear cell renal cell carcinoma (ccRCC) diagnosed with or without metastasis. Material and Methods miRNA and mRNA microarray expression profiles derived from primary ccRCC from patients with (16 samples) or without diagnosed metastasis (22 samples) were used to identify anti-correlated miRNA-mRNA interaction in ccRCC. For this purpose, Ingenuity pathway analysis microRNA Target Filter, which enables prioritization of experimentally validated and predicted mRNA targets was used. By applying an expression pairing tool, the analysis was focused on targets exhibiting altered expression in our analysis, finding miRNAs and their target genes with opposite or same expression. The resulting identified interactions were revalidated by RT-qPCR in another cohort of ccRCC patients. A selection of the predicted miRNA-mRNA interactions was tested by functional analyses using miRNA knockdown and overexpression experiments in renal cancer cell lines. Results Among the significantly differentially expressed miRNAs, we have identified three miRNAs (miR-146a-5p, miR-128a-3p, and miR-17-5p) that were upregulated in primary tumors from patients without metastasis and downregulated in primary tumors from patients with metastasis. We have further identified mRNA targets, which expression were inversely correlated to these 3 miRNAs, and have been previously experimentally demonstrated in cancer setting in humans. Specifically, we showed that CXCL8/IL8, UHRF1, MCM10, and CDKN3 were downregulated and targeted by miR-146a-5p. The interaction between miR-146a-5p and their targets CXCL8 and UHRF1 was validated in cell culture experiments. Conclusions We identified novel target genes of dysregulated miRNAs, which are involved in the transition from primary RCC without metastases into tumors generating distant metastasis.	[Wotschofsky, Zofia; Liep, Julia; Stephan, Carsten; Jung, Klaus; Meyer, Hellmuth-Alexander] Charite, Dept Urol, D-13353 Berlin, Germany; [Wotschofsky, Zofia; Gummlich, Linda; Liep, Julia; Stephan, Carsten; Jung, Klaus] Berlin Inst Urol Res, Berlin, Germany; [Gummlich, Linda] Charite, Dept Gen Visceral Vasc & Thorac Surg, Div Mol Biol, D-13353 Berlin, Germany; [Kilic, Ergin] Charite, Inst Pathol, D-13353 Berlin, Germany; [Billaud, Jean-Noel] QIAGEN, 1700 Seaport Blvd, Redwood City, CA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meyer, HA (corresponding author), Charite, Dept Urol, D-13353 Berlin, Germany.; Billaud, JN (corresponding author), QIAGEN, 1700 Seaport Blvd, Redwood City, CA USA.	jean-noel.billaud@qiagen.com; hellmuth.meyer@web.de	Jung, Klaus/Z-2122-2018	Jung, Klaus/0000-0001-9797-5362; Stephan, Carsten/0000-0002-3270-258X	Foundation Urologic Research, Berlin, Germany; QIAGEN	Foundation Urologic Research, Berlin, Germany; QIAGEN	This work was supported by fellowships from the Foundation Urologic Research, Berlin, Germany for Julia Liep (JL) and Linda Gummlich (LG) as part of their doctoral thesis. The sponsor had no involvement in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication. QIAGEN provided support in the form of salaries (JNB) for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Andel M, 2015, METHODS, V83, P88, DOI 10.1016/j.ymeth.2015.04.006; Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Bronner C, 2013, BIOCHEM PHARMACOL, V86, P1643, DOI 10.1016/j.bcp.2013.10.002; Busch J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0180-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butz H, 2014, CLIN CHEM, V60, P1314, DOI 10.1373/clinchem.2014.225854; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cui L, 2015, MOL CELL BIOCHEM, V400, P223, DOI 10.1007/s11010-014-2279-9; Das M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069607; De Mulder PHM, 2007, EUR UROL SUPPL, V6, P665, DOI 10.1016/j.eursup.2007.03.010; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Ficarra V, 2007, EUR UROL SUPPL, V6, P623, DOI 10.1016/j.eursup.2007.03.008; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gales Dominique, 2013, ISRN Oncol, V2013, P859154, DOI 10.1155/2013/859154; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Gowrishankar B, 2014, CANCER BIOL THER, V15, P329, DOI 10.4161/cbt.27314; Ha E, 2010, MOL MED REP, V3, P275, DOI 10.3892/mmr_00000251; Heinzelmann J, 2014, ANN SURG ONCOL, V21, P1046, DOI 10.1245/s10434-013-3361-3; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Howlader N., 2017, SEER CANC STAT REV 1; Huang PX, 2014, J CELL MOL MED, V18, P218, DOI 10.1111/jcmm.12153; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Khella HWZ, 2012, TUMOR BIOL, V33, P131, DOI 10.1007/s13277-011-0255-5; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; Li HL, 2014, INT J ONCOL, V45, P197, DOI 10.3892/ijo.2014.2415; Li M, 2015, ONCOL REP, V33, P1571, DOI 10.3892/or.2015.3799; Li TR, 2014, ONCOL REP, V31, P1825, DOI 10.3892/or.2014.3045; Li W, 2013, KIDNEY BLOOD PRESS R, V37, P506, DOI 10.1159/000355726; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Li XL, 2012, ONCOL REP, V28, P375, DOI 10.3892/or.2012.1792; Lin F, 2012, CANCER CHEMOTH PHARM, V69, P1079, DOI 10.1007/s00280-011-1801-y; Ljungberg B., 2015, GUIDELINES RENAL CEL; M'hamed IF, 2015, CELL ONCOL, V38, P433, DOI 10.1007/s13402-015-0239-3; Ma J, 2015, BIOCHEM BIOPH RES CO, V464, P147, DOI 10.1016/j.bbrc.2015.06.104; Meyer HA, 2009, EUR UROL, V55, P669, DOI 10.1016/j.eururo.2008.04.001; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Rabien A, 2007, EUR UROL, V51, P1259, DOI 10.1016/j.eururo.2006.05.050; Sanmamed MF, 2014, CLIN CANCER RES, V20, P5697, DOI 10.1158/1078-0432.CCR-13-3203; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slaby O, 2012, GENE CHROMOSOME CANC, V51, P707, DOI 10.1002/gcc.21957; Sobin LH, 2002, TNM CLASSIFICATION M, P193; Sun M, 2015, CANCER BIOMARK, V15, P33, DOI 10.3233/CBM-140431; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Tang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10272; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Van Poppel H, 2007, EUR UROL, V51, P1606, DOI 10.1016/j.eururo.2006.11.013; Wang RJ, 2015, INT J CLIN EXP PATHO, V8, P765; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Warnecke-Eberz U, 2015, TUMOR BIOL, V36, P4643, DOI 10.1007/s13277-015-3112-0; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wotschofsky Z, 2013, CLIN CHIM ACTA, V416, P5, DOI 10.1016/j.cca.2012.11.010; Wotschofsky Z, 2012, INT J BIOL SCI, V8, P1363, DOI 10.7150/ijbs.5106; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Xing CY, 2012, BIOCHEM BIOPH RES CO, V420, P29, DOI 10.1016/j.bbrc.2012.02.107; Xu CF, 2015, BRIT J CANCER, V112, P1190, DOI 10.1038/bjc.2015.64; Yang Cheng, 2015, Asian Pac J Cancer Prev, V16, P965; Yang CR, 2013, MOL BIOL REP, V40, P5225, DOI 10.1007/s11033-013-2559-6; Yeh CT, 2003, BIOCHEM BIOPH RES CO, V305, P311, DOI 10.1016/S0006-291X(03)00757-5; Yoo KH, 2013, ONCOL LETT, V5, P39, DOI 10.3892/ol.2012.992; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhou L, 2013, FASEB J, V27, P4929, DOI 10.1096/fj.13-233387	82	70	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148746	10.1371/journal.pone.0148746	http://dx.doi.org/10.1371/journal.pone.0148746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859141	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400074
J	Li, J; Ge, X; Wang, XN; Liu, X; Ma, JM				Li, Jing; Ge, Xin; Wang, Xiaona; Liu, Xiao; Ma, Jianmin			Complement System in the Pathogenesis of Benign Lymphoepithelial Lesions of the Lacrimal Gland	PLOS ONE			English	Article							AUTOIMMUNE PANCREATITIS; IGG4-RELATED DISEASE; ACTIVATION	Objective We aimed to examine the potential involvement of local complement system gene expression in the pathogenesis of benign lymphoepithelial lesions (BLEL) of the lacrimal gland. Methods We collected data from 9 consecutive pathologically confirmed patients with BLEL of the lacrimal gland and 9 cases with orbital cavernous hemangioma as a control group, and adopted whole genome microarray to screen complement system-related differential genes, followed by RT-PCR verification and in-depth enrichment analysis (Gene Ontology analysis) of the gene sets. Results The expression of 14 complement system-related genes in the pathologic tissue, including C2, C3, ITGB2, CR2, C1QB, CR1, ITGAX, CFP, C1QA, C4B vertical bar C4A, FANCA, C1QC, C3AR1 and CFHR4, were significantly upregulated while 7 other complement system-related genes, C5, CFI, CFHR1 vertical bar CFH, CFH, CD55, CR1L and CFD were significantly downregulated in the lacrimal glands of BLEL patients. The microarray results were consistent with RT-PCR analysis results. Immunohistochemistry analysis of C3c and C1q complement component proteins in the resected tissue were positive in BLEL patients, while the control group had negative expression of these proteins. Gene ontology (GO) analysis revealed that activation of the genes of complement system-mediated signaling pathways were the most enriched differential gene group in BLEL patients. Conclusions Local expression of complement components is prominently abnormal in BLEL, and may well play a role in its pathogenesis.	[Li, Jing; Ge, Xin; Wang, Xiaona; Liu, Xiao; Ma, Jianmin] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Li, Jing; Wang, Xiaona] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Ma, JM (corresponding author), Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	jmma@sina.com		Li, Jing/0000-0001-9392-6600	National Natural Science Foundation of China [81371052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by National Natural Science Foundation of China (grant number: 81371052; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abud-Mendoza C, 2013, REUMATOL CLIN, V9, P133, DOI [10.1016/j.reumae.2013.02.002, 10.1016/j.reuma.2013.02.003]; Bora NS, 2008, SEMIN IMMUNOPATHOL, V30, P85, DOI 10.1007/s00281-008-0110-y; Cornell LD, 2007, AM J SURG PATHOL, V31, P1586, DOI 10.1097/PAS.0b013e318059b87c; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; Divatia M, 2012, YONSEI MED J, V53, P15, DOI 10.3349/ymj.2012.53.1.15; Jeon H, 2014, J IMMUNOL METHODS, V415, P57, DOI 10.1016/j.jim.2014.09.002; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Ma JM, 2015, CHINESE MED J-PEKING, V128, P493, DOI 10.4103/0366-6999.151102; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Muraki T, 2006, PANCREAS, V32, P16, DOI 10.1097/01.mpa.0000188308.75043.e4; Osthoff M, 2014, MOL VIS, V20, P38; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; WANG J, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/748435; Yang MM, 2012, INVEST OPHTH VIS SCI, V53, P4969, DOI 10.1167/iovs.12-9478; Yu WK, 2015, JPN J OPHTHALMOL, V59, P8, DOI 10.1007/s10384-014-0353-1	15	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148290	10.1371/journal.pone.0148290	http://dx.doi.org/10.1371/journal.pone.0148290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849056	Green Published, gold			2022-12-26	WOS:000369554000066
J	Zhao, WJ; Pan, JM; Li, HP; Huang, YJ; Liu, F; Tao, MF; Jia, WP				Zhao, Weijing; Pan, Jiemin; Li, Huaping; Huang, Yajuan; Liu, Fang; Tao, Minfang; Jia, Weiping			Relationship between High Serum Cystatin C Levels and the Risk of Gestational Diabetes Mellitus	PLOS ONE			English	Article							INSULIN-RESISTANCE; KIDNEY-FUNCTION; RENAL-FUNCTION; HOMOCYSTEINE; ASSOCIATION; WOMEN; CREATININE; MORTALITY; MARKER; ADULTS	Aims Serum cystatin C (CysC) has recently been shown to be associated with the incidence of type 2 diabetes mellitus (T2DM) and progression to the pre-diabetic state. The aim of this study was to explore the relationship between serum CysC and the risk of gestational diabetes mellitus (GDM) in Chinese pregnant women. Methods This cross-sectional study consisted of 400 pregnant women including111 with GDM and 289 with normal glucose tolerance at 24-28 weeks of gestation. The subjects were further divided into four groups according to the CysC quartiles, and their clinical characteristics were compared. The serum CysC concentration was measured using immunoturbidimetry and the degree of insulin resistance was assessed by the homeostasis model assessment of insulin resistance (HOMA-IR). Results Serum CysC levels were significantly higher in pregnant women with GDM than in the healthy pregnant women[1.0(0.8-1.8) vs 0.7(0.6-1.0), P<0.01). The Spearman's correlation analysis showed that serum CysC was positively associated with HOMA-IR(r = 0.118, P<0.05) and the occurrence of GDM(r = 0.348, P<0.01). The pregnant women were divided into quartiles according to their serum CysC concentrations. Compared to the first quartile, pregnant women in Q2 (OR, 2.441; P = 0.025), Q3 (OR, 3.383; P = 0.001) and Q4 (OR, 5.516; P<0.001) had higher risk of GDM after adjusted for age, BMI, HbA1c and HOMA-IR. Further, with a rise in the serum CysC, there was an increasing trend in the HOMA-IR levels (P<0.05). A binary logistic regression analysis after adjusting for other confounding variables revealed a significant and independent association between serum CysC and GDM [OR = 14.269; 95% confidence interval, 4.977-40.908, P<0.01]. The receiver operating characteristic curve analysis revealed that the optimal cutoff point for serum CysC to indicate GDM was 0.95mg/L. Conclusions Serum CysC is significantly and independently associated with insulin resistance and GDM. It may be a helpful biomarker to identify the risk of GDM in Chinese pregnant women.	[Zhao, Weijing; Pan, Jiemin; Liu, Fang; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Med Ctr Diabet,Shanghai Key Lab Dia, Shanghai Key Clin Ctr Metab Dis,Shanghai Inst Dia, Shanghai 200030, Peoples R China; [Li, Huaping; Huang, Yajuan; Tao, Minfang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, F (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Med Ctr Diabet,Shanghai Key Lab Dia, Shanghai Key Clin Ctr Metab Dis,Shanghai Inst Dia, Shanghai 200030, Peoples R China.; Huang, YJ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	huangyajuan2006@126.com; f-liu@sjtu.edu.cn			National Science Foundation of China [81270397, 81500625]; Specific Program for Public Welfare by National Health and Family Planning Commission [201502011]; Shanghai Science & Technology Pillar Program in the Field of Medicine and Agriculture [15411953100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Program for Public Welfare by National Health and Family Planning Commission; Shanghai Science & Technology Pillar Program in the Field of Medicine and Agriculture	This study was supported by grants from the National Science Foundation of China (81270397 for FL, 81500625 for JP), the Specific Program for Public Welfare supported by the National Health and Family Planning Commission (201502011 for FL and YH) and the Shanghai Science & Technology Pillar Program in the Field of Medicine and Agriculture (15411953100 for FL).	Alanbay I, 2012, GYNECOL ENDOCRINOL, V28, P208, DOI 10.3109/09513590.2011.588756; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Artenisio AC, 1999, DIABETES NUTR METAB, V12, P264; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Chang Y, 2014, DIABETES RES CLIN PR, V106, P236, DOI 10.1016/j.diabres.2014.08.020; Cho NH, 2005, DIABETES CARE, V28, P2750, DOI 10.2337/diacare.28.11.2750; Clark CM, 1997, DIABETES CARE, V20, P867, DOI 10.2337/diacare.20.5.867; Dandana A, 2014, J CLIN LAB ANAL, V28, P191, DOI 10.1002/jcla.21665; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Donahue RP, 2007, DIABETES CARE, V30, P1724, DOI 10.2337/dc07-0040; Emoto M, 2001, DIABETES CARE, V24, P533, DOI 10.2337/diacare.24.3.533; Golbahar J, 2007, DIABETES RES CLIN PR, V76, P1, DOI 10.1016/j.diabres.2006.07.026; He R, 2013, EUR J EPIDEMIOL, V28, P775, DOI 10.1007/s10654-013-9839-2; Hu YY, 2014, EUR J ENDOCRINOL, V171, P641, DOI 10.1530/EJE-14-0381; Idzior-Walus B, 2008, ARCH GYNECOL OBSTET, V278, P309, DOI 10.1007/s00404-008-0571-1; Iyidir OT, 2014, GYNECOL ENDOCRINOL, V30, P640, DOI 10.3109/09513590.2014.922946; Laterza OF, 2002, CLIN CHEM, V48, P699; Lee SH, 2010, METABOLISM, V59, P241, DOI 10.1016/j.metabol.2009.07.019; Li Y, 2013, J BIOL CHEM, V288, P9583, DOI 10.1074/jbc.M112.431627; Liu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066907; Liu H, 2015, J CLIN DIAGN RES, V9, pOC14, DOI 10.7860/JCDR/2015/11585.5475; Medina MA, 2000, EUR J CLIN INVEST, V30, P754; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Muntner P, 2008, AM J MED, V121, P341, DOI 10.1016/j.amjmed.2008.01.003; Nagalla Srinivasa R, 2015, Indian J Endocrinol Metab, V19, P155, DOI 10.4103/2230-8210.140226; Naour N, 2009, OBESITY, V17, P2121, DOI 10.1038/oby.2009.96; Norlund L, 1998, CLIN CHEM LAB MED, V36, P175, DOI 10.1515/CCLM.1998.032; Pucci L, 2007, CLIN CHEM, V53, P480, DOI 10.1373/clinchem.2006.076042; Reutens AT, 2013, NEPHROL DIAL TRANSPL, V28, P1820, DOI 10.1093/ndt/gfs561; Ristiniemi N, 2012, CLIN BIOCHEM, V45, P535, DOI 10.1016/j.clinbiochem.2012.02.012; Roos JF, 2007, CLIN BIOCHEM, V40, P383, DOI 10.1016/j.clinbiochem.2006.10.026; Sabanayagam C, 2013, EUR J EPIDEMIOL, V28, P311, DOI 10.1007/s10654-013-9781-3; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; Servais A, 2008, AM J MED, V121, P426, DOI 10.1016/j.amjmed.2008.01.040; Shankar A, 2011, J CLIN HYPERTENS, V13, P925, DOI 10.1111/j.1751-7176.2011.00548.x; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Sridhar SB, 2014, DIABETES CARE, V37, P1878, DOI 10.2337/dc13-2229; Stehouwer CDA, 1999, KIDNEY INT, V55, P308, DOI 10.1046/j.1523-1755.1999.00256.x; Surendar J, 2010, DIABETES TECHNOL THE, V12, P907, DOI 10.1089/dia.2010.0077; Uruska A, 2014, CLIN BIOCHEM, V47, P1235, DOI 10.1016/j.clinbiochem.2014.06.014; van Leeuwen M, 2010, BJOG-INT J OBSTET GY, V117, P69, DOI 10.1111/j.1471-0528.2009.02425.x; Xie Q, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-108; Yousefzadeh G, 2014, DIABETES METAB SYND, V8, P33, DOI 10.1016/j.dsx.2013.10.016; Yu X, 2009, ACTA BIOCH BIOPH SIN, V41, P1027, DOI 10.1093/abbs/gmp097	45	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147277	10.1371/journal.pone.0147277	http://dx.doi.org/10.1371/journal.pone.0147277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849560	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000011
J	Mumaw, CL; Levesque, S; McGraw, C; Robertson, S; Lucas, S; Stafflinger, JE; Campen, MJ; Hall, P; Norenberg, JP; Anderson, T; Lund, AK; McDonald, JD; Ottens, AK; Block, ML				Mumaw, Christen L.; Levesque, Shannon; McGraw, Constance; Robertson, Sarah; Lucas, Selita; Stafflinger, Jillian E.; Campen, Matthew J.; Hall, Pamela; Norenberg, Jeffrey P.; Anderson, Tamara; Lund, Amie K.; McDonald, Jacob D.; Ottens, Andrew K.; Block, Michelle L.			Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors	FASEB JOURNAL			English	Article						neuroinflammation; inhaled pollutants; glia	PARTICULATE MATTER; RESIDENTIAL PROXIMITY; PARKINSONS-DISEASE; COGNITIVE FUNCTION; EXPOSURE; NEUROINFLAMMATION; INFLAMMATION; CHILDREN; DEMENTIA; EXHAUST	Air pollution is implicated in neurodegenerative disease risk and progression and in microglial activation, but the mechanisms are unknown. In this study, microglia remained activated 24 h after ozone (O-3) exposure in rats, suggesting a persistent signal from lung to brain. Ex vivo analysis of serum from O-3-treated rats revealed an augmented microglial proinflammatory response and beta-amyloid 42 (A beta 42) neurotoxicity independent of traditional circulating cytokines, where macrophage-1 antigen-mediated microglia proinflammatory priming. Aged mice exhibited reduced pulmonary immune profiles and the most pronounced neuroinflammation and microglial activation in response to mixed vehicle emissions. Consistent with this premise, cluster of differentiation 36 (CD36)(-/-) mice exhibited impaired pulmonary immune responses concurrent with augmented neuroinflammation and microglial activation in response to O-3. Further, aging glia were more sensitive to the proinflammatory effects of O-3 serum. Together, these findings outline the lung-brain axis, where air pollutant exposures result in circulating, cytokine-independent signals present in serum that elevate the brain proinflammatory milieu, which is linked to the pulmonary response and is further augmented with age.-Mumaw, C. L., Levesque, S., McGraw, C., Robertson, S., Lucas, S., Stafflinger, J. E., Campen, M. J., Hall, P., Norenberg, J. P., Anderson, T., Lund, A. K., McDonald, J. D., Ottens, A. K., Block, M. L. Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors. www.fasebj.org	[Mumaw, Christen L.; Block, Michelle L.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Levesque, Shannon; McGraw, Constance; Stafflinger, Jillian E.; Ottens, Andrew K.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Campus, Richmond, VA USA; [Robertson, Sarah; Lucas, Selita; Campen, Matthew J.; Hall, Pamela] Univ New Mexico, Coll Pharm, Keck Univ New Mexico Small Anim Imaging Resource, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Norenberg, Jeffrey P.; Anderson, Tamara] Univ New Mexico, Coll Pharm, Keck Univ New Mexico Small Anim Imaging Resource, Radiopharmaceut Sci, Albuquerque, NM 87131 USA; [Lund, Amie K.] Univ N Texas, Dept Biol Sci, Adv Environm Res Inst, Denton, TX 76203 USA; [McDonald, Jacob D.] Lovelace Resp Res Inst, Albuquerque, NM USA	Indiana University System; Indiana University Bloomington; Virginia Commonwealth University; University of New Mexico; University of New Mexico; University of North Texas System; University of North Texas Denton; Lovelace Respiratory Research Institute	Block, ML (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	mlblock@iupui.edu	Lund, Amie K/L-4355-2017; Norenberg, Jeffrey/AAL-1725-2021; Hall, Pamela/O-5402-2016	Lund, Amie K/0000-0002-0878-751X; Block, Michelle/0000-0001-8303-7914; Ottens, Andrew/0000-0002-2118-3796; McGraw, Constance/0000-0001-5635-0892; Hall, Pamela/0000-0003-2367-3382	U.S. National Institutes of Health/National Institute of Environmental Health Sciences [ES016951, ES014639]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES014639, R01ES016951, R01ES014639] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the U.S. National Institutes of Health/National Institute of Environmental Health Sciences [ES016951 (to M.L.B.) and ES014639 (to M.J.C.)]. The authors declare no conflicts of interest.	Antonini JM, 2009, NEUROTOXICOLOGY, V30, P915, DOI 10.1016/j.neuro.2009.09.006; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Bedada GB, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-77; Bell ML, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-41; Bentayeb M, 2012, INT J TUBERC LUNG D, V16, P1149, DOI 10.5588/ijtld.11.0666; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Calderon-Garciduenas L, 2004, TOXICOL PATHOL, V32, P650, DOI 10.1080/01926230490520232; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/161687; Calderon-Garciduenas L, 2012, J ALZHEIMERS DIS, V28, P93, DOI 10.3233/JAD-2011-110722; Calderon-Garciduenas L, 2011, INT J DEV NEUROSCI, V29, P365, DOI 10.1016/j.ijdevneu.2011.03.007; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Campbell A, 2014, TOXICOL IN VITRO, V28, P1290, DOI 10.1016/j.tiv.2014.06.015; Campbell A, 2009, J NANOSCI NANOTECHNO, V9, P5099, DOI 10.1166/jnn.2009.GR07; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; Chen MH, 2014, J AM MED DIR ASSOC, V15, P763, DOI 10.1016/j.jamda.2014.06.003; Cole MP, 2009, AM J PHYSIOL-LUNG C, V297, pL205, DOI 10.1152/ajplung.00187.2009; Dodd JW, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0116-3; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fiore AM, 2012, CHEM SOC REV, V41, P6663, DOI 10.1039/c2cs35095e; Gerlofs-Nijland ME, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-12; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Jung CR, 2015, J ALZHEIMERS DIS, V44, P573, DOI 10.3233/JAD-140855; Kioumourtzoglou MA, 2016, ENVIRON HEALTH PERSP, V124, P23, DOI 10.1289/ehp.1408973; Kirrane EF, 2015, J OCCUP ENVIRON MED, V57, P509, DOI 10.1097/JOM.0000000000000451; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Liao KM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000930; Liao WC, 2015, EUR J NEUROL, V22, P334, DOI 10.1111/ene.12573; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; Lund AK, 2011, AM J RESP CRIT CARE, V184, P82, DOI 10.1164/rccm.201012-1967OC; Mauderly JL, 2010, INHAL TOXICOL, V22, P1, DOI 10.3109/08958371003793846; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Oppenheim HA, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-62; Paffett ML, 2015, TOXICOL SCI, V146, P244, DOI 10.1093/toxsci/kfv093; Pei Z, 2007, GLIA, V55, P1362, DOI 10.1002/glia.20545; Peng YH, 2015, J EPIDEMIOL COMMUN H, V69, P123, DOI 10.1136/jech-2014-204445; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Poria RB, 2006, CANCER BIOTHER RADIO, V21, P418, DOI 10.1089/cbr.2006.21.418; Postlethwait EM, 1998, AM J PHYSIOL-LUNG C, V274, pL1006, DOI 10.1152/ajplung.1998.274.6.L1006; Power MC, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-16; Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Roberts AL, 2013, ENVIRON HEALTH PERSP, V121, P978, DOI 10.1289/ehp.1206187; Robertson S, 2013, TOXICOL SCI, V134, P304, DOI 10.1093/toxsci/kft107; Rozovsky I, 1998, NEUROBIOL AGING, V19, P97, DOI 10.1016/S0197-4580(97)00169-3; Sama P, 2007, INHAL TOXICOL, V19, P1079, DOI 10.1080/08958370701628721; Santiago-Lopez D, 2010, TOXICOL LETT, V197, P193, DOI 10.1016/j.toxlet.2010.05.020; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Takano T, 2015, DEV NEUROSCI-BASEL, V37, P195, DOI 10.1159/000398791; Thomson EM, 2013, TOXICOL SCI, V135, P169, DOI 10.1093/toxsci/kft137; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; Wellenius GA, 2012, J AM GERIATR SOC, V60, P2075, DOI 10.1111/j.1532-5415.2012.04195.x; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zhou J, 2012, CRIT CARE MED, V40, P2438, DOI 10.1097/CCM.0b013e3182546855	68	93	94	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1880	1891		10.1096/fj.201500047	http://dx.doi.org/10.1096/fj.201500047			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26864854	Green Published			2022-12-26	WOS:000374879400017
J	Corradi, GR; Czysezon, NA; Mazzitelli, LR; Sarbia, N; Adamo, HP				Corradi, Gerardo R.; Czysezon, Nicolas A.; Mazzitelli, Luciana R.; Sarbia, Nicolas; Adamo, Hugo P.			Inhibition of the Formation of the Spf1p Phosphoenzyme by Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; TRANSPORT ATPASES; ATP13A2; CA2&-ATPASE; CALCIUM; PATHWAY; CYCLE; ADP	P5-ATPases are important for processes associated with the endosomal-lysosomal system of eukaryotic cells. In humans, the loss of function of P5-ATPases causes neurodegeneration. In the yeast Saccharomyces cerevisiae, deletion of P5-ATPase Spf1p gives rise to endoplasmic reticulum stress. The reaction cycle of P5-ATPases is poorly characterized. Here, we showed that the formation of the Spf1p catalytic phosphoenzyme was fast in a reaction medium containing ATP, Mg2+, and EGTA. Low concentrations of Ca2+ in the phosphorylation medium decreased the rate of phosphorylation and the maximal level of phosphoenzyme. Neither Mn2+ nor Mg2+ had an inhibitory effect on the formation of the phosphoenzyme similar to that of Ca2+. The K-m for ATP in the phosphorylation reaction was similar to 1 mu M and did not significantly change in the presence of Ca2+. Half-maximal phosphorylation was attained at 8 mu M Mg2+, but higher concentrations partially protected from Ca2+ inhibition. In conditions similar to those used for phosphorylation, Ca2+ had a small effect accelerating dephosphorylation and minimally affected ATPase activity, suggesting that the formation of the phosphoenzyme was not the limiting step of the ATP hydrolytic cycle.	[Corradi, Gerardo R.; Czysezon, Nicolas A.; Mazzitelli, Luciana R.; Sarbia, Nicolas; Adamo, Hugo P.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Adamo, HP (corresponding author), Fac Farm & Bioquim, IQUIFIB, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Adamo, Hugo Pedro/ABB-8338-2021	Adamo, Hugo Pedro/0000-0002-1712-8049; Sarbia, Nicolas/0000-0003-3958-5803; Corradi, Gerardo Raul/0000-0003-0354-7709	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1240]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 1042]; Universidad de Buenos Aires	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by Grant PICT 1240 from Agencia Nacional de Promocion Cientifica y Tecnologica, by Grant PIP 1042 from Consejo Nacional de Investigaciones Cientificas y Tecnologicas, and by a research grant from Universidad de Buenos Aires. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMO HP, 1988, J BIOL CHEM, V263, P17548; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; CARIDE AJ, 1986, BIOCHIM BIOPHYS ACTA, V863, P165, DOI 10.1016/0005-2736(86)90256-7; Cohen Y., 2013, PLOS ONE, V8; Corradi GR, 2012, J BIOL CHEM, V287, P30477, DOI 10.1074/jbc.M112.363465; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Ekberg K, 2010, P NATL ACAD SCI USA, V107, P21400, DOI 10.1073/pnas.1010416107; GARRAHAN PJ, 1978, BIOCHIM BIOPHYS ACTA, V513, P59, DOI 10.1016/0005-2736(78)90111-6; HOBBS AS, 1985, J BIOL CHEM, V260, P2035; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lustoza ACDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027843; MENDLEIN J, 1989, J BIOL CHEM, V264, P18512; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; NAKAMURA Y, 1986, J BIOL CHEM, V261, P3090; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Perrett RM, 2015, MOL CELL NEUROSCI, V66, P21, DOI 10.1016/j.mcn.2015.02.009; Pinto F. de Tezanos, 2011, J LIFE SCI, V5, P1; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sorensen DM, 2015, BBA-GEN SUBJECTS, V1850, P524, DOI 10.1016/j.bbagen.2014.05.008; Sorensen DM, 2012, J BIOL CHEM, V287, P28336, DOI 10.1074/jbc.M112.387191; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Vallipuram J, 2010, CELL MOL NEUROBIOL, V30, P233, DOI 10.1007/s10571-009-9445-8; van Veen S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00048; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111	36	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7767	7773		10.1074/jbc.M115.695122	http://dx.doi.org/10.1074/jbc.M115.695122			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858246	Green Published, hybrid			2022-12-26	WOS:000383447600045
J	Xiang, RF; Stack, D; Huston, SM; Li, SS; Ogbomo, H; Kyei, SK; Mody, CH				Xiang, Richard F.; Stack, Danuta; Huston, Shaunna M.; Li, Shu Shun; Ogbomo, Henry; Kyei, Stephen K.; Mody, Christopher H.			Ras-related C3 Botulinum Toxin Substrate (Rac) and Src Family Kinases (SFK) Are Proximal and Essential for Phosphatidylinositol 3-Kinase (PI3K) Activation in Natural Killer (NK) Cell-mediated Direct Cytotoxicity against Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; fungi; natural killer cells (NK cells); phosphatidylinositide 3-kinase (PI 3-kinase); Rac (Rac GTPase); Src; Cellular signaling; Cryptococcus	PHOSPHOINOSITIDE 3-KINASE; SMALL GTPASES; PLC-GAMMA; T-CELLS; RECEPTOR; PROTEINS; POLARIZATION; LYMPHOCYTES; IMMUNITY; SIGNALS	The activity of Rac in leukocytes is essential for immunity. However, its role in NK cell-mediated anti-microbial signaling remains unclear. In this study, we investigated the role of Rac in NK cell mediated anti-cryptococcal killing. We found that Cryptococcus neoformans independently activates both Rac and SFK pathways in NK cells, and unlike in tumor killing, Cryptococcus initiated a novel Rac PI3K Erk cytotoxicity cascade. Remarkably, Rac was not required for conjugate formation, despite its essential role in NK cytotoxicity against C. neoformans. Taken together, our data show that, unlike observations with tumor cells, NK cells use a novel Rac cytotoxicity pathway in conjunction with SFK, to kill C. neoformans.	[Xiang, Richard F.; Stack, Danuta; Huston, Shaunna M.; Li, Shu Shun; Ogbomo, Henry; Kyei, Stephen K.; Mody, Christopher H.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Mody, Christopher H.] Univ Calgary, Dept Internal Med, Calgary, AB T2N 4N1, Canada; [Xiang, Richard F.; Stack, Danuta; Huston, Shaunna M.; Li, Shu Shun; Ogbomo, Henry; Kyei, Stephen K.; Mody, Christopher H.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary	Mody, CH (corresponding author), Hlth Res Innovat Ctr, Jessie Boden Lloyd Prof Immunol, Rm 4AA14,3280 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	cmody@ucalgary.ca		Li, ShuShun/0000-0002-8725-4614; Mody, Christopher H./0000-0001-7264-3679	Canadian Institute for Health Research [247301]; Lung Association-Alberta and Northwest Territories	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Lung Association-Alberta and Northwest Territories	This work was supported by Canadian Institute for Health Research Grant 247301 (to C. H. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a studentship from the Lung Association-Alberta and Northwest Territories.	Amin ARMR, 2003, INT J ONCOL, V23, P1727; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Brown ACN, 2012, BLOOD, V120, P3729, DOI 10.1182/blood-2012-05-429977; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; BUHL AM, 1995, J BIOL CHEM, V270, P19828, DOI 10.1074/jbc.270.34.19828; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Diaz-Flores E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004125; Djeu JY, 2002, CLIN CANCER RES, V8, P636; Emmer PM, 2000, HUM REPROD, V15, P1163, DOI 10.1093/humrep/15.5.1163; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Filbert EL, 2012, J IMMUNOL, V188, P5421, DOI 10.4049/jimmunol.1200242; Fraison Jean-Baptiste, 2013, J Crohns Colitis, V7, pe11, DOI 10.1016/j.crohns.2012.04.016; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gibson JF, 2015, FUNGAL GENET BIOL, V78, P76, DOI 10.1016/j.fgb.2014.11.006; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; HIDORE MR, 1986, J IMMUNOL, V137, P3624; HIDORE MR, 1991, INFECT IMMUN, V59, P1747, DOI 10.1128/IAI.59.5.1747-1754.1991; Huston SM, 2013, J IMMUNOL, V191, P249, DOI 10.4049/jimmunol.1202707; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Inukai K, 2000, BIOCHEM J, V346, P483, DOI 10.1042/0264-6021:3460483; Islam A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003439; James AM, 2013, BLOOD, V121, P2627, DOI 10.1182/blood-2012-06-437012; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jones GJ, 2009, INT IMMUNOL, V21, P423, DOI 10.1093/intimm/dxp010; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Kwon Hyung-Joon, 2012, Immune Netw, V12, P240, DOI 10.4110/in.2012.12.6.240; LEVITZ SM, 1994, INFECT IMMUN, V62, P194, DOI 10.1128/IAI.62.1.194-202.1994; Li SS, 2013, CELL HOST MICROBE, V14, P387, DOI 10.1016/j.chom.2013.09.007; LIPSCOMB MF, 1987, AM J PATHOL, V128, P354; Lou ZK, 2000, J EXP MED, V191, P347, DOI 10.1084/jem.191.2.347; Ma LL, 2004, J IMMUNOL, V173, P3357, DOI 10.4049/jimmunol.173.5.3357; Maffucci T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008285; Malorni W, 2003, J IMMUNOL, V171, P4195, DOI 10.4049/jimmunol.171.8.4195; Marinkovic G, 2013, ARTERIOSCL THROM VAS, V33, P2380, DOI 10.1161/ATVBAHA.113.301394; Meng XB, 2007, J PROTEOME RES, V6, P744, DOI 10.1021/pr060382t; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; Morse RHA, 2001, J NEUROIMMUNOL, V116, P107, DOI 10.1016/S0165-5728(01)00289-2; MURPHY JW, 1991, INFECT IMMUN, V59, P1476, DOI 10.1128/IAI.59.4.1476-1488.1991; Neurath Markus, 2010, Gastroenterol Hepatol (N Y), V6, P435; Oykhman P, 2013, INFECT IMMUN, V81, P3912, DOI 10.1128/IAI.00533-13; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Perez-Villar JJ, 2002, BIOCHEMISTRY-US, V41, P10732, DOI 10.1021/bi025554o; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Porter JC, 2002, J IMMUNOL, V168, P6330, DOI 10.4049/jimmunol.168.12.6330; Putney JW, 2002, NAT CELL BIOL, V4, pE280, DOI 10.1038/ncb1202-e280; Sethi NK, 2007, EUR J GASTROEN HEPAT, V19, P913, DOI 10.1097/MEG.0b013e3282cf4ed9; SHIRAKAWA F, 1986, J IMMUNOL, V137, P551; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Vyas YM, 2001, J IMMUNOL, V167, P4358, DOI 10.4049/jimmunol.167.8.4358; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Wiseman JCD, 2007, J IMMUNOL, V178, P6456, DOI 10.4049/jimmunol.178.10.6456; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007	67	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6912	6922		10.1074/jbc.M115.681544	http://dx.doi.org/10.1074/jbc.M115.681544			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26867574	hybrid, Green Published			2022-12-26	WOS:000373299700028
J	Gao, Z; Han, Y; Hu, YH; Wu, XY; Wang, YB; Zhang, XQ; Fu, JJ; Zou, X; Zhang, J; Chen, XW; Jose, PA; Lu, X; Zeng, CY				Gao, Zhao; Han, Yu; Hu, Yunhui; Wu, Xiaoyan; Wang, Yongbin; Zhang, Xiaoqun; Fu, Jinjuan; Zou, Xue; Zhang, Jun; Chen, Xiongwen; Jose, Pedro A.; Lu, Xi; Zeng, Chunyu			Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; INDUCED NEPHROPATHY; NLRP3 INFLAMMASOME; HEME OXYGENASE-1; UP-REGULATION; RISK-FACTORS; RAT MODEL; ACTIVATION; EGCG; APOPTOSIS	Both oxidative stress and inflammation are involved in the pathogenesis of contrast-induced nephropathy (CIN). Epigallocatechin-3-gallate (EGCG), a purified catechin from green tea, has antioxidant and anti-inflammatory effects. However, it is unknown whether or not EGCG is effective in treating CIN. Our present study found that intravenous administration of EGCG, either before or just after the establishment of CIN, had a protective effect, determined by normalization of serum creatinine and blood urea nitrogen levels, improvement in renal histopathological scoring and alleviation of apoptosis, accompanied by decreased oxidative stress and inflammation. Because EGCG is a potent inducer of the antioxidant heme oxygenase-1 (HO-1), we studied HO-1 signaling in CIN. HO-1 levels were increased in CIN; treatment with EGCG further increased HO-1 levels, accompanied by an increase in Nrf2, a regulator of antioxidant proteins. Interestingly, blockade of HO-1 with protoporphyrin IX zinc (II) (ZnPP) prevented the protective effect of EGCG on CIN. ZnPP also blocked the ability of EGCG to increase the activity of an antioxidant (superoxide dismutase), and decrease markers of oxidative stress (myeloperoxidase and malondialdehyde) and inflammation (myeloperoxidase and IL-1 beta), indicating that HO-1 is the upstream molecule that regulates the EGCG-mediated protection. To determine further the role of HO-1 on the EGCG-mediated inhibition of inflammation, we studied the effect of EGCG on the NLRP3 inflammasome, an upstream signaling of IL-1 beta. EGCG down-regulated NLRP3 expression, which was blocked by ZnPP, indicating that HO-1 links EGCG with NLRP3. Therefore, EGCG, via up-regulation of HO-1, protects against CIN by amelioration of oxidative stress and inflammation.	[Gao, Zhao; Han, Yu; Hu, Yunhui; Wu, Xiaoyan; Wang, Yongbin; Zhang, Xiaoqun; Fu, Jinjuan; Zou, Xue; Zhang, Jun; Chen, Xiongwen; Lu, Xi; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Gao, Zhao; Han, Yu; Hu, Yunhui; Wu, Xiaoyan; Wang, Yongbin; Zhang, Xiaoqun; Fu, Jinjuan; Zou, Xue; Zhang, Jun; Chen, Xiongwen; Lu, Xi; Zeng, Chunyu] Chongqing Inst Cardiol, Chongqing Key Lab Hypertens Res, Chongqing, Peoples R China; [Jose, Pedro A.] George Washington Univ, Sch Med & Hlth Sci, Dept Med, Div Renal Dis & Hypertens, Washington, DC 20052 USA; [Jose, Pedro A.] George Washington Univ, Sch Med & Hlth Sci, Dept Physiol, Washington, DC 20052 USA	Army Medical University; Chinese Academy of Sciences; George Washington University; George Washington University	Lu, X; Zeng, CY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	xixi0332@126.com; chunyuzeng01@163.com	Chen, Xiongwen/D-5988-2012	Chen, Xiongwen/0000-0002-3829-5815	National Natural Science Foundation of China [31430043, 31471089]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088243] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (31430043, 31471089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMON Y, 1994, J CLIN INVEST, V94, P1069, DOI 10.1172/JCI117421; Alpert MA, 2014, J AM COLL CARDIOL, V63, P80, DOI 10.1016/j.jacc.2013.07.097; Bakker PJ, 2014, AM J PATHOL, V184, P2013, DOI 10.1016/j.ajpath.2014.04.005; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Berry M, 2012, IMMUNOTHERAPY-UK, V4, P323, DOI [10.2217/IMT.11.175, 10.2217/imt.11.175]; Bird JE, 1996, J AM SOC NEPHROL, V7, P1153; Caiazza A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/578974; Chok Mohammed Koussai, 2009, Inflammation & Allergy Drug Targets, V8, P252; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Doria A, 2012, AUTOIMMUN REV, V12, P22, DOI 10.1016/j.autrev.2012.07.018; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Guan WW, 2015, EUR J PHARMACOL, V761, P144, DOI 10.1016/j.ejphar.2015.05.009; Hosseinian N, 2015, THER ADV RESPIR DIS, V9, P188, DOI 10.1177/1753465815586335; Inoue H, 2013, BIOSCI BIOTECH BIOCH, V77, P1223, DOI 10.1271/bbb.121003; Jorgensen AL, 2013, CRIT CARE NURSE, V33, P37, DOI 10.4037/ccn2013680; Kaizu T, 2003, KIDNEY INT, V63, P1393, DOI 10.1046/j.1523-1755.2003.00882.x; Kakuta Y, 2011, TRANSPL INT, V24, P514, DOI 10.1111/j.1432-2277.2011.01224.x; Kanwar YS, 2013, AM J PHYSIOL-RENAL, V304, pF1167, DOI 10.1152/ajprenal.00032.2013; Khurana S, 2013, NUTRIENTS, V5, P3779, DOI 10.3390/nu5103779; Kim SJ, 2013, FREE RADICAL BIO MED, V65, P997, DOI 10.1016/j.freeradbiomed.2013.08.178; Kochi T, 2014, CANCER LETT, V342, P60, DOI 10.1016/j.canlet.2013.08.031; Kodama A, 2013, KIDNEY INT, V83, P446, DOI 10.1038/ki.2012.429; Kwon MS, 2015, INT J MOL SCI, V16, P5028, DOI 10.3390/ijms16035028; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Li QW, 2014, CELL BIOCHEM BIOPHYS, V69, P495, DOI 10.1007/s12013-014-9823-9; Liu TQ, 2015, FREE RADICAL BIO MED, V81, P170, DOI 10.1016/j.freeradbiomed.2014.10.509; Luo YP, 2014, INT IMMUNOPHARMACOL, V20, P24, DOI 10.1016/j.intimp.2014.02.017; Maioli M, 2012, CIRCULATION, V125, P3099, DOI 10.1161/CIRCULATIONAHA.111.085290; McCullough PA, 2011, CIRCULATION, V124, P1210, DOI 10.1161/CIRCULATIONAHA.111.054502; Navaneethan SD, 2009, AM J KIDNEY DIS, V53, P617, DOI 10.1053/j.ajkd.2008.08.033; Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133; Pan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124775; Peng A, 2011, KIDNEY INT, V80, P601, DOI 10.1038/ki.2011.121; Piazza M, 2011, INNATE IMMUN-LONDON, V17, P293, DOI 10.1177/1753425910369020; Quintavalle C, 2012, CIRCULATION, V126, P3008, DOI 10.1161/CIRCULATIONAHA.112.103317; Reinecke H, 2007, CLIN RES CARDIOL, V96, P130, DOI 10.1007/s00392-007-0473-4; Ribaldo PDB, 2009, J NUTR, V139, P96, DOI 10.3945/jn.108.095018; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Stone GW, 2003, JAMA-J AM MED ASSOC, V290, P2284, DOI 10.1001/jama.290.17.2284; Takahashi T, 2009, J CLIN BIOCHEM NUTR, V44, P28, DOI 10.3164/jcbn.08-210-HO; Tang XJ, 2014, CURR OPIN NEPHROL HY, V23, P385, DOI 10.1097/01.mnh.0000447017.28852.52; Toldo S, 2015, ANTIOXID REDOX SIGN, V22, P1146, DOI 10.1089/ars.2014.5989; Toprak O, 2008, NEPHROL DIAL TRANSPL, V23, P853, DOI 10.1093/ndt/gfm691; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Turner CM, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-21; Twal M, 2013, PHARMACOL RES, V67, P68, DOI 10.1016/j.phrs.2012.10.011; van Kempen TS, 2015, NAT REV RHEUMATOL, V11, P483, DOI 10.1038/nrrheum.2015.60; Wagner M, 2003, KIDNEY INT, V63, P1564, DOI 10.1046/j.1523-1755.2003.00897.x; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wang YQ, 2015, BASIC CLIN PHARMACOL, V117, P164, DOI 10.1111/bcpt.12383; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wu JJ, 2014, EUR J PHARMACOL, V745, P59, DOI 10.1016/j.ejphar.2014.09.046; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yang YD, 2015, INT J CLIN EXP PATHO, V8, P2484; Ye T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119543; Yokozawa T, 1999, J PHARM PHARMACOL, V51, P1325, DOI 10.1211/0022357991776912; Yoon SN, 2014, ACTA HISTOCHEM, V116, P1210, DOI 10.1016/j.acthis.2014.07.003; Zeng CY, 2006, CIRC RES, V99, P494, DOI 10.1161/01.RES.0000240500.96746.ec; Zhao BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116583; Zhou P, 2013, MOL MED REP, V7, P1096, DOI 10.3892/mmr.2013.1296	63	76	81	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149032	10.1371/journal.pone.0149032	http://dx.doi.org/10.1371/journal.pone.0149032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866373	Green Submitted, Green Published, gold			2022-12-26	WOS:000370050700056
J	Lee, J; Oh, KJ; Lee, D; Kim, BY; Choi, JS; Ku, B; Kim, SJ				Lee, Juhyeon; Oh, Kyoung-Jin; Lee, Dasom; Kim, Bo Yeon; Choi, Joon Sig; Ku, Bonsu; Kim, Seung Jun			Structural Study of the HD-PTP Bro1 Domain in a Complex with the Core Region of STAM2, a Subunit of ESCRT-0	PLOS ONE			English	Article							PROTEIN; ALIX; RECEPTOR; BINDING; MEMBRANE; EGFR; TRAFFICKING; MACHINERY; INTERACT; SHARE	EGFR is a key player in cell proliferation and survival signaling, and its sorting into MVBs for eventual lysosomal degradation is controlled by the coordination of multiple ESCRT complexes on the endosomal membrane. HD-PTP is a cytosolic protein tyrosine phosphatase, and is associated with EGFR trafficking by interacting with the ESCRT-0 protein STAM2 and the ESCRT-III protein CHMP4B via its N-terminal Bro1 domain. Intriguingly, the homologous domain of two other human Bro1 domain-containing proteins, Alix and Brox, binds CHMP4B but not STAM2, despite their high structural similarity. To elucidate this binding specificity, we determined the complex structure of the HD-PTP Bro1 domain bound to the STAM2 core region. STAM2 binds to the hydrophobic concave pocket of the HD-PTP Bro1 domain, as CHMP4B does to the pocket of Alix, Brox, or HD-PTP but in the opposite direction. Critically, Thr145 of HD-PTP, corresponding to Lys151 of Alix and Arg145 of Brox, is revealed to be a determinant residue enabling this protein to bind STAM2, as the Alix-or Brox-mimicking mutations of this residue blocks the intermolecular interaction. This work therefore provides the structural basis for how HD-PTP recognizes the ESCRT-0 component to control EGFR sorting.	[Lee, Juhyeon; Ku, Bonsu; Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Lee, Juhyeon; Choi, Joon Sig] Chungnam Natl Univ, Dept Biochem, Daejeon, South Korea; [Oh, Kyoung-Jin; Lee, Dasom] Korea Res Inst Biosci & Biotechnol, Res Ctr Metab Regulat, Daejeon, South Korea; [Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, World Class Inst, Incurable Dis Therapeut Res Ctr, Ochang, Cheongwon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Ku, B; Kim, SJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea.	bku@kribb.re.kr; ksj@kribb.re.kr	Kim, Seung Jun/N-5248-2019; Oh, Kyoung-Jin/AAV-1483-2021	Kim, Seung Jun/0000-0002-6913-6358; Oh, Kyoung-Jin/0000-0002-2224-7202; Choi, Joon Sig/0000-0002-8463-841X; Ku, Bonsu/0000-0003-1784-8975	National Research Foundation of Korea [2011-0030027, 2015M3A9B5030308]; World Class Institute program - Ministry of Science, ICT and Future Planning [WCI 2009-002]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Creative Research	National Research Foundation of Korea(National Research Foundation of Korea); World Class Institute program - Ministry of Science, ICT and Future Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Creative Research	This work was supported by grants from the National Research Foundation of Korea (2011-0030027 and 2015M3A9B5030308; to SJK) and the World Class Institute program (WCI 2009-002; to BYK) funded by the Ministry of Science, ICT and Future Planning. This work was also supported by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Creative Research (to BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adell MAY, 2014, J CELL BIOL, V205, P33, DOI 10.1083/jcb.201310114; Ali N, 2013, CURR BIOL, V23, P453, DOI 10.1016/j.cub.2013.02.033; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Castiglioni S, 2007, BIOCHEM BIOPH RES CO, V364, P534, DOI 10.1016/j.bbrc.2007.10.022; Chen DY, 2012, J CELL SCI, V125, P4841, DOI 10.1242/jcs.108597; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Kimura Y, 2015, EUKARYOT CELL, V14, P976, DOI 10.1128/EC.00091-15; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Kostaras E, 2013, ONCOGENE, V32, P5220, DOI 10.1038/onc.2012.554; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Mariotti M, 2009, INT J BIOCHEM CELL B, V41, P687, DOI 10.1016/j.biocel.2008.08.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Mu RL, 2012, STRUCTURE, V20, P887, DOI 10.1016/j.str.2012.03.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Pradhan-Sundd T, 2014, DEV BIOL, V392, P93, DOI 10.1016/j.ydbio.2014.04.019; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Schuh AL, 2014, CRIT REV BIOCHEM MOL, V49, P242, DOI 10.3109/10409238.2014.881777; Sette P, 2011, STRUCTURE, V19, P1485, DOI 10.1016/j.str.2011.07.016; Sirisaengtaksin N, 2014, J BIOL CHEM, V289, P3026, DOI 10.1074/jbc.M113.495671; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Sun S, 2015, BIOCHEM J, V466, P475, DOI 10.1042/BJ20141156; Tanaka K, 2013, J BIOL CHEM, V288, P23990, DOI 10.1074/jbc.M113.478891; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Zhai QT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027466	39	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149113	10.1371/journal.pone.0149113	http://dx.doi.org/10.1371/journal.pone.0149113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866605	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700067
J	Nigatu, YT; Reijneveld, SA; de Jonge, P; van Rossum, E; Bultmann, U				Nigatu, Yeshambel T.; Reijneveld, Sijmen A.; de Jonge, Peter; van Rossum, Elisabeth; Bultmann, Ute			The Combined Effects of Obesity, Abdominal Obesity and Major Depression/Anxiety on Health-Related Quality of Life: the LifeLines Cohort Study	PLOS ONE			English	Article							MEDICAL DISORDERS; ECONOMIC BURDEN; BODY-WEIGHT; ASSOCIATION; POPULATION; DETERMINANTS; VALIDATION; OVERWEIGHT; COUNTRIES; TRENDS	Background Obesity and major depressive disorder (MDD)/anxiety disorders often co-occur and aggravate each other resulting in adverse health-related outcomes. As little is known about the potential effects of interaction between obesity and MDD and/or anxiety disorders on health-related quality of life (HR-QoL), this study was aimed at examining these combined effects. Methods We collected data among N = 89,332 participants from the LifeLines cohort study. We categorized body weight using body mass index (kg/m(2)) as normal weight (18.5-24.99), overweight (25-29.9), mild obesity (30-34.9) and moderate/severe obesity (>= 35); we measured abdominal obesity using a waist circumference of >= 102 and >= 88 cm for males and females, respectively. MDD and anxiety disorders were diagnosed with the Mini-International Neuropsychiatric Interview. HR-QoL was assessed using the RAND-36 questionnaire to compute physical and mental quality of life scores. We used binary logistic and linear regression analyses. Results The combined effect of obesity and MDD and/or anxiety disorders on physical QoL was larger than the sum of their separate effects; regression coefficients, B (95%-confidence interval, 95%-CI) were: - 1.32 (-1.75; -0.90). However, the combined effect of obesity and major depression alone on mental QoL was less than the additive effect. With increasing body weight participants report poorer physical QoL; when they also have MDD and/or anxiety disorders participants report even poorer physical QoL. In persons without MDD and/or anxiety disorders, obesity was associated with a better mental QoL. Conclusions Obesity and MDD and/or anxiety disorders act synergistically on physical and mental QoL. The management of MDD and/or anxiety disorders and weight loss may be important routes to improve HR-QoL.	[Nigatu, Yeshambel T.; Reijneveld, Sijmen A.; Bultmann, Ute] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [van Rossum, Elisabeth] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC	Nigatu, YT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands.	y.t.nigatu@umcg.nl	van Rossum, Elisabeth/AAP-9388-2020; Nigatu, Yeshambel/N-9628-2019; de Jonge, Peter/L-6395-2013	Nigatu, Yeshambel Tesfa/0000-0002-5192-4188; de Jonge, Peter/0000-0002-0866-6929; Bultmann, Ute/0000-0001-9589-9220; Reijneveld, Sijmen/0000-0002-1206-7523				Afari N, 2010, DEPRESS ANXIETY, V27, P799, DOI 10.1002/da.20704; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Atlantis E, 2012, QUAL LIFE RES, V21, P1695, DOI 10.1007/s11136-011-0101-7; Badia X, 2014, PITUITARY, V17, P187, DOI 10.1007/s11102-013-0484-2; Barajas Gutierrez M A, 1998, Rev Esp Salud Publica, V72, P221, DOI 10.1590/S1135-57271998000300007; Barnes RD, 2014, OBESITY, V22, P2508, DOI 10.1002/oby.20889; Baune BT, 2007, J PSYCHOSOM RES, V62, P109, DOI 10.1016/j.jpsychores.2006.09.014; Blumenthal SR, 2014, JAMA PSYCHIAT, V71, P889, DOI 10.1001/jamapsychiatry.2014.414; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; de Wit LM, 2010, DEPRESS ANXIETY, V27, P1057, DOI 10.1002/da.20738; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Fontaine KR, 2000, INT J EAT DISORDER, V27, P101, DOI 10.1002/(SICI)1098-108X(200001)27:1&lt;101::AID-EAT12&gt;3.0.CO;2-D; Friedman KE, 2002, OBES RES, V10, P33, DOI 10.1038/oby.2002.5; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gariepy G, 2010, OBESITY, V18, P1033, DOI 10.1038/oby.2009.333; Ghoorah K, 2016, EUR HEART J-ACUTE CA, V5, P77, DOI 10.1177/2048872614523349; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hilbert A, 2014, OBESITY, V22, P79, DOI 10.1002/oby.20561; Kabadi SM, 2012, DIABETES CARE, V35, P2048, DOI 10.2337/dc12-0235; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Krueger RF, 2015, WORLD PSYCHIATRY, V14, P27, DOI 10.1002/wps.20175; Laaksonen M, 2005, OBES RES, V13, P2169, DOI 10.1038/oby.2005.269; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Muller-Riemenschneider F, 2008, EUR J EPIDEMIOL, V23, P499, DOI 10.1007/s10654-008-9239-1; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nigatu Y, 2013, EUROPEAN J PUBLIC S1, V23; Nigatu YT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1682-9; Pan A, 2012, INT J OBESITY, V36, P595, DOI 10.1038/ijo.2011.111; Pan A, 2014, AM J EPIDEMIOL, V180, P254, DOI 10.1093/aje/kwu136; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; Pi-Sunyer FX, 2002, OBES SURG, V12, p6S, DOI 10.3810/pgm.2009.11.2074; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Renzaho A, 2010, QUAL LIFE RES, V19, P515, DOI 10.1007/s11136-010-9610-z; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slagter SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096406; Sobocki P, 2007, EUR PSYCHIAT, V22, P146, DOI 10.1016/j.eurpsy.2006.10.006; Sobocki P, 2007, VALUE HEALTH, V10, P153, DOI 10.1111/j.1524-4733.2006.00162.x; Soto M, 2005, QUAL LIFE RES, V14, P759; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Thormann J, 2013, FORTSCHR NEUROL PSYC, V81, P145, DOI 10.1055/s-0032-1330351; van Zutven K, 2015, INT J OBESITY, V39, P346, DOI 10.1038/ijo.2014.100; Vetter ML, 2011, INT J OBESITY, V35, P1087, DOI 10.1038/ijo.2010.230; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Ware J, 1994, SF 36 PHYS MENTAL SU; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Whisman MA, 2005, J FAM PSYCHOL, V19, P111, DOI 10.1037/0893-3200.19.1.111; WHO, 2008, WAIST CIRCUMFERENCE	51	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148871	10.1371/journal.pone.0148871	http://dx.doi.org/10.1371/journal.pone.0148871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866920	Green Submitted, gold, Green Published			2022-12-26	WOS:000370050700043
J	van Geemen, D; Soares, ALF; Oomen, PJA; Driessen-Mol, A; den Broek, MWJTJV; van den Bogaerdt, AJ; Bogers, AJJC; Goumans, MJTH; Baaijens, FPT; Bouten, CVC				van Geemen, Daphne; Soares, Ana L. F.; Oomen, Pim J. A.; Driessen-Mol, Anita; Janssen-van den Broek, Marloes W. J. T.; van den Bogaerdt, Antoon J.; Bogers, Ad J. J. C.; Goumans, Marie-Jose T. H.; Baaijens, Frank P. T.; Bouten, Carlijn V. C.			Age-Dependent Changes in Geometry, Tissue Composition and Mechanical Properties of Fetal to Adult Cryopreserved Human Heart Valves	PLOS ONE			English	Article							CELL PHENOTYPE; AORTIC VALVES; COLLAGEN; CALCIFICATION; RELEVANCE; PRESSURE; LEAFLETS; BEHAVIOR; ELASTIN; MATRIX	There is limited information about age-specific structural and functional properties of human heart valves, while this information is key to the development and evaluation of living valve replacements for pediatric and adolescent patients. Here, we present an extended data set of structure-function properties of cryopreserved human pulmonary and aortic heart valves, providing age-specific information for living valve replacements. Tissue composition, morphology, mechanical properties, and maturation of leaflets from 16 pairs of structurally unaffected aortic and pulmonary valves of human donors (fetal-53 years) were analyzed. Interestingly, no major differences were observed between the aortic and pulmonary valves. Valve annulus and leaflet dimensions increase throughout life. The typical three-layered leaflet structure is present before birth, but becomes more distinct with age. After birth, cell numbers decrease rapidly, while remaining cells obtain a quiescent phenotype and reside in the ventricularis and spongiosa. With age and maturation-but more pronounced in aortic valves-the matrix shows an increasing amount of collagen and collagen cross-links and a reduction in glycosaminoglycans. These matrix changes correlate with increasing leaflet stiffness with age. Our data provide a new and comprehensive overview of the changes of structure-function properties of fetal to adult human semilunar heart valves that can be used to evaluate and optimize future therapies, such as tissue engineering of heart valves. Changing hemodynamic conditions with age can explain initial changes in matrix composition and consequent mechanical properties, but cannot explain the ongoing changes in valve dimensions and matrix composition at older age.	[van Geemen, Daphne; Soares, Ana L. F.; Oomen, Pim J. A.; Driessen-Mol, Anita; Janssen-van den Broek, Marloes W. J. T.; Baaijens, Frank P. T.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomech & Engn, POB 513, NL-5600 MB Eindhoven, Netherlands; [Oomen, Pim J. A.; Driessen-Mol, Anita; Baaijens, Frank P. T.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands; [van den Bogaerdt, Antoon J.; Bogers, Ad J. J. C.] Erasmus Univ, Med Ctr, Heart Valve Bank Rotterdam, Dept Cardiothorac Surg, Rotterdam, Netherlands; [Bogers, Ad J. J. C.] Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, Rotterdam, Netherlands; [Goumans, Marie-Jose T. H.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bouten, CVC (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomech & Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.; Bouten, CVC (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands.	C.V.C.Bouten@tue.nl	Goumans, Marie-José/AAG-4994-2021; Goumans, Marie Jose/U-1455-2019; Bouten, Carlijn/AAT-5187-2020	Goumans, Marie Jose/0000-0001-9344-6746; Bouten, Carlijn/0000-0003-1035-5094; Baaijens, Frank/0000-0002-0975-5376; Bogers, Ad/0000-0001-6200-1998; Oomen, Pim/0000-0002-0069-4538	Dutch Technology Foundation (STW); applied science division of The Netherlands Organisation for Scientific Research (NWO); Technology Program of the Dutch Ministry of Economic Affairs [06233]	Dutch Technology Foundation (STW)(Technologiestichting STW); applied science division of The Netherlands Organisation for Scientific Research (NWO); Technology Program of the Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research is supported by the Dutch Technology Foundation (STW, http://www.stw.nl/en), applied science division of The Netherlands Organisation for Scientific Research (NWO, http://www.nwo.nl/en/), and the Technology Program of the Dutch Ministry of Economic Affairs under grant agreement under grant number 06233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Balguid A, 2007, TISSUE ENG, V13, P1501, DOI 10.1089/ten.2006.0279; BASHEY RI, 1967, J GERONTOL, V22, P203, DOI 10.1093/geronj/22.2.203; CHRISTIE GW, 1995, ANN THORAC SURG, V60, pS156, DOI 10.1016/0003-4975(95)00219-B; Cox MAJ, 2008, J BIOMECH, V41, P422, DOI 10.1016/j.jbiomech.2007.08.006; Dainese L, 2006, ARTIF ORGANS, V30, P259, DOI 10.1111/j.1525-1594.2006.00213.x; Delgadillo Jorge O. Virues, 2010, Journal of Biomedical Science & Engineering, V3, P645, DOI 10.4236/jbise.2010.37088; Driessen NJB, 2005, J BIOMECH ENG-T ASME, V127, P329, DOI 10.1115/1.1865187; Gao YS, 2010, PHYSIOL REV, V90, P1291, DOI 10.1152/physrev.00032.2009; Gerson CJ, 2009, CRYOBIOLOGY, V59, P171, DOI 10.1016/j.cryobiol.2009.06.012; Gross L, 1931, AM J PATHOL, V7, P0445; Hasan A, 2014, J BIOMECH, V47, P1949, DOI 10.1016/j.jbiomech.2013.09.023; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hjortnaes J, 2015, ATHEROSCLEROSIS, V242, P251, DOI 10.1016/j.atherosclerosis.2015.07.008; Kasyanov V, 2013, CONNECT TISSUE RES, V8207, P1; Kortsmit J, 2009, TISSUE ENG PART C-ME, V15, P707, DOI [10.1089/ten.tec.2008.0658, 10.1089/ten.TEC.2008.0658]; Kortsmit J, 2009, TISSUE ENG PT A, V15, P797, DOI 10.1089/ten.tea.2008.0197; Kriemler S, 2008, EUR RESPIR J, V32, P664, DOI 10.1183/09031936.00166407; Leeson-Dietrich J, 1995, J Heart Valve Dis, V4, P88; Lindeman JHN, 2010, P NATL ACAD SCI USA, V107, P862, DOI 10.1073/pnas.0910312107; MARON BJ, 1974, AM J PATHOL, V74, P331; McDonald PC, 2002, CARDIOVASC PATHOL, V11, P193, DOI 10.1016/S1054-8807(01)00102-8; Merryman WD, 2010, J BIOMECH, V43, P87, DOI 10.1016/j.jbiomech.2009.09.013; Merryman WD, 2006, AM J PHYSIOL-HEART C, V290, pH224, DOI 10.1152/ajpheart.00521.2005; Mol A, 2006, CIRCULATION, V114, pI152, DOI 10.1161/CIRCULATIONAHA.105.001123; MORETTI A, 1963, BIOCHEM J, V87, P396, DOI 10.1042/bj0870396; Oomen PJA, 2016, ACTA BIOMATER, V29, P161, DOI 10.1016/j.actbio.2015.10.044; Rabkin E, 2002, J HEART VALVE DIS, V11, P308; Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841; ROSS D, 1992, EUR J CARDIO-THORAC, V6, P113, DOI 10.1016/1010-7940(92)90115-E; Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015; Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293; SAUREN AAHJ, 1983, J BIOMECH, V16, P327, DOI 10.1016/0021-9290(83)90016-7; Schoen FJ, 2012, ANNU REV PATHOL-MECH, V7, P161, DOI 10.1146/annurev-pathol-011110-130257; Schoen FJ, 2011, CURR OPIN BIOTECH, V22, P698, DOI 10.1016/j.copbio.2011.01.004; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Soares ALF, 2014, J MECH BEHAV BIOMED, V29, P557, DOI 10.1016/j.jmbbm.2013.07.009; Stephens EH, 2008, ACTA BIOMATER, V4, P1148, DOI 10.1016/j.actbio.2008.03.014; Stephens EH, 2007, J HEART VALVE DIS, V16, P672; Stephens EH, 2010, TISSUE ENG PT A, V16, P867, DOI [10.1089/ten.tea.2009.0288, 10.1089/ten.TEA.2009.0288]; Stradins P, 2004, EUR J CARDIO-THORAC, V26, P634, DOI 10.1016/j.ejcts.2004.05.043; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Vesely I, 2000, J HEART VALVE DIS, V9, P27; Votteler M, 2013, DEVELOPMENT, V140, P2345, DOI 10.1242/dev.093500	44	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149020	10.1371/journal.pone.0149020	http://dx.doi.org/10.1371/journal.pone.0149020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867221	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700055
J	Xue, C; Peng, RJ; Cao, Y; Wang, SS; Shi, YX; An, X; Xu, F; Yuan, ZY				Xue, Cong; Peng, Roujun; Cao, Ye; Wang, Shusen; Shi, Yanxia; An, Xin; Xu, Fei; Yuan, Zhongyu			Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; PROGNOSTIC IMPACT; YOUNG-WOMEN; AMENORRHEA; THERAPY; METAANALYSIS; SURVIVAL; MARKERS; RISK	The role of adjuvant ovarian suppression or ablation (OS/OA) in premenopausal women with hormone receptor-positive breast cancer remains controversial. The purpose of our study was to examine which patients might benefit from the addition of OS/OA to tamoxifen. We analyzed the data of 2065 premenopausal patients with hormone receptor-positive invasive ductal carcinomas who were treated at Sun Yat-Sen University Cancer Center from 2000 to 2008. The five-year disease-free survival rate (DFSR) and overall survival rate (OSR) were compared by menstrual status and treatment. Compared with patients older than forty years of age, patients younger than forty years old had significant lower DFSRs and OSRs. The addition of OS/OA to tamoxifen increased the DFSR and OSR of patients with normal menstrual cycles after chemotherapy, regardless of their age at diagnosis. Patients with normal menstrual cycles after chemotherapy are the main beneficiaries of an adjuvant OS/OA.	[Xue, Cong; Peng, Roujun; Wang, Shusen; Shi, Yanxia; An, Xin; Xu, Fei; Yuan, Zhongyu] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Ye] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept GCP,Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Yuan, ZY (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510275, Guangdong, Peoples R China.	yuanzhy@sysucc.org.cn			National Natural Science Foundation of China [81372820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	ZY Yuan was supported by National Natural Science Foundation of China (Grant No. 81372820). http://www.nsfc.gov.cn/publish/portal0/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Ahn SH, 2007, J CLIN ONCOL, V25, P2360, DOI 10.1200/JCO.2006.10.3754; Anders C, 2008, CANCER INVEST, V26, P286, DOI 10.1080/07357900701829777; Anderson RA, 2013, EUR J CANCER, V49, P3404, DOI 10.1016/j.ejca.2013.07.014; [Anonymous], 1996, Lancet, V348, P1189; Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718; Bliss JM, 2007, JNCI-J NATL CANCER I, V99, P516, DOI 10.1093/jnci/djk109; BONADONNA G, 1995, NEW ENGL J MED, V332, P901, DOI 10.1056/NEJM199504063321401; Burstein HJ, 2000, NEW ENGL J MED, V343, P1086, DOI 10.1056/NEJM200010123431506; Cuzick J, 2007, LANCET, V369, P1711; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; GOLDHIRSCH A, 1990, ANN ONCOL, V1, P183, DOI 10.1093/oxfordjournals.annonc.a057718; Goodwin PJ, 1999, J CLIN ONCOL, V17, P2365, DOI 10.1200/JCO.1999.17.8.2365; Henry NL, 2013, ANN ONCOL, V24, P2011, DOI 10.1093/annonc/mdt149; Pagani O, 1998, EUR J CANCER, V34, P632, DOI 10.1016/S0959-8049(97)10036-3; Park IH, 2012, ANN ONCOL, V23, P2283, DOI 10.1093/annonc/mds006; Parulekar WR, 2005, J CLIN ONCOL, V23, P6002, DOI 10.1200/JCO.2005.07.096; Puhalla S, 2009, BREAST, V18, pS122, DOI 10.1016/S0960-9776(09)70286-3; Yu B, 2010, CANCER-AM CANCER SOC, V116, P2099, DOI 10.1002/cncr.25037	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148849	10.1371/journal.pone.0148849	http://dx.doi.org/10.1371/journal.pone.0148849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866810	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700042
J	Alvarado-Facundo, E; Vassell, R; Schmeisser, F; Weir, JP; Weiss, CD; Wang, W				Alvarado-Facundo, Esmeralda; Vassell, Russell; Schmeisser, Falko; Weir, Jerry P.; Weiss, Carol D.; Wang, Wei			Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; RECEPTOR-BINDING; LENTIVIRAL VECTOR; IMMUNE-RESPONSE; GENE DELIVERY; CELL-CULTURE; IN-VIVO; VIRUS; VACCINE; PSEUDOTYPES	Human infections with H7 subtype influenza virus have been reported, including an H7N7 outbreak in Netherlands in 2003 and H7N9 infections in China in 2013. Previously, we reported murine monoclonal antibodies (mAbs) that recognize the antigenic site A of H7 hemagglutinin (HA). To better understand protective immunity of H7 vaccines and vaccine candidate selection, we used these mAbs to assess the antigenic relatedness among two H7 HA isolated from past human infections and determine residues that affect susceptibility to neutralization. We found that these mAbs neutralize pseudoviruses bearing HA of A/Shanghai/02/2013(H7N9), but not A/Netherlands/219/2003(H7N7). Glycosylation of the asparagine residue at position 141 (N141) (N133, H3 HA numbering) in the HA of A/Netherlands/219/2003 HA is responsible for this resistance, and it affects the infectivity of HA-pseudoviruses. The presence of threonine at position 143 (T135, H3 HA numbering) in the HA of A/Netherlands/219/2003, rather than an alanine found in the HA of A/Shanghai/02/2013(H7N9), accounts for these differences. These results demonstrate a key role for glycosylation of residue N141 in affecting H7 influenza HA-mediated entry and sensitivity to neutralizing antibodies, which have implications for candidate vaccine design.	[Alvarado-Facundo, Esmeralda; Vassell, Russell; Weiss, Carol D.; Wang, Wei] US FDA, Immunoregulat Lab, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA; [Schmeisser, Falko; Weir, Jerry P.] US FDA, Lab DNA Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Weiss, CD; Wang, W (corresponding author), US FDA, Immunoregulat Lab, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	carol.weiss@fda.hhs.gov; wei.wang@fda.hhs.gov	Weiss, Carol D./F-6438-2011	Weiss, Carol D./0000-0002-9965-1289	US Food and Drug Administration; Biomedical Advanced Research and Development Authority, Department of Health and Human Services	US Food and Drug Administration; Biomedical Advanced Research and Development Authority, Department of Health and Human Services	This work was supported by the US Food and Drug Administration and the Biomedical Advanced Research and Development Authority, Department of Health and Human Services. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SUMM STAT DEV AV A H; Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; CDC, AV INFL A H7N9 VIR; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Daniels PS, 1987, EMBO J, V6, P1459; DASSR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI DOI 10.1073/PNAS.1108754108; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GERBER P, 1955, J EXP MED, V101, P627, DOI 10.1084/jem.101.6.627; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hutter J, 2013, J IMMUNOL, V190, P220, DOI 10.4049/jimmunol.1201060; Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916; Jadhao SJ, 2008, VACCINE, V26, P1742, DOI 10.1016/j.vaccine.2008.01.036; Jernigan DB, 2015, ANNU REV MED, V66, P361, DOI 10.1146/annurev-med-010714-112311; Job ER, 2013, J IMMUNOL, V190, P2169, DOI 10.4049/jimmunol.1202433; Kumar SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128940; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lopez-Martinez I, 2013, EMERG INFECT DIS, V19, P1531, DOI 10.3201/eid1909.130087; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pappas C, 2007, CLIN VACCINE IMMUNOL, V14, P1425, DOI 10.1128/CVI.00174-07; Schmeisser F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117108; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang W., 2011, MOL PAIN, V23, P7, DOI DOI 10.1371/J0URNAL.PPAT.1002081; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wang W, 2010, VIROLOGY, V407, P374, DOI 10.1016/j.virol.2010.08.027; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Whiteley A, 2007, INFLUENZA OTHER RESP, V1, P157, DOI 10.1111/j.1750-2659.2007.00022.x; World Health Organization, SUMM STAT DEV AV AV; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H, 2013, J VIROL, V87, P12433, DOI 10.1128/JVI.01854-13; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; YEWDELL JW, 1986, J VIROL, V57, P623, DOI 10.1128/JVI.57.2.623-628.1986; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	39	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149149	10.1371/journal.pone.0149149	http://dx.doi.org/10.1371/journal.pone.0149149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862918	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600161
J	Meiring, S; Cohen, C; Quan, V; de Gouveia, L; Feldman, C; Karstaedt, A; Klugman, KP; Madhi, SA; Rabie, H; Sriruttan, C; von Gottberg, A				Meiring, Susan; Cohen, Cheryl; Quan, Vanessa; de Gouveia, Linda; Feldman, Charles; Karstaedt, Alan; Klugman, Keith P.; Madhi, Shabir A.; Rabie, Helene; Sriruttan, Charlotte; von Gottberg, Anne		GERMS-SA	HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV)	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIBIOTIC-RESISTANCE; BACTEREMIA; IMPACT; ERA; PREVALENCE; INDIVIDUALS; MORTALITY; COHORT; PNEUMONIA	Introduction Streptococcus pneumoniae is the commonest cause of bacteremic pneumonia among HIVinfected persons. As more countries with high HIV prevalence are implementing infant pneumococcal conjugate vaccine (PCV) programs, we aimed to describe the baseline clinical characteristics of adult invasive pneumococcal disease (IPD) in the pre-PCV era in South Africa in order to interpret potential indirect effects following vaccine use. Methods National, active, laboratory-based surveillance for IPD was conducted in South Africa from 1 January 2003 through 31 December 2008. At 25 enhanced surveillance (ES) hospital sites, clinical data, including HIV serostatus, were collected from IPD patients >= 5 years of age. We compared the clinical characteristics of individuals with IPD in those HIV-infected and -uninfected using multivariable analysis. PCV was introduced into the routine South African Expanded Program on Immunization (EPI) in 2009. Results In South Africa, from 2003-2008, 17 604 cases of IPD occurred amongst persons >= 5 years of age, with an average incidence of 7 cases per 100 000 person-years. Against a national HIV-prevalence of 18%, 89% (4190/4734) of IPD patients from ES sites were HIV-infected. IPD incidence in HIV-infected individuals is 43 times higher than in HIV-uninfected persons (52 per 100 000 vs. 1.2 per 100 000), with a peak in the HIV-infected elderly population of 237 per 100 000 persons. Most HIV-infected individuals presented with bacteremia (74%, 3 091/4 190). HIV-uninfected individuals were older; and had more chronic conditions (excluding HIV) than HIV-infected persons (39% (210/544) vs. 19% (790/4190), p< 0.001). During the pre-PCV immunization era in South Africa, 71% of serotypes amongst HIVinfected persons were covered by PCV13 vs. 73% amongst HIV-uninfected persons, p = 0.4, OR 0.9 (CI 0.7-1.1). Conclusion Seventy to eighty-five percent of adult IPD in the pre-PCV era were vaccine serotypes and 93% of cases had recognized risk factors (including HIV-infection) for pneumococcal vaccination. These data describe the epidemiology of IPD amongst HIV-infected and -uninfected adults during the pre-PCV era and provide a robust baseline to calculate the indirect effect of PCV in future studies.	[Meiring, Susan; Quan, Vanessa; de Gouveia, Linda] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Cohen, Cheryl; Klugman, Keith P.; Madhi, Shabir A.; von Gottberg, Anne] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Feldman, Charles] Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Div Pulmonol, Johannesburg, South Africa; [Karstaedt, Alan] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Klugman, Keith P.] Chris Hani Baragwanath Acad Hosp, Dept Internal Med, Johannesburg, South Africa; [Klugman, Keith P.] Emory Univ, Hubert Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Madhi, Shabir A.] Univ Witwatersrand, Sch Pathol, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.; von Gottberg, Anne] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Rabie, Helene] Tygerberg Hosp, Dept Pediat Med, Cape Town, South Africa; [Sriruttan, Charlotte] Natl Inst Communicable Dis, Ctr Opportunist Trop & Hosp Associated Infect, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Emory University; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Tygerberg Hospital; National Institute for Communicable Diseases (NICD)	Meiring, S (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa.	susan.meiring@nhls.ac.za	Meiring, Susan/M-1463-2019; Rabie, Helena/ABH-1437-2020; Feldman, Charles/ABF-3315-2020; Lekalakala, Ruth/D-4944-2017	Meiring, Susan/0000-0003-4508-5469; Rabie, Helena/0000-0001-6336-2963; Feldman, Charles/0000-0002-6881-8314; Keddy, Karen Helena/0000-0001-8640-2235; McCarthy, Kerrigan/0000-0001-8958-9795; Govender, Nelesh/0000-0001-7869-9462; Whitelaw, Andrew/0000-0001-9070-5247; Cohen, Cheryl/0000-0003-0376-2302; Heney, Claire/0000-0002-4201-9530; von Gottberg, Anne/0000-0002-0243-7455; ahmed, khatija/0000-0003-0309-1641; Davidsson, Leigh/0000-0002-8822-7554; Lekalakala, Ruth/0000-0001-8560-8581	National Health Laboratory Service/National Institute for Communicable Disease; HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) [U62/PSO022901]	National Health Laboratory Service/National Institute for Communicable Disease; HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP)	Development of this publication was partially funded by the National Health Laboratory Service/National Institute for Communicable Disease and by the HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) Cooperative Agreement U62/PSO022901. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; [Anonymous], 2005, ASSA2003 AIDS DEMOGR; [Anonymous], 2006, INITIAL OBSERVATIONS; [Anonymous], 2008, MIDYEAR POPULATION E; [Anonymous], 2009, GERMS SA ANN REPORT; Atashili J, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-138; Bar-Zeev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128738; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bhorat AE, 2015, AIDS, V29, P1345, DOI 10.1097/QAD.0000000000000689; Buie KA, 2004, J INFECT DIS, V189, P1996, DOI 10.1086/386548; Burgos J, 2015, EUR J CLIN MICROBIOL, V34, P177, DOI 10.1007/s10096-014-2221-9; Burgos J, 2012, JAIDS-J ACQ IMM DEF, V59, P31, DOI 10.1097/QAI.0b013e31823d0f5f; Cheyip M, 2007, GERMS SA COLLECTION; Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd; CreweBrown HH, 1997, CLIN INFECT DIS, V25, P1165, DOI 10.1086/516104; Crowther-Gibson P, 2012, ANTIMICROB AGENTS CH, V56, P5088, DOI 10.1128/AAC.06463-11; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Feikin DR, 2005, CLIN INFECT DIS, V41, P481, DOI 10.1086/432015; Feldman C, 1999, S AFR MED J, V89, P1222; Ferrand RA, 2012, CLIN INFECT DIS, V55, P145, DOI 10.1093/cid/cis271; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Hibbs JR, 1997, CLIN INFECT DIS, V25, P195, DOI 10.1086/514538; JANOFF EN, 1992, ANN INTERN MED, V117, P314, DOI 10.7326/0003-4819-117-4-314; Johnson L., 2011, S AFR J HIV MED, V13, P22; Johnson LF, 2015, AIDS, V29, P1401, DOI 10.1097/QAD.0000000000000721; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Mayanja BN, 2010, TROP MED INT HEALTH, V15, P697, DOI 10.1111/j.1365-3156.2010.02528.x; Moroney JF, 2001, CLIN INFECT DIS, V33, P797, DOI 10.1086/322623; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ranieri R, 2005, AIDS RES HUM RETROV, V21, P407, DOI 10.1089/aid.2005.21.407; Sepako E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100640; Siemieniuk RAC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-314; Soeters HM, 2012, ANTIMICROB AGENTS CH, V56, P1602, DOI 10.1128/AAC.05813-11; Souter J, 2014, SA PHARM J, V81, P15; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; von Mollendorf C, 2016, EMERG INFECT DIS, V22, P261, DOI 10.3201/eid2202.150967; Wayne PA, 2008, PERF STAND ANT SUS S; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wong KK, 2015, BMC INFECT IN PRESS; Yin Z, 2012, AIDS, V26, P87, DOI 10.1097/QAD.0b013e32834dcf27; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	54	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149104	10.1371/journal.pone.0149104	http://dx.doi.org/10.1371/journal.pone.0149104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863135	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600154
J	Ounnas, F; Prive, F; Salen, P; Gaci, N; Tottey, W; Calani, L; Bresciani, L; Lopez-Gutierrez, N; Hazane-Puch, F; Laporte, F; Brugere, JF; Del Rio, D; Demeilliers, C; de Lorgeril, M				Ounnas, Faycal; Prive, Florence; Salen, Patricia; Gaci, Nadia; Tottey, William; Calani, Luca; Bresciani, Letizia; Lopez-Gutierrez, Noelia; Hazane-Puch, Florence; Laporte, Francois; Brugere, Jean-Francois; Del Rio, Daniele; Demeilliers, Christine; de Lorgeril, Michel			Whole Rye Consumption Improves Blood and Liver n-3 Fatty Acid Profile and Gut Microbiota Composition in Rats	PLOS ONE			English	Article							ALPHA-LINOLENIC ACID; COLONIC FERMENTATION; WHEAT BREAD; METABOLISM; GRAIN; LIGNANS; OBESITY; DIET; ENTEROLACTONE; HEALTH	Background Whole rye (WR) consumption seems to be associated with beneficial health effects. Although rye fiber and polyphenols are thought to be bioactive, the mechanisms behind the health effects of WR have yet to be fully identified. This study in rats was designed to investigate whether WR can influence the metabolism of n-3 and n-6 long-chain fatty acids (LCFA) and gut microbiota composition. Methods For 12 weeks, rats were fed a diet containing either 50% WR or 50% refined rye (RR). The WR diet provided more fiber (+21%) and polyphenols (+29%) than the RR diet. Fat intake was the same in both diets and particularly involved similar amounts of essential (18-carbon) n-3 and n-6 LCFAs. Results The WR diet significantly increased the 24-hour urinary excretion of polyphenol metabolites-including enterolactone-compared with the RR diet. The WR rats had significantly more n-3 LCFA-in particular, eicosapentanoic (EPA) and docosahexanoic (DHA) acids-in their plasma and liver. Compared with the RR diet, the WR diet brought significant changes in gut microbiota composition, with increased diversity in the feces (Shannon and Simpson indices), decreased Firmicutes/ Bacteroidetes ratio and decreased proportions of uncultured Clostridiales cluster IA and Clostridium cluster IV in the feces. In contrast, no difference was found between groups with regards to cecum microbiota. The WR rats had lower concentrations of total short-chain fatty acids (SCFA) in cecum and feces (p<0.05). Finally, acetate was lower (p<0.001) in the cecum of WR rats while butyrate was lower (p<0.05) in the feces of WR rats. Interpretation This study shows for the first time that WR consumption results in major biological modifications- increased plasma and liver n-3 EPA and DHA levels and improved gut microbiota profile, notably with increased diversity-known to provide health benefits. Unexpectedly, WR decreased SCFA levels in both cecum and feces. More studies are needed to understand the interactions between whole rye (fiber and polyphenols) and gut microbiota and also the mechanisms of action responsible for stimulating n-3 fatty acid metabolism.	[Ounnas, Faycal; Prive, Florence; Salen, Patricia; de Lorgeril, Michel] Univ Grenoble 1, Lab TIMC IMAG CNRS UMR 5525, Equipe PRETA, Coeur & Nutr, Grenoble 1, France; [Ounnas, Faycal; Prive, Florence; Demeilliers, Christine] Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget LBFA, Grenoble, France; [Ounnas, Faycal; Prive, Florence; Demeilliers, Christine] INSERM, U1055, Grenoble, France; [Gaci, Nadia; Tottey, William; Brugere, Jean-Francois] Univ Auvergne, Clermont Univ, EA CIDAM 4678, Clermont Ferrand, France; [Calani, Luca; Bresciani, Letizia; Del Rio, Daniele] Univ Parma, Lab Phytochem Physiol, Interlab Grp LS9, Dept Food Sci,Med Sch, Bldg C,Via Volturno 39, I-43125 Parma, Italy; [Hazane-Puch, Florence; Laporte, Francois] CHU Grenoble, Dept Biochim Pharmacol & Toxicol, Unite Biochim Hormonale & Nutr, F-38043 Grenoble, France; [Lopez-Gutierrez, Noelia] Univ Almeria, Res Ctr Agr & Food Biotechnol BITAL, Dept Chem & Phys, Analyt Chem Area,CeiA3, Agrifood Campus Int Excellence, E-04120 Almeria, Spain	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); University of Parma; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universidad de Almeria	Ounnas, F (corresponding author), Univ Grenoble 1, Lab TIMC IMAG CNRS UMR 5525, Equipe PRETA, Coeur & Nutr, Grenoble 1, France.; Ounnas, F (corresponding author), Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget LBFA, Grenoble, France.; Ounnas, F (corresponding author), INSERM, U1055, Grenoble, France.	ounnasf@ujf-grenoble.fr	Demeilliers, Christine/GWZ-9743-2022; Brugère, Jean-François/AAB-4001-2019; Del Rio, Daniele/E-8696-2010	Brugère, Jean-François/0000-0002-1559-2331; Del Rio, Daniele/0000-0001-5394-1259; PUCH, Florence/0000-0003-2770-289X; Demeilliers, Christine/0000-0002-8648-4805; Bresciani, Letizia/0000-0002-7768-4987	Barilla G. R. Fratelli Spa; European Community [245121]	Barilla G. R. Fratelli Spa; European Community(European Commission)	This project has been funded by Barilla G. R. Fratelli Spa and supported in part by the 7th Framework Program ATHENA [Grant agreement no.: 245121] from the European Community. The funding is managed by the Grenoble University (School of Medicine) without involvement of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen MF, 2001, J AGR FOOD CHEM, V49, P5679, DOI 10.1021/jf010668c; Andreasen MF, 2000, J AGR FOOD CHEM, V48, P2837, DOI 10.1021/jf991266w; Belobrajdic DP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-62; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Boto-Ordonez M, 2014, FOOD FUNCT, V5, P1932, DOI [10.1039/c4fo00029c, 10.1039/C4FO00029C]; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Calani L, 2014, FOOD FUNCT, V5, P1738, DOI [10.1039/C4FO00328D, 10.1039/c4fo00328d]; Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448; Caricilli AM, 2013, NUTRIENTS, V5, P829, DOI 10.3390/nu5030829; Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Czank C, 2013, AM J CLIN NUTR, V97, P995, DOI 10.3945/ajcn.112.049247; Damdimopoulou P, 2011, J NUTR, V141, P1583, DOI 10.3945/jn.111.140277; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Lorgeril M, 2008, AM HEART J, V155, P175, DOI 10.1016/j.ahj.2007.08.009; di Giuseppe R, 2009, AM J CLIN NUTR, V89, P354, DOI 10.3945/ajcn.2008.26661; Emken EA, 2001, LIPIDS, V36, P965, DOI 10.1007/s11745-001-0807-4; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Feria-Gervasio D, 2011, APPL MICROBIOL BIOT, V91, P1425, DOI 10.1007/s00253-011-3462-5; Freeland KR, 2010, BRIT J NUTR, V103, P82, DOI 10.1017/S0007114509991462; Frolich W, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.18503; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Glitso LV, 1998, BRIT J NUTR, V80, P457, DOI 10.1017/S0007114598001536; Glitso LV, 2000, BRIT J NUTR, V84, P429; Gobert M, 2009, J DAIRY SCI, V92, P6095, DOI 10.3168/jds.2009-2087; Hallmans G, 2003, P NUTR SOC, V62, P193, DOI 10.1079/PNS2002229; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Juntunen KS, 2000, BRIT J NUTR, V84, P839; Kyro C, 2012, SCAND J PUBLIC HEALT, V40, P76, DOI 10.1177/1403494811421057; Landete JM, 2012, FOOD RES INT, V46, P410, DOI 10.1016/j.foodres.2011.12.023; Lankinen M, 2010, NUTR METAB CARDIOVAS, V20, P249, DOI 10.1016/j.numecd.2009.04.009; Lappi J, 2013, J NUTR, V143, P648, DOI 10.3945/jn.112.172668; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Le Gall M, 2009, BRIT J NUTR, V102, P1590, DOI 10.1017/S0007114509990924; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martinez-Ramirez HR, 2013, J ANIM SCI, V91, P2729, DOI 10.2527/jas.2012-5783; Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6; Nilsson M, 1997, J SCI FOOD AGR, V73, P143, DOI 10.1002/(SICI)1097-0010(199702)73:2&lt;143::AID-JSFA698&gt;3.0.CO;2-H; Nordlund E, 2012, J AGR FOOD CHEM, V60, P8134, DOI 10.1021/jf3008037; Ounnas F, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.24604; Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009; Pawlosky R, 2003, BRIT J NUTR, V90, P993, DOI 10.1079/BJN2003985; Penttinen P, 2007, ENDOCRINOLOGY, V148, P4875, DOI 10.1210/en.2007-0289; Reeves PG, 1993, J NUTR, V123; Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110; Sibbons CM, 2014, PROSTAG LEUKOTR ESS, V90, P47, DOI 10.1016/j.plefa.2013.12.006; Siurek B, 2012, FOOD SCI TECHNOL INT, V18, P559, DOI 10.1177/1082013211433079; Superko HR, 2013, CIRCULATION, V128, P2154, DOI 10.1161/CIRCULATIONAHA.113.002731; Theil PK, 2011, BRIT J NUTR, V105, P373, DOI 10.1017/S0007114510003715; Tottey W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062544; Toufektsian MC, 2011, J NUTR, V141, P37, DOI 10.3945/jn.110.127225; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Unno T, 2014, J NUTR SCI VITAMINOL, V60, P213, DOI 10.3177/jnsv.60.213; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu HY, 2015, JAMA INTERN MED, V175, P373, DOI 10.1001/jamainternmed.2014.6283; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089	61	17	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148118	10.1371/journal.pone.0148118	http://dx.doi.org/10.1371/journal.pone.0148118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862900	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600044
J	Liu, SZ; Zhao, ZZ; Han, L; Liu, S; Luo, B				Liu, Shuzhen; Zhao, Zhenzhen; Han, Lu; Liu, Song; Luo, Bing			Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China	PLOS ONE			English	Article							TO-CELL CONTACT; HUMAN EPITHELIAL-CELLS; NASOPHARYNGEAL CARCINOMA; GENOTYPIC ANALYSIS; SOUTHERN CHINA; PERIPHERAL-BLOOD; HEALTHY CARRIERS; NPC BIOPSIES; STUMP CANCER; TUMOR-CELLS	Background Epstein-Barr virus (EBV) is associated with a subset of gastric carcinoma which was defined as EBV associated gastric carcinoma (EBVaGC). The proportion of EBVaGC in gastric remnant carcinoma (GRC) which occurs in the intact stomach five or more years after gastric surgery for benign disease is significantly higher than that in conventional gastric carcinoma (CGC). The infection of EBV in recurrent gastric carcinoma (RGC) with local anastomotic recurrence is poorly understood. Methods 53 cases of GRC and 58 cases of RGC were analyzed for the presence of EBV, and the variants of EBV Encoded RNAs (EBER), EBV Nuclear Antigen 1 (EBNA1) and Latent Membrane Protein 1 (LMP1) gene in both groups were investigated. Results Thirteen (24.5%) out of 53 GRC cases and 3 (5.2%) out of 58 RGC cases were identified as EBVaGCs. In 17 paired RGC cases, only one case was classified as EBVaGC in both times specimen. Another one case was identified as EBVaGC in the primary gastroectomy specimen while the recurrent gastric cancer was not. The third EBVaGC in RGC was identified while the primary gastric cancer was not EBVaGC. In GRC and RGC cases, type 1, type F, EB-6m, V-val subtype, del-LMP1 were predominant type or variants, accounting for 10 (76.9%) and 2(66.7%), 13(100%) and 3(100%), 13(100%) and 3(100%), 9(69.2%) and 3 (100%), 12(92.3%) and 3(100%), respectively. However, Type C was the predominant type in GRC accounting for 9(69.2%) cases while type D was the predominant one accounting for 2(66.7%) cases in RGC. Conclusions The prevalence of EBVaGc in GRC and RGC was significantly different. The distributions of these variants were similar to each other in the two groups which indicated that there were no more aggressive EBV variants in EBVaGC in GRC compared with that in RGC.	[Liu, Shuzhen] Affiliated Hosp Qingdao Univ, Dept Blood Transfus, 16 Jiangsu Rd, Qingdao 266003, Peoples R China; [Zhao, Zhenzhen; Liu, Song; Luo, Bing] Qingdao Univ, Coll Med, Dept Med Microbiol, 38 Dengzhou Rd, Qingdao 266021, Peoples R China; [Han, Lu] Affiliated Hosp Qingdao Univ, Dept Clin Lab, 16 Jiangsu Rd, Qingdao 266003, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Luo, B (corresponding author), Qingdao Univ, Coll Med, Dept Med Microbiol, 38 Dengzhou Rd, Qingdao 266021, Peoples R China.	qdluobing@163.com			Ministry of Education of China [20133706110001]; Department of Science & Technology of Shandong Province [ZR2011CM016]; Qingdao Municipal Science and Technology Commission [13-1-3-50-jch]	Ministry of Education of China(Ministry of Education, China); Department of Science & Technology of Shandong Province; Qingdao Municipal Science and Technology Commission	This work was supported by the Ministry of Education of China, grant number: 20133706110001 (http://www.moe.gov.cn/), the Department of Science & Technology of Shandong Province, grant number: ZR2011CM016 (http://www.sdstc.gov.cn/), and the Qingdao Municipal Science and Technology Commission, grant number: 13-1-3-50-jch (http://www.qdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAMID M, 1992, VIROLOGY, V190, P168, DOI 10.1016/0042-6822(92)91202-6; Akiba S, 2008, CANCER SCI, V99, P195, DOI 10.1111/j.1349-7006.2007.00674.x; Baas IO, 1998, J CLIN PATHOL, V51, P662, DOI 10.1136/jcp.51.9.662; BORISCH B, 1993, INT J CANCER, V55, P748, DOI 10.1002/ijc.2910550509; Bornkamm GW, 2009, INT J CANCER, V124, P1745, DOI 10.1002/ijc.24223; BOUZID M, 1994, INT J CANCER, V56, P468, DOI 10.1002/ijc.2910560403; Camargo MC, 2011, BRIT J CANCER, V105, P38, DOI 10.1038/bjc.2011.215; Chang MS, 2000, PATHOL INT, V50, P486, DOI 10.1046/j.1440-1827.2000.01072.x; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chen JN, 2011, VIRUS RES, V160, P191, DOI 10.1016/j.virusres.2011.06.011; Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170; Correa RM, 2004, J MED VIROL, V73, P583, DOI 10.1002/jmv.20129; Cui Y, 2011, INTERVIROLOGY, V54, P131, DOI 10.1159/000319632; Dawson CW, 2000, VIROLOGY, V272, P204, DOI 10.1006/viro.2000.0344; Fielding CA, 2001, J VIROL, V75, P9129, DOI 10.1128/JVI.75.19.9129-9141.2001; Gutierrez MI, 1998, BLOOD, V92, P600, DOI 10.1182/blood.V92.2.600.414k33_600_606; Gutierrez MI, 1997, J GEN VIROL, V78, P1663, DOI 10.1099/0022-1317-78-7-1663; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Imai S, 1998, J VIROL, V72, P4371, DOI 10.1128/JVI.72.5.4371-4378.1998; Kaizaki Y, 2005, J GASTROENTEROL, V40, P570, DOI 10.1007/s00535-005-1590-3; Khanim F, 1996, BLOOD, V88, P3491, DOI 10.1182/blood.V88.9.3491.bloodjournal8893491; Klemenc P, 2006, J MED VIROL, V78, P1083, DOI 10.1002/jmv.20666; Koriyama C, 2005, J EXP CLIN CANC RES, V24, P547; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2009, J GASTROEN HEPATOL, V24, P354, DOI 10.1111/j.1440-1746.2009.05775.x; LUNG ML, 1990, VIROLOGY, V177, P44, DOI 10.1016/0042-6822(90)90458-4; LUNG ML, 1994, INT J CANCER, V59, P743; LUNG ML, 1992, INT J CANCER, V52, P34, DOI 10.1002/ijc.2910520108; LUNG ML, 1991, VIROLOGY, V185, P67, DOI 10.1016/0042-6822(91)90754-Y; LUNG ML, 1992, INT J CANCER, V52, P174, DOI 10.1002/ijc.2910520203; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Mai SJ, 2007, ONCOL REP, V17, P141; Niedobitek G, 2000, J CLIN PATHOL-MOL PA, V53, P248, DOI 10.1136/mp.53.5.248; Nishikawa J, 2002, SCAND J GASTROENTERO, V37, P825, DOI 10.1080/713786518; RICKINSON AB, 1987, J VIROL, V61, P1310, DOI 10.1128/JVI.61.5.1310-1317.1987; Safatle-Ribeiro AV, 1998, DIGEST DIS, V16, P159, DOI 10.1159/000016860; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Sidagis J, 1997, INT J CANCER, V72, P72, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;72::AID-IJC11&gt;3.0.CO;2-C; Sinning C, 2007, EJSO-EUR J SURG ONC, V33, P133, DOI 10.1016/j.ejso.2006.09.006; Speck P, 2000, J NATL CANCER I, V92, P1849, DOI 10.1093/jnci/92.22.1849; Sugiura M, 1996, BRIT J CANCER, V74, P625, DOI 10.1038/bjc.1996.412; Takada K, 2000, J CLIN PATHOL-MOL PA, V53, P255, DOI 10.1136/mp.53.5.255; TAMURA S, 1993, JPN J CANCER RES, V84, P246, DOI 10.1111/j.1349-7006.1993.tb02863.x; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Wang Y, 2005, WORLD J GASTROENTERO, V11, P3234, DOI 10.3748/wjg.v11.i21.3234; Wang Y, 2010, J MED VIROL, V82, P829, DOI 10.1002/jmv.21714; Wang Y, 2010, VIRUS RES, V147, P258, DOI 10.1016/j.virusres.2009.11.010; YAMAMOTO N, 1994, CANCER, V74, P805, DOI 10.1002/1097-0142(19940801)74:3<805::AID-CNCR2820740304>3.0.CO;2-L; Yang Ting-ting, 2009, Chinese Journal of Virology, V25, P29; ZIMBER U, 1986, VIROLOGY, V154, P56, DOI 10.1016/0042-6822(86)90429-0	53	6	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148342	10.1371/journal.pone.0148342	http://dx.doi.org/10.1371/journal.pone.0148342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859565	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400033
J	Malanga, D; Belmonte, S; Colelli, F; Scarfo, M; De Marco, C; Oliveira, DM; Mirante, T; Camastra, C; Gagliardi, M; Rizzuto, A; Mignogna, C; Paciello, O; Papparella, S; Fagman, H; Viglietto, G				Malanga, Donatella; Belmonte, Stefania; Colelli, Fabiana; Scarfo, Marzia; De Marco, Carmela; Oliveira, Duarte Mendes; Mirante, Teresa; Camastra, Caterina; Gagliardi, Monica; Rizzuto, Antonia; Mignogna, Chiara; Paciello, Orlando; Papparella, Serenella; Fagman, Henrik; Viglietto, Giuseppe			AKT1(E17K) Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer	PLOS ONE			English	Article							BRONCHIOALVEOLAR STEM-CELLS; E17K MUTATION; SIGNALING PATHWAY; HIGH-FREQUENCY; RAS ONCOGENE; PIK3CA; AKT1; TUMORIGENESIS; GENE; EXPRESSION	The hotspot AKT1(E17K) mutation in the pleckstrin homology domain of AKT1 occurs in approximately 0.6-2% of human lung cancers. Recently, we have demonstrated that AKT1(E17K) transforms immortalized human bronchial cells. Here by use of a transgenic Cre-inducible murine strain in the wild type Rosa26 (R26) locus (R26-AKT1(E17)K mice) we demonstrate that AKT1(E17K) is a bona-fide oncogene and plays a role in the development of lung cancer in vivo. In fact, we report that mutant AKT1(E17K) induces bronchial and/or bronchiolar hyperplastic lesions in murine lung epithelium, which progress to frank carcinoma at very low frequency, and accelerates tumor formation induced by chemical carcinogens. In conclusion, AKT1(E17K) induces hyperplasia of mouse lung epithelium in vivo and cooperates with urethane to induce the fully malignant phenotype.	[Malanga, Donatella; De Marco, Carmela; Oliveira, Duarte Mendes; Mirante, Teresa; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy; [Malanga, Donatella; Belmonte, Stefania; Colelli, Fabiana; Scarfo, Marzia; De Marco, Carmela; Viglietto, Giuseppe] BIOGEM, Ist Ric Genet, Ariano Irpino, AV, Italy; [Camastra, Caterina] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Unita Anat Patol, Catanzaro, Italy; [Gagliardi, Monica] Magna Graecia Univ Catanzaro, IBFM CNR, Catanzaro, Italy; [Rizzuto, Antonia] Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy; [Paciello, Orlando; Papparella, Serenella] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Fagman, Henrik] Sahlgrens Univ Hosp, Dept Clin Pathol & Genet, Gothenburg, Sweden	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of Naples Federico II; Sahlgrenska University Hospital	Malanga, D; Viglietto, G (corresponding author), Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy.; Malanga, D; Viglietto, G (corresponding author), BIOGEM, Ist Ric Genet, Ariano Irpino, AV, Italy.	malanga@unicz.it; viglietto@unicz.it	rizzuto, antonia/GVT-4842-2022; Viglietto, Giuseppe/AAC-2852-2019; Malanga, Donatella/J-4877-2018; De Marco, Carmela/J-6797-2015	rizzuto, antonia/0000-0003-4359-4702; Viglietto, Giuseppe/0000-0003-2327-7515; Malanga, Donatella/0000-0002-0491-7698; De Marco, Carmela/0000-0002-4893-4246; Mendes Oliveira, Duarte/0000-0003-3922-3060; Mignogna, Chiara/0000-0001-5576-4946	Associazione Italiana Ricerca sul Cancro (AIRC) [IG_12969]; Ministero Istruzione Universita e Ricerca (MIUR PRIN) [2010W4J4RM_001, PONa3_00239, PON01_02782]; Vastra Gotalandsregionen; Assar Gabrielssons Foundation; Magnus Bergvalls Foundation	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Istruzione Universita e Ricerca (MIUR PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Vastra Gotalandsregionen; Assar Gabrielssons Foundation; Magnus Bergvalls Foundation	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC 2012-14, IG_12969) and Ministero Istruzione Universita e Ricerca (MIUR PRIN, prot. 2010W4J4RM_001; PONa3_00239; PON01_02782) to GV. HF was supported by Vastra Gotalandsregionen under the LUA/ALF agreement and by the Assar Gabrielssons and Magnus Bergvalls Foundations.; The authors thank Marzia Scarfo, Andrea Affuso and Antonio Dionisio (Biogem s.c.a r.l., Ariano Irpino, Italy) for mouse experiments. This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC 2012-14, IG_12969) and Ministero Istruzione Universita Ricerca (MIUR, PRIN, prot. 2010W4J4RM_001; PONa3_00239; PON01_02782) to GV. HF was supported by Vastra Gotalandsregionen under the LUA/ALF agreement and by the Assar Gabrielssons and Magnus Bergvalls Foundations.	Almendro V, 2011, CLIN TRANSL ONCOL, V13, P767, DOI 10.1007/s12094-011-0731-9; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Boch C, 2013, BMJ OPEN, V3; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; De Marco C, 2015, ONCOTARGET; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Do HD, 2010, CELL CYCLE, V9, P4411, DOI 10.4161/cc.9.21.13654; Do H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-142; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Felip E, 2011, ANN ONCOL, V22, P1507, DOI 10.1093/annonc/mdr150; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hayashi SM, 2001, TOXICOL PATHOL, V29, P422, DOI 10.1080/01926230152499908; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Iwanaga K, 2008, CANCER RES, V68, P1119, DOI 10.1158/0008-5472.CAN-07-3117; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; KAWANO R, 1995, JPN J CANCER RES, V86, P802, DOI 10.1111/j.1349-7006.1995.tb03089.x; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Lauring J, 2010, ONCOGENE, V29, P2337, DOI 10.1038/onc.2009.516; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Mason RJ, 2000, AM J PATHOL, V156, P175, DOI 10.1016/S0002-9440(10)64717-7; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; NUZUM EO, 1990, MOL CARCINOGEN, V3, P287, DOI 10.1002/mc.2940030509; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Redente EF, 2007, AM J PATHOL, V170, P693, DOI 10.2353/ajpath.2007.060566; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; RODENHUIS S, 1992, CANCER RES, V52, pS2665; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; Viglietto G, 2009, CELL CYCLE, V8, P2869, DOI 10.4161/cc.8.18.9757; Xu Cheng-Xiong, 2010, Front Biosci (Elite Ed), V2, P1472; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yi KH, 2013, ONCOTARGET, V4, P29, DOI 10.18632/oncotarget.755; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zheng DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071028	65	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147334	10.1371/journal.pone.0147334	http://dx.doi.org/10.1371/journal.pone.0147334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859676	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400007
J	Manell, E; Hedenqvist, P; Svensson, A; Jensen-Waern, M				Manell, Elin; Hedenqvist, Patricia; Svensson, Anna; Jensen-Waern, Marianne			Establishment of a Refined Oral Glucose Tolerance Test in Pigs, and Assessment of Insulin, Glucagon and Glucagon-Like Peptide-1 Responses	PLOS ONE			English	Article							BETA-CELL FUNCTION; FASTING SERUM-INSULIN; DIABETES-MELLITUS; GENE-EXPRESSION; LIFE EXPECTANCY; POLYPEPTIDE; TYPE-1; SENSITIVITY; SECRETION; INCRETIN	Diabetes mellitus is increasing worldwide and reliable animal models are important for progression of the research field. The pig is a commonly used large animal model in diabetes research and the present study aimed to refine a model for oral glucose tolerance test (OGTT) in young growing pigs, as well as describing intravenous glucose tolerance test (IVGTT) in the same age group. The refined porcine OGTT will reflect that used in children and adolescents. Eighteen pigs were obtained one week after weaning and trained for two weeks to bottle-feed glucose solution, mimicking the human OGTT. The pigs subsequently underwent OGTT (1.75 g/kg BW) and IVGTT (0.5 g/kg BW). Blood samples were collected from indwelling vein catheters for measurements of glucose and the diabetes related hormones insulin, glucagon and active glucagon-like peptide-1. The study confirmed that pigs can be trained to bottle-feed glucose dissolved in water and thereby undergo an OGTT more similar to the human standard OGTT than previously described methods in pigs. With the refined method for OGTT, oral intake only consists of glucose and water, which is an advantage over previously described methods in pigs where glucose is given together with feed which will affect glucose absorption. Patterns of hormonal secretion in response to oral and intravenous glucose were similar to those in humans; however, the pigs were more glucose tolerant with lower insulin levels than humans. In translational medicine, this refined OGTT and IVGTT methods provide important tools in diabetes research when pigs are used as models for children and adolescents in diabetes research.	[Manell, Elin; Hedenqvist, Patricia; Svensson, Anna; Jensen-Waern, Marianne] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences	Manell, E (corresponding author), Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden.	elin.manell@slu.se	Hedenqvist, Patricia/B-7871-2017	Hedenqvist, Patricia/0000-0003-4540-6250; Svensson, Anna/0000-0003-4015-2001; Jensen-Waern, Marianne/0000-0001-6195-7066; Manell, Elin/0000-0002-4491-7609	Michael Forsgrens Foundation [2015-1]	Michael Forsgrens Foundation	The study was supported by Michael Forsgrens Foundation (2015-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1970, Q J EXP PHYSIOL CMS, V55, P104, DOI 10.1113/expphysiol.1970.sp002055; Bagger JI, 2014, DIABETOLOGIA, V57, P1720, DOI 10.1007/s00125-014-3264-2; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bellinger DA, 2012, MINIPIG IN BIOMEDICAL RESEARCH, P445; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bervoets L, 2015, HORM METAB RES, V47, P445, DOI 10.1055/s-0034-1395551; Christensen M, 2011, DIABETES, V60, P3103, DOI 10.2337/db11-0979; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Deacon CF, 1996, AM J PHYSIOL-ENDOC M, V271, pE458, DOI 10.1152/ajpendo.1996.271.3.E458; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; ELRICK H, 1964, J CLIN ENDOCR METAB, V24, P1076, DOI 10.1210/jcem-24-10-1076; Faerch K, 2015, DIABETES; Fagot-Campagna A, 2000, J PEDIATR ENDOCR MET, V13, P1395; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Garansson L., 2011, NUTR RECOMMENDATIONS; George P, 2013, DIABETIC MED, V30, P179, DOI 10.1111/j.1464-5491.2012.03744.x; GRANT DB, 1967, ARCH DIS CHILD, V42, P375, DOI 10.1136/adc.42.224.375; Greenbaum CJ, 2002, DIABETES, V51, P951, DOI 10.2337/diabetes.51.4.951; Hare KJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE832, DOI 10.1152/ajpendo.00700.2009; Issa CM, 2012, CURR DIABETES REP, V12, P560, DOI 10.1007/s11892-012-0291-6; Jeffery AN, 2012, DIABETES CARE, V35, P536, DOI 10.2337/dc11-1281; JENKINS DJA, 1978, BRIT MED J, V1, P1392, DOI 10.1136/bmj.1.6124.1392; Kanauchi M, 2005, INT J CLIN PRACT, V59, P427, DOI 10.1111/j.1368-5031.2005.00422.x; Knop FK, 2010, REGUL PEPTIDES, V164, P144, DOI 10.1016/j.regpep.2010.05.011; KREYMANN B, 1987, LANCET, V2, P1300; Larsen Marianne Olholm, 2003, Exp Diabesity Res, V4, P93, DOI 10.1155/EDR.2003.93; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; Manell EAK, 2014, LAB ANIM-UK, V48, P261, DOI 10.1177/0023677213517683; Matsuo T, 2014, DIABETES RES CLIN PR, V106, pE25, DOI 10.1016/j.diabres.2014.09.002; Meier JJ, 2007, DIABETOLOGIA, V50, P806, DOI 10.1007/s00125-007-0598-z; Messenger B, 2003, J ENDOCRINOL, V177, P407, DOI 10.1677/joe.0.1770407; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Peplies J, 2014, INT J OBESITY, V38, pS39, DOI 10.1038/ijo.2014.134; Privatdnanupunt J, 2014, ACTA HISTOCHEM, V116, P545, DOI 10.1016/j.acthis.2013.11.007; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; SANDHU KS, 1987, GASTROENTEROLOGY, V92, P486, DOI 10.1016/0016-5085(87)90146-6; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Swindle M.M, 2007, SWINE LAB SURG ANEST; TORSDOTTIR I, 1989, J NUTR, V119, P1925, DOI 10.1093/jn/119.12.1925; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; TSENG CC, 1995, MOL CELL ENDOCRINOL, V115, P13, DOI 10.1016/0303-7207(95)03665-T; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yeung CM, 1999, MOL CELL ENDOCRINOL, V154, P161, DOI 10.1016/S0303-7207(99)00106-9	47	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148896	10.1371/journal.pone.0148896	http://dx.doi.org/10.1371/journal.pone.0148896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859145	Green Published, gold			2022-12-26	WOS:000370038400101
J	Martinez-Reina, J; Ojeda, J; Mayo, J				Martinez-Reina, Javier; Ojeda, Joaquin; Mayo, Juana			On the Use of Bone Remodelling Models to Estimate the Density Distribution of Bones. Uniqueness of the Solution	PLOS ONE			English	Article							PROXIMAL FEMUR; ADAPTATION; ELASTICITY; REPAIR; BEHAVIOR; POROSITY; LOADS	Bone remodelling models are widely used in a phenomenological manner to estimate numerically the distribution of apparent density in bones from the loads they are daily subjected to. These simulations start from an arbitrary initial distribution, usually homogeneous, and the density changes locally until a bone remodelling equilibrium is achieved. The bone response to mechanical stimulus is traditionally formulated with a mathematical relation that considers the existence of a range of stimulus, called dead or lazy zone, for which no net bone mass change occurs. Implementing a relation like that leads to different solutions depending on the starting density. The non-uniqueness of the solution has been shown in this paper using two different bone remodelling models: one isotropic and another anisotropic. It has also been shown that the problem of non-uniqueness is only mitigated by removing the dead zone, but it is not completely solved unless the bone formation and bone resorption rates are limited to certain maximum values.	[Martinez-Reina, Javier; Ojeda, Joaquin; Mayo, Juana] Univ Seville, Dept Mech Engn, Seville, Spain	University of Sevilla	Martinez-Reina, J (corresponding author), Univ Seville, Dept Mech Engn, Seville, Spain.	jmreina@us.es	Ojeda, Joaquín/AAA-3222-2021; Mayo, Juana/L-1448-2015; Ojeda, Joaquín/I-2380-2014	Ojeda, Joaquín/0000-0002-6894-197X; Mayo, Juana/0000-0001-8752-8585; Ojeda, Joaquín/0000-0002-6894-197X	Ministerio de Economia y Competitividad (ES) grant [DPI2013-44371-P, DPI2014-58233-P]	Ministerio de Economia y Competitividad (ES) grant	This work was supported by Ministerio de Economia y Competitividad (ES) grant number DPI2013-44371-P (author: JM) and Ministerio de Economia y Competitividad (ES) grant number DPI2014-58233-P (author: JMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 1997, J BIOMECH, V30, P671, DOI 10.1016/S0021-9290(97)00004-3; BEAUPRE GS, 1990, J ORTHOPAED RES, V8, P662, DOI 10.1002/jor.1100080507; BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506; Behrens BA, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-7; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; CARTER DR, 1987, J BIOMECH, V20, P1095, DOI 10.1016/0021-9290(87)90027-3; Christen P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5855; COWIN SC, 1976, J ELASTICITY, V6, P313, DOI 10.1007/BF00041724; COWIN SC, 1978, J ELASTICITY, V8, P285, DOI 10.1007/BF00130467; CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1; Doblare M, 2002, J BIOMECH, V35, P1, DOI 10.1016/S0021-9290(01)00178-6; Doblare M, 2001, J BIOMECH, V34, P1157, DOI 10.1016/S0021-9290(01)00069-0; Fernandes P., 1999, Comput Methods Biomech Biomed Engin, V2, P125, DOI 10.1080/10255849908907982; Franzoso G, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005162; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Garcia-Aznar JM, 2005, BIOMECH MODEL MECHAN, V4, P147, DOI 10.1007/s10237-005-0067-x; Garijo N, 2014, COMPUT METHOD APPL M, V268, P437, DOI 10.1016/j.cma.2013.10.005; Geraldes DM, 2014, INT J NUMER METH BIO, V30, P873, DOI 10.1002/cnm.2633; Heller MO, 2005, J BIOMECH, V38, P1155, DOI 10.1016/j.jbiomech.2004.05.022; Hernandez CJ, 2001, BONE, V29, P74, DOI 10.1016/S8756-3282(01)00467-7; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; Jacobs C, 1994, THESIS STANFORD U; JACOBS CR, 1995, J BIOMECH, V28, P449, DOI 10.1016/0021-9290(94)00087-K; Klika V, 2014, J MATH BIOL, V69, P1383, DOI 10.1007/s00285-013-0736-9; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Lenaerts L, 2015, COMPUT METHOD BIOMEC, V18, P1392, DOI 10.1080/10255842.2014.908856; Machado MM, 2013, J BIOMECH, V46, P2179, DOI 10.1016/j.jbiomech.2013.06.031; MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179; Martinez-Reina J, 2009, BIOMECH MODEL MECHAN, V8, P111, DOI 10.1007/s10237-008-0122-5; Mengoni M, 2015, COMPUT METHOD BIOMEC, V18, P1367, DOI 10.1080/10255842.2014.903933; Monnier J, 1998, COMPUT METHOD APPL M, V151, P539, DOI 10.1016/S0045-7825(97)00164-3; WEINANS H, 1992, J BIOMECH, V25, P1425, DOI 10.1016/0021-9290(92)90056-7; Zysset PK, 2003, J BIOMECH, V36, P1469, DOI 10.1016/S0021-9290(03)00128-3	34	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148603	10.1371/journal.pone.0148603	http://dx.doi.org/10.1371/journal.pone.0148603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859888	Green Submitted, gold, Green Published			2022-12-26	WOS:000370038400055
J	von Baczko, MB; Desojo, JB				Belen von Baczko, Maria; Brenda Desojo, Julia			Cranial Anatomy and Palaeoneurology of the Archosaur Riojasuchus tenuisceps from the Los Colorados Formation, La Rioja, Argentina	PLOS ONE			English	Article							EARLY EVOLUTION; BRAINCASE; OSTEOLOGY; TAXONOMY; DIAPSIDA; REPTILE; REDESCRIPTION; AETOSAURIA; EUPARKERIA; DINOSAURS	Riojasuchus tenuisceps Bonaparte 1967 is currently known from four specimens, including two complete skulls, collected in the late 1960s from the upper levels of the Los Colorados Formation (Late Triassic), La Rioja, Argentina. Computed tomography (CT) scans of the skulls of the holotype and a referred specimen of Riojasuchus tenuisceps and the repreparation of the latter allows recognition of new features for a detailed analysis of its cranial anatomy and its comparison with a wide variety of other archosauriform taxa. The diagnosis of Riojasuchus tenuisceps is emended and two autapomorphies are identified on the skull: (1) a deep antorbital fossa with its anterior and ventral edges almost coinciding with the same edges of the maxilla itself and (2) a suborbital fenestra equal in size to the palatinepterygoid fenestra. Also, the first digital 3D reconstruction of the encephalon of Riojasuchus tenuisceps was carried out to study its neuroanatomy, showing a shape and cranial nerve disposition consistent to that of other pseudosuchians.	[Belen von Baczko, Maria; Brenda Desojo, Julia] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Belen von Baczko, Maria; Brenda Desojo, Julia] Museo Argentino Ciencias Nat Bernardino Rivadavia, Secc Paleontol Vertebrados, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	von Baczko, MB (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	belen_vb@macn.gov.ar		von Baczko, Maria Belen/0000-0003-2570-3418; Desojo, Julia Brenda/0000-0002-2739-3276	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2014-609]; Deutscher Akademischer Austausch Dienst (DAAD)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The research was funded by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) though PICT 2014-609 granted to JBD and the European collection visits were funded by a project granted to MBvB during 2014 by the Deutscher Akademischer Austausch Dienst (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcober O, 2000, J VERTEBR PALEONTOL, V20, P302, DOI 10.1671/0272-4634(2000)020[0302:ROTSOS]2.0.CO;2; ARCUCCI A, 1990, Ameghiniana, V27, P365; Arcucci AB, 2004, GEOBIOS-LYON, V37, P557, DOI 10.1016/j.geobios.2003.04.008; BARBERENA MC, 1978, PESQUISAS, V7, P111; Von Baczko MB, 2014, J VERTEBR PALEONTOL, V34, P1342, DOI 10.1080/02724634.2014.860150; Von Baczko MB, 2013, GEOL SOC SPEC PUBL, V379, P187, DOI 10.1144/SP379.4; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Bittencourt JS, 2015, J SYST PALAEONTOL, V13, P189, DOI 10.1080/14772019.2013.878758; Bona P, 2013, ANAT REC, V296, P227, DOI 10.1002/ar.22625; Bona P, 2011, J MORPHOL, V272, P780, DOI 10.1002/jmor.10894; Bonaparte J.F., 1981, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" y Instituto Nacional de Investigacion de las Ciencias Naturales Palaeontologia, V3, P55; Bonaparte J.F, 1970, P PAP 2 GONDW S S AF, P665; Bonaparte J. F., 1967, GONDWANA S P PAPERS, V1, P283; BONAPARTE J.F., 1973, 5 C GEOL ARG ACT, VIII, P123; Bonaparte JF, 1972, OPERA LILLOANA, V22, P13; Desojo JB, 2007, PALAEONTOLOGY, V50, P266; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Brusatte SL, 2009, ACTA PALAEONTOL POL, V54, P221, DOI 10.4202/app.2008.0065; Butler RJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-128; Case EC, 1921, J COMP NEUROL, V33, P133; Clark JM, 2002, ZOOL J LINN SOC-LOND, V136, P77, DOI 10.1046/j.1096-3642.2002.00026.x; Clark JM, 2000, J VERTEBR PALEONTOL, V20, P683, DOI 10.1671/0272-4634(2000)020[0683:ANSOHA]2.0.CO;2; Cope ED., 1871, SYNOPSIS EXTINCT BAT; CROMPTON AW, 1962, NATURE, V196, P1074, DOI 10.1038/1961074a0; Desojo JB, 2013, ANAT REC, P296; Desojo JB, 2013, GEOL SOC SPEC PUBL, V379, P203, DOI 10.1144/SP379.17; Desojo JB, 2011, J VERTEBR PALEONTOL, V31, P596, DOI 10.1080/02724634.2011.572936; Desojo JB, 2009, J VERTEBR PALEONTOL, V29, P1311, DOI 10.1671/039.029.0422; Dilkes D, 2012, PALAEONTOLOGY, V55, P853, DOI 10.1111/j.1475-4983.2012.01170.x; Dilkes D, 2009, J VERTEBR PALEONTOL, V29, P58, DOI 10.1080/02724634.2009.10010362; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; Dzik Jerzy, 2007, PALAEONTOLOGIA POLONICA, P3; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2015, PALAEONTOLOGY, V58, P141, DOI 10.1111/pala.12130; Ferigolo J., 2006, HIST BIOL, V19, P1, DOI DOI 10.1080/08912960600845767; Gauthier J., 1985, P185; GOW C E, 1975, Palaeontologia Africana, V18, P89; Gow CE, 2000, J VERTEBR PALEONTOL, V20, P49, DOI 10.1671/0272-4634(2000)020[0049:TSOPHA]2.0.CO;2; Gower DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111154; Gower David John, 2003, Annals of the South African Museum, V110, P1; Gower DJ, 1997, J ZOOL, V242, P557; Gower DJ, 2002, ZOOL J LINN SOC-LOND, V136, P7, DOI 10.1046/j.1096-3642.2002.00023.x; Gower DJ, 2002, ZOOL J LINN SOC-LOND, V136, P49, DOI 10.1046/j.1096-3642.2002.00025.x; Gower DJ, 1997, J VERTEBR PALEONTOL, V17, P60, DOI 10.1080/02724634.1997.10010954; Gower DJ, 1998, BIOL REV, V73, P367, DOI 10.1017/S0006323198005222; Gower DJ, 1996, PALAEONTOLOGY, V39, P883; Gower DJ, 2010, J VERTEBR PALEONTOL, V26, P79; Holliday CM, 2013, GEOL SOC SPEC PUBL, V379, P555, DOI 10.1144/SP379.2; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Huene F.von, 1908, GEOLOGISCHE PALAON S, P1; Hungerbuhler A, 2000, NEUES JAHRB GEOL P-M, P467; Hungerbuhler A, 2002, PALAEONTOLOGY, V45, P377, DOI 10.1111/1475-4983.00242; HUNT A P, 1990, Palaeontologische Zeitschrift, V64, P317; Huxley TH, 1877, MEM GEOL SURV UK, VIII, P5; Trotteyn MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111388; Kent DV, 2014, P NATL ACAD SCI USA, V111, P7958, DOI 10.1073/pnas.1402369111; Langer MC, 2013, GEOL SOC SPEC PUBL, V379, P353, DOI 10.1144/SP379.16; Langer MC, 2005, J S AM EARTH SCI, V19, P219, DOI 10.1016/j.jsames.2005.04.002; Lautenschlager S, 2015, ZOOL J LINN SOC-LOND, V173, P55, DOI 10.1111/zoj.12196; Lecuona A, 2011, EARTH ENV SCI T R SO, V102, P105, DOI 10.1017/S1755691011000181; Li C, 2006, NATURWISSENSCHAFTEN, V93, P200, DOI 10.1007/s00114-006-0097-y; Lucas S. G., 2007, NEW MEXICO MUSEUM NA, V41, P259; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Mastrantonio BM, 2013, GEOL SOC SPEC PUBL, V379, P425, DOI 10.1144/SP379.10; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2013, GEOL SOC SPEC PUBL, V379, P241, DOI 10.1144/SP379.1; Nesbitt SJ, 2012, EARTH ENV SCI T R SO, V103, P365, DOI 10.1017/S1755691013000224; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Norman DB, 2011, ZOOL J LINN SOC-LOND, V163, P182, DOI 10.1111/j.1096-3642.2011.00697.x; Parker W, 2008, J VERTEBR PALEONTOL, V28, p125A; PARRISH JM, 1994, J VERTEBR PALEONTOL, V14, P196, DOI 10.1080/02724634.1994.10011552; Paulina Carabajal Ariana, 2012, Vertebrata Palasiatica, V50, P85; Paulina-Carabajal A, 2015, J VERTEBR PALEONTOL, V34, P870, DOI [10.1080/02724634.2014.838174, DOI 10.1080/02724634.2014.838174]; Paulina-Carabajal A., 2015, REPTILES EXTINTOS VO; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Romer A. S., 1971, Breviora, VNo. 379, P1; Romer A.S., 1972, Breviora, VNo. 389, P1; Romer A.S., 1972, Breviora, VNo. 390, P1; Schoch RR, 2007, NEUES JAHRB GEOL P-A, V246, P1, DOI 10.1127/0077-7749/2007/0246-0001; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; Sues HD, 2003, J VERTEBR PALEONTOL, V23, P329, DOI 10.1671/0272-4634(2003)023[0329:ANCAFT]2.0.CO;2; Sulej T, 2005, J VERTEBR PALEONTOL, V25, P78, DOI 10.1671/0272-4634(2005)025[0078:ANRRDA]2.0.CO;2; Taborda JRA, 2012, AMEGHINIANA, V49, p4R; Trotteyn MJ, 2012, J VERTEBR PALEONTOL, V32, P867, DOI 10.1080/02724634.2012.670178; Trotteyn MJ, 2010, 10 C ARG PAL BIOESTR; von Baczko MB, 2012, THESIS U BUENOS AIRE; WALKER AD, 1990, PHILOS T ROY SOC B, V330, P1, DOI 10.1098/rstb.1990.0185; WALKER AD, 1961, PHILOS T R SOC B, V244, P103, DOI 10.1098/rstb.1961.0007; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; WEEMS RE, 1980, T AM PHILOS SOC, V70, P3; Weinbaum Jonathan C., 2011, Paleobios, V30, P18; Welman J, 1998, J VERTEBR PALEONTOL, V18, P340, DOI 10.1080/02724634.1998.10011062; Welman J, 1995, S AFR J SCI, V91, P533; Wu XC, 2001, J VERTEBR PALEONTOL, V21, P40, DOI 10.1671/0272-4634(2001)021[0040:ROTDAA]2.0.CO;2; Wu Xiao-Chun, 1993, Journal of Vertebrate Paleontology, V13, P58; Young C.C., 1973, MEMOIRS I VERTEBRA B, V10, P15; Zittel KA, 1887, HDB PALAONTOLOGIE 1, VIII	104	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148575	10.1371/journal.pone.0148575	http://dx.doi.org/10.1371/journal.pone.0148575			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849433	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000130
J	Lu, ML; Wu, YX; Chen, CH; Kuo, PT; Chen, YH; Lin, CH; Wu, TH				Lu, Mong-Liang; Wu, Yi-Xiu; Chen, Chun-Hsin; Kuo, Pei-Ting; Chen, Yi-Hua; Lin, Chia-Hui; Wu, Tzu-Hua			Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia	PLOS ONE			English	Article							SMOKING; DRUG; SEX; AGE; COMEDICATION; GUIDELINES; MANAGEMENT; SERUM; PANSS	Background This therapeutic drug monitoring (TDM) study aimed to determine the role of olanzapine (OLZ) and N-desmethyl-OLZ (DMO) levels in the therapeutic efficacy of OLZ in patients with schizophrenia. Method Plasma concentrations of OLZ (C-OLZ) and DMO (C-DMO) in schizophrenic patients 12 hours post-dose were assessed. The correlations of C-OLZ and C-DMO with the various scores of the Positive and Negative Syndrome Scale (PANSS) were evaluated. A receiver operating characteristic curve (ROC) was utilized to identify the threshold C-OLZ and C-OLZ/C-DMO ratio for maintenance of satisfactory efficacy. Results A total of 151 samples from patients with schizophrenia were analyzed for individual C-OLZ and C-DMO levels. The mean C-OLZ and C-DMO levels were 37.0 +/- 25.6 and 6.9 +/- 4.7 ng/mL, respectively, and C-OLZ was similar to 50% higher in female or nonsmokers (p<0.01). In all patients, the daily dose of OLZ was positively correlated with C-OLZ and C-DMO. Linear relationships between C-OLZ and OLZ dose were observed in both nonsmokers and smokers (r(s) = 0.306, 0.426, p<0.01), although C-DMO was only correlated with OLZ dose in smokers (r(s) = 0.485, p<0.01) and not nonsmokers. In all patients, C-OLZ was marginally negatively correlated with the total PANSS score. The total PANSS score was significantly negatively correlated with the C-OLZ/C-DMO ratio (p<0.005), except in smokers. The ROC analysis identified a C-OLZ/C-DMO ratio >= 2.99 or C-OLZ >= 22.77 ng/mL as a predictor of maintenance of an at least mildly ill status (PANSS score <= 58) of schizophrenia in all patients. Conclusions A significantly negative correlation between the steady-state C-OLZ/C-DMO ratio and total PANSS score was observed in Taiwanese schizophrenic patients. TDM of both OLZ and DMO levels could assist clinical practice when individualizing OLZ dosage adjustments for patients with schizophrenia.	[Lu, Mong-Liang; Chen, Chun-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Psychiat, Taipei, Taiwan; [Lu, Mong-Liang; Chen, Chun-Hsin] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan; [Wu, Yi-Xiu; Kuo, Pei-Ting; Lin, Chia-Hui; Wu, Tzu-Hua] Taipei Med Univ, Coll Pharm, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Wu, TH (corresponding author), Taipei Med Univ, Coll Pharm, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	thwu@tmu.edu.tw		Lu, Mong-Liang/0000-0003-3184-6554; Chen, Yi-Hua/0000-0003-2464-2537	Ministry of Science and Technology [NSC-96-2314-B-038-031-MY3, MOST104-2320-B-038-018]; Department of Health, Executive Yuan [DOH96-TD-D-113-033]; National Health Research Institute [NHRI-EX99-9741PI]; Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan [103TMU-WFH-13]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Department of Health, Executive Yuan; National Health Research Institute(National Health Research Institutes - Taiwan); Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan	The Ministry of Science and Technology (NSC-96-2314-B-038-031-MY3; MOST104-2320-B-038-018), Department of Health, Executive Yuan (DOH96-TD-D-113-033), National Health Research Institute (NHRI-EX99-9741PI), and Taipei Medical University-Wan Fang Hospital (103TMU-WFH-13), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Bigos KL, 2008, J CLIN PHARMACOL, V48, P157, DOI 10.1177/0091270007310385; Bishara D, 2013, J CLIN PSYCHOPHARM, V33, P329, DOI 10.1097/JCP.0b013e31828b28d5; Callaghan JT, 1999, CLIN PHARMACOKINET, V37, P177, DOI 10.2165/00003088-199937030-00001; Citrome L, 2009, J CLIN PSYCHOPHARM, V29, P278, DOI 10.1097/JCP.0b013e3181a289cb; Fellows L, 2003, THER DRUG MONIT, V25, P682, DOI 10.1097/00007691-200312000-00006; Fulton B, 1997, DRUGS, V53, P281, DOI 10.2165/00003495-199753020-00007; Gex-Fabry M, 2003, THER DRUG MONIT, V25, P46, DOI 10.1097/00007691-200302000-00007; Hasan A, 2012, WORLD J BIOL PSYCHIA, V13, P318, DOI 10.3109/15622975.2012.696143; Hatta K, 2009, SCHIZOPHR RES, V113, P49, DOI 10.1016/j.schres.2009.05.030; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Kassahun K, 1997, DRUG METAB DISPOS, V25, P81; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006654.pub2; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065719; Mauri MC, 2005, EUR PSYCHIAT, V20, P55, DOI 10.1016/j.eurpsy.2004.09.009; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Nozawa M, 2008, THER DRUG MONIT, V30, P35, DOI 10.1097/FTD.0b013e31816336fd; Opler MGA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-35; Perry PJ, 1997, J CLIN PSYCHOPHARM, V17, P472, DOI 10.1097/00004714-199712000-00006; Perry PJ, 2001, J CLIN PSYCHOPHARM, V21, P14, DOI 10.1097/00004714-200102000-00004; Skogh E, 2002, THER DRUG MONIT, V24, P518, DOI 10.1097/00007691-200208000-00010; Skogh E, 2011, J CLIN PSYCHOPHARM, V31, P4, DOI 10.1097/JCP.0b013e318204d9e2; Takahashi M, 2015, OPEN J PSYCHIAT, V5, P301; Taylor D, 2009, MAUDSLEY PRESCRIBING; Theisen FM, 2006, THER DRUG MONIT, V28, P750, DOI 10.1097/01.ftd.0000249950.75462.7f; Wakamatsu Akihide, 2013, Innov Clin Neurosci, V10, P23; Weiss U, 2005, J CLIN PSYCHOPHARM, V25, P570, DOI 10.1097/01.jcp.0000185427.08268.db; Wu TH, 2008, PROG NEURO-PSYCHOPH, V32, P1889, DOI 10.1016/j.pnpbp.2008.08.022	31	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148539	10.1371/journal.pone.0148539	http://dx.doi.org/10.1371/journal.pone.0148539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849777	Green Submitted, gold, Green Published			2022-12-26	WOS:000369554000121
J	Vega, M; Riera, A; Fernandez-Cid, A; Herrero, P; Moreno, F				Vega, Montserrat; Riera, Alberto; Fernandez-Cid, Alejandra; Herrero, Pilar; Moreno, Fernando			Hexokinase 2 Is an Intracellular Glucose Sensor of Yeast Cells That Maintains the Structure and Activity of Mig1 Protein Repressor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REPRESSION; CATABOLITE REPRESSION; SUBCELLULAR-LOCALIZATION; REGULATORY MECHANISMS; NUCLEAR-LOCALIZATION; CRYSTAL-STRUCTURE; UPSTREAM KINASES; SNF1 KINASE; SUC2 GENE	Hexokinase 2 (Hxk2) from Saccharomyces cerevisiae is a bifunctional enzyme, being both a catalyst in the cytosol and an important regulator of the glucose repression signal in the nucleus. Despite considerable recent progress, little is known about the regulatory mechanism that controls nuclear Hxk2 association with the SUC2 promoter chromatin and how this association is necessary for SUC2 gene repression. Our data indicate that in the SUC2 promoter context, Hxk2 functions through a variety of structurally unrelated factors, mainly the DNA-binding Mig1 and Mig2 repressors and the regulatory Snf1 and Reg1 factors. Hxk2 sustains the repressor complex architecture maintaining transcriptional repression at the SUC2 gene. Using chromatin immunoprecipitation assays, we discovered that the Hxk2 in its open configuration, at low glucose conditions, leaves the repressor complex that induces its dissociation and promotes SUC2 gene expression. In high glucose conditions, Hxk2 adopts a close conformation that promotes Hxk2 binding to the Mig1 protein and the reassembly of the SUC2 repressor complex. Additional findings highlight the possibility that Hxk2 constitutes an intracellular glucose sensor that operates by changing its conformation in response to cytoplasmic glucose levels that regulate its interaction with Mig1 and thus its recruitment to the repressor complex of the SUC2 promoter. Thus, our data indicate that Hxk2 is more intimately involved in gene regulation than previously thought.	[Vega, Montserrat; Riera, Alberto; Fernandez-Cid, Alejandra; Herrero, Pilar; Moreno, Fernando] Univ Oviedo, Dept Biochem & Mol Biol, E-33006 Oviedo, Spain; [Riera, Alberto; Fernandez-Cid, Alejandra] MRC, Ctr Clin Sci, Imperial Coll, Fac Med, Hammersmith Hosp Campus, London W12 ONN, England	University of Oviedo; Imperial College London	Moreno, F (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Campus El Cristo, E-33006 Oviedo, Spain.	fmoreno@uniovi.es	Vega, Montserrat/ABE-7870-2021	Fernandez-Cid, Alejandra/0000-0002-6746-6791; Vega, Montserrat/0000-0002-4837-0671	Ministerio de Ciencia e Innovacion (Spain) [BFU2007-66063-C02-02, BFU2010-19628-C02-01]; Formacion Personal Investigador FPI fellowship [BFU2010-19628-C02-01]; Ministerio de Ciencia e Innovacion (Spain)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Formacion Personal Investigador FPI fellowship; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in whole or part by Ministerio de Ciencia e Innovacion (Spain) Grants BFU2007-66063-C02-02 and BFU2010-19628-C02-01 (to F. M.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Formacion Personal Investigador FPI fellowship associated with Grant BFU2010-19628-C02-01 and provided by the Ministerio de Ciencia e Innovacion (Spain).	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; Alms GR, 1999, EMBO J, V18, P4157, DOI 10.1093/emboj/18.15.4157; Barrett L, 2012, EUKARYOT CELL, V11, P119, DOI 10.1128/EC.05061-11; Bermejo C, 2011, NAT PROTOC, V6, P1806, DOI 10.1038/nprot.2011.391; Bu Y, 1998, NUCLEIC ACIDS RES, V26, P1002, DOI 10.1093/nar/26.4.1002; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; DELAFUENTE G, 1970, EUR J BIOCHEM, V16, P240, DOI 10.1111/j.1432-1033.1970.tb01077.x; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Dombek KM, 1999, MOL CELL BIOL, V19, P6029; FERNANDEZ R, 1985, J GEN MICROBIOL, V131, P2705; FERNANDEZ R, 1986, J GEN MICROBIOL, V132, P3467; Fernandez-Cid A, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-31; Fernandez-Garcia P, 2012, J BIOL CHEM, V287, P42151, DOI 10.1074/jbc.M112.401679; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GASCON S, 1968, J BIOL CHEM, V243, P1567; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Hecht A, 1999, METH MOL B, V119, P469; Heidrich K, 1997, BIOCHEMISTRY-US, V36, P1960, DOI 10.1021/bi9623643; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Liu Y, 2011, EUKARYOT CELL, V10, P313, DOI 10.1128/EC.00291-10; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Lutfiyya LL, 1996, MOL CELL BIOL, V16, P4790; Lutfiyya LL, 1998, GENETICS, V150, P1377; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Mayordomo I, 2002, J BIOL CHEM, V277, P35650, DOI 10.1074/jbc.M204198200; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MERCADO JJ, 1991, FEBS LETT, V291, P97, DOI 10.1016/0014-5793(91)81112-L; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Moreno F, 2002, FEMS MICROBIOL REV, V26, P83, DOI 10.1111/j.1574-6976.2002.tb00600.x; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; NEIGEBORN L, 1984, GENETICS, V108, P845; Noubhani A, 2009, J BIOL CHEM, V284, P27229, DOI 10.1074/jbc.M109.029454; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Palomino A, 2005, BIOCHEM J, V388, P697, DOI 10.1042/BJ20050160; Pelaez R, 2012, J BIOL CHEM, V287, P3518, DOI 10.1074/jbc.M111.317230; Pelaez R, 2010, BIOCHEM J, V432, P181, DOI 10.1042/BJ20100663; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Randez-Gil F, 1998, FEBS LETT, V425, P475, DOI 10.1016/S0014-5793(98)00289-0; Redd MJ, 1997, J BIOL CHEM, V272, P11193; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; ROTH SY, 1995, CURR OPIN GENET DEV, V5, P168, DOI 10.1016/0959-437X(95)80004-2; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Schuurmans JM, 2008, FEMS YEAST RES, V8, P26, DOI 10.1111/j.1567-1364.2007.00309.x; Schuurmans JM, 2008, FEMS YEAST RES, V8, P195, DOI 10.1111/j.1567-1364.2007.00319.x; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tabba S, 2010, CELL SIGNAL, V22, P1013, DOI 10.1016/j.cellsig.2010.02.003; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; Varanasi US, 1996, MOL CELL BIOL, V16, P6707; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227	70	44	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7267	7285		10.1074/jbc.M115.711408	http://dx.doi.org/10.1074/jbc.M115.711408			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865637	Green Published, hybrid			2022-12-26	WOS:000383447600006
J	Bashiri, G; Rehan, AM; Sreebhavan, S; Baker, HM; Baker, EN; Squire, CJ				Bashiri, Ghader; Rehan, Aisyah M.; Sreebhavan, Sreevalsan; Baker, Heather M.; Baker, Edward N.; Squire, Christopher J.			Elongation of the Poly--glutamate Tail of F-420 Requires Both Domains of the F-420:-Glutamyl Ligase (FbiB) of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; high-performance liquid chromatography (HPLC); mass spectrometry (MS); Mycobacterium tuberculosis; x-ray crystallography; FbiB; cofactor F420; gamma-glutamyl ligase; poly-gamma-glutamate tail	COENZYME F-420; METHANOCOCCUS-JANNASCHII; CRYSTAL-STRUCTURES; BOVIS BCG; X-RAY; BIOSYNTHESIS; CRYSTALLIZATION; EXPRESSION; IDENTIFICATION; PURIFICATION	Cofactor F-420 is an electron carrier with a major role in the oxidoreductive reactions of Mycobacterium tuberculosis, the causative agent of tuberculosis. A -glutamyl ligase catalyzes the final steps of the F-420 biosynthesis pathway by successive additions of l-glutamate residues to F-420-0, producing a poly--glutamate tail. The enzyme responsible for this reaction in archaea (CofE) comprises a single domain and produces F-420-2 as the major species. The homologous M. tuberculosis enzyme, FbiB, is a two-domain protein and produces F-420 with predominantly 5-7 l-glutamate residues in the poly--glutamate tail. The N-terminal domain of FbiB is homologous to CofE with an annotated -glutamyl ligase activity, whereas the C-terminal domain has sequence similarity to an FMN-dependent family of nitroreductase enzymes. Here we demonstrate that full-length FbiB adds multiple l-glutamate residues to F-420-0 in vitro to produce F-420-5 after 24 h; communication between the two domains is critical for full -glutamyl ligase activity. We also present crystal structures of the C-terminal domain of FbiB in apo-, F-420-0-, and FMN-bound states, displaying distinct sites for F-420-0 and FMN ligands that partially overlap. Finally, we discuss the features of a full-length structural model produced by small angle x-ray scattering and its implications for the role of N- and C-terminal domains in catalysis.	[Bashiri, Ghader; Rehan, Aisyah M.; Baker, Heather M.; Baker, Edward N.; Squire, Christopher J.] Univ Auckland, Sch Biol Sci, Struct Biol Lab, Private Bag 92019, Auckland 1010, New Zealand; [Bashiri, Ghader; Rehan, Aisyah M.; Baker, Heather M.; Baker, Edward N.; Squire, Christopher J.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1010, New Zealand; [Sreebhavan, Sreevalsan] Univ Auckland, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1010, New Zealand	University of Auckland; University of Auckland; University of Auckland	Squire, CJ (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1010, New Zealand.	c.squire@auckland.ac.nz	Rehan, Aisyah Mohamed/N-6806-2019; Bashiri, Ghader/R-4957-2017	Rehan, Aisyah Mohamed/0000-0001-7841-1705; Bashiri, Ghader/0000-0002-5092-3749; Squire, Christopher/0000-0001-9212-0461; Baker, Edward/0000-0003-2456-7661	Health Research Council of New Zealand; New Zealand Synchrotron Group Ltd.; IPTA Academic Training Scheme from the Ministry of Higher Education, Malaysia; International Islamic University Malaysia	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Synchrotron Group Ltd.; IPTA Academic Training Scheme from the Ministry of Higher Education, Malaysia; International Islamic University Malaysia	This work was supported by the Health Research Council of New Zealand, and access to the Australian Synchrotron was supported by the New Zealand Synchrotron Group Ltd. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. scholarship from the IPTA Academic Training Scheme from the Ministry of Higher Education, Malaysia, and the International Islamic University Malaysia. Present address: Dept. of Biotechnology, Kulliyyah of Science, International Islamic University Malaysia Kuantan Campus, Jalan Sultan Ahmad Shah, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ahmed FH, 2015, J MOL BIOL, V427, P3554, DOI 10.1016/j.jmb.2015.09.021; Bair TB, 2001, ARCH MICROBIOL, V176, P37, DOI 10.1007/s002030100290; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2007, PROTEIN EXPRES PURIF, V54, P38, DOI 10.1016/j.pep.2007.01.014; Bashiri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045003; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2011, BUSTER; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dauter Z, 1999, J MOL BIOL, V289, P93, DOI 10.1006/jmbi.1999.2744; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; EIRICH LD, 1978, BIOCHEMISTRY-US, V17, P4583, DOI 10.1021/bi00615a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Graupner M, 2002, BIOCHEMISTRY-US, V41, P3754, DOI 10.1021/bi011937v; Gurumurthy M, 2013, MOL MICROBIOL, V87, P744, DOI 10.1111/mmi.12127; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lapalikar GV, 2012, CATAL SCI TECHNOL, V2, P1560, DOI 10.1039/c2cy20129a; Li H, 2003, BIOCHEMISTRY-US, V42, P9771, DOI 10.1021/bi034779b; Mashalidis EH, 2015, PROTEIN SCI, V24, P729, DOI 10.1002/pro.2645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nocek B, 2007, J MOL BIOL, V372, P456, DOI 10.1016/j.jmb.2007.06.063; Ogunleye A, 2015, MICROBIOL-SGM, V161, P1, DOI 10.1099/mic.0.081448-0; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Purwantini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081985; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; Rehan AM, 2011, ACTA CRYSTALLOGR F, V67, P1274, DOI 10.1107/S1744309111028958; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6882	6894		10.1074/jbc.M115.689026	http://dx.doi.org/10.1074/jbc.M115.689026			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26861878	Green Published, hybrid			2022-12-26	WOS:000373299700026
J	Wada, T; Sunaga, H; Miyata, K; Shirasaki, H; Uchiyama, Y; Shimba, S				Wada, Taira; Sunaga, Hiroshi; Miyata, Kazuki; Shirasaki, Haruno; Uchiyama, Yuki; Shimba, Shigeki			Aryl Hydrocarbon Receptor Plays Protective Roles against High Fat Diet (HFD)-induced Hepatic Steatosis and the Subsequent Lipotoxicity via Direct Transcriptional Regulation of Socs3 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; lipid metabolism; liver; liver injury; liver metabolism; aryl hydrocarbon receptor (AhR); suppressor of cytokine signal 3 (Socs3)	NECROSIS-FACTOR-ALPHA; AH-RECEPTOR; INSULIN-RESISTANCE; SIGNALING PATHWAYS; DIOXIN RECEPTOR; SKELETAL-MUSCLE; ADIPOSE-TISSUE; MOUSE-LIVER; MICE; ACTIVATION	Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor regulating the expression of genes involved in xenobiotic response. Recent studies have suggested that AhR plays essential roles not only in xenobiotic detoxification but also energy metabolism. Thus, in this study, we studied the roles of AhR in lipid metabolism. Under high fat diet (HFD) challenge, liver-specific AhR knock-out (AhR LKO) mice exhibited severe steatosis, inflammation, and injury in the liver. Gene expression analysis and biochemical study revealed that de novo lipogenesis activity was significantly increased in AhR LKO mice. In contrast, induction of suppressor of cytokine signal 3 (Socs3) expression by HFD was attenuated in the livers of AhR LKO mice. Rescue of the Socs3 gene in the liver of AhR LKO mice cancelled the HFD-induced hepatic lipotoxicities. Promoter analysis established Socs3 as novel transcriptional target of AhR. These results indicated that AhR plays a protective role against HFD-induced hepatic steatosis and the subsequent lipotoxicity effects, such as inflammation, and that the mechanism of protection involves the direct transcriptional regulation of Socs3 expression by AhR.	[Wada, Taira; Sunaga, Hiroshi; Miyata, Kazuki; Shirasaki, Haruno; Uchiyama, Yuki; Shimba, Shigeki] Nihon Univ, Sch Pharm, Dept Hlth Sci, Funabashi, Chiba 2748555, Japan	Nihon University	Shimba, S (corresponding author), Nihon Univ, Sch Pharm, Dept Hlth Sci, Funabashi, Chiba 2748555, Japan.	shimba.shigeki@nihon-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; "High-Tech Research Center" Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [26670066] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "High-Tech Research Center" Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Japan (to S. S. and T. W), and the "High-Tech Research Center" Project for Private Universities, and a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology 2007. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Adachi J, 2001, J BIOL CHEM, V276, P31475, DOI 10.1074/jbc.C100238200; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brant F, 2014, INFECT IMMUN, V82, P3127, DOI 10.1128/IAI.01733-14; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; Carson L. A., 1963, J ATHEROSCLER RES, V3, P334; Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715; Dabir P, 2008, CIRC RES, V102, P1558, DOI 10.1161/CIRCRESAHA.108.176990; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FOLCH J, 1957, J BIOL CHEM, V226, P497; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Huang YL, 2013, MOLECULES, V18, P12987, DOI 10.3390/molecules181012987; JAMDAR SC, 1978, BIOCHEM J, V170, P153, DOI 10.1042/bj1700153; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; La Merrill M, 2009, ENVIRON HEALTH PERSP, V117, P1414, DOI 10.1289/ehp.0800530; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lu PP, 2015, HEPATOLOGY, V61, P1908, DOI 10.1002/hep.27719; McMillan BJ, 2007, P NATL ACAD SCI USA, V104, P1412, DOI 10.1073/pnas.0607296104; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Oesch-Bartlomowicz B, 2005, P NATL ACAD SCI USA, V102, P9218, DOI 10.1073/pnas.0503488102; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Palanivel R, 2012, DIABETOLOGIA, V55, P3083, DOI 10.1007/s00125-012-2665-3; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Sato S, 2008, TOXICOL APPL PHARM, V229, P10, DOI 10.1016/j.taap.2007.12.029; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09; Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590; Steinberg GR, 2004, AM J PHYSIOL-ENDOC M, V286, pE57, DOI 10.1152/ajpendo.00302.2003; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wada T, 2013, MOL PHARMACOL, V83, P1133, DOI 10.1124/mol.112.083303; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Watabe Y, 2010, BIOL PHARM BULL, V33, P389, DOI 10.1248/bpb.33.389; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Xu JL, 2012, DRUG METAB DISPOS, V40, P259, DOI 10.1124/dmd.111.039925; Yan CG, 2013, FASEB J, V27, P2967, DOI 10.1096/fj.12-225797; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Zhang S, 2003, ENVIRON HEALTH PERSP, V111, P1877, DOI 10.1289/ehp.6322; Zhu BM, 2008, J INVEST DERMATOL, V128, P1821, DOI 10.1038/sj.jid.5701224	56	46	48	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7004	7016		10.1074/jbc.M115.693655	http://dx.doi.org/10.1074/jbc.M115.693655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26865635	hybrid, Green Published			2022-12-26	WOS:000373299700036
J	Jiang, S; Zheng, XY; Yu, PY; Yue, XY; Ahmed, M; Cai, DY; Teng, YW				Jiang, Shuang; Zheng, Xiaoyan; Yu, Peiyuan; Yue, Xiaoyan; Ahmed, Maqsood; Cai, Danying; Teng, Yuanwen			Primitive Genepools of Asian Pears and Their Complex Hybrid Origins Inferred from Fluorescent Sequence-Specific Amplification Polymorphism (SSAP) Markers Based on LTR Retrotransposons	PLOS ONE			English	Article							GENETIC-RELATIONSHIPS; PHYLOGENETIC UTILITY; HYPERVARIABLE REGIONS; PYRUS SPP.; GENOME; DIVERSITY; DNA; CULTIVARS; AFLP; CLASSIFICATION	Recent evidence indicated that interspecific hybridization was the major mode of evolution in Pyrus. The genetic relationships and origins of the Asian pear are still unclear because of frequent hybrid events, fast radial evolution, and lack of informative data. Here, we developed fluorescent sequence-specific amplification polymorphism (SSAP) markers with lots of informative sites and high polymorphism to analyze the population structure among 93 pear accessions, including nearly all species native to Asia. Results of a population structure analysis indicated that nearly all Asian pear species experienced hybridization, and originated from five primitive genepools. Four genepools corresponded to four primary Asian species: P. betulaefolia, P. pashia, P. pyrifolia, and P. ussuriensis. However, cultivars of P. ussuriensis were not monophyletic and introgression occurred from P. pyrifolia. The specific genepool detected in putative hybrids between occidental and oriental pears might be from occidental pears. The remaining species, including P. calleryana, P. xerophila, P. sinkiangensis, P. phaeocarpa, P. hondoensis, and P. hopeiensis in Asia, were inferred to be of hybrid origins and their possible genepools were identified. This study will be of great help for understanding the origin and evolution of Asian pears.	[Jiang, Shuang; Yu, Peiyuan; Yue, Xiaoyan; Teng, Yuanwen] Zhejiang Univ, Dept Hort, State Agr Minist Key Lab Hort Plant Growth Dev &, Hangzhou 310058, Zhejiang, Peoples R China; [Jiang, Shuang] Shanghai Acad Agr Sci, Forest & Fruit Tree Inst, Shanghai 201403, Peoples R China; [Zheng, Xiaoyan] Lishui Univ, Inst Hort & Landscape, Coll Ecol, Lishui 323000, Zhejiang, Peoples R China; [Ahmed, Maqsood] MUST, Dept Biotechnol, Main Allama Iqbal Rd, Mirpur 10250, Azad Kashmir, Pakistan; [Cai, Danying] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Shanghai Academy of Agricultural Sciences; Lishui University; Zhejiang Academy of Agricultural Sciences	Teng, YW (corresponding author), Zhejiang Univ, Dept Hort, State Agr Minist Key Lab Hort Plant Growth Dev &, Hangzhou 310058, Zhejiang, Peoples R China.; Cai, DY (corresponding author), Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China.	dycai@zju.edu.cn; ywteng@zju.edu.cn	Teng, Yuanwen/A-3515-2015	Teng, Yuanwen/0000-0001-8656-9035	National Natural Science Foundation of China [31201592]; Specialized Research Fund for the Doctoral Program of Higher Education [20110101110091]; Grant for Innovative Research Team of Zhejiang Province of China [2013TD05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Grant for Innovative Research Team of Zhejiang Province of China	This research was funded by a Grant from the National Natural Science Foundation of China (No. 31201592, http://www.nsfc.gov.cn/) awarded to DC, and a Specialized Research Fund for the Doctoral Program of Higher Education (20110101110091, http://www.cutech.edu.cn/cn/index.htm) and a Grant for Innovative Research Team of Zhejiang Province of China (2013TD05, http://www.zjnsf.gov.cn/) awarded to YT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, AFR J BIOTECHNOL, V9, P8323; Bailey L, 1917, STANDARD CYCLOPEDIA, P2865; Bao L, 2008, SCI HORTIC-AMSTERDAM, V116, P374, DOI 10.1016/j.scienta.2008.02.008; Bao L, 2007, GENET RESOUR CROP EV, V54, P959, DOI 10.1007/s10722-006-9152-y; Bassil N, 2010, GENET RESOUR CROP EV, V57, P357, DOI 10.1007/s10722-009-9474-7; CHALLICE JS, 1973, BOT J LINN SOC, V67, P121, DOI 10.1111/j.1095-8339.1973.tb01734.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Iketani H, 1998, GENET RESOUR CROP EV, V45, P533, DOI 10.1023/A:1008646016181; Iketani H, 2012, PLANT SYST EVOL, V298, P1689, DOI 10.1007/s00606-012-0670-0; Iketani H, 2010, CONSERV GENET, V11, P115, DOI 10.1007/s10592-009-0009-8; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiang S, 2015, MOL GENET GENOMICS, V290, P225, DOI 10.1007/s00438-014-0914-5; Kalendar R, 2011, HEREDITY, V106, P520, DOI 10.1038/hdy.2010.93; Katayama H, 2012, TREE GENET GENOMES, V8, P313, DOI 10.1007/s11295-011-0442-y; KIKUCHI A, 1948, HORTICULTURE FRUIT T; Kim H, 2012, BREEDING SCI, V62, P53, DOI 10.1270/jsbbs.62.53; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Liu J, 2013, TREE GENET GENOMES, V9, P433, DOI 10.1007/s11295-012-0564-x; Lo EYY, 2012, MOL PHYLOGENET EVOL, V63, P230, DOI 10.1016/j.ympev.2011.10.005; Monte-Corvo L, 2000, GENET RESOUR CROP EV, V47, P257, DOI 10.1023/A:1008794809807; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubtsov GA, 1944, AM NAT, V78, P358, DOI 10.1086/281206; Sabot F, 2006, HEREDITY, V97, P381, DOI 10.1038/sj.hdy.6800903; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Syed NH, 2006, THEOR APPL GENET, V112, P517, DOI 10.1007/s00122-005-0155-4; Syed NH, 2007, NATURE PROTOCOLS, V1, P2746; Tam SM, 2005, THEOR APPL GENET, V110, P819, DOI 10.1007/s00122-004-1837-z; Teng Y, 2004, ACTA HORTIC, P175, DOI 10.17660/ActaHortic.2004.634.21; Teng YW, 2002, J AM SOC HORTIC SCI, V127, P262, DOI 10.21273/JASHS.127.2.262; Teng YW, 2001, J HORTIC SCI BIOTECH, V76, P771; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Wuyun T, 2013, TREE GENET GENOMES, V9, P167, DOI 10.1007/s11295-012-0544-1; Yu D. J., 1979, TAXONOMY FRUIT TREE; Zheng XY, 2008, MOL PHYLOGENET EVOL, V48, P892, DOI 10.1016/j.ympev.2008.05.039; Zheng XY, 2014, MOL PHYLOGENET EVOL, V80, P54, DOI 10.1016/j.ympev.2014.07.009; Zheng XY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-255	49	19	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149192	10.1371/journal.pone.0149192	http://dx.doi.org/10.1371/journal.pone.0149192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871452	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100123
J	Li, XQ; Ma, N; Li, XG; Wang, B; Sun, SS; Gao, F; Mo, DP; Song, LG; Sun, X; Liu, L; Zhao, XQ; Wang, YL; Wang, YJ; Zhao, ZG; Miao, ZR				Li, Xiao-Qing; Ma, Ning; Li, Xin-Gang; Wang, Bo; Sun, Shu-Sen; Gao, Feng; Mo, Da-Peng; Song, Li-Gang; Sun, Xuan; Liu, Lian; Zhao, Xing-Quan; Wang, Yi-Long; Wang, Yong-Jun; Zhao, Zhi-Gang; Miao, Zhong-Rong			Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting	PLOS ONE			English	Article							CLOPIDOGREL PLATELET REACTIVITY; PERCUTANEOUS CORONARY INTERVENTION; GENE SEQUENCE VARIATIONS; PROTON PUMP INHIBITORS; CHINESE PATIENTS; ANTIPLATELET THERAPY; RESPONSE VARIABILITY; ASPIRIN RESISTANCE; CYTOCHROME-P450 3A; P2Y(12) RECEPTOR	Background and Purpose Short-term combined use of clopidogrel and aspirin improves cerebrovascular outcomes in patients with symptomatic extracranial or intracranial stenosis. Antiplatelet non-responsiveness is related to recurrent ischemic events, but the culprit genetic variants responsible for the non-responsiveness have not been well studied. We aimed to identify the genetic variants associated with poor clinical outcomes. Methods Patients with symptomatic extracranial or intracranial stenosis scheduled for stenting and receiving dual antiplatelets (clopidogrel 75 mg and aspirin 100 mg daily) for at least 5 days before intervention were enrolled. Ischemic events including recurrent transient ischemic attack, stroke, myocardial infarction, and vascular-related mortality within 12 months follow-up were recorded. We examined the influence of genetic polymorphisms on treatment outcome in our patients. Results A total of 268 patients were enrolled into our study and ischemic events were observed in 39 patients. For rs662 of paraoxonase 1 (PON1), allele C was associated with an increased risk of ischemic events (OR = 1.64, 95% CI = 1.03-2.62, P = 0.029). The A-allele carriers of rs2046934 of P2Y12 had a significant association with adverse events (OR = 2.01, 95% CI = 1.10-3.67, P = 0.041). The variant T-allele of cyclooxygenase-1 (COX1) rs1330344 significantly increased the risk of recurrent clinical events (OR = 1.85, 95% CI = 1.12-3.03, P = 0.017). The other single nucleotide polymorphism (SNP) had no association with ischemic events. Conclusions PON1, P2Y12 and COX1 polymorphisms were associated with poorer vascular outcomes. Testing for these polymorphisms may be valuable in the identification of patients at risk for recurrent ischemic events.	[Li, Xiao-Qing; Ma, Ning; Wang, Bo; Gao, Feng; Mo, Da-Peng; Song, Li-Gang; Sun, Xuan; Liu, Lian; Miao, Zhong-Rong] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Natl Clin Res Ctr Neurol Dis,Ctr Stroke,Beijing I, Beijing, Peoples R China; [Li, Xiao-Qing] Shaanxi Prov Peoples Hosp, Dept Neurol, Xian, Peoples R China; [Li, Xin-Gang; Zhao, Zhi-Gang] Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China; [Sun, Shu-Sen] Western New England Univ, Coll Pharm, Springfield, MA USA; [Zhao, Xing-Quan; Wang, Yi-Long; Wang, Yong-Jun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University; Xi'an Medical University; Capital Medical University; Western New England University; Capital Medical University	Miao, ZR (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Natl Clin Res Ctr Neurol Dis,Ctr Stroke,Beijing I, Beijing, Peoples R China.; Zhao, ZG (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China.	1022zzg@sina.com; zhongrongm@163.com		Li, Xingang/0000-0001-6726-9571	National Natural Science Foundation of China [81371290, 81503157]; Beijing High-level Personnel Funds [2013-2-19]; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases [2014NXGZ01]; National Science and Technology Support Program of 'The 12th Five-Year Plan' of the Ministry of Science and Technology; Organization Department of Beijing Municipal Committee [2014000021469G258]; Social Development Key Projects of Shannxi Province [12015SF023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing High-level Personnel Funds; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases; National Science and Technology Support Program of 'The 12th Five-Year Plan' of the Ministry of Science and Technology; Organization Department of Beijing Municipal Committee; Social Development Key Projects of Shannxi Province	This study was funded by the National Natural Science Foundation of China (81371290, 81503157), Beijing High-level Personnel Funds (2013-2-19), National Science and Technology Support Program of 'The 12th Five-Year Plan' of the Ministry of Science and Technology, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases (2014NXGZ01), Organization Department of Beijing Municipal Committee (2014000021469G258) and Social Development Key Projects of Shannxi Province (12015SF023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Angiolillo DJ, 2009, AM J CARDIOL, V103, p27A, DOI 10.1016/j.amjcard.2008.11.020; Anselmi CV, 2013, JACC-CARDIOVASC INTE, V6, P1166, DOI 10.1016/j.jcin.2013.06.010; Bliden KP, 2007, J AM COLL CARDIOL, V49, P657, DOI 10.1016/j.jacc.2006.10.050; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Brown DG, 2015, J AM ACAD DERMATOL, V72, P524, DOI 10.1016/j.jaad.2014.10.027; Campo G, 2011, J THROMB HAEMOST, V9, P2106, DOI 10.1111/j.1538-7836.2011.04457.x; Cao LP, 2014, GENE, V546, P172, DOI 10.1016/j.gene.2014.06.023; Cavallari U, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-59; Chai Y, 2013, INT J NEUROSCI, V123, P752, DOI 10.3109/00207454.2013.798733; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Cuisset T, 2007, THROMB RES, V120, P893, DOI 10.1016/j.thromres.2007.01.012; Delaney JT, 2012, CLIN PHARMACOL THER, V91, P257, DOI 10.1038/clpt.2011.221; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Fan L, 2013, GERONTOLOGY, V59, P122, DOI 10.1159/000342489; Farid NA, 2007, CLIN PHARMACOL THER, V81, P735, DOI 10.1038/sj.clpt.6100139; Fontana P, 2003, CIRCULATION, V108, P2971, DOI 10.1161/01.CIR.0000106904.80795.35; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Frelinger AL, 2013, J AM COLL CARDIOL, V61, P872, DOI 10.1016/j.jacc.2012.11.040; Geeganage CM, 2012, STROKE, V43, P1058, DOI 10.1161/STROKEAHA.111.637686; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Li XL, 2013, CLIN APPL THROMB-HEM, V19, P513, DOI 10.1177/1076029612444002; Lins R, 1999, SEMIN THROMB HEMOST, V25, P29; Mackness B, 1998, GEN PHARMACOL-VASC S, V31, P329, DOI 10.1016/S0306-3623(98)00028-7; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mooij MG, 2016, CLIN PHARMACOKINET, V55, P507, DOI 10.1007/s40262-015-0328-5; Oh IY, 2012, HEART, V98, P139, DOI 10.1136/hrt.2011.227272; Park KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052779; Rudberg I, 2008, CLIN PHARMACOL THER, V83, P322, DOI 10.1038/sj.clpt.6100291; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Storey RF, 2006, CURR PHARM DESIGN, V12, P1255, DOI 10.2174/138161206776361318; Tresukosol D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110188; Wang X, 2013, INT J STROKE, V8, P663, DOI 10.1111/j.1747-4949.2012.00828.x; Wu HY, 2013, INT J CARDIOL, V165, P204, DOI 10.1016/j.ijcard.2012.08.017; Wu HY, 2012, PHARMACOGENET GENOM, V22, P887, DOI 10.1097/FPC.0b013e328359253a; Xie C, 2014, PHARMACOGENET GENOM, V24, P204, DOI 10.1097/FPC.0000000000000035; Zhang LN, 2013, THROMB RES, V132, P81, DOI 10.1016/j.thromres.2013.05.006; Zhu P, 2013, J APPL MATH, DOI 10.1155/2013/105752	45	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148891	10.1371/journal.pone.0148891	http://dx.doi.org/10.1371/journal.pone.0148891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870959	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100068
J	Choudhury, D; Ghosh, A; Chanda, DD; Das Talukdar, A; Choudhury, MD; Paul, D; Maurya, AP; Chakravorty, A; Bhattacharjee, A				Choudhury, Debarati; Ghosh, Anamika; Chanda, Debadatta Dhar; Das Talukdar, Anupam; Choudhury, Manabendra Dutta; Paul, Deepjyoti; Maurya, Anand Prakash; Chakravorty, Atanu; Bhattacharjee, Amitabha			Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; BETA-LACTAMASE; EXPRESSION; OPERON; PREVALENCE; EMERGENCE; REPRESSOR; SYSTEM; IMPACT	Objectives The present study was undertaken to investigate the mutations that are present in mexR gene of multidrug resistant (MDR) isolates of Pseudomonas aeruginosa collected from a tertiary referral hospital of north east India. Methods 76 MDR clinical isolates of P. aeruginosa were obtained from the patients who were admitted to or attended the clinics of Silchar medical college and hospital. They were screened phenotypically for the presence of efflux pump activity by an inhibitor based method. Acquired resistance mechanisms were detected by multiplex PCR. Real time PCR was performed to study the expression of mexA gene of MexAB-OprM efflux pump in isolates with increase efflux pump activity. mexR gene of the isolates with overexpressed MexAB-OprM efflux pump was amplified, sequenced and analysed. Results Out of 76 MDR isolates, 24 were found to exhibit efflux pump activity phenotypically against ciprofloxacin and meropenem. Acquired resistance mechanisms were absent in 11 of them and among those isolates, 8 of them overexpressed MexAB-OprM. All the 8 isolates possessed mutation in mexR gene. 11 transversions, 4 transitions, 2 deletion mutations and 2 insertion mutations were found in all the isolates. However, the most significant observation was the formation of a termination codon at 35th position which resulted in the termination of the polypeptide and leads to overexpression of the MexAB-OprM efflux pump. Conclusions This study highlighted emergence of a novel mutation which is probably associated with multi drug resistance. Therefore, further investigations and actions are needed to prevent or at least hold back the expansion and emergence of newer mutations in nosocomial pathogens which may compromise future treatment options.	[Choudhury, Debarati; Das Talukdar, Anupam; Choudhury, Manabendra Dutta] Assam Univ, Dept Life Sci & Bioinformat, Silchar, Assam, India; [Ghosh, Anamika; Paul, Deepjyoti; Maurya, Anand Prakash; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar, Assam, India; [Chanda, Debadatta Dhar; Chakravorty, Atanu] Silchar Med Coll & Hosp, Dept Microbiol, Silchar, Assam, India	Assam University; Assam University	Bhattacharjee, A (corresponding author), Assam Univ, Dept Microbiol, Silchar, Assam, India.	ab0404@gmail.com	Choudhury, Manabendra/AAP-1817-2021	Paul, Deepjyoti/0000-0002-6078-9408; Ghose, Anamika/0000-0002-3616-3085; Dutta Choudhury, Manabendra/0000-0002-9472-0572; Talukdar, Anupam Das/0000-0001-8916-2791; Maurya, Anand Prakash/0000-0001-5231-8174	Department of Biotechnology (DBT) government of India [Assam University Institutional Biotech Hub] [BT/04/NE/2009]; University grants commission-basic scientific research fellowship [F.7-13/2007(BSR)]; DBT, Govt. of India; Department of Biotechnology (DBT) government of India [DBT-NER twining] [BCIL/NER-BPMC/2014-203]	Department of Biotechnology (DBT) government of India [Assam University Institutional Biotech Hub]; University grants commission-basic scientific research fellowship; DBT, Govt. of India(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT) government of India [DBT-NER twining]	This work was supported by the Department of Biotechnology (DBT) government of India [Assam University Institutional Biotech Hub (BT/04/NE/2009), DBT-NER twining (BCIL/NER-BPMC/2014-203)] (www.dbtindia.nic.in); University grants commission-basic scientific research fellowship(F.7-13/2007(BSR))(www.ugc.ac.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the help from Assam University Biotech Hub for providing laboratory facility to complete this work. They also acknowledge the help of HOD, Microbiology, Assam University for providing infrastructure. e-journal access facility provided by Bioinformatics Centre, Assam University, Assam funded by DBT, Govt. of India is acknowledged. The authors are indebted to Prof. K. Poole, Queens University, Canada, for providing strains (P. aeruginosa PAO1 and P. aeruginosa knockout mutant of MexAB-OprM).	Clinical and Laboratory Standards Institute Performance standards for Antimicrobial Susceptibility Testing Twenty-First Informational Supplement, M100S21 CLSI; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Jh Y., 2002, J ANTIMICROB CHEMOTH, V49, P837; Kriengkauykiat J, 2005, ANTIMICROB AGENTS CH, V49, P565, DOI 10.1128/AAC.49.2.565-570.2005; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V47, P247, DOI 10.1093/jac/47.3.247; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Maurya AP, 2014, ANTIMICROB AGENTS CH, V58, P6966, DOI 10.1128/AAC.02365-14; Mendes RE, 2009, J ANTIMICROB CHEMOTH, V63, P55, DOI 10.1093/jac/dkn434; Mesaros N, 2007, J ANTIMICROB CHEMOTH, V59, P378, DOI 10.1093/jac/dkl504; Poole K, 1996, ANTIMICROB AGENTS CH, V40, P2021, DOI 10.1128/AAC.40.9.2021; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Pournaras S, 2005, J ANTIMICROB CHEMOTH, V56, P761, DOI 10.1093/jac/dki296; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Rodriguez-Martinez JM, 2009, ANTIMICROB AGENTS CH, V53, P4783, DOI 10.1128/AAC.00574-09; Saito K, 2001, FEMS MICROBIOL LETT, V195, P23, DOI 10.1016/S0378-1097(00)00539-5; Shibl A, 2013, INT J INFECT DIS, V17, pE1130, DOI 10.1016/j.ijid.2013.06.016; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wu JJ, 2007, ANTIMICROB AGENTS CH, V51, P1223, DOI 10.1128/AAC.01195-06; Xavier DE, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-217; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Ziha-Zarifi I, 1999, ANTIMICROB AGENTS CH, V43, P287, DOI 10.1128/AAC.43.2.287	25	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149156	10.1371/journal.pone.0149156	http://dx.doi.org/10.1371/journal.pone.0149156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866484	gold, Green Submitted, Green Published			2022-12-26	WOS:000370050700075
J	Mahoney, JM; Titiz, AS; Hernan, AE; Scott, RC				Mahoney, J. Matthew; Titiz, Ali S.; Hernan, Amanda E.; Scott, Rod C.			Short-Range Temporal Interactions in Sleep; Hippocampal Spike Avalanches Support a Large Milieu of Sequential Activity Including Replay	PLOS ONE			English	Article							PLACE-CELL SEQUENCES; FIRING PATTERNS; MEMORY; ORGANIZATION; ASSEMBLIES	Hippocampal neural systems consolidate multiple complex behaviors into memory. However, the temporal structure of neural firing supporting complex memory consolidation is unknown. Replay of hippocampal place cells during sleep supports the view that a simple repetitive behavior modifies sleep firing dynamics, but does not explain how multiple episodes could be integrated into associative networks for recollection during future cognition. Here we decode sequential firing structure within spike avalanches of all pyramidal cells recorded in sleeping rats after running in a circular track. We find that short sequences that combine into multiple long sequences capture the majority of the sequential structure during sleep, including replay of hippocampal place cells. The ensemble, however, is not optimized for maximally producing the behavior-enriched episode. Thus behavioral programming of sequential correlations occurs at the level of short-range interactions, not whole behavioral sequences and these short sequences are assembled into a large and complex milieu that could support complex memory consolidation.	[Mahoney, J. Matthew; Hernan, Amanda E.; Scott, Rod C.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Titiz, Ali S.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; [Scott, Rod C.] UCL, Inst Child Hlth, Neurosci Unit, London, England	University of Vermont; University of California System; University of California Los Angeles; University of London; University College London	Mahoney, JM (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	John.M.Mahoney@uvm.edu		Hernan, Amanda/0000-0003-4931-3481; Scott, Rod/0000-0002-8944-928X	National Institutes of Health [NS074450, NS073083, R01-NS075249]; Great Ormond Street Hospital Children's Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075249, R01NS074450, R01NS073083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Great Ormond Street Hospital Children's Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the following: National Institutes of Health grants (RCS): NS074450, NS073083, and R01-NS075249; and Great Ormond Street Hospital Children's Charity (RCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MI, 2003, J NEUROSCI, V23, P8827; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; Beggs JM, 2003, J NEUROSCIENCE; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Begleiter R, 2004, J ARTIF INTELL RES, V22, P385, DOI 10.1613/jair.1491; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brown EN, 1998, J NEUROSCI, V18, P7411; Buhry L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/203462; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2005, NAT REV NEUROSCI; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lenck-Santini PP, 2002, J NEUROSCI, V22, P9035; Mehta MR, 2007, NAT NEUROSCI, V10, P13, DOI 10.1038/nn0107-13; MULLER RU, 1987, J NEUROSCI, V7, P1935; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Wamsley EJ, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0433-5; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; Zhou JL, 2007, EPILEPSIA, V48, P720, DOI 10.1111/j.1528-1167.2006.00972.x	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0147708	10.1371/journal.pone.0147708	http://dx.doi.org/10.1371/journal.pone.0147708			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866597	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700004
J	Zupancic, J; Babic, MN; Zalar, P; Gunde-Cimerman, N				Zupancic, Jerneja; Babic, Monika Novak; Zalar, Polona; Gunde-Cimerman, Nina			The Black Yeast Exophiala dermatitidis and Other Selected Opportunistic Human Fungal Pathogens Spread from Dishwashers to Kitchens	PLOS ONE			English	Article							BLASTOSCHIZOMYCES-CAPITATUS; AUREOBASIDIUM-PULLULANS; CRYPTOCOCCUS-NEOFORMANS; WANGIELLA-DERMATITIDIS; RHODOTORULA INFECTION; CANDIDA-PARAPSILOSIS; WATER; DIVERSITY; GEOTRICHUM; FUSARIUM	We investigated the diversity and distribution of fungi in nine different sites inside 30 residential dishwashers. In total, 503 fungal strains were isolated, which belong to 10 genera and 84 species. Irrespective of the sampled site, 83% of the dishwashers were positive for fungi. The most frequent opportunistic pathogenic species were Exophiala dermatitidis, Candida parapsilosis sensu stricto, Exophiala phaeomuriformis, Fusarium dimerum, and the Saprochaete/Magnusiomyces clade. The black yeast E. dermatitidis was detected in 47% of the dishwashers, primarily at the dishwasher rubber seals, at up to 10(6) CFU/cm(2); the other fungi detected were in the range of 10(2) to 10(5) CFU/cm(2). The other most heavily contaminated dishwasher sites were side nozzles, doors and drains. Only F. dimerum was isolated from washed dishes, while dishwasher waste water contained E. dermatitidis, Exophiala oligosperma and Sarocladium killiense. Plumbing systems supplying water to household appliances represent the most probable route for contamination of dishwashers, as the fungi that represented the core dishwasher mycobiota were also detected in the tap water. Hot aerosols from dishwashers contained the human opportunistic yeast C. parapsilosis, Rhodotorula mucilaginosa and E. dermatitidis (as well as common air-borne genera such as Aspergillus, Penicillium, Trichoderma and Cladosporium). Comparison of fungal contamination of kitchens without and with dishwashers revealed that virtually all were contaminated with fungi. In both cases, the most contaminated sites were the kitchen drain and the dish drying rack. The most important difference was higher prevalence of black yeasts (E. dermatitidis in particular) in kitchens with dishwashers. In kitchens without dishwashers, C. parapsilosis strongly prevailed with negligible occurrence of E. dermatitidis. F. dimerum was isolated only from kitchens with dishwashers, while Saprochaete/Magnusiomyces isolates were only found within dishwashers. We conclude that dishwashers represent a reservoir of enriched opportunistic pathogenic species that can spread from the dishwasher into the indoor biome.	[Zupancic, Jerneja; Babic, Monika Novak; Zalar, Polona; Gunde-Cimerman, Nina] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Gunde-Cimerman, Nina] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Ljubljana	Gunde-Cimerman, N (corresponding author), Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia.; Gunde-Cimerman, N (corresponding author), Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia.	nina.gunde-cimerman@bf.uni-lj.si	Babič, Monika Novak/AAF-6089-2020	Babič, Monika Novak/0000-0003-3028-6057; Gunde-Cimerman, Nina/0000-0002-9464-3263	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; Ministry of Higher Education, Science and Technology; University of Ljubljana [1244]; Slovenian Research Agency through the Infrastructural Centre Mycosmo, MRIC UL; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP); European Commission [ICT-2013-612944 MAESTRA, ICT-2013-604102 HBP]; Slovenia Research Agency [382228-1/2013]; Slovenian Research Agency (Infrastructural Centre Mycosmo, MRIC UL);  [P2-0103]	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; Ministry of Higher Education, Science and Technology; University of Ljubljana; Slovenian Research Agency through the Infrastructural Centre Mycosmo, MRIC UL; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP); European Commission(European CommissionEuropean Commission Joint Research Centre); Slovenia Research Agency(Slovenian Research Agency - Slovenia); Slovenian Research Agency (Infrastructural Centre Mycosmo, MRIC UL)(Slovenian Research Agency - Slovenia); 	The authors acknowledge the financial support received from: Ministry of Higher Education, Science and Technology of the Republic of Slovenia in corporation with Slovenia Research Agency, as a Young Researcher grant (JZ) (no. 382228-1/2013); Ministry of Higher Education, Science and Technology and the University of Ljubljana via the "Innovative scheme for co-financing of doctoral studies", Contract No. 1244 (MNB); Slovenian Research Agency through the Infrastructural Centre Mycosmo, MRIC UL and the grant P2-0103 (PZ); Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP); European Commission, via the grants ICT-2013-612944 MAESTRA and ICT-2013-604102 HBP (NGC).r Our acknowledgments go to all of the people who kindly provided samples from their dishwashers and kitchens surfaces. This study was supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia, as a Young Researcher grant to JZ. We also thank the Slovenian Research Agency (Infrastructural Centre Mycosmo, MRIC UL) and the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP), for providing financial support. Last but not least we wish to thank prof. Borge Diderichsen for careful and critical reading of the manuscript.	Abe N, 2011, BIOCONTROL SCI, V16, P139, DOI 10.4265/bio.16.139; Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Adams RI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078866, 10.1371/journal.pone.0067861]; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; [Anonymous], 2003, J OCCUP ENVIRON MED, V45, P470; Ara K, 2008, ALLERGOL INT, V53, P369; Barraclough G, 1978, TIMES ATLAS WORLD HI; Beumer RR, 2003, INT BIODETER BIODEGR, V51, P299, DOI 10.1016/S0964-8305(03)00041-6; Billings C G, 1998, Monaldi Arch Chest Dis, V53, P43; Birrenbach T, 2012, EMERG INFECT DIS, V18, P98, DOI 10.3201/eid1801.111192; Boekhout T, 1996, NONCONVENT YEASTS BI, P1, DOI [10.1007/978-3-642-79856-6_1, DOI 10.1007/978-3-642-79856-6_1]; Bonassoli LA, 2005, J HOSP INFECT, V59, P159, DOI 10.1016/j.jhin.2004.06.033; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Butinar L, 2005, FEMS MICROBIOL LETT, V244, P229, DOI 10.1016/j.femsle.2005.01.043; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chotirmall SH, 2014, INT J BIOCHEM CELL B, V52, P161, DOI 10.1016/j.biocel.2014.03.001; Das I, 2011, INT J INFECT DIS, V15, pE759, DOI 10.1016/j.ijid.2011.06.006; de Hoog GS, 2004, STUD MYCOL, P489; de Hoog GS, 2014, ATLAS CLIN FUNGI ULT; Desnos-Ollivier M, 2014, J CLIN MICROBIOL, V52, P2196, DOI 10.1128/JCM.00039-14; DIXON DM, 1980, MYCOPATHOLOGIA, V70, P153, DOI 10.1007/BF00443026; Dogen A, 2013, MED MYCOL, V51, P493, DOI 10.3109/13693786.2012.738313; Doggett MS, 2000, APPL ENVIRON MICROB, V66, P1249, DOI 10.1128/AEM.66.3.1249-1251.2000; De Almeida GMD, 2008, MED MYCOL, V46, P547, DOI 10.1080/13693780801972490; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Garcia-Suarez J, 2011, MYCOSES, V54, P318, DOI 10.1111/j.1439-0507.2010.01868.x; Gardini F, 2001, FEMS YEAST RES, V1, P161; Girmenia C, 2005, J CLIN MICROBIOL, V43, P1818, DOI 10.1128/JCM.43.4.1818-1828.2005; Gostincar C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-549; Gostincar C, 2011, FUNGAL BIOL-UK, V115, P1008, DOI 10.1016/j.funbio.2011.03.004; Grandesso Stefano, 2012, Infez Med, V20, P25; GUEHO E, 1987, J CLIN MICROBIOL, V25, P1191; Gurgui M, 2011, J HOSP INFECT, V78, P274, DOI 10.1016/j.jhin.2011.01.027; Hageskal G, 2006, APPL ENVIRON MICROB, V72, P7586, DOI 10.1128/AEM.01628-06; Hamada N, 2010, BIOCONTROL SCI, V15, P51, DOI 10.4265/bio.15.51; Hamada N, 2009, MYCOSCIENCE, V50, P421, DOI 10.1007/s10267-009-0500-6; Heinrich J, 2011, INT J HYG ENVIR HEAL, V214, P3, DOI 10.1016/j.ijheh.2010.08.009; Heinrichs G, 2013, MYCOPATHOLOGIA, V175, P399, DOI 10.1007/s11046-013-9619-2; HIRUMA M, 1993, MYCOSES, V36, P1, DOI 10.1111/j.1439-0507.1993.tb00679.x; Horner WE, 2004, APPL ENVIRON MICROB, V70, P6394, DOI 10.1128/AEM.70.11.6394-6400.2004; Isola D, 2013, MYCOPATHOLOGIA, V175, P369, DOI 10.1007/s11046-013-9635-2; Jain A, 2010, J PHARM BIOALLIED SC, V2, P314, DOI 10.4103/0975-7406.72131; Kanzler D, 2008, MYCOSES, V51, P165, DOI 10.1111/j.1439-0507.2007.01454.x; Karuppayil SM, 1997, J MED VET MYCOL, V35, P379; Kauffmann-Lacroix C, 2008, PRESSE MED, V37, P751, DOI 10.1016/j.lpm.2007.09.015; Kinsey G., 2003, HDB WATER WASTEWATER, P77, DOI DOI 10.1016/B978-012470100-7/50006-6; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Kondori N, 2011, J CLIN MICROBIOL, V49, P1004, DOI 10.1128/JCM.01899-10; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P3, DOI 10.1016/B978-0-444-52149-1.00001-X; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Lian X, 2010, MED MYCOL, V48, P622, DOI 10.3109/13693780903405774; Libkind D, 2004, FOLIA MICROBIOL, V49, P19, DOI 10.1007/BF02931640; Lord ATK, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-11; LOURIA DB, 1960, NEW ENGL J MED, V263, P1281, DOI 10.1056/NEJM196012222632504; Lunardi LW, 2006, CLIN INFECT DIS, V43, pE60, DOI 10.1086/507036; MARTINO P, 1990, REV INFECT DIS, V12, P570; Matos T, 2002, MYCOSES, V45, P373, DOI 10.1046/j.1439-0507.2002.00779.x; Matos T, 2003, ANTON LEEUW INT J G, V83, P293, DOI 10.1023/A:1023373329502; MATSUMOTO T, 1993, MYCOSES, V36, P145, DOI 10.1111/j.1439-0507.1993.tb00743.x; Muller FMC, 2010, EXPERT REV ANTI-INFE, V8, P957, DOI [10.1586/eri.10.72, 10.1586/ERI.10.72]; MUOTOEOKAFOR FA, 1993, MYCOPATHOLOGIA, V122, P95, DOI 10.1007/BF01103605; NISHIMURA K, 1987, MYCOPATHOLOGIA, V97, P17, DOI 10.1007/BF00437326; Nishiuchi Y, 2009, JPN J INFECT DIS, V62, P182; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; O'Donnell K, 2010, J CLIN MICROBIOL, V48, P3708, DOI 10.1128/JCM.00989-10; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Ojima M, 2002, J APPL MICROBIOL, V93, P800, DOI 10.1046/j.1365-2672.2002.01746.x; Packeu A, 2012, J MED MICROBIOL, V61, P1226, DOI 10.1099/jmm.0.042317-0; Peat JK, 1998, ALLERGY, V53, P120, DOI 10.1111/j.1398-9995.1998.tb03859.x; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Pires-Goncalves RH, 2008, LETT APPL MICROBIOL, V46, P542, DOI 10.1111/j.1472-765X.2008.02349.x; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Prenafeta-Boldu FX, 2006, FEMS MICROBIOL REV, V30, P109, DOI 10.1111/j.1574-6976.2005.00007.x; Randhawa HS, 2001, MYCOPATHOLOGIA, V151, P63, DOI 10.1023/A:1010906220888; Richardson G, 2005, J ADV NURS, V52, P328, DOI 10.1111/j.1365-2648.2005.03591.x; Russo Juan Pedro, 2010, Skinmed, V8, P366; SAMSON RA, 2001, MICROORGANISMS HOME, P287, DOI DOI 10.1201/9780203302934; Sautour M, 2012, INT J HYG ENVIR HEAL, V215, P286, DOI 10.1016/j.ijheh.2011.11.003; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Sowiak M, 2012, MED PR, V63, P1; Straus DC, 2009, TOXICOL IND HEALTH, V25, P617, DOI 10.1177/0748233709348287; Strausbaugh LJ, 1996, J CLIN MICROBIOL, V34, P471, DOI 10.1128/JCM.34.2.471-473.1996; Sudfeld CR, 2010, J CYST FIBROS, V9, P110, DOI 10.1016/j.jcf.2009.11.010; Sudhadham M, 2008, STUD MYCOL, P145, DOI 10.3114/sim.2008.61.15; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thrasher JD, 2009, TOXICOL IND HEALTH, V25, P583, DOI 10.1177/0748233709348386; Tournas VH, 2006, FOOD MICROBIOL, V23, P684, DOI 10.1016/j.fm.2006.01.003; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Tuon FF, 2008, REV IBEROAM MICOL, V25, P135, DOI 10.1016/S1130-1406(08)70032-9; van den Ende AHGG, 1999, STUD MYCOL, P151; Vaux S, 2014, MBIO, V5, DOI 10.1128/mBio.02309-14; von Baum H, 2010, INFECTION, V38, P181, DOI 10.1007/s15010-010-0005-4; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wirth Fernanda, 2012, Interdiscip Perspect Infect Dis, V2012, P465717, DOI 10.1155/2012/465717; Yurlova NA, 2002, MYCOSES, V45, P443, DOI 10.1046/j.1439-0507.2002.d01-132.x; Zalar P, 2011, FUNGAL BIOL-UK, V115, P997, DOI 10.1016/j.funbio.2011.04.007; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02; Zalar P, 2015, FUNG BIOL; Zalar P, 2013, ELECT ABSTRACTS, P15; Zeng JS, 2007, J CLIN MICROBIOL, V45, P3713, DOI 10.1128/JCM.02012-06	111	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148166	10.1371/journal.pone.0148166	http://dx.doi.org/10.1371/journal.pone.0148166			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867131	gold, Green Submitted, Green Published			2022-12-26	WOS:000370050700009
J	Martinez-Montiel, N; Morales-Lara, L; Hernandez-Perez, JM; Martinez-Contreras, RD				Martinez-Montiel, Nancy; Morales-Lara, Laura; Hernandez-Perez, Julio M.; Martinez-Contreras, Rebeca D.			In Silico Analysis of the Structural and Biochemical Features of the NMD Factor UPF1 in Ustilago maydis	PLOS ONE			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; EXON JUNCTION COMPLEX; CAENORHABDITIS-ELEGANS; SURVEILLANCE COMPLEX; MOLECULAR-DYNAMICS; PROTEIN; GENE; PHOSPHORYLATION; TRANSLATION	The molecular mechanisms regulating the accuracy of gene expression are still not fully understood. Among these mechanisms, Nonsense-mediated Decay (NMD) is a quality control process that detects post-transcriptionally abnormal transcripts and leads them to degradation. The UPF1 protein lays at the heart of NMD as shown by several structural and functional features reported for this factor mainly for Homo sapiens and Saccharomyces cerevisiae. This process is highly conserved in eukaryotes but functional diversity can be observed in various species. Ustilago maydis is a basidiomycete and the best-known smut, which has become a model to study molecular and cellular eukaryotic mechanisms. In this study, we performed in silico analysis to investigate the structural and biochemical properties of the putative UPF1 homolog in Ustilago maydis. The putative homolog for UPF1 was recognized in the annotated genome for the basidiomycete, exhibiting 66% identity with its human counterpart at the protein level. The known structural and functional domains characteristic of UPF1 homologs were also found. Based on the crystal structures available for UPF1, we constructed different three-dimensional models for umUPF1 in order to analyze the secondary and tertiary structural features of this factor. Using these models, we studied the spatial arrangement of umUPF1 and its capability to interact with UPF2. Moreover, we identified the critical amino acids that mediate the interaction of umUPF1 with UPF2, ATP, RNA and with UPF1 itself. Mutating these amino acids in silico showed an important effect over the native structure. Finally, we performed molecular dynamic simulations for UPF1 proteins from H. sapiens and U. maydis and the results obtained show a similar behavior and physicochemical properties for the protein in both organisms. Overall, our results indicate that the putative UPF1 identified in U. maydis shows a very similar sequence, structural organization, mechanical stability, physicochemical properties and spatial organization in comparison to the NMD factor depicted for Homo sapiens. These observations strongly support the notion that human and fungal UPF1 could perform equivalent biological activities.	[Martinez-Montiel, Nancy; Martinez-Contreras, Rebeca D.] Benemerita Univ Autonoma Puebla, Lab Ecol Mol Microbiana, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Morales-Lara, Laura] Benemerita Univ Autonoma Puebla, Fac Ciencias Quim, Puebla, Mexico; [Hernandez-Perez, Julio M.] Benemerita Univ Autonoma Puebla, Posgrad Ciencias Quim, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla	Martinez-Contreras, RD (corresponding author), Benemerita Univ Autonoma Puebla, Lab Ecol Mol Microbiana, Ctr Invest Ciencias Microbiol, Puebla, Mexico.	rebeca.martinez@correo.buap.mx	Martínez-Contreras, Rebeca/S-9605-2019	Hernandez-Perez, Julio M./0000-0002-1178-2146	Consejo Nacional de Ciencia y Tecnologia; Consejo Nacional de Ciencia y Tecnologia (Mexico)	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	RMC received a grant from Consejo Nacional de Ciencia y Tecnologia for partial funding of this work. NMM received a PhD funding from Consejo Nacional de Ciencia y Tecnologia (Mexico).	ALTAMURA N, 1992, J MOL BIOL, V224, P575, DOI 10.1016/0022-2836(92)90545-U; Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; Arciga-Reyes L, 2006, PLANT J, V47, P480, DOI 10.1111/j.1365-313X.2006.02802.x; Avery P, 2011, RNA, V17, P624, DOI 10.1261/rna.2404211; Azzalin CM, 2006, CELL CYCLE, V5, P1496, DOI 10.4161/cc.5.14.3093; Belostotsky DA, 2005, TRENDS PLANT SCI, V10, P347, DOI 10.1016/j.tplants.2005.05.004; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bicknell AA, 2012, BIOESSAYS, V34, P1025, DOI 10.1002/bies.201200073; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; CHANG JC, 1979, NATURE, V281, P602, DOI 10.1038/281602a0; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Clerici M, 2009, EMBO J, V28, P2293, DOI 10.1038/emboj.2009.175; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Compton J, 2003, ADV UNDERSTANDING MO, P210; Culbertson MR, 2007, GENETICS, V177, P1; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; CZAPLINSKI K, 1995, RNA, V1, P610; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fiorini F, 2012, METHOD ENZYMOL, V511, P255, DOI 10.1016/B978-0-12-396546-2.00012-7; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gleghorn ML, 2011, MOL CELL, V41, P621, DOI 10.1016/j.molcel.2011.03.001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Ho EC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-334; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang LL, 2012, WIRES RNA, V3, P807, DOI 10.1002/wrna.1137; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Kerenyi F, 2013, PLANT J, V76, P836, DOI 10.1111/tpj.12346; Khodadadi S, 2015, SOFT MATTER, V11, P4984, DOI 10.1039/c5sm00636h; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Lasalde C, 2014, NUCLEIC ACIDS RES, V42, P1916, DOI 10.1093/nar/gkt1049; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Maquat LE, 2006, NONSENSE MEDIATED MR; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mekouar M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r65; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Morozov IY, 2012, MOL CELL BIOL, V32, P2585, DOI 10.1128/MCB.00316-12; Munsterkotter M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-473; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; Nyiko T, 2013, NUCLEIC ACIDS RES, V41, P6715, DOI 10.1093/nar/gkt366; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Padariya M, 2015, BBA-BIOMEMBRANES, V1848, P2065, DOI 10.1016/j.bbamem.2015.05.014; Page MF, 1999, MOL CELL BIOL, V19, P5943; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodriguez-Gabriel MA, 2006, MOL CELL BIOL, V26, P6347, DOI 10.1128/MCB.00286-06; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Singh Guramrit, 2006, P59; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Steinberg G, 2008, TRENDS CELL BIOL, V18, P61, DOI 10.1016/j.tcb.2007.11.008; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takahashi S, 2008, RNA, V14, P1950, DOI 10.1261/rna.536308; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Wen JK, 2010, EMBO J, V29, P1537, DOI 10.1038/emboj.2010.48; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2013, GENES CELLS, V18, P161, DOI 10.1111/gtc.12033; Yamashita A, 2009, GENE DEV, V23, P1091, DOI 10.1101/gad.1767209	90	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148191	10.1371/journal.pone.0148191	http://dx.doi.org/10.1371/journal.pone.0148191			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863136	gold, Green Submitted, Green Published			2022-12-26	WOS:000370046600046
J	Petropolis, DB; Faust, DM; Tolle, M; Riviere, L; Valentin, T; Neuveut, C; Hernandez-Cuevas, N; Dufour, A; Olivo-Marin, JC; Guillen, N				Petropolis, Debora B.; Faust, Daniela M.; Tolle, Matthieu; Riviere, Lise; Valentin, Tanguy; Neuveut, Christine; Hernandez-Cuevas, Nora; Dufour, Alexandre; Olivo-Marin, Jean-Christophe; Guillen, Nancy			Human Liver Infection in a Dish: Easy-To-Build 3D Liver Models for Studying Microbial Infection	PLOS ONE			English	Article							HEPATITIS-B; ENTAMOEBA-HISTOLYTICA; IN-VITRO; VIRUS-REPLICATION; X-PROTEIN; CELLS; CULTURE; SYSTEM; ENTRY; NTCP	Human liver infection is a major cause of death worldwide, but fundamental studies on infectious diseases affecting humans have been hampered by the lack of robust experimental models that accurately reproduce pathogen-host interactions in an environment relevant for the human disease. In the case of liver infection, one consequence of this absence of relevant models is a lack of understanding of how pathogens cross the sinusoidal endothelial barrier and parenchyma. To fill that gap we elaborated human 3D liver in vitro models, composed of human liver sinusoidal endothelial cells (LSEC) and Huh-7 hepatoma cells as hepatocyte model, layered in a structure mimicking the hepatic sinusoid, which enable studies of key features of early steps of hepatic infection. Built with established cell lines and scaffold, these models provide a reproducible and easy-to-build cell culture approach of reduced complexity compared to animal models, while preserving higher physiological relevance compared to standard 2D systems. For proof-of-principle we challenged the models with two hepatotropic pathogens: the parasitic amoeba Entamoeba histolytica and hepatitis B virus (HBV). We constructed four distinct setups dedicated to investigating specific aspects of hepatic invasion: 1) pathogen 3D migration towards hepatocytes, 2) hepatocyte barrier crossing, 3) LSEC and subsequent hepatocyte crossing, and 4) quantification of human hepatic virus replication (HBV). Our methods comprise automated quantification of E. histolytica migration and hepatic cells layer crossing in the 3D liver models. Moreover, replication of HBV virus occurs in our virus infection 3D liver model, indicating that routine in vitro assays using HBV or others viruses can be performed in this easy-to-build but more physiological hepatic environment. These results illustrate that our new 3D liver infection models are simple but effective, enabling new investigations on infectious disease mechanisms. The better understanding of these mechanisms in a human-relevant environment could aid the discovery of drugs against pathogenic liver infection.	[Petropolis, Debora B.; Faust, Daniela M.; Tolle, Matthieu; Valentin, Tanguy; Hernandez-Cuevas, Nora; Guillen, Nancy] Inst Pasteur, INSERM, U786, Cell Biol Parasitism Unit,BCI, F-75724 Paris, France; [Riviere, Lise; Neuveut, Christine] Inst Pasteur, Dept Virol, Hepaciviruses & Innate Immun Unit, Paris, France; [Petropolis, Debora B.; Dufour, Alexandre; Olivo-Marin, Jean-Christophe; Guillen, Nancy] Inst Pasteur, BCI, Quantitat Image Anal, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Petropolis, DB (corresponding author), Inst Pasteur, INSERM, U786, Cell Biol Parasitism Unit,BCI, F-75724 Paris, France.; Petropolis, DB (corresponding author), Inst Pasteur, BCI, Quantitat Image Anal, Paris, France.	petropolis.debora@gmail.com	Lauterbach-Riviere, Lise/AAF-2593-2021	Lauterbach-Riviere, Lise/0000-0001-6705-3439; Neuveut, Christine/0000-0001-6520-271X; Dufour, Alexandre/0000-0002-9417-7389	National French Research Agency [ANR-2010-GENM-0011-01]; French Parasitology consortium Labex ParaFrap [ANR-11-LABX0024]; DIM Ile de France	National French Research Agency(French National Research Agency (ANR)); French Parasitology consortium Labex ParaFrap; DIM Ile de France	The work was funded by the National French Research Agency (ANR-2010-GENM-0011-01, GENAMIBE), the French Parasitology consortium Labex ParaFrap (grant ANR-11-LABX0024). The authors wanted to acknowledge the generous support of "DIM Ile de France" for the Two-photon microscope acquirement and for the fellowship to D. Petropolis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale SS, 2015, TISSUE ENG PART C-ME, V21, P413, DOI [10.1089/ten.tec.2014.0152, 10.1089/ten.TEC.2014.0152]; Bale SS, 2014, EXP BIOL MED, V239, P1180, DOI 10.1177/1535370214531872; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Faust DM, 2012, MICROBES INFECT, V14, P1428, DOI 10.1016/j.micinf.2012.05.013; Faust DM, 2011, CELL MICROBIOL, V13, P1091, DOI 10.1111/j.1462-5822.2011.01604.x; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Gunness P, 2013, TOXICOL SCI, V133, P67, DOI 10.1093/toxsci/kft021; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; Kim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015456; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Mathur A, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt375; Ng S, 2015, STEM CELL REP, V4, P1; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Petropolis DB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004381; Petropolis DB, 2014, PEERJ, V2, DOI 10.7717/peerj.317; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	27	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148667	10.1371/journal.pone.0148667	http://dx.doi.org/10.1371/journal.pone.0148667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863526	gold, Green Submitted, Green Published			2022-12-26	WOS:000370046600095
J	Sorrentino, G; Haworth, M; Wahbi, S; Mahmood, T; Zuomin, S; Centritto, M				Sorrentino, Giuseppe; Haworth, Matthew; Wahbi, Said; Mahmood, Tariq; Zuomin, Shi; Centritto, Mauro			Abscisic Acid Induces Rapid Reductions in Mesophyll Conductance to Carbon Dioxide	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; CO2 TRANSFER CONDUCTANCE; RELATIVE WATER-CONTENT; ISOTOPE DISCRIMINATION; GAS-EXCHANGE; STOMATAL CONDUCTANCE; LEAF ANATOMY; PHOTOSYNTHETIC LIMITATIONS; CHLOROPHYLL FLUORESCENCE; ELECTRON-TRANSPORT	The rate of photosynthesis (A) of plants exposed to water deficit is a function of stomatal (g(s)) and mesophyll (g(m)) conductance determining the availability of CO2 at the site of carboxylation within the chloroplast. Mesophyll conductance often represents the greatest impediment to photosynthetic uptake of CO2, and a crucial determinant of the photosynthetic effects of drought. Abscisic acid (ABA) plays a fundamental role in signalling and coordination of plant responses to drought; however, the effect of ABA on g(m) is not welldefined. Rose, cherry, olive and poplar were exposed to exogenous ABA and their leaf gas exchange parameters recorded over a four hour period. Application with ABA induced reductions in values of A, g(s) and g(m) in all four species. Reduced g(m) occurred within one hour of ABA treatment in three of the four analysed species; indicating that the effect of ABA on g(m) occurs on a shorter timescale than previously considered. These declines in g(m) values associated with ABA were not the result of physical changes in leaf properties due to altered turgor affecting movement of CO2, or caused by a reduction in the sub-stomatal concentration of CO2 (C-i). Increased [ABA] likely induces biochemical changes in the properties of the interface between the sub-stomatal air-space and mesophyll layer through the actions of cooporins to regulate the transport of CO2. The results of this study provide further evidence that g(m) is highly responsive to fluctuations in the external environment, and stress signals such as ABA induce co-ordinated modifications of both g(s) and g(m) in the regulation of photosynthesis.	[Sorrentino, Giuseppe] CNR, Inst Mediterranean Agr & Forest Syst, Via Patacca 85, I-80056 Ercolano, NA, Italy; [Haworth, Matthew; Centritto, Mauro] CNR, Tree & Timber Inst, IVALSA, Via Madonna del Piano 10, I-50019 Sesto Fiorentino, FI, Italy; [Wahbi, Said] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biotechnol & Physiol Vegetale, Blvd My Abdellah BP 2390, Marrakech, Morocco; [Mahmood, Tariq] Pir Mehr Ali Shah Arid Agr Univ, Dept Environm Sci, Murree Rd, Rawalpindi, Pakistan; [Zuomin, Shi] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Key Lab Forest Ecol & Environm Sci, State Forestry Adm, Beijing, Peoples R China	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); Cadi Ayyad University of Marrakech; Arid Agriculture University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Haworth, M (corresponding author), CNR, Tree & Timber Inst, IVALSA, Via Madonna del Piano 10, I-50019 Sesto Fiorentino, FI, Italy.	haworth@ivalsa.cnr.it	Haworth, Matthew/B-7817-2013	WAHBI, Said/0000-0002-3066-5586; Haworth, Matthew/0000-0002-3225-6620	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT" Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: Progetto Premiale "Aqua"; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT" and Progetto Premiale "Aqua"; Marie Curie IEF [2010-275626]	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT" Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: Progetto Premiale "Aqua"; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT" and Progetto Premiale "Aqua"; Marie Curie IEF(European Commission)	This work was funded by Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN 2010-2011 "PRO-ROOT" Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: Progetto Premiale 2012 "Aqua". http://www.istruzione.it/Marie Curie IEF (2010-275626) http://ec.europa.eu/research/mariecurieactions/.; This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN 2010-2011 "PRO-ROOT" and Progetto Premiale 2012 "Aqua". MH acknowledges funding from a Marie Curie IEF (2010-275626).	Adachi S, 2013, J EXP BOT, V64, P1061, DOI 10.1093/jxb/ers382; Aganchich B, 2009, TREE PHYSIOL, V29, P685, DOI 10.1093/treephys/tpp012; Aroca R, 2006, ANN BOT-LONDON, V98, P1301, DOI 10.1093/aob/mcl219; Bernacchi CJ, 2002, PLANT PHYSIOL, V130, P1992, DOI 10.1104/pp.008250; BLACKMAN PG, 1983, J EXP BOT, V34, P1619, DOI 10.1093/jxb/34.12.1619; Bramley H, 2013, PLANT SOIL, V369, P257, DOI 10.1007/s11104-012-1568-x; Brilli F, 2013, J EXP BOT, V64, P519, DOI 10.1093/jxb/ers353; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Chater C, 2013, CURR OPIN PLANT BIOL, V16, P638, DOI 10.1016/j.pbi.2013.06.013; CORREIA MJ, 1995, PLANT CELL ENVIRON, V18, P511, DOI 10.1111/j.1365-3040.1995.tb00551.x; COWAN IR, 1982, AUST J PLANT PHYSIOL, V9, P489, DOI 10.1071/PP9820489; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; DIAZPEREZ JC, 1995, J EXP BOT, V46, P111, DOI 10.1093/jxb/46.1.111; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; EVANS JR, 1994, AUST J PLANT PHYSIOL, V21, P475, DOI 10.1071/PP9940475; EVANS JR, 1986, AUST J PLANT PHYSIOL, V13, P281, DOI 10.1071/PP9860281; Flexas J, 2006, NEW PHYTOL, V172, P73, DOI 10.1111/j.1469-8137.2006.01794.x; Flexas J, 2002, FUNCT PLANT BIOL, V29, P461, DOI 10.1071/PP01119; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Flexas J, 2006, PLANT J, V48, P427, DOI 10.1111/j.1365-313X.2006.02879.x; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; GEHRING CA, 1990, P NATL ACAD SCI USA, V87, P9645, DOI 10.1073/pnas.87.24.9645; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert ME, 2012, J EXP BOT, V63, P413, DOI 10.1093/jxb/err288; Gleason SM, 2012, FUNCT ECOL, V26, P343, DOI 10.1111/j.1365-2435.2012.01962.x; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; Greenway H, 2003, FUNCT PLANT BIOL, V30, P999, DOI 10.1071/PP98096; Grondin A, 2015, PLANT CELL, V27, P1945, DOI 10.1105/tpc.15.00421; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Haworth M, 2016, FUNCT PLANT BIOL, V43, P26, DOI 10.1071/FP15232; Haworth M, 2015, AM J BOT, V102, P677, DOI 10.3732/ajb.1400508; Heckwolf M, 2011, PLANT J, V67, P795, DOI 10.1111/j.1365-313X.2011.04634.x; Hoagland DR, 1950, CAL AGR EXP STN CIRC, V347, DOI [DOI 10.1016/S0140-6736(00)73482-9, 10.1016/S0140-6736(00)73482-9]; Kaldenhoff R, 2012, CURR OPIN PLANT BIOL, V15, P276, DOI 10.1016/j.pbi.2012.01.011; KOK B., 1948, ENZYMOLOGIA [HAGUE], V13, P1; Laisk A, 1996, PLANT PHYSIOL, V110, P903, DOI 10.1104/pp.110.3.903; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; Lauteri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109054; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; LORETO F, 1992, PLANT PHYSIOL, V98, P1437, DOI 10.1104/pp.98.4.1437; Loreto F, 2003, PLANT CELL ENVIRON, V26, P595, DOI 10.1046/j.1365-3040.2003.00994.x; Loreto F, 2009, J EXP BOT, V60, P2283, DOI 10.1093/jxb/erp112; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; McAdam SAM, 2012, PLANT CELL, V24, P1510, DOI 10.1105/tpc.112.096404; Mizokami Y, 2015, PLANT CELL ENVIRON, V38, P388, DOI 10.1111/pce.12394; Pallozzi E, 2013, ENVIRON EXP BOT, V95, P50, DOI 10.1016/j.envexpbot.2013.06.001; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; Rodeghiero M, 2007, PLANT CELL ENVIRON, V30, P1006, DOI 10.1111/j.1365-3040.2007.001689.x; Scartazza A, 1998, AUST J PLANT PHYSIOL, V25, P489, DOI 10.1071/PP98017; Schaufele R, 2011, PLANT CELL ENVIRON, V34, P127, DOI 10.1111/j.1365-3040.2010.02230.x; Shatil-Cohen A, 2011, PLANT J, V67, P72, DOI 10.1111/j.1365-313X.2011.04576.x; Shi Z, 2008, PLANT BIOSYST, V142, P525, DOI 10.1080/11263500802410876; SNAITH PJ, 1982, PLANT CELL ENVIRON, V5, P309, DOI 10.1111/1365-3040.ep11572699; Sun PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105165; TARDIEU F, 1992, PLANT PHYSIOL, V98, P540, DOI 10.1104/pp.98.2.540; Tardieu F, 1996, PLANT CELL ENVIRON, V19, P75, DOI 10.1111/j.1365-3040.1996.tb00228.x; Tazoe Y, 2015, PLANT CELL ENVIRON, V38, P385, DOI 10.1111/pce.12437; Tazoe Y, 2011, PLANT CELL ENVIRON, V34, P580, DOI 10.1111/j.1365-3040.2010.02264.x; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; Terashima I, 2002, PLANT CELL PHYSIOL, V43, P70, DOI 10.1093/pcp/pcf001; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; Thomas DS, 1999, J EXP BOT, V50, P243, DOI 10.1093/jexbot/50.331.243; Tomas M, 2013, J EXP BOT, V64, P2269, DOI 10.1093/jxb/ert086; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; TREJO CL, 1991, J EXP BOT, V42, P1507, DOI 10.1093/jxb/42.12.1507; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; Uehlein N, 2012, PLANT CELL ENVIRON, V35, P1077, DOI 10.1111/j.1365-3040.2011.02473.x; Vrabl D, 2009, J EXP BOT, V60, P2315, DOI 10.1093/jxb/erp115; Warren CR, 2007, 14 INT C PHOT JUL 22; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559; Xu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079618; Xu ZJ, 2002, PLANT PHYSIOL, V129, P1285, DOI 10.1104/pp.001784; Yin XY, 2011, J EXP BOT, V62, P3489, DOI 10.1093/jxb/err038; ZHANG J, 1990, PLANT CELL ENVIRON, V13, P277, DOI 10.1111/j.1365-3040.1990.tb01312.x; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439	81	34	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148554	10.1371/journal.pone.0148554	http://dx.doi.org/10.1371/journal.pone.0148554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862904	Green Published, gold			2022-12-26	WOS:000370046600080
J	Blomfeldt, A; Hasan, AA; Aamot, HV				Blomfeldt, Anita; Hasan, Abdullahi Abdi; Aamot, Hege Vangstein			Can MLVA Differentiate among Endemic-Like MRSA Isolates with Identical Spa-Type in a Low-Prevalence Region?	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; TANDEM REPEAT ANALYSIS; TRANSMISSION; SUFFICIENT	The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in Norway is low, but an endemic-like MRSA clone with Staphylococcal protein A (spa)-type t304 has been established especially in nursing homes in the Oslo region causing several large outbreaks. The challenge was that spa-typing and the gold standard Pulsed-Field Gel Electrophoresis (PFGE) were inadequate in discriminating isolates in outbreak investigations. Additional higher resolution genotyping methods were needed. The aims of this study were a) to evaluate whether Multiple-Locus Variable number of tandem repeat Analysis (MLVA) could differentiate within the PFGE clusters between epidemiologically related and unrelated endemiclike ST8-MRSA-IV-t304-PVL-neg (MRSA-t304) isolates and b) investigate the evolution of the endemic-like MRSA-t304 clone over a 15-year time period. All MRSA-t304 isolates detected in the region from 1998 through April 2013 were included. In total, 194 of 197 isolates were available for PFGE and MLVA analyses. PFGE results on isolates from 19982010 have been published previously. Two PFGE clusters subdivided into eight MLVA types were detected. One major outbreak clone (PFGE cluster C2/MLVA type MT5045) appeared from 2004 to 2011 causing long-lasting and large outbreaks in seven nursing homes and one hospital. Five new MLVA types (N = 9 isolates) differing in only one VNTR compared to the outbreak clone C2/MT5045 were detected, but only one (C2/MT5044) was seen after 2011. We suggest that MLVA can replace PFGE analysis, but MLVA may not be the optimal method in this setting as it did not discriminate between all epidemiologically unrelated isolates. The results may indicate that all eight outbreaks in different locations within the PFGE C2 cluster may be branches of one large regional outbreak. The major outbreak strain C2/MT5045 may now, however, be under control, extinguished or has moved geographically.	[Blomfeldt, Anita; Aamot, Hege Vangstein] Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway; [Hasan, Abdullahi Abdi] Oslo & Akershus Univ, Fac Hlth Sci, Coll Appl Sci, Oslo, Norway; [Aamot, Hege Vangstein] Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, Div Med, Lorenskog, Norway; [Aamot, Hege Vangstein] Univ Oslo, Lorenskog, Norway	University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Aamot, HV (corresponding author), Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway.; Aamot, HV (corresponding author), Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, Div Med, Lorenskog, Norway.; Aamot, HV (corresponding author), Univ Oslo, Lorenskog, Norway.	hege.vangstein.aamot@ahus.no		Blomfeldt, aNita/0000-0003-2044-412X				[Anonymous], 2009, NAT GUID PREV SPREAD; Azarian T, 2015, INFECT CONT HOSP EP, V36, P777, DOI 10.1017/ice.2015.73; Bartels MD, 2015, EURO SURVEILL, V20; Bosch T, 2015, FUTURE MICROBIOL, V10, P1155, DOI 10.2217/fmb.15.35; Chroboczek T, 2013, J TRAVEL MED, V20, P283, DOI 10.1111/jtm.12047; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Helgason KO, 2008, J CLIN MICROBIOL, V46, P832, DOI 10.1128/JCM.02154-07; Moen AEF, 2014, J HOSP INFECT, V88, P72, DOI 10.1016/j.jhin.2014.06.008; Monecke Stefan, 2013, BMC Res Notes, V6, P548, DOI 10.1186/1756-0500-6-548; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Steen Tore Walgaard, 2013, Tidsskr Nor Laegeforen, V133, P1800, DOI 10.4045/tidsskr.13.0191; Steen Tore Walgaard, 2013, Tidsskr Nor Laegeforen, V133, P1819, DOI 10.4045/tidsskr.12.0935; Uhlemann AC, 2012, EUR J CLIN MICROBIOL, V31, P505, DOI 10.1007/s10096-011-1339-2; Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x	17	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148772	10.1371/journal.pone.0148772	http://dx.doi.org/10.1371/journal.pone.0148772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859765	Green Published, gold			2022-12-26	WOS:000370038400080
J	Hall, E; Bishop, DC; Gee, TI				Hall, Emma; Bishop, Daniel C.; Gee, Thomas I.			Effect of Plyometric Training on Handspring Vault Performance and Functional Power in Youth Female Gymnasts	PLOS ONE			English	Article							RELIABILITY; ELITE	This study aimed to determine the effect of plyometric training (PT) when added to habitual gymnastic training (HT) on handspring vault (HV) performance variables. Twenty youth female competitive gymnasts (Age: 12.5 +/- 1.67 y) volunteered to participate and were randomly assigned to two independent groups. The experimental plyometric training group (PTG) undertook a six-week plyometric program, involving two additional 45 min PT sessions a week, alongside their HT, while the control group (CG) performed regular HT only. Videography was used (120 Hz) in the sagittal plane to record both groups performing three HVs for both the baseline and post-intervention trials. Furthermore, participants completed a countermovement jump test (CMJ) to assess the effect of PT on functional power. Through the use of Quintic biomechanics software, significant improvements (P < 0.05) were found for the PTG for run-up velocity, take-off velocity, hurdle to board distance, board contact time, table contact time and post-flight time and CMJ height. However, there were no significant improvements on pre-flight time, shoulder angle or hip angle on the vault for the PTG. The CG demonstrated no improvement for all HV measures. A sport-specific PT intervention improved handspring vault performance measures and functional power when added to the habitual training of youth female gymnasts. The additional two hours plyometric training seemingly improved the power generating capacity of movement-specific musculature, which consequently improved aspects of vaulting performance. Future research is required to examine the whether the improvements are as a consequence of the additional volume of sprinting and jumping activities, as a result of the specific PT method or a combination of these factors.	[Hall, Emma; Bishop, Daniel C.; Gee, Thomas I.] Lincoln Univ, Sch Sport & Exercise Sci, Lincoln, NE 68505 USA		Gee, TI (corresponding author), Lincoln Univ, Sch Sport & Exercise Sci, Lincoln, NE 68505 USA.	tgee@lincoln.ac.uk		Gee, Thomas/0000-0001-7253-2055; Bishop, Daniel/0000-0002-2094-7045				Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Adams K., 1992, J STRENGTH COND RES, V6, P36, DOI DOI 10.1519/00124278-199202000-00006; Ahmet A, 2013, SERB J SPORTS SCI, V7, P45; Arazi H, 2012, S AFR J RES SPORT PH, V34, P1; Arkaev L., 2004, GYMNASTICS CREATE CH; Atikovic A, 2012, J HUM KINET, V35, P119, DOI 10.2478/v10078-012-0085-6; BALE P, 1990, SPORTS MED, V10, P139, DOI 10.2165/00007256-199010030-00001; Ball NB, 2009, J STRENGTH COND RES, V23, P1433, DOI 10.1519/JSC.0b013e3181a4e97f; Bencke J, 2002, SCAND J MED SCI SPOR, V12, P171, DOI 10.1034/j.1600-0838.2002.01128.x; Bishop DC, 2009, J STRENGTH COND RES, V23, P2137, DOI 10.1519/JSC.0b013e3181b866d0; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; Bradshaw EJ, 2014, P INT C BIOM SPORT 1; Bradshaw E, 2010, SPORT BIOMECH, V9, P79, DOI 10.1080/14763141.2010.488298; Bradshaw Elizabeth J, 2004, Sports Biomech, V3, P249, DOI 10.1080/14763140408522844; Chimera NJ, 2004, J ATHL TRAINING, V39, P24; FIG (Federation International de Gymnastique), 2013, 2013 COD POINTS WOM; Ford P, 2011, J SPORT SCI, V29, P389, DOI 10.1080/02640414.2010.536849; Hopkins WG, 2003, SPREADSHEET ANAL STR; Jemni M, 2006, J STRENGTH COND RES, V20, P899; Kums T, 2005, BIOL SPORT, V22, P237; Lockwood K, 2004, SPORT J, V7, P184; Makanuk H, 2010, HUMAN MOVEMENT, V11, P17; Marina M, 2014, J STRENGTH COND RES, V28, P1015, DOI 10.1519/JSC.0000000000000247; Meylan C, 2009, J STRENGTH COND RES, V23, P2605, DOI 10.1519/JSC.0b013e3181b1f330; Potteiger JA, 1999, J STRENGTH COND RES, V13, P275, DOI 10.1519/00124278-199908000-00016; Ramirez-Campillo R, 2013, J STRENGTH COND RES, V27, P2714, DOI 10.1519/JSC.0b013e318280c9e9; Slinde F, 2008, J STRENGTH COND RES, V22, P640, DOI 10.1519/JSC.0b013e3181660475; TAKEI Y, 1990, INT J SPORT BIOMECH, V6, P29, DOI 10.1123/ijsb.6.1.29; Takei Y, 1998, J APPL BIOMECH, V14, P190, DOI 10.1123/jab.14.2.190; Vassal K, 2010, J HUM SPORT EXERC, V7, P34	30	83	90	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148790	10.1371/journal.pone.0148790	http://dx.doi.org/10.1371/journal.pone.0148790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859381	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000370038400085
J	Hwang, SH; Kang, JM; Seo, JH; Han, KD; Joo, YH				Hwang, Se-Hwan; Kang, Jun-Myung; Seo, Jae-Hyun; Han, Kyung-do; Joo, Young-Hoon			Gender Difference in the Epidemiological Association between Metabolic Syndrome and Olfactory Dysfunction: The Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							DIABETES-MELLITUS; HORMONES; SMELL; RISK	Metabolic syndrome (MetS) is associated with a higher risk of morbidity and/or mortality for various chronic diseases. The aim of this study was to investigate the relationships of MetS and its components with olfactory dysfunction in a representative Korean population. We analyzed the data from the Korean National Health and Nutrition Examination Survey (2008-2010). A total of 11,609 adults who underwent otolaryngological examination were evaluated. The olfactory function was classified as normosmia or hyposmia by a self-report questionnaire according to the sense problems of smell during the past 3 months. MetS was diagnosed if a participant had at least three of the following: (1) WC >= 90 cm in men and >= 80 cm in women; (2) fasting blood sugar >= 100 mg/dL or medication use for elevated glucose; (3) fasting triglyceride >= 150 mg/dL or cholesterol-lowering medication use; (4) HDL-cholesterol <40 mg/dL in men and <50 mg/dL in women or cholesterol-lowering medication use; and (5) SBP >= 130 mmHg and/or DBP >= 85 mmHg or antihypertensive drug use for patients with a history of hypertension. The prevalence of olfactory dysfunction in the study population was 6.3%. The prevalence of olfactory dysfunction was significantly higher in older people with MetS than in those without MetS in both sexes (male, 42.0 +/- 3.4% vs. 34.7 +/- 0.9%, p = 0.0354; female, 46.2 +/- 2.8% vs. 37.8 +/- 0.8%, p = 0.0026). However, elevated waist circumference, elevated fasting glucose, elevated triglycerides, reduced HDL cholesterol, elevated blood pressure, severe stress, depressed mood, and suicidal ideation were significantly associated with olfactory dysfunction only in women. After controlling for confounders, olfactory dysfunction was significantly associated with MetS (odds ratio, 1.352; 95% confidence interval, 1.005-1.820) only in women. MetS are associated with olfactory dysfunction only in Korean women.	[Hwang, Se-Hwan; Kang, Jun-Myung; Seo, Jae-Hyun; Joo, Young-Hoon] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Han, Kyung-do] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Joo, YH (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	joodoct@catholic.ac.kr	Joo, Young Hoon/AAU-7285-2020	Joo, Young Hoon/0000-0002-4662-1916; Hwang, Se Hwan/0000-0002-2838-7820				Banos G., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P137; Brady S, 2013, CHEM SENSES, V38, P497, DOI 10.1093/chemse/bjt013; Gouveri E, 2014, ANGIOLOGY, V65, P869, DOI 10.1177/0003319714520956; Henkin RI, 2014, NUTRITION, V30, P690, DOI 10.1016/j.nut.2013.11.003; HUBERT HB, 1980, SCIENCE, V208, P607, DOI 10.1126/science.7189296; Johnson P, 2015, WORKPLACE HEALTH SAF, V63, P245, DOI 10.1177/2165079915576920; Joo YH, 2015, AM J RHINOL ALLERGY, V29, P268, DOI 10.2500/ajra.2015.29.4194; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Lee DH, 2013, DIABETES METAB J, V37, P132, DOI 10.4093/dmj.2013.37.2.132; Lee WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062725; Lim W, 2015, J PHYS THER SCI, V27, P555, DOI 10.1589/jpts.27.555; Obrebowski A, 2000, INT J PEDIATR OTORHI, V55, P191, DOI 10.1016/S0165-5876(00)00397-9; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Pankevich DE, 2008, OBESITY, V16, P1539, DOI 10.1038/oby.2008.221; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011; Rhee CS, 2014, AM J RHINOL ALLERGY, V28, pE107, DOI 10.2500/ajra.2014.28.4040; Sanchez I, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0471-5; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Thiebaud N, 2014, J NEUROSCI, V34, P6970, DOI 10.1523/JNEUROSCI.3366-13.2014; Tucker KR, 2012, PHYSIOL BEHAV, V107, P424, DOI 10.1016/j.physbeh.2012.09.007; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z; Zamora R, 2012, CLIN NEUROPHYSIOL, V123, P918, DOI 10.1016/j.clinph.2011.09.001	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148813	10.1371/journal.pone.0148813	http://dx.doi.org/10.1371/journal.pone.0148813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859830	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400090
J	Weinkauf, MFG; Kunze, JG; Waniek, JJ; Kucera, M				Weinkauf, Manuel F. G.; Kunze, Jose G.; Waniek, Joanna J.; Kucera, Michal			Seasonal Variation in Shell Calcification of Planktonic Foraminifera in the NE Atlantic Reveals Species-Specific Response to Temperature, Productivity, and Optimum Growth Conditions	PLOS ONE			English	Article							CARBONATE ION CONCENTRATION; SEA-SURFACE TEMPERATURES; CLIMATE-CHANGE; INTERANNUAL VARIABILITY; SECONDARY CALCIFICATION; AZORES FRONT; OCEAN; WEIGHT; SIZE; ASSEMBLAGES	Using shells collected from a sediment trap series in the Madeira Basin, we investigate the effects of seasonal variation of temperature, productivity, and optimum growth conditions on calcification in three species of planktonic Foraminifera. The series covers an entire seasonal cycle and reflects conditions at the edge of the distribution of the studied species, manifesting more suitable growth conditions during different parts of the year. The seasonal variation in seawater carbonate saturation at the studied site is negligible compared to other oceanic regions, allowing us to assess the effect of parameters other than carbonate saturation. Shell calcification is quantified using weight and size of individual shells. The size-weight scaling within each species is robust against changes in environmental parameters, but differs among species. An analysis of the variation in calcification intensity (size-normalized weight) reveals species-specific response patterns. In Globigerinoides ruber (white) and Globigerinoides elongatus, calcification intensity is correlated with temperature (positive) and productivity (negative), whilst in Globigerina bulloides no environmental forcing is observed. The size-weight scaling, calcification intensity, and response of calcification intensity to environmental change differed between G. ruber (white) and G. elongatus, implying that patterns extracted from pooled analyses of these species may reflect their changing proportions in the samples. Using shell flux as a measure of optimum growth conditions, we observe significant positive correlation with calcification intensity in G. elongatus, but negative correlation in G. bulloides. The lack of a consistent response of calcification intensity to optimum growth conditions is mirrored by the results of shell size analyses. We conclude that calcification intensity in planktonic Foraminifera is affected by factors other than carbonate saturation. These factors include temperature, productivity, and optimum growth conditions, but the strength and sign of the relationships differ among species, potentially complicating interpretations of calcification data from the fossil record.	[Weinkauf, Manuel F. G.; Kunze, Jose G.] Univ Tubingen, Dept Geosci, Tubingen, Germany; [Weinkauf, Manuel F. G.; Kucera, Michal] Univ Bremen, MARUM, D-28359 Bremen, Germany; [Waniek, Joanna J.] Leibniz Inst Baltic Sea Res Warnemunde, Marine Chem Sect, Rostock, Germany; [Weinkauf, Manuel F. G.] Univ Geneva, Dept Earth Sci, Geneva, Switzerland	Eberhard Karls University of Tubingen; University of Bremen; Leibniz Institut fur Ostseeforschung Warnemunde; University of Geneva	Weinkauf, MFG (corresponding author), Univ Tubingen, Dept Geosci, Tubingen, Germany.; Weinkauf, MFG (corresponding author), Univ Bremen, MARUM, D-28359 Bremen, Germany.; Weinkauf, MFG (corresponding author), Univ Geneva, Dept Earth Sci, Geneva, Switzerland.	Manuel.Weinkauf@unige.ch	Kucera, Michal/ABH-6065-2020; Kucera, Michal/B-9277-2009; Weinkauf, Manuel/AAL-5704-2020; Kucera, Michal/AAE-8115-2020	Kucera, Michal/0000-0002-7817-9018; Kucera, Michal/0000-0002-7817-9018; Weinkauf, Manuel F. G./0000-0002-4640-9659; Waniek, Joanna J./0000-0003-3724-073X	Landesgraduiertenforderung of the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg; Joanna M. Resig Foraminiferal Research Fellowship of the Cushman Foundation for Foraminiferal Research	Landesgraduiertenforderung of the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg; Joanna M. Resig Foraminiferal Research Fellowship of the Cushman Foundation for Foraminiferal Research	MFGW received funding from the Landesgraduiertenforderung of the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg (https://mwk.baden-wuerttemberg.de/de/startseite/) and the Joanna M. Resig Foraminiferal Research Fellowship of the Cushman Foundation for Foraminiferal Research (http://www.cushmanfoundation.org/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldridge D, 2012, BIOGEOSCIENCES, V9, P1725, DOI 10.5194/bg-9-1725-2012; [Anonymous], 2013, NOAA ATLAS NESDIS; Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Barker S, 2002, SCIENCE, V297, P833, DOI 10.1126/science.1072815; Barrows TT, 2005, QUATERNARY SCI REV, V24, P1017, DOI 10.1016/j.quascirev.2004.07.020; Be A.W.H., 1977, OCEANIC MICROPALEONT, P1; BE AWH, 1964, SCIENCE, V145, P823, DOI 10.1126/science.145.3634.823; Beer CJ, 2010, BIOGEOSCIENCES, V7, P2193, DOI 10.5194/bg-7-2193-2010; Beer CJ, 2010, GEOLOGY, V38, P103, DOI 10.1130/G30150.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijma J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000388; Bijma J., 1999, USE PROXIES PALEOCEA, DOI DOI 10.1007/978-3-642-58646-0_20; Broecker W, 2001, PALEOCEANOGRAPHY, V16, P531, DOI 10.1029/2000PA000600; Broecker WS, 2001, PALEOCEANOGRAPHY, V16, P669, DOI 10.1029/2001PA000660; Brummer G.J., 1988, PLANKTONIC FORAMINIF; CARON DA, 1982, J MAR BIOL ASSOC UK, V62, P435, DOI 10.1017/S0025315400057374; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Davis CV, 2013, BIOGEOSCIENCES, V10, P6131, DOI 10.5194/bg-10-6131-2013; Davison AC, 1997, CAMBRIDGE SERIES STA, V1; de Moel H, 2009, BIOGEOSCIENCES, V6, P1917, DOI 10.5194/bg-6-1917-2009; de Villiers S, 2004, MAR BIOL, V144, P45, DOI 10.1007/s00227-003-1183-8; Dixon P. M., 2002, ENCY ENV, P212; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; EREZ J, 1981, PALAEOGEOGR PALAEOCL, V33, P129, DOI 10.1016/0031-0182(81)90035-3; FLIGNER MA, 1976, J AM STAT ASSOC, V71, P210, DOI 10.2307/2285771; Frundt B, 2012, CENT EUR J GEOSCI, V4, P531, DOI 10.2478/s13533-012-0102-2; Gonzalez-Davila M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001993; Gonzalez-Davila M, 2008, SURFACE CARBON DIOXI; Gonzalez-Mora B, 2008, QUATERNARY SCI REV, V27, P956, DOI 10.1016/j.quascirev.2008.01.008; Good SA, 2013, J GEOPHYS RES-OCEANS, V118, P6704, DOI 10.1002/2013JC009067; Goyet C., 2000, GLOBAL DISTRIBUTION; HECHT A D, 1976, Journal of Foraminiferal Research, V6, P295; Helsel D. R., 2002, TECHNIQUES WATER RES, V4, pA3, DOI DOI 10.2307/1269385; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; KLEIN B, 1989, J GEOPHYS RES-OCEANS, V94, P6159, DOI 10.1029/JC094iC05p06159; Kremling K, 1996, REV SCI INSTRUM, V67, P4360, DOI 10.1063/1.1147582; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kucera M, 2005, QUATERNARY SCI REV, V24, P951, DOI 10.1016/j.quascirev.2004.07.014; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; Levitus S, 2013, NOAA ATLAS NESDIS, V4, P1; Lewis E., 1998, PROGRAM DEV CO2 SYST; Locarnini RA, 2013, NOAA ATLAS NESDIS, V73, P1; LOHMANN GP, 1995, PALEOCEANOGRAPHY, V10, P445, DOI 10.1029/95PA00059; Lombard F, 2010, BIOGEOSCIENCES, V7, P247, DOI 10.5194/bg-7-247-2010; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Manno C, 2012, POLAR BIOL, V35, P1311, DOI 10.1007/s00300-012-1174-7; Marshall BJ, 2013, PALEOCEANOGRAPHY, V28, P363, DOI 10.1002/palo.20034; McDonald J.H., 2009, HDB BIOL STAT; Media Cybernetics Inc., 2006, IM PROPL VERS 6 0 WI; Mohan R, 2015, ACTA GEOL SIN-ENGL, V89, P27; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Naik SS, 2013, J EARTH SYST SCI, V122, P1153, DOI 10.1007/s12040-013-0330-y; Naik SS, 2011, CURR SCI INDIA, V101, P1370; Naik SS, 2010, MAR GEOL, V275, P278, DOI 10.1016/j.margeo.2010.05.004; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Numberger L, 2009, MAR MICROPALEONTOL, V73, P90, DOI 10.1016/j.marmicro.2009.07.004; Parket F. L., 1962, Micropaleontology, V8, P219, DOI 10.2307/1484745; Peeters F, 1999, MAR MICROPALEONTOL, V36, P31, DOI 10.1016/S0377-8398(98)00026-7; R Development Core Team, 2014, R LANG ENV STAT COMP; ROBBINS LL, 1988, J FORAMIN RES, V18, P326, DOI 10.2113/gsjfr.18.4.326; Schiebel R, 2002, DEEP-SEA RES PT II, V49, P4035, DOI 10.1016/S0967-0645(02)00141-8; Schlitzer R., 2014, OCEAN DATA VIEW; Schmidt DN, 2004, MAR MICROPALEONTOL, V50, P319, DOI 10.1016/S0377-8398(03)00098-7; Schmidt DN, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000831; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; SPERO HJ, 1988, MAR BIOL, V99, P9, DOI 10.1007/BF00644972; Steinke S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000926; Storz D, 2006, THESIS EBERHARD KARL; Storz D, 2009, DEEP-SEA RES PT I, V56, P107, DOI 10.1016/j.dsr.2008.08.009; Tabor J, 2010, J STAT ED, V18, P1; Theil H., 1950, P KONINKLIJKE NEDERL, V53, P1397; van Sebille E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7521; Wang LJ, 2000, PALAEOGEOGR PALAEOCL, V161, P381, DOI 10.1016/S0031-0182(00)00094-8; Waniek JJ, 2005, DEEP-SEA RES PT I, V52, P33, DOI 10.1016/j.dsr.2004.08.008; Weinkauf MFG, 2013, BIOGEOSCIENCES, V10, P6639, DOI 10.5194/bg-10-6639-2013; Yoder J, 2005, LIVE ACCESS US JGOFS; YOHAI VJ, 1991, IMA V MATH, V34, P365	82	30	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148363	10.1371/journal.pone.0148363	http://dx.doi.org/10.1371/journal.pone.0148363			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859838	Green Published, gold			2022-12-26	WOS:000370038400036
J	Frankel, ML; Demeter, MA; Lemire, JA; Turner, RJ				Frankel, Mathew L.; Demeter, Marc A.; Lemire, Joe A.; Turner, Raymond J.			Evaluating the Metal Tolerance Capacity of Microbial Communities Isolated from Alberta Oil Sands Process Water	PLOS ONE			English	Article							NAPHTHENIC ACIDS; WASTE-WATER; HEAVY-METALS; BIOFILM; TOXICITY; MECHANISMS; BIODEGRADATION; METABOLISM; RESISTANCE; SYSTEMS	Anthropogenic activities have resulted in the intensified use of water resources. For example, open pit bitumen extraction by Canada's oil sands operations uses an estimated volume of three barrels of water for every barrel of oil produced. The waste tailings-oil sands process water (OSPW)-are stored in holding ponds, and present an environmental concern as they are comprised of residual hydrocarbons and metals. Following the hypothesis that endogenous OSPWmicrobial communities have an enhanced tolerance to heavy metals, we tested the capacity of planktonic and biofilm populations from OSPW to withstand metal ion challenges, using Cupriavidus metallidurans, a known metal-resistant organism, for comparison. The toxicity of the metals toward biofilm and planktonic bacterial populations was determined by measuring the minimum biofilm inhibitory concentrations (MBICs) and planktonic minimum inhibitory concentrations (MICs) using the MBEC T assay. We observed that the OSPW community and C. metallidurans had similar tolerances to 22 different metals. While thiophillic elements (Te, Ag, Cd, Ni) were found to be most toxic, the OSPW consortia demonstrated higher tolerance to metals reported in tailings ponds (Al, Fe, Mo, Pb). Metal toxicity correlated with a number of physicochemical characteristics of the metals. Parameters reflecting metal-ligand affinities showed fewer and weaker correlations for the community compared to C. metallidurans, suggesting that the OSPW consortia may have developed tolerance mechanisms toward metals present in their environment.	[Frankel, Mathew L.; Demeter, Marc A.; Lemire, Joe A.; Turner, Raymond J.] Univ Calgary, Dept Biol Sci, Biofilm Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada	University of Calgary	Turner, RJ (corresponding author), Univ Calgary, Dept Biol Sci, Biofilm Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	turner@ucalgary.ca	Turner, Raymond J./M-3961-2015	Turner, Raymond J./0000-0002-9263-0776	Natural Sciences and Engineering Research Council of Canada [NSERC DG RGPIN 216887-2010]; Alberta Innovates [201300520] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates	This work was funded by The Natural Sciences and Engineering Research Council of Canada (Grant no. NSERC DG RGPIN 216887-2010, URL: http://www.nserc-crsng.gc.ca/index_eng.asp), and received by RJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolfazlzadehdoshanbehbazari M., 2011, CHARACTERIZING TRANS; Allen EW, 2008, J ENVIRON ENG SCI, V7, P123, DOI 10.1139/S07-038; BAATH E, 1989, WATER AIR SOIL POLL, V47, P335, DOI 10.1007/BF00279331; Baes C.F., 1976, HYDROLYSIS CATIONS, DOI 10.1002/bbpc.19770810252; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Barranguet C, 2000, EUR J PHYCOL, V35, P397, DOI 10.1080/09670260010001736001; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; BIESINGER KE, 1972, J FISH RES BOARD CAN, V29, P1691, DOI 10.1139/f72-269; Booth SC, 2013, METALLOMICS, V5, P723, DOI 10.1039/c3mt20240b; Booth SC, 2011, J PROTEOME RES, V10, P3190, DOI 10.1021/pr2002353; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Bushnell LD, 1941, J BACTERIOL, V41, P653, DOI 10.1128/JB.41.5.653-673.1941; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; COLLINS YE, 1992, APPL ENVIRON MICROB, V58, P1592, DOI 10.1128/AEM.58.5.1592-1600.1992; Cornelis G, 2008, APPL GEOCHEM, V23, P955, DOI 10.1016/j.apgeochem.2008.02.001; Danielli JF, 1951, ADV ENZYMOL RELAT AR, P69; Demeter MA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00936; Demeter MA, 2014, CHEMOSPHERE, V97, P78, DOI 10.1016/j.chemosphere.2013.11.016; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; EPA, 2013, SUMM DAT 2013 PRIOR; Golby S, 2014, MICROB ECOL, V68, P70, DOI 10.1007/s00248-013-0331-z; Golby S, 2012, FEMS MICROBIOL ECOL, V79, P240, DOI 10.1111/j.1574-6941.2011.01212.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harrison JJ, 2004, ENVIRON MICROBIOL, V6, P1220, DOI 10.1111/j.1462-2920.2004.00656.x; Harrison JJ, 2005, ENVIRON MICROBIOL, V7, P981, DOI 10.1111/j.1462-2920.2005.00777.x; Harrison JJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-53; Harrison JJ, 2008, ANTIMICROB AGENTS CH, V52, P2870, DOI 10.1128/AAC.00203-08; Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774; Haynes WM, 2016, CRC HDB CHEM PHYS, V95th, DOI [10.1097/00000441-196906000-00020, DOI 10.233]; HERMAN DC, 1994, CAN J MICROBIOL, V40, P467, DOI 10.1139/m94-076; Hulecki JC, 2010, J IND MICROBIOL BIOT, V37, P471, DOI 10.1007/s10295-010-0693-x; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; JONES MM, 1978, J INORG NUCL CHEM, V40, P2081, DOI 10.1016/0022-1902(78)80212-7; KAISER KL, 1980, CAN J FISH AQUAT SCI, V37, P211, DOI 10.1139/f80-027; Kannel PR, 2012, J ENVIRON SCI HEAL A, V47, P1, DOI 10.1080/10934529.2012.629574; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; LICHT S, 1988, J ELECTROCHEM SOC, V135, P2971, DOI 10.1149/1.2095471; MacKinnon MD, 1981, SYNCRUDE ENV RES MON, V1981-1; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Monchy S, 2006, INT J ENVIRON AN CH, V86, P677, DOI 10.1080/03067310600583824; Monsieurs P, 2011, BIOMETALS, V24, P1133, DOI 10.1007/s10534-011-9473-y; National Energy Board, 2006, CAN OIL SANDS OPP CH; Nicolella C, 2000, J BIOTECHNOL, V80, P1, DOI 10.1016/S0168-1656(00)00229-7; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Pearson RG, 1967, HALOGEN CHEM, P55, DOI [10.1016/B978-0-12-395589-0.50007-9, DOI 10.1016/B978-0-12-395589-0.50007-9]; Quagraine EK, 2005, J ENVIRON SCI HEAL A, V40, P685, DOI 10.1081/ESE-200046649; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Sandrin TR, 2003, ENVIRON HEALTH PERSP, V111, P1093, DOI 10.1289/ehp.5840; Sandrin TR, 2007, ENV BIOREMEDIATION S; SHAW WHR, 1954, J AM CHEM SOC, V76, P2160, DOI 10.1021/ja01637a034; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Siwik PL, 2000, ENVIRON TOXICOL CHEM, V19, P1837, DOI 10.1002/etc.5620190718; Smith MB, 2015, MBIO, V6, DOI 10.1128/mBio.00326-15; SOMERS E, 1961, ANN APPL BIOL, V49, P246, DOI 10.1111/j.1744-7348.1961.tb03612.x; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suncor, 2013, SUNC REP SUST 2013; Syncrude, 2008, SYNCR 2008 09 SUST R; Tatara CP, 1997, AQUAT TOXICOL, V39, P279, DOI 10.1016/S0166-445X(97)00030-1; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Teitzel GM, 2003, APPL ENVIRON MICROB, V69, P2313, DOI 10.1128/AEM.69.4.2313-2320.2003; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Walker JD, 2003, ENVIRON TOXICOL CHEM, V22, P1916, DOI 10.1897/02-568; Workentine ML, 2008, ENVIRON MICROBIOL, V10, P238, DOI 10.1111/j.1462-2920.2007.01448.x; Wuertz S, 2004, WATER SCI TECHNOL, V49, P327, DOI 10.2166/wst.2004.0873; WYNDHAM RC, 1981, APPL ENVIRON MICROB, V41, P783, DOI 10.1128/AEM.41.3.783-790.1981; Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027	67	9	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148682	10.1371/journal.pone.0148682	http://dx.doi.org/10.1371/journal.pone.0148682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849649	gold, Green Submitted, Green Published			2022-12-26	WOS:000369554000156
J	Romanienko, PJ; Giacalone, J; Ingenito, J; Wang, YJ; Isaka, M; Johnson, T; You, Y; Mark, WH				Romanienko, Peter J.; Giacalone, Joseph; Ingenito, Joanne; Wang, Yijie; Isaka, Mayumi; Johnson, Thomas; You, Yun; Mark, Willie H.			A Vector with a Single Promoter for In Vitro Transcription and Mammalian Cell Expression of CRISPR gRNAs	PLOS ONE			English	Article							MICE; SPECIFICITY; ZEBRAFISH; DELIVERY; KNOCKOUT; SYSTEM; CAS9; GENE	The genomes of more than 50 organisms have now been manipulated due to rapid advancement of gene editing technology. One way to perform gene editing in the mouse using the CRISPR/CAS system, guide RNA (gRNA) and CAS9 mRNA transcribed in vitro are microinjected into fertilized eggs that are then allowed to develop to term. As a rule, gRNAs are tested first in tissue culture cells and the one with the highest locus-specific cleavage activity is chosen for microinjection. For cell transfections, gRNAs are typically expressed using the human U6 promoter (hU6). However, gRNAs for microinjection into zygotes are obtained by in vitro transcription from a T7 bacteriophage promoter in a separate plasmid vector. Here, we describe the design and construction of a combined U6T7 hybrid promoter from which the same gRNA sequence can be expressed. An expression vector containing such a hybrid promoter can now be used to generate gRNA for testing in mammalian cells as well as for microinjection purposes. The gRNAs expressed and transcribed from this vector are found to be functional in cells as well as in mice.	[Romanienko, Peter J.; Giacalone, Joseph; Ingenito, Joanne; Wang, Yijie; Isaka, Mayumi; Johnson, Thomas; You, Yun; Mark, Willie H.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mouse Genet Core Facil, 1275 York Ave, New York, NY 10021 USA; [Romanienko, Peter J.; You, Yun; Mark, Willie H.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Romanienko, PJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mouse Genet Core Facil, 1275 York Ave, New York, NY 10021 USA.; Romanienko, PJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	romaniep@mskcc.org		Romanienko, Peter/0000-0001-6586-3841	NIH/NCI Cancer Center Support Grant [P30 CA008748]; Sloan Kettering Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NIH/NCI Cancer Center Support Grant; Sloan Kettering Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the NIH/NCI Cancer Center Support Grant P30 CA008748 and internal funding from Sloan Kettering Institute (institutional funding).	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Behringer R, 2014, MANIPULATING MOUSE E, V4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fujihara Y, 2014, METHOD ENZYMOL, V546, P319, DOI 10.1016/B978-0-12-801185-0.00015-5; GOOMER RS, 1992, NUCLEIC ACIDS RES, V20, P4903, DOI 10.1093/nar/20.18.4903; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	16	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148362	10.1371/journal.pone.0148362	http://dx.doi.org/10.1371/journal.pone.0148362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849369	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000081
J	Li, JW; Johnson, KA				Li, Jiawen; Johnson, Kenneth A.			Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase Allosterically Block the Transition from Initiation to Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INFECTION; MECHANISM; DISCRIMINATION; EXPLORER; COMPLEX; AZT; HCV	Replication of the hepatitis C viral genome is catalyzed by the NS5B (nonstructural protein 5B) RNA-dependent RNA polymerase, which is a major target of antiviral drugs currently in the clinic. Prior studies established that initiation of RNA replication could be facilitated by starting with a dinucleotide (pGG). Here we establish conditions for efficient initiation from GTP to form the dinucleotide and subsequent intermediates leading to highly processive elongation, and we examined the effects of four classes of nonnucleoside inhibitors on each step of the reaction. We show that palm site inhibitors block initiation starting from GTP but not when starting from pGG. In addition we show that nonnucleoside inhibitors binding to thumb site-2 (NNI2) lead to the accumulation of abortive intermediates three-five nucleotides in length. Our kinetic analysis shows that NNI2 do not significantly block initiation or elongation of RNA synthesis; rather, they block the transition from initiation to elongation, which is thought to proceed with significant structural rearrangement of the enzyme-RNA complex including displacement of the beta-loop from the active site. Direct measurement in single turnover kinetic studies show that pyrophosphate release is faster than the chemistry step, which appears to be rate-limiting during processive synthesis. These results reveal important new details to define the steps involved in initiation and elongation during viral RNA replication, establish the allosteric mechanisms by which NNI2 inhibitors act, and point the way to the design of more effective allosteric inhibitors that exploit this new information.	[Li, Jiawen; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, 4800,2500 Speedway,MBB 3-122, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, 4800,2500 Speedway,MBB 3-122, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [1R01AI110577]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI110577 (NIAID; to K. A. J.) and the Welch Foundation (F-1604 to K. A. J.). K. A. J. is the president of KinTek, which provided the RQF-3 rapid quench-flow instrument and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Deredge D, 2016, J BIOL CHEM, V291, P10078, DOI 10.1074/jbc.M115.708370; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; Jin ZN, 2013, P NATL ACAD SCI USA, V110, pE348, DOI 10.1073/pnas.1214924110; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Muir AJ, 2015, CLIN GASTROENTEROL H, V13, P2166, DOI 10.1016/j.cgh.2015.07.015; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Watkins WJ, 2010, CURR OPIN DRUG DISC, V13, P441; Wilder JM, 2016, HEPATOLOGY, V63, P437, DOI 10.1002/hep.28334; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	22	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10067	10077		10.1074/jbc.M115.708354	http://dx.doi.org/10.1074/jbc.M115.708354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26851276	Green Published, hybrid			2022-12-26	WOS:000375602800019
J	Bischof, LF; Friedrich, C; Harms, A; Sogaard-Andersen, L; van der Does, C				Bischof, Lisa Franziska; Friedrich, Carmen; Harms, Andrea; Sogaard-Andersen, Lotte; van der Does, Chris			The Type IV Pilus Assembly ATPase PilB of Myxococcus xanthus Interacts with the Inner Membrane Platform Protein PilC and the Nucleotide-binding Protein PilM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; cell motility; membrane reconstitution; membrane transport; secretion; type IV pili; Myxococcus xanthus	II SECRETION SYSTEM; N-TERMINAL DOMAIN; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; NEISSERIA-MENINGITIDIS; CYTOPLASMIC DOMAIN; BIOGENESIS PROTEIN; THERMUS-THERMOPHILUS; TWITCHING MOTILITY; CRYSTAL-STRUCTURE	Type IV pili (T4P) are ubiquitous bacterial cell surface structures, involved in processes such as twitching motility, biofilm formation, bacteriophage infection, surface attachment, virulence, and natural transformation. T4P are assembled by machinery that can be divided into the outer membrane pore complex, the alignment complex that connects components in the inner and outer membrane, and the motor complex in the inner membrane and cytoplasm. Here, we characterize the inner membrane platform protein PilC, the cytosolic assembly ATPase PilB of the motor complex, and the cytosolic nucleotide-binding protein PilM of the alignment complex of the T4P machinery of Myxococcus xanthus. PilC was purified as a dimer and reconstituted into liposomes. PilB was isolated as a monomer and bound ATP in a non-cooperative manner, but PilB fused to Hcp1 of Pseudomonas aeruginosa formed a hexamer and bound ATP in a cooperative manner. Hexameric but not monomeric PilB bound to PilC reconstituted in liposomes, and this binding stimulated PilB ATPase activity. PilM could only be purified when it was stabilized by a fusion with a peptide corresponding to the first 16 amino acids of PilN, supporting an interaction between PilM and PilN(1-16). PilM-N(1-16) was isolated as a monomer that bound but did not hydrolyze ATP. PilM interacted directly with PilB, but only with PilC in the presence of PilB, suggesting an indirect interaction. We propose that PilB interacts with PilC and with PilM, thus establishing the connection between the alignment and the motor complex.	[Bischof, Lisa Franziska; Friedrich, Carmen; Harms, Andrea; Sogaard-Andersen, Lotte; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Bischof, Lisa Franziska; van der Does, Chris] Univ Freiburg, Inst Biol 2, Mol Biol Archaea, Schaenzlestr 1, D-79104 Freiburg, Germany	Max Planck Society; University of Freiburg	van der Does, C (corresponding author), Univ Freiburg, Inst Biol, Schaenzlestr 1, D-79104 Freiburg, Germany.	chris.van.der.does@biologie.uni-freiburg.de		Sogaard-Andersen, Lotte/0000-0002-0674-0013	German Research Council within the framework of the Collaborative Research Center "Microbial Diversity in Environmental Signal Response" [SFB987]; Max Planck Society; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology; Collaborative Research Center "Functional Specificity by Coupling and Modification of Proteins" [SFB746]	German Research Council within the framework of the Collaborative Research Center "Microbial Diversity in Environmental Signal Response"; Max Planck Society(Max Planck Society); International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology; Collaborative Research Center "Functional Specificity by Coupling and Modification of Proteins"	This work was supported in part by the German Research Council within the framework of the Collaborative Research Center SFB987 "Microbial Diversity in Environmental Signal Response," intramural funding of the Max Planck Society, and by a fellowship from the International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology (to C. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Collaborative Research Center SFB746 "Functional Specificity by Coupling and Modification of Proteins."	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Albers SV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00023; Arts J, 2007, MICROBIOL-SGM, V153, P1582, DOI 10.1099/mic.0.2006/002840-0; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; Banerjee A, 2013, FEBS J, V280, P6141, DOI 10.1111/febs.12534; Banerjee A, 2012, J BIOL CHEM, V287, P43322, DOI 10.1074/jbc.M112.414383; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen Y, 2005, J BIOL CHEM, V280, P42356, DOI 10.1074/jbc.M506843200; Chiang P, 2005, J BACTERIOL, V187, P829, DOI 10.1128/JB.187.3.829-839.2005; Claeys D, 2005, ELECTROPHORESIS, V26, P1189, DOI 10.1002/elps.200406196; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Collins RF, 2007, J BACTERIOL, V189, P6389, DOI 10.1128/JB.00648-07; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Friedrich C, 2014, J BACTERIOL, V196, P378, DOI 10.1128/JB.01094-13; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Karuppiah V, 2010, PROTEINS, V78, P2049, DOI 10.1002/prot.22720; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Leviatan S, 2010, J BIOL CHEM, V285, P23548, DOI 10.1074/jbc.M110.125492; Li CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070144; Lu C, 2014, J STRUCT BIOL, V187, P223, DOI 10.1016/j.jsb.2014.07.006; Lu C, 2013, STRUCTURE, V21, P1707, DOI 10.1016/j.str.2013.06.027; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reindl S, 2013, MOL CELL, V49, P1069, DOI 10.1016/j.molcel.2013.01.014; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; Siewering K, 2014, P NATL ACAD SCI USA, V111, pE953, DOI 10.1073/pnas.1322889111; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; SPORMANN AM, 1995, J BACTERIOL, V177, P5846, DOI 10.1128/jb.177.20.5846-5852.1995; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Laan M, 2013, METHODS MOL BIOL, V1033, P325, DOI 10.1007/978-1-62703-487-6_21; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Yamagata A, 2012, J MOL BIOL, V419, P110, DOI 10.1016/j.jmb.2012.02.041	69	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6946	6957		10.1074/jbc.M115.701284	http://dx.doi.org/10.1074/jbc.M115.701284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26851283	Green Published, hybrid			2022-12-26	WOS:000373299700031
J	Nakanishi, H; Kurosaki, M; Takahashi, Y; Itakura, J; Ueda, K; Suzuki, S; Yasui, Y; Tamaki, N; Nakakuki, N; Takada, H; Ueda, M; Hayashi, T; Kuwabara, K; Takaura, K; Higuchi, M; Komiyama, Y; Yoshida, T; Izumi, N				Nakanishi, Hiroyuki; Kurosaki, Masayuki; Takahashi, Yuka; Itakura, Jun; Ueda, Ken; Suzuki, Shoko; Yasui, Yutaka; Tamaki, Nobuharu; Nakakuki, Natsuko; Takada, Hitomi; Ueda, Masako; Hayashi, Tsuguru; Kuwabara, Konomi; Takaura, Kenta; Higuchi, Mayu; Komiyama, Yasuyuki; Yoshida, Tsubasa; Izumi, Namiki			Pretreatment Gastric Lavage Reduces Postoperative Bleeding after Endoscopic Submucosal Dissection for Gastric Neoplasms	PLOS ONE			English	Article							CANCER; RESECTION; OUTCOMES	Aim For patients receiving endoscopic submucosal dissection (ESD), there is urgent need pertaining to the prevention of postoperative bleeding. We conducted a retrospective propensity score-matched study that evaluated whether pre-ESD gastric lavage prevents postoperative bleeding after ESD for gastric neoplasms. Methods From September 2002 to October 2015, the 760 consecutive patients receiving ESD for gastric neoplasm were enrolled and data regarding them were retrospectively analyzed. All patients received conventional preventive treatment against delayed bleeding after ESD, including the administration of proton pump inhibitor and preventive coagulation of visible vessels, at the end of the ESD procedure. Results Pre-ESD risk factors for postoperative bleeding included tumor size and no gastric lavage. Using multivariate analysis tumor size >2.0 cm (HR 2.90, 95% CI 1.65-5.10, p = 0.0002) and no gastric lavage (HR 3.20, 95% CI 1.13-9.11, p = 0.029) were found to be independent risk factors. Next, we evaluated the effect of gastric lavage on the prevention of post-ESD bleeding using a propensity score-matching method. A total of 284 subjects (142 per group) were selected. Adjusted odds ratio of gastric lavage for post-ESD bleeding was 0.25 (95% CI 0.071-0.886, p = 0.032). Conclusion Pretreatment gastric lavage reduced postoperative bleeding in patients receiving ESD for gastric neoplasm.	[Nakanishi, Hiroyuki; Kurosaki, Masayuki; Takahashi, Yuka; Itakura, Jun; Ueda, Ken; Suzuki, Shoko; Yasui, Yutaka; Tamaki, Nobuharu; Nakakuki, Natsuko; Takada, Hitomi; Ueda, Masako; Hayashi, Tsuguru; Kuwabara, Konomi; Takaura, Kenta; Higuchi, Mayu; Komiyama, Yasuyuki; Yoshida, Tsubasa; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan		Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Tamaki, Nobuharu/0000-0003-4634-6616; Yasui, Yutaka/0000-0002-6117-4990				Abe N, 2012, GASTRIC CANCER, V15, P70, DOI 10.1007/s10120-011-0067-8; Akasaka T, 2011, DIGEST ENDOSC, V23, P73, DOI 10.1111/j.1443-1661.2010.01062.x; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Goto O, 2009, ENDOSCOPY, V41, P118, DOI 10.1055/s-0028-1119452; Gotoda T, 2010, BRIT J SURG, V97, P868, DOI 10.1002/bjs.7033; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Hirasaki S, 2007, WORLD J GASTROENTERO, V13, P3981, DOI 10.3748/wjg.v13.i29.3981; Imagawa A, 2006, ENDOSCOPY, V38, P987, DOI 10.1055/s-2006-944716; Kakushima N, 2008, WORLD J GASTROENTERO, V14, P2962, DOI 10.3748/wjg.14.2962; Kato M, 2012, GASTRIC CANCER, V15, P15, DOI 10.1007/s10120-011-0050-4; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065377; Nakanishi T, 2014, ENDOSC INT OPEN, V2, pE141, DOI 10.1055/s-0034-1377274; Oda I., 2006, GASTRIC CANCER, V9, P262, DOI DOI 10.1007/S10120-006-0389-0]; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Ono H, 2016, DIGEST ENDOSC, V28, P3, DOI 10.1111/den.12518; Onogi F, 2010, ENDOSCOPY, V42, P441, DOI 10.1055/s-0029-1244013; Organization TWH, 2011, 2011 GUID DRINK WAT; Sugimoto Mitsushige, 2012, Diagn Ther Endosc, V2012, P791873, DOI 10.1155/2012/791873; Yamamoto H, 2005, BEST PRACT RES CL GA, V19, P909, DOI 10.1016/j.bpg.2005.03.004	19	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149235	10.1371/journal.pone.0149235	http://dx.doi.org/10.1371/journal.pone.0149235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871449	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100132
J	Oudejans, C; Poutsma, A; Michel, O; Mulders, J; Visser, A; van Dijk, M; Nauta, T; Bokslag, A; Paulus, W; de Haas, A; Koolwijk, P; de Groot, CJM				Oudejans, Cees; Poutsma, Ankie; Michel, Omar; Mulders, Joyce; Visser, Allerdien; van Dijk, Marie; Nauta, Tessa; Bokslag, Anouk; Paulus, Walter; de Haas, Andreas; Koolwijk, Pieter; de Groot, Christianne J. M.			Genome-Wide Identification of Epigenetic Hotspots Potentially Related to Cardiovascular Risk in Adult Women after a Complicated Pregnancy	PLOS ONE			English	Article							DNA METHYLATION; DISEASE RISK; PREECLAMPSIA; ASSOCIATIONS; LEUKOCYTES	Background The physiological demands of pregnancy on the maternal cardiovascular system can catapult women into a metabolic syndrome that predisposes to atherosclerosis in later life. We sought to identify the nature of the epigenomic changes associated with the increased cardiovascular disease (CVD) risk in adult women following pre-eclampsia. Findings We assessed the genome wide epigenetic profile by methyl-C sequencing of monozygotic parous twin sister pairs discordant for a severe variant of pre-eclampsia. In the adult twin sisters at risk for CVD as a consequence of a complicated pregnancy, a set of 12 differentially methylated regions with at least 50% difference in methylation percentage and the same directional change was found to be shared between the affected twin sisters and significantly different compared to their unaffected monozygous sisters. Conclusion The current epigenetic marker set will permit targeted analysis of differentially methylated regions potentially related to CVD risk in large cohorts of adult women following complicated pregnancies.	[Oudejans, Cees; Poutsma, Ankie; Michel, Omar; Mulders, Joyce; Visser, Allerdien; van Dijk, Marie] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Oudejans, Cees; Poutsma, Ankie; Michel, Omar; Mulders, Joyce; Visser, Allerdien; van Dijk, Marie] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res ICaR VU, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Nauta, Tessa; Paulus, Walter; de Haas, Andreas; Koolwijk, Pieter] Vrije Univ Amsterdam Med Ctr, Dept Physiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Nauta, Tessa] A Skin BV, De Boelelaan 1118, NL-1081 HZ Amsterdam, Netherlands; [Bokslag, Anouk; de Groot, Christianne J. M.] Vrije Univ Amsterdam Med Ctr, Dept Obstet Gynaecol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Oudejans, C (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	cbm.oudejans@vumc.nl	van Dijk, Marie/L-1901-2014	de Groot, Christianne/0000-0003-3277-2542; Oudejans, Cees/0000-0003-0717-4946; van Dijk, Marie/0000-0003-1461-3441	Netherlands Organisation for Scientific Research (NWO) [91611177]; Dutch Program for Tissue Engineering (DPTE); Netherlands Initiative for Regenerative Medicine (NIRM)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Program for Tissue Engineering (DPTE); Netherlands Initiative for Regenerative Medicine (NIRM)	MvD is supported by the Netherlands Organisation for Scientific Research (NWO grant no 91611177). TN and PK are supported by the Dutch Program for Tissue Engineering (DPTE) and the Netherlands Initiative for Regenerative Medicine (NIRM). The funder (A-Skin) provided support in the form of salaries for authors [TN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Hermes W, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-28; Koopmans Corine M, 2007, BMC Pregnancy Childbirth, V7, P14, DOI 10.1186/1471-2393-7-14; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Soreq L, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00010; Treloar SA, 2001, AM J OBSTET GYNECOL, V184, P374, DOI 10.1067/mob.2001.109400; Williams D, 2003, CURR OPIN OBSTET GYN, V15, P465, DOI 10.1097/00001703-200312000-00002; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yinon Y, 2010, CIRCULATION, V122, P1846, DOI 10.1161/CIRCULATIONAHA.110.948455	17	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148313	10.1371/journal.pone.0148313	http://dx.doi.org/10.1371/journal.pone.0148313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870946	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100023
J	Lin, XL; Tang, XD; Cai, ZX; Wang, FY; Li, P; Sui, H; Guo, HS				Lin, Xue-Lian; Tang, Xu-Dong; Cai, Zheng-Xu; Wang, Feng-Yun; Li, Ping; Sui, Hua; Guo, Hui-Shu			NPs/NPRs Signaling Pathways May Be Involved in Depression-Induced Loss of Gastric ICC by Decreasing the Production of mSCF	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; RECEPTOR-C EXPRESSION; INDUCED DIABETIC MICE; SMOOTH-MUSCLE-CELLS; NATRIURETIC-PEPTIDE; INTERSTITIAL-CELLS; PSYCHOSOCIAL-ASPECTS; CAJAL; TRACT; RATS	It is well known that natriuretic peptides (NPs) are involved in the regulation of gastrointestinal motility. Interstitial cells of Cajal (ICC) are the pacemaker cells of gastrointestinal motility and gastrointestinal dyskinesia is one of the important digestive tract symptoms of depression. However, it is unclear whether they are involved in depression-induced loss of ICC. The aim of the present study was to investigate the relationship between the natriuretic peptide signaling pathway and depression-induced loss of gastric ICC in depressed rats. These results showed that the expression of c-kit and stem cell factor (SCF) in smooth muscle layers of stomach were down-regulated in depressed rats at the mRNA and protein levels. The expression of natriuretic peptide receptor (NPR)-A, B and C were up-regulated in the stomach of depressed rats at the mRNA and protein levels. NPR-A, B and C can significantly decrease the expression of SCF to treat cultured gastric smooth muscle cells (GSMCs) obtained from normal rats with different concentrations of C-type natriuretic peptide (CNP). Pretreatment of cultured GSMCs with 8-Brom-cGMP (8-Br-cGMP, a membrane permeable cGMP analog), cANF (a specific NPR-C agonist) and CNP (10(-6) mol/L) demonstrated that 8-Br-cGMP had a similar effect as CNP, but treatment with cANF did not. The results of the methyl thiazolyl tetrazolium bromide (MTT) assay indicated that high concentrations of cANF (10(-6) mol/L) restrained the proliferation of cultured GSMCs. Taken together, these results indicate that the up-regulation of the NPs/NPR-C and NPs/NPR-A, B/cGMP signaling pathways may be involved in depression-induced loss of gastric ICC.	[Lin, Xue-Lian; Li, Ping; Guo, Hui-Shu] Dalian Med Univ, Affiliated Hosp 1, Cent Lab, Dalian 116011, Liaoning Provin, Peoples R China; [Tang, Xu-Dong; Wang, Feng-Yun] China Acad Chinese Med Sci, Xiyuan Hosp, Dept Gastroenterol, Beijing 100091, Peoples R China; [Cai, Zheng-Xu] Dalian Med Univ, Affiliated Hosp 1, Dept Neurol, Dalian 116011, Liaoning Provin, Peoples R China; [Sui, Hua] Dalian Med Univ, Inst Basic Res Integrat Med, Dalian 116044, Liaoning Provin, Peoples R China	Dalian Medical University; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; Dalian Medical University; Dalian Medical University	Guo, HS (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Cent Lab, Dalian 116011, Liaoning Provin, Peoples R China.; Cai, ZX (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Neurol, Dalian 116011, Liaoning Provin, Peoples R China.	caizhengxu999@126.com; guohuishu1@126.com			National Basic Research Program of China (973 Program) [2013CB531703]; National Natural Science Foundation of China [81273919]; Natural Science Foundation of Liaoning Province [2012225020, 2013023002]; First Affiliated Hospital of Dalian Medical University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); First Affiliated Hospital of Dalian Medical University	The work was supported by the following: National Basic Research Program of China (973 Program), No. 2013CB531703, HSG; The National Natural Science Foundation of China, No. 81273919, HSG; and Natural Science Foundation of Liaoning Province, No. 2012225020 and No. 2013023002, HSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to graciously acknowledge the staff at Central Laboratory, The First Affiliated Hospital of Dalian Medical University, for their help and support in this project.	Abbey-Hosch SE, 2005, BIOCHEM PHARMACOL, V70, P686, DOI 10.1016/j.bcp.2005.04.034; Al-Shboul OA, 2013, SAUDI J GASTROENTERO, V19, P3, DOI 10.4103/1319-3767.105909; Blair PJ, 2014, J NEUROGASTROENTEROL, V20, P294, DOI 10.5056/jnm14060; Bodukam V, 2011, RHEUMATOLOGY, V50, P330, DOI 10.1093/rheumatology/keq296; Breuer C, 2010, WORLD J GASTROENTERO, V16, P4363, DOI 10.3748/wjg.v16.i34.4363; Bulbul M, 2012, AM J PHYSIOL-GASTR L, V302, pG702, DOI 10.1152/ajpgi.00447.2011; Cai YL, 2009, WORLD J GASTROENTERO, V15, P2125, DOI 10.3748/wjg.15.2125; Chen ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086100; Del Ry S, 2008, PEPTIDES, V29, P2208, DOI 10.1016/j.peptides.2008.09.005; Drossman DA, 1999, GUT, V45, P25; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fu XY, 2014, NUTR METAB, V11; Fujishige K, 1998, AM J PHYSIOL-LUNG C, V274, pL425, DOI 10.1152/ajplung.1998.274.3.L425; Geeraerts B, 2011, AM J PHYSIOL-GASTR L, V300, pG228, DOI 10.1152/ajpgi.00020.2010; Gower WR, 2006, MOL CELL BIOCHEM, V293, P103, DOI 10.1007/s11010-006-9234-3; Kim JH, 2004, REGUL PEPTIDES, V120, P93, DOI 10.1016/j.regpep.2004.02.021; Levy RL, 2006, GASTROENTEROLOGY, V130, P1447, DOI 10.1053/j.gastro.2005.11.057; Li P, 2015, WORLD J GASTROENTERO, V21, P1518, DOI 10.3748/wjg.v21.i5.1518; Li Y, 2006, CARDIOVASC RES, V72, P464, DOI 10.1016/j.cardiores.2006.08.012; Li Y, 2012, CARDIOVASC RES, V93, P350, DOI 10.1093/cvr/cvr319; Lin L, 2010, AM J PHYSIOL-GASTR L, V298, pG241, DOI 10.1152/ajpgi.90706.2008; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Mayer EA, 2006, ALIMENT PHARM THER, V24, P919, DOI 10.1111/j.1365-2036.2006.03078.x; McCann CJ, 2014, J NEUROGASTROENTEROL, V20, P326, DOI 10.5056/jnm14026; Mei F, 2009, ANAT REC, V292, P985, DOI 10.1002/ar.20928; North CS, 2007, WORLD J GASTROENTERO, V13, P2020, DOI 10.3748/wjg.v13.i14.2020; Noubani A, 2000, ENDOCRINOLOGY, V141, P551, DOI 10.1210/en.141.2.551; Pandey KN, 2011, CAN J PHYSIOL PHARM, V89, P557, DOI [10.1139/Y11-054, 10.1139/y11-054]; Park KS, 2014, J NEUROGASTROENTEROL, V20, P281, DOI 10.5056/jnm14064; Qiu ZX, 2010, WORLD J GASTROENTERO, V16, P48, DOI 10.3748/wjg.v16.i1.48; Rahmutula D, 2005, ENDOCRINOLOGY, V146, P4968, DOI 10.1210/en.2005-0262; Rao JN, 2013, DIGEST DIS SCI, V58, P1449, DOI 10.1007/s10620-013-2683-0; Sanders KM, 2014, J NEUROGASTROENTEROL, V20, P171, DOI [10.5056/jnm.20.2.171, 10.5056/jnm.2014.20.2.171]; Sellitti DF, 2004, J ENDOCRINOL, V180, P23, DOI 10.1677/joe.0.1800023; Shahi PK, 2014, J GASTROENTEROL, V49, P1001, DOI 10.1007/s00535-013-0849-3; Sogawa C, 2013, AM J PATHOL, V182, P172, DOI 10.1016/j.ajpath.2012.09.015; Sogawa C, 2010, AM J PATHOL, V177, P822, DOI 10.2353/ajpath.2010.091278; Wang LL, 2014, INT J MED SCI, V11, P262, DOI 10.7150/ijms.7287; Wu YS, 2013, PEPTIDES, V40, P104, DOI 10.1016/j.peptides.2012.12.024; Yanaka N, 1998, AM J PHYSIOL-ENDOC M, V275, pE965, DOI 10.1152/ajpendo.1998.275.6.E965	40	5	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149031	10.1371/journal.pone.0149031	http://dx.doi.org/10.1371/journal.pone.0149031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862759	Green Published, gold			2022-12-26	WOS:000370046600142
J	Qadeer, E; Fatima, R; Yaqoob, A; Tahseen, S; Haq, MU; Ghafoor, A; Asif, M; Straetemans, M; Tiemersma, EW				Qadeer, Ejaz; Fatima, Razia; Yaqoob, Aashifa; Tahseen, Sabira; Haq, Mahboob Ul; Ghafoor, Abdul; Asif, Muhammad; Straetemans, Masja; Tiemersma, Edine W.			Population Based National Tuberculosis Prevalence Survey among Adults (> 15 Years) in Pakistan, 2010-2011	PLOS ONE			English	Article							SEX-DIFFERENCES; LESSONS; GENDER; INDIA	Background We aimed to determine the prevalence of pulmonary tuberculosis (TB) amongst the adult population in 2010-2011 in Pakistan. Method A nationwide cross-sectional survey with multistage cluster sampling was conducted among adults (>= 15 years) in 95 clusters in 2010-2011. All consenting participants were screened for cough and by chest X-ray. Participants with presumptive TB submitted two sputum samples for smear microscopy, culture, and molecular testing if needed. The TB prevalence estimates were adjusted for missing data and the cluster design. Result Of 131,329 eligible individuals, 105,913 (81%) participated in the survey, of whom 10,471 (9.9%) were eligible for sputum examination. We found 341 bacteriologically positive TB cases of whom 233 had sputum smear-positive TB. The adjusted prevalence estimates for smear and bacteriologically positive TB were 270/100,000 (95% confidence interval (CI) 217-323), and 398/100,000 (95% CI 333-463), respectively. Only 61% of the diagnosed TB cases screened positive on symptoms (cough >2wks), whereas the other TB cases were detected based on X-ray abnormalities. The TB prevalence increased with age and was 1.8 times higher among men than women. The prevalence-to-notification ratio of smear-positive TB was 3.1 (95% CI 2.5-3.7), was higher among men than women, and increased with age. Conclusion Our data suggest that there is under-detection and/or - notification of TB, especially among men and elderly. TB control should be strengthened specifically in these risk groups. X-ray examination should be combined with symptom screening to enhance case detection.	[Qadeer, Ejaz; Fatima, Razia; Yaqoob, Aashifa; Tahseen, Sabira; Haq, Mahboob Ul; Ghafoor, Abdul; Asif, Muhammad] Natl TB Control Program Pakistan, Islamabad, Pakistan; [Straetemans, Masja; Tiemersma, Edine W.] KNCV TB Fdn, The Hague, Netherlands; [Straetemans, Masja] Royal Trop Inst KIT, Amsterdam, Netherlands	KNCV Tuberculosis Foundation	Fatima, R (corresponding author), Natl TB Control Program Pakistan, Islamabad, Pakistan.	drraziafatima@gmail.com	Tahseen, Sabira/AAV-8653-2020	Tahseen, Sabira/0000-0002-6887-8149; Ul Haq, Mahboob/0000-0002-3709-3496	American people through the United States Agency for International Development (USAID)	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of TB CARE I and do not necessarily reflect the views of USAID or the United States Government. KIT Biomedical Research provided support in the form of a salary for author MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency CI, 2015, WORLD FACTBOOK; [Anonymous], 2011, GLOB TUB CONTR; Bhushan B, 2012, INT J TUBERC LUNG D, V16, P1210, DOI 10.5588/ijtld.11.0778; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Dogar OF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-244; Eddy JJ, 2015, TUBERCULOSIS, V95, pS23, DOI 10.1016/j.tube.2015.02.005; Fatima R, 2014, INT J TUBERC LUNG D, V18, P55, DOI 10.5588/ijtld.13.0198; Floyd S, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-10; HARBOE M, 1986, INFECT IMMUN, V52, P293, DOI 10.1128/IAI.52.1.293-302.1986; Harkanen T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1150; Ijaiya G. T., 2010, Pakistan Economic and Social Review, V48, P85; KUDOH S, 1974, B WORLD HEALTH ORGAN, V51, P71; Law I, 2015, TROP MED INT HEALTH, V20, P1146, DOI 10.1111/tmi.12536; Long NH, 1999, SOC SCI MED, V49, P815, DOI 10.1016/S0277-9536(99)00171-9; Mao TE, 2014, B WORLD HEALTH ORGAN, V92, P573, DOI 10.2471/BLT.13.131581; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Mushtaq MU, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-8; Naqvi SA, 2012, INT J TUBERC LUNG D, V16, P817, DOI 10.5588/ijtld.11.0440; National TB Control Program, 2013, EP REV TB PAK; National TB Control Program, 2014, NAT STRAT PLAN VIS 2; National TB Control Program, 2012, ANN REP 2011; National TB Control Program, 1990, PAK TUB PREV SURV 19; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Nishtar S, 2013, LANCET, V381, P2193, DOI 10.1016/S0140-6736(13)60019-7; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Pakistan Bureau of Statistics, 2010, NAT HLTH ACC PAK 200; Rajagopalan S, 2000, Z GERONTOL GERIATR, V33, P374, DOI 10.1007/s003910070034; Rhines AS, 2013, TUBERCULOSIS, V93, P104, DOI 10.1016/j.tube.2012.10.012; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2007, WHO GLOB TASK FORC T; WHO, 2014, GLOB TUB REP 2014; WHO, 2014, PAK HLTH PROF; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd; World Health Organization, 2015, GLOB TUB REP 2015; Zaman K, 2006, EPIDEMIOL INFECT, V134, P1052, DOI 10.1017/S0950268806006108	37	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148293	10.1371/journal.pone.0148293	http://dx.doi.org/10.1371/journal.pone.0148293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863617	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600051
J	Yueh, AE; Payne, SN; Leystra, AA; Van De Hey, DR; Foley, TM; Pasch, CA; Clipson, L; Matkowskyj, KA; Deming, DA				Yueh, Alexander E.; Payne, Susan N.; Leystra, Alyssa A.; Van De Hey, Dana R.; Foley, Tyler M.; Pasch, Cheri A.; Clipson, Linda; Matkowskyj, Kristina A.; Deming, Dustin A.			Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K	PLOS ONE			English	Article							GENETIC ALTERATIONS; COLORECTAL-CANCER; PIK3CA MUTATION; PATHWAY; INHIBITION	The phosphoinositide 3-kinase (PI3K) signaling pathway is critical for multiple important cellular functions, and is one of the most commonly altered pathways in human cancers. We previously developed a mouse model in which colon cancers were initiated by a dominant active PI3K p110-p85 fusion protein. In that model, well-differentiated mucinous adenocarcinomas developed within the colon and initiated through a non-canonical mechanism that is not dependent on WNT signaling. To assess the potential relevance of PI3K mutations in human cancers, we sought to determine if one of the common mutations in the human disease could also initiate similar colon cancers. Mice were generated expressing the Pik3-ca(H1047R) mutation, the analog of one of three human hotspot mutations in this gene. Mice expressing a constitutively active PI3K, as a result of this mutation, develop invasive adenocarcinomas strikingly similar to invasive adenocarcinomas found in human colon cancers. These tumors form without a polypoid intermediary and also lack nuclear CTNNB1 (beta-catenin), indicating a non-canonical mechanism of tumor initiation mediated by the PI3K pathway. These cancers are sensitive to dual PI3K/mTOR inhibition indicating dependence on the PI3K pathway. The tumor tissue remaining after treatment demonstrated reduction in cellular proliferation and inhibition of PI3K signaling.	[Yueh, Alexander E.; Van De Hey, Dana R.; Foley, Tyler M.; Deming, Dustin A.] Univ Wisconsin, Dept Med, Div Hematol & Oncol, Sch Med & Publ Hlth, Madison, WI USA; [Payne, Susan N.; Pasch, Cheri A.; Matkowskyj, Kristina A.; Deming, Dustin A.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Leystra, Alyssa A.; Clipson, Linda] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Matkowskyj, Kristina A.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth Madison, Madison, WI USA; [Matkowskyj, Kristina A.; Deming, Dustin A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Deming, DA (corresponding author), Univ Wisconsin, Dept Med, Div Hematol & Oncol, Sch Med & Publ Hlth, Madison, WI USA.; Deming, DA (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.; Deming, DA (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA.	ddeming@medicine.wisc.edu			National Institutes of Health [P30 CA014520]; UW Carbone Cancer Center; UW Department of Medicine; UW School of Medicine and Public Health; UW Graduate School through the Wisconsin Alumni Research Foundation; Funk Out Cancer; UW Carbone Cancer Center Gastrointestinal Disease Oriented Working Group; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Carbone Cancer Center; UW Department of Medicine; UW School of Medicine and Public Health; UW Graduate School through the Wisconsin Alumni Research Foundation; Funk Out Cancer; UW Carbone Cancer Center Gastrointestinal Disease Oriented Working Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the National Institutes of Health (http://www.nih.gov/) P30 CA014520 (Core Grant, University of Wisconsin Carbone Cancer Center); start-up funds (D.A.D) from the UW Carbone Cancer Center, UW Department of Medicine, UW School of Medicine and Public Health, and the UW Graduate School through the Wisconsin Alumni Research Foundation; Funk Out Cancer (http://www.funkoutcancer.com/) and UW Carbone Cancer Center Gastrointestinal Disease Oriented Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Deming DA, 2014, ONCOGENE, V33, P2245, DOI 10.1038/onc.2013.167; Deming DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060709; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; IJspeert JEG, 2015, NAT REV GASTRO HEPAT, V12, P401, DOI 10.1038/nrgastro.2015.73; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Liu G, 2011, CLIN CANCER RES, V17, P7634, DOI 10.1158/1078-0432.CCR-11-1677; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Moore KN, 2015, J CLIN ONCOL, V33; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Payne SN, ONCOGENESIS IN PRESS; Pena CE, 2015, J CLIN ONCOL, V33; Rodon J, 2013, CANC RES S1, V8, P73; Rodrigues HV, 2015, J CLIN ONCOL, V33; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Stelzer MK, 2010, CANCER PREV RES, V3, P1542, DOI 10.1158/1940-6207.CAPR-10-0228; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148730	10.1371/journal.pone.0148730	http://dx.doi.org/10.1371/journal.pone.0148730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863299	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600102
J	Tschochner, M; Leary, S; Cooper, D; Strautins, K; Chopra, A; Clark, H; Choo, L; Dunn, D; James, I; Carroll, WM; Kermode, AG; Nolan, D				Tschochner, Monika; Leary, Shay; Cooper, Don; Strautins, Kaija; Chopra, Abha; Clark, Hayley; Choo, Linda; Dunn, David; James, Ian; Carroll, William M.; Kermode, Allan G.; Nolan, David			Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS INFECTION; NASOPHARYNGEAL CARCINOMA; HLA-DR; SEQUENCE VARIATION; RISK-FACTORS; EPITOPES; PROTEIN; IDENTIFICATION; RECOGNITION	Background Epstein-Barr virus (EBV) infection represents a major environmental risk factor for multiple sclerosis (MS), with evidence of selective expansion of Epstein-Barr Nuclear Antigen-1 (EBNA1)-specific CD4+ T cells that cross-recognize MS-associated myelin antigens in MS patients. HLA-DRB1*15-restricted antigen presentation also appears to determine susceptibility given its role as a dominant risk allele. In this study, we have utilised standard and next-generation sequencing techniques to investigate EBNA-1 sequence variation and its relationship to HLA-DR15 binding affinity, as well as examining potential cross-reactive immune targets within the central nervous system proteome. Methods Sanger sequencing was performed on DNA isolated from peripheral blood samples from 73 Western Australian MS cases, without requirement for primary culture, with additional FLX 454 Roche sequencing in 23 samples to identify low-frequency variants. Patient-derived viral sequences were used to predict HLA-DRB1*1501 epitopes (NetMHCII, NetMHCIIpan) and candidates were evaluated for cross recognition with human brain proteins. Results EBNA-1 sequence variation was limited, with no evidence of multiple viral strains and only low levels of variation identified by FLX technology (8.3% nucleotide positions at a 1% cutoff). In silico epitope mapping revealed two known HLA-DRB1*1501-restricted epitopes ('AEG': aa 481-496 and 'MVF': aa 562-577), and two putative epitopes between positions 502-543. We identified potential cross-reactive targets involving a number of major myelin antigens including experimentally confirmed HLA-DRB1*15-restricted epitopes as well as novel candidate antigens within myelin and paranodal assembly proteins that may be relevant to MS pathogenesis. Conclusions This study demonstrates the feasibility of obtaining autologous EBNA-1 sequences directly from buffy coat samples, and confirms divergence of these sequences from standard laboratory strains. This approach has identified a number of immunogenic regions of EBNA-1 as well as known and novel targets for autoreactive HLA-DRB1*15-restricted T cells within the central nervous system that could arise as a result of cross-reactivity with EBNA-1-specific immune responses.	[Tschochner, Monika; Leary, Shay; Cooper, Don; Strautins, Kaija; Chopra, Abha; Clark, Hayley; Choo, Linda; Dunn, David; James, Ian; Kermode, Allan G.; Nolan, David] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia; [Carroll, William M.; Kermode, Allan G.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Carroll, William M.; Kermode, Allan G.] Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia; [Nolan, David] Royal Perth Hosp, Dept Clin Immunol, GPO Box X2213, Perth, WA 6001, Australia	Murdoch University; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia	Tschochner, M (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia.	M.Tschochner@iiid.com.au	Kermode, Allan/G-3568-2019	Kermode, Allan/0000-0002-4476-4016; Chopra, Abha/0000-0001-5008-9080; Leary, Shay/0000-0002-6966-2294	McCusker Charitable Foundation; Multiple Sclerosis Research Australia (MSRA) [12040]	McCusker Charitable Foundation; Multiple Sclerosis Research Australia (MSRA)	This project was funded by the McCusker Charitable Foundation; URL: http://www.mccuskercharitable.com.au (MT, KS, DN) and Multiple Sclerosis Research Australia (MSRA)-Grant number 12040; URL: http://www.msra.org.au (MT, WMC, AGK, DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1998, EMBO J, V17, P6394, DOI 10.1093/emboj/17.21.6394; Bell MJ, 2008, J INFECT DIS, V197, P1594, DOI 10.1086/587848; Ben-Nun A, 2014, J AUTOIMMUN, V54, P33, DOI 10.1016/j.jaut.2014.06.004; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bernig T, 2014, MOL BIOL REP, V41, P6995, DOI 10.1007/s11033-014-3587-6; Bollard CM, 2014, J CLIN ONCOL, V32, P798, DOI 10.1200/JCO.2013.51.5304; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Chia WK, 2014, MOL THER, V22, P132, DOI 10.1038/mt.2013.242; Chou YK, 2004, J NEUROSCI RES, V75, P516, DOI 10.1002/jnr.20000; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2008, NEUROLOGY, V70, P1113, DOI 10.1212/01.wnl.0000294325.63006.f8; Derfuss T, 2010, J MOL MED, V88, P753, DOI 10.1007/s00109-010-0632-3; Dhaunchak AS, 2010, GLIA, V58, P1949, DOI 10.1002/glia.21064; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; Ehlers B, 2010, J GEN VIROL, V91, P630, DOI 10.1099/vir.0.017251-0; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Haahr S, 2006, REV MED VIROL, V16, P297, DOI 10.1002/rmv.503; Habeshaw G, 1999, J VIROL, V73, P965, DOI 10.1128/JVI.73.2.965-975.1999; Hawkins JB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003685; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Ikegaya H, 2008, J VIROL METHODS, V147, P78, DOI 10.1016/j.jviromet.2007.08.010; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kaushansky N, 2006, J IMMUNOL, V177, P7364, DOI 10.4049/jimmunol.177.10.7364; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Kruger S, 2003, J IMMUNOTHER, V26, P212, DOI 10.1097/00002371-200305000-00005; Kumar A, 2014, MOL BIOSYST, V10, P2043, DOI 10.1039/c4mb00203b; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059711; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lay MLJ, 2012, INTERVIROLOGY, V55, P372, DOI 10.1159/000334693; Leen A, 2001, J VIROL, V75, P8649, DOI 10.1128/JVI.75.18.8649-8659.2001; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Long HM, 2013, J EXP MED, V210, P933, DOI 10.1084/jem.20121437; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Mackay LK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000699; Mechelli R, 2011, MULT SCLER J, V17, P1290, DOI 10.1177/1352458511410515; Mechelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063300; Merlo A, 2010, HAEMATOL-HEMATOL J, V95, P1769, DOI 10.3324/haematol.2010.023689; Metz I, 2014, ANN NEUROL, V75, P728, DOI 10.1002/ana.24163; Midgley RS, 2003, J VIROL, V77, P11517, DOI 10.1128/JVI.77.21.11517-11530.2003; Munz C, 2004, J EXP MED, V199, P1301, DOI 10.1084/jem.20040730; Muraro PA, 2002, J NEUROIMMUNOL, V130, P233, DOI 10.1016/S0165-5728(02)00229-1; Nolan D, 2012, NEUROLOGY, V79, P538, DOI 10.1212/WNL.0b013e318263c407; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pavlovic MD, 2014, J IMMUNOL METHODS, V407, P90, DOI 10.1016/j.jim.2014.03.027; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Pender MP, 2014, MULT SCLER J, V20, P1541, DOI 10.1177/1352458514521888; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Santon A, 2011, MULT SCLER J, V17, P1295, DOI 10.1177/1352458511411063; Santpere G, 2014, GENOME BIOL EVOL, V6, P846, DOI 10.1093/gbe/evu054; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Sim ACN, 2013, SCI REP-UK, V3, DOI 10.1038/srep03232; Simon KC, 2011, ACTA NEUROL SCAND, V124, P53, DOI 10.1111/j.1600-0404.2010.01410.x; SKARE J, 1982, J VIROL, V44, P1088, DOI 10.1128/JVI.44.3.1088-1091.1982; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Strautins K, 2014, MULT SCLER J, V20, P286, DOI 10.1177/1352458513498829; Sundstrom P, 2008, MULT SCLER J, V14, P1120, DOI 10.1177/1352458508092353; TANAKA J, 1994, J NEUROSCI, V14, P1038, DOI 10.1523/JNEUROSCI.14-03-01038.1994; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Thorley-Lawson DA, 2013, CURR OPIN VIROL, V3, P227, DOI 10.1016/j.coviro.2013.04.005; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; Tsang CW, 2006, J VIROL, V80, P8263, DOI 10.1128/JVI.00400-06; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Voo KS, 2005, CANCER RES, V65, P1577, DOI 10.1158/0008-5472.CAN-04-2552; Wang WY, 2002, CLIN CANCER RES, V8, P2586; Weissert R, 2002, J IMMUNOL, V169, P548, DOI 10.4049/jimmunol.169.1.548; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Zhang X, 2008, EUR J IMMUNOL, V38, P1297, DOI 10.1002/eji.200737519	74	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147567	10.1371/journal.pone.0147567	http://dx.doi.org/10.1371/journal.pone.0147567			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849221	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000020
J	Collazo, L; Klinman, JP				Collazo, Lara; Klinman, Judith P.			Control of the Position of Oxygen Delivery in Soybean Lipoxygenase-1 by Amino Acid Side Chains within a Gas Migration Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; ENZYME STRUCTURE; ACTIVE-SITE; DIFFUSION; PATHWAYS; DIOXYGEN; BINDING; OXIDASE; O-2; HYDROGENASE	Understanding gas migration pathways is critical to unraveling structure-function relationships in enzymes that process gaseous substrates such as O-2, H-2, and N-2. This work investigates the role of a defined pathway for O-2 in regulating the peroxidation of linoleic acid by soybean lipoxygenase 1. Computational and mutagenesis studies provide strong support for a dominant delivery channel that shuttles molecular oxygen to a specific region of the active site, thereby ensuring the regio- and stereospecificity of product. Analysis of reaction kinetics and product distribution in channel mutants also reveals a plasticity to the gas migration pathway. The findings show that a single site mutation (I553W) limits oxygen accessibility to the active site, greatly increasing the fraction of substrate that reacts with oxygen free in solution. They also show how a neighboring site mutation (L496W) can result in a redirection of oxygen toward an alternate position of the substrate, changing the regio- and stereospecificity of peroxidation. The present data indicate that modest changes in a protein scaffold may modulate the access of small gaseous molecules to enzyme-bound substrates.	[Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Collazo, Lara] Genentech Inc, One DNA Way, San Francisco, CA 94080 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Roche Holding; Genentech	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	klinman@berkeley.edu			National Science Foundation GRFP [DGE-1106400, CHE-0840505]; National Institutes of Health [GM025765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025765, R35GM118117, R01GM025765] Funding Source: NIH RePORTER	National Science Foundation GRFP(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation GRFP Grants DGE-1106400 (to L. C.) and CHE-0840505 and the National Institutes of Health Grant GM025765 (to J. P. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Berry H, 1998, J BIOL CHEM, V273, P2769, DOI 10.1074/jbc.273.5.2769; Brodkin HR, 2015, PROTEIN SCI, V24, P762, DOI 10.1002/pro.2648; Case D., 2010, AMBER 11, P142; Chen L, 2008, BIOCHEMISTRY-US, V47, P5368, DOI 10.1021/bi800228w; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Cohen J, 2005, STRUCTURE, V13, P1321, DOI 10.1016/j.str.2005.05.013; Cohen J, 2008, METHOD ENZYMOL, V437, P439, DOI 10.1016/S0076-6879(07)37022-5; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Edwards SJ, 2010, J PHYS CHEM B, V114, P6653, DOI 10.1021/jp100133p; GIAMMONA DA, 1984, THESIS U CALIFORNIA; Glickman MH, 1996, BIOCHEMISTRY-US, V35, P12882, DOI 10.1021/bi960985q; Hatcher E, 2007, J AM CHEM SOC, V129, P187, DOI 10.1021/ja0667211; Hu SS, 2014, J AM CHEM SOC, V136, P8157, DOI 10.1021/ja502726s; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Lee J, 2011, CHEM REV, V111, P7595, DOI 10.1021/cr100042n; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Luna VM, 2008, BIOCHEMISTRY-US, V47, P4657, DOI 10.1021/bi800045y; Meyer MP, 2008, P NATL ACAD SCI USA, V105, P1146, DOI 10.1073/pnas.0710643105; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Mullins LS, 1999, J AM CHEM SOC, V121, P3803, DOI 10.1021/ja990063l; Rickert KW, 1999, BIOCHEMISTRY-US, V38, P12218, DOI 10.1021/bi990834y; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Scorciapino MA, 2009, J AM CHEM SOC, V131, P11825, DOI 10.1021/ja9028473; Song WJ, 2011, P NATL ACAD SCI USA, V108, P14795, DOI 10.1073/pnas.1106514108; Tomita A, 2009, P NATL ACAD SCI USA, V106, P2612, DOI 10.1073/pnas.0807774106; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang PH, 2012, P NATL ACAD SCI USA, V109, P6399, DOI 10.1073/pnas.1121176109; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108	37	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9052	9059		10.1074/jbc.M115.709154	http://dx.doi.org/10.1074/jbc.M115.709154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26867580	Green Published, hybrid			2022-12-26	WOS:000374849000019
J	Blech-Hermoni, Y; Dasgupta, T; Coram, RJ; Ladd, AN				Blech-Hermoni, Yotam; Dasgupta, Twishasri; Coram, Ryan J.; Ladd, Andrea N.			Identification of Targets of CUG-BP, Elav-Like Family Member 1 (CELF1) Regulation in Embryonic Heart Muscle	PLOS ONE			English	Article							BINDING PROTEIN CUGBP1; MESSENGER-RNA DECAY; GU-RICH ELEMENTS; GENE-EXPRESSION; ALTERNATIVE POLYADENYLATION; DEVELOPMENTAL EXPRESSION; INCREASES TRANSLATION; SPLICING EVENTS; MODEL; OVEREXPRESSION	CUG-BP, Elav-like family member 1 (CELF1) is a highly conserved RNA binding protein that regulates pre-mRNA alternative splicing, polyadenylation, mRNA stability, and translation. In the heart, CELF1 is expressed in the myocardium, where its levels are tightly regulated during development. CELF1 levels peak in the heart during embryogenesis, and aberrant up-regulation of CELF1 in the adult heart has been implicated in cardiac pathogenesis in myotonic dystrophy type 1, as well as in diabetic cardiomyopathy. Either inhibition of CELF activity or over-expression of CELF1 in heart muscle causes cardiomyopathy in transgenic mice. Nonetheless, many of the cardiac targets of CELF1 regulation remain unknown. In this study, to identify cardiac targets of CELF1 we performed cross-linking immunoprecipitation (CLIP) for CELF1 from embryonic day 8 chicken hearts. We identified a previously unannotated exon in MYH7B as a novel target of CELF1-mediated regulation. We demonstrated that knockdown of CELF1 in primary chicken embryonic cardiomyocytes leads to increased inclusion of this exon and decreased MYH7B levels. We also investigated global changes in the transcriptome of primary embryonic cardiomyocytes following CELF1 knockdown in a published RNA-seq dataset. Pathway and network analyses identified strong associations between CELF1 and regulation of cell cycle and translation. Important regulatory proteins, including both RNA binding proteins and a cardiac transcription factor, were affected by loss of CELF1. Together, these data suggest that CELF1 is a key regulator of cardiomyocyte gene expression.	[Blech-Hermoni, Yotam; Dasgupta, Twishasri; Coram, Ryan J.; Ladd, Andrea N.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Blech-Hermoni, Yotam; Ladd, Andrea N.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cell Biol Program, Cleveland, OH 44106 USA; [Blech-Hermoni, Yotam] NINDS, Hereditary Muscle Dis Unit, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Dasgupta, Twishasri] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Coram, Ryan J.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA	Cleveland Clinic Foundation; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Case Western Reserve University; University System of Ohio; Ohio University	Ladd, AN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.; Ladd, AN (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cell Biol Program, Cleveland, OH 44106 USA.	ladda@ccf.org			National Institutes of Health [R01HL089376, 5T32GM008056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant to ANL from the National Institutes of Health (R01HL089376). YB-H was supported in part by a National Institutes of Health training grant (5T32GM008056). The National Institutes of Health had no involvement in the study design, collection, analysis, or interpretation of the data, or the writing or submission of this article for publication.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Beisang D, 2014, GENE, V550, P93, DOI 10.1016/j.gene.2014.08.021; Beisang D, 2012, J BIOL CHEM, V287, P950, DOI 10.1074/jbc.M111.291658; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Blech-Hermoni Y, 2013, DEV DYNAM, V242, P767, DOI 10.1002/dvdy.23959; Blech-Hermoni Y, 2015, GENOMICS DATA, P674; Brimacombe KR, 2007, DEV DYNAM, V236, P2216, DOI 10.1002/dvdy.21209; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Dasgupta T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124462; Dasgupta T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056590; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Dujardin G, 2010, NUCLEIC ACIDS RES, V38, P7273, DOI 10.1093/nar/gkq573; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esposito T, 2013, ORPHANET J RARE DIS, P891; Faustino N, 2005, MOL CELL BIOL, P25879; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Giudice J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4603; Graindorge A, 2008, NUCLEIC ACIDS RES, V36, P1861, DOI 10.1093/nar/gkn031; Ho T, 2004, EMBO J; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Kartha RV, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00008; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Ladd A, 2004, J CELL SCI; Ladd A, 2005, MOL CELL BIOL; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Lee KY, 2013, EMBO MOL MED, V5, P1887, DOI 10.1002/emmm.201303275; LeMasters KE, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-22; Liu Yong, 2014, Clin Invest Med, V37, pE10; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lu HJ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0544-8; Marquis J, 2006, BIOCHEM J, V400, P291, DOI 10.1042/BJ20060490; Masuda A, 2012, SCI REP, P2209; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Mori D, 2008, J BIOCHEM, V143, P377, DOI 10.1093/jb/mvm230; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Paillard L, 2003, BIOL CELL, V95, P107, DOI 10.1016/S0248-4900(03)00010-8; Palacios IM, 2013, BRIEF FUNCT GENOMICS, V12, P25, DOI 10.1093/bfgp/els051; Parra MK, 2012, MOL CELL BIOL, V32, P2044, DOI 10.1128/MCB.05716-11; Peng XP, 2015, BBA-MOL BASIS DIS, V1852, P1490, DOI 10.1016/j.bbadis.2015.04.010; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Philips A, 1998, SCIENCE; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Schoser B, 2010, CURR GENOMICS, V11, P77, DOI 10.2174/138920210790886844; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Takahashi N, 2000, BIOCHEM BIOPH RES CO; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Terenzi F, 2009, J MOL CELL CARDIOL, V46, P395, DOI 10.1016/j.yjmcc.2008.10.030; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Trivedi CM, 2011, J MOL CELL CARDIOL, V50, P1056, DOI 10.1016/j.yjmcc.2011.02.015; Tsuda K, 2009, NUCLEIC ACIDS RES, V37, P5151, DOI 10.1093/nar/gkp546; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Vajda NA, 2009, DEV DYNAM, V238, P3266, DOI 10.1002/dvdy.22155; Verma SK, 2013, J BIOL CHEM, V288, P35372, DOI 10.1074/jbc.M113.507426; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Vlasova IA, 2008, RNA BIOL, V5, P201, DOI 10.4161/rna.7056; Vlasova-St Louis I, 2013, BBA-GENE REGUL MECH, V1829, P695, DOI 10.1016/j.bbagrm.2013.01.001; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Warkman AS, 2012, CYTOSKELETON, V69, P324, DOI 10.1002/cm.21029; Zhang CL, 2013, NUCLEIC ACIDS RES, V41, P6793, DOI 10.1093/nar/gkt421; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002	84	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149061	10.1371/journal.pone.0149061	http://dx.doi.org/10.1371/journal.pone.0149061			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866591	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700058
J	de la Riva, EG; Olmo, M; Poorter, H; Ubera, JL; Villar, R				de la Riva, Enrique G.; Olmo, Manuel; Poorter, Hendrik; Luis Ubera, Jose; Villar, Rafael			Leaf Mass per Area (LMA) and Its Relationship with Leaf Structure and Anatomy in 34 Mediterranean Woody Species along a Water Availability Gradient	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; LITTER DECOMPOSITION RATE; PLANT ECONOMICS SPECTRUM; CHEMICAL-COMPOSITION; FUNCTIONAL TRAITS; PHOTOSYNTHETIC CAPACITY; CONSTRUCTION COSTS; LIFE-SPAN; DRY MASS; NUTRIENT	Leaf mass per area (LMA) is a morphological trait widely used as a good indicator of plant functioning (i.e. photosynthetic and respiratory rates, chemical composition, resistance to herbivory, etc.). The LMA can be broken down into the leaf density (LD) and leaf volume to area ratio (LVA or thickness), which in turn are determined by anatomical tissues and chemical composition. The aim of this study is to understand the anatomical and chemical characteristics related to LMA variation in species growing in the field along a water availability gradient. We determined LMA and its components (LD, LVA and anatomical tissues) for 34 Mediterranean (20 evergreen and 14 deciduous) woody species. Variation in LMA was due to variation in both LD and LVA. For both deciduous and evergreen species LVA variation was strongly and positively related with mesophyll volume per area (VA or thickness), but for evergreen species positive relationships of LVA with the VA of epidermis, vascular plus sclerenchyma tissues and air spaces were found as well. The leaf carbon concentration was positively related with mesophyll VA in deciduous species, and with VA of vascular plus sclerenchymatic tissues in evergreens. Species occurring at the sites with lower water availability were generally characterised by a high LMA and LD.	[de la Riva, Enrique G.; Olmo, Manuel; Villar, Rafael] Univ Cordoba, Fac Ciencias, Area Ecol, Cordoba 14071, Spain; [Poorter, Hendrik] Forschungszentrum Julich, Plant Sci IBG2, D-52425 Julich, Germany; [Luis Ubera, Jose] Univ Cordoba, Fac Ciencias, Area Bot, Cordoba 14071, Spain	Universidad de Cordoba; Helmholtz Association; Research Center Julich; Universidad de Cordoba	Villar, R (corresponding author), Univ Cordoba, Fac Ciencias, Area Ecol, Cordoba 14071, Spain.	rafael.villar@uco.es	Poorter, Hendrik/Y-2542-2019; Villar, Rafael/F-7507-2010; de la Riva, Enrique/R-5805-2016; Poorter, Hendrik/B-8062-2010	Poorter, Hendrik/0000-0001-9900-2433; Villar, Rafael/0000-0002-3895-9984; de la Riva, Enrique/0000-0002-3393-8375; Poorter, Hendrik/0000-0001-9900-2433	Spanish MEC coordinated project DIVERBOS [CGL2011-30285-C02-01, CGL2011-30285-C02-02]; ECO-MEDIT [CGL2014-53236-R]; Andalusian ANASINQUE project [PGC2010-RNM-5782]; Life + Biodehesa Project [11/BIO/ES/000726]; European FEDER funds	Spanish MEC coordinated project DIVERBOS; ECO-MEDIT; Andalusian ANASINQUE project; Life + Biodehesa Project; European FEDER funds(European Commission)	This study was funded by the Spanish MEC coordinated project DIVERBOS (CGL2011-30285-C02-01 and C02-02), ECO-MEDIT (CGL2014-53236-R), the Andalusian ANASINQUE project (PGC2010-RNM-5782), the Life + Biodehesa Project (11/BIO/ES/000726), and European FEDER funds.	Antunez I, 2001, OECOLOGIA, V128, P172, DOI 10.1007/s004420100645; Castro-Diez P, 2000, OECOLOGIA, V124, P476, DOI 10.1007/PL00008873; CHABOT BF, 1982, ANNU REV ECOL SYST, V13, P229, DOI 10.1146/annurev.es.13.110182.001305; CHOONG MF, 1992, NEW PHYTOL, V121, P597, DOI 10.1111/j.1469-8137.1992.tb01131.x; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; CUTLER JM, 1977, PHYSIOL PLANTARUM, V40, P255, DOI 10.1111/j.1399-3054.1977.tb04068.x; de la Riva EG, 2016, OIKOS, V125, P354, DOI 10.1111/oik.01875; de la Riva EG, 2016, J VEG SCI, V27, P187, DOI 10.1111/jvs.12341; Dominguez MT, 2012, PLANT SOIL, V357, P407, DOI 10.1007/s11104-012-1214-7; Fernandez-Mazuecos M, 2010, MOL ECOL, V19, P1381, DOI 10.1111/j.1365-294X.2010.04549.x; Field C., 1986, EC PLANT FORM FUNCTI, P22; Garcia de la Riva E., 2014, Ecosistemas, V23, P82; GARNIER E, 1994, NEW PHYTOL, V128, P725, DOI 10.1111/j.1469-8137.1994.tb04036.x; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Givnish TJ, 2002, EVOL ECOL, V16, P213, DOI 10.1023/A:1019676410041; Groom PK, 1997, NEW PHYTOL, V136, P231, DOI 10.1046/j.1469-8137.1997.00732.x; John GP, 2013, AM J BOT, V100, P1936, DOI 10.3732/ajb.1200608; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Lopez-Iglesias B, 2014, PLANT SOIL, V381, P177, DOI 10.1007/s11104-014-2109-6; Lopez-Iglesias B, 2014, ACTA OECOL, V56, P10, DOI 10.1016/j.actao.2014.01.003; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Maximov NA., 1929, PLANT RELATION WATER; Mediavilla S, 2003, NEW PHYTOL, V159, P203, DOI 10.1046/j.1469-8137.2003.00798.x; Mediavilla S, 2001, TREE PHYSIOL, V21, P251, DOI 10.1093/treephys/21.4.251; Meziane D, 1999, PLANT CELL ENVIRON, V22, P447, DOI 10.1046/j.1365-3040.1999.00423.x; MOONEY HA, 1970, EVOLUTION, V24, P292, DOI 10.1111/j.1558-5646.1970.tb01762.x; NIEMANN GJ, 1992, OECOLOGIA, V89, P567, DOI 10.1007/BF00317165; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Niinemets U, 1999, INT J PLANT SCI, V160, P837, DOI 10.1086/314180; OREN R, 1986, OECOLOGIA, V70, P187, DOI 10.1007/BF00379238; Orme D., 2011, R FORGE COMP ANAL PH; PAMMENTER NW, 1986, NEW PHYTOL, V102, P143, DOI 10.1111/j.1469-8137.1986.tb00806.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poorter H, 1998, INHERENT VARIATION IN PLANT GROWTH, P309; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter H, 2014, NEW PHYTOL, V201, P378, DOI 10.1111/nph.12547; Poorter Hendrik, 1997, P39, DOI 10.1016/B978-012083490-7/50003-7; Pyankov VI, 1999, NEW PHYTOL, V143, P131, DOI 10.1046/j.1469-8137.1999.00435.x; Quero JL, 2006, NEW PHYTOL, V170, P819, DOI 10.1111/j.1469-8137.2006.01713.x; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; REICH PB, 1991, OECOLOGIA, V86, P16, DOI 10.1007/BF00317383; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Renton M, 2011, NEW PHYTOL, V190, P5, DOI 10.1111/j.1469-8137.2010.03629.x; Roderick ML, 1999, FUNCT ECOL, V13, P696, DOI 10.1046/j.1365-2435.1999.00369.x; Ruiz-Robleto J, 2005, PLANT BIOLOGY, V7, P484, DOI 10.1055/s-2005-865905; Sack L, 2013, J EXP BOT, V64, P4053, DOI 10.1093/jxb/ert316; SHIELDS LM, 1950, BOT REV, V16, P399, DOI 10.1007/BF02869988; SHIPLEY B, 1995, FUNCT ECOL, V9, P312, DOI 10.2307/2390579; Slaton MR, 2002, INT J PLANT SCI, V163, P937, DOI 10.1086/342517; TURNER IM, 1994, J BIOGEOGR, V21, P413, DOI 10.2307/2845759; Utrillas MJ, 1997, INT J PLANT SCI, V158, P313, DOI 10.1086/297443; VANARENDONK JJCM, 1994, PLANT CELL ENVIRON, V17, P963, DOI 10.1111/j.1365-3040.1994.tb00325.x; Verdu M, 2013, EVOLUTION, V67, P1756, DOI 10.1111/evo.12049; Villar R, 2001, NEW PHYTOL, V151, P213, DOI 10.1046/j.1469-8137.2001.00147.x; Villar R, 2006, PLANT CELL ENVIRON, V29, P1629, DOI 10.1111/j.1365-3040.2006.01540.x; Villar R, 2013, AM J BOT, V100, P1969, DOI 10.3732/ajb.1200562; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; WITKOWSKI ETF, 1991, OECOLOGIA, V88, P486, DOI 10.1007/BF00317710; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x	66	138	142	12	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148788	10.1371/journal.pone.0148788	http://dx.doi.org/10.1371/journal.pone.0148788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867213	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700037
J	Leyh, R; Heinisch, C; Behringer, J; Reiner, I; Spangler, G				Leyh, Rainer; Heinisch, Christine; Behringer, Johanna; Reiner, Iris; Spangler, Gottfried			Maternal Attachment Representation and Neurophysiological Processing during the Perception of Infants' Emotional Expressions	PLOS ONE			English	Article							FACIAL EXPRESSIONS; SOCIAL COMPETENCE; FACE PERCEPTION; BRAIN RESPONSES; ADULT; P300; INTERVIEW; MOTHERS; ERP; RECOGNITION	The perception of infant emotions is an integral part of sensitive caregiving within the mother-child relationship, a maternal ability which develops in mothers during their own attachment history. In this study we address the association between maternal attachment representation and brain activity underlying the perception of infant emotions. Event related potentials (ERPs) of 32 primiparous mothers were assessed during a three stimulus oddball task presenting negative, positive and neutral emotion expressions of infants as target, deviant or standard stimuli. Attachment representation was assessed with the Adult Attachment Interview during pregnancy. Securely attached mothers recognized emotions of infants more accurately than insecurely attached mothers. ERPs yielded amplified N170 amplitudes for insecure mothers when focusing on negative infant emotions. Secure mothers showed enlarged P3 amplitudes to target emotion expressions of infants compared to insecure mothers, especially within conditions with frequent negative infant emotions. In these conditions, P3 latencies were prolonged in insecure mothers. In summary, maternal attachment representation was found associated with brain activity during the perception of infant emotions. This further clarifies psychological mechanisms contributing to maternal sensitivity.	[Leyh, Rainer; Heinisch, Christine; Behringer, Johanna; Spangler, Gottfried] Univ Erlangen Nurnberg, Dept Dev & Educ Psychol, D-91054 Erlangen, Germany; [Reiner, Iris] Johannes Gutenberg Univ Mainz, Klin & Poliklin Psychosomat Med & Psychotherapie, D-55122 Mainz, Germany	University of Erlangen Nuremberg; Johannes Gutenberg University of Mainz	Heinisch, C (corresponding author), Univ Erlangen Nurnberg, Dept Dev & Educ Psychol, D-91054 Erlangen, Germany.	christine.heinisch@fau.de			DFG [SP 312/18-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG SP 312/18-1.	Ainsworth M., 1978, PATTERNS ATTACHMENT; ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; BAKERMANSKRANENBURG MJ, 1993, DEV PSYCHOL, V29, P870, DOI 10.1037/0012-1649.29.5.870; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Behringer J, 2011, J FAM PSYCHOL, V25, P210, DOI 10.1037/a0023083; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bobes MA, 2007, BIOL PSYCHOL, V75, P146, DOI 10.1016/j.biopsycho.2007.01.006; Bowlby J, 1969, VOLUME 1 ATTACHMENT, V1; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Caharel S, 2014, J COGNITIVE NEUROSCI, V26, P81, DOI 10.1162/jocn_a_00451; COHN DA, 1990, CHILD DEV, V61, P152, DOI 10.2307/1131055; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Crowell JA, 1996, CHILD DEV, V67, P2584, DOI 10.1111/j.1467-8624.1996.tb01876.x; Darwin C., 1874, DESCENT MAN SELECTIO; de Haan M, 2004, J CHILD PSYCHOL PSYC, V45, P1209, DOI 10.1111/j.1469-7610.2004.00320.x; De Wolff MS, SENSITIVITY ATTACHME; Doi H, 2012, NEUROPSYCHOLOGIA, V50, P1297, DOI 10.1016/j.neuropsychologia.2012.02.013; Eimer M, 1998, NEUROREPORT, V9, P2945, DOI 10.1097/00001756-199809140-00005; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Fraedrich EM, 2010, ATTACH HUM DEV, V12, P231, DOI 10.1080/14616731003759724; George C., 1985, ADULT ATTACHMENT INT; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Gloger-Tipplet G, 2001, PSYCHOL HDB BINDUNG; Grossmann K, 1985, GROWING POINTS ATTAC; Grossmann K, 1988, RELATIONSHIPS FAMILI, P241; Haxby JV, 2002, BIOL PSYCHIAT; Hesse E, 2008, HDB ATTACHMENT; Hoehl S, 2008, CHILD DEV, V79, P1752, DOI 10.1111/j.1467-8624.2008.01223.x; Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003; Isreal JB, 1980, PSYCHOPHYSIOLOGY, P17; Izard C.E., 1971, FACE EMOTION; Kahneman D., 1973, ATTENTION EFFORT; Kolassa IT, 2006, BRAIN RES, V1118, P130, DOI 10.1016/j.brainres.2006.08.019; Krippl M, 2010, J PSYCHOPHYSIOL, V24, P173, DOI 10.1027/0269-8803/a000008; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; MAIN M, 1985, MONOGR SOC RES CHILD, V50, P66, DOI 10.2307/3333827; Main M, 2002, UNPUBLISHED MANUSCRI; Manassis K, 1999, AUST NZ J PSYCHIAT, V33, P559, DOI 10.1080/j.1440-1614.1999.00560.x; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Moreira JM, 1998, PERS INDIV DIFFER, V24, P565, DOI 10.1016/S0191-8869(97)00200-6; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Roisman GI, 2007, J PERS SOC PSYCHOL, V92, P678, DOI 10.1037/0022-3514.92.4.678; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Spangler G, 1999, Attach Hum Dev, V1, P270, DOI 10.1080/14616739900134151; Spangler G, 2001, INT J PSYCHOPHYSIOL, V41, P155, DOI 10.1016/S0167-8760(01)00127-1; Spangler G, 2010, DEV PSYCHOBIOL, V52, P411, DOI 10.1002/dev.20441; Steele H, 1996, ASS ATTACHMENT CLASS; Steele H, 2008, ATTACH HUM DEV, V10, P379, DOI 10.1080/14616730802461409; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; van Ijzendoorn MH, 1995, ADULT ATTACHMENT REP; Ward A, 2001, BRIT J MED PSYCHOL, V74, P497, DOI 10.1348/000711201161145; Wieser MJ, 2010, PSYCHOPHYSIOLOGY, V47, P271, DOI 10.1111/j.1469-8986.2009.00938.x; Zhang X, 2008, NEUROREPORT, V19, P437, DOI 10.1097/WNR.0b013e3282f55728	67	26	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147294	10.1371/journal.pone.0147294	http://dx.doi.org/10.1371/journal.pone.0147294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862743	gold, Green Published			2022-12-26	WOS:000370046600025
J	Lundberg, K; Rydnert, F; Broos, S; Andersson, M; Greiff, L; Lindstedt, M				Lundberg, Kristina; Rydnert, Frida; Broos, Sissela; Andersson, Morgan; Greiff, Lennart; Lindstedt, Malin			Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets	PLOS ONE			English	Article							HUMAN BLOOD; CROSS-PRESENTATION; STEADY-STATE; ANTIGEN; RECEPTORS; RECOGNITION; EFFICIENT; RESPONSES; COMPLEX; T(H)2	Allergen-specific immunotherapy (AIT) induces tolerance and shifts the Th2 response towards a regulatory T-cell profile. The underlying mechanisms are not fully understood, but dendritic cells (DC) play a vital role as key regulators of T-cell responses. DCs interact with allergens via Fc receptors (FcRs) and via certain C-type lectin receptors (CLRs), including CD209/DC-SIGN, CD206/MR and Dectin-2/CLEC6A. In this study, the effect of AIT on the frequencies as well as the FcR and CLR expression profiles of human DC subsets was assessed. PBMC was isolated from peripheral blood from seven allergic donors before and after 8 weeks and 1 year of subcutaneous AIT, as well as from six non-allergic individuals. Cells were stained with antibodies against DC subset-specific markers and a panel of FcRs and CLRs and analyzed by flow cytometry. After 1 year of AIT, the frequency of CD123(+) DCs was increased and a larger proportion expressed Fc epsilon RI. Furthermore, the expression of CD206 and Dectin-2 was reduced on CD141(+) DCs after 1 year of treatment and CD206 as well as Dectin-1 was additionally down regulated in CD1c(+) DCs. Interestingly, levels of DNGR1/CLEC9A on CD141(+) DCs were increased by AIT, reaching levels similar to cells isolated from non-allergic controls. The modifications in phenotype and occurrence of specific DC subsets observed during AIT suggest an altered capacity of DC subsets to interact with allergens, which can be part of the mechanisms by which AIT induces allergen tolerance.	[Lundberg, Kristina; Rydnert, Frida; Broos, Sissela; Lindstedt, Malin] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Andersson, Morgan; Greiff, Lennart] Skane Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Lundberg, K (corresponding author), Lund Univ, Dept Immunotechnol, Lund, Sweden.	kristina.lundberg@immun.lth.se	Lindstedt, Malin/A-3855-2009	Lindstedt, Malin/0000-0001-9136-1087	Signhild Engkvist foundation; Faculty of Engineering (LTH); Skane County Council Research Foundation; Lund University Research Foundation (ALF)	Signhild Engkvist foundation; Faculty of Engineering (LTH); Skane County Council Research Foundation; Lund University Research Foundation (ALF)	This study was funded by grants from Signhild Engkvist foundation, Faculty of Engineering (LTH), Skane County Council Research Foundation and Lund University Research Foundation (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Boltjes A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00131; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Dreschler K, 2011, J ALLERGY CLIN IMMUN, V127, P487, DOI 10.1016/j.jaci.2010.12.003; Farrell E, 2007, ALLERGY, V62, P1139, DOI 10.1111/j.1398-9995.2007.01465.x; Flinsenberg TWH, 2012, BLOOD, V120, P5163, DOI 10.1182/blood-2012-06-434498; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Huang HJ, 2011, MUCOSAL IMMUNOL, V4, P519, DOI 10.1038/mi.2011.17; Hulse KE, 2008, J ALLERGY CLIN IMMUN, V121, P756, DOI 10.1016/j.jaci.2007.10.016; Joetham A, 2011, J IMMUNOL, V186, P113, DOI 10.4049/jimmunol.1001663; Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419; Joo H, 2015, J IMMUNOL, V195, P1723, DOI 10.4049/jimmunol.1402276; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Lilly LM, 2012, J IMMUNOL, V189, P3653, DOI 10.4049/jimmunol.1201797; Lundberg K, 2008, CLIN IMMUNOL, V128, P358, DOI 10.1016/j.clim.2008.04.011; Lundberg K, 2014, IMMUNOLOGY, V142, P279, DOI 10.1111/imm.12252; Lundberg K, 2010, HUM IMMUNOL, V71, P931, DOI 10.1016/j.humimm.2010.07.008; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; Rydnert F, 2014, IMMUNOL CELL BIOL, V92, P557, DOI 10.1038/icb.2014.23; Salazar F, 2013, J ALLERGY CLIN IMMUN, V132, P27, DOI 10.1016/j.jaci.2013.02.001; Schreibelt G, 2012, BLOOD, V119, P2284, DOI 10.1182/blood-2011-08-373944; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Tel J, 2013, J IMMUNOL, V191, P5005, DOI 10.4049/jimmunol.1300787; Vittorakis S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231036; Wang CM, 2013, ANN ALLERG ASTHMA IM, V110, P107, DOI 10.1016/j.anai.2012.11.019; Yu CI, 2014, J IMMUNOL, V193, P4335, DOI 10.4049/jimmunol.1401159	34	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148838	10.1371/journal.pone.0148838	http://dx.doi.org/10.1371/journal.pone.0148838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863539	gold, Green Submitted, Green Published			2022-12-26	WOS:000370046600113
J	Marchal, S; Bregeras, O; Puaux, D; Gervais, R; Ferry, B				Marchal, Sophie; Bregeras, Olivier; Puaux, Didier; Gervais, Remi; Ferry, Barbara			Rigorous Training of Dogs Leads to High Accuracy in Human Scent Matching-To-Sample Performance	PLOS ONE			English	Article							CANIS-FAMILIARIS; IDENTIFICATION; BLOODHOUNDS; RELIABILITY; DETECTORS; EFFICACY; ODORANT	Human scent identification is based on a matching-to-sample task in which trained dogs are required to compare a scent sample collected from an object found at a crime scene to that of a suspect. Based on dogs' greater olfactory ability to detect and process odours, this method has been used in forensic investigations to identify the odour of a suspect at a crime scene. The excellent reliability and reproducibility of the method largely depend on rigor in dog training. The present study describes the various steps of training that lead to high sensitivity scores, with dogs matching samples with 90% efficiency when the complexity of the scents presented during the task in the sample is similar to that presented in the in lineups, and specificity reaching a ceiling, with no false alarms in human scent matching-to-sample tasks. This high level of accuracy ensures reliable results in judicial human scent identification tests. Also, our data should convince law enforcement authorities to use these results as official forensic evidence when dogs are trained appropriately.	[Marchal, Sophie; Bregeras, Olivier; Puaux, Didier] Cent Serv Judicial Ident, Cent Direct Judicial Police, DTSP, Forens Sect, 31 Ave Franklin Roosevelt, F-69134 Ecully, France; [Gervais, Remi; Ferry, Barbara] Univ Lyon 1, Ctr Rech Neurosci Lyon, UMR CNRS 5292, INSERM U1028, 50 Ave Tony Garnier, F-69366 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Ferry, B (corresponding author), Univ Lyon 1, Ctr Rech Neurosci Lyon, UMR CNRS 5292, INSERM U1028, 50 Ave Tony Garnier, F-69366 Lyon, France.	barbara.ferry@cnrs.fr	Ferry, Barbara/N-6685-2014; Gervais, Remi/O-4470-2017	Ferry, Barbara/0000-0001-5191-3035; Gervais, Remi/0000-0001-8658-9490	LABEX CORTEX of Universite de Lyon [ANR-11-LABX-0042]; "Investissements d'Avenir" [ANR-11-IDEX-0007]	LABEX CORTEX of Universite de Lyon; "Investissements d'Avenir"(French National Research Agency (ANR))	The analysis, interpretation of data and the writing of the report were supported by the LABEX CORTEX of Universite de Lyon; Grant number: ANR-11-LABX-0042; Grant sponsor: "Investissements d'Avenir" operated by the French National Research Agency (ANR); Grant number: ANR-11-IDEX-0007.	BRISBIN IL, 1991, ANIM BEHAV, V42, P63, DOI 10.1016/S0003-3472(05)80606-2; Chaput MA, 2012, EUR J NEUROSCI, V35, P584, DOI 10.1111/j.1460-9568.2011.07976.x; Curran AM, 2007, J CHROMATOGR B, V846, P86, DOI 10.1016/j.jchromb.2006.08.039; Curran AM, 2010, FORENSIC SCI INT, V199, P103, DOI 10.1016/j.forsciint.2010.03.021; Curran AM, 2005, FORENSIC SCI COMMUN, V7, P1; Ensminger J, 2012, POLICE MILITARY DOGS, P101; Furton KG, 2001, TALANTA, V54, P487, DOI 10.1016/S0039-9140(00)00546-4; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; Harvey LM, 2006, J FORENSIC SCI, V51, P1109, DOI 10.1111/j.1556-4029.2006.00231.x; Harvey LM, 2003, J FORENSIC SCI, V48, P811; HEPPER PG, 1988, PERCEPTION, V17, P549, DOI 10.1068/p170549; Jezierski T, 2008, POL PSYCHOL B, V39, P71, DOI [10.2478/v10059-008-0010-y., DOI 10.2478/V10059-008-0010-Y]; Jezierski T, 2014, FORENSIC SCI INT, V237, P112, DOI 10.1016/j.forsciint.2014.01.013; KALMUS H., 1955, BRIT JOUR ANIMAL BEHAVIOUR, V3, P25, DOI 10.1016/S0950-5601(55)80072-X; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kay LM, 2005, BEHAV NEUROSCI, V119, P726, DOI 10.1037/0735-7044.119.3.726; Laing DG, 2001, CHIMIA, V55, P413; Leitch O, 2013, FORENSIC SCI INT, V232, P92, DOI 10.1016/j.forsciint.2013.07.004; Lit L, 2011, ANIM COGN, V14, P387, DOI 10.1007/s10071-010-0373-2; Locard E., 1934, POLICE METHODES SCI; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Nowlan M, 2007, J FORENSIC SCI, V52, P643, DOI 10.1111/j.1556-4029.2007.00408.x; Oesterhelweg L, 2008, FORENSIC SCI INT, V174, P35, DOI 10.1016/j.forsciint.2007.02.031; Ostrovskaya A, 2002, J COSMET SCI, V53, P147; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Pinc L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020704; Roberts SC, 2005, CHEM SENSES, V30, P651, DOI 10.1093/chemse/bji058; Romanes GJ., 1887, NATURE, V36, P273; Schoon GAA, 1996, APPL ANIM BEHAV SCI, V49, P257, DOI 10.1016/0168-1591(95)00656-7; Schoon GAA, 1998, J FORENSIC SCI, V43, P70; SCHOON GAA, 1994, FORENSIC SCI INT, V69, P111, DOI 10.1016/0379-0738(94)90247-X; Schwartz B, 2002, PSYCHOL LEARNING BEH, P298; SOMMERVILLE BA, 1993, ANIM BEHAV, V46, P189, DOI 10.1006/anbe.1993.1174; Stockham RA, 2004, FORENSIC SCI COMM, V6; STOCKHAM RA, 2004, FORENSIC SCI COMMUNI, V6, P4; TASLITZ AE, 1990, HASTINGS LAW J, V42, P15; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Xu Y, 2007, ANAL CHEM, V79, P5633, DOI 10.1021/ac070134w; Zubedat S, 2014, APPL ANIM BEHAV SCI, V158, P69, DOI 10.1016/j.applanim.2014.05.004	40	35	36	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146963	10.1371/journal.pone.0146963	http://dx.doi.org/10.1371/journal.pone.0146963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863620	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600015
J	Wieck, MM; Spurrier, RG; Levin, DE; Mojica, SG; Hiatt, MJ; Reddy, R; Hou, XG; Navarro, S; Lee, J; Lundin, A; Driscoll, B; Grikscheit, TC				Wieck, Minna M.; Spurrier, Ryan G.; Levin, Daniel E.; Mojica, Salvador Garcia; Hiatt, Michael J.; Reddy, Raghava; Hou, Xiaogang; Navarro, Sonia; Lee, Jooeun; Lundin, Amber; Driscoll, Barbara; Grikscheit, Tracy C.			Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease	PLOS ONE			English	Article							RESPIRATORY-DISTRESS; DOWN-REGULATION; CROSS-TALK; EXPRESSION; INHIBITION; ANGIOGENESIS; HYPEROXIA; CELLS; MMP-9; EPITHELIUM	Rationale Neonatal respiratory distress syndrome is a restrictive lung disease characterized by surfactant deficiency. Decreased vascular endothelial growth factor (VEGF), which demonstrates important roles in angiogenesis and vasculogenesis, has been implicated in the pathogenesis of restrictive lung diseases. Current animal models investigating VEGF in the etiology and outcomes of RDS require premature delivery, hypoxia, anatomically or temporally limited inhibition, or other supplemental interventions. Consequently, little is known about the isolated effects of chronic VEGF inhibition, started at birth, on subsequent developing lung structure and function. Objectives To determine whether inducible, mesenchyme-specific VEGF inhibition in the neonatal mouse lung results in long-term modulation of AECII and whole lung function. Methods Triple transgenic mice expressing the soluble VEGF receptor sFlt-1 specifically in the mesenchyme (Dermo-1/rtTA/sFlt-1) were generated and compared to littermate controls at 3 months to determine the impact of neonatal downregulation of mesenchymal VEGF expression on lung structure, cell composition and function. Reduced tissue VEGF bioavailability has previously been demonstrated with this model. Measurements and Main Results Triple transgenic mice demonstrated restrictive lung pathology. No differences in gross vascular development or protein levels of vascular endothelial markers was noted, but there was a significant decrease in perivascular smooth muscle and type I collagen. Mutants had decreased expression levels of surfactant protein C and hypoxia inducible factor 1-alpha without a difference in number of type II pneumocytes. Conclusions These data show that mesenchyme-specific inhibition of VEGF in neonatal mice results in late restrictive disease, making this transgenic mouse a novel model for future investigations on the consequences of neonatal RDS and potential interventions.	[Wieck, Minna M.; Spurrier, Ryan G.; Levin, Daniel E.; Mojica, Salvador Garcia; Hou, Xiaogang; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Saban Res Inst, Div Pediat Surg, Los Angeles, CA 90027 USA; [Hiatt, Michael J.; Reddy, Raghava; Navarro, Sonia; Lee, Jooeun; Lundin, Amber; Driscoll, Barbara; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program, Saban Res Inst, Los Angeles, CA 90027 USA; [Navarro, Sonia] Univ So Calif, Herman Ostrow Sch Dent, Los Angeles, CA USA; [Driscoll, Barbara] Univ So Calif, Keck Sch Med, Integrat Biol Dis Grad Program, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Div Pediat Surg, Los Angeles, CA 90027 USA.; Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program, Saban Res Inst, Los Angeles, CA 90027 USA.	tgrikscheit@chla.usc.edu			California Institute for Regenerative Medicine [RN 2 00946-1, RN 3 06425]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	Support was provided by California Institute for Regenerative Medicine (https://www.cirm.ca.gov/) RN 2 00946-1 and RN 3 06425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Clement A, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-22; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; De Santis M, 2012, ANN RHEUM DIS, V71, P1461, DOI 10.1136/annrheumdis-2011-200657; Dishop MK, 2011, PAEDIATR RESPIR REV, V12, P230, DOI 10.1016/j.prrv.2011.01.002; Domigan CK, 2014, CELL, V159, P473, DOI 10.1016/j.cell.2014.10.008; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Glasser SW, 2003, J BIOL CHEM, V278, P14291, DOI 10.1074/jbc.M210909200; Greenberg JM, 2014, DEV DYNAM, V224, P144; Greenough A, 2008, NEONATOLOGY, V93, P324, DOI 10.1159/000121459; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hollborn M, 2007, INVEST OPHTH VIS SCI, V48, P4360, DOI 10.1167/iovs.06-1234; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Klekamp JG, 1999, AM J PATHOL, V154, P823, DOI 10.1016/S0002-9440(10)65329-1; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Landry JS, 2014, AM J RESP CRIT CARE, pA2337; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981, DOI 10.1164/ajrccm.164.10.2012036; Lau AC, 2008, ARTHRITIS RHEUM-US, V58, P854, DOI 10.1002/art.23225; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Levesque BM, 2014, NEONATOLOGY, V104, P56; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Liu FL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-88; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Mallampalli RK, 2015, ANNALS OF THE AMERIC; Matthews JA, 2012, J SURG RES, V172, P40, DOI 10.1016/j.jss.2011.04.043; Meller S, 2012, EXP LUNG RES, V38, P192, DOI 10.3109/01902148.2012.663454; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Nogee LM, 2004, ANNU REV PHYSIOL, V66, P601, DOI 10.1146/annurev.physiol.66.032102.134711; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Perkett EA, 1998, CHEST, V114, p52S, DOI 10.1378/chest.114.1_Supplement.52S; Rovina N, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-53; Saini Y, 2008, J BIOL CHEM, V283, P33650, DOI 10.1074/jbc.M805927200; Sanchez-Esteban J, 2012, AM J RESP CELL MOL B, V30, P76; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Soll R., 1998, COCHRANE DB SYST REV, V1998, DOI [10.1002/14651858.CD001149, DOI 10.1002/14651858.CD001149]; Takahashi Y, 2013, INT J MED SCI, V10, P1702, DOI 10.7150/ijms.7114; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Todorova L, 2010, RESP MED, V104, P1799, DOI 10.1016/j.rmed.2010.06.015; Tsao PN, 2005, PEDIATR PULM, V39, P461, DOI 10.1002/ppul.20205; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Vadivel A, 2014, AM J RESP CELL MOL, V50, P96, DOI 10.1165/rcmb.2012-0250OC; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Whitsett JA, 2015, ANNU REV PATHOL-MECH, V10, P371, DOI 10.1146/annurev-pathol-012513-104644; Yamamoto H, 2007, DEV BIOL, V308, P44, DOI 10.1016/j.ydbio.2007.04.042; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139; Zhao LQ, 2005, MECH DEVELOP, V122, P877, DOI 10.1016/j.mod.2005.04.001; Zhong H, 2000, CANCER RES, V60, P1541	59	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148323	10.1371/journal.pone.0148323	http://dx.doi.org/10.1371/journal.pone.0148323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863115	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600055
J	Kim, H; Park, CM; Song, YS; Sunwoo, L; Choi, YR; Kim, JI; Kim, JH; Bae, JS; Lee, JH; Goo, JM				Kim, Hyungjin; Park, Chang Min; Song, Yong Sub; Sunwoo, Leonard; Choi, Ye Ra; Kim, Jung Im; Kim, Jae Hyun; Bae, Jae Seok; Lee, Jong Hyuk; Goo, Jin Mo			Measurement Variability of Persistent Pulmonary Subsolid Nodules on Same-Day Repeat CT: What Is the Threshold to Determine True Nodule Growth during Follow-Up?	PLOS ONE			English	Article							GROUND-GLASS NODULES; INTER-READER VARIABILITY; SOLID COMPONENT; LUNG ADENOCARCINOMA; MANAGEMENT; SIZE; CLASSIFICATION; GUIDELINES; INDICATOR; SOCIETY	Purpose To assess the measurement variability of subsolid nodules (SSNs) in follow-up situations and to compare the degree of variability between measurement metrics. Methods Two same-day repeat-CT scans of 69 patients (24 men and 45 women) with 69 SSNs were randomly assigned as initial or follow-up scans and were read by the same (situation 1) or different readers (situation 2). SSN size and solid portion size were measured in both situations. Measurement variability was calculated and coefficients of variation were used for comparisons. Results Measurement variability for the longest and average diameter of SSNs was +/- 1.3 mm (+/- 13.0%) and +/- 1.3 mm (+/- 14.4%) in situation 1, and +/- 2.2 mm (+/- 21.0%) and +/- 2.1 mm (+/- 21.3%) in situation 2, respectively. For solid portion, measurement variability on lung and mediastinal windows was +/- 1.2 mm (+/- 27.1%) and +/- 0.8 mm (+/- 24.0%) in situation 1, and +/- 3.7 mm (+/- 61.0%) and +/- 1.5 mm (+/- 47.3%) in situation 2, respectively. There were no significant differences in the degree of variability between the longest and average diameters and between the lung and mediastinal window settings (p>0.05). However, measurement variability significantly increased when the follow-up and initial CT readers were different (p<0.001). Conclusions A cutoff of +/- 2.2 mm can be reliably used to determine true nodule growth on follow-up CT. Solid portion measurements were not reliable in evaluating SSNs' change when readers of initial and follow-up CT were different.	[Kim, Hyungjin; Park, Chang Min; Song, Yong Sub; Choi, Ye Ra; Kim, Jae Hyun; Bae, Jae Seok; Lee, Jong Hyuk; Goo, Jin Mo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Hyungjin] Air Force Educ & Training Command, Aerosp Med Grp, Jinju, South Korea; [Park, Chang Min; Goo, Jin Mo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Chang Min; Goo, Jin Mo] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Sunwoo, Leonard; Choi, Ye Ra] SMG SNU Boramae Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Jung Im] Kyung Hee Univ Hosp Gangdong, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Kyung Hee University; Kyung Hee University Hospital	Park, CM (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	cmpark.morphius@gmail.com		Sunwoo, Leonard/0000-0003-0374-8658; Lee, Jong Hyuk/0000-0002-9594-683X	Korean Foundation for Cancer Research [CB-2011-02-01]	Korean Foundation for Cancer Research	CMP received research grant of the Korean Foundation for Cancer Research (grant number: CB-2011-02-01), http://www.koreanfcr.or.kr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas-Jimenez J, 2013, RADIOLOGY, V268, P305, DOI 10.1148/radiol.13130209; Austin J.H., 2013, RADIOLOGY, V266, P62, DOI DOI 10.1148/RADI0L.12120240; Callister MEJ, 2015, THORAX, V70, P1, DOI 10.1136/thoraxjnl-2015-207168; de Hoop B, 2010, RADIOLOGY, V255, P199, DOI 10.1148/radiol.09090571; Godoy MCB, 2012, J THORAC IMAG, V27, P240, DOI 10.1097/RTI.0b013e31825d515b; Goo JM, 2011, AM J ROENTGENOL, V196, P533, DOI 10.2214/AJR.10.5813; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Hwang EJ, 2015, EUR RADIOL, V25, P558, DOI 10.1007/s00330-014-3441-1; Kakinuma R, 2012, ACAD RADIOL, V19, P389, DOI 10.1016/j.acra.2011.12.002; Kim H, 2014, EUR RADIOL, V24, P2700, DOI 10.1007/s00330-014-3306-7; Kim H, 2013, RADIOLOGY, V269, P584, DOI 10.1148/radiol.13121849; Lee HJ, 2012, J THORAC IMAG, V27, P340, DOI 10.1097/RTI.0b013e3182688d62; Lee SM, 2013, RADIOLOGY, V268, P265, DOI 10.1148/radiol.13120949; MacMahon H, 2013, RADIOLOGY, V268, P306; McNitt-Gray MF, 2015, TRANSL ONCOL, V8, P55, DOI 10.1016/j.tranon.2015.01.001; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Oxnard GR, 2011, J CLIN ONCOL, V29, P3114, DOI 10.1200/JCO.2010.33.7071; Park CM, 2007, RADIOGRAPHICS, V27, P391, DOI 10.1148/rg.272065061; Penn A, 2015, ACTA RADIOL, V56, P1180, DOI 10.1177/0284185114551975; Scholten ET, 2015, EUR RADIOL, V25, P1040, DOI 10.1007/s00330-014-3478-1; Scholten ET, 2015, EUR RADIOL, V25, P488, DOI 10.1007/s00330-014-3427-z; Scholten ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080249; Zhao BS, 2013, EUR J RADIOL, V82, P959, DOI 10.1016/j.ejrad.2013.02.018	23	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148853	10.1371/journal.pone.0148853	http://dx.doi.org/10.1371/journal.pone.0148853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859665	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400097
J	Meseck, SL; Alix, JH; Swiney, KM; Long, WC; Wikfors, GH; Foy, RJ				Meseck, Shannon L.; Alix, Jennifer H.; Swiney, Katherine M.; Long, W. Christopher; Wikfors, Gary H.; Foy, Robert J.			Ocean Acidification Affects Hemocyte Physiology in the Tanner Crab (Chionoecetes bairdi)	PLOS ONE			English	Article							ACID-BASE-BALANCE; INTRACELLULAR PH MEASUREMENT; BLUE-CRAB; SEAWATER ACIDIFICATION; CRASSOSTREA-VIRGINICA; CARCINUS-MAENAS; FIDDLER-CRAB; HEMOLYMPH COMPOSITION; CALLINECTES-SAPIDUS; TEMPERATURE STRESS	We used flow cytometry to determine if there would be a difference in hematology, selected immune functions, and hemocyte pH (pH(i)), under two different, future ocean acidification scenarios (pH = 7.50, 7.80) compared to current conditions (pH = 8.09) for Chionoecetes bairdi, Tanner crab. Hemocytes were analyzed after adult Tanner crabs were held for two years under continuous exposure to acidified ocean water. Total counts of hemocytes did not vary among control and experimental treatments; however, there were significantly greater number of dead, circulating hemocytes in crabs held at the lowest pH treatment. Phagocytosis of fluorescent microbeads by hemocytes was greatest at the lowest pH treatment. These results suggest that hemocytes were dying, likely by apoptosis, at a rate faster than upregulated phagocytosis was able to remove moribund cells from circulation at the lowest pH. Crab hemolymph pH (pH(e)) averaged 8.09 and did not vary among pH treatments. There was no significant difference in internal pH (pHi) within hyalinocytes among pH treatments and the mean pHi (7.26) was lower than the mean pHe. In contrast, there were significant differences among treatments in pHi of the semi-granular+granular cells. Control crabs had the highest mean semi-granular+granular pHi compared to the lowest pH treatment. As physiological hemocyte functions changed from ambient conditions, interactions with the number of eggs in the second clutch, percentage of viable eggs, and calcium concentration in the adult crab shell was observed. This suggested that the energetic costs of responding to ocean acidification and maintaining defense mechanisms in Tanner crab may divert energy from other physiological processes, such as reproduction.	[Meseck, Shannon L.; Alix, Jennifer H.; Wikfors, Gary H.] NOAA, Natl Marine Fisheries Serv, Northeaster Fisheries Sci Ctr, Milford, CT USA; [Swiney, Katherine M.; Long, W. Christopher; Foy, Robert J.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Resource Assessment & Conservat Engn Div,Kodiak L, Kodiak, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Meseck, SL (corresponding author), NOAA, Natl Marine Fisheries Serv, Northeaster Fisheries Sci Ctr, Milford, CT USA.	Shannon.Meseck@noaa.gov	Long, William C/C-7074-2009	Long, William C/0000-0002-7095-1245; Swiney, Katherine/0000-0001-5482-2710	NOAA Ocean Acidification Program [AFSC001]	NOAA Ocean Acidification Program	The authors would like to thank the NOAA Ocean Acidification Program for funding project AFSC001.	AbeleOeschger D, 1997, COMP BIOCHEM PHYS C, V117, P123, DOI 10.1016/S0742-8413(97)00059-5; Adamo SA, 2012, HORM BEHAV, V62, P324, DOI 10.1016/j.yhbeh.2012.02.012; Al-Sawalmih A, 2008, ADV FUNCT MATER, V18, P3307, DOI 10.1002/adfm.200800520; Bauchau AG, 2012, INVERTEBRATE BLOOD C, P385; Beesley A, 2008, CLIM RES, V37, P215, DOI 10.3354/cr00765; Bentov S, 2009, P NATL ACAD SCI USA, V106, P21500, DOI 10.1073/pnas.0906636106; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CAMERON JN, 1985, J EXP BIOL, V114, P181; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chan B, 2013, THESIS U HONG KONG P; CHEN SL, 1995, AQUACULTURE, V131, P205, DOI 10.1016/0044-8486(94)00327-K; Chow S, 1996, CYTOMETRY, V24, P360; Chung J Sook, 2012, Aquat Biosyst, V8, P21, DOI 10.1186/2046-9063-8-21; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; Dickson A.G., 2007, GUIDE BEST PRACTICES; DILLAMAN RM, 1980, J MORPHOL, V163, P135, DOI 10.1002/jmor.1051630203; Donaghy L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046594; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; ELLINGTON WR, 1993, BIOL BULL-US, V184, P209, DOI 10.2307/1542228; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fan LF, 2013, J PROTEOMICS, V80, P196, DOI 10.1016/j.jprot.2012.12.017; Fan TJ, 2009, ACTA BIOCH BIOPH SIN, V41, P865, DOI 10.1093/abbs/gmp078; Fan TJ, 2002, ACTA BIOCH BIOPH SIN, V34, P589; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; FINDLEY AM, 1978, MAR BIOL, V46, P9, DOI 10.1007/BF00393814; Foy RJ, 2014, 1010 AL FISH SCI CTR; GAILLARD S, 1983, MOL PHYSIOL, V4, P231; Gimenez B, 2010, LWT-FOOD SCI TECHNOL, V43, P1240, DOI 10.1016/j.lwt.2010.02.017; Gollas-Galvan T, 1999, COMP BIOCHEM PHYS B, V122, P77, DOI 10.1016/S0305-0491(98)10143-8; Gutowska MA, 2010, J COMP PHYSIOL B, V180, P323, DOI 10.1007/s00360-009-0412-y; Heath-Heckman EAC, 2011, ZOOLOGY, V114, P191, DOI 10.1016/j.zool.2011.02.002; Hegaret H, 2003, J EXP MAR BIOL ECOL, V293, P249, DOI 10.1016/S0022-0981(03)00235-1; Hernroth B, 2012, FISH SHELLFISH IMMUN, V33, P1095, DOI 10.1016/j.fsi.2012.08.011; Hernroth B, 2011, AQUAT TOXICOL, V103, P222, DOI 10.1016/j.aquatox.2011.03.001; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; JOHANSSON MW, 1985, J COMP PHYSIOL B, V156, P175, DOI 10.1007/BF00695771; Johnson PT, 1980, HIST BLUE CRAB; Johnstone MB, 2015, J EXP MAR BIOL ECOL, V463, P8, DOI 10.1016/j.jembe.2014.10.014; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Lavigne H., 2011, SEACARB SEAWATER CAR; Le Moullac G, 2000, AQUACULTURE, V191, P121, DOI 10.1016/S0044-8486(00)00422-1; Leyval D, 1997, J MICROBIOL METH, V29, P121, DOI 10.1016/S0167-7012(97)00031-6; LINDINGER MI, 1984, MAR BIOL LETT, V5, P371; Liu GX, 2006, FISH SHELLFISH IMMUN, V20, P47, DOI 10.1016/j.fsi.2005.03.012; Long WC, 2013, MAR POLLUT BULL, V69, P38, DOI 10.1016/j.marpolbul.2013.01.011; Long WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060959; MACKAY WC, 1970, COMP BIOCHEM PHYSIOL, V34, P273, DOI 10.1016/0010-406X(70)90166-0; Mackenzie CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086764; MAJNO G, 1995, AM J PATHOL, V146, P3; Marie D, 1999, CURR PROTOCOLS CYTOM, V11, P1, DOI [DOI 10.1002/0471142956.CY1111S10, 10.1002/0471142956.cy1111s10, 10.1002/0471142956.cy1112s11]; Matozzo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033820; Matozzo V, 2010, FISH SHELLFISH IMMUN, V28, P534, DOI 10.1016/j.fsi.2009.12.003; MCDONALD DG, 1979, J EXP BIOL, V79, P47; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Miccoli L, 1996, BIOCHEM J, V313, P957, DOI 10.1042/bj3130957; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Naraoka T, 2003, EUR J BIOCHEM, V270, P4026, DOI 10.1046/j.1432-1033.2003.03795.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pallet N, 2012, NEPHROL DIAL TRANSPL, V27, P483, DOI 10.1093/ndt/gfr611; Pan JZ, 2000, ANTIVIR RES, V48, P39, DOI 10.1016/S0166-3542(00)00117-0; Pane EF, 2007, MAR ECOL PROG SER, V334, P1, DOI 10.3354/meps334001; Perazzolo LM, 2002, AQUACULTURE, V214, P19, DOI 10.1016/S0044-8486(02)00137-0; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Portner HO, 1998, J EXP BIOL, V201, P43; Pressman B C, 1977, Adv Exp Med Biol, V84, P285; Qin Q, 2012, AQUAT TOXICOL, V106, P140, DOI 10.1016/j.aquatox.2011.08.013; RAFFIN JP, 1988, J COMP PHYSIOL B, V158, P223, DOI 10.1007/BF01075836; RATCLIFFE NA, 1985, INT REV CYTOL, V97, P183, DOI 10.1016/S0074-7696(08)62351-7; Raven J, 2005, 1205 ROYAL SOC, P68; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; ROER R, 1984, AM ZOOL, V24, P893; Romano N, 2006, AQUACULTURE, V260, P151, DOI 10.1016/j.aquaculture.2006.06.019; Sakamoto T., 2013, HOAJ BIOL, V2, P5, DOI DOI 10.7243/2050-0874-2-5; Sartoris FJ, 1997, J EXP BIOL, V200, P785; Schrunder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077498; SIMPSON BK, 1987, J AGR FOOD CHEM, V35, P918, DOI 10.1021/jf00078a017; Small D, 2010, AQUAT BIOL, V10, P11, DOI 10.3354/ab00266; Smith VJ, 2010, ENCY LIFE SCI ELS, DOI [10.1002/9780470015902.a0002344.pub2, DOI 10.1002/9780470015902.A0002344.PUB2]; Smith VJ, 1983, BIOL RES, V233, P295; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; SODERHALL K, 1986, CELL TISSUE RES, V245, P43; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Spicer JI, 2007, MAR BIOL, V151, P1117, DOI 10.1007/s00227-006-0551-6; STAPLES DJ, 1991, J EXP MAR BIOL ECOL, V154, P251, DOI 10.1016/0022-0981(91)90168-V; Sugumaran Manickam, 1996, P355; Sung HH, 2003, AQUAT TOXICOL, V64, P25, DOI 10.1016/S0166-445X(03)00011-0; Tanner CA, 2006, COMP BIOCHEM PHYS A, V144, P218, DOI 10.1016/j.cbpa.2006.02.042; TAYLOR EW, 1989, J EXP BIOL, V144, P417; Terwilliger NB, 2006, BIOL BULL-US, V210, P38, DOI 10.2307/4134535; Tomanek L, 2011, J EXP BIOL, V214, P1836, DOI 10.1242/jeb.055475; Trump BF, 1996, MAR ENVIRON RES, V42, P57, DOI 10.1016/0141-1136(96)00074-8; TRUSCOTT R, 1990, FUNCT ECOL, V4, P455, DOI 10.2307/2389609; VACCA LL, 1975, COMP BIOCHEM PHYS B, V51, P475, DOI 10.1016/0305-0491(75)90042-5; VACCA LL, 1975, COMP BIOCHEM PHYS B, V51, P483, DOI 10.1016/0305-0491(75)90043-7; VACCA LL, 1983, BIOL BULL, V165, P758, DOI 10.2307/1541477; VargasAlbores F, 1997, COMP BIOCHEM PHYS B, V116, P453, DOI 10.1016/S0305-0491(96)00268-4; Vazquez L, 2009, INNATE IMMUN-LONDON, V15, P179, DOI 10.1177/1753425909102876; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; VICTOR B, 1990, J ENVIRON BIOL, V11, P61; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Watson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2377; WEEKS JM, 1993, MAR ECOL PROG SER, V97, P91, DOI 10.3354/meps097091; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; WHEATLY MG, 1992, J EXP ZOOL, V263, P127, DOI 10.1002/jez.1402630204; WHEATLY MG, 1991, PHYSIOL ZOOL, V64, P323, DOI 10.1086/physzool.64.1.30158527; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Whiteley Nia M., 1999, Society for Experimental Biology Seminar Series, V68, P233; Whiteley NM, 2001, J EXP BIOL, V204, P1003; WHITELEY NM, 1992, J CRUSTACEAN BIOL, V12, P19, DOI 10.2307/1548715; WIEDER ED, 1993, CYTOMETRY, V14, P916, DOI 10.1002/cyto.990140810; Yeh SP, 2009, FISH SHELLFISH IMMUN, V26, P582, DOI 10.1016/j.fsi.2008.09.010; ZANGE J, 1990, J EXP BIOL, V150, P95; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	119	30	31	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148477	10.1371/journal.pone.0148477	http://dx.doi.org/10.1371/journal.pone.0148477			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859148	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400047
J	Sharples, SA; Gould, JA; Vandenberk, MS; Kalmar, JM				Sharples, Simon A.; Gould, Jason A.; Vandenberk, Michael S.; Kalmar, Jayne M.			Cortical Mechanisms of Central Fatigue and Sense of Effort	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED-POTENTIALS; HUMAN MUSCLE FATIGUE; INTERVAL INTRACORTICAL INHIBITION; MAXIMAL VOLUNTARY CONTRACTIONS; FRONTAL-LOBE INPUTS; INTERHEMISPHERIC INHIBITION; CHRONIC STROKE; CORTEX; EXCITABILITY	The purpose of this study was to investigate cortical mechanisms upstream to the corticospinal motor neuron that may be associated with central fatigue and sense of effort during and after a fatigue task. We used two different isometric finger abduction protocols to examine the effects of muscle activation and fatigue the right first dorsal interosseous (FDI) of 12 participants. One protocol was intended to assess the effects of muscle activation with minimal fatigue (control) and the other was intended to elicit central fatigue (fatigue). We hypothesized that high frequency repetitive transcranial magnetic stimulation (rTMS) of the supplementary motor area (SMA) would hasten recovery from central fatigue and offset a fatigue-induced increase in sense of effort by facilitating the primary motor cortex (M1). Constant force-sensation contractions were used to assess sense of effort associated with muscle contraction. Paired-pulse TMS was used to assess intracortical inhibition (ICI) and facilitation (ICF) in the active M1 and interhemispheric inhibitory (IHI) was assessed to determine if compensation occurs via the resting M1. These measures were made during and after the muscle contraction protocols. Corticospinal excitability progressively declined with fatigue in the active hemisphere. ICF increased at task failure and ICI was also reduced at task failure with no changes in IHI found. Although fatigue is associated with progressive reductions in corticospinal excitability, compensatory changes in inhibition and facilitation may act within, but not between hemispheres of the M1. rTMS of the SMA following fatigue enhanced recovery of maximal voluntary force and higher levels of ICF were associated with lower sense of effort following stimulation. rTMS of the SMA may have reduced the amount of upstream drive required to maintain motor output, thus contributing to a lower sense of effort and increased rate of recovery of maximal force.	[Sharples, Simon A.; Gould, Jason A.; Vandenberk, Michael S.; Kalmar, Jayne M.] Wilfrid Laurier Univ, Dept Kinesiol, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University	Kalmar, JM (corresponding author), Wilfrid Laurier Univ, Dept Kinesiol, Waterloo, ON N2L 3C5, Canada.	jkalmar@wlu.ca	Sharples, Simon/E-1064-2019	Sharples, Simon/0000-0003-2316-1504	Natural Science and Engineering Research Council of Canada [386601]; Wilfrid Laurier University Short Term Research Grant; NSERC-IPS1 graduate studentship	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wilfrid Laurier University Short Term Research Grant; NSERC-IPS1 graduate studentship	This work was supported by the Natural Science and Engineering Research Council of Canada, grant number 386601 (JK), Wilfrid Laurier University Short Term Research Grant (JK), and NSERC-IPS1 graduate studentship (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Benwell NM, 2006, EXP BRAIN RES, V175, P575, DOI 10.1007/s00221-006-0573-9; Benwell NM, 2006, EXP BRAIN RES, V170, P191, DOI 10.1007/s00221-005-0195-7; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; Butler JE, 2003, J NEUROSCI, V23, P10224; Chen R, 1997, CAN J NEUROL SCI, V24, P284, DOI 10.1017/S0317167100032947; Debaere F, 2003, NEUROIMAGE, V19, P764, DOI 10.1016/S1053-8119(03)00148-4; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Gandevia S. C., 1996, HDB PHYSL 12, P128, DOI DOI 10.1002/CPHY.CP120104; GANDEVIA SC, 1982, BRAIN, V105, P151, DOI 10.1093/brain/105.1.151; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; GHOSH S, 1987, J COMP NEUROL, V259, P424, DOI 10.1002/cne.902590309; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Hamada M, 2008, MOVEMENT DISORD, V23, P1524, DOI 10.1002/mds.22168; Hortobagyi T, 2011, MED SCI SPORT EXER, V43, P1188, DOI 10.1249/MSS.0b013e31820a94b8; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; JONES LA, 1983, EUR J APPL PHYSIOL O, V51, P75, DOI 10.1007/BF00952540; Kalmar JM, 2006, EXP BRAIN RES, V173, P446, DOI 10.1007/s00221-006-0383-0; Kalmar JM, 2006, J APPL PHYSIOL, V100, P1757, DOI 10.1152/japplphysiol.01347.2005; Kalmar JM, 2004, J NEUROSCI METH, V138, P15, DOI 10.1016/j.jneumeth.2004.03.006; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Liepert J, 1996, MUSCLE NERVE, V19, P1429, DOI 10.1002/(SICI)1097-4598(199611)19:11<1429::AID-MUS7>3.0.CO;2-E; Maruyama A, 2006, CLIN NEUROPHYSIOL, V117, P864, DOI 10.1016/j.clinph.2005.12.019; Matsunaga K, 2005, J PHYSIOL-LONDON, V562, P295, DOI 10.1113/jphysiol.2004.070755; McNeil CJ, 2009, J PHYSIOL-LONDON, V587, P5601, DOI 10.1113/jphysiol.2009.180968; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Plaskett CJ, 2001, J APPL PHYSIOL, V91, P1535, DOI 10.1152/jappl.2001.91.4.1535; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Samii A, 1996, NEUROLOGY, V46, P1376, DOI 10.1212/WNL.46.5.1376; Sharples SA, 2012, J NEUROSCI METH, V210, P178, DOI 10.1016/j.jneumeth.2012.07.018; Shibuya K, 2011, PHYSIOL MEAS, V32, P1929, DOI 10.1088/0967-3334/32/12/004; Smith JL, 2007, J APPL PHYSIOL, V103, P560, DOI 10.1152/japplphysiol.00220.2007; STEENHUIS RE, 1990, J CLIN EXP NEUROPSYC, V12, P921, DOI 10.1080/01688639008401031; Takahashi K, 2009, CLIN NEUROPHYSIOL, V120, P198, DOI 10.1016/j.clinph.2008.10.003; Tanaka M, 2012, NEUROSCI BIOBEHAV R, V36, P727, DOI 10.1016/j.neubiorev.2011.10.004; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Taylor JL, 1999, EXP BRAIN RES, V127, P108, DOI 10.1007/s002210050779; Terao Y, 2007, J COGNITIVE NEUROSCI, V19, P1556, DOI 10.1162/jocn.2007.19.9.1556; van Duinen H, 2007, NEUROIMAGE, V35, P1438, DOI 10.1016/j.neuroimage.2007.02.008; Wang Y, 2001, NEUROSCI RES, V39, P39, DOI 10.1016/S0168-0102(00)00198-X; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686; Williams PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093284; ZANETTE G, 1995, EXP BRAIN RES, V107, P80	52	17	17	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149026	10.1371/journal.pone.0149026	http://dx.doi.org/10.1371/journal.pone.0149026			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859391	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400121
J	Van Laeken, N; Taylor, O; Polis, I; Neyt, S; Kersemans, K; Dobbeleir, A; Saunders, J; Goethals, I; Peremans, K; De Vos, F				Van Laeken, Nick; Taylor, Olivia; Polis, Ingeborgh; Neyt, Sara; Kersemans, Ken; Dobbeleir, Andre; Saunders, Jimmy; Goethals, Ingeborg; Peremans, Kathelijne; De Vos, Filip			In Vivo Evaluation of Blood Based and Reference Tissue Based PET Quantifications of [C-11] DASB in the Canine Brain	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SEROTONIN TRANSPORTER; GRAPHICAL ANALYSIS; HIGH-QUALITY; BINDING; MODEL; C-11-DASB; RECEPTOR; OCCUPANCY; VOLUME	This first-in-dog study evaluates the use of the PET-radioligand [C-11] DASB to image the density and availability of the serotonin transporter (SERT) in the canine brain. Imaging the serotonergic system could improve diagnosis and therapy of multiple canine behavioural disorders. Furthermore, as many similarities are reported between several human neuropsychiatric conditions and naturally occurring canine behavioural disorders, making this tracer available for use in dogs also provide researchers an interesting non-primate animal model to investigate human disorders. Five adult beagles underwent a 90 minutes dynamic PET scan and arterial whole blood was sampled throughout the scan. For each ROI, the distribution volume (V-T), obtained via the one-and two-tissue compartment model (1-TC, 2-TC) and the Logan Plot, was calculated and the goodness-of-fit was evaluated by the Akaike Information Criterion (AIC). For the preferred compartmental model BPND values were estimated and compared with those derived by four reference tissue models: 4-parameter RTM, SRTM2, MRTM2 and the Logan reference tissue model. The 2-TC model indicated in 61% of the ROIs a better fit compared to the 1-TC model. The Logan plot produced almost identical VT values and can be used as an alternative. Compared with the 2-TC model, all investigated reference tissue models showed high correlations but small underestimations of the BPND-parameter. The highest correlation was achieved with the Logan reference tissue model (Y = 0.9266 x + 0.0257; R-2 = 0.9722). Therefore, this model can be put forward as a non-invasive standard model for future PET-experiments with [C-11] DASB in dogs.	[Van Laeken, Nick; Neyt, Sara; De Vos, Filip] Univ Ghent, Dept Radiopharm, B-9000 Ghent, Belgium; [Taylor, Olivia; Saunders, Jimmy; Peremans, Kathelijne] Univ Ghent, Dept Med Imaging & Small Anim Orthoped, B-9000 Ghent, Belgium; [Polis, Ingeborgh] Univ Ghent, Dept Med & Clin Biol Small Anim, B-9000 Ghent, Belgium; [Kersemans, Ken; Dobbeleir, Andre; Goethals, Ingeborg] Ghent Univ Hosp, Dept Radiol & Nucl Med, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University Hospital	Van Laeken, N (corresponding author), Univ Ghent, Dept Radiopharm, B-9000 Ghent, Belgium.	nick.vanlaeken@ugent.be						Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Belanger MJ, 2004, NUCL MED BIOL, V31, P1097, DOI 10.1016/j.nucmedbio.2004.09.002; Dua-Sharma S., 1970, CANINE BRAIN STEREOT; Frankle WG, 2006, J NUCL MED, V47, P815; Frankle WG, 2004, J NUCL MED, V45, P682; Ginovart N, 2001, J CEREBR BLOOD F MET, V21, P1342, DOI 10.1097/00004647-200111000-00010; Ginovart N, 2003, SYNAPSE, V47, P123, DOI 10.1002/syn.10155; Haeusler D, 2009, APPL RADIAT ISOTOPES, V67, P1654, DOI 10.1016/j.apradiso.2009.03.005; Hesse S, 2011, INT J NEUROPSYCHOPH, V14, P606, DOI 10.1017/S1461145710001604; Hoekzema E, 2011, EXP GERONTOL, V46, P1020, DOI 10.1016/j.exger.2011.09.007; Houle S, 2000, EUR J NUCL MED, V27, P1719, DOI 10.1007/s002590000365; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hume SP, 1998, EUR J NUCL MED, V25, P173, DOI 10.1007/s002590050211; Huot P, 2011, PROG NEUROBIOL, V95, P163, DOI 10.1016/j.pneurobio.2011.08.004; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jensen SB, 2003, SYNAPSE, V49, P170, DOI 10.1002/syn.10222; KEYES SR, 1982, J BIOL CHEM, V257, P1172; Kornum BR, 2009, J CEREBR BLOOD F MET, V29, P186, DOI 10.1038/jcbfm.2008.110; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42, DOI 10.1097/00004647-199601000-00005; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lanzenberger R, 2012, NEUROIMAGE, V63, P874, DOI 10.1016/j.neuroimage.2012.07.023; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Lim R. K. S., 1960, STEREOTAXIC ATLAS DO; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lundquist P, 2007, SYNAPSE, V61, P440, DOI 10.1002/syn.20382; Meyer JH, 2007, J PSYCHIATR NEUROSCI, V32, P86; Nelissen N, 2008, KINETIC MODELLING HU; Ouchi Y, 2009, J NUCL MED, V50, P1260, DOI 10.2967/jnumed.109.063008; Parsey RV, 2006, J NUCL MED, V47, P1796; Parsey RV, 2006, BIOL PSYCHIAT, V59, P821, DOI 10.1016/j.biopsych.2005.08.010; Peremans K, 2003, EUR J NUCL MED MOL I, V30, P1538, DOI 10.1007/s00259-003-1250-x; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Schmidt KC, 2002, Q J NUCL MED, V46, P70; Selvaraj S, 2011, PSYCHOPHARMACOLOGY, V213, P555, DOI 10.1007/s00213-009-1660-y; Tang RQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r25; Van Laeken N, 2013, APPL RADIAT ISOTOPES, V78, P62, DOI 10.1016/j.apradiso.2013.04.009; Vermeire S, 2012, PSYCHIAT RES-NEUROIM, V201, P78, DOI 10.1016/j.pscychresns.2011.06.006; Vermeire S, 2009, BRAIN IMAGING BEHAV, V3, P342, DOI 10.1007/s11682-009-9076-1; Wilson AA, 2002, NUCL MED BIOL, V29, P509, DOI 10.1016/S0969-8051(02)00316-5; Wilson AA, 2000, J MED CHEM, V43, P3103, DOI 10.1021/jm000079i; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34; Yokoyama C, 2010, SYNAPSE, V64, P594, DOI 10.1002/syn.20766	45	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148943	10.1371/journal.pone.0148943	http://dx.doi.org/10.1371/journal.pone.0148943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859850	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400108
J	Aldamiz-Echevarria, T; Berenguer, J; Miralles, P; Jimenez-Sousa, MA; Carrero, A; Pineda-Tenor, D; Diez, C; Tejerina, F; Perez-Latorre, L; Bellon, JM; Resino, S				Aldamiz-Echevarria, Teresa; Berenguer, Juan; Miralles, Pilar; Jimenez-Sousa, Maria A.; Carrero, Ana; Pineda-Tenor, Daniel; Diez, Cristina; Tejerina, Francisco; Perez-Latorre, Leire; Bellon, Jose M.; Resino, Salvador			Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome	PLOS ONE			English	Article							C VIRUS-INFECTION; HEPATITIS-C; LIVER; INFLAMMATION; CIRRHOSIS; DYSFUNCTION; STATEMENT; FIBROSIS; SERUM	Background Higher serum levels of adhesion molecules (sICAM-1 and sVCAM-1) are associated with advanced liver fibrosis in patients coinfected with human immunodeficiency virus and hepatitis C virus. We assessed the relationship between serum levels of adhesion molecules and liver-related events (LRE) or death, in coinfected patients. Methods We studied clinical characteristics and outcomes of 182 coinfected patients with a baseline liver biopsy (58 with advanced fibrosis) and simultaneous plasma samples who were followed for median of 9 years. We used receiver-operating characteristic (ROC) curves to calculate optimized cutoff values (OCV) of sICAM-1 and sVCAM-1, defined as the values with the highest combination of sensitivity and specificity for LRE. We used multivariate regression analysis to test the association between OCVs of sICAM-1 and sVCAM-1 and outcomes. The variables for adjustment were age, HIV transmission category, liver fibrosis, baseline CD4+ T-cell counts, antiretroviral therapy, and sustained virologic response (SVR). Results During the study period 51 patients had SVR, 19 had LRE, and 16 died. The OCVs for LRE were 5.68 Log pg/mL for sICAM-1 and 6.25 Log pg/mL for sVCAM-1, respectively. The adjusted subhazard ratio (aSHR) (95% confidence interval [CI]) of death or LRE, whichever occurred first, for sICAM-1 and sVCAM-1 > OCV were 3.98 ([1.14; 13.89], P = 0.030) and 2.81 ([1.10; 7.19], respectively (P = 0.030). Conclusions Serum levels of sICAM-1 and sVCAM-1 can serve as markers of outcome in HIV/HCV-coinfected patients. Therapies targeting necroinflammatory damage and fibrogenesis may have a role in the management chronic hepatitis C.	[Aldamiz-Echevarria, Teresa; Berenguer, Juan; Miralles, Pilar; Carrero, Ana; Diez, Cristina; Tejerina, Francisco; Perez-Latorre, Leire] Hosp Gen Univ Gregorio Maranon, Infect Dis & HIV Unit, Madrid, Spain; [Aldamiz-Echevarria, Teresa; Berenguer, Juan; Miralles, Pilar; Carrero, Ana; Diez, Cristina; Tejerina, Francisco; Perez-Latorre, Leire; Bellon, Jose M.] Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Jimenez-Sousa, Maria A.; Pineda-Tenor, Daniel; Resino, Salvador] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain	General University Gregorio Maranon Hospital; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Berenguer, J (corresponding author), Hosp Gen Univ Gregorio Maranon, Infect Dis & HIV Unit, Madrid, Spain.; Berenguer, J (corresponding author), Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain.	jbb4@me.com	Berenguer, Juan/A-1347-2009; Jiménez-Sousa, Maria A./I-8725-2012; Resino, Salvador/B-2430-2008; Bellon-Cano, José María/G-6120-2016; Cano, Jose Maria Bellon/G-3061-2012	Berenguer, Juan/0000-0001-8541-8200; Jiménez-Sousa, Maria A./0000-0002-1945-6169; Resino, Salvador/0000-0001-8783-0450; Bellon-Cano, José María/0000-0002-8492-1565; Cano, Jose Maria Bellon/0000-0002-8492-1565; Pineda-Tenor, Daniel/0000-0001-6343-5384; Perez-Latorre, Leire/0000-0001-9919-3778; Tejerina, Francisco/0000-0002-4136-3575	Fondo de Investigacion de Sanidad en Espana (FIS) (Spanish Health Funds for Research) [PI11/01556, PI14/01094, PI11/00245, PI14CIII/00011]; Plan Nacional R+D+I [RD12/0017/0004, RD12/0017/0024]; ISCIII Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Programa de Intensificacion de la Actividad Investigadora en el Sistema Nacional de Salud (I3SNS) [INT10/009, INT12/154]; ISCIII [CM12/00043, CD13/00013]	Fondo de Investigacion de Sanidad en Espana (FIS) (Spanish Health Funds for Research); Plan Nacional R+D+I; ISCIII Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Programa de Intensificacion de la Actividad Investigadora en el Sistema Nacional de Salud (I3SNS); ISCIII(Instituto de Salud Carlos III)	This work was supported by grants PI11/01556, PI14/01094, PI11/00245 and PI14CIII/00011 given by Fondo de Investigacion de Sanidad en Espana (FIS) (Spanish Health Funds for Research) and by grants RD12/0017/0004 and RD12/0017/0024 from Plan Nacional R+D+I and cofinanced by ISCIII Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER). JB is an investigator from the Programa de Intensificacion de la Actividad Investigadora en el Sistema Nacional de Salud (I3SNS; Refs INT10/009 and INT12/154). DPT and MAJS are supported by ISCIII grants CM12/00043 and CD13/00013, respectively.	Afford SC, 2014, HEPATOLOGY, V59, P1932, DOI 10.1002/hep.26965; Ala A, 2003, INT J EXP PATHOL, V84, P1, DOI 10.1046/j.1365-2613.2003.00235.x; Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Brown PMJ, 2001, CLIN BIOCHEM, V34, P167, DOI 10.1016/S0009-9120(01)00210-7; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bruno CM, 2005, WORLD J GASTROENTERO, V11, P4566, DOI 10.3748/wjg.v11.i29.4566; Buck M, 2014, HEPATOLOGY, V59, P1052, DOI 10.1002/hep.26755; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; de Castro IF, 2010, AIDS, V24, P2059, DOI 10.1097/QAD.0b013e32833ce54d; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Giron-Gonzalez JA, 2005, SCAND J GASTROENTERO, V40, P217, DOI 10.1080/00365520510011470; Giron-Gonzalez JA, 2004, LIVER INT, V24, P437, DOI 10.1111/j.1478-3231.2004.0951.x; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; JACOBS WH, 1989, DIGEST DIS SCI, V34, P322, DOI 10.1007/BF01536249; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Kaplanski G, 1997, DIGEST DIS SCI, V42, P2277, DOI 10.1023/A:1018818801824; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; Lo Iacono O, 2008, LIVER INT, V28, P1129, DOI 10.1111/j.1478-3231.2008.01763.x; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Male D, 2014, IMMUNOLOGY ILLUSTRAT; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Panel de expertos de GeSIDA, 2014, Enferm Infecc Microbiol Clin, V32, DOI 10.1016/j.eimc.2014.02.019; PIGOTT R, 1992, BIOCHEM BIOPH RES CO, V187, P584, DOI 10.1016/0006-291X(92)91234-H; R Development Core Team, 2015, R PROJECT STAT COMPU; Serra A, 2008, J IMMUNOL, V181, P174, DOI 10.4049/jimmunol.181.1.174; Suliman ME, 2006, NEPHROL DIAL TRANSPL, V21, P1603, DOI 10.1093/ndt/gfl005; VOLPES R, 1990, HEPATOLOGY, V12, P59, DOI 10.1002/hep.1840120110; VOLPES R, 1992, HEPATOLOGY, V15, P269, DOI 10.1002/hep.1840150216	31	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148537	10.1371/journal.pone.0148537	http://dx.doi.org/10.1371/journal.pone.0148537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849641	Green Published, gold			2022-12-26	WOS:000369554000120
J	Kristianto, J; Litscher, SJ; Johnson, MG; Patel, F; Patel, M; Fisher, J; Zastrow, RK; Radcliff, AB; Blank, RD				Kristianto, Jasmin; Litscher, Suzanne J.; Johnson, Michael G.; Patel, Forum; Patel, Mital; Fisher, Jacqueline; Zastrow, Ryley K.; Radcliff, Abigail B.; Blank, Robert D.			Congenic Strains Confirm the Pleiotropic Effect of Chromosome 4 QTL on Mouse Femoral Geometry and Biomechanical Performance	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BONE-MINERAL DENSITY; CORTICAL BONE; SEX-DIFFERENCES; GENETIC COMPOSITION; CANDIDATE GENES; SKELETAL SIZE; BODY-SIZE; MICE; STRENGTH	A pleiotropic quantitative trait locus (QTL) for bone geometry and mechanical performance in mice was mapped to distal chromosome 4 via an intercross of recombinant congenic mice HcB-8 and HcB-23. To study the QTL in isolation, we have generated C3H. B10-(rs6355453-rs13478087) (C. B. 4.3) and C3H. B10-(rs6369860-D4Mit170) (C. B. 4.2) congenic strains that harbor similar to 20 Mb and similar to 3 Mb, respectively, of chromosome 4 overlapping segments from C57BL/10ScSnA (B10) within the locus on a C3H/DiSnA (C3H) background. Using 3-point bend testing and standard beam equations, we phenotyped these mice for femoral mid-diaphyseal geometry and biomechanical performance. We analyzed the results via 2-way ANOVA, using sex and genotype as factors. In the C. B. 4.3 strain, we found that homozygous B10/B10 male mice had smaller cross sectional area (CSA) and reduced total displacement than homozygous C3H/C3H mice. Sex by genotype interaction was also observed for maximum load and stiffness for C3H/C3H and B10/B10 mice, respectively. In C. B. 4.2 strain, we found that homozygous B10/B10 mice had lower total displacement, post-yield displacement (PYD), stiffness, yield load and maximum load than mice harboring C3H allele. Sex by genotype interaction was observed in B10/B10 mice for perimeter, outer minor axis (OMA) and CSA. There were no significant differences in tissue level mechanical performance, which suggest that the QTL acts primarily on circumferential bone size. These data confirm the prior QTL mapping data and support other work demonstrating the importance of chromosome 4 QTL on bone modeling and bone responses to mechanical loading.	[Kristianto, Jasmin; Litscher, Suzanne J.; Johnson, Michael G.; Patel, Forum; Patel, Mital; Fisher, Jacqueline; Zastrow, Ryley K.; Radcliff, Abigail B.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Blank, Robert D.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Blank, Robert D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Blank, Robert D.] Milwaukee VA Med Ctr, Milwaukee, WI USA	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Kristianto, J (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA.	jkristianto@medicine.wisc.edu	Blank, Robert D./V-5995-2019	Blank, Robert D./0000-0003-2950-1944; Patel, Mital/0000-0002-0389-9600	Office of Research and Development, Rehabilitation Research and Development Service [I21 RX1440]; Merit Review Award from the Office of Research and Development, Biomedical and Laboratory Research and Development Service, the Department of Veterans Affairs; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health [NIH AR54753]; NIH [AR54753]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054753] Funding Source: NIH RePORTER; Veterans Affairs [I21RX001440] Funding Source: NIH RePORTER	Office of Research and Development, Rehabilitation Research and Development Service; Merit Review Award from the Office of Research and Development, Biomedical and Laboratory Research and Development Service, the Department of Veterans Affairs; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank Marc Drezner and Baozhi Yuan for helpful discussions. This material is based on work supported in part by award I21 RX1440, by the Office of Research and Development, Rehabilitation Research and Development Service, and a Merit Review Award from the Office of Research and Development, Biomedical and Laboratory Research and Development Service, the Department of Veterans Affairs, and performed in the Geriatrics Research, Education, and Clinical Center at the William S. Middleton Memorial Veterans Hospital. The views expressed here are those of the authors, and the contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.; Research reported in this publication was supported in part by National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health under Award Number NIH AR54753. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.; Funded by NIH AR54753. www.nih.gov. (Robert Blank). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2010, J BONE MINER RES, V25, P1808, DOI 10.1002/jbmr.72; Agueda L, 2010, CALCIFIED TISSUE INT, V87, P14, DOI 10.1007/s00223-010-9361-4; Beamer WG, 2012, J BONE MINER RES, V27, P47, DOI 10.1002/jbmr.515; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; BEAMER WG, 2001, J BONE MINER RES, V20, P1701, DOI DOI 10.1359/JBMR.2005.20.9.1700; Blank RD, 2003, CONNECT TISSUE RES, V44, P134, DOI 10.1080/03008200390223918; Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828; Clark EM, 2006, PEDIATRICS, V117, pE291, DOI 10.1542/peds.2005-1404; Delahunty KM, 2006, ENDOCRINOLOGY, V147, P3915, DOI 10.1210/en.2006-0277; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Dennison E, 2006, RHEUM DIS CLIN N AM, V32, P617, DOI 10.1016/j.rdc.2006.08.003; Devoto M, 2005, EUR J HUM GENET, V13, P781, DOI 10.1038/sj.ejhg.5201411; Ermakov S, 2010, BONE, V46, P1244, DOI 10.1016/j.bone.2009.11.018; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Franco GEL, 2004, J CLIN DENSITOM, V7, P326; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; Huang QY, 2009, BONE, V44, P984, DOI 10.1016/j.bone.2009.01.368; Jepsen KJ, 2011, CLIN ORTHOP RELAT R, V469, P2150, DOI 10.1007/s11999-010-1706-9; Jones BH, 2002, EPIDEMIOL REV, V24, P228, DOI 10.1093/epirev/mxf011; Kammerer CM, 1995, J MED PRIMATOL, V24, P236, DOI 10.1111/j.1600-0684.1995.tb00176.x; Karasik D, 2004, BONE, V34, P547, DOI 10.1016/j.bone.2003.11.017; Katsumura T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2259; KELLY PJ, 1990, J BONE MINER RES, V5, P1169; Kesavan C, 2006, BONE, V39, P634, DOI 10.1016/j.bone.2006.03.005; Koller DL, 2003, J BONE MINER RES, V18, P1758, DOI 10.1359/jbmr.2003.18.10.1758; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; LINDAHL O, 1968, ACTA ORTHOP SCAND, V39, P129, DOI 10.3109/17453676808989447; Lipkin EW, 2001, BONE, V29, P249, DOI 10.1016/S8756-3282(01)00508-7; McCaffery JM, 2003, PSYCHOSOM MED, V65, P721, DOI 10.1097/01.PSY.0000088585.67365.1D; Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005; OYSTER N, 1992, AGE AGEING, V21, P353, DOI 10.1093/ageing/21.5.353; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Robling AG, 2007, J BONE MINER RES, V22, P984, DOI 10.1359/JBMR.070327; Saless N, 2011, CELLS TISSUES ORGANS, V194, P244, DOI 10.1159/000324774; Saless N, 2011, BONE, V48, P647, DOI 10.1016/j.bone.2010.10.165; Saless N, 2010, BONE, V46, P1251, DOI 10.1016/j.bone.2010.01.375; Saless N, 2009, FASEB J, V23, P2142, DOI 10.1096/fj.08-118679; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Seeman E, 2001, J CLIN ENDOCR METAB, V86, P4576, DOI 10.1210/jc.86.10.4576; Shultz KL, 2003, J BONE MINER RES, V18, P175, DOI 10.1359/jbmr.2003.18.2.175; Smith LM, 2014, BONE, V67, P130, DOI 10.1016/j.bone.2014.06.035; Stassen APM, 1996, MAMM GENOME, V7, P55, DOI 10.1007/s003359900013; Streeten EA, 2006, J BONE MINER RES, V21, P1433, DOI 10.1359/JBMR.060602; Tommasini SM, 2005, J BONE MINER RES, V20, P817, DOI 10.1359/JBMR.041234; Tommasini SM, 2009, J BONE MINER RES, V24, P606, DOI [10.1359/jbmr.081224, 10.1359/JBMR.081224]; Turner CH, 2001, J BONE MINER RES, V16, P206, DOI 10.1359/jbmr.2001.16.2.206; Visscher PM, 1996, GENETICS, V144, P1923; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Xiong DH, 2006, J BONE MINER RES, V21, P1678, DOI 10.1359/JBMR.060808; Yershov Y, 2001, J BONE MINER RES, V16, P992, DOI 10.1359/jbmr.2001.16.6.992; Zhang H, 2009, OSTEOPOROSIS INT, V20, P341, DOI 10.1007/s00198-008-0668-1	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148571	10.1371/journal.pone.0148571	http://dx.doi.org/10.1371/journal.pone.0148571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849124	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000127
J	Liu, JF; Wang, DR; Xiong, Y; Liu, B; Hao, ZL; Tao, WD; Liu, M				Liu, Junfeng; Wang, Deren; Xiong, Yao; Liu, Bian; Hao, Zilong; Tao, Wendan; Liu, Ming			Association of Elevated High Sensitivity Cardiac Troponin T(hs-cTnT) Levels with Hemorrhagic Transformation and 3-Month Mortality in Acute Ischemic Stroke Patients with Rheumatic Heart Disease in China	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; T ELEVATION; FREQUENCY; DETERMINANTS; PROGNOSIS; ASSAY; RISK	Background and Objective Elevated levels of high sensitivity cardiac troponin T (hs-cTnT) occur in a substantial proportion of patients with acute ischemic stroke (AIS) and can predict poor outcome and mortality after stroke. Whether elevated hs-cTnT levels can also predict hemorrhagic transformation (HT) or prognosis in AIS patients with rheumatic heart disease (RHD) remains unclear. Methods Data from the Chengdu Stroke Registry on consecutive AIS patients with RHD admitted to West China Hospital within1 month of stroke onset from October 2011 to February 2014 were examined. Clinico-demographic characteristics, HT, functional outcomes and stroke recurrence were compared between patients with elevated hs-cTnT levels(>= 14ng/ L) and patients with normal hs-cTnT levels (<14ng/ L). Results The final analysis involved 84 patients (31 males; mean age, 61.6 +/- 12.2years), of whom serum hs-cTnT levels were elevated in 58.3%. Renal impairment was independently associated with elevated hs-cTnT levels (OR 4.184, 95% CI 1.17 to 15.01, P = 0.028), and patients with elevated hs-cTnT levels were at significantly higher risk of HT, 3-month mortality and 3-month disability/mortality (all P <= 0.029). After controlling for age, sex, hypertension, renal impairment and National Institutes of Health Stroke Scale score on admission, the risk of HT and 3-month mortality was, respectively, 4.0- and 5.5-fold higher in patients with elevated hs-cTnT levels than in patients with normal hs-cTnT levels. Conclusion Elevated hs-cTnT levels are independently associated with HT and 3-month mortality in AIS patients with RHD. These results with a small cohort should be verified and extended in large studies.	[Liu, Junfeng; Wang, Deren; Xiong, Yao; Liu, Bian; Hao, Zilong; Tao, Wendan; Liu, Ming] Sichuan Univ, West China Hosp, Dept Neurol, Stroke Clin Res Unit, Chengdu 610064, Peoples R China	Sichuan University	Liu, M (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Stroke Clin Res Unit, Chengdu 610064, Peoples R China.	wyplmh@hotmail.com	Wang, Deren/GLU-7114-2022	Wang, Deren/0000-0002-2388-3585	National Natural Science Foundation of China [81371282, 81400964]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81371282 and 81400964).	Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Amarenco P, 2011, STROKE, V42, P22, DOI 10.1161/STROKEAHA.110.584086; Ay H, 2002, STROKE, V33, P286, DOI 10.1161/hs0102.101544; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chalela JA, 2004, NEUROCRIT CARE, V1, P343, DOI 10.1385/NCC:1:3:343; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Di Angelantonio E, 2005, J NEUROL NEUROSUR PS, V76, P76, DOI 10.1136/jnnp.2004.041491; Etgen T, 2005, STROKE, V36, P270, DOI 10.1161/01.STR.0000151364.19066.a1; Faiz KW, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-96; Faiz KW, 2014, J STROKE CEREBROVASC, V23, P241, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.005; Filion KB, 2015, AM HEART J, V169, P31, DOI 10.1016/j.ahj.2014.10.005; Frankenstein L, 2011, CLIN CHEM, V57, P1068, DOI 10.1373/clinchem.2010.158964; Fure B, 2006, J INTERN MED, V259, P592, DOI 10.1111/j.1365-2796.2006.01639.x; Iltumur K, 2006, AM HEART J, V151, P1115, DOI 10.1016/j.ahj.2005.05.022; Jacobs LH, 2009, ANN CLIN BIOCHEM, V46, P283, DOI 10.1258/acb.2009.008197; James P, 2000, BRIT MED J, V320, P1502, DOI 10.1136/bmj.320.7248.1502; Jensen JK, 2012, EUR NEUROL, V68, P287, DOI 10.1159/000341340; Jensen JK, 2007, AM J CARDIOL, V99, P867, DOI 10.1016/j.amjcard.2006.10.052; Jensen JK, 2007, AM J CARDIOL, V99, P108, DOI 10.1016/j.amjcard.2006.07.071; Kral M, 2013, AM J CARDIOL, V112, P117, DOI 10.1016/j.amjcard.2013.02.067; Lankeit M, 2010, EUR HEART J, V31, P1836, DOI 10.1093/eurheartj/ehq234; Lindley Richard I, 2004, J Stroke Cerebrovasc Dis, V13, P235, DOI 10.1016/j.jstrokecerebrovasdis.2004.03.003; Liu B, 2015, CURR NEUROVASC RES; Ozdemir O, 2011, PEDIATR CARDIOL, V32, P55, DOI 10.1007/s00246-010-9814-6; Scheitz JF, 2014, INT J CARDIOL, V177, P886, DOI 10.1016/j.ijcard.2014.10.036; Scheitz JF, 2012, INT J CARDIOL, V157, P239, DOI 10.1016/j.ijcard.2012.01.055; Tan S, 2014, J NEUROL, V261, P905, DOI 10.1007/s00415-014-7297-8; Wang DR, 2012, STROKE, V43, P2853, DOI 10.1161/STROKEAHA.112.670893; Wang DR, 2011, CLIN NEUROL NEUROSUR, V113, P442, DOI 10.1016/j.clineuro.2011.01.005; Wang ZM, 2006, INT J CARDIOL, V107, P356, DOI 10.1016/j.ijcard.2005.03.048; World Health Organization, INT STAT CLASS DIS R, V10th; Wu AHB, 2007, CLIN CHEM, V53, P2086, DOI 10.1373/clinchem.2007.095679; Yoshimura S, 2008, ANN NEUROL, V64, P547, DOI 10.1002/ana.21459	34	6	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148444	10.1371/journal.pone.0148444	http://dx.doi.org/10.1371/journal.pone.0148444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849554	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000095
J	Li, M; Kandror, O; Akopian, T; Dharkar, P; Wlodawer, A; Maurizi, MR; Goldberg, AL				Li, Mi; Kandror, Olga; Akopian, Tatos; Dharkar, Poorva; Wlodawer, Alexander; Maurizi, Michael R.; Goldberg, Alfred L.			Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; COLI CLPAP PROTEASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; AXIAL CHANNEL; TRANSLOCATION; DEGRADATION; MECHANISM; PEPTIDE; BINDING	The ClpP protease complex and its regulatory ATPases, ClpC1 and ClpX, in Mycobacterium tuberculosis (Mtb) are essential and, therefore, promising drug targets. The Mtb ClpP protease consists of two heptameric rings, one composed of ClpP1 and the other of ClpP2 subunits. Formation of the enzymatically active ClpP1P2 complex requires binding of N-blocked dipeptide activators. We have found a new potent activator, benzoyl-leucine-leucine (Bz-LL), that binds with higher affinity and promotes 3-4-fold higher peptidase activity than previous activators. Bz-LL-activated ClpP1P2 specifically stimulates the ATPase activity of Mtb ClpC1 and ClpX. The ClpC1P1P2 and ClpXP1P2 complexes exhibit 2-3-fold enhanced ATPase activity, peptide cleavage, and ATP-dependent protein degradation. The crystal structure of ClpP1P2 with bound Bz-LL was determined at a resolution of 3.07 angstrom and with benzyloxycarbonyl-Leu-Leu (Z-LL) bound at 2.9 angstrom. Bz-LL was present in all 14 active sites, whereas Z-LL density was not resolved. Surprisingly, Bz-LL adopts opposite orientations in ClpP1 and ClpP2. In ClpP1, Bz-LL binds with the C-terminal leucine side chain in the S1 pocket. One C-terminal oxygen is close to the catalytic serine, whereas the other contacts backbone amides in the oxyanion hole. In ClpP2, Bz-LL binds with the benzoyl group in the S1 pocket, and the peptide hydrogen bonded between parallel beta-strands. The ClpP2 axial loops are extended, forming an open axial channel as has been observed with bound ADEP antibiotics. Thus occupancy of the active sites of ClpP allosterically alters sites on the surfaces thereby affecting the association of ClpP1 and ClpP2 rings, interactions with regulatory ATPases, and entry of protein substrates.	[Li, Mi; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Li, Mi] Frederick Natl Lab, Leidos Biomed Res, Basic Res Program, Frederick, MD 21702 USA; [Kandror, Olga; Akopian, Tatos; Goldberg, Alfred L.] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Dharkar, Poorva; Maurizi, Michael R.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Goldberg, AL (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.; Maurizi, MR (corresponding author), NCI, Bldg 37,Rm 2128,37 Convent Dr, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov; Alfred_Goldberg@hms.harvard.edu	Dharkar, Poorva/E-3367-2012		United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Diffraction data were collected on the SER-CAT 22ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38.	Akopian T, 2015, J BIOL CHEM, V290, P11008, DOI 10.1074/jbc.M114.625640; Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Alexopoulos J, 2013, MOL MICROBIOL, V90, P167, DOI 10.1111/mmi.12356; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Benaroudj N, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-61; Bewley MC, 2009, J STRUCT BIOL, V165, P118, DOI 10.1016/j.jsb.2008.10.005; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Butler SM, 2006, MOL MICROBIOL, V60, P553, DOI 10.1111/j.1365-2958.2006.05128.x; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Dahmen M, 2015, ANGEW CHEM INT EDIT, V54, P3598, DOI 10.1002/anie.201409325; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Gao W, 2015, ANTIMICROB AGENTS CH, V59, P880, DOI 10.1128/AAC.04054-14; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gersch M, 2012, J BIOL CHEM, V287, P9484, DOI 10.1074/jbc.M111.336222; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajfasz JK, 2011, MICROBIOL-SGM, V157, P2880, DOI 10.1099/mic.0.052407-0; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Lee JW, 2009, J BIOL CHEM, V284, P33475, DOI 10.1074/jbc.M109.045807; Leodolter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125345; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schmitz KR, 2014, P NATL ACAD SCI USA, V111, pE4587, DOI 10.1073/pnas.1417120111; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Turgay K, 1998, EMBO J, V17, P6730; Ye F, 2013, J BIOL CHEM, V288, P17643, DOI 10.1074/jbc.M113.452714; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848	56	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7465	7476		10.1074/jbc.M115.700344	http://dx.doi.org/10.1074/jbc.M115.700344			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858247	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000383447600022
J	Khan, S; Imran, A; Khan, AA; Abul Kalam, M; Alshamsan, A				Khan, Shahanavaj; Imran, Ahamad; Khan, Abdul Arif; Abul Kalam, Mohd; Alshamsan, Aws			Systems Biology Approaches for the Prediction of Possible Role of Chlamydia pneumoniae Proteins in the Etiology of Lung Cancer	PLOS ONE			English	Article							DNA-POLYMERASE-BETA; CHLAMYDOPHILA-PNEUMONIAE; GENOME SEQUENCES; CELL-CYCLE; INFECTION; RISK; LOCALIZATION; ASSOCIATION; INDUCTION; MISMATCH	Accumulating evidence has recently supported the association of bacterial infection with the growth and development of cancers, particularly in organs that are constantly exposed to bacteria such as the lungs, colon, cervical cancer etc. Our in silico study on the proteome of Chlamydia pneumoniae suggests an unprecedented idea of the etiology of lung cancer and have revealed that the infection of C. pneumoniae is associated with lung cancer development and growth. It is reasonable to assume that C. pneumoniae transports its proteins within host-intracellular organelles during infection, where they may work with host-cell proteome. The current study was performed for the prediction of nuclear targeting protein of C. pneumoniae in the host cell using bioinformatics predictors including ExPASy pI/Mw tool, nuclear localization signal (NLS) mapper, balanced sub cellular localization predictor (BaCeILo), and Hum-mPLoc 2.0. We predicted 47/1112 nuclear-targeting proteins of C. pneumoniae connected with several possible alterations in host replication and transcription during intracellular infection. These nuclear-targeting proteins may direct to competitive interactions of host and C. pneumoniae proteins with the availability of same substrate and may be involved as etiological agents in the growth and development of lung cancer. These novel findings are expected to access in better understanding of lung cancer etiology and identifying molecular targets for therapy.	[Khan, Shahanavaj; Khan, Abdul Arif; Abul Kalam, Mohd; Alshamsan, Aws] King Saud Univ, Coll Pharm, Dept Pharmaceut, Nanomed Res Unit, POB 2457, Riyadh 11451, Saudi Arabia; [Imran, Ahamad; Alshamsan, Aws] King Saud Univ, King Abdullah Inst Nanotechnol, POB 2455, Riyadh 11451, Saudi Arabia	King Saud University; King Saud University	Alshamsan, A (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut, Nanomed Res Unit, POB 2457, Riyadh 11451, Saudi Arabia.; Alshamsan, A (corresponding author), King Saud Univ, King Abdullah Inst Nanotechnol, POB 2455, Riyadh 11451, Saudi Arabia.	aalshamsan@ksu.edu.sa	Kalam, Mohd Abul/AAG-2864-2021; Kalam, Mohd Abul/ABA-9199-2020; Alshamsan, Aws/D-2569-2015; Khan, Abdul Arif/F-1938-2018; Khan, Shahanavaj/F-1032-2019	Kalam, Mohd Abul/0000-0002-5713-8858; Kalam, Mohd Abul/0000-0002-5713-8858; Alshamsan, Aws/0000-0002-8950-6571; Khan, Abdul Arif/0000-0002-8748-1841	Research Groups Program (Research Group), Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia [RG-1436-027]	Research Groups Program (Research Group), Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	This project was funded by the Research Groups Program (Research Group number RG-1436-027), Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.	Chaturvedi AK, 2010, CANCER EPIDEM BIOMAR, V19, P1498, DOI 10.1158/1055-9965.EPI-09-1261; Chu DJ, 2012, ASIAN PAC J CANCER P, V13, P2819, DOI 10.7314/APJCP.2012.13.6.2819; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Eickhoff M, 2007, INFECT IMMUN, V75, P2853, DOI 10.1128/IAI.01045-06; Gisserot O, 2014, REV MED INTERNE, V35, P259, DOI 10.1016/j.revmed.2013.11.014; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; HATTORI H, 1992, CELL STRUCT FUNCT, V17, P77, DOI 10.1247/csf.17.77; Hess S, 2003, CELL MICROBIOL, V5, P785, DOI 10.1046/j.1462-5822.2003.00319.x; Jackson LA, 2000, CANCER EPIDEM BIOMAR, V9, P1263; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; KARIN M, 1990, New Biologist, V2, P126; Kocazeybek B, 2003, J MED MICROBIOL, V52, P721, DOI 10.1099/jmm.0.04845-0; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Koyi H, 2001, APMIS, V109, P572, DOI 10.1034/j.1600-0463.2001.d01-177.x; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Laurila AL, 1997, INT J CANCER, V74, P31, DOI 10.1002/(SICI)1097-0215(19970220)74:1&lt;31::AID-IJC6&gt;3.0.CO;2-1; LEONARDI E, 1992, J CLIN PATHOL, V45, P416, DOI 10.1136/jcp.45.5.416; Lin TY, 2014, LUNG, V192, P159, DOI 10.1007/s00408-013-9523-z; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; Littman AJ, 2004, CANCER EPIDEM BIOMAR, V13, P1624; Mojica SA, 2015, MOL BIOL CELL, V26, P1918, DOI 10.1091/mbc.E14-11-1530; Mote J, 1998, J BIOL CHEM, V273, P16843, DOI 10.1074/jbc.273.27.16843; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Redecke V, 1998, AM J RESP CELL MOL, V19, P721, DOI 10.1165/ajrcmb.19.5.3072; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shirai M, 2000, NUCLEIC ACIDS RES, V28, P2311, DOI 10.1093/nar/28.12.2311; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith JS, 2008, INT J CANCER, V123, P2469, DOI 10.1002/ijc.23814; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Su ECY, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S13; Suzuki M, 2013, MUTAT RES-FUND MOL M, V743, P111, DOI 10.1016/j.mrfmmm.2012.07.003; Tan XH, 2015, INT J BIOL SCI, V11, P144, DOI 10.7150/ijbs.10692; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang SC, 2014, TRENDS PHARMACOL SCI, V35, P178, DOI 10.1016/j.tips.2014.02.004; World Health Organization, 2012, GLOBOCAN 2012 EST CA; Yang J, 2003, INFECT IMMUN, V71, P614, DOI 10.1128/IAI.71.2.614-620.2003; Zhan P, 2011, EUR J CANCER, V47, P742, DOI 10.1016/j.ejca.2010.11.003	46	24	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148530	10.1371/journal.pone.0148530	http://dx.doi.org/10.1371/journal.pone.0148530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871581	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100034
J	Laliberte, C; Dunn, S; Pound, C; Sourial, N; Yasseen, AS; Millar, D; White, RR; Walker, M; Lacaze-Masmonteil, T				Laliberte, Corinne; Dunn, Sandra; Pound, Catherine; Sourial, Nadia; Yasseen, Abdool S., III; Millar, David; White, Ruth Rennicks; Walker, Mark; Lacaze-Masmonteil, Thierry			A Randomized Controlled Trial of Innovative Postpartum Care Model for Mother-Baby Dyads	PLOS ONE			English	Article							FEEDING SELF-EFFICACY; MATERNAL RECALL; HOME VISITS; SUPPORT; DISCHARGE; INFANTS; WORKERS; SCALE	Objective To evaluate the efficacy, safety, and maternal satisfaction of a newly established integrative postpartum community-based clinic providing comprehensive support for mothers during the first month after discharge from the hospital. Our primary interests were breastfeeding rates, readmission and patient satisfaction. Methods A randomized controlled trial was conducted in Ottawa, Canada, where 472 mothers were randomized via a 1: 2 ratio to either receive standard of care (n = 157) or to attend the postpartum breastfeeding clinic (n = 315). Outcome data were captured through questionnaires completed by the participants at 2, 4, 12 and 24 weeks postpartum. Unadjusted and adjusted logistic regression models were conducted to determine the effect of the intervention on exclusive breastfeeding at 12 weeks (primary outcome). Secondary outcomes included breastfeeding rate at 2, 4 and 24 weeks, breastfeeding self-efficacy scale, readmission rate, and satisfaction score. Results More mothers in the intervention group (n = 195, 66.1%) were exclusively breastfeeding at 12 weeks compared to mothers in the control group (n = 81, 60.5%), however no statistically significant difference was observed (OR = 1.28; 95% CI: 0.84-1.95)). The rate of emergency room visits at 2 weeks for the intervention group was 11.4% compared to the standard of care group (15.2%) (OR = 0.69; 95% CI: 0.39-1.23). The intervention group was significantly more satisfied with the overall care they received for breastfeeding compared to the control group (OR = 1.96; 95% CI: 3.50-6.88)). Conclusion This new model of care did not significantly increase exclusive breastfeeding at 12 weeks. However, there were clinically meaningful improvements in the rate of postnatal problems and satisfaction that support this new service delivery model for postpartum care. A community-based multidisciplinary postpartum clinic is feasible to implement and can provide appropriate and highly satisfactory care to mother-baby dyads. This model of care may be more beneficial in a population that is not already predisposed to breastfeed.	[Laliberte, Corinne; Dunn, Sandra; Pound, Catherine; Sourial, Nadia; Yasseen, Abdool S., III; Lacaze-Masmonteil, Thierry] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Dunn, Sandra; Yasseen, Abdool S., III] Better Outcomes Registry & Network Ontario, Ottawa, ON, Canada; [Pound, Catherine; Lacaze-Masmonteil, Thierry] Univ Ottawa, Dept Paediat, Ottawa, ON, Canada; [Millar, David] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [White, Ruth Rennicks; Walker, Mark] Ottawa Hosp, Res Inst, Obstet & Maternal Newborn Invest, Ottawa, ON, Canada; [Walker, Mark] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Lacaze-Masmonteil, T (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.; Lacaze-Masmonteil, T (corresponding author), Univ Ottawa, Dept Paediat, Ottawa, ON, Canada.	tlacaze@cheo.on.ca		Yasseen, Abdool S./0000-0001-9814-9249	Ontario Ministry of Health and Long-Term Care	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	All phases of this study were supported by the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funds were distributed to and managed by the Children's Hospital of Eastern Ontario Research Institute, The Ottawa Hospital Research Institute, and BORN.	Abbass-Dick J, 2015, PEDIATRICS, V135, P102, DOI 10.1542/peds.2014-1416; [Anonymous], 2010, IND ASS INF CHILD FE; [Anonymous], 2013, QUAL BAS PROC CLIN H; Bilirubin Screening and Management of Hyperbilirubinemia, 2006, BIL SCREEN MAN HYP; Blyth RJ, 2004, J HUM LACT, V20, P30, DOI 10.1177/0890334403261109; Busch DW, 2014, J PEDIATR HEALTH CAR, V28, P486, DOI 10.1016/j.pedhc.2014.02.007; Cheng CY, 2006, J PERINAT EDUC, V15, P34, DOI 10.1624/105812406X119002; City of Ottawa PH, 2005, INF CAR SURV; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Darj E, 2000, UPSALA J MED SCI, V105, P57, DOI 10.1517/03009734000000047; Dennis CL, 2003, JOGNN-J OBST GYN NEO, V32, P734, DOI 10.1177/0884217503258459; Souza EFD, 2014, ACTA PAUL ENFERM, V27, P465, DOI 10.1590/1982-0194201400076; Dodge KA, 2014, AM J PUBLIC HEALTH, V104, pS136, DOI 10.2105/AJPH.2013.301361; Escobar GJ, 2001, PEDIATRICS, V108, P719, DOI 10.1542/peds.108.3.719; Jolly K, 2012, MIDWIFERY, V28, P740, DOI 10.1016/j.midw.2011.08.005; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; LAUNER LJ, 1992, J EPIDEMIOL COMMUN H, V46, P203, DOI 10.1136/jech.46.3.203; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Mannan I, 2008, J PERINATOL, V28, P632, DOI 10.1038/jp.2008.64; Morrell CJ, 2000, BRIT MED J, V321, P593, DOI 10.1136/bmj.321.7261.593; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Parry JE, 2013, J HUM LACT, V29, P527, DOI 10.1177/0890334412474719; Paul IM, 2012, ARCH PEDIAT ADOL MED, V166, P263, DOI 10.1001/archpediatrics.2011.198; Pound CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119624; Pound CM, 2009, PAED CHILD HEALT-CAN, V14, P445, DOI 10.1093/pch/14.7.445; Public Health Agency of Canada, 2009, WHAT MOTH SAY CAN MA, P173; Quarles A, 1994, Matern Child Nurs J, V22, P102; Scott J A, 1999, Breastfeed Rev, V7, P5; Seagraves Kendra, 2013, Nurs Womens Health, V17, P498, DOI 10.1111/1751-486X.12078; Statistics Canada, CAN COMM HLTH SURV C; Steel O, 2002, CAN J PUBLIC HLTH, V94, P98; Stuebe AM, 2014, OBSTET GYNECOL, V123, P643, DOI 10.1097/AOG.0000000000000142; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; Wheeler BJ, 2013, JOGNN-J OBST GYN NEO, V42, P70, DOI 10.1111/j.1552-6909.2012.01431.x; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; World Health Organization, 2014, WHO REC POSTN CAR MO; Yang C, 2012, J PAEDIATR CHILD H, V48, P931, DOI 10.1111/j.1440-1754.2012.02519.x; Yang WC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-145	38	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148520	10.1371/journal.pone.0148520	http://dx.doi.org/10.1371/journal.pone.0148520			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871448	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100033
J	Vandewalle, B; Llibre, JM; Parienti, JJ; Ustianowski, A; Camacho, R; Smith, C; Miners, A; Ferreira, D; Felix, J				Vandewalle, Bjoern; Llibre, Josep M.; Parienti, Jean-Jacques; Ustianowski, Andrew; Camacho, Ricardo; Smith, Colette; Miners, Alec; Ferreira, Diana; Felix, Jorge			EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISOPROXIL FUMARATE; INITIAL TREATMENT; DRUG-RESISTANCE; INFECTED ADULTS; VIRAL LOAD; ADHERENCE; MORTALITY; MEDICATION; PROGRAM	The goal of this research was to establish a new and innovative framework for cost-effectiveness modeling of HIV-1 treatment, simultaneously considering both clinical and epidemiological outcomes. EPICE-HIV is a multi-paradigm model based on a within-host microsimulation model for the disease progression of HIV-1 infected individuals and an agentbased sexual contact network (SCN) model for the transmission of HIV-1 infection. It includes HIV-1 viral dynamics, CD4(+) T cell infection rates, and pharmacokinetics/pharmacodynamics modeling. Disease progression of HIV-1 infected individuals is driven by the interdependent changes in CD4(+) T cell count, changes in plasma HIV-1 RNA, accumulation of resistance mutations and adherence to treatment. The two parts of the model are joined through a per-sexual-act and viral load dependent probability of disease transmission in HIV-discordant couples. Internal validity of the disease progression part of the model is assessed and external validity is demonstrated in comparison to the outcomes observed in the STaR randomized controlled clinical trial. We found that overall adherence to treatment and the resulting pattern of treatment interruptions are key drivers of HIV-1 treatment outcomes. Our model, though largely independent of efficacy data from RCT, was accurate in producing 96-week outcomes, qualitatively and quantitatively comparable to the ones observed in the STaR trial. We demonstrate that multi-paradigm micro-simulation modeling is a promising tool to generate evidence about optimal policy strategies in HIV-1 treatment, including treatment efficacy, HIV-1 transmission, and cost-effectiveness analysis.	[Vandewalle, Bjoern; Ferreira, Diana; Felix, Jorge] Exigo Consultores, Lisbon, Portugal; [Llibre, Josep M.] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio Lluita SIDA, E-08193 Barcelona, Spain; [Parienti, Jean-Jacques] Cote de Nacre Univ Hosp, Dept Clin Res & Biostat, Caen, France; [Ustianowski, Andrew] North Manchester Gen Hosp, Reg Infect Dis Unit, Manchester, Lancs, England; [Camacho, Ricardo] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Smith, Colette] UCL, Dept Infect & Populat Hlth, London, England; [Miners, Alec] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; CHU de Caen NORMANDIE; Universite de Caen Normandie; KU Leuven; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Felix, J (corresponding author), Exigo Consultores, Lisbon, Portugal.	jorge.felix@exigoconsultores.com	Parienti, Jean-Jacques/AAD-1701-2021	Parienti, Jean-Jacques/0000-0002-4774-5590; Smith, Colette/0000-0003-2847-3355; Felix, Jorge/0000-0003-0544-0323; Ustianowski, Andrew/0000-0002-6134-7855	Gilead	Gilead(Gilead Sciences)	Gilead contracted with Exigo for the development of the model and its validation using STaR clinical trial data. Gilead also made STaR study data available for external model validation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Exigo Consultores provided support in the form of salaries for authors BV, DF, JF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Administration DoHaA-TG, 2012, AUSTR PUBL ASS REP R, V2012; Aragao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044774; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2008, J INFECT DIS, V197, pS272, DOI 10.1086/533415; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bonora S, 2009, J MED VIROL, V81, P400, DOI 10.1002/jmv.21405; Braithwaite RS, 2007, VALUE HEALTH, V10, P204, DOI 10.1111/j.1524-4733.2007.00170.x; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266; Cohen C, 2014, ICAAC; Cohen C, 2014, AIDS, V28, P989, DOI 10.1097/QAD.0000000000000169; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; Frentz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094495; Gardner EM, 2009, AIDS, V23, P1035, DOI 10.1097/QAD.0b013e32832ba8ec; Goujard C, 2003, JAIDS-J ACQ IMM DEF, V34, P191, DOI 10.1097/00126334-200310010-00009; Gras G, 2012, JAIDS-J ACQ IMM DEF, V61, P265, DOI 10.1097/QAI.0b013e31826cc592; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Kessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073269; Krakovska O, 2007, J THEOR BIOL, V246, P499, DOI 10.1016/j.jtbi.2006.12.038; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Parienti JJ, 2010, CLIN INFECT DIS, V50, P1192, DOI 10.1086/651419; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Pearson CR, 2007, AIDS CARE, V19, P594, DOI 10.1080/09540120701203337; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Pradier C, 2003, HIV CLIN TRIALS, V4, P121; Programs DoHaS, 2014, HIV CAR TREATM SERV; Raffi F, 2015, J ANTIMICROB CHEMOTH, V70, P2121, DOI 10.1093/jac/dkv083; Ramkissoon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049492; Rawlings MK, 2003, JAIDS-J ACQ IMM DEF, V34, P174, DOI 10.1097/00126334-200310010-00007; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Schmid BV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002470; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Smith SR, 2003, PATIENT EDUC COUNS, V50, P187; Society EAC, 2014, GUID VERS 7 1; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Vercauteren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061436; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; World Health Organization, 2013, CONSOLIDATED GUIDELI; Young B, 2014, 20 INT AIDS C 2014 J	55	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149007	10.1371/journal.pone.0149007	http://dx.doi.org/10.1371/journal.pone.0149007			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26870960	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000370054100086
J	Hedrick, MS; Moon, IJ; Woo, J; Won, JH				Hedrick, Mark S.; Moon, Il Joon; Woo, Jihwan; Won, Jong Ho			Effects of Physiological Internal Noise on Model Predictions of Concurrent Vowel Identification for Normal-Hearing Listeners	PLOS ONE			English	Article							AUDITORY-NERVE RESPONSES; DIFFERENT FUNDAMENTAL FREQUENCIES; COCKTAIL PARTY PROBLEM; PHENOMENOLOGICAL MODEL; NEURAL REPRESENTATION; OLIVOCOCHLEAR REFLEX; SPEECH-PERCEPTION; CORTICAL-NEURONS; CORTEX; ENHANCEMENT	Previous studies have shown that concurrent vowel identification improves with increasing temporal onset asynchrony of the vowels, even if the vowels have the same fundamental frequency. The current study investigated the possible underlying neural processing involved in concurrent vowel perception. The individual vowel stimuli from a previously published study were used as inputs for a phenomenological auditory-nerve (AN) model. Spectrotemporal representations of simulated neural excitation patterns were constructed (i.e., neurograms) and then matched quantitatively with the neurograms of the single vowels using the Neurogram Similarity Index Measure (NSIM). A novel computational decision model was used to predict concurrent vowel identification. To facilitate optimum matches between the model predictions and the behavioral human data, internal noise was added at either neurogram generation or neurogram matching using the NSIM procedure. The best fit to the behavioral data was achieved with a signal-to-noise ratio (SNR) of 8 dB for internal noise added at the neurogram but with a much smaller amount of internal noise (SNR of 60 dB) for internal noise added at the level of the NSIM computations. The results suggest that accurate modeling of concurrent vowel data from listeners with normal hearing may partly depend on internal noise and where internal noise is hypothesized to occur during the concurrent vowel identification process.	[Hedrick, Mark S.; Won, Jong Ho] Univ Tennessee, Hlth Sci Ctr, Dept Audiol & Speech Pathol, Knoxville, TN USA; [Moon, Il Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Woo, Jihwan] Univ Ulsan, Dept Biomed Engn, Ulsan 680749, South Korea	University of Tennessee System; University of Tennessee Health Science Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan	Woo, J (corresponding author), Univ Ulsan, Dept Biomed Engn, Ulsan 680749, South Korea.	jhwoo@ulsan.ac.kr						Alain C, 2005, J COGNITIVE NEUROSCI, V17, P811, DOI 10.1162/0898929053747621; Arehart KH, 2011, J SPEECH LANG HEAR R, V54, P190, DOI 10.1044/1092-4388(2010/09-0145); ASSMANN PF, 1990, J ACOUST SOC AM, V88, P680, DOI 10.1121/1.399772; Assmann PF, 1996, J ACOUST SOC AM, V100, P1141, DOI 10.1121/1.416299; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bregman AS, 1990, AUDITORY SCENE ANAL, p[65, 396, 491, 594, 625]; Bruce IC, 2003, J ACOUST SOC AM, V113, P369, DOI 10.1121/1.1519544; Chintanpalli A, 2014, JARO-J ASSOC RES OTO, V15, P823, DOI 10.1007/s10162-014-0475-7; Chintanpalli A, 2013, J ACOUST SOC AM, V134, P2988, DOI 10.1121/1.4820888; Chintanpalli A, 2012, JARO-J ASSOC RES OTO, V13, P219, DOI 10.1007/s10162-011-0310-3; CULLING JF, 1994, J ACOUST SOC AM, V95, P1559, DOI 10.1121/1.408543; de Cheveigne A, 1999, J ACOUST SOC AM, V106, P327, DOI 10.1121/1.427059; DECHEVEIGNE A, 1995, J ACOUST SOC AM, V97, P3736, DOI 10.1121/1.412389; deCheveigne A, 1997, J ACOUST SOC AM, V101, P2857, DOI 10.1121/1.419480; Doi E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003761; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Fishman YI, 2014, J NEUROSCI, V34, P12425, DOI 10.1523/JNEUROSCI.0025-14.2014; Fishman YI, 2013, J NEUROSCI, V33, P10312, DOI 10.1523/JNEUROSCI.0020-13.2013; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Goldwyn JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002247; HALL JW, 1994, J ACOUST SOC AM, V96, P150, DOI 10.1121/1.410474; Handel S., 1989, LISTENING INTRO PERC, p[190, 235, 259, 521]; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Haykin S, 2005, NEURAL COMPUT, V17, P1875, DOI 10.1162/0899766054322964; Hedrick MS, 2009, J SPEECH LANG HEAR R, V52, P696, DOI 10.1044/1092-4388(2008/07-0094); Hines A, 2012, SPEECH COMMUN, V54, P306, DOI 10.1016/j.specom.2011.09.004; Hines A, 2010, SPEECH COMMUN, V52, P736, DOI 10.1016/j.specom.2010.04.006; Javel E, 2000, J ACOUST SOC AM, V107, P908, DOI 10.1121/1.428269; Jones PR, 2013, J ACOUST SOC AM, V133, P970, DOI 10.1121/1.4773864; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Lentz JJ, 2006, J SPEECH LANG HEAR R, V49, P1354, DOI 10.1044/1092-4388(2006/097); LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Manjarrez E, 2003, J NEUROSCI, V23, P1997; McClelland JL, 2006, TRENDS COGN SCI, V10, P363, DOI 10.1016/j.tics.2006.06.007; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; MEDDIS R, 1992, J ACOUST SOC AM, V91, P233, DOI 10.1121/1.402767; Mesgarani N, 2014, P NATL ACAD SCI USA, V111, P6792, DOI 10.1073/pnas.1318017111; Miller P, 2010, J NEUROSCI, V30, P2559, DOI 10.1523/JNEUROSCI.3047-09.2010; Moon IJ, 2014, J NEUROSCI, V34, P12145, DOI 10.1523/JNEUROSCI.1025-14.2014; Norris D, 2000, BEHAV BRAIN SCI, V23, P299, DOI 10.1017/S0140525X00003241; SCHEFFERS MTM, 1983, THESIS U GRONINGEN; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P492, DOI 10.1016/j.cogbrainres.2005.03.002; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V336, P357, DOI 10.1098/rstb.1992.0069; SUMMERFIELD Q, 1989, PERCEPT PSYCHOPHYS, V45, P529, DOI 10.3758/BF03208060; Tan Q, 2003, J ACOUST SOC AM, V114, P2007, DOI 10.1121/1.1608963; Valentine S, 2012, J SPEECH LANG HEAR R, V55, P1750, DOI 10.1044/1092-4388(2012/11-0033); Vinay, 2007, INT J AUDIOL, V46, P39, DOI 10.1080/14992020601077992; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang XD, 2001, J ACOUST SOC AM, V109, P648, DOI 10.1121/1.1336503; Zilany MSA, 2009, J ACOUST SOC AM, V126, P2390, DOI 10.1121/1.3238250	54	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149128	10.1371/journal.pone.0149128	http://dx.doi.org/10.1371/journal.pone.0149128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866811	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700069
J	Chalub, LLFH; Martins, CC; Ferreira, RC; Vargas, AMD				Chalub, Loliza L. F. H.; Martins, Carolina C.; Ferreira, Raquel C.; Vargas, Andrea M. D.			Functional Dentition in Brazilian Adults: An Investigation of Social Determinants of Health (SDH) Using a Multilevel Approach	PLOS ONE			English	Article							CHEWING ABILITY; DENTAL-CARIES; POPULATION; ASSOCIATION; INEQUALITIES	Objectives Estimate the prevalence of functional dentition among Brazilian adults using four different definitions and identify associated factors. Methods A cross-sectional study was conducted involving 9564 Brazilian adults aged 35-44 years who participated in the 2010 National Oral Health Survey. Data collection involved oral examinations and the administration of questionnaires. The following definitions were used: 1-WHO Functional Dentition (FDWHO: >= 20 teeth present); 2-well-distributed teeth (WDT: >= 10 teeth in each arch); 3-Functional dentition classified by esthetics and occlusion (FDClass5: dentitions that sequentially exhibit at least one tooth in each arch, at least 10 teeth in each arch, all maxillary and mandibular anterior teeth, three or four premolar posterior occluding pairs [POPs], and at least one molar POP bilaterally); 4-Functional dentition classified by esthetics, occlusion and periodontal status (FDClass6: corresponds to FDClass5 with the addition of periodontal status of all sextants in the oral cavity with, at most, shallow pockets and/or clinical attachment level of 5 mm (CPI <= 3 and/or CAL <= 1). The independent variables were individual factors (gender, self-declared skin color, schooling, monthly household income, age group, self-rated treatment need, dental pain, dental appointment in the previous 12 months and dental services) and contextual factors (Municipal Human Development Index [MHDI]), Gini coefficient, fluoridated water supply and oral health coverage). Multilevel mixed-effect Poisson regression analyses were performed. Results The prevalence of functional dentition based on the FDWHO, WDT, FDClass5 and FDClass6 definitions was 77.9%, 72.9%, 42.6% and 40.3%, respectively. Adults with >= 12 years of schooling and monthly household income from US$ 853 to 2557 had higher prevalence rates of FDWHO (PR: 1.41 and 1.10, respectively), WDT (PR: 1.58 and 1.14, respectively), FDClass5 (PR: 2.03 and 1.27, respectively) and FDClass6 (PR: 2.15 and 1.35, respectively). These values in the final models were adjusted for gender, self-declared skin color (FDClass5), age group, self-rated treatment need (FDWHO, FDClass5 and FDClass6), dental appointment in the previous 12 months (FDWHO and WDT), dental services (FDWHO and WDT) and contextual factors. A very high MHDI and presence of fluoridated water supply were associated with higher prevalence rates of the four outcomes. Conclusions The incorporation of the criteria of new definitions of functional dentition led to a lower prevalence rate among Brazilian adults. Striking individual and contextual inequalities were identified with regard to the four definitions analyzed, which need to be addressed through inter-sector efforts.	[Chalub, Loliza L. F. H.; Ferreira, Raquel C.; Vargas, Andrea M. D.] Univ Fed Minas Gerais, Sch Dent, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil; [Martins, Carolina C.] Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Chalub, LLFH (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil.	lolischalub@gmail.com	Martins, Carolina/AFD-8433-2022; Martins, Carolina Castro/O-2514-2014; Ferreira, Raquel Conceição/J-5236-2015	Martins, Carolina/0000-0001-9072-3226; Martins, Carolina Castro/0000-0001-9072-3226; Ferreira, Raquel Conceição/0000-0001-8897-9345; VARGAS, ANDREA/0000-0002-4371-9862	FAPEMIG; CNPq	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the Brazilian fostering agencies FAPEMIG and CNPq for funding the publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CONCEPTUAL FRAMEWORK; Bernabe E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104808; Celeste RK, 2014, CAD SAUDE PUBLICA, V30, P511, DOI 10.1590/0102-311X00011913; Celeste RK, 2013, COMMUNITY DENT ORAL, V41, P509, DOI 10.1111/cdoe.12051; Chalub LLFH, 2016, CLIN ORAL INVEST, V20, P1567, DOI 10.1007/s00784-015-1637-7; da Silva NN, 2013, REV SAUDE PUBL, V47, P3, DOI 10.1590/S0034-8910.2013047004362; Damyanov ND, 2013, CLIN ORAL INVEST, V17, P2139, DOI 10.1007/s00784-013-0925-3; [Departamento de Atencao Basica Ministery of Health (BR) Secretaria de Atencao a Saude], 2004, PROJ SB BRAS 2003 CO; do Nascimento S, 2013, REV SAUDE PUBL, V47, P69, DOI 10.1590/S0034-8910.2013047004288; Chalub LLFH, 2014, COMMUNITY DENT ORAL, V42, P503, DOI 10.1111/cdoe.12112; Hobdell M, 2003, INT DENT J, V53, P285, DOI 10.1111/j.1875-595X.2003.tb00761.x; IBGE, 2008, PESQ NAC SAN BAS; [International Association for Dental Research World Health Organization], 1993, 4 WORLD C PREV DENT; Koltermann AP, 2011, CAD SAUDE PUBLICA, V27, P173, DOI 10.1590/S0102-311X2011000100018; Freire MDM, 2013, REV SAUDE PUBL, V47, P40, DOI 10.1590/S0034-8910.2013047004322; Ministery of Health (BR), IND DES SIST UN SAUD; Ministery of Health (BR), 2004, DIR POL NAC SAUD BUC; Ministery of Health (BR) Secretaria de Vigilancia em Saude, 2011, SB BRAS 2010 PESQ NA; Nguyen TC, 2011, INT J PROSTHODONT, V24, P428; Nguyen TC, 2011, INT J PROSTHODONT, V24, P30; Nguyen TC, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-2; Okada T, 2014, J ORAL REHABIL, V41, P912, DOI 10.1111/joor.12214; Peres MA, 2013, REV SAUDE PUBLICA S3, V47, P1; Petersen PE, 2004, COMMUNITY DENT ORAL, V32, P319, DOI 10.1111/j.1600-0528.2004.00175.x; Programa das Nacoes Unidas para o Desenvolvimento, 2013, IND DES HUM MUN BRAS; Roncalli AG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1097; Roncalli AG, 2012, CAD SAUDE PUBLICA, V28, pS40, DOI 10.1590/S0102-311X2012001300006; Sabbah W, 2007, J DENT RES, V86, P992, DOI 10.1177/154405910708601014; UNDP, 2011, HUM DEV REP 2011 SUS; United Nations Development Programme, 2013, BRAZ ATL HUM DEV; Vettore MV, 2013, REV SAUDE PUBL, V47, P29, DOI 10.1590/S0034-8910.2013047004422; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Watt RG, 2012, COMMUNITY DENT ORAL, V40, P289, DOI 10.1111/j.1600-0528.2012.00680.x; WHO, 2011, P WORLD C SOC DET HL; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; World Health Organization (WHO), 1992, REC ADV OR HLTH WHO; Zhang Q, 2013, CLIN ORAL INVEST, V17, P1471, DOI 10.1007/s00784-012-0834-x; Zhang Q, 2013, CLIN ORAL INVEST, V17, P1425, DOI 10.1007/s00784-012-0822-1; Zhang Q, 2012, CLIN ORAL INVEST, V16, P1251, DOI 10.1007/s00784-011-0616-x	39	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148859	10.1371/journal.pone.0148859	http://dx.doi.org/10.1371/journal.pone.0148859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862892	Green Published, gold			2022-12-26	WOS:000370046600116
J	Gallagher, AM; Williams, T; Leufkens, HGM; de Vries, F				Gallagher, Arlene M.; Williams, Tim; Leufkens, Hubert G. M.; de Vries, Frank			The Impact of the Choice of Data Source in Record Linkage Studies Estimating Mortality in Venous Thromboembolism	PLOS ONE			English	Article							RISK; VALIDITY; VALIDATION; FRACTURE; CODES	Linked electronic healthcare databases are increasingly being used in observational research. The objective of this study was to investigate the impact of the choice of data source in estimating mortality following VTE, with a secondary aim to investigate the influence of the denominator definition. We used the UK Clinical Practice Research Datalink (CPRD) to identify patients aged 18+ with venous thromboembolism (VTE). Multiple cohorts were identified in order to assess how mortality rates differed with a range of data sources. For each of the cohorts, incidence rates per 1,000 person years (/1000py) and relative rates (RRs) of all-cause mortality were calculated. The lowest mortality rate was found when only primary care data were used for both the exposure (VTE) and the outcome (death) (108.4/1000py). The highest mortality rate was found for patients diagnosed in secondary care (237.2/1000py). When linked primary and secondary care data were included for eligible patients and for the overlapping period of data collection, a mortality rate of 173.2/1000py was found. Sensitivity analyses varying the denominator definition provided a range of results (140.6-164.3/1000py). The relative rates of mortality by gender and age were comparable across all cohorts. Depending on the choice of data source, the population studied may be different. This may have substantial impact on the main findings, in particular on incidence rates of mortality following VTE.	[Gallagher, Arlene M.; Williams, Tim] Med & Healthcare Prod Regulatory Agcy, Clin Practice Res Datalink, London, England; [Gallagher, Arlene M.; Leufkens, Hubert G. M.; de Vries, Frank] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	The Medicines & Healthcare Products Regulatory Agency; Utrecht University	Gallagher, AM (corresponding author), Med & Healthcare Prod Regulatory Agcy, Clin Practice Res Datalink, London, England.; Gallagher, AM (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	arlene.gallagher@cprd.com	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319	IMI; TI Pharma; Netherlands Organisation for Health Research and Development (ZonMW); EU; Dutch Medicines Evaluation Board (MEB); National Health Care Institute (ZIN); Dutch Ministry of Health	IMI; TI Pharma; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); EU(European Commission); Dutch Medicines Evaluation Board (MEB); National Health Care Institute (ZIN); Dutch Ministry of Health	The authors received no specific funding for this work. Bert Leufkens receives no direct funding or donations from private parties, including the pharmaceutical industry. Research funding from public-private partnerships, i.e. IMI and TI Pharma (www.tipharma.nl), has been accepted under the condition that no company-specific product or company related study is conducted. He has received unrestricted research funding from public sources, i.e. the Netherlands Organisation for Health Research and Development (ZonMW), the EU 7th Framework Program (FP7), the Dutch Medicines Evaluation Board (MEB), the National Health Care Institute (ZIN) and the Dutch Ministry of Health.	Bazelier MT, 2012, NEUROLOGY, V79, P922, DOI 10.1212/WNL.0b013e318266faae; Bazelier MT, 2012, MULT SCLER J, V18, P628, DOI 10.1177/1352458511426737; Bazelier MT, 2011, J BONE MINER RES, V26, P2271, DOI 10.1002/jbmr.418; Gallagher AM, 2012, CLIN APPL THROMB-HEM, V18, P370, DOI 10.1177/1076029611426139; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Herrett E., 2015, INT J EPIDEMIOL; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; HSCIC, HOSP EP STAT; HSCIC, MORT DAT OFF NAT STA; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Huerta C, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-10; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lo Re V, 2013, PHARMACOEPIDEM DR S, V22, P861, DOI 10.1002/pds.3470; Movig KLL, 2003, J CLIN EPIDEMIOL, V56, P530, DOI 10.1016/S0895-4356(03)00006-4; Robertson LM, 2014, HLTH INFORM J; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	17	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148349	10.1371/journal.pone.0148349	http://dx.doi.org/10.1371/journal.pone.0148349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863417	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600058
J	Sroka, J; Krecioch, I; Zimolag, E; Lasota, S; Rak, M; Kedracka-Krok, S; Borowicz, P; Gajek, M; Madeja, Z				Sroka, Jolanta; Krecioch, Izabela; Zimolag, Eliza; Lasota, Slawomir; Rak, Monika; Kedracka-Krok, Sylwia; Borowicz, Pawel; Gajek, Marta; Madeja, Zbigniew			Lamellipodia and Membrane Blebs Drive Efficient Electrotactic Migration of Rat Walker Carcinosarcoma Cells WC 256	PLOS ONE			English	Article							CURRENT ELECTRIC-FIELD; DIRECTIONAL MIGRATION; DICTYOSTELIUM CELLS; HUMAN KERATINOCYTES; CALCIUM-IONS; FOLIC-ACID; GALVANOTAXIS; CHEMOTAXIS; SHAPE; LOCOMOTION	The endogenous electric field (EF) may provide an important signal for directional cell migration during wound healing, embryonic development and cancer metastasis but the mechanism of cell electrotaxis is poorly understood. Additionally, there is no research addressing the question on the difference in electrotactic motility of cells representing various strategies of cell movement-specifically blebbing vs. lamellipodial migration. In the current study we constructed a unique experimental model which allowed for the investigation of electrotactic movement of cells of the same origin but representing different modes of cell migration: weakly adherent, spontaneously blebbing (BC) and lamellipodia forming (LC) WC256 cells. We report that both BC and LC sublines show robust cathodal migration in a physiological EF (1-3 V/cm). The directionality of cell movement was completely reversible upon reversing the field polarity. However, the full reversal of cell direction after the change of EF polarity was much faster in the case of BC (10 minutes) than LC cells (30 minutes). We also investigated the distinct requirements for Rac, Cdc42 and Rho pathways and intracellular Ca2+ in electrotaxis of WC256 sublines forming different types of cell protrusions. It was found that Rac1 is required for directional movement of LC to a much greater extent than for BC, but Cdc42 and RhoA are more crucial for BC than for LC cells. The inhibition of ROCK did not affect electrotaxis of LC in contrast to BC cells. The results also showed that intracellular Ca2+ is essential only for the electrotactic reaction of BC cells. Moreover, inhibition of MLCK and myosin II did not affect the electrotaxis of LC in contrast to BC cells. In conclusion, our results revealed that both lamellipodia and membrane blebs can efficiently drive electrotactic migration of WC 256 carcinosarcoma cells, however directional migration is mediated by different signalling pathways.	[Sroka, Jolanta; Krecioch, Izabela; Zimolag, Eliza; Lasota, Slawomir; Rak, Monika; Borowicz, Pawel; Gajek, Marta; Madeja, Zbigniew] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Gronostajowa 7, PL-30387 Krakow, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Gronostajowa 7, PL-30387 Krakow, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Malopolska Ctr Biotechnol, Gronostajowa 7b, PL-30387 Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University	Sroka, J; Madeja, Z (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Gronostajowa 7, PL-30387 Krakow, Poland.	jolanta.sroka@uj.edu.pl; z.madeja@uj.edu.pl	; Rak, Monika/U-7025-2018	Sroka, Jolanta/0000-0003-3728-752X; Zimolag, Eliza/0000-0003-4104-0095; Krecioch, Izabela/0000-0002-3629-8123; Madeja, Zbigniew/0000-0002-5523-1215; Borowicz, Pawel/0000-0002-5604-5844; Rak, Monika/0000-0003-4746-944X; Lasota, Slawomir/0000-0002-9477-5338	National Science Centre, Poland [2012/07/B/NZ3/02909]; Ministry of Science and Higher Education; European Regional Development Fund [POIG.02.01.00-12-167/08]; National Science Center, Krakow, Poland [UMO-2012/05/B/NZ4/02428]	National Science Centre, Poland(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Regional Development Fund(European Commission); National Science Center, Krakow, Poland(National Science Centre, Poland)	This work was supported by a grant from the National Science Centre 2012/07/B/NZ3/02909, Poland. Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. The LC-MS/MS measurements were done with the equipment spectrometer Q-Exactive purchased by the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract No. POIG.02.01.00-12-167/08, project Malopolska Center of Biotechnology) and supported by grant UMO-2012/05/B/NZ4/02428 from the National Science Center, Krakow, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GM, 2013, CURR BIOL, V23, P560, DOI 10.1016/j.cub.2013.02.047; BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chi QJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1072; COOPER MS, 1984, P NATL ACAD SCI-BIOL, V81, P160, DOI 10.1073/pnas.81.1.160; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; DUNN GA, 1986, J CELL SCI, V83, P313; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; FRIEDL P, 1993, J IMMUNOL METHODS, V165, P157, DOI 10.1016/0022-1759(93)90341-4; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; GRULER H, 1991, CELL MOTIL CYTOSKEL, V19, P121, DOI 10.1002/cm.970190207; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Korohoda W, 2002, CELL MOTIL CYTOSKEL, V53, P1, DOI 10.1002/cm.10052; Korohoda W, 1997, CELL MOTIL CYTOSKEL, V38, P38, DOI 10.1002/(SICI)1097-0169(1997)38:1<38::AID-CM5>3.3.CO;2-O; Korohoda W, 2000, CELL MOTIL CYTOSKEL, V45, P10, DOI 10.1002/(SICI)1097-0169(200001)45:1<10::AID-CM2>3.0.CO;2-T; Krecioch I, 2015, ACTA BIOCHIM POL, V62, P401, DOI 10.18388/abp.2015_1019; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Nakajima K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9532; Nishimura KY, 1996, J CELL SCI, V109, P199; ONUMA EK, 1988, J CELL BIOL, V106, P2067, DOI 10.1083/jcb.106.6.2067; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Rajnicek AM, 2007, DEV BIOL, V312, P448, DOI 10.1016/j.ydbio.2007.09.051; RAPP B, 1988, EUR BIOPHYS J BIOPHY, V16, P313, DOI 10.1007/BF00254068; Rassokhin MA, 2014, CELL BIOCHEM BIOPHYS, V69, P555, DOI 10.1007/s12013-014-9831-9; Rassokhin MA, 2012, J MEMBRANE BIOL, V245, P521, DOI 10.1007/s00232-012-9433-7; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sheridan DM, 1996, J INVEST DERMATOL, V106, P642, DOI 10.1111/1523-1747.ep12345456; Sixt M, 2012, J CELL BIOL, V197, P346, DOI 10.1083/jcb.201204039; Sowa M, 2015, MAT SCI ENG C-MATER, V49, P159, DOI 10.1016/j.msec.2014.12.073; Sroka J, 2002, TOXICOLOGY, V180, P275, DOI 10.1016/S0300-483X(02)00419-5; Sroka J, 2002, INT J BIOCHEM CELL B, V34, P882, DOI 10.1016/S1357-2725(01)00178-9; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; Sun YH, 2013, CURR BIOL, V23, P569, DOI 10.1016/j.cub.2013.02.026; Tyson RA, 2014, P NATL ACAD SCI USA, V111, P11703, DOI 10.1073/pnas.1322291111; Wang CC, 2011, LAB CHIP, V11, P695, DOI 10.1039/c0lc00155d; Wang Q, 1998, CLIN ORTHOP RELAT R, P259; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu D, 2013, CELL BIOCHEM BIOPHYS, V67, P1115, DOI 10.1007/s12013-013-9615-7; Wu JD, 2014, ADV WOUND CARE, V3, P149, DOI 10.1089/wound.2013.0453; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147; Zhang JP, 2011, STEM CELL REV REP, V7, P987, DOI 10.1007/s12015-011-9247-5; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	56	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149133	10.1371/journal.pone.0149133	http://dx.doi.org/10.1371/journal.pone.0149133			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863616	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600159
J	Fournier-Larente, J; Azelmat, J; Yoshioka, M; Hinode, D; Grenier, D				Fournier-Larente, Jade; Azelmat, Jabrane; Yoshioka, Masami; Hinode, Daisuke; Grenier, Daniel			The Daiokanzoto (TJ-84) Kampo Formulation Reduces Virulence Factor Gene Expression in Porphyromonas gingivalis and Possesses Anti-Inflammatory and Anti-Protease Activities	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSES; CREVICULAR FLUID; KAPPA-B; PERIODONTITIS; INTERLEUKIN-6; PATHOGENESIS; MEDICINE; RANTES; TISSUE	Kampo formulations used in Japan to treat a wide variety of diseases and to promote health are composed of mixtures of crude extracts from the roots, bark, leaves, and rhizomes of a number of herbs. The present study was aimed at identifying the beneficial biological properties of Daiokanzoto (TJ-84), a Kampo formulation composed of crude extracts of Rhubarb rhizomes and Glycyrrhiza roots, with a view to using it as a potential treatment for periodontal disease. Daiokanzoto dose-dependently inhibited the expression of major Porphyromonas gingivalis virulence factors involved in host colonization and tissue destruction. More specifically, Daiokanzoto reduced the expression of the fimA, hagA, rgpA, and rgpB genes, as determined by quantitative real-time PCR. The U937-3x kappa B-LUC monocyte cell line transfected with a luciferase reporter gene was used to evaluate the anti-inflammatory properties of Daiokanzoto. Daiokanzoto attenuated the P. gingivalis-mediated activation of the NF-kappa B signaling pathway. It also reduced the secretion of pro-inflammatory cytokines (IL-6 and CXCL8) by lipopolysaccharide-stimulated oral epithelial cells and gingival fibroblasts. Lastly, Daiokanzoto, dose-dependently inhibited the catalytic activity of matrix metalloproteinases (-1 and -9). In conclusion, the present study provided evidence that Daiokanzoto shows potential for treating and/or preventing periodontal disease. The ability of this Kampo formulation to act on both bacterial pathogens and the host inflammatory response, the two etiological components of periodontal disease, is of high therapeutic interest.	[Fournier-Larente, Jade; Azelmat, Jabrane; Grenier, Daniel] Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada; [Yoshioka, Masami] Univ Tokushima, Inst Biomed Sci, Dept Oral Hlth Sci & Social Welf, Grad Sch, Tokushima 770, Japan; [Hinode, Daisuke] Univ Tokushima, Inst Biomed Sci, Dept Hyg & Oral Hlth Sci, Grad Sch, Tokushima 770, Japan	Laval University; Tokushima University; Tokushima University	Grenier, D (corresponding author), Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca			Quebec Ministere de l'Economie, de l'Innovation et des Exportations [PSR-SIIRI-438]	Quebec Ministere de l'Economie, de l'Innovation et des Exportations	This study was supported by PSR-SIIRI-438 Quebec Ministere de l'Economie, de l'Innovation et des Exportations DG.	Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Ara T, 2008, BIOL PHARM BULL, V31, P1141, DOI 10.1248/bpb.31.1141; Ara T, 2010, BIOL PHARM BULL, V33, P611, DOI 10.1248/bpb.33.611; Azelmat J, 2015, ARCH ORAL BIOL, V60, P342, DOI 10.1016/j.archoralbio.2014.11.006; Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; de Souza JAC, 2012, J APPL ORAL SCI, V20, P128, DOI 10.1590/S1678-77572012000200002; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Gamonal J, 2001, J PERIODONTAL RES, V36, P194, DOI 10.1034/j.1600-0765.2001.360309.x; Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Hassell T M, 1993, Periodontol 2000, V3, P9, DOI 10.1111/j.1600-0757.1993.tb00230.x; Herrera D, 2008, J CLIN PERIODONTOL, V35, P45, DOI 10.1111/j.1600-051X.2008.01260.x; Hosseinzadeh H, 2015, PHYTOTHER RES, V29, P1868, DOI 10.1002/ptr.5487; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Irwin C R, 1998, Oral Dis, V4, P43; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kubota T, 1996, ARCH ORAL BIOL, V41, P253, DOI 10.1016/0003-9969(95)00126-3; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Liao J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436206; Liao J, 2013, PHARM BIOL, V51, P1538, DOI 10.3109/13880209.2013.801995; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Pizzo G, 2010, EUR J INTERN MED, V21, P496, DOI 10.1016/j.ejim.2010.07.011; Sapna G, 2014, ORAL DIS, V20, P538, DOI 10.1111/odi.12159; TAKAHASHI K, 1994, J PERIODONTOL, V65, P147, DOI 10.1902/jop.1994.65.2.147; Takashiba S, 2003, J PERIODONTOL, V74, P103, DOI 10.1902/jop.2003.74.1.103; Takeda O, 2014, ARCH ORAL BIOL, V59, P1130, DOI 10.1016/j.archoralbio.2014.06.010; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; TENG YT, 1992, J PERIODONTAL RES, V27, P544, DOI 10.1111/j.1600-0765.1992.tb01830.x; Watanabe K, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq067; Yakubo S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/535146; Yoshida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112689; Zenobia C, 2015, VIRULENCE, V6, P236, DOI 10.1080/21505594.2014.999567	37	6	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148860	10.1371/journal.pone.0148860	http://dx.doi.org/10.1371/journal.pone.0148860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859747	gold, Green Published			2022-12-26	WOS:000370038400098
J	Qian, J; Nunez, S; Reed, E; Reilly, MP; Foulkes, AS				Qian, Jing; Nunez, Sara; Reed, Eric; Reilly, Muredach P.; Foulkes, Andrea S.			A Simple Test of Class-Level Genetic Association Can Reveal Novel Cardiometabolic Trait Loci	PLOS ONE			English	Article							RARE VARIANTS; SUSCEPTIBILITY LOCI; ENRICHMENT ANALYSIS; IDENTIFIES 13; METAANALYSIS	Background Characterizing the genetic determinants of complex diseases can be further augmented by incorporating knowledge of underlying structure or classifications of the genome, such as newly developed mappings of protein-coding genes, epigenetic marks, enhancer elements and non-coding RNAs. Methods We apply a simple class-level testing framework, termed Genetic Class Association Testing (GenCAT), to identify protein-coding gene association with 14 cardiometabolic (CMD) related traits across 6 publicly available genome wide association (GWA) meta-analysis data resources. GenCAT uses SNP-level meta-analysis test statistics across all SNPs within a class of elements, as well as the size of the class and its unique correlation structure, to determine if the class is statistically meaningful. The novelty of findings is evaluated through investigation of regional signals. A subset of findings are validated using recently updated, larger meta-analysis resources. A simulation study is presented to characterize overall performance with respect to power, control of family-wise error and computational efficiency. All analysis is performed using the GenCAT package, R version 3.2.1. Results We demonstrate that class-level testing complements the common first stage minP approach that involves individual SNP-level testing followed by post-hoc ascribing of statistically significant SNPs to genes and loci. GenCAT suggests 54 protein-coding genes at 41 distinct loci for the 13 CMD traits investigated in the discovery analysis, that are beyond the discoveries of minP alone. An additional application to biological pathways demonstrates flexibility in defining genetic classes. Conclusions We conclude that it would be prudent to include class-level testing as standard practice in GWA analysis. GenCAT, for example, can be used as a simple, complementary and efficient strategy for class-level testing that leverages existing data resources, requires only summary level data in the form of test statistics, and adds significant value with respect to its potential for identifying multiple novel and clinically relevant trait associations.	[Qian, Jing] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Nunez, Sara; Reed, Eric; Foulkes, Andrea S.] Mt Holyoke Coll, Dept Math & Stat, S Hadley, MA 01075 USA; [Reilly, Muredach P.] Columbia Univ, Dept Med, New York, NY USA	University of Massachusetts System; University of Massachusetts Amherst; Mount Holyoke College; Columbia University	Foulkes, AS (corresponding author), Mt Holyoke Coll, Dept Math & Stat, S Hadley, MA 01075 USA.	afoulkes@mtholyoke.edu		Reilly, Muredach/0000-0002-3035-9386	National Institutes of Health, National Heart, Lung and Blood Institute [R01-HL107196, K24-HL107643, R01-HL-113147]; NIH/NHLBI [R01-HL107196, K24-HL107643, R01-HL-113147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107196, K24HL107643, R01HL113147] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this research is provided by National Institutes of Health, National Heart, Lung and Blood Institute R01-HL107196 (JQ, ER, SN, MPR and ASF); K24-HL107643 (MPR); and R01-HL-113147 (MPR).; Support for this research is provided by NIH/NHLBI R01-HL107196 (JQ, ER, SN, MPR and ASF); K24-HL107643 (MPR); and R01-HL-113147 (MPR).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foulkes AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054812; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hu YJ, 2013, AM J HUM GENET, V93, P236, DOI 10.1016/j.ajhg.2013.06.011; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148218	10.1371/journal.pone.0148218	http://dx.doi.org/10.1371/journal.pone.0148218			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859766	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400026
J	Reuchlein, B; Henn, L; Brian, T; Schier, K; Hardt, J				Reuchlein, Bettina; Henn, Lea; Brian, Tamara; Schier, Katarzyna; Hardt, Jochen			Childhood Adversities and Adult Headache in Poland and Germany	PLOS ONE			English	Article							CHRONIC PAIN; RETROSPECTIVE REPORTS; MENTAL-DISORDERS; DAILY-LIFE; PREVALENCE; GENETICS; IMPACT; ABUSE; MALTREATMENT; ASSOCIATION	Objective Various childhood adversities have been found to be associated with chronic pain in adulthood. However, associations were moderate in most studies, i.e. odds ratios (OR) were between one and two. Method An internet survey was performed in 508 Polish and 500 German subjects. A total of 19 childhood adversities were selected and their associations with headaches explored. Age, gender and country were included as potential confounders, as well as their two-way interaction with the risk factors. Results Two strong risk factors were identified. (1) A combined score for physical and emotional neglect showed an odds ratio (OR) of 2.78 (p < .002) to the frequency of headache in adulthood as a main effect. (2) Father having had chronic pain showed an OR of 4.36 (p < .001) with headache in adulthood for women, but not for men (OR = 0.86, p < .556). The majority of the examined childhood adversities were not associated with adult headache, neither when tested individually nor as a sum score. Conclusion This study confirms results from previous ones that childhood adversities may play a role in the development of adult headache, but it is a rather minor one. Contrary to other studies, neglect turned out to be one of the strongest predictors.	[Reuchlein, Bettina; Henn, Lea; Brian, Tamara; Hardt, Jochen] Johannes Gutenberg Univ Mainz, Univ Med, Klin Psychosomat Med & Psychotherapie, Med Psychol & Med Soziol, D-55122 Mainz, Germany; [Schier, Katarzyna] Univ Warsaw, Fac Psychol, Warsaw, Poland	Johannes Gutenberg University of Mainz; University of Warsaw	Hardt, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med, Klin Psychosomat Med & Psychotherapie, Med Psychol & Med Soziol, D-55122 Mainz, Germany.	jochen.hardt@gmx.de			Heigl-Stiftung, Duesseldorf; Koehler-Stiftung, Essen [100064-06]	Heigl-Stiftung, Duesseldorf; Koehler-Stiftung, Essen	This work was supported, in part, by the Heigl-Stiftung, Duesseldorf and the Koehler-Stiftung, Essen (grant number 100064-06).	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berger K, 2014, BUNDESGESUNDHEITSBLA, V57, P913, DOI 10.1007/s00103-014-1993-5; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brian T, 2014, PSYCHOPATHOLOGY, V47, P17, DOI 10.1159/000348483; Brown J, 2005, CLIN J PAIN, V21, P374, DOI 10.1097/01.ajp.0000149797.16370.dc; Clarke A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105450; Cohen J.E., 1988, STAT POWER ANAL BEHA; Couch JR, 2011, CURR TREAT OPTION NE, V13, P41, DOI 10.1007/s11940-010-0104-7; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; de Heer EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106907; Dureja GP, 2014, PAIN PRACT, V14, pE51, DOI 10.1111/papr.12132; Egle U. T., 2004, KLIN INTERVIEWS RATI, V4, P261; ENGEL GL, 1959, AM J MED, V26, P899, DOI 10.1016/0002-9343(59)90212-8; Franz M, 2003, Z PSYCHOSOM MED PSYC, V49, P115; Franz M, 2005, SEXUELLER MISSBRAUCH, P116; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Hardt J, 2010, PSYCHOL REP, V107, P425, DOI 10.2466/02.04.09.10.16.21.PR0.107.5.425-440; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Kaniecki Robert G, 2012, Continuum (Minneap Minn), V18, P823, DOI 10.1212/01.CON.0000418645.32032.32; KENDALLTACKETT KA, 1993, PSYCHOL BULL, V113, P164, DOI 10.1037/0033-2909.113.1.164; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Loeser JD, 2013, CLIN J PAIN, V29, P311, DOI 10.1097/AJP.0b013e3182516e64; Moore RA, 2014, PAIN PRACT, V14, P79, DOI 10.1111/papr.12050; Nicholson RA, 2003, HEADACHE, V43, P651, DOI 10.1046/j.1526-4610.2003.03108.x; Russell MB, 2007, J HEADACHE PAIN, V8, P190, DOI 10.1007/s10194-007-0389-4; Russell MB, 2007, AM J MED GENET B, V144B, P982, DOI 10.1002/ajmg.b.30497; Russell Michael Bjorn, 2007, J Headache Pain, V8, P71, DOI 10.1007/s10194-007-0366-y; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; Schier K, 2005, BEZ TCHU BEZ SLOWA W; Schier K, 2011, PSYCHOTHER PSYCH MED, V61, P364, DOI 10.1055/s-0031-1277188; Scott KM, 2011, ARCH GEN PSYCHIAT, V68, P838, DOI 10.1001/archgenpsychiatry.2011.77; Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d; Shibata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090984; Silva AA, 2012, HEADACHE, V52, P483, DOI 10.1111/j.1526-4610.2012.02090.x; StataCorp, 2011, STAT STAT SOFTW REL; Steiner TJ, 2011, J HEADACHE PAIN, V12, P501, DOI 10.1007/s10194-011-0368-7; Stoltenborgh M, 2012, SOC PSYCHIAT PSYCHIA; Traue HC, 2005, VERHALTENSTHERAPIE V, V26, P213; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Westergaard ML, 2014, PAIN, V155, P2005, DOI 10.1016/j.pain.2014.07.002; Widom CS, 2004, CHILD ABUSE NEGLECT, V28, P715, DOI 10.1016/j.chiabu.2004.03.009; World Health Organization, ADV CHILDH EXP INT Q; YARROW MR, 1970, MONOGR SOC RES CHILD, V35, P1	45	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148162	10.1371/journal.pone.0148162	http://dx.doi.org/10.1371/journal.pone.0148162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859500	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400023
J	Shi, WB; Wang, Q; Choi, W; Li, J				Shi, Weibin; Wang, Qian; Choi, Wonseok; Li, Jing			Mapping and Congenic Dissection of Genetic Loci Contributing to Hyperglycemia and Dyslipidemia in Mice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LIPOPROTEIN CHOLESTEROL LEVELS; DEFICIENT MOUSE STRAINS; GLUCOSE-HOMEOSTASIS; ATHEROSCLEROSIS SUSCEPTIBILITY; HDL-CHOLESTEROL; CAROTID ATHEROSCLEROSIS; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; APOLIPOPROTEIN-B	Background Patients with dyslipidemia have an increased risk of developing type 2 diabetes, and diabetic patients often have dyslipidemia. Potential genetic connections of fasting plasma glucose with plasma lipid profile were evaluated using hyperlipidemic mice. Methods 225 male F-2 mice were generated from BALB/cJ (BALB) and SM/J(SM) Apoe-deficient (Apoe(-/-)) mice and fed a Western diet for 5 weeks. Fasting plasma glucose and lipid levels of F2 mice were measured before and after 5 weeks of Western diet and quantitative trait locus (QTL) analysis was performed using data collected from these two time points. 144 SNP(single nucleotide polymorphism) markers across the entire genome were typed. Results One major QTL (logarithm of odds ratio (LOD): 6.46) peaked at 12.7 cM on chromosome 9, Bglu16, and 3 suggestive QTLs on chromosomes 15, 18 and X were identified for fasting glucose, and over 10 loci identified for lipid traits. Bglu16 was adjacent to a major QTL, Hdlq17, for high-density lipoprotein (HDL) cholesterol (LOD: 6.31, peak: 19.1 cM). A congenic strain with a donor chromosomal region harboring Bglu16 and Hdlq17 on the Apoe(-/-) background showed elevations in plasma glucose and HDL levels. Fasting glucose levels were significantly correlated with non-HDL cholesterol and triglyceride levels, especially on the Western diet, but only marginally correlated with HDL levels in F2 mice. Conclusions We have demonstrated a correlative relationship between fasting glucose and plasma lipids in a segregating F2 population under hyperlipidemic conditions, and this correlation is partially due to genetic linkage between the two disorders.	[Shi, Weibin; Wang, Qian; Choi, Wonseok; Li, Jing] Univ Virginia, Dept Radiol, Charlottesville, VA USA; [Shi, Weibin; Wang, Qian; Choi, Wonseok; Li, Jing] Univ Virginia, Dept Med Imaging, Charlottesville, VA USA; [Shi, Weibin] Univ Virginia, Biochem & Mol Genet, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Shi, WB (corresponding author), Univ Virginia, Dept Radiol, Charlottesville, VA USA.; Shi, WB (corresponding author), Univ Virginia, Dept Med Imaging, Charlottesville, VA USA.; Shi, WB (corresponding author), Univ Virginia, Biochem & Mol Genet, Charlottesville, VA USA.	ws4v@virginia.edu	, ws4v/L-4372-2019		NIH [DK097120, HL112281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097120] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK097120 and HL112281.; This work was supported by NIH grants DK097120 and HL112281. The authors thank Dr. Ani Manichaikul for advice with the statistical analyses.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Ackert-Bicknell C, 2013, J LIPID RES, V54, P984, DOI 10.1194/jlr.M033035; Albert JS, 2014, NEW ENGL J MED, V370, P2307, DOI 10.1056/NEJMoa1315496; Bayram F, 2014, J CLIN LIPIDOL, V8, P206, DOI 10.1016/j.jacl.2013.12.011; Breslow JL, 2000, CIRCULATION, V102, P5, DOI 10.1161/01.CIR.102.1.5; Drew BG, 2012, NAT REV ENDOCRINOL, V8, P237, DOI 10.1038/nrendo.2011.235; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Farbstein D, 2012, EXPERT REV CARDIOVAS, V10, P353, DOI [10.1586/erc.11.182, 10.1586/ERC.11.182]; Hu Y, 2007, J LIPID RES, V48, P1681, DOI 10.1194/jlr.M600382-JLR200; Hwang YC, 2014, DIABETIC MED, V31, P24, DOI 10.1111/dme.12278; Hwang YC, 2014, ACTA DIABETOL, V51, P941, DOI 10.1007/s00592-014-0587-x; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Ley SH, 2010, CLIN CHEM, V56, P666, DOI 10.1373/clinchem.2009.136994; Li J, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-117; Li NS, 2014, DIABETES, V63, P3149, DOI 10.2337/db13-1800; Li NS, 2014, ATHEROSCLEROSIS, V233, P130, DOI 10.1016/j.atherosclerosis.2013.12.013; Li QZ, 2008, STROKE, V39, P166, DOI 10.1161/STROKEAHA.107.492165; Liu SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120935; Lyons MA, 2004, PHYSIOL GENOMICS, V17, P114, DOI 10.1152/physiolgenomics.00168.2003; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Manichaikul A, 2011, AM J PHYSIOL-HEART C, V301, pH1056, DOI 10.1152/ajpheart.00366.2011; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mbikay M, 2015, J DIABETES, V7, P74, DOI 10.1111/1753-0407.12139; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Rowlan JS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000260; Rowlan JS, 2013, PHYSIOL GENOMICS, V45, P332, DOI 10.1152/physiolgenomics.00099.2012; Rowlan JS, 2013, PHYSL GENOMICS; Saleheen D, 2006, INT J CARDIOL, V110, P259, DOI 10.1016/j.ijcard.2005.06.059; Sehayek E, 2003, J LIPID RES, V44, P1744, DOI 10.1194/jlr.M300139-JLR200; Seidelmann SB, 2005, ARTERIOSCL THROM VAS, V25, P204, DOI 10.1161/01.ATV.0000149146.32385.1b; Shi WB, 2000, CIRC RES, V86, P1078, DOI 10.1161/01.RES.86.10.1078; Shi WB, 2010, CIRC-CARDIOVASC GENE, V3, P409, DOI 10.1161/CIRCGENETICS.110.957449; Shike T, 2001, DIABETES, V50, P1943, DOI 10.2337/diabetes.50.8.1943; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Stylianou IM, 2008, J LIPID RES, V49, P2402, DOI 10.1194/jlr.M800244-JLR200; Stylianou IM, 2006, GENETICS, V174, P999, DOI 10.1534/genetics.106.059717; Su ZG, 2006, HUM MOL GENET, V15, P1650, DOI 10.1093/hmg/ddl088; Su ZG, 2006, GENETICS, V172, P1799, DOI 10.1534/genetics.105.051912; Su Z, 2008, J LIPID RES, V49, P1500, DOI 10.1194/jlr.M800053-JLR200; Su ZG, 2009, J LIPID RES, V50, P116, DOI 10.1194/jlr.M800411-JLR200; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian J, 2005, BIOCHEM BIOPH RES CO, V329, P1102, DOI 10.1016/j.bbrc.2005.02.090; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Wang Q, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0292-y; Weng CY, 2013, AM J MED SCI, V346, P289, DOI 10.1097/MAJ.0b013e3182732e97; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wilson P W, 1985, Monogr Atheroscler, V13, P1; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wittenburg H, 2006, J LIPID RES, V47, P1780, DOI 10.1194/jlr.M500544-JLR200; Yuan ZB, 2009, CIRC-CARDIOVASC GENE, V2, P220, DOI 10.1161/CIRCGENETICS.108.792499; Zhang Y, 2015, NUCL MED BIOL, V42, P381, DOI 10.1016/j.nucmedbio.2014.12.001; Zhang ZM, 2012, CIRC-CARDIOVASC GENE, V5, P190, DOI 10.1161/CIRCGENETICS.111.961649	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148462	10.1371/journal.pone.0148462	http://dx.doi.org/10.1371/journal.pone.0148462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859786	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400044
J	de Kovel, CG; Mulder, F; van Setten, J; van't Slot, R; Al-Rubaish, A; Alshehri, AM; Al Faraidy, K; Al-Ali, A; Al-Madan, M; Al Aqaili, I; Larbi, E; Al-Ali, R; Alzahrani, A; Asselbergs, FW; Koeleman, BPC; Al-Ali, A				de Kovel, Carolien G.; Mulder, Flip; van Setten, Jessica; van't Slot, Ruben; Al-Rubaish, Abdullah; Alshehri, Abdullah M.; Al Faraidy, Khalid; Al-Ali, Abdullah; Al-Madan, Mohammed; Al Aqaili, Issa; Larbi, Emmanuel; Al-Ali, Rudaynah; Alzahrani, Alhusain; Asselbergs, Folkert W.; Koeleman, Bobby P. C.; Al-Ali, Amein			Exome-Wide Association Analysis of Coronary Artery Disease in the Kingdom of Saudi Arabia Population	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; RISK-FACTORS; LOCI; IMPUTATION; GENETICS	Coronary Artery Disease (CAD) remains the leading cause of mortality worldwide. Mortality rates associated with CAD have shown an exceptional increase particularly in fast developing economies like the Kingdom of Saudi Arabia (KSA). Over the past twenty years, CAD has become the leading cause of death in KSA and has reached epidemic proportions. This rise is undoubtedly caused by fast urbanization that is associated with a life-style that promotes CAD. However, the question remains whether genetics play a significant role and whether genetic susceptibility is increased in KSA compared to the well-studied Western European populations. Therefore, we performed an Exome-wide association study (EWAS) in 832 patients and 1,076 controls of Saudi Arabian origin to test whether population specific, strong genetic risk factors for CAD exist, or whether the polygenic risk score for known genetic risk factors for CAD, lipids, and Type 2 Diabetes show evidence for an enriched genetic burden. Our results do not show significant associations for a single genetic locus. However, the heritability estimate for CAD for this population was high (h(2) = 0.53, S.E. = 0.1, p = 4e(-12)) and we observed a significant association of the polygenic risk score for CAD that demonstrates that the population of KSA, at least in part, shares the genetic risk associated to CAD in Western populations.	[de Kovel, Carolien G.; Mulder, Flip; van Setten, Jessica; van't Slot, Ruben; Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands; [Al-Rubaish, Abdullah; Alshehri, Abdullah M.; Larbi, Emmanuel; Al-Ali, Rudaynah] Univ Dammam, King Fahd Hosp Univ, Dept Med, Dammam, Saudi Arabia; [Al Faraidy, Khalid] King Fahd Mil Med Complex, Dept Cardiol, Al Khobar, Saudi Arabia; [Al-Ali, Abdullah] Prince Sultan Cardiac Ctr, Al Hasa, Saudi Arabia; [Al-Madan, Mohammed] Univ Dammam, King Fahd Hosp Univ, Dammam, Saudi Arabia; [Al Aqaili, Issa] Qatif Cent Hosp, Dept Med, Qatif, Saudi Arabia; [Alzahrani, Alhusain] King Saud Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Al-Ali, Amein] Univ Dammam, Coll Med, Prince Mohammed Ctr Res & Consultat Studies, Dammam, Saudi Arabia	Utrecht University; Utrecht University Medical Center; Imam Abdulrahman Bin Faisal University; King Fahd Military Medical Complex; Prince Sultan Cardiac Center; Imam Abdulrahman Bin Faisal University; Qatif Central Hospital; King Saud University; Utrecht University; Utrecht University Medical Center; Imam Abdulrahman Bin Faisal University	Koeleman, BPC (corresponding author), Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands.	b.p.c.koeleman@umcutrecht.nl	Alshehri, Abdullah/AAS-9771-2020; Asselbergs, Folkert W./ABD-6752-2021; Al-Ali, Amein/AAR-3020-2020; de Kovel, Carolien/AAI-3531-2021	Alshehri, Abdullah/0000-0002-0795-1760; Asselbergs, Folkert W./0000-0002-1692-8669; de Kovel, Carolien/0000-0002-7818-1396; Al-Rubaish, Abdullah Mohammed/0000-0002-9136-2853	University of Dammam, Kingdom of Saudi Arabia; King Abdulaziz City for Science Technology	University of Dammam, Kingdom of Saudi Arabia; King Abdulaziz City for Science Technology	This study was funded by the University of Dammam, Kingdom of Saudi Arabia and King Abdulaziz City for Science & Technology. The authors would like to acknowledge the technical support extended by the Center for Research & Medical Consultation at the University of Dammam.	Borchers AT, 2010, AUTOIMMUN REV, V9, pA355, DOI 10.1016/j.autrev.2009.12.003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; DORMAN JS, 1990, P NATL ACAD SCI USA, V87, P7370, DOI 10.1073/pnas.87.19.7370; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Gelb BD, 2014, COLD SPRING HARB PER, V4; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Kukko M, 2004, DIABETES CARE, V27, P676, DOI 10.2337/diacare.27.3.676; Levenson James W, 2002, Prev Cardiol, V5, P188, DOI 10.1111/j.1520-037X.2002.00564.x; Li M, 2014, MOL PSYCHIATR, V19, P452, DOI 10.1038/mp.2013.37; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Miller CL, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0406-4; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; O'Toole Timothy E., 2008, Reviews on Environmental Health, V23, P167; Ozaki K, 2015, J HUM GENET; Purcell S, 2007, AM J HUM GENET, P81; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sibai AM, 2011, ANN NUTR METAB, V57, P193, DOI 10.1159/000321527; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Yuan S, 2013, CURR OPIN GENET DEV, V23, P352, DOI 10.1016/j.gde.2013.05.004	28	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0146502	10.1371/journal.pone.0146502	http://dx.doi.org/10.1371/journal.pone.0146502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849363	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000009
J	Philip, F; Sahu, S; Golebiewska, U; Scarlata, S				Philip, Finly; Sahu, Shriya; Golebiewska, Urszula; Scarlata, Suzanne			RNA-induced silencing attenuates G protein-mediated calcium signals	FASEB JOURNAL			English	Article						calcium signaling; G protein signaling; phospholipase C beta	PHOSPHOLIPASE C-BETA; C3PO; INTERFERENCE; C-BETA(2); SUBUNITS; BINDING	Phospholipase C beta (PLC beta) is activated by G protein subunits in response to environmental stimuli to increase intracellular calcium. In cells, a significant portion of PLC beta is cytosolic, where it binds a protein complex required for efficient RNA-induced silencing called C3PO (component 3 promoter of RISC). Binding between C3PO and PLC beta raises the possibility that RNA silencing activity can affect the ability of PLC beta to mediate calcium signals. By use of human and rat neuronal cell lines (SK-N-SH and PC12), we show that overexpression of one of the main components of C3PO diminishes Ca2+ release in response to G alpha(q)/PLC beta stimulation by 30 to 40%. In untransfected SK-N-SH or PC12 cells, the introduction of siRNA(GAPDH) [small interfering RNA(glyceraldehyde 3-phosphate dehydrogenase)] reduces PLC beta-mediated calcium signals by similar to 30%, but addition of siRNA(Hsp90) (heat shock protein 90) had little effect. Fluorescence imaging studies suggest an increase in PLC beta-C3PO association in cells treated with siRNA(GAPDH) but not siRNA(Hsp90). Taken together, our studies raise the possibility that Ca2+ responses to extracellular stimuli can be modulated by components of the RNA silencing machinery.-Philip, F., Sahu, S., Golebiewska, U., Scarlata, S. RNA-induced silencing attenuates G protein-mediated calcium signals. www.fasebj.org	[Philip, Finly; Sahu, Shriya; Golebiewska, Urszula; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Golebiewska, Urszula] Queensborough Community Coll, Dept Biol Sci, Bayside, NY USA; [Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Worcester Polytechnic Institute	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [GM116187]	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to P. Brink for providing the HNC2 morpholino, B. Calizo for help with the fluorescence correlation spectroscopy instrument, Drs. Yerramelli and Guo for their helpful comments, and O. Garwain for sharing his PLC beta localization data. This study was supported by the U.S. National Institutes of Health, National Institute of General Medical Sciences Grant GM116187.	Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Bading H, 1997, BIOCHEM BIOPH RES CO, V236, P541, DOI 10.1006/bbrc.1997.7037; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Guo YJ, 2011, BIOPHYS J, V100, P1599, DOI 10.1016/j.bpj.2011.02.013; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Kim TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109378; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Oka T, 2002, BRIT J PHARMACOL, V135, P1959, DOI 10.1038/sj.bjp.0704662; Philip Finly, 2013, Advances in Biological Regulation, V53, P319, DOI 10.1016/j.jbior.2013.07.002; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Sahu S, 2014, J BIOL CHEM, V289, P5134, DOI 10.1074/jbc.M113.531467; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tuschl Thomas, 2003, P265; Ullu E, 2002, PHILOS T ROY SOC B, V357, P65, DOI 10.1098/rstb.2001.0952; Valiunas V, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12286; Wang J, 2004, BIOCHEMISTRY-US, V43, P13424, DOI 10.1021/bi048847l; Yang SC, 2004, J BIOL CHEM, V279, P12605, DOI 10.1074/jbc.M313133200; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032	25	8	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1958	1967		10.1096/fj.201500140	http://dx.doi.org/10.1096/fj.201500140			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26862135	Green Published			2022-12-26	WOS:000374879400023
J	Madsen, AS; Andersen, C; Daoud, M; Anderson, KA; Laursen, JS; Chakladar, S; Huynh, FK; Colaco, AR; Backos, DS; Fristrup, P; Hirschey, MD; Olsen, CA				Madsen, Andreas S.; Andersen, Christian; Daoud, Mohammad; Anderson, Kristin A.; Laursen, Jonas S.; Chakladar, Saswati; Huynh, Frank K.; Colaco, Ana R.; Backos, Donald S.; Fristrup, Peter; Hirschey, Matthew D.; Olsen, Christian A.			Investigating the Sensitivity of NAD(+)-dependent Sirtuin Deacylation Activities to NADH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; fatty acid; histone deacetylase (HDAC); nicotinamide adenine dinucleotide (NADH); protein acylation; sirtuin; lysine myristoylation; lysine palmitoylation; nicotinamide adenine dinucleotide (NAD plus ); post-translational modification (PTM)	NICOTINAMIDE-ADENINE-DINUCLEOTIDE; HISTONE DEACETYLASE INHIBITORS; LIFE-SPAN EXTENSION; REDOX STATE; CALORIE RESTRICTION; LYSINE ACETYLATION; DNA-DAMAGE; POSTTRANSLATIONAL MODIFICATION; HISTONE/PROTEIN DEACETYLASES; PROTEIN ACETYLATION	Protein lysine posttranslational modification by an increasing number of different acyl groups is becoming appreciated as a regulatory mechanism in cellular biology. Sirtuins are class III histone deacylases that use NAD(+) as a co-substrate during amide bond hydrolysis. Several studies have described the sirtuins as sensors of the NAD(+)/NADH ratio, but it has not been formally tested for all the mammalian sirtuins in vitro. To address this problem, we first synthesized a wide variety of peptide-based probes, which were used to identify the range of hydrolytic activities of human sirtuins. These probes included aliphatic E-N-acyllysine modifications with hydrocarbon lengths ranging from formyl (C-1) to palmitoyl (C-16) as well as negatively charged dicarboxyl-derived modifications. In addition to the well established activities of the sirtuins, long chain acyllysine modifications were also shown to be prone to hydrolytic cleavage by SIRT1-3 and SIRT6, supporting recent findings. We then tested the ability of NADH, ADP-ribose, and nicotinamide to inhibit these NAD(+)-dependent deacylase activities of the sirtuins. In the commonly used 7-amino-4-methylcoumarin-coupled fluorescence-based assay, the fluorophore has significant spectral overlap with NADH and therefore cannot be used to measure inhibition by NADH. Therefore, we turned to an HPLC-MS-based assay to directly monitor the conversion of acylated peptides to their deacylated forms. All tested sirtuin deacylase activities showed sensitivity to NADH in this assay. However, the inhibitory concentrations of NADH in these assays are far greater than the predicted concentrations of NADH in cells; therefore, our data indicate that NADH is unlikely to inhibit sirtuins in vivo. These data suggest a re-evaluation of the sirtuins as direct sensors of the NAD(+)/NADH ratio.	[Madsen, Andreas S.; Laursen, Jonas S.; Chakladar, Saswati; Olsen, Christian A.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Biopharmaceut, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Madsen, Andreas S.; Andersen, Christian; Daoud, Mohammad; Colaco, Ana R.; Fristrup, Peter; Olsen, Christian A.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Anderson, Kristin A.; Huynh, Frank K.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, 300 N Duke St, Durham, NC 27701 USA; [Backos, Donald S.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Computat Chem & Biol Core Facil, Anschutz Med Campus, Aurora, CO 80045 USA	University of Copenhagen; Technical University of Denmark; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus	Madsen, AS; Olsen, CA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Biopharmaceut, Univ Pk 2, DK-2100 Copenhagen, Denmark.; Hirschey, MD (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, 300 N Duke St, Durham, NC 27701 USA.	andreas.madsen@sund.ku.dk; matthew.hirschey@duke.edu; cao@sund.ku.dk	Backos, Donald/Q-4791-2018; Backos, Donald/N-5265-2019; Fristrup, Peter/A-7211-2008; Huynh, Frank/AAK-9575-2020	Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210; Fristrup, Peter/0000-0001-7175-3796; Huynh, Frank/0000-0002-4764-9558; Olsen, Christian Adam/0000-0002-2953-8942; Madsen, Andreas Stahl/0000-0001-7283-2090; Hirschey, Matthew/0000-0003-4541-5376	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science [UL1TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022146] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF15OC0017334] Funding Source: researchfish	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank the reviewers for valuable input. We thank Tina Gustafsson (DTU Chemistry) for technical assistance. The University of Colorado Computational Chemistry and Biology Core Facility is supported partly by National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Award Grant UL1TR001082.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; Bao XC, 2014, ELIFE, V3, DOI 10.7554/eLife.02999; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Beis K, 2003, J AM CHEM SOC, V125, P11872, DOI 10.1021/ja035796r; Biel M, 2005, ANGEW CHEM INT EDIT, V44, P3186, DOI 10.1002/anie.200461346; Bilan DS, 2014, BBA-GEN SUBJECTS, V1840, P951, DOI 10.1016/j.bbagen.2013.11.018; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Brandl A, 2012, J MOL CELL BIOL, V4, P284, DOI 10.1093/jmcb/mjs013; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Chiang YL, 2016, ORG BIOMOL CHEM, V14, P2186, DOI 10.1039/c5ob02609a; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christensen CE, 2014, J BIOL CHEM, V289, P2344, DOI 10.1074/jbc.M113.498626; Dai LZ, 2014, NAT CHEM BIOL, V10, P365, DOI [10.1038/NCHEMBIO.1497, 10.1038/nchembio.1497]; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Edrissi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003328; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Fischer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045098; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Galleano I, 2016, J MED CHEM, V59, P1021, DOI 10.1021/acs.jmedchem.5b01532; Gambini J, 2011, ARCH BIOCHEM BIOPHYS, V512, P24, DOI 10.1016/j.abb.2011.04.020; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Hirschey MD, 2011, CELL METAB, V14, P718, DOI 10.1016/j.cmet.2011.10.006; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu J, 2013, ORG BIOMOL CHEM, V11, P5213, DOI 10.1039/c3ob41138a; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jang SY, 2012, J BIOL CHEM, V287, P19304, DOI 10.1074/jbc.M112.363747; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Jing H, 2015, CHEM REV, V115, P2350, DOI 10.1021/cr500457h; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Liu L, 1999, MOL CELL BIOL, V19, P1202; Madsen AS, 2012, ANGEW CHEM INT EDIT, V51, P9083, DOI 10.1002/anie.201203754; Madsen AS, 2012, J MED CHEM, V55, P5582, DOI 10.1021/jm300526r; Marcu R, 2014, MOL CELL BIOL, V34, P2890, DOI 10.1128/MCB.00068-14; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moellering RE, 2013, SCIENCE, V341, P549, DOI 10.1126/science.1238327; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Olsen CA, 2014, CHEMMEDCHEM, V9, P434, DOI 10.1002/cmdc.201300421; Olsen CA, 2012, ANGEW CHEM INT EDIT, V51, P3755, DOI 10.1002/anie.201200316; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schemies J, 2010, MED RES REV, V30, P861, DOI 10.1002/med.20178; Schmidt MT, 2004, J BIOL CHEM, V279, P40122, DOI 10.1074/jbc.M407484200; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; STEVENSON FT, 1993, P NATL ACAD SCI USA, V90, P7245, DOI 10.1073/pnas.90.15.7245; STEVENSON FT, 1992, J EXP MED, V176, P1053, DOI 10.1084/jem.176.4.1053; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Teng YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08529; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vogelauer M, 2012, J BIOL CHEM, V287, P32006, DOI 10.1074/jbc.M112.362467; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wilhelm F, 2011, J NEUROSCI RES, V89, P1956, DOI 10.1002/jnr.22638; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WU YD, 1991, J AM CHEM SOC, V113, P2353, DOI 10.1021/ja00007a002; WU YD, 1993, J ORG CHEM, V58, P2043, DOI 10.1021/jo00060a017; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Yu QR, 2009, J PHOTOCH PHOTOBIO B, V95, P46, DOI 10.1016/j.jphotobiol.2008.12.010; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	102	68	69	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7128	7141		10.1074/jbc.M115.668699	http://dx.doi.org/10.1074/jbc.M115.668699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26861872	Green Published, hybrid			2022-12-26	WOS:000373299700046
J	Druzinsky, RE; Balhoff, JP; Crompton, AW; Done, J; German, RZ; Haendel, MA; Herrel, A; Herring, SW; Lapp, H; Mabee, PM; Muller, HM; Mungall, CJ; Sternberg, PW; Van Auken, K; Vinyard, CJ; Williams, SH; Wall, CE				Druzinsky, Robert E.; Balhoff, James P.; Crompton, Alfred W.; Done, James; German, Rebecca Z.; Haendel, Melissa A.; Herrel, Anthony; Herring, Susan W.; Lapp, Hilmar; Mabee, Paula M.; Muller, Hans-Michael; Mungall, Christopher J.; Sternberg, Paul W.; Van Auken, Kimberly; Vinyard, Christopher J.; Williams, Susan H.; Wall, Christine E.			Muscle Logic: New Knowledge Resource for Anatomy Enables Comprehensive Searches of the Literature on the Feeding Muscles of Mammals	PLOS ONE			English	Article							ONTOLOGIES; TOOL; UNIFICATION; ANNOTATION; MORPHOLOGY; EVOLUTION; ORGANISM; GENOMICS	Background In recent years large bibliographic databases have made much of the published literature of biology available for searches. However, the capabilities of the search engines integrated into these databases for text-based bibliographic searches are limited. To enable searches that deliver the results expected by comparative anatomists, an underlying logical structure known as an ontology is required. Development and Testing of the Ontology Here we present the Mammalian Feeding Muscle Ontology (MFMO), a multi-species ontology focused on anatomical structures that participate in feeding and other oral/pharyngeal behaviors. A unique feature of the MFMO is that a simple, computable, definition of each muscle, which includes its attachments and innervation, is true across mammals. This construction mirrors the logical foundation of comparative anatomy and permits searches using language familiar to biologists. Further, it provides a template for muscles that will be useful in extending any anatomy ontology. The MFMO is developed to support the Feeding Experiments End-User Database Project (FEED, https://feedexp.org/), a publicly-available, online repository for physiological data collected from in vivo studies of feeding (e.g., mastication, biting, swallowing) in mammals. Currently the MFMO is integrated into FEED and also into two literature-specific implementations of Textpresso, a text-mining system that facilitates powerful searches of a corpus of scientific publications. We evaluate the MFMO by asking questions that test the ability of the ontology to return appropriate answers (competency questions). We compare the results of queries of the MFMO to results from similar searches in PubMed and Google Scholar. Results and Significance Our tests demonstrate that the MFMO is competent to answer queries formed in the common language of comparative anatomy, but PubMed and Google Scholar are not. Overall, our results show that by incorporating anatomical ontologies into searches, an expanded and anatomically comprehensive set of results can be obtained. The broader scientific and publishing communities should consider taking up the challenge of semantically enabled search capabilities.	[Druzinsky, Robert E.] Univ Illinois, Dept Oral Biol, Chicago, IL USA; [Balhoff, James P.] RTI Int, Res Triangle Pk, NC USA; [Crompton, Alfred W.] Harvard Univ, Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Done, James; Muller, Hans-Michael; Sternberg, Paul W.; Van Auken, Kimberly] CALTECH, Div Biol & Biol Engn, M-C 156-29, Pasadena, CA 91125 USA; [German, Rebecca Z.; Vinyard, Christopher J.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Haendel, Melissa A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Herrel, Anthony] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, F-75231 Paris, France; [Herring, Susan W.] Univ Washington, Dept Orthodont, Seattle, WA 98195 USA; [Lapp, Hilmar] Natl Evolutionary Synth Ctr, Durham, NC USA; [Lapp, Hilmar] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Mabee, Paula M.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, M-C 156-29, Pasadena, CA 91125 USA; [Williams, Susan H.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Wall, Christine E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Research Triangle Institute; Harvard University; California Institute of Technology; Northeast Ohio Medical University (NEOMED); Oregon Health & Science University; Museum National d'Histoire Naturelle (MNHN); University of Washington; University of Washington Seattle; The National Evolutionary Synthesis Center; Duke University; University of South Dakota; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California Institute of Technology; Howard Hughes Medical Institute; University System of Ohio; Ohio University; Duke University	Druzinsky, RE (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL USA.	druzinsk@uic.edu	Muller, Hans-Michael/J-9624-2015; Mungall, Chris/I-6006-2019; Herrel, Anthony/C-3712-2013	Mungall, Chris/0000-0002-6601-2165; Herrel, Anthony/0000-0003-0991-4434; Lapp, Hilmar/0000-0001-9107-0714; Williams, Susan/0000-0003-4167-678X; Haendel, Melissa/0000-0001-9114-8737; Balhoff, James/0000-0002-8688-6599	National Science Foundation [DBI-1062350, DBI-1062327, DBI-1062333, DBI-1343588, DBI-1062332, DBI-1062542, DEB-0956049]; National Evolutionary Synthesis Center [EF-0905606]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Phenotype Ontology Research Coordination Network [DEB-0956049]; Phenotype RCN; National Institutes of Health [U41-HG002223]; National Evolutionary Synthesis Center (NESCent) [EF-0905606]; Phenotype RCN (NSF) [DEB-0956049]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG002223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009980] Funding Source: NIH RePORTER; Direct For Biological Sciences [0956049, 1062350, 1062327] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062333, 1062542, 1062404] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Evolutionary Synthesis Center; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Phenotype Ontology Research Coordination Network; Phenotype RCN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Phenotype RCN (NSF); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work received support from the following sources: National Science Foundation (nsf.gov) to RED DBI-1062350; to SHW DBI-1062327; to CEW DBI-1062333; to RZG DBI-1343588; to CJV DBI-1062332; to PMM DBI-1062542 and DEB-0956049; National Evolutionary Synthesis Center (https://www.nescent.org/; NESCent; NSF EF-0905606). NESCent hosted FEED Workshops in May, 2012, and May, 2014. CJM was supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231 (http://energy.gov/eere/vehicles/downloads/office-science-basicenergy-sciences). PMM acknowledges funding from the National Science Foundation (DBI-1062542) and the Phenotype Ontology Research Coordination Network (DEB-0956049). Phenotype RCN (www.phenotypercn.org/) also provided support for RED and CJM. National Institutes of Health (www.nih.gov/; U41-HG002223) to PWS. PWS is also an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Gowri Ramachandran and Matt O'Neill provided support to help organize and enter data on muscle anatomy and terminology. Kun Peng and Elizabeth Ro performed data entry for the Textpresso for FEED project. Work on the MFMO is supported by the National Science Foundation (DBI-1062350 to Robert Druzinsky). We thank Wasila Dahdul for all of her advice and support. We would like to thank Kathleen Smith, Allen Rodrigo, Susan Alberts, and the National Evolutionary Synthesis Center (NESCent; NSF EF-0905606). NESCent hosted FEED Workshops in May, 2012, and May, 2014. Chris Mungall was supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Paula Mabee and Wasila Dahdul acknowledge funding from the National Science Foundation (DBI-1062542) and the Phenotype Ontology Research Coordination Network (DEB-0956049). The Phenotype RCN (NSF DEB-0956049) also provided support for Robert Druzinsky and Chris Mungall. Paul Sternberg is an investigator of the Howard Hughes Medical Institute.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balhoff JP, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-45; Balhoff JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010500; BALL SS, 1995, J MORPHOL, V224, P265, DOI 10.1002/jmor.1052240303; Bard JBL, 1998, MECH DEVELOP, V74, P111, DOI 10.1016/S0925-4773(98)00069-0; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Bizer C, 2009, J WEB SEMANT, V7, P154, DOI 10.1016/j.websem.2009.07.002; Costa M, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-32; Cui H, 2012, J AM SOC INF SCI TEC, V63, P738, DOI 10.1002/asi.22618; Dahdul W, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav040; Dahdul WM, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-34; Dahdul WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051070; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; Dahdul WM, 2010, EVOLUTIONARY CHARACT, Ve10708; Daly M, 2015, ZOOLOGISCHER ANZEIGE; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Drake RL., 2014, GRAYS ANATOMY STUDEN, P569; Gkoutos GV, 2004, COMP FUNCT GENOM, V5, P545, DOI 10.1002/cfg.430; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Gruaninger Michael., 1995, METHODOLOGY DESIGN E; Haddock NT, 2008, J RECONSTR MICROSURG, V24, P343, DOI 10.1055/s-2008-1080537; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; Haendel MA, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-21; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Heidorn PB, 2008, LIBR TRENDS, V57, P280; Herring SW, 2011, INTEGR COMP BIOL; Hoehndorf R, 2015, BRIEF BIOINFORM; Kardong K., 2006, VERTEBRATES COMP ANA; Katayama R, 2010, OPEN DENT J, V4, P1, DOI 10.2174/1874210601004010001; Kazakov Y, 2014, J AUTOM REASONING, V53, P1, DOI 10.1007/s10817-013-9296-3; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Maglia AM, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P367; Midford PE, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-34; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Osumi-Sutherland D, 2012, BIOINFORMATICS, V28, P1262, DOI 10.1093/bioinformatics/bts113; Rosse C., 2007, ANATOMY ONTOLOGIES B, P63, DOI [10.1007/978-1-84628-885-2_4, DOI 10.1007/978-1-84628-885-2_4]; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Trelease Robert B., 2006, Anatomical Record Part B:The New Anatomist, V289, P72, DOI 10.1002/ar.b.20095; Van Auken K, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas040; Van Slyke CE, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-12; Vinyard CJ, 2011, INTEGR COMP BIOL, V51, P260, DOI 10.1093/icb/icr066; WACHTER T, 2008, COMPU BIOL, P177; Wall CE, 2011, INTEGR COMP BIOL; Williams SH, 2011, INTEGR COMP BIOL, V51, P247, DOI 10.1093/icb/icr068; WINKLER LA, 1991, INT J PRIMATOL, V12, P45, DOI 10.1007/BF02547558; Yuan Ren, 2014, The Semantic Web: Trends and Challenges. 11th International Conference (ESWC 2014). Proceedings: LNCS 8465, P752, DOI 10.1007/978-3-319-07443-6_50	48	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149102	10.1371/journal.pone.0149102	http://dx.doi.org/10.1371/journal.pone.0149102			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870952	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000370054100104
J	Bach, AG; Taute, BM; Baasai, N; Wienke, A; Meyer, HJ; Schramm, D; Surov, A				Bach, Andreas Gunter; Taute, Bettina-Maria; Baasai, Nansalmaa; Wienke, Andreas; Meyer, Hans Jonas; Schramm, Dominik; Surov, Alexey			30-Day Mortality in Acute Pulmonary Embolism: Prognostic Value of Clinical Scores and Anamnestic Features	PLOS ONE			English	Article							RIGHT-VENTRICULAR DYSFUNCTION; SEVERITY; DISEASE; SCALE; COMA; CT	Purpose Identification of high-risk patients with pulmonary embolism is vital. The aim of the present study was to examine clinical scores, their single items, and anamnestic features in their ability to predict 30-day mortality. Materials and Methods A retrospective, single-center study from 06/2005 to 01/2010 was performed. Inclusion criteria were presence of pulmonary embolism, availability of patient records and 30-day follow-up. The following clinical scores were calculated: Acute Physiology and Chronic Health Evaluation II, original and simplified pulmonary embolism severity index, Glasgow Coma Scale, and euroSCORE II. Results In the study group of 365 patients 39 patients (10.7%) died within 30 days due to pulmonary embolism. From all examined scores and parameters the best predictor of 30-day mortality were the Glasgow Coma scale (<= 10) and parameters of the circulatory system including presence of mechanical ventilation, arterial pH (<7.335), and systolic blood pressure (<99 mm Hg). Conclusions Easy to ascertain circulatory parameters have the same or higher prognostic value than the clinical scores that were applied in this study. From all clinical scores studied the Glasgow Coma Scale was the most time- and cost-efficient one.	[Bach, Andreas Gunter; Baasai, Nansalmaa; Meyer, Hans Jonas; Schramm, Dominik; Surov, Alexey] Univ Halle Wittenberg, Dept Radiol, Ernst Grube Str 40, D-06120 Halle, Germany; [Taute, Bettina-Maria] Univ Halle Wittenberg, Dept Internal Med, Ernst Grube Str 40, D-06120 Halle, Germany; [Wienke, Andreas] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Magdeburger Str 8, D-06112 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Surov, A (corresponding author), Univ Halle Wittenberg, Dept Radiol, Ernst Grube Str 40, D-06120 Halle, Germany.	alex.surow@medizin.uni-halle.de	Wienke, Andreas/AAN-3707-2020					Ahun E, 2014, ULUS TRAVMA ACIL CER, V20, P241, DOI 10.5505/tjtes.2014.76399; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Bertoletti L, 2012, EUR RESPIR J, V39, P862, DOI 10.1183/09031936.00058811; Castelli R, 2014, THROMB RES; Gong Xiao-wei, 2013, Zhonghua Yi Xue Za Zhi, V93, P2534; Henzler T, 2012, EUR RESPIR J, V39, P919, DOI 10.1183/09031936.00088711; Jimenez D, 2014, THORAX, V69, P109, DOI 10.1136/thoraxjnl-2012-202900; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Masotti L, 2009, VASC HEALTH RISK MAN, V5, P567; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; TEASDALE G, 1974, LANCET, V2, P81; Torbicki A, 2010, REV ESP CARDIOL, V63, P832, DOI 10.1016/S0300-8932(10)70186-X; Vedovati MC, 2013, J THROMB HAEMOST, V11, P2092, DOI 10.1111/jth.12429	15	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148728	10.1371/journal.pone.0148728	http://dx.doi.org/10.1371/journal.pone.0148728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866472	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700030
J	Bolch, SN; Dugger, DR; Chong, T; McDowell, JH; Smith, WC				Bolch, Susan N.; Dugger, Donald R.; Chong, Timothy; McDowell, J. Hugh; Smith, W. Clay			A Splice Variant of Bardet-Biedl Syndrome 5 (BBS5) Protein that Is Selectively Expressed in Retina	PLOS ONE			English	Article							MESSENGER-RNA DECAY; INTRACELLULAR CALCIUM; PHOTORECEPTOR CELLS; CILIARY MEMBRANE; BBSOME; MOUSE; MUTATION; MODEL; RETINOPATHY; PHENOTYPE	Purpose Bardet-Biedl syndrome is a complex ciliopathy that usually manifests with some form of retinal degeneration, amongst other ciliary-related deficiencies. One of the genetic causes of this syndrome results from a defect in Bardet-Biedl Syndrome 5 ( BBS5) protein. BBS5 is one component of the BBSome, a complex of proteins that regulates the protein composition in cilia. In this study, we identify a smaller molecular mass form of BBS5 as a variant formed by alternative splicing and show that expression of this splice variant is restricted to the retina. Methods Reverse transcription PCR from RNA was used to isolate and identify potential alternative transcripts of Bbs5. A peptide unique to the C-terminus of the BBS5 splice variant was synthesized and used to prepare antibodies that selectively recognized the BBS5 splice variant. These antibodies were used on immunoblots of tissue extracts to determine the extent of expression of the alternative transcript and on tissue slices to determine the localization of expressed protein. Pull-down of fluorescently labeled arrestin1 by immunoprecipitation of the BBS5 splice variant was performed to assess functional interaction between the two proteins. Results PCR from mouse retinal cDNA using Bbs5-specific primers amplified a unique cDNA that was shown to be a splice variant of BBS5 resulting from the use of cryptic splicing sites in Intron 7. The resulting transcript codes for a truncated form of the BBS5 protein with a unique 24 amino acid C-terminus, and predicted 26.5 kD molecular mass. PCR screening of RNA isolated from various ciliated tissues and immunoblots of protein extracts from these same tissues showed that this splice variant was expressed in retina, but not brain, heart, kidney, or testes. Quantitative PCR showed that the splice variant transcript is 8.9-fold (+/-1.1-fold) less abundant than the full-length transcript. In the retina, the splice variant of BBS5 appears to be most abundant in the connecting cilium of photoreceptors, where BBS5 is also localized. Like BBS5, the binding of BBS5L to arrestin1 can be modulated by phosphorylation through protein kinase C. Conclusions In this study we have identified a novel splice variant of BBS5 that appears to be expressed only in the retina. The BBS5 splice variant is expressed at approximately 10% of full-length BBS5 level. No unique functional or localization properties could be identified for the splice variant compared to BBS5.	[Bolch, Susan N.; Dugger, Donald R.; Chong, Timothy; McDowell, J. Hugh; Smith, W. Clay] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	State University System of Florida; University of Florida	Smith, WC (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL USA.	wcsmith@ufl.edu	Smith, W. Clay/AAQ-1589-2021		National Institutes of Health [EY014864, EY021721]; Research to Prevent Blindness; C.M. Overstreet Retinal Eye Disease ARMD Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021721, R01EY014864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); C.M. Overstreet Retinal Eye Disease ARMD Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants from the National Institutes of Health (EY014864, EY021721), Research to Prevent Blindness, and the C.M. Overstreet Retinal Eye Disease ARMD Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the gift of anti-RP1 antibody from Eric Pierce, and the Lions Eye Institute for Research and Translation for providing donor retinal tissue. This research was supported by grants from the National Institutes of Health (EY014864, EY021721), Research to Prevent Blindness, and the C.M. Overstreet Retinal Eye Disease ARMD Research Fund.	Al-Hamed Mohamed H, 2014, Cilia, V3, P3, DOI 10.1186/2046-2530-3-3; Besharse JC, 1990, PHOTORECEPTOR CONNEC, P389; Breslow DK, 2013, J CELL BIOL, V203, P129, DOI 10.1083/jcb.201212024; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Brown JM, 2015, CURR BIOL, V25, P1583, DOI 10.1016/j.cub.2015.04.060; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Deveault C, 2011, HUM MUTAT, V32, P610, DOI 10.1002/humu.21480; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Forsythe E, 2013, EUR J HUM GENET, V21, P8, DOI 10.1038/ejhg.2012.115; Gamsiz ED, 2012, GENOMICS, V99, P44, DOI 10.1016/j.ygeno.2011.09.003; Gerth C, 2008, VISION RES, V48, P392, DOI 10.1016/j.visres.2007.08.024; Hirano M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136317; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Lechtreck KF, 2013, J CELL BIOL, V201, P249, DOI 10.1083/jcb.201207139; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; McDowell JH, 1999, BIOCHEMISTRY-US, V38, P6119, DOI 10.1021/bi990175p; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Mockel A, 2011, PROG RETIN EYE RES, V30, P258, DOI 10.1016/j.preteyeres.2011.03.001; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Murphy D, 2015, MOL CELL BIOL, V35, P1860, DOI 10.1128/MCB.00040-15; Nachury MV, 2008, METHOD ENZYMOL, V439, P501, DOI 10.1016/S0076-6879(07)00434-X; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nickless A, 2014, NAT MED, V20, P961, DOI 10.1038/nm.3620; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pretorius PR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000884; Riazuddin SA, 2010, AM J HUM GENET, V86, P805, DOI 10.1016/j.ajhg.2010.04.001; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Smith TS, 2013, CELL MOL LIFE SCI, V70, P4603, DOI 10.1007/s00018-013-1403-4; Wan J, 2011, NUCLEIC ACIDS RES, V39, P7920, DOI 10.1093/nar/gkr545; Wang J, 2014, PROG RETIN EYE RES, V38, P1, DOI 10.1016/j.preteyeres.2013.08.004; Wheway G, 2014, ORGANOGENESIS, V10, P69, DOI 10.4161/org.26710; WOLFRUM U, 1995, CELL MOTIL CYTOSKEL, V32, P55, DOI 10.1002/cm.970320107; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yuan SL, 2013, ANNU REV GENET, V47, P353, DOI 10.1146/annurev-genet-111212-133243	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148773	10.1371/journal.pone.0148773	http://dx.doi.org/10.1371/journal.pone.0148773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867008	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700035
J	Krammer, J; Dutschke, A; Kaiser, CG; Schnitzer, A; Gerhardt, A; Radosa, JC; Brade, J; Schoenberg, SO; Wasser, K				Krammer, Julia; Dutschke, Anja; Kaiser, Clemens G.; Schnitzer, Andreas; Gerhardt, Axel; Radosa, Julia C.; Brade, Joachim; Schoenberg, Stefan O.; Wasser, Klaus			Impact of Tumor Localization and Method of Preoperative Biopsy on Sentinel Lymph Node Mapping After Periareolar Nuclide Injection	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; SUBAREOLAR INJECTION; LYMPHOSCINTIGRAPHY; IDENTIFICATION; FAILURE; MANAGEMENT; IDENTIFY; DRAINAGE; DISEASE	Background To evaluate whether tumor localization and method of preoperative biopsy affect sentinel lymph node (SLN) detection after periareolar nuclide injection in breast cancer patients. Methods and Findings 767 breast cancer patients were retrospectively included. For lymphscintigraphy periareolar nuclide injection was performed and the SLN was located by gamma camera. Patient and tumor characteristics were correlated to the success rate of SLN mapping. SLN marking failed in 9/61 (14.7%) patients with prior vacuum-assisted biopsy and 80/706 (11.3%) patients with prior core needle biopsy. Individually evaluated, biopsy method (p = 0.4) and tumor localization (p = 0.9) did not significantly affect the SLN detection rate. Patients with a vacuum-assisted biopsy of a tumor in the upper outer quadrant had a higher odds ratio of failing in SLN mapping (OR 3.8, p = 0.09) compared to core needle biopsy in the same localization (OR 0.9, p = 0.5). Conclusions Tumor localization and preoperative biopsy method do not significantly impact SLN mapping with periareolar nuclide injection. However, the failure risk tends to rise if vacuum-assisted biopsy of a tumor in the upper outer quadrant is performed.	[Krammer, Julia; Dutschke, Anja; Kaiser, Clemens G.; Schnitzer, Andreas; Schoenberg, Stefan O.; Wasser, Klaus] Heidelberg Univ, Inst Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany; [Gerhardt, Axel] Heidelberg Univ, Dept Obstet & Gynaecol, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany; [Radosa, Julia C.] Saarland Univ Hosp, Dept Obstet & Gynaecol, Homburg, Germany; [Brade, Joachim] Heidelberg Univ, Inst Med Stat Biomath & Data Proc, Med Fac Mannheim, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Universitatsklinikum des Saarlandes; Ruprecht Karls University Heidelberg	Krammer, J (corresponding author), Heidelberg Univ, Inst Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany.	Julia.Knaudt@medma.uni-heidelberg.de	Radosa, Julia/AAH-8266-2019	Kaiser, Clemens/0000-0003-4438-3624				Ahrendt GM, 2002, J AM COLL SURGEONS, V194, P278, DOI 10.1016/S1072-7515(01)01174-7; Bembenek A, 2007, WORLD J SURG, V31, P267, DOI 10.1007/s00268-005-0720-7; Caruso G, 2014, ACTA RADIOL, V55, P39, DOI 10.1177/0284185113493775; Caudle AS, 2014, SURG ONCOL CLIN N AM, V23, P473, DOI 10.1016/j.soc.2014.03.007; Chagpar AB, 2005, AM J SURG, V190, P551, DOI 10.1016/j.amjsurg.2005.06.009; Chagpar AB, 2005, SURGERY, V138, P56, DOI 10.1016/j.surg.2005.03.003; D'Eredita G, 2003, ANN SURG ONCOL, V10, P942, DOI 10.1245/ASO.2003.01.022; Estourgie SH, 2007, BRIT J SURG, V94, P1088, DOI 10.1002/bjs.5763; Estourgie SH, 2004, ANN SURG, V239, P232, DOI 10.1097/01.sla.0000109156.26378.90; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Goyal A, 2005, EUR J CANCER, V41, P238, DOI 10.1016/j.ejca.2004.05.008; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Gschwantler-Kaulich D, 2011, EUR J CANCER CARE, V20, P627, DOI 10.1111/j.1365-2354.2011.01241.x; Haigh PI, 2000, J NUCL MED, V41, P1682; Heuts EM, 2006, EJSO, V32, P278, DOI 10.1016/j.ejso.2005.09.001; Humphrey KL, 2014, RADIOGRAPHICS, V34, P1807, DOI 10.1148/rg.347130141; Kern KA, 2002, J AM COLL SURGEONS, V195, P467, DOI 10.1016/S1072-7515(02)01312-1; Kollias J, 2000, AUST NZ J SURG, V70, P485, DOI 10.1046/j.1440-1622.2000.01861.x; Leppanen E, 2002, EUR J SURG ONCOL, V28, P821, DOI 10.1053/ejso.2002.1325; Manguso N, 2015, ONCOLOGY-NY, V29, P733; Motomura K, 2002, BIOMED PHARMACOTHER, V56, p209S; Schrenk P, 2001, LANCET, V357, P122, DOI 10.1016/S0140-6736(00)03550-9; Sener SF, 2004, J AM COLL SURGEONS, V198, P732, DOI 10.1016/j.jamcollsurg.2004.01.006; Straalman K, 2008, BREAST, V17, P167, DOI 10.1016/j.breast.2007.08.008; Valero V, 2010, CLIN BREAST CANCER, V10, P477, DOI 10.3816/CBC.2010.n.063	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149018	10.1371/journal.pone.0149018	http://dx.doi.org/10.1371/journal.pone.0149018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867137	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700054
J	Stehling, MK; Guenther, E; Mikus, P; Klein, N; Rubinsky, L; Rubinsky, B				Stehling, Michael K.; Guenther, Enric; Mikus, Paul; Klein, Nina; Rubinsky, Liel; Rubinsky, Boris			Synergistic Combination of Electrolysis and Electroporation for Tissue Ablation	PLOS ONE			English	Article							HIGH ELECTRIC-FIELDS; ELECTROCHEMICAL TREATMENT; TUMOR TREATMENT; IN-VIVO; IRREVERSIBLE ELECTROPORATION; CURRENT THERAPY; MAMMARY; MICROORGANISMS; DENSITY; CELLS	Electrolysis, electrochemotherapy with reversible electroporation, nanosecond pulsed electric fields and irreversible electroporation are valuable non-thermal electricity based tissue ablation technologies. This paper reports results from the first large animal study of a new non-thermal tissue ablation technology that employs "Synergistic electrolysis and electroporation" (SEE). The goal of this pre-clinical study is to expand on earlier studies with small animals and use the pig liver to establish SEE treatment parameters of clinical utility. We examined two SEE methods. One of the methods employs multiple electrochemotherapy-type reversible electroporation magnitude pulses, designed in such a way that the charge delivered during the electroporation pulses generates the electrolytic products. The second SEE method combines the delivery of a small number of electrochemotherapy magnitude electroporation pulses with a low voltage electrolysis generating DC current in three different ways. We show that both methods can produce lesion with dimensions of clinical utility, without the need to inject drugs as in electrochemotherapy, faster than with conventional electrolysis and with lower electric fields than irreversible electroporation and nanosecond pulsed ablation.	[Stehling, Michael K.; Guenther, Enric; Mikus, Paul; Rubinsky, Liel; Rubinsky, Boris] Inter Sci GmbH, Biophys, Luzern, Switzerland; [Klein, Nina] Inst Bildgebende Diagnost Tumortherapy Ctr, R&D, Offenbach, Germany		Guenther, E (corresponding author), Inter Sci GmbH, Biophys, Luzern, Switzerland.	enric@interscience.ch			MKS; Inter Science GmbH	MKS; Inter Science GmbH	The costs for the animal care facility was paid by MKS. Inter Science GmbH provided support in the form of salaries for authors MKS, EG, PM, LR and BR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. There was no additional funding for this study except the funds for the animal care facility by MKS.	Amory R, 1886, TREATISE ELECT ITS T; Apollonio F, 2012, ANT PROP EUCAP 2012; Pupo AEB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-85; Ciria HMC, 2013, CHINESE J CANCER RES, V25, P223, DOI 10.3978/j.issn.1000-9604.2013.03.03; Colombo L, 2007, BIOELECTROCHEMISTRY, V71, P223, DOI 10.1016/j.bioelechem.2007.07.001; Czymek R, 2011, SAUDI J GASTROENTERO, V17, P335, DOI 10.4103/1319-3767.84491; Czymek R, 2012, SURG ONCOL, V21, P79, DOI 10.1016/j.suronc.2010.10.007; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; GRIFFIN DT, 1995, BRIT J CANCER, V72, P31, DOI 10.1038/bjc.1995.272; GRIFFIN DT, 1994, BRIT J CANCER, V69, P875, DOI 10.1038/bjc.1994.169; Haggendal E, 1969, Int Anesthesiol Clin, V7, P353; HAMILTON WA, 1967, BIOCHIM BIOPHYS ACTA, V148, P789, DOI 10.1016/0304-4165(67)90053-0; Ivic MLA, 2003, J ELECTROANAL CHEM, V549, P129, DOI 10.1016/S0022-0728(03)00251-1; Martin RCG, 2013, J GASTROINTEST SURG, V17, P1850, DOI 10.1007/s11605-013-2309-z; Miklavcic D, 1997, ELECTRO MAGNETOBIOL, V16, P119, DOI 10.3109/15368379709009837; Miklavcic D, 1997, BIOELECTROCH BIOENER, V43, P253, DOI 10.1016/S0302-4598(96)05190-2; MIKLAVCIC D, 1994, BIOELECTROCH BIOENER, V35, P93, DOI 10.1016/0302-4598(94)87017-9; Miklavcic D, 2013, J MEMBRANE BIOL, V246, P723, DOI 10.1007/s00232-013-9595-y; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; NEUMANN E, 1972, J MEMBRANE BIOL, V10, P279, DOI 10.1007/BF01867861; Neumann E., 1989, ELECTROPORATION ELEC; Nilsson E, 1999, J ELECTROANAL CHEM, V460, P88, DOI 10.1016/S0022-0728(98)00352-0; Nilsson E, 1998, BIOELECTROCH BIOENER, V47, P11, DOI 10.1016/S0302-4598(98)00157-3; Nilsson E, 2000, BIOELECTROCHEMISTRY, V51, P1, DOI 10.1016/S0302-4598(99)00073-2; Noad HM, 1849, LECT ELECT COMPRISIN; NORDENSTROM B, 1978, IRCS (International Research Communications System) Medical Science Library Compendium, V6, P537; NORDENSTROM BEW, 1994, EUR J SURG, P93; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Olaiz N, 2010, ELECTROCHEM COMMUN, V12, P94, DOI 10.1016/j.elecom.2009.10.044; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Phillips M, 2015, TECHNOLOGY, V3, P45, DOI 10.1142/S233954781550003X; Phillips M, 2015, TECHNOL CANCER RES T, V14, P395, DOI 10.1177/1533034614560102; Jimenez RP, 2011, BIOELECTROMAGNETICS, V32, P120, DOI 10.1002/bem.20611; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; SALE AJH, 1968, BIOCHIM BIOPHYS ACTA, V163, P37, DOI 10.1016/0005-2736(68)90030-8; SALE AJH, 1967, BIOCHIM BIOPHYS ACTA, V148, P781, DOI 10.1016/0304-4165(67)90052-9; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; STAMPFLI R, 1957, EXPERIENTIA, V13, P297, DOI 10.1007/BF02158430; STAMPFLI R, 1958, J Physiol (Paris), V50, P520; STAMPFLJ R., 1958, AN ACAD BRASIL CIENC, V30, P57; Teissie J, 2014, METHODS MOL BIOL, V1121, P25, DOI 10.1007/978-1-4614-9632-8_2; TITOMIROV AV, 1991, BIOCHIM BIOPHYS ACTA, V1088, P131, DOI 10.1016/0167-4781(91)90162-F; Turjanski P, 2009, ELECTROCHIM ACTA, V54, P6199, DOI 10.1016/j.electacta.2009.05.062; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003; von Euler H, 1999, ELECTRO MAGNETOBIOL, V18, P93, DOI 10.3109/15368379909012903; von Euler H, 2001, BIOELECTROCHEMISTRY, V54, P117, DOI 10.1016/S1567-5394(01)00118-9; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4	50	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148317	10.1371/journal.pone.0148317	http://dx.doi.org/10.1371/journal.pone.0148317			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866693	Green Published, gold			2022-12-26	WOS:000370050700014
J	Chung, CY; Wang, JC; Chuang, HS				Chung, Chih-Yao; Wang, Jhih-Cheng; Chuang, Han-Sheng			Rapid Bead-Based Antimicrobial Susceptibility Testing by Optical Diffusometry	PLOS ONE			English	Article							ANTIBIOTIC SUSCEPTIBILITY; MICROFLUIDIC PLATFORM; BACTERIA; RESISTANCE; CAPTURE	This study combined optical diffusometry and bead-based immunoassays to develop a novel technique for quantifying the growth of specific microorganisms and achieving rapid AST. Diffusivity rises when live bacteria attach to particles, resulting in additional energy from motile microorganisms. However, when UV-sterilized (dead) bacteria attach to particles, diffusivity declines. The experimental data are consistent with the theoretical model predicted according to the equivalent volume diameter. Using this diffusometric platform, the susceptibility of Pseudomonas aeruginosa to the antibiotic gentamicin was tested. The result suggests that the proliferation of bacteria is effectively controlled by gentamicin. This study demonstrated a sensitive (one bacterium on single particles) and time-saving (within 2 h) platform with a small sample volume (similar to 0.5 mu L) and a low initial bacteria count (50 CFU per droplet similar to 10(5) CFU/mL) for quantifying the growth of microorganisms depending on Brownian motion. The technique can be applied further to other bacterial strains and increase the success of treatments against infectious diseases in the near future.	[Chung, Chih-Yao; Wang, Jhih-Cheng; Chuang, Han-Sheng] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan; [Wang, Jhih-Cheng] Chi Mei Med Ctr, Div Urol, Dept Surg, Tainan, Taiwan; [Chuang, Han-Sheng] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan	National Cheng Kung University; Chi Mei Hospital; National Cheng Kung University	Chuang, HS (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.; Chuang, HS (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.	oswaldchuang@mail.ncku.edu.tw	Chung, Chih-Yao/AEY-3140-2022; Chuang, Han-Sheng/ABH-3992-2020	Chung, Chih-Yao/0000-0002-2263-4181; Chuang, Han-Sheng/0000-0002-7257-6565	Ministry of Science and Technology, Taiwan [102-2221-E-006-024-MY2]; Chimei Medical Center, Taiwan [CMNCKU10405]; Chimei Medical Center [CMNCKU10405]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chimei Medical Center, Taiwan; Chimei Medical Center	This study was funded by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/), grant number 102-2221-E-006-024-MY2 to HSC, and by Chimei Medical Center, Taiwan (http://www.chimei.org.tw/index_c.htm), grant number CMNCKU10405 to JCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Ministry of Science and Technology under the grant number 102-2221-E-006-024-MY2. We appreciate Dr. H.C. Chang for his kind share of P. aeruginosa (ATCC 27853). Moreover, Dr. Wang would also like to thank Chimei Medical Center for the grant CMNCKU10405.	Angelani L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.138302; Boedicker JQ, 2008, LAB CHIP, V8, P1265, DOI 10.1039/b804911d; Braibanti M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108303; Cao BY, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4861661; Chen CH, 2010, ANAL CHEM, V82, P1012, DOI 10.1021/ac9022764; Cheng IF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02365; Choi J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009650; Chung CC, 2012, ANAL CHEM, V84, P3347, DOI 10.1021/ac300093w; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Dong RY, 2015, MICROFLUID NANOFLUID, V19, P805, DOI 10.1007/s10404-015-1605-1; Einstein A, 1956, INVESTIGATIONS THEOR; Fan L.-S., 1998, SIZE PROPERTIES PART; Fan YJ, 2010, LANGMUIR, V26, P13751, DOI 10.1021/la102137j; Fan YJ, 2009, BIOSENS BIOELECTRON, V25, P688, DOI 10.1016/j.bios.2009.07.037; Gorti VA, 2008, LANGMUIR, V24, P2947, DOI 10.1021/la703224b; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kalashnikov M, 2012, LAB CHIP, V12, P4523, DOI 10.1039/c2lc40531h; KEANE RD, 1992, APPL SCI RES, V49, P191, DOI 10.1007/BF00384623; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kinnunen P, 2011, BIOSENS BIOELECTRON, V26, P2751, DOI 10.1016/j.bios.2010.10.010; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Langevin P., 1908, CR ACAD SCI PARIS, V146; Leptos KC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198103; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Liu TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1546; Longo G, 2013, NAT NANOTECHNOL, V8, P522, DOI [10.1038/nnano.2013.120, 10.1038/NNANO.2013.120]; Mino G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048102; Mohan R, 2013, BIOSENS BIOELECTRON, V49, P118, DOI 10.1016/j.bios.2013.04.046; Rafai S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.098102; Sie YS, 2014, MICROFLUID NANOFLUID, V16, P65, DOI 10.1007/s10404-013-1219-4; Sinn I, 2012, ANAL CHEM, V84, P5250, DOI 10.1021/ac300128p; Sokolov A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.148101; Wang KC, 2014, LAB CHIP, V14, P3958, DOI 10.1039/c4lc00661e; Weibull E, 2014, J CLIN MICROBIOL, V52, P3310, DOI 10.1128/JCM.01161-14; Weile J, 2009, ANAL BIOANAL CHEM, V394, P731, DOI 10.1007/s00216-009-2779-8; Wen JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05191; Wu MM, 2006, APPL ENVIRON MICROB, V72, P4987, DOI 10.1128/AEM.00158-06; Yongsunthon R, 2006, J ELECTRON SPECTROSC, V150, P228, DOI 10.1016/j.elspec.2005.06.012	38	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148864	10.1371/journal.pone.0148864	http://dx.doi.org/10.1371/journal.pone.0148864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863001	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600117
J	Park, JR; Ahn, JH; Jung, MH; Koh, JS; Park, Y; Hwang, SJ; Jeong, YH; Kwak, CH; Lee, YS; Seo, HG; Kim, JH; Hwang, JY				Park, Jeong Rang; Ahn, Jong Hwa; Jung, Myeong Hee; Koh, Jin-Sin; Park, Yongwhi; Hwang, Seok-Jae; Jeong, Young-Hoon; Kwak, Choong Hwan; Lee, Young Soo; Seo, Han Geuk; Kim, Jin Hyun; Hwang, Jin-Yong			Effects of Peroxisome Proliferator-Activated Receptor-delta Agonist on Cardiac Healing after Myocardial Infarction	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; PPAR-DELTA; MYOFIBROBLAST DIFFERENTIATION; ISCHEMIA/REPERFUSION INJURY; MATRIX METALLOPROTEINASES; FIBROBLAST PROLIFERATION; INHIBITION; MECHANISMS; HEART	Peroxisome proliferator-activated receptor-delta (PPAR-delta)-dependent signaling is associated with rapid wound healing in the skin. Here, we investigated the therapeutic effects of PPAR-delta-agonist treatment on cardiac healing in post-myocardial infarction (MI) rats. Animals were assigned to the following groups: sham-operated control group, left anterior descending coronary artery ligation (MI) group, or MI with administration of the PPAR-delta agonist GW610742 group. GW610742 (1 mg/kg) was administrated intraperitoneally after the operation and repeated every 3 days. Echocardiographic data showed no differences between the two groups in terms of cardiac function and remodeling until 4 weeks. However, the degrees of angiogenesis and fibrosis after MI were significantly higher in the GW610742-treated rats than in the untreated MI rats at 1 week following MI, which changes were not different at 2 weeks after MI. Naturally, PPAR-delta expression in infarcted myocardium was highest increased in 3 day after MI and then disappeared in 14 day after MI. GW610742 increased myofibroblast differentiation and transforming growth factor-beta 2 expression in the infarct zone at 7 days after MI. GW610742 also increased bone marrowderived mesenchymal stem cell (MSC) recruitment in whole myocardium, and increased serum platelet-derived growth factor B, stromal-derived factor-1 alpha, and matrix metallopeptidase 9 levels at day 3 after MI. PPAR-delta agonists treatment have the temporal effect on early fibrosis of infarcted myocardium, which might not sustain the functional and structural beneficial effect.	[Park, Jeong Rang; Ahn, Jong Hwa; Koh, Jin-Sin; Park, Yongwhi; Hwang, Seok-Jae; Jeong, Young-Hoon; Kwak, Choong Hwan; Hwang, Jin-Yong] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Jinju, South Korea; [Park, Jeong Rang; Ahn, Jong Hwa; Koh, Jin-Sin; Park, Yongwhi; Hwang, Seok-Jae; Jeong, Young-Hoon; Kwak, Choong Hwan; Hwang, Jin-Yong] Gyeongsang Natl Univ Hosp, Jinju, South Korea; [Park, Jeong Rang; Ahn, Jong Hwa; Koh, Jin-Sin; Park, Yongwhi; Hwang, Seok-Jae; Jeong, Young-Hoon; Kwak, Choong Hwan; Kim, Jin Hyun; Hwang, Jin-Yong] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea; [Jung, Myeong Hee; Kim, Jin Hyun] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, South Korea; [Lee, Young Soo] Gyeongsang Natl Univ, Dept Pharmacol, Sch Med, Jinju, South Korea; [Seo, Han Geuk] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Konkuk University	Hwang, JY (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Jinju, South Korea.; Hwang, JY (corresponding author), Gyeongsang Natl Univ Hosp, Jinju, South Korea.; Kim, JH; Hwang, JY (corresponding author), Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea.; Kim, JH (corresponding author), Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, South Korea.	ajini7044@hanmail.net; jyhwang@gnu.ac.kr	Jeong, Young-Hoon/F-3476-2015; Jeong, Young-Hoon/AAO-4401-2020	Jeong, Young-Hoon/0000-0003-0403-3726; Kwak, Choong Hwan/0000-0001-6035-4415	Gyeongsang National University Hospital [GNUHBRIF-2013-0006]	Gyeongsang National University Hospital	This work was supported by biomedical research institute funds (GNUHBRIF-2013-0006) from Gyeongsang National University Hospital.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; dos Santos L, 2008, BRAZ J MED BIOL RES, V41, P199, DOI 10.1590/S0100-879X2008005000007; Frantz S, 2008, BASIC RES CARDIOL, V103, P485, DOI 10.1007/s00395-008-0739-7; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Ham SA, 2010, J CELL MOL MED, V14, P1747, DOI 10.1111/j.1582-4934.2009.00816.x; Han JK, 2008, CIRCULATION, V118, P1021, DOI 10.1161/CIRCULATIONAHA.108.777169; Han JK, 2013, EUR HEART J, V34, P1755, DOI 10.1093/eurheartj/ehr365; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kapoor A, 2010, SHOCK, V34, P117, DOI 10.1097/SHK.0b013e3181cd86d6; Kim HJ, 2008, CIRC RES, V102, P193, DOI 10.1161/CIRCRESAHA.107.158477; Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005; Nedeau AE, 2008, EXP CELL RES, V314, P2176, DOI 10.1016/j.yexcr.2008.04.007; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; Shi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028134; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Vanhoutte D, 2006, CARDIOVASC RES, V69, P604, DOI 10.1016/j.cardiores.2005.10.002; Yue TL, 2008, J PHARMACOL EXP THER, V325, P466, DOI 10.1124/jpet.107.135327; Zamilpa R, 2010, J MOL CELL CARDIOL, V48, P558, DOI 10.1016/j.yjmcc.2009.06.012	26	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148510	10.1371/journal.pone.0148510	http://dx.doi.org/10.1371/journal.pone.0148510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862756	gold, Green Published			2022-12-26	WOS:000370046600079
J	Rosenbaum, S; Hirwa, JP; Silk, JB; Vigilant, L; Stoinski, TS				Rosenbaum, Stacy; Hirwa, Jean Paul; Silk, Joan B.; Vigilant, Linda; Stoinski, Tara S.			Infant Mortality Risk and Paternity Certainty Are Associated with Postnatal Maternal Behavior toward Adult Male Mountain Gorillas (Gorilla beringei beringei)	PLOS ONE			English	Article							MALE-FEMALE RELATIONSHIPS; SOCIAL RELATIONSHIPS; MULTIMALE GROUPS; REPRODUCTIVE COMPETITION; INDUCED-ABORTION; SEXUAL-BEHAVIOR; PRIMATE SOCIETY; MALE TAKEOVERS; WILD GELADAS; LIFE-HISTORY	Sexually selected infanticide is an important source of infant mortality in many mammalian species. In species with long-term male-female associations, females may benefit from male protection against infanticidal outsiders. We tested whether mountain gorilla (Gorilla beringei beringei) mothers in single and multi-male groups monitored by the Dian Fossey Gorilla Fund's Karisoke Research Center actively facilitated interactions between their infants and a potentially protective male. We also evaluated the criteria mothers in multi-male groups used to choose a preferred male social partner. In single male groups, where infanticide risk and paternity certainty are high, females with infants <1 year old spent more time near and affiliated more with males than females without young infants. In multi-male groups, where infanticide rates and paternity certainty are lower, mothers with new infants exhibited few behavioral changes toward males. The sole notable change was that females with young infants proportionally increased their time near males they previously spent little time near when compared to males they had previously preferred, perhaps to encourage paternity uncertainty and deter aggression. Rank was a much better predictor of females' social partner choice than paternity. Older infants (2-3 years) in multi-male groups mirrored their mothers' preferences for individual male social partners; 89% spent the most time in close proximity to the male their mother had spent the most time near when they were <1 year old. Observed discrepancies between female behavior in single and multi-male groups likely reflect different levels of postpartum intersexual conflict; in groups where paternity certainty and infanticide risk are both high, male-female interests align and females behave accordingly. This highlights the importance of considering individual and group-level variation when evaluating intersexual conflict across the reproductive cycle.	[Rosenbaum, Stacy] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Hirwa, Jean Paul] Dian Fossey Gorilla Fund Int, Musanze, Rwanda; [Silk, Joan B.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Silk, Joan B.] Arizona State Univ, Inst Human Origins, Tempe, AZ USA; [Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Stoinski, Tara S.] Dian Fossey Gorilla Fund Int, Atlanta, GA USA	University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Max Planck Society	Rosenbaum, S (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	srosenbaum@uchicago.edu		Rosenbaum, Stacy/0000-0002-7576-5302	LSB Leakey Foundation; National Science Foundation SBE Doctoral Dissertation Improvement Grant [1122321]; Wenner-Gren Foundation for Anthropological Research Dissertation Research Grant [201101446]; Rwandan government; Volcanoes National Park authorities; SBE Off Of Multidisciplinary Activities [1552185] Funding Source: National Science Foundation	LSB Leakey Foundation; National Science Foundation SBE Doctoral Dissertation Improvement Grant; Wenner-Gren Foundation for Anthropological Research Dissertation Research Grant; Rwandan government; Volcanoes National Park authorities; SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by an LSB Leakey Foundation Research Grant, http://www.leakeyfoundation.org/research-grants/ (to SR & JS); a National Science Foundation SBE Doctoral Dissertation Improvement Grant #1122321 http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13453 (to SR); and a Wenner-Gren Foundation for Anthropological Research Dissertation Research Grant #201101446 http://www.wennergren.org/ programs/dissertation-fieldwork-grants (to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank W. Eckhart for contributing behavioral data, B. Scelza, S. Perry, and two anonymous reviewers for their comments on the manuscript, and P. Ender for assistance with statistical analyses. The Karisoke Research Center is a project of the Dian Fossey Gorilla Fund International (DFGFI). The authors and DFGFI thank the Rwandan government and Volcanoes National Park authorities for their long-term commitment to gorilla conservation, and their support of the Karisoke Research Center. DFGFI is greatly indebted to the many Karisoke field assistants and researchers for their work collecting demographic and behavioral data over the last 49 years. We wish to acknowledge the many staff members who have shown extraordinary commitment under dangerous conditions, in some cases giving their lives while protecting and studying the gorillas.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Arandjelovic M, 2010, BIOL CONSERV, V143, P1780, DOI 10.1016/j.biocon.2010.04.030; Arnqvist Goran, 2005, pUnpaginated; Beehner JC, 2008, AM J PRIMATOL, V70, P1152, DOI 10.1002/ajp.20614; BERGER J, 1983, NATURE, V303, P59, DOI 10.1038/303059a0; BERTRAM BCR, 1975, J ZOOL, V177, P463; BOELLSTORFF DE, 1994, ANIM BEHAV, V47, P1057, DOI 10.1006/anbe.1994.1144; Borries C, 1999, BEHAV ECOL SOCIOBIOL, V46, P350, DOI 10.1007/s002650050629; Borries C, 2011, BEHAV ECOL SOCIOBIOL, V65, P685, DOI 10.1007/s00265-010-1070-5; Bradley BJ, 2005, P NATL ACAD SCI USA, V102, P9418, DOI 10.1073/pnas.0502019102; Bradley BJ, 2001, CONSERV GENET, V2, P179, DOI 10.1023/A:1011847528045; BRUCE HM, 1960, J REPROD FERTIL, V1, P96, DOI 10.1530/jrf.0.0010096; CAMPAGNA C, 1992, ANIM BEHAV, V43, P541, DOI 10.1016/0003-3472(92)90077-M; Charpentier MJE, 2008, P NATL ACAD SCI USA, V105, P1988, DOI 10.1073/pnas.0711219105; Clarke Parry, 2009, P42; COLMENARES F, 1988, FOLIA PRIMATOL, V50, P157, DOI 10.1159/000156343; Cords M, 2010, INT J PRIMATOL, V31, P409, DOI [10.1007/s10764-010-9400-z, 10.1007/s10764-010-9405-7]; COULON J, 1995, ETHOL ECOL EVOL, V7, P191, DOI 10.1080/08927014.1995.9522965; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; Dunbar R., 1984, REPROD DECISIONS EC; Ebensperger LA, 1998, BIOL REV, V73, P321, DOI 10.1017/S0006323198005209; ELWOOD RW, 1990, ANIM BEHAV, V40, P1080, DOI 10.1016/S0003-3472(05)80174-5; Enstam KL, 2002, INT J PRIMATOL, V23, P85, DOI 10.1023/A:1013249808137; FAIRBANKS LA, 1987, INT J PRIMATOL, V8, P351, DOI 10.1007/BF02737388; FAY JM, 1995, J HUM EVOL, V29, P93, DOI 10.1006/jhev.1995.1048; Fletcher A, 2001, MOUNTAIN GORILLAS 3, P153; Goodall J, 1986, THE CHIMPANZEES OF G; Harcourt A.H., 2007, GORILLA SOC CONFLICT; HARCOURT AH, 1979, ANIM BEHAV, V27, P325, DOI 10.1016/0003-3472(79)90166-0; HARCOURT AH, 1979, ANIM BEHAV, V27, P251, DOI 10.1016/0003-3472(79)90145-3; HARCOURT AH, 1987, ANIM BEHAV, V35, P182, DOI 10.1016/S0003-3472(87)80223-3; Harcourt AH, 2001, ANIM BEHAV, V62, P905, DOI 10.1006/anbe.2001.1835; Harcourt AH, 1981, REPROD BIOL GREAT AP, P310; Henzi P, 2003, EVOL ANTHROPOL, V12, P217, DOI 10.1002/evan.10121; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Huchard E, 2013, BEHAV ECOL, V24, P229, DOI 10.1093/beheco/ars158; Janson Charles H., 2000, P469, DOI 10.1017/CBO9780511542312.021; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kitchen DM, 2003, BEHAV ECOL SOCIOBIOL, V53, P374, DOI 10.1007/s00265-003-0588-1; Klemme I, 2010, BIOL LETTERS, V6, P24, DOI 10.1098/rsbl.2009.0500; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Lukas D, 2014, SCIENCE, V346, P841, DOI 10.1126/science.1257226; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; MORI U, 1985, Z TIERPSYCHOL, V67, P215; Moscovice LR, 2010, ANIM BEHAV, V79, P1007, DOI 10.1016/j.anbehav.2010.01.013; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Newton-Fisher NE, 2006, INT J PRIMATOL, V27, P1589, DOI 10.1007/s10764-006-9087-3; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; OCONNELL SM, 1994, ANIM BEHAV, V48, P687, DOI 10.1006/anbe.1994.1288; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Palombit Ryne, 2009, P377; Palombit Ryne A., 2012, P432; Palombit Ryne A., 2000, P123, DOI 10.1017/CBO9780511542312.008; PEREIRA ME, 1991, BEHAV ECOL SOCIOBIOL, V28, P141; Perry S, 2012, ADV STUD BEHAV, V44, P135, DOI 10.1016/B978-0-12-394288-3.00004-6; Persson J, 2003, WILDLIFE BIOL, V9, P21, DOI 10.2981/wlb.2003.004; PIELOU E C, 1969, P286; Pusey A. E., 1994, INFANTICIDE PARENTAL, P277; Robbins AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078256; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; Robbins MM, 1999, ANIM BEHAV, V57, P1013, DOI 10.1006/anbe.1998.1063; Robbins MM, 1996, ETHOLOGY, V102, P942; ROBBINS MM, 2001, MOUNTAIN GORILLAS 3, P00029; Roberts EK, 2012, SCIENCE, V335, P1222, DOI 10.1126/science.1213600; Rodel HG, 2008, ETHOLOGY, V114, P22, DOI 10.1111/j.1439-0310.2007.01447.x; Rosenbaum S, 2016, PRIMATES, V57, P17, DOI 10.1007/s10329-015-0490-2; Rosenbaum S, 2015, ANIM BEHAV, V104, P13, DOI 10.1016/j.anbehav.2015.02.025; Rosenbaum S, 2011, AM J PRIMATOL, V73, P356, DOI 10.1002/ajp.20905; Scelza BA, 2010, CURR ANTHROPOL, V51, P295, DOI 10.1086/651051; Shenk MK, 2012, J BIOSOC SCI, V44, P549, DOI 10.1017/S0021932012000053; SICOTTE P, 1994, ETHOLOGY, V97, P47; Sicotte P., 2001, MOUNTAIN GORILLAS 3, P59, DOI [10.1017/CBO9780511661631.004, DOI 10.1017/CBO9780511661631.004]; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; Soltis J, 2000, BEHAV ECOL SOCIOBIOL, V48, P195, DOI 10.1007/s002650000224; STEHN RA, 1981, J MAMMAL, V62, P369, DOI 10.2307/1380713; Stewart K. J., 2001, MOUNTAIN GORILLAS 3, P184; Stoinski TS, 2009, BEHAVIOUR, V146, P1193, DOI 10.1163/156853909X419992; Stoinski TS, 2009, ANIM BEHAV, V77, P1155, DOI 10.1016/j.anbehav.2008.12.030; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Teichroeb JA, 2012, BEHAV ECOL, V23, P1348, DOI 10.1093/beheco/ars128; van Dijk RE, 2008, ELS, DOI [10.1002/9780470015902.a0003665, DOI 10.1002/9780470015902.A0003665]; van Schaik Carel P., 2000, P61, DOI 10.1017/CBO9780511542312.005; VanSchaik CP, 1997, P ROY SOC B-BIOL SCI, V264, P1687, DOI 10.1098/rspb.1997.0234; Vigilant L, 2015, BEHAV ECOL SOCIOBIOL, V69, P1163, DOI 10.1007/s00265-015-1930-0; Watts David P., 1993, P148; WATTS DP, 1991, AM J PRIMATOL, V24, P211, DOI 10.1002/ajp.1350240307; Watts DP, 2000, PRIMATES, V41, P357, DOI 10.1007/BF02557646; WATTS DP, 1989, ETHOLOGY, V81, P1; WATTS DP, 1994, BEHAV ECOL SOCIOBIOL, V34, P347, DOI 10.1007/BF01209781; WATTS DP, 1992, AM J PRIMATOL, V28, P159, DOI 10.1002/ajp.1350280302; WATTS DP, 1990, ZOO BIOL, V9, P185, DOI 10.1002/zoo.1430090302; WOLFF JO, 1985, ANIM BEHAV, V33, P117, DOI 10.1016/S0003-3472(85)80125-1; WRANGHAM RW, 1993, HUM NATURE-INT BIOS, V4, P47, DOI 10.1007/BF02734089; WRANGHAM RW, 1979, SOC SCI INFORM, V18, P335; [No title captured]	101	6	6	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147441	10.1371/journal.pone.0147441	http://dx.doi.org/10.1371/journal.pone.0147441			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863300	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600030
J	Swart, EM; van Gageldonk, PGM; de Melker, HE; van der Klis, FR; Berbers, GAM; Mollema, L				Swart, E. M.; van Gageldonk, P. G. M.; de Melker, H. E.; van der Klis, F. R.; Berbers, G. A. M.; Mollema, L.			Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study	PLOS ONE			English	Article							PERTUSSIS-VACCINE; TETANUS; ANTITOXIN; ADULTS; IMMUNOGENICITY; IMMUNIZATION; SEROPREVALENCE; ANTIBODIES; IMMUNITY; CHILDREN	Background and Aims To evaluate the National Immunisation Programme (NIP) a population-based cross-sectional seroepidemiological study was performed in the Netherlands. We assessed diphtheria antitoxin levels in the general Dutch population and in low vaccination coverage (LVC) areas where a relatively high proportion of orthodox Protestants live who decline vaccination based on religious grounds. Results were compared with a nationwide seroepidemiological study performed 11 years earlier. Methods In 2006/2007 a national serum bank was established. Blood samples were tested for diphtheria antitoxin IgG concentrations using a multiplex immunoassay for 6383 participants from the national sample (NS) and 1518 participants from LVC municipalities. A cut-off above 0.01 international units per ml (IU/ml) was used as minimum protective level. Results In the NS 91% of the population had antibody levels above 0.01 IU/ml compared to 88% in the 1995/1996 serosurvey (p<0.05). On average, 82% (vs. 78% in the 1995/1996 serosurvey, p<0.05) of individuals from the NS born before introduction of diphtheria vaccination in the NIP and 46% (vs. 37% in the 1995/1996 serosurvey, p = 0.11) of orthodox Protestants living in LVC areas had antibody levels above 0.01 IU/ml. Linear regression analysis among fully immunized individuals (six vaccinations) without evidence of revaccination indicated a continuous decline in antibodies in both serosurveys, but geometric mean antibodies remained well above 0.01 IU/ml in all age groups. Conclusions The NIP provides long-term protection against diphtheria, although antibody levels decline after vaccination. As a result of natural waning immunity, a substantial proportion of individuals born before introduction of diphtheria vaccination in the NIP lack adequate levels of diphtheria antibodies. Susceptibility due to lack of vaccination is highest among strictly orthodox Protestants. The potential risk of spread of diphtheria within the geographically clustered orthodox Protestant community after introduction in the Netherlands has not disappeared, despite national long-term high vaccination coverage.	[Swart, E. M.; van Gageldonk, P. G. M.; de Melker, H. E.; van der Klis, F. R.; Berbers, G. A. M.; Mollema, L.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Swart, EM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	esther.swart@rivm.nl		van Gageldonk, Pieter/0000-0003-2753-9674				31European Commission, 2015, CAS DIPHTH SPAIN, P8; Bickel P.J., 2001, MATH STAT BASIC IDEA; BOOY R, 1992, LANCET, V339, P507, DOI 10.1016/0140-6736(92)90336-2; Both L, 2014, EUROSURVEILLANCE, V19, P19, DOI 10.2807/1560-7917.ES2014.19.24.20830; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; de Melker HE, 1999, EMERG INFECT DIS, V5, P694, DOI 10.3201/eid0505.990511; Di Giovine P, 2013, EPIDEMIOL INFECT, V141, P132, DOI 10.1017/S0950268812000210; Di Giovine P, 2010, CLIN VACCINE IMMUNOL, V17, P1282, DOI 10.1128/CVI.00096-10; Dittmann S, 2000, J INFECT DIS, V181, pS10, DOI 10.1086/315534; Galazka A, 2000, J INFECT DIS, V181, pS2, DOI 10.1086/315533; Hardy IRB, 1996, LANCET, V347, P1739, DOI 10.1016/S0140-6736(96)90811-9; Health Council of the Netherlands, 2004, VACC PERT; HENDRIKSEN CFM, 1989, J BIOL STAND, V17, P191, DOI 10.1016/0092-1157(89)90009-7; Hoppenbrouwers K, 2011, HDB VACCINATIES A; Kurugol Z, 2011, VACCINE, V29, P4341, DOI 10.1016/j.vaccine.2011.04.016; Melker HE, 2015, RIVM REPORT 2015 013; Melker HE, 2014, 1502020022013 RIVM; Miller E, 1997, VACCINE, V15, P51, DOI 10.1016/S0264-410X(96)00112-0; Mollema L, 2009, PIENTER 2 PROJECT 2; Neal S, 2007, Euro Surveill, V12, pE9; Olander RM, 2009, VACCINE, V27, P5295, DOI 10.1016/j.vaccine.2009.06.080; PICHICHERO ME, 1987, PEDIATR INFECT DIS J, V6, P352, DOI 10.1097/00006454-198704000-00004; R Core Team, 2021, R LANGUAGE ENV STAT; RAMSAY MEB, 1993, LANCET, V342, P203, DOI 10.1016/0140-6736(93)92298-8; Ruijs WLM, 2012, EUR J PUBLIC HEALTH, V22, P359, DOI 10.1093/eurpub/ckr081; Scheifele D., 2009, IMMUNOLOGICAL BASIS; Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052; van den Hof S, 1997, 213675005 RIVM; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2011, CLIN VACCINE IMMUNOL, V18, P1183, DOI 10.1128/CVI.05081-11; van Lier EA, 2014, 1502020032014 RIVM; Volzke H, 2006, CLIN MICROBIOL INFEC, V12, P961, DOI 10.1111/j.1469-0691.2006.01477.x; von Hunolstein C, 2014, J IMMUNOL CLIN RES, V2, P1022; Wagner KS, 2009, VACCINE, V28, P14, DOI 10.1016/j.vaccine.2009.09.094; Wagner KS, 2012, VACCINE, V30, P7111, DOI 10.1016/j.vaccine.2012.09.029; Zasada AA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-551	36	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148605	10.1371/journal.pone.0148605	http://dx.doi.org/10.1371/journal.pone.0148605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863307	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600084
J	Fu, X; Xie, FN; Dong, P; Li, QC; Yu, GY; Xiao, R				Fu, Xin; Xie, Fang-Nan; Dong, Ping; Li, Qiu-Chen; Yu, Guang-Yan; Xiao, Ran			High-Dose Fluoride Impairs the Properties of Human Embryonic Stem Cells via JNK Signaling	PLOS ONE			English	Article							IN-VITRO MODEL; SODIUM-FLUORIDE; DEVELOPMENTAL TOXICITY; BCL-2 FAMILY; INDUCED APOPTOSIS; PROGENITOR CELLS; DRINKING-WATER; DIFFERENTIATION; BODIES; PROTEIN	Fluoride is a ubiquitous natural substance that is often used in dental products to prevent dental caries. The biphasic actions of fluoride imply that excessive systemic exposure to fluoride can cause harmful effects on embryonic development in both animal models and humans. However, insufficient information is available on the effects of fluoride on human embryonic stem cells (hESCs), which is a novel in vitro humanized model for analyzing the embryotoxicities of chemical compounds. Therefore, we investigated the effects of sodium fluoride (NaF) on the proliferation, differentiation and viability of H9 hESCs. For the first time, we showed that 1 mM NaF did not significantly affect the proliferation of hESCs but did disturb the gene expression patterns of hESCs during embryoid body (EB) differentiation. Higher doses of NaF (2 mM and above) markedly decreased the viability and proliferation of hESCs. The mode and underlying mechanism of high-dose NaF-induced cell death were further investigated by assessing the sub-cellular morphology, mitochondrial membrane potential (MMP), caspase activities, cellular reactive oxygen species (ROS) levels and activation of mitogen-activated protein kinases (MAPKs). High-dose NaF caused the death of hESCs via apoptosis in a caspase-mediated but ROS-independent pathway, coupled with an increase in the phospho-c-Jun N-terminal kinase (p-JNK) levels. Pretreatment with a p-JNK-specific inhibitor (SP600125) could effectively protect hESCs from NaF-induced cell death in a concentration-and time-dependent manner. These findings suggest that NaF might interfere with early human embryogenesis by disturbing the specification of the three germ layers as well as osteogenic lineage commitment and that high-dose NaF could cause apoptosis through a JNK-dependent pathway in hESCs.	[Fu, Xin; Xie, Fang-Nan; Dong, Ping; Li, Qiu-Chen; Xiao, Ran] Chinese Acad Med Sci, Res Ctr Plast Surg Hosp, 33 Ba Da Chu Rd, Beijing, Peoples R China; [Fu, Xin; Xie, Fang-Nan; Dong, Ping; Li, Qiu-Chen; Xiao, Ran] Peking Union Med Coll, 33 Ba Da Chu Rd, Beijing, Peoples R China; [Yu, Guang-Yan] Peking Univ, Dept Oral & Maxillofacial Surg, Sch Stomatol, 22 Zhong Guan Cun South St, Beijing 100081, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Xiao, R (corresponding author), Chinese Acad Med Sci, Res Ctr Plast Surg Hosp, 33 Ba Da Chu Rd, Beijing, Peoples R China.; Xiao, R (corresponding author), Peking Union Med Coll, 33 Ba Da Chu Rd, Beijing, Peoples R China.	xiaoran@psh.pumc.edu.cn			National Natural Science Foundation of China [31201102, 30871433, 31071305]; International S&T Cooperation Program of China [2011DFA32190]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) with grants numbers as 31201102 (XF), 30871433 (RX) and 31071305 (RX); and from International S&T Cooperation Program of China (http://www.istcp.org.cn) with grant number as 2011DFA32190 (GYY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler S, 2008, TOXICOL IN VITRO, V22, P200, DOI 10.1016/j.tiv.2007.07.013; Agalakova N. I., 2012, ISRN CELL BIOL, V2012, DOI [10.5402/2012/403835, DOI 10.5402/2012/403835]; [Anonymous], 2011, ENCY ENV HLTH; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Chlubek D, 2003, J TRACE ELEM MED BIO, V17, P57, DOI 10.1016/S0946-672X(03)80047-0; Choi AL, 2012, ENVIRON HEALTH PERSP, V120, P1362, DOI 10.1289/ehp.1104912; Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009; de Jong E, 2012, TOXICOL IN VITRO, V26, P970, DOI 10.1016/j.tiv.2012.05.015; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Everett ET, 2011, J DENT RES, V90, P552, DOI 10.1177/0022034510384626; Feraud O, 2001, LAB INVEST, V81, P1669, DOI 10.1038/labinvest.3780380; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; FRENI SC, 1994, J TOXICOL ENV HEALTH, V42, P109, DOI 10.1080/15287399409531866; Gao XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108510; Goh EH, 2003, FOOD CHEM TOXICOL, V41, P1501, DOI 10.1016/S0278-6915(03)00166-2; Griffin SO, 2007, J DENT RES, V86, P410, DOI 10.1177/154405910708600504; Gupta RS, 2007, TOXICOL IND HEALTH, V23, P507, DOI 10.1177/0748233708089041; HALL BK, 1987, BONE, V8, P111, DOI 10.1016/8756-3282(87)90079-2; Haneline LS, 2008, ANTIOXID REDOX SIGN, V10, P1849, DOI 10.1089/ars.2008.2141; Hong EJ, 2013, TOX RESEARCH, V29, P221, DOI 10.5487/TR.2013.29.4.221; Kopper O, 2010, STEM CELLS, V28, P75, DOI 10.1002/stem.260; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Krtolica A, 2009, REGEN MED, V4, P449, DOI [10.2217/rme.09.13, 10.2217/RME.09.13]; Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; LANTZ O, 1987, AM J KIDNEY DIS, V10, P136, DOI 10.1016/S0272-6386(87)80046-X; Lau KHW, 1998, J BONE MINER RES, V13, P1660, DOI 10.1359/jbmr.1998.13.11.1660; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee JH, 2008, TOXICOLOGY, V243, P340, DOI 10.1016/j.tox.2007.10.026; Lee YE, 2010, J DENT, V38, P166, DOI 10.1016/j.jdent.2009.10.002; Li P, 2013, TOXICOLOGY, V308, P138, DOI 10.1016/j.tox.2013.03.016; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Meganathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044228; Mehta A, 2008, CELL BIOL INT, V32, P1412, DOI 10.1016/j.cellbi.2008.08.012; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; Oguro A, 2003, IN VITRO CELL DEV-AN, V39, P243; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pettinato G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100742; Reddy GB, 2003, TOXICOL SCI, V72, P363, DOI 10.1093/toxsci/kfg030; Rohwedel J, 2001, TOXICOL IN VITRO, V15, P741, DOI 10.1016/S0887-2333(01)00074-1; Sherlin DMG, 2001, NEUROTOXICOL TERATOL, V23, P197, DOI 10.1016/S0892-0362(00)00123-9; Shi Jingpu, 1995, Zhonghua Yufang Yixue Zazhi, V29, P103; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tam DNN, 2012, TOXICOL APPL PHARM, V259, P329, DOI 10.1016/j.taap.2012.01.010; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thrane EV, 2001, TOXICOL SCI, V61, P83, DOI 10.1093/toxsci/61.1.83; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Warkus ELL, 2016, TOXICOL SCI, V149, P15, DOI 10.1093/toxsci/kfv209; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Xiong XZ, 2007, ENVIRON RES, V103, P112, DOI 10.1016/j.envres.2006.05.008; Yang SY, 2011, BIOCHEM BIOPH RES CO, V410, P910, DOI 10.1016/j.bbrc.2011.06.094; Zhang M, 2008, TOXICOL LETT, V179, P1, DOI 10.1016/j.toxlet.2008.03.002; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou X, 2003, DEV BIOL, V255, P407, DOI 10.1016/S0012-1606(02)00080-5; Zhu JQ, 2014, ARCH TOXICOL, V88, P241, DOI 10.1007/s00204-013-1122-5	61	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148819	10.1371/journal.pone.0148819	http://dx.doi.org/10.1371/journal.pone.0148819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859149	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400092
J	Pereboeva, L; Hubbard, M; Goldman, FD; Westin, ER				Pereboeva, Larisa; Hubbard, Meredith; Goldman, Frederick D.; Westin, Erik R.			Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells	PLOS ONE			English	Article							BONE-MARROW FAILURE; TELOMERE BIOLOGY; HEMATOPOIETIC STEM; OXIDATIVE STRESS; FANCONI-ANEMIA; LIFE-SPAN; P53; MUTATIONS; DISEASE; PROTEIN	Dyskeratosis Congenita (DC) is an inherited multisystem premature aging disorder with characteristic skin and mucosal findings as well as a predisposition to cancer and bone marrow failure. DC arises due to gene mutations associated with the telomerase complex or telomere maintenance, resulting in critically shortened telomeres. The pathogenesis of DC, as well as several congenital bone marrow failure (BMF) syndromes, converges on the DNA damage response (DDR) pathway and subsequent elevation of reactive oxygen species (ROS). Historically, DC patients have had poor outcomes following bone marrow transplantation (BMT), perhaps as a consequence of an underlying DNA hypersensitivity to cytotoxic agents. Previously, we demonstrated an activated DDR and increased ROS, augmented by chemotherapy and radiation, in somatic cells isolated from DC patients with a mutation in the RNA component of telomerase, TERC. The current study was undertaken to determine whether previous findings related to ROS and DDR in TERC patients' cells could be extended to other DC mutations. Of particular interest was whether an antioxidant approach could counter increased ROS and decrease DC pathologies. To test this, we examined lymphocytes from DC patients from different DC mutations (TERT, TINF2, and TERC) for the presence of an active DDR and increased ROS. All DC mutations led to increased steady-state p53 (2-fold to 10-fold) and ROS (1.5-fold to 2-fold). Upon exposure to ionizing radiation (XRT), DC cells increased in both DDR and ROS to a significant degree. Exposing DC cells to hydrogen peroxide also revealed that DC cells maintain a significant oxidant burden compared to controls (1.5-fold to 3-fold). DC cell culture supplemented with N-acetylcysteine, or alternatively grown in low oxygen, afforded significant proliferative benefits (proliferation: maximum 2-fold increase; NAC: 5-fold p53 decrease; low oxygen: maximum 3.5-fold p53 decrease). Together, our data supports a mechanism whereby telomerase deficiency and subsequent shortened telomeres initiate a DDR and create a pro-oxidant environment, especially in cells carrying the TINF2 mutations. Finally, the ameliorative effects of antioxidants in vitro suggest this could translate to therapeutic benefits in DC patients.	[Pereboeva, Larisa] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA; [Hubbard, Meredith; Goldman, Frederick D.; Westin, Erik R.] Univ Alabama Birmingham, Dept Pediat, Div Hematol Oncol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Westin, ER (corresponding author), Univ Alabama Birmingham, Dept Pediat, Div Hematol Oncol, Birmingham, AL USA.	erik.r.westin@gmail.com			DoD [W81XWH-15-1-0099]; Kaul Pediatric Research Institute (UAB School of Medicine); Kaul Pediatric Research Institute (FDG); Department of Defense (FDG) [W81XWH-15-1-0099]	DoD(United States Department of Defense); Kaul Pediatric Research Institute (UAB School of Medicine); Kaul Pediatric Research Institute (FDG); Department of Defense (FDG)(United States Department of Defense)	This work was supported by DoD: W81XWH-15-1-0099 (http://cdmrp.army.mil/default.shtml) and Kaul Pediatric Research Institute (UAB School of Medicine) (https://www.uab.edu/medicine/peds/residency-program/18-fac-staff/fac-dev/48-kprigrant-info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially funded by the Kaul Pediatric Research Institute (FDG) and the Department of Defense (FDG; W81XWH-15-1-0099).	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Avery-Kiejda KA, 2008, CLIN CANCER RES, V14, P1659, DOI 10.1158/1078-0432.CCR-07-1422; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Chakraborty A, 2011, WIRES RNA, V2, P507, DOI 10.1002/wrna.73; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Darbro BW, 2006, ONCOGENE, V25, P7421, DOI 10.1038/sj.onc.1209729; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dietz AC, 2011, BONE MARROW TRANSPL, V46, P98, DOI 10.1038/bmt.2010.65; Dokal I, 2015, EUR J HUM GENET, V23, DOI 10.1038/ejhg.2014.170; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Du HY, 2007, AGING CELL, V6, P689, DOI 10.1111/j.1474-9726.2007.00324.x; Goldman FD, 2008, BLOOD, V111, P4523, DOI 10.1182/blood-2007-10-120204; Griffiths HR, 2011, BIOCHEM SOC T, V39, P1273, DOI 10.1042/BST0391273; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Gu BW, 2009, CELL CYCLE, V8, P6, DOI 10.4161/cc.8.1.7265; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kirwan M, 2011, BRIT J HAEMATOL, V153, P634, DOI 10.1111/j.1365-2141.2011.08679.x; Knudson M, 2005, BLOOD, V105, P682, DOI 10.1182/blood-2004-04-1673; Lee MS, 2009, J DERMATOL SCI, V56, P154, DOI 10.1016/j.jdermsci.2009.08.008; Manguan-Garcia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101424; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; PACKER L, 1977, P NATL ACAD SCI USA, V74, P1640, DOI 10.1073/pnas.74.4.1640; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Pereboeva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076473; Rani R, 2008, CANCER RES, V68, P9693, DOI 10.1158/0008-5472.CAN-08-1790; Reeves DA, 2015, BLOOD CELL MOL DIS, V55, P189, DOI 10.1016/j.bcmd.2015.06.007; Richardson C, 2015, INT J MOL SCI, V16, P2366, DOI 10.3390/ijms16022366; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Roesslein M, 2013, INT J MOL SCI, V14, P24320, DOI 10.3390/ijms141224320; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Solyakov L, 2009, ONCOGENE, V28, P3619, DOI 10.1038/onc.2009.225; Stout GJ, 2009, DIS MODEL MECH, V2, P139, DOI 10.1242/dmm.002121; Tummala H, 2015, J CLIN INVEST, V125, P2151, DOI 10.1172/JCI78963; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; Yang D, 2011, J BIOL CHEM, V286, P23022, DOI 10.1074/jbc.M111.225870; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	50	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148793	10.1371/journal.pone.0148793	http://dx.doi.org/10.1371/journal.pone.0148793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859482	Green Submitted, gold, Green Published			2022-12-26	WOS:000370038400086
J	Su, YC; Davuluri, GVN; Chen, CH; Shiau, DC; Chen, CC; Chen, CL; Lin, YS; Chang, CP				Su, Yu-Chi; Davuluri, Goutham Venkata Naga; Chen, Cheng-Hao; Shiau, Dong-Che; Chen, Chien-Chin; Chen, Chia-Ling; Lin, Yee-Shin; Chang, Chih-Peng			Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma	PLOS ONE			English	Article							INDUCED APOPTOSIS; OVARIAN-CANCER; CELL-ADHESION; LIVER-CANCER; CHEMOTHERAPY; PROGRESSION; INHIBITION; GALECTINS; DIFFERENTIATION; CHEMORESISTANCE	Hepatocellular carcinoma (HCC) is one of the most common cancers in Taiwan. Although chemotherapy is the primary treatment for HCC patients, drug resistance often leads to clinical failure. Galectin-1 is a beta-galactoside binding lectin which is up-regulated in HCC patients and promotes tumor growth by mediating cancer cell adhesion, migration and proliferation, but its role in chemoresistance of HCC is poorly understood. In this study we found that galectin-1 is able to lead to chemoresistance against cisplatin treatment, and subsequent inhibition has reversed the effect of cell death in HCC cells. Moreover, galectin-1 was found to induce autophagic flux in HCC cells. Inhibition of autophagy by inhibitors or knockdown of Atg5 cancels galectin-1-induced cisplatin resistance in HCC cells. Increase of mitophagy triggered by galectin-1 was found to reduce the mitochondrial potential loss and apoptosis induced by cisplatin treatment. Finally, using an in situ hepatoma mouse model, we clearly demonstrated that inhibition of galectin-1 by thiodigalactoside could significantly augment the anti-HCC effect of cisplatin. Taken together, our findings offer a new insight into the chemoresistance galectin-1 causes against cisplatin treatment, and points to a potential approach to improve the efficacy of cisplatin in the treatment of HCC patients.	[Su, Yu-Chi; Chen, Cheng-Hao; Shiau, Dong-Che; Lin, Yee-Shin; Chang, Chih-Peng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Davuluri, Goutham Venkata Naga; Lin, Yee-Shin; Chang, Chih-Peng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; [Chen, Chien-Chin] Chia Yi Christian Hosp, Dept Pathol, Chiayi 600, Taiwan; [Chen, Chien-Chin] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan 701, Taiwan; [Chen, Chia-Ling] Taipei Med Univ, Translat Res Ctr, Taipei 110, Taiwan; [Lin, Yee-Shin; Chang, Chih-Peng] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; Chia Nan University of Pharmacy & Science; Taipei Medical University; National Cheng Kung University	Chang, CP (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan.; Chang, CP (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan.; Chang, CP (corresponding author), Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan.	cpchang@mail.ncku.edu.tw	Chen, Chien-Chin/A-9977-2016	Chen, Chien-Chin/0000-0001-9599-0884; Chang, Chih-Peng/0000-0002-0061-3478	Ministry of Science and Technology, Taiwan [NSC 102-2320-B-006 -024 -MY3, MOST 104-2320-B-006 -038 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC 102-2320-B-006 -024 -MY3 and MOST 104-2320-B-006 -038 -MY3 from the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando E, 2002, CANCER-AM CANCER SOC, V95, P588, DOI 10.1002/cncr.10694; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Chang CP, 2013, CELL DEATH DIFFER, V20, P515, DOI 10.1038/cdd.2012.146; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Chourasia AH, 2015, AUTOPHAGY, V11, P1937, DOI 10.1080/15548627.2015.1085136; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Espelt MV, 2011, HEPATOLOGY, V53, P2097, DOI 10.1002/hep.24294; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fong MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042265; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Hirama M, 2006, ONCOL REP, V16, P997; Hughes RC, 2001, BIOCHIMIE, V83, P667; JONES TW, 1985, LAB INVEST, V52, P363; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Mathieu V, 2012, J INVEST DERMATOL, V132, P2245, DOI 10.1038/jid.2012.142; MURATA T, 1990, BIOCHEM INT, V20, P949; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Song YJ, 2013, CANCER LETT, V339, P70, DOI 10.1016/j.canlet.2013.07.021; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Sun Y, 2013, ONCOL RES, V21, P261, DOI 10.3727/096504014X13946388748992; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wu H, 2012, J GASTROEN HEPATOL, V27, P1312, DOI 10.1111/j.1440-1746.2012.07130.x; Xu Y, 2012, CANCER LETT, V314, P232, DOI 10.1016/j.canlet.2011.09.034; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yeh CC, 2015, MOL CELL PROTEOMICS, V14, P1527, DOI 10.1074/mcp.M114.046417; Zhang P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.526	35	48	51	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148408	10.1371/journal.pone.0148408	http://dx.doi.org/10.1371/journal.pone.0148408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859293	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400039
J	Tiede, J; Wemheuer, B; Traugott, M; Daniel, R; Tscharntke, T; Ebeling, A; Scherber, C				Tiede, Julia; Wemheuer, Bernd; Traugott, Michael; Daniel, Rolf; Tscharntke, Teja; Ebeling, Anne; Scherber, Christoph			Trophic and Non-Trophic Interactions in a Biodiversity Experiment Assessed by Next-Generation Sequencing	PLOS ONE			English	Article							PTEROSTICHUS-MELANARIUS COLEOPTERA; GROUND BEETLES COLEOPTERA; INTRAGUILD PREDATION; MOLECULAR-DETECTION; PLANT DIVERSITY; PREY DNA; LAND-USE; DIET; SOIL; COMMUNITIES	Plant diversity affects species richness and abundance of taxa at higher trophic levels. However, plant diversity effects on omnivores (feeding on multiple trophic levels) and their trophic and non-trophic interactions are not yet studied because appropriate methods were lacking. A promising approach is the DNA-based analysis of gut contents using next generation sequencing (NGS) technologies. Here, we integrate NGS-based analysis into the framework of a biodiversity experiment where plant taxonomic and functional diversity were manipulated to directly assess environmental interactions involving the omnivorous ground beetle Pterostichus melanarius. Beetle regurgitates were used for NGS-based analysis with universal 18S rDNA primers for eukaryotes. We detected a wide range of taxa with the NGS approach in regurgitates, including organisms representing trophic, phoretic, parasitic, and neutral interactions with P. melanarius. Our findings suggest that the frequency of (i) trophic interactions increased with plant diversity and vegetation cover; (ii) intraguild predation increased with vegetation cover, and (iii) neutral interactions with organisms such as fungi and protists increased with vegetation cover. Experimentally manipulated plant diversity likely affects multitrophic interactions involving omnivorous consumers. Our study therefore shows that trophic and non-trophic interactions can be assessed via NGS to address fundamental questions in biodiversity research.	[Tiede, Julia; Tscharntke, Teja; Scherber, Christoph] Univ Gottingen, Agroecol, Dept Crop Sci, Grisebachstr 6, D-37077 Gottingen, Germany; [Wemheuer, Bernd; Daniel, Rolf] Univ Gottingen, Inst Microbiol & Genet, Dept Genom & Appl Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany; [Traugott, Michael] Univ Innsbruck, Inst Ecol, Mt Agr Res Unit, Technikerstr 25, A-6020 Innsbruck, Austria; [Ebeling, Anne] Univ Jena, Inst Ecol, Dornburger Str 159, D-07743 Jena, Germany; [Tiede, Julia; Scherber, Christoph] Univ Munster, Inst Landscape Ecol, Heisenbergstr 2, D-48149 Munster, Germany	University of Gottingen; University of Gottingen; University of Innsbruck; Friedrich Schiller University of Jena; University of Munster	Tiede, J (corresponding author), Univ Gottingen, Agroecol, Dept Crop Sci, Grisebachstr 6, D-37077 Gottingen, Germany.; Tiede, J (corresponding author), Univ Munster, Inst Landscape Ecol, Heisenbergstr 2, D-48149 Munster, Germany.	ju.tiede@gmail.com	Tscharntke, Teja/N-5123-2014; Tiede, Julia/AAG-5272-2019; Scherber, Christoph/B-6611-2009; Daniel, Rolf/AAQ-5933-2021	Tiede, Julia/0000-0003-0037-8559; Scherber, Christoph/0000-0001-7924-8911; Daniel, Rolf/0000-0002-8646-7925; Traugott, Michael/0000-0001-9719-5059	Deutsche Forschungsgemeinschaft [FOR 1451/2, SCHE 1621/3-2]; Georg-August University Goettingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-August University Goettingen	CS, JT, and AE were funded by the Deutsche Forschungsgemeinschaft (grants FOR 1451/2 and SCHE 1621/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We especially acknowledge Christiane Roscher for providing data on vegetation cover, Jan-Hendrik Dudenhoffer for his support during fieldwork, Sigrid Dassen, Sarah Zieger, and Stefan Geisen for information on taxa. We thank the gardeners, technical staff, and student helpers for maintaining the experimental plots. We also thank two anonymous reviewers of PLoS ONE for useful comments and suggestions. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Funds of Georg-August University Goettingen.	Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; Bates ST, 2012, LICHENOLOGIST, V44, P137, DOI 10.1017/S0024282911000648; Bohan DA, 2000, J ANIM ECOL, V69, P367, DOI 10.1046/j.1365-2656.2000.00399.x; Bohan DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029028; Boyer S., 2015, FOOD WEBS, V3, P1, DOI DOI 10.1016/J.F00WEB.2015.02.001; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Clare EL, 2014, EVOL APPL, V7, P1144, DOI 10.1111/eva.12225; Clare EL, 2014, MOL ECOL, V23, P3618, DOI 10.1111/mec.12542; Davey JS, 2013, J APPL ECOL, V50, P271, DOI 10.1111/1365-2664.12008; Deagle BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Draganova S. A., 2010, Pesticidi i Fitomedicina, V25, P59; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Ebeling A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106529; Ebeling A, 2014, BASIC APPL ECOL, V15, P229, DOI 10.1016/j.baae.2014.02.003; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fain A., 1995, International Journal of Acarology, V21, P107; Foltan P, 2005, MOL ECOL, V14, P4147, DOI 10.1111/j.1365-294X.2005.02732.x; FORSYTHE T G, 1982, Coleopterists Bulletin, V36, P26; Gibb H, 2015, OECOLOGIA, V177, P519, DOI 10.1007/s00442-014-3101-9; Grace JB, 2014, FUNCT ECOL, V28, P787, DOI 10.1111/1365-2435.12269; Grant JB, 2006, J EXP BIOL, V209, P3018, DOI 10.1242/jeb.02335; Gross J, 1998, J INVERTEBR PATHOL, V72, P296, DOI 10.1006/jipa.1998.4781; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hector A, 2007, FUNCT ECOL, V21, P998, DOI 10.1111/j.1365-2435.2007.01308.x; HENGEVELD R, 1980, NETH J ZOOL, V30, P564, DOI 10.1163/002829679X00197; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hunter MD, 2009, AGR FOREST ENTOMOL, V11, P125, DOI 10.1111/j.1461-9563.2008.00427.x; Kefi S, 2015, ECOLOGY, V96, P291, DOI 10.1890/13-1424.1; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Lefcheck JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7936; Lilleskov EA, 2005, MYCOLOGIA, V97, P762, DOI 10.3852/mycologia.97.4.762; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Lundgren JG, 2007, ANN ENTOMOL SOC AM, V100, P275, DOI 10.1603/0013-8746(2007)100[275:BCWDTO]2.0.CO;2; Lundgren JG, 2014, MOL ECOL, V23, P3790, DOI 10.1111/mec.12700; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; LYMBERY A, 1980, J AUST ENTOMOL SOC, V19, P129; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKemey AR, 2001, BIOCONTROL SCI TECHN, V11, P81, DOI 10.1080/09583150020029763; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; O'Rorke R, 2012, MOL ECOL RESOUR, V12, P5, DOI 10.1111/j.1755-0998.2011.03091.x; O'Rorke R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042757; Olckers T, 2000, COLEOPTS BULL, V54, P497, DOI 10.1649/0010-065X(2000)054[0497:BAPHRO]2.0.CO;2; Parker JR, 1957, GRASSHOPPER EGG PODS; Petit S, 2014, EUR J ENTOMOL, DOI 10.14411/eje.2014.086; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Pompanon F, 2015, GENETICA, V143, P133, DOI 10.1007/s10709-015-9816-7; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Prasad RP, 2006, J APPL ECOL, V43, P343, DOI 10.1111/j.1365-2664.2006.01129.x; Quast C., 2012, NUCLEIC ACIDS RES, V41, pD590, DOI DOI 10.1093/NAR/GKS1219; Raso L, 2014, MOL ECOL, V23, P3744, DOI 10.1111/mec.12649; Robertson Ian C., 1992, Psyche (Cambridge), V99, P189, DOI 10.1155/1992/85675; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Ruggiero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119248; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Sienkiewicz P, 2009, POL J ENTOMOL, V4; Specht J, 2008, J ANIM ECOL, V77, P1047, DOI 10.1111/j.1365-2656.2008.01395.x; Stefana G, 2014, PEDOBIOLOGIA, V57, P205, DOI 10.1016/j.pedobi.2014.10.001; Symondson WOC, 2014, MOL ECOL, V23, P3601, DOI 10.1111/mec.12831; Symondson William O.C., 2012, P166; Symondson WOC, 2000, MOL ECOL, V9, P1279, DOI 10.1046/j.1365-294x.2000.01006.x; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Toberman H, 2008, FEMS MICROBIOL ECOL, V66, P426, DOI 10.1111/j.1574-6941.2008.00560.x; Traugott M, 2013, ECOLOGICAL NETWORKS; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vesterinen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082168; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Waldner T, 2013, SOIL BIOL BIOCHEM, V63, P116, DOI 10.1016/j.soilbio.2013.03.030; Waldner T, 2012, MOL ECOL RESOUR, V12, P669, DOI 10.1111/j.1755-0998.2012.03135.x; Wallinger C, 2014, MOL ECOL, V23, P3826, DOI 10.1111/mec.12579; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wimp GM, 2013, OECOLOGIA, V171, P505, DOI 10.1007/s00442-012-2435-4; Wolkovich EM, 2014, ECOLOGY, V95, P3376, DOI 10.1890/13-1721.1; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092	84	17	18	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148781	10.1371/journal.pone.0148781	http://dx.doi.org/10.1371/journal.pone.0148781			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859146	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400083
J	Turmel, M; de Cambiaire, JC; Otis, C; Lemieux, C				Turmel, Monique; de Cambiaire, Jean-Charles; Otis, Christian; Lemieux, Claude			Distinctive Architecture of the Chloroplast Genome in the Chlorodendrophycean Green Algae Scherffelia dubia and Tetraselmis sp CCMP 881	PLOS ONE			English	Article							DNA-SEQUENCE; COMPLETE MITOCHONDRIAL; NEPHROSELMIS-OLIVACEA; PHYLOGENETIC ANALYSES; PEDINOMONAS-MINOR; CATALYTIC INTRONS; PLASTID GENOME; P RNA; REVEALS; TOOL	The Chlorodendrophyceae is a small class of green algae belonging to the core Chlorophyta, an assemblage that also comprises the Pedinophyceae, Trebouxiophyceae, Ulvophyceae and Chlorophyceae. Here we describe for the first time the chloroplast genomes of chlorodendrophycean algae (Scherffelia dubia, 137,161 bp; Tetraselmis sp. CCMP 881, 100,264 bp). Characterized by a very small single-copy (SSC) region devoid of any gene and an unusually large inverted repeat (IR), the quadripartite structures of the Scherffelia and Tetraselmis genomes are unique among all core chlorophytes examined thus far. The lack of genes in the SSC region is offset by the rich and atypical gene complement of the IR, which includes genes from the SSC and large single-copy regions of prasinophyte and streptophyte chloroplast genomes having retained an ancestral quadripartite structure. Remarkably, seven of the atypical IR-encoded genes have also been observed in the IRs of pedinophycean and trebouxiophycean chloroplast genomes, suggesting that they were already present in the IR of the common ancestor of all core chlorophytes. Considering that the relationships among the main lineages of the core Chlorophyta are still unresolved, we evaluated the impact of including the Chlorodendrophyceae in chloroplast phylogenomic analyses. The trees we inferred using data sets of 79 and 108 genes from 71 chlorophytes indicate that the Chlorodendrophyceae is a deep-diverging lineage of the core Chlorophyta, although the placement of this class relative to the Pedinophyceae remains ambiguous. Interestingly, some of our phylogenomic trees together with our comparative analysis of gene order data support the monophyly of the Trebouxiophyceae, thus offering further evidence that the previously observed affiliation between the Chlorellales and Pedinophyceae is the result of systematic errors in phylogenetic reconstruction.	[Turmel, Monique; de Cambiaire, Jean-Charles; Otis, Christian; Lemieux, Claude] Univ Laval, Inst Biol Integrat & Syst, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	Laval University	Turmel, M (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.	monique.turmel@bcm.ulaval.ca	Lemieux, Claude/L-8831-2015; Turmel, Monique/AAC-9752-2020	Lemieux, Claude/0000-0001-9580-8042; Turmel, Monique/0000-0001-7060-035X	Natural Sciences and Engineering Research Council of Canada [2830-2007]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) (Grant No. 2830-2007 to MT and CL).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen R. A., 2005, ALGAL CULTURING TECH; Brouard JS, 2011, GENOME BIOL EVOL, V3, P505, DOI 10.1093/gbe/evr037; Brouard JS, 2010, GENOME BIOL EVOL, V2, P240, DOI 10.1093/gbe/evq014; Brouard JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-290; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Civan P, 2014, GENOME BIOL EVOL, V6, P897, DOI 10.1093/gbe/evu061; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; de la Cruz J, 2003, GENE, V321, P47, DOI 10.1016/S0378-1119(03)00831-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fucikova K, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00063; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Janouskovec J, 2013, MOL BIOL EVOL, V30, P2447, DOI 10.1093/molbev/mst144; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; KELLER MD, 1987, J PHYCOL, V23, P633; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Leliaert F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1418-3; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; LEMIEUX C, 1985, PLANT MOL BIOL, V5, P77, DOI 10.1007/BF00020089; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Lemieux C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-857; Lemieux C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0211-2; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maddison D. R., 2000, MACCLADE 4 ANALYSIS; Maddison W.P., 2015, MESQUITE A MODULAR S; Marin B, 2012, PROTIST, V163, P778, DOI 10.1016/j.protis.2011.11.004; Massjuk N., 2006, UKR BOT J, V63, P601; Matsumoto T, 2011, PROTIST, V162, P268, DOI 10.1016/j.protis.2010.07.001; Mattox K. R., 1984, SYSTEMATICS GREEN AL, V27, P29; Melkonian M., 1990, P600; Melton JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121020; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nakayama T, 1998, PROTIST, V149, P367, DOI 10.1016/S1434-4610(98)70043-4; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; Servin-Garciduenas LE, 2012, EUKARYOT CELL, V11, P1417, DOI 10.1128/EC.00244-12; Sheveleva EV, 2004, NUCLEIC ACIDS RES, V32, P803, DOI 10.1093/nar/gkh225; Siegel RW, 1996, RNA, V2, P452; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sym Stuart D., 1993, Progress in Phycological Research, V9, P281; Telford MJ, 2015, CURR BIOL, V25, pR876, DOI 10.1016/j.cub.2015.07.060; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Turmel M, 1999, PLANT CELL, V11, P1717, DOI 10.1105/tpc.11.9.1717; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Turmel M, 2015, GENOME BIOL EVOL, V7, P2062, DOI 10.1093/gbe/evv130; Turmel M, 2009, MOL BIOL EVOL, V26, P2317, DOI 10.1093/molbev/msp138; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257	59	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148934	10.1371/journal.pone.0148934	http://dx.doi.org/10.1371/journal.pone.0148934			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849226	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000188
J	Brison, Y; Malbert, Y; Czaplicki, G; Mourey, L; Remaud-Simeon, M; Tranier, S				Brison, Yoann; Malbert, Yannick; Czaplicki, Georges; Mourey, Lionel; Remaud-Simeon, Magali; Tranier, Samuel			Structural Insights into the Carbohydrate Binding Ability of an alpha-(1 -> 2) Branching Sucrase from Glycoside Hydrolase Family 70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAN-BINDING; MOLECULAR CHARACTERIZATION; DSR-E; STREPTOCOCCAL GLUCOSYLTRANSFERASE; GLUCANSUCRASE GTF180; SUGAR-BINDING; DEXTRANSUCRASE; SEQUENCE; AMBER; DOMAIN	The alpha-(1 -> 2) branching sucrase Delta N-123-GBD-CD2 is a transglucosylase belonging to glycoside hydrolase family 70 (GH70) that catalyzes the transfer of D-glucosyl units from sucrose to dextrans or gluco-oligosaccharides via the formation of alpha-(1 -> 2) glucosidic linkages. The first structures of Delta N-123-GBD-CD2 in complex with D-glucose, isomaltosyl, or isomaltotriosyl residues were solved. The glucose complex revealed three glucose-binding sites in the catalytic gorge and six additional binding sites at the surface of domains B, IV, and V. Soaking with isomaltotriose or gluco-oligosaccharides led to structures in which isomaltosyl or isomaltotriosyl residues were found in glucan binding pockets located in domain V. One aromatic residue is systematically identified at the bottom of these pockets in stacking interaction with one glucosyl moiety. The carbohydrate is also maintained by a network of hydrogen bonds and van der Waals interactions. The sequence of these binding pockets is conserved and repeatedly present in domain V of several GH70 glucansucrases known to bind alpha-glucans. These findings provide the first structural evidence of the molecular interaction occurring between isomalto-oligosaccharides and domain V of the GH70 enzymes.	[Brison, Yoann; Malbert, Yannick; Remaud-Simeon, Magali] Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France; [Malbert, Yannick; Remaud-Simeon, Magali] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Remaud-Simeon, Magali] CNRS, UMR5504, F-31400 Toulouse, France; [Czaplicki, Georges; Mourey, Lionel; Tranier, Samuel] CNRS, IPBS, 205 Route Narbonne,BP 64182, F-31077 Toulouse, France; [Czaplicki, Georges; Mourey, Lionel; Tranier, Samuel] Univ Toulouse 3, Univ Toulouse, IPBS, F-31077 Toulouse, France; [Brison, Yoann] Toulouse White Biotechnol, INRA UMS1337, CNRS UMS3582, Parc Technol Canal,3 Rue Ariane, F-31520 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); INRAE	Remaud-Simeon, M (corresponding author), LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.; Tranier, S (corresponding author), Inst Pharmacol & Biol Struct, 205 Route Narbonne,BP 64182, F-31077 Toulouse, France.	remaud@insa-toulouse.fr; samuel.tranier@ipbs.fr	Mourey, Lionel/B-5662-2009; Tranier, Samuel/C-6059-2011; Czaplicki, Georges/ABC-7047-2020	Mourey, Lionel/0000-0002-8259-1259; Czaplicki, Georges/0000-0001-5348-4107; Tranier, Samuel/0000-0001-9751-163X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105958] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM105958] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; ABO H, 1991, J BACTERIOL, V173, P989, DOI 10.1128/jb.173.3.989-996.1991; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; BANAS JA, 1990, INFECT IMMUN, V58, P667, DOI 10.1128/IAI.58.3.667-673.1990; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bozonnet S, 2002, J BACTERIOL, V184, P5753, DOI 10.1128/JB.184.20.5753-5761.2002; Brison Y, 2013, CARBOHYD POLYM, V94, P567, DOI 10.1016/j.carbpol.2013.01.064; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Brison Y, 2010, APPL MICROBIOL BIOT, V86, P545, DOI 10.1007/s00253-009-2241-z; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cote GL, 2005, J IND MICROBIOL BIOT, V32, P53, DOI 10.1007/s10295-004-0194-x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabre E, 2005, J BACTERIOL, V187, P296, DOI 10.1128/JB.187.1.296-303.2005; Falconer DJ, 2011, CARBOHYD RES, V346, P280, DOI 10.1016/j.carres.2010.10.024; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; FERRETTI JJ, 1987, J BACTERIOL, V169, P4271, DOI 10.1128/jb.169.9.4271-4278.1987; GIFFARD PM, 1991, J GEN MICROBIOL, V137, P2577, DOI 10.1099/00221287-137-11-2577; GIFFARD PM, 1993, J GEN MICROBIOL, V139, P1511, DOI 10.1099/00221287-139-7-1511; GIFFARD PM, 1994, J DENT RES, V73, P1133, DOI 10.1177/00220345940730060201; GILMORE KS, 1990, INFECT IMMUN, V58, P2452, DOI 10.1128/IAI.58.8.2452-2458.1990; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x; Joucla G, 2006, FEBS LETT, V580, P763, DOI 10.1016/j.febslet.2006.01.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kingston KB, 2002, MICROBIOL-SGM, V148, P549, DOI 10.1099/00221287-148-2-549; Komatsu H, 2007, BIOCHEMISTRY-US, V46, P8436, DOI 10.1021/bi700282c; Kozlikova B, 2014, BIOINFORMATICS, V30, P2684, DOI 10.1093/bioinformatics/btu364; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Leemhuis H, 2013, APPL MICROBIOL BIOT, V97, P181, DOI 10.1007/s00253-012-3943-1; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; LIS M, 1995, APPL ENVIRON MICROB, V61, P2040, DOI 10.1128/AEM.61.5.2040-2042.1995; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maestro B, 2011, PROTEIN ENG DES SEL, V24, P113, DOI 10.1093/protein/gzq087; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng XF, 2015, APPL MICROBIOL BIOT, V99, P5885, DOI 10.1007/s00253-014-6361-8; MOOSER G, 1988, INFECT IMMUN, V56, P880, DOI 10.1128/IAI.56.4.880-884.1988; Mori T, 2011, J AM CHEM SOC, V133, P5701, DOI 10.1021/ja200094f; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322; Nihira T, 2011, LANGMUIR, V27, P2107, DOI 10.1021/la104550m; Olvera C, 2007, MICROBIOL-SGM, V153, P3994, DOI 10.1099/mic.0.2007/008854-0; Passerini D, 2015, FEBS J, V282, P2115, DOI 10.1111/febs.13261; Pijning T, 2014, FEBS J, V281, P2159, DOI 10.1111/febs.12769; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Shah DSH, 2004, J BACTERIOL, V186, P8301, DOI 10.1128/JB.186.24.8301-8308.2004; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Suwannarangsee S, 2007, FEBS LETT, V581, P4675, DOI 10.1016/j.febslet.2007.08.062; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; TAKEO K, 1995, J CHROMATOGR A, V698, P89, DOI 10.1016/0021-9673(94)01265-G; Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5; Vettori M. H. P. B, 2012, DIALOGOS CIENC, V2012, P171, DOI [./10.7447/dc2012.018, DOI 10.7447/DC2012.018]; Vuillemin M, 2014, APPL MICROBIOL BIOT, V98, P5173, DOI 10.1007/s00253-014-5627-5; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	69	22	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7527	7540		10.1074/jbc.M115.688796	http://dx.doi.org/10.1074/jbc.M115.688796			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865636	Green Published, hybrid			2022-12-26	WOS:000383447600027
J	Mazurkewich, S; Brott, AS; Kimber, MS; Seah, SYK				Mazurkewich, Scott; Brott, Ashley S.; Kimber, Matthew S.; Seah, Stephen Y. K.			Structural and Kinetic Characterization of the 4-Carboxy-2-hydroxymuconate Hydratase from the Gallate and Protocatechuate 4,5-Cleavage Pathways of Pseudomonas putida KT2440	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOPROTOCATECHUATE DEGRADATION PATHWAY; LIGNIN-RELATED BIPHENYL; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; DEACETYLASE MSHB; 4-OXALOMESACONATE HYDRATASE; MOLECULAR CHARACTERIZATION; STRUCTURE REFINEMENT; AROMATIC-COMPOUNDS; GALLIC ACID	The bacterial catabolism of lignin and its breakdown products is of interest for applications in industrial processing of lignobiomass. The gallate degradation pathway of Pseudomonas putida KT2440 requires a 4-carboxy-2-hydroxymuconate (CHM) hydratase (GalB), which has a 12% sequence identity to a previously identified CHM hydratase (LigJ) from Sphingomonas sp. SYK-6. The structure of GalB was determined and found to be a member of the PIG-L N-acetylglucosamine deacetylase family; GalB is structurally distinct from the amidohydrolase fold of LigJ. LigJ has the same stereospecificity as GalB, providing an example of convergent evolution for catalytic conversion of a common metabolite in bacterial aromatic degradation pathways. Purified GalB contains a bound Zn2+ cofactor; however the enzyme is capable of using Fe2+ and Co2+ with similar efficiency. The general base aspartate in the PIG-L deacetylases is an alanine in GalB; replacement of the alanine with aspartate decreased the GalB catalytic efficiency for CHM by 9.5 x 10(4)-fold, and the variant enzyme did not have any detectable hydrolase activity. Kinetic analyses and pH dependence studies of the wild type and variant enzymes suggested roles for Glu-48 and His-164 in the catalytic mechanism. A comparison with the PIG-L deacetylases led to a proposed mechanism for GalB wherein Glu-48 positions and activates the metal-ligated water for the hydration reaction and His-164 acts as a catalytic acid.	[Mazurkewich, Scott; Brott, Ashley S.; Kimber, Matthew S.; Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East,Sci Complex, Guelph, ON N1G 2W1, Canada	University of Guelph	Seah, SYK (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East,Sci Complex, Guelph, ON N1G 2W1, Canada.	sseah@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586; Mazurkewich, Scott/0000-0002-9238-0615	National Science and Engineering Research Council of Canada [2015-05366]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Grant 2015-05366 from the National Science and Engineering Research Council of Canada (to S. Y. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALVAREZSANTOS S, 1994, CAN J CHEM, V72, P2077, DOI 10.1139/v94-264; Becker HM, 2014, SUBCELL BIOCHEM, V75, P105, DOI 10.1007/978-94-007-7359-2_7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadley SG, 2012, ACTA CRYSTALLOGR D, V68, P1450, DOI 10.1107/S090744491203449X; Burks EA, 1998, J AM CHEM SOC, V120, P7665, DOI 10.1021/ja9808402; Chan HC, 2011, MOL BIOSYST, V7, P1224, DOI 10.1039/c0mb00320d; DAGLEY S, 1960, NATURE, V188, P560, DOI 10.1038/188560a0; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadouloglou VE, 2007, FEBS J, V274, P3044, DOI 10.1111/j.1742-4658.2007.05834.x; Fang Z, 2013, BIOCHEM J, V454, P239, DOI 10.1042/BJ20130415; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Hara H, 2000, J BACTERIOL, V182, P6950, DOI 10.1128/JB.182.24.6950-6957.2000; Hobbs ME, 2012, BIOCHEMISTRY-US, V51, P3497, DOI 10.1021/bi300307b; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORN JM, 1991, MOL MICROBIOL, V5, P2459, DOI 10.1111/j.1365-2958.1991.tb02091.x; Huang XY, 2012, J BIOL CHEM, V287, P10424, DOI 10.1074/jbc.M111.320184; Huang XY, 2011, J BIOL CHEM, V286, P20275, DOI 10.1074/jbc.M111.234229; Izumi A, 2007, J MOL BIOL, V370, P899, DOI 10.1016/j.jmb.2007.05.006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamimura N, 2010, APPL ENVIRON MICROB, V76, P8093, DOI 10.1128/AEM.01863-10; KATAYAMA Y, 1988, FEBS LETT, V233, P129, DOI 10.1016/0014-5793(88)81369-3; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li SH, 2007, BIOSCI BIOTECH BIOCH, V71, P449, DOI 10.1271/bbb.60503; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MARUYAMA K, 1990, J BIOCHEM-TOKYO, V108, P327, DOI 10.1093/oxfordjournals.jbchem.a123201; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; McCarthy AA, 2004, J MOL BIOL, V335, P1131, DOI 10.1016/j.jmb.2003.11.034; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mine S, 2014, FEBS J, V281, P2584, DOI 10.1111/febs.12805; Ni B, 2013, APPL MICROBIOL BIOT, V97, P6031, DOI 10.1007/s00253-012-4402-8; Nogales J, 2005, J BIOL CHEM, V280, P35382, DOI 10.1074/jbc.M502585200; Nogales J, 2011, MOL MICROBIOL, V79, P359, DOI 10.1111/j.1365-2958.2010.07448.x; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Peng X, 1999, APPL ENVIRON MICROB, V65, P2789; Peng X, 1998, APPL ENVIRON MICROB, V64, P2520; Pollard JR, 1998, EUR J BIOCHEM, V251, P98, DOI 10.1046/j.1432-1327.1998.2510098.x; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; REEKE GN, 1967, P NATL ACAD SCI USA, V58, P2220, DOI 10.1073/pnas.58.6.2220; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; RITTER CS, 1973, J BACTERIOL, V113, P1064, DOI 10.1128/JB.113.2.1064-1065.1973; SHANNON LM, 1962, J BIOL CHEM, V237, P3342; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TACK BF, 1972, J BIOL CHEM, V247, P6438; TACK BF, 1972, J BIOL CHEM, V247, P6444; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Volkamer A, 2010, J CHEM INF MODEL, V50, P2041, DOI 10.1021/ci100241y; Wang WJ, 2010, J BIOL CHEM, V285, P36608, DOI 10.1074/jbc.M110.159509; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu SS, 2010, J PHYS CHEM B, V114, P9259, DOI 10.1021/jp101448j; Yoshikata T, 2014, APPL ENVIRON MICROB, V80, P7142, DOI 10.1128/AEM.02236-14; Zou Y, 2008, CHEM BIOL, V15, P533, DOI 10.1016/j.chembiol.2008.05.009	63	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7669	7686		10.1074/jbc.M115.682054	http://dx.doi.org/10.1074/jbc.M115.682054			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26867578	hybrid, Green Published			2022-12-26	WOS:000383447600038
J	Ho, NAT; Dawes, SS; Crowe, AM; Casabon, I; Gao, C; Kendall, SL; Baker, EN; Eltis, LD; Lott, JS				Ngoc Anh Thu Ho; Dawes, Stephanie S.; Crowe, Adam M.; Casabon, Israel; Gao, Chen; Kendall, Sharon L.; Baker, Edward N.; Eltis, Lindsay D.; Lott, J. Shaun			The Structure of the Transcriptional Repressor KstR in Complex with CoA Thioester Cholesterol Metabolites Sheds Light on the Regulation of Cholesterol Catabolism in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; STRUCTURE REFINEMENT; PROTEIN-PRODUCTION; TETR FAMILY; FATTY-ACIDS; SIDE-CHAIN; CRYSTALLOGRAPHY; DEGRADATION; MACROPHAGES; INFECTION	Cholesterol can be a major carbon source for Mycobacterium tuberculosis during infection, both at an early stage in the macrophage phagosome and later within the necrotic granuloma. KstR is a highly conserved TetR family transcriptional repressor that regulates a large set of genes responsible for cholesterol catabolism. Many genes in this regulon, including kstR, are either induced during infection or are essential for survival of M. tuberculosis in vivo. In this study, we identified two ligands for KstR, both of which are CoA thioester cholesterol metabolites with four intact steroid rings. A metabolite in which one of the rings was cleaved was not a ligand. We confirmed the ligand-protein interactions using intrinsic tryptophan fluorescence and showed that ligand binding strongly inhibited KstR-DNA binding using surface plasmon resonance (IC50 for ligand = 25 nM). Crystal structures of the ligand-free form of KstR show variability in the position of the DNA-binding domain. In contrast, structures of KstR.ligand complexes are highly similar to each other and demonstrate a position of the DNA-binding domain that is unfavorable for DNA binding. Comparison of ligand-bound and ligand-free structures identifies residues involved in ligand specificity and reveals a distinctive mechanism by which the ligand-induced conformational change mediates DNA release.	[Ngoc Anh Thu Ho; Dawes, Stephanie S.; Casabon, Israel; Gao, Chen; Baker, Edward N.; Lott, J. Shaun] Univ Auckland, Sch Biol Sci, 3a Symonds St, Auckland 1142, New Zealand; [Ngoc Anh Thu Ho; Dawes, Stephanie S.; Casabon, Israel; Gao, Chen; Baker, Edward N.; Lott, J. Shaun] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, 3a Symonds St, Auckland 1142, New Zealand; [Kendall, Sharon L.] Royal Vet Coll, Dept Pathol & Pathogen Biol, Royal Coll St, London NW1 0TU, England; [Crowe, Adam M.; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Casabon, Israel; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Gao, Chen] St Vincents Inst Med Res, Struct Biol Grp, 9 Princes St, Fitzroy, Vic 3065, Australia	University of Auckland; University of Auckland; University of London; University of London Royal Veterinary College; University of British Columbia; University of British Columbia; St. Vincent's Institute of Medical Research	Eltis, LD (corresponding author), Univ British Columbia, Inst Life Sci, 2350 Hlth Sci Mall\, Vancouver, BC V6T 1Z3, Canada.; Lott, JS (corresponding author), Univ Auckland, Rm 110-424B,3 Symonds St,Private Bag 92019, Auckland 1142, New Zealand.	leltis@mail.ubc.ca; s.lott@auckland.ac.nz	; Eltis, Lindsay/J-8272-2015	Ho, Thu/0000-0001-9291-8860; Baker, Edward/0000-0003-2456-7661; Lott, Shaun/0000-0003-3660-452X; Eltis, Lindsay/0000-0002-6774-8158; Kendall, Sharon/0000-0003-3277-3035; Crowe, Adam/0000-0002-5487-2520	Health Research Council of New Zealand [12/1111]; Canadian Institutes for Health Research (CIHR) [MOP-133647]; University of Auckland; CIHR; Fonds de Recherche en Sante du Quebec; Michael Smith Foundation for Health Research	Health Research Council of New Zealand(Health Research Council of New Zealand); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Auckland; CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by Health Research Council of New Zealand Program Grant 12/1111 (to E. N. B. and J. S. L.) and Canadian Institutes for Health Research (CIHR) Operating Grant MOP-133647 (to L. D. E.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a doctoral scholarship from the University of Auckland.r Supported by a CIHR doctoral fellowship.r Supported by a postdoctoral fellowship from the Fonds de Recherche en Sante du Quebec and the Michael Smith Foundation for Health Research.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Balhana RJC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1696-9; Bricogne G., 2011, BUSTER VERSION 2 8 0; Brzostek A, 2007, FEMS MICROBIOL LETT, V275, P106, DOI 10.1111/j.1574-6968.2007.00865.x; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Capyk JK, 2011, J BIOL CHEM, V286, P40717, DOI 10.1074/jbc.M111.289975; Casabon I, 2014, J BACTERIOL, V196, P579, DOI 10.1128/JB.01012-13; Casabon I, 2013, MOL MICROBIOL, V89, P1201, DOI 10.1111/mmi.12340; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crowe AM, 2015, J BIOL CHEM, V290, P872, DOI 10.1074/jbc.M114.607481; Dubnau E, 2002, INFECT IMMUN, V70, P2787, DOI 10.1128/IAI.70.6.2787-2795.2002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Fernandez E, 2014, J BIOL CHEM, V289, P17576, DOI 10.1074/jbc.M113.545715; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grkovic S, 2003, BIOCHEMISTRY-US, V42, P15226, DOI 10.1021/bi035447+; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le TBK, 2011, J MOL BIOL, V408, P40, DOI 10.1016/j.jmb.2011.02.035; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Powell HR, 2013, ACTA CRYSTALLOGR D, V69, P1195, DOI 10.1107/S0907444912048524; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; VanderVen BC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004679; Willems AR, 2008, J MOL BIOL, V376, P1377, DOI 10.1016/j.jmb.2007.12.061; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2015, GLOB TUB REP 2015; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang M, 2015, ACS INFECT DIS, V1, P110, DOI 10.1021/id500033m	48	24	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7256	7266		10.1074/jbc.M115.707760	http://dx.doi.org/10.1074/jbc.M115.707760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858250	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000383447600005
J	Beaulieu, YB; Machado, JAL; Ethier, S; Gaudreau, L; Steimle, V				Beaulieu, Yves B.; Machado, Jorge A. Leon; Ethier, Sylvain; Gaudreau, Luc; Steimle, Viktor			Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III	PLOS ONE			English	Article							LEUCINE-RICH REPEATS; TRANSCRIPTIONAL COACTIVATOR; PROTEIN; EXPRESSION; UBIQUITIN; COMPLEX; PROTEASOME; ASSOCIATION; TURNOVER; BINDING	Multiple relationships between ubiquitin-proteasome mediated protein turnover and transcriptional activation have been well documented, but the underlying mechanisms are still poorly understood. One way to induce degradation is via ubiquitination of the N-terminal alpha-amino group of proteins. The major histocompatibility complex (MHC) class II transactivator CIITA is the master regulator of MHC class II gene expression and we found earlier that CIITA is a short-lived protein. Using stable and transient transfections of different CIITA constructs into HEK-293 and HeLa cell lines, we show here that the extreme N-terminal end of CIITA isoform III induces both rapid degradation and transactivation. It is essential that this sequence resides at the N-terminal end of the protein since blocking of the N-terminal end with an epitope-tag stabilizes the protein and reduces transactivation potential. The first ten amino acids of CIITA isoform III act as a portable degron and transactivation sequence when transferred as N-terminal extension to truncated CIITA constructs and are also able to destabilize a heterologous protein. The same is observed with the N-terminal ends of several known N-terminal ubiquitination substrates, such as Id2, Cdt1 and MyoD. Arginine and proline residues within the N-terminal ends contribute to rapid turnover. The N-terminal end of CIITA isoform III is responsible for efficient in vivo recruitment to the HLA-DRA promoter and increased interaction with components of the transcription machinery, such as TBP, p300, p400/Domino, the 19S ATPase S8, and the MHC-II promoter binding complex RFX. These experiments reveal a novel function of free N-terminal ends of proteins in degradation-dependent transcriptional activation.	[Beaulieu, Yves B.; Machado, Jorge A. Leon; Ethier, Sylvain; Gaudreau, Luc; Steimle, Viktor] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Ethier, Sylvain] McGill Univ, Dept Biochem, Montreal, PQ, Canada	University of Sherbrooke; McGill University	Steimle, V (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	viktor.steimle@usherbrooke.ca			Natural Sciences and Engineering Research Council of Canada, (NSERC) [262845]; Canadian Institute for Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada, (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada, (NSERC, #262845 to VS). LG holds a Canada research chair on mechanisms of gene transcription and is supported by the Canadian Institute for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Bhat KP, 2010, IMMUNOL CELL BIOL, V88, P807, DOI 10.1038/icb.2010.45; Bhat KP, 2010, J BIOL CHEM, V285, P25893, DOI 10.1074/jbc.M110.127746; Bontron S, 1997, MOL CELL BIOL, V17, P4249, DOI 10.1128/MCB.17.8.4249; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Brown JA, 1996, IMMUNOGENETICS, V43, P88; Camacho-Carvajal MM, 2004, INT IMMUNOL, V16, P65, DOI 10.1093/intimm/dxh010; CARREL S, 1981, MOL IMMUNOL, V18, P403, DOI 10.1016/0161-5890(81)90102-4; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Drozina G, 2006, J BIOL CHEM, V281, P39963, DOI 10.1074/jbc.M608538200; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Masternak K, 2000, GENE DEV, V14, P1156; Meinnel T, 2008, PROTEOMICS, V8, P626, DOI 10.1002/pmic.200700592; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nickerson K, 2001, J BIOL CHEM, V276, P19089, DOI 10.1074/jbc.M101295200; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Otten LA, 1998, EUR J IMMUNOL, V28, P473, DOI 10.1002/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO;2-E; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Schnappauf F, 2003, EUR J IMMUNOL, V33, P2337, DOI 10.1002/eji.200323490; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; TANGUAY RM, 1993, DEV GENET, V14, P112, DOI 10.1002/dvg.1020140205; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; van den Elsen PJ, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00048; Zaman Z, 1998, COLD SPRING HARB SYM, V63, P167, DOI 10.1101/sqb.1998.63.167; Zhu XS, 2001, MOL CELL BIOL, V21, P7078, DOI 10.1128/MCB.21.20.7078-7088.2001	58	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148753	10.1371/journal.pone.0148753	http://dx.doi.org/10.1371/journal.pone.0148753			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871568	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100052
J	Arnette, C; Frye, K; Kaverina, I				Arnette, Christopher; Frye, Keyada; Kaverina, Irina			Microtubule and Actin Interplay Drive Intracellular c-Src Trafficking	PLOS ONE			English	Article							ACTIVATION; KINASE; CELLS; METASTASIS; RESISTANCE; MEMBRANE; SURVIVAL; SIGNALS; CANCER; RHOB	The proto-oncogene c-Src is involved in a variety of signaling processes. Therefore, c-Src spatiotemporal localization is critical for interaction with downstream targets. However, the mechanisms regulating this localization have remained elusive. Previous studies have shown that c-Src trafficking is a microtubule-dependent process that facilitates c-Src turn-over in neuronal growth cones. As such, microtubule depolymerization lead to the inhibition of c-Src recycling. Alternatively, c-Src trafficking was also shown to be regulated by RhoB-dependent actin polymerization. Our results show that c-Src vesicles primarily exhibit microtubule-dependent trafficking; however, microtubule depolymerization does not inhibit vesicle movement. Instead, vesicular movement becomes both faster and less directional. This movement was associated with actin polymerization directly at c-Src vesicle membranes. Interestingly, it has been shown previously that c-Src delivery is an actin polymerization-dependent process that relies on small GTPase RhoB at c-Src vesicles. In agreement with this finding, microtubule depolymerization induced significant activation of RhoB, together with actin comet tail formation. These effects occurred downstream of GTP-exchange factor, GEF-H1, which was released from depolymerizing MTs. Accordingly, GEF-H1 activity was necessary for actin comet tail formation at the Src vesicles. Our results indicate that regulation of c-Src trafficking requires both microtubules and actin polymerization, and that GEF-H1 coordinates c-Src trafficking, acting as a molecular switch between these two mechanisms.	[Arnette, Christopher; Frye, Keyada; Kaverina, Irina] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Arnette, Christopher] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Vanderbilt University; Northwestern University; Feinberg School of Medicine	Kaverina, I (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA.	irina.kaverina@vanderbilt.edu			NIH Integrated Biological Systems Training in Oncology (IBSTO) training grant [5T32CA119925-03]; American Heart Predoctoral Fellowship [12PRE12040218]; NIH Training Grant in Mechanisms of Vascular Disease fellowship [5T32HL007751-19]; NIH [R01-GM078373]; American Heart Association [13GRNT16980096]; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078373, R25GM062459] Funding Source: NIH RePORTER	NIH Integrated Biological Systems Training in Oncology (IBSTO) training grant; American Heart Predoctoral Fellowship; NIH Training Grant in Mechanisms of Vascular Disease fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH Integrated Biological Systems Training in Oncology (IBSTO) training grant (5T32CA119925-03) (to CA), American Heart Predoctoral Fellowship 12PRE12040218 (to CA), NIH Training Grant in Mechanisms of Vascular Disease (5T32HL007751-19) fellowship (to KF), NIH grant R01-GM078373 (to IK), and American Heart Association Grant-in-Aid 13GRNT16980096 (to IK).	Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Armaiz-Pena GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2413; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ichijo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116252; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Luis-Ravelo D, 2014, MOL ONCOL, V8, P196, DOI 10.1016/j.molonc.2013.11.001; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Vega FM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120076; Wu BB, 2008, MOL BIOL CELL, V19, P4611, DOI 10.1091/mbc.E08-06-0603; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	20	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148996	10.1371/journal.pone.0148996	http://dx.doi.org/10.1371/journal.pone.0148996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866809	Green Submitted, Green Published, gold			2022-12-26	WOS:000370050700051
J	Bekolo, CE; O'Bryan, G; Tchago, FE; Nangue, C; Bekoule, PS; Kollo, B				Bekolo, Cavin Epie; O'Bryan, Gillian; Tchago, Francois Edmond; Nangue, Charlette; Bekoule, Patrick Sylvestre; Kollo, Basile			Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; POSITIVE WOMEN; HAART; PREVALENCE; BEHAVIOR	Background While the effect of highly active antiretroviral therapy (HAART) on natural history of cervical lesions remains controversial, resource limited countries need to understand the relevance of their own data to their settings. We compared the risk of cervical disease in HAART-experienced women with that in women in the general population of Cameroon. Methods A retrospective cross sectional survey of women aged 35 years and above, attending a voluntary screening campaign for cervical cancer at the Nkongsamba Regional Hospital in Cameroon between February and May 2014. Squamous intraepithelial lesions (SIL) were determined by Pap smear. Multiple logistic regression was used to compare the odds of SIL in women on HAART to women from the community with unknown HIV status. Results Included were 302 women of whom 131(43.4%) were HIV-infected and receiving HAART on the site while 171 (56.6%) were women from the community. Cervical disease was observed in 51(16.9%) persons of whom 15 (11.5%) cases in the HAART group and 36 (21.1%) cases in the general group (p = 0.027). After controlling for age and other covariates, women in the HAART group had a 67% reduction in the odds of cervical lesions compared with the community group [adjusted odd ratio (aOR) = 0.33, 95% CI: 0.15-0.73, p = 0.006). Conclusion HIV-infected women receiving HAART have a lower risk of cancer than women in the general population. This finding may not be attributed to HAART alone but to all the health benefits derived from receiving a comprehensive HIV care.	[Bekolo, Cavin Epie] Ctr Med Arrondissement Bare, Nkongsamba, Cameroon; [O'Bryan, Gillian] I TECH, Seattle, WA USA; [Tchago, Francois Edmond; Bekoule, Patrick Sylvestre] Reg Hosp Nkongsamba, Nkongsamba, Cameroon; [Nangue, Charlette] Univ Teaching Hosp, Yaounde, Cameroon; [Kollo, Basile] Univ Douala, Dept Publ Hlth, Douala, Cameroon		Bekolo, CE (corresponding author), Ctr Med Arrondissement Bare, Nkongsamba, Cameroon.	cavinep@yahoo.co.uk	Bekolo, Cavin Epie/HIR-2638-2022	Bekolo, Cavin Epie/0000-0002-9845-9842				Abraham AG, 2013, JAIDS-J ACQ IMM DEF, V62, P405, DOI 10.1097/QAI.0b013e31828177d7; Adler DH, 2012, AIDS, V26, P1645, DOI 10.1097/QAD.0b013e32835536a3; Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; Atashili J, 2012, CANCER EPIDEMIOL, V36, P263, DOI 10.1016/j.canep.2011.10.003; Bekolo CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-236; Bekolo Cavin Epie, 2013, BMC Res Notes, V6, P512, DOI 10.1186/1756-0500-6-512; Bratcher Lara F, 2010, Infect Agent Cancer, V5, P8, DOI 10.1186/1750-9378-5-8; Bruni L, 2015, PAPILOMAVIRUS RELATE; BUCREP, 2010, POP CAM 2010; Del Mistro A, 2004, CLIN INFECT DIS, V38, P737, DOI 10.1086/381681; Fu TC, 2012, AIDS, V26, P2383, DOI 10.1097/QAD.0b013e32835ad438; Gravitt PE, 2010, J INFECT DIS, V201, P650, DOI 10.1086/650468; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Lillo FB, 2001, J INFECT DIS, V184, P547, DOI 10.1086/322856; Mandelblatt JS, 1999, CANCER EPIDEM BIOMAR, V8, P97; Minkoff HL, 1999, AM J OBSTET GYNECOL, V180, P824, DOI 10.1016/S0002-9378(99)70653-8; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; MINSANTE, 2011, RAPP ANN ACT LUTT CO; Mogtomo KML, 2009, INFECT AGENTS CANCER, V4, P9, DOI [10.1186/1750-9378-4-9, DOI 10.1186/1750-9378-4-9]; Mwanahamuntu MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001032; Paramsothy P, 2009, OBSTET GYNECOL, V113, P26, DOI 10.1097/AOG.0b013e31819225cb; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; Venkatesh KK, 2010, AIDS, V24, P2687, DOI 10.1097/QAD.0b013e32833e78d4; Wilson JMG, 1968, PRINCIPLES PRACTICE; World Health Organization, 2013, COMPR CERV CANC PREV	25	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149152	10.1371/journal.pone.0149152	http://dx.doi.org/10.1371/journal.pone.0149152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866371	Green Submitted, gold, Green Published			2022-12-26	WOS:000370050700074
J	Mohan, DM; Kumar, P; Mahmood, F; Wong, KF; Agrawal, A; Elgendi, M; Shukla, R; Ang, N; Ching, A; Dauwels, J; Chan, AHD				Mohan, Dhanya Menoth; Kumar, Parmod; Mahmood, Faisal; Wong, Kian Foong; Agrawal, Abhishek; Elgendi, Mohamed; Shukla, Rohit; Ang, Natania; Ching, April; Dauwels, Justin; Chan, Alice H. D.			Effect of Subliminal Lexical Priming on the Subjective Perception of Images: A Machine Learning Approach	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; AUTOMATIC ACTIVATION; EMOTIONAL ADJECTIVES; BRAIN POTENTIALS; DECISION-MAKING; MASKED WORDS; TIME-COURSE; TASK; ERP; INFORMATION	The purpose of the study is to examine the effect of subliminal priming in terms of the perception of images influenced by words with positive, negative, and neutral emotional content, through electroencephalograms (EEGs). Participants were instructed to rate how much they like the stimuli images, on a 7-point Likert scale, after being subliminally exposed to masked lexical prime words that exhibit positive, negative, and neutral connotations with respect to the images. Simultaneously, the EEGs were recorded. Statistical tests such as repeated measures ANOVAs and two-tailed paired-samples t-tests were performed to measure significant differences in the likability ratings among the three prime affect types; the results showed a strong shift in the likeness judgment for the images in the positively primed condition compared to the other two. The acquired EEGs were examined to assess the difference in brain activity associated with the three different conditions. The consistent results obtained confirmed the overall priming effect on participants' explicit ratings. In addition, machine learning algorithms such as support vector machines (SVMs), and AdaBoost classifiers were applied to infer the prime affect type from the ERPs. The highest classification rates of 95.0% and 70.0% obtained respectively for average-trial binary classifier and average-trial multi-class further emphasize that the ERPs encode information about the different kinds of primes.	[Mohan, Dhanya Menoth; Agrawal, Abhishek; Dauwels, Justin] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Kumar, Parmod] INRIA Sophia Antipolis, Sophia Antipolis, France; [Mahmood, Faisal] Okinawa Inst Sci & Technol, Kunigami, Okinawa, Japan; [Wong, Kian Foong] Duke NUS Grad Med Sch, Ctr Cognit Neurosci, Singapore, Singapore; [Elgendi, Mohamed] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Shukla, Rohit] Univ Wisconsin, Madison, WI 53706 USA; [Ang, Natania; Ching, April; Chan, Alice H. D.] Nanyang Technol Univ, Linguist & Multilingual Studies, Sch Humanities & Social Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Okinawa Institute of Science & Technology Graduate University; National University of Singapore; University of British Columbia; University of Wisconsin System; University of Wisconsin Madison; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Dauwels, J (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore.; Chan, AHD (corresponding author), Nanyang Technol Univ, Linguist & Multilingual Studies, Sch Humanities & Social Sci, Singapore 639798, Singapore.	jdauwels@ntu.edu.sg; alice@ntu.edu.sg	Shukla, Rohit/AAG-5495-2019; Elgendi, Mohamed/I-8596-2016; Mahmood, Faisal/C-1021-2015	Shukla, Rohit/0000-0001-9367-9654; Elgendi, Mohamed/0000-0003-1831-0202; Menoth Mohan, Dhanya/0000-0002-4591-2412; Mahmood, Faisal/0000-0001-7587-1562	Singapore Ministry of Education [M4011102.040]; College of Humanities, Arts & Social Sciences at Nanyang Technological University [M58100050, M4011089, M4011393]; MOE Tier 1 grant [M4011102.040]	Singapore Ministry of Education(Ministry of Education, Singapore); College of Humanities, Arts & Social Sciences at Nanyang Technological University(Nanyang Technological University); MOE Tier 1 grant(Ministry of Education, Singapore)	This research was supported by the Singapore Ministry of Education (http://www.moe.gov.sg/) Tier 1 grant (M4011102.040) awarded to J.D., and grants (M58100050 and M4011089) from College of Humanities, Arts & Social Sciences at Nanyang Technological University (http://www.hss.ntu.edu.sg/Pages/Home.aspx) to A.H.D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the MOE Tier 1 grant (M4011102.040) awarded to J.D., and grants (M58100050, M4011089, and M4011393) from College of Humanities, Arts & Social Sciences at Nanyang Technological University to A.H.D.C.	Aarts H, 2005, CONSCIOUS COGN, V14, P439, DOI 10.1016/j.concog.2004.11.001; Bayer M, 2012, PSYCHOPHYSIOLOGY, V49, P959, DOI 10.1111/j.1469-8986.2012.01381.x; Behroozi M, 2015, BRAIN IMAGING BEHAV, V9, P178, DOI 10.1007/s11682-014-9294-z; Behroozi M, 2014, J INTEGR NEUROSCI, V13, P645, DOI 10.1142/S0219635214500241; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Bode S, 2012, J NEUROSCI, V32, P12488, DOI 10.1523/JNEUROSCI.1708-12.2012; Cheng WC, 2013, IEEE J BIOMED HEALTH, V17, P411, DOI 10.1109/JBHI.2012.2237034; Comesana M, 2013, COMPUT HUM BEHAV, V29, P588, DOI 10.1016/j.chb.2012.10.020; Cristinacce D., 2003, BMVC, P1; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Daliri Mohammad Reza, 2013, J Med Signals Sens, V3, P37; Das K, 2010, NEUROIMAGE, V51, P1425, DOI 10.1016/j.neuroimage.2010.03.030; DAUBECHIES I, 1988, COMMUN PUR APPL MATH, V41, P909, DOI 10.1002/cpa.3160410705; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Draine SC, 1998, J EXP PSYCHOL GEN, V127, P286, DOI 10.1037/0096-3445.127.3.286; Esghaei M, 2014, DECODING VISUAL ATTE; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Fischler I, 2006, PROG BRAIN RES, V156, P185, DOI 10.1016/S0079-6123(06)56009-1; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Gibbons H, 2009, CONSCIOUS COGN, V18, P383, DOI 10.1016/j.concog.2009.02.007; GREENWALD AG, 1989, MEM COGNITION, V17, P35, DOI 10.3758/BF03199555; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; HERMANS D, 1994, COGNITION EMOTION, V8, P515, DOI 10.1080/02699939408408957; Houwer JD, 2009, SOCIAL PERSONALITY P, V3, P36, DOI [10.1111/j.1751-9004.2008.00162.x, DOI 10.1111/J.1751-9004.2008.00162.X]; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; Klauer KC, 1997, J EXP PSYCHOL LEARN, V23, P246, DOI 10.1037/0278-7393.23.1.246; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kotz SA, 2011, LANG LINGUIST COMPAS, V5, P108, DOI 10.1111/j.1749-818x.2010.00267.x; Kumar P, 2014, IEEE ENG MED BIO, P5438, DOI 10.1109/EMBC.2014.6944856; Liao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085192; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lowery BS, 2007, BASIC APPL SOC PSYCH, V29, P151, DOI 10.1080/01973530701331718; Lu Y, 2011, NEUROSCI LETT, V502, P182, DOI 10.1016/j.neulet.2011.07.040; Lv F, 2006, LECT NOTES COMPUT SC, V3954, P359; Makeig S, 1996, ADV NEUR IN, V8, P145; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Marcos JL, 2005, PSICOTHEMA, V17, P332; McFarland DJ, 2006, IEEE T NEUR SYS REH, V14, P135, DOI 10.1109/TNSRE.2006.875637; Mitchell JP, 2002, MEMORY, V10, P381, DOI 10.1080/09658210244000207; Morris J, 2011, LANG COGNITIVE PROC, V26, P558, DOI 10.1080/01690965.2010.495482; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Newell BR, 2014, BEHAV BRAIN SCI, V37, P1, DOI 10.1017/S0140525X12003214; Niu B, 2006, PROTEIN PEPTIDE LETT, V13, P489, DOI 10.2174/092986606776819619; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otten S, 1999, EUR J SOC PSYCHOL, V29, P1049, DOI 10.1002/(SICI)1099-0992(199912)29:8<1049::AID-EJSP985>3.0.CO;2-Q; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Rotteveel M, 2001, EMOTION, V1, P348, DOI 10.1037//1528-3542.1.4.348; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Seif Z, COGNITIVE NEURODYNAM, P1; Soman K.P., 2010, INSIGHT WAVELETS THE; Stewart AX, 2014, J NEUROSCI METH, V228, P1, DOI 10.1016/j.jneumeth.2014.02.014; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Taghizadeh-Sarabi M., 2014, BRAIN TOPOGRAPHY, P1; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Zhang Q, 2006, BRAIN RES BULL, V71, P316, DOI 10.1016/j.brainresbull.2006.09.023; Zhang Q, 2010, BRAIN RES, V1329, P142, DOI 10.1016/j.brainres.2010.03.021	67	8	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148332	10.1371/journal.pone.0148332	http://dx.doi.org/10.1371/journal.pone.0148332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866807	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700015
J	Peng, L; Li, GY; Xiao, M; Xie, L				Peng, Lei; Li, Guangyao; Xiao, Mang; Xie, Li			Robust CPD Algorithm for Non-Rigid Point Set Registration Based on Structure Information	PLOS ONE			English	Article							MATCHING ALGORITHM	Recently, the Coherent Point Drift (CPD) algorithm has become a very popular and efficient method for point set registration. However, this method does not take into consideration the neighborhood structure information of points to find the correspondence and requires a manual assignment of the outlier ratio. Therefore, CPD is not robust for large degrees of degradation. In this paper, an improved method is proposed to overcome the two limitations of CPD. A structure descriptor, such as shape context, is used to perform the auxiliary calculation of the correspondence, and the proportion of each GMM component is adjusted by the similarity. The outlier ratio is formulated in the EM framework so that it can be automatically calculated and optimized iteratively. The experimental results on both synthetic data and real data demonstrate that the proposed method described here is more robust to deformation, noise, occlusion, and outliers than CPD and other state-of-the-art algorithms.	[Peng, Lei; Li, Guangyao; Xiao, Mang; Xie, Li] Tongji Univ, Coll Elect & Informat Engn, Shanghai 200092, Peoples R China; [Peng, Lei] Taishan Med Univ, Coll Informat Engn, Tai An, Shandong, Peoples R China	Tongji University; Shandong First Medical University & Shandong Academy of Medical Sciences	Peng, L (corresponding author), Tongji Univ, Coll Elect & Informat Engn, Shanghai 200092, Peoples R China.; Peng, L (corresponding author), Taishan Med Univ, Coll Informat Engn, Tai An, Shandong, Peoples R China.	pengleisd@163.com			Shandong Provincial Natural Science Foundation, China [ZR2015FL005]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by Shandong Provincial Natural Science Foundation, China, grant number ZR2015FL005 (http://www.sdnsf.gov.cn/portal/, recipient: Lei Peng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Chen J, 2015, SIGNAL PROCESS, V106, P62, DOI 10.1016/j.sigpro.2014.07.004; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; de Sousa S, 2015, PATTERN RECOGN, V48, P368, DOI 10.1016/j.patcog.2014.06.011; Gao Y, 2014, PATTERN ANAL APPL, V17, P379, DOI 10.1007/s10044-013-0324-z; Ge S, 2014, IEEE COMPUT SOC CONF, P245, DOI 10.1109/CVPRW.2014.45; Gerogiannis D, 2012, NEUROCOMPUTING, V89, P122, DOI 10.1016/j.neucom.2012.02.018; Habert S, 2013, SPIE MED IMAGING; Han X, 2010, FEATURE CONSTRAINED, P63; Hu YP, 2010, LECT NOTES COMPUT SC, V6326, P60; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Jin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095576; Lee JH, 2011, IEEE T PATTERN ANAL, V33, P427, DOI 10.1109/TPAMI.2010.179; Liu SL, 2015, J APPL REMOTE SENS, V9, DOI 10.1117/1.JRS.9.095085; Ma JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092282; Ma JY, 2013, PROC CVPR IEEE, P2147, DOI 10.1109/CVPR.2013.279; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Qu HB, 2014, INT C PATT RECOG, P58, DOI 10.1109/ICPR.2014.20; Sang Q, 2013, PATTERN RECOGN LETT, V34, P1557, DOI 10.1016/j.patrec.2013.06.019; Schlkopf B., 2006, ADV NEURAL INFORM PR, P1009; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; Tang J, 2014, PATTERN RECOGN, V47, P1469, DOI 10.1016/j.patcog.2013.09.017; Tao WB, 2014, PROC CVPR IEEE, P1598, DOI 10.1109/CVPR.2014.207; Wang G, 2015, COMPUT VIS IMAGE UND, V141, P67, DOI 10.1016/j.cviu.2015.05.014; Wang G, 2015, BIOMED SIGNAL PROCES, V19, P68, DOI 10.1016/j.bspc.2015.03.004; Wang P, 2011, SCI CHINA INFORM SCI, V54, P2639, DOI 10.1007/s11432-011-4465-7; Wang SH, 2012, IEEE GEOSCI REMOTE S, V9, P649, DOI 10.1109/LGRS.2011.2177437; Yan XW, 2013, J CENT SOUTH UNIV, V20, P3077, DOI 10.1007/s11771-013-1831-1; Yang Y, 2015, PATTERN RECOGN, V48, P156, DOI 10.1016/j.patcog.2014.06.017; Zhang K, 2014, IEEE GEOSCI REMOTE S, V11, P469, DOI 10.1109/LGRS.2013.2267771; Zheng YF, 2006, IEEE T PATTERN ANAL, V28, P643, DOI 10.1109/TPAMI.2006.81; Zhou ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091381	34	18	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148483	10.1371/journal.pone.0148483	http://dx.doi.org/10.1371/journal.pone.0148483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866918	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700016
J	Pugh, BF; Venters, BJ				Pugh, B. Franklin; Venters, Bryan J.			Genomic Organization of Human Transcription Initiation Complexes	PLOS ONE			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; BIDIRECTIONAL PROMOTERS; INTEGRATIVE ANALYSIS; MAMMALIAN PROMOTERS; YEAST; GENE; VISUALIZATION; RECRUITMENT; RESOURCES	A repertoire of transcription initiation factors engage the core promoter of mRNA genes to recruit RNA polymerase (Pol) II to initiate transcription, yet their precise spatial organization remains unclear. Using ChIP-exo, here we detail the interactions and genomic organization of initiation factors TBP, TFIIB, and Pol II at mRNA genes and within CpG islands. We find that when Pol II moves into a transcriptionally paused state, TBP/TFIIB remain at the promoter. We show that TBP and TFIIB bound to the core promoter at two separate, resolvable locations that coincided with sites of divergent transcription initiation. We also examine the precise binding of TBP at Pol III transcribed tRNA genes. We find that TBP crosslinked to tRNA genes in a similar manner as at Pol II transcribed genes. This comprehensive and high resolution genome-wide detection of the initiation machinery produces a consolidated view of transcription initiation events humans at Pol II coding and Pol III transcribed tRNA genes.	[Pugh, B. Franklin; Venters, Bryan J.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Venters, Bryan J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Vanderbilt University	Venters, BJ (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.; Venters, BJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	bryan.venters@vanderbilt.edu			National Institutes of Health [GM059055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM059055.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Gaertner B, 2014, DEVELOPMENT, V141, P1179, DOI 10.1242/dev.088492; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu LQ, 2014, CELL STEM CELL, V15, P574, DOI 10.1016/j.stem.2014.09.018; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; WHITE RJ, 1992, CELL, V71, P1041, DOI 10.1016/0092-8674(92)90398-V; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang H, 2012, Cold Spring Harb Symp Quant Biol, V77, P161, DOI 10.1101/sqb.2012.77.014936	39	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149339	10.1371/journal.pone.0149339	http://dx.doi.org/10.1371/journal.pone.0149339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866362	Green Accepted, Green Published, gold			2022-12-26	WOS:000370050700083
J	Xiao, M; Zhao, R; Zhang, Q; Fan, X; O'Sullivan, MVN; Li, DF; Wang, XY; Wu, HL; Kong, FR; Xu, YC				Xiao, Meng; Zhao, Rui; Zhang, Qi; Fan, Xin; O'Sullivan, Matthew V. N.; Li, Dong-Fang; Wang, Xin-Ying; Wu, Hong-Long; Kong, Fanrong; Xu, Ying-Chun			Genotypic Diversity of Staphylococcus aureus alpha-Hemolysin Gene (hla) and Its Association with Clonal Background: Implications for Vaccine Development	PLOS ONE			English	Article							METHICILLIN-RESISTANT; PASSIVE-IMMUNIZATION; MURINE MODEL; MOUSE MODEL; TOXIN GENE; SEQUENCE; EPIDEMIOLOGY; MUTAGENESIS; ADAPTATION; PROTECTION	The alpha-hemolysin, encoded by the hla gene, is a major virulence factor in S. aureus infections. Changes in key amino acid residues of a-hemolysin can result in reduction, or even loss, of toxicity. The aim of this study was to investigate the diversity of the hla gene sequence and the relationship of hla variants to the clonal background of S. aureus isolates. A total of 47 clinical isolates from China were used in this study, supplemented with in silico analysis of 318 well-characterized whole genome sequences from globally distributed isolates. A total of 28 hla genotypes were found, including three unique to isolates from China, 20 found only in the global genomes and five found in both. The hla genotype generally correlated with the clonal background, particularly the multilocus sequence type, but was not related to geographic origin, host source or methicillin-resistance phenotype. In addition, the hla gene showed greater diversity than the seven loci utilized in the MLST scheme for S. aureus. Our investigation has provided genetic data which may be useful for future studies of toxicity, immunogenicity and vaccine development.	[Xiao, Meng; Zhang, Qi; Fan, Xin; Xu, Ying-Chun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China; [Zhao, Rui] Beijing Elect Power Hosp, Dept Lab, Beijing, Peoples R China; [O'Sullivan, Matthew V. N.; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR Pathol West, Westmead, NSW 2145, Australia; [O'Sullivan, Matthew V. N.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Li, Dong-Fang; Wang, Xin-Ying; Wu, Hong-Long] BGI Shenzhen, Binhai Genom Inst, BGI Tianjin, Tianjin, Peoples R China; [Li, Dong-Fang; Wang, Xin-Ying; Wu, Hong-Long] BGI Shenzhen, Tianjin Translat Genom Ctr, BGI Tianjin, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Sydney; University of Sydney; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Xu, YC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008; O'Sullivan, Matthew/0000-0001-8783-5323	Ministry of Health of China [201402001]	Ministry of Health of China	YCX recieved a National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001, http://www.moh.gov.cn/qjjys/s3577/201401/e9f3635e7acb47778225ccb729ffec62.shtml) from the Ministry of Health of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Talib H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-113; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Carvalho KS, 2010, BRAZ J INFECT DIS, V14, P71, DOI 10.1590/S1413-86702010000100014; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Chen Y, 2015, J INFECT DIS, V211, P472, DOI 10.1093/infdis/jiu462; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; GRAY GS, 1984, INFECT IMMUN, V46, P615, DOI 10.1128/IAI.46.2.615-618.1984; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kurt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058155; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mathur Purva, 2013, J Lab Physicians, V5, P5, DOI 10.4103/0974-2727.115898; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; McGavin MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00048; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Mocca CP, 2014, CLIN VACCINE IMMUNOL, V21, P622, DOI 10.1128/CVI.00051-14; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Stinear TP, 2014, GENOME BIOL EVOL, V6, P366, DOI 10.1093/gbe/evu022; Stryjewski ME, 2014, CLIN INFECT DIS, V58, pS10, DOI 10.1093/cid/cit613; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; WALKER B, 1992, J BIOL CHEM, V267, P10902; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Xiao M, 2013, J CLIN MICROBIOL, V51, P3638, DOI 10.1128/JCM.01375-13; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001	33	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149112	10.1371/journal.pone.0149112	http://dx.doi.org/10.1371/journal.pone.0149112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866483	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700066
J	Hu, J; Juan, W; Sahyoun, NR				Hu, Jing; Juan, WenYen; Sahyoun, Nadine R.			Intake and Biomarkers of Folate and Risk of Cancer Morbidity in Older Adults, NHANES 1999-2002 with Medicare Linkage	PLOS ONE			English	Article							FOLIC-ACID; MULTIVITAMIN USE; COLON-CANCER; CLAIMS DATA; FORTIFICATION; ACCURACY; DEFICIENCY; PREVENTION; REDUCTASE; PROSTATE	Background After the 1998 mandatory folic acid fortification of enriched cereal-grain products in the U.S., safety concerns were raised that excess consumption of folic acid and high blood folate biomarkers detected in adults may increase the risk of certain types of cancer. Methods Baseline data from about 1400 participants in the National Health and Nutrition Examination Survey (NHANES) 1999-2002, aged >= 57 years were linked to Medicare and mortality files through December 31, 2007. Using cox proportional hazards regression models, we assessed associations between dietary folate equivalents, folate biomarkers, the presence of unmetabolized folic acid and, overall cancer incidence. Results With 8,114 person-years of follow-up (median follow-up, 6.3 years), about 125 cancer cases were identified. After adjusting for confounders, the hazard ratios of the highest quartile versus the second quartile of RBC folate and dietary folate equivalents were 0.54 (95% CI: 0.31-0.93) and 0.54 (95% CI: 0.30-0.95), respectively. Additionally, serum and RBC folate as continuous variables were inversely and significantly associated with cancer incidence (p<0.01). No significant associations were observed between the presence of unmetabolized folic acid, intake of naturally-occurring food folate or folic acid separately, and cancer incidence. Conclusions High total folate intake and biomarkers in older adults appear to be protective against cancer in post-folic acid fortification years. This study does not show a negative impact of current level of folic acid fortification on cancer risk. As this is one of the few studies to examine the association between unmetabolized folic acid and cancer outcome, a study including a larger nationwide representative sample of the U.S. population is needed.	[Hu, Jing; Sahyoun, Nadine R.] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Juan, WenYen] US FDA, Off Nutr Labeling & Dietary Supplements, Ctr Food Safety & Appl Nutr, College Pk, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Sahyoun, NR (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	nsahyoun@umd.edu		Sahyoun, Nadine/0000-0003-2309-1868	Maryland Agricultural Experiment Station (MAES) [MD-HNFS-7307]	Maryland Agricultural Experiment Station (MAES)	This work was fully supported by a grant from the Maryland Agricultural Experiment Station (MAES), MD-HNFS-7307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bailey RL, 2012, FOOD NUTR RES, V56; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; *CDCP, NHANES 2001 2002 PUB; Centers for Disease Control and Prevention, NHANES 1999 2000 PUB; Centers for Disease Control and Prevention, DESCR NCHS CMS MED L; Cho E, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv260; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Cooper GS, 1999, MED CARE, V37, P436, DOI 10.1097/00005650-199905000-00003; Dietrich M, 2005, J AM COLL NUTR, V24, P266, DOI 10.1080/07315724.2005.10719474; DOLNICK BJ, 1978, J BIOL CHEM, V253, P3563; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; Figueiredo JC, 2009, JNCI-J NATL CANCER I, V101, P432, DOI 10.1093/jnci/djp019; Fuchs CS, 2002, CANCER EPIDEM BIOMAR, V11, P227; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Hirsch S, 2009, EUR J GASTROEN HEPAT, V21, P346, DOI 10.1097/MEG.0b013e328306ccdb; HSIA DC, 1992, JAMA-J AM MED ASSOC, V268, P896, DOI 10.1001/jama.268.7.896; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Hu J, 2016, CRIT REV FOOD SCI, V56, P1325, DOI 10.1080/10408398.2013.807221; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; MATTHEWS RG, 1980, BIOCHEMISTRY-US, V19, P2040, DOI 10.1021/bi00551a005; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Pfeiffer CM, 2012, J NUTR, V142, P886, DOI 10.3945/jn.111.156919; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Suitor CW, 2000, J AM DIET ASSOC, V100, P88, DOI 10.1016/S0002-8223(00)00027-4; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Ulrich CM, 2007, AM J CLIN NUTR, V86, P271, DOI 10.1093/ajcn/86.2.271; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; WHITTLE J, 1991, MED CARE, V29, P1226, DOI 10.1097/00005650-199112000-00005; Wu K, 2009, AM J CLIN NUTR, V90, P1623, DOI 10.3945/ajcn.2009.28319	34	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148697	10.1371/journal.pone.0148697	http://dx.doi.org/10.1371/journal.pone.0148697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862893	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600098
J	Jayakumaran, JS; Aaron, E; Gracely, EJ; Schriver, E; Szep, Z				Jayakumaran, Jenani Sarah; Aaron, Erika; Gracely, Ed J.; Schriver, Emily; Szep, Zsofia			Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among Individuals Living with HIV in an Urban HIV Clinic	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; MEN; INFECTION; PREP; CARE; SEX	Introduction Pre-exposure prophylaxis (PrEP) is an effective tool to reduce HIV transmission. The primary objective of this study was to assess awareness of PrEP by individuals living with HIV (HIV+) and acceptance of its use for their HIV negative (HIV-) partners. Methods A cross sectional survey was conducted among individuals living with HIV who received care at an urban HIV clinic between January 2013 and June 2013. The survey examined knowledge, attitudes, and acceptability of PrEP, and perception of transmission risk of HIV. Chi-Square test and Fisher's Exact test were used to compare proportions. Results Among 206 subjects living with HIV, 15.3% (32) had heard of PrEP. Men who have sex with men (MSM) were more likely to be aware of PrEP than all others (p = 0.003). Once educated about PrEP those who believed PrEP would reduce their partner's risk for HIV were more likely to recommend PrEP to their partner (p<0.001) .92% of all respondents said they would be "extremely likely/likely" to discuss PrEP use with their provider. Of 159 subjects whose main partner was HIV-, MSM (p = 0.007), male participants (p = 0.044), and those who were consistently taking meds (p = 0.049) were more likely to be aware of PrEP. Those who perceived they were at risk of transmitting HIV (p<0.001) and those who were consistently taking meds (0.049) were more likely to agree that PrEP could reduce the risk of HIV to their partners. Conclusion This study illustrates a low awareness of PrEP but once educated the willingness of a cohort of individuals living with HIV to recommend PrEP to their partners. Our findings demonstrate the importance of providers informing their patients living with HIV about PrEP, as these persons are an underutilized link to support the uptake of PrEP by their HIV-partners.	[Jayakumaran, Jenani Sarah] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Aaron, Erika; Szep, Zsofia] Drexel Univ, Coll Med, Dept Infect Dis & HIV Med, Philadelphia, PA 19104 USA; [Gracely, Ed J.; Schriver, Emily] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Schriver, Emily] Drexel Univ, Sch Publ Hlth, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University; Drexel University	Jayakumaran, JS (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	Jsj43@drexel.edu	Gracely, Ed/B-7188-2014	Gracely, Ed/0000-0002-8344-3223; Schriver, Emily/0000-0003-4522-1029				Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bekker LG, 2015, HPTN 067 ADAPT CAPE; Campbell JD, 2013, AM J PREV MED, V44, pS63, DOI 10.1016/j.amepre.2012.09.045; Denning Paul H., 2011, Morbidity and Mortality Weekly Report, V60, P1045; Dombrowski JC, 2010, AIDS PATIENT CARE ST, V24, P747, DOI 10.1089/apc.2010.0198; Gamarel KE, 2014, ANN BEHAV MED, V47, pS18, DOI 10.1007/s12160-014-9646-3; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hoff CC, 2015, AIDS PATIENT CARE ST, V29, P408, DOI 10.1089/apc.2014.0315; Johnson MO, 2012, AIDS BEHAV, V16, P1511, DOI 10.1007/s10461-011-0021-0; Kelesidis Theodoros, 2011, Curr HIV/AIDS Rep, V8, P94, DOI 10.1007/s11904-011-0078-4; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2015, PRAGMATIC OPEN LABEL; Mimiaga MJ, 2014, ARCH SEX BEHAV, V43, P99, DOI 10.1007/s10508-013-0208-8; Molina JM CC, 2015, DEM PREP WTIH OR TDF; Oldenburg CE, 2015, AIDS, V29, P837, DOI 10.1097/QAD.0000000000000622; Rawlings KM R., 2013, STATUS TRUVADA TVD H; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038	25	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0145670	10.1371/journal.pone.0145670	http://dx.doi.org/10.1371/journal.pone.0145670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862744	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600007
J	Shin, JE; Shin, JC; Lee, Y; Kim, SJ				Shin, Jae Eun; Shin, Jong Chul; Lee, Young; Kim, Sa Jin			Serial Change in Cervical Length for the Prediction of Emergency Cesarean Section in Placenta Previa	PLOS ONE			English	Article							SPONTANEOUS ONSET; GESTATIONAL-AGE; RISK; PREGNANCY; WOMEN; HEMORRHAGE; DELIVERY; LABOR; TERM	Purpose To evaluate whether serial change in cervical length (CL) over time can be a predictor for emergency cesarean section (CS) in patients with placenta previa. Methods This was a retrospective cohort study of patients with placenta previa between January 2010 and November 2014. All women were offered serial measurement of CL by transvaginal ultrasound at 19 to 23 weeks (CL1), 24 to 28 weeks (CL2), 29 to 31 weeks (CL3), and 32 to 34 weeks (CL4). We compared clinical characteristics, serial change in CL, and outcomes between the emergency CS group (case group) and elective CS group (control group). The predictive value of change in CL for emergency CS was evaluated. Results A total of 93 women were evaluated; 31 had emergency CS due to massive vaginal bleeding. CL tended to decrease with advancing gestational age in each group. Until 29-31 weeks, CL showed no significant differences between the two groups, but after that, CL in the emergency CS group decreased abruptly, even though CL in the elective CS group continued to gradually decrease. On multivariate analysis to determine risk factors, only admissions for bleeding (odds ratio, 34.710; 95% CI, 5.239-229.973) and change in CL (odds ratio, 3.522; 95% CI, 1.210-10.253) were significantly associated with emergency CS. Analysis of the receiver operating characteristic curve showed that change in CL could be the predictor of emergency CS (area under the curve 0.734, p < 0.001), with optimal cutoff for predicting emergency cesarean delivery of 6.0 mm. Conclusions Previous admission for vaginal bleeding and change in CL are independent predictors of emergency CS in placenta previa. Women with change in CL more than 6 mm between the second and third trimester are at high risk of emergency CS in placenta previa. Single measurements of short CL at the second or third trimester do not seem to predict emergency CS.	[Shin, Jae Eun; Shin, Jong Chul; Lee, Young; Kim, Sa Jin] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea	Kim, SJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	ksajin@catholic.ac.kr						Bayramoglu O, 2005, AM J PERINAT, V22, P35, DOI 10.1055/s-2004-837268; Berghella V, 2007, OBSTET GYNECOL, V110, P311, DOI 10.1097/01.AOG.0000270112.05025.1d; Colombo DF, 2000, CLIN OBSTET GYNECOL, V43, P735, DOI 10.1097/00003081-200012000-00004; Cook CM, 1996, BRIT J OBSTET GYNAEC, V103, P16, DOI 10.1111/j.1471-0528.1996.tb09509.x; Dashe JS, 2002, OBSTET GYNECOL, V99, P692, DOI 10.1016/S0029-7844(02)01935-X; Fox NS, 2010, AM J OBSTET GYNECOL, V203, pE15, DOI 10.1016/j.ajog.2010.06.064; Fukushima K, 2012, J OBSTET GYNAECOL RE, V38, P192, DOI 10.1111/j.1447-0756.2011.01669.x; Garcia-Espinosa M, 2014, ULTRASOUND OBST GYN, V44, P16; Ghi T, 2009, ULTRASOUND OBST GYN, V33, P209, DOI 10.1002/uog.6301; Hasegawa J, 2011, J CLIN ULTRASOUND, V39, P458, DOI 10.1002/jcu.20849; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P304, DOI 10.1046/j.1469-0705.1998.12050304.x; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Jenkins SM, 2006, ULTRASOUND OBST GYN, V27, P373, DOI 10.1002/uog.2741; Meijer-Hoogeveen M, 2008, ULTRASOUND OBST GYN, V32, P652, DOI 10.1002/uog.5291; Rosello JM, 2013, J MATERN-FETAL NEO M, V26, P1807, DOI 10.3109/14767058.2013.804049; Naim A, 2002, AM J OBSTET GYNECOL, V186, P887, DOI 10.1067/mob.2002.123058; Oppenheimer L, 2007, J OBSTET GYNAECOL CA, V29, P261, DOI 10.1016/S1701-2163(16)32401-X; Palacio M, 2007, ULTRASOUND OBST GYN, V29, P421, DOI 10.1002/uog.3950; Pritchard J, 2014, WILLIAMS OBSTET, P780; Sekiguchi A, 2015, J CLIN ULTRASOUND, V43, P17, DOI 10.1002/jcu.22205; Sotiriadis A, 2010, ULTRASOUND OBST GYN, V35, P54, DOI 10.1002/uog.7457; Souka AP, 2011, J ULTRAS MED, V30, P997, DOI 10.7863/jum.2011.30.7.997; Stafford IA, 2010, OBSTET GYNECOL, V116, P595, DOI 10.1097/AOG.0b013e3181ea2deb; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Zaitoun MM, 2011, ARCH GYNECOL OBSTET, V284, P867, DOI 10.1007/s00404-010-1737-1	25	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149036	10.1371/journal.pone.0149036	http://dx.doi.org/10.1371/journal.pone.0149036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863133	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600145
J	Endo, T; Kimura, O; Ohta, C; Koga, N; Kato, Y; Fujii, Y; Haraguchi, K				Endo, Tetsuya; Kimura, Osamu; Ohta, Chiho; Koga, Nobuyuki; Kato, Yoshihisa; Fujii, Yukiko; Haraguchi, Koichi			Metal Concentrations in the Liver and Stable Isotope Ratios of Carbon and Nitrogen in the Muscle of Silvertip Shark (Carcharhinus albimarginatus) Culled off Ishigaki Island, Japan: Changes with Growth	PLOS ONE			English	Article							GALEOCERDO-CUVIER; COASTAL WATERS; TRACE-ELEMENTS; NORTHERN AREA; TOTAL MERCURY; HEAVY-METALS; TIGER SHARK; WHALES; SELENIUM; AGE	We analyzed Hg, Cd, Zn, Cu and Fe concentrations in liver samples as well as the Hg concentration and stable isotope ratios of carbon and nitrogen (delta C-13 and delta N-15) in muscle samples from silvertip sharks (Carcharhinus albimarginatus) in Japan. Muscular and hepatic Hg concentrations increased with increased body length. However, these increases were more prominent in the liver than in the muscle samples, and appeared to occur after maturation. Hepatic Zn and Cu concentrations decreased during the growth stage, and then increased concomitantly thereafter with increases in Cd burden. Hepatic Fe concentration from males increased proportionally with increases in body length, whereas no increase was observed in samples from females, probably due to the mother-to-embryo transfer of Fe. The delta C-13 values tended to decrease with increases in body length, whereas no decrease in the delta N-15 values was observed.	[Endo, Tetsuya; Kimura, Osamu] Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan; [Ohta, Chiho; Koga, Nobuyuki] Nakamura Gakuen Univ, Fac Nutr Sci, Jonan Ku, 5-7-1 Befu, Fukuoka 8140198, Japan; [Kato, Yoshihisa] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, 1314-1 Shido, Sanuki, Kagawa 7692193, Japan; [Fujii, Yukiko; Haraguchi, Koichi] Daiichi Coll Pharmaceut Sci, Minami Ku, 22-1 Tamagawa Cho, Fukuoka 8158511, Japan	Health Sciences University of Hokkaido; Tokushima Bunri University	Endo, T (corresponding author), Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	endotty@hoku-iryo-u.ac.jp	Fujii, Yukiko/E-4406-2017	Fujii, Yukiko/0000-0001-6218-3453; Endo, Tetsuya/0000-0003-4278-5689; Kato, Yoshihisa/0000-0003-3980-1115; Fujii, Yukiko/0000-0003-2349-4907	Japan Society for the Promotion of Science [24614012, 26614012, 25303011]; Grants-in-Aid for Scientific Research [26881008] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 24614012 O.K. and No. 26614012 Y.F.) and a Grant-in-Aid for Scientific Research (B) (No. 25303011 K.H.) from Japan Society for the Promotion of Science.	Adams DH, 1999, FISH B-NOAA, V97, P372; Barrera-Garcia A, 2013, COMP BIOCHEM PHYS A, V165, P483, DOI 10.1016/j.cbpa.2013.01.024; Bisi TL, 2012, ECOL INDIC, V18, P291, DOI 10.1016/j.ecolind.2011.11.015; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bourg BL, 2014, J FISH BIOL, V84, P1574, DOI [10.1111/jfb.12357, DOI 10.1111/JFB.12357]; Branco V, 2007, ENVIRON POLLUT, V150, P373, DOI 10.1016/j.envpol.2007.01.040; Bustamante P, 1998, SCI TOTAL ENVIRON, V220, P71, DOI 10.1016/S0048-9697(98)00250-2; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Compagno L, 2005, SHARKS WORLD, p[77, 289]; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Das K, 2000, CELL MOL BIOL, V46, P283; de Pinho AP, 2002, ENVIRON RES, V89, P250, DOI 10.1006/enrs.2002.4365; Endo T, 2002, SCI TOTAL ENVIRON, V300, P15, DOI 10.1016/S0048-9697(02)00137-7; Endo T, 2008, MAR POLLUT BULL, V56, P1774, DOI 10.1016/j.marpolbul.2008.06.003; Endo T, 2008, SCI TOTAL ENVIRON, V401, P73, DOI 10.1016/j.scitotenv.2008.04.006; Endo T, 2007, CHEMOSPHERE, V67, P51, DOI 10.1016/j.chemosphere.2006.09.086; Endo T, 2006, ENVIRON POLLUT, V144, P145, DOI 10.1016/j.envpol.2005.12.035; Endo T, 2015, ECOL INDIC, V55, P86, DOI 10.1016/j.ecolind.2015.03.008; Endo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128149; Endo T, 2013, ARCH ENVIRON CON TOX, V64, P467, DOI 10.1007/s00244-012-9858-0; Endo T, 2012, ECOTOX ENVIRON SAFE, V79, P35, DOI 10.1016/j.ecoenv.2012.01.020; Endo T, 2009, CHEMOSPHERE, V77, P1333, DOI 10.1016/j.chemosphere.2009.09.041; Hisamichi Y, 2012, ARCH ENVIRON CON TOX, V62, P296, DOI 10.1007/s00244-011-9696-5; HONDA K, 1983, AGR BIOL CHEM TOKYO, V47, P1219, DOI 10.1080/00021369.1983.10863383; Honda K, 1978, ARCH ENV CONTAM TOXI, V16, P209; HORNUNG H, 1993, MAR BIOL, V115, P331, DOI 10.1007/BF00346351; Karimi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074695; KETCHEN KS, 1975, J FISH RES BOARD CAN, V32, P43, DOI 10.1139/f75-006; Kneebone J, 2008, MAR BIOL, V154, P423, DOI 10.1007/s00227-008-0934-y; Lailson-Brito J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042162; Last PR, 2009, SHARKS RAYS AUSTR, P248; Logan JM, 2008, RAPID COMMUN MASS SP, V22, P1081, DOI 10.1002/rcm.3471; LYLE JM, 1984, AUST J MAR FRESH RES, V35, P441, DOI 10.1071/MF9840441; McMeans BC, 2009, J FISH BIOL, V75, P2464, DOI 10.1111/j.1095-8649.2009.02402.x; Meyer CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084799; Pethybridge H, 2010, MAR ENVIRON RES, V69, P18, DOI 10.1016/j.marenvres.2009.07.006; Rumbold D, 2014, ARCH ENVIRON CON TOX, V67, P402, DOI 10.1007/s00244-014-0050-6; Storelli MM, 2002, B ENVIRON CONTAM TOX, V69, P516, DOI 10.1007/s00128-002-0092-8; Storelli MM, 2000, B ENVIRON CONTAM TOX, V64, P333, DOI 10.1007/s001280000004; TAGUCHI M, 1979, MAR ENVIRON RES, V2, P239, DOI 10.1016/0141-1136(79)90021-7; Taguchi M, 1980, JAP J CHEM, V34, P44; Tayasu I, 2011, LIMNOLOGY, V12, P261, DOI 10.1007/s10201-011-0345-5; VAS P, 1991, MAR POLLUT BULL, V22, P67, DOI 10.1016/0025-326X(91)90138-I; Vaudo JJ, 2010, J FISH BIOL, V77, P1724, DOI 10.1111/j.1095-8649.2010.02813.x; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0; Zhang L, 2005, AQUAT TOXICOL, V73, P353, DOI 10.1016/j.aquatox.2005.04.001; Zhou JL, 2001, SCI TOTAL ENVIRON, V273, P61, DOI 10.1016/S0048-9697(00)00844-5	47	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147797	10.1371/journal.pone.0147797	http://dx.doi.org/10.1371/journal.pone.0147797			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859569	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400015
J	Gupta, S; Termini, JM; Issac, B; Guirado, E; Stone, GW				Gupta, Sachin; Termini, James M.; Issac, Biju; Guirado, Elizabeth; Stone, Geoffrey W.			Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NF-KAPPA-B; PRIMARY HUMAN MACROPHAGES; PLACEBO-CONTROLLED TRIAL; YELLOW-FEVER VACCINE; CHRONIC HEPATITIS-C; RIG-I; ALPHA-INTERFERON; T-CELLS; ANTIVIRAL RESPONSE	Type I interferon is known to inhibit HIV-1 replication through the induction of interferon stimulated genes (ISG), including a number of HIV-1 restriction factors. To better understand interferon-mediated HIV-1 restriction, we constructed a constitutively active form of the RIG-I adapter protein MAVS. Constitutive MAVS was generated by fusion of full length MAVS to a truncated form of the Epstein Barr virus protein LMP1 (Delta LMP1). Supernatant from Delta LMP1-MAVS-transfected 293T cells contained high levels of type I interferons and inhibited HIV replication in both TZM-bl and primary human CD4+ T cells. Supernatant from Delta LMP1-MAVS-transfected 293T cells also inhibited replication of VSV-G pseudotyped single cycle SIV in TZM-bl cells, suggesting restriction was post-entry and common to both HIV and SIV. Gene array analysis of Delta LMP1-MAVS-transfected 293T cells and trans-activated CD4+ T cells showed significant upregulation of ISG, including previously characterized HIV restriction factors Viperin, Tetherin, MxB, and ISG56. Interferon blockade studies implicated interferon-beta in this response. In addition to direct viral inhibition, Delta LMP1-MAVS markedly enhanced secretion of IFN-beta and IL-12p70 by dendritic cells and the activation and maturation of dendritic cells. Based on this immunostimulatory activity, an adenoviral vector (Ad5) expressing Delta LMP1-MAVS was tested as a molecular adjuvant in an HIV vaccine mouse model. Ad5-Gag antigen combined with Ad5-Delta LMP1-MAVS enhanced control of vaccinia-gag replication in a mouse challenge model, with 4/5 animals showing undetectable virus following challenge. Overall, Delta LMP1-MAVS is a promising reagent to inhibit HIV-1 replication in infected tissues and enhance vaccine-mediated immune responses, while avoiding toxicity associated with systemic type I interferon administration.	[Gupta, Sachin; Termini, James M.; Guirado, Elizabeth; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Gupta, Sachin; Termini, James M.; Guirado, Elizabeth; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Issac, Biju] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Div Bioinformat Biostat & Bioinformat Core, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA.; Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	gstone@med.miami.edu		Issac, Biju/0000-0002-7311-678X	National Institutes of Health (NIH), National Institutes of Allergies and Infectious Diseases (NIAID) [R21AI093294]; Florida Department of Health James and Esther King Biomedical Research Technology Transfer Feasibility (TTF) Award [4KF03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093294, P30AI073961] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institutes of Allergies and Infectious Diseases (NIAID); Florida Department of Health James and Esther King Biomedical Research Technology Transfer Feasibility (TTF) Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: National Institutes of Health (NIH), National Institutes of Allergies and Infectious Diseases (NIAID) grant R21AI093294 to GWS, http://grants.nih.gov/grants/guide/contacts/parent_R21.html; and Florida Department of Health James and Esther King Biomedical Research Technology Transfer Feasibility (TTF) Award 4KF03 to GWS, http://www.floridahealth.gov/provider-and-partner-resources/research/FINAL-FY-15-16-King-Program-FOA1.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DEWIT R, 1988, LANCET, V2, P1214; DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FERNIE BF, 1991, J VIROL, V65, P3968, DOI 10.1128/JVI.65.7.3968-3971.1991; Frentzen A, 2015, J VIROL; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; GENDELMAN HE, 1990, AIDS RES HUM RETROV, V6, P1045, DOI 10.1089/aid.1990.6.1045; Geonnotti AR, 2010, AIDS RES HUM RETROV, V26, P279, DOI 10.1089/aid.2009.0186; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Gupta S, 2014, J VIROL, V88, P1492, DOI 10.1128/JVI.02229-13; Gupta S, 2011, J LEUKOCYTE BIOL, V90, P389, DOI 10.1189/jlb.0211068; Gupta S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-39; HARTSHORN KL, 1987, AIDS RES HUM RETROV, V3, P125, DOI 10.1089/aid.1987.3.125; Hatzivassiliou E, 1998, J IMMUNOL, V160, P1116; HO DD, 1985, LANCET, V1, P602; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kobiyama K, 2009, J IMMUNOL, V182, P1593, DOI 10.4049/jimmunol.182.3.1593; LANE HC, 1990, ANN INTERN MED, V112, P805, DOI 10.7326/0003-4819-112-11-805; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maurais E, 2009, VIROLOGY, V385, P227, DOI 10.1016/j.virol.2008.11.033; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; PITHA PM, 1994, ANTIVIR RES, V24, P205, DOI 10.1016/0166-3542(94)90068-X; POLI G, 1989, SCIENCE, V244, P575, DOI 10.1126/science.2470148; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Scherer E, 2008, CLIN EXP IMMUNOL, V154, P6, DOI 10.1111/j.1365-2249.2008.03750.x; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SHIRAZI Y, 1992, J VIROL, V66, P1321, DOI 10.1128/JVI.66.3.1321-1328.1992; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Soni V, 2006, J VIROL, V80, P10787, DOI 10.1128/JVI.01214-06; Stone GW, 2009, J THORAC ONCOL, V4, P802, DOI 10.1097/JTO.0b013e3181a8634d; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wang YZ, 2013, J LEUKOCYTE BIOL, V94, P337, DOI 10.1189/jlb.0313158; Welsch C, 2014, J HEPATOL; Woelk CH, 2004, AIDS RES HUM RETROV, V20, P1210, DOI 10.1089/aid.2004.20.1210; Xiao HY, 2013, J IMMUNOL, V190, P5866, DOI 10.4049/jimmunol.1203470; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; YAMAMOTO JK, 1986, J INTERFERON RES, V6, P143, DOI 10.1089/jir.1986.6.143; Yasui T, 2004, P NATL ACAD SCI USA, V101, P278, DOI 10.1073/pnas.2237224100; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200	75	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148929	10.1371/journal.pone.0148929	http://dx.doi.org/10.1371/journal.pone.0148929			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849062	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000186
J	Keranen, T; Hommo, T; Hamalainen, M; Moilanen, E; Korhonen, R				Keranen, Tiina; Hommo, Tuija; Hamalainen, Mari; Moilanen, Eeva; Korhonen, Riku			Anti-Inflammatory Effects of beta(2)-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DUAL-SPECIFICITY PHOSPHATASES; P38 MAPK; TYROSINE-PHOSPHATASE; GENE-EXPRESSION; INHIBITION; CAMP; DEXAMETHASONE; INFLAMMATION; ROFLUMILAST	Mitogen-activated protein kinase phosphatase 1 (MKP-1) expression is induced by inflammatory factors, and it is an endogenous suppressor of inflammatory response. MKP-1 expression is increased by PDE4 inhibitor rolipram suggesting that it is regulated by cAMP-enhancing compounds. Therefore, we investigated the effect of beta(2)-receptor agonists on MKP-1 expression and inflammatory response. We found that beta(2)-receptor agonists salbutamol and terbutaline, as well as 8-Br-cAMP, increased MKP-1 expression. Salbutamol and terbutaline also inhibited p38 MAPK phosphorylation and TNF production in J774 mouse macrophages. Interestingly, salbutamol suppressed carrageenan-induced paw inflammation in wild-type mice, but the effect was attenuated in MKP-1(-/-) mice. In conclusion, these data show that beta(2)-receptor agonists increase MKP-1 expression, which seems to mediate, at least partly, the observed anti-inflammatory effects of beta(2)-receptor agonists.	[Korhonen, Riku] Univ Tampere, Immunopharmacol Res Grp, Sch Med, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital	Korhonen, R (corresponding author), Univ Tampere, Immunopharmacol Res Grp, Sch Med, FIN-33101 Tampere, Finland.	riku.korhonen@staff.uta.fi		Hamalainen, Mari/0000-0002-6409-3758; Korhonen, Riku/0000-0002-7264-517X	Academy of Finland; Pirkanmaa Hospital District, Finland; Tampere Tuberculosis Foundation	Academy of Finland(Academy of Finland); Pirkanmaa Hospital District, Finland; Tampere Tuberculosis Foundation	This work was financially supported by grants from The Academy of Finland, from the Competitive Research Funding of the Pirkanmaa Hospital District, Finland, and from Tampere Tuberculosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Badger AM, 2000, OSTEOARTHR CARTILAGE, V8, P434, DOI 10.1053/joca.1999.0319; Baouz S, 2005, INT IMMUNOL, V17, P1473, DOI 10.1093/intimm/dxh325; Bateman ED, 2011, EUR RESPIR J, V38, P553, DOI 10.1183/09031936.00178710; Bobick Brent E., 2008, Birth Defects Research, V84, P131, DOI 10.1002/bdrc.20126; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brion L, 2011, ENDOCRINOLOGY, V152, P2665, DOI 10.1210/en.2011-0021; Burnette BL, 2009, PHARMACOLOGY, V84, P42, DOI 10.1159/000227286; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Cazzola M, 2013, AM J RESP CRIT CARE, V187, P690, DOI 10.1164/rccm.201209-1739PP; Cazzola M, 2012, PHARMACOL REV, V64, P450, DOI 10.1124/pr.111.004580; Chen KH, 2007, BIOCHEM PHARMACOL, V73, P215, DOI 10.1016/j.bcp.2006.09.018; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Grimshaw MJ, 2001, EUR J IMMUNOL, V31, P480, DOI 10.1002/1521-4141(200102)31:2<480::AID-IMMU480>3.0.CO;2-L; Huang GH, 2011, IMMUNITY, V35, P45, DOI 10.1016/j.immuni.2011.05.014; Huang X, 2003, TOXICOL APPL PHARM, V191, P40, DOI 10.1016/S0041-008X(03)00194-7; Kaur M, 2008, AM J PHYSIOL-LUNG C, V295, pL505, DOI 10.1152/ajplung.00046.2008; Korhonen R, 2014, BASIC CLIN PHARMACOL, V114, P24, DOI 10.1111/bcpt.12141; Korhonen R, 2013, BRIT J PHARMACOL, V169, P1525, DOI 10.1111/bph.12189; Korhonen R, 2012, MOL IMMUNOL, V51, P219, DOI 10.1016/j.molimm.2012.03.019; Korhonen R, 2011, MOL IMMUNOL, V48, P2059, DOI 10.1016/j.molimm.2011.06.439; KWAK SP, 1994, J BIOL CHEM, V269, P3596; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Liang L, 2013, RESPIROLOGY, V18, P20, DOI 10.1111/resp.12189; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Manetsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059635; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Nieminen R, 2010, ARTHRITIS RHEUM-US, V62, P1650, DOI 10.1002/art.27409; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; Patel BS, 2014, AM J RESPIR CELL MOL; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Saleh TSF, 1996, BRIT J PHARMACOL, V118, P811, DOI 10.1111/j.1476-5381.1996.tb15472.x; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Theron AJ, 2013, DRUG DES DEV THER, V7, P1387, DOI 10.2147/DDDT.S50995; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Uzkeser H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/438912; Vida G, 2011, FASEB J, V25, P4476, DOI 10.1096/fj.11-191007; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; Zarrindast MR, 2002, PHARMACOL BIOCHEM BE, V72, P203, DOI 10.1016/S0091-3057(01)00749-3; Zhang J, 2008, CELL DEATH DIFFER, V15, P1654, DOI 10.1038/cdd.2008.87; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	52	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148144	10.1371/journal.pone.0148144	http://dx.doi.org/10.1371/journal.pone.0148144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849227	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000044
J	Schluter, N				Schlueter, Nils			Ecophenotypic Variation and Developmental Instability in the Late Cretaceous Echinoid Micraster brevis (Irregularia; Spatangoida)	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; GENE-EXPRESSION; EVOLUTION; ENVIRONMENTS; VARIABILITY; SHAPE	The Late Cretaceous echinoid genus Micraster (irregular echinoids, Spatangoida) is one of the most famous examples of a continuous evolutionary lineage in invertebrate palaeontology. The influence of the environment on the phenotype, however, was not tested so far. This study analyses differences in phenotypical variations within three populations of Micraster (Gibbaster) brevis from the early Coniacian, two from the Munsterland Cretaceous Basin (Germany) and one from the North Cantabrian Basin (Spain). The environments of the Spanish and the German sites differed by their sedimentary characteristics, which are generally a crucial factor for morphological adaptations in echinoids. Most of the major phenotypical variations (position of the ambitus, periproct and development of the subanal fasciole) among the populations can be linked to differences in their host sediments. These phenotypic variations are presumed to be an expression of phenotpic plasticiy, which has not been considered in Micraster in previous studies. Two populations (Erwitte area, Germany; Liencres area, Spain) were tested for stochastic variation (fluctuating asymmetry) due to developmental instability, which was present in all studied traits. However, differences in the amount of fluctuating asymmetry between both populations were recognised only in one trait (amount of pore pairs in the anterior paired petals). The results strengthen previous assumptions on ecophenotypic variations in Micraster.	[Schlueter, Nils] Univ Gottingen, Geosci Ctr, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany	University of Gottingen	Schluter, N (corresponding author), Univ Gottingen, Geosci Ctr, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.	nils.schluter@gmail.com		Schluter, Nils/0000-0002-5699-3684	German Research Foundation; Gottingen University; SYNTHESYS Project - European Community [FR-TAF-4917]	German Research Foundation(German Research Foundation (DFG)); Gottingen University; SYNTHESYS Project - European Community	The author acknowledges support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. This research received in parts support from the SYNTHESYS Project, http://www.synthesys.info/, which is financed by European Community Research Infrastructure Action under the FP7, Capacities" Program (FR-TAF-4917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur W, 2000, EVOL DEV, V2, P49, DOI 10.1046/j.1525-142x.2000.00028.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Braendle C, 2006, BIOESSAYS, V28, P868, DOI 10.1002/bies.20456; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Chauffe KM, 1995, PALAEONTOLOGY, V38, P875; Chenuil A, 2003, ECHINODERM RES 2001, P15; Cunningham JA, 2009, BIOL LETTERS, V5, P647, DOI 10.1098/rsbl.2009.0302; DAVID B, 1984, GEOBIOS-LYON, V17, P447, DOI 10.1016/S0016-6995(84)80019-4; De Baets K, 2015, TOP GEOBIOL, V43, P359, DOI 10.1007/978-94-017-9630-9_9; De Ridder C, 1982, ECHINODERM NUTR, P97; DeWitt T.J., 2004, PHENOTYPIC PLASTICIT; Drummond PVO, 1983, GEOLOGIE MEDITERRANE, V10, P177; Egea E, 2016, MOL PHYLOGENET EVOL, V94, P207, DOI 10.1016/j.ympev.2015.07.023; Ernst G., 1970, Mitt. geol. St. Inst., Hamb., V39, P117; Ernst G., 1972, Geologisches Jb (A), VNo. 4, P63; Ernst G., 1977, CONCEPTS METHODS BIO, P541; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Fouray M., 1981, Annales de Paleontologie Invertebres, V67, P81; Francois E, 2006, GEOBIOS-LYON, V39, P355, DOI 10.1016/j.geobios.2005.01.002; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; HIGGINS RC, 1974, J ZOOL, V173, P451; Hunt G, 2004, PALEOBIOLOGY, V30, P426, DOI 10.1666/0094-8373(2004)030<0426:PVIFSM>2.0.CO;2; Jablonski D, 1999, SCIENCE, V284, P2114, DOI 10.1126/science.284.5423.2114; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KANAZAWA K, 1992, PALAEONTOLOGY, V35, P733; Kaplan U, 1998, BOCHUMER GEOL GEOTEC, V48, P184; Kaplan U., 1994, GEOLOGIE PALAONTOLOG, V31, P1; Karvonen E, 2003, OIKOS, V100, P507, DOI 10.1034/j.1600-0706.2003.11851.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg Christian Peter, 2003, P14; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1999, EVOLUTION, V53, P358, DOI [10.2307/2640773, 10.1111/j.1558-5646.1999.tb03772.x]; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Lambert J., 1909, ESSAI NOMENCLATURE R; Lawrence JM, 1998, INVERTEBR BIOL, V117, P94, DOI 10.2307/3226855; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McKinney ML, 1991, EVOLUTION ONTOGENY; MCNAMARA KJ, 1980, ALCHERINGA, V4, P47, DOI 10.1080/03115518008558980; MCNAMARA KJ, 1987, PALEOBIOLOGY, V13, P312; Moller AP, 1997, ASYMMETRY DEV STABIL; Neraudeau D, 1998, LETHAIA, V31, P323; Neraudeau Didier, 2001, Biosystema, V19, P93; NICHOLS D, 1959, PHILOS T ROY SOC B, V242, P347, DOI 10.1098/rstb.1959.0007; Olszewska-Nejbert D, 2007, ACTA GEOL POL, V57, P1; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pigliucci M, 1998, CURR OPIN PLANT BIOL, V1, P87, DOI 10.1016/S1369-5266(98)80133-7; Polak M, 1997, AM NAT, V149, P955, DOI 10.1086/286032; Rowe A., 1899, Quarterly Journal of the Geological Society, Vlv, P494; Saitoh M, 2012, ZOOSYMPOSIA, V7, P255, DOI 10.11646/zoosymposia.7.1.24; Saucede T, 2006, BIOL J LINN SOC, V88, P165, DOI 10.1111/j.1095-8312.2006.00603.x; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seibertz E., 1979, AUFSCHLUSS SONDERBAN, V29, P85; Smith A. B., 2012, Monograph of the Palaeontographical Society, P635; Smith A.B., 1980, Palaeontology (Oxford), V23, P39; Smith A.B., 1984, ECHINOID PALAEOBIOLO; Stige LC, 2006, J EVOLUTION BIOL, V19, P492, DOI 10.1111/j.1420-9101.2005.01011.x; STOKES R B, 1975, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V31, P1; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; SWAIN DP, 1987, AM NAT, V129, P761, DOI 10.1086/284671; Troger K.-A., 1974, Freiberger Forschungshefte, VNo. C298, P109; VANVALEN L, 1962, EVOLUTION, V16, P125; Villier L, 2001, ECHINODERMS 2000, P563; Voigt S, 2003, INT J EARTH SCI, V92, P285, DOI 10.1007/s00531-003-0315-1; Walker Danielle E., 2014, Journal of Marine Biology, P297631; West-Eberhard Mary Jane, 2003, pi; Wiese F, 2002, GEOBIOS-LYON, V35, P65, DOI 10.1016/S0016-6995(02)00010-4; Wiese F, 1997, BERLINER GEOWISSENSC, V24, P1; Willmore KE, 2007, EVOL BIOL, V34, P99, DOI 10.1007/s11692-007-9008-1; Willmore KE, 2005, VARIATION CENTRAL CO, P191; ZAGHBIBTURKI D, 1990, ECHINODERM RESEARCH, P49; Ziegler P.A, 1988, AAPG MEMOIR, V43	76	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148341	10.1371/journal.pone.0148341	http://dx.doi.org/10.1371/journal.pone.0148341			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849648	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000072
J	Ubiali, T; Sanfins, MD; Borges, LR; Colella-Santos, MF				Ubiali, Thalita; Sanfins, Milaine Dominici; Borges, Leticia Reis; Colella-Santos, Maria Francisca			Contralateral Noise Stimulation Delays P300 Latency in School-Aged Children	PLOS ONE			English	Article							MEDIAL OLIVOCOCHLEAR SYSTEM; AUDITORY-EVOKED POTENTIALS; OTOACOUSTIC EMISSION; COCHLEAR SENSITIVITY; INFERIOR COLLICULUS; SOUND LOCALIZATION; NORMAL-HEARING; BRAIN-STEM; MODULATION; CORTEX	Background and Objective The auditory cortex modulates auditory afferents through the olivocochlear system, which innervates the outer hair cells and the afferent neurons under the inner hair cells in the cochlea. Most of the studies that investigated the efferent activity in humans focused on evaluating the suppression of the otoacoustic emissions by stimulating the contralateral ear with noise, which assesses the activation of the medial olivocochlear bundle. The neurophysiology and the mechanisms involving efferent activity on higher regions of the auditory pathway, however, are still unknown. Also, the lack of studies investigating the effects of noise on human auditory cortex, especially in peadiatric population, points to the need for recording the late auditory potentials in noise conditions. Assessing the auditory efferents in schoolaged children is highly important due to some of its attributed functions such as selective attention and signal detection in noise, which are important abilities related to the development of language and academic skills. For this reason, the aim of the present study was to evaluate the effects of noise on P300 responses of children with normal hearing. Methods P300 was recorded in 27 children aged from 8 to 14 years with normal hearing in two conditions: with and whitout contralateral white noise stimulation. Results P300 latencies were significantly longer at the presence of contralateral noise. No significant changes were observed for the amplitude values. Conclusion Contralateral white noise stimulation delayed P300 latency in a group of school-aged children with normal hearing. These results suggest a possible influence of the medial olivocochlear activation on P300 responses under noise condition.	[Ubiali, Thalita; Sanfins, Milaine Dominici; Borges, Leticia Reis; Colella-Santos, Maria Francisca] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil	Universidade Estadual de Campinas	Ubiali, T (corresponding author), Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil.	thalita.ubiali@gmail.com	Colella-Santos, Maria Francisca/AAC-6110-2021; Colella-Santos, Maria Francisca/A-6008-2013; Ubiali, Thalita/B-4858-2019; Sanfins, Milaine Dominici/K-2262-2012	Colella-Santos, Maria Francisca/0000-0002-7456-9502; Ubiali, Thalita/0000-0003-1723-0614; Sanfins, Milaine Dominici/0000-0002-3647-3999	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/14944-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/14944-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andeol G, 2011, J NEUROSCI, V31, P6759, DOI 10.1523/JNEUROSCI.0248-11.2011; ANDERSEN RA, 1980, J COMP NEUROL, V191, P479, DOI 10.1002/cne.901910310; Bajo VM, 2007, CEREB CORTEX, V17, P475, DOI 10.1093/cercor/bhj164; Bidelman GM, 2015, NEUROREPORT, V26, P483, DOI 10.1097/WNR.0000000000000376; Canale A, 2014, INT J PEDIATR OTORHI, V78, P455, DOI 10.1016/j.ijporl.2013.12.016; CASSEDAY JH, 1976, J COMP NEUROL, V166, P303, DOI 10.1002/cne.901660304; Chaubet J, 2014, INT ARCH OTORHINOLAR, V18, P146, DOI 10.1055/s-0033-1363465; COLLET L, 1990, HEARING RES, V43, P251, DOI 10.1016/0378-5955(90)90232-E; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; de Boer J, 2012, J NEUROPHYSIOL, V107, P1301, DOI 10.1152/jn.00222.2011; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Dragicevic CD, 2015, JARO-J ASSOC RES OTO, V16, P223, DOI 10.1007/s10162-015-0509-9; Frizzo ACF, 2012, INT ARCH OTORHINOLAR, V16, P335, DOI 10.7162/S1809-97772012000300006; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Guinan JJ, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00142; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Irving S, 2011, J NEUROSCI, V31, P2493, DOI 10.1523/JNEUROSCI.2679-10.2011; Jager K, 2015, HEARING RES, V332, P61; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; KARNISKI W, 1989, ELECTROEN CLIN NEURO, V72, P373, DOI 10.1016/0013-4694(89)90043-6; Keefe DH, 2010, HEARING RES, V263, P52, DOI 10.1016/j.heares.2009.09.008; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kouni SN, 2013, AM J OTOLARYNG, V34, P646, DOI 10.1016/j.amjoto.2013.07.004; Kraus D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100486; Krishnamurti S., 2001, CONTEM ISSUES COMMUN, V28, P40; Lauer AM, 2011, JARO-J ASSOC RES OTO, V12, P329, DOI 10.1007/s10162-011-0262-7; Leon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036203; Lopez L, 2003, ANN NY ACAD SCI, V999, P124, DOI 10.1196/annals.1284.013; Matas Carla Gentile, 2011, Rev. soc. bras. fonoaudiol., V16, P37, DOI 10.1590/S1516-80342011000100008; McPherson DL, 1996, EVOKED POTENCIAL SER; Wiemes GRM, 2012, BRAZ J OTORHINOLAR, V78, P91, DOI 10.1590/S1808-86942012000300016; Mishra SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085756; Northern J, 2005, AUDICAO NA INFANCIA, P129; OATMAN LC, 1971, EXP NEUROL, V32, P341, DOI 10.1016/0014-4886(71)90003-3; OLIVER DL, 1978, J COMP NEUROL, V182, P459, DOI 10.1002/cne.901820306; Perez-Villa YE, 2014, ACTA OTORRINOLAR ESP, V65, P332, DOI 10.1016/j.otorri.2014.02.010; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Perrot X, 2014, HEARING RES, V308, P27, DOI 10.1016/j.heares.2013.08.010; POLICH J, 1985, BIOL PSYCHOL, V21, P309, DOI 10.1016/0301-0511(85)90185-1; Rabbitt RD, 2011, CURR OPIN OTOLARYNGO, V19, P376, DOI 10.1097/MOO.0b013e32834a5be1; Rabelo CM, 2015, BRAZ J OTORHINOLAR, V81, P63, DOI 10.1016/j.bjorl.2014.11.003; RASMUSSEN GL, 1946, J COMP NEUROL, V84, P141, DOI 10.1002/cne.900840204; Reis Ana Cláudia Mirândola Barbosa, 2014, Audiol., Commun. Res., V19, P293, DOI 10.1590/S2317-643120140003000014; Ryugo DK, 2011, SPRINGER HANDB AUDIT, V38, P1, DOI 10.1007/978-1-4419-7070-1_1; Saldana E, 2015, CEREBELLUM, V14, P584, DOI 10.1007/s12311-015-0694-4; Salisbury DF, 2002, PSYCHOPHYSIOLOGY, V39, P111, DOI 10.1017/S0048577201020030; Salo SK, 2003, J PSYCHOPHYSIOL, V17, P189, DOI 10.1027/0269-8803.17.4.189; Sandman CA, 2000, CLIN NEUROPHYSIOL, V111, P1427, DOI 10.1016/S1388-2457(00)00320-5; Schochat E, 2012, ACTA NEUROBIOL EXP, V72, P296; Schofield BR, 2006, HEARING RES, V216, P81, DOI 10.1016/j.heares.2006.01.004; Terreros G, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00134; Tervaniemi M, 2006, NEUROREPORT, V17, P1225, DOI 10.1097/01.wnr.0000230510.55596.8b; Tokgoz-Yilmaz S, 2013, AURIS NASUS LARYNX, V40, P521, DOI 10.1016/j.anl.2013.04.003; Ungan P, 2013, NEUROL SCI, V34, P25, DOI 10.1007/s10072-012-0961-9; Urnau D, 2012, BRAZ J OTORHINOLAR, V78, P87, DOI 10.1590/S1808-86942012000100014; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Weihing J, 2008, J AM ACAD AUDIOL, V19, P481, DOI 10.3766/jaaa.19.6.4; Wersinger E, 2011, HEARING RES, V279, P1, DOI 10.1016/j.heares.2010.12.018; Winer JA, 1998, J COMP NEUROL, V400, P147; Wittekindt A, 2014, J NEUROSCI, V34, P9995, DOI 10.1523/JNEUROSCI.4861-13.2014; Wolpert S, 2014, AUDIOL NEURO-OTOL, V19, P31, DOI 10.1159/000354913; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Zhao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018725	63	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148360	10.1371/journal.pone.0148360	http://dx.doi.org/10.1371/journal.pone.0148360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849224	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000080
J	Tatler, AL; Habgood, A; Porte, J; John, AE; Stavrou, A; Hodge, E; Kerama-Likoko, C; Violette, SM; Weinreb, PH; Knox, AJ; Laurent, G; Parfrey, H; Wolters, PJ; Wallace, W; Alberti, S; Nordheim, A; Jenkins, G				Tatler, Amanda L.; Habgood, Anthony; Porte, Joanne; John, Alison E.; Stavrou, Anastasios; Hodge, Emily; Kerama-Likoko, Cheryl; Violette, Shelia M.; Weinreb, Paul H.; Knox, Alan J.; Laurent, Geoffrey; Parfrey, Helen; Wolters, Paul John; Wallace, William; Alberti, Siegfried; Nordheim, Alfred; Jenkins, Gisli			Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin alpha v beta 6 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LUNG EPITHELIAL-CELLS; TRANSCRIPTIONAL ACTIVATION; LIVER FIBROSIS; INTEGRIN-ALPHA-V-BETA-6; INFLAMMATION; RECEPTOR; DIFFERENTIATION; DEGRADATION; INHIBITION	Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with high mortality. Active TGF beta 1 is considered central to the pathogenesis of IPF. A major mechanism of TGF beta 1 activation in the lung involves the epithelially restricted alpha v beta 6 integrin. Expression of the alpha v beta 6 integrin is dramatically increased in IPF. How alpha v beta 6 integrin expression is regulated in the pulmonary epithelium is unknown. Here we identify a region in the beta 6 subunit gene(ITGB6) promoter acting to markedly repress basal gene transcription, which responds to both the Ets domain-containing protein Elk1 (Elk1) and the glucocorticoid receptor (GR). Both Elk1 and GR can regulate alpha v beta 6 integrin expression in vitro. We demonstrate Elk1 binding to the ITGB6 promoter basally and that manipulation of Elk1 or Elk1 binding alters ITGB6 promoter activity, gene transcription, and alpha v beta 6 integrin expression. Crucially, we find that loss of Elk1 causes enhanced Itgb6 expression and exaggerated lung fibrosis in an in vivo model of fibrosis, whereas the GR agonist dexamethasone inhibits Itgb6 expression. Moreover, Elk1 dysregulation is present in epithelium from patients with IPF. These data reveal a novel role for Elk1 regulating ITGB6 expression and highlight how dysregulation of Elk1 can contribute to human disease.	[Tatler, Amanda L.; Habgood, Anthony; Porte, Joanne; John, Alison E.; Stavrou, Anastasios; Hodge, Emily; Kerama-Likoko, Cheryl; Knox, Alan J.; Jenkins, Gisli] Univ Nottingham, Univ Nottingham Hosp, Div Resp Med, City Campus, Nottingham NG5 1PB, England; [Violette, Shelia M.; Weinreb, Paul H.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Laurent, Geoffrey] UCL, Ctr Resp Res, London WC1E 6JF, England; [Laurent, Geoffrey] Univ Western Australia, Ctr Cell Therapy & Regenerat Med, Crawley, WA 6009, Australia; [Parfrey, Helen] Univ Cambridge, Dept Med, Cambridge CB2 0SP, England; [Parfrey, Helen] Papworth Hosp NHSFT, Cambridge CB2 0SP, England; [Wolters, Paul John] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Wallace, William] Univ Edinburgh, Div Pathol, Edinburgh EH4 2XR, Midlothian, Scotland; [Alberti, Siegfried; Nordheim, Alfred] Univ Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Biogen; University of London; University College London; University of Western Australia; University of Cambridge; Papworth Hospital; University of California System; University of California San Francisco; University of Edinburgh; Eberhard Karls University of Tubingen	Tatler, AL (corresponding author), Univ Nottingham Hosp, Div Resp Med, City Campus,Hucknall Rd, Nottingham NG5 1PB, England.	amanda.tatler@nottingham.ac.uk	Jenkins, Gisli/R-8143-2017; tatler, amanda/I-2620-2019	Jenkins, Gisli/0000-0002-7929-2119; tatler, amanda/0000-0002-4644-4614; John, Alison/0000-0002-0453-3221; Weinreb, Paul/0000-0002-0802-0052; Knox, Alan/0000-0002-5906-4143	Wellcome Trust [085350]; National Centre for the Replacement, Refinement, and Reduction of Animals in Research Grant [G110564]; German Cancer Aid Grant [109886]; NC3Rs David Sainsbury fellowship; GlaxoSmithKline; Intermune; Boehringer Ingelheim; Biogen; PharmAkea; Medimmune; Roche; Novartis; Medical Research Council [MR/N005953/1] Funding Source: researchfish; Medical Research Foundation [MRF-091-0004-RG-TATLE] Funding Source: researchfish; National Centre for the Replacement [G1100564/1, NC/K500501/1] Funding Source: researchfish; MRC [MR/N005953/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for the Replacement, Refinement, and Reduction of Animals in Research Grant(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); German Cancer Aid Grant; NC3Rs David Sainsbury fellowship; GlaxoSmithKline(GlaxoSmithKline); Intermune; Boehringer Ingelheim(Boehringer Ingelheim); Biogen(Biogen); PharmAkea; Medimmune(AstraZenecaMedimmune); Roche(Roche Holding); Novartis(Novartis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 085350 (to G. J.), the National Centre for the Replacement, Refinement, and Reduction of Animals in Research Grant G110564 (to G. J.), German Cancer Aid Grant 109886 (to A. N.), and an NC3Rs David Sainsbury fellowship (to A. T.). S. M. V. and P. H. W. are shareholders of Biogen Idec. G. J. has received consultancy fees from GlaxoSmithKline, Intermune, Boehringer Ingelheim, Biogen, and PharmAkea and lecture fees from Intermune, Medimmune, Roche, and Boehringer Ingelheim and has sponsored research agreements with GlaxoSmithKline, Novartis, and Biogen.	Adcock IM, 1996, AM J RESP CRIT CARE, V154, P771, DOI 10.1164/ajrccm.154.3.8810618; Aigner A, 2006, J BIOTECHNOL, V124, P12, DOI 10.1016/j.jbiotec.2005.12.003; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Carreras I, 2001, AM J PHYSIOL-LUNG C, V281, pL766, DOI 10.1152/ajplung.2001.281.4.L766; Castelbaum AJ, 1997, J CLIN ENDOCR METAB, V82, P136, DOI 10.1210/jc.82.1.136; Cesari F, 2004, GENESIS, V38, P87, DOI 10.1002/gene.20003; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; Hagimoto N, 2002, J IMMUNOL, V168, P6470, DOI 10.4049/jimmunol.168.12.6470; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Ji HL, 2011, REPROD SCI, V18, P156, DOI 10.1177/1933719110382305; John AE, 2013, J NUCL MED, V54, P2146, DOI 10.2967/jnumed.113.120592; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Oak SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021253; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rock K, 2011, J BIOL CHEM, V286, P18268, DOI 10.1074/jbc.M110.201665; Saini G, 2015, EUR RESPIR J, V46, P486, DOI 10.1183/09031936.00210414; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; SHEPPARD D, 1992, J BIOL CHEM, V267, P17409; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; Sullivan BP, 2010, AM J PATHOL, V177, P2837, DOI 10.2353/ajpath.2010.100425; Tanswell AK, 1998, AM J PHYSIOL-LUNG C, V275, pL452, DOI 10.1152/ajplung.1998.275.3.L452; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zoz DF, 2011, AM J MED SCI, V341, P435, DOI 10.1097/MAJ.0b013e31821a9d8e	40	19	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9540	9553		10.1074/jbc.M115.692368	http://dx.doi.org/10.1074/jbc.M115.692368			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26861876	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000375602300014
J	Parthasarathy, S; Parapatla, H; Nandavaram, A; Palmer, T; Siddavattam, D				Parthasarathy, Sunil; Parapatla, Hari; Nandavaram, Aparna; Palmer, Tracy; Siddavattam, Dayananda			Organophosphate Hydrolase Is a Lipoprotein and Interacts with P-i-specific Transport System to Facilitate Growth of Brevundimonas diminuta Using OP Insecticide as Source of Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; ESCHERICHIA-COLI; PSEUDOMONAS-DIMINUTA; FLAVOBACTERIUM SP; OUTER-MEMBRANE; STREPTOMYCES-COELICOLOR; CYTOPLASMIC MEMBRANE; PROTEIN EXPORT; NERVE AGENTS; PATHWAY	Organophosphate hydrolase (OPH), encoded by the organophosphate degradation (opd) island, hydrolyzes the triester bond found in a variety of organophosphate insecticides and nerve agents. OPH is targeted to the inner membrane of Brevundimonas diminuta in a pre-folded conformation by the twin arginine transport (Tat) pathway. The OPH signal peptide contains an invariant cysteine residue at the junction of the signal peptidase (Spase) cleavage site along with a well conserved lipobox motif. Treatment of cells producing native OPH with the signal peptidase II inhibitor globomycin resulted in accumulation of most of the pre-OPH in the cytoplasm with negligible processed OPH detected in the membrane. Substitution of the conserved lipobox cysteine to serine resulted in release of OPH into the periplasm, confirming that OPH is a lipoprotein. Analysis of purified OPH revealed that it was modified with the fatty acids palmitate and stearate. Membrane-bound OPH was shown to interact with the outer membrane efflux protein TolC and with PstS, the periplasmic component of the ABC transporter complex (PstSACB) involved in phosphate transport. Interaction of OPH with PstS appears to facilitate transport of Pi generated from organophosphates due to the combined action of OPH and periplasmically located phosphatases. Consistent with this model, opd null mutants of B. diminuta failed to grow using the organophosphate insecticide methyl parathion as sole source of phosphate.	[Parthasarathy, Sunil; Parapatla, Hari; Nandavaram, Aparna; Siddavattam, Dayananda] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India; [Palmer, Tracy] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee, Scotland	University of Hyderabad; University of Dundee	Siddavattam, D (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	sdsl@uohyd.ernet.in		Palmer, Tracy/0000-0001-9043-2592	Department of Biotechnology, Govt. of India; DST-FIST (Department of Science and Technology-Fund for Improvement of SAMP;T Infrastructure); School of Life Sciences, University of Hyderabad by DBT-CREBB/BUILDER (Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology/Boost); Shantha Biotechnics Junior Research Fellowship (JRF); Commonwealth Split-Site Fellowships, British Council, UK; MRC [G117/519] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/0000A189] Funding Source: researchfish; Medical Research Council [G117/519] Funding Source: researchfish	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); DST-FIST (Department of Science and Technology-Fund for Improvement of SAMP;T Infrastructure); School of Life Sciences, University of Hyderabad by DBT-CREBB/BUILDER (Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology/Boost); Shantha Biotechnics Junior Research Fellowship (JRF); Commonwealth Split-Site Fellowships, British Council, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Department of Biotechnology, Govt. of India (to D. S. Laboratory). Department of Animal Biology was supported by the DST-FIST (Department of Science and Technology-Fund for Improvement of S&T Infrastructure), and the School of Life Sciences, University of Hyderabad is supported by DBT-CREBB/BUILDER (Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology/Boost to University Interdisciplinary Life Science Departments for Education and Research). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Shantha Biotechnics Junior Research Fellowship (JRF) and Commonwealth Split-Site Fellowships, British Council, UK.	Bachmann J, 2006, FEBS J, V273, P4817, DOI 10.1111/j.1742-4658.2006.05480.x; Benning MM, 2001, BIOCHEMISTRY-US, V40, P2712, DOI 10.1021/bi002661e; Beven L, 1996, CURR MICROBIOL, V33, P317, DOI 10.1007/s002849900121; Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004; BROWN KA, 1980, SOIL BIOL BIOCHEM, V12, P105, DOI 10.1016/0038-0717(80)90044-9; CHAUDHRY GR, 1988, APPL ENVIRON MICROB, V54, P288, DOI 10.1128/AEM.54.2.288-293.1988; Cho CMH, 2002, APPL ENVIRON MICROB, V68, P2026, DOI 10.1128/AEM.68.4.2026-2030.2002; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Efremenko EN, 2001, RUSS CHEM B+, V50, P1826, DOI 10.1023/A:1014377912147; Gimenez MI, 2007, MOL MICROBIOL, V66, P1597, DOI 10.1111/j.1365-2958.2007.06034.x; Gorla P, 2009, J BACTERIOL, V191, P6292, DOI 10.1128/JB.00824-09; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Hobbs EC, 2012, P NATL ACAD SCI USA, V109, P16696, DOI 10.1073/pnas.1210093109; Ichihara K, 2010, J LIPID RES, V51, P635, DOI 10.1194/jlr.D001065; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kanugula AK, 2011, INDIAN J BIOCHEM BIO, V48, P29; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Keller R, 2012, J CELL BIOL, V199, P303, DOI 10.1083/jcb.201204149; Kim MS, 2010, J AM SOC MASS SPECTR, V21, P1606, DOI 10.1016/j.jasms.2010.04.011; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Mullerova D, 2009, FEMS MICROBIOL LETT, V299, P74, DOI 10.1111/j.1574-6968.2009.01737.x; MULBRY WW, 1989, APPL ENVIRON MICROB, V55, P289, DOI 10.1128/AEM.55.2.289-293.1989; Nadeau O. W., 2007, CSH PROTOC, V2007; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; OMBURO GA, 1992, J BIOL CHEM, V267, P13278; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Pandeeti EVP, 2012, G3-GENES GENOM GENET, V2, P1541, DOI 10.1534/g3.112.004051; Pandeeti EVP, 2011, PLASMID, V65, P226, DOI 10.1016/j.plasmid.2011.02.003; Poole R K, 1993, Methods Mol Biol, V19, P109; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Sambrook, 2001, MOL CLONING LAB MANU, V3rd; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHNAITM.CA, 1970, J BACTERIOL, V104, P890, DOI 10.1128/JB.104.2.890-901.1970; SERDAR CM, 1982, APPL ENVIRON MICROB, V44, P246, DOI 10.1128/AEM.44.1.246-249.1982; Siddavattam D, 2003, APPL ENVIRON MICROB, V69, P2533, DOI 10.1128/AEM.69.5.2533-2539.2003; Siddavattam D, 2006, PESTIC BIOCHEM PHYS, V86, P146, DOI 10.1016/j.pestbp.2006.02.007; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Tanaka S, 2007, J BIOL CHEM, V282, P13379, DOI 10.1074/jbc.M611840200; Thompson BJ, 2010, MOL MICROBIOL, V77, P943, DOI 10.1111/j.1365-2958.2010.07261.x; Valente FMA, 2007, FEBS LETT, V581, P3341, DOI 10.1016/j.febslet.2007.06.020; vanGeest M, 1996, J BIOL CHEM, V271, P25582, DOI 10.1074/jbc.271.41.25582; WALKER CH, 1993, CHEM-BIOL INTERACT, V87, P17, DOI 10.1016/0009-2797(93)90021-P; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Widdick DA, 2011, MOL MICROBIOL, V80, P1395, DOI 10.1111/j.1365-2958.2011.07656.x; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; ZWIEBEL LJ, 1981, J BACTERIOL, V145, P654, DOI 10.1128/JB.145.1.654-656.1981	54	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7774	7785		10.1074/jbc.M116.715110	http://dx.doi.org/10.1074/jbc.M116.715110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26861877	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000383447600046
J	Dahine, J; Mardini, L; Jayaraman, D				Dahine, Joseph; Mardini, Louay; Jayaraman, Dev			The Perceived Likelihood of Outcome of Critical Care Patients and Its Impact on Triage Decisions: A Case-Based Survey of Intensivists and Internists in a Canadian, Quaternary Care Hospital Network	PLOS ONE			English	Article							UNIT; DISAGREEMENT; RESIDENTS; FUTILITY	Introduction There is high variability amongst physicians' assessments of appropriate ICU admissions, which may be based on potential assessments of benefit. We aimed to examine whether opinions over benefit of ICU admissions of critically ill medical inpatients differed based on physician specialty, namely intensivists and internists. Materials and Methods We carried out an anonymous, web-based questionnaire survey containing 5 typical ICU cases to all ICU physicians regardless of their base specialty as well as to all internists in 3 large teaching hospitals. For each case, we asked the participants to determine if the patient was an appropriate ICU admission and to assess different parameters (e.g. baseline function, likelihood of survival to ICU discharge, etc.). Agreement was measured using kappa values. Results 21 intensivists and 22 internists filled out the survey (response rate = 87.5% and 35% respectively). Predictions of likelihood of survival to ICU admission, hospital discharge and return to baseline were not significantly different between the two groups. However, agreement between individuals within each group was only slight to fair (kappa range = 0.09-0.22). There was no statistically significant difference in predicting ICU survival and prediction of survival to hospital discharge between both groups. The accuracy with which physicians predicted actual outcomes ranged between 35% and 100% and did not significantly differ between the two groups. A greater proportion of internists favoured non resuscitative measures (24.6% of intensivists and 46.9% internists [p = 0.002]). Conclusion In a case-based survey, physician specialty base did not affect assessments of ICU admission benefit or accuracy in outcome prediction, but resulted in a statistically significant difference in level of care assignments. Of note, significant disagreement amongst individuals in each group was found.	[Dahine, Joseph; Mardini, Louay] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Dept Crit Care, Montreal, PQ H3A 1A1, Canada; [Jayaraman, Dev] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Crit Care, Montreal, PQ H3G 1A4, Canada; [Jayaraman, Dev] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Gen Internal Med, Montreal, PQ H3G 1A4, Canada; [Jayaraman, Dev] McGill Univ, Jewish Gen Hosp, Dept Crit Care, Montreal, PQ H3T 1E2, Canada	McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University	Jayaraman, D (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Crit Care, Montreal, PQ H3G 1A4, Canada.; Jayaraman, D (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Gen Internal Med, Montreal, PQ H3G 1A4, Canada.; Jayaraman, D (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Crit Care, Montreal, PQ H3T 1E2, Canada.	dev.jayaraman@mcgill.ca						[Anonymous], 2007, ETH LEG CONS MIT PAN; Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Boumendil A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034387; BRANNEN AL, 1989, ARCH INTERN MED, V149, P1083, DOI 10.1001/archinte.149.5.1083; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cohen J, 1960, EDUC PSYCHOL MEAS; Cook D, 2006, AM J CRIT CARE, V15, P269; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Frick S, 2003, CRIT CARE MED, V31, P456, DOI 10.1097/01.CCM.0000049945.69373.7C; Frost DW, 2011, CRIT CARE MED, V39, P1174, DOI 10.1097/CCM.0b013e31820eacf2; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; Lanken PN, 1997, AM J RESP CRIT CARE, V156, P1282; Lorin S, 2005, CHEST, V127, P630, DOI 10.1378/chest.127.2.630; Meadow W, 2011, CRIT CARE MED, V39, P474, DOI 10.1097/CCM.0b013e318205df9b; POSES RM, 1989, CRIT CARE MED, V17, P827, DOI 10.1097/00003246-198908000-00021; POSES RM, 1991, CRIT CARE MED, V19, P1533, DOI 10.1097/00003246-199112000-00016; Public Health Agency of Canada Health Canada, LESS LEARN REV PUBL; Sinuff T, 2004, CRIT CARE MED, V32, P1588, DOI 10.1097/01.CCM.0000130175.38521.9F; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; UEBERSAX JS, 1987, PSYCHOL BULL, V101, P140, DOI 10.1037/0033-2909.101.1.140; WEIL PA, 1981, ANN INTERN MED, V94, P691, DOI 10.7326/0003-4819-94-5-691; Wilkinson DJC, 2013, INTENS CARE MED, V39, P1128, DOI 10.1007/s00134-013-2871-6; Nguyen YL, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-29	24	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149196	10.1371/journal.pone.0149196	http://dx.doi.org/10.1371/journal.pone.0149196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871587	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100124
J	Keogh, K; Kenny, DA; Cormican, P; McCabe, MS; Kelly, AK; Waters, SM				Keogh, Kate; Kenny, David A.; Cormican, Paul; McCabe, Matthew S.; Kelly, Alan K.; Waters, Sinead M.			Effect of Dietary Restriction and Subsequent Re-Alimentation on the Transcriptional Profile of Bovine Skeletal Muscle	PLOS ONE			English	Article							RESIDUAL FEED-INTAKE; BELGIAN-BLUE BULLS; ACUTE CALORIC RESTRICTION; GENE-EXPRESSION DATA; COMPENSATORY GROWTH; MITOCHONDRIAL BIOGENESIS; CARNITINE PALMITOYLTRANSFERASE; ENERGY RESTRICTION; PLASMA METABOLITES; DIFFERENT PERIODS	Compensatory growth (CG), an accelerated growth phenomenon which occurs following a period of dietary restriction is exploited worldwide in animal production systems as a method to lower feed costs. However the molecular mechanisms regulated CG expression remain to be elucidated fully. This study aimed to uncover the underlying biology regulating CG in cattle, through an examination of skeletal muscle transcriptional profiles utilising next generation mRNA sequencing technology. Twenty Holstein Friesian bulls were fed either a restricted diet for 125 days, with a target growth rate of 0.6 kg/day (Period 1), following which they were allowed feed ad libitum for a further 55 days (Period 2) or fed ad libitum for the entirety of the trial. M. longissimus dorsi biopsies were harvested from all bulls on days 120 and 15 of periods 1 and 2 respectively and RNAseq analysis was performed. During realimentation in Period 2, previously restricted animals displayed CG, growing at 1.8 times the rate of the ad libitum control animals. Compensating animals were also more feed efficient during re-alimentation and compensated for 48% of their previous dietary restriction. 1,430 and 940 genes were identified as significantly differentially expressed (Benjamini Hochberg adjusted P < 0.1) in periods 1 and 2 respectively. Additionally, 2,237 genes were differentially expressed in animals undergoing CG relative to dietary restriction. Dietary restriction in Period 1 was associated with altered expression of genes involved in lipid metabolism and energy production. CG expression in Period 2 occurred in association with greater expression of genes involved in cellular function and organisation. This study highlights some of the molecular mechanisms regulating CG in cattle. Differentially expressed genes identified are potential candidate genes for the identification of biomarkers for CG and feed efficiency, which may be incorporated into future breeding programmes.	[Keogh, Kate; Kenny, David A.; Cormican, Paul; McCabe, Matthew S.; Waters, Sinead M.] TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland; [Keogh, Kate; Kelly, Alan K.] UCD Sch Agr & Food Sci, Dublin 4, Ireland	Teagasc	Waters, SM (corresponding author), TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland.	sinead.waters@teagasc.ie	Keogh, Kate/AAY-2455-2020; Kenny, David/B-1653-2013	Keogh, Kate/0000-0001-8338-5177; Kenny, David/0000-0001-9204-098X	Science Foundation Ireland [09/RFP/GEN/2447]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors received funding from Science Foundation Ireland, grant number: 09/RFP/GEN/2447	Ashfield A, 2014, J AGR SCI-CAMBRIDGE, V152, P805, DOI 10.1017/S0021859613000531; Barilli A, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-32; Bottje W, 2009, POULTRY SCI, V88, P1683, DOI 10.3382/ps.2009-00100; Bottje WG, 2009, J ANIM SCI, V87, pE48, DOI 10.2527/jas.2008-1379; BRITTON CH, 1995, P NATL ACAD SCI USA, V92, P1984, DOI 10.1073/pnas.92.6.1984; Byrne KA, 2005, J ANIM SCI, V83, P1; Cabaraux JF, 2003, ANIM SCI, V77, P205, DOI 10.1017/S135772980005894X; CARSTENS GE, 1991, J ANIM SCI, V69, P3251; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Connor EE, 2010, FUNCT INTEGR GENOMIC, V10, P39, DOI 10.1007/s10142-009-0138-7; Corton JC, 2004, J BIOL CHEM, V279, P46204, DOI 10.1074/jbc.M406739200; Dervishi E, 2011, MEAT SCI, V89, P91, DOI 10.1016/j.meatsci.2011.04.003; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAYDEN JM, 1993, J ANIM SCI, V71, P3327, DOI 10.2527/1993.71123327x; HENRIKSSON J, 1990, EUR J CLIN NUTR, V44, P55; Higami Y, 2006, J NUTR, V136, P343, DOI 10.1093/jn/136.2.343; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Hornick JL, 1998, J ANIM SCI, V76, P249; Hornick JL, 1998, J ANIM SCI, V76, P260; Hornick JL, 2000, DOMEST ANIM ENDOCRIN, V19, P121, DOI 10.1016/S0739-7240(00)00072-2; KEANE MG, 1994, IRISH J AGR FOOD RES, V33, P111; Kelly AK, 2011, PHYSIOL GENOMICS, V43, P12, DOI 10.1152/physiolgenomics.00213.2009; Keogh K, 2015, J ANIM SCI, V93, P3590, DOI 10.2527/jas.2014-8471; Keogh K, 2015, J ANIM SCI, V93, P3578, DOI 10.2527/jas.2014-8470; Keogh K., 2015, THESIS U COLL DUBLIN; Kolath WH, 2006, J ANIM SCI, V84, P861, DOI 10.2527/2006.844861x; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Lehninger AL, 1993, PRINCIPLES OF BIOCHE; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Matsuzaka T, 2002, J LIPID RES, V43, P911; MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305; Moibi JA, 2000, CAN J ANIM SCI, V80, P59, DOI 10.4141/A99-049; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROMPALA RE, 1985, J ANIM SCI, V61, P637, DOI 10.2527/jas1985.613637x; Ryan W. J., 1990, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V60, P653; RYAN WJ, 1993, AUST J AGR RES, V44, P1623, DOI 10.1071/AR9931623; RYAN WJ, 1993, AUST J AGR RES, V44, P1609, DOI 10.1071/AR9931609; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; SAINZ RD, 1995, J ANIM SCI, V73, P2971; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Turyn J, 2010, MOL CELL BIOCHEM, V345, P181, DOI 10.1007/s11010-010-0571-x; van Weeghel M, 2012, FASEB J, V26, P4316, DOI 10.1096/fj.12-206326; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yambayamba ESK, 1996, LIVEST PROD SCI, V46, P19, DOI 10.1016/0301-6226(96)00014-0; Yambayamba ESK, 1996, J ANIM SCI, V74, P57; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang DY, 2002, J BIOL CHEM, V277, P9127, DOI 10.1074/jbc.M112228200	59	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149373	10.1371/journal.pone.0149373	http://dx.doi.org/10.1371/journal.pone.0149373			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871690	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100152
J	Ruiz-Castellano, C; Tomas, G; Ruiz-Rodriguez, M; Martin-Galvez, D; Soler, JJ				Ruiz-Castellano, Cristina; Tomas, Gustavo; Ruiz-Rodriguez, Magdalena; Martin-Galvez, David; Jose Soler, Juan			Nest Material Shapes Eggs Bacterial Environment	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; AROMATIC PLANTS; INCUBATION BEHAVIOR; COLOR COMPOSITION; BLUE TITS; FEATHERS; STARLINGS; EVOLUTION; EGGSHELLS; SIZE	Selective pressures imposed by pathogenic microorganisms to embryos have selected in hosts for a battery of antimicrobial lines of defenses that includes physical and chemical barriers. Due to the antimicrobial properties of volatile compounds of green plants and of chemicals of feather degrading bacteria, the use of aromatic plants and feathers for nest building has been suggested as one of these barriers. However, experimental evidence suggesting such effects is scarce in the literature. During two consecutive years, we explored experimentally the effects of these nest materials on loads of different groups of bacteria (mesophilic bacteria, Enterobacteriaceae, Staphylococcus and Enterococcus) of eggshells in nests of spotless starlings (Sturnus unicolor) at the beginning and at the end of the incubation period. This was also explored in artificial nests without incubation activity. We also experimentally increased bacterial density of eggs in natural and artificial nests and explored the effects of nest lining treatments on eggshell bacterial load. Support for the hypothetical antimicrobial function of nest materials was mainly detected for the year and location with larger average values of eggshell bacterial density. The beneficial effects of feathers and plants were more easily detected in artificial nests with no incubation activity, suggesting an active role of incubation against bacterial colonization of eggshells. Pigmented and unpigmented feathers reduced eggshell bacterial load in starling nests and artificial nest boxes. Results from artificial nests allowed us to discuss and discard alternative scenarios explaining the detected association, particularly those related to the possible sexual role of feathers and aromatic plants in starling nests. All these results considered together confirm the antimicrobial functionality mainly of feathers but also of plants used as nest materials, and highlight the importance of temporally and geographically environmental variation associated with risk of bacterial proliferation determining the strength of such effects. Because of costs associated to nest building, birds should adjust nest building effort to expected bacterial environments during incubation, a prediction that should be further explored.	[Ruiz-Castellano, Cristina; Tomas, Gustavo; Ruiz-Rodriguez, Magdalena; Martin-Galvez, David; Jose Soler, Juan] CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain; [Tomas, Gustavo] UTPL, Dept Ciencias Nat, Loja, Ecuador; [Martin-Galvez, David] EBI, EMBL, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad Tecnica Particular de Loja; European Molecular Biology Laboratory (EMBL)	Ruiz-Castellano, C (corresponding author), CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain.	cristinarc@eeza.csic.es	Tomas, Gustavo/J-7559-2012; Ruiz-Rodríguez, Magdalena/AAZ-6384-2021; Soler, J. J./H-2363-2011; Ruiz-Rodríguez, Magdalena/D-4226-2014; Martín-Gálvez, David/H-3707-2011	Tomas, Gustavo/0000-0001-6701-2055; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Soler, J. J./0000-0003-2990-1489; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Martín-Gálvez, David/0000-0002-1501-9578	Spanish Ministerio de Ciencia e Innovacion, European funds (FEDER) [CGL2010-19233-C03-01, CGL2010-19233-C03-03, CGL2013-48193-C3-1-P, CGL2013-48193-C3-3-P]; Spanish Government; Juan de la Cierva programme (Spain); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT) through a Prometeo research grant	Spanish Ministerio de Ciencia e Innovacion, European funds (FEDER); Spanish Government(Spanish GovernmentEuropean Commission); Juan de la Cierva programme (Spain); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT) through a Prometeo research grant	This work was financed by Spanish Ministerio de Ciencia e Innovacion, European funds (FEDER) (CGL2010-19233-C03-01, CGL2010-19233-C03-03, CGL2013-48193-C3-1-P, CGL2013-48193-C3-3-P). MRR and DMG received a postdoc from the programmes "JAE-Doc" and CRC had a predoctoral grant from the Spanish Government. GT was supported by Juan de la Cierva programme (Spain) and by Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT) through a Prometeo research grant.	Berrang ME, 1999, J APPL POULTRY RES, V8, P499, DOI 10.1093/japr/8.4.499; Board R. G., 1994, P43; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; Bruce J., 1994, P63; Cantarero A, 2013, ACTA ORNITHOL, V48, P39, DOI 10.3161/000164513X669982; Chipeva VA, 2013, AFR J TRADIT COMPLEM, V10, P559, DOI 10.4314/ajtcam.v10i6.30; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; CLARK L, 1990, PARASITOL TODAY, V6, P358, DOI 10.1016/0169-4758(90)90415-Z; CLAYTON DH, 1993, TRENDS ECOL EVOL, V8, P60, DOI 10.1016/0169-5347(93)90160-Q; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; D'Alba L, 2015, J ORNITHOL, V156, pS399, DOI 10.1007/s10336-015-1226-1; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Dubiec A, 2013, AVIAN BIOL RES, V6, P133, DOI 10.3184/175815513X13615363233558; Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127; GALVEZ A, 1994, ANTIMICROB AGENTS CH, V38, P1314, DOI 10.1128/AAC.38.6.1314; de Hierro LGL, 2013, ETHOLOGY, V119, P199, DOI 10.1111/eth.12053; Garcia-Navas V, 2015, ANIM BEHAV, V99, P95, DOI 10.1016/j.anbehav.2014.10.024; Godard RD, 2007, J AVIAN BIOL, V38, P709, DOI 10.1111/j.0908-8857.2007.04052.x; Gonzalez-Braojos S, 2012, ACTA ORNITHOL, V47, P119, DOI 10.3161/000164512X662223; Gwinner H, 2005, J ORNITHOL, V146, P365, DOI 10.1007/s10336-005-0012-x; Hilton GM, 2004, AUK, V121, P777, DOI 10.1642/0004-8038(2004)121[0777:UANTTI]2.0.CO;2; Horrocks NPC, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-49; Sanz JJ, 2011, BEHAV ECOL, V22, P240, DOI 10.1093/beheco/arq199; Soler JJ, 2015, OECOLOGIA, V179, P63, DOI 10.1007/s00442-015-3322-6; Soler JJ, 2011, NATURWISSENSCHAFTEN, V98, P807, DOI 10.1007/s00114-011-0830-z; Lafuma L, 2001, BEHAV PROCESS, V56, P113, DOI 10.1016/S0376-6357(01)00191-7; Lislevand T, 2004, ETHOLOGY, V110, P177, DOI 10.1111/j.1439-0310.2004.00967.x; Mainwaring MC, 2014, ECOL EVOL, V4, P3909, DOI 10.1002/ece3.1054; Mainwaring MC, 2013, AVIAN BIOL RES, V6, P12, DOI 10.3184/175815512X13528994072997; Peralta-Sanchez JM, 2014, MICROB ECOL, V67, P480, DOI 10.1007/s00248-013-0338-5; Martin-Vivaldi M, 2014, J ANIM ECOL, V83, P1289, DOI 10.1111/1365-2656.12243; Mazgajski TD, 2007, POL J ECOL, V55, P377; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Mennerat A, 2009, ANIM BEHAV, V77, P569, DOI 10.1016/j.anbehav.2008.11.008; Meyre-Silva C, 2010, CURR PHARM DESIGN, V16, P3503, DOI 10.2174/138161210793563392; Moller AP, 2015, ECOL EVOL, V5, P1676, DOI 10.1002/ece3.1473; Moller AP, 2013, OECOLOGIA, V173, P169, DOI 10.1007/s00442-013-2600-4; Moller AP, 2000, BEHAV ECOL, V11, P472, DOI 10.1093/beheco/11.5.472; Moreno J, 2012, AVIAN BIOL RES, V5, P238, DOI 10.3184/175815512X13534385822786; Narushin VG, 1997, J AGR ENG RES, V68, P201, DOI 10.1006/jaer.1997.0188; Pacejka AJ, 1996, J FIELD ORNITHOL, V67, P558; Peralta-Sanchez JM, 2011, BIOL J LINN SOC, V102, P67, DOI 10.1111/j.1095-8312.2010.01557.x; Peralta-Sanchez JM, 2010, FUNCT ECOL, V24, P426, DOI 10.1111/j.1365-2435.2009.01669.x; PINOWSKI J, 1994, J BIOSCIENCES, V19, P441, DOI 10.1007/BF02703180; Playfair J, 2004, INFECT IMMUNITY; Polo V, 2006, J ANIM ECOL, V75, P942, DOI 10.1111/j.1365-2656.2006.01103.x; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P111, DOI DOI 10.1017/CB09780511806384.007; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Selles C, 2013, NAT PROD RES, V27, P2231, DOI 10.1080/14786419.2013.811409; Shawkey MD, 2008, BEHAV ECOL, V19, P920, DOI 10.1093/beheco/arn019; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler JJ, 2012, J EVOLUTION BIOL, V25, P1779, DOI 10.1111/j.1420-9101.2012.02561.x; Soler JJ, 1998, EVOL ECOL, V12, P427, DOI 10.1023/A:1006520821219; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Suarez-Rodriguez M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0931; Tomas G, 2012, BEHAV PROCESS, V90, P246, DOI 10.1016/j.beproc.2012.02.003; Tomas G, 2007, ANIM BEHAV, V73, P805, DOI 10.1016/j.anbehav.2006.06.016; Tomas G, 2013, BEHAV ECOL, V24, P926, DOI 10.1093/beheco/art015; Veiga JP, 2011, BEHAVIOUR, V148, P1359, DOI 10.1163/000579511X608684; Veiga JP, 2006, ETHOLOGY, V112, P196, DOI 10.1111/j.1439-0310.2006.01148.x; Veiga JP, 2005, BIOL LETT-UK, V1, P334, DOI 10.1098/rsbl.2005.0329; Wellman-Labadie O, 2008, COMP BIOCHEM PHYS B, V149, P640, DOI 10.1016/j.cbpb.2008.01.001; Windsor RL, 2013, J AVIAN BIOL, V44, P305, DOI 10.1111/j.1600-048X.2013.05768.x	66	34	35	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148894	10.1371/journal.pone.0148894	http://dx.doi.org/10.1371/journal.pone.0148894			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871451	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100069
J	Zeh, C; Inzaule, SC; Ondoa, P; Nafisa, LG; Kasembeli, A; Otieno, F; Vandenhoudt, H; Amornkul, PN; Mills, LA; Nkengasong, JN				Zeh, Clement; Inzaule, Seth C.; Ondoa, Pascale; Nafisa, Lillian G.; Kasembeli, Alex; Otieno, Fredrick; Vandenhoudt, Hilde; Amornkul, Pauli N.; Mills, Lisa A.; Nkengasong, John N.			Molecular Epidemiology and Transmission Dynamics of Recent and Long-Term HIV-1 Infections in Rural Western Kenya	PLOS ONE			English	Article							DISEASE PROGRESSION; GENETIC DIVERSITY; GENITAL ULCERS; PREGNANT-WOMEN; TYPE-1; SUBTYPE; KISUMU; IDENTIFICATION; INTERVENTIONS; PREVALENCE	Objective To identify unique characteristics of recent versus established HIV infections and describe sexual transmission networks, we characterized circulating HIV-1 strains from two randomly selected populations of ART-naive participants in rural western Kenya. Methods Recent HIV infections were identified by the HIV-1 subtype B, E and D, immunoglobulin G capture immunoassay (IgG BED-CEIA) and BioRad avidity assays. Genotypic and phylogenetic analyses were performed on the pol gene to identify transmitted drug resistance (TDR) mutations, characterize HIV subtypes and potential transmission clusters. Factors associated with recent infection and clustering were assessed by logistic regression. Results Of the 320 specimens, 40 (12.5%) were concordantly identified by the two assays as recent infections. Factors independently associated with being recently infected were age <= 19 years (P = 0.001) and history of sexually transmitted infections (STIs) in the past six months (P = 0.004). HIV subtype distribution differed in recently versus chronically infected participants, with subtype A observed among 53% recent vs. 68% chronic infections (p = 0.04) and subtype D among 26% recent vs. 12% chronic infections (p = 0.012). Overall, the prevalence of primary drug resistance was 1.16%. Of the 258 sequences, 11.2% were in monophyletic clusters of between 2-4 individuals. In multivariate analysis factors associated with clustering included having recent HIV infection P = 0.043 and being from Gem region P = 0.002. Conclusions Recent HIV-1 infection was more frequent among 13-19 year olds compared with older age groups, underscoring the ongoing risk and susceptibility of younger persons for acquiring HIV infection. Our findings also provide evidence of sexual networks. The association of recent infections with clustering suggests that early infections may be contributing significant proportions of onward transmission highlighting the need for early diagnosis and treatment as prevention for ongoing prevention. Larger studies are needed to better understand the structure of these networks and subsequently implement and evaluate targeted interventions.	[Zeh, Clement; Amornkul, Pauli N.; Mills, Lisa A.] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent CDC, Kisumu, Kenya; [Inzaule, Seth C.; Nafisa, Lillian G.; Kasembeli, Alex; Otieno, Fredrick; Mills, Lisa A.] Kenya Med Res Inst KEMRI CDC Res & Publ Hlth Coll, Kisumu Field Res Stn, Kisumu, Kenya; [Inzaule, Seth C.] Univ Amsterdam, Acad Med Ctr, AIGHD, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Vandenhoudt, Hilde] Inst Trop Med, B-2000 Antwerp, Belgium; [Nkengasong, John N.] CDC, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA 30333 USA	Kenya Medical Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Zeh, C (corresponding author), US Ctr Dis Control & Prevent, Div HIV AIDS Prevent CDC, Kisumu, Kenya.	cbz2@cdc.gov		Otieno, Fredrick Odhiambo/0000-0003-0823-412X	Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology [5U19C1000323-04]	Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Kenya Medical Research Institute through a cooperative agreement with the U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology, grant award number-5U19C1000323-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Bernasconi D, 2010, J CLIN VIROL, V48, P180, DOI 10.1016/j.jcv.2010.04.010; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DeLong AK, 2012, AIDS RES HUM RETROV, V28, P894, DOI [10.1089/aid.2011.0120, 10.1089/AID.2011.0120]; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Khamadi SA, 2009, AIDS RES HUM RETROV, V25, P919, DOI 10.1089/aid.2009.0005; Khoja S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003191; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; O'Farrell N, 2002, SEX TRANSM INFECT, V78, P143, DOI 10.1136/sti.78.2.143; O'Farrell N, 2001, B WORLD HEALTH ORGAN, V79, P569; Oluoch Tom, 2011, Open AIDS J, V5, P125, DOI 10.2174/1874613601105010125; Pilcher CD, 2008, PLOS MED, V5, P350, DOI 10.1371/journal.pmed.0050069; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rothenberg R, 2009, CURR OPIN HIV AIDS, V4, P260, DOI 10.1097/COH.0b013e32832c7cfc; Skoura L, 2011, J ANTIMICROB CHEMOTH, V66, P2831, DOI 10.1093/jac/dkr386; Slaymaker E, 2009, SEX TRANSM INFECT, V85, pI12, DOI 10.1136/sti.2008.034009; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Syvertsen JL, 2015, DRUG ALCOHOL DEPEN, V151, P262, DOI 10.1016/j.drugalcdep.2015.02.037; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; White RG, 2008, SEX TRANSM INFECT, V84, pII12, DOI 10.1136/sti.2008.029918; Yang CF, 2004, AIDS RES HUM RETROV, V20, P565, DOI 10.1089/088922204323087822; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147436	10.1371/journal.pone.0147436	http://dx.doi.org/10.1371/journal.pone.0147436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871567	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100007
J	Brautaset, R; Birkeldh, U; Alstig, PF; Wiken, P; Nilsson, M				Brautaset, Rune; Birkeldh, Ulrika; Alstig, Petra Frehr; Wiken, Petra; Nilsson, Maria			Repeatability Using Automatic Tracing with Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; THICKNESS MEASUREMENTS; EPIRETINAL MEMBRANE; RETINAL THICKNESS; PUPIL-DILATION; SD-OCT; DOMAIN; REPRODUCIBILITY; ABILITY	Background Optical coherence tomography (OCT), can be used in clinical practice to provide high resolution cross-sectional images of the retina, optic disc and macula structure. These measurements can be useful for early detection, diagnosis, monitoring and treatment guidance for retinal diseases. Therefore, repeatability of measurements in OCT is of great importance. Methods Macula and optic disc parameters from the right eye of 30 healthy subjects were obtained twice with the Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000. Repeatability was evaluated by use of the coefficient of repeatability (CR) and the coefficient of repeatability as a percentage of the mean (CR%), and the obtained measurements were compared between the instruments. Results CR% of optic disc parameters ranged between 0.90 and 22.22% and 0.00 and 16.00% with the Canon and Zeiss OCT respectively. For macular parameters CR% ranged between 0.62 and 2.81% and 0.99 and 1.81% with the Canon and Zeiss OCT respectively. No statistical difference could be found when comparing the CR of all macular and disc measurements between the instruments. Compared to our previously published data repeatability has significantly improved with the inclusion of automatic tracking systems with both the Canon and Zeiss OCT. Conclusion Automatic tracking function improves repeatability in both Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000. However, measurements generated by the two instruments are still not interchangeable.	[Brautaset, Rune; Birkeldh, Ulrika; Alstig, Petra Frehr; Wiken, Petra; Nilsson, Maria] Karolinska Inst, St Erik Eye Hosp, Dept Clin Neurosci, Unit Optometry, Stockholm, Sweden	Karolinska Institutet	Brautaset, R (corresponding author), Karolinska Inst, St Erik Eye Hosp, Dept Clin Neurosci, Unit Optometry, Stockholm, Sweden.	rune.brautaset@ki.se	Brautaset, Rune/GQZ-1681-2022	Nilsson, Maria/0000-0001-8416-4819				Altemir I, 2013, AM J OPHTHALMOL, V155, P171, DOI 10.1016/j.ajo.2012.06.012; Bentaleb-Machkour Z, 2012, SCI WORLD J, DOI 10.1100/2012/842795; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brautaset R, 2014, EUR J OPHTHALMOL, V24, P722, DOI 10.5301/ejo.5000437; Chen YL, 2009, OPT EXPRESS, V17, P4046, DOI 10.1364/OE.17.004046; Cheng CSM, 2011, CLIN EXP OPHTHALMOL, V39, P215, DOI 10.1111/j.1442-9071.2010.02460.x; de Sisternes L, 2015, INVEST OPHTH VIS SCI, V56, P3415, DOI 10.1167/iovs.14-16345; de Sisternes L, 2014, INVEST OPHTH VIS SCI, V55, P7093, DOI 10.1167/iovs.14-14918; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang Jianfeng, 2014, Zhonghua Yan Ke Za Zhi, V50, P900; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Lee EJ, 2009, INVEST OPHTH VIS SCI, V50, P662, DOI 10.1167/iovs.08-1682; Lee HJ, 2015, INVEST OPHTH VIS SCI, V56, P4554, DOI 10.1167/iovs.15-16949; Liu XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087996; Massa GC, 2010, EYE, V24, P1498, DOI 10.1038/eye.2010.72; Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072; Menke MN, 2008, INVEST OPHTH VIS SCI, V49, P5386, DOI 10.1167/iovs.07-1435; Parravano M, 2010, INVEST OPHTH VIS SCI, V51, P4788, DOI 10.1167/iovs.09-4976; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Pierro L, 2012, INVEST OPHTH VIS SCI, V53, P5912, DOI 10.1167/iovs.11-8644; Pinilla I, 2013, RETINA-J RET VIT DIS, V33, P1448, DOI 10.1097/IAE.0b013e3182807683; Sato S, 2012, CLIN EXP OPHTHALMOL, V40, P721, DOI 10.1111/j.1442-9071.2012.02782.x; Savini G, 2010, EYE, V24, P1503, DOI 10.1038/eye.2010.66; Schulze A, 2011, GRAEF ARCH CLIN EXP, V249, P1039, DOI 10.1007/s00417-010-1585-5; Serbecic N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00020; Simavli H, 2015, AM J OPHTHALMOL, V159, P545, DOI 10.1016/j.ajo.2014.12.004; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Wong E, 2015, OPTOMETRY VISION SCI, V92, P83, DOI 10.1097/OPX.0000000000000452	28	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149138	10.1371/journal.pone.0149138	http://dx.doi.org/10.1371/journal.pone.0149138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867021	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700071
J	Dummer, LA; Araujo, IL; Campos, FS; da Rosa, MC; Finger, PF; de Oliveira, PD; Conceicao, FR; Fischer, G; Roehe, PM; Leite, FPL				Dummer, Luana A.; Araujo, Itaua L.; Campos, Fabricio S.; da Rosa, Matheus C.; Finger, Paula F.; de Oliveira, Patricia D.; Conceicao, Fabricio R.; Fischer, Geferson; Roehe, Paulo M.; Leite, Fabio P. L.			Development of an Indirect ELISA for Serological Diagnosis of Bovine herpesvirus 5	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; BOVINE HERPESVIRUSES TYPE-1; GLYCOPROTEIN-D; RESTRICTION-ENDONUCLEASE; TRUNCATED FORM; ANTIBODIES; EXPRESSION; BHV-1; DISEASE; YEAST	Bovine herpesviruses 1 and 5 (BoHV-1 and BoHV-5) are economically important pathogens, associated with a variety of clinical syndromes, including respiratory and genital disease, reproductive failure and meningoencephalitis. The standard serological assay to diagnose BoHV-1 and BoHV-5 infections is the virus neutralization test (VNT), a time consuming procedure that requires manipulation of infectious virus. In the present study a highly sensitive and specific single dilution indirect ELISA was developed using recombinant glycoprotein D from BoHV-5 as antigen (rgD5ELISA). Bovine serum samples (n = 450) were screened by VNT against BoHV-5a and by rgD5ELISA. Compared with the VNT, the rgD5ELISA demonstrated accuracy of 99.8%, with 100% sensitivity, 96.7% specificity and coefficient of agreement between the tests of 0.954. The rgD5ELISA described here shows excellent agreement with the VNT and is shown to be a simple, convenient, specific and highly sensitive virus-free assay for detection of serum antibodies to BoHV-5.	[Dummer, Luana A.; Araujo, Itaua L.; da Rosa, Matheus C.; de Oliveira, Patricia D.; Leite, Fabio P. L.] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Nucleo Biotecnol, Bacteriol Lab, Pelotas, RS, Brazil; [Campos, Fabricio S.; Roehe, Paulo M.] Univ Fed Rio Grande do Sul, Virol Lab, Porto Alegre, RS, Brazil; [Finger, Paula F.; Conceicao, Fabricio R.] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Nucleo Biotecnol, Lab Imunol Aplicada, Pelotas, RS, Brazil; [Fischer, Geferson] Univ Fed Pelotas, Fac Vet, Lab Virol & Imunol Anim, Pelotas, RS, Brazil; [Roehe, Paulo M.] Fundacao Estadual Pesquisa Agr, Saude Anim Inst Pesquisas Vet Desiderio Finamor I, Eldorado Do Sul, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Leite, FPL (corresponding author), Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Nucleo Biotecnol, Bacteriol Lab, Pelotas, RS, Brazil.	fabio_leite@ufpel.tche.br	Campos, Fabricio S/D-8819-2014; Diaz, Patrícia Silva/L-9364-2017; ROEHE, PAULO MICHEL/K-1208-2012	Campos, Fabricio S/0000-0002-5948-472X; Diaz, Patrícia Silva/0000-0001-9601-296X; ROEHE, PAULO MICHEL/0000-0002-2370-7661; Leston Araujo, Itaua/0000-0001-7973-512X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [478461/2004-6, 140287/2010-8]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grants 478461/2004-6 and 140287/2010-8). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMAGID OY, 1995, VIROLOGY, V206, P242, DOI 10.1016/S0042-6822(95)80039-5; Alvarado JF, 2002, J VET DIAGN INVEST, V14, P240, DOI 10.1177/104063870201400309; Ao JQ, 2003, J VIROL METHODS, V114, P145, DOI 10.1016/j.jviromet.2003.09.012; Babiuk LA, 1996, VET MICROBIOL, V53, P31, DOI 10.1016/S0378-1135(96)01232-1; Balamurugan V, 2010, EXPERT REV MOL DIAGN, V10, P731, DOI 10.1586/ERM.10.61; Bashir S, 2011, ASIAN PAC J TROP MED, V4, P363, DOI 10.1016/S1995-7645(11)60104-1; Campos FS, 2009, VET MICROBIOL, V139, P67, DOI 10.1016/j.vetmic.2009.05.015; Claus MP, 2007, BRAZ J MICROBIOL, V38, P485, DOI 10.1590/S1517-83822007000300019; Claus MP, 2002, HERPESVIRUS BOVINO T, V23, P131; COLLINS JK, 1985, VET MICROBIOL, V10, P133, DOI 10.1016/0378-1135(85)90015-X; D'Arce RCF, 2002, VET MICROBIOL, V88, P315, DOI 10.1016/S0378-1135(02)00126-8; Delhon G, 2003, J VIROL, V77, P10339, DOI 10.1128/JVI.77.19.10339-10347.2003; Dummer LA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0111-x; Dummer LA, 2014, VACCINE, V32, P2413, DOI 10.1016/j.vaccine.2014.03.011; Dummer LA, 2009, J VIROL METHODS, V161, P84, DOI 10.1016/j.jviromet.2009.05.022; Esteves PA, 2008, VIRUS RES, V131, P16, DOI 10.1016/j.virusres.2007.08.004; Fischer G, 2007, VET IMMUNOL IMMUNOP, V116, P79, DOI 10.1016/j.vetimm.2007.01.003; Gabev E, 2010, J VIROL, V84, P5583, DOI 10.1128/JVI.00228-10; HOUSE JA, 1971, CORNELL VET, V61, P320; Huang CJ, 2006, J VIROL METHODS, V132, P40, DOI 10.1016/j.jviromet.2005.08.020; Jones C, 2003, CLIN MICROBIOL REV, V16, P79, DOI 10.1128/CMR.16.1.79-95.2003; Kramps JA, 2004, VET MICROBIOL, V102, P169, DOI 10.1016/j.vetmic.2004.07.003; KRAMPS JA, 1994, J CLIN MICROBIOL, V32, P2175, DOI 10.1128/JCM.32.9.2175-2181.1994; Li K, 2012, J VIROL METHODS, V180, P43, DOI 10.1016/j.jviromet.2011.12.008; Oliveira SAM, 2013, PESQUI VET BRASIL, V33, P41, DOI 10.1590/S0100-736X2013000100008; Pidone CL, 1999, J VET MED B, V46, P453, DOI 10.1046/j.1439-0450.1999.00257.x; Salvador SC, 1998, PESQUI VET BRASIL, V18, P76, DOI 10.1590/S0100-736X1998000200007; Shehata AA, 2012, J VIROL METHODS, V180, P18, DOI 10.1016/j.jviromet.2011.12.004; Souza VF, 2002, PESQUISA VET BRASIL, V22, P13, DOI 10.1590/S0100-736X2002000100004; STUDDERT MJ, 1989, VET REC, V125, P584; Takiuchi E., 2001, Semina: Ciencias Agrarias (Londrina), V22, P203; Traesel CK, 2014, VIRUS GENES, V48, P438, DOI 10.1007/s11262-014-1040-5; Varela APM, 2010, VET MICROBIOL, V142, P254, DOI 10.1016/j.vetmic.2009.10.016; Vogel Fernanda Silveira Flores, 2002, Cienc. Rural, V32, P881, DOI 10.1590/S0103-84782002000500022; Vogel FSF, 2003, J CLIN MICROBIOL, V41, P4512, DOI 10.1128/JCM.41.10.4512-4520.2003; Wang Zhan-yong, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P159; Zajac MPD, 2006, RES VET SCI, V81, P327, DOI 10.1016/j.rvsc.2006.01.004	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149134	10.1371/journal.pone.0149134	http://dx.doi.org/10.1371/journal.pone.0149134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866923	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700070
J	Leibler, JH; Jordan, JA; Brownstein, K; Lander, L; Price, LB; Perry, MJ				Leibler, Jessica H.; Jordan, Jeanne A.; Brownstein, Kirsten; Lander, Lina; Price, Lance B.; Perry, Melissa J.			Staphylococcus aureus Nasal Carriage among Beefpacking Workers in a Midwestern United States Slaughterhouse	PLOS ONE			English	Article							LIVESTOCK-ASSOCIATED MRSA; NORTH-CAROLINA; LACERATION INJURIES; MULTIDRUG-RESISTANT; GENETIC DIVERSITY; RISK-FACTORS; PREVALENCE; COLONIZATION; PERSISTENCE; INFECTIONS	Occupational contact with livestock is an established risk factor for exposure to livestock-associated methicillin-resistant Staphylococcus aureus (MRSA), particularly among industrial swine workers. While S. aureus is known to infect cattle, livestock-associated S. aureus carriage among workers in the beef production chain has received limited attention. Beefpacking workers, who slaughter, butcher and process cattle, have intensified exposure to potentially infectious animal materials and may be at risk of livestock-associated S. aureus exposure. We conducted a cross-sectional study of beefpacking workers (n = 137) at an industrial slaughterhouse in the Midwestern United States to evaluate prevalence and characteristics of S. aureus nasal colonization, specifically the absence of the scn gene to identify putative association with livestock, antibiotic susceptibility, presence of Panton-Valentin leukocidin (PVL) genes lukS-PV and lukF-PV, and spa type. Overall prevalence of S. aureus nasal carriage was 27.0%. No workers carried livestock-associated MRSA. Methicillin-sensitive S. aureus isolates (MSSA) recovered from five workers (3.6%) lacked the scn gene and were considered putative livestock-associated S. aureus (pLA-SA). Among pLA-SA isolates, spa types t338, t748, t1476 and t2379 were identified. To our knowledge, these spa types have not previously been identified as associated with livestock. Prevalence of human-adapted MRSA carriage in workers was 3.6%. MRSA isolates were identified as spa types t002, t008 and t024, and four of five MRSA isolates were PVL-positive. To date, this is the first study to indicate that industrial beefpacking workers in the United States may be exposed to livestock-associated S. aureus, notably MSSA, and to spa types not previously identified in livestock and livestock workers. Occupational exposure to livestock-associated S. aureus in the beef production chain requires further epidemiologic investigation.	[Leibler, Jessica H.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Jordan, Jeanne A.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA; [Brownstein, Kirsten; Price, Lance B.; Perry, Melissa J.] George Washington Univ, Dept Environm & Occupat Hlth, Milken Inst Sch Publ Hlth, Washington, DC USA; [Lander, Lina] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Epidemiol, Omaha, NE USA; [Price, Lance B.] Translat Genom Res Inst, Div Pathogen Genom, Flagstaff, AZ USA	Boston University; George Washington University; George Washington University; University of Nebraska System; University of Nebraska Medical Center; Translational Genomics Research Institute	Leibler, JH (corresponding author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA.	jleibler@bu.edu		Lander, Lina/0000-0002-6180-223X; Leibler, Jessica/0000-0002-0605-0928	George Washington University	George Washington University	This study was funded by a pilot grant from the George Washington University to Dr. Leibler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesiyun AA, 1998, J FOOD PROTECT, V61, P629, DOI 10.4315/0362-028X-61.5.629; Alba P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137143; Antoci Eugenio, 2013, Infez Med, V21, P125; Boost MV, 2013, FOODBORNE PATHOG DIS, V10, P705, DOI 10.1089/fpd.2012.1415; Bureau of Labor Statistics UD of L, INJ ILLN FAT; Cai CB, 2005, AM J IND MED, V47, P403, DOI 10.1002/ajim.20157; Capurro A, 2010, J DAIRY SCI, V93, P180, DOI 10.3168/jds.2009-2471; Casey JA, 2014, ENVIRON HEALTH PERSP, V122, P464, DOI 10.1289/ehp.1307370; Clinical Laboratory Standards Institute, 2010, 2009 S AUR CLSI BREA; Dorado-Garcia A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003272; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Gilbert MJ, 2012, OCCUP ENVIRON MED, V69, P472, DOI 10.1136/oemed-2011-100069; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Gustafson CJ, 2014, INT J DERMATOL, V53, P1091, DOI 10.1111/j.1365-4632.2012.05833.x; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Harper AL, 2010, J AGROMEDICINE, V15, P101, DOI 10.1080/10599241003627110; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Knox J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049900; Kyeremateng-Amoah E, 2014, AM J IND MED, V57, P669, DOI 10.1002/ajim.22325; Lim SK, 2013, FOODBORNE PATHOG DIS, V10, P731, DOI 10.1089/fpd.2012.1436; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095; Nemeghaire S, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-153; Neyra RC, 2014, ENVIRON HEALTH PERSP, V122, P471, DOI 10.1289/ehp.1306741; Normanno G, 2015, FOOD MICROBIOL, V51, P51, DOI 10.1016/j.fm.2015.04.007; Paterson GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068463; Peton V, 2014, INFECT GENET EVOL, V21, P602, DOI 10.1016/j.meegid.2013.08.011; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Roberts MC, 2002, MOL BIOTECHNOL, V20, P261, DOI 10.1385/MB:20:3:261; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Smith Tara C, 2015, Curr Environ Health Rep, V2, P41, DOI 10.1007/s40572-014-0034-8; Smith TC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004564; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645; Tenhagen BA, 2014, J ANIM SCI, V92, P2741, DOI 10.2527/jas.2014-7665; van Cleef BAGL, 2010, EPIDEMIOL INFECT, V138, P756, DOI 10.1017/S0950268810000245; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van Duijkeren E, 2014, VET MICROBIOL, V171, P364, DOI 10.1016/j.vetmic.2013.12.024; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Vanderhaeghen W, 2013, J ANTIMICROB CHEMOTH, V68, P300, DOI 10.1093/jac/dks403; Vanderhaeghen W, 2010, VET MICROBIOL, V144, P166, DOI 10.1016/j.vetmic.2009.12.044; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2012, ZOONOSES PUBLIC HLTH, V59, P144, DOI 10.1111/j.1863-2378.2011.01428.x; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	51	17	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148789	10.1371/journal.pone.0148789	http://dx.doi.org/10.1371/journal.pone.0148789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866374	Green Published, gold			2022-12-26	WOS:000370050700038
J	Ogasawara, K; Yamada, K; Hatsugai, N; Imada, C; Nishimura, M				Ogasawara, Kimi; Yamada, Kenji; Hatsugai, Noriyuki; Imada, Chiaki; Nishimura, Mikio			Hexose Oxidase-Mediated Hydrogen Peroxide as a Mechanism for the Antibacterial Activity in the Red Seaweed Ptilophora subcostata	PLOS ONE			English	Article							ALGA CHONDRUS-CRISPUS; OXIDATIVE BURST; INNATE IMMUNITY; BACTERIAL FLAGELLIN; MARINE-ALGAE; DEFENSE; SYSTEM; PURIFICATION; MACROALGAE; PERCEPTION	Marine algae have unique defense strategies against microbial infection. However, their mechanisms of immunity remain to be elucidated and little is known about the similarity of the immune systems of marine algae and terrestrial higher plants. Here, we suggest a possible mechanism underlying algal immunity, which involves hexose oxidase (HOX)-dependent production of hydrogen peroxide (H2O2). We examined crude extracts from five different red algal species for their ability to prevent bacterial growth. The extract from one of these algae, Ptilophora subcostata, was particularly active and prevented the growth of gram-positive and -negative bacteria, which was completely inhibited by treatment with catalase. The extract did not affect the growth of either a yeast or a filamentous fungus. We partially purified from P. subcostata an enzyme involved in its antibacterial activity, which shared 50% homology with the HOX of red seaweed Chondrus crispus. In-gel carbohydrate oxidase assays revealed that P. subcostata extract had the ability to produce H2O2 in a hexose-dependent manner and this activity was highest in the presence of galactose. In addition, Bacillus subtilis growth was strongly suppressed near P. subcostata algal fronds on GYP agar plates. These results suggest that HOX plays a role in P. subcostata resistance to bacterial attack by mediating H2O2 production in the marine environment.	[Ogasawara, Kimi; Yamada, Kenji; Nishimura, Mikio] Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Cell Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan; [Ogasawara, Kimi; Imada, Chiaki] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan; [Hatsugai, Noriyuki] Hokkaido Univ, Res Ctr Cooperat Projects, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Ogasawara, Kimi] Nagoya Univ, JST, ERATO, Higashiyama Live Holon Project,Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Ogasawara, Kimi] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Yamada, Kenji] Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto 6068502, Japan; [Hatsugai, Noriyuki] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo University of Marine Science & Technology; Hokkaido University; Japan Science & Technology Agency (JST); Nagoya University; Nagoya University; Kyoto University; University of Minnesota System; University of Minnesota Twin Cities	Ogasawara, K (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Cell Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.; Ogasawara, K (corresponding author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.; Ogasawara, K (corresponding author), Nagoya Univ, JST, ERATO, Higashiyama Live Holon Project,Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.; Ogasawara, K (corresponding author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	ogasawara.kimi@g.mbox.nagoya-u.ac.jp	Hatsugai, Noriyuki/O-9156-2015	Hatsugai, Noriyuki/0000-0002-5708-4263; Nishimura, Mikio/0000-0001-7960-9721	JST, ERATO	JST, ERATO(Japan Science & Technology Agency (JST))	This work was partly supported by JST, ERATO.	Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Bouarab K, 1999, PLANT CELL, V11, P1635, DOI 10.1105/tpc.11.9.1635; Cabrita MT, 2010, MAR DRUGS, V8, P2301, DOI 10.3390/md8082301; Carter CJ, 2004, PLANT PHYSIOL, V134, P460, DOI 10.1104/pp.103.027482; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Cosse A., 2007, ADV BOT RES, V46, P221, DOI DOI 10.1016/S0065-2296(07)46006-2; Egan S, 2014, ENVIRON MICROBIOL, V16, P925, DOI 10.1111/1462-2920.12288; Faulkner DJ, 2001, NAT PROD REP, V18, P1, DOI 10.1039/b006897g; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Groen BW, 1997, EUR J BIOCHEM, V244, P858, DOI 10.1111/j.1432-1033.1997.00858.x; Hansen OC, 1997, J BIOL CHEM, V272, P11581; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kupper FC, 2001, PLANT PHYSIOL, V125, P278, DOI 10.1104/pp.125.1.278; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Nylund GM, 2005, MAR ECOL PROG SER, V302, P27, DOI 10.3354/meps302027; Potin P, 1999, CURR OPIN MICROBIOL, V2, P276, DOI 10.1016/S1369-5274(99)80048-4; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Rand T, 2006, FEBS J, V273, P2693, DOI 10.1111/j.1742-4658.2006.05285.x; SULLIVAN JD, 1973, BIOCHIM BIOPHYS ACTA, V309, P11, DOI 10.1016/0005-2744(73)90312-4; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Wang SS, 2013, J APPL PHYCOL, V25, P1215, DOI 10.1007/s10811-012-9911-4; Wang XJ, 2013, J APPL PHYCOL, V25, P1895, DOI 10.1007/s10811-013-0009-4; Weinberger F, 1999, J PHYCOL, V35, P747, DOI 10.1046/j.1529-8817.1999.3540747.x; Weinberger F, 2005, J EXP BOT, V56, P1317, DOI 10.1093/jxb/eri132; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zambounis A, 2012, MOL BIOL EVOL, V29, P1263, DOI 10.1093/molbev/msr296	35	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149084	10.1371/journal.pone.0149084	http://dx.doi.org/10.1371/journal.pone.0149084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867214	gold, Green Submitted, Green Published			2022-12-26	WOS:000370050700064
J	Zhao, M; Finlay, D; Zharkikh, I; Vuori, K				Zhao, Ming; Finlay, Darren; Zharkikh, Irina; Vuori, Kristiina			Novel Role of Src in Priming Pyk2 Phosphorylation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE KINASE; FERM DOMAIN; SIGNAL-TRANSDUCTION; FAMILY KINASES; SH3 DOMAINS; ACTIVATION; FAK; BINDING; CANCER	Proline-rich tyrosine kinase 2 (Pyk2) is a member of the focal adhesion kinase (FAK) family of non-receptor tyrosine kinases and plays an important role in diverse cellular events downstream of the integrin-family of receptors, including cell migration, proliferation and survival. Here, we have identified a novel role for Src kinase in priming Pyk2 phosphorylation and subsequent activation upon cell attachment on the integrin-ligand fibronectin. By using complementary methods, we show that Src activity is indispensable for the initial Pyk2 phosphorylation on the Y402 site observed in response to cell attachment. In contrast, the initial fibronectin-induced autophosphorylation of FAK in the homologous Y397 site occurs in a Src-independent manner. We demonstrate that the SH2-domain of Src is required for Src binding to Pyk2 and for Pyk2 phosphorylation at sites Y402 and Y579. Moreover, Y402 phosphorylation is a prerequisite for the subsequent Y579 phosphorylation. While this initial phosphorylation of Pyk2 by Src is independent of Pyk2 kinase activity, subsequent autophosphorylation of Pyk2 in trans is required for full Pyk2 phosphorylation and activation. Collectively, our studies reveal a novel function of Src in priming Pyk2 (but not FAK) phosphorylation and subsequent activation downstream of integrins, and shed light on the signaling events that regulate the function of Pyk2.	[Zhao, Ming; Finlay, Darren; Zharkikh, Irina; Vuori, Kristiina] Sanford Burnham Prebys Med Discovery Inst, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Vuori, K (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA USA.	kvuori@sbpdiscovery.org			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH to KV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ericka Eggleston for technical assistance, and the various colleagues noted in "Materials and Methods" for reagents. This work was supported by grants from the NIH (to KV).	Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Canobbio I, 2015, BIOCHEM J, V469, P199, DOI 10.1042/BJ20150048; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Fan HP, 2011, J BIOL CHEM, V286, P18573, DOI 10.1074/jbc.M110.200717; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; Laird AD, 2003, MOL CANCER THER, V2, P461; Lechertier T, 2012, J PATHOL, V226, P404, DOI 10.1002/path.3018; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lipinski CA, 2006, BIOCHEM BIOPH RES CO, V349, P939, DOI 10.1016/j.bbrc.2006.08.134; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Riggs D, 2011, CELL SIGNAL, V23, P288, DOI 10.1016/j.cellsig.2010.09.015; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Yoon H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088587; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	39	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149231	10.1371/journal.pone.0149231	http://dx.doi.org/10.1371/journal.pone.0149231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866924	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700079
J	Boundenga, L; Makanga, B; Ollomo, B; Gilabert, A; Rougeron, V; Mve-Ondo, B; Arnathau, C; Durand, P; Moukodoum, ND; Okouga, AP; Delicat-Loembet, L; Yacka-Mouele, L; Rahola, N; Leroy, E; Tidiane, BAC; Renaud, F; Prugnolle, F; Paupy, C				Boundenga, Larson; Makanga, Boris; Ollomo, Benjamin; Gilabert, Aude; Rougeron, Virginie; Mve-Ondo, Bertrand; Arnathau, Celine; Durand, Patrick; Moukodoum, Nancy Diamella; Okouga, Alain-Prince; Delicat-Loembet, Lucresse; Yacka-Mouele, Lauriane; Rahola, Nil; Leroy, Eric; Tidiane, Cheikh B. A.; Renaud, Francois; Prugnolle, Franck; Paupy, Christophe			Haemosporidian Parasites of Antelopes and Other Vertebrates from Gabon, Central Africa	PLOS ONE			English	Article							MALARIA PARASITES; PLASMODIUM-FALCIPARUM; PHYLOGENETIC ANALYSIS; CYTOCHROME-B; GREAT APES; DIVERSITY; EVOLUTION; ORIGIN; POLYCHROMOPHILUS; GAMETOCYTES	Re-examination, using molecular tools, of the diversity of haemosporidian parasites (among which the agents of human malaria are the best known) has generally led to rearrangements of traditional classifications. In this study, we explored the diversity of haemosporidian parasites infecting vertebrate species (particularly mammals, birds and reptiles) living in the forests of Gabon (Central Africa), by analyzing a collection of 492 bushmeat samples. We found that samples from five mammalian species (four duiker and one pangolin species), one bird and one turtle species were infected by haemosporidian parasites. In duikers (from which most of the infected specimens were obtained), we demonstrated the existence of at least two distinct parasite lineages related to Polychromophilus species (i. e., bat haemosporidian parasites) and to sauropsid Plasmodium (from birds and lizards). Molecular screening of sylvatic mosquitoes captured during a longitudinal survey revealed the presence of these haemosporidian parasite lineages also in several Anopheles species, suggesting a potential role in their transmission. Our results show that, differently from what was previously thought, several independent clades of haemosporidian parasites (family Plasmodiidae) infect mammals and are transmitted by anopheline mosquitoes.	[Boundenga, Larson; Makanga, Boris; Ollomo, Benjamin; Rougeron, Virginie; Mve-Ondo, Bertrand; Moukodoum, Nancy Diamella; Okouga, Alain-Prince; Delicat-Loembet, Lucresse; Yacka-Mouele, Lauriane; Rahola, Nil; Leroy, Eric; Prugnolle, Franck] CIRMF, BP 769, Franceville, Gabon; [Boundenga, Larson; Tidiane, Cheikh B. A.] Cheikh Anta Diop Univ Dakar, Fac Sci & Tech, Lab Evolutionary Biol Ecol & Management Ecosyst, Dakar, Senegal; [Makanga, Boris; Gilabert, Aude; Rougeron, Virginie; Arnathau, Celine; Durand, Patrick; Rahola, Nil; Leroy, Eric; Renaud, Francois; Prugnolle, Franck; Paupy, Christophe] Ctr IRD Montpellier, UMR IRD CNRS UM 224 5290, Lab MIVEGEC, F-34295 Montpellier, France; [Makanga, Boris] Inst Rech Ecol Trop, Libreville, Gabon	University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boundenga, L (corresponding author), CIRMF, BP 769, Franceville, Gabon.; Boundenga, L (corresponding author), Cheikh Anta Diop Univ Dakar, Fac Sci & Tech, Lab Evolutionary Biol Ecol & Management Ecosyst, Dakar, Senegal.	larsonamedeo@yahoo.fr; franck.prugnolle@ird.fr	Paupy, Christophe/I-4847-2017; Gilabert, Aude/G-5884-2016; larson, Boundenga/AAK-5003-2020; RAHOLA, Nil/G-2397-2019; MAKANGA, Boris Kevin MBK/E-5239-2019; LEROY, Eric M/I-4347-2016; Rougeron, Virginie/AAH-7447-2020	Paupy, Christophe/0000-0002-7122-2079; Gilabert, Aude/0000-0003-0764-9171; larson, Boundenga/0000-0001-9551-3017; RAHOLA, Nil/0000-0003-4067-6438; MAKANGA, Boris Kevin MBK/0000-0003-1172-6109; LEROY, Eric M/0000-0003-0022-0890; Moukodoum, Nancy/0000-0003-0121-6068; Prugnolle, Franck/0000-0001-8519-1253; Rougeron, Virginie/0000-0001-5873-5681	Centre International de Recherches Medicales de Franceville (CIRMF, Gabon); Centre National de la Recherche Scientifique (CNRS, France); Institut de Recherche pour le Developpement (IRD, France); Agence Nationale de la Recherche (ANR, France) [ORIGIN JCJC 012]; ANBG	Centre International de Recherches Medicales de Franceville (CIRMF, Gabon); Centre National de la Recherche Scientifique (CNRS, France)(Centre National de la Recherche Scientifique (CNRS)); Institut de Recherche pour le Developpement (IRD, France); Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); ANBG	The study was funded by the Centre International de Recherches Medicales de Franceville (CIRMF, Gabon), the Centre National de la Recherche Scientifique (CNRS, France), the Institut de Recherche pour le Developpement (IRD, France) and the Agence Nationale de la Recherche (ANR, France, grant ORIGIN JCJC 012). Larson Boundenga was financed by an ANBG scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Ayouba A, 2012, INT J PARASITOL, V42, P709, DOI 10.1016/j.ijpara.2012.05.004; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boundenga L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0622-6; BRUCECHWATT LJ, 1966, B WORLD HEALTH ORGAN, V35, P405; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duval L, 2012, INFECT GENET EVOL, V12, P1558, DOI 10.1016/j.meegid.2012.06.006; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Garnham P. C. C., 1969, Bulletin de la Societe de Pathologie Exotique, V62, P325; GARNHAM P C C, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P549; GARNHAM PCC, 1980, PROC R SOC SER B-BIO, V206, P395, DOI 10.1098/rspb.1980.0003; Gilles H. M., 1968, Tropical Diseases Bulletin, V65, P213; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; JORDAN HB, 1975, J PROTOZOOL, V22, P241, DOI 10.1111/j.1550-7408.1975.tb05859.x; Keeling PJ, 2015, PARASITOLOGY, V142, pS16, DOI 10.1017/S0031182014000766; KEYMER IF, 1966, ANN TROP MED PARASIT, V60, P129, DOI 10.1080/00034983.1966.11686396; KEYMER IF, 1969, PHILOS T R SOC B, V255, P33, DOI 10.1098/rstb.1969.0003; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; LANDAU I, 1979, ANN PARASIT HUM COMP, V54, P145, DOI 10.1051/parasite/1979542145; LANDAU I, 1980, ANN PARASIT HUM COMP, V55, P271, DOI 10.1051/parasite/1980553271; LANDAU I, 1979, CR ACAD SCI D NAT, V288, P521; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Maganga GD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-82; Manwell RD, 1943, AM J HYG, V38, P211, DOI 10.1093/oxfordjournals.aje.a118884; Martinsen ES, 2007, PARASITOLOGY, V134, P483, DOI 10.1017/S0031182006001922; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Pacheco MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-299; Paupy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057294; Pauwels Olivier S. G. VwJP., 2008, REPTILES GABON FRENC; Perkins SL, 2000, P ROY SOC B-BIOL SCI, V267, P2345, DOI 10.1098/rspb.2000.1290; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Perkins SL, 2014, J PARASITOL, V100, P11, DOI 10.1645/13-362.1; Perkins SL, 2008, MITOCHONDR DNA, V19, P471, DOI 10.1080/19401730802570926; Pineda-Catalan O, 2013, J PARASITOL, V99, P1089, DOI 10.1645/13-296.1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2011, P NATL ACAD SCI USA, V108, P11948, DOI 10.1073/pnas.1109368108; Prugnolle F, 2011, VIRULENCE, V2, P71, DOI 10.4161/viru.2.1.14608; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Rahola N, 2014, INFECT GENET EVOL, V28, P628, DOI 10.1016/j.meegid.2014.05.012; Ray S, 1999, SIMPLOT WINDOWS 95 9; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Schaer J, 2013, P NATL ACAD SCI USA, V110, P17415, DOI 10.1073/pnas.1311016110; Valkiunas G, 2005, J WILDLIFE DIS, V41, P580, DOI 10.7589/0090-3558-41.3.580; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Witsenburg F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-53	49	23	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148958	10.1371/journal.pone.0148958	http://dx.doi.org/10.1371/journal.pone.0148958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863304	Green Published, gold			2022-12-26	WOS:000370046600129
J	Izumi, Y; Zorumski, CF				Izumi, Yukitoshi; Zorumski, Charles F.			GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DIRECT CORTICAL INPUT; PERFORANT PATH; AREA CA1; RECEPTOR ACTIVATION; NMDA RECEPTORS; NITRIC-OXIDE; DEPRESSION; AMPA; PLASTICITY	Long-term potentiation (LTP) of Schaffer collateral (SC) synapses in the hippocampus is thought to play a key role in episodic memory formation. Because the hippocampus is a shorter-term, limited capacity storage system, repeated bouts of learning and synaptic plasticity require that SC synapses reset to baseline at some point following LTP. We previously showed that repeated low frequency activation of temperoammonic (TA) inputs to the CA1 region depotentiates SC LTP without persistently altering basal transmission. This heterosynaptic depotentiation involves adenosine A1 receptors but not N-methyl-D-aspartate receptors, metabotropic glutamate receptors or L-type calcium channels. In the present study, we used rat hippocampal slices to explore other messengers contributing to TA-induced SC depotentiation, and provide evidence for the involvement of cannabinoid-1 and gamma-aminobutyric acid (GABA) type-A receptors as more proximal signaling events leading to synaptic resetting, with A1 receptor activation serving as a downstream event. Surprisingly, we found that TA-induced SC depotentiation is independent of alpha-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid (AMPA)/kainate glutamate receptors. We also examined the involvement of mitogen-activated protein kinases (MAPKs), and found a role for extra-cellular-signal related kinase 1/2 and p38 MAPK, but not c-Jun-N-terminal kinase. These results indicate that low frequency stimulation of TA inputs to CA1 activates a complex signaling network that instructs SC synaptic resetting. The involvement of GABA and endocannabinoids suggest mechanisms that could contribute to cognitive dysfunction associated with substance abuse and neuropsychiatric disorders.	[Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA; [Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Ctr Brain Res Mood Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zorumski, CF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.; Zorumski, CF (corresponding author), Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA.; Zorumski, CF (corresponding author), Washington Univ, Sch Med, Ctr Brain Res Mood Disorders, St Louis, MO USA.	zorumskc@wustl.edu			NIH [MH10184, MH077791, AA017413]; Bantly Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077791, R01MH101874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017413] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bantly Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funded by NIH grants MH10184, MH077791 and AA017413 and the Bantly Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; Aksoy-Aksel Ayla, 2013, Front Synaptic Neurosci, V5, P5, DOI 10.3389/fnsyn.2013.00005; Basu J, 2016, SCIENCE, V351, P138, DOI 10.1126/science.aaa5694; Bushell TJ, 1996, BRIT J PHARMACOL, V117, P1457, DOI 10.1111/j.1476-5381.1996.tb15306.x; BUZSAKI G, 1995, HIPPOCAMPUS, V5, P141, DOI 10.1002/hipo.450050210; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Chen JD, 2013, GLIA, V61, P178, DOI 10.1002/glia.22425; Chen ZC, 2014, J NEUROSCI, V34, P9621, DOI 10.1523/JNEUROSCI.3991-13.2014; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P635, DOI 10.1073/pnas.0811685106; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; EMPSON RM, 1995, HIPPOCAMPUS, V5, P104, DOI 10.1002/hipo.450050203; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Huang CC, 1999, J NEUROSCI, V19, P9728; IZUMI Y, 1993, NEUROREPORT, V4, P1131; Izumi Y, 2008, J NEUROSCI, V28, P9557, DOI 10.1523/JNEUROSCI.3346-08.2008; Izumi Y, 2008, HIPPOCAMPUS, V18, P258, DOI 10.1002/hipo.20383; Izumi Y, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.133; Izumi Y, 2012, NEUROPSYCHOPHARMACOL, V37, P609, DOI 10.1038/npp.2011.243; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim JI, 2011, NAT NEUROSCI, V14, P1447, DOI 10.1038/nn.2937; Kiss J, 1996, HIPPOCAMPUS, V6, P239, DOI 10.1002/(SICI)1098-1063(1996)6:3<239::AID-HIPO3>3.0.CO;2-I; Levy WB, 1998, LEARN MEMORY, V4, P510, DOI 10.1101/lm.4.6.510; LEVY WB, 1995, HIPPOCAMPUS, V5, P137, DOI 10.1002/hipo.450050209; Liang YC, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-13; Maccaferri G, 2011, J PHYSIOL-LONDON, V589, P1885, DOI 10.1113/jphysiol.2010.201079; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Otmakhova NA, 2005, J NEUROPHYSIOL, V94, P1413, DOI 10.1152/jn.00217.2005; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Peterfi Z, 2012, J NEUROSCI, V32, P14448, DOI 10.1523/JNEUROSCI.1676-12.2012; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Tokuda K, 2011, J NEUROSCI, V31, P9905, DOI 10.1523/JNEUROSCI.1660-11.2011; Tokuda K, 2010, J NEUROSCI, V30, P16788, DOI 10.1523/JNEUROSCI.4101-10.2010; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Xu JY, 2012, J PHYSIOL-LONDON, V590, P2305, DOI 10.1113/jphysiol.2011.223511; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Yasuda H, 2008, P NATL ACAD SCI USA, V105, P3106, DOI 10.1073/pnas.0708349105; Zhang Q, 2005, J NEURAL TRANSM, V112, P121, DOI 10.1007/s00702-004-0119-x; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037; Zorumski CF, 2012, NEUROSCI BIOBEHAV R, V36, P989, DOI 10.1016/j.neubiorev.2011.12.011	55	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149034	10.1371/journal.pone.0149034	http://dx.doi.org/10.1371/journal.pone.0149034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862899	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600143
J	Petre, B; Saunders, DGO; Sklenar, J; Lorrain, C; Krasileva, KV; Win, J; Duplessis, S; Kamoun, S				Petre, Benjamin; Saunders, Diane G. O.; Sklenar, Jan; Lorrain, Cecile; Krasileva, Ksenia V.; Win, Joe; Duplessis, Sebastien; Kamoun, Sophien			Heterologous Expression Screens in Nicotiana benthamiana Identify a Candidate Effector of the Wheat Yellow Rust Pathogen that Associates with Processing Bodies	PLOS ONE			English	Article							PLANT IMMUNE-SYSTEM; STRIPE RUST; P-BODY; POSTEMBRYONIC DEVELOPMENT; RNA; PROTEINS; INFECTION; PATHWAY; TARGETS; BIOLOGY	Rust fungal pathogens of wheat (Triticum spp.) affect crop yields worldwide. The molecular mechanisms underlying the virulence of these pathogens remain elusive, due to the limited availability of suitable molecular genetic research tools. Notably, the inability to perform high-throughput analyses of candidate virulence proteins (also known as effectors) impairs progress. We previously established a pipeline for the fast-forward screens of rust fungal candidate effectors in the model plant Nicotiana benthamiana. This pipeline involves selecting candidate effectors in silico and performing cell biology and protein-protein interaction assays in planta to gain insight into the putative functions of candidate effectors. In this study, we used this pipeline to identify and characterize sixteen candidate effectors from the wheat yellow rust fungal pathogen Puccinia striiformis f sp tritici. Nine candidate effectors targeted a specific plant subcellular compartment or protein complex, providing valuable information on their putative functions in plant cells. One candidate effector, PST02549, accumulated in processing bodies (P-bodies), protein complexes involved in mRNA decapping, degradation, and storage. PST02549 also associates with the P-body-resident ENHANCER OF mRNA DECAPPING PROTEIN 4 (EDC4) from N. benthamiana and wheat. We propose that P-bodies are a novel plant cell compartment targeted by pathogen effectors.	[Petre, Benjamin; Saunders, Diane G. O.; Sklenar, Jan; Lorrain, Cecile; Krasileva, Ksenia V.; Win, Joe; Kamoun, Sophien] Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England; [Petre, Benjamin; Lorrain, Cecile; Duplessis, Sebastien] INRA, Ctr INRA Nancy Lorraine, UMR Interact Arbres Microorganismes 1136, Champenoux, France; [Petre, Benjamin; Lorrain, Cecile; Duplessis, Sebastien] Univ Lorraine, Fac Sci & Technol, UMR Interact Arbres Microorganismes 1136, Vandoeuvre Les Nancy, France; [Saunders, Diane G. O.; Krasileva, Ksenia V.] Genome Anal Ctr, Norwich Res Pk, Norwich, Norfolk, England; [Saunders, Diane G. O.] John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; INRAE; Universite de Lorraine; Universite de Lorraine; The Genome Analysis Centre (TGAC); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kamoun, S (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	Sophien.Kamoun@tsl.ac.uk	, DUPLESSIS/G-4150-2011; Win, Joe/H-2557-2014; Petre, Benjamin/AAF-1156-2019; Kamoun, Sophien/B-3529-2009; Lorrain, Cecile/ABB-2483-2021	, DUPLESSIS/0000-0002-2072-2989; Win, Joe/0000-0002-9851-2404; Petre, Benjamin/0000-0002-3204-4249; Kamoun, Sophien/0000-0002-0290-0315; Krasileva, Ksenia/0000-0002-1679-0700	French National Research Agency through the Labex ARBRE [ANR-12-LABXARBRE-01]; French National Research Agency through the Young Scientist Grant POPRUST [ANR-2010-JCJC-1709-01]; INRA Contrat Jeune Scientifique; European Union [267196]; Biotechnology and Biological Sciences Research Council; Gatsby Charitable Foundation; Leverhulme early career fellowship; fellowship in computational biology at TGAC; John Innes Centre; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish	French National Research Agency through the Labex ARBRE(French National Research Agency (ANR)); French National Research Agency through the Young Scientist Grant POPRUST(French National Research Agency (ANR)); INRA Contrat Jeune Scientifique; European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Leverhulme early career fellowship(Leverhulme Trust); fellowship in computational biology at TGAC; John Innes Centre; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BP, CL, and SD were supported by the French National Research Agency through the Labex ARBRE (ANR-12-LABXARBRE-01) and the Young Scientist Grant POPRUST (ANR-2010-JCJC-1709-01). BP and CL are supported by an INRA Contrat Jeune Scientifique. BP was supported by the European Union, in the framework of the Marie-Curie FP7 COFUND People Programme, through the award of an AgreenSkills' fellowship (under grant agreement no 267196). BP, JS, JW, KVK, DGOS, and SK are supported by the Biotechnology and Biological Sciences Research Council and the Gatsby Charitable Foundation. DGOS is supported by a Leverhulme early career fellowship and a fellowship in computational biology at TGAC, in partnership with the John Innes Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Beddow JM, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.132, 10.1038/nplants.2015.132]; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Cantu D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-270; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Chen WQ, 2014, MOL PLANT PATHOL, V15, P433, DOI 10.1111/mpp.12116; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Emanuelle S, 2016, TRENDS PLANT SCI, V21, P341, DOI 10.1016/j.tplants.2015.11.001; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eulalio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017296; Fritzler MJ, 2012, ADV EXPT MED BIOL; Garnica DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067150; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Hubbard A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0590-8; Maldonado-Bonilla LD, 2014, PLANT CELL PHYSIOL, V55, P412, DOI 10.1093/pcp/pct175; Martin F, 2012, EFFECTORS PLANT MICR; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Pais M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-211; Perez-Vilaro G, 2015, J HEPATOL, V62, P785, DOI 10.1016/j.jhep.2014.11.018; Petre B, 2016, CELL MICROBIOL, V18, P453, DOI 10.1111/cmi.12530; Petre B, 2015, MOL PLANT MICROBE IN, V28, P689, DOI 10.1094/MPMI-01-15-0003-R; Petre Benjamin, 2014, Front Plant Sci, V5, P416, DOI 10.3389/fpls.2014.00416; Qiao YL, 2015, P NATL ACAD SCI USA, V112, P5850, DOI 10.1073/pnas.1421475112; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Roux ME, 2015, EMBO J, V34, P593, DOI 10.15252/embj.201488645; Sarris PF, 2015, ONCOTARGET, V6, P16824, DOI 10.18632/oncotarget.4838; Spanu PD, 2015, NEW PHYTOL, V207, P991, DOI 10.1111/nph.13495; Steffens A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002188; Upadhyaya NM, 2014, MOL PLANT MICROBE IN, V27, P255, DOI 10.1094/MPMI-07-13-0187-FI; Weiberg A, 2014, ANNU REV PHYTOPATHOL, V52, P495, DOI 10.1146/annurev-phyto-102313-045933; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Wu CH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00134; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Xu J, 2009, PLANT CELL, V21, P3270, DOI 10.1105/tpc.109.070078; Zheng WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3673	39	51	53	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149035	10.1371/journal.pone.0149035	http://dx.doi.org/10.1371/journal.pone.0149035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863009	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000370046600144
J	Chua, SK; Wang, BW; Lien, LM; Lo, HM; Chiu, CZ; Shyu, KG				Chua, Su-Kiat; Wang, Bao-Wei; Lien, Li-Ming; Lo, Huey-Ming; Chiu, Chiung-Zuan; Shyu, Kou-Gi			Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat Cardiomyocytes	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; INDUCED HEART-FAILURE; MITOCHONDRIAL FISSION; GROWTH-FACTOR; MYOCYTE APOPTOSIS; VOLUME-OVERLOAD; DRP1; DEPHOSPHORYLATION; ACTIVATION; ALPHA	Background MicroRNAs play an important role in cardiac remodeling. MicroRNA 499 (miR499) is highly enriched in cardiomyocytes and targets the gene for Calcineurin A (CnA), which is associated with mitochondrial fission and apoptosis. The mechanism regulating miR499 in stretched cardiomyocytes and in volume overloaded heart is unclear. We sought to investigate the mechanism regulating miR499 and CnA in stretched cardiomyocytes and in volume overload-induced heart failure. Methods & Results Rat cardiomyocytes grown on a flexible membrane base were stretched via vacuum to 20% of maximum elongation at 60 cycles/min. An in vivo model of volume overload with aortacaval shunt in adult rats was used to study miR499 expression. Mechanical stretch downregulated miR499 expression, and enhanced the expression of CnA protein and mRNA after 12 hours of stretch. Expression of CnA and calcineurin activity was suppressed with miR499 overexpression; whereas, expression of dephosphorylated dynamin-related protein 1 (Drp1) was suppressed with miR499 overexpression and CnA siRNA. Adding p53 siRNA reversed the downregulation of miR499 when stretched. A gel shift assay and promoter-activity assay demonstrated that stretch increased p53 DNA binding activity but decreased miR499 promoter activity. When the miR499 promoter p53-binding site was mutated, the inhibition of miR499 promoter activity with stretch was reversed. The in vivo aorta-caval shunt also showed downregulated myocardial miR499 and overexpression of miR499 suppressed CnA and cellular apoptosis. Conclusion The miR499-controlled apoptotic pathway involving CnA and Drp1 in stretched cardiomyocytes may be regulated by p53 through the transcriptional regulation of miR499.	[Chua, Su-Kiat; Shyu, Kou-Gi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chua, Su-Kiat; Wang, Bao-Wei; Lo, Huey-Ming; Chiu, Chiung-Zuan; Shyu, Kou-Gi] Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Chua, Su-Kiat; Wang, Bao-Wei; Lo, Huey-Ming; Chiu, Chiung-Zuan] Fu Jen Catholic Univ, Sch Med, Taipei, Taipei County, Taiwan; [Lien, Li-Ming] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Lien, Li-Ming] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan	Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital	Shyu, KG (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Shyu, KG (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	shyukg@ms12.hinet.net			National Science Council, Taiwan; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	This work was supported by The National Science Council, Taiwan, and Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.	Amorim PA, 2010, J THORAC CARDIOV SUR, V140, P1160, DOI 10.1016/j.jtcvs.2010.08.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basson M, 2007, NAT MED, V13, P541, DOI 10.1038/nm0507-541; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Cai Q, 1998, CARDIOVASC DRUG THER, V12, P499, DOI 10.1023/A:1007745814463; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cheng WP, 2012, CARDIOVASC RES, V93, P181, DOI 10.1093/cvr/cvr280; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Diniz GP, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0504-7; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Leri A, 2000, AM J PATHOL, V157, P843, DOI 10.1016/S0002-9440(10)64598-1; Leychenko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029055; Li PF, 2010, J CARDIOVASC TRANSL, V3, P219, DOI 10.1007/s12265-010-9175-9; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liao XD, 2004, CELL RES, V14, P16, DOI 10.1038/sj.cr.7290198; Lim HW, 1999, NAT MED, V5, P246, DOI 10.1038/6430; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Nantajit D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012341; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Seqqat R, 2012, J MOL CELL CARDIOL, V53, P240, DOI 10.1016/j.yjmcc.2012.05.004; Shyu KG, 2005, J CARD FAIL, V11, P152, DOI 10.1016/j.cardfail.2004.06.433; Shyu KG, 2001, J MOL CELL CARDIOL, V33, P691, DOI 10.1006/jmcc.2000.1333; Shyu KG, 2013, EUR J HEART FAIL, V15, P36, DOI 10.1093/eurjhf/hfs143; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swietach P, 2010, CARDIOVASC RES, V85, P729, DOI 10.1093/cvr/cvp343; Talmadge RJ, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-28; Tan WQ, 2008, CIRCULATION, V118, P2268, DOI 10.1161/CIRCULATIONAHA.107.750869; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Todd LR, 2010, MOL BIOL CELL, V21, P1225, DOI 10.1091/mbc.E09-11-0937; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang JJ, 2014, RNA BIOL, V11, P339, DOI 10.4161/rna.28300; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zheng B, 2015, J MOL CELL CARDIOL, V82, P201, DOI 10.1016/j.yjmcc.2015.03.011	44	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148683	10.1371/journal.pone.0148683	http://dx.doi.org/10.1371/journal.pone.0148683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859150	Green Published, gold			2022-12-26	WOS:000370038400065
J	Geng, RS; Noda, T; Mulvaney, JF; Lin, VYW; Edge, ASB; Dabdoub, A				Geng, Ruishuang; Noda, Teppei; Mulvaney, Joanna F.; Lin, Vincent Y. W.; Edge, Albert S. B.; Dabdoub, Alain			Comprehensive Expression of Wnt Signaling Pathway Genes during Development and Maturation of the Mouse Cochlea	PLOS ONE			English	Article							BETA-CATENIN; INNER-EAR; REGENERATION; CELLS	Background In the inner ear Wnt signaling is necessary for proliferation, cell fate determination, growth of the cochlear duct, polarized orientation of stereociliary bundles, differentiation of the periotic mesenchyme, and homeostasis of the stria vascularis. In neonatal tissue Wnt signaling can drive proliferation of cells in the sensory region, suggesting that Wnt signaling could be used to regenerate the sensory epithelium in the damaged adult inner ear. Manipulation of Wnt signaling for regeneration will require an understanding of the dynamics of Wnt pathway gene expression in the ear. We present a comprehensive screen for 84 Wnt signaling related genes across four developmental and postnatal time points. Results We identified 72 Wnt related genes expressed in the inner ear on embryonic day (E) 12.5, postnatal day (P) 0, P6 and P30. These genes included secreted Wnts, Wnt antagonists, intracellular components of canonical signaling and components of non-canonical signaling/planar cell polarity. Conclusion A large number of Wnt signaling molecules were dynamically expressed during cochlear development and in the early postnatal period, suggesting complex regulation of Wnt transduction. The data revealed several potential key regulators for further study.	[Geng, Ruishuang; Noda, Teppei; Mulvaney, Joanna F.; Lin, Vincent Y. W.; Dabdoub, Alain] Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada; [Lin, Vincent Y. W.; Dabdoub, Alain] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Edge, Albert S. B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Dabdoub, Alain] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Harvard University; Harvard Medical School; University of Toronto	Dabdoub, A (corresponding author), Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada.; Dabdoub, A (corresponding author), Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada.; Dabdoub, A (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	alain.dabdoub@sri.utoroto.ca	Edge, Albert/Q-5448-2019; Geng, Ruishuang/F-8255-2013	Mulvaney, Joanna/0000-0002-8014-4535; Dabdoub, Alain/0000-0002-4259-2425	Hearing Health Foundation; Sunnybrook Hearing Regeneration Initiative; Hearing Health Foundation's Hearing Restoration Project; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014089] Funding Source: NIH RePORTER	Hearing Health Foundation; Sunnybrook Hearing Regeneration Initiative; Hearing Health Foundation's Hearing Restoration Project; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for this work came from the Hearing Health Foundation (AD and AE) (http://hearinghealthfoundation.org/) and the Sunnybrook Hearing Regeneration Initiative (AD).; We thank Drs. Stricker and De Robertis for providing Dkk3 and Sfrp3 plasmids respectively. We also thank Dr. D. Sweetman for providing comments on an earlier version of the manuscript. Funding for this study was provided by the Hearing Health Foundation's Hearing Restoration Project (AE, AD) and the Sunnybrook Hearing Regeneration Initiative.	Atkinson PJ, 2015, DEVELOPMENT, V142, P1561, DOI 10.1242/dev.114926; Belluoccio D, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058154, DOI 10.1371/J0URNAL.P0NE.0058154]; Berschneider B, 2011, INT J BIOCHEM CELL B, V43, P306, DOI 10.1016/j.biocel.2010.11.013; Brown AS, 2015, DEV BIOL, V399, P177, DOI 10.1016/j.ydbio.2015.01.001; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Huang MQ, 2011, CELL CYCLE, V10, P337, DOI 10.4161/cc.10.2.14640; Huyghe A, 2015, CELL REP, V13, P31, DOI 10.1016/j.celrep.2015.08.054; Jacques BE, 2012, DEVELOPMENT, V139, P4395, DOI 10.1242/dev.080358; Jansson L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00066; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mulvaney JF, 2013, DEV DYNAM, V242, P179, DOI 10.1002/dvdy.23908; Noda T, 2012, DEV BIOL, V362, P83, DOI 10.1016/j.ydbio.2011.11.019; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Shi FX, 2014, J NEUROSCI, V34, P6470, DOI 10.1523/JNEUROSCI.4305-13.2014; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; Swain Rajeeb Kumar, 2005, Cell Commun Signal, V3, P12, DOI 10.1186/1478-811X-3-12; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Waldhaus J, 2015, CELL REP, V11, P1385, DOI 10.1016/j.celrep.2015.04.062; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001	28	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148339	10.1371/journal.pone.0148339	http://dx.doi.org/10.1371/journal.pone.0148339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859490	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400032
J	Wu, GC; Johnson, SK; Bornman, JF; Bennett, SJ; Singh, V; Simic, A; Fang, ZX				Wu, Gangcheng; Johnson, Stuart K.; Bornman, Janet F.; Bennett, Sarita J.; Singh, Vijaya; Simic, Azra; Fang, Zhongxiang			Effects of Genotype and Growth Temperature on the Contents of Tannin, Phytate and In Vitro Iron Availability of Sorghum Grains	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; CEREALS; ZINC; FERMENTATION; IMPACT	Background It has been predicted that the global temperature will rise in the future, which means crops including sorghum will likely be grown under higher temperatures, and consequently may affect the nutritional properties. Methods The effects of two growth temperatures (OT, day/night 32/21 degrees C; HT 38/21 degrees C) on tannin, phytate, mineral, and in vitro iron availability of raw and cooked grains (as porridge) of six sorghum genotypes were investigated. Results Tannin content significantly decreased across all sorghum genotypes under high growth temperature (P <= 0.05), while the phytate and mineral contents maintained the same level, increased or decreased significantly, depending on the genotype. The in vitro iron availability in most sorghum genotypes was also significantly reduced under high temperature, except for Ai4, which showed a pronounced increase (P <= 0.05). The cooking process significantly reduced tannin content in all sorghum genotypes (P <= 0.05), while the phytate content and in vitro iron availability were not significantly affected. Conclusions This research provides some new information on sorghum grain nutritional properties when grown under predicted future higher temperatures, which could be important for humans where sorghum grains are consumed as staple food.	[Wu, Gangcheng; Johnson, Stuart K.; Fang, Zhongxiang] Curtin Univ, Food Sci & Technol Program, Sch Publ Hlth, Perth, WA 6845, Australia; [Bornman, Janet F.] Curtin Univ, IIAFS, POB U1987, Perth, WA 6845, Australia; [Bennett, Sarita J.] Curtin Univ, Sch Sci, Dept Environm & Agr, Perth, WA 6845, Australia; [Singh, Vijaya] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia; [Simic, Azra] Natl Measurement Inst, Perth, WA 6151, Australia; [Fang, Zhongxiang] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia	Curtin University; Curtin University; Curtin University; University of Queensland; National Measurement Institute Australia - NMI; University of Melbourne	Fang, ZX (corresponding author), Curtin Univ, Food Sci & Technol Program, Sch Publ Hlth, Perth, WA 6845, Australia.; Fang, ZX (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia.	zhongxiang.fang@unimelb.edu.au	Fang, Zhongxiang/A-8988-2019; Johnson, Stuart/B-5174-2012	Fang, Zhongxiang/0000-0002-9902-3426; Johnson, Stuart/0000-0001-8357-797X	Curtin International Postgraduate Research Scholarships (CIPRS)	Curtin International Postgraduate Research Scholarships (CIPRS)	Financial support was provided by Curtin International Postgraduate Research Scholarships (CIPRS).	Afify AMR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025512; BRUNE M, 1989, EUR J CLIN NUTR, V43, P547; Cohen SD, 2010, CRIT REV FOOD SCI, V50, P620, DOI 10.1080/10408390802603441; Dlamini NR, 2007, FOOD CHEM, V105, P1412, DOI 10.1016/j.foodchem.2007.05.017; Duodu KG, 1999, FOOD CHEM, V66, P21, DOI 10.1016/S0308-8146(98)00070-3; Dykes L, 2007, CEREAL FOOD WORLD, V52, P105, DOI 10.1094/CFW-52-3-0105; Dykes L, 2005, J AGR FOOD CHEM, V53, P6813, DOI 10.1021/jf050419e; Dykes L, 2006, J CEREAL SCI, V44, P236, DOI 10.1016/j.jcs.2006.06.007; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; GLENNIE CW, 1981, J AGR FOOD CHEM, V29, P965, DOI 10.1021/jf00107a020; Hassan A. B., 2009, Pakistan Journal of Nutrition, V8, P167, DOI 10.3923/pjn.2009.167.171; HAUG W, 1983, J SCI FOOD AGR, V34, P1423, DOI 10.1002/jsfa.2740341217; Hemalatha S, 2007, J TRACE ELEM MED BIO, V21, P1, DOI 10.1016/j.jtemb.2006.10.002; Horvatic M, 1996, J AGRON CROP SCI, V176, P73, DOI 10.1111/j.1439-037X.1996.tb00448.x; Idris WH, 2006, INT J FOOD SCI TECH, V41, P1229, DOI 10.1111/j.1365-2621.2006.01190.x; IPCC, 2007, IPCC 4 ASS REP AR4, V11, P17; Kayode APP, 2007, LWT-FOOD SCI TECHNOL, V40, P834, DOI 10.1016/j.lwt.2006.04.001; Kayode APP, 2006, J AGR FOOD CHEM, V54, P256, DOI 10.1021/jf0521404; Kruger J, 2012, FOOD CHEM, V131, P220, DOI 10.1016/j.foodchem.2011.08.063; Li EP, 2013, CEREAL CHEM, V90, P223, DOI 10.1094/CCHEM-09-12-0113-R; Lopez MAA, 2004, INT J FOOD SCI NUTR, V55, P597, DOI 10.1080/09637480500085820; Luten J, 1996, J SCI FOOD AGR, V72, P415, DOI [10.1002/(SICI)1097-0010(199612)72:4<415::AID-JSFA675>3.3.CO;2-O, 10.1002/(SICI)1097-0010(199612)72:4&lt;415::AID-JSFA675&gt;3.0.CO;2-X]; Martinez-Navarrete N, 2002, FOOD RES INT, V35, P225, DOI 10.1016/S0963-9969(01)00189-2; Matuschek E, 2001, J AGR FOOD CHEM, V49, P5630, DOI 10.1021/jf0108157; Nguyen CT, 2013, FUNCT PLANT BIOL, V40, P439, DOI 10.1071/FP12264; Nyachoti CM, 1997, WORLD POULTRY SCI J, V53, P5, DOI 10.1079/WPS19970002; PRICE ML, 1978, J AGR FOOD CHEM, V26, P1214, DOI 10.1021/jf60219a031; Proietti I, 2013, INT J FOOD SCI TECH, V48, P1526, DOI 10.1111/ijfs.12121; RADHAKRISHNAN MR, 1980, J AGR FOOD CHEM, V28, P55, DOI 10.1021/jf60227a038; Singh V, 2015, FIELD CROP RES, V171, P32, DOI 10.1016/j.fcr.2014.11.003; Towo E, 2006, FOOD CHEM, V94, P369, DOI 10.1016/j.foodchem.2004.11.027; WANISKA RD, 1989, J CEREAL SCI, V10, P217, DOI 10.1016/S0733-5210(89)80051-7; Wedad H., 2008, PAKISTAN J NUTR, V7, P335, DOI DOI 10.3923/PJN.2008.335.341	33	29	29	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148712	10.1371/journal.pone.0148712	http://dx.doi.org/10.1371/journal.pone.0148712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859483	Green Published, gold			2022-12-26	WOS:000370038400068
J	Bose, B; Reed, SE; Besprozvannaya, M; Burton, BM				Bose, Baundauna; Reed, Sydney E.; Besprozvannaya, Marina; Burton, Briana M.			Missense Mutations Allow a Sequence-Blind Mutant of SpoIIIE to Successfully Translocate Chromosomes during Sporulation	PLOS ONE			English	Article							BACILLUS-SUBTILIS SPOIIIE; DNA TRANSLOCATION; GENE-EXPRESSION; MEMBRANE FISSION; CELL-DIVISION; STRANDED-DNA; FTSK; PROTEIN; SEGREGATION; MECHANISM	SpoIIIE directionally pumps DNA across membranes during Bacillus subtilis sporulation and vegetative growth. The sequence-reading domain (gamma domain) is required for directional DNA transport, and its deletion severely impairs sporulation. We selected suppressors of the spoIIIE Delta gamma sporulation defect. Unexpectedly, many suppressors were intragenic missense mutants, and some restore sporulation to near-wild-type levels. The mutant proteins are likely not more abundant, faster at translocating DNA, or sequence-sensitive, and rescue does not involve the SpoIIIE homolog SftA. Some mutants behave differently when co-expressed with spoIIIE Delta gamma, consistent with the idea that some, but not all, variants may form mixed oligomers. In full-length spoIIIE, these mutations do not affect sporulation, and yet the corresponding residues are rarely found in other SpoIIIE/FtsK family members. The suppressors do not rescue chromosome translocation defects during vegetative growth, indicating that the role of the. domain cannot be fully replaced by these mutations. We present two models consistent with our findings: that the suppressors commit to transport in one arbitrarily-determined direction or delay spore development. It is surprising that missense mutations somehow rescue loss of an entire domain with a complex function, and this raises new questions about the mechanism by which SpoIIIE pumps DNA and the roles SpoIIIE plays in vivo.	[Bose, Baundauna; Reed, Sydney E.; Besprozvannaya, Marina; Burton, Briana M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Bose, Baundauna] Evelo Biosci, Cambridge, MA USA; [Besprozvannaya, Marina] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Harvard University; University of California System; University of California Davis	Burton, BM (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	briana.burton@wisc.edu			Massachusetts Life Science Foundation; NSF GRFP fellowship [DGE-1144152]; Molecules, Cells, and Organisms Training Grant [GM-07598]	Massachusetts Life Science Foundation; NSF GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); Molecules, Cells, and Organisms Training Grant	This work was supported in part by the Massachusetts Life Science Foundation (to BMB). MB was supported by NSF GRFP fellowship (DGE-1144152) and by Molecules, Cells, and Organisms Training Grant (GM-07598). The authors declare no conflict of interest in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Besprozvannaya M, 2014, J BACTERIOL, V196, P2481, DOI 10.1128/JB.01725-14; Besprozvannaya M, 2013, J BIOL CHEM, V288, P28962, DOI 10.1074/jbc.M113.484055; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Biller SJ, 2009, MOL MICROBIOL, V74, P790, DOI 10.1111/j.1365-2958.2009.06893.x; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Cattoni DI, 2014, NUCLEIC ACIDS RES, V42, P2624, DOI 10.1093/nar/gkt1231; Cattoni DI, 2013, EMBO REP, V14, P473, DOI 10.1038/embor.2013.39; Doan T, 2013, GENE DEV, V27, P322, DOI 10.1101/gad.209049.112; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Fiche JB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001557; Fleming TC, 2010, GENE DEV, V24, P1160, DOI 10.1101/gad.1925210; FOULGER D, 1989, MOL MICROBIOL, V3, P1247, DOI 10.1111/j.1365-2958.1989.tb00275.x; Harwood CR, 1990, MOL BIOL METHODS BAC, pxxxv; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kaimer C, 2011, CURR OPIN MICROBIOL, V14, P719, DOI 10.1016/j.mib.2011.10.004; Levy O, 2005, P NATL ACAD SCI USA, V102, P17618, DOI 10.1073/pnas.0508932102; Liu NJL, 2006, MOL MICROBIOL, V59, P1097, DOI 10.1111/j.1365-2958.2005.05004.x; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Nolivos S, 2012, NUCLEIC ACIDS RES, V40, P5535, DOI 10.1093/nar/gks171; Pogliano J, 2002, J BACTERIOL, V184, P1743, DOI 10.1128/JB.184.4.1743-1749.2002; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; Ptacin JL, 2008, NAT STRUCT MOL BIOL, V15, P485, DOI 10.1038/nsmb.1412; Ptacin JL, 2006, NAT STRUCT MOL BIOL, V13, P1023, DOI 10.1038/nsmb1157; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sciochetti SA, 2001, J BACTERIOL, V183, P1058, DOI 10.1128/JB.183.3.1058-1068.2001; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; Sharp MD, 2003, J BACTERIOL, V185, P2005, DOI 10.1128/JB.185.6.2005-2008.2003; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; Yates J, 2006, MOL MICROBIOL, V59, P1754, DOI 10.1111/j.1365-2958.2005.05033.x	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148365	10.1371/journal.pone.0148365	http://dx.doi.org/10.1371/journal.pone.0148365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849443	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000082
J	Busset, N; De Felice, A; Chaintreuil, C; Gully, D; Fardoux, J; Romdhane, S; Molinaro, A; Silipo, A; Giraud, E				Busset, Nicolas; De Felice, Antonia; Chaintreuil, Clemence; Gully, Djamel; Fardoux, Joel; Romdhane, Sana; Molinaro, Antonio; Silipo, Alba; Giraud, Eric			The LPS O-Antigen in Photosynthetic Bradyrhizobium Strains Is Dispensable for the Establishment of a Successful Symbiosis with Aeschynomene Legumes	PLOS ONE			English	Article							NOD FACTORS; LIPOPOLYSACCHARIDE; INFECTION; BACTERIA; PLANTS; MONOSACCHARIDE; MUTAGENESIS; GENETICS; INDICA; MUTANT	The photosynthetic bradyrhizobia are able to use a Nod-factor independent process to induce nitrogen-fixing nodules on some semi-aquatic Aeschynomene species. These bacteria display a unique LPS O-antigen composed of a new sugar, the bradyrhizose that is regarded as a key symbiotic factor due to its non-immunogenic character. In this study, to check this hypothesis, we isolated mutants affected in the O-antigen synthesis by screening a transposon mutant library of the ORS285 strain for clones altered in colony morphology. Over the 10,000 mutants screened, five were selected and found to be mutated in two genes, rfaL, encoding for a putative O-antigen ligase and gdh encoding for a putative dTDP-glucose 4,6-dehydratase. Biochemical analysis confirmed that the LPS of these mutants completely lack the O-antigen region. However, no effect of the mutations could be detected on the symbiotic properties of the mutants indicating that the O-antigen region of photosynthetic Bradyrhizobium strains is not required for the establishment of symbiosis with Aeschynomene.	[Busset, Nicolas; Chaintreuil, Clemence; Gully, Djamel; Fardoux, Joel; Romdhane, Sana; Giraud, Eric] UMR IRD SupAgro INRA UM2 CIRAD, IRD, Lab Symbioses Trop & Mediterraneennes, Campus Int Baillarguet,TA A-82-J, F-34398 Montpellier 5, France; [De Felice, Antonia; Molinaro, Antonio; Silipo, Alba] Univ Naples Federico II, Dipartimento Sci Chim, Complesso Univ Monte St Angelo, Via Cintia 4, I-80126 Naples, Italy	CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Naples Federico II	Giraud, E (corresponding author), UMR IRD SupAgro INRA UM2 CIRAD, IRD, Lab Symbioses Trop & Mediterraneennes, Campus Int Baillarguet,TA A-82-J, F-34398 Montpellier 5, France.	eric.giraud@ird.fr	Romdhane, sana/J-6359-2019; Silipo, Alba/L-5929-2014	GULLY, Djamel/0000-0003-1695-5744	French national research agency [ANR-BugsInaCell-13-BSV7-0013]	French national research agency(French National Research Agency (ANR))	This work was supported by the French national research agency (ANR-BugsInaCell-13-BSV7-0013).	Arrighi JF, 2012, MOL PLANT MICROBE IN, V25, P851, DOI 10.1094/MPMI-02-12-0045-TA; Berry MC, 2009, FEMS MICROBIOL LETT, V291, P80, DOI 10.1111/j.1574-6968.2008.01438.x; Bonaldi K, 2011, MOL PLANT MICROBE IN, V24, P1359, DOI 10.1094/MPMI-04-11-0093; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P760, DOI 10.1094/MPMI-23-6-0760; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; CARLSON RW, 1987, J BACTERIOL, V169, P4923, DOI 10.1128/jb.169.11.4923-4928.1987; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Gao MS, 2001, MOL PLANT MICROBE IN, V14, P857, DOI 10.1094/MPMI.2001.14.7.857; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Giraud E, 2010, METHOD ENZYMOL, V471, P135, DOI 10.1016/S0076-6879(10)71009-0; Gourion B, 2015, TRENDS PLANT SCI, V20, P186, DOI 10.1016/j.tplants.2014.11.008; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jaubert M, 2009, PHOTOSYNTH RES, V100, P97, DOI 10.1007/s11120-009-9433-3; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Li W, 2015, CHEM COMMUN, V51, P6964, DOI 10.1039/c5cc00752f; Liang Y, 2013, SCIENCE, V341, P1384, DOI 10.1126/science.1242736; Molouba F, 1999, APPL ENVIRON MICROB, V65, P3084; Noel KD, 2000, J BACTERIOL, V182, P5317, DOI 10.1128/JB.182.19.5317-5324.2000; Noh JG, 2015, INT J MOL SCI, V16, P16778, DOI 10.3390/ijms160816778; Okazaki S, 2016, ISME J, V10, P64, DOI 10.1038/ismej.2015.103; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Podlesakova K, 2013, MOL PLANT MICROBE IN, V26, P1232, DOI 10.1094/MPMI-03-13-0076-R; Reeve WG, 1999, MICROBIOL-SGM, V145, P1307, DOI 10.1099/13500872-145-6-1307; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Silipo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6106; Silipo A, 2011, ANGEW CHEM INT EDIT, V50, P12610, DOI 10.1002/anie.201106548; Vincent J. M., 1970, HANDBOOK, V15; Xu LL, 2010, ARCH MICROBIOL, V192, P1039, DOI 10.1007/s00203-010-0635-z	33	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148884	10.1371/journal.pone.0148884	http://dx.doi.org/10.1371/journal.pone.0148884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849805	Green Published, gold			2022-12-26	WOS:000369554000181
J	de Castro, AP; da Silva, MRSS; Quirino, BF; Bustamante, MMD; Kruger, RH				de Castro, Alinne Pereira; Silveira Sartori da Silva, Maria Regina; Quirino, Betania Ferraz; da Cunha Bustamante, Mercedes Maria; Krueger, Ricardo Henrique			Microbial Diversity in Cerrado Biome (Neotropical Savanna) Soils	PLOS ONE			English	Article							FUNGAL COMMUNITIES; BACTERIAL COMMUNITIES; MICROORGANISMS; INCREASES; RESPONSES; DYNAMICS; PATTERNS; RESOURCE; GRADIENT; RAINFALL	The Cerrado, the largest savanna region in South America, is located in central Brazil. Cerrado physiognomies, which range from savanna grasslands to forest formations, combined with the highly weathered, acidic clay Cerrado soils form a unique ecoregion. In this study, high-throughput sequencing of ribosomal RNA genes was combined with shotgun metagenomic analysis to explore the taxonomic composition and potential functions of soil microbial communities in four different vegetation physiognomies during both dry and rainy seasons. Our results showed that changes in bacterial, archaeal, and fungal community structures in cerrado denso, cerrado sensu stricto, campo sujo, and gallery forest soils strongly correlated with seasonal patterns of soil water uptake. The relative abundance of AD3, WPS-2, Planctomycetes, Thermoprotei, and Glomeromycota typically decreased in the rainy season, whereas the relative abundance of Proteobacteria and Ascomycota increased. In addition, analysis of shotgun metagenomic data revealed a significant increase in the relative abundance of genes associated with iron acquisition and metabolism, dormancy, and sporulation during the dry season, and an increase in the relative abundance of genes related to respiration and DNA and protein metabolism during the rainy season. These gene functional categories are associated with adaptation to water stress. Our results further the understanding of how tropical savanna soil microbial communities may be influenced by vegetation covering and temporal variations in soil moisture.	[de Castro, Alinne Pereira; Krueger, Ricardo Henrique] Univ Brasilia, Enzymol Lab, Dept Biol Celular, Brasilia, DF, Brazil; [de Castro, Alinne Pereira] Univ Catolica Dom Bosco, Biotechnol Program, Campo Grande, MS, Brazil; [Silveira Sartori da Silva, Maria Regina; da Cunha Bustamante, Mercedes Maria] Univ Brasilia, Lab Ecol Ecossistemas, Dept Ecol, Inst Ciencias Biol, Brasilia, DF, Brazil; [Quirino, Betania Ferraz] Embrapa Agroenergy, Brasilia, DF, Brazil; [Quirino, Betania Ferraz] Univ Catolica Brasilia, Genom Sci & Biotechnol Program, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade Catolica Dom Bosco (UCDB); Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia	Kruger, RH (corresponding author), Univ Brasilia, Enzymol Lab, Dept Biol Celular, Brasilia, DF, Brazil.	kruger@unb.br	Bustamante, Mercedes MC/H-7597-2015; Bustamante, Mercedes/GQZ-8625-2022; Quirino, Betania F/H-8835-2013; Bustamante, Mercedes/AAQ-7231-2020; Castro, Alinne/F-5101-2019; Kruger, Ricardo/Y-9595-2019	Bustamante, Mercedes MC/0000-0003-1008-452X; Bustamante, Mercedes/0000-0003-1008-452X; Castro, Alinne/0000-0002-9703-0577; Quirino, Betania/0000-0002-7578-6314; Kruger, Ricardo/0000-0002-8443-9402	National Council for Scientific and Technological Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	The authors thank the National Council for Scientific and Technological Development (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF) for financial support.; The authors acknowledge grant support from the following Brazilian government agencies: National Council for Scientific and Technological Development (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF). The authors declare no competing financial interests.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Andrew DR, 2012, APPL ENVIRON MICROB, V78, P7527, DOI 10.1128/AEM.01459-12; Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Araujo JF, 2012, MICROB ECOL, V64, P760, DOI 10.1007/s00248-012-0057-3; Armougom F., 2009, J COMPUT SCI SYST BI, V2, P74, DOI DOI 10.4172/JCSB.1000019; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bouskill NJ, 2013, ISME J, V7, P384, DOI 10.1038/ismej.2012.113; Bruce T, 2012, ADV MICROB ECOL, DOI [10.1007/978-1-4614-2182-5_13, DOI 10.1007/978-1-4614-2182-5_]; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chu HY, 2011, SOIL SCI SOC AM J, V75, P1756, DOI 10.2136/sssaj2011.0057; Clark J, 2009, MICROB ECOL, V57, P248, DOI 10.1007/s00248-008-9475-7; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; de Castro AP, 2008, ARCH MICROBIOL, V190, P129, DOI 10.1007/s00203-008-0374-6; de Castro AP, 2011, BIOTECHNOL LETT, V33, P2169, DOI 10.1007/s10529-011-0693-6; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Faoro H, 2010, APPL ENVIRON MICROB, V76, P4744, DOI 10.1128/AEM.03025-09; Fierer N., 2012, P NATL ACAD SCI USA, V109, P21390, DOI [10.1073/pnas.1215210110., DOI 10.1073/pnas.1215210110]; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Gray SB, 2011, SOIL SCI SOC AM J, V75, P2217, DOI 10.2136/sssaj2011.0135; Grossman JM, 2010, MICROB ECOL, V60, P192, DOI 10.1007/s00248-010-9689-3; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hawksworth DL, 2012, BIODIVERS CONSERV, V21, P2425, DOI 10.1007/s10531-012-0335-x; Lau JA, 2012, P NATL ACAD SCI USA, V109, P14058, DOI 10.1073/pnas.1202319109; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lentendu G, 2011, FUNGAL DIVERS, V49, P113, DOI 10.1007/s13225-011-0101-5; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; Mendonca R.C., 2008, CERRADO ECOLOGIA FLO, P423; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Millard P, 2010, NUTR CYCL AGROECOSYS, V88, P147, DOI 10.1007/s10705-009-9314-3; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Placella SA, 2012, P NATL ACAD SCI USA, V109, P10931, DOI 10.1073/pnas.1204306109; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; Quirino BF, 2009, MICROBIOL RES, V164, P59, DOI 10.1016/j.micres.2006.12.001; Rasche F, 2011, ISME J, V5, P389, DOI 10.1038/ismej.2010.138; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Ribeiro JF, 1998, CERRADO AMBIENTE FLO, P89; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Shary S, 2007, APPL ENVIRON MICROB, V73, P6691, DOI 10.1128/AEM.01361-07; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Sugiyama M, 2010, P NATL ACAD SCI USA, V107, P571, DOI 10.1073/pnas.0903186107; Valentini AMC, 2008, J GEOPHYS RES, V113, P10; Van der Putten WH, 2012, ANNU REV ECOL EVOL S, V43, P365, DOI 10.1146/annurev-ecolsys-110411-160423; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wang JJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00064; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Zhang XF, 2013, J APPL MICROBIOL, V114, P1054, DOI 10.1111/jam.12106; [No title captured]; [No title captured]	61	44	45	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148785	10.1371/journal.pone.0148785	http://dx.doi.org/10.1371/journal.pone.0148785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849674	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000169
J	Li, H; Xu, LY; Wu, FZ; Yang, WQ; Ni, XY; He, J; Tan, B; Hu, Y				Li, Han; Xu, Liya; Wu, Fuzhong; Yang, Wanqin; Ni, Xiangyin; He, Jie; Tan, Bo; Hu, Yi			Forest Gaps Alter the Total Phenol Dynamics in Decomposing Litter in an Alpine Fir Forest	PLOS ONE			English	Article							LEAF-LITTER; NITROGEN; BIODEGRADATION; TEMPERATURE; PATTERNS; LEAVES; CARBON; SEASON; PLANTS; WINTER	The total phenol content in decomposing litter not only acts as a crucial litter quality indicator, but is also closely related to litter humification due to its tight absorption to clay particles. However, limited attention has been focused on the total phenol dynamics in foliar litter in relation to forest gaps. Here, the foliar litter of six representative tree species was incubated on the forest floor from the gap center to the closed canopy of an alpine Minjiang fir (Abies faxoniana) forest in the upper reaches of the Yangtze River and eastern Tibetan Plateau. The dynamics of total phenol concentration in the incubated litter was measured from November 2012 to October 2014. Over two-year incubation, 78.22% to 94.06% of total phenols were lost from the foliar litter, but 52.08% to 86.41% of this occurred in the first year. Forest gaps accelerated the loss of total phenols in the foliar litter in the winter, although they inhibited the loss of total phenols during the growing season in the first year. In comparison with the effects of forest gaps, the variations of litter quality among different species were much stronger on the dynamics of total phenols in the second year. Overall, the loss of total phenols in the foliar litter was slightly higher in both the canopy gap and the expanded gap than in the gap center and under the closed canopy. The results suggest that the predicted decline in snow cover resulting from winter warming or vanishing gaps caused by forest regeneration will retard the loss of total phenol content in the foliar litter of alpine forest ecosystems, especially in the first decomposition year.	[Li, Han; Xu, Liya; Wu, Fuzhong; Yang, Wanqin; Ni, Xiangyin; He, Jie; Tan, Bo; Hu, Yi] Sichuan Agr Univ, Inst Ecol & Forestry, Long Term Res Stn Alpine Forest Ecosyst, Chengdu 611130, Peoples R China; [Wu, Fuzhong; Yang, Wanqin; Tan, Bo] Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu 611130, Peoples R China; [Xu, Liya] Sichuan Technol & Business Univ, Int Business Sch, 9 Min River Eastern Sect, Meishan City, Peoples R China	Sichuan Agricultural University	Yang, WQ (corresponding author), Sichuan Agr Univ, Inst Ecol & Forestry, Long Term Res Stn Alpine Forest Ecosyst, Chengdu 611130, Peoples R China.; Yang, WQ (corresponding author), Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu 611130, Peoples R China.	scyangwq@163.com		Ni, Xiangyin/0000-0002-2507-3463	National Natural Science Foundation of China [31270498, 31570445, 31500509]; China Postdoctoral Science Foundation [2012T50782]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This project was supported by the National Natural Science Foundation of China (31270498, 31570445, 31500509) and the China Postdoctoral Science Foundation Special Funding (2012T50782).	Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Baptist F, 2010, PLANT SOIL, V328, P397, DOI 10.1007/s11104-009-0119-6; BEART JE, 1985, J CHEM SOC PERK T 2, P1439, DOI 10.1039/p29850001439; Bending GD, 1996, SOIL BIOL BIOCHEM, V28, P1603, DOI 10.1016/S0038-0717(96)00258-1; Berg B., 2008, PLANT LITTER; Bokhorst S, 2013, SOIL BIOL BIOCHEM, V62, P157, DOI 10.1016/j.soilbio.2013.03.016; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; De Marco A, 2012, SOIL BIOL BIOCHEM, V51, P1, DOI 10.1016/j.soilbio.2012.03.025; GALLARDO A, 1992, BIOGEOCHEMISTRY, V15, P213; GALLET C, 1995, SOIL BIOL BIOCHEM, V27, P157, DOI 10.1016/0038-0717(94)00167-Y; Gupta G, 1998, J ENVIRON SCI HEAL A, V33, P83, DOI 10.1080/10934529809376719; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; He J., 2015, SCI REP-UK, V4, P1; He W., 2015, 2015 IEEE International Vacuum Electronics Conference (IVEC), P1, DOI 10.1109/IVEC.2015.7223785; Isaac SR, 2005, SOIL BIOL BIOCHEM, V37, P1656, DOI 10.1016/j.soilbio.2005.02.002; Kennedy J, 1996, EUR J SOIL SCI, V47, P615, DOI 10.1111/j.1365-2389.1996.tb01860.x; Konestabo HS, 2007, APPL SOIL ECOL, V36, P136, DOI 10.1016/j.apsoil.2007.01.003; KUITERS AT, 1990, ACTA BOT NEERL, V39, P329, DOI 10.1111/j.1438-8677.1990.tb01412.x; KUITERS AT, 1986, SOIL BIOL BIOCHEM, V18, P475, DOI 10.1016/0038-0717(86)90003-9; Lu R., 1999, SOIL AGROCHEMICAL AN, P146; Mallik AU, 2014, FOREST ECOL MANAG, V312, P117, DOI 10.1016/j.foreco.2013.10.015; Ni XY, 2015, GEODERMA, V241, P136, DOI 10.1016/j.geoderma.2014.11.018; Ni XY, 2014, CAN J SOIL SCI, V94, P453, DOI 10.4141/CJSS2013-121; Olsson PQ, 2003, ARCT ANTARCT ALP RES, V35, P74, DOI 10.1657/1523-0430(2003)035[0074:FSOTAA]2.0.CO;2; PALM CA, 1990, BIOTROPICA, V22, P330, DOI 10.2307/2388550; Preston CM, 2009, ECOSYSTEMS, V12, P1078, DOI 10.1007/s10021-009-9267-z; Preston CM, 2009, ECOSYSTEMS, V12, P1053, DOI 10.1007/s10021-009-9266-0; Ritter E, 2005, FOREST ECOL MANAG, V206, P15, DOI 10.1016/j.foreco.2004.08.011; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Scharenbroch BC, 2007, PLANT SOIL, V294, P219, DOI 10.1007/s11104-007-9248-y; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schofield JA, 1998, J CHEM ECOL, V24, P1409, DOI 10.1023/A:1021287018787; SLAPOKAS T, 1991, BIOL FERT SOILS, V10, P241, DOI 10.1007/BF00337374; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Tan Bo, 2011, Yingyong Shengtai Xuebao, V22, P2553; Tan B, 2011, ACTA AGR SCAND B-S P, V61, P670, DOI 10.1080/09064710.2010.541489; TORTI SD, 1995, J CHEM ECOL, V21, P117, DOI 10.1007/BF02036646; Vanderbilt KL, 2008, J ARID ENVIRON, V72, P696, DOI 10.1016/j.jaridenv.2007.10.010; VANSOEST PJ, 1968, J ASSOC OFF ANA CHEM, V51, P780; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; Wu F, 2014, BIOGEOSCI DISCUSS, V11, P9539, DOI DOI 10.5194/BGD-11-9539-2014; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Wu QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097112; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073	44	4	6	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148426	10.1371/journal.pone.0148426	http://dx.doi.org/10.1371/journal.pone.0148426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849120	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000091
J	Souverein, D; Houtman, P; Euser, SM; Herpers, BL; Kluytmans, J; Den Boer, JW				Souverein, Dennis; Houtman, Patricia; Euser, Sjoerd M.; Herpers, Bjorn L.; Kluytmans, Jan; Den Boer, Jeroen W.			Costs and Benefits Associated with the MRSA Search and Destroy Policy in a Hospital in the Region Kennemerland, The Netherlands	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANCE; BACTEREMIA; MORTALITY	Objective The objective of this study was to analyze the costs and benefits of the MRSA Search and Destroy (S&D) policy between 2008 and 2013 in the Kennemer Gasthuis, a 400 bed teaching hospital in the region Kennemerland, the Netherlands. Methods A patient registration database was used to retrospectively calculate costs, including screening, isolation, follow-up, contact tracing, cleaning, treatment, deployment of extra healthcare workers, salary for an infection control practitioner (ICP) and service of isolation rooms. The estimated benefits (costs and lives when no MRSA S&D was applied) were based on a varying MRSA prevalence rate (up to 50%). Results When no MRSA S&D policy was applied, the additional costs and deaths due to MRSA bacteraemia were estimated to be (sic) 1,388,907 and 33 respectively (at a MRSA prevalence rate of 50%). Currently, the total costs were estimated to be (sic) 290,672 ((sic) 48,445 annually) and a MRSA prevalence rate of 17.3% was considered as break-even point. Between 2008 and 2013, a total of 576 high risk patients were screened for MRSA carriage, of whom 19 (3.3%) were found to be MRSA positive. Forty-nine patients (72.1%) were found unexpectedly. Conclusions Application of the MRSA S&D policy saves lives and money, although the high rate of unexpected MRSA cases is alarming.	[Souverein, Dennis; Euser, Sjoerd M.; Herpers, Bjorn L.; Den Boer, Jeroen W.] Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands; [Houtman, Patricia] Kennemer Gasthuis, Dept Infect Control, Haarlem, Netherlands; [Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan] Univ Med Ctr, Utrecht, Netherlands	Spaarne Hospital; Amphia Hospital; Utrecht University; Utrecht University Medical Center	Souverein, D (corresponding author), Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands.	d.souverein@streeklabhaarlem.nl						[Anonymous], 2005, METH RES STAPH AUR M; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; CDC, 2006, MAN MULT RES ORG HEA; College bouw ziekenhuisvoorzieningen, 2003, 0113 COLL BOUW ZIEK; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; ECDC, 2012, SUMM LAT DAT ANT RES; Filice GA, 2010, INFECT CONT HOSP EP, V31, P365, DOI 10.1086/651094; Kramer A, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000144; Nulens E, 2008, J HOSP INFECT, V68, P301, DOI 10.1016/j.jhin.2008.01.018; NVMM, 2013, GUID LAB DET HIGHL R; Pan A, 2013, INFECTION, V41, P783, DOI 10.1007/s15010-013-0454-7; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Stichting Werkgroep Antibiotica Beleid, SWAB RICHTL BEH MRSA; van der Zee A, 2013, AM J INFECT CONTROL, V41, P204, DOI 10.1016/j.ajic.2012.02.033; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Vriens M, 2002, EUR J CLIN MICROBIOL, V21, P782, DOI 10.1007/s10096-002-0811-4; Wassenberg Marjan W M, 2010, Ned Tijdschr Geneeskd, V154, pA2575; Wassenberg MWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011562; Werkgroep Infectie Preventie, 2013, BIJZ RES MICR BRMO; Werkgroep Infectie Preventie, 2012, MET RES STAPH AUR; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	22	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148175	10.1371/journal.pone.0148175	http://dx.doi.org/10.1371/journal.pone.0148175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849655	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000048
J	Liao, Y; Lu, B; Ma, Q; Wu, G; Lai, XR; Zang, JS; Shi, Y; Liu, DX; Han, F; Zhou, NM				Liao, Yuan; Lu, Bin; Ma, Qiang; Wu, Gang; Lai, Xiangru; Zang, Jiashu; Shi, Ying; Liu, Dongxiang; Han, Feng; Zhou, Naiming			Human Neuropeptide S Receptor Is Activated via a G alpha(q) Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL SELECTIVITY; SENSING RECEPTOR; FOOD-INTAKE; IDENTIFICATION; AGONISTS; PHARMACOLOGY; PEPTIDE; MICE; RATS; DELINEATION	Human neuropeptide S (NPS) and its cognate receptor regulate important biological functions in the brain and have emerged as a future therapeutic target for treatment of a variety of neurological and psychiatric diseases. The human NPS (hNPS) receptor has been shown to dually couple to G alpha(s)- and G alpha(q)-dependent signaling pathways. The human NPS analog hNPS-(1-10), lacking 10 residues from the C terminus, has been shown to stimulate Ca2+ mobilization in a manner comparable with full-length hNPS in vitro but seems to fail to induce biological activity in vivo. Here, results derived from a number of cell-based functional assays, including intracellular cAMP-response element (CRE)-driven luciferase activity, Ca2+ mobilization, and ERK1/2 phosphorylation, show that hNPS-(1-10) preferentially activates G alpha(q)-dependent Ca2+ mobilization while exhibiting less activity in triggering G alpha(s)-dependent CRE-driven luciferase activity. We further demonstrate that both G alpha(q)- and G alpha(s)-coupled signaling pathways contribute to full-length hNPS-mediated activation of ERK1/2, whereas hNPS-(1-10)promoted ERK1/2 activation is completely inhibited by the G alpha(q) inhibitor UBO-QIC but not by the PKA inhibitor H89. Moreover, the results of Ala-scanning mutagenesis of hNPS-(1-13) indicated that residues Lys(11) and Lys(12) are structurally crucial for the hNPS receptor to couple to G alpha(s)-dependent signaling. In conclusion, our findings demonstrate that hNPS-(1-10) is a biased agonist favoring G alpha(q)-dependent signaling. It may represent a valuable chemical probe for further investigation of the therapeutic potential of human NPS receptor-directed signaling in vivo.	[Liao, Yuan; Lu, Bin; Ma, Qiang; Lai, Xiangru; Zang, Jiashu; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Gang; Han, Feng] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Dongxiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Han, F (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Zijingang Campus,866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Zijingang Campus,866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	changhuahan@zju.edu.cn; zhounaiming@zju.edu.cn	Zhou, Naiming/AHC-1121-2022		Ministry of Science and Technology of China [2012CB910402, 2012AA020303]; National Natural Science Foundation of China [81173106, 31200621]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K22AA020303] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Ministry of Science and Technology of China Grants 2012CB910402 and 2012AA020303 and National Natural Science Foundation of China Grants 81173106 and 31200621. The authors declare that they have no conflicts of interest with the contents of this article.	Alonso N, 2014, BIOCHEM J, V459, P117, DOI 10.1042/BJ20131226; Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; Arey BJ, 2011, REV ENDOCR METAB DIS, V12, P275, DOI 10.1007/s11154-011-9188-y; Badia-Elder NE, 2008, ALCOHOL CLIN EXP RES, V32, P1380, DOI 10.1111/j.1530-0277.2008.00713.x; Beck B, 2005, BIOCHEM BIOPH RES CO, V332, P859, DOI 10.1016/j.bbrc.2005.05.029; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Brule C, 2014, FASEB J, V28, P5148, DOI 10.1096/fj.14-249771; Busnelli M, 2012, J BIOL CHEM, V287, P3617, DOI 10.1074/jbc.M111.277178; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Clark SD, 2010, PEPTIDES, V31, P130, DOI 10.1016/j.peptides.2009.10.015; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Davey AE, 2012, ENDOCRINOLOGY, V153, P1232, DOI 10.1210/en.2011-1426; Erdmann F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117319; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Han RW, 2009, NEUROSCI LETT, V455, P74, DOI 10.1016/j.neulet.2009.03.023; He XB, 2015, BIOCHEM J, V466, P391, DOI 10.1042/BJ20141146; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; Lee HY, 2010, FEBS LETT, V584, P4102, DOI 10.1016/j.febslet.2010.08.036; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Leonard SK, 2011, NEUROSCIENCE, V172, P153, DOI 10.1016/j.neuroscience.2010.10.020; Leonard SK, 2008, PSYCHOPHARMACOLOGY, V197, P601, DOI 10.1007/s00213-008-1080-4; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; Maudsley S, 2015, MOL PHARMACOL, V87, P706, DOI 10.1124/mol.114.095224; Meis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002695; Mottola DM, 2002, J PHARMACOL EXP THER, V301, P1166, DOI 10.1124/jpet.301.3.1166; Okamura N, 2011, NEUROPSYCHOPHARMACOL, V36, P744, DOI 10.1038/npp.2010.207; Patel CB, 2010, MOL PHARMACOL, V78, P983, DOI 10.1124/mol.110.067066; Pietras CO, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-39; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reinscheid RK, 2007, PEPTIDES, V28, P830, DOI 10.1016/j.peptides.2007.01.008; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; Roth AL, 2006, J BIOL CHEM, V281, P20809, DOI 10.1074/jbc.M601846200; Sato S, 2002, International Patent Application, Patent No. [WO2002072829 A1, 2002072829]; Sbai O, 2014, FASEB J, V28, P3734, DOI 10.1096/fj.13-243402; Smith KL, 2006, ENDOCRINOLOGY, V147, P3510, DOI 10.1210/en.2005-1280; Sroussi HY, 2012, MOL IMMUNOL, V50, P42, DOI 10.1016/j.molimm.2011.12.001; Thorsell A, 2013, J NEUROSCI, V33, P10132, DOI 10.1523/JNEUROSCI.4742-12.2013; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Watts AO, 2013, BRIT J PHARMACOL, V168, P1662, DOI 10.1111/bph.12064; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	52	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7505	7516		10.1074/jbc.M115.704122	http://dx.doi.org/10.1074/jbc.M115.704122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26865629	hybrid, Green Published			2022-12-26	WOS:000383447600025
J	Wu, TF; Li, YT; Liu, BH; Zhang, SQ; Wu, LQ; Zhu, XN; Chen, QX				Wu, Tingfeng; Li, Yuntao; Liu, Baohui; Zhang, Shenqi; Wu, Liquan; Zhu, Xiaonan; Chen, Qianxue			Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway	PLOS ONE			English	Article							CANCER GENOMICS; APOPTOSIS; STRESS; GROWTH; TUMORS	Accumulating evidence suggests that iron-associated proteins contribute to tumor initiation and development. Ferritin light chain (FTL), a key protein in iron metabolism, is associated with the survival of glioblastoma multiforme (GBM) patients; however, the molecular mechanisms underlying this association remain largely unclear. Therefore, in the present study, we investigated the role of FTL in the pathogenesis of GBM. By using quantitative real-time RT-PCR, we found that expression of FTL was higher in patients with GBM than in those with low-grade glioma. Immunofluorescence showed that FTL was mainly localized in the nucleus of GBM cells and was closely associated with mitotic spindles. Knockdown of FTL resulted in inhibition of cell growth and activation of the GADD45A/JNK pathway in GBM cells. Immunoblotting revealed that levels of GADD45A protein decreased in GBM cells when FTL expression increased. Furthermore, transfection of GADD45A in GBM cells significantly decreased cell viability, and this effect was impeded by co-transfection of FTL. Moreover, FTL was found to localize with GADD45A in GBM cells, and a co-immunoprecipitation experiment showed that the two proteins physically interacted. Taken together, these results demonstrate a novel mechanism by which FTL regulates the growth of GBM cells via the GADD45/JNK pathway.	[Wu, Tingfeng; Li, Yuntao; Liu, Baohui; Zhang, Shenqi; Wu, Liquan; Zhu, Xiaonan; Chen, Qianxue] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Chen, QX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430072, Hubei Province, Peoples R China.	chenqx666@sohu.com		Chen, Qianxue/0000-0002-9413-1030; Li, Yuntao/0000-0001-8788-7537	National Natural Science Foundation of China [81572489]; Neural tumor research project [csno-2013-MSD 004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Neural tumor research project	This work was supported by the National Natural Science Foundation of China (Grant No. 81572489, URL: http://www.nsfc.gov.cn/publish/portal1/), Neural tumor research project (csno-2013-MSD 004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant No. 81572489, URL: http://www.nsfc.gov.cn/publish/portal1/), Neural tumor research project (csno-2013-MSD 004).	Alkhateeb AA, 2013, BBA-REV CANCER, V1836, P245, DOI 10.1016/j.bbcan.2013.07.002; AROSIO P, 1976, CANCER RES, V36, P1735; Bru A, 2007, MED ONCOL, V24, P436, DOI 10.1007/s12032-007-0025-9; Camorani S, 2014, MOL THER, V22, P828, DOI 10.1038/mt.2013.300; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; JAIN SK, 1985, J BIOL CHEM, V260, P1762; Ji J, 2007, ONCOGENE, V26, P6396, DOI 10.1038/sj.onc.1210469; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Liu XL, 2011, CANCER RES, V71, P2240, DOI 10.1158/0008-5472.CAN-10-1375; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Schrag JD, 2008, P NATL ACAD SCI USA, V105, P6566, DOI 10.1073/pnas.0800086105; Schwartzbaum JA, 2000, NUTR CANCER, V38, P40, DOI 10.1207/S15327914NC381_7; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; Thomas AA, 2014, JAMA NEUROL, V71, P1437, DOI 10.1001/jamaneurol.2014.1701; Tolmachev V, 2014, J NUCL MED, V55, P294, DOI 10.2967/jnumed.113.121814; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699	29	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149361	10.1371/journal.pone.0149361	http://dx.doi.org/10.1371/journal.pone.0149361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871431	gold, Green Published			2022-12-26	WOS:000370054100150
J	Poudyal, N; Baral, N; Asah, ST				Poudyal, Niraj; Baral, Nabin; Asah, Stanley T.			Wolf Lethal Control and Livestock Depredations: Counter-Evidence from Respecified Models	PLOS ONE			English	Article							REPLICATION; RELIABILITY; INFERENCE; STRATEGY	We replicated the study conducted by Wielgus and Peebles (2014) on the effect of wolf mortality on livestock depredations in Montana, Wyoming and Idaho states in the US. Their best models were found to be misspecified due to the omission of the time index and incorrect functional form. When we respecified the models, this replication failed to confirm the magnitude, direction and often the very existence of the original results. Wielgus and Peebles (2014) reported that the increase in the number of wolves culled the previous year would increase the expected number of livestock killed this year by 4 to 6%. But our results showed that the culling of one wolf the previous year would decrease the expected number of cattle killed this year by 1.9%, and the expected number of sheep killed by 3.4%. However, for every wolf killed there is a corresponding 2.2% increase in the expected number of sheep killed in the same year. The increase in sheep depredation appears to be a short term phenomenon.	[Poudyal, Niraj] Kathmandu Univ, Sch Arts, Lalitpur, Nepal; [Baral, Nabin; Asah, Stanley T.] Univ Washington, Sch Environm & Forest Sci, Coll Environm, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Baral, N (corresponding author), Univ Washington, Sch Environm & Forest Sci, Coll Environm, Seattle, WA 98195 USA.	nbaral@uw.edu						Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Ausband DE, 2015, ANIM CONSERV, V18, P415, DOI 10.1111/acv.12187; Bradley EH, 2015, J WILDLIFE MANAGE, V79, P1337, DOI 10.1002/jwmg.948; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; CATCHPOLE CK, 1989, TRENDS ECOL EVOL, V4, P286, DOI 10.1016/0169-5347(89)90021-9; Duncan GJ, 2014, DEV PSYCHOL, V50, P2417, DOI 10.1037/a0037996; Duvendack M, 2013, PROG DEV STUD, V13, P307, DOI 10.1177/1464993413490480; EBERHARDT LL, 1991, ECOL MONOGR, V61, P53, DOI 10.2307/1942999; Johnson DH, 2002, J WILDLIFE MANAGE, V66, P919, DOI 10.2307/3802926; Kachigan S.K., 1986, STAT ANAL INTERDISCI; LEVINS R, 1966, AM SCI, V54, P421; Mayo DG, 2004, PHILOS SCI, V71, P1007, DOI 10.1086/425064; Myers J. L., 2010, RES DESIGN STAT ANAL; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Singh K, 2003, J MANAGE, V29, P533, DOI 10.1016/S0149-2063(03)00024-2; Spanos A, 2007, PHILOS SCI, V74, P1046, DOI 10.1086/525643; Spanos A, 2010, ECON MODEL, V27, P1436, DOI 10.1016/j.econmod.2010.07.007; Spanos A, 2010, J ECONOMETRICS, V158, P204, DOI 10.1016/j.jeconom.2010.01.011; Tsang EWK, 1999, ACAD MANAGE REV, V24, P759, DOI 10.2307/259353; Venables WN, 2002, MODERN APPL STAT R; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505	21	18	18	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148743	10.1371/journal.pone.0148743	http://dx.doi.org/10.1371/journal.pone.0148743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866592	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700031
J	Wu, F; Koenig, KL; Zeleniuch-Jacquotte, A; Jonas, S; Afanasyeva, Y; Wojcik, OP; Costa, M; Chen, Y				Wu, Fen; Koenig, Karen L.; Zeleniuch-Jacquotte, Anne; Jonas, Saran; Afanasyeva, Yelena; Wojcik, Oktawia P.; Costa, Max; Chen, Yu			Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; CARDIOVASCULAR-DISEASES; NUTRITIONAL FACTOR; VEGETABLE INTAKE; ORAL TAURINE; MORTALITY; SUPPLEMENTATION; ASSOCIATION; POPULATIONS	Background Taurine (2-aminoethanesulfonic acid), a conditionally essential sulfur-containing amino acid, is mainly obtained from diet in humans. Experimental studies have shown that taurine's main biological actions include bile salt conjugation, blood pressure regulation, antioxidation, and anti-inflammation. Methods We conducted a prospective case-control study nested in the New York University Women's Health Study, a cohort study involving 14,274 women enrolled since 1985. Taurine was measured in pre-diagnostic serum samples of 241 stroke cases and 479 matched controls. Results There was no statistically significant association between serum taurine and stroke risk in the overall study population. The adjusted ORs for stroke were 1.0 (reference), 0.87 (95% CI, 0.59-1.28), and 1.03 (95% CI, 0.69-1.54) in increasing tertiles of taurine (64.3-126.6, 126.7-152.9, and 153.0-308.5 nmol/mL, respectively). A significant inverse association between serum taurine and stroke risk was observed among never smokers, with an adjusted OR of 0.66 (95% CI, 0.37-1.18) and 0.50 (95% CI, 0.26-0.94) for the second and third tertile, respectively (p for trend = 0.01), but not among past or current smokers (p for interaction < 0.01). Conclusions We observed no overall association between serum taurine and stroke risk, although a protective effect was observed in never smokers, which requires further investigation. Taurine, Stroke, Epidemiology, Prospective, Case-control study, NYUWHS.	[Wu, Fen; Koenig, Karen L.; Zeleniuch-Jacquotte, Anne; Afanasyeva, Yelena; Chen, Yu] NYU, Sch Med, Dept Populat Hlth, 650 First Ave, New York, NY USA; [Jonas, Saran] NYU, Dept Neurol, Sch Med, 462 First Ave, New York, NY 10016 USA; [Wojcik, Oktawia P.] Robert Wood Johnson Fdn, Route 1 & Coll Rd East, Princeton, NJ 08540 USA; [Costa, Max] NYU, Sch Med, Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY USA	New York University; New York University; Robert Wood Johnson Foundation (RWJF); New York University	Chen, Y (corresponding author), NYU, Sch Med, Dept Populat Hlth, 650 First Ave, New York, NY USA.	yu.chen@nyumc.org		Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Chen, Yu/0000-0002-1519-4894	National Heart, Lung, and Blood Institute [R21-HL-106309]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106309] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (R21-HL-106309) received by YC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2002, TOXICOLOGY, V180, P121, DOI 10.1016/S0300-483X(02)00386-4; Breslow N, 1980, STAT METHODS CANC RE, P248; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Dallongeville J, 1998, J NUTR, V128, P1450; Denipote F, 2011, CELL PHYSIOL BIOCHEM, V27, P291, DOI 10.1159/000327955; Dietrich M, 2003, AM J CLIN NUTR, V77, P160, DOI 10.1093/ajcn/77.1.160; Fennessy FM, 2003, CIRCULATION, V107, P410, DOI 10.1161/01.CIR.0000046447.72402.47; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Frankenfeld CL, 2008, AM J CLIN NUTR, V87, P1439, DOI 10.1093/ajcn/87.5.1439; FUJITA T, 1987, CIRCULATION, V75, P525, DOI 10.1161/01.CIR.75.3.525; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Janz KF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.5.e63; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Liu LJ, 2001, HYPERTENS RES, V24, P315, DOI 10.1291/hypres.24.315; Liu SM, 1999, AM J CLIN NUTR, V70, P412; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; Mizushima S, 1996, ADV EXP MED BIOL, V403, P615; Mizushima S, 1997, J Cardiovasc Risk, V4, P191, DOI 10.1097/00043798-199706000-00006; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Parvez S, 2008, BASIC CLIN PHARMACOL, V102, P382, DOI 10.1111/j.1742-7843.2008.00208.x; Rosa FT, 2014, EUR J NUTR, V53, P823, DOI 10.1007/s00394-013-0586-7; Sagara M, 2015, ADV EXP MED BIOL, V803, P623, DOI 10.1007/978-3-319-15126-7_50; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Tang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-162; TONIOLO PG, 1991, BREAST CANCER RES TR, V18, pS23, DOI 10.1007/BF02633522; TRAUTWEIN EA, 1990, AM J CLIN NUTR, V52, P758, DOI 10.1093/ajcn/52.4.758; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wojcik OP, 2013, EUR J NUTR, V52, P169, DOI 10.1007/s00394-011-0300-6; Wojcik OP, 2010, BRIT J NUTR, V104, P629, DOI 10.1017/S000711451000108X; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; Xiao C, 2008, DIABETOLOGIA, V51, P139, DOI 10.1007/s00125-007-0859-x; Yamori Y, 2001, HYPERTENS RES, V24, P453, DOI 10.1291/hypres.24.453; Yamori Y, 1996, ADV EXP MED BIOL, V403, P623; Yamori Yukio, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS20, DOI 10.1111/j.1440-1681.2004.04122.x; Yamori Y, 2006, J HYPERTENS, V24, P1499, DOI 10.1097/01.hjh.0000239284.12691.2e; Yamori Y, 2009, ADV EXP MED BIOL, V643, P13, DOI 10.1007/978-0-387-75681-3_2; Zhang M, 2004, AMINO ACIDS, V26, P267, DOI 10.1007/s00726-003-0059-z	40	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149348	10.1371/journal.pone.0149348	http://dx.doi.org/10.1371/journal.pone.0149348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866594	Green Submitted, gold, Green Published			2022-12-26	WOS:000370050700085
J	Hu, Q; Wang, XY; Kang, LK; Wei, HM; Xu, CM; Wang, T; Wen, ZH				Hu, Qiao; Wang, Xiao-Yan; Kang, Li-Ke; Wei, Hai-Ming; Xu, Chun-Mei; Wang, Tao; Wen, Zong-Hua			RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo	PLOS ONE			English	Article							MICROBUBBLES; EXPRESSION; US; INFLAMMATION; FEASIBILITY	Objective To prepare arginine-glycine-aspartate (RGD)-targeted ultrasound contrast microbubbles (MBs) and explore the feasibility of their use in assessing dynamic changes in alpha v beta 3 integrin expression in a murine model of tumor angiogenesis. Methods RGD peptides were conjugated to the surfaces of microbubbles via biotin-avidin linkage. Microbubbles bearing RADfK peptides were prepared as controls. The RGD-MBs were characterized using an Accusizer 780 and optical microscopy. The binding specificity of the RGD-MBs for alpha v beta 3-expressing endothelial cells (bEnd.3) was demonstrated in vitro by a competitive inhibition experiment. In an in vivo study, mice bearing tumors of three different stages were intravenously injected with RGD-MBs and subjected to targeted, contrast-enhanced, high-frequency ultrasound. Subsequently, tumors were harvested and sectioned for immunofluorescence analysis of alpha v beta 3 expression. Results The mean size of the RGD-MBs was 2.36 +/- 1.7 mu m. The RGD-MBs showed significantly higher adhesion levels to bEnd.3 cells compared to control MBs (P < 0.01). There was rarely binding of RGD-MBs to alpha v beta 3-negative MCF-7 cells. Adhesion of the RGD-MBs to the bEnd.3 cells was significantly inhibited following treatment with anti-alpha(v) antibodies. The quantitative acoustic video intensity for high-frequency, contrast-enhanced ultrasound imaging of subcutaneous human laryngeal carcinoma (Hep-2) tumor xenografts was significantly higher in small tumors (19.89 +/- 2.49) than in medium tumors (11.25 +/- 2.23) and large tumors (3.38 +/- 0.67) (P < 0.01). Conclusions RGD-MBs enable noninvasive in vivo visualization of changes in tumor angiogenesis during tumor growth in subcutaneous cancer xenografts.	[Hu, Qiao; Wang, Xiao-Yan; Kang, Li-Ke; Xu, Chun-Mei] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Diagnost Ultrasound, Nanning, Peoples R China; [Wei, Hai-Ming; Wen, Zong-Hua] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Pathol, Nanning, Peoples R China; [Wang, Tao] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Otolaryngol Head & Neck Surg, Nanning, Peoples R China		Hu, Q (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Diagnost Ultrasound, Nanning, Peoples R China.	xyyxyhq@163.com			National Natural Science Foundation of China [81260223]; Guangxi Natural Science Foundation [2012GXNSFBA053083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study was supported by the National Natural Science Foundation of China (No. 81260223) and Guangxi Natural Science Foundation project (2012GXNSFBA053083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2011, INVEST RADIOL, V46, P215, DOI 10.1097/RLI.0b013e3182034fed; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Chai LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061136; Deshpande N, 2011, RADIOLOGY, V258, P804, DOI 10.1148/radiol.10101079; Deshpande N, 2010, ANGIOGENESIS, V13, P175, DOI 10.1007/s10456-010-9175-z; Ellegala DB, 2003, CIRCULATION, V108, P336, DOI 10.1161/01.CIR.0000080326.15367.0C; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Golestani R, 2015, J NUCL CARDIOL, V22, P1179, DOI 10.1007/s12350-014-0061-8; Hauff P, 2004, RADIOLOGY, V231, P667, DOI 10.1148/radiol.2313030425; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Kaufmann BA, 2007, CURR OPIN BIOTECH, V18, P11, DOI [10.1016/j.copbio.2007.01.004, 10.1159/000203128]; Kaufmann BA, 2009, CARDIOVASC RES, V83, P617, DOI 10.1093/cvr/cvp179; Lindner JR, 2009, CARDIOVASC RES, V84, P182, DOI 10.1093/cvr/cvp302; Liu S, 2006, MOL PHARMACEUT, V3, P472, DOI 10.1021/mp060049x; Lucidarme O, 2006, RADIOLOGY, V239, P730, DOI 10.1148/radiol.2392040986; Lyshchik A, 2007, J ULTRAS MED, V26, P1575, DOI 10.7863/jum.2007.26.11.1575; Needles A, 2010, ULTRASOUND MED BIOL, V36, P2097, DOI 10.1016/j.ultrasmedbio.2010.08.012; Rashidi LH, 2016, PHOTODIAGN PHOTODYN, V13, P244, DOI 10.1016/j.pdpdt.2015.08.001; Razavian M, 2011, ARTERIOSCL THROM VAS, V31, P2820, DOI 10.1161/ATVBAHA.111.231654; Schnell O, 2009, NEURO-ONCOLOGY, V11, P861, DOI 10.1215/15228517-2009-024; Sorace AG, 2012, J ULTRAS MED, V31, P1543; Streeter JE, 2011, MOL IMAGING, V10, P460, DOI 10.2310/7290.2011.00015; Wei SP, 2014, ULTRASOUND MED BIOL, V40, P1250, DOI 10.1016/j.ultrasmedbio.2013.12.001; Willmann JK, 2008, RADIOLOGY, V246, P508, DOI 10.1148/radiol.2462070536; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007; Wu WL, 2013, INVEST RADIOL, V48, P803, DOI 10.1097/RLI.0b013e318298652d; Yan F, 2012, ULTRASOUND MED BIOL, V38, P670, DOI 10.1016/j.ultrasmedbio.2011.12.025	27	15	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149075	10.1371/journal.pone.0149075	http://dx.doi.org/10.1371/journal.pone.0149075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862757	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600151
J	Ishijima, S				Ishijima, Sumio			Self-Sustained Oscillatory Sliding Movement of Doublet Microtubules and Flagellar Bend Formation	PLOS ONE			English	Article							SPERM; SPERMATOZOA; CAMP; CA2+; REGULATIONS; AXONEMES; AXIS	It is well established that the basis for flagellar and ciliary movements is ATP-dependent sliding between adjacent doublet microtubules. However, the mechanism for converting microtubule sliding into flagellar and ciliary movements has long remained unresolved. The author has developed new sperm models that use bull spermatozoa divested of their plasma membrane and midpiece mitochondrial sheath by Triton X-100 and dithiothreitol. These models enable the observation of both the oscillatory sliding movement of activated doublet microtubules and flagellar bend formation in the presence of ATP. A long fiber of doublet microtubules extruded by synchronous sliding of the sperm flagella and a short fiber of doublet microtubules extruded by metachronal sliding exhibited spontaneous oscillatory movements and constructed a one beat cycle of flagellar bending by alternately actuating. The small sliding displacement generated by metachronal sliding formed helical bends, whereas the large displacement by synchronous sliding formed planar bends. Therefore, the resultant waveform is a half-funnel shape, which is similar to ciliary movements.	[Ishijima, Sumio] Tokyo Inst Technol, Dept Bioengn, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan	Tokyo Institute of Technology	Ishijima, S (corresponding author), Tokyo Inst Technol, Dept Bioengn, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan.	sishijim@bio.titech.ac.jp						AFZELIUS B, 1959, J BIOPHYS BIOCHEM CY, V5, P269, DOI 10.1083/jcb.5.2.269; ISHIJIMA S, 1992, J EXP BIOL, V163, P15; ISHIJIMA S, 1986, GAMETE RES, V13, P185, DOI 10.1002/mrd.1120130302; Ishijima S, 1996, J CELL SCI, V109, P2833; ISHIJIMA S, 1993, BIOPHYS J, V65, P1445, DOI 10.1016/S0006-3495(93)81210-4; Ishijima S, 2007, CELL MOTIL CYTOSKEL, V64, P809, DOI 10.1002/cm.20228; Ishijima S, 2006, MOL REPROD DEV, V73, P1129, DOI 10.1002/mrd.20420; Ishijima S, 2015, P JPN ACAD B-PHYS, V91, P99, DOI 10.2183/pjab.91.99; Ishijima S, 2013, CELL STRUCT FUNCT, V38, P89, DOI 10.1247/csf.12021; KANOUS KS, 1993, CELL MOTIL CYTOSKEL, V26, P66, DOI 10.1002/cm.970260107; Ohmuro J, 2006, MOL REPROD DEV, V73, P1412, DOI 10.1002/mrd.20521; OLSON GE, 1977, J ULTRA MOL STRUCT R, V61, P21, DOI 10.1016/S0022-5320(77)90004-1; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; SMITHWICK EB, 1978, BIOL REPROD, V19, P280, DOI 10.1095/biolreprod19.2.280	14	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148880	10.1371/journal.pone.0148880	http://dx.doi.org/10.1371/journal.pone.0148880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863204	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600119
J	Sood, C; Marin, M; Mason, CS; Melikyan, GB				Sood, Chetan; Marin, Mariana; Mason, Caleb S.; Melikyan, Gregory B.			Visualization of Content Release from Cell Surface-Attached Single HIV-1 Particles Carrying an Extra-Viral Fluorescent pH-Sensor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLATHRIN-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; VIROLOGICAL SYNAPSES; REQUIRE ENDOCYTOSIS; EARLY ENDOSOMES; 6-HELIX BUNDLE; T-LYMPHOCYTES; HOST ICAM-1; FUSION	HIV-1 fusion leading to productive entry has long been thought to occur at the plasma membrane. However, our previous single virus imaging data imply that, after Env engagement of CD4 and coreceptors at the cell surface, the virus enters into and fuses with intracellular compartments. We were unable to reliably detect viral fusion at the plasma membrane. Here, we implement a novel virus labeling strategy that biases towards detection of virus fusion that occurs in a pH-neutral environment-at the plasma membrane or, possibly, in early pH-neutral vesicles. Virus particles are co-labeled with an intra-viral content marker, which is released upon fusion, and an extra-viral pH sensor consisting of ecliptic pHluorin fused to the transmembrane domain of ICAM-1. This sensor fully quenches upon virus trafficking to a mildly acidic compartment, thus precluding subsequent detection of viral content release. As an interesting secondary observation, the incorporation of the pH-sensor revealed that HIV-1 particles occasionally shuttle between neutral and acidic compartments in target cells expressing CD4, suggesting a small fraction of viral particles is recycled to the plasma membrane and re-internalized. By imaging viruses bound to living cells, we found that HIV-1 content release in neutral-pH environment was a rare event (similar to 0.4% particles). Surprisingly, viral content release was not significantly reduced by fusion inhibitors, implying that content release was due to spontaneous formation of viral membrane defects occurring at the cell surface. We did not measure a significant occurrence of HIV-1 fusion at neutral pH above this defect-mediated background loss of content, suggesting that the pH sensor may destabilize the membrane of the HIV-1 pseudovirus and, thus, preclude reliable detection of single virus fusion events at neutral pH.	[Sood, Chetan; Marin, Mariana; Mason, Caleb S.; Melikyan, Gregory B.] Emory Univ, Sch Med, Div Pediat Infect Dis, Atlanta, GA USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Sch Med, Div Pediat Infect Dis, Atlanta, GA USA.; Melikyan, GB (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA USA.	gmeliki@emory.edu			NIH R01 grant [GM054787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787, R29GM054787] Funding Source: NIH RePORTER	NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH R01 grant GM054787 to GBM.	Bastiani L, 1997, J VIROL, V71, P3444, DOI 10.1128/JVI.71.5.3444-3450.1997; Beausejour Y, 2004, J VIROL, V78, P11916, DOI 10.1128/JVI.78.21.11916-11925.2004; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Clotet-Codina I, 2009, ANTIVIR RES, V83, P94, DOI 10.1016/j.antiviral.2009.03.009; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Demirkhanyan L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003431; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Desai TM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0215-z; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Grover JR, 2015, J VIROL, V89, P454, DOI 10.1128/JVI.02178-14; Herold N, 2014, J VIROL, V88, P13956, DOI 10.1128/JVI.01543-14; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jalaguier P, 2015, J VIROL, V89, P323, DOI 10.1128/JVI.02701-14; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Jones DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13449; Koch P, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-84; Kondo N, 2015, J BIOL CHEM, V290, P6558, DOI 10.1074/jbc.M114.623181; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; Marechal V, 1998, J VIROL, V72, P2208; MCCLURE MO, 1988, EMBO J, V7, P513, DOI 10.1002/j.1460-2075.1988.tb02839.x; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2015, J VIROL, V89; Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Padilla-Parra S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-47; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Padilla-Parra S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002694; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Platt EJ, 2014, J VIROL, V88, P4304, DOI 10.1128/JVI.03447-13; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Tardif MR, 2003, J VIROL, V77, P12299, DOI 10.1128/JVI.77.22.12299-12309.2003; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148944	10.1371/journal.pone.0148944	http://dx.doi.org/10.1371/journal.pone.0148944			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863211	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600128
J	Jagodzinski, AM; Ziolkowski, J; Warnkowska, A; Prais, H				Jagodzinski, Andrzej M.; Ziolkowski, Jedrzej; Warnkowska, Aleksandra; Prais, Hubert			Tree Age Effects on Fine Root Biomass and Morphology over Chronosequences of Fagus sylvatica, Quercus robur and Alnus glutinosa Stands	PLOS ONE			English	Article							SCOTS PINE STANDS; NORWAY SPRUCE FOREST; PICEA-ABIES L.; SILVER BIRCH; BOREAL FORESTS; SYLVESTRIS L.; VERTICAL-DISTRIBUTION; ABOVEGROUND BIOMASS; PLANTATION FORESTS; TEMPERATE FORESTS	There are few data on fine root biomass and morphology change in relation to stand age. Based on chronosequences for beech (9-140 years old), oak (11-140 years) and alder (476 years old) we aimed to examine how stand age affects fine root biomass and morphology. Soil cores from depths of 0-15 cm and 16-30 cm were used for the study. In contrast to previously published studies that suggested that maximum fine root biomass is reached at the canopy closure stage of stand development, we found almost linear increases of fine root biomass over stand age within the chronosequences. We did not observe any fine root biomass peak in the canopy closure stage. However, we found statistically significant increases of mean fine root biomass for the average individual tree in each chronosequence. Mean fine root biomass (0-30 cm) differed significantly among tree species chronosequences studied and was 4.32 Mg ha(-1), 3.71 Mg ha(-1) and 1.53 Mg ha(-1), for beech, oak and alder stands, respectively. The highest fine root length, surface area, volume and number of fine root tips (0-30 cm soil depth), expressed on a stand area basis, occurred in beech stands, with medium values for oak stands and the lowest for alder stands. In the alder chronosequence all these values increased with stand age, in the beech chronosequence they decreased and in the oak chronosequence they increased until ca. 50 year old stands and then reached steady-state. Our study has proved statistically significant negative relationships between stand age and specific root length (SRL) in 0-30 cm soil depth for beech and oak chronosequences. Mean SRLs for each chronosequence were not significantly different among species for either soil depth studied. The results of this study indicate high fine root plasticity. Although only limited datasets are currently available, these data have provided valuable insight into fine root biomass and morphology of beech, oak and alder stands.	[Jagodzinski, Andrzej M.] Polish Acad Sci, Inst Dendrol, Parkowa 5, PL-62035 Kornik, Poland; [Jagodzinski, Andrzej M.; Ziolkowski, Jedrzej; Warnkowska, Aleksandra; Prais, Hubert] Poznan Univ Life Sci, Dept Game Management & Forest Protect, Fac Forestry, Wojska Polskiego 71c, PL-60625 Poznan, Poland	Polish Academy of Sciences; Poznan University of Life Sciences	Jagodzinski, AM (corresponding author), Polish Acad Sci, Inst Dendrol, Parkowa 5, PL-62035 Kornik, Poland.; Jagodzinski, AM (corresponding author), Poznan Univ Life Sci, Dept Game Management & Forest Protect, Fac Forestry, Wojska Polskiego 71c, PL-60625 Poznan, Poland.	amj@man.poznan.pl	Jagodziński, Andrzej M./AAA-2537-2021	Jagodziński, Andrzej M./0000-0001-6899-0985	General Directorate of State Forests, Warsaw, Poland	General Directorate of State Forests, Warsaw, Poland	This study was supported by General Directorate of State Forests, Warsaw, Poland (research projects: Carbon balance of the major forest-forming tree species in Poland' (2007-2011) and 'Environmental and genetic factors affecting productivity of forest ecosystems on forest and postindustrial habitats' (2011-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by General Directorate of State Forests, Warsaw, Poland (research projects: 'Carbon balance of the major forest-forming tree species in Poland' (2007-2011) and 'Environmental and genetic factors affecting productivity of forest ecosystems on forest and post-industrial habitats' (2011-2015)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Dr. Lee E. Frelich (University of Minnesota, USA) for valuable suggestions and linguistic revision of the manuscript and Dr. Jan Bocianowski (Department of Mathematical and Statistical Methods, Poznan University of Life Sciences, Poland) for statistical advice. We are also grateful to Marcin Dyderski for preparation of figures and valuable comments to the earlier version of the manuscript. Before we established the study sites, the approvals were obtained for each location from the respective local forest district managers (Andrzej Wawrzyniak-Piaski Forest District, Dr. Roman Bartol-Trzcianka Forest District, Roman Wojcik-Gryfino Forest District) that represent the State Forests National Forest Holding.	[Anonymous], 2014, R LANG ENV STAT COMP; Aosaar J, 2013, EUR J FOREST RES, V132, P737, DOI 10.1007/s10342-013-0706-1; Bakker MR, 2008, J FOREST RES-JPN, V13, P176, DOI 10.1007/s10310-008-0068-6; Bauhus J, 1999, CAN J FOREST RES, V29, P260, DOI 10.1139/cjfr-29-2-260; Bauhus J, 1999, AGRON J, V91, P142, DOI 10.2134/agronj1999.00021962009100010022x; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Borja I, 2008, TREE PHYSIOL, V28, P773, DOI 10.1093/treephys/28.5.773; Brassard BW, 2009, CRIT REV PLANT SCI, V28, P179, DOI 10.1080/07352680902776572; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chang RY, 2012, ECOL RES, V27, P827, DOI 10.1007/s11284-012-0958-0; Chen WJ, 2004, PLANT SOIL, V265, P31, DOI 10.1007/s11104-005-8503-3; Claessens H, 2010, FORESTRY, V83, P163, DOI 10.1093/forestry/cpp038; Claus A, 2005, CAN J FOREST RES, V35, P1617, DOI 10.1139/x05-079; Comas LH, 2002, OECOLOGIA, V132, P34, DOI 10.1007/s00442-002-0922-8; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; DAWSON JO, 1981, FOREST SCI, V27, P239; Di Iorio A, 2013, TREES-STRUCT FUNCT, V27, P1503, DOI 10.1007/s00468-013-0897-6; EISSENSTAT DM, 1991, NEW PHYTOL, V118, P63, DOI 10.1111/j.1469-8137.1991.tb00565.x; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Finer L, 2007, PLANT BIOSYST, V141, P394, DOI 10.1080/11263500701625897; Finer L, 1997, CAN J FOREST RES, V27, P304, DOI 10.1139/x96-170; Finer L, 2011, FOREST ECOL MANAG, V262, P2008, DOI 10.1016/j.foreco.2011.08.042; Finer L, 2011, FOREST ECOL MANAG, V261, P265, DOI 10.1016/j.foreco.2010.10.016; Fujimaki R, 2007, J FOREST RES-JPN, V12, P96, DOI 10.1007/s10310-006-0256-1; Goebel M, 2011, ECOL MONOGR, V81, P89, DOI 10.1890/09-2390.1; Gower S. T., 1994, ECOL BULL, P115; Hartmann P, 2014, CAN J FOREST RES, V44, P71, DOI 10.1139/cjfr-2013-0357; Helmisaari HS, 2007, TREE PHYSIOL, V27, P1493, DOI 10.1093/treephys/27.10.1493; Helmisaari HS, 2002, FOREST ECOL MANAG, V165, P317, DOI 10.1016/S0378-1127(01)00648-X; Hertel D, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12124; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Idol TW, 2000, FOREST ECOL MANAG, V127, P153, DOI 10.1016/S0378-1127(99)00127-9; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jagodzinski AM, 2008, DENDROBIOLOGY, V59, P57; Jagodzinski AM, 2011, DENDROBIOLOGY, V66, P71; Jagodzinski AM, 2010, DENDROBIOLOGY, V64, P19; Jagodzinski AM, 2009, SYLWAN, V153, P147; Kalliokoski T, 2010, PLANT SOIL, V330, P73, DOI 10.1007/s11104-009-0177-9; Konopka B, 2005, PLANT SOIL, V276, P33, DOI 10.1007/s11104-004-2976-3; Leuschner C, 2003, PROG BOT, V64, P405; Leuschner C, 2004, PLANT SOIL, V258, P43, DOI 10.1023/B:PLSO.0000016508.20173.80; Litton CM, 2003, CAN J FOREST RES, V33, P351, DOI 10.1139/X02-181; LOHMUS K, 1989, PLANT SOIL, V119, P245, DOI 10.1007/BF02370415; Lohmus Krista, 2002, Archiv fuer Hydrobiologie Supplement, V141, P321; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; McCormack ML, 2015, NEW PHYTOL, V207, P505, DOI 10.1111/nph.13363; Mei L, 2010, J FOREST RES-JPN, V15, P194, DOI 10.1007/s10310-009-0176-y; Meinen C, 2009, ECOSYSTEMS, V12, P1103, DOI 10.1007/s10021-009-9271-3; Meinen C, 2009, OECOLOGIA, V161, P99, DOI 10.1007/s00442-009-1352-7; Mund M, 2002, FOREST ECOL MANAG, V171, P275, DOI 10.1016/S0378-1127(01)00788-5; Noguchi K, 2007, J FOREST RES-JPN, V12, P83, DOI 10.1007/s10310-006-0262-3; Ostonen I, 2007, PLANT BIOSYST, V141, P426, DOI 10.1080/11263500701626069; Ostonen I, 2006, OIL SHALE, V23, P187; Ostonen I, 2005, FOREST ECOL MANAG, V212, P264, DOI 10.1016/j.foreco.2005.03.064; Ostonen I, 2007, TREE PHYSIOL, V27, P1627, DOI 10.1093/treephys/27.11.1627; Peichl M, 2006, AGR FOREST METEOROL, V140, P51, DOI 10.1016/j.agrformet.2006.08.004; PERSSON HA, 1983, PLANT SOIL, V71, P87, DOI 10.1007/BF02182644; Persson HA, 2010, PLANT SOIL, V330, P329, DOI 10.1007/s11104-009-0206-8; Persson HA, 2009, PLANT SOIL, V318, P1, DOI 10.1007/s11104-008-9811-1; Rosenvald K, 2013, EUR J FOREST RES, V132, P219, DOI 10.1007/s10342-012-0669-7; Rosenvald K, 2011, ECOL ENG, V37, P1027, DOI 10.1016/j.ecoleng.2010.05.011; SAINJU UM, 1993, PLANT SOIL, V150, P87, DOI 10.1007/BF00779179; Schenk HJ, 2005, PROG BOT, V66, P341; Schmid I, 2002, FOREST ECOL MANAG, V159, P37, DOI 10.1016/S0378-1127(01)00708-3; Vanninen P, 1999, TREE PHYSIOL, V19, P823; Vanninen P, 1996, TREES-STRUCT FUNCT, V10, P231, DOI 10.1007/BF02185674; Vares A, 2004, OIL SHALE, V21, P43; Vogt K.A., 1991, TECHNIQUES APPROACHE, P477; Vogt KA, 1996, PLANT SOIL, V187, P159, DOI 10.1007/BF00017088; VOGT KA, 1987, J ECOL, V75, P857, DOI 10.2307/2260210; Withington JM, 2006, ECOL MONOGR, V76, P381, DOI 10.1890/0012-9615(2006)076[0381:COSALS]2.0.CO;2; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Xiao CW, 2003, TREE PHYSIOL, V23, P505, DOI 10.1093/treephys/23.8.505; Yuan ZY, 2012, FUNCT ECOL, V26, P991, DOI 10.1111/j.1365-2435.2012.02007.x; Yuan ZY, 2010, CRIT REV PLANT SCI, V29, P204, DOI 10.1080/07352689.2010.483579; Yuste JC, 2005, TREE PHYSIOL, V25, P701, DOI 10.1093/treephys/25.6.701; Zadworny M, 2015, TREE PHYSIOL, V35, P644, DOI 10.1093/treephys/tpv018; Zadworny M, 2011, NEW PHYTOL, V190, P213, DOI 10.1111/j.1469-8137.2010.03598.x; Zhou ZC, 2007, PLANT SOIL, V291, P119, DOI 10.1007/s11104-006-9179-z	80	37	39	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148668	10.1371/journal.pone.0148668	http://dx.doi.org/10.1371/journal.pone.0148668			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859755	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400062
J	Prior, KK; Wittig, I; Leisegang, MS; Groenendyk, J; Weissmann, N; Michalak, M; Jansen-Durr, P; Shah, AM; Brandes, RP				Prior, Kim-Kristin; Wittig, Ilka; Leisegang, Matthias S.; Groenendyk, Jody; Weissmann, Norbert; Michalak, Marek; Jansen-Duerr, Pidder; Shah, Ajay M.; Brandes, Ralf P.			The Endoplasmic Reticulum Chaperone Calnexin Is a NADPH Oxidase NOX4 Interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); NADPH oxidase; protein-protein interaction; proteomics; reactive oxygen species (ROS); blue native PAGE	OXYGEN SPECIES GENERATION; NAD(P)H OXIDASE; SMOOTH-MUSCLE; QUALITY-CONTROL; IDENTIFICATION; REVEALS; FLAVOCYTOCHROME; GLYCOSYLATION; MITOCHONDRIA; DEGRADATION	Within the family of NADPH oxidases, NOX4 is unique as it is predominantly localized in the endoplasmic reticulum, has constitutive activity, and generates hydrogen peroxide (H2O2). We hypothesize that these features are consequences of a so far unidentified NOX4-interacting protein. Two-dimensional blue native (BN) electrophorese combined with SDS-PAGE yielded NOX4 to reside in macromolecular complexes. Interacting proteins were screened by quantitative SILAC (stable isotope labeling of amino acids in cell culture) co-immunoprecipitation (Co-IP) in HEK293 cells stably overexpressing NOX4. By this technique, several interacting proteins were identified with calnexin showing the most robust interaction. Calnexin also resided in NOX4-containing complexes as demonstrated by complexome profiling from BN-PAGE. The calnexin NOX4 interaction could be confirmed by reverse Co-IP and proximity ligation assay, whereas NOX1, NOX2, or NOX5 did not interact with calnexin. Calnexin deficiency as studied in mouse embryonic fibroblasts from calnexin(-/-) mice or in response to calnexin shRNA reduced cellular NOX4 protein expression and reactive oxygen species formation. Our results suggest that endogenous NOX4 forms macromolecular complexes with calnexin, which are needed for the proper maturation, processing, and function of NOX4 in the endoplasmic reticulum.	[Prior, Kim-Kristin; Leisegang, Matthias S.; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Funct Prote, Core Unit SFB 815, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60590 Frankfurt, Germany; [Groenendyk, Jody; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Weissmann, Norbert] Univ Giessen, Excellence Cluster Cardiopulm Syst, D-60590 Giessen, Germany; [Jansen-Duerr, Pidder] Univ Innsbruck, Inst Biomed Ageing Res, A-6020 Innsbruck, Austria; [Jansen-Duerr, Pidder] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria; [Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London WC2R 2LS, England; [Prior, Kim-Kristin; Wittig, Ilka; Leisegang, Matthias S.; Brandes, Ralf P.] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Theodor Stern Kai 7, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of Alberta; Justus Liebig University Giessen; University of Innsbruck; University of Innsbruck; University of London; King's College London; German Centre for Cardiovascular Research	Brandes, RP (corresponding author), Goethe Univ Frankfurt, Fachbereich Med, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	brandes@vrc.uni-frankfurt.de	Leisegang, Matthias S./ABD-8062-2021; Jansen-Dürr, Pidder/ABG-2466-2020; Leisegang, Matthias S./P-6006-2017; Brandes, Ralf/L-3058-2017	Leisegang, Matthias S./0000-0002-6084-6484; Jansen-Dürr, Pidder/0000-0001-7771-3429; Leisegang, Matthias S./0000-0002-6084-6484; Brandes, Ralf/0000-0002-8035-0048; Weissmann, Norbert/0000-0003-2675-3871; Shah, Ajay/0000-0002-6547-0631	Deutsche Forschungsgemeinschaft Excellence Cluster "Cardiopulmonary System-ECCPS" [SFB 815 TP A1, TP Z1, SFB 834 TPA2]; Faculty of Medicine, Goethea-Universitat, Frankfurt am Main, Germany; Austrian Research Promoti Agency (FFG) [848474]; British Heart Foundation; British Heart Foundation [RG/13/11/30384] Funding Source: researchfish	Deutsche Forschungsgemeinschaft Excellence Cluster "Cardiopulmonary System-ECCPS"(German Research Foundation (DFG)); Faculty of Medicine, Goethea-Universitat, Frankfurt am Main, Germany; Austrian Research Promoti Agency (FFG); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The work was supported in part by the Deutsche Forschungsgemeinschaft Excellence Cluster "Cardiopulmonary System-ECCPS," SFB 815 TP A1 (to R. P. B.) and TP Z1 (to I. W.) and SFB 834 TPA2 (to R. P. B.) and the Faculty of Medicine, Goethea-Universitat, Frankfurt am Main, Germany. The authors declare that they have no relevant financial, personal or professional relationships to disclose which could be perceived as a conflict of interest or as potentially influencing or biasing the authors' work.; Supported by the Austrian Research Promoti Agency (FFG) Grant 848474.; Supported by the British Heart Foundation.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Anilkumar N, 2013, ARTERIOSCL THROM VAS, V33, pE104, DOI 10.1161/ATVBAHA.112.300956; Babelova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080328; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; BAKSH S, 1995, FEBS LETT, V376, P53, DOI 10.1016/0014-5793(95)01246-4; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Fontanini A, 2005, J BIOL CHEM, V280, P2378, DOI 10.1074/jbc.M405104200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Giese H, 2015, BIOINFORMATICS, V31, P440, DOI 10.1093/bioinformatics/btu623; Lorenzo AFG, 2015, CELL PHYSIOL BIOCHEM, V36, P2183, DOI 10.1159/000430184; Goetz JG, 2007, J CELL SCI, V120, P3553, DOI 10.1242/jcs.03486; Hayee B, 2011, GLYCOBIOLOGY, V21, P914, DOI 10.1093/glycob/cwr023; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Konno T, 2015, J CELL BIOL, V211, P253, DOI 10.1083/jcb.201506123; Kruse C, 2015, ARTERIOSCL THROM VAS, V35, P1954, DOI 10.1161/ATVBAHA.115.305678; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Rezende F, 2016, ANTIOXID REDOX SIGN, V24, P392, DOI 10.1089/ars.2015.6314; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Santos CXC, 2009, J LEUKOCYTE BIOL, V86, P989, DOI 10.1189/jlb.0608354; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tong XY, 2010, CIRC RES, V107, P975, DOI 10.1161/CIRCRESAHA.110.221242; VasquezVivar J, 1997, FEBS LETT, V403, P127, DOI 10.1016/S0014-5793(97)00036-7; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; Wilkins MR, 1999, METH MOL B, V112, P531; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xi G, 2013, J BIOL CHEM, V288, P15641, DOI 10.1074/jbc.M113.456046; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	59	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7045	7059		10.1074/jbc.M115.710772	http://dx.doi.org/10.1074/jbc.M115.710772			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26861875	Green Published, hybrid			2022-12-26	WOS:000373299700039
J	Asano, Y; Fairchild, MD; Blonde, L				Asano, Yuta; Fairchild, Mark D.; Blonde, Laurent			Individual Colorimetric Observer Model	PLOS ONE			English	Article							PIGMENT OPTICAL-DENSITY; HUMAN OCULAR MEDIA; COLOR-MATCHING FUNCTIONS; HUMAN CONE PHOTOPIGMENTS; AGE-RELATED MACULOPATHY; HUMAN CRYSTALLINE LENS; MACULAR PIGMENT; SERUM CONCENTRATIONS; ABSORPTION-SPECTRA; HIGH ILLUMINANCES	This study proposes a vision model for individual colorimetric observers. The proposed model can be beneficial in many color-critical applications such as color grading and soft proofing to assess ranges of color matches instead of a single average match. We extended the CIE 2006 physiological observer by adding eight additional physiological parameters to model individual color-normal observers. These eight parameters control lens pigment density, macular pigment density, optical densities of L-, M-, and S-cone photopigments, and lambda(max) shifts of L-, M-, and S-cone photopigments. By identifying the variability of each physiological parameter, the model can simulate color matching functions among color-normal populations using Monte Carlo simulation. The variabilities of the eight parameters were identified through two steps. In the first step, extensive reviews of past studies were performed for each of the eight physiological parameters. In the second step, the obtained variabilities were scaled to fit a color matching dataset. The model was validated using three different datasets: traditional color matching, applied color matching, and Rayleigh matches.	[Asano, Yuta; Fairchild, Mark D.] Rochester Inst Technol, Munsell Color Sci Lab, Rochester, NY 14623 USA; [Asano, Yuta] Motorola Mobil, Chicago, IL USA; [Blonde, Laurent] Technicolor, Rennes, France	Rochester Institute of Technology; Legend Holdings; Lenovo; Technicolor SA	Fairchild, MD (corresponding author), Rochester Inst Technol, Munsell Color Sci Lab, Rochester, NY 14623 USA.	Mark.Fairchild@rit.edu	Blondé, Laurent/G-6233-2010	Blondé, Laurent/0000-0003-3112-7701	Technicolor	Technicolor	The funder (Technicolor) provided support in the form of salaries for an author (YA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section. Also, the author Yuta Asano is affiliated with a company "Motorola Mobility".	Alfvin RL, 1997, COLOR RES APPL, V22, P174, DOI 10.1002/(SICI)1520-6378(199706)22:3<174::AID-COL6>3.0.CO;2-O; Allen E., 1970, P 1 AIC C COL, P771; ALPERN M, 1979, J PHYSIOL-LONDON, V288, P85; Artigas JM, 2012, INVEST OPHTH VIS SCI, V53, P4076, DOI 10.1167/iovs.12-9471; Asano, 2015, THESIS ROCHESTER I T; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Berendschot TTJM, 2010, ESSENT OPHTHALMOL, P51, DOI 10.1007/978-3-540-85540-8_6; Berendschot TTJM, 2004, ARCH BIOCHEM BIOPHYS, V430, P149, DOI 10.1016/j.abb.2004.04.029; Berendschot TTJM, 1996, J PHYSIOL-LONDON, V492, P307, DOI 10.1113/jphysiol.1996.sp021310; Berendschot TTJM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1732, DOI 10.1001/archopht.120.12.1732; Berendschot TTJM, 2002, INVEST OPHTH VIS SCI, V43, P1928; Bone RA, 2003, J NUTR, V133, P992, DOI 10.1093/jn/133.4.992; Broekmans WMR, 2002, AM J CLIN NUTR, V76, P595, DOI 10.1093/ajcn/76.3.595; BURNS SA, 1993, J OPT SOC AM A, V10, P221, DOI 10.1364/JOSAA.10.000221; BURNS SA, 1985, J OPT SOC AM A, V2, P698, DOI 10.1364/JOSAA.2.000698; CIE, 1989, CIE PUBL, V80; CIE, 2006, CIE PUBL, V170; Ciulla TA, 2001, OPHTHALMOLOGY, V108, P730, DOI 10.1016/S0161-6420(00)00655-2; COOK CA, 1994, VISION RES, V34, P2945, DOI 10.1016/0042-6989(94)90266-6; CVRL, STIL BURCH IND COL M; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; Delori FC, 2001, J OPT SOC AM A, V18, P1212, DOI 10.1364/JOSAA.18.001212; DENATALE R, 1992, INT OPHTHALMOL, V16, P1; DENATALE R, 1988, OPHTHALMOLOGICA, V197, P14, DOI 10.1159/000309911; ELSNER AE, 1988, J OPT SOC AM A, V5, P2106, DOI 10.1364/JOSAA.5.002106; Fairchild Mark D., 2013, Twenty-first Color and Imaging Conference. Color Science and Engineering Systems, Technologies, and Applications (CIC21). Proceedings, P185; Fairchild MD, 1996, OSA ANN M ROCH, V126; Hammond BR, 2005, OPTOMETRY VISION SCI, V82, P387, DOI 10.1097/01.OPX.0000162652.85875.D2; Hammond BR, 1996, VISION RES, V36, P2001, DOI 10.1016/0042-6989(95)00290-1; Hammond BR, 2000, INVEST OPHTH VIS SCI, V41, P1492; Hammond BR, 1999, OPHTHAL PHYSL OPT, V19, P300, DOI 10.1046/j.1475-1313.1999.00444.x; Heckaman RL, 2015, COLOR RES A IN PRESS; Howells O, 2013, INVEST OPHTH VIS SCI, V54, P2711, DOI 10.1167/iovs.12-10957; Howells O, 2011, GRAEF ARCH CLIN EXP, V249, P315, DOI 10.1007/s00417-010-1577-5; Iannaccone A, 2007, INVEST OPHTH VIS SCI, V48, P1458, DOI 10.1167/iovs.06-0438; JOHNSON CA, 1993, OPTOMETRY VISION SCI, V70, P944, DOI 10.1097/00006324-199311000-00012; KEUNEN JEE, 1987, INVEST OPHTH VIS SCI, V28, P985; Liew SHM, 2005, INVEST OPHTH VIS SCI, V46, P4430, DOI 10.1167/iovs.05-0519; LUTZE M, 1991, INVEST OPHTH VIS SCI, V32, P194; MCSL, MUNS COL SCI LAB US; MCSL, MUNSELL COLOR SCIENC; MELLERIO J, 1971, VISION RES, V11, P129, DOI 10.1016/0042-6989(71)90229-X; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; Moreland JD, 1997, DOC OPHTH P, V59, P363; NAYATANI Y, 1983, COLOR RES APPL, V8, P47, DOI 10.1002/col.5080080110; NEITZ J, 1990, VISION RES, V30, P621, DOI 10.1016/0042-6989(90)90073-T; Neitz J, 1999, NAT NEUROSCI, V2, P884, DOI 10.1038/13185; NEITZ J, 1993, VISION RES, V33, P117, DOI 10.1016/0042-6989(93)90064-4; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Nolan J, 2004, INVEST OPHTH VIS SCI, V45, P3940, DOI 10.1167/iovs.04-0273; Nolan JM, 2007, EXP EYE RES, V84, P61, DOI 10.1016/j.exer.2006.08.016; NORREN DV, 1974, VISION RES, V14, P1237, DOI 10.1016/0042-6989(74)90222-3; NORTH AD, 1993, COLOR RES APPL, V18, P163, DOI 10.1002/col.5080180306; OHTA N, 1985, COLOR RES APPL, V10, P156, DOI 10.1002/col.5080100304; POKORNY J, 1976, J OPT SOC AM, V66, P705, DOI 10.1364/JOSA.66.000705; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; Polo V, 1997, INT OPHTHALMOL, V20, P7; Renner AB, 2004, VISUAL NEUROSCI, V21, P827, DOI 10.1017/S0952523804216030; RICH DC, 1995, COLOR RES APPL, V20, P29, DOI 10.1002/col.5080200106; Rufer F, 2012, GRAEF ARCH CLIN EXP, V250, P1267, DOI 10.1007/s00417-012-1949-0; SANOCKI E, 1993, VISION RES, V33, P2139, DOI 10.1016/0042-6989(93)90012-L; Savage GL, 2001, OPTOMETRY VISION SCI, V78, P386, DOI 10.1097/00006324-200106000-00010; Sharpe LT, 1998, J NEUROSCI, V18, P10053; Sharpe LT, 2001, COLOR VISION GENES P; Stiles W. S., 1959, OPT ACTA, V6, P1, DOI [10.1080/713826267, DOI 10.1080/713826267]; Stockman A, 1999, VISION RES, V39, P2901, DOI 10.1016/S0042-6989(98)00225-9; Swanson WH, 1996, VISION RES, V36, P2079, DOI 10.1016/0042-6989(95)00280-4; Thurston GM, 1997, CURR EYE RES, V16, P197, DOI 10.1076/ceyr.16.3.197.15410; Trieschmann M, 2006, GRAEF ARCH CLIN EXP, V244, P1565, DOI 10.1007/s00417-006-0289-3; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; VANNORREN D, 1985, INVEST OPHTH VIS SCI, V26, P1014; WEBSTER MA, 1988, J OPT SOC AM A, V5, P1722, DOI 10.1364/JOSAA.5.001722; WERNER JS, 1982, J OPT SOC AM, V72, P247, DOI 10.1364/JOSA.72.000247; Whitehead AJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1038, DOI 10.1001/archopht.124.7.1038; Wild JM, 1998, INVEST OPHTH VIS SCI, V39, P54; Wustemeyer H, 2003, GRAEF ARCH CLIN EXP, V241, P647, DOI 10.1007/s00417-003-0730-9; WYSZECKI G, 1980, VISION RES, V20, P23, DOI 10.1016/0042-6989(80)90138-8; Wyszecki G, 1982, COLOR SCI, Vsecond	79	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0145671	10.1371/journal.pone.0145671	http://dx.doi.org/10.1371/journal.pone.0145671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862905	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600008
J	Diaz, P; Sibley, CP; Greenwood, SL				Diaz, Paula; Sibley, Colin P.; Greenwood, Susan L.			Oxygen-Sensitive K+ Channels Modulate Human Chorionic Gonadotropin Secretion from Human Placental Trophoblast	PLOS ONE			English	Article							OXIDATIVE STRESS; HUMAN CYTOTROPHOBLAST; VILLOUS EXPLANTS; CA2+ ENTRY; EXPRESSION; APOPTOSIS; DIFFERENTIATION; PREECLAMPSIA; HCG; SYNCYTIOTROPHOBLAST	Human chorionic gonadotropin (hCG) is a key autocrine/paracrine regulator of placental syncytiotrophoblast, the transport epithelium of the human placenta. Syncytiotrophoblast hCG secretion is modulated by the partial pressure of oxygen (pO(2)), reactive oxygen species (ROS) and potassium (K+) channels. Here we test the hypothesis that K+ channels mediate the effects of pO(2) and ROS on hCG secretion. Placental villous explants from normal term pregnancies were cultured for 6 days at 6% (normoxia), 21% (hyperoxia) or 1% (hypoxia) pO(2). On days 3-5, explants were treated with 5mM 4-aminopyridine (4-AP) or tetraethylammonium (TEA), blockers of pO(2)-sensitive voltage-gated K+ (K-V) channels, or ROS (10-1000 mu M H2O2). hCG secretion and lactate dehydrogenase (LDH) release, a marker of necrosis, were determined daily. At day 6, hCG and LDH were measured in tissue lysate and Rb-86 (K+) efflux assessed to estimate syncytiotrophoblast K+ permeability. hCG secretion and Rb-86 efflux were significantly greater in explants maintained in 21% pO(2) than normoxia. 4-AP/TEA inhibited hCG secretion to a greater extent at 21% than 6% and 1% pO(2), and reduced Rb-86 efflux at 21% but not 6% pO(2). LDH release and tissue LDH/hCG were similar in 6%, 21% and 1% pO(2) and unaffected by 4-AP/TEA. H2O2 stimulated Rb-86 efflux and hCG secretion at normoxia but decreased Rb-86 efflux, without affecting hCG secretion, at 21% pO(2). 4-AP/TEA-sensitive K+ channels participate in pO(2)-sensitive hCG secretion from syncytiotrophoblast. ROS effects on both hCG secretion and Rb-86 efflux are pO(2)-dependent but causal links between the two remain to be established.	[Diaz, Paula; Sibley, Colin P.; Greenwood, Susan L.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Diaz, Paula; Sibley, Colin P.; Greenwood, Susan L.] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester, Lancs, England	University of Manchester; University of Manchester	Diaz, P (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.; Diaz, P (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester, Lancs, England.	pdiaztm@gmail.com	DIAZ, PAULA/ABG-5263-2021	DIAZ, PAULA/0000-0003-1479-7340	Tommy's, the baby charity; CONICYT-Becas Chile [72090593]; Action Medical Research	Tommy's, the baby charity; CONICYT-Becas Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Action Medical Research	This work was supported by Tommy's, the baby charity, CONICYT-Becas Chile 72090593 and Action Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Appiah I, 2009, BRIT J PHARMACOL, V158, P1932, DOI 10.1111/j.1476-5381.2009.00490.x; Archer SL, 2004, BIOL CHEM, V385, P205, DOI 10.1515/BC.2004.014; Aris AK, 2007, CLIN BIOCHEM, V40, P94, DOI 10.1016/j.clinbiochem.2006.10.008; BOYD CAR, 1983, CIBA F SYMP, V95, P300; BROWN PD, 1993, PLACENTA, V14, P103, DOI 10.1016/S0143-4004(05)80253-X; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Cindrova-Davies T, 2009, PLACENTA, V30, pS55, DOI 10.1016/j.placenta.2008.11.020; Clarson LH, 2003, J PHYSIOL-LONDON, V550, P515, DOI 10.1113/jphysiol.2003.044149; Clarson LH, 2002, J PHYSL; Corcoran J, 2008, HYPERTENS PREGNANCY, V27, P75, DOI 10.1080/10641950701826158; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; Crocker IP, 2004, J HISTOCHEM CYTOCHEM, V52, P749, DOI 10.1369/jhc.3A6176.2004; CRONIER L, 1994, ENDOCRINOLOGY, V135, P402, DOI 10.1210/en.135.1.402; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Hempstock J, 2003, PLACENTA, V24, P517, DOI 10.1053/plac.2002.0955; Higgins L, 2013, J MATERN-FETAL NEO M, V26, P783, DOI 10.3109/14767058.2012.760539; HSU CD, 1994, AM J OBSTET GYNECOL, V170, P1135, DOI 10.1016/S0002-9378(94)70108-3; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Huppertz B, 2014, J REPROD IMMUNOL, V101, P74, DOI 10.1016/j.jri.2013.04.003; Kharfi A, 2005, CLIN BIOCHEM, V38, P717, DOI 10.1016/j.clinbiochem.2005.04.011; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Lacey H, 2005, THE JOURNAL OF PHYSI, V565P, pPC173; Lim KH, 1997, AM J PATHOL, V151, P1809; Longtine MS, 2012, PLACENTA, V33, P971, DOI 10.1016/j.placenta.2012.09.013; Longtine MS, 2012, REPRODUCTION, V143, P107, DOI 10.1530/REP-11-0340; Lybaert P, 2013, PLACENTA, V34, P467, DOI 10.1016/j.placenta.2013.03.006; MEURIS S, 1994, BBA-MOL CELL RES, V1220, P101, DOI 10.1016/0167-4889(94)90124-4; Moll SJ, 2007, APOPTOSIS, V12, P1611, DOI 10.1007/s10495-007-0092-6; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Platoshyn O, 2001, AM J PHYSIOL-LUNG C, V280, pL801, DOI 10.1152/ajplung.2001.280.4.L801; Poston L, 2011, AM J CLIN NUTR, V94, p1980S, DOI 10.3945/ajcn.110.001156; Raijmakers MTM, 2005, CURR PHARM DESIGN, V11, P711, DOI 10.2174/1381612053381837; Rogers PA, 2007, AM J PHYSIOL-HEART C, V292, pH1404, DOI 10.1152/ajpheart.00696.2006; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Takagi Y, 2004, VIRCHOWS ARCH, V444, P49, DOI 10.1007/s00428-003-0903-2; Turner MA, 2006, PLACENTA, V27, P98, DOI 10.1016/j.placenta.2004.12.004; Wang YP, 1996, J SOC GYNECOL INVEST, V3, P179, DOI 10.1016/1071-5576(96)00015-9; Weedon-Fekjraer MS, 2012, PLACENTA, V33, pS87, DOI 10.1016/j.placenta.2011.11.003; Williams JLR, 2008, AM J PHYSIOL-REG I, V295, pR1204, DOI 10.1152/ajpregu.00193.2008; Williams JLR, 2009, REPROD SCI, V16, p346A; Yoshida Yoshinobu, 2005, Medical Molecular Morphology, V38, P104, DOI 10.1007/s00795-004-0258-z	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149021	10.1371/journal.pone.0149021	http://dx.doi.org/10.1371/journal.pone.0149021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863525	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600140
J	Hoffmann, A; Kunze, R; Helluy, X; Milford, D; Heiland, S; Bendszus, M; Pham, M; Marti, HH				Hoffmann, Angelika; Kunze, Reiner; Helluy, Xavier; Milford, David; Heiland, Sabine; Bendszus, Martin; Pham, Mirko; Marti, Hugo H.			High-Field MRI Reveals a Drastic Increase of Hypoxia-Induced Microhemorrhages upon Tissue Reoxygenation in the Mouse Brain with Strong Predominance in the Olfactory Bulb	PLOS ONE			English	Article							ALTITUDE CEREBRAL EDEMA; ACUTE MOUNTAIN-SICKNESS; ENDOTHELIAL-CELLS; BARRIER PERMEABILITY; VASCULAR LEAKAGE; RAT; EXPRESSION; MICROSCOPY; STRESS	Human pathophysiology of high altitude hypoxic brain injury is not well understood and research on the underlying mechanisms is hampered by the lack of well-characterized animal models. In this study, we explored the evolution of brain injury by magnetic resonance imaging (MRI) and histological methods in mice exposed to normobaric hypoxia at 8% oxygen for 48 hours followed by rapid reoxygenation and incubation for further 24 h under normoxic conditions. T2*-, diffusion-weighted and T2-relaxometry MRI was performed before exposure, immediately after 48 hours of hypoxia and 24 hours after reoxygenation. Cerebral microhemorrhages, previously described in humans suffering from severe high altitude cerebral edema, were also detected in mice upon hypoxia-reoxygenation with a strong region-specific clustering in the olfactory bulb, and to a lesser extent, in the basal ganglia and cerebral white matter. The number of microhemorrhages determined immediately after hypoxia was low, but strongly increased 24 hours upon onset of reoxygenation. Histologically verified microhemorrhages were exclusively located around cerebral microvessels with disrupted interendothelial tight junction protein ZO-1. In contrast, quantitative T2 and apparent-diffusion-coefficient values immediately after hypoxia and after 24 hours of reoxygenation did not show any region-specific alteration, consistent with subtle multifocal but not with regional or global brain edema.	[Hoffmann, Angelika; Bendszus, Martin; Pham, Mirko] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Kunze, Reiner; Marti, Hugo H.] Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; [Helluy, Xavier; Milford, David; Heiland, Sabine] Univ Heidelberg Hosp, Dept Neuroradiol, Div Expt Radiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hoffmann, A (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany.; Marti, HH (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany.	angelika.hoffmann@med.uni-heidelberg.de; hugo.marti@physiologie.uni-heidelberg.de	Hoffmann, Ary/R-2972-2019; Pham, Mirko/AAI-8713-2020; Kunze, Reiner/K-8048-2019; Hoffmann, Angelika/E-5011-2019	Hoffmann, Ary/0000-0001-9497-7645; Kunze, Reiner/0000-0002-8428-1027; Hoffmann, Angelika/0000-0003-4552-0694; Marti, Hugo/0000-0002-8456-334X	University of Heidelberg; Dietmar-Hopp Stiftung; Else Kroner-Fresenius-Stiftung; Else Kroner-Fresenius-Stiftung [2012_A171]	University of Heidelberg; Dietmar-Hopp Stiftung; Else Kroner-Fresenius-Stiftung; Else Kroner-Fresenius-Stiftung	The expert technical assistance of Manuel Fischer, Maria Harlacher and Inge Keller is gratefully acknowledged. AH is supported by a postdoctoral fellowship of the University of Heidelberg, DM by a grant of the Dietmar-Hopp Stiftung, and MP by a memorial stipend of the Else Kroner-Fresenius-Stiftung. RK and HHM were supported by Else Kroner-Fresenius-Stiftung (2012_A171).	Barthelmes D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0011532; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Binienda Z, 1996, INT J DEV NEUROSCI, V14, P399; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; DICKINSON J, 1983, THORAX, V38, P646, DOI 10.1136/thx.38.9.646; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Fischer R, 2004, CEPHALALGIA, V24, P66, DOI 10.1111/j.1468-2982.2004.00619.x; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hackett PH, 2004, HIGH ALT MED BIOL, V5, P136, DOI 10.1089/1527029041352054; Hackett PH, 1999, WILD ENVIRON MED, V10, P97, DOI 10.1580/1080-6032(1999)010[0097:TCEOHA]2.3.CO;2; Hunt JS, 2013, J CEREBR BLOOD F MET, V33, P372, DOI 10.1038/jcbfm.2012.184; Kallenberg K, 2008, J CEREBR BLOOD F MET, V28, P1635, DOI 10.1038/jcbfm.2008.55; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; Lai JCK, 2003, NEUROCHEM RES, V28, P933, DOI 10.1023/A:1023235712524; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Luks AM, 2014, WILD ENVIRON MED, V25, pS4, DOI 10.1016/j.wem.2014.06.017; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Mairer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050334; Martin SF, 2005, VASC PHARMACOL, V43, P148, DOI 10.1016/j.vph.2005.05.002; Natah SS, 2009, J APPL PHYSIOL, V107, P1348, DOI 10.1152/japplphysiol.91484.2008; Park SH, 2008, MAGN RESON MED, V59, P855, DOI 10.1002/mrm.21573; Patir H, 2012, FREE RADICAL BIO MED, V53, P659, DOI 10.1016/j.freeradbiomed.2012.06.010; Roach RC, 2001, J EXP BIOL, V204, P3161; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schommer K, 2013, NEUROLOGY, V81, P1776, DOI 10.1212/01.wnl.0000435563.84986.78; Schoonman GG, 2008, J CEREBR BLOOD F MET, V28, P198, DOI 10.1038/sj.jcbfm.9600513; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Williams RW, 2001, BEHAV GENET, V31, P61, DOI 10.1023/A:1010209925783; Wilson MH, 2013, ANN NEUROL, V73, P381, DOI 10.1002/ana.23796; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Witt KA, 2008, MICROVASC RES, V75, P91, DOI 10.1016/j.mvr.2007.06.004; Yu BT, 2013, HIGH ALT MED BIOL, V14, P61, DOI 10.1089/ham.2012.1080; Yu G, 2007, MICROCIRCULATION, V14, P125, DOI 10.1080/10739680601131218; Yu G, 2010, FREE RADICAL BIO MED, V49, P1008, DOI 10.1016/j.freeradbiomed.2010.06.005; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080749; Zulueta JJ, 1997, AM J PHYSIOL-LUNG C, V272, pL897, DOI 10.1152/ajplung.1997.272.5.L897	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148441	10.1371/journal.pone.0148441	http://dx.doi.org/10.1371/journal.pone.0148441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863147	Green Published, gold			2022-12-26	WOS:000370046600073
J	Singer, BH; Newstead, MW; Zeng, XY; Cooke, CL; Thompson, RC; Singer, K; Ghantasala, R; Parent, JM; Murphy, GG; Iwashyna, TJ; Standiford, TJ				Singer, Benjamin H.; Newstead, Michael W.; Zeng, Xianying; Cooke, Christopher L.; Thompson, Robert C.; Singer, Kanakadurga; Ghantasala, Ramya; Parent, Jack M.; Murphy, Geoffrey G.; Iwashyna, Theodore J.; Standiford, Theodore J.			Cecal Ligation and Puncture Results in Long-Term Central Nervous System Myeloid Inflammation	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; POSTTRAUMATIC-STRESS-DISORDER; NECROSIS-FACTOR-ALPHA; COGNITIVE IMPAIRMENT; MICROGLIAL ACTIVATION; MACROPHAGE POLARIZATION; SEVERE SEPSIS; LUNG INJURY; EXPRESSION; FEAR	Survivors of sepsis often experience long-term cognitive and functional decline. Previous studies utilizing lipopolysaccharide injection and cecal ligation and puncture in rodent models of sepsis have demonstrated changes in depressive-like behavior and learning and memory after sepsis, as well as evidence of myeloid inflammation and cytokine expression in the brain, but the long-term course of neuroinflammation after sepsis remains unclear. Here, we utilize cecal ligation and puncture with greater than 80% survival as a model of sepsis. We found that sepsis survivor mice demonstrate deficits in extinction of conditioned fear, but no acquisition of fear conditioning, nearly two months after sepsis. These cognitive changes occur in the absence of neuronal loss or changes in synaptic density in the hippocampus. Sepsis also resulted in infiltration of monocytes and neutrophils into the CNS at least two weeks after sepsis in a CCR2 independent manner. Cellular inflammation is accompanied by long-term expression of pro-inflammatory cytokine and chemokine genes, including TNFa and CCR2 ligands, in whole brain homogenates. Gene expression analysis of microglia revealed that while microglia do express anti-microbial genes and damage-associated molecular pattern molecules of the S100A family of genes at least 2 weeks after sepsis, they do not express the cytokines observed in whole brain homogenates. Our results indicate that in a naturalistic model of infection, sepsis results in long-term neuroinflammation, and that this sustained inflammation is likely due to interactions among multiple cell types, including resident microglia and peripherally derived myeloid cells.	[Singer, Benjamin H.; Newstead, Michael W.; Zeng, Xianying; Ghantasala, Ramya; Iwashyna, Theodore J.; Standiford, Theodore J.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Cooke, Christopher L.; Thompson, Robert C.; Murphy, Geoffrey G.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Singer, Kanakadurga] Univ Michigan, Sch Med, Dept Pediat, Div Endocrinol & Metab, Ann Arbor, MI USA; [Parent, Jack M.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Murphy, Geoffrey G.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Iwashyna, Theodore J.] VA Ann Arbor Hlth Syst, Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Singer, BH (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA.	singerb@med.umich.edu	Singer, Benjamin/J-6330-2019	Singer, Benjamin/0000-0002-4721-6920; Singer, Kanakadurga/0000-0001-8278-3800	National Heart Lungs and Blood Institute [T32 HL007749, R01 HL123515]; University of Michigan Depression Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123515, T32HL007749] Funding Source: NIH RePORTER	National Heart Lungs and Blood Institute; University of Michigan Depression Center(University of Michigan System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	BHS is supported by National Heart Lungs and Blood Institute T32 HL007749. This work was supported by National Heart Lungs and Blood Institute R01 HL123515 to TJS and a Strategic Translational Research Award from the University of Michigan Depression Center to BHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aguliar-Valles A, 2014, MOL PSYCHIATR, V19, P599, DOI 10.1038/mp.2013.137; Anderson ST, 2015, BRAIN BEHAV IMMUN, V43, P98, DOI 10.1016/j.bbi.2014.07.007; Anderson ST, 2013, LONG LASTING ACUTE E; Araujo CV, 2012, MICROVASC RES, V84, P218, DOI 10.1016/j.mvr.2012.05.006; Ballinger MN, 2012, J IMMUNOL, V189, P356, DOI 10.4049/jimmunol.1103124; Bard F, 2012, EXP NEUROL, V238, P38, DOI 10.1016/j.expneurol.2012.07.022; Barichello T, 2007, BRAZ J MED BIOL RES, V40, P831, DOI 10.1590/S0100-879X2007000600013; Barichello T, 2005, CRIT CARE MED, V33, P1671, DOI 10.1097/01.CCM.0000170192.54682.C1; Barichello T, 2005, CRIT CARE MED, V33, P221, DOI 10.1097/01.CCM.0000150741.12906.BD; Bienvenu OJ, 2013, PSYCHOL MED, V43, P2657, DOI 10.1017/S0033291713000214; Boer KR, 2007, CRIT CARE, V11, DOI 10.1186/cc5710; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Calsavara AC, 2015, METAB BRAIN DIS, V30, P669, DOI 10.1007/s11011-014-9610-8; Calsavara AC, 2013, NEUROTOX RES, V24, P103, DOI 10.1007/s12640-012-9364-1; Catlow BJ, 2013, EXP BRAIN RES, V228, P481, DOI 10.1007/s00221-013-3579-0; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115828; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Comim CM, 2011, INTENS CARE MED, V37, P711, DOI 10.1007/s00134-011-2151-2; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donzis EJ, 2014, NEUROBIOL LEARN MEM, V115, P68, DOI 10.1016/j.nlm.2014.08.008; Drevets DA, 2010, BRAIN BEHAV IMMUN, V24, P919, DOI 10.1016/j.bbi.2010.02.011; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Frank MG, 2006, J NEUROSCI METH, V151, P121, DOI 10.1016/j.jneumeth.2005.06.026; Fu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106331; Gallaher ZR, 2012, NEUROSCI LETT, V513, P31, DOI 10.1016/j.neulet.2012.01.079; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Guyon A, 2009, NEUROSCIENCE, V162, P1072, DOI 10.1016/j.neuroscience.2009.05.048; Harkness KA, 2003, J NEUROIMMUNOL, V142, P1, DOI 10.1016/S0165-5728(03)00251-0; Hofer S, 2008, J SURG RES, V146, P276, DOI 10.1016/j.jss.2007.07.021; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5707; Jackson JC, 2010, AM J RESP CRIT CARE, V182, P183, DOI 10.1164/rccm.200903-0442OC; Karrer M, 2015, BRAIN BEHAV IMMUN, V47, P186, DOI 10.1016/j.bbi.2014.11.008; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kondo S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-27; Kutlu MG, 2014, BEHAV BRAIN RES, V263, P133, DOI 10.1016/j.bbr.2014.01.031; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Larochelle A, 2015, BRAIN BEHAV IMMUN, V46, P221, DOI 10.1016/j.bbi.2015.02.019; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Lu SM, 2015, BRAIN BEHAV IMMUN, V44, P221, DOI 10.1016/j.bbi.2014.10.011; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Michels M, 2015, BRAIN BEHAV IMMUN, V43, P54, DOI 10.1016/j.bbi.2014.07.002; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Moraes CA, 2015, MOL NEUROBIOL, V52, P653, DOI 10.1007/s12035-014-8868-5; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Nakajima A, 2004, J NEUROSCI, V24, P2212, DOI 10.1523/JNEUROSCI.4847-03.2004; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Ponnusamy R, 2005, LEARN MEMORY, V12, P399, DOI 10.1101/lm.96605; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; SEITZ RJ, 1985, ACTA NEUROPATHOL, V68, P15, DOI 10.1007/BF00688950; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Starickova EA, 2011, B EXP BIOL MED+, V150, P446, DOI 10.1007/s10517-011-1165-7; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Tuon L, 2008, INTENS CARE MED, V34, P1724, DOI 10.1007/s00134-008-1129-1; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wache C, 2015, J INFECT DIS, V212, P247, DOI 10.1093/infdis/jiv028; Wakida N, 2014, J PHARMACOL SCI, V125, P68, DOI 10.1254/jphs.14032FP; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009; Woolley CS, 1997, J NEUROSCI, V17, P1848	78	56	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149136	10.1371/journal.pone.0149136	http://dx.doi.org/10.1371/journal.pone.0149136			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862765	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600160
J	Verma, S; Grover, S; Tyagi, C; Goyal, S; Jamal, S; Singh, A; Grover, A				Verma, Sharad; Grover, Sonam; Tyagi, Chetna; Goyal, Sukriti; Jamal, Salma; Singh, Aditi; Grover, Abhinav			Hydrophobic Interactions Are a Key to MDM2 Inhibition by Polyphenols as Revealed by Molecular Dynamics Simulations and MM/PBSA Free Energy Calculations	PLOS ONE			English	Article							P53; BINDING; PROTEIN; ANTAGONISTS; ACTIVATION; MECHANICS; GROMACS; CANCER; TOOL	p53, a tumor suppressor protein, has been proven to regulate the cell cycle, apoptosis, and DNA repair to prevent malignant transformation. MDM2 regulates activity of p53 and inhibits its binding to DNA. In the present study, we elucidated the MDM2 inhibition potential of polyphenols (Apigenin, Fisetin, Galangin and Luteolin) by MD simulation and MM/PBSA free energy calculations. All polyphenols bind to hydrophobic groove of MDM2 and the binding was found to be stable throughout MD simulation. Luteolin showed the highest negative binding free energy value of -173.80 kJ/mol followed by Fisetin with value of -172.25 kJ/mol. It was found by free energy calculations, that hydrophobic interactions (vdW energy) have major contribution in binding free energy.	[Verma, Sharad; Tyagi, Chetna; Grover, Abhinav] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Grover, Sonam] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi, India; [Goyal, Sukriti; Jamal, Salma] Banasthali Vidyapith, Dept Biosci & Biotechnol, Tonk, Rajasthan, India; [Singh, Aditi] TERI Univ, Dept Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Banasthali Vidyapith; TERI University	Grover, A (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India.	abhinavgr@gmail.com	Tyagi, Chetna/CAH-0155-2022	Tyagi, Chetna/0000-0001-7067-4770; verma, sharad/0000-0002-9261-6878; Singh, Aditi/0000-0001-7438-2863				AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bautista AD, 2010, J AM CHEM SOC, V132, P2904, DOI 10.1021/ja910715u; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Birt DF, 1997, ANTICANCER RES, V17, P85; Bozzi F, 2013, LAB INVEST, V93, P1232, DOI 10.1038/labinvest.2013.107; Dastidar SG, 2009, BMC BIOINF P; Fasan R, 2004, ANGEW CHEM INT EDIT, V43, P2109, DOI 10.1002/anie.200353242; Fu T, 2012, INT J MOL SCI, V13, P9709, DOI 10.3390/ijms13089709; Gosu V, 2014, SCI REP-UK, V4, DOI 10.1038/srep05748; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kimira M, 1998, J Epidemiol, V8, P168; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kritzer JA, 2004, J AM CHEM SOC, V126, P9468, DOI 10.1021/ja031625a; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee SB, 2007, BIOL PHARM BULL, V30, P1074, DOI 10.1248/bpb.30.1074; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Miyajima Y, 2004, BIOFACTORS, V21, P301; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pishas KI, 2011, CLIN CANCER RES, V17, P494, DOI 10.1158/1078-0432.CCR-10-1587; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seelinger G, 2008, MOLECULES, V13, P2628, DOI 10.3390/molecules13102628; Seufi AM, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-80; Sonnemann J, 2011, EUR J CANCER, V47, P1432, DOI 10.1016/j.ejca.2011.01.015; Stoll R, 2001, BIOCHEMISTRY-US, V40, P336, DOI 10.1021/bi000930v; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; van Gunsteren W. F., 1998, ENCY COMPUTATIONAL C, V2, P1211, DOI DOI 10.1002/0470845015.CGA011; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verma S, 2013, MED CHEM RES, V22, P2778, DOI 10.1007/s00044-012-0274-9; Verma S, 2013, MOL INFORM, V32, P203, DOI 10.1002/minf.201200113; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yamaguchi H, 1998, NUCLEIC ACIDS RES, V26, P1939, DOI 10.1093/nar/26.8.1939; Zauli G, 2007, J BONE MINER RES, V22, P1621, DOI 10.1359/JBMR.070618; Zhao JH, 2002, CANCER LETT, V183, P69, DOI 10.1016/S0304-3835(02)00084-8	44	81	83	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149014	10.1371/journal.pone.0149014	http://dx.doi.org/10.1371/journal.pone.0149014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863418	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600139
J	Ku, LJE; Pai, MC; Shih, PY				Ku, Li-Jung Elizabeth; Pai, Ming-Chyi; Shih, Pei-Yu			Economic Impact of Dementia by Disease Severity: Exploring the Relationship between Stage of Dementia and Cost of Care in Taiwan	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INFORMAL CARE; ASIAN COUNTRY; MILD	Objective Given the shortage of cost-of-illness studies in dementia outside of the Western population, the current study estimated the annual cost of dementia in Taiwan and assessed whether different categories of care costs vary by severity using multiple disease-severity measures. Methods This study included 231 dementia patient-caregiver dyads in a dementia clinic at a national university hospital in southern Taiwan. Three disease measures including cognitive, functional, and behavioral disturbances were obtained from patients based on medical history. A societal perspective was used to estimate the total costs of dementia according to three cost sub-categories. The association between dementia severity and cost of care was examined through bivariate and multivariate analyses. Results Total costs of care for moderate dementia patient were 1.4 times the costs for mild dementia and doubled from mild to severe dementia among our community-dwelling dementia sample. Multivariate analysis indicated that functional declines had a greater impact on all cost outcomes as compared to behavioral disturbance, which showed no impact on any costs. Informal care costs accounted for the greatest share in total cost of care for both mild (42%) and severe (43%) dementia patients. Conclusions Since the total costs of dementia increased with severity, providing care to delay disease progression, with a focus on maintaining patient physical function, may reduce the overall cost of dementia. The greater contribution of informal care to total costs as opposed to social care also suggests a need for more publicly-funded long-term care services to assist family caregivers of dementia patients in Taiwan.	[Ku, Li-Jung Elizabeth; Shih, Pei-Yu] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Publ Hlth, Tainan 70101, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Behav Neurol,Dept Neurol, Tainan 70101, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ Hosp, Alzheimers Dis Res Ctr, Tainan 70428, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Ku, LJE (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Publ Hlth, Tainan 70101, Taiwan.	eljku@mail.ncku.edu.tw		Ku, Li-Jung Elizabeth/0000-0002-4644-8439	National Science Council [NSC 102-2410-H-006 -001 -SS2]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council (NSC 102-2410-H-006 -001 -SS2). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Benaim C., 2005, Annales de Readaptation et de Medecine Physique, V48, P336, DOI 10.1016/j.annrmp.2005.04.005; Bureau of National Health Insurance, 2013, REIMB RUL DRUGS ACT; Chan SWC, 2010, DEMENT GERIATR COGN, V30, P469, DOI 10.1159/000322086; Chong MS, 2013, INT PSYCHOGERIATR, V25, P1475, DOI 10.1017/S1041610213000707; Chou LF, 2000, NATIL CHENGCHI U J, V82, P1; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gerves C, 2014, HEALTH POLICY, V116, P114, DOI 10.1016/j.healthpol.2014.01.001; Hill J, 2006, PHARMACOECONOMICS, V24, P265, DOI 10.2165/00019053-200624030-00006; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; International Monetary Fund, WORLD EC OUTL DAT 20; Jonsson L, 2006, INT J GERIATR PSYCH, V21, P449, DOI 10.1002/gps.1489; Jonsson L, 2009, PHARMACOECONOMICS, V27, P391, DOI 10.2165/00019053-200927050-00004; Kuo YC, 2010, ARCH GERONTOL GERIAT, V51, P159, DOI 10.1016/j.archger.2009.10.001; Lafortune L, 2009, MED CARE, V47, P286, DOI 10.1097/MLR.0b013e3181894293; Leicht H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070018; Lim J, 2012, INT PSYCHOGERIATR, V24, P1571, DOI 10.1017/S1041610212000919; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Mauskopf J, 2010, J NUTR HEALTH AGING, V14, P655, DOI 10.1007/s12603-010-0312-6; Ministry of Health and Welfare, 2014, SOC WELF SUBS IT SCH; Neubauer S, 2008, INT PSYCHOGERIATR, V20, P1160, DOI 10.1017/S1041610208007564; Quentin W, 2010, ACTA PSYCHIAT SCAND, V121, P243, DOI 10.1111/j.1600-0447.2009.01461.x; Rapp T, 2012, VALUE HEALTH, V15, P412, DOI 10.1016/j.jval.2012.02.003; Schaller S, 2015, INT J GERIATR PSYCH, V30, P111, DOI 10.1002/gps.4198; Schwarzkopf L, 2011, VALUE HEALTH, V14, P827, DOI 10.1016/j.jval.2011.04.005; Small GW, 2002, J AM GERIATR SOC, V50, P321, DOI 10.1046/j.1532-5415.2002.50065.x; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; Thomas P, 2006, INT J GERIATR PSYCH, V21, P50, DOI 10.1002/gps.1422; Wimo A, 2010, WORLD ALZHEIMER REPO; Wimo A., 2015, WORLD ALZHEIMER REPO; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P429, DOI 10.1016/j.jalz.2012.06.008; Zhu CW, 2008, DEMENT GERIATR COGN, V26, P416, DOI 10.1159/000164797	35	27	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148779	10.1371/journal.pone.0148779	http://dx.doi.org/10.1371/journal.pone.0148779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859891	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400082
J	Nakayama-Imaohji, H; Hirota, K; Yamasaki, H; Yoneda, S; Nariya, H; Suzuki, M; Secher, T; Miyake, Y; Oswald, E; Hayashi, T; Kuwahara, T				Nakayama-Imaohji, Haruyuki; Hirota, Katsuhiko; Yamasaki, Hisashi; Yoneda, Saori; Nariya, Hirofumi; Suzuki, Motoo; Secher, Thomas; Miyake, Yoichiro; Oswald, Eric; Hayashi, Tetsuya; Kuwahara, Tomomi			DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COMMENSAL BACTERIUM; SYMBIOTIC BACTERIA; GENE-EXPRESSION; PHASE VARIATION; SALMONELLA; MICROBIOTA; VIRULENCE; RNA; COLONIZATION	Phase changes in Bacteroides fragilis, a member of the human colonic microbiota, mediate variations in a vast array of cell surface molecules, such as capsular polysaccharides and outer membrane proteins through DNA inversion. The results of the present study show that outer membrane vesicle (OMV) formation in this anaerobe is also controlled by DNA inversions at two distantly localized promoters, IVp-I and IVp-II that are associated with extracellular polysaccharide biosynthesis and the expression of outer membrane proteins. These promoter inversions are mediated by a single tyrosine recombinase encoded by BF2766 (orthologous to tsr19 in strain NCTC9343) in B. fragilis YCH46, which is located near IVp-I. A series of BF2766 mutants were constructed in which the two promoters were locked in different configurations (IVp-I/IVp-II = ON/ON, OFF/OFF, ON/OFF or OFF/ON). ON/ON B. fragilis mutants exhibited hypervesiculating, whereas the other mutants formed only a trace amount of OMVs. The hypervesiculating ON/ON mutants showed higher resistance to treatment with bile, LL-37, and human beta-defensin 2. Incubation of wild-type cells with 5% bile increased the population of cells with the ON/ON genotype. These results indicate that B. fragilis regulates the formation of OMVs through DNA inversions at two distantly related promoter regions in response to membrane stress, although the mechanism underlying the interplay between the two regions controlled by the invertible promoters remains unknown.	[Nakayama-Imaohji, Haruyuki; Yoneda, Saori; Nariya, Hirofumi; Suzuki, Motoo; Kuwahara, Tomomi] Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa 7610793, Japan; [Hirota, Katsuhiko; Miyake, Yoichiro] Univ Tokushima, Inst Biomed Sci, Dept Oral Microbiol, Grad Sch, Tokushima 7708503, Japan; [Yamasaki, Hisashi] Wakayama Med Univ, Grad Sch Med, Dept Cellular & Mol Med, Wakayama 6418509, Japan; [Secher, Thomas; Oswald, Eric] Inserm UMR1043, Toulouse, France; [Secher, Thomas; Oswald, Eric] INRA USC 1360 Toulouse, Toulouse, France; [Secher, Thomas; Oswald, Eric] CNRS UMR5282 Toulouse, Toulouse, France; [Secher, Thomas; Oswald, Eric] Univ Toulouse, UPS, CPTP, Toulouse, France; [Oswald, Eric] CHU Toulouse, Hop Purpan, Serv Bacteriol Hyg, Toulouse, France; [Hayashi, Tetsuya] Kyushu Univ, Dept Bacteriol, Fac Med Sci, Fukuoka 8128582, Japan	Kagawa University; Tokushima University; Wakayama Medical University; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Kyushu University	Kuwahara, T (corresponding author), Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa 7610793, Japan.	tomomi@med.kagawa-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020; SECHER, Thomas/P-4795-2016	Oswald, Eric/0000-0002-3017-0081	KAKENHI [15K00822, 26460530]; Grants-in-Aid for Scientific Research [25460535] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-aid for Scientific Research (KAKENHI, www.jsps.go.jp/) to HNI (15K00822) and TK (26460530).	ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chatzidaki-Livanis M, 2008, J BACTERIOL, V190, P1020, DOI 10.1128/JB.01519-07; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Elhenawy W, 2014, MBIO, V5, DOI 10.1128/mBio.00909-14; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Goedhart J, 1999, BIOCHEMISTRY-US, V38, P10898, DOI 10.1021/bi990714q; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Ichimura M, 2014, J BASIC MICROB, V54, P558, DOI 10.1002/jobm.201200763; Ichimura M, 2010, APPL ENVIRON MICROB, V76, P3325, DOI 10.1128/AEM.02420-09; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kitagawa R, 2010, J BACTERIOL, V192, P5645, DOI 10.1128/JB.00590-10; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; KUTSUKAKE K, 1980, NATURE, V284, P479, DOI 10.1038/284479a0; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nakayama-Imaohji H, 2009, J BACTERIOL, V191, P6003, DOI 10.1128/JB.00687-09; PATRICK S, 1983, J MED MICROBIOL, V16, P239, DOI 10.1099/00222615-16-2-239; Prouty AM, 2004, MICROBIOL-SGM, V150, P775, DOI 10.1099/mic.0.26769-0; Pumbwe L, 2007, MICROB PATHOGENESIS, V43, P78, DOI 10.1016/j.micpath.2007.04.002; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramasundara M, 2009, J GASTROEN HEPATOL, V24, P202, DOI 10.1111/j.1440-1746.2008.05772.x; Rocha ER, 1997, J BACTERIOL, V179, P7033, DOI 10.1128/jb.179.22.7033-7039.1997; Roche-Hakansson H, 2007, J BACTERIOL, V189, P2119, DOI 10.1128/JB.01362-06; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Salyers AA, 1999, METHOD MICROBIOL, V29, P229; Sanchez B, 2005, J BACTERIOL, V187, P5799, DOI 10.1128/JB.187.16.5799-5808.2005; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; SILVERMAN M, 1980, CELL, V19, P845, DOI 10.1016/0092-8674(80)90075-6; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; VALENTINE PJ, 1988, J BACTERIOL, V170, P1319, DOI 10.1128/jb.170.3.1319-1324.1988; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Wakimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053829; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580; Weinacht KG, 2004, MOL MICROBIOL, V53, P1319, DOI 10.1111/j.1365-2958.2004.04219.x; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	48	12	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148887	10.1371/journal.pone.0148887	http://dx.doi.org/10.1371/journal.pone.0148887			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859882	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400100
J	Sun, HL; Tsai, WC; Li, BY; Tao, W; Chen, PS; Rubart, M				Sun, Hong-Li; Tsai, Wen-Chin; Li, Bai-Yan; Tao, Wen; Chen, Peng-Sheng; Rubart, Michael			Voltage-Induced Ca2+ Release in Postganglionic Sympathetic Neurons in Adult Mice	PLOS ONE			English	Article							2-AMINOETHOXYDIPHENYL BORATE; DIHYDROPYRIDINE RECEPTORS; RYANODINE RECEPTORS; CALCIUM-CHANNELS; RAT; EXCITATION; ACTIVATION; CADMIUM; SIGNAL; STORE	Recent studies have provided evidence that depolarization in the absence of extracellular Ca2+ can trigger Ca2+ release from internal stores in a variety of neuron subtypes. Here we examine whether postganglionic sympathetic neurons are able to mobilize Ca2+ from intracellular stores in response to depolarization, independent of Ca2+ influx. We measured changes in cytosolic Delta F/F-0 in individual fluo-4-loaded sympathetic ganglion neurons in response to maintained K+ depolarization in the presence (2 mM) and absence of extracellular Ca2+ ([Ca2+](e)). Progressive elevations in extracellular [K+](e) caused increasing membrane depolarizations that were of similar magnitude in 0 and 2 mM [Ca2+](e). Peak amplitude of Delta F/F-0 transients in 2 mM [Ca2+](e) increased in a linear fashion as the membrane become more depolarized. Peak elevations of Delta F/F-0 in 0 mM [Ca2+](e) were similar to 5-10% of those evoked at the same membrane potential in 2 mM [Ca2+](e) and exhibited an inverse U-shaped dependence on voltage. Both the rise and decay of Delta F/F-0 transients in 0 mM [Ca2+](e) were slower than those of Delta F/F-0 transients evoked in 2 mM [Ca2+](e). Rises in Delta F/F-0 evoked by high [K+](e) in the absence of extracellular Ca2+ were blocked by thapsigargin, an inhibitor of endoplasmic reticulum Ca2+ ATPase, or the inositol 1,4,5-triphosphate (IP3) receptor antagonists 2-aminoethoxydiphenyl borate and xestospongin C, but not by extracellular Cd2+, the dihydropyridine antagonist nifedipine, or by ryanodine at concentrations that caused depletion of ryanodine-sensitive Ca2+ stores. These results support the notion that postganglionic sympathetic neurons possess the ability to release Ca2+ from IP3-sensitive internal stores in response to membrane depolarization, independent of Ca2+ influx.	[Sun, Hong-Li; Tao, Wen; Rubart, Michael] Indiana Univ Sch Med, Riley Heart Res Ctr, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Sun, Hong-Li] Harbin Med Univ Daqing, Dept Pharmacol, Daqing, Heilongjiang, Peoples R China; [Tsai, Wen-Chin; Chen, Peng-Sheng] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Tsai, Wen-Chin; Chen, Peng-Sheng] Indiana Univ Sch Med, Div Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Tsai, Wen-Chin] Hualein Tzu Chi Gen Hosp, Dept Med, Div Cardiol, Hualein, Taiwan; [Li, Bai-Yan] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Harbin Medical University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Buddhist Tzu Chi General Hospital; Indiana University System; Indiana University-Purdue University Indianapolis	Rubart, M (corresponding author), Indiana Univ Sch Med, Riley Heart Res Ctr, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	mrubartv@iu.edu	Tsai, WEN-CHIN/AGY-3079-2022		National Natural Science Foundation of China [81202509]; National Heart, Lung and Blood Institute [R01HL07165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078931] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Natural Science Foundation of China (81202509, http://www.nsfc.gov.cn/) to HS and the National Heart, Lung and Blood Institute (R01HL07165, http://www.nhlbi.nih.gov/) to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita T, 2000, J GEN PHYSIOL, V116, P697, DOI 10.1085/jgp.116.5.697; Albrecht MA, 2001, J GEN PHYSIOL, V118, P83, DOI 10.1085/jgp.118.1.83; Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Beam KG, 2010, J GEN PHYSIOL, V136, P7, DOI 10.1085/jgp.201010461; BELLUZZI O, 1989, J PHYSIOL-LONDON, V412, P493, DOI 10.1113/jphysiol.1989.sp017628; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Blumenstein Y, 2004, J PHYSIOL-LONDON, V556, P121, DOI 10.1113/jphysiol.2003.056168; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; De Crescenzo V, 2006, J NEUROSCI, V26, P7565, DOI 10.1523/JNEUROSCI.1512-06.2006; Eltit JM, 2004, BIOPHYS J, V86, P3042, DOI 10.1016/S0006-3495(04)74353-2; Esteve E, 2010, J GEN PHYSIOL, V135, P619, DOI 10.1085/jgp.200910328; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HINKLE PM, 1992, J BIOL CHEM, V267, P25553; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Kukwa W, 1998, J AUTONOM NERV SYST, V74, P143, DOI 10.1016/S0165-1838(98)00154-4; Li BY, 2007, J NEUROSCI METH, V164, P75, DOI 10.1016/j.jneumeth.2007.04.003; Martinez-Pinna J, 2002, BRAIN RES, V951, P227, DOI 10.1016/S0006-8993(02)03165-7; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; Nimmrich V, 2012, BRIT J PHARMACOL, V167, P741, DOI 10.1111/j.1476-5381.2012.02069.x; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Parri HR, 1998, J NEUROSCI, V18, P854; PoloParada L, 1997, J GEN PHYSIOL, V109, P693, DOI 10.1085/jgp.109.6.693; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; THAYER SA, 1988, MOL PHARMACOL, V34, P664; Usai C, 1999, J NEUROCHEM, V72, P2154, DOI 10.1046/j.1471-4159.1999.0722154.x; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148962	10.1371/journal.pone.0148962	http://dx.doi.org/10.1371/journal.pone.0148962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859144	Green Published, gold			2022-12-26	WOS:000370038400110
J	Yu, YP; Pan, G; Gong, YY; Xu, KD; Zheng, NG; Hua, WD; Zheng, XX; Wu, ZH				Yu, Yipeng; Pan, Gang; Gong, Yongyue; Xu, Kedi; Zheng, Nenggan; Hua, Weidong; Zheng, Xiaoxiang; Wu, Zhaohui			Intelligence-Augmented Rat Cyborgs in Maze Solving	PLOS ONE			English	Article							REMOTE-CONTROL; BRAIN; NAVIGATION; REPRESENTATION; DIRECTION; MACHINE; ROBOTS	Cyborg intelligence is an emerging kind of intelligence paradigm. It aims to deeply integrate machine intelligence with biological intelligence by connecting machines and living beings via neural interfaces, enhancing strength by combining the biological cognition capability with the machine computational capability. Cyborg intelligence is considered to be a new way to augment living beings with machine intelligence. In this paper, we build rat cyborgs to demonstrate how they can expedite the maze escape task with integration of machine intelligence. We compare the performance of maze solving by computer, by individual rats, and by computer-aided rats (i.e. rat cyborgs). They were asked to find their way from a constant entrance to a constant exit in fourteen diverse mazes. Performance of maze solving was measured by steps, coverage rates, and time spent. The experimental results with six rats and their intelligence-augmented rat cyborgs show that rat cyborgs have the best performance in escaping from mazes. These results provide a proof-of-principle demonstration for cyborg intelligence. In addition, our novel cyborg intelligent system (rat cyborg) has great potential in various applications, such as search and rescue in complex terrains.	[Yu, Yipeng; Pan, Gang; Gong, Yongyue; Hua, Weidong; Wu, Zhaohui] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Kedi; Zheng, Nenggan; Zheng, Xiaoxiang] Qiushi Acad Adv Studies, Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Pan, G (corresponding author), Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	gpan@zju.edu.cn	Pan, Gang/B-5978-2013	Pan, Gang/0000-0002-4049-6181	National Key Basic Research Program of China [2013CB329504]; Zhejiang Provincial Natural Science Foundation of China [LR15F020001]; Program for New Century Excellent Talents in University [NCET-13-0521]	National Key Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work has been supported by National Key Basic Research Program of China (2013CB329504) (http://www.973.gov.cn/English/Index.aspx), Zhejiang Provincial Natural Science Foundation of China (LR15F020001) (http://www.zjnsf.gov.cn/), and Program for New Century Excellent Talents in University (NCET-13-0521) (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by National Key Basic Research Program of China (2013CB329504), Zhejiang Provincial Natural Science Foundation of China (LR15F020001), and Program for New Century Excellent Talents in University (NCET-13-0521). The authors are grateful to the editor and reviewers for their insightful comments. They also are pleased to thank Liqiang Gao, Liujing Zhuang, Shengzhang Lai for technical support and Chaonan Yu for the rat surgery.	Abelson H., 1981, TURTLE GEOMETRY; [Anonymous], 2004, BEHAV LAB RAT HDB TE; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; Berger TW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046017; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Chen N, 1996, PROC FRONT EDUC CONF, P1057, DOI 10.1109/FIE.1996.567748; Crenshaw DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117973; Cully A, 2015, NATURE, V521, P503, DOI 10.1038/nature14422; DiGiovanna J, 2009, IEEE T BIO-MED ENG, V56, P54, DOI 10.1109/TBME.2008.926699; Ejaz N, 2011, JOVE-J VIS EXP, V10, P218; Etienne S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096275; Feng ZY, 2007, J ZHEJIANG UNIV-SC A, V8, P323, DOI 10.1631/jzus.2007.A0323; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Holzer R., 1997, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robot and Systems. Innovative Robotics for Real-World Applications. IROS '97 (Cat. No.97CH36108), P1514, DOI 10.1109/IROS.1997.656559; Julia M, 2012, AUTON ROBOT, V33, P427, DOI 10.1007/s10514-012-9298-8; Khan AG, 2012, NATURE COMMUNICATION, V3, P23; Lee MG, 2010, BEHAV PROCESS, V84, P715, DOI 10.1016/j.beproc.2010.04.007; MATHER JG, 1981, NATURE, V291, P152, DOI 10.1038/291152a0; Milford MJ, 2008, IEEE T ROBOT, V24, P1038, DOI 10.1109/TRO.2008.2004520; Muheim R, 2006, LEARN BEHAV, V34, P366, DOI 10.3758/BF03193201; Nicolelis M. A. L., 2013, NATURE COMMUN, V4, P66; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; Phillips JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073112; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Sadik A. M. J., 2010, 2010 International Conference on Artificial Intelligence and Computational Intelligence (AICI 2010), P52, DOI 10.1109/AICI.2010.18; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Sun C, 2013, J BIONIC ENG, V10, P46, DOI 10.1016/S1672-6529(13)60198-5; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thrun S, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P944; Vasile C, 2010, IFAC P; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Wang YM, 2015, IEEE COMPUT INTELL M, V10, P42, DOI 10.1109/MCI.2015.2405318; Wen Y, 2015, MAGN RESON IMAGING, V33, P465, DOI 10.1016/j.mri.2015.01.013; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wu ZH, 2013, IEEE INTELL SYST, V28, P28, DOI 10.1109/MIS.2013.137; Xu Dongrong, 2012, Int J Virtual Real, V11, P63; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zhang SW, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00088; Zhang SW, 2000, LEARN MEMORY, V7, P363, DOI 10.1101/lm.32900	44	18	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147754	10.1371/journal.pone.0147754	http://dx.doi.org/10.1371/journal.pone.0147754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859299	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400012
J	Schwanz, LE; Robert, KA				Schwanz, Lisa E.; Robert, Kylie A.			Costs of Rearing the Wrong Sex: Cross-Fostering to Manipulate Offspring Sex in Tammar Wallabies	PLOS ONE			English	Article							LOCAL RESOURCE COMPETITION; MATERNAL INVESTMENT; MACROPUS-EUGENII; POUCH YOUNG; FACULTATIVE ADJUSTMENT; RATIO; ALLOCATION; LACTATION; SELECTION; TRIVERS	Sex allocation theory assumes that offspring sex (son vs. daughter) has consequences for maternal fitness. The most compelling experiment to test this theory would involve manipulating offspring sex and measuring the fitness consequences of having the "wrong" sex. Unfortunately, the logistical challenges of such an experiment limit its application. In tammar wallabies (Macropus eugenii), previous evidence suggests that mothers in good body condition are more likely to produce sons compared to mothers in poor condition, in support of the Trivers-Willard Hypothesis (TW) of condition-dependent sex allocation. More recently, we have found in our population of tammar wallabies that females with seemingly poor access to resources (based on condition loss over the dry summer) are more likely to produce sons, consistent with predictions from the Local Resource Competition (LRC) hypothesis, which proposes that production of sons or daughters is driven by the level of potential competition between mothers and philopatric daughters. We conducted a cross-fostering experiment in free-ranging tammar wallabies to disassociate the effects of rearing and birthing offspring of each sex. This allowed us to test the prediction of the LRC hypothesis that rearing daughters reduces the future direct fitness of mothers post-weaning and the prediction of the TW hypothesis that rearing sons requires more energy during lactation. Overall, we found limited costs to the mother of rearing the "wrong" sex, with switching of offspring sex only reducing the likelihood of a mother having a pouch young the following year. Thus, we found some support for both hypotheses in that rearing an unexpected son or an unexpected daughter both lead to reduced future maternal fitness. The study suggests that there may be context-specific costs associated with rearing the "wrong" sex.	[Schwanz, Lisa E.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Schwanz, Lisa E.] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Robert, Kylie A.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Robert, Kylie A.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Schwanz, Lisa E.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	James Cook University; University of Canberra; University of Western Australia; La Trobe University; University of New South Wales Sydney	Schwanz, LE (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Lisa.Schwanz@gmail.com	Robert, Kylie/C-5181-2009	Robert, Kylie/0000-0002-8554-8440	U.S. National Science Foundation International Research Fellowship [NSF IRFP 0754299]; University of Western Australia Postdoctoral Research Fellowship; University of Western Australia Research Grants Scheme; Australian Department of Defence	U.S. National Science Foundation International Research Fellowship(National Science Foundation (NSF)); University of Western Australia Postdoctoral Research Fellowship; University of Western Australia Research Grants Scheme; Australian Department of Defence(Australian Government)	The research was funded by an U.S. National Science Foundation International Research Fellowship (LES; NSF IRFP 0754299), a University of Western Australia Postdoctoral Research Fellowship (KAR), University of Western Australia Research Grants Scheme (KAR), and the Australian Department of Defence (KAR and LES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks SC, 2008, J ANIM ECOL, V77, P1250, DOI 10.1111/j.1365-2656.2008.01448.x; Blumstein DT, 1999, ANIM BEHAV, V58, P351, DOI 10.1006/anbe.1999.1156; Blumstein DT, 2002, ETHOLOGY, V108, P815, DOI 10.1046/j.1439-0310.2002.00813.x; Blumstein DT, 2002, ETHOLOGY, V108, P937, DOI 10.1046/j.1439-0310.2002.00823.x; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Chambers BK, 2009, THESIS U W AUSTR; Charnov EL, 1982, THEORY SEX ALLOCATIO; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; COCKBURN A, 1985, OECOLOGIA, V66, P427, DOI 10.1007/BF00378310; CORK SJ, 1991, J ZOOL, V225, P567, DOI 10.1111/j.1469-7998.1991.tb04325.x; CORK SJ, 1989, J ZOOL, V219, P399, DOI 10.1111/j.1469-7998.1989.tb02588.x; Cripps JK, 2011, BIOL LETTERS, V7, P859, DOI 10.1098/rsbl.2011.0526; CROFT DB, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P505; DICKMAN CR, 1988, AM NAT, V132, P289, DOI 10.1086/284851; Dusek A, 2011, BEHAV ECOL SOCIOBIOL, V65, P2209, DOI 10.1007/s00265-011-1229-8; EMLEN ST, 1986, AM NAT, V127, P1, DOI 10.1086/284463; Findlay L., 1984, Symposia of the Zoological Society of London, P403; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Gelin U, 2015, J ANIM ECOL, V84, P239, DOI 10.1111/1365-2656.12266; Gelin U, 2013, ANIM BEHAV, V86, P885, DOI 10.1016/j.anbehav.2013.08.016; Goltsman M, 2005, BEHAV ECOL SOCIOBIOL, V59, P198, DOI 10.1007/s00265-005-0025-8; GOWATY PA, 1985, AM NAT, V126, P347, DOI 10.1086/284421; GREEN B, 1988, AUST J ZOOL, V36, P217, DOI 10.1071/ZO9880217; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; HIRAIWAHASEGAWA M, 1993, TRENDS ECOL EVOL, V8, P395, DOI 10.1016/0169-5347(93)90040-V; Hynes EF, 2005, REPRODUCTION, V130, P123, DOI 10.1530/rep.1.00624; Inns R.W, 1980, ECOLOGY KANGAROO ISL; Isaac JL, 2005, J ANIM ECOL, V74, P552, DOI 10.1111/j.1365-2656.2005.00954.x; JOHNSON CN, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P593; Johnson CN, 2001, P ROY SOC B-BIOL SCI, V268, P2001, DOI 10.1098/rspb.2001.1723; Julliard R, 2000, BEHAV ECOL, V11, P421, DOI 10.1093/beheco/11.4.421; King WJ, 2015, ECOL EVOL, V5, P2084, DOI 10.1002/ece3.1498; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Koskela E, 2009, J ANIM ECOL, V78, P1007, DOI 10.1111/j.1365-2656.2009.01574.x; Le Gall-Payne C, 2015, BEHAV ECOL SOCIOBIOL, V69, P795, DOI 10.1007/s00265-015-1896-y; MacDonald AJ, 2013, HEREDITY, V2013, P1; Martin JGA, 2011, ECOLOGY, V92, P441, DOI 10.1890/09-2413.1; Miller EJ, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P77; Moore EPB, 2015, J MAMMAL, V96, P1203, DOI 10.1093/jmammal/gyv129; MYERS JH, 1978, AM NAT, V112, P381, DOI 10.1086/283280; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nager RG, 2000, BEHAV ECOL SOCIOBIOL, V48, P452, DOI 10.1007/s002650000262; Pelletier F, 2007, EVOLUTION, V61, P1969, DOI 10.1111/j.1558-5646.2007.00160.x; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Poole WE, 1991, TABLES AGE DETERMINA; Radersma R, 2011, ANIM BEHAV, V81, P69, DOI 10.1016/j.anbehav.2010.09.007; Robert KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1745; Robert KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051099; Robert KA, 2011, MAMMAL REV, V41, P1, DOI 10.1111/j.1365-2907.2010.00168.x; Robert KA, 2010, BIOL LETTERS, V6, P242, DOI 10.1098/rsbl.2009.0774; RUDD CD, 1994, J ZOOL, V232, P151, DOI 10.1111/j.1469-7998.1994.tb01565.x; Rutkowska J, 2011, P ROY SOC B-BIOL SCI, V278, P2962, DOI 10.1098/rspb.2010.2654; Schwanz LE, 2006, AM NAT, V168, P521, DOI 10.1086/507993; Schwanz LE, 2014, BEHAV ECOL SOCIOBIOL, V68, P1085, DOI 10.1007/s00265-014-1720-0; Schwanz LE, 2012, AUST J ZOOL, V60, P111, DOI 10.1071/ZO12024; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; SILK JB, 1983, AM NAT, V121, P56, DOI 10.1086/284039; Silk JB, 2008, P ROY SOC B-BIOL SCI, V275, P1761, DOI 10.1098/rspb.2008.0340; Sunnucks P, 1997, AUST J ZOOL, V45, P573, DOI 10.1071/ZO97038; Taggart D, 2002, ANZCCART NEWS, V15, P1; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Trott JF, 2003, BIOL REPROD, V68, P929, DOI 10.1095/biolreprod.102.005934; Tyndale-Biscoe H., 1987, REPROD PHYSL MARSUPI; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Wild G, 2007, AM NAT, V170, pE112, DOI 10.1086/522057; Wild G, 2006, EVOLUTION, V60, P2012, DOI 10.1111/j.0014-3820.2006.tb01839.x; WILLIAMS GC, 1979, PROC R SOC SER B-BIO, V205, P567, DOI 10.1098/rspb.1979.0085; Windley HR, 2013, OECOLOGIA, V173, P203, DOI 10.1007/s00442-013-2616-9	70	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0146011	10.1371/journal.pone.0146011	http://dx.doi.org/10.1371/journal.pone.0146011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849128	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000369554000007
J	Shi, HB; Zhang, GD; Zhou, M; Cheng, L; Yang, HX; Wang, J; Sun, J; Wang, ZZ				Shi, Hongbo; Zhang, Guangde; Zhou, Meng; Cheng, Liang; Yang, Haixiu; Wang, Jing; Sun, Jie; Wang, Zhenzhen			Integration of Multiple Genomic and Phenotype Data to Infer Novel miRNA-Disease Associations	PLOS ONE			English	Article							MICRORNA TARGET PREDICTION; NETWORK; SIMILARITY; WALKING; PRIORITIZATION; IDENTIFICATION; INTERACTOME; EXPRESSION; RESOURCE; GENES	MicroRNAs (miRNAs) play an important role in the development and progression of human diseases. The identification of disease-associated miRNAs will be helpful for understanding the molecular mechanisms of diseases at the post-transcriptional level. Based on different types of genomic data sources, computational methods for miRNA-disease association prediction have been proposed. However, individual source of genomic data tends to be incomplete and noisy; therefore, the integration of various types of genomic data for inferring reliable miRNA-disease associations is urgently needed. In this study, we present a computational framework, CHNmiRD, for identifying miRNA-disease associations by integrating multiple genomic and phenotype data, including protein-protein interaction data, gene ontology data, experimentally verified miRNA-target relationships, disease phenotype information and known miRNA-disease connections. The performance of CHNmiRD was evaluated by experimentally verified miRNA-disease associations, which achieved an area under the ROC curve (AUC) of 0.834 for 5-fold cross-validation. In particular, CHNmiRD displayed excellent performance for diseases without any known related miRNAs. The results of case studies for three human diseases (glioblastoma, myocardial infarction and type 1 diabetes) showed that all of the top 10 ranked miRNAs having no known associations with these three diseases in existing miRNA-disease databases were directly or indirectly confirmed by our latest literature mining. All these results demonstrated the reliability and efficiency of CHNmiRD, and it is anticipated that CHNmiRD will serve as a powerful bioinformatics method for mining novel disease-related miRNAs and providing a new perspective into molecular mechanisms underlying human diseases at the post-transcriptional level. CHNmiRD is freely available at http://www.bio-bigdata.com/CHNmiRD.	[Shi, Hongbo; Zhou, Meng; Cheng, Liang; Yang, Haixiu; Wang, Jing; Sun, Jie; Wang, Zhenzhen] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China; [Zhang, Guangde] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Shi, HB; Sun, J; Wang, ZZ (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China.	shihongbo@ems.hrbmu.edu.cn; suncarajie@hotmail.com; wangzz@ems.hrbmu.edu.cn	Zhou, Meng/G-7674-2011; Cheng, Liang/ABY-7421-2022	Zhou, Meng/0000-0001-9987-9024; Sun, Jie/0000-0002-0932-7195; Cheng, Liang/0000-0002-6665-6710	National Natural Science Foundation of China [31500675]; Postdoctoral Foundation of Heilongjiang Province [LBH-Z15162]; Natural Science Foundation of Heilongjiang Province [QC2013C019]; Science Foundation of Heilongjiang Provincial Health Department [2013126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Science Foundation of Heilongjiang Provincial Health Department	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 31500675), the Postdoctoral Foundation of Heilongjiang Province (Grant No. LBH-Z15162), the Natural Science Foundation of Heilongjiang Province (Grant No. QC2013C019) and the Science Foundation of Heilongjiang Provincial Health Department (Grant Nos. 2013126). There was no additional external funding received for this study.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chakraborty C, 2014, WIRES RNA, V5, P697, DOI 10.1002/wrna.1240; Chen HL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-12; Chen X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05501; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Jiang QH, 2013, INT J DATA MIN BIOIN, V8, P282, DOI 10.1504/IJDMB.2013.056078; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jiang R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S2; Kim AH, 2012, SCHIZOPHR RES, V141, P60, DOI 10.1016/j.schres.2012.06.038; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Li SF, 2014, J MOL CELL CARDIOL, V75, P49, DOI 10.1016/j.yjmcc.2014.06.017; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Li YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S27; Li YJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S20; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lv SL, 2012, J R SOC INTERFACE, V9, P1063, DOI 10.1098/rsif.2011.0551; Macropol K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-283; Mork S, 2014, BIOINFORMATICS, V30, P392, DOI 10.1093/bioinformatics/btt677; Parekh Vanisha, 2011, Nat Rev Neurol, V7, P304, DOI 10.1038/nrneurol.2011.68; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Spinetti G, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300418; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069719; Szeto CC, 2012, DIS MARKERS, V33, P137, DOI 10.1155/2012/842764; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang QH, 2011, BIOINFORMATICS, V27, P1521, DOI 10.1093/bioinformatics/btr154; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu J, 2011, MOL CANCER THER, V10, P1857, DOI 10.1158/1535-7163.MCT-11-0055; Xuan P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070204, 10.1371/annotation/a076115e-dd8c-4da7-989d-c1174a8cd31e]; Yang Z, 2014, ACTA DIABETOL; Zitman-Gal T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-8	49	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148521	10.1371/journal.pone.0148521	http://dx.doi.org/10.1371/journal.pone.0148521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849207	Green Published, gold			2022-12-26	WOS:000369554000116
J	Svensson, K; Albert, V; Cardel, B; Salatino, S; Handschin, C				Svensson, Kristoffer; Albert, Verena; Cardel, Bettina; Salatino, Silvia; Handschin, Christoph			Skeletal muscle PGC-1 alpha modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice	FASEB JOURNAL			English	Article						ketone body metabolism; diabetes; exercise; ketoacidosis; transcriptional regulation	TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; PROLIFERATOR-ACTIVATED RECEPTOR; ENERGY-METABOLISM; REGULATORY SITES; GENE-EXPRESSION; ERR-ALPHA; EXERCISE; RATS; KETOACIDOSIS; DISORDERS	Ketone bodies (KBs) are crucial energy substrates during states of low carbohydrate availability. However, an aberrant regulation of KB homeostasis can lead to complications such as diabetic ketoacidosis. Exercise and diabetes affect systemic KB homeostasis, but the regulation of KB metabolism is still enigmatic. In our study in mice with either knockout or overexpression of the peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1 alpha in skeletal muscle, PGC-1 alpha regulated ketolytic gene transcription in muscle. Furthermore, KB homeostasis of these mice was investigated during withholding of food, exercise, and ketogenic diet feeding, and after streptozotocin injection. In response to these ketogenic stimuli, modulation of PGC-1 alpha levels in muscle affected systemic KB homeostasis. Moreover, the data demonstrate that skeletal muscle PGC-1 alpha is necessary for the enhanced ketolytic capacity in response to exercise training and overexpression of PGC-1 alpha in muscle enhances systemic ketolytic capacity and is sufficient to ameliorate diabetic hyperketonemia in mice. In cultured myotubes, the transcription factor estrogen-related receptor-a was a partner of PGC-1 alpha In the regulation of ketolytic gene transcription. These results demonstrate a central role of skeletal muscle PGC-1 alpha in the transcriptional regulation of systemic ketolytic capacity.-Svensson, K., Albert, V., Cardel, B., Salatino, S., Handschin, C. Skeletal muscle PGC-1 alpha modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice. www.fasebj.org	[Svensson, Kristoffer; Albert, Verena; Cardel, Bettina; Salatino, Silvia; Handschin, Christoph] Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	University of Basel	Handschin, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	christoph.handschin@unibas.ch	Handschin, Christoph/E-6886-2015	Handschin, Christoph/0000-0003-0603-1097; Salatino, Silvia/0000-0003-1286-3076	ERC [616830-MUSCLE_NET]; Swiss National Science Foundation, SystemsX.ch; Swiss Society for Research on Muscle Diseases (SSEM); Novartis Foundation for Medical-Biological Research; University of Basel; Biozentrum	ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation, SystemsX.ch(Swiss National Science Foundation (SNSF)); Swiss Society for Research on Muscle Diseases (SSEM); Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Basel; Biozentrum	The authors thank Prof. A. Kralli (Scripps Research Institute, La Jolla, CA, USA) for the providing the shERR alpha adenovirus. This project was funded by ERC Consolidator Grant 616830-MUSCLE_NET, the Swiss National Science Foundation, SystemsX.ch, the Swiss Society for Research on Muscle Diseases (SSEM), the Novartis Foundation for Medical-Biological Research, the University of Basel, and the Biozentrum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. K.S. and C.H. designed research and wrote the manuscript; K.S., V.A., B.C., and S.S. performed research and analyzed data. The authors declare no conflicts of interest.	ADAMS JH, 1988, J PHYSIOL-LONDON, V407, P453, DOI 10.1113/jphysiol.1988.sp017425; Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Baresic M, 2014, MOL CELL BIOL, V34, P2996, DOI 10.1128/MCB.01710-13; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; El Midaoui A, 2005, AM J PHYSIOL-ENDOC M, V288, pE748, DOI 10.1152/ajpendo.00515.2004; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; JOHNSON RH, 1972, Q J EXP PHYSIOL CMS, V57, P73, DOI 10.1113/expphysiol.1972.sp002139; JOHNSON RH, 1969, LANCET, V2, P452; Kamel KS, 2015, NEW ENGL J MED, V372, P546, DOI 10.1056/NEJMra1207788; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; McNeill J. H, 1999, EXPT MODELS DIABETES; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OHMORI H, 1990, ENDOCRINOL JAPON, V37, P421; Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145; Perez-Schindler J, 2013, P NATL ACAD SCI USA, V110, P20314, DOI 10.1073/pnas.1312039110; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Pugliese G, 2009, DIABETES-METAB RES, V25, pS11, DOI 10.1002/dmrr.982; Shafqat N, 2013, J INHERIT METAB DIS, V36, P983, DOI 10.1007/s10545-013-9589-z; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Westerberg DP, 2013, AM FAM PHYSICIAN, V87, P337; WINDER WW, 1974, EUR J BIOCHEM, V47, P461, DOI 10.1111/j.1432-1033.1974.tb03713.x; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	32	25	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1976	1986		10.1096/fj.201500128	http://dx.doi.org/10.1096/fj.201500128			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26849960	Green Accepted			2022-12-26	WOS:000374879400025
J	De Giorgio, R; Mazzoni, M; Vallorani, C; Latorre, R; Bombardi, C; Bacci, ML; Forni, M; Falconi, M; Sternini, C; Clavenzani, P				De Giorgio, Roberto; Mazzoni, Maurizio; Vallorani, Claudia; Latorre, Rocco; Bombardi, Cristiano; Bacci, Maria Laura; Forni, Monica; Falconi, Mirella; Sternini, Catia; Clavenzani, Paolo			Regulation of alpha-Transducin and alpha-Gustducin Expression by a High Protein Diet in the Pig Gastrointestinal Tract	PLOS ONE			English	Article							BITTER TASTE RECEPTORS; ENTEROENDOCRINE STC-1 CELLS; CALCIUM-SENSING RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; UMAMI TASTE; SWEET TASTE; IMMUNOREACTIVE CELLS; SENSORY ORGAN; BODY-WEIGHT	Background The expression of taste receptors (TASRs) and their signalling molecules in the gastrointestinal (GI) epithelial cells, including enteroendocrine cells (EECs), suggests they participate in chemosensing mechanisms influencing GI physiology via the release of endocrine messengers. TASRs mediate gustatory signalling by interacting with different transducers, including alpha-gustducin (G(alpha gust)) and alpha-transducin (G(alpha tran)) G protein subunits. This study tested whether G(alpha tran) and G(alpha gust) immunoreactive (-IR) cells are affected by a short-term (3 days) and long-term (30 days) high protein (Hp) diet in the pig GI tract. Result In the stomach, G(alpha gust) and G(alpha tran)-IR cells contained serotonin (5-HT) and ghrelin (GHR), while in the small and large intestine, G(alpha gust) and G(alpha tran)-IR colocalized with 5-HT-, cholecystokinin (CCK)-and peptide YY (PYY)-IR. There was a significant increase in the density of G(alpha tran)-IR cells in the pyloric mucosa in both short- and long-term Hp diet groups (Hp3 and Hp30) vs. the control group (Ctr) (P<0.05), while the increase of G(alpha gust)-IR cells in the pyloric mucosa was significant in Hp30 group vs. Ctr and vs. Hp3 (P<0.05); these cells included G(alpha tran)/5HT-IR and G(alpha tran)/GHR-IR cells (P<0.05 and P<0.001 vs. Ctr, respectively) as well as G(alpha gust)/5-HT-IR or G(alpha gust)/GHR-IR cells (P<0.05 and P<0.01 vs. Ctr, respectively). In the small intestine, we recorded a significant increase in G(alpha tran)-IR cells in the duodenal cryptsand a significant increase of G(alpha gust)-IR cells in the jejunal crypts in Hp3 group compared to HP30 (P<0.05). With regard to the number of G(alpha tran)-G(alpha gust) IR cells colocalized with CCK or 5-HT, there was only a significant increase of G(alpha tran)/CCK-IR cells in Hp3 group compared to Ctr (P = 0.01). Conclusion This study showed an upregulation of selected subpopulations of G(alpha gust) / G(alpha tran)-IR cells in distinct regions of the pig GI tract by short- and long-term Hp diet lending support to TASR-mediated effects in metabolic homeostasis and satiety mechanisms.	[De Giorgio, Roberto] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Mazzoni, Maurizio; Vallorani, Claudia; Latorre, Rocco; Bombardi, Cristiano; Bacci, Maria Laura; Forni, Monica; Clavenzani, Paolo] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Falconi, Mirella] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE Digest Dis Res Ctr,Digest Dis Div, Los Angeles, CA 90095 USA; [Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Sternini, Catia] Greater Los Angeles Hlth Syst, Vet Adm, Los Angeles, CA USA	University of Bologna; University of Bologna; University of Bologna; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mazzoni, M (corresponding author), Univ Bologna, Dept Vet Med Sci, Bologna, Italy.	m.mazzoni@unibo.it	Mazzoni, Maurizio/J-1918-2016	Mazzoni, Maurizio/0000-0002-7384-5990; Bacci, Maria Laura/0000-0001-6702-5868; Forni, Monica/0000-0003-1310-6202	National Institutes of Health (NIH) [DK09, 41301]; Italian Ministry of Education, University and Research (MIUR; PRIN); 'Fondazione Del Monte di Bologna e Ravenna', Italy; University of Bologna; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK098447] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Education, University and Research (MIUR; PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); 'Fondazione Del Monte di Bologna e Ravenna', Italy(Fondazione del Monte di Bologna e Ravenna); University of Bologna; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present work was supported by National Institutes of Health (NIH) grants DK09 and 41301 (C.S.), grants from the Italian Ministry of Education, University and Research (MIUR; PRIN2009; R. De G.), from 'Fondazione Del Monte di Bologna e Ravenna', Italy, and funds from the University of Bologna (R. De G. and P.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Bensaid A, 2002, PHYSIOL BEHAV, V75, P577, DOI 10.1016/S0031-9384(02)00646-7; Buchan AMJ, 2001, GASTROENTEROLOGY, V120, P1128, DOI 10.1053/gast.2001.23246; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Choi S, 2007, AM J PHYSIOL-GASTR L, V292, pG98, DOI 10.1152/ajpgi.00295.2006; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Fujita T, 1980, Adv Biochem Psychopharmacol, V25, P321; Fujita Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE473, DOI 10.1152/ajpendo.90636.2008; Furness JB, 1999, AM J PHYSIOL-GASTR L, V277, pG922, DOI 10.1152/ajpgi.1999.277.5.G922; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Haid D, 2011, J MOL HISTOL, V42, P355, DOI 10.1007/s10735-011-9339-1; Haid DC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00065; Hao SZ, 2008, AM J PHYSIOL-REG I, V294, pR33, DOI 10.1152/ajpregu.00675.2007; Hao S, 2009, AM J PHYSIOL-REG I, V296, pR528, DOI 10.1152/ajpregu.90423.2008; He W, 2002, CHEM SENSES, V27, P719, DOI 10.1093/chemse/27.8.719; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hofer D, 1999, NEWS PHYSIOL SCI, V14, P18; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Hofer D, 1998, HISTOCHEM CELL BIOL, V110, P303, DOI 10.1007/s004180050292; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kinsey-Jones JS, 2015, OBESITY, V23, P1194, DOI 10.1002/oby.21083; Latorre R, 2013, FISH PHYSIOL BIOCHEM, V39, P1555, DOI 10.1007/s10695-013-9808-4; Lejeune MPGM, 2006, AM J CLIN NUTR, V83, P89; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Lobley GE, 2015, BRIT J NUTR, V113, P1254, DOI 10.1017/S0007114515000069; Maehashi K, 2009, CELL MOL LIFE SCI, V66, P1661, DOI 10.1007/s00018-009-8755-9; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mazzoni M, 2015, FISH PHYSIOL BIOCHEM, V41, P603, DOI 10.1007/s10695-015-0031-3; Mazzoni M, 2013, J CELL MOL MED, V17, P466, DOI 10.1111/jcmm.12026; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Moran AW, 2010, BRIT J NUTR, V104, P637, DOI 10.1017/S0007114510000917; Moran TH, 2009, INT J OBESITY, V33, pS7, DOI 10.1038/ijo.2009.9; Nakamura E, 2011, DIGESTION, V83, P13, DOI 10.1159/000323399; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Sainz E, 2007, DEV NEUROBIOL, V67, P948, DOI 10.1002/dneu.20403; Shirazi-Beechey SP, 2014, BRIT J NUTR, V111, pS1, DOI 10.1017/S000711451300233X; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; Takahashi T, 2012, J ANIM SCI, V90, P4807, DOI 10.2527/jas.2011-4596; Vallejo-Cremades MT, 2004, REGUL PEPTIDES, V121, P113, DOI 10.1016/j.regpep.2004.04.016; Vancleef L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15725; Vegezzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107732; Wang SY, 2015, HORM RES PAEDIAT, V83, P19, DOI 10.1159/000362168; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Widmayer P, 2011, HISTOCHEM CELL BIOL, V136, P37, DOI 10.1007/s00418-011-0824-0; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yasumatsu K, 2012, J PHYSIOL-LONDON, V590, P1155, DOI 10.1113/jphysiol.2011.211920; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932	67	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148954	10.1371/journal.pone.0148954	http://dx.doi.org/10.1371/journal.pone.0148954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871573	Green Submitted, gold, Green Published			2022-12-26	WOS:000370054100079
J	Gordon, SL; Harper, CB; Smillie, KJ; Cousin, MA				Gordon, Sarah L.; Harper, Callista B.; Smillie, Karen J.; Cousin, Michael A.			A Fine Balance of Synaptophysin Levels Underlies Efficient Retrieval of Synaptobrevin II to Synaptic Vesicles	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPSES; ENDOCYTOSIS; PROTEINS; SYNAPTOTAGMIN; TERMINALS; KINETICS; REVEALS; NEURONS; DOMAIN; BINDS	Synaptobrevin II (sybII) is a vesicular soluble NSF attachment protein receptor (SNARE) protein that is essential for neurotransmitter release, and thus its correct trafficking to synaptic vesicles (SVs) is critical to render them fusion competent. The SV protein synaptophysin binds to sybII and facilitates its retrieval to SVs during endocytosis. Synaptophysin and sybII are the two most abundant proteins on SVs, being present in a 1: 2 ratio. Synaptophysin and sybII are proposed to form a large multimeric complex, and the copy number of the proteins in this complex is also in a 1: 2 ratio. We investigated the importance of this ratio between these proteins for the localisation and trafficking of sybII in central neurons. SybII was overexpressed in mouse hippocampal neurons at either 1.6 or 2.15-2.35-fold over endogenous protein levels, in the absence or presence of varying levels of synaptophysin. In the absence of exogenous synaptophysin, exogenous sybII was dispersed along the axon, trapped on the plasma membrane and retrieved slowly during endocytosis. Coexpression of exogenous synaptophysin rescued all of these defects. Importantly, the expression of synaptophysin at nerve terminals in a 1: 2 ratio with sybII was sufficient to fully rescue normal sybII trafficking. These results demonstrate that the balance between synaptophysin and sybII levels is critical for the correct targeting of sybII to SVs and suggests that small alterations in synaptophysin levels might affect the localisation of sybII and subsequent presynaptic performance.	[Gordon, Sarah L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia; [Harper, Callista B.; Smillie, Karen J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Edinburgh	Gordon, SL (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia.; Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	sarah.gordon@florey.edu.au; M.Cousin@ed.ac.uk		Cousin, Michael/0000-0002-1762-160X; Smillie, Karen/0000-0003-4369-0470	Biotechnology and Biological Sciences Research Council [BB/L019329/1]; National Health and Medical Research Council (NHMRC) of Australia [GNT1085483]; Victorian Government; Operational Infrastructure Support Grant; BBSRC [BB/L019329/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Operational Infrastructure Support Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by a grant from the Biotechnology and Biological Sciences Research Council (BB/L019329/1) and The National Health and Medical Research Council (NHMRC) of Australia (GNT1085483). The Florey Institute of Neuroscience and Mental Health acknowledges the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13659; Arthur CP, 2007, STRUCTURE, V15, P707, DOI 10.1016/j.str.2007.04.011; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Baker K, 2015, J CLIN INVEST; Becher A, 1999, J NEUROSCI, V19, P1922; Bonanomi D, 2007, BIOCHEM J, V404, P525, DOI 10.1042/BJ20061907; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Gordon SL, 2014, TRAFFIC, V15, P245, DOI 10.1111/tra.12140; Gordon SL, 2013, J NEUROSCI, V33, P13695, DOI 10.1523/JNEUROSCI.0636-13.2013; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kaempf N, 2015, P NATL ACAD SCI USA, V112, P7297, DOI 10.1073/pnas.1501627112; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; Maritzen T, 2012, BIOL CELL, V104, P588, DOI 10.1111/boc.201200008; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Pan PY, 2015, J BIOL CHEM, V290, P22593, DOI 10.1074/jbc.M115.651711; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Wang J, 2014, P NATL ACAD SCI USA, V111, P13966, DOI 10.1073/pnas.1415849111; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Xu JH, 2013, CELL REP, V3, P1414, DOI 10.1016/j.celrep.2013.03.010; Yelamanchili SV, 2005, EUR J CELL BIOL, V84, P467, DOI 10.1016/j.ejcb.2004.11.007; Zhang N, 2015, J NEUROSCI, V35, P2492, DOI 10.1523/JNEUROSCI.4248-14.2015; Zhang Z, 2013, J NEUROSCI, V33, P9169, DOI 10.1523/JNEUROSCI.0301-13.2013	34	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149457	10.1371/journal.pone.0149457	http://dx.doi.org/10.1371/journal.pone.0149457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871701	Green Published, gold			2022-12-26	WOS:000370054100161
J	Izquierdo, L; Oliveira, C; Fournier, C; Descamps, V; Morel, V; Dubuisson, J; Brochot, E; Francois, C; Castelain, S; Duverlie, G; Helle, F				Izquierdo, Laure; Oliveira, Catarina; Fournier, Carole; Descamps, Veronique; Morel, Virginie; Dubuisson, Jean; Brochot, Etienne; Francois, Catherine; Castelain, Sandrine; Duverlie, Gilles; Helle, Francois			Hepatitis C Virus Resistance to Carbohydrate-Binding Agents	PLOS ONE			English	Article							CULTURE-ADAPTIVE MUTATIONS; ENVELOPE GLYCOPROTEIN E2; HEPATOMA-CELL LINES; N-LINKED GLYCANS; IN-VITRO; NEUTRALIZING ANTIBODIES; VIRION INFECTIVITY; EBOLA-VIRUS; PROTEIN; ENTRY	Carbohydrate binding agents (CBAs), including natural lectins, are more and more considered as broad-spectrum antivirals. These molecules are able to directly inhibit many viruses such as Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Dengue Virus, Ebola Virus or Severe Acute Respiratory Syndrome Coronavirus through binding to envelope protein N-glycans. In the case of HIV, it has been shown that CBAs select for mutant viruses with N-glycosylation site deletions which are more sensitive to neutralizing antibodies. In this study we aimed at evaluating the HCV resistance to CBAs in vitro. HCV was cultivated in the presence of increasing Galanthus nivalis agglutinin (GNA), Cyanovirin-N, Concanavalin-A or Griffithsin concentrations, during more than eight weeks. At the end of lectin exposure, the genome of the isolated strains was sequenced and several potential resistance mutations in the E1E2 envelope glycoproteins were identified. The effect of these mutations on viral fitness as well as on sensitivity to inhibition by lectins, soluble CD81 or the 3/11 neutralizing antibody was assessed. Surprisingly, none of these mutations, alone or in combination, conferred resistance to CBAs. In contrast, we observed that some mutants were more sensitive to 3/11 or CD81-LEL inhibition. Additionally, several mutations were identified in the Core and the non-structural proteins. Thus, our results suggest that in contrast to HIV, HCV resistance to CBAs is not directly conferred by mutations in the envelope protein genes but could occur through an indirect mechanism involving mutations in other viral proteins. Further investigations are needed to completely elucidate the underlying mechanisms.	[Izquierdo, Laure; Oliveira, Catarina; Fournier, Carole; Descamps, Veronique; Morel, Virginie; Brochot, Etienne; Francois, Catherine; Castelain, Sandrine; Duverlie, Gilles; Helle, Francois] Ctr Hosp Univ, Ctr Univ Rech Sante, Lab Virol, EA4294, Amiens, France; [Izquierdo, Laure; Oliveira, Catarina; Fournier, Carole; Descamps, Veronique; Morel, Virginie; Brochot, Etienne; Francois, Catherine; Castelain, Sandrine; Duverlie, Gilles; Helle, Francois] Univ Picardie Jules Verne, Amiens, France; [Dubuisson, Jean] Univ Lille, CNRS, INSERM,CHU Lille, U1019,UMR 8204,CIIL,Inst Pasteur Lille,Ctr Infect, Lille, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Helle, F (corresponding author), Ctr Hosp Univ, Ctr Univ Rech Sante, Lab Virol, EA4294, Amiens, France.; Helle, F (corresponding author), Univ Picardie Jules Verne, Amiens, France.	francois.helle@u-picardie.fr	BROCHOT, ETIENNE/I-5318-2012; FRANCOIS, Catherine/AAJ-8289-2020; Castelain, Sandrine/AAA-6344-2019; CASTELAIN, SANDRINE/AAJ-7506-2020; HELLE, Francois/G-7427-2011; Dubuisson, Jean/E-6813-2016	BROCHOT, ETIENNE/0000-0002-8677-6349; CASTELAIN, SANDRINE/0000-0002-2670-3148; HELLE, Francois/0000-0001-6884-2456; Dubuisson, Jean/0000-0003-1626-7693	Conseil Regional de Picardie [Parivir, Hepanovir, Oncovir]	Conseil Regional de Picardie(Region Hauts-de-France)	This study was funded by the Conseil Regional de Picardie (grant no. Parivir, Hepanovir, Oncovir). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen MMF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021658; Aligeti M, 2015, J VIROL, V89, P11523, DOI 10.1128/JVI.01185-15; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-248; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Barrientos LG, 2003, ANTIVIR RES, V58, P47, DOI 10.1016/S0166-3542(02)00183-3; Bertaux C, 2007, VIROLOGY, V366, P40, DOI 10.1016/j.virol.2007.04.008; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Carlsen THR, 2013, J VIROL, V87, P1385, DOI 10.1128/JVI.00684-12; Castelain S, 2004, J CLIN VIROL, V31, P227, DOI 10.1016/j.jcv.2004.03.009; Combet C., 2009, Infectious Disorders - Drug Targets, V9, P272; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dhillon S, 2010, J VIROL, V84, P5494, DOI 10.1128/JVI.02153-09; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Dubuisson J, 2014, J HEPATOL, V61, pS3, DOI 10.1016/j.jhep.2014.06.031; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Fournier C, 2013, J GEN VIROL, V94, P996, DOI 10.1099/vir.0.049676-0; Gal-Tanamy M, 2008, P NATL ACAD SCI USA, V105, P19450, DOI 10.1073/pnas.0809879105; Garrison AR, 2014, ANTIVIR RES, V112, P1, DOI 10.1016/j.antiviral.2014.09.012; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Helle F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070809; Helle F, 2011, VIRUSES-BASEL, V3, P1909, DOI 10.3390/v3101909; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kachko A, 2013, MOL PHARMACEUT, V10, P4590, DOI 10.1021/mp400399b; Kang JI, 2009, VIRUS RES, V144, P107, DOI 10.1016/j.virusres.2009.04.002; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Korber B, COMPUTATIONAL ANAL H, P55; Kumaki Y, 2011, ANTIVIR RES, V90, P22, DOI 10.1016/j.antiviral.2011.02.003; Li YL, 2015, J BIOL CHEM, V290, P10117, DOI 10.1074/jbc.M115.643528; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044965; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McCaffrey K, 2011, J GEN VIROL, V92, P112, DOI 10.1099/vir.0.026385-0; Meuleman P, 2011, ANTIMICROB AGENTS CH, V55, P5159, DOI 10.1128/AAC.00633-11; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09; Pantua H, 2013, J MOL BIOL, V425, P1899, DOI 10.1016/j.jmb.2013.02.025; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Pawlotsky JM, 2015, GUT, V64, P362, DOI 10.1136/gutjnl-2014-307452; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sabahi A, 2014, J VIROL, V88, P10280, DOI 10.1128/JVI.00874-14; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; Takebe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064449; Takeda M, 2012, J GEN VIROL, V93, P1422, DOI 10.1099/vir.0.040725-0; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yu LJ, 2010, J VIROL METHODS, V169, P380, DOI 10.1016/j.jviromet.2010.08.009	55	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149064	10.1371/journal.pone.0149064	http://dx.doi.org/10.1371/journal.pone.0149064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871442	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100096
J	Smith, SH; Peredo, CE; Takeda, Y; Bui, T; Neil, J; Rickard, D; Millerman, E; Therrien, JP; Nicodeme, E; Brusq, JM; Birault, V; Viviani, F; Hofland, H; Jetten, AM; Cote-Sierra, J				Smith, Susan H.; Peredo, Carlos E.; Takeda, Yukimasa; Thi Bui; Neil, Jessica; Rickard, David; Millerman, Elizabeth; Therrien, Jean-Philippe; Nicodeme, Edwige; Brusq, Jean-Marie; Birault, Veronique; Viviani, Fabrice; Hofland, Hans; Jetten, Anton M.; Cote-Sierra, Javier			Development of a Topical Treatment for Psoriasis Targeting ROR gamma: From Bench to Skin	PLOS ONE			English	Article							NUCLEAR RECEPTORS; T-CELLS; DIFFERENTIATION; INFLAMMATION; POTENT; IDENTIFICATION; ACTIVATION; EXPRESSION; ANTIBODY; IL-17	Background Psoriasis is a chronic inflammatory skin disorder involving marked immunological changes. IL-17-targeting biologics have been successful in reducing the disease burden of psoriasis patients with moderate-to-severe disease. Unfortunately, the stratum corneum prevents penetration of large molecule weight proteins, including monoclonal antibodies. Thus, for the majority of psoriasis patients ineligible for systemic treatments, a small molecule targeting ROR gamma t, the master regulator of IL-17 family cytokines, may represent an alternative topical medicine with biologic-like efficacy. Methods and Findings The preclinical studies described in this manuscript bridge the gap from bench to bedside to provide the scientific foundation for a compound entering clinical trials for patients with mild to moderate psoriasis. In addition to several ex vivo reporter assays, primary T cell cultures, and the imiquimod mouse model, we demonstrate efficacy in a newly developed human ex vivo skin assay, where Th17-skewed cytokine expression is induced from skin-resident immune cells. Importantly, the skin barrier remains intact allowing for the demonstration of topical drug delivery. With the development of this novel assay, we demonstrate potent compound activity in the target tissue: human skin. Finally, target engagement by this small molecule was confirmed in ex vivo lesional psoriatic skin. Conclusions Our work describes a progressive series of assays to demonstrate the potential clinical value of a novel ROR gamma inverse agonist small molecule with high potency and selectivity, which will enter clinical trials in late 2015 for psoriasis patients.	[Smith, Susan H.; Peredo, Carlos E.; Thi Bui; Neil, Jessica; Millerman, Elizabeth; Therrien, Jean-Philippe; Hofland, Hans; Cote-Sierra, Javier] Stiefel, Discovery & Preclin Dev, Res Triangle Pk, NC USA; [Takeda, Yukimasa; Jetten, Anton M.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Nicodeme, Edwige; Brusq, Jean-Marie; Viviani, Fabrice] GlaxoSmithKline, Flexible Discovery Unit, Les Ulis, France; [Rickard, David] GlaxoSmithKline, MDR PTS, Res Triangle Pk, NC USA; [Birault, Veronique] GlaxoSmithKline, Med Res Ctr, Resp Therapeut Area, Gunnels Wood Rd, Stevenage, Herts, England; [Hofland, Hans] Dermira Inc, Redwood City, CA USA; [Cote-Sierra, Javier] Pfizer Inc, External R&D Innovat Inflammat & Immunol, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Pfizer	Smith, SH (corresponding author), Stiefel, Discovery & Preclin Dev, Res Triangle Pk, NC USA.	susan.h.smith@stiefel.com	Therrien, Jean-Philippe/AAW-8912-2021; Jetten, Anton/C-3736-2019	Therrien, Jean-Philippe/0000-0001-5878-6841; Jetten, Anton/0000-0003-0954-4445; Neil, Jessica/0000-0003-0770-5321	GlaxoSmithKline, plc.; Intramural Research Program of the NIEHS, NIH [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER	GlaxoSmithKline, plc.(GlaxoSmithKline); Intramural Research Program of the NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funder (GlaxoSmithKline, plc.) provided support in the form of salaries for authors (SHS, CEP, TB, JN, DR, EM, JPT, EN, JMB, VB, HH, JCS). The specific roles these authors are articulated in the "author contributions" section. This work was also in part funded by the Intramural Research Program of the NIEHS, NIH (Z01-ES-100485) in the form of salaries for authors (YT and AMJ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Berg EL, 2015, INT J MOL SCI, V16, P1008, DOI 10.3390/ijms16011008; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Fauber BP, 2014, J MED CHEM, V57, P5871, DOI 10.1021/jm401901d; Huh JR, 2013, ACS MED CHEM LETT, V4, P79, DOI 10.1021/ml300286h; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Krueger JG, 2012, NAT MED, V18, P1750, DOI 10.1038/nm.3025; Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Kurebayashi S, 2004, BIOCHEM BIOPH RES CO, V315, P919, DOI 10.1016/j.bbrc.2004.01.131; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Qu XYA, 2014, DRUG DISCOV TODAY, V19, P1364, DOI 10.1016/j.drudis.2014.03.015; Rene O, 2015, ACS MED CHEM LETT, V6, P276, DOI 10.1021/ml500420y; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, FASEB J, V28, P2775, DOI 10.1096/fj.13-242040; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Takeda Y, 2012, NUCLEIC ACIDS RES, V40, P8519, DOI 10.1093/nar/gks630; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wang YH, 2014, BIOORGAN MED CHEM, V22, P692, DOI 10.1016/j.bmc.2013.12.021; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang W, 2012, MOL PHARMACOL, V82, P583, DOI 10.1124/mol.112.078667; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	38	62	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147979	10.1371/journal.pone.0147979	http://dx.doi.org/10.1371/journal.pone.0147979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870941	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100014
J	Weston-Bell, NJ; Tapper, W; Gibson, J; Bryant, D; Moreno, Y; John, M; Ennis, S; Kluin-Nelemans, HC; Collins, AR; Sahota, SS				Weston-Bell, Nicola J.; Tapper, Will; Gibson, Jane; Bryant, Dean; Moreno, Yurany; John, Melford; Ennis, Sarah; Kluin-Nelemans, Hanneke C.; Collins, Andrew R.; Sahota, Surinder S.			Exome Sequencing in Classic Hairy Cell Leukaemia Reveals Widespread Variation in Acquired Somatic Mutations between Individual Tumours Apart from the Signature BRAF V(600) E Lesion	PLOS ONE			English	Article							B-CELLS; KINASES STRUCTURE; V600E MUTATION; IMMUNOGLOBULIN; CANCER; EXPRESSION; SIGNALS; VARIANT; MAP2K1; GENES	In classic Hairy cell leukaemia (HCLc), a single case has thus far been interrogated by whole exome sequencing (WES) in a treatment naive patient, in which BRAF V(600) E was identified as an acquired somatic mutation and confirmed as occurring near-universally in this form of disease by conventional PCR-based cohort screens. It left open however the question whether other genome-wide mutations may also commonly occur at high frequency in presentation HCLc disease. To address this, we have carried out WES of 5 such typical HCLc cases, using highly purified splenic tumour cells paired with autologous T cells for germline. Apart from BRAF V(600) E, no other recurrent somatic mutation was identified in these HCLc exomes, thereby excluding additional acquired mutations as also prevalent at a near-universal frequency in this form of the disease. These data then place mutant BRAF at the centre of the neoplastic drive in HCLc. A comparison of our exome data with emerging genetic findings in HCL indicates that additional somatic mutations may however occur recurrently in smaller subsets of disease. As mutant BRAF alone is insufficient to drive malignant transformation in other histological cancers, it suggests that individual tumours utilise largely differing patterns of genetic somatic mutations to coalesce with BRAF V(600) E to drive pathogenesis of malignant HCLc disease.	[Weston-Bell, Nicola J.; Bryant, Dean; Moreno, Yurany; Sahota, Surinder S.] Univ Southampton, Fac Med, Canc Sci Unit, Tumour Immunogenet Grp, Southampton SO9 5NH, Hants, England; [Tapper, Will; Ennis, Sarah; Collins, Andrew R.] Univ Southampton, Fac Med, Human Genet, Genet Epidemiol & Genom Informat Grp, Southampton SO9 5NH, Hants, England; [Gibson, Jane] Univ Southampton, Fac Nat & Environm Studies, Ctr Biol Sci, Southampton, Hants, England; [John, Melford] Univ W Indies, Fac Med Sci, Dept Preclin Sci, St Augustine, Trinidad Tobago; [Kluin-Nelemans, Hanneke C.] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Southampton; University of Southampton; University of Southampton; University West Indies Mona Jamaica; University West Indies Saint Augustine; University of Groningen	Sahota, SS (corresponding author), Univ Southampton, Fac Med, Canc Sci Unit, Tumour Immunogenet Grp, Southampton SO9 5NH, Hants, England.	s.s.sahota@soton.ac.uk	Collins, Andrew/A-6595-2010; Kluin-Nelemans, Johanna C/F-8658-2018; Collins, Andrew/S-2196-2019; Gibson, Jane/I-1630-2012	Collins, Andrew/0000-0001-7108-0771; Kluin-Nelemans, Johanna C/0000-0003-2617-9427; Collins, Andrew/0000-0001-7108-0771; Gibson, Jane/0000-0002-0973-8285; Tapper, William/0000-0002-5896-1889; Weston-Bell, Nicola/0000-0003-0075-7276; Bryant, Dean/0000-0003-3163-608X	Bloodwise (United Kingdom)	Bloodwise (United Kingdom)	The project was funded by the Leukaemia & Lymphoma Research (United Kingdom) [now called Bloodwise (United Kingdom)].	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arcaini L, 2012, BLOOD, V119, P188, DOI 10.1182/blood-2011-08-368209; Arons E, 2009, BLOOD, V114, P4687, DOI 10.1182/blood-2009-01-201731; Berres ML, 2014, J EXP MED, V211, P669, DOI 10.1084/jem.20130977; Brown NA, 2014, BLOOD, V124, P1655, DOI 10.1182/blood-2014-05-577361; Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Chung SS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008004; Dietrich S, 2015, BLOOD, V126, P1005, DOI 10.1182/blood-2015-04-643361; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Forconi F, 2004, BLOOD, V104, P3312, DOI 10.1182/blood-2004-03-0950; Forconi F, 2001, BLOOD, V98, P1174, DOI 10.1182/blood.V98.4.1174; Forconi F, 2008, HAEMATOLOGICA, V93, P697, DOI 10.3324/haematol.12282; Forconi F, 2011, HEMATOL ONCOL, V29, P55, DOI 10.1002/hon.975; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KLUINNELEMANS HC, 1990, BLOOD, V75, P972; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kreitman RJ, 2013, CLIN CANCER RES, V19, P6873, DOI 10.1158/1078-0432.CCR-13-1752; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Laurini JA, 2012, AM J CLIN PATHOL, V138, P877, DOI 10.1309/AJCP5TWORA0TMXGL; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lefranc MP, 2014, BIOMOLECULES, V4, P1102, DOI 10.3390/biom4041102; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Mullighan CG, 2013, BLOOD, V122, P3899, DOI 10.1182/blood-2013-08-460311; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roskoski R, 2012, BIOCHEM BIOPH RES CO, V417, P5, DOI 10.1016/j.bbrc.2011.11.145; Roy DM, 2014, PROTEIN CELL, V5, P265, DOI 10.1007/s13238-014-0031-6; Seshan V., 2010, DNACOPY DNA COPY NUM; Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tiacci E, 2006, NAT REV CANCER, V6, P437, DOI 10.1038/nrc1888; Tiacci E, 2012, BLOOD, V119, P192, DOI 10.1182/blood-2011-08-371179; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang KP, 2015, ADV CANCER RES, V128, P173, DOI 10.1016/bs.acr.2015.04.014; Waterfall JJ, 2014, NAT GENET, V46, P8, DOI 10.1038/ng.2828; Weston-Bell N, 2009, LEUKEMIA, V23, P2075, DOI 10.1038/leu.2009.178; Weston-Bell NJ, 2013, LEUKEMIA, V27, P241, DOI 10.1038/leu.2012.163; Weston-Bell NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086556; Xi LQ, 2012, BLOOD, V119, P3330, DOI 10.1182/blood-2011-09-379339	48	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149162	10.1371/journal.pone.0149162	http://dx.doi.org/10.1371/journal.pone.0149162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871591	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000370054100115
J	Park, S; Yoon, JH; Sohn, J; Park, HS; Moon, HJ; Kim, MJ; Kim, EK; Kim, SI; Park, BW				Park, Seho; Yoon, Jung Hyun; Sohn, Joohyuk; Park, Hyung Seok; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung; Kim, Seung Il; Park, Byeong-Woo			Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer	PLOS ONE			English	Article							PATHOLOGICAL RESPONSE; PREOPERATIVE CHEMOTHERAPY; SYSTEMIC THERAPY; MRI; TRIAL; RECOMMENDATIONS; ULTRASOUND; PHENOTYPE; CONSENSUS; UPDATE	Background The accurate evaluation of favorable response to neoadjuvant chemotherapy (NCT) is critical to determine the extent of surgery. We investigated independent clinicopathological and radiological predictors to discriminate no residual carcinoma (ypT0) from residual ductal carcinoma in situ (ypTis) in breast cancer patients who received NCT. Patients and Methods Parameters of 117 patients attaining pathological complete response (CR) in the breast after NCT between January 2010 and December 2013 were retrospectively evaluated by univariate and multivariate analyses. All patients underwent mammography, ultrasound, and magnetic resonance imaging (MRI) before and after NCT. Results There were 67 (57.3%) patients with ypT0. These patients were associated with hormone receptor-negative status, human epidermal growth factor receptor-2 (HER2)-negative tumors, and a higher likelihood of breast-conservation surgery. Baseline mammographic and MRI presentation of the main lesion, absence of associated microcalcifications, shape, posterior features, and absence of calcifications on ultrasound were significantly associated with ypT0. CR in mammography, ultrasound, or MRI after NCT was also related to ypT0. By multivariate analysis, independent predictors of ypT0 were the triple-negative subtype [Odds ratio (OR), 4.23; 95% confidence interval (CI), 1.11-16.09] and CR in MRI after NCT (OR, 5.23; 95% CI, 1.53-17.85). Stratified analysis by breast cancer subtype demonstrated that MRI well predicted ypT0 in all subtypes except the HER2-positive subtype. In particular, of 40 triple-negative subtypes, 22 showed CR in MRI and 21 (95.5%) were ypT0 after NCT. Conclusion Among imaging modalities, breast MRI can potentially distinguish between ypT0 and ypTis after NCT, especially in patients with triple-negative breast cancer. This information can help clinicians evaluate tumor response to NCT and plan surgery for breast cancer patients of all subtypes except for those with HER2-enriched tumors after NCT.	[Park, Seho; Park, Hyung Seok; Kim, Seung Il; Park, Byeong-Woo] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Yoon, Jung Hyun; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol,Res Inst Radiol Sci, Seoul, South Korea; [Sohn, Joohyuk] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol,Res Inst Radiol Sci, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Moon, Hee Jung/0000-0002-5643-5885; Park, Hyung Seok/0000-0001-5322-6036; Park, Seho/0000-0001-8089-2755; Sohn, Joohyuk/0000-0002-2303-2764; Yoon, Jung Hyun/0000-0002-2100-3513; Park, Byeong-Woo/0000-0003-1353-2607	Bumsuk Academic Research Fund [2014-31-0768]	Bumsuk Academic Research Fund	The work was supported by the Bumsuk Academic Research Fund in 2014 (Grant No. 2014-31-0768), SP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrada BE, 2015, ANN SURG ONCOL, V22, P1111, DOI 10.1245/s10434-014-4113-8; Berruti Alfredo, 2011, Journal of the National Cancer Institute Monographs, P147, DOI 10.1093/jncimonographs/lgr037; Brown-Glaberman U, 2014, ONCOLOGY-NY, V28, P281; Buchholz TA, 2008, J CLIN ONCOL, V26, P791, DOI 10.1200/JCO.2007.15.0326; Chen K, 2011, AM SURGEON, V77, P1700; Choi HK, 2012, EUR J RADIOL, V81, P737, DOI 10.1016/j.ejrad.2011.01.013; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; De los Santos JF, 2013, CANCER-AM CANCER SOC, V119, P1776, DOI 10.1002/cncr.27995; Gebreamlak EP, 2013, ANTI-CANCER AGENT ME, V13, P222; Gradishar WJ, 2014, J NATL COMPR CANC NE, V12, P542, DOI 10.6004/jnccn.2014.0058; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hooley RJ, 2013, RADIOLOGY, V268, P642, DOI 10.1148/radiol.13121606; Kaufmann M, 2012, ANN SURG ONCOL, V19, P1508, DOI 10.1245/s10434-011-2108-2; Kim MJ, 2015, ACTA RADIOL, V56, P1069, DOI 10.1177/0284185114548507; Lee MC, 2015, ANN SURG ONCOL, V22, P2888, DOI 10.1245/s10434-014-4357-3; Li JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088853; Marchio Caterina, 2011, Journal of the National Cancer Institute Monographs, P86, DOI 10.1093/jncimonographs/lgr025; Marinovich ML, 2015, INT J CANCER, V136, P2730, DOI 10.1002/ijc.29323; Mercado CL, 2014, RADIOL CLIN N AM, V52, P481, DOI 10.1016/j.rcl.2014.02.008; Moon HG, 2013, ANN SURG, V257, P133, DOI 10.1097/SLA.0b013e3182686bd9; Mukhtar RA, 2013, ANN SURG ONCOL, V20, P3823, DOI 10.1245/s10434-013-3038-y; Trop I, 2014, RADIOGRAPHICS, V34, P1178, DOI 10.1148/rg.345130049; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; von Minckwitz G, 2012, BREAST CANCER RES TR, V132, P863, DOI 10.1007/s10549-011-1621-0; Wang SS, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-166; Weiss A, 2014, ANN SURG ONCOL, V21, P3310, DOI 10.1245/s10434-014-3914-0; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yuan Y, 2010, AM J ROENTGENOL, V195, P260, DOI 10.2214/AJR.09.3908	28	9	10	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149347	10.1371/journal.pone.0149347	http://dx.doi.org/10.1371/journal.pone.0149347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866475	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700084
J	Senft, RA; Meddle, SL; Baugh, AT				Senft, Rebecca A.; Meddle, Simone L.; Baugh, Alexander T.			Distribution and Abundance of Glucocorticoid and Mineralocorticoid Receptors throughout the Brain of the Great Tit (Parus major)	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CORTICOSTEROID RECEPTORS; INDIVIDUAL VARIATION; NEURAL RESPONSE; STRESS-RESPONSE; FEMALE SONG; URBAN NOISE; BEHAVIOR; PERSONALITY; SPARROWS	The glucocorticoid stress response, regulated by the hypothalamic-pituitary-adrenal (HPA) axis, enables individuals to cope with stressors through transcriptional effects in cells expressing the appropriate receptors. The two receptors that bind glucocorticoids-the mineralocorticoid receptor (MR) and glucocorticoid receptor (GR)-are present in a variety of vertebrate tissues, but their expression in the brain is especially important. Neural receptor patterns have the potential to integrate multiple behavioral and physiological traits simultaneously, including self-regulation of glucocorticoid secretion through negative feedback processes. In the present work, we quantified the expression of GR and MR mRNA throughout the brain of a female great tit (Parus major), creating a distribution map encompassing 48 regions. This map, the first of its kind for P. major, demonstrated a widespread but not ubiquitous distribution of both receptor types. In the paraventricular nucleus of the hypothalamus (PVN) and the hippocampus (HP)-the two brain regions that we sampled from a total of 25 birds, we found high GR mRNA expression in the former and, unexpectedly, low MR mRNA in the latter. We examined the covariation of MR and GR levels in these two regions and found a strong, positive relationship between MR in the PVN and MR in the HP and a similar trend for GR across these two regions. This correlation supports the idea that hormone pleiotropy may constrain an individual's behavioral and physiological phenotype. In the female song system, we found moderate GR in hyperstriatum ventrale, pars caudalis (HVC), and moderate MR in robust nucleus of the arcopallium (RA). Understanding intra-and interspecific patterns of glucocorticoid receptor expression can inform us about the behavioral processes (e.g. song learning) that may be sensitive to stress and stimulate future hypotheses concerning the relationships between receptor expression, circulating hormone concentrations and performance traits under selection, including behavior.	[Senft, Rebecca A.; Baugh, Alexander T.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Meddle, Simone L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland	Swarthmore College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Senft, RA (corresponding author), Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA.	senftrebecca@gmail.com	Baugh, Alexander T/E-4777-2010	Baugh, Alexander T/0000-0003-2032-892X; Senft, Rebecca/0000-0003-0081-4170	Alexander von Humboldt Foundation [1141248]; Max Planck Institute for Ornithology; Roslin Institute at the University of Edinburgh; Howard Hughes Medical Institute; Biology Department at Swarthmore College; BBSRC [BBS/E/D/20221656, BBS/E/D/20251969, BBS/E/D/20221655] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221656, BBS/E/D/20221655, BBS/E/D/20251969] Funding Source: researchfish	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Institute for Ornithology(Max Planck Society); Roslin Institute at the University of Edinburgh; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Biology Department at Swarthmore College; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Alexander von Humboldt Foundation grant number 1141248 (ATB), the Max Planck Institute for Ornithology (ATB), the Roslin Institute at the University of Edinburgh (SLM), Howard Hughes Medical Institute and the Biology Department at Swarthmore College (RAS, ATB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2012, FRONT NEUROENDOCRIN, V33, P67, DOI 10.1016/j.yfrne.2011.08.002; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; BAPTISTA LF, 1993, ANIM BEHAV, V46, P511, DOI 10.1006/anbe.1993.1219; Baugh AT, 2014, GEN COMP ENDOCR, V208, P154, DOI 10.1016/j.ygcen.2014.08.014; Baugh AT, 2013, GEN COMP ENDOCR, V189, P96, DOI 10.1016/j.ygcen.2013.04.030; Baugh AT, 2012, GEN COMP ENDOCR, V175, P488, DOI 10.1016/j.ygcen.2011.12.012; Besedovsky L, 2014, EUR J IMMUNOL, V44, P1759, DOI 10.1002/eji.201344265; Blumenrath SH, 2007, ANIM BEHAV, V73, P789, DOI 10.1016/j.anbehav.2006.07.011; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Breuner CW, 1998, GEN COMP ENDOCR, V111, P386, DOI 10.1006/gcen.1998.7128; Breuner CW, 2001, J NEUROENDOCRINOL, V13, P412, DOI 10.1046/j.1365-2826.2001.00646.x; Butler A.B., 2005, COMP VERTEBRATE NEUR, Vsecond; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; Del Negro C, 1998, BEHAV BRAIN RES, V96, P151, DOI 10.1016/S0166-4328(98)00009-6; Deviche P, 2000, J NEUROBIOL, V42, P202, DOI 10.1002/(SICI)1097-4695(20000205)42:2<202::AID-NEU4>3.0.CO;2-G; Dickens M, 2009, J NEUROENDOCRINOL, V21, P832, DOI 10.1111/j.1365-2826.2009.01908.x; Dickens MJ, 2011, GEN COMP ENDOCR, V170, P569, DOI 10.1016/j.ygcen.2010.11.018; Dingemanse NJ, 2012, J ANIM ECOL, V81, P116, DOI 10.1111/j.1365-2656.2011.01877.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dosmann A, 2015, ANIM BEHAV, V101, P179, DOI 10.1016/j.anbehav.2014.12.026; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Dumont Y, 1998, J COMP NEUROL, V402, P372; Farrell TM, 2015, ANIM BEHAV, V102, P157, DOI 10.1016/j.anbehav.2015.01.018; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Gorissen L, 2004, AUK, V121, P184, DOI 10.1642/0004-8038(2004)121[0184:ICBMAF]2.0.CO;2; Halfwerk W, 2011, P NATL ACAD SCI USA, V108, P14549, DOI 10.1073/pnas.1109091108; Hamao S, 2011, ETHOL ECOL EVOL, V23, P111, DOI 10.1080/03949370.2011.554881; Hamilton KS, 1997, NEUROBIOL LEARN MEM, V68, P325, DOI 10.1006/nlme.1997.3781; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; Heppner KM, 2015, ENDOCRINOLOGY, V156, P255, DOI 10.1210/en.2014-1675; Hodgson ZG, 2007, P ROY SOC B-BIOL SCI, V274, P239, DOI 10.1098/rspb.2006.3704; Krause JS, 2015, J NEUROENDOCRINOL, V27, P66, DOI 10.1111/jne.12237; Kriengwatana B, 2014, HORM BEHAV, V65, P285, DOI 10.1016/j.yhbeh.2013.12.013; Lattin CR, 2015, ENDOCRINOLOGY, V156, P1354, DOI 10.1210/en.2014-1811; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Liebl AL, 2013, GEN COMP ENDOCR, V183, P32, DOI 10.1016/j.ygcen.2012.11.021; Lind H, 1996, ANIM BEHAV, V52, P667, DOI 10.1006/anbe.1996.0211; Maguire SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063239; Matsunaga E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00028; Medina CO, 2013, GEN COMP ENDOCR, V193, P27, DOI 10.1016/j.ygcen.2013.07.008; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Odom KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4379; Patel PD, 2000, J PSYCHIATR RES, V34, P383, DOI 10.1016/S0022-3956(00)00035-2; Pryce CR, 2008, BRAIN RES REV, V57, P596, DOI 10.1016/j.brainresrev.2007.08.005; Riebel K, 2009, ANIM BEHAV, V78, P1397, DOI 10.1016/j.anbehav.2009.09.011; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Ronchi E, 1998, BRAIN RES, V780, P348, DOI 10.1016/S0006-8993(97)01303-6; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schmidt KL, 2013, ANIM BEHAV, V85, P825, DOI 10.1016/j.anbehav.2013.01.029; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Srividya R, 2004, NEUROREPORT, V15, P1831, DOI 10.1097/01.wnr.0000135698.68152.86; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Suzuki K, 2011, NEUROSCIENCE, V194, P72, DOI 10.1016/j.neuroscience.2011.07.073; Uz T, 2001, FASEB J, V15, P1792, DOI 10.1096/fj.00-0836fje; Wada H, 2008, J EXP BIOL, V211, P1696, DOI 10.1242/jeb.009191; Wada H, 2010, DEV NEUROBIOL, V70, P853, DOI 10.1002/dneu.20819; Wada H, 2009, PHYSIOL BIOCHEM ZOOL, V82, P325, DOI 10.1086/599320; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003	65	16	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148516	10.1371/journal.pone.0148516	http://dx.doi.org/10.1371/journal.pone.0148516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867218	Green Published, gold			2022-12-26	WOS:000370050700019
J	Wang, K; Levinson, DM				Wang, Kai; Levinson, David M.			Towards a Metropolitan Fundamental Diagram Using Travel Survey Data	PLOS ONE			English	Article								Using travel diary data from 2000-2001 and 2010-2012 this research examines fundamental traffic relationships at the metropolitan level. The results of this paper can help to explain the causes of some traffic phenomena. Network average speed by time of day can be explained by trip length and cumulative number of vehicles on the road. A clockwise hysteresis loop is found in the Metropolitan Fundamental Diagram in the morning period and a reverse process happens in the afternoon.	[Wang, Kai] Beijing Univ Technol, Beijing Key Lab Traff Engn, Beijing 100124, Peoples R China; [Levinson, David M.] Dept Civil Environm & Geoengn, 500 Pillsbury Dr SE, Minneapolis, MN 55455 USA	Beijing University of Technology	Levinson, DM (corresponding author), Dept Civil Environm & Geoengn, 500 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	dlevinson@umn.edu	Levinson, David/A-8554-2012	Levinson, David/0000-0002-4563-2963	National Basic Research Program of China [2012CB725403]; National Natural Science Foundation of China [51338008, 51378036]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received funding from National Basic Research Program of China (No. 2012CB725403), and National Natural Science Foundation of China (Grant No.51338008 and 51378036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank HongZhi Guan, and funding from the National Basic Research Program of China (No. 2012CB725403) and the National Natural Science Foundation of China (Grant No.51338008 and 51378036). This work was conducted while Kai Wang was a Visiting Scholar at the University of Minnesota, Department of Civil, Environmental, and Geo-Engineering. The authors would like to thank Andrew Owen for the guidance of Open-TripPlanner's application. The authors also thank Jessica Schoner for help on ArcGIS during Kai's stay at the University of Minnesota, where this work was conducted. We would like to acknowledge comments from Mohsen Ramezani and Nikolas Geroliminis on an earlier draft of the work.	[Anonymous], 2012, PEAK TRAVEL PEAK CAR; Buisson C, 2009, TRANSP RES RECORD, P127, DOI 10.3141/2124-12; Daganzo CF, 2011, TRANSPORT RES B-METH, V45, P278, DOI 10.1016/j.trb.2010.06.006; Gayah VV, 2013, TRANSPORT RES REC, P76, DOI 10.3141/2390-09; Geroliminis N, 2008, TRANSPORT RES B-METH, V42, P759, DOI 10.1016/j.trb.2008.02.002; Geroliminis N, 2011, TRANSPORT RES A-POL, V45, P966, DOI 10.1016/j.tra.2011.04.004; Geroliminis N, 2011, TRANSPORT RES B-METH, V45, P605, DOI 10.1016/j.trb.2010.11.004; HERMAN R, 1979, SCIENCE, V204, P148, DOI 10.1126/science.204.4389.148; Leclercq L, 2014, TRANSPORT RES B-METH, V62, P1, DOI 10.1016/j.trb.2014.01.007; Mahmassani H., 1987, TRANSPORTATION TRAFF; Mahmassani H, 1984, TRANSPORT RES REC, P971; Mahmassani HS, 2013, TRANSPORT RES C-EMER, V36, P480, DOI 10.1016/j.trc.2013.07.002; MAHMASSANI HS, 1990, TRANSPORT RES A-POL, V24, P149, DOI 10.1016/0191-2607(90)90022-X; Mahmassani HS, 1993, TRANSPORT RES REC, p1408w; Metropolitan Council, 2013, 2010 MSP REG TRAV BE; Millard-Ball A, 2011, TRANSPORT REV, V31, P357, DOI 10.1080/01441647.2010.518291; Parthasarathi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077718; Puentes R, 2012, HAVE AM HIT PEAK TRA; Ramezani M, 2015, TRANSPORT RES B-METH, V74, P1, DOI 10.1016/j.trb.2014.12.010; Tang W, 2014, EMPIRICAL STUDY DEVI; Zhu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134322	21	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148660	10.1371/journal.pone.0148660	http://dx.doi.org/10.1371/journal.pone.0148660			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866913	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700025
J	Preyer, O; Johansen, D; Holly, J; Stocks, T; Pompella, A; Nagel, G; Concin, H; Ulmer, H; Concin, N				Preyer, Oliver; Johansen, Dorthe; Holly, Jessica; Stocks, Tanja; Pompella, Alfonso; Nagel, Gabriele; Concin, Hans; Ulmer, Hanno; Concin, Nicole			gamma-Glutamyltransferase and Breast Cancer Risk Beyond Alcohol Consumption and Other Life Style Factors - A Pooled Cohort Analysis	PLOS ONE			English	Article							TRANSPEPTIDASE ACTIVITY; CARDIOVASCULAR-DISEASE; H2O2 PRODUCTION; ASSOCIATION; CELLS; MEN; MODULATION; MORTALITY	Objective Elevated gamma-Glutamyltransferase serum levels are associated with increased risk of overall cancer incidence and several site-specific malignancies. In the present prospective study we report on the associations of serum gamma-Glutamyltransferase with the risk of breast cancer in a pooled population-based cohort considering established life style risk factors. Methods Two cohorts were included in the present study, i. e. the Vorarlberg (n = 97,268) and the Malmoe cohort (n = 9,790). Cox proportional hazards regression models were fitted to estimate HRs for risk of breast cancer. Results In multivariate analysis adjusted for age, bodymass index and smoking status, women with gamma-Glutamyltransferase levels in the top quartile were at significantly higher risk for breast cancer compared to women in the lowest quartile (HR 1.21, 95% CI 1.09 to 1.35; p = 0.005). In the subgroup analysis of the Malmoe cohort, gamma-Glutamyltransferase remained an independent risk factor for breast cancer when additionally considering alcohol intake. A statistically significant increase in risk was seen in women with gamma-Glutamyltransferase-levels in the top versus lowest quartile in a multivariate model adjusted for age, body mass index, smoking status, physical activity, parity, oral contraceptive-use and alcohol consumption (HR 1.37, 95% CI 1.11-1.69, p = 0.006). Conclusion Our findings identified.-Glutamyltransferase as an independent risk factor for breast cancer beyond the consumption of alcohol and other life style risk factors.	[Preyer, Oliver; Nagel, Gabriele; Concin, Hans] Agcy Prevent & Social Med, Bregenz, Vorarlberg, Austria; [Johansen, Dorthe] Lund Univ, Surg Res Unit, Malmo, Sweden; [Holly, Jessica; Concin, Nicole] Med Univ Innsbruck, Dept Obstet & Gynaecol, A-6020 Innsbruck, Austria; [Stocks, Tanja] Lund Univ, Ctr Diabet, Diabet & Cardiovasc Dis Genet Epidemiol Dept Clin, CRC, Malmo, Sweden; [Pompella, Alfonso] Univ Pisa, Sch Med, Dept Expt Pathol, I-56100 Pisa, Italy; [Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria	Lund University; Medical University of Innsbruck; Lund University; University of Pisa; Ulm University; Medical University of Innsbruck	Concin, N (corresponding author), Med Univ Innsbruck, Dept Obstet & Gynaecol, A-6020 Innsbruck, Austria.	nicole.concin@i-med.ac.at	vhmpp, aks/F-9756-2012; Ulmer, Hanno/S-6615-2019; Nagel, Gabriele/C-3635-2012	Ulmer, Hanno/0000-0001-5911-1002; Nagel, Gabriele/0000-0001-6185-8535; Concin, Nicole/0000-0002-9795-2643				Corti A, 2010, ANTICANCER RES, V30, P1169; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; Del Bello B, 1999, FASEB J, V13, P69; Dominici S, 1999, FREE RADICAL BIO MED, V27, P623, DOI 10.1016/S0891-5849(99)00111-2; Dominici S, 2005, METHOD ENZYMOL, V401, P484, DOI 10.1016/S0076-6879(05)01029-3; Fentiman IS, 2010, BRIT J CANCER, V103, P90, DOI 10.1038/sj.bjc.6605719; Franzini M, 2006, EUR J CANCER, V42, P2623, DOI 10.1016/j.ejca.2006.04.016; Grimm C, 2013, BRIT J CANCER, V109, P610, DOI 10.1038/bjc.2013.323; Jousilahti P, 2000, STROKE, V31, P1851, DOI 10.1161/01.STR.31.8.1851; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Maellaro E, 2000, J CELL SCI, V113, P2671; Nilsson-Ehle PGP, 2003, LAURELLS KLINISK KEM; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; Pompella A, 2004, CLIN CHEM LAB MED, V42, P1085, DOI 10.1515/CCLM.2004.224; Pompella A, 2007, CURR OPIN PHARMACOL, V7, P360, DOI 10.1016/j.coph.2007.04.004; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Seebacher V, 2012, BRIT J CANCER, V106, P1551, DOI 10.1038/bjc.2012.16; SHIBUYA A, 1988, AM J HUM GENET, V43, P744; Staudigl C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125317; Strasak AM, 2008, INT J CANCER, V123, P1902, DOI 10.1002/ijc.23714; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; Strasak AM, 2010, CANCER RES, V70, P3586, DOI 10.1158/0008-5472.CAN-09-3197; TRELL E, 1983, PREV MED, V12, P397, DOI 10.1016/0091-7435(83)90248-7; Tsuboya T, 2012, J EPIDEMIOL, V22, P144, DOI 10.2188/jea.JE20110071; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149122	10.1371/journal.pone.0149122	http://dx.doi.org/10.1371/journal.pone.0149122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863311	Green Submitted, gold, Green Published			2022-12-26	WOS:000370046600156
J	Streit, AK; Fan, YN; Masullo, L; Baines, RA				Streit, Anne K.; Fan, Yuen Ngan; Masullo, Laura; Baines, Richard A.			Calcium Imaging of Neuronal Activity in Drosophila Can Identify Anticonvulsive Compounds	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; SEIZURE SUSCEPTIBILITY; ANTIEPILEPTIC DRUGS; EPILEPTIC SEIZURES; NEURAL CIRCUITS; SUPPRESSION; MODEL; MUTATIONS; EXCITABILITY; MELANOGASTER	Although there are now a number of antiepileptic drugs (AEDs) available, approximately one-third of epilepsy patients respond poorly to drug intervention. The reasons for this are complex, but are probably reflective of the increasing number of identified mutations that predispose individuals to this disease. Thus, there is a clear requirement for the development of novel treatments to address this unmet clinical need. The existence of gene mutations that mimic a seizure-like behaviour in the fruit fly, Drosophila melanogaster, offers the possibility to exploit the powerful genetics of this insect to identify novel cellular targets to facilitate design of more effective AEDs. In this study we use neuronal expression of GCaMP, a potent calcium reporter, to image neuronal activity using a non-invasive and rapid method. Expression in motoneurons in the isolated CNS of third instar larvae shows waves of calcium-activity that pass between segments of the ventral nerve cord. Time between calcium peaks, in the same neurons, between adjacent segments usually show a temporal separation of greater than 200 ms. Exposure to proconvulsants (picrotoxin or 4-aminopyridine) reduces separation to below 200 ms showing increased synchrony of activity across adjacent segments. Increased synchrony, characteristic of epilepsy, is similarly observed in genetic seizure mutants: bangsenseless(1) (bss(1)) and paralyticK1270T (paraK1270T). Exposure of bss(1) to clinically-used antiepileptic drugs (phenytoin or gabapentin) significantly reduces synchrony. In this study we use the measure of synchronicity to evaluate the effectiveness of known and novel anticonvulsive compounds (antipain, isethionate, etopiside rapamycin and dipyramidole) to reduce seizure-like CNS activity. We further show that such compounds also reduce the Drosophila voltage-gated persistent Na+ current (INaP) in an identified motoneuron (aCC). Our combined assays provide a rapid and reliable method to screen unknown compounds for potential to function as anticonvulsants.	[Streit, Anne K.; Fan, Yuen Ngan; Masullo, Laura; Baines, Richard A.] Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England; [Masullo, Laura] MRC Lab Mol Biol, Cambridge Biomedical Campus, Cambridge CB2 0QH, England	University of Manchester; MRC Laboratory Molecular Biology	Baines, RA (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	Richard.Baines@manchester.ac.uk			Medical Research Council (UK) [MR/J009180/1]; Wellcome Trust [087742/Z/08/Z]; MRC [MR/J009180/1] Funding Source: UKRI; Medical Research Council [MR/J009180/1] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (UK, MR/J009180/1). Work on this project benefited from the Manchester Fly Facility, established through funds from the University and the Wellcome Trust (087742/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LL, 2014, EPILEPSIA, V55, P1274, DOI 10.1111/epi.12657; Baines RA, 1998, J NEUROSCI, V18, P4673; Baxendale S, 2012, DIS MODEL MECH, V5, P773, DOI 10.1242/dmm.010090; Broussard GJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00097; Cunliffe VT, 2015, SEIZURE-EUR J EPILEP, V24, P44, DOI 10.1016/j.seizure.2014.09.018; Fosque BF, 2015, SCIENCE, V347, P755, DOI 10.1126/science.1260922; GANETZKY B, 1982, GENETICS, V100, P597; Ghannad-Rezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029869; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; Hekmat-Scafe DS, 2005, GENETICS, V169, P1477, DOI 10.1534/genetics.104.036558; Jefferys J.G.R., 2012, JASPERS BASIC MECH E, DOI DOI 10.1093/MED/9780199746545.003.0014; Jiruska P, 2013, J PHYSIOL-LONDON, V591, P787, DOI 10.1113/jphysiol.2012.239590; Kuebler D, 2001, J NEUROPHYSIOL, V86, P1211, DOI 10.1152/jn.2001.86.3.1211; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Lin WH, 2015, BRAIN, V138, P891, DOI 10.1093/brain/awv012; Lin WH, 2015, MOL NEUROBIOL, V51, P57, DOI 10.1007/s12035-014-8674-0; Lin WH, 2009, J NEUROPHYSIOL, V102, P1994, DOI 10.1152/jn.00613.2009; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marley R, 2011, J NEUROPHYSIOL, V106, P18, DOI 10.1152/jn.00808.2010; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Montaser-Kouhsari L, 2011, SEIZURE-EUR J EPILEP, V20, P409, DOI 10.1016/j.seizure.2011.01.014; Muraro Nara I, 2008, SEB Exp Biol Ser, V60, P141; Nieoczym D, 2013, PROG NEURO-PSYCHOPH, V47, P104, DOI 10.1016/j.pnpbp.2013.08.009; Noebels J, 2015, NAT NEUROSCI, V18, P344, DOI 10.1038/nn.3933; Parker L, 2011, GENETICS, V187, P523, DOI 10.1534/genetics.110.123299; Pulver SR, 2015, J NEUROPHYSIOL, V114, P2564, DOI 10.1152/jn.00731.2015; Reynolds ER, 2004, J NEUROBIOL, V58, P503, DOI 10.1002/neu.10297; Song J, 2008, PROG NEUROBIOL, V84, P182, DOI 10.1016/j.pneurobio.2007.10.006; Stafstrom Carl E, 2007, Epilepsy Curr, V7, P15, DOI 10.1111/j.1535-7511.2007.00156.x; Sun L, 2012, J NEUROSCI, V32, P14145, DOI 10.1523/JNEUROSCI.2932-12.2012; Tan JS, 2004, BRAIN RES, V1020, P45, DOI 10.1016/j.brainres.2004.05.111; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119	34	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148461	10.1371/journal.pone.0148461	http://dx.doi.org/10.1371/journal.pone.0148461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863447	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600076
J	Villandre, L; Stephens, DA; Labbe, A; Gunthard, HF; Kouyos, R; Stadler, T				Villandre, Luc; Stephens, David A.; Labbe, Aurelie; Guenthard, Huldrych F.; Kouyos, Roger; Stadler, Tanja		Swiss HIV Cohort Study	Assessment of Overlap of Phylogenetic Transmission Clusters and Communities in Simple Sexual Contact Networks: Applications to HIV-1	PLOS ONE			English	Article							MODEL	Background Transmission patterns of sexually-transmitted infections (STIs) could relate to the structure of the underlying sexual contact network, whose features are therefore of interest to clinicians. Conventionally, we represent sexual contacts in a population with a graph, that can reveal the existence of communities. Phylogenetic methods help infer the history of an epidemic and incidentally, may help detecting communities. In particular, phylogenetic analyses of HIV-1 epidemics among men who have sex with men (MSM) have revealed the existence of large transmission clusters, possibly resulting from within-community transmissions. Past studies have explored the association between contact networks and phylogenies, including transmission clusters, producing conflicting conclusions about whether network features significantly affect observed transmission history. As far as we know however, none of them thoroughly investigated the role of communities, defined with respect to the network graph, in the observation of clusters. Methods The present study investigates, through simulations, community detection from phylogenies. We simulate a large number of epidemics over both unweighted and weighted, undirected random interconnected-islands networks, with islands corresponding to communities. We use weighting to modulate distance between islands. We translate each epidemic into a phylogeny, that lets us partition our samples of infected subjects into transmission clusters, based on several common definitions from the literature. We measure similarity between subjects' island membership indices and transmission cluster membership indices with the adjusted Rand index. Results and Conclusion Analyses reveal modest mean correspondence between communities in graphs and phylogenetic transmission clusters. We conclude that common methods often have limited success in detecting contact network communities from phylogenies. The rarely-fulfilled requirement that network communities correspond to clades in the phylogeny is their main drawback. Understanding the link between transmission clusters and communities in sexual contact networks could help inform policymaking to curb HIV incidence in MSMs.	[Villandre, Luc; Labbe, Aurelie] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Stephens, David A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Labbe, Aurelie] Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [Guenthard, Huldrych F.; Kouyos, Roger] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Guenthard, Huldrych F.; Kouyos, Roger] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Stadler, Tanja] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Stadler, Tanja] Swiss Inst Bioinformat, Lausanne, Switzerland	McGill University; McGill University; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Stadler, T (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.; Stadler, T (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	tanja.stadler@bsse.ethz.ch	gunthard, huldrych f/F-1724-2011; Stadler, Tanja/J-4742-2013; Kouyos, Roger/ABB-2291-2021; Kouyos, Roger/G-6226-2014	gunthard, huldrych f/0000-0002-1142-6723; Stadler, Tanja/0000-0001-6431-535X; Kouyos, Roger/0000-0002-9220-8348; Kouyos, Roger/0000-0002-9220-8348; TARR, Philip/0000-0002-1488-5407; Egger, Matthias/0000-0001-7462-5132; Stephens, David/0000-0001-9811-7140	ThinkSwiss program; Fonds de recherche du Quebec-Sante (FRQS); Fonds de recherche-Nature et technologies (FRQNT) [232259]; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; Canadian Institutes of Health Research (CIHR) grant [CIHR HHP-126781]; Swiss National Science Foundation (SNF) [148522, PZ00P3-142411, 320030_159868]; SHCS Research Foundation; Yvonne Jacob Foundation; European Research Council under the Seventh Framework Programme of the European Commission [335529]; Swiss HIV Cohort Study (SHCS project) [776]	ThinkSwiss program; Fonds de recherche du Quebec-Sante (FRQS); Fonds de recherche-Nature et technologies (FRQNT); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SHCS Research Foundation; Yvonne Jacob Foundation; European Research Council under the Seventh Framework Programme of the European Commission; Swiss HIV Cohort Study (SHCS project)	L.V.' s research stay at the D-BSSE was partly funded by the ThinkSwiss program (http://thinkswiss.tumblr.com/About). L.V. received a training award from the Fonds de recherche du Quebec-Sante (FRQS, http://www.frqs.gouv.qc.ca/en/). A.L. received a team grant from the Fonds de recherche-Nature et technologies (FRQNT, number 232259, http://www.frqnt.gouv.qc.ca/accueil). D.A.S. was awarded a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng.asp). D.A.S. is funding L.V.' s work with a Canadian Institutes of Health Research (CIHR) grant (CIHR HHP-126781, http://www.cihr-irsc.gc.ca/e/193.html). The SHCS is supported by the Swiss National Science Foundation (SNF grant number 148522, http://www.snf.ch/en/Pages/default.aspx) and by the SHCS Research Foundation (http://www.shcs.ch). R. K. was supported by the Swiss National Science Foundation (SNF grant number PZ00P3-142411). H.F.G. was supported by the Swiss National Science Foundation (SNF grant number 320030_159868) and by the Yvonne Jacob Foundation. T.S. is supported in part by the European Research Council under the Seventh Framework Programme of the European Commission (PhyPD: grant agreement number 335529, http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has been conducted within the framework of the Swiss HIV Cohort Study (SHCS project number 776). The members of the SHCS are: Aubert V, Battegay M, Bernasconi E, Boni J, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H (Chairman of the Clinical and Laboratory Committee), Fux CA, Gorgievski M, Gunthard H (President of the SHCS), Haerry D (deputy of "Positive Council"), Hasse B, Hirsch HH, Hoffmann M, Hosli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Muller N, Nadal D, Nicca D, Pantaleo G, Rauch A (Chairman of the Scientific Board), Regenass S, Rickenbach M (Head of Data Centre), Rudin C (Chairman of the Mother & Child Substudy), Schoni-Affolter F, Schmid P, Schupbach J, Speck R, Tarr P, Telenti A, Trkola A, Vernazza P, Weber R, Yerly S.	Allen LJS, 2008, LECT NOTES MATH, V1945, P81, DOI 10.1007/978-3-540-78911-6_3; [Anonymous], 2015, STAGES HIV INFECT; Avila D, 2014, AM J EPIDEMIOL, V179, P1514, DOI 10.1093/aje/kwu076; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bocour A, 2010, SEX TRANSM DIS, V37, P784, DOI 10.1097/OLQ.0b013e3181e7107f; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2013, JAIDS-J ACQ IMM DEF, V63, pS248, DOI 10.1097/QAI.0b013e3182986f96; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Leventhal GE, 2014, MOL BIOL EVOL, V31, P6, DOI 10.1093/molbev/mst172; Leventhal GE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002413; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nguyen X. V., 2009, P 26 ANN INT C MACHI, P1073, DOI [10.1145/1553374.1553511, DOI 10.1145/1553374.1553511]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pons P, 2005, ARXIV PHYS E PRINTS; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Robinson K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003105; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Toivonen R, 2006, PHYSICA A, V371, P851, DOI 10.1016/j.physa.2006.03.050; Welch D, 2011, VIRUSES-BASEL, V3, P659, DOI 10.3390/v3060659; World Health Organization, 2012, PROGR UPD ANT TREATM; Zarrabi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046156	31	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148459	10.1371/journal.pone.0148459	http://dx.doi.org/10.1371/journal.pone.0148459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863322	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000370046600075
J	Yang, JF; Wang, Q; He, FF; Ding, YX; Sun, QY; Hua, TM; Xi, MM				Yang, Jinfang; Wang, Qian; He, Fenfen; Ding, Yanxia; Sun, Qingyan; Hua, Tianmiao; Xi, Minmin			Dietary Restriction Affects Neuronal Response Property and GABA Synthesis in the Primary Visual Cortex	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CALORIC RESTRICTION; NORADRENERGIC MODULATION; SYNAPTIC-TRANSMISSION; CORTICAL-CELLS; LIVE LONGER; BRAIN; INHIBITION; MECHANISMS; EXPRESSION	Previous studies have reported inconsistent effects of dietary restriction (DR) on cortical inhibition. To clarify this issue, we examined the response properties of neurons in the primary visual cortex (V1) of DR and control groups of cats using in vivo extracellular single-unit recording techniques, and assessed the synthesis of inhibitory neurotransmitter GABA in the V1 of cats from both groups using immunohistochemical and Western blot techniques. Our results showed that the response of V1 neurons to visual stimuli was significantly modified by DR, as indicated by an enhanced selectivity for stimulus orientations and motion directions, decreased visually-evoked response, lowered spontaneous activity and increased signal-to-noise ratio in DR cats relative to control cats. Further, it was shown that, accompanied with these changes of neuronal responsiveness, GABA immunoreactivity and the expression of a key GABA-synthesizing enzyme GAD67 in the V1 were significantly increased by DR. These results demonstrate that DR may retard brain aging by increasing the intracortical inhibition effect and improve the function of visual cortical neurons in visual information processing. This DR-induced elevation of cortical inhibition may favor the brain in modulating energy expenditure based on food availability.	[Yang, Jinfang; Wang, Qian; He, Fenfen; Ding, Yanxia; Sun, Qingyan; Hua, Tianmiao] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Xi, Minmin] Univ West Scotland, Sch Business, Glasgow, Lanark, Scotland	Anhui Normal University	Hua, TM (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China.	tmhua@ahnu.edu.cn			National Natural Science Foundation of China [31171082]; Anhui Provincial Natural Science Foundation [070413138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This research was supported by the National Natural Science Foundation of China (No. 31171082), Anhui Provincial Natural Science Foundation (No. 070413138), and Foundation of Anhui university scientific research innovation platform team (No. AT161805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2015, CURR OPIN NEUROBIOL, V31, P81, DOI 10.1016/j.conb.2014.08.016; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caputi A, 2013, CURR OPIN NEUROBIOL, V23, P179, DOI 10.1016/j.conb.2013.01.021; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; [陈翠云 Chen Cuiyun], 2014, [解剖学报, Acta Anatomica Sinica], V45, P304; Cheng CM, 2004, J NEUROSCI RES, V77, P270, DOI 10.1002/jnr.20144; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Chung KW, 2013, EXP GERONTOL, V48, P1049, DOI 10.1016/j.exger.2012.11.007; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; COLOMBO JP, 1992, ANN NUTR METAB, V36, P23, DOI 10.1159/000177695; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Ego-Stengel V, 2002, NEUROSCIENCE, V111, P275, DOI 10.1016/S0306-4522(02)00011-8; Escanilla O, 2010, EUR J NEUROSCI, V32, P458, DOI 10.1111/j.1460-9568.2010.07297.x; Flores CE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00327; Fontan-Lozano A, 2008, MOL NEUROBIOL, V38, P167, DOI 10.1007/s12035-008-8040-1; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gribble KE, 2013, J GERONTOL A-BIOL, V68, P349, DOI 10.1093/gerona/gls170; Hasselmo ME, 1997, J NEUROPHYSIOL, V77, P3326, DOI 10.1152/jn.1997.77.6.3326; Henneberger C, 2005, NEUROSCIENCE, V135, P749, DOI 10.1016/j.neuroscience.2005.06.044; Hestrin S, 2011, NEURON, V71, P197, DOI 10.1016/j.neuron.2011.07.007; Hirata A, 2006, J NEUROSCI, V26, P4426, DOI 10.1523/JNEUROSCI.5298-05.2006; Hong YM, 2014, GENET MOL RES, V13, P6455, DOI 10.4238/2014.August.25.9; Hu B, 2000, BRAIN RES, V885, P87, DOI 10.1016/S0006-8993(00)02946-2; Hua TM, 2008, BRAIN RES BULL, V75, P119, DOI 10.1016/j.brainresbull.2007.08.001; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Hua TM, 2009, NEUROSCI LETT, V451, P25, DOI 10.1016/j.neulet.2008.12.041; Hua TM, 2006, NEUROBIOL AGING, V27, P155, DOI 10.1016/j.neurobiolaging.2004.11.012; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ikeda MZ, 2015, J NEUROSCI, V35, P9356, DOI 10.1523/JNEUROSCI.4445-14.2015; Ingram DK, 2007, NEUROSCIENCE, V145, P1359, DOI 10.1016/j.neuroscience.2006.10.031; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kishi T, 2015, INT HEART J, V56, P110, DOI 10.1536/ihj.14-168; Kuhla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068778; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Leonhardt S, 1999, J NEUROENDOCRINOL, V11, P613; Levenson CW, 2007, NUTR REV, V65, P412, DOI 10.1111/j.1753-4887.2007.tb00319.x; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Liang Z, 2010, NEUROBIOL AGING, V31, P863, DOI 10.1016/j.neurobiolaging.2008.06.013; Ling LL, 2005, NEUROSCIENCE, V132, P1103, DOI 10.1016/j.neuroscience.2004.12.043; Luebke JI, 2004, NEUROSCIENCE, V125, P277, DOI 10.1016/j.neuroscience.2004.01.035; Mair W, 2010, AGING CELL, V9, P916, DOI 10.1111/j.1474-9726.2010.00602.x; Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002; Mattson MP, 2002, MECH AGEING DEV, V123, P947, DOI 10.1016/S0047-6374(02)00032-5; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; Meneguello-Coutinho M, 2014, IMMUNOL INVEST, V43, P113, DOI 10.3109/08820139.2013.847456; Meng JJ, 2013, EXP BRAIN RES, V225, P377, DOI 10.1007/s00221-012-3378-z; Moncada R, 2016, OBES SURG, V26, P1549, DOI 10.1007/s11695-015-1919-9; Mower GD, 2001, DEV BRAIN RES, V126, P65, DOI 10.1016/S0165-3806(00)00139-5; Moxon KA, 2007, BRAIN RES, V1147, P105, DOI 10.1016/j.brainres.2007.02.006; Mu SH, 2016, NEUROCHEM RES, V41, P707, DOI 10.1007/s11064-015-1739-2; Murphy T, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/563160; Nayak P, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-4; Newton IG, 2005, NEUROBIOL AGING, V26, P683, DOI 10.1016/j.neurobiolaging.2004.06.005; Okada M, 2003, MOL BRAIN RES, V111, P175, DOI 10.1016/S0169-328X(03)00028-7; Paille V, 2013, J NEUROSCI, V33, P9353, DOI 10.1523/JNEUROSCI.5796-12.2013; Palizvan MR, 2004, NEUROSCIENCE, V126, P955, DOI 10.1016/j.neuroscience.2004.03.053; Pani G, 2015, SEMIN CELL DEV BIOL, V40, P106, DOI 10.1016/j.semcdb.2015.03.004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peng Qing-Song, 2011, Zoological Research, V32, P337, DOI 10.3724/SP.J.1141.2011.03337; Pezet S, 2002, MOL CELL NEUROSCI, V21, P51, DOI 10.1006/mcne.2002.1166; Pinto JGA, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00016; Ribaric S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/741468; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Roth LW, 2012, MATURITAS, V71, P315, DOI 10.1016/j.maturitas.2011.12.017; Rudofsky G, 2011, HORM METAB RES, V43, P343, DOI 10.1055/s-0031-1271778; Sanchez-Huertas C, 2011, CEREB CORTEX, V21, P777, DOI 10.1093/cercor/bhq150; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Seki K, 2011, J EXP NEUROSCI, V5, P9, DOI 10.4137/JEN.S6833; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; Smyers ME, 2015, PHYSIOL BEHAV, V139, P303, DOI 10.1016/j.physbeh.2014.11.044; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Spolidoro M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1323; Tan N, 2016, HISTOPATHOLOGY, V68, P221, DOI 10.1111/his.12738; Thanos PK, 2008, SYNAPSE, V62, P50, DOI 10.1002/syn.20468; Tsutsumi A, 2011, BIOCHEM BIOPH RES CO, V404, P339, DOI 10.1016/j.bbrc.2010.11.120; Tucci P, 2012, AGING-US, V4, P525, DOI 10.18632/aging.100481; van de Lagemaat LN, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00394; Vaz SH, 2011, J BIOL CHEM, V286, P40464, DOI 10.1074/jbc.M111.232009; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Wang H, 2006, BRAIN RES, V1122, P93, DOI 10.1016/j.brainres.2006.09.010; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Xiang L, 2011, ANN NUTR METAB, V58, P42, DOI 10.1159/000323748; Yang Y, 2008, NEUROSCIENCE, V156, P748, DOI 10.1016/j.neuroscience.2008.08.007; Yoon H, 2008, BIOCHEM BIOPH RES CO, V371, P495, DOI 10.1016/j.bbrc.2008.04.102; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang K, 2014, NEUROSCIENCE, V275, P238, DOI 10.1016/j.neuroscience.2014.06.020; Zhou Jun, 2011, Zoological Research, V32, P533, DOI 10.3724/SP.J.1141.2011.05533	95	10	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149004	10.1371/journal.pone.0149004	http://dx.doi.org/10.1371/journal.pone.0149004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863207	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600137
J	Zhang, ZB; Nie, CS; Jia, YX; Jiang, RS; Xia, HJ; Lv, XZ; Chen, Y; Li, JY; Li, XY; Ning, ZH; Xu, GY; Chen, JL; Yang, N; Qu, LJ				Zhang, Zebin; Nie, Changsheng; Jia, Yaxiong; Jiang, Runshen; Xia, Haijian; Lv, Xueze; Chen, Yu; Li, Junying; Li, Xianyao; Ning, Zhonghua; Xu, Guiyun; Chen, Jilan; Yang, Ning; Qu, Lujiang			Parallel Evolution of Polydactyly Traits in Chinese and European Chickens	PLOS ONE			English	Article							RANGE SHH ENHANCER; TRIPHALANGEAL THUMB; POLARIZING ACTIVITY; MNX1 MUTATIONS; LMBR1 GENE; LIMB; EXPRESSION; MOUSE; ZRS; SEQUENCE	Polydactyly is one of the most common hereditary congenital limb malformations in chickens and other vertebrates. The zone of polarizing activity regulatory sequence (ZRS) is critical for the development of polydactyly. The causative mutation of polydactyly in the Silkie chicken has been mapped to the ZRS; however, the causative mutations of other chicken breeds are yet to be established. To understand whether the same mutation decides the polydactyly phenotype in other chicken breeds, we detected the single-nucleotide polymorphism in 26 different chicken breeds, specifically, 24 Chinese indigenous breeds and 2 European breeds. The mutation was found to have fully penetrated chickens with polydactyly in China, indicating that it is causative for polydactyly in Chinese indigenous chickens. In comparison, the mutation showed no association with polydactyly in Houdan chickens, which originate from France, Europe. Based on the different morphology of polydactyly in Chinese and European breeds, we assumed that the trait might be attributable to different genetic foundations. Therefore, we subsequently performed genome-wide association analysis (GWAS) to locate the region associated with polydactyly. As a result, a similar to 0.39 Mb genomic region on GGA2p was identified. The region contains six candidate genes, with the causative mutation found in Chinese indigenous breeds also being located in this region. Our results demonstrate that polydactyly in chickens from China and Europe is caused by two independent mutation events that are closely located in the chicken genome.	[Zhang, Zebin; Nie, Changsheng; Xia, Haijian; Li, Junying; Ning, Zhonghua; Xu, Guiyun; Yang, Ning; Qu, Lujiang] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Dept Anim Genet & Breeding, Beijing 100193, Peoples R China; [Jia, Yaxiong; Lv, Xueze; Chen, Yu] Beijing Municipal Gen Stn Anim Sci, Beijing 100107, Peoples R China; [Jiang, Runshen] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei 230036, Peoples R China; [Li, Xianyao] Shandong Agr Univ, Coll Anim Sci, Tai An 271018, Shandong, Peoples R China; [Chen, Jilan] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	China Agricultural University; Anhui Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Qu, LJ (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Dept Anim Genet & Breeding, Beijing 100193, Peoples R China.	quluj@163.com	Zhang, Zebin/AAE-4976-2019	Zhang, Zebin/0000-0002-9828-4245; Yang, Ning/0000-0001-5772-3320	earmarked fund for the Beijing Innovation Team of the Modern Agro-industry Technology Research System; New Star project in science and technology of Beijing Agriculture Municipal Bureau [20150304034219]; National Scientific Supporting Projects of China [2015BAD03B03]	earmarked fund for the Beijing Innovation Team of the Modern Agro-industry Technology Research System; New Star project in science and technology of Beijing Agriculture Municipal Bureau; National Scientific Supporting Projects of China	This work was funded in part by the earmarked fund for the Beijing Innovation Team of the Modern Agro-industry Technology Research System (http://219.232.192.143/bpm/main.jsp), New Star project in science and technology of Beijing Agriculture Municipal Bureau (20150304034219, http://www.bjny.gov.cn/) and National Scientific Supporting Projects of China (2015BAD03B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054454; Albuisson J, 2011, CLIN GENET, V79, P371, DOI 10.1111/j.1399-0004.2010.01465.x; American Poultry Association, 1998, AM STAND PERF; Anderson E, 2014, DEVELOPMENT, V141, P3934, DOI 10.1242/dev.108480; ASHCRAFT KW, 1974, J PEDIATR SURG, V9, P691, DOI 10.1016/0022-3468(74)90107-9; Babbs C, 2008, MECH DEVELOP, V125, P517, DOI 10.1016/j.mod.2008.01.001; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Belloni E, 2000, AM J HUM GENET, V66, P312, DOI 10.1086/302723; Bouldin CM, 2009, DEV BIOL, V334, P133, DOI 10.1016/j.ydbio.2009.07.009; Britton NF, 2003, ESSENTIAL MATH BIOL, P117; China National Commission of Animal Genetic Resources, 2010, AN GEN RES CHIN POUL; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Dodgson Jerry B, 2004, Curr Protoc Hum Genet, VChapter 15, DOI 10.1002/0471142905.hg1505s40; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Dunn IC, 2011, DEV DYNAM, V240, P1163, DOI 10.1002/dvdy.22623; Elgar G, 1996, TRENDS GENET, V12, P145, DOI 10.1016/0168-9525(96)10018-4; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Flanagan SE, 2014, CELL METAB, V19, P146, DOI 10.1016/j.cmet.2013.11.021; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Girisha KM, 2014, AM J MED GENET A, V164, P898, DOI 10.1002/ajmg.a.36367; Gopal M, 2007, EUR J PEDIATR SURG, V17, P214, DOI 10.1055/s-2007-965121; Gurnett CA, 2007, AM J MED GENET A, V143A, P27, DOI 10.1002/ajmg.a.31563; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang YQ, 2006, GENE, V374, P10, DOI 10.1016/j.gene.2005.07.047; Ianakiev P, 2001, AM J HUM GENET, V68, P38, DOI 10.1086/316955; Johnson EJ, 2014, DEV BIOL, V392, P209, DOI 10.1016/j.ydbio.2014.05.025; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li H, 2009, EUR J HUM GENET, V17, P604, DOI 10.1038/ejhg.2008.240; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lohan S, 2014, CLIN GENET, V86, P318, DOI 10.1111/cge.12352; Maas SA, 2004, DEV DYNAM, V229, P520, DOI 10.1002/dvdy.10502; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Merello E, 2013, EUR J MED GENET, V56, P648, DOI 10.1016/j.ejmg.2013.09.011; Qu LJ, 2006, SCI CHINA SER C, V49, P332, DOI 10.1007/s11427-006-2001-6; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sagai T, 2009, DEVELOPMENT, V136, P1665, DOI 10.1242/dev.032714; Sheng XH, 2015, GENE, V568, P176, DOI 10.1016/j.gene.2015.05.049; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; VanderMeer JE, 2014, HUM MUTAT, V35, P945, DOI 10.1002/humu.22581; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Wang ZQ, 2007, BIOCHEM BIOPH RES CO, V355, P312, DOI 10.1016/j.bbrc.2007.01.129; Warren DC, 1944, GENETICS, V29, P217; Wragg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071393; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Yang K, 2013, ANIM GENET, V44, P118, DOI 10.1111/j.1365-2052.2012.02369.x; Yang Y, 1998, DEVELOPMENT, V125, P3123; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zguricas J, 1999, J MED GENET, V36, P32; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	57	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149010	10.1371/journal.pone.0149010	http://dx.doi.org/10.1371/journal.pone.0149010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859147	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400119
J	Chan, BKK; Wang, TW; Chen, PC; Lin, CW; Chan, TY; Tsang, LM				Chan, Benny Kwok Kan; Wang, Teng-Wei; Chen, Pin-Chen; Lin, Chia-Wei; Chan, Tin-Yam; Tsang, Ling Ming			Community Structure of Macrobiota and Environmental Parameters in Shallow Water Hydrothermal Vents off Kueishan Island, Taiwan	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; NE-TAIWAN; OCEAN ACIDIFICATION; DEEP-SEA; PACIFIC; CRAB; DIVERSITY; BRACHYURA; GRADIENT; BEHAVIOR	Hydrothermal vents represent a unique habitat in the marine ecosystem characterized with high water temperature and toxic acidic chemistry. Vents are distributed at depths ranging from a few meters to several thousand meters. The biological communities of shallow-water vents have, however, been insufficiently studied in most biogeographic areas. We attempted to characterize the macrofauna and macroflora community inhabiting the shallow-water vents off Kueishan Island, Taiwan, to identify the main abiotic factors shaping the community structure and the species distribution. We determined that positively buoyant vent fluid exhibits a more pronounced negative impact to species on the surface water than on the bottom layer. Species richness increased with horizontal distance from the vent, and continuing for a distance of 2000 m, indicating that the vent fluid may exert a negative impact over several kilometers. The community structure off Kueishan Island displayed numerous transitions along the horizontal gradient, which were broadly congruent with changes in environmental conditions. Combination of variation in Ca2+, Cl-, temperature, pH and depth were revealed to show the strongest correlation with the change in benthic community structure, suggesting multiple factors of vent fluid were influencing the associated fauna. Only the vent crabs of Kueishan Island may have an obligated relationship with vents and inhabit the vent mouths because other fauna found nearby are opportunistic taxa that are more tolerant to acidic and toxic environments.	[Chan, Benny Kwok Kan; Wang, Teng-Wei] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chen, Pin-Chen] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Lin, Chia-Wei] Natl Museum Marine Biol & Aquarium, Dept Exhibit, Pingtung 944, Taiwan; [Chan, Tin-Yam; Tsang, Ling Ming] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Chan, Tin-Yam; Tsang, Ling Ming] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan	Academia Sinica - Taiwan; Tunghai University; National Museum of Marine Biology & Aquarium; National Taiwan Ocean University; National Taiwan Ocean University	Tsang, LM (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.; Tsang, LM (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.	lmtsang@mail.ntou.edu.tw	Tsang, Ling Ming/Q-7628-2018	Tsang, Ling Ming/0000-0002-5029-5690; Chan, Benny/0000-0001-9479-024X	Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan; Ministry of Science and Technology, Taiwan, R.O.C.	Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan; Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research is supported by funding from the Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan. This work is also supported by research grants from the Ministry of Science and Technology, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Chan IN, 2012, ZOOL STUD, V51, P1319; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Chen CTA, 2005, ACTA OCEANOL SIN, V24, P125; Chen YJ, 2015, BIOGEOSCIENCES, V12, P2631, DOI 10.5194/bg-12-2631-2015; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Dahms HU, 2013, J MAR SCI TECH-TAIW, V21, P711, DOI 10.6119/JMST-012-1128-1; Dai C, 2009, SCLERACTINIA FAUNA T; Dando PR, 2010, TOP GEOBIOL, V33, P333, DOI 10.1007/978-90-481-9572-5_11; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; FRICKE H, 1989, MAR BIOL, V102, P425, DOI 10.1007/BF00428495; Gorley C.K., 2006, GETTING STARTED PRIM; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hebbinghaus R, 2000, B I OCEANOGRAPHIQUE, V20, P355; Ho TW, 2015, MAR BIOL, V162, P1787, DOI 10.1007/s00227-015-2711-z; Hu MYA, 2012, AQUAT BIOL, V15, P11, DOI 10.3354/ab00396; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Jeng MS, 2004, NATURE, V432, P969, DOI 10.1038/432969a; Karlen DJ, 2010, PAC SCI, V64, P391, DOI 10.2984/64.3.391; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Li GX, 2006, CONT SHELF RES, V26, P1954, DOI 10.1016/j.csr.2006.06.008; Melwani AR, 2008, ACTA OECOL, V33, P162, DOI 10.1016/j.actao.2007.10.008; Merck KGaA Darmstadt, 1999, TEST KITS PHOT METH; Miyake S., 1982, MACRUCA ANOMURA STOM, VI, P1; Miyake S, 1983, BRACHYURA CRABS, V2; Morton B, 2006, J MAR BIOL ASSOC UK, V86, P141, DOI 10.1017/S0025315406012951; Ng NK, 2014, P BIOL SOC WASH, V127, P391, DOI 10.2988/0006-324X-127.2.391; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Okutani T., MARINE MOLLUSKS JAPA; Segawa S, 1962, COLOURED ILLUSTRATIO; Takeda M., 1993, NATURE ENV SCI RES, V6, P59; Tang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072958; Tarasov VG, 2006, ADV MAR BIOL, V50, P267, DOI 10.1016/S0065-2881(05)50004-X; Tarasov VG, 1999, CONT SHELF RES, V19, P79, DOI 10.1016/S0278-4343(98)00073-9; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thiermann F, 1997, MAR BIOL, V128, P149, DOI 10.1007/s002270050078; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Vermeij MJA, 2005, CORAL REEFS, V24, P442, DOI 10.1007/s00338-005-0489-z; Wang TW, 2014, MAR BIOL, V161, P2447, DOI 10.1007/s00227-014-2479-6; Wang TW, 2013, B MAR SCI, V89, P505, DOI 10.5343/bms.2012.1036; Yang LY, 2012, MAR CHEM, V128, P64, DOI 10.1016/j.marchem.2011.10.003; Zeng ZG, 2011, J ASIAN EARTH SCI, V40, P661, DOI 10.1016/j.jseaes.2010.10.019; Zeppilli D, 2009, AQUAT BIOL, V5, P75, DOI 10.3354/ab00140; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024	47	24	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148675	10.1371/journal.pone.0148675	http://dx.doi.org/10.1371/journal.pone.0148675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849440	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000154
J	Czaikoski, PG; Mota, JM; Nascimento, DC; Sonego, F; Castanheira, FVES; Melo, PH; Scortegagna, GT; Silva, RL; Barroso-Sousa, R; Souto, FO; Pazin, A; Figueiredo, F; Alves, JC; Cunha, FQ				Czaikoski, Paula Giselle; Mota, Jose Mauricio; Nascimento, Daniele Carvalho; Sonego, Fabiane; Vargas e Silva Castanheira, Fernanda; Melo, Paulo Henrique; Scortegagna, Gabriela Trentin; Silva, Rangel Leal; Barroso-Sousa, Romualdo; Souto, Fabricio Oliveira; Pazin-Filho, Antonio; Figueiredo, Florencio; Alves-Filho, Jose Carlos; Cunha, Fernando Queiroz			Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis	PLOS ONE			English	Article							POLYMICROBIAL SEPSIS; NETTING NEUTROPHILS; KIDNEY INJURY; HISTONES; LUNG; PATHOPHYSIOLOGY; CONTRIBUTE; MIGRATION; FAILURE; NETOSIS	Organ dysfunction is a major concern in sepsis pathophysiology and contributes to its high mortality rate. Neutrophil extracellular traps (NETs) have been implicated in endothelial damage and take part in the pathogenesis of organ dysfunction in several conditions. NETs also have an important role in counteracting invading microorganisms during infection. The aim of this study was to evaluate systemic NETs formation, their participation in host bacterial clearance and their contribution to organ dysfunction in sepsis. C57Bl/6 mice were subjected to endotoxic shock or a polymicrobial sepsis model induced by cecal ligation and puncture (CLP). The involvement of cf-DNA/NETs in the physiopathology of sepsis was evaluated through NETs degradation by rhDNase. This treatment was also associated with a broad-spectrum antibiotic treatment (ertapenem) in mice after CLP. CLP or endotoxin administration induced a significant increase in the serum concentrations of NETs. The increase in CLP-induced NETs was sustained over a period of 3 to 24 h after surgery in mice and was not inhibited by the antibiotic treatment. Systemic rhDNase treatment reduced serum NETs and increased the bacterial load in non-antibiotic-treated septic mice. rhDNase plus antibiotics attenuated sepsis-induced organ damage and improved the survival rate. The correlation between the presence of NETs in peripheral blood and organ dysfunction was evaluated in 31 septic patients. Higher cf-DNA concentrations were detected in septic patients in comparison with healthy controls, and levels were correlated with sepsis severity and organ dysfunction. In conclusion, cf-DNA/NETs are formed during sepsis and are associated with sepsis severity. In the experimental setting, the degradation of NETs by rhDNase attenuates organ damage only when combined with antibiotics, confirming that NETs take part in sepsis pathogenesis. Altogether, our results suggest that NETs are important for host bacterial control and are relevant actors in the pathogenesis of sepsis.	[Czaikoski, Paula Giselle; Sonego, Fabiane; Vargas e Silva Castanheira, Fernanda; Silva, Rangel Leal; Alves-Filho, Jose Carlos; Cunha, Fernando Queiroz] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, BR-14049 Ribeirao Preto, Brazil; [Mota, Jose Mauricio; Barroso-Sousa, Romualdo; Pazin-Filho, Antonio] Univ Sao Paulo, Dept Clin, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, Brazil; [Nascimento, Daniele Carvalho; Melo, Paulo Henrique; Scortegagna, Gabriela Trentin; Souto, Fabricio Oliveira] Univ Sao Paulo, Dept Biochem & Immunol, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, Brazil; [Figueiredo, Florencio] Univ Brasilia, Dept Pathol, Sch Med, Brasilia, DF, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Brasilia	Cunha, FQ (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, BR-14049 Ribeirao Preto, Brazil.	fdqcunha@fmrp.usp.br	Cunha, Fernando Q/M-3090-2014; Souto, Fabricio/AAS-7671-2020; Barroso-Sousa, Romualdo/G-2244-2014; Alves-Filho, Jose Carlos/B-5814-2008; BARROSO-SOUSA, ROMUALDO/T-6405-2019; Silva, Rangel Leal/G-2009-2016; Pazin Filho, Antonio/E-9495-2010; Mota, Jose Mauricio/O-5577-2015; Souto, Fabricio/AAX-8668-2021; SCORTEGAGNA, GABRIELA/GPK-6327-2022	Barroso-Sousa, Romualdo/0000-0002-1825-9876; Alves-Filho, Jose Carlos/0000-0002-9918-8714; BARROSO-SOUSA, ROMUALDO/0000-0002-1825-9876; Silva, Rangel Leal/0000-0002-1322-7808; Pazin Filho, Antonio/0000-0001-5242-329X; Mota, Jose Mauricio/0000-0001-9510-6956; Souto, Fabricio/0000-0002-2392-8499; Castanheira, Fernanda/0000-0002-2024-7858; Cunha, Fernando Queiroz/0000-0003-4755-1670; De Melo, Paulo/0000-0001-8911-1142	European Union [HEALTH-F4-2011-281608]; Sao Paulo Research Foundation (FAPESP) [2011/19670-0, 2013/08216-2]; University of Sao Paulo NAP-DIN [11.1.21625.01.0]	European Union(European Commission); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Sao Paulo NAP-DIN	The authors have received financial support from European Union Seventh Framework Programme (FP7-2007-2013) under grant agreement number HEALTH-F4-2011-281608 (TIMER), from Sao Paulo Research Foundation (FAPESP - http://www.fapesp.br/en/) under grant agreements number 2011/19670-0 (projeto tematico) and 2013/08216-2 (Center for Research in Inflammatory Disease), and from University of Sao Paulo NAP-DIN under grant agreement number 11.1.21625.01.0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Canetti C, 2001, BRIT J PHARMACOL, V134, P1619, DOI 10.1038/sj.bjp.0704403; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; CUNHA FQ, 1994, IMMUNOLOGY, V81, P211; Fattahi F, 2015, IMMUNOL RES, V61, P177, DOI 10.1007/s12026-015-8628-2; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gao X, 2015, J SURG RES, V195, P211, DOI 10.1016/j.jss.2014.12.019; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hamaguchi S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/614518; Hashiba M, 2015, J SURG RES, V194, P248, DOI 10.1016/j.jss.2014.09.033; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lopes JA, 2008, CRIT CARE, V12, DOI 10.1186/cc6997; Luo LT, 2014, AM J PHYSIOL-LUNG C, V307, pL586, DOI 10.1152/ajplung.00365.2013; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Martinod K, 2015, BLOOD, V125, P1948, DOI 10.1182/blood-2014-07-587709; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Tanaka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111888; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637	47	195	210	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148142	10.1371/journal.pone.0148142	http://dx.doi.org/10.1371/journal.pone.0148142			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849138	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000043
J	Hsu, WY; Lin, CL; Kao, CH				Hsu, Wen-Yu; Lin, Cheng-Li; Kao, Chia-Hung			A Population-Based Cohort Study on Peripheral Arterial Disease in Patients with Schizophrenia	PLOS ONE			English	Article							ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; DIABETES-MELLITUS; OCCLUSIVE DISEASE; RISK-FACTORS; PREVALENCE; MORTALITY; PEOPLE; ANTIPSYCHOTICS; HYPERLIPIDEMIA	Purpose Peripheral arterial disease (PAD) is considered the leading cause of atherosclerotic cardiovascular morbidity. Several risk factors of PAD have been observed in patients with schizophrenia. Therefore, we hypothesize that the incidence of PAD is higher in the schizophrenia population than in the general population. Methods The patients in this population-based cohort study were selected from the Taiwanese National Health Insurance Research Database on the basis of the claims data from 2000 to 2011. We compared the incidence of PAD between schizophrenia and nonschizophrenia cohorts. Cox proportional hazard regression models were employed for analyzing the risk of PAD after adjustment for sex, age, and comorbidities. Results The adjusted hazard ratio (HR) for PAD in the schizophrenia cohort was 1.26-fold higher than that in the nonschizophrenia cohort. Furthermore, patients with schizophrenia using atypical antipsychotics exhibited a high adjusted HR for PAD. Conclusion Compared with the general population, the risk of PAD is higher among patients with schizophrenia. Early diagnosis and intervention can mitigate complications resulting from cardiovascular diseases and lower mortality.	[Hsu, Wen-Yu] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hsu, Wen-Yu] Lutung Christian Hosp, Dept Psychiat, Lukang, Taiwan; [Hsu, Wen-Yu] Chung Shan Med Univ, Sch Med, Dept Psychiat, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039 -006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Bai YM, 2013, J AFFECT DISORDERS, V150, P57, DOI 10.1016/j.jad.2013.02.019; Barrett E, 2004, OBES RES, V12, P362; Beratis S, 2001, COMPR PSYCHIAT, V42, P393, DOI 10.1053/comp.2001.26273; Burghardt KJ, 2014, J PSYCHOPHARMACOL, V28, P349, DOI 10.1177/0269881113516200; Cacoub Patrice P, 2009, Atherosclerosis, V204, pe86, DOI 10.1016/j.atherosclerosis.2008.10.023; Carman TL, 2000, AM FAM PHYSICIAN, V61, P1027; Ciccone MM, 2014, J DIABETES METAB, V5, DOI 10.4172/2155-6156.1000364; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Ellingrod VL, 2011, SCHIZOPHR RES, V130, P20, DOI 10.1016/j.schres.2011.03.031; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Hooi JD, 2001, AM J EPIDEMIOL, V153, P666, DOI 10.1093/aje/153.7.666; Hsieh PH, 2013, J CLIN PSYCHOPHARM, V33, P299, DOI 10.1097/JCP.0b013e3182900dfe; Hsu JH, 2012, GEN HOSP PSYCHIAT, V34, P360, DOI 10.1016/j.genhosppsych.2012.02.004; Israel AK, 2011, SCHIZOPHR RES, V128, P44, DOI 10.1016/j.schres.2011.02.007; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; McCreadie RG, 2002, BRIT J PSYCHIAT, V181, P321, DOI 10.1192/bjp.181.4.321; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shammas NW, 2007, VASC HEALTH RISK MAN, V3, P229, DOI 10.2147/vhrm.2007.3.2.229; Sigvant B, 2007, J VASC SURG, V45, P1185, DOI 10.1016/j.jvs.2007.02.004; Stubbs B, 2015, ACTA PSYCHIAT SCAND, V132, P144, DOI 10.1111/acps.12439; Vancampfort D, 2012, ACTA PSYCHIAT SCAND, V125, P352, DOI 10.1111/j.1600-0447.2011.01814.x	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148759	10.1371/journal.pone.0148759	http://dx.doi.org/10.1371/journal.pone.0148759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871697	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100053
J	Shulgin, B; Helmlinger, G; Kosinsky, Y				Shulgin, Boris; Helmlinger, Gabriel; Kosinsky, Yuri			A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies	PLOS ONE			English	Article							T-CELLS; IN-VIVO; BIOLOGICAL-ACTIVITY; ANTI-IL-2 MABS; CUTTING EDGE; RECEPTOR; COMPLEXES; IL-2; INTERNALIZATION; BINDING	Enhancement or inhibition of cytokine signaling and corresponding immune cells responses are critical factors in various disease treatments. Cytokine signaling may be inhibited by cytokine-neutralizing antibodies (CNAs), which prevents further activation of cytokine receptors. However, CNAs may result in enhanced-instead of inhibitory-cytokine signaling (an "agonistic effect") in various in vitro and in vivo experiments. This may lead to lack of efficacy or adverse events for cytokine-inhibiting based medicines. Alternatively, cytokine-antibody complexes may produce stronger signaling vs. cytokine alone, thereby increasing the efficacy of stimulating cytokine-based drugs, at equal or lower cytokine doses. In this paper, the effect of cytokine signaling enhancement by a CNA was studied in a generic mathematical model of interleukin-4 (IL-4) driven T-cell proliferation. The occurrence of the agonistic effect depends upon the antibody-to-cytokine binding affinity and initial concentrations of antibody and cytokine. Model predictions were in agreement with experimental studies. When the cytokine receptor consists of multiple subunits with substantially differing affinities (e.g., IL-4 case), the choice of the receptor chain to be blocked by the antibody is critical, for the agonistic effect to appear. We propose a generic mechanism for the effect: initially, binding of the CNA to the cytokine reduces free cytokine concentration; yet, cytokine molecules bound within the cytokine-CNA complex-and released later and over time-are "rescued" from earlier clearance via cellular internalization. Hence, although free cytokine-dependent signalling may be less potent initially, it will also be more sustained over time; and given non-linear dynamics, it will lead ultimately to larger cellular effector responses, vs. the same amount of free cytokine in the absence of CNA. We suggest that the proposed mechanism is a generic property of {cytokine, CNA, receptor} triads, both in vitro and in vivo, and can occur in a predictable fashion for a variety of cytokines of the immune system.	[Shulgin, Boris; Kosinsky, Yuri] M&S Decis LLC, Moscow, Russia; [Helmlinger, Gabriel] AstraZeneca Pharmaceut LP, Innovat Med, Early Clin Dev, Quantitat Clin Pharmacol, Waltham, MA USA	AstraZeneca	Helmlinger, G (corresponding author), AstraZeneca Pharmaceut LP, Innovat Med, Early Clin Dev, Quantitat Clin Pharmacol, Waltham, MA USA.	gabriel.helmlinger@astrazeneca.com	Shulgin, Boris V/ABI-7645-2020	Shulgin, Boris/0000-0003-2117-3499				BENDTZEN K, 1990, IMMUNOL TODAY, V11, P167, DOI 10.1016/0167-5699(90)90068-K; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Boyman Surh C, 2006, VACCINES ANTIBODIES, V6, P1323; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Fallon EM, 2000, BIOTECHNOL PROGR, V16, P905, DOI 10.1021/bp000097t; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Friedrich K, 1999, EUR J BIOCHEM, V265, P457, DOI 10.1046/j.1432-1327.1999.00773.x; GALIZZI JP, 1989, J BIOL CHEM, V264, P6984; Garcia-Martinez K, 2012, INT IMMUNOL, V24, P427, DOI 10.1093/intimm/dxr120; Hamilton SE, 2010, J IMMUNOL, V185, P6584, DOI 10.4049/jimmunol.1001215; Hao JW, 2011, ANN NEUROL, V69, P721, DOI 10.1002/ana.22339; Jin GH, 2008, INT IMMUNOL, V20, P783, DOI 10.1093/intimm/dxn036; JONES AT, 1993, BLOOD, V82, P1133; Jung T, 1999, EUR J IMMUNOL, V29, P864, DOI 10.1002/(SICI)1521-4141(199903)29:03<864::AID-IMMU864>3.0.CO;2-T; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leon K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00439; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Martin CE, 2013, BLOOD, V121, P4484, DOI 10.1182/blood-2012-08-449215; MAY LT, 1993, J IMMUNOL, V151, P3225; Molloy MJ, 2009, J IMMUNOL, V182, P4512, DOI 10.4049/jimmunol.0804175; Morelon E, 1998, J BIOL CHEM, V273, P22044, DOI 10.1074/jbc.273.34.22044; Mostbock S, 2009, CURR PHARM DESIGN, V15, P809, DOI 10.2174/138161209787582174; Phelan JD, 2008, J IMMUNOL, V180, P44, DOI 10.4049/jimmunol.180.1.44; Ramanathan M, 1996, PHARMACEUT RES, V13, P84, DOI 10.1023/A:1016033418207; RATHJEN DA, 1992, BRIT J CANCER, V65, P852, DOI 10.1038/bjc.1992.180; Reynolds J, 2013, FRONTIERS IMMUNOLOGY, V4, P1; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Rubinstein MP, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-75; SATO TA, 1993, J IMMUNOL, V150, P2717; Votavova P, 2014, IMMUNOL LETT, V159, P1, DOI 10.1016/j.imlet.2014.01.017; Whitty A, 1998, P NATL ACAD SCI USA, V95, P13165, DOI 10.1073/pnas.95.22.13165; Zabeau L, 2001, EUR J IMMUNOL, V31, P1087, DOI 10.1002/1521-4141(200104)31:4<1087::AID-IMMU1087>3.0.CO;2-Q; Zhao Y, 2013, OXID STRESS CELL LON, V2013, P1, DOI DOI 10.1155/2013/316523	37	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149154	10.1371/journal.pone.0149154	http://dx.doi.org/10.1371/journal.pone.0149154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870966	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100113
J	Cullen, JK; Murad, NA; Yeo, A; McKenzie, M; Ward, M; Chong, KL; Schieber, NL; Parton, RG; Lim, YC; Wolvetang, E; Maghzal, GJ; Stocker, R; Lavin, MF				Cullen, Jason K.; Murad, Norazian Abdul; Yeo, Abrey; McKenzie, Matthew; Ward, Micheal; Chong, Kok Leong; Schieber, Nicole L.; Parton, Robert G.; Lim, Yi Chieh; Wolvetang, Ernst; Maghzal, Ghassan J.; Stocker, Roland; Lavin, Martin F.			AarF Domain Containing Kinase 3 (ADCK3) Mutant Cells Display Signs of Oxidative Stress, Defects in Mitochondrial Homeostasis and Lysosomal Accumulation	PLOS ONE			English	Article							COENZYME Q(10) DEFICIENCY; SACCHAROMYCES-CEREVISIAE; UBIQUINONE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; COQ(10) DEFICIENCY; CEREBELLAR-ATAXIA; RAT-LIVER; LIFE-SPAN; COMPLEX; MUTATIONS	Autosomal recessive ataxias are a clinically diverse group of syndromes that in some cases are caused by mutations in genes with roles in the DNA damage response, transcriptional regulation or mitochondrial function. One of these ataxias, known as Autosomal Recessive Cerebellar Ataxia Type-2 (ARCA-2, also known as SCAR9/COQ10D4; OMIM: #612016), arises due to mutations in the ADCK3 gene. The product of this gene (ADCK3) is an atypical kinase that is thought to play a regulatory role in coenzyme Q(10) (CoQ(10)) biosynthesis. Although much work has been performed on the S. cerevisiae orthologue of ADCK3, the cellular and biochemical role of its mammalian counterpart, and why mutations in this gene lead to human disease is poorly understood. Here, we demonstrate that ADCK3 localises to mitochondrial cristae and is targeted to this organelle via the presence of an N-terminal localisation signal. Consistent with a role in CoQ(10) biosynthesis, ADCK3 deficiency decreased cellular CoQ(10) content. In addition, endogenous ADCK3 was found to associate in vitro with recombinant Coq3, Coq5, Coq7 and Coq9, components of the CoQ(10) biosynthetic machinery. Furthermore, cell lines derived from ARCA-2 patients display signs of oxidative stress, defects in mitochondrial homeostasis and increases in lysosomal content. Together, these data shed light on the possible molecular role of ADCK3 and provide insight into the cellular pathways affected in ARCA-2 patients.	[Cullen, Jason K.; Murad, Norazian Abdul; Yeo, Abrey; Lim, Yi Chieh] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [McKenzie, Matthew] Ctr Genet Dis, Hudson Inst Med Res, Melbourne, Vic, Australia; [Ward, Micheal] Translat Res Inst, Glycat & Diabet Complicat Grp, Mater Med Res Inst, Brisbane, Qld, Australia; [Chong, Kok Leong] Queensland Univ Technol, ARC Ctr Excellence Free Radical Chem & Biotechnol, Brisbane, Qld 4001, Australia; [Schieber, Nicole L.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Schieber, Nicole L.; Parton, Robert G.] Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Wolvetang, Ernst] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Maghzal, Ghassan J.; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Darlinghurst, NSW, Australia; [Murad, Norazian Abdul] UKM Med Mol Biol Inst, Kuala Lumpur, Malaysia; [Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; Hudson Institute of Medical Research; Mater Research; Queensland University of Technology (QUT); University of Queensland; University of Queensland; University of Queensland; Victor Chang Cardiac Research Institute; Universiti Kebangsaan Malaysia; University of Queensland	Cullen, JK (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Lavin, MF (corresponding author), Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.	jason.cullen@qimrberghofer.edu.au; m.lavin@uq.edu.au	McKenzie, Matthew/H-4926-2019; Yeo, Abrey J/D-9695-2015; Wolvetang, Ernst jurgen/D-6644-2017; Stocker, Roland/AAV-4489-2021; Stocker, Roland/L-9157-2019; Parton, Robert/C-5673-2009; Lavin, Martin/F-5961-2014	McKenzie, Matthew/0000-0001-7508-1800; Yeo, Abrey J/0000-0003-4470-4854; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Schieber, Nicole L./0000-0002-3212-5057; Lim, Yi Chieh/0000-0003-1261-5419; Parton, Robert/0000-0002-7494-5248; Lavin, Martin/0000-0002-5940-4769; Cullen, Jason/0000-0003-4961-1673	Australian Research Council (ARC) [DP1092466]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by the Australian Research Council (ARC Discovery Project Grant DP1092466). See www.arc.gov.au.; We would like to thank Prof. Michel Koenig for supplying the adck3 mutant cell lines described in this work and Jason Liminos for generating lentiviral LC3-GFP particles. Many thanks also go to Dr. Sergei Kozlov and Dr. Olivier Becherel for advice related to experimentation and critical reading of the manuscript, and Dr. Kerenaftali Klein for statistical help. The authors also acknowledge the facilities and the scientific and technical assistance of 1) The Flow Cytometry and Imaging Facility, QIMR Berghofer Medical Research Institute and 2) The Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy and Microanalysis, The University of Queensland. This work was supported by the Australian Research Council (ARC Discovery Project Grant DP1092466).	Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; CHEN PC, 1978, NATURE, V274, P484, DOI 10.1038/274484a0; De Rasmo D, 2008, CELL SIGNAL, V20, P989, DOI 10.1016/j.cellsig.2008.01.017; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Devun F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011792; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gazdag Z, 2011, FOLIA MICROBIOL, V56, P353, DOI 10.1007/s12223-011-0058-5; Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Iiizumi M, 2002, CANCER RES, V62, P1246; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KALEN A, 1990, J BIOL CHEM, V265, P1158; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2; Miyamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016054; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nohl H, 2005, REDOX REP, V10, P199, DOI 10.1179/135100005X70170; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SATTLER W, 1994, METHOD ENZYMOL, V233, P469; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Smith Bryan John, 2003, Methods Mol Biol, V211, P19; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; TECLEBRHAN H, 1993, J BIOL CHEM, V268, P23081; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	60	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148213	10.1371/journal.pone.0148213	http://dx.doi.org/10.1371/journal.pone.0148213			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866375	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700011
J	de Greef, BTA; Hoeijmakers, JGJ; Wolters, EE; Smeets, HJM; van den Wijngaard, A; Merkies, ISJ; Faber, CG; Gerrits, MM				de Greef, Bianca T. A.; Hoeijmakers, Janneke G. J.; Wolters, Emma E.; Smeets, Hubertus J. M.; van den Wijngaard, Arthur; Merkies, Ingemar S. J.; Faber, Catharina G.; Gerrits, Monique M.			No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE-BETA THERAPY; PAINFUL NEUROPATHY; BASE-LINE; DIAGNOSIS; MUTATIONS; DENSITY	Objective Screening for Fabry disease in patients with small fiber neuropathy has been suggested, especially since Fabry disease is potentially treatable. However, the diagnostic yield of testing for Fabry disease in isolated small fiber neuropathy patients has never been systematically investigated. Our aim is to determine the presence of Fabry disease in patients with small fiber neuropathy. Methods Patients referred to our institute, who met the criteria for isolated small fiber neuropathy were tested for Fabry disease by measurement of alpha-Galactosidase A activity in blood, lysosomal globotriaosylsphingosine in urine and analysis on possible GLA gene mutations. Results 725 patients diagnosed with small fiber neuropathy were screened for Fabry disease. No skin abnormalities were seen except for redness of the hands or feet in 30.9% of the patients. Alfa-Galactosidase A activity was tested in all 725 patients and showed diminished activity in eight patients. Lysosomal globotriaosylsphingosine was examined in 509 patients and was normal in all tested individuals. Screening of GLA for mutations was performed for 440 patients, including those with diminished alpha-Galactosidase A activity. Thirteen patients showed a GLA gene variant. One likely pathogenic variant was found in a female patient. The diagnosis Fabry disease could not be confirmed over time in this patient. Eventually none of the patients were diagnosed with Fabry disease. Conclusions In patients with isolated small fiber neuropathy, and no other signs compatible with Fabry disease, the diagnostic yield of testing for Fabry disease is extremely low. Testing for Fabry disease should be considered only in cases with additional characteristics, such as childhood onset, cardiovascular disease, renal failure, or typical skin lesions.	[de Greef, Bianca T. A.; Hoeijmakers, Janneke G. J.; Wolters, Emma E.; Merkies, Ingemar S. J.; Faber, Catharina G.] Maastricht Univ, Med Ctr, Dept Neurol, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands; [Smeets, Hubertus J. M.; van den Wijngaard, Arthur] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [Merkies, Ingemar S. J.; Gerrits, Monique M.] Spaarne Hosp, Dept Neurol, Hoofddorp, Netherlands	Maastricht University; Maastricht University; Spaarne Hospital	de Greef, BTA (corresponding author), Maastricht Univ, Med Ctr, Dept Neurol, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands.	bianca.greef@mumc.nl	Hoeijmakers, Janneke/AAI-7260-2020	Gerrits, Monique/0000-0002-9503-9404	Prinses Beatrix Spierfonds [W.OR12-01]; GBS/CIDP foundation international for PeriNomS study; European Union 7th Framework Programme [602273]	Prinses Beatrix Spierfonds; GBS/CIDP foundation international for PeriNomS study; European Union 7th Framework Programme	The authors of this manuscript have the following competing interests: BTAG reports a grant from the Prinses Beatrix Spierfonds (W.OR12-01), outside the submitted work. JGJH reports no disclosure. EEW reports no disclosure. HJMS reports no disclosure. AW reports no disclosure. ISJM reports grants from GBS/CIDP foundation international for PeriNomS study and from European Union 7th Framework Programme (grant agreement no. 602273, 2013); Participation in steering committees of the Talecris ICE Study, CSL Behring, LFB, Novartis and Octapharma (a research foundation at the University of Maastricht received the honoraria on behalf of dr. Merkies), outside the submitted work. CGF reports grants from European Union 7th Framework Programme (grant agreement no. 602273, 2013), outside the submitted work, and the Prinses Beatrix Spierfonds (W.OR12-01), outside the submitted work. MMG reports a grant from European Union 7th Framework Programme (grant agreement no. 602273, 2013), outside the submitted work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Auray-Blais C, 2010, CLIN CHIM ACTA, V411, P1906, DOI 10.1016/j.cca.2010.07.038; Bakkers M, 2015, MUSCLE NERVE, V51, P870, DOI 10.1002/mus.24473; Bakkers M, 2014, MUSCLE NERVE, V49, P329, DOI 10.1002/mus.23910; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Bertelsen AK, 2013, J NEUROL, V260, P917, DOI 10.1007/s00415-012-6800-3; Biegstraaten M, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0365-4; Biegstraaten M, 2012, MOL GENET METAB, V106, P135, DOI 10.1016/j.ymgme.2012.03.010; Biegstraaten M, 2011, EUR J PAIN, V15, P822, DOI 10.1016/j.ejpain.2011.01.014; Burlina AP, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-61; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; Desnick RJ IY, 2001, METABOLIC MOL BASES; El-Abassi R, 2014, J NEUROL SCI, V344, P5, DOI 10.1016/j.jns.2014.06.029; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Gal A, 2011, J INHERIT METAB DIS, V34, P509, DOI 10.1007/s10545-010-9261-9; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Gorson KC, 2008, J NEUROL NEUROSUR PS, V79, P163, DOI 10.1136/jnnp.2007.128801; GORSON KC, 1995, ACTA NEUROL SCAND, V92, P376; Hilz MJ, 2004, NEUROLOGY, V62, P1066, DOI 10.1212/01.WNL.0000118207.84514.40; Hoeijmakers JG, 2012, NAT REV NEUROL, V8, P369, DOI 10.1038/nrneurol.2012.97; Huang JY, 2014, BRAIN, V137, P1627, DOI 10.1093/brain/awu079; Lauria G, 2010, J PERIPHER NERV SYST, V15, P202, DOI 10.1111/j.1529-8027.2010.00271.x; MacDermot J, 2001, EUR J PHARMACOL, V429, P121, DOI 10.1016/S0014-2999(01)01312-7; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Mehta A, 2002, GENEREVIEWS; Peters MJH, 2013, NEUROLOGY, V81, P1356, DOI 10.1212/WNL.0b013e3182a8236e; Salviati A, 2010, NEUROL SCI, V31, P299, DOI 10.1007/s10072-009-0211-y; Samuelsson K, 2014, J CLIN NEUROL, V10, P108, DOI 10.3988/jcn.2014.10.2.108; Schiffmann R, 2006, MUSCLE NERVE, V34, P53, DOI 10.1002/mus.20550; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; STEWART JD, 1992, MUSCLE NERVE, V15, P661, DOI 10.1002/mus.880150605; Tanislav C, 2011, EUR J NEUROL, V18, P631, DOI 10.1111/j.1468-1331.2010.03227.x; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Uceyler N, 2011, J PERIPHER NERV SYST, V16, P304, DOI 10.1111/j.1529-8027.2011.00365.x; van der Tol L, 2014, J MED GENET, V51, P1, DOI 10.1136/jmedgenet-2013-101857; Wallis Y, 2013, ASS CLIN GENETIC SCI, P1; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; YARNITSKY D, 1994, J NEUROL SCI, V125, P39, DOI 10.1016/0022-510X(94)90239-9; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	39	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148316	10.1371/journal.pone.0148316	http://dx.doi.org/10.1371/journal.pone.0148316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866599	gold, Green Submitted, Green Published			2022-12-26	WOS:000370050700013
J	Ndir, A; Diop, A; Faye, PM; Cisse, MF; Ndoye, B; Astagneau, P				Ndir, Awa; Diop, Amadou; Faye, Pape Makhtar; Cisse, Moussa Fafa; Ndoye, Babacar; Astagneau, Pascal			Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal	PLOS ONE			English	Article							TIME-DEPENDENT BIAS; LENGTH-OF-STAY; RISK-FACTORS; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; ECONOMIC-IMPACT; BACTEREMIA; MORTALITY; CHILDREN	Context Severe bacterial infections are not considered as a leading cause of death in young children in sub-Saharan Africa. The worldwide emergence of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) could change the paradigm, especially in neonates who are at high risk of developing healthcare-associated infections. Objective To evaluate the epidemiology and the burden of ESBL-E bloodstream infections (BSI). Methods A case-case-control study was conducted in patients admitted in a pediatric hospital during two consecutive years. Cases were patients with Enterobacteriaceae BSI and included ESBL-positive (cases 1) and ESBL-negative BSI (cases 2). Controls were patients with no BSI. Multivariate analysis using a stepwise logistic regression was performed to identify risk factors for ESBL acquisition and for fatal outcomes. A multistate model was used to estimate the excess length of hospital stay (LOS) attributable to ESBL production while accounting for time of infection. Cox proportional hazards models were performed to assess the independent effect of ESBL-positive and negative BSI on LOS. Results The incidence rate of ESBL-E BSI was of 1.52 cases/1000 patient-days (95% CI: 1.2-5.6 cases per 1000 patient-days). Multivariate analysis showed that independent risk factors for ESBL-BSI acquisition were related to underlying comorbidities (sickle cell disease OR = 3.1 (95% CI: 2.3-4.9), malnutrition OR = 2.0 (95% CI: 1.7-2.6)) and invasive procedures (mechanical ventilation OR = 3.5 (95% CI: 2.7-5.3)). Neonates were also identified to be at risk for ESBL-E BSI. Inadequate initial antibiotic therapy was more frequent in ESBL-positive BSI than ESBL-negative BSI (94.2% versus 5.7%, p<0.0001). ESBL-positive BSI was associated with higher case-fatality rate than ESBL-negative BSI (54.8% versus 15.4%, p<0.001). Multi-state modelling indicated an excess LOS attributable to ESBL production of 4.3 days. The adjusted end-of-LOS hazard ratio for ESBL-positive BSI was 0.07 (95% CI, 0.04-0.12). Conclusion Control of ESBL-E spread is an emergency in pediatric populations and could be achieved with simple cost-effective measures such as hand hygiene, proper management of excreta and better stewardship of antibiotic use, especially for empirical therapy.	[Ndir, Awa] Univ Paris 06, PhD Program, Paris, France; [Ndir, Awa] Inst Pasteur, Dakar, Senegal; [Diop, Amadou; Faye, Pape Makhtar; Cisse, Moussa Fafa] Hop Enfants Albert Royer, Dakar, Senegal; [Ndoye, Babacar] Minist Hlth, Natl Nosocomial Infect Program, Dakar, Senegal; [Astagneau, Pascal] Univ Sorbonne Paris Cite, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Ndir, A (corresponding author), Univ Paris 06, PhD Program, Paris, France.; Ndir, A (corresponding author), Inst Pasteur, Dakar, Senegal.	andir@pasteur.sn	Astagneau, Pascal/AAF-3473-2020					AALEN OO, 1978, SCAND J STAT, V5, P141; Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Anderson DJ, 2006, ANTIMICROB AGENTS CH, V50, P1715, DOI 10.1128/AAC.50.5.1715-1720.2006; Barnett AG, 2011, VALUE HEALTH, V14, P381, DOI 10.1016/j.jval.2010.09.008; Beyersmann J, 2008, STAT MED, V27, P6439, DOI 10.1002/sim.3437; Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Beyersmann J, 2011, BIOMETRICAL J, V53, P332, DOI 10.1002/bimj.201000146; Beyersmann J, 2009, INFECT CONT HOSP EP, V30, P273, DOI 10.1086/596020; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Brun-Buisson C, 2003, INTENS CARE MED, V29, P1464, DOI 10.1007/s00134-003-1877-x; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Carbonnel A, 2013, J ANTIMICROB CHEMOTH, V68, P954, DOI 10.1093/jac/dks464; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; De Angelis G, 2010, CLIN MICROBIOL INFEC, V16, P1729, DOI 10.1111/j.1469-0691.2010.03332.x; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Green N, 2015, J PEDIAT INF DIS SOC, V4, P305, DOI 10.1093/jpids/piu073; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Harris AD, 2004, CLIN INFECT DIS, V39, P872, DOI 10.1086/423814; Haut Conseil de la Sante Publique, 2010, REC REL MES METTR OE; Hyle EP, 2005, CLIN INFECT DIS, V40, P1317, DOI 10.1086/429239; Hyle EP, 2005, ARCH INTERN MED, V165, P1375, DOI 10.1001/archinte.165.12.1375; Jarlier V, 2010, ARCH INTERN MED, V170, P552, DOI 10.1001/archinternmed.2010.32; Kaya O, 2013, J INFECT DEV COUNTR, V7, P507, DOI 10.3855/jidc.2788; Kaye KS, 2004, EMERG INFECT DIS, V10, P1125, DOI 10.3201/eid1006.020665; Kim BN, 2002, J HOSP INFECT, V52, P99, DOI 10.1053/jhin.2002.1288; Kim YK, 2002, ANTIMICROB AGENTS CH, V46, P1481, DOI 10.1128/AAC.46.5.1481-1491.2002; Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee SY, 2006, INFECT CONT HOSP EP, V27, P1226, DOI 10.1086/507962; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pena C, 1997, J HOSP INFECT, V35, P9, DOI 10.1016/S0195-6701(97)90163-8; Reseau d'alerte d'Investigation et de Surveillance des Infections Nosocomiales (RAISIN), 2011, SURV BACT MULT ET SA; Rodriguez-Bano J, 2008, EXPERT REV ANTI-INFE, V6, P671, DOI 10.1586/14787210.6.5.671; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Societe Francaise de Microbiologie, 2015, EUR SOC CLIN MICR IN; Stewardson A, 2013, INFECT CONT HOSP EP, V34, P133, DOI 10.1086/669086; Tsai MH, 2014, PEDIATRICS, V133, pE322, DOI 10.1542/peds.2013-1248; Tumbarello M, 2006, ANTIMICROB AGENTS CH, V50, P498, DOI 10.1128/AAC.50.2.498-504.2006; Tumbarello M, 2008, ANTIMICROB AGENTS CH, V52, P3244, DOI 10.1128/AAC.00063-08; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Tumbarello M, 2010, ANTIMICROB AGENTS CH, V54, P4085, DOI 10.1128/AAC.00143-10; Zavascki AP, 2004, CLIN INFECT DIS, V39, P871, DOI 10.1086/423805	47	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0143729	10.1371/journal.pone.0143729	http://dx.doi.org/10.1371/journal.pone.0143729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867226	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700001
J	Pain, M; Fuller, AW; Basore, K; Pillai, AD; Solomon, T; Bokhari, AAB; Desai, SA				Pain, Margaret; Fuller, Alexandra W.; Basore, Katherine; Pillai, Ajay D.; Solomon, Tsione; Bokhari, Abdullah A. B.; Desai, Sanjay A.			Synergistic Malaria Parasite Killing by Two Types of Plasmodial Surface Anion Channel Inhibitors	PLOS ONE			English	Article							FALCIPARUM IN-VITRO; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; NUTRIENT-UPTAKE; CLAG3 GENES; ANTIMALARIAL-DRUGS; MULTIGENE FAMILY; PERMEATION; MECHANISMS; RESISTANCE	Malaria parasites increase their host erythrocyte's permeability to a broad range of ions and organic solutes. The plasmodial surface anion channel (PSAC) mediates this uptake and is an established drug target. Development of therapies targeting this channel is limited by several problems including interactions between known inhibitors and permeating solutes that lead to incomplete channel block. Here, we designed and executed a high-throughput screen to identify a novel class of PSAC inhibitors that overcome this solute-inhibitor interaction. These new inhibitors differ from existing blockers and have distinct effects on channel-mediated transport, supporting a model of two separate routes for solute permeation though PSAC. Combinations of inhibitors specific for the two routes had strong synergistic action against in vitro parasite propagation, whereas combinations acting on a single route produced only additive effects. The magnitude of synergism depended on external nutrient concentrations, consistent with an essential role of the channel in parasite nutrient acquisition. The identified inhibitors will enable a better understanding of the channel's structure-function and may be starting points for novel combination therapies that produce synergistic parasite killing.	[Pain, Margaret; Fuller, Alexandra W.; Basore, Katherine; Pillai, Ajay D.; Solomon, Tsione; Bokhari, Abdullah A. B.; Desai, Sanjay A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	sdesai@niaid.nih.gov	Singh, Balbir/A-3610-2009	Desai, Sanjay/0000-0003-2150-2483; Basore, Katherine/0000-0001-5974-0968	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; Medicines for Malaria Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medicines for Malaria Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases and by the Medicines for Malaria Venture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalil A, 2007, CELL MICROBIOL, V9, P851, DOI 10.1111/j.1462-5822.2006.00834.x; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Bokhari A, 2008, J MEMBRANE BIOL, V226, P27, DOI 10.1007/s00232-008-9136-2; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Burrows JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-187; CANFIELD CJ, 1995, EXP PARASITOL, V80, P373, DOI 10.1006/expr.1995.1049; Cohn JV, 2003, MOL BIOCHEM PARASIT, V132, P27, DOI 10.1016/j.molbiopara.2003.08.001; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Desai SA, 2005, J BIOL CHEM, V280, P16861, DOI 10.1074/jbc.M414629200; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; Duranton C, 2008, CELL PHYSIOL BIOCHEM, V22, P395, DOI 10.1159/000185483; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; KUTNER S, 1987, BIOCHEM PHARMACOL, V36, P123, DOI 10.1016/0006-2952(87)90389-3; Lisk G, 2005, EUKARYOT CELL, V4, P2153, DOI 10.1128/EC.4.12.2153-2159.2005; Lisk G, 2007, MOL PHARMACOL, V71, P1241, DOI 10.1124/mol.106.030734; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Ohrt C, 2002, ANTIMICROB AGENTS CH, V46, P2518, DOI 10.1128/AAC.46.8.2518-2524.2002; Pillai AD, 2013, MOL MICROBIOL, V88, P20, DOI 10.1111/mmi.12159; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Pillai AD, 2010, MOL PHARMACOL, V77, P724, DOI 10.1124/mol.109.062711; Rich SM, 2003, ADV PARASIT, V54, P255, DOI 10.1016/S0065-308X(03)54005-2; Rovira-Graells N, 2015, NUCLEIC ACIDS RES, V43, P8243, DOI 10.1093/nar/gkv730; Shanks GD, 2015, T ROY SOC TROP MED H, V109, P182, DOI 10.1093/trstmh/tru199; Sharma P, 2013, J BIOL CHEM, V288, P19429, DOI 10.1074/jbc.M113.468371; Snyder C, 2007, EXP PARASITOL, V115, P296, DOI 10.1016/j.exppara.2006.09.016; Sokolov S, 2010, J GEN PHYSIOL, V136, P225, DOI 10.1085/jgp.201010414; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; UPSTON JM, 1995, BBA-BIOMEMBRANES, V1236, P249, DOI 10.1016/0005-2736(95)00055-8; Vandenberg RJ, 2005, SCI STKE, V2005, pe17; Verloo P, 2004, J BIOL CHEM, V279, P10316, DOI 10.1074/jbc.M311540200; Voss TS, 2014, CURR OPIN MICROBIOL, V20, P88, DOI 10.1016/j.mib.2014.05.007; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wagner MA, 2003, BIOPHYS J, V84, P116, DOI 10.1016/S0006-3495(03)74836-X; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149214	10.1371/journal.pone.0149214	http://dx.doi.org/10.1371/journal.pone.0149214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866812	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700078
J	Conlon, K; Monaghan, A; Hayden, M; Wilhelmi, O				Conlon, Kathryn; Monaghan, Andrew; Hayden, Mary; Wilhelmi, Olga			Potential Impacts of Future Warming and Land Use Changes on Intra-Urban Heat Exposure in Houston, Texas	PLOS ONE			English	Article							URBAN CANOPY MODEL; CLIMATE-CHANGE; AMBIENT-TEMPERATURE; HUMAN MORTALITY; EXTREME HEAT; STRESS; HEALTH; CITIES; OZONE; HOSPITALIZATIONS	Extreme heat events in the United States are projected to become more frequent and intense as a result of climate change. We investigated the individual and combined effects of land use and warming on the spatial and temporal distribution of daily minimum temperature (T-min) and daily maximum heat index (HImax) during summer in Houston, Texas. Present-day (2010) and near-future (2040) parcel-level land use scenarios were embedded within 1-km resolution land surface model (LSM) simulations. For each land use scenario, LSM simulations were conducted for climatic scenarios representative of both the present-day and near-future periods. LSM simulations assuming present-day climate but 2040 land use patterns led to spatially heterogeneous temperature changes characterized by warmer conditions over most areas, with summer average increases of up to 1.5 degrees C (T-min) and 7.3 degrees C (HImax) in some newly developed suburban areas compared to simulations using 2010 land use patterns. LSM simulations assuming present-day land use but a 1 degrees C temperature increase above the urban canopy (consistent with warming projections for 2040) yielded more spatially homogeneous metropolitan-wide average increases of about 1 degrees C (T-min) and 2.5 degrees C (HImax), respectively. LSM simulations assuming both land use and warming for 2040 led to summer average increases of up to 2.5 degrees C (T-min) and 8.3 degrees C (HImax), with the largest increases in areas projected to be converted to residential, industrial and mixed-use types. Our results suggest that urbanization and climate change may significantly increase the average number of summer days that exceed current threshold temperatures for initiating a heat advisory for metropolitan Houston, potentially increasing population exposure to extreme heat.	[Conlon, Kathryn; Monaghan, Andrew; Hayden, Mary; Wilhelmi, Olga] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Conlon, K (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	kconlon@ucar.edu		Monaghan, Andrew/0000-0002-8170-2359	Climate and Health Program of the National Center for Environmental Health, U.S. Centers for Disease Control and Prevention; National Aeronautics and Space Administration [NNX10AK79G]; National Science Foundation	Climate and Health Program of the National Center for Environmental Health, U.S. Centers for Disease Control and Prevention; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	KC received funding from the Climate and Health Program of the National Center for Environmental Health, U.S. Centers for Disease Control and Prevention. AM, MH, and OW received funding from the National Aeronautics and Space Administration (grant NNX10AK79G). The National Science Foundation sponsors the National Center for Atmospheric Research.	Adachi SA, 2014, J APPL METEOROL CLIM, V53, P1886, DOI 10.1175/JAMC-D-13-0194.1; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2013, AM J RESP CRIT CARE, V187, P1098, DOI 10.1164/rccm.201211-1969OC; Argueso D, 2014, CLIM DYNAM, V42, P2183, DOI 10.1007/s00382-013-1789-6; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2008, EPIDEMIOLOGY, V19, P138, DOI 10.1097/EDE.0b013e31815c1da7; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bobb JF, 2014, JAMA-J AM MED ASSOC, V312, P2659, DOI 10.1001/jama.2014.15715; Borden KA, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-64; Chen F, 2001, MON WEATHER REV, V129, P569, DOI 10.1175/1520-0493(2001)129<0569:CAALSH>2.0.CO;2; Chen F, 2007, J APPL METEOROL CLIM, V46, P694, DOI 10.1175/JAM2463.1; Chen F, 2011, INT J CLIMATOL, V31, P273, DOI 10.1002/joc.2158; Cheng YY, 2008, ATMOS ENVIRON, V42, P7795, DOI 10.1016/j.atmosenv.2008.04.055; Ching J, 2009, B AM METEOROL SOC, V90, P1157, DOI 10.1175/2009BAMS2675.1; City of Houston, 2015, CODE OF ORDINANCES, V2015, P639; Cosgrove BA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003118; Council H-GA, 2013, REP REG GROWTH FOR Q; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Davis RE, 2002, CLIMATE RES, V22, P175, DOI 10.3354/cr022175; Demographer OotS, 2014, PROJ POP TEX COUNT T; Department GHPR, 2014, SOC EC DEM CHAR METR; Emerson M, 2014, 33 KINDER I HOUSTON; Georgescu M, 2013, NAT CLIM CHANGE, V3, P37, DOI 10.1038/nclimate1656; Gosling SN, 2009, CLIMATIC CHANGE, V92, P299, DOI [10.1007/s10584-008-9441-x, 10.1007/S10584-008-9441-X]; Gronlund CJ, 2014, ENV RES IN PRESS; Gulyas A, 2006, BUILD ENVIRON, V41, P1713, DOI 10.1016/j.buildenv.2005.07.001; Hajat S, 2010, AM J PUBLIC HEALTH, V100, P1137, DOI 10.2105/AJPH.2009.169748; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hao YP, 2015, AM J RESP CRIT CARE, V192, P337, DOI 10.1164/rccm.201410-1852OC; Harlan SL, 2006, SOC SCI MED, V63, P2847, DOI 10.1016/j.socscimed.2006.07.030; Heaton MJ, 2014, SPAT SPATIO-TEMPORAL, V8, P23, DOI 10.1016/j.sste.2014.01.002; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Hondula DM, 2014, SCI TOTAL ENVIRON, V490, P538, DOI 10.1016/j.scitotenv.2014.04.130; Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456; Inspector C, 2015, CLIM CHANG SCEN; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kosatsky Tom, 2005, Euro Surveill, V10, P148; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kusaka H, 2001, BOUND-LAY METEOROL, V101, P329, DOI 10.1023/A:1019207923078; Kusaka H, 2012, J METEOROL SOC JPN, V90B, P47, DOI 10.2151/jmsj.2012-B04; Luber G, 1999, HEAT RELATED DEATHS, V2006; Martilli A, 2014, URBAN CLIMA IN PRESS; Mathes R, 2013, ONLINE JOURNAL OF PU, V5, pe156; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Monaghan AJ, 2014, J GEOPHYS RES-ATMOS, V119, P6376, DOI 10.1002/2013JD021227; NOAA NWS, BEAT HEAT WEATH READ; O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; Oleson KW, 2015, CLIMATIC CHANGE, V129, P525, DOI 10.1007/s10584-013-0936-8; Patz JA, 2000, ENVIRON HEALTH PERSP, V108, P367, DOI 10.2307/3454357; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Ruckstuhl C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007850; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; Sampson NR, 2013, GLOBAL ENVIRON CHANG, V23, P475, DOI 10.1016/j.gloenvcha.2012.12.011; SCHUMAN SH, 1972, ENVIRON RES, V5, P59, DOI 10.1016/0013-9351(72)90020-5; Solecki W.D., 2005, ENVIRON HAZARDS-UK, V6, P39, DOI [10.1016/j.hazards.2004.12.002, DOI 10.1016/J.HAZARDS.2004.12.002]; STEADMAN RG, 1979, J APPL METEOROL, V18, P861, DOI 10.1175/1520-0450(1979)018<0861:TAOSPI>2.0.CO;2; Stone B, 2012, CITY AND THE COMING CLIMATE: CLIMATE CHANGE IN THE PLACES WE LIVE, P1, DOI 10.1017/CBO9781139061353; Stone B, 2010, ENVIRON HEALTH PERSP, V118, P1425, DOI 10.1289/ehp.0901879; Stone B, 2013, ENVIRON SCI TECHNOL, V47, P7780, DOI 10.1021/es304352e; Vanos JK, 2010, INT J BIOMETEOROL, V54, P319, DOI 10.1007/s00484-010-0301-9; Voorhees AS, 2011, ENVIRON SCI TECHNOL, V45, P1450, DOI 10.1021/es102820y; Whitman S, 1997, AM J PUBLIC HEALTH, V87, P1515, DOI 10.2105/AJPH.87.9.1515; Wilhelmi O, 2015, EOS T AM GE IN PRESS; Wilhelmi OV, 2015, 95 ANN M AM MET SOC, V2015; Willett KM, 2008, J CLIMATE, V21, P5364, DOI 10.1175/2008JCLI2274.1; Xia YL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016048; Zhou WH, 2014, ENVIRON RES, V135, P81, DOI 10.1016/j.envres.2014.08.025	69	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148890	10.1371/journal.pone.0148890	http://dx.doi.org/10.1371/journal.pone.0148890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863298	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600120
J	Hsu, KH; Su, BH; Tu, YS; Lin, OA; Tseng, YFJ				Hsu, Kuo-Hsiang; Su, Bo-Han; Tu, Yi-Shu; Lin, Olivia A.; Tseng, Yufeng J.			Mutagenicity in a Molecule: Identification of Core Structural Features of Mutagenicity Using a Scaffold Analysis	PLOS ONE			English	Article							CARCINOGENICITY; TOXICOLOGY; CLASSIFICATION; PREDICTION; SYSTEMS; ALERTS	With advances in the development and application of Ames mutagenicity in silico prediction tools, the International Conference on Harmonisation (ICH) has amended its M7 guideline to reflect the use of such prediction models for the detection of mutagenic activity in early drug safety evaluation processes. Since current Ames mutagenicity prediction tools only focus on functional group alerts or side chain modifications of an analog series, these tools are unable to identify mutagenicity derived from core structures or specific scaffolds of a compound. In this study, a large collection of 6512 compounds are used to perform scaffold tree analysis. By relating different scaffolds on constructed scaffold trees with Ames mutagenicity, four major and one minor novel mutagenic groups of scaffold are identified. The recognized mutagenic groups of scaffold can serve as a guide for medicinal chemists to prevent the development of potentially mutagenic therapeutic agents in early drug design or development phases, by modifying the core structures of mutagenic compounds to form non-mutagenic compounds. In addition, five series of substructures are provided as recommendations, for direct modification of potentially mutagenic scaffolds to decrease associated mutagenic activities.	[Hsu, Kuo-Hsiang; Tu, Yi-Shu; Lin, Olivia A.; Tseng, Yufeng J.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Su, Bo-Han; Tseng, Yufeng J.] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Tseng, YFJ (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.; Tseng, YFJ (corresponding author), Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan.	yjtseng@csie.ntu.edu.tw	Tu, Yi-shu/H-3180-2013; Tseng, Yufeng/AAY-4971-2021	Tu, Yi-shu/0000-0003-0210-3778; Tseng, Yufeng Jane/0000-0002-8461-6181	Ministry of Science and Technology, Taiwan [103-2325-B-002-048-, 104-2321-B-002-037-, 104-2325-B-400-014-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by the Ministry of Science and Technology, Taiwan, grant numbers 103-2325-B-002-048-, 104-2321-B-002-037-, and 104-2325-B-400-014-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; [Anonymous], 2015, MULT GUID M7 GEN IMP; ASHBY J, 1985, ENVIRON MUTAGEN, V7, P919, DOI 10.1002/em.2860070613; Benigni R, 2008, 23241 EUR EN, p[1, 23241]; Benigni R, 2013, CHEM REV, V113, P2940, DOI 10.1021/cr300206t; Benigni R, 2011, CHEM REV, V111, P2507, DOI 10.1021/cr100222q; Benigni R, 2010, EXPERT OPIN DRUG MET, V6, P809, DOI 10.1517/17425255.2010.486400; Chemaxon Inc, 2015, MARV SUIT; Contrera JF, 2013, REGUL TOXICOL PHARM, V67, P285, DOI 10.1016/j.yrtph.2013.08.008; [European Medicines Agency Committee for Medicinal Products for Human Use (CHMP)], 2006, GUID LIM GEN IMP; Feng J, 2003, J CHEM INF COMP SCI, V43, P1463, DOI 10.1021/ci034032s; FERGUSON LR, 1988, MUTAT RES, V204, P207, DOI 10.1016/0165-1218(88)90091-2; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Hansen K, 2009, J CHEM INF MODEL, V49, P2077, DOI 10.1021/ci900161g; Helma C, 2004, J CHEM INF COMP SCI, V44, P1402, DOI 10.1021/ci034254q; Hillebrecht A, 2011, CHEM RES TOXICOL, V24, P843, DOI 10.1021/tx2000398; Judson PN, 2005, TOXICOLOGY, V213, P117, DOI 10.1016/j.tox.2005.05.014; Kazius J, 2005, J MED CHEM, V48, P312, DOI 10.1021/jm040835a; Kho R, 2005, J MED CHEM, V48, P6671, DOI 10.1021/jm050564j; KLOPMAN G, 1992, QUANT STRUCT-ACT REL, V11, P176, DOI 10.1002/qsar.19920110208; Lead-scope Inc, 2013, LEADSC MOD APPL COL; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; MATIJASEVIC Z, 1985, MUTAT RES, V142, P149, DOI 10.1016/0165-7992(85)90014-4; Mostrag-Szlichtyng A, 2010, EXPERT OPIN DRUG MET, V6, P785, DOI 10.1517/17425255.2010.489551; Nagarathna K.M., 2013, INT J PHARM SCI REV, V22, P236; Nantasenamat C, 2009, EXCLI J, V8, P74; Ridings JE, 1996, TOXICOLOGY, V106, P267, DOI 10.1016/0300-483X(95)03190-Q; U. S. National Library of Medicine, 2014, GEN TOX DAT BANK GEN; U. S. National Library of Medicine, 2009, CHEM CARC RES INF SY; von der Ohe PC, 2005, CHEM RES TOXICOL, V18, P536, DOI 10.1021/tx0497954; Webb SJ, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-8; Wetzel S, 2009, NAT CHEM BIOL, V5, P581, DOI 10.1038/nchembio.187	33	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148900	10.1371/journal.pone.0148900	http://dx.doi.org/10.1371/journal.pone.0148900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863515	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600122
J	Josephson, MP; Chai, YP; Ou, GS; Lundquist, EA				Josephson, Matthew P.; Chai, Yongping; Ou, Guangshuo; Lundquist, Erik A.			EGL-20/Wnt and MAB-5/Hox Act Sequentially to Inhibit Anterior Migration of Neuroblasts in C. elegans	PLOS ONE			English	Article							WNT-PRODUCING CELLS; CAENORHABDITIS-ELEGANS; NEURONAL MIGRATION; GENE-EXPRESSION; HOX GENES; ASYMMETRY; NEMATODE; UNC-40/DCC; PROTEINS; SYSTEM	Directed neuroblast and neuronal migration is important in the proper development of nervous systems. In C. elegans the bilateral Q neuroblasts QR (on the right) and QL (on the left) undergo an identical pattern of cell division and differentiation but migrate in opposite directions (QR and descendants anteriorly and QL and descendants posteriorly). EGL-20/Wnt, via canonical Wnt signaling, drives the expression of MAB-5/Hox in QL but not QR. MAB-5 acts as a determinant of posterior migration, and mab-5 and egl-20 mutants display anterior QL descendant migrations. Here we analyze the behaviors of QR and QL descendants as they begin their anterior and posterior migrations, and the effects of EGL-20 and MAB-5 on these behaviors. The anterior and posterior daughters of QR (QR.a/p) after the first division immediately polarize and begin anterior migration, whereas QL.a/p remain rounded and non-migratory. After similar to 1 hour, QL. a migrates posteriorly over QL.p. We find that in egl-20/Wnt, bar-1/beta-catenin, and mab-5/Hox mutants, QL.a/p polarize and migrate anteriorly, indicating that these molecules normally inhibit anterior migration of QL.a/p. In egl-20/Wnt mutants, QL.a/p immediately polarize and begin migration, whereas in bar-1/beta-catenin and mab-5/Hox, the cells transiently retain a rounded, non-migratory morphology before anterior migration. Thus, EGL-20/Wnt mediates an acute inhibition of anterior migration independently of BAR-1/beta-catenin and MAB-5/Hox, and a later, possible transcriptional response mediated by BAR-1/beta-catenin and MAB-5/Hox. In addition to inhibiting anterior migration, MAB-5/Hox also cell-autonomously promotes posterior migration of QL. a (and QR. a in a mab-5 gain-of-function).	[Josephson, Matthew P.; Lundquist, Erik A.] Univ Kansas, Dept Mol Biosci, Genet Program, Lawrence, KS 66045 USA; [Josephson, Matthew P.; Lundquist, Erik A.] Univ Kansas, Dept Mol Biosci, Program Mol Cellular & Dev Biol, Lawrence, KS 66045 USA; [Chai, Yongping; Ou, Guangshuo] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	University of Kansas; University of Kansas; Tsinghua University	Lundquist, EA (corresponding author), Univ Kansas, Dept Mol Biosci, Genet Program, Lawrence, KS 66045 USA.; Lundquist, EA (corresponding author), Univ Kansas, Dept Mol Biosci, Program Mol Cellular & Dev Biol, Lawrence, KS 66045 USA.	erikl@ku.edu			National Institutes of Health [R01 NS040945, R21 NS070417, P20 GM103638, P20 GM103418]; National Basic Research Program of China (973 Program) [2013CB945600, 2012CB945002]; National Natural Science Foundation of China [31201009, 31222035, 31171295, 31190063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070417, R01NS040945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funded by National Institutes of Health grants R01 NS040945, R21 NS070417, P20 GM103638, and P20 GM103418 to E.A.L. (http://www.nih.gov/), The National Basic Research Program of China to G.O. (973 Program, 2013CB945600 and 2012CB945002) (http://rd.zju.edu.cn/en/index.php?c = main&a = detail&id=93), and The National Natural Science Foundation of China to G.O. and Y.C. (31201009, 31222035, 31171295 and 31190063) (http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boitard M, 2015, CELL REP, V10, P1349, DOI 10.1016/j.celrep.2015.01.061; Branda CS, 2000, DEV BIOL, V226, P137, DOI 10.1006/dbio.2000.9853; CHALFIE M, 1983, SCIENCE, V221, P61, DOI 10.1126/science.6857263; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chapman JO, 2008, DEV BIOL, V324, P245, DOI 10.1016/j.ydbio.2008.09.014; CHOW KL, 1994, DEVELOPMENT, V120, P2579; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Harris J, 1996, DEVELOPMENT, V122, P3117; Herman MA, 2003, WNT SIGNALING DEV, P187; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Ji N, 2013, CELL, V155, P869, DOI 10.1016/j.cell.2013.09.060; KENYON C, 1986, CELL, V46, P477, DOI 10.1016/0092-8674(86)90668-9; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Mentink RA, 2014, DEV CELL, V31, P188, DOI 10.1016/j.devcel.2014.08.008; Middelkoop Teije C, 2014, WormBook, P1, DOI 10.1895/wormbook.1.173.1; Minevich G, 2012, GENETICS, V192, P1249, DOI 10.1534/genetics.112.144204; Ou GS, 2009, J CELL BIOL, V185, P77, DOI 10.1083/jcb.200812077; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Penigault JB, 2011, DEV BIOL, V357, P428, DOI 10.1016/j.ydbio.2011.06.006; SALSER SJ, 1993, GENE DEV, V7, P1714, DOI 10.1101/gad.7.9.1714; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Schafer ST, 2015, J NEUROSCI, V35, P4983, DOI 10.1523/JNEUROSCI.4130-14.2015; Shen ZF, 2014, DEV CELL, V30, P625, DOI 10.1016/j.devcel.2014.07.017; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Sundararajan L, 2015, G3-GENES GENOM GENET, V5, P1567, DOI 10.1534/g3.115.018770; Sundararajan L, 2014, DEV BIOL, V392, P141, DOI 10.1016/j.ydbio.2014.06.009; Sundararajan L, 2012, GENETICS, V192, P1373, DOI 10.1534/genetics.112.145706; Tamayo JV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-304; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Tian D, 2015, CURR BIOL, V25, P1135, DOI 10.1016/j.cub.2015.02.072; Wang XM, 2013, P NATL ACAD SCI USA, V110, P11175, DOI 10.1073/pnas.1301849110; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	37	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148658	10.1371/journal.pone.0148658	http://dx.doi.org/10.1371/journal.pone.0148658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863303	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600093
J	Tang, MF; Hammond, GR; Badcock, DR				Tang, Matthew F.; Hammond, Geoffrey R.; Badcock, David R.			Are Participants Aware of the Type and Intensity of Transcranial Direct Current Stimulation?	PLOS ONE			English	Article							MOTOR CORTEX; VISUAL PSYCHOPHYSICS; MAJOR DEPRESSION; DC STIMULATION; CLINICAL-TRIAL; TDCS; MODULATION; CONSOLIDATION; PERCEPTION; COMFORT	Transcranial direct current stimulation (tDCS) is commonly used to alter cortical excitability but no experimental study has yet determined whether human participants are able to distinguish between the different types (anodal, cathodal, and sham) of stimulation. If they can then they are not blind to experimental conditions. We determined whether participants could identify different types of stimulation (anodal, cathodal, and sham) and current strengths after experiencing the sensations of stimulation during current onset and offset (which are associated with the most intense sensations) in Experiment 1 and also with a prolonged period of stimulation in Experiment 2. We first familiarized participants with anodal, cathodal, and sham stimulation at both 1 and 2 mA over either primary motor or visual cortex while their sensitivity to small changes in visual stimuli was assessed. The different stimulation types were then applied for a short (Experiment 1) or extended (Experiment 2) period with participants indicating the type and strength of the stimulation on the basis of the evoked sensations. Participants were able to identify the intensity of stimulation with shorter, but not longer periods, of stimulation at better than chance levels but identification of the different stimulation types was at chance levels. This result suggests that even after exposing participants to stimulation, and ensuring they are fully aware of the existence of a sham condition, they are unable to identify the type of stimulation from transient changes in stimulation intensity or from more prolonged stimulation. Thus participants are able to identify intensity of stimulation but not the type of stimulation.	[Tang, Matthew F.; Hammond, Geoffrey R.; Badcock, David R.] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Tang, Matthew F.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Western Australia; University of Queensland	Tang, MF (corresponding author), Univ Western Australia, Sch Psychol, Crawley, WA, Australia.; Tang, MF (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	m.tang1@uq.edu.au	Badcock, David R/A-4913-2008; Tang, Matthew/E-6520-2016	Badcock, David R/0000-0002-4517-435X; Tang, Matthew/0000-0001-5858-5126	Australian Research Council [DP130102580, DP110104553]; University of Western Australia	Australian Research Council(Australian Research Council); University of Western Australia	This work was supported by Australian Research Council grants DP130102580 and DP110104553 to DRB. The University of Western Australia also provided a scholarship to MFT.	Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2006, BRAIN RES BULL, V68, P459, DOI 10.1016/j.brainresbull.2005.10.006; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunoni AR, 2014, CLIN NEUROPHYSIOL, V125, P298, DOI 10.1016/j.clinph.2013.07.020; Cecere R, 2013, J NEUROSCI, V33, P6469, DOI 10.1523/JNEUROSCI.3431-12.2013; Dundas JE, 2007, CLIN NEUROPHYSIOL, V118, P1166, DOI 10.1016/j.clinph.2007.01.010; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Horvath JC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00002; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; METHA AB, 1993, BEHAV RES METH INSTR, V25, P371, DOI 10.3758/BF03204528; Moos K, 2012, J NEUROSCI, V32, P16360, DOI 10.1523/JNEUROSCI.6233-11.2012; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Palm U, 2013, BRAIN STIMUL, V6, P690, DOI 10.1016/j.brs.2013.01.005; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peters MAK, 2013, NEUROPSYCHOLOGIA, V51, P1234, DOI 10.1016/j.neuropsychologia.2013.03.013; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Russo R, 2013, BRAIN STIMUL, V6, P946, DOI 10.1016/j.brs.2013.05.009; Spiegel DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036220; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Tang MF, 2013, J VISION, V13, DOI 10.1167/13.13.20; Tang MF, 2013, EUR J NEUROSCI, V38, P2802, DOI 10.1111/ejn.12280; TANG MF, 2015, J VISION, V15, DOI DOI 10.1167/15.13.4	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148825	10.1371/journal.pone.0148825	http://dx.doi.org/10.1371/journal.pone.0148825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863314	Green Submitted, gold, Green Published			2022-12-26	WOS:000370046600111
J	Yu, PL; Chen, LH; Chung, KR				Yu, Pei-Ling; Chen, Li-Hung; Chung, Kuang-Ren			How the Pathogenic Fungus Alternaria alternata Copes with Stress via the Response Regulators SSK1 and SHO1	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; TANGERINE PATHOTYPE; OXIDATIVE STRESS; PLANT INFECTION; PROTEIN-KINASE; VIRULENCE; ACTIVATION; RESISTANCE; SYSTEM; ROLES	The tangerine pathotype of Alternaria alternata is a necrotrophic fungal pathogen causing brown spot disease on a number of citrus cultivars. To better understand the dynamics of signal regulation leading to oxidative and osmotic stress response and fungal infection on citrus, phenotypic characterization of the yeast SSK1 response regulator homolog was performed. It was determined that SSK1 responds to diverse environmental stimuli and plays a critical role in fungal pathogenesis. Experiments to determine the phenotypes resulting from the loss of SSK1 reveal that the SSK1 gene product may be fulfilling similar regulatory roles in signaling pathways involving a HOG1 MAP kinase during ROS resistance, osmotic resistance, fungicide sensitivity and fungal virulence. The SSK1 mutants display elevated sensitivity to oxidants, fail to detoxify H2O2 effectively, induce minor necrosis on susceptible citrus leaves, and displays resistance to dicarboximide and phenylpyrrole fungicides. Unlike the SKN7 response regulator, SSK1 and HOG1 confer resistance to salt-induced osmotic stress via an unknown kinase sensor rather than the "two component" histidine kinase HSK1. SSK1 and HOG1 play a moderate role in sugar-induced osmotic stress. We also show that SSK1 mutants are impaired in their ability to produce germ tubes from conidia, indicating a role for the gene product in cell differentiation. SSK1 also is involved in multidrug resistance. However, deletion of the yeast SHO1 (synthetic high osmolarity) homolog resulted in no noticeable phenotypes. Nonetheless, our results show that A. alternata can sense and react to different types of stress via SSK1, HOG1 and SKN7 in a cooperative manner leading to proper physiological and pathological functions.	[Yu, Pei-Ling; Chen, Li-Hung; Chung, Kuang-Ren] Natl Chung Hsing Univ, Coll Agr & Nat Resources, Dept Plant Pathol, Taichung 40227, Taiwan; [Chen, Li-Hung] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	National Chung Hsing University; University of California System; University of California Davis	Chung, KR (corresponding author), Natl Chung Hsing Univ, Coll Agr & Nat Resources, Dept Plant Pathol, Taichung 40227, Taiwan.	krchung@nchu.edu.tw	Chung, Kuang-Ren/Q-1157-2019; YU, PEI-LING/M-1348-2019	Chen, Li-Hung/0000-0002-9636-9501	Ministry of Science and Technology of Taiwan [103-2313-B-005-044-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the Ministry of Science and Technology of Taiwan (103-2313-B-005-044-MY2) to KRC. The funder had no roles in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; Chen LH, 2013, MOL PLANT PATHOL, V14, P497, DOI 10.1111/mpp.12021; Chen LH, 2012, FUNGAL GENET BIOL, V49, P802, DOI 10.1016/j.fgb.2012.07.006; Chung KR, 2002, FEMS MICROBIOL LETT, V213, P33, DOI 10.1111/j.1574-6968.2002.tb11282.x; Chung KR, 2014, PLANT PATHOL B, V23, P307; Chung KR, 2014, PHYSIOL MOL PLANT P, V88, P10, DOI 10.1016/j.pmpp.2014.08.001; Chung KR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/635431; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Gu Q, 2015, NEW PHYTOL, V206, P315, DOI 10.1111/nph.13158; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Jiang JH, 2011, MOL PLANT PATHOL, V12, P425, DOI 10.1111/j.1364-3703.2010.00684.x; KATEKAR GF, 1980, PLANT PHYSIOL, V66, P1190, DOI 10.1104/pp.66.6.1190; KOHMOTO K, 1993, PHYTOPATHOLOGY, V83, P495, DOI 10.1094/Phyto-83-495; Kruppa M, 2006, FEMS YEAST RES, V6, P149, DOI 10.1111/j.1567-1364.2006.00024.x; Lanver D, 2010, PLANT CELL, V22, P2085, DOI 10.1105/tpc.109.073734; Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952; Lin CH, 2011, CURR MICROBIOL, V62, P807, DOI 10.1007/s00284-010-9795-y; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Lin CH, 2010, FUNGAL GENET BIOL, V47, P381, DOI 10.1016/j.fgb.2009.12.009; Lin CH, 2009, MOL PLANT MICROBE IN, V22, P942, DOI 10.1094/MPMI-22-8-0942; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Motoyama T, 2008, CURR GENET, V54, P185, DOI 10.1007/s00294-008-0211-0; Nerud F, 2001, CHEMOSPHERE, V44, P957, DOI 10.1016/S0045-6535(00)00482-3; Perez-Nadales E, 2015, MOL PLANT PATHOL, V16, P593, DOI 10.1111/mpp.12217; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Tatebayashi K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7975; Thomason P, 2000, J CELL SCI, V113, P3141; Tsai HC, 2014, MICROBIOL-SGM, V160, P1453, DOI 10.1099/mic.0.077818-0; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Vargas-Perez I, 2007, EUKARYOT CELL, V6, P1570, DOI 10.1128/EC.00085-07; Wang ZL, 2014, APPL MICROBIOL BIOT, V98, P5607, DOI 10.1007/s00253-014-5644-4; Yan LY, 2011, APPL MICROBIOL BIOT, V90, P215, DOI 10.1007/s00253-010-3027-z; Yang SL, 2016, ENVIRON MICROBIOL, V18, P923, DOI 10.1111/1462-2920.13125; Yang SL, 2013, MOL PLANT PATHOL, V14, P543, DOI 10.1111/mpp.12026; Yang SL, 2012, MOL PLANT PATHOL, V13, P900, DOI 10.1111/j.1364-3703.2012.00799.x; Yang SL, 2010, FUNGAL BIOL-UK, V114, P64, DOI 10.1016/j.mycres.2009.10.007; Yang SL, 2009, PHYSIOL MOL PLANT P, V74, P100, DOI 10.1016/j.pmpp.2009.09.007; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005	45	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149153	10.1371/journal.pone.0149153	http://dx.doi.org/10.1371/journal.pone.0149153			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863027	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600162
J	Bhagwandin, VJ; Bishop, JM; Wright, WE; Shay, JW				Bhagwandin, Vikash J.; Bishop, J. Michael; Wright, Woodring E.; Shay, Jerry W.			The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells	PLOS ONE			English	Article							SIDE POPULATION CELLS; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1; DRUG EFFLUX CAPACITY; MULTIDRUG-RESISTANCE; MESENCHYMAL TRANSITION; P-GLYCOPROTEIN; MELANOMA-CELLS; IN-VITRO; GEMCITABINE; LINES	Cancer stem cells (CSCs) typically have the capacity to evade chemotherapy and may be the principal source of metastases. CSCs for human pancreatic ductal carcinoma (PDAC) have been identified, but neither the metastatic potential nor the chemoresistance of these cells has been adequately evaluated. We have addressed these issues by examining sidepopulation (SP) cells isolated from the Panc-1 and BxPC3 lines of human PDAC cells, the oncogenotypes of which differ. SP cells could be isolated from monolayers of Panc-1, but only from spheroids of BxPC3. Using orthotopic xenografts into the severely immunocompromised NSG mouse, we found that SP cells isolated from both cell lines produced tumors that were highly metastatic, in contrast to previous experience with PDAC cell lines. SP cells derived from both cell lines expressed the ABCG2 transporter, which was demonstrably responsible for the SP phenotype. SP cells gave rise to non-SP (NSP) cells in vitro and in vivo, a transition that was apparently due to posttranslational inhibition of the ABCG2 transporter. Twenty-two other lines of PDAC cells also expressed ABCG2. The sensitivity of PDAC SP cells to the vinca alkaloid vincristine could be greatly increased by verapamil, a general inhibitor of transporters. In contrast, verapamil had no effect on the killing of PDAC cells by gemcitabine, the current first-line therapeutic for PDAC. We conclude that the isolation of SP cells can be a convenient and effective tool for the study of PDAC CSCs; that CSCs may be the principal progenitors of metastasis by human PDAC; that the ABCG2 transporter is responsible for the SP phenotype in human PDAC cells, and may be a ubiquitous source of drug-resistance in PDAC, but does not confer resistance to gemcitabine; and that inhibition of ABCG2 might offer a useful adjunct in a therapeutic attack on the CSCs of PDAC.	[Bhagwandin, Vikash J.; Wright, Woodring E.; Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Bhagwandin, Vikash J.; Bishop, J. Michael] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Bhagwandin, VJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.; Bhagwandin, VJ (corresponding author), Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA.	vikash.bhagwandin@va.gov			National Aeronautics and Space Administration-Specialized Center of Research [NNJ05HD36G]; National Institute of Health, Ruth L. Kirschstein National Research Service Award, Institutional Training Grant (T32) [CA09043]; NATIONAL CANCER INSTITUTE [T32CA009043] Funding Source: NIH RePORTER	National Aeronautics and Space Administration-Specialized Center of Research; National Institute of Health, Ruth L. Kirschstein National Research Service Award, Institutional Training Grant (T32)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: 1. National Aeronautics and Space Administration-Specialized Center of Research: NNJ05HD36G (VJB, WEW, JWS), and 2. National Institute of Health, Ruth L. Kirschstein National Research Service Award, Institutional Training Grant (T32) for The G.W. Hooper Research Foundation: CA09043 (VJB, JMB).	BATES SE, 1991, J CLIN ENDOCR METAB, V73, P18, DOI 10.1210/jcem-73-1-18; Bello-Reuss E, 2000, AM J PHYSIOL-CELL PH, V278, pC1256, DOI 10.1152/ajpcell.2000.278.6.C1256; Bhagwandin VJ, 2009, BBA-MOL BASIS DIS, V1792, P248, DOI 10.1016/j.bbadis.2009.02.007; Bold RJ, 1999, ANN SURG ONCOL, V6, P279, DOI 10.1007/s10434-999-0279-x; Chow EKH, 2012, HEPATOLOGY, V56, P1331, DOI 10.1002/hep.25776; Du ZY, 2011, DIGEST DIS SCI, V56, P741, DOI 10.1007/s10620-010-1340-0; Giovannetti E, 2006, ANN ONCOL, V17, pV17, DOI 10.1093/annonc/mdj943; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Giovannetti E, 2006, MOL CANCER THER, V5, P1387, DOI 10.1158/1535-7163.MCT-06-0004; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Gysin S, 2005, GENE CHROMOSOME CANC, V44, P37, DOI 10.1002/gcc.20216; Gysin S, 2012, MOL CANCER RES, V10, P1607, DOI 10.1158/1541-7786.MCR-12-0188; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Miranda-Lorenzo I, 2014, NAT METHODS, V11, P1161, DOI [10.1038/NMETH.3112, 10.1038/nmeth.3112]; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Nakanishi T, 2006, BLOOD, V108, P678, DOI 10.1182/blood-2005-10-4020; Okazaki T, 2010, CLIN CANCER RES, V16, P320, DOI 10.1158/1078-0432.CCR-09-1555; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Xu ZW, 2001, INT J CANCER, V94, P268, DOI 10.1002/ijc.1447; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774; Yin LQ, 2008, CANCER RES, V68, P800, DOI 10.1158/0008-5472.CAN-07-2545; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595; Zhou J, 2008, WORLD J GASTROENTERO, V14, P925, DOI 10.3748/wjg.14.925	50	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148807	10.1371/journal.pone.0148807	http://dx.doi.org/10.1371/journal.pone.0148807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859746	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400089
J	Lei, R; Zhang, K; Wei, YX; Chen, M; Weinstein, LS; Hong, Y; Zhu, MY; Li, HC; Li, HS				Lei, Run; Zhang, Ke; Wei, Yanxia; Chen, Min; Weinstein, Lee S.; Hong, Yang; Zhu, Minyan; Li, Hongchang; Li, Huashun			G-Protein alpha-Subunit Gs alpha Is Required for Craniofacial Morphogenesis	PLOS ONE			English	Article							STIMULATORY G-PROTEIN; ELEMENT-BINDING PROTEIN; CRANIAL NEURAL CREST; PARATHYROID-HORMONE REQUIRES; EPIDERMAL-GROWTH-FACTOR; PIERRE-ROBIN SEQUENCE; INDIAN-HEDGEHOG; BONE-FORMATION; OSTEOBLASTIC CELLS; CLEFT-PALATE	The heterotrimeric G protein subunit Gs alpha couples receptors to activate adenylyl cyclase and is required for the intracellular cAMP response and protein kinase A (PKA) activation. Gs alpha is ubiquitously expressed in many cell types; however, the role of Gs alpha in neural crest cells (NCCs) remains unclear. Here we report that NCCs-specific Gs alpha knockout mice die within hours after birth and exhibit dramatic craniofacial malformations, including hypoplastic maxilla and mandible, cleft palate and craniofacial skeleton defects. Histological and anatomical analysis reveal that the cleft palate in Gs alpha knockout mice is a secondary defect resulting from craniofacial skeleton deficiencies. In Gs alpha knockout mice, the morphologies of NCCs-derived cranial nerves are normal, but the development of dorsal root and sympathetic ganglia are impaired. Furthermore, loss of Gs alpha in NCCs does not affect cranial NCCs migration or cell proliferation, but significantly accelerate osteochondrogenic differentiation. Taken together, our study suggests that Gs alpha is required for neural crest cells-derived craniofacial development.	[Lei, Run; Zhang, Ke; Wei, Yanxia; Li, Huashun] Sichuan Univ, West China Dev & Stem Cell Inst, West China Second Hosp, Chengdu 610064, Sichuan, Peoples R China; [Lei, Run; Zhang, Ke; Wei, Yanxia; Li, Huashun] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Lei, Run; Zhang, Ke; Li, Hongchang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Lab Dev & Regenerat Biol,Inst Biomed & Biotechnol, Shenzhen, Guangdong, Peoples R China; [Lei, Run; Zhang, Ke; Zhu, Minyan; Li, Huashun] Chinese Acad Sci, Tongji Univ, SARITEX Ctr Stem Cell Engn Translat Med, Shanghai East Hosp,Sch Med, Shanghai, Peoples R China; [Chen, Min; Weinstein, Lee S.] Natl Inst Diabet & Digest & Kidney Dis, Metab Dis Branch, NIH, Bethesda, MD USA; [Hong, Yang] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA	Sichuan University; Sichuan University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Tongji University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, HS (corresponding author), Sichuan Univ, West China Dev & Stem Cell Inst, West China Second Hosp, Chengdu 610064, Sichuan, Peoples R China.; Li, HS (corresponding author), Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.; Li, HC (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Lab Dev & Regenerat Biol,Inst Biomed & Biotechnol, Shenzhen, Guangdong, Peoples R China.; Li, HS (corresponding author), Chinese Acad Sci, Tongji Univ, SARITEX Ctr Stem Cell Engn Translat Med, Shanghai East Hosp,Sch Med, Shanghai, Peoples R China.	hc.li@siat.ac.cn; huashunli@tongji.edu.cn	Li, Hongchang/GQO-9662-2022	Weinstein, Lee/0000-0002-1899-5152	Ministry of Science & Technology-China [2014CB964600, 2012CB966800, 2013ZX09509104, 2007CB947202, 2009CB941402, 2010CB945600, 2011CB965100, 2009R0002]; National Science Foundation of China [31301125, 30771102, 31071283, 81370457, 81271498]; Shenzhen Peacock Plan [KQCX20130628112914292]; Shenzhen Key Laboratory for Molecular Biology of Neural Development [ZDSY20120617112838879]; faculty development support (West China Women's & Children Hospital & Shenzhen Institutes of Advanced Technology-CAS & Tongji University Shanghai East Hospital); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER	Ministry of Science & Technology-China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Plan; Shenzhen Key Laboratory for Molecular Biology of Neural Development; faculty development support (West China Women's & Children Hospital & Shenzhen Institutes of Advanced Technology-CAS & Tongji University Shanghai East Hospital); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by grants from the Ministry of Science & Technology-China (2014CB964600, 2012CB966800,2013ZX09509104, 2007CB947202,2009CB941402, 2010CB945600, 2011CB965100, 2013ZX09509104, and 2009R0002), National Science Foundation of China (31301125, 30771102, 31071283,81370457, 81271498), Shenzhen Peacock Plan (No. KQCX20130628112914292), and faculty development support (West China Women's & Children Hospital & Shenzhen Institutes of Advanced Technology-CAS & Tongji University Shanghai East Hospital) and Shenzhen Key Laboratory for Molecular Biology of Neural Development (ZDSY20120617112838879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; BELLOWS CG, 1990, ENDOCRINOLOGY, V127, P3111, DOI 10.1210/endo-127-6-3111; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Brault V, 2001, DEVELOPMENT, V128, P1253; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chai Y, 1998, INT J DEV BIOL, V42, P87; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Chung U, 2000, IN VIVO FUNCTION STI, pS175; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Dettlaff-Swiercz DA, 2005, DEV BIOL, V282, P174, DOI 10.1016/j.ydbio.2005.03.006; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Farlie Peter G, 2004, Birth Defects Res C Embryo Today, V72, P173, DOI 10.1002/bdrc.20013; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Graul-Neumann LM, 2009, AM J MED GENET A, V149A, P1487, DOI 10.1002/ajmg.a.32889; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; HALL BK, 1980, J EMBRYOL EXP MORPH, V56, P71; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; HOGAN B, 1986, MANIPULATING MOUSE E; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Ivey K, 2003, DEV BIOL, V255, P230, DOI 10.1016/S0012-1606(02)00097-0; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kim TH, 2012, ANAT CELL BIOL, V45, P193, DOI 10.5115/acb.2012.45.3.193; Knecht AK, 2002, NAT REV GENET; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; MARK M, 1993, DEVELOPMENT, V119, P319; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nanes M, 1995, OLIGONUCLEOTIDES ANT, P62; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Qin L, 2005, J CELL BIOCHEM, V96, P632, DOI 10.1002/jcb.20550; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Ricks JE, 2002, TERATOLOGY, V65, P116, DOI 10.1002/tera.10022; ROSEN V, 1994, J BONE MINER RES, V9, P1759; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Ruest LB, 2009, DEV BIOL, V328, P94, DOI 10.1016/j.ydbio.2009.01.005; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; Sakamoto A, 2005, J BONE MINER RES, V20, P663, DOI 10.1359/JBMR.041210; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; SEEGMILLER RE, 1977, J EMBRYOL EXP MORPH, V38, P227; SHENKER A, 1993, J PEDIATR-US, V123, P509, DOI 10.1016/S0022-3476(05)80943-6; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stewart K, 2013, DEVELOPMENT, V140, P3413, DOI 10.1242/dev.094532; Swarthout JT, 2002, J BONE MINER RES, V17, P1401, DOI 10.1359/jbmr.2002.17.8.1401; Tataria M, 2006, J PEDIATR SURG, V41, P624, DOI 10.1016/j.jpedsurg.2005.12.001; Taya Y, 1999, DEVELOPMENT, V126, P3869; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; TURKSEN K, 1990, J CELL PHYSIOL, V142, P61, DOI 10.1002/jcp.1041420109; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Weinstein L, 1996, PRINCIPLES BONE BIOL, V2, P1165; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zhang RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020780; Zhang YP, 2012, DEV DYNAM, V241, P924, DOI 10.1002/dvdy.23776; Zhen XC, 2001, J BIOL CHEM, V276, P4879, DOI 10.1074/jbc.M004990200; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	87	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147535	10.1371/journal.pone.0147535	http://dx.doi.org/10.1371/journal.pone.0147535			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859889	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000370038400010
J	Pawlowski, CS; Andersen, HB; Troelsen, J; Schipperijn, J				Pawlowski, Charlotte Skau; Andersen, Henriette Bondo; Troelsen, Jens; Schipperijn, Jasper			Children's Physical Activity Behavior during School Recess: A Pilot Study Using GPS, Accelerometer, Participant Observation, and Go-Along Interview	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; ENVIRONMENTS; PLAY; INTERVENTIONS; DETERMINANT; ADOLESCENTS; PLAYGROUNDS; FACILITIES; BARRIERS; DESIGN	Schoolyards are recognized as important settings for physical activity interventions during recess. However, varying results have been reported. This pilot study was conducted to gain in-depth knowledge of children's physical activity behavior during recess using a mixed-methods approach combining quantitative GPS and accelerometer measurements with qualitative go-along group interviews and participant observations. Data were collected during three weekdays in a public school in Denmark. Eighty-one children (47 girls) wore an accelerometer (ActiGraph GT3X) and GPS (QStarz BT-Q1000xt), sixteen children participated in go-along group interviews, and recess behavior was observed using an ethnographical participant observation approach. All data were analyzed separated systematically answering the Five W Questions. Children were categorized into Low, Middle and High physical activity groups and these groups were predominantly staying in three different locations during recess: school building, schoolyard and field, respectively. Mostly girls were in the building remaining in there because of a perceived lack of attractive outdoor play facilities. The children in the schoolyard were predominantly girls who preferred the schoolyard over the field to avoid the competitive soccer games on the field whereas boys dominated the field playing soccer. Using a mixed-methods approach to investigate children's physical activity behavior during recess helped gain in-depth knowledge that can aid development of future interventions in the school environment.	[Pawlowski, Charlotte Skau; Andersen, Henriette Bondo; Troelsen, Jens; Schipperijn, Jasper] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Res Unit Act Living, Campusvej 55, DK-5230 Odense M, Denmark; [Pawlowski, Charlotte Skau; Andersen, Henriette Bondo; Troelsen, Jens; Schipperijn, Jasper] Univ Southern Denmark, Ctr Intervent Res Hlth Promot & Dis Prevent, Natl Inst Publ Hlth, Oster Farimagsgade 5a, DK-1353 Copenhagen K, Denmark	University of Southern Denmark; University of Southern Denmark	Pawlowski, CS (corresponding author), Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Res Unit Act Living, Campusvej 55, DK-5230 Odense M, Denmark.; Pawlowski, CS (corresponding author), Univ Southern Denmark, Ctr Intervent Res Hlth Promot & Dis Prevent, Natl Inst Publ Hlth, Oster Farimagsgade 5a, DK-1353 Copenhagen K, Denmark.	cspawlowski@health.sdu.dk		Schipperijn, Jasper/0000-0002-6558-7610; Troelsen, Jens/0000-0001-8105-0349	Danish Cancer Society	Danish Cancer Society(Danish Cancer Society)	This study was funded by The Danish Cancer Society.	Adams MA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-49; Andersen HB, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1828-9; Andersen HB, 2015, LANDSCAPE URBAN PLAN, V134, P83, DOI 10.1016/j.landurbplan.2014.10.005; Andersen Lars Bo, 2004, Int J Behav Nutr Phys Act, V1, P6, DOI 10.1186/1479-5868-1-6; [Anonymous], 2011, PETER LISTENING YOUN; Anthamatten P, 2014, J PHYS ACT HEALTH, V11, P564, DOI 10.1123/jpah.2012-0064; Anthamatten P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-27; Bailey DP, 2012, EUR J PEDIATR, V171, P1805, DOI 10.1007/s00431-012-1827-0; Blatchford P, 2003, BRIT J DEV PSYCHOL, V21, P481, DOI 10.1348/026151003322535183; BLATCHFORD P, 1996, J RES CHILDHOOD ED, V11, P14, DOI DOI 10.1080/02568549609594692; Boyle DE, 2003, AM BEHAV SCI, V46, P1326, DOI 10.1177/0002764203046010004; Brink LA, 2010, AM J PUBLIC HEALTH, V100, P1672, DOI 10.2105/AJPH.2009.178939; Carpiano RM, 2009, HEALTH PLACE, V15, P263, DOI 10.1016/j.healthplace.2008.05.003; Colabianchi N, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-32; Cook H., 2013, ED STUD BOD TAK PHYS; Darbyshire P, 2005, QUALITATIVE RES, V5, P417, DOI DOI 10.1177/1468794105056921; Dessing D, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-97; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Dyment JE, 2009, CHILD GEOGR, V7, P261, DOI 10.1080/14733280903024423; Emerson R, 2011, WRITING ETHNOGRAPHIC; Escalante Y, 2014, HEALTH EDUC BEHAV, V41, P138, DOI 10.1177/1090198113490725; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fairclough SJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-406; Fjortoft I, 2010, SCAND J PUBLIC HEALT, V38, P28, DOI 10.1177/1403494810384909; Fjortoft I, 2009, LANDSCAPE URBAN PLAN, V93, P210, DOI 10.1016/j.landurbplan.2009.07.008; Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363; Hammersley Martin, 2007, ETHNOGRAPHY; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Hornby-Turner YC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-74; Horner SD, 2000, RES NURS HLTH, V23; Huberty JL, 2011, J PHYS ACT HEALTH, V8, pS249, DOI 10.1123/jpah.8.s2.s249; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Knowles ZR, 2013, J PHYS ACT HEALTH, V10, P406, DOI 10.1123/jpah.10.3.406; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Krueger RA, 2002, FOCUS GROUPS PRACTIC; Kusenbach M, 2003, ETHNOGRAPHY, V4, P455, DOI DOI 10.1177/146613810343007; MacDougall C., 2004, EARLY CHILD DEV CARE, V174, P369, DOI [10.1080/0300443032000153426, DOI 10.1080/0300443032000153426]; de Rezende LFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131342; McKenzie TL, 2010, J SCHOOL HEALTH, V80, P470, DOI 10.1111/j.1746-1561.2010.00530.x; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Morgan A, 2012, HLTH BEHAV SCH AGED; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nielsen G, 2012, J PHYS ACT HEALTH, V9, P104, DOI 10.1123/jpah.9.1.104; Nielsen G, 2010, J PHYS ACT HEALTH, V7, P490, DOI 10.1123/jpah.7.4.490; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ozdemir A, 2008, J ENVIRON PSYCHOL, V28, P287, DOI 10.1016/j.jenvp.2008.02.004; Parrish AM, 2013, SPORTS MED, V43, P287, DOI 10.1007/s40279-013-0024-2; Parrish AM, 2012, HEALTH EDUC RES, V27, P269, DOI 10.1093/her/cyr049; Pawlowski CS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-639; Pawlowski CS, 2014, EUR PHYS ED REV; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Ridgers ND, 2006, SPORTS MED, V36, P359, DOI 10.2165/00007256-200636040-00005; Ridgers ND, 2005, PREV MED, V41, P102, DOI 10.1016/j.ypmed.2004.10.023; Ridgers ND, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-74; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Ridgers ND, 2011, HEALTH EDUC RES, V26, P586, DOI 10.1093/her/cyr014; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Santelli John S, 2003, J Adolesc Health, V33, P396; Schipperijn J, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00021; Spradley J. P., 2016, PARTICIPANT OBSERVAT; Stanley RM, 2012, J SCI MED SPORT, V15, P44, DOI 10.1016/j.jsams.2011.08.002; Swain J, 2006, SPORT EDUC SOC, V11, P317, DOI 10.1080/13573320600924841; Taylor RW, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-38; Thorne B., 1993, GENDER PLAY GIRLS BO; Toftager M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099369; Troelsen J, 2013, NEIGHBOURHOOD STRUCT, P249; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Willenberg LJ, 2010, J SCI MED SPORT, V13, P210, DOI 10.1016/j.jsams.2009.02.011; Wolcott HF., 1994, TRANSFORMING QUALITA; Wood C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108701; Yin RK., 2013, CASE STUDY RES DESIG, V5th ed; Yirmiya N, 2010, J CHILD PSYCHOL PSYC, V51, P1297, DOI 10.1111/j.1469-7610.2010.02344.x; Zask A, 2001, PREV MED, V33, P402, DOI 10.1006/pmed.2001.0905	77	43	43	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148786	10.1371/journal.pone.0148786	http://dx.doi.org/10.1371/journal.pone.0148786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859288	Green Published, gold			2022-12-26	WOS:000370038400084
J	Romero, AC; Bergamaschi, CT; de Souza, DN; Nogueira, FN				Romero, Ana Carolina; Bergamaschi, Cassia Toledo; de Souza, Douglas Nesadal; Nogueira, Fernando Neves			Salivary Alterations in Rats with Experimental Chronic Kidney Disease	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; WHOLE SALIVA; GLAND; SECRETION; EXCRETION; PROTEIN; HYPERTENSION; PEROXIDASE; MECHANISMS	Objective This study aimed to analyze changes in saliva composition and salivary secretion process of rats with chronic kidney disease induced by 5/6 nephrectomy to set the foundation for salivary studies related to CKD. Methods CKD was induced in Wistar rats via 5/6 nephrectomy. Blood and saliva samples were collected from Control, Sham and CKD groups at 8 and 12 weeks after the surgery. Salivation was stimulated via intraperitoneal injections of pilocarpine (1.0 mg/Kg body weight) or isoproterenol (5.0 mg/Kg body weight). Saliva was collected and immediately stored at -80 degrees C until analysis. The salivary flow rate, total protein, amylase and peroxidase activities, and urea concentrations were measured. The blood urea nitrogen (BUN) and serum creatinine concentrations were also evaluated. Results Increases in BUN and serum creatinine concentrations were observed in the CKD groups. Amylase activity was significantly reduced in response to both stimuli in the CKD groups at 8 weeks and increased in the CKD groups at 12 weeks in response to isoproterenol stimulus. The peroxidase activities of the CKD groups were significantly reduced in response to isoproterenol stimulation and were increased at 12 weeks in response to pilocarpine stimulation. Salivary urea was significantly increased in the CKD groups at 8 weeks in response to the isoproterenol stimuli and at 12 weeks in response to both salivary agonists. Conclusions The pattern of alterations observed in this experimental model is similar to those observed in patients and clearly demonstrates the viability of 5/6 nephrectomy as an experimental model in future studies to understand the alterations in salivary compositions and in salivary glands that are elicited by CKD.	[Romero, Ana Carolina; de Souza, Douglas Nesadal; Nogueira, Fernando Neves] Univ Sao Paulo, Dept Biomat & Biol Oral, Fac Odontol, Sao Paulo, Brazil; [Bergamaschi, Cassia Toledo] Escola Paulista Med UNIFESP, Dept Fisiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Nogueira, FN (corresponding author), Univ Sao Paulo, Dept Biomat & Biol Oral, Fac Odontol, Sao Paulo, Brazil.	fnn@usp.br	Bergamaschi, Cassia/AAZ-9441-2020; Nogueira, Fernando/I-7549-2015	Nogueira, Fernando/0000-0002-6595-9154; Bergamaschi, Cassia/0000-0002-5741-6993	FAPESP (the Research Council for the State of Sao Paulo) [2013/18609-1]	FAPESP (the Research Council for the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (the Research Council for the State of Sao Paulo) (2013/18609-1).	ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; Amano O, 2012, ACTA HISTOCHEM CYTOC, V45, P241, DOI 10.1267/ahc.12013; ANDERSON LC, 1986, ARCH ORAL BIOL, V31, P501, DOI 10.1016/0003-9969(86)90027-0; Ashby MT, 2008, J DENT RES, V87, P900, DOI 10.1177/154405910808701003; Augustyniak RA, 2002, J HYPERTENS, V20, P3, DOI 10.1097/00004872-200201000-00002; BASSECHES PJ, 1982, ARCH INT PHARMACOD T, V257, P180; Bergamaschi CT, 1997, MED SCI SPORT EXER, V29, P169, DOI 10.1097/00005768-199702000-00001; Bossola M, 2012, NAT REV NEPHROL, V8, P176, DOI 10.1038/nrneph.2011.218; CAMPESE VM, 1981, KIDNEY INT, V20, P246, DOI 10.1038/ki.1981.127; Cardoso EML, 2009, SCAND J CLIN LAB INV, V69, P330, DOI 10.1080/00365510802588076; CHANDRA T, 1977, EUR J BIOCHEM, V72, P259, DOI 10.1111/j.1432-1033.1977.tb11248.x; Chanutin A, 1932, ARCH INTERN MED, V49, P767, DOI 10.1001/archinte.1932.00150120057006; Davidovich E, 2011, NEPHROL DIAL TRANSPL, V26, P1541, DOI 10.1093/ndt/gfq587; Davidovich E, 2009, NEPHROL DIAL TRANSPL, V24, P2439, DOI 10.1093/ndt/gfp101; DAWES C, 1970, J DENT RES, V49, P1263, DOI 10.1177/00220345700490061501; DAWES C, 1984, J PHYSIOL-LONDON, V346, P579, DOI 10.1113/jphysiol.1984.sp015042; DEMUNIZ BR, 1983, ARCH ORAL BIOL, V28, P575, DOI 10.1016/0003-9969(83)90004-3; Ding GH, 1998, J PHARMACOL EXP THER, V287, P31; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Ersson C, 2011, ORAL SURG ORAL MED O, V112, P209, DOI 10.1016/j.tripleo.2011.03.016; Eyre S, 2008, J RENAL NUTR, V18, P269, DOI 10.1053/j.jrn.2007.11.013; FISHER EH, 1961, BIOCHEM PREP, V8, P27; Fregoneze AP, 2013, SPEC CARE DENT, V33, P118, DOI 10.1111/scd.12008; HEINTZE U, 1983, SWED DENT J, V7, P227; Hostetter TH, 2001, J CLIN INVEST, V107, P161, DOI 10.1172/JCI12066; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Kao CH, 2000, AM J KIDNEY DIS, V36, P1110, DOI 10.1053/ajkd.2000.19810; Kho HS, 1999, ORAL SURG ORAL MED O, V88, P316, DOI 10.1016/S1079-2104(99)70035-1; Klassen Judith T, 2002, J Can Dent Assoc, V68, P34; KUMANO K, 1986, KIDNEY INT, V30, P433, DOI 10.1038/ki.1986.203; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martins C, 2006, SPEC CARE DENT, V26, P205, DOI 10.1111/j.1754-4505.2006.tb01439.x; Martins C, 2012, PEDIATR NEPHROL, V27, P1961, DOI 10.1007/s00467-012-2194-9; Naugle K, 1998, Ann Periodontol, V3, P197, DOI 10.1902/annals.1998.3.1.197; OBRY F, 1987, J DENT CHILD, V54, P429; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Peng CH, 2013, CLIN BIOCHEM, V46, P275, DOI 10.1016/j.clinbiochem.2012.10.029; Postorino M, 2003, AM J KIDNEY DIS, V42, P722, DOI 10.1016/S0272-6386(03)00908-9; Ribeiro DA, 2009, EUR J CLIN INVEST, V39, P289, DOI 10.1111/j.1365-2362.2009.02100.x; Romero AC, 2012, ARCH ORAL BIOL, V57, P1189, DOI 10.1016/j.archoralbio.2012.02.016; Savica V, 2008, CLIN NEPHROL, V69, P229; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; SHANNON IL, 1966, ARCH ORAL BIOL, V11, P451, DOI 10.1016/0003-9969(66)90109-9; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; Tomas I, 2008, ARCH ORAL BIOL, V53, P528, DOI 10.1016/j.archoralbio.2008.01.006; TSIANOS EV, 1994, INT J PANCREATOL, V15, P105; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; Vaziri ND, 2004, CURR HYPERTENS REP, V6, P314, DOI 10.1007/s11906-004-0027-3; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Vesterinen M, 2007, QUINTESSENCE INT, V38, P211; Weiner DE, 2007, J MANAGE CARE PHARM, V13, pS1; Yu XF, 2012, RENAL FAILURE, V34, P907, DOI 10.3109/0886022X.2012.691012	53	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148742	10.1371/journal.pone.0148742	http://dx.doi.org/10.1371/journal.pone.0148742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859883	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400073
J	Sarian, FD; Rahman, DY; Schepers, O; van der Maarel, MJEC				Sarian, Fean Davisunjaya; Rahman, Delicia Yunita; Schepers, Otto; van der Maarel, Marc Jos Elise Cornelis			Effects of Oxygen Limitation on the Biosynthesis of Photo Pigments in the Red Microalgae Galdieria sulphuraria Strain 074G	PLOS ONE			English	Article							COPROPORPHYRINOGEN-III OXIDASE; TETRAPYRROLE BIOSYNTHESIS; HEME; GLUCOSE	As a consequence of the inhibition of one of the steps in the biosynthesis of the photopigments chlorophyll and phycobilin, the red microalga Galdieria partita excretes coproporphyrinogen III in the medium when growing on glucose. No coproporphyrinogen III was found when the closely related red microalgae G. sulphuraria strain 074G was grown on glucose and excessive amounts of oxygen. When under the same conditions oxygen was limiting, coproporphyrinogen III was present in the medium. We conclude that not glucose but the amount of oxygen in the medium results in the accumulation of coproporphyrinogen III. This is explained by the inactivition of the oxygen-dependent coproporphyrinogen III oxidase that converts coproporhyrinogen III to protoporphyrinogen IX, one of the intermediate steps in the biosynthesis of chlorophyl and phycobilin.	[Sarian, Fean Davisunjaya] Inst Teknol Bandung, Fac Math & Nat Sci, Div Biochem Res, Bandung, Indonesia; [Sarian, Fean Davisunjaya; Rahman, Delicia Yunita; Schepers, Otto; van der Maarel, Marc Jos Elise Cornelis] Univ Groningen, Engn & Technol Inst ENTEG, Aquat Biotechnol & Bioprod Engn, Groningen, Netherlands	Institute Technology of Bandung; University of Groningen	van der Maarel, MJEC (corresponding author), Univ Groningen, Engn & Technol Inst ENTEG, Aquat Biotechnol & Bioprod Engn, Groningen, Netherlands.	m.j.e.c.van.der.maarel@rug.nl		rahman, delicia/0000-0002-8170-3247; Sarian, Fean Davisunjaya/0000-0001-7540-8746				ALLEN MB, 1959, ARCH MIKROBIOL, V32, P270, DOI 10.1007/BF00409348; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BATLLE AMD, 1965, BIOCHEM J, V97, P731, DOI 10.1042/bj0970731; Battersby AR, 2000, NAT PROD REP, V17, P507, DOI 10.1039/b002635m; Breckau D, 2003, J BIOL CHEM, V278, P46625, DOI 10.1074/jbc.M308553200; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Cozzolino S, 2000, HYDROBIOLOGIA, V433, P145, DOI 10.1023/A:1004035224715; FALK JE, 1953, NATURE, V172, P292, DOI 10.1038/172292a0; FALK JE, 1964, BIOCHEM J, V90, P66, DOI 10.1042/bj0900066; Falk JE, 1975, PORPHYRINS METALLOPO; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; GROSS W, 1995, PLANT CELL PHYSIOL, V36, P633; HENDRY GAF, 1980, J MED GENET, V17, P1, DOI 10.1136/jmg.17.1.1; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Komatsu Y, 2015, INT J ASTROBIOL, V14, P505, DOI 10.1017/S147355041400072X; KRUSE E, 1995, PLANTA, V196, P796, DOI 10.1007/BF01106776; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; McDonald AG, 2008, NUCLEIC ACIDS RES, V37, P593; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; POULSON R, 1974, J BIOL CHEM, V249, P6367; REINBOTHE S, 1991, PLANT PHYSIOL BIOCH, V29, P297; Sloth JK, 2006, ENZYME MICROB TECH, V38, P168, DOI 10.1016/j.enzmictec.2005.05.010; Stadnichuk I, 1998, PLANT SCI, V136, P11, DOI 10.1016/S0168-9452(98)00088-0; STEINMULLER K, 1984, PLANT PHYSIOL, V76, P935, DOI 10.1104/pp.76.4.935; XU KP, 1993, J BACTERIOL, V175, P4990, DOI 10.1128/JB.175.16.4990-4999.1993	28	7	7	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148358	10.1371/journal.pone.0148358	http://dx.doi.org/10.1371/journal.pone.0148358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859750	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400035
J	van Leeuwen, N; Lingsma, HF; Vanrolleghem, AM; Sturkenboom, MCJM; van Doorn, PA; Steyerberg, EW; Jacobs, BC				van Leeuwen, Nikki; Lingsma, Hester F.; Vanrolleghem, Ann M.; Sturkenboom, Miriam C. J. M.; van Doorn, Pieter A.; Steyerberg, Ewout W.; Jacobs, Bart C.			Hospital Admissions, Transfers and Costs of Guillain-Barre Syndrome	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS	Background Guillain-Barre syndrome (GBS) has a highly variable clinical course, leading to frequent transfers within and between hospitals and high associated costs. We defined the current admissions, transfers and costs in relation to disease severity of GBS. Methods Dutch neurologists were requested to report patients diagnosed with GBS between November 2009 and November 2010. Information regarding clinical course and transfers was obtained via neurologists and general practitioners. Results 87 GBS patients were included with maximal GBS disability score of 1 or 2 (28%), 3 or 4 (53%), 5 (18%) and 6 (1%). Four mildly affected GBS patients were not hospital admitted. Of the 83 hospitalized patients 68 (82%) were initially admitted at a neurology department, 4 (5%) at an ICU, 4 (5%) at pediatrics, 4 (5%) at pediatrics neurology and 3 (4%) at internal medicine. Median hospital stay was 17 days (IQR 11-26 days, absolute range 1-133 days). Transfers between departments or hospitals occurred in 33 (40%) patients and 25 (30%) were transferred 2 times or more. From a cost-effectiveness perspective 21 (25%) of the admissions was suboptimal. Median costs for hospital admission of GBS patients were 15,060 Euro (IQR 11,226-23,683). Maximal GBS disability score was significantly correlated with total length of stay, number of transfers, ICU admission and costs. Conclusions Hospital admissions for GBS patients are highly heterogeneous, with frequent transfers and higher costs for those with more severe disease. Future research should aim to develop prediction models to early identify the most cost-effective allocation in individual patients.	[van Leeuwen, Nikki; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Vanrolleghem, Ann M.; Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Med Informat, POB 2040, NL-3000 CA Rotterdam, Netherlands; [van Doorn, Pieter A.; Jacobs, Bart C.] Erasmus MC, Dept Neurol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Jacobs, Bart C.] Erasmus MC, Dept Immunol, POB 2040, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Leeuwen, N (corresponding author), Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	n.vanleeuwen.1@erasmusmc.nl	Jacobs, Bart/ABE-2210-2021	Sturkenboom, Miriam/0000-0003-1360-2388				[Anonymous], HANDLEIDING KOSTENON; Barratt H, 2012, CRIT CARE, V16, DOI 10.1186/cc11662; de Wit Marie-Claire Y, 2011, Ned Tijdschr Geneeskd, V155, pA3808; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285; Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1; Havelaar AH, 2000, EPIDEMIOL INFECT, V125, P505, DOI 10.1017/S0950268800004933; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Ligtenberg JJM, 2005, CRIT CARE, V9, pR446, DOI 10.1186/cc3749; Mehndiratta M M, 2001, J Assoc Physicians India, V49, P459; Nagpal S, 1999, J CLIN APHERESIS, V14, P107, DOI 10.1002/(SICI)1098-1101(1999)14:3<107::AID-JCA1>3.0.CO;2-3; Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62; Ruts L, 2005, NEUROLOGY, V65, P138, DOI 10.1212/01.wnl.0000167549.09664.b8; Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Van Koningsveld R, 2001, NEUROLOGY, V56, P564, DOI 10.1212/WNL.56.4.564; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407; Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976; Winters JL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-101	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0143837	10.1371/journal.pone.0143837	http://dx.doi.org/10.1371/journal.pone.0143837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859880	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400001
J	Farino, ZJ; Morgenstern, TJ; Vallaghe, J; Gregor, N; Donthamsetti, P; Harris, PE; Pierre, N; Freyberg, R; Charrier-Savournin, F; Javitch, JA; Freyberg, Z				Farino, Zachary J.; Morgenstern, Travis J.; Vallaghe, Julie; Gregor, Nathalie; Donthamsetti, Prashant; Harris, Paul E.; Pierre, Nicolas; Freyberg, Robin; Charrier-Savournin, Fabienne; Javitch, Jonathan A.; Freyberg, Zachary			Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; DOPAMINE-RECEPTORS; GLUCOSE-TOLERANCE; OBESE SUBJECTS; ISLET SIZE; BROMOCRIPTINE; SECRETION; RATS; IMMUNOASSAY; ACTIVATION	Direct measurement of insulin is critical for basic and clinical studies of insulin secretion. However, current methods are expensive and time-consuming. We developed an insulin assay based on homogenous time-resolved fluorescence that is significantly more rapid and cost-effective than current commonly used approaches. This assay was applied effectively to an insulin secreting cell line, INS-1E cells, as well as pancreatic islets, allowing us to validate the assay by elucidating mechanisms by which dopamine regulates insulin release. We found that dopamine functioned as a significant negative modulator of glucose-stimulated insulin secretion. Further, we showed that bromocriptine, a known dopamine D2/D3 receptor agonist and newly approved drug used for treatment of type II diabetes mellitus, also decreased glucose-stimulated insulin secretion in islets to levels comparable to those caused by dopamine treatment.	[Farino, Zachary J.; Morgenstern, Travis J.; Donthamsetti, Prashant; Javitch, Jonathan A.; Freyberg, Zachary] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Farino, Zachary J.; Morgenstern, Travis J.; Donthamsetti, Prashant; Javitch, Jonathan A.; Freyberg, Zachary] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Vallaghe, Julie; Gregor, Nathalie; Pierre, Nicolas; Charrier-Savournin, Fabienne] Cisbio Bioassays, Res Dept, Codolet, France; [Donthamsetti, Prashant; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA; [Harris, Paul E.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Endocrinol, New York, NY USA; [Freyberg, Robin] Yeshiva Univ, Stern Coll Women, Dept Psychol, New York, NY 10033 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Yeshiva University	Freyberg, Z (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA.; Freyberg, Z (corresponding author), New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA.	zf2101@cumc.columbia.edu	Freyberg, Zachary/L-4927-2018	Freyberg, Zachary/0000-0001-6460-0118; HARRIS, PAUL/0000-0003-4806-8242; Javitch, Jonathan/0000-0001-7395-2967	Louis V. Gerstner Jr., Scholars Program (Columbia University); Cisbio Bioassays; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077493, R01DK104740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA031241, K05DA022413] Funding Source: NIH RePORTER	Louis V. Gerstner Jr., Scholars Program (Columbia University); Cisbio Bioassays; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Louis V. Gerstner Jr., Scholars Program (Columbia University) - Z.F. Cisbio Bioassays - J.V., N.G., N.P., F.C.S. The funder Cisbio Bioassays provided support in the form of salaries for authors J.V., N.G., N.P., F.C.S.; Columbia University provided salary support for Z.F. Neither funder had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ARMBRUSTER DA, 1994, CLIN CHEM, V40, P1233; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Ayoub MA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00094; Burns SM, 2015, CELL METAB, V21, P126, DOI 10.1016/j.cmet.2014.12.010; Burns SM V A, 2012, HIGH THROUGHPUT SCRE; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Chen Y, 2014, CELL TISSUE RES, V357, P597, DOI 10.1007/s00441-014-1894-9; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; CINCOTTA AH, 1993, AM J PHYSIOL, V264, pE285, DOI 10.1152/ajpendo.1993.264.2.E285; Cincotta AH, 1997, LIFE SCI, V61, P951, DOI 10.1016/S0024-3205(97)00599-7; Cincotta AH, 1996, DIABETES CARE, V19, P667, DOI 10.2337/diacare.19.6.667; CINCOTTA AH, 1991, METABOLISM, V40, P639, DOI 10.1016/0026-0495(91)90057-4; Claret EJ, 2004, HIGH THROUGHPUT HTRF; COLELLA RM, 1985, LIFE SCI, V37, P1059, DOI 10.1016/0024-3205(85)90597-1; Daijo JE, 1999, J PHARMACEUT BIOMED, V19, P335, DOI 10.1016/S0731-7085(98)00126-5; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Doucet J, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/290670; Drummond GB, 2010, EXP PHYSIOL, V95, P841, DOI 10.1113/expphysiol.2010.053785; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Ezrokhi M, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-104; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Granata R, 2014, DIABETES, V63, P2380, DOI 10.2337/db13-1522; Hiram-Bab S, 2012, PANCREAS, V41, P238, DOI 10.1097/MPA.0b013e3182277e56; Holt RIG, 2010, DIABETES OBES METAB, V12, P1048, DOI 10.1111/j.1463-1326.2010.01304.x; HOPCROFT DW, 1985, HORM METAB RES, V17, P559, DOI 10.1055/s-2007-1013606; Imai S, 2014, ANAL BIOCH; JAHR H, 1978, ACTA BIOL MED GER, V37, P659; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kalra S, 2011, RECENT PATENTS ENDOC, V5, P61, DOI 10.2174/187221411794351842; Kawasaki E, 2000, FRONT BIOSCI, V5, pE181, DOI 10.2741/kawasaki; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kok P, 2006, AM J PHYSIOL-ENDOC M, V291, pE1038, DOI 10.1152/ajpendo.00567.2005; KRATZSCH J, 1990, EXP CLIN ENDOCRINOL, V95, P229, DOI 10.1055/s-0029-1210957; LANCRANJAN I, 1981, J NEURAL TRANSM, V51, P61, DOI 10.1007/BF01664005; LEAHY JL, 1993, DIABETES, V42, P22, DOI 10.2337/diabetes.42.1.22; Mahajan R, 2009, INDIAN J PHARMACOL, V41, P197, DOI 10.4103/0253-7613.56070; Mathis G, 1999, J BIOMOL SCREEN, V4, P309, DOI 10.1177/108705719900400605; MEIER AH, 1992, EXPERIENTIA, V48, P248, DOI 10.1007/BF01930467; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mikhail N, 2011, CURR DRUG DELIV, V8, P511, DOI 10.2174/156720111796642255; Pijl H, 2000, DIABETES CARE, V23, P1154, DOI 10.2337/diacare.23.8.1154; REAVEN EP, 1981, HORM METAB RES, V13, P673, DOI 10.1055/s-2007-1019372; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; SEEMAN P, 1993, CURR OPIN NEUROL NEU, V6, P602; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; Ustione A, 2012, MOL ENDOCRINOL, V26, P1928, DOI 10.1210/me.2012-1226; Valiquette G, 2011, CARDIOL REV, V19, P272, DOI 10.1097/CRD.0b013e318229d2d2; van Weenen JED, 2010, BIOCHEM PHARMACOL, V79, P1827, DOI 10.1016/j.bcp.2010.01.029; Vuojola J, 2014, METHODS APPL FLUORES, V2, DOI 10.1088/2050-6120/2/1/012001; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yan D, 2015, LIFE SCI; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2015, PANCREAS, V44, P925, DOI 10.1097/MPA.0000000000000357; Zhang ZY, 2010, FASEB J, V24, P1497, DOI 10.1096/fj.09-136572	58	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148684	10.1371/journal.pone.0148684	http://dx.doi.org/10.1371/journal.pone.0148684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849707	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000157
J	Gardini, S; Cheli, S; Baroni, S; Di Lascio, G; Mangiavacchi, G; Micheletti, N; Monaco, CL; Savini, L; Alocci, D; Mangani, S; Niccolai, N				Gardini, Simone; Cheli, Sara; Baroni, Silvia; Di Lascio, Gabriele; Mangiavacchi, Guido; Micheletti, Nicholas; Monaco, Carmen Luigia; Savini, Lorenzo; Alocci, Davide; Mangani, Stefano; Niccolai, Neri			On Nature's Strategy for Assigning Genetic Code Multiplicity	PLOS ONE			English	Article							ATOM DEPTH; EVOLUTION; ORIGIN; USAGE; PATHWAYS; PROTEINS; MUTATION; ERROR; MODEL; DNA	Genetic code redundancy would yield, on the average, the assignment of three codons for each of the natural amino acids. The fact that this number is observed only for incorporating Ile and to stop RNA translation still waits for an overall explanation. Through a Structural Bioinformatics approach, the wealth of information stored in the Protein Data Bank has been used here to look for unambiguous clues to decipher the rationale of standard genetic code (SGC) in assigning from one to six different codons for amino acid translation. Leu and Arg, both protected from translational errors by six codons, offer the clearest clue by appearing as the most abundant amino acids in protein-protein and protein-nucleic acid interfaces. Other SGC hidden messages have been sought by analyzing, in a protein structure framework, the roles of over-and under-protected amino acids.	[Gardini, Simone; Cheli, Sara; Baroni, Silvia; Di Lascio, Gabriele; Mangiavacchi, Guido; Micheletti, Nicholas; Monaco, Carmen Luigia; Savini, Lorenzo; Alocci, Davide; Mangani, Stefano; Niccolai, Neri] Univ Siena, Dept Biotechnol Chem & Pharm, Via Laterina 8, I-53100 Siena, Italy	University of Siena	Niccolai, N (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via Laterina 8, I-53100 Siena, Italy.	neri.niccolai@unisi.it						Alocci D, 2013, BIOCHEM BIOPH RES CO, V436, P725, DOI 10.1016/j.bbrc.2013.06.024; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buhrman H, 2013, J MOL EVOL, V77, P170, DOI 10.1007/s00239-013-9571-2; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Di Giulio M, 2005, BIOSYSTEMS, V80, P175, DOI 10.1016/j.biosystems.2004.11.005; Di Giulio M, 2000, TRENDS BIOCHEM SCI, V25, P44, DOI 10.1016/S0968-0004(99)01522-4; Freeland SJ, 2000, MOL BIOL EVOL, V17, P511, DOI 10.1093/oxfordjournals.molbev.a026331; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Freeland SJ, 2000, TRENDS BIOCHEM SCI, V25, P44, DOI 10.1016/S0968-0004(99)01531-5; GOLDBERG AL, 1966, SCIENCE, V153, P420, DOI 10.1126/science.153.3734.420; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Higgs PG, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-16; Kay L. E., 2000, WHO WROTE BOOK LIFE; Knight RD, 2000, CELL, V101, P569, DOI 10.1016/S0092-8674(00)80866-1; Knight RD, 1999, TRENDS BIOCHEM SCI, V24, P241, DOI 10.1016/S0968-0004(99)01392-4; Koonin EV, 2009, IUBMB LIFE, V61, P99, DOI 10.1002/iub.146; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lenstra R, 2014, J THEOR BIOL, V347, P95, DOI 10.1016/j.jtbi.2014.01.002; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Marquez R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r91; NIRENBERG MW, 1963, SCI AM, V208, P80, DOI 10.1038/scientificamerican0363-80; Santos J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-56; Sengupta S, 2015, J MOL EVOL, V80, P229, DOI 10.1007/s00239-015-9686-8; SHIELDS DC, 1990, J MOL EVOL, V31, P71, DOI 10.1007/BF02109476; Varrazzo D, 2005, BIOINFORMATICS, V21, P2856, DOI 10.1093/bioinformatics/bti444; WOESE CR, 1966, P NATL ACAD SCI USA, V55, P966, DOI 10.1073/pnas.55.4.966; WOESE CR, 1964, SCIENCE, V144, P1030, DOI 10.1126/science.144.3621.1030; Zhu CT, 2003, J MOL EVOL, V57, P533, DOI 10.1007/s00239-003-2505-7	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148174	10.1371/journal.pone.0148174	http://dx.doi.org/10.1371/journal.pone.0148174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849571	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000047
J	Haulsee, DE; Fox, DA; Breece, MW; Clauss, TM; Oliver, MJ				Haulsee, Danielle E.; Fox, Dewayne A.; Breece, Matthew W.; Clauss, Tonya M.; Oliver, Matthew J.			Implantation and Recovery of Long-Term Archival Transceivers in a Migratory Shark with High Site Fidelity	PLOS ONE			English	Article							TIGERS CARCHARIAS-TAURUS; SAND TIGER; MOVEMENT PATTERNS; EAST-COAST; ATLANTIC; BEHAVIOR; GROWTH; FISH; ABUNDANCE; SURVIVAL	We developed a long-term tagging method that can be used to understand species assemblages and social groupings associated with large marine fishes such as the Sand Tiger shark Carcharias taurus. We deployed internally implanted archival VEMCO Mobile Transceivers (VMTs; VEMCO Ltd. Nova Scotia, Canada) in 20 adult Sand Tigers, of which two tags were successfully recovered (10%). The recovered VMTs recorded 29,646 and 44,210 detections of telemetered animals respectively. To our knowledge, this is the first study to demonstrate a method for long-term (similar to 1 year) archival acoustic transceiver tag implantation, retention, and recovery in a highly migratory marine fish. Results show low presumed mortality (n = 1, 5%), high VMT retention, and that non-lethal recovery after almost a year at liberty can be achieved for archival acoustic transceivers. This method can be applied to study the social interactions and behavioral ecology of large marine fishes.	[Haulsee, Danielle E.; Breece, Matthew W.; Oliver, Matthew J.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA; [Fox, Dewayne A.] Delaware State Univ, Dept Agr & Nat Resources, Dover, DE USA; [Clauss, Tonya M.] Georgia Aquarium, Atlanta, GA USA	University of Delaware; Delaware State University	Haulsee, DE (corresponding author), Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA.	dhaulsee@udel.edu	Haulsee, Danielle/W-7513-2019	Haulsee, Danielle/0000-0003-0691-0278	Robertson's Fund; NOAA-NMFS Proactive Species Conservation Program; The Georgia Aquarium	Robertson's Fund; NOAA-NMFS Proactive Species Conservation Program; The Georgia Aquarium	This work was supported by the generous support of The Robertson's Fund and the NOAA-NMFS Proactive Species Conservation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Georgia Aquarium provided support in the form of salary for author TMC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BRANSTETTER S, 1994, T AM FISH SOC, V123, P242, DOI 10.1577/1548-8659(1994)123<0242:AAGEFT>2.3.CO;2; Chiaramonte G., 2007, IUCN RED LIST THREAT; Compagno L, 1984, FAO SPECIES CATALO 1, V4; Cooke SJ, 2003, J FISH BIOL, V62, P1366, DOI 10.1046/j.1095-8649.2003.00119.x; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P127, DOI 10.1007/s11160-010-9193-3; Croft DP, 2005, OECOLOGIA, V143, P211, DOI 10.1007/s00442-004-1796-8; Dicken ML, 2006, AFR J MAR SCI, V28, P589, DOI 10.2989/18142320609504209; Dicken ML, 2006, ICES J MAR SCI, V63, P1640, DOI 10.1016/j.icesjms.2006.06.009; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Driggers WB, 2014, J EXP MAR BIOL ECOL, V459, P61, DOI 10.1016/j.jembe.2014.05.006; Fox DA, 2015, CONSERVATION SAND TI; Goldman KJ, 2006, ENVIRON BIOL FISH, V77, P241, DOI 10.1007/s10641-006-9128-y; Gurshin CWD, 2004, J FISH BIOL, V65, P973, DOI 10.1111/j.0022-1112.2004.00501.x; Guttridge TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009324; Hammerschlag N, 2014, METHODS ECOL EVOL, V5, P1147, DOI 10.1111/2041-210X.12248; Harms CA, 2005, LAB ANIMAL, V34, P28, DOI 10.1038/laban0105-28; Hayes SA, 2013, ENVIRON BIOL FISH, V96, P189, DOI 10.1007/s10641-011-9940-x; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; Holland Kim N., 2010, Endangered Species Research, V10, P287; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Jacoby DMP, 2010, BEHAV ECOL, V21, P808, DOI 10.1093/beheco/arq061; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kilfoil J., 2014, THESIS DELAWARE STAT; KLIMLEY AP, 1984, BEHAV ECOL SOCIOBIOL, V15, P45, DOI 10.1007/BF00310214; Kneebone J, 2014, MAR BIOL, V161, P1149, DOI 10.1007/s00227-014-2407-9; Kneebone J, 2013, FISH RES, V147, P103, DOI 10.1016/j.fishres.2013.04.009; Kneebone J, 2012, MAR ECOL PROG SER, V471, P165, DOI 10.3354/meps09989; Kynard B, 1997, REJECTION INTERNAL T, P58; Lidgard DC, 2014, MAR ECOL PROG SER, V501, P157, DOI 10.3354/meps10670; Lidgard DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048962; Lucifora LO, 2009, ANIM CONSERV, V12, P291, DOI 10.1111/j.1469-1795.2009.00247.x; Lucifora LO, 2002, ICES J MAR SCI, V59, P553, DOI 10.1006/jmsc.2002.1183; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; McAuley, 2003, IUCN RED LIST THREAT; McCandless Camilla T., 2007, V50, P45; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meyer CG, 2007, AQUAT LIVING RESOUR, V20, P291, DOI 10.1051/alr:2008002; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Pollard D., 2009, IUCN RED LIST THREAT; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Ripley W. E., 1946, California Fish and Game Commission Fish Bulletin, V64, P1; Sibert J., 2001, ELECT TAGGING TRACKI; Teter SM, 2015, MAR FRESHWATER RES, V66, P158, DOI 10.1071/MF14129; WATSKY MA, 1990, FISH PHYSIOL BIOCHEM, V8, P207, DOI 10.1007/BF00004459; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Winter J.D., 1983, P371	47	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148617	10.1371/journal.pone.0148617	http://dx.doi.org/10.1371/journal.pone.0148617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849043	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000138
J	Kim, SW; Jung, HW; Kim, CH; Kim, KI; Chin, HJ; Lee, H				Kim, Sun-wook; Jung, Hee-Won; Kim, Cheol-Ho; Kim, Kwang-Il; Chin, Ho Jun; Lee, Hajeong			A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BIOELECTRICAL-IMPEDANCE ANALYSIS; SERUM CREATININE; BODY-COMPOSITION; URINARY CREATININE; KIDNEY-FUNCTION; RENAL-FUNCTION; HEALTH; SARCOPENIA; PREVALENCE	Background With evaluation for physical performance, measuring muscle mass is an important step in detecting sarcopenia. However, there are no methods to estimate muscle mass from blood sampling. Methods To develop a new equation to estimate total-body muscle mass with serum creatinine and cystatin C level, we designed a cross-sectional study with separate derivation and validation cohorts. Total body muscle mass and fat mass were measured using dual-energy x-ray absorptiometry (DXA) in 214 adults aged 25 to 84 years who underwent physical checkups from 2010 to 2013 in a single tertiary hospital. Serum creatinine and cystatin C levels were also examined. Results Serum creatinine was correlated with muscle mass (P < .001), and serum cystatin C was correlated with body fat mass (P < .001) after adjusting glomerular filtration rate (GFR). After eliminating GFR, an equation to estimate total-body muscle mass was generated and coefficients were calculated in the derivation cohort. There was an agreement between muscle mass calculated by the novel equation and measured by DXA in both the derivation and validation cohort (P < .001, adjusted R-2 = 0.829, beta = 0.95, P < .001, adjusted R-2 = 0.856, beta = 1.03, respectively). Conclusion The new equation based on serum creatinine and cystatin C levels can be used to estimate total-body muscle mass.	[Kim, Sun-wook; Jung, Hee-Won; Kim, Cheol-Ho; Kim, Kwang-Il; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Kim, Sun-wook; Kim, Cheol-Ho; Kim, Kwang-Il; Chin, Ho Jun; Lee, Hajeong] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Jung, Hee-Won] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Lee, Hajeong] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital	Lee, H (corresponding author), Seoul Natl Univ, Coll Med, Seoul, South Korea.; Lee, H (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	mdhjlee@gmail.com	Kim, Kwang-il/AAP-7315-2021; Jung, Hee-Won/B-4269-2015; Kim, Kwang-il/D-8024-2012	Kim, Kwang-il/0000-0002-6658-047X; Jung, Hee-Won/0000-0002-2583-3354; Kim, Kwang-il/0000-0002-6658-047X				Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chew-Harris JSC, 2013, ANN CLIN BIOCHEM, V50, P39, DOI 10.1258/acb.2012.011241; Chien MY, 2008, J AM GERIATR SOC, V56, P1710, DOI 10.1111/j.1532-5415.2008.01854.x; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; ENGSTROM CM, 1991, J ANAT, V176, P139; Frazee EN, 2014, CRIT CARE, V18, DOI 10.1186/cc13899; GOLDBERG TH, 1987, ARCH INTERN MED, V147, P1430, DOI 10.1001/archinte.147.8.1430; Hart A, 2013, J AM GERIATR SOC, V61, P1530, DOI 10.1111/jgs.12413; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Horber FF, 1997, NUTRITION, V13, P524, DOI 10.1016/S0899-9007(97)00031-2; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Kottgen A, 2008, AM J KIDNEY DIS, V51, P385, DOI 10.1053/j.ajkd.2007.11.019; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; LAKE KD, 1985, PHARMACOTHERAPY, V5, P340; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Muntner P, 2008, AM J MED, V121, P341, DOI 10.1016/j.amjmed.2008.01.003; Naour N, 2009, OBESITY, V17, P2121, DOI 10.1038/oby.2009.96; Odden MC, 2006, AM J EPIDEMIOL, V164, P1180, DOI 10.1093/aje/kwj333; Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Shlipak MG, 2006, J AM SOC NEPHROL, V17, P254, DOI 10.1681/ASN.2005050545; Srikanthan P, 2014, AM J MED, V127, P547, DOI 10.1016/j.amjmed.2014.02.007; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Trutschnigg B, 2008, APPL PHYSIOL NUTR ME, V33, P1232, DOI 10.1139/H08-122; Wasen E, 2003, AM J KIDNEY DIS, V42, P36, DOI 10.1016/S0272-6386(03)00406-2	38	32	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148495	10.1371/journal.pone.0148495	http://dx.doi.org/10.1371/journal.pone.0148495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849842	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000109
J	Thormann, B; Ahrens, D; Armijos, DM; Peters, MK; Wagner, T; Wagele, JW				Thormann, Birthe; Ahrens, Dirk; Armijos, Diego Marin; Peters, Marcell K.; Wagner, Thomas; Waegele, Johann W.			Exploring the Leaf Beetle Fauna (Coleoptera: Chrysomelidae) of an Ecuadorian Mountain Forest Using DNA Barcoding	PLOS ONE			English	Article							SPECIES DELIMITATION; BIOLOGICAL IDENTIFICATIONS; BIODIVERSITY ASSESSMENT; INSECT HERBIVORES; TROPICAL FORESTS; RAIN-FOREST; DIVERSITY; RICHNESS; TAXONOMY; PHYLOGENY	Background Tropical mountain forests are hotspots of biodiversity hosting a huge but little known diversity of insects that is endangered by habitat destruction and climate change. Therefore, rapid assessment approaches of insect diversity are urgently needed to complement slower traditional taxonomic approaches. We empirically compare different DNA-based species delimitation approaches for a rapid biodiversity assessment of hyperdiverse leaf beetle assemblages along an elevational gradient in southern Ecuador and explore their effect on species richness estimates. Methodology/Principal Findings Based on a COI barcode data set of 674 leaf beetle specimens (Coleoptera: Chrysomelidae) of 266 morphospecies from three sample sites in the Podocarpus National Park, we employed statistical parsimony analysis, distance-based clustering, GMYC- and PTP-modelling to delimit species-like units and compared themtomorphology-based (parataxonomic) species identifications. The four different approaches for DNA-based species delimitation revealed highly similar numbers of molecular operational taxonomic units (MOTUs) (n = 284-289). Estimated total species richness was considerably higher than the sampled amount, 414 for morphospecies (Chao2) and 469-481 for the different MOTU types. Assemblages at different elevational levels (1000 vs. 2000 m) had similar species numbers but a very distinct species composition for all delimitation methods. Most species were found only at one elevation while this turnover pattern was even more pronounced for DNA-based delimitation. Conclusions/Significance Given the high congruence of DNA-based delimitation results, probably due to the sampling structure, our study suggests that when applied to species communities on a regionally limited level with high amount of rare species (i.e. similar to 50% singletons), the choice of species delimitation method can be of minor relevance for assessing species numbers and turnover in tropical insect communities. Therefore, DNA-based species delimitation is confirmed as a valuable tool for evaluating biodiversity of hyperdiverse insect communities, especially when exact taxonomic identifications are missing.	[Thormann, Birthe; Ahrens, Dirk; Waegele, Johann W.] Zool Res Museum Alexander Koenig, Bonn, Germany; [Armijos, Diego Marin] Univ Tecn Particular Loja, Dept Ciencias Nat, Museo Colecc Biol MUTPL, Loja, Ecuador; [Peters, Marcell K.] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany; [Wagner, Thomas] Univ Koblenz Landau, Abt Biol, Inst Integrierte Nat Wissensch, Koblenz, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Universidad Tecnica Particular de Loja; University of Wurzburg; University of Koblenz & Landau	Thormann, B (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	birthe.thormann.zfmk@uni-bonn.de	Ahrens, Dirk/AAR-1310-2021; Wagner, Thomas/S-9370-2019	Peters, Marcell/0000-0002-1262-0827; Marin-Armijos, Diego/0000-0001-7138-3916	German Science Foundation (DFG) [WA 530/46-1]; Leibniz Association	German Science Foundation (DFG)(German Research Foundation (DFG)); Leibniz Association	Funding for this study was provided by grants of the German Science Foundation (DFG) to J.W.W. (WA 530/46-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The publication of this article was funded by the Open Access fund of the Leibniz Association.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Andrew NR, 2004, ECOL ENTOMOL, V29, P527, DOI 10.1111/j.0307-6946.2004.00639.x; Astrin JJ, 2012, MOL PHYLOGENET EVOL, V63, P1, DOI 10.1016/j.ympev.2011.11.018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Basset Y, 2001, BIOL J LINN SOC, V72, P585, DOI 10.1111/j.1095-8312.2001.tb01340.x; Basset Y, 2001, OECOLOGIA, V129, P253, DOI 10.1007/s004420100724; Basset Y, 2007, B I R SC N B ENTOMOL, V77; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Beck EH, 2008, BASIC APPL ECOL, V9, P1, DOI 10.1016/j.baae.2007.06.017; Bendix J, 2006, INT J BIOMETEOROL, V50, P370, DOI 10.1007/s00484-006-0029-8; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blackwelder RE, 1947, B US NATL MUSEUM, V185; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Borowiec Lech, 2000, Genus (Wroclaw), V11, P229; Borowiec Lech, 2000, Genus (Wroclaw), V11, P49; Borowiec Lech, 1998, Genus (Wroclaw), V9, P155; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Brehm G, 2003, J BIOGEOGR, V30, P431, DOI 10.1046/j.1365-2699.2003.00832.x; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brummitt N, 2003, CONSERV BIOL, V17, P1442, DOI 10.1046/j.1523-1739.2003.02344.x; Cabrera N, 2001, PHYSIS A B C, V58, pC47; Cardoso A, 2005, MOL ECOL, V14, P3531, DOI 10.1111/j.1365-294X.2005.02679.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chaboo CS, 2007, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2007)305[1:BAPOTC]2.0.CO;2; Chamorro ML, 2011, ZOOKEYS, P43, DOI 10.3897/zookeys.78.980; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Charles E, 2005, J TROP ECOL, V21, P329, DOI 10.1017/S0266467405002300; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Costa C, 2000, PROYECTO IBEROAMERIC; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Descampe A, 2008, ENVIRON ENTOMOL, V37, P224, DOI 10.1603/0046-225X(2008)37[224:PARFNO]2.0.CO;2; Didham Raphael K., 2003, Weta, V26, P1; Donoso DA, 2009, ANN SOC ENTOMOL FR, V45, P487, DOI 10.1080/00379271.2009.10697631; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; FAO, 2020, GLOBAL FOREST RESOUR; Farrell B.D., 1988, Series Entomologica (Dordrecht), V42, P73; Flowers RW, 2009, ZOOTAXA, P65, DOI 10.11646/zootaxa.2132.1.4; Flowers RW, 2009, ZOOTAXA, P65; Flowers RW, 2003, SPECIAL TOPICS LEAF, P25; Flowers Wills, 2009, Insecta Mundi, V0095, P1; Fontaneto D, 2011, HYDROBIOLOGIA, V662, P27, DOI 10.1007/s10750-010-0481-7; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Furth David G., 2003, International Congress of Entomology Proceedings, V21, P1; Furth David G., 1996, Insecta Mundi, V10, P45; Garcia-Lopez A, 2013, J BIOGEOGR, V40, P2134, DOI 10.1111/jbi.12148; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Gomez-Zurita J, 2008, CLADISTICS, V24, P34, DOI 10.1111/j.1096-0031.2007.00167.x; Gomez-Zurita J, 2014, SYST ENTOMOL, V39, P111, DOI 10.1111/syen.12038; Gotelli Nicholas J., 2011, P39; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Homeier J., 2008, V198, P87; Homeier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047128; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Sanchez-Reyes UJ, 2014, ZOOKEYS, P103, DOI 10.3897/zookeys.417.7551; Jolivet P, 1988, BIOL CHRYSOMELIDAE; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kanzaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043865; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Linzmeier AM, 2012, J NAT HIST, V46, P1921, DOI 10.1080/00222933.2012.707237; Linzmeier AM, 2013, BIOTA NEOTROP, V13, P153, DOI 10.1590/S1676-06032013000100018; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; May RM, 2010, SCIENCE, V329, P41, DOI 10.1126/science.1191058; Mayden R. L., 1997, V54, P381; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mosandl R., 2008, V198, P37; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; Papadopoulou A, 2013, ZOOL J LINN SOC-LOND, V168, P473, DOI 10.1111/zoj.12039; Papadopoulou A, 2011, AM NAT, V178, P241, DOI 10.1086/660828; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rodriguez-Castaneda G, 2010, ECOL LETT, V13, P1348, DOI 10.1111/j.1461-0248.2010.01525.x; Sekerka L, 2012, ANN ZOOL, V62, P669, DOI 10.3161/000345412X659722; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Staines C.L., 2012, Insecta Mundi, V0232, P1; Staines CL, 2002, P ENTOMOL SOC WASH, V104, P721; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Swietojanska Jolanta, 2000, Genus (Wroclaw), V11, P607; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; TEMPLETON AR, 1992, GENETICS, V132, P619; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wagner T, 2000, BIOTROPICA, V32, P502, DOI 10.1111/j.1744-7429.2000.tb00496.x; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	121	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148268	10.1371/journal.pone.0148268	http://dx.doi.org/10.1371/journal.pone.0148268			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849826	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000061
J	Tiptiri-Kourpeti, A; Spyridopoulou, K; Santarmaki, V; Aindelis, G; Tompoulidou, E; Lamprianidou, EE; Saxami, G; Ypsilantis, P; Lampri, ES; Simopoulos, C; Kotsianidis, I; Galanis, A; Kourkoutas, Y; Dimitrellou, D; Chlichlia, K				Tiptiri-Kourpeti, Angeliki; Spyridopoulou, Katerina; Santarmaki, Valentina; Aindelis, Georgios; Tompoulidou, Evgenia; Lamprianidou, Eleftheria E.; Saxami, Georgia; Ypsilantis, Petros; Lampri, Evangeli S.; Simopoulos, Constantinos; Kotsianidis, Ioannis; Galanis, Alex; Kourkoutas, Yiannis; Dimitrellou, Dimitra; Chlichlia, Katerina			Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SUPPRESSES TUMOR-GROWTH; GUT MICROBIOTA; COLORECTAL-CANCER; RHAMNOSUS-GG; PROBIOTIC BACTERIA; HT-29 CELLS; ANNEXIN-V; IN-VITRO; ATCC 393	Probiotic microorganisms such as lactic acid bacteria (LAB) exert a number of strain-specific health-promoting activities attributed to their immunomodulatory, anti-inflammatory and anti-carcinogenic properties. Despite recent attention, our understanding of the biological processes involved in the beneficial effects of LAB strains is still limited. To this end, the present study investigated the growth-inhibitory effects of Lactobacillus casei ATCC 393 against experimental colon cancer. Administration of live Lactobacillus casei (as well as bacterial components thereof) on murine (CT26) and human (HT29) colon carcinoma cell lines raised a significant concentration-and time-dependent anti-proliferative effect, determined by cell viability assays. Specifically, a dramatic decrease in viability of colon cancer cells co-incubated with 10(9) CFU/mL L. casei for 24 hours was detected (78% for HT29 and 52% for CT26 cells). In addition, live L. casei induced apoptotic cell death in both cell lines as revealed by annexin V and propidium iodide staining. The significance of the in vitro anti-proliferative effects was further confirmed in an experimental tumor model. Oral daily administration of 10(9) CFU live L. casei for 13 days significantly inhibited in vivo growth of colon carcinoma cells, resulting in approximately 80% reduction in tumor volume of treated mice. Tumor growth inhibition was accompanied by L. casei-driven up-regulation of the TNF-related apoptosis-inducing ligand TRAIL and down-regulation of Survivin. Taken together, these findings provide evidence for beneficial tumor-inhibitory, anti-proliferative and proapoptotic effects driven by this probiotic LAB strain.	[Tiptiri-Kourpeti, Angeliki; Spyridopoulou, Katerina; Santarmaki, Valentina; Aindelis, Georgios; Tompoulidou, Evgenia; Saxami, Georgia; Galanis, Alex; Kourkoutas, Yiannis; Dimitrellou, Dimitra; Chlichlia, Katerina] Democritus Univ Thrace, Sch Hlth Sci, Dept Mol Biol & Genet, Univ Campus Dragana, Alexandroupolis 68100, Greece; [Lamprianidou, Eleftheria E.; Kotsianidis, Ioannis] Democritus Univ Thrace, Sch Hlth Sci, Dept Hematol, Univ Campus Dragana, Alexandroupolis 68100, Greece; [Ypsilantis, Petros; Simopoulos, Constantinos] Democritus Univ Thrace, Sch Hlth Sci, Lab Expt Surg & Surg Res, Alexandroupolis 68100, Greece; [Lampri, Evangeli S.] Univ Ioannina, Sch Med, Dept Pathol, GR-45110 Ioannina, Greece	Democritus University of Thrace; Democritus University of Thrace; Democritus University of Thrace; University of Ioannina	Chlichlia, K (corresponding author), Democritus Univ Thrace, Sch Hlth Sci, Dept Mol Biol & Genet, Univ Campus Dragana, Alexandroupolis 68100, Greece.	achlichl@mbg.duth.gr	Dimitrellou, Dimitra/M-1242-2019; Chlichlia, Katerina/Q-3948-2019; Kotsianidis, Ioannis/AGH-1791-2022; Ypsilantis, Petros/AAO-8216-2021; Spyridopoulou, Katerina/AAJ-1631-2021; KOTSIANIDIS, IOANNIS/ABH-1436-2021; Ypsilantis, Petros/ABH-2143-2021; Galanis, Alex/ABF-4762-2020; Kourkoutas, Yiannis/AAM-8253-2021	Spyridopoulou, Katerina/0000-0003-4905-9567; KOTSIANIDIS, IOANNIS/0000-0001-7668-0186; Galanis, Alex/0000-0001-9991-3173; Simopoulos, Konstantinos/0000-0002-7994-3583; Chlichlia, Katerina/0000-0003-4952-0675; Dimitrellou, Dimitra/0000-0002-8120-7585	European Social Fund (ESF); Greek State	European Social Fund (ESF)(European Social Fund (ESF)); Greek State	The research project was implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and was co-financed by the European Social Fund (ESF) and the Greek State.	Baldwin C, 2010, NUTR CANCER, V62, P371, DOI 10.1080/01635580903407197; Bianchi MA, 2004, LETT APPL MICROBIOL, V39, P301, DOI 10.1111/j.1472-765X.2004.01589.x; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chen CC, 2012, BRIT J NUTR, V107, P1623, DOI 10.1017/S0007114511004934; Choi SS, 2006, LETT APPL MICROBIOL, V42, P452, DOI 10.1111/j.1472-765X.2006.01913.x; Cicenia A, 2014, J CLIN GASTROENTEROL, V48, pS18, DOI 10.1097/MCG.0000000000000231; Clarke RG, 2000, CYTOMETRY, V39, P141, DOI 10.1002/(SICI)1097-0320(20000201)39:2<141::AID-CYTO7>3.3.CO;2-F; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; CORBETT TH, 1975, CANCER RES, V35, P2434; de LeBlanc AD, 2014, WORLD J GASTROENTERO, V20, P16518, DOI 10.3748/wjg.v20.i44.16518; Di Luccia B, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0069102; Diao ZJ, 2013, CANCER IMMUNOL IMMUN, V62, P653, DOI 10.1007/s00262-012-1370-x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Escamilla J, 2012, NUTR CANCER, V64, P871, DOI 10.1080/01635581.2012.700758; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fang J, 2014, J PHARM SCI-US, V103, P3235, DOI 10.1002/jps.24083; Fogh J, 1975, HUMAN TUMOR CELLS IN; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Gianotti L, 2010, WORLD J GASTROENTERO, V16, P167, DOI 10.3748/wjg.v16.i2.167; Hirayama K, 2000, MICROBES INFECT, V2, P681, DOI 10.1016/S1286-4579(00)00357-9; Horinaka M, 2010, FEBS LETT, V584, P577, DOI 10.1016/j.febslet.2009.12.004; Ishii M, 2007, CANCER LETT, V245, P134, DOI 10.1016/j.canlet.2005.12.040; Ishikawa H, 2005, INT J CANCER, V116, P762, DOI 10.1002/ijc.21115; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; KATO I, 1994, INT J IMMUNOPHARMACO, V16, P29, DOI 10.1016/0192-0561(94)90116-3; KATO I, 1981, GANN, V72, P517; Khazaie K, 2012, P NATL ACAD SCI USA, V109, P10462, DOI 10.1073/pnas.1207230109; Kim JE, 2007, J MICROBIOL BIOTECHN, V17, P1227; Kim Y, 2010, LETT APPL MICROBIOL, V51, P123, DOI 10.1111/j.1472-765X.2010.02859.x; Kodaikkal V., 2012, INT J APPL ANIMAL SC, V1, P01; Kourkoutas Y, 2006, J DAIRY SCI, V89, P1439, DOI 10.3168/jds.S0022-0302(06)72212-3; Kumar M, 2010, INT J FOOD SCI NUTR, V61, P473, DOI 10.3109/09637480903455971; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Lee Jung-Woo, 2004, J Vet Sci, V5, P41; Liu CT, 2011, MUTAT RES-GEN TOX EN, V721, P157, DOI 10.1016/j.mrgentox.2011.01.005; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; MATSUZAKI T, 1985, CANCER IMMUNOL IMMUN, V20, P18; Neish AS, 2011, J CLIN GASTROENTEROL, V45, P571, DOI 10.1097/MCG.0b013e318219221d; Oelschlaeger TA, 2010, INT J MED MICROBIOL, V300, P57, DOI 10.1016/j.ijmm.2009.08.005; Orlando A, 2012, NUTR CANCER, V64, P1103, DOI 10.1080/01635581.2012.717676; Pagnini C, 2011, J CLIN GASTROENTEROL, V45, P602, DOI 10.1097/MCG.0b013e31820abf29; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Rafter J, 2004, NUTR RES REV, V17, P277, DOI 10.1079/NRR200484; Rauch M, 2010, GUT MICROBES, V1, P335, DOI 10.4161/gmic.1.5.13169; Raviv Z, 2011, BRIT J PHARMACOL, V164, P1422; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seow SW, 2010, CANCER SCI, V101, P751, DOI 10.1111/j.1349-7006.2009.01426.x; Serban DE, 2014, CANCER LETT, V345, P258, DOI 10.1016/j.canlet.2013.08.013; Shida K, 2011, GUT MICROBES, V2, P109, DOI 10.4161/gmic.2.2.15661; Sidira M, 2014, MEAT SCI, V96, P948, DOI 10.1016/j.meatsci.2013.09.013; Sidira M, 2013, J DAIRY SCI, V96, P3369, DOI 10.3168/jds.2012-6343; Sidira M, 2010, J MOL MICROB BIOTECH, V19, P224, DOI 10.1159/000321115; Stolfi C, 2011, MOL CANCER THER, V10, P1969, DOI 10.1158/1535-7163.MCT-11-0316; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Tsilingiri K, 2013, BENEF MICROBES, V4, P101, DOI 10.3920/BM2012.0046; Tuo YF, 2010, J DAIRY SCI, V93, P2362, DOI 10.3168/jds.2010-3069; Uccello M, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-S1-S35; van Geelen CMM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-39; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035; Wan Y, 2014, ONCOL LETT, V7, P1738, DOI 10.3892/ol.2014.1959; Wang K, 2014, INT J BIOL MACROMOL, V63, P133, DOI 10.1016/j.ijbiomac.2013.10.036; Wang SM, 2014, RES MICROBIOL, V165, P202, DOI 10.1016/j.resmic.2014.02.004; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Zhong L, 2014, WORLD J GASTROENTERO, V20, P7878, DOI 10.3748/wjg.v20.i24.7878; Zhu YM, 2011, CANCER LETT, V309, P119, DOI 10.1016/j.canlet.2011.06.004	68	139	144	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147960	10.1371/journal.pone.0147960	http://dx.doi.org/10.1371/journal.pone.0147960			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849051	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000030
J	Wei, CH; Chen, JJ; Kuang, HH				Wei, Chunhua; Chen, Jiongjiong; Kuang, Hanhui			Dramatic Number Variation of R Genes in Solanaceae Species Accounted for by a Few R Gene Subfamilies	PLOS ONE			English	Article							DISEASE RESISTANCE GENES; NUCLEOTIDE-BINDING SITE; REPEAT-ENCODING GENES; GENOME-WIDE ANALYSIS; PROVIDES INSIGHTS; EVOLUTIONARY PATTERNS; TOMATO; SOLANUM; FAMILY; SEQUENCE	Most disease resistance genes encode nucleotide-binding-site (NBS) and leucine-rich-repeat (LRR) domains, and the NBS-LRR encoding genes are often referred to as R genes. Using newly developed approach, 478, 485, 1,194, 1,665, 2,042 and 374 R genes were identified from the genomes of tomato Heinz1706, wild tomato LA716, potato DM1-3, pepper Zunla-1 and wild pepper Chiltepin and tobacco TN90, respectively. The majority of R genes from Solanaceae were grouped into 87 subfamilies, including 16 TIR-NBS-LRR (TNL) and 71 non-TNL subfamilies. Each subfamily was annotated manually, including identification of intron/exon structure and intron phase. Interestingly, TNL subfamilies have similar intron phase patterns, while the non-TNL subfamilies have diverse intron phase due to frequent gain of introns. Prevalent presence/absence polymorphic R gene loci were found among Solanaceae species, and an integrated map with 427 R loci was constructed. The pepper genome (2,042 in Chiltepin) has at least four times of R genes as in tomato (478 in Heinz1706). The high number of R genes in pepper genome is due to the amplification of R genes in a few subfamilies, such as the Rpi-blb2 and BS2 subfamilies. The mechanism underlying the variation of R gene number among different plant genomes is discussed.	[Wei, Chunhua; Chen, Jiongjiong; Kuang, Hanhui] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, MOA,Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China; [Wei, Chunhua; Chen, Jiongjiong; Kuang, Hanhui] Huazhong Agr Univ, Key Lab Hort Crop Biol & Genet Improvement Cent R, MOA, Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China; [Wei, Chunhua] Northwest A&F Univ, Coll Hort, Yangling 712100, Shanxi, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Northwest A&F University - China	Chen, JJ (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, MOA,Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China.; Chen, JJ (corresponding author), Huazhong Agr Univ, Key Lab Hort Crop Biol & Genet Improvement Cent R, MOA, Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China.	jjchen@mail.hzau.edu.cn			National Natural Science Foundation of China [31221062, 31272030]; "973" National Key Basic Research Program [2009CB119000]; Natural Science Foundation of Hubei Province of China [2013CFB204]; Fundamental Research Funds for the Central Universities [2014PY031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" National Key Basic Research Program(National Basic Research Program of China); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China: No. [31221062] and [31272030]; "973" National Key Basic Research Program: no. 2009CB119000; Natural Science Foundation of Hubei Province of China: NO. [2013CFB204]; The Fundamental Research Funds for the Central Universities: No.[2014PY031].	Andolfo G, 2013, NEW PHYTOL, V197, P223, DOI 10.1111/j.1469-8137.2012.04380.x; Andolfo G, 2014, MOL BREEDING; Arya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107987; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; Gu L, 2014, MOL GENET GENOMICS; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; He LM, 2004, MOL PLANT MICROBE IN, V17, P1234, DOI 10.1094/MPMI.2004.17.11.1234; Hirakawa H, 2014, DNA RES; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Lin X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-335; Lozano R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1554-9; Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034775; Luo S, 2012, PLANT PHYSIOL, V159, P197, DOI 10.1104/pp.111.192062; Luo S, 2011, MOL BIOL EVOL, V28, P313, DOI 10.1093/molbev/msq216; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Nguyen HD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-69; Park TH, 2005, MOL PLANT MICROBE IN, V18, P722, DOI 10.1094/MPMI-18-0722; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shao ZQ, 2014, PLANT PHYSIOL, V166, P217, DOI 10.1104/pp.114.243626; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan SL, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/418208; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wei CH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-743; Wei Hengling, 2013, PLoS One, V8, pe68435, DOI 10.1371/journal.pone.0068435; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110	49	26	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148708	10.1371/journal.pone.0148708	http://dx.doi.org/10.1371/journal.pone.0148708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849045	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000162
J	An, XB; Wang, JJ; Li, H; Lu, ZZ; Bai, Y; Xiao, H; Zhang, YY; Song, Y				An, Xiangbo; Wang, Jingjing; Li, Hao; Lu, Zhizhen; Bai, Yan; Xiao, Han; Zhang, Youyi; Song, Yao			Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; TISSUE DOPPLER; PRESSURE; ECHOCARDIOGRAPHY; MECHANISMS; FAILURE; MOUSE	Cardiac hypertrophy is a key pathological process of many cardiac diseases. However, early detection of cardiac hypertrophy is difficult by the currently used non-invasive method and new approaches are in urgent need for efficient diagnosis of cardiac malfunction. Here we report that speckle tracking-based strain analysis is more sensitive than conventional echocardiography for early detection of pathological cardiac hypertrophy in the isoproterenol (ISO) mouse model. Pathological hypertrophy was induced by a single subcutaneous injection of ISO. Physiological cardiac hypertrophy was established by daily treadmill exercise for six weeks. Strain analysis, including radial strain (RS), radial strain rate (RSR) and longitudinal strain (LS), showed marked decrease as early as 3 days after ISO injection. Moreover, unlike the regional changes in cardiac infarction, strain analysis revealed global cardiac dysfunction that affects the entire heart in ISO-induced hypertrophy. In contrast, conventional echocardiography, only detected altered E/E', an index reflecting cardiac diastolic function, at 7 days after ISO injection. No change was detected on fractional shortening (FS), E/A and E'/A' at 3 days or 7 days after ISO injection. Interestingly, strain analysis revealed cardiac dysfunction only in ISO-induced pathological hypertrophy but not the physiological hypertrophy induced by exercise. Taken together, our study indicates that strain analysis offers a more sensitive approach for early detection of cardiac dysfunction than conventional echocardiography. Moreover, multiple strain readouts distinguish pathological cardiac hypertrophy from physiological hypertrophy.	[An, Xiangbo; Wang, Jingjing; Li, Hao; Lu, Zhizhen; Bai, Yan; Xiao, Han; Zhang, Youyi; Song, Yao] Peking Univ, Key Lab Cardiovasc Mol Biol & Regulatory Peptide, Beijing Key Lab Cardiovasc Receptors Res, Hosp 3,Inst Vasc Med,Minist Hlth, Beijing 100191, Peoples R China	Peking University	Zhang, YY; Song, Y (corresponding author), Peking Univ, Key Lab Cardiovasc Mol Biol & Regulatory Peptide, Beijing Key Lab Cardiovasc Receptors Res, Hosp 3,Inst Vasc Med,Minist Hlth, Beijing 100191, Peoples R China.	zhangyy@bjmu.edu.cn; songyao@bjmu.edu.cn	Xiao, Han/T-5032-2019	, Wang/0000-0002-5119-3960	national natural science foundation of China [81530009, 81300067]; National Key Basic Research Program of the People's Republic of China [2012CB518000]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of the People's Republic of China	The study was supported by national natural science foundation of China (81530009, 81300067, http://www.nsfc.gov.cn) and National Key Basic Research Program of the People's Republic of China (2012CB518000, http://english.iee.cas.cn). YZ received the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Condorelli Gianluigi, 2008, Heart Fail Monit, V5, P112; Edvardsen T, 2006, PROG CARDIOVASC DIS, V49, P207, DOI 10.1016/j.pcad.2006.08.008; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Hashimoto I, 2003, J AM COLL CARDIOL, V42, P1574, DOI 10.1016/j.jacc.2003.05.002; Hoit BD, 2006, TOXICOL PATHOL, V34, P105, DOI 10.1080/01926230500369535; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Ingul CB, 2010, J AM SOC ECHOCARDIOG, V23, P432, DOI 10.1016/j.echo.2010.01.018; Jassal DS, 2009, J AM SOC ECHOCARDIOG, V22, P418, DOI 10.1016/j.echo.2009.01.016; Lapa C, 2015, INT J CARDIOL, V194, P44, DOI 10.1016/j.ijcard.2015.05.073; Li C, 2010, EUR J ECHOCARDIOGR, V11, P296, DOI 10.1093/ejechocard/jep218; Meoli DF, 2004, J CLIN INVEST, V113, P1684, DOI 10.1172/JCI200420352; Moreira-Goncalves D, 2015, J PHYSIOL-LONDON, V593, P3885, DOI 10.1113/JP270685; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Powers SK, 2014, PHYSIOLOGY, V29, P27, DOI 10.1152/physiol.00030.2013; Saeed M, 2015, CARDIOVASC DIAGN THE, V5, P290, DOI 10.3978/j.issn.2223-3652.2015.06.07; Stanton T, 2010, JACC-CARDIOVASC IMAG, V3, P867, DOI 10.1016/j.jcmg.2010.05.011; Strijkers GJ, 2009, NMR BIOMED, V22, P182, DOI 10.1002/nbm.1299; Thibault H, 2009, J AM SOC ECHOCARDIOG, V22, P198, DOI 10.1016/j.echo.2008.11.019; Zhang Y, 2005, J AM COLL CARDIOL, V46, P864, DOI 10.1016/j.jacc.2005.05.054; Zhong M, 2013, J NUCL MED, V54, P609, DOI 10.2967/jnumed.112.108092	22	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149155	10.1371/journal.pone.0149155	http://dx.doi.org/10.1371/journal.pone.0149155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871457	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100114
J	Kolekar, PS; Waman, VP; Kale, MM; Kulkarni-Kale, U				Kolekar, Pandurang S.; Waman, Vaishali P.; Kale, Mohan M.; Kulkarni-Kale, Urmila			RV-Typer: A Web Server for Typing of Rhinoviruses Using Alignment-Free Approach	PLOS ONE			English	Article							MOSAIC STRUCTURE; RECOMBINATION; SEQUENCES; CLASSIFICATION; PHYLOGENY; PROPOSALS; ALGORITHM; VP1	Rhinoviruses (RV) are increasingly being reported to cause mild to severe infections of respiratory tract in humans. RV are antigenically the most diverse species of the genus Enterovirus and family Picornaviridae. There are three species of RV (RV-A, -B and -C), with 80, 32 and 55 serotypes/types, respectively. Antigenic variation is the main limiting factor for development of a cross-protective vaccine against RV. Serotyping of Rhinoviruses is carried out using cross-neutralization assays in cell culture. However, these assays become laborious and time-consuming for the large number of strains. Alternatively, serotyping of RV is carried out by alignment-based phylogeny of both protein and nucleotide sequences of VP1. However, serotyping of RV based on alignment-based phylogeny is a multi-step process, which needs to be repeated every time a new isolate is sequenced. In view of the growing need for serotyping of RV, an alignment-free method based on "return time distribution" (RTD) of amino acid residues in VP1 protein has been developed and implemented in the form of a web server titled RV-Typer. RV-Typer accepts nucleotide or protein sequences as an input and computes return times of di-peptides (k = 2) to assign serotypes. The RV-Typer performs with 100% sensitivity and specificity. It is significantly faster than alignment based methods.	[Kolekar, Pandurang S.; Waman, Vaishali P.; Kulkarni-Kale, Urmila] Savitribai Phule Pune Univ, Bioinformat Ctr, Pune 411007, Maharashtra, India; [Kale, Mohan M.] Savitribai Phule Pune Univ, Dept Stat, Pune 411007, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University	Kulkarni-Kale, U (corresponding author), Savitribai Phule Pune Univ, Bioinformat Ctr, Pune 411007, Maharashtra, India.	urmila@bioinfo.net.in	Kolekar, Pandurang/ABF-7389-2020; Kulkarni-Kale, Urmila/G-6946-2011	Kolekar, Pandurang/0000-0003-0044-0076; 	Centre of Excellence (COE) Grant by the DBT, Government of India; BioInformatics National Certification (BINC) fellowship, Department of Biotechnology (DBT) by the Government of India; DBT fellowship; Centre of Excellence (COE) Grant by the DBT	Centre of Excellence (COE) Grant by the DBT, Government of India; BioInformatics National Certification (BINC) fellowship, Department of Biotechnology (DBT) by the Government of India; DBT fellowship; Centre of Excellence (COE) Grant by the DBT	This work was supported under the Centre of Excellence (COE) Grant by the DBT, Government of India to the Bioinformatics Centre, Savitribai Phule Pune University, Pune (India). PSK acknowledges the BioInformatics National Certification (BINC) fellowship awarded by the Department of Biotechnology (DBT), Government of India. VPW acknowledges DBT fellowship. UKK acknowledges the Centre of Excellence (COE) Grant by the DBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported under the Centre of Excellence (COE) Grant by the DBT, Government of India to the Bioinformatics Centre, Savitribai Phule Pune University, Pune (India). PSK acknowledges the BioInformatics National Certification (BINC) fellowship awarded by the Department of Biotechnology (DBT), Government of India. VPW acknowledges DBT fellowship. UKK acknowledges the Centre of Excellence (COE) Grant by the DBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1967, NATURE, V213, P761, DOI 10.1038/213761a0; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Glanville N, 2015, CURR OPIN VIROL, V11, P83, DOI 10.1016/j.coviro.2015.03.004; HAMPARIAN VV, 1987, VIROLOGY, V159, P191; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Kolekar P, 2011, IMMUNOME RES, V7, P1; Kolekar P, 2011, MOL EVOLUTION PHYLOG; Kolekar P, 2014, J VIROL METHODS, V198, P41, DOI 10.1016/j.jviromet.2013.12.012; Kolekar P, 2012, MOL PHYLOGENET EVOL, V65, P510, DOI 10.1016/j.ympev.2012.07.003; Kolekar PS, 2010, AIP CONF PROC, V1298, P307, DOI 10.1063/1.3516320; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Linder JE, 2013, J ALLERGY CLIN IMMUN, V131, P69, DOI 10.1016/j.jaci.2012.09.033; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ruuskanen O, 2013, PEDIATR INFECT DIS J, V32, P553, DOI 10.1097/INF.0b013e3182833c90; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; SMITH JM, 1992, J MOL EVOL, V34, P126; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Waman VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088981; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149350	10.1371/journal.pone.0149350	http://dx.doi.org/10.1371/journal.pone.0149350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870949	Green Published, gold			2022-12-26	WOS:000370054100149
J	Berdan, CA; Erion, KA; Burritt, NE; Corkey, BE; Deeney, JT				Berdan, Charles A.; Erion, Karel A.; Burritt, Nathan E.; Corkey, Barbara E.; Deeney, Jude T.			Inhibition of Monoacylglycerol Lipase Activity Decreases Glucose-Stimulated Insulin Secretion in INS-1 (832/13) Cells and Rat Islets	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ACYL-COA ESTERS; POTASSIUM CHANNEL; CHRONIC EXPOSURE; EXOCYTOSIS; 2-ARACHIDONOYLGLYCEROL; MODULATION; ACTIVATION; MECHANISMS; LIPOLYSIS	Lipid signals derived from lipolysis and membrane phospholipids play an important role in glucose-stimulated insulin secretion (GSIS), though the exact secondary signals remain unclear. Previous reports have documented a stimulatory role of exogenously added monoacyl-glycerol (MAG) on insulin secretion from cultured beta-cells and islets. In this report we have determined effects of increasing intracellular MAG in the beta-cell by inhibiting monoacyl-glycerol lipase (MGL) activity, which catalyzes the final step in triacylglycerol breakdown, namely the hydrolysis of MAG to glycerol and free fatty acid (FA). To determine the role of MGL in GSIS, we used three different pharmacological agents (JZL184, MJN110 and URB602). All three inhibited GSIS and depolarization-induced insulin secretion in INS-1 (832/13). JZL184 significantly inhibited both GSIS and depolarization-induced insulin secretion in rat islets. JZL184 significantly decreased lipolysis and increased both mono- and diacyglycerol species in INS-1 cells. Analysis of the kinetics of GSIS showed that inhibition was greater during the sustained phase of secretion. A similar pattern was observed in the response of Ca2+ to glucose and depolarization but to a lesser degree suggesting that altered Ca2+ handling alone could not explain the reduction in insulin secretion. In addition, a significant reduction in long chain-CoA (LC-CoA) was observed in INS-1 cells at both basal and stimulatory glucose following inhibition of MGL. Our data implicate an important role for MGL in insulin secretion.	[Berdan, Charles A.; Erion, Karel A.; Burritt, Nathan E.; Corkey, Barbara E.; Deeney, Jude T.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA	Boston University	Deeney, JT (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	jdeeney@bu.edu		Deeney, Jude/0000-0003-0988-9419	National Institutes of Health [DK74778, DK35914]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, R37DK035914, R56DK035914, R01DK074778, T32DK007201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant number DK74778, National Institutes of Health grant number DK35914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; Brown H, 2000, DIABETES, V49, P383, DOI 10.2337/diabetes.49.3.383; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; CORKEY BE, 1988, METHOD ENZYMOL, V166, P55; Cunningham BA, 1996, AM J PHYSIOL-ENDOC M, V271, pE702, DOI 10.1152/ajpendo.1996.271.4.E702; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; DEENEY JT, 1992, J BIOL CHEM, V267, P19840; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Erion KA, 2015, J BIOL CHEM, V290, P16191, DOI 10.1074/jbc.M114.620351; Gauthier BR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1279, DOI 10.1152/ajpendo.90568.2008; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Iglesias J, 2016, J LIPID RES, V57, P131, DOI 10.1194/jlr.D058438; Labar G, 2010, CURR MED CHEM, V17, P2588, DOI 10.2174/092986710791859414; Larsson O, 1996, J BIOL CHEM, V271, P10623, DOI 10.1074/jbc.271.18.10623; Li C, 2012, CELL PHYSIOL BIOCHEM, V30, P347, DOI 10.1159/000339069; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Mulvihill MM, 2013, LIFE SCI, V92, P492, DOI 10.1016/j.lfs.2012.10.025; Niphakis MJ, 2013, ACS CHEM NEUROSCI, V4, P1322, DOI 10.1021/cn400116z; Olofsson CS, 2007, DIABETES, V56, P1888, DOI 10.2337/db06-1150; OLSZEWSKI S, 1994, J BIOL CHEM, V269, P27987; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Tian YR, 2008, AM J PHYSIOL-ENDOC M, V294, pE1178, DOI 10.1152/ajpendo.90237.2008; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Winzell MS, 2006, NUTR METAB CARDIOVAS, V16, pS11, DOI 10.1016/j.numecd.2005.11.006; Yaney GC, 2002, AM J PHYSIOL-ENDOC M, V283, pE880, DOI 10.1152/ajpendo.00474.2001; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003	40	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149008	10.1371/journal.pone.0149008	http://dx.doi.org/10.1371/journal.pone.0149008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867016	gold, Green Submitted, Green Published			2022-12-26	WOS:000370050700053
J	Pradhan, A; Anasuya, A; Pradhan, MM; Kavitha, AK; Kar, P; Sahoo, KC; Panigrahi, P; Dutta, A				Pradhan, Ashirbad; Anasuya, Anita; Pradhan, Madan Mohan; Kavitha, A. K.; Kar, Priyanka; Sahoo, Krushna Chandra; Panigrahi, Pinaki; Dutta, Ambarish			Trends in Malaria in Odisha, India-An Analysis of the 2003-2013 Time-Series Data from the National Vector Borne Disease Control Program	PLOS ONE			English	Article							SEGMENTED REGRESSION; PREVALENCE; BURDEN; IMPACT; POLICY	Background Although Odisha is the largest contributor to the malaria burden in India, no systematic study has examined its malaria trends. Hence, the spatio-temporal trends in malaria in Odisha were assessed against the backdrop of the various anti-malaria strategies implemented in the state. Methods Using the district-wise malaria incidence and blood examination data (2003-2013) from the National Vector Borne Disease Control Program, blood examination-adjusted time-trends in malaria incidence were estimated and predicted for 2003-2013 and 2014-2016, respectively. An interrupted time series analysis using segmented regression was conducted to compare the disease trends between the pre (2003-2007) and post-intensification (2009-2013) periods. Key-informant interviews of state stakeholders were used to collect the information on the various anti-malaria strategies adopted in the state. Results The state annual malaria incidence declined from 10.82/1000 to 5.28/1000 during 2003-2013 (adjusted annual decline: -0.54/1000, 95% CI: -0.78 to -0.30). However, the annual blood examination rate remained almost unchanged from 11.25% to 11.77%. The keyinformants revealed that intensification of anti-malaria activities in 2008 led to a more rapid decline in malaria incidence during 2009-2013 as compared to that in 2003-2007 [adjusted decline: -0.83 (-1.30 to -0.37) and -0.27 (-0.41 to -0.13), respectively]. There was a significant difference in the two temporal slopes, i.e., -0.054 (-0.10 to -0.002, p = 0.04) per 1000 population per month, between these two periods, indicating almost a 200% greater decline in the post-intensification period. Although, the seven southern high-burden districts registered the highest decline, they continued to remain in that zone, thereby, making the achievement of malaria elimination (incidence <1/1000) unlikely by 2017. Conclusion The anti-malaria strategies in Odisha, especially their intensification since 2008, have helped improve its malaria situation in recent years. These successful measures need to be sustained and perhaps intensified further for eliminating malaria from Odisha.	[Pradhan, Ashirbad; Kavitha, A. K.; Sahoo, Krushna Chandra; Dutta, Ambarish] Asian Inst Publ Hlth, Ctr Dis Epidemiol & Surveillance, Bhubaneswar, Odisha, India; [Anasuya, Anita] United Kingdom Supported Tech & Management Suppor, Dept Int Dev, Bhubaneswar, Odisha, India; [Pradhan, Madan Mohan; Kar, Priyanka] Govt Odisha, Natl Vector Borne Dis Control Programme, Dept Hlth & Family Welf, Bhubaneswar, Odisha, India; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Omaha, NE USA; [Dutta, Ambarish] Publ Hlth Fdn India, Indian Inst Publ Hlth, Bhubaneswar, Odisha, India	Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); University of Nebraska System; University of Nebraska Medical Center; Public Health Foundation of India	Dutta, A (corresponding author), Asian Inst Publ Hlth, Ctr Dis Epidemiol & Surveillance, Bhubaneswar, Odisha, India.; Dutta, A (corresponding author), Publ Hlth Fdn India, Indian Inst Publ Hlth, Bhubaneswar, Odisha, India.	Ambarish.dutta@iiphb.org	Sahoo, Krushna Chandra/AAF-2813-2020	Dutta, Ambarish/0000-0002-4019-7472; PRADHAN, ASHIRBAD/0000-0003-2400-1385	Department for International Development (DFID), Government of United Kingdom; DFID; CARE India	Department for International Development (DFID), Government of United Kingdom; DFID; CARE India	This study was funded by the Department for International Development (DFID), Government of United Kingdom, through a project support (Odisha Health Sector Plan) to the Government of Odisha, channelized through Infrastructure Professional Enterprises (IPE) Global Private Limited, one of the consortium partners of the project, the other being Options Consulting UK and CARE India. Neither of the three agencies were funding agencies, however they were implementing partners for the project. The funding support from DFID is acknowledged, however, there was no influence of DFID on the conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-173; [Anonymous], 2012, ODISHA HTLH SECTOR P, P1; [Anonymous], 2007, STRATEGIC ACTION PLA, P1; [Anonymous], 2012, EVALUATION USE LLIN; [Anonymous], 2009, GUID PRINC MATH CURR, P1; [Anonymous], 2012, STRATEGIC ACTION PLA, P1; [Anonymous], 2011, ANN REPORT PEOPLE HL, P1; [Anonymous], 2009, OPERATIONAL MANUAL I, P19; Anvikar AR, 2014, INDIAN J MED RES, V139, P205; Aregawi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106359; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Das A, 2012, ACTA TROP, V121, P267, DOI 10.1016/j.actatropica.2011.11.008; Dayer MJ, 2015, LANCET, V385, P1219, DOI 10.1016/S0140-6736(14)62007-9; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Fox J., 2002, TIME SERIES REGRESSI, P1; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; HINKLEY DV, 1970, BIOMETRIKA, V57, P1; Jandoc R, 2015, J CLIN EPIDEMIOL, V68, P950, DOI 10.1016/j.jclinepi.2014.12.018; Kamuliwo M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-437; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Patil Rajan R, 2011, Trop Parasitol, V1, P26, DOI 10.4103/2229-5070.72111; R Core Team, 2016, R FDN STAT COMP; Sahu SS, 2011, INDIAN J MED RES, V133, P655; Shah NK, 2011, LANCET, V377, P991, DOI 10.1016/S0140-6736(11)60378-4; Shah NK, 2012, LANCET, V380, P560, DOI 10.1016/S0140-6736(12)61322-1; Singh N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-274; Taljaard M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-77; Valadez JJ, 2014, TROP MED INT HEALTH, V19, P1226, DOI 10.1111/tmi.12354; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	34	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149126	10.1371/journal.pone.0149126	http://dx.doi.org/10.1371/journal.pone.0149126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866696	Green Submitted, Green Published, gold			2022-12-26	WOS:000370050700068
J	Gogoi-Tiwari, J; Williams, V; Waryah, CB; Mathavan, S; Tiwari, HK; Costantino, P; Mukkur, T				Gogoi-Tiwari, Jully; Williams, Vincent; Waryah, Charlene Babra; Mathavan, Sangeetha; Tiwari, Harish Kumar; Costantino, Paul; Mukkur, Trilochan			Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology	PLOS ONE			English	Article							AUREUS MASTITIS; BINDING-PROTEIN; IMMUNE EVASION; DAIRY-COWS; VACCINE; ANTIBODY; INFECTION; PERSISTENCE; BIOFILMS; EFFICACY	Protein A, encoded by the spa gene, is one of the major immune evading MSCRAMM of S. aureus, demonstrated to be prevalent in a significant percentage of clinical bovine mastitis isolates in Australia. Given its' reported significance in biofilm formation and the superior performance of S. aureus biofilm versus planktonic vaccine in the mouse mastitis model, it was of interest to determine the immunogenicity and protective potential of Protein A as a potential vaccine candidate against bovine mastitis using the mouse mastitis model. Pregnant Balb/c mice were immunised with Protein A emulsified in an alum-based adjuvant by subcutaneous (s/c) or intramammary (i/mam) routes. While humoral immune response of mice post-immunization were determined using indirect ELISA, cell-mediated immune response was assessed by estimation of interferon-gamma (IFN-gamma) produced by protein A-stimulated splenocyte supernatants. Protective potential of Protein A against experimental mastitis was determined by challenge of immunized versus sham-vaccinated mice by i/mam route, based upon manifestation of clinical symptoms, total bacterial load and histopathological damage to mammary glands. Significantly (p<0.05) higher levels of IgG1 iso-type were produced in mice immunized by the s/c route. In contrast, significantly higher levels of the antibody isotype IgG2a were produced in mice immunized by the i/mam route (p<0.05). There was significant reduction (p<0.05) in bacterial loads of the mammary glands of mice immunized by Protein A regardless of the route of immunization, with medium level of clinical symptoms observed up to day 3 post-challenge. However, Protein A vaccine failed to protect immunized mice post-challenge with biofilm producing encapsulated S. aureus via i/mam route, regardless of the route of immunization, as measured by the level of mammary tissue damage. It was concluded that, Protein A in its' native state was apparently not a suitable candidate for inclusion in a cell-free vaccine formulation against mastitis.	[Gogoi-Tiwari, Jully; Williams, Vincent; Waryah, Charlene Babra; Mathavan, Sangeetha; Costantino, Paul; Mukkur, Trilochan] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6102, Australia; [Gogoi-Tiwari, Jully] Cent Agr Univ, Coll Vet Sci & Anim Husb, Aizawl 796014, Mizoram, India; [Waryah, Charlene Babra] Albert Einstein Coll Med, Dept Med & Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Tiwari, Harish Kumar] Murdoch Univ, Sch Vet & Life Sci, Perth, WA 6150, Australia	Curtin University; Yeshiva University; Albert Einstein College of Medicine; Murdoch University	Mukkur, T (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6102, Australia.	tk_mukkur@hotmail.com	Tiwari, Harish/AAU-9372-2021	Tiwari, Harish/0000-0002-6950-8422; Tiwari, Harish/0000-0002-2911-9895; Waryah, Charlene/0000-0002-1295-320X	Curtin University; Australian Postgraduate Award	Curtin University; Australian Postgraduate Award(Australian Government)	Curtin University provided the International Postgraduate Research Scholarship and the Australian Postgraduate Award to JG-T in support of her doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2014, EXPERT REV VACCINES, V13, P1253, DOI 10.1586/14760584.2014.936391; ANDERSON JC, 1975, J COMP PATHOL, V85, P499, DOI 10.1016/0021-9975(75)90117-6; Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; Babra C, 2013, FOLIA MICROBIOL, V58, P469, DOI 10.1007/s12223-013-0232-z; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; BJORK I, 1972, European Journal of Biochemistry, V29, P579, DOI 10.1111/j.1432-1033.1972.tb02024.x; Buzzola FR, 2006, INFECT IMMUN, V74, P3498, DOI 10.1128/IAI.01507-05; DOSSETT JH, 1969, J IMMUNOL, V103, P1405; Dutta GN, 2001, INDIAN J MED RES, V113, P11; El-Din ANMN, 2006, VACCINE, V24, P1997, DOI 10.1016/j.vaccine.2005.11.033; Falugi F, 2013, MBIO, V4, DOI 10.1128/mBio.00575-13; FORSGREN A, 1970, Infection and Immunity, V2, P672; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fry SR, 2008, J MED MICROBIOL, V57, P28, DOI 10.1099/jmm.0.47527-0; Gamble M., 2008, THEORY PRACTICE HIST, V6th, P121, DOI DOI 10.1016/B978-0-443-10279-0.50016-6; Gogoi-Tiwari J, 2015, Aust Vet J, V93, P278, DOI 10.1111/avj.12349; Gogoi-Tiwari J, 2015, BIOFOULING, V31, P543, DOI 10.1080/08927014.2015.1074681; Gogoi-Tiwari J, 2015, VIRULENCE, V6, P419, DOI 10.1080/21505594.2015.1043508; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; GREENBERG DP, 1989, INFECT IMMUN, V57, P1113, DOI 10.1128/IAI.57.4.1113-1118.1989; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hartleib J, 2000, BLOOD, V96, P2149; Kim HK, 2012, INFECT IMMUN, V80, P3460, DOI 10.1128/IAI.00230-12; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Kobayashi SD, 2013, MBIO, V4, DOI 10.1128/mBio.00764-13; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LEE JC, 1988, J INFECT DIS, V157, P723, DOI 10.1093/infdis/157.4.723; Lee JW, 2005, CAN J VET RES, V69, P11; Leitner G, 2000, RES VET SCI, V69, P181, DOI 10.1053/rvsc.2000.0409; Leitner G, 2003, VET IMMUNOL IMMUNOP, V93, P153, DOI 10.1016/S0165-2427(03)00062-X; Maira-Litran T, 2004, VACCINE, V22, P872, DOI 10.1016/j.vaccine.2003.11.033; MAMO W, 1994, VACCINE, V12, P988, DOI 10.1016/0264-410X(94)90333-6; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Middleton JR, 2008, EXPERT REV VACCINES, V7, P805, DOI 10.1586/14760584.7.6.805; MOKS T, 1986, EUR J BIOCHEM, V156, P637, DOI 10.1111/j.1432-1033.1986.tb09625.x; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; OLLETT WS, 1947, J PATHOL BACTERIOL, V59, P357; PANKEY JW, 1985, J DAIRY SCI, V68, P726, DOI 10.3168/jds.S0022-0302(85)80879-1; Pauli NT, 2014, J EXP MED, V211, P2331, DOI 10.1084/jem.20141404; Pozzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046648; ROSS S, 1974, JAMA-J AM MED ASSOC, V229, P1075, DOI 10.1001/jama.229.8.1075; SJODAHL J, 1977, EUR J BIOCHEM, V73, P343, DOI 10.1111/j.1432-1033.1977.tb11324.x; SPIKA JS, 1981, INFECT IMMUN, V34, P455, DOI 10.1128/IAI.34.2.455-460.1981; Tenhagen BA, 2001, J VET MED A, V48, P601, DOI 10.1046/j.1439-0442.2001.00397.x; Thammavongsa V, 2015, VACCINE, V33, P523, DOI 10.1016/j.vaccine.2014.11.051; Tiwari J. G., 2013, Journal of Vaccines and Vaccination, V4, P1000176; TWORT Frederick W., 1924, Journal of State Medicine, V32, P351; UHLEN M, 1984, J BACTERIOL, V159, P713; Watson DL, 1996, AUST VET J, V74, P447, DOI 10.1111/j.1751-0813.1996.tb07567.x	51	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148383	10.1371/journal.pone.0148383	http://dx.doi.org/10.1371/journal.pone.0148383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862761	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600061
J	Johnson, DT; Hooker, E; Luong, R; Yu, EJ; He, YF; Gonzalgo, ML; Sun, ZJ				Johnson, Daniel T.; Hooker, Erika; Luong, Richard; Yu, Eun-Jeong; He, Yongfeng; Gonzalgo, Mark L.; Sun, Zijie			Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice	PLOS ONE			English	Article							PROSTATE; TUMORIGENESIS; PROGRESSION; METASTASIS; CARCINOMA; ESTROGEN	Bladder cancer represents a significant human tumor burden, accounting for about 7.7% and 2.4% of all cancer cases in males and females, respectively. While men have a higher risk of developing bladder cancer, women tend to present at a later stage of disease and with more aggressive tumors. Previous studies have suggested a promotional role of androgen signaling in enhancing bladder cancer development. To directly assess the role of androgens in bladder tumorigenesis, we have developed a novel transgenic mouse strain, R26hAR(LoxP/+):Upk3a(GCE/+), in which the human AR transgene is conditionally expressed in bladder urothelium. Intriguingly, both male and female R26hAR(LoxP/+):Upk3a(GCE/+) mice display a higher incidence of urothelial cell carcinoma (UCC) than the age and sex matched control littermates in response to the carcinogen, N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN). We detect expression of the human AR transgene in CK5-positive and p63-positive basal cells in bladder urothelium. Further analyses of UCC tissues from R26hAR(LoxP/+):Upk3a(GCE/+) mice showed that the majority of tumor cells are of urothelial basal cell origin. Positive immunostaining of transgenic AR protein was observed in the majority of tumor cells of the transgenic mice, providing a link between transgenic AR expression and oncogenic transformation. We observed an increase in Ki67 positive cells within the UCC lesions of transgenic AR mice. Manipulating endogenous androgen levels by castration and androgen supplementation directly affected bladder tumor development in male and female R26hAR(LoxP/+):Upk3a(GCE/+) mice, respectively. Taken together, our data demonstrate for the first time that conditional activation of transgenic AR expression in bladder urothelium enhances carciongen-induced bladder tumor formation in mice. This new AR transgenic mouse line mimics certain features of human bladder cancer and can be used to study bladder tumorigenesis and for drug development.	[Johnson, Daniel T.; Hooker, Erika; Yu, Eun-Jeong; He, Yongfeng; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Gonzalgo, Mark L.] Univ Miami, Miller Sch Med, Dept Urol, Miami, FL 33136 USA	Stanford University; Stanford University; University of Miami	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	zsun@stanford.edu	He, Yongfeng/AAR-8257-2020	Johnson, Daniel/0000-0003-4669-037X; Hooker, Erika/0000-0002-4515-4041	National Institute of Health [R01CA070297, R01CA151623, R01CA166894, R21CA190021, R01DK104941]; NATIONAL CANCER INSTITUTE [R01CA070297, R01CA166894, R21CA190021, R01CA151623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health grants R01CA070297, R01CA151623, R01CA166894, R21CA190021, and R01DK104941.	Ahmad I, 2012, DIS MODEL MECH, V5, P323, DOI 10.1242/dmm.008888; [Anonymous], 2010, UPK3A GCE ALL CHAR; Baffa R, 2008, CARCINOGENESIS, V29, P846, DOI 10.1093/carcin/bgn006; Culig Z, 2003, UROLOGY, V62, P21, DOI 10.1016/S0090-4295(03)00698-8; DEWINTER JAR, 1991, J HISTOCHEM CYTOCHEM, V39, P927, DOI 10.1177/39.7.1865110; Gakis G, 2013, SCAND J UROL, V47, P173, DOI 10.3109/00365599.2012.756929; Gandhi D, 2013, DEV CELL, V26, P469, DOI 10.1016/j.devcel.2013.07.017; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; Hsu JW, 2013, AM J PATHOL, V182, P1811, DOI 10.1016/j.ajpath.2013.01.018; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Izumi K, 2014, ANDROGEN DEPRIVATION; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kobayashi T, 2015, NAT REV CANCER, V15, P42, DOI 10.1038/nrc3858; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Li Y, 2013, ENDOCR-RELAT CANCER, V20, P293, DOI 10.1530/ERC-12-0328; Lin CX, 2013, CANCER RES, V73, P5914, DOI 10.1158/0008-5472.CAN-12-4198; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; Lubet RA, 2005, CARCINOGENESIS, V26, P571, DOI 10.1093/carcin/bgh352; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; Mir C, 2011, BJU INT, V108, P24, DOI 10.1111/j.1464-410X.2010.09834.x; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Miyamoto H, 2012, BJU INT, V109, P1716, DOI 10.1111/j.1464-410X.2011.10706.x; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NORONHA RFX, 1986, UROLOGY, V28, P401, DOI 10.1016/0090-4295(86)90073-7; Overdevest JB, 2012, P NATL ACAD SCI USA, V109, pE3588, DOI 10.1073/pnas.1113960109; Overdevest JB, 2011, CANCER RES, V71, P3802, DOI 10.1158/0008-5472.CAN-11-0519; SCHAAFSMA HE, 1990, AM J PATHOL, V136, P329; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Van Batavia J, 2014, NAT CELL BIOL, V16, P982, DOI 10.1038/ncb3038; WU XR, 1994, J BIOL CHEM, V269, P13716; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	36	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148851	10.1371/journal.pone.0148851	http://dx.doi.org/10.1371/journal.pone.0148851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862755	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600115
J	Mao, HF; Chang, LH; Tsai, AYJ; Huang, WN; Wang, J				Mao, Hui-Fen; Chang, Ling-Hui; Tsai, Athena Yi-Jung; Huang, Wen-Ni; Wang, Jye			Developing a Referral Protocol for Community-Based Occupational Therapy Services in Taiwan: A Logistic Regression Analysis	PLOS ONE			English	Article							HOME-CARE; ELDERLY-PEOPLE; INTERVENTION; REHABILITATION; DEMENTIA; OUTCOMES; FEAR; PREVALENCE; DISABILITY; CAREGIVERS	Because resources for long-term care services are limited, timely and appropriate referral for rehabilitation services is critical for optimizing clients' functions and successfully integrating them into the community. We investigated which client characteristics are most relevant in predicting Taiwan's community-based occupational therapy (OT) service referral based on experts' beliefs. Data were collected in face-to-face interviews using the Multidimensional Assessment Instrument (MDAI). Community-dwelling participants (n = 221) >= 18 years old who reported disabilities in the previous National Survey of Long-term Care Needs in Taiwan were enrolled. The standard for referral was the judgment and agreement of two experienced occupational therapists who reviewed the results of the MDAI. Logistic regressions and Generalized Additive Models were used for analysis. Two predictive models were proposed, one using basic activities of daily living (BADLs) and one using instrumental ADLs (IADLs). Dementia, psychiatric disorders, cognitive impairment, joint range-of-motion limitations, fear of falling, behavioral or emotional problems, expressive deficits (in the BADL-based model), and limitations in IADLs or BADLs were significantly correlated with the need for referral. Both models showed high area under the curve (AUC) values on receiver operating curve testing (AUC = 0.977 and 0.972, respectively). The probability of being referred for community OT services was calculated using the referral algorithm. The referral protocol facilitated communication between healthcare professionals to make appropriate decisions for OT referrals. The methods and findings should be useful for developing referral protocols for other long-term care services.	[Mao, Hui-Fen] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei 10764, Taiwan; [Chang, Ling-Hui] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Dept Occupat Therapy, Tainan 70101, Taiwan; [Chang, Ling-Hui] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 701, Taiwan; [Tsai, Athena Yi-Jung] Kaohsiung Med Univ, Dept Occupat Therapy, Kaohsiung, Taiwan; [Huang, Wen-Ni] I Shou Univ, Dept Phys Therapy, Kaohsiung, Taiwan; [Wang, Jye] Chang Jung Christian Univ, Dept Hlth Care Adm, Tainan, Taiwan	National Taiwan University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; I Shou University; Chang Jung Christian University	Wang, J (corresponding author), Chang Jung Christian Univ, Dept Hlth Care Adm, Tainan, Taiwan.	jyewang@mail.cjcu.edu.tw	Chang, Ling-Hui/AAG-2410-2019	Chang, Ling Hui/0000-0003-4129-6947; MAO, HUI-FEN/0000-0002-4847-4243	Ministry of Health and Welfare, Taiwan (R.O.C.) [102N6021]; Ministry of Health and Welfare	Ministry of Health and Welfare, Taiwan (R.O.C.); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant Number 102N6021 from the Ministry of Health and Welfare, Taiwan (R.O.C.), to AYJT (http://www.mohw.gov.tw/EN/Ministry/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the study participants and their caregivers for their cooperation and support, the Ministry of Health and Welfare officials responsible for LTC insurance planning in Taiwan, and the interviewers for their valuable contributions. This study is supported by a grant from the Ministry of Health and Welfare for Dr. Athena Yi-Jung Tsa. The findings and opinions expressed in this study are the sole responsibilities of the authors and do not necessarily represent the official position of the government of the Republic of China, Taiwan.	Archer KR, 2009, PHYS THER, V89, P893, DOI 10.2522/ptj.20080321; Buhr GT, 2006, J AM MED DIR ASSOC, V7, P180, DOI 10.1016/j.jamda.2005.12.003; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; CAOT, 2008, CAOT POS STAT OCC TH; Cheng L, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0203-1; Chiu HC, 2002, J AGING SOC POLICY, V13, P217; Chu TK, 2015, PUBLIC GOVERNANCE Q, V3, P108; Cohen-Mansfield J., 1991, INSTRUCTION MANUAL C; Crocker T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004294.pub3; Deb S, 2001, J INTELL DISABIL RES, V45, P495, DOI 10.1046/j.1365-2788.2001.00374.x; DEIMLING GT, 1986, J GERONTOL, V41, P778, DOI 10.1093/geronj/41.6.778; Dopp CME, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-70; Emerson E, 2001, RES DEV DISABIL, V22, P77, DOI 10.1016/S0891-4222(00)00061-5; Executive Yuan T ROC, 2010, NAT LONG TERM CAR NE; Executive Yuan Taiwan Reublic of China, 2014, REP CHIN YB; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Gauthier R, 2006, OCCUPATIONAL THERAPY, V8, P10; Gitlin LN, 2006, J AM GERIATR SOC, V54, P950, DOI 10.1111/j.1532-5415.2006.00733.x; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; Gitlin LN, 2003, GERONTOLOGIST, V43, P532, DOI 10.1093/geront/43.4.532; Graff MJL, 2007, J GERONTOL A-BIOL, V62, P1002, DOI 10.1093/gerona/62.9.1002; Graff MJL, 2008, BMJ-BRIT MED J, V336, P134, DOI 10.1136/bmj.39408.481898.BE; Harding K, 2009, BRIT J OCCUP THER, V72, P153, DOI 10.1177/030802260907200403; Harris-Kojetin L., 2013, LONG TERM CARE SERVI; Hershkovitz A, 2007, ARCH PHYS MED REHAB, V88, P916, DOI 10.1016/j.apmr.2007.03.029; Hirdes JP, 2006, AGE AGEING, V35, P329, DOI 10.1093/ageing/afl036; Hirdes JP, 2004, GERONTOLOGIST, V44, P665, DOI 10.1093/geront/44.5.665; Hirdes JP, 1997, CAN J AGING, V16, P53; Hirdes JP., 2010, INTERRAI CONTACT ASS; Huang C. P., 2006, TAIWANESE J PSYCHIAT, V20, P3; Johnston KN, 2013, PRIM CARE RESP J, V22, P319, DOI 10.4104/pcrj.2013.00062; Kim SY, 2012, NEUROREHABILITATION, V31, P107, DOI 10.3233/NRE-2012-0779; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee Y.C., 2013, COMMUNITY DEV J, V141, P26; Legters K, 2002, PHYS THER, V82, P264, DOI 10.1093/ptj/82.3.264; MAHONEY F I, 1965, Md State Med J, V14, P61; Miller EA, 2012, J AGING SOC POLICY, V24, P101, DOI 10.1080/08959420.2012.659912; Ministry of Health and Welfare, 2007, PLAN 10 YEAR LONG TE; Mohammed R, 2013, PHYSIOTHER CAN, V65, P125, DOI 10.3138/ptc.2012-09; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Nursing and Health Care Division, 2013, LONG TERM CAR SERV N; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Polensek SH, 2009, INT J CLIN PRACT, V63, P1604, DOI 10.1111/j.1742-1241.2009.02104.x; Reisberg B, 1996, Int Psychogeriatr, V8 Suppl 3, P301; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Steultjens EMJ, 2004, AGE AGEING, V33, P453, DOI 10.1093/ageing/afh174; Wahl HW, 2009, GERONTOLOGIST, V49, P355, DOI 10.1093/geront/gnp056; WALKER JE, 1991, AM J OCCUP THER, V45, P119, DOI 10.5014/ajot.45.2.119; Wang HH, 2012, KAOHSIUNG J MED SCI, V28, P465, DOI 10.1016/j.kjms.2012.04.002; WILLER B, 1981, AM J MENT DEF, V86, P252; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481; Yee TW, 2013, VGAM VECTOR GEN LINE	55	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148414	10.1371/journal.pone.0148414	http://dx.doi.org/10.1371/journal.pone.0148414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863544	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600068
J	Marimon, JM; Ercibengoa, M; Tamayo, E; Alonso, M; Perez-Trallero, E				Marimon, Jose M.; Ercibengoa, Maria; Tamayo, Esther; Alonso, Marta; Perez-Trallero, Emilio			Long-Term Epidemiology of Streptococcus pneumoniae Serogroup 6 in a Region of Southern Europe with Special Reference to Serotype 6E	PLOS ONE			English	Article							PREVALENCE	Streptococcus pneumoniae serotype 6E has recently been described, but its long-term epidemiology is not well known. From 1981-2013, 704 serogroup 6 clinical isolates were obtained in Gipuzkoa, Basque Country, Spain. All invasive and one in four non-invasive isolates were included. Overall, 75, 97, 51 and 45 serotypes 6A, 6B, 6C and 6E isolates, respectively, were detected. No serotype 6D isolates were identified. The prevalence of serotypes 6E and 6B, but not that of serotypes 6A and 6C, declined after the introduction of pneumococcal conjugate vaccines. Serotype 6E isolates showed the highest resistance rate. Most serotype 6E isolates were ST90.	[Marimon, Jose M.; Alonso, Marta; Perez-Trallero, Emilio] Hosp Univ Donostia, Inst Biodonostia, Dept Microbiol, San Sebastian, Spain; [Marimon, Jose M.; Ercibengoa, Maria; Tamayo, Esther; Perez-Trallero, Emilio] Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain; [Perez-Trallero, Emilio] Univ Basque Country, UPV EHU, Fac Med, San Sebastian, Spain	Instituto de Investigacion Sanitaria Biodonostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; University of Basque Country	Marimon, JM (corresponding author), Hosp Univ Donostia, Inst Biodonostia, Dept Microbiol, San Sebastian, Spain.; Marimon, JM (corresponding author), Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain.	JOSEMARIA.MARIMONORTIZDEZ@osakidetza.eus	MARIMON, JOSE MARIA/AAM-5581-2021; Ercibengoa, María/ABH-9481-2020	MARIMON, JOSE MARIA/0000-0002-2787-7094; Alonso, Marta/0000-0002-8909-4968; Tamayo, Esther/0000-0002-4185-1210	Basque Country Government's Department of Education, Universities and Research [IT656/13]; Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III, Spanish Ministry of Health, Social Services and Equality;  [PI 13/01708]	Basque Country Government's Department of Education, Universities and Research; Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III, Spanish Ministry of Health, Social Services and Equality; 	This work was partially financed by the grant IT656/13 from the Basque Country Government's Department of Education, Universities and Research and from the grant PI 13/01708 (http://www.hezkuntza.ejgv.euskadi.eus/r43-2591/es) and Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III, Spanish Ministry of Health, Social Services and Equality (http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-143; Baek JY, 2014, DIAGN MICR INFEC DIS, V80, P334, DOI 10.1016/j.diagmicrobio.2014.08.017; Baek JY, 2014, J CLIN MICROBIOL, V52, P2096, DOI 10.1128/JCM.00228-14; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20CLSI; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Kawaguchiya M, 2015, MICROB DRUG RESIST, V21, P209, DOI 10.1089/mdr.2014.0181; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Marimon JM, 2010, J MICROBIOL METH, V80, P274, DOI 10.1016/j.mimet.2010.01.011; Marimon JM, 2003, MICROB DRUG RESIST, V9, P133, DOI 10.1089/107662903765826714; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Shi W, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-467; van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848; van Tonder AJ, 2015, J CLIN MICROBIOL, V53, P2271, DOI 10.1128/JCM.00744-15	14	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149047	10.1371/journal.pone.0149047	http://dx.doi.org/10.1371/journal.pone.0149047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863305	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600147
J	Petrosino, JM; Heiss, VJ; Maurya, SK; Kalyanasundaram, A; Periasamy, M; LaFountain, RA; Wilson, JM; Simonetti, OP; Ziouzenkova, O				Petrosino, Jennifer M.; Heiss, Valerie J.; Maurya, Santosh K.; Kalyanasundaram, Anuradha; Periasamy, Muthu; LaFountain, Richard A.; Wilson, Jacob M.; Simonetti, Orlando P.; Ziouzenkova, Ouliana			Graded Maximal Exercise Testing to Assess Mouse Cardio-Metabolic Phenotypes	PLOS ONE			English	Article							HIGH-FAT DIET; HEART-FAILURE; ANAEROBIC THRESHOLD; GAS-EXCHANGE; MITOCHONDRIAL DYSFUNCTION; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; ENDURANCE EXERCISE; MODERATE EXERCISE	Functional assessments of cardiovascular fitness (CVF) are needed to establish animal models of dysfunction, test the effects of novel therapeutics, and establish the cardio-metabolic phenotype ofmice. In humans, the graded maximal exercise test (GXT) is a standardized diagnostic for assessing CVF and mortality risk. These tests, which consist of concurrent staged increases in running speed and inclination, provide diagnostic cardio-metabolic parameters, such as, VO2max, anaerobic threshold, and metabolic crossover. Unlike the human-GXT, published mouse treadmill tests have set, not staged, increases in inclination as speed progress until exhaustion (PXT). Additionally, they often lack multiple cardio-metabolic parameters. Here, we developed a mouse-GXT with the intent of improving mouse-exercise testing sensitivity and developing translatable parameters to assess CVF in healthy and dysfunctional mice. The mouse-GXT, like the human-GXT, incorporated staged increases in inclination, speed, and intensity; and, was designed by considering imitations of the PXT and differences between human and mouse physiology. The mouse-GXT and PXTs were both tested in healthy mice (C57BL/6J, FVBN/J) to determine their ability to identify cardio-metabolic parameters (anaerobic threshold, VO2max, metabolic crossover) observed in human-GXTs. Next, theses assays were tested on established diet-induced (obese-C57BL/6J) and genetic (cardiac isoform Casq2(-/-)) models of cardiovascular dysfunction. Results showed that both tests reported VO2max and provided reproducible data about performance. Only the mouse-GXT reproducibly identified anaerobic threshold, metabolic crossover, and detected impaired CVF in dysfunctional models. Our findings demonstrated that the mouse-GXT is a sensitive, non-invasive, and cost-effective method for assessing CVF inmice. This new test can be used as a functional assessment to determine the cardio-metabolic phenotype of various animalmodels or the effects of novel therapeutics.	[Petrosino, Jennifer M.; Heiss, Valerie J.; LaFountain, Richard A.; Ziouzenkova, Ouliana] Ohio State Univ, Coll Educ & Human Ecol, Dept Human Sci, Columbus, OH 43210 USA; [Maurya, Santosh K.; Periasamy, Muthu] Sanford Burnham Med Res Inst Lake Nona, Cardiovasc Pathobiol Program, Orland, FL USA; [Kalyanasundaram, Anuradha] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Wilson, Jacob M.] Univ Tampa, Dept Human Performance, Tampa, FL 33606 USA; [Simonetti, Orlando P.] Ohio State Univ, Coll Med, Dept Radiol, Columbus, OH 43210 USA; [Simonetti, Orlando P.] Ohio State Univ, Coll Med, Dept Cardiovasc Med, Columbus, OH 43210 USA; [Petrosino, Jennifer M.] Ohio State Univ, Coll Med, Program Biomed Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Tampa; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ziouzenkova, O (corresponding author), Ohio State Univ, Coll Educ & Human Ecol, Dept Human Sci, Columbus, OH 43210 USA.	ziouzenkova.1@osu.edu	Maurya, Santosh/O-9066-2017; Ziouzenkova, Ouliana/B-3690-2012; Ziouzenkova, Ouliana/AAM-1971-2020	Maurya, Santosh/0000-0002-7610-2463; Ziouzenkova, Ouliana/0000-0003-2449-2591; Petrosino, Jennifer M/0000-0002-5951-8942	American Egg Board [20020728]; Novo Nordisk Pharmaceuticals [10040042]; Food Innovation Center; National Center for Research Resources - Office of the Director (OD), National Institutes of Health [R21OD017244, UL1TR001070, UL1RR025755, NCI P30CA16058]; NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD017244] Funding Source: NIH RePORTER	American Egg Board; Novo Nordisk Pharmaceuticals(Novo Nordisk); Food Innovation Center; National Center for Research Resources - Office of the Director (OD), National Institutes of Health; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Award Number 20020728 from American Egg Board and Award Number 10040042 from Novo Nordisk Pharmaceuticals, as well as by the Food Innovation Center (OZ, JMP). The project described was supported by Award Number R21OD017244 (OZ), UL1TR001070 (CCTS), UL1RR025755 and NCI P30CA16058 (OSUCCC) from the National Center for Research Resources, funded by the Office of the Director (OD), National Institutes of Health and supported by the NIH Roadmap for Medical Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.	Abdurrachim D, 2015, CARDIOVASC RES, V106, P194, DOI 10.1093/cvr/cvv105; Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; Aoi W, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0067-x; Aoyagi T, 2015, AM J PHYSIOL-HEART C, V308, pH1530, DOI 10.1152/ajpheart.00008.2015; Appukutty M, 2015, BENEF MICROBES, V6, P491, DOI 10.3920/BM2014.0129; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Barrett EJ, 2009, DIABETOLOGIA, V52, P752, DOI 10.1007/s00125-009-1313-z; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Booth FW, 2010, J APPL PHYSIOL, V108, P219, DOI 10.1152/japplphysiol.00125.2009; Breckenridge R, 2010, DIS MODEL MECH, V3, P138, DOI 10.1242/dmm.005017; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; CAIOZZO VJ, 1982, J APPL PHYSIOL, V53, P1184, DOI 10.1152/jappl.1982.53.5.1184; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; CHALMERS RJ, 1976, EUR J APPL PHYSIOL O, V35, P261, DOI 10.1007/BF00423285; Cho J, 2015, MED SCI SPORT EXER, V47, P1814, DOI 10.1249/MSS.0000000000000612; Chu GX, 2002, J CARD FAIL, V8, pS432, DOI 10.1054/jcaf.2002.129284; Courtney SM, 2012, PHYSIOL GENOMICS, V44, P948, DOI 10.1152/physiolgenomics.00051.2012; Darrow MD, 1999, AM FAM PHYSICIAN, V59, P401; Desai KH, 1997, AM J PHYSIOL-HEART C, V272, pH1053, DOI 10.1152/ajpheart.1997.272.2.H1053; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; Ehrman JK, 2010, ACSMS RESOURCE MANUA; Ericsson M, 2010, J APPL PHYSIOL, V108, P1311, DOI 10.1152/japplphysiol.01133.2009; Fentz J, 2015, FASEB J, V29, P1725, DOI 10.1096/fj.14-266650; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Fiedler LR, 2014, CURR TOP DEV BIOL, V109, P171, DOI 10.1016/B978-0-12-397920-9.00002-0; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Francis J, 2005, HEART RHYTHM, V2, P550, DOI 10.1016/j.hrthm.2005.01.024; Fueger PT, 2005, J PHYSIOL-LONDON, V566, P533, DOI 10.1113/jphysiol.2005.085043; Garcia-Pelagio KP, 2015, AM J PHYSIOL-CELL PH, V308, pC448, DOI 10.1152/ajpcell.00331.2014; Giacomello E, 2015, AM J PHYSIOL-CELL PH, V308, pC123, DOI 10.1152/ajpcell.00090.2014; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Glukhov AV, 2015, EUR HEART J, V36, P686, DOI 10.1093/eurheartj/eht452; Gupta S, 2011, CIRCULATION, V123, P1377, DOI 10.1161/CIRCULATIONAHA.110.003236; Han YQ, 2001, ENDOCR J, V48, P551, DOI 10.1507/endocrj.48.551; Henderson KK, 2002, J APPL PHYSIOL, V93, P1265, DOI 10.1152/japplphysiol.00809.2001; Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Jordy AB, 2015, AM J PHYSIOL-ENDOC M, V308, pE778, DOI 10.1152/ajpendo.00547.2014; Kadoguchi T, 2015, EXP PHYSIOL, V100, P312, DOI 10.1113/expphysiol.2014.084095; Kalyanasundaram A, 2012, AM J PHYSIOL-HEART C, V302, pH253, DOI 10.1152/ajpheart.00578.2011; Kemi OJ, 2002, J APPL PHYSIOL, V93, P1301, DOI 10.1152/japplphysiol.00231.2002; Kim DS, 2015, BIOCHEM BIOPH RES CO, V459, P534, DOI 10.1016/j.bbrc.2015.02.144; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Knudsen JG, 2015, MOL CELL BIOCHEM, V403, P209, DOI 10.1007/s11010-015-2351-0; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Krahwinkel W, 1997, EUR HEART J, V18, pD9; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Li YH, 2008, J VASC RES, V45, P205, DOI 10.1159/000112133; Lin TW, 2015, NEUROBIOL LEARN MEM, V118, P189, DOI 10.1016/j.nlm.2014.12.005; Lujan HL, 2013, AM J PHYSIOL-REG I, V304, pR286, DOI 10.1152/ajpregu.00517.2012; Lund J, 2015, AM J PHYSIOL-HEART C, V308, pH823, DOI 10.1152/ajpheart.00734.2014; Macpherson REK, 2015, MED SCI SPORT EXER, V47, P2034, DOI 10.1249/MSS.0000000000000660; Marchon C, 2015, CELL PHYSIOL BIOCHEM, V35, P397, DOI 10.1159/000369705; MEAD WF, 1979, J FAM PRACTICE, V9, P479; Meek TH, 2010, INT J OBESITY, V34, P960, DOI 10.1038/ijo.2010.25; Myers J, 1996, ESSENTIALS OF CARDIO, Vxiii; Ostler JE, 2014, AM J PHYSIOL-ENDOC M, V306, pE592, DOI 10.1152/ajpendo.00277.2013; Pate KM, 2015, J APPL PHYSIOL, V118, P760, DOI 10.1152/japplphysiol.00112.2014; Pescatello LS, 2014, ACSMS GUIDELINES EXE, VNinth; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Piguet AC, 2015, J HEPATOL, V62, P1296, DOI 10.1016/j.jhep.2015.01.017; Pincu Y, 2015, CYTOKINE, V73, P23, DOI 10.1016/j.cyto.2015.01.013; Platt C, 2015, CELL METAB, V21, P227, DOI 10.1016/j.cmet.2015.01.014; Podolin DA, 1999, J APPL PHYSIOL, V86, P1374, DOI 10.1152/jappl.1999.86.4.1374; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; PUTMAN CT, 1995, AM J PHYSIOL-ENDOC M, V269, pE458, DOI 10.1152/ajpendo.1995.269.3.E458; Rank MM, 2015, J PHYSIOL-LONDON, V593, P331, DOI 10.1113/jphysiol.2014.282640; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Rezende EL, 2005, J EXP BIOL, V208, P2447, DOI 10.1242/jeb.01631; Rezende EL, 2006, J APPL PHYSIOL, V101, P477, DOI 10.1152/japplphysiol.00042.2006; Roberts TJ, 1996, J EXP BIOL, V199, P1651; Rocco AB, 2014, MUSCLE NERVE, V50, P541, DOI 10.1002/mus.24184; ROSTON WL, 1987, AM REV RESPIR DIS, V135, P1080; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sommer W, 2015, J THORAC CARDIOV SUR, V149, P330, DOI 10.1016/j.jtcvs.2014.10.029; Stolen TO, 2009, CIRC RES, V105, P527, DOI 10.1161/CIRCRESAHA.109.199810; Swain DP., 2014, ACSMS RESOURCE MANUA; Uchiyama M, 2015, TRANSPL INT, V28, P352, DOI 10.1111/tri.12491; Vogel J, 2015, J PHYSIOL-LONDON, V593, P2145, DOI 10.1113/jphysiol.2014.284901; Wallace IJ, 2015, J ANAT, V226, P224, DOI 10.1111/joa.12277; Wallace IJ, 2015, BONE, V72, P1, DOI 10.1016/j.bone.2014.11.013; WASSERMAN K, 1994, Z KARDIOL, V83, P1; WASSERMAN K, 1964, AM J CARDIOL, V14, P844, DOI 10.1016/0002-9149(64)90012-8; WASSERMAN K, 1984, CLIN CHEST MED, V5, P77; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; WASSERMAN K, 1967, J APPL PHYSIOL, V22, P71, DOI 10.1152/jappl.1967.22.1.71; WASSERMAN K, 1967, CAN MED ASSOC J, V96, P775; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008; Wiesmann F, 2001, CIRC RES, V88, P563, DOI 10.1161/01.RES.88.6.563; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wood LK, 2016, J ORTHOP RES, V34, P346, DOI 10.1002/jor.22824; Zeng H, 2015, J CELL MOL MED, V19, P1847, DOI 10.1111/jcmm.12556; Zheng DM, 2015, BIOCHEM BIOPH RES CO, V456, P519, DOI 10.1016/j.bbrc.2014.11.118; Zou K, 2015, MED SCI SPORT EXER, V47, P315, DOI 10.1249/MSS.0000000000000405	104	43	43	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148010	10.1371/journal.pone.0148010	http://dx.doi.org/10.1371/journal.pone.0148010			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859763	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400017
J	Boire, N; Zhang, S; Khuvis, J; Lee, R; Rivers, J; Crandall, P; Keel, MK; Parrish, N				Boire, Nicholas; Zhang, Sean; Khuvis, Joshua; Lee, Rick; Rivers, Jennifer; Crandall, Philip; Keel, M. Kevin; Parrish, Nicole			Potent Inhibition of Pseudogymnoascus destructans, the Causative Agent of White-Nose Syndrome in Bats, by Cold-Pressed, Terpeneless, Valencia Orange Oil	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; IN-VITRO; AGRICULTURE; MORTALITY; PATHOGEN	The causative agent of White-nose Syndrome (WNS), Pseudogymnoascus destructans, has been shown to be fatal to several species of bats in North America. To date, no compounds or chemical control measures have been developed which eliminates the growth of the fungus in the environment or in affected animals. In the current study, we evaluated the activity of cold-pressed, terpeneless orange oil (CPT) against multiple isolates of P. destructans in vitro. For all assays, a modified Kirby-Bauer disk diffusion assay was used. Standardized spore suspensions were prepared, adjusted to a specific optical density, and used to plate fungal lawns. Plates were incubated at either 15 degrees C or 4 degrees C for up to 6 months and checked at regular intervals for growth. Once controls had grown, zones of inhibition were measured (mm) on test plates and compared to those obtained using current antifungal drugs. All P. destructans isolates were completely inhibited by 100% CPT (10 mu L) at 1 month of incubation regardless of temperature (4 degrees C and 15 degrees C). Complete inhibition persisted up to 6 months following a single exposure at this concentration. Of the standard anti-fungals, only amphotericin B demonstrated any activity, resulting in zone diameters ranging from 58 mm to 74 mm. CPT, at the highest concentration tested (100%), had no significant effect against a variety of other environmental organisms including various filamentous fungi, bacteria and aerobic actinomycetes. Given that CPT is relatively non-toxic, the possibility exists that the all-natural, mixture could be used as an environmental pre-treatment to eradicate P. destructans from bat habitats. Additional studies are needed to assess any undesirable effects of CPT on bat behavior and health and overall impacts on other members of the interconnected ecosystem(s).	[Boire, Nicholas; Zhang, Sean; Khuvis, Joshua; Lee, Rick; Parrish, Nicole] Johns Hopkins Sch Med, Baltimore, MD USA; [Rivers, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Crandall, Philip] Univ Arkansas, Fayetteville, AR 72701 USA; [Keel, M. Kevin] UC Davis Sch Vet Med, Davis, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California Davis	Parrish, N (corresponding author), Johns Hopkins Sch Med, Baltimore, MD USA.	nicholasboire@gmail.com		Crandall, Phil/0000-0002-5180-3204				Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Blehert DS, 2011, MICROBE, V6, P267; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Brooks RT, 2011, BIODIVERS CONSERV, V20, P2537, DOI 10.1007/s10531-011-9996-0; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chaturvedi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017032; Clinical and Laboratory Standards Institute, 2010, M51A CLSI; Cornelison CT, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0246-y; Cox SD, 1998, LETT APPL MICROBIOL, V26, P355, DOI 10.1046/j.1472-765X.1998.00348.x; Crandall PG, 2012, J ENVIRON SCI HEAL B, V47, P736, DOI 10.1080/03601234.2012.669331; Cryan PM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-47; Dzal Y, 2011, BIOL LETTERS, V7, P392, DOI 10.1098/rsbl.2010.0859; Fisher K, 2006, J APPL MICROBIOL, V101, P1232, DOI 10.1111/j.1365-2672.2006.03035.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Hill J., 1992, BATS NATURAL HIST; Isman MB, 2011, PHYTOCHEM REV, V10, P197, DOI 10.1007/s11101-010-9170-4; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Muthaiyan A, 2012, J APPL MICROBIOL, V112, P1020, DOI 10.1111/j.1365-2672.2012.05270.x; Muthaiyan A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-125; Rasooli I, 2006, INT J INFECT DIS, V10, P236, DOI 10.1016/j.ijid.2005.05.006; Turner Gregory G., 2011, Bat Research News, V52, P13; U.S. Fish and Wildlife Service, WHIT NOS SYNDR IS IT; United States Subcommittee on Fisheries Wildlife Oceans and Insular Affairs, 2011, WHY WE SHOULD CAR BA; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076	28	13	14	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148473	10.1371/journal.pone.0148473	http://dx.doi.org/10.1371/journal.pone.0148473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849057	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000102
J	Brennan-Ing, M; Seidel, L; Rodgers, L; Ernst, J; Wirth, D; Tietz, D; Morretti, A; Karpiak, SE				Brennan-Ing, Mark; Seidel, Liz; Rodgers, Leslie; Ernst, Jerome; Wirth, Doug; Tietz, Daniel; Morretti, Antonio; Karpiak, Stephen E.			The Impact of Comprehensive Case Management on HIV Client Outcomes	PLOS ONE			English	Article							UNITED-STATES; ANTIRETROVIRAL ADHERENCE; OLDER-ADULTS; CARE; ASSOCIATION; PROGRAM; ACCESS	In 1990, New York State instituted Comprehensive Medicaid Case Management, also known as Target Case Management (TCM), for people dealing with multiple comorbid conditions, including HIV. The goal of TCM is to assist clients in navigating the health care system to increase care engagement and treatment adherence for individuals with complex needs. HIV-positive individuals engaged in care are more likely to be virally suppressed, improving clinical outcomes and decreasing chances of HIV transmission. The purpose of this study was to understand the impact of TCM management on outcomes for people with HIV. Data were obtained from Amida Care, which operates not-for-profit managed care Medicaid and Medicare Special Needs Plans (SNPs) for HIV clients. Changes in clinical, cost, as well as medical and pharmacy utilization data among TCM clients were examined between January 2011 through September 2012 from the start of case management enrollment through the end of the study period (i. e., up to 6 months after disenrollment). Additionally, CD4 counts were compared between Amida Care TCM clients and non-TCM clients. Notable findings include increased CD4 counts for TCM clients over the one-year study period, achieving parity with non-TCM clients (i. e., Mean CD4 count > 500). When looking exclusively at TCM clients, there were increases in medication costs over time, which were concomitant with increased care engagement. Current findings demonstrate that TCM is able to achieve its goals of improving care engagement and treatment adherence. Subsequent policy changes resulting from the Affordable Care Act and the New York State Medicaid Redesign have made the Health Home the administrator of TCM services. Government entities charged with securing and managing TCM and care coordination for people with HIV should provide thoughtful and reasonable guidance and oversight in order to maintain optimal clinical outcomes for TCM clients and reduce the transmission of HIV.	[Brennan-Ing, Mark; Seidel, Liz; Ernst, Jerome; Karpiak, Stephen E.] ACRIA, Ctr HIV & Aging, New York, NY USA; [Brennan-Ing, Mark; Karpiak, Stephen E.] NYU, Coll Nursing, New York, NY USA; [Seidel, Liz] Fordham Univ, Grad Sch Social Serv, New York, NY 10023 USA; [Rodgers, Leslie] BOOM Hlth, Bronx, NY USA; [Ernst, Jerome; Wirth, Doug] Amida Care Inc, New York, NY USA; [Tietz, Daniel] City New York, Human Resources Adm, New York, NY USA; [Morretti, Antonio] Columbia Univ, New York, NY USA	New York University; Fordham University; Columbia University	Brennan-Ing, M (corresponding author), ACRIA, Ctr HIV & Aging, New York, NY USA.; Brennan-Ing, M (corresponding author), NYU, Coll Nursing, New York, NY USA.	mbrennan@acria.org						AIDS.gov, 2015, HIV AIDS CAR CONT; Allen G, 2014, DELIVERY SYSTEM REFO; Brennan M, 2010, HIV AIDS-MED SOC PSY, P1; Brennan-Ing M, 2014, P 18 US C AIDS OCT 2; Brennan-Ing M, 2014, J HOMOSEXUAL, V61, P166, DOI 10.1080/00918369.2013.835608; Brennan-Ing M, 2014, J HOMOSEXUAL, V61, P21, DOI 10.1080/00918369.2013.835235; Broaddus MR, 2015, AIDS CARE; Cahill SR, 2015, AM J PUBLIC HEALTH, V105, P1078, DOI 10.2105/AJPH.2014.302442; Freedman J, 2003, HIST AIDS SOCIAL WOR, P59; Gursansky D., 2020, CASE MANAGEMENT POLI, DOI [10.4324/9781003115113, DOI 10.4324/9781003115113]; Hajewski CJ, 2014, J NURS ADMIN, V44, P577, DOI 10.1097/NNA.0000000000000129; Havlik RJ, 2011, SEX HEALTH, V8, P551, DOI 10.1071/SH11017; Hirschhorna LR, 2009, GROUND BUILDING COMP; Irvine MK, 2015, CLIN INFECT DIS, V60, P298, DOI 10.1093/cid/ciu783; Kates J., 2011, MEDICAID HIV NATL AN; Kates Jennifer, 2013, Top Antivir Med, V21, P138; Kim JJ, 2014, AIDS EDUC PREV, V26, P429, DOI 10.1521/aeap.2014.26.5.429; Kushel MB, 2006, CLIN INFECT DIS, V43, P234, DOI 10.1086/505212; Lehrman SE, 2001, AIDS CARE, V13, P481, DOI 10.1080/09540120120058012; Mallory R, 2011, COBRA MED OUTCOMES E; McColl WD, 2013, HIV SPECIALIST, V5, P2; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; New York City Department of Health, 2010, NEW YORK CIT ANN HIV; New York State Department of Health AIDS Institute: Office of Medicaid Policy and Programs, 2013, NEW YORK STAT MED RE; OPTUM, 2015, IMP PRO HLTH CAR AN; Pecoraro A, 2013, AIDS CARE, V25, P1399, DOI 10.1080/09540121.2013.772273; Sood N, 2014, HEALTH AFFAIR, V33, P394, DOI 10.1377/hlthaff.2013.1297; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Wagner EH, 2014, MED CARE, V52, pS33, DOI 10.1097/MLR.0000000000000197; World Health Organization, 2015, CONS STRAT INF GUID	30	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148865	10.1371/journal.pone.0148865	http://dx.doi.org/10.1371/journal.pone.0148865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849561	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000179
J	Sobolevsky, S; Sitko, I; des Combes, RT; Hawelka, B; Arias, JM; Ratti, C				Sobolevsky, Stanislav; Sitko, Izabela; Tachet des Combes, Remi; Hawelka, Bartosz; Murillo Arias, Juan; Ratti, Carlo			Cities through the Prism of People's Spending Behavior	PLOS ONE			English	Article							HUMAN MOBILITY; PATTERNS; PROXY; LIFE	Scientific studies of society increasingly rely on digital traces produced by various aspects of human activity. In this paper, we exploit a relatively unexplored source of data-anonymized records of bank card transactions collected in Spain by a big European bank, and propose a new classification scheme of cities based on the economic behavior of their residents. First, we study how individual spending behavior is qualitatively and quantitatively affected by various factors such as customer's age, gender, and size of his/her home city. We show that, similar to other socioeconomic urban quantities, individual spending activity exhibits a statistically significant superlinear scaling with city size. With respect to the general trends, we quantify the distinctive signature of each city in terms of residents' spending behavior, independently from the effects of scale and demographic heterogeneity. Based on the comparison of city signatures, we build a novel classification of cities across Spain in three categories. That classification exhibits a substantial stability over different city definitions and connects with a meaningful socioeconomic interpretation. Furthermore, it corresponds with the ability of cities to attract foreign visitors, which is a particularly remarkable finding given that the classification was based exclusively on the behavioral patterns of city residents. This highlights the far-reaching applicability of the presented classification approach and its ability to discover patterns that go beyond the quantities directly involved in it.	[Sobolevsky, Stanislav] NYU, Ctr Urban Sci & Progress, Brooklyn, NY USA; [Sobolevsky, Stanislav; Tachet des Combes, Remi; Ratti, Carlo] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Sitko, Izabela; Hawelka, Bartosz] Salzburg Univ, Dept Geoinformat Z GIS, A-5020 Salzburg, Austria; [Murillo Arias, Juan] Data & Analyt BBVA, Madrid, Spain	New York University; Massachusetts Institute of Technology (MIT); Salzburg University	Sobolevsky, S (corresponding author), NYU, Ctr Urban Sci & Progress, Brooklyn, NY USA.	sobolevsky@nyu.edu	Sobolevsky, Stanislav/ABH-7108-2020	Sobolevsky, Stanislav/0000-0001-6281-0656	Austrian Science Fund (FWF) through the Doctoral College GIScience at the University of Salzburg [DK W 1237-N23]; SENSEable city lab consortium; Austrian Science Fund (FWF) through the Doctoral College GIScience [DK W 1237-N23]	Austrian Science Fund (FWF) through the Doctoral College GIScience at the University of Salzburg(Austrian Science Fund (FWF)); SENSEable city lab consortium; Austrian Science Fund (FWF) through the Doctoral College GIScience(Austrian Science Fund (FWF))	IS and BH are receiving financial support from Austrian Science Fund (FWF, https://www.fwf.ac.at/en/) through the Doctoral College GIScience at the University of Salzburg (DK W 1237-N23). This research has been funded through the SENSEable city lab consortium, where BBVA acted as one of the sponsors. One of the authors of the paper (JMA) is BBVA's employee. The funder provided support in the form of salaries for the specified author as well as funding for the SENSEable city lab where other authors (SS, RTC, CR) are employed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; The authors would like to thank BBVA for providing the dataset for this research. Special thanks to Assaf Biderman, Marco Bressan, Elena Alfaro Martinez, Maria Hernandez Rubio and Heribert Valero for organizational support of the project and stimulating discussions. We further thank the BBVA, MIT SMART Program, Center for Complex Engineering Systems (CCES) at KACST and MIT, Accenture, Air Liquide, The Coca Cola Company, Emirates Integrated Telecommunications Company, The ENELfoundation, Ericsson, Expo 2015, Ferrovial, Liberty Mutual, The Regional Municipality of Wood Buffalo, Volkswagen Electronics Research Lab, UBER and all the members of the MIT Senseable City Lab Consortium for supporting the research. IS and BH acknowledge the support of the Austrian Science Fund (FWF) through the Doctoral College GIScience (DK W 1237-N23).	Amini A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds31; [Anonymous], 2007, FINAL REPORT; Arcaute E, 2014, PREPRINT; Arribas-Bel D, 2013, CITIES, V31, P248, DOI 10.1016/j.cities.2012.06.019; Bagchi M, 2005, TRANSP POLICY, V12, P464, DOI 10.1016/j.tranpol.2005.06.008; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bhatnagar A, 2000, COMMUN ACM, V43, P98, DOI 10.1145/353360.353371; Borzekowski R, 2008, J MONEY CREDIT BANK, V40, P149, DOI 10.1111/j.1538-4616.2008.00107.x; Bounie D, 2006, SSRN SCHOLARLY PAPER; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chan PK, 1999, IEEE INTELL SYST APP, V14, P67, DOI 10.1109/5254.809570; Childers TL, 2001, J RETAILING, V77, P511, DOI 10.1016/S0022-4359(01)00056-2; Dholakia R. R., 1999, INT J RETAIL DISTRIB, V27, P154, DOI [DOI 10.1108/09590559910268499, 10.1108/09590559910268499]; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Girardin F, 2008, IEEE PERVAS COMPUT, V7, P36, DOI 10.1109/MPRV.2008.71; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grauwin S, 2015, GEOTECH ENVIRON, V13, P363, DOI 10.1007/978-3-319-11469-9_15; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Hayhoe CR, 2008, JOURNAL OF CONSUMER, V34, P113, DOI [10.1111/j.1745-, DOI 10.1111/J.1745-]; Hui T.-K., 2007, INT J CONSUM STUD, V31, P310, DOI [10.1111/j.1470-6431.2006.00554.x, DOI 10.1111/J.1470-6431.2006.00554.X]; Krumme C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01645; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Lathia Neal, 2012, Pervasive Computing. Proceedings of the 10th International Conference, Pervasive 2012, P91, DOI 10.1007/978-3-642-31205-2_6; Lenormand M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10075; LLOYD R, 1978, ECON GEOGR, V54, P157, DOI 10.2307/142850; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; MacQueen J.B., 1967, STATISTICS, VI; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Paldino S, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0043-3; Pei T, 2014, INT J GEOGR INF SCI, V28, P1988, DOI 10.1080/13658816.2014.913794; Pennacchioli D, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0033-x; Quercia Daniele, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P971, DOI 10.1109/ICDM.2010.152; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rysman M, 2007, J IND ECON, V55, P1, DOI 10.1111/j.1467-6451.2007.00301.x; Santi P, 2014, P NATL ACAD SCI USA, V111, P13290, DOI 10.1073/pnas.1403657111; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Sobolevsky S, 2014, BIG DATA SCIENCE AND; Sobolevsky S, 2015, PREPRTINT ARXIV 1504; Sobolevsky S, 2014, IEEE INT CONGR BIG, P136, DOI 10.1109/BigData.Congress.2014.28; Sobolevsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081707; Szell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089052; World Factbook (The), MOTHERS MEAN AGE AT	46	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0146291	10.1371/journal.pone.0146291	http://dx.doi.org/10.1371/journal.pone.0146291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849218	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000008
J	Song, MS; Choi, SY; Ryu, PD; Lee, SY				Song, Min Seok; Choi, Seon Young; Ryu, Pan Dong; Lee, So Yeong			Voltage-Gated K+ Channel, K(v)3.3 Is Involved in Hemin-Induced K562 Differentiation	PLOS ONE			English	Article							KV3.3 POTASSIUM CHANNELS; CELL-PROLIFERATION; MEGAKARYOCYTIC DIFFERENTIATION; ERYTHROID-DIFFERENTIATION; HEMOGLOBIN-SYNTHESIS; MOLECULAR DIVERSITY; ION CHANNELS; ACTIVATION; EXPRESSION; LINE	Voltage-gated K+ (K-v) channels are well known to be involved in cell proliferation. However, even though cell proliferation is closely related to cell differentiation, the relationship between K-v channels and cell differentiation remains poorly investigated. This study demonstrates that K(v)3.3 is involved in K562 cell erythroid differentiation. Down-regulation of K(v)3.3 using siRNA-K(v)3.3 increased hemin-induced K562 erythroid differentiation through decreased activation of signal molecules such as p38, cAMP response element-binding protein, and c-fos. Down-regulation of K(v)3.3 also enhanced cell adhesion by increasing integrin beta 3 and this effect was amplified when the cells were cultured with fibronectin. The K-v channels, or at least K(v)3.3, appear to be associated with cell differentiation; therefore, understanding the mechanisms of K-v channel regulation of cell differentiation would provide important information regarding vital cellular processes.	[Lee, So Yeong] Seoul Natl Univ, Coll Vet Med, Lab Vet Pharmacol, Seoul, South Korea; Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, SY (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Vet Pharmacol, Seoul, South Korea.	leeso@snu.ac.kr	Ryu, Pan Dong/AGX-5700-2022	Ryu, Pan Dong/0000-0003-4130-2251	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2011-0014514, NRF-2014R1A1A3A04052757]; BK21 PLUS program for Creative Veterinary Science Research; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2011-0014514, NRF-2014R1A1A3A04052757]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; BK21 PLUS program for Creative Veterinary Science Research; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2011-0014514, NRF-2014R1A1A3A04052757) and BK21 PLUS program for Creative Veterinary Science Research.; This research was supported by Basic Science Research Program through National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2011-0014514, NRF-2014R1A1A3A04052757).	Akel S, 2007, PLATELETS, V18, P566, DOI 10.1080/09537100701549546; Arcangeli A, 2004, BIOCHEM SOC T, V32, P826, DOI 10.1042/BST0320826; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; de Nigris F, 2003, TRENDS MOL MED, V9, P351, DOI 10.1016/S1471-4914(03)00139-4; Di Pietro R, 2007, J CELL BIOCHEM, V100, P1070, DOI 10.1002/jcb.21106; Fernandez FR, 2003, J BIOL CHEM, V278, P40890, DOI 10.1074/jbc.M304235200; GOLDING B, 1988, J IMMUNOL, V141, P2564; Guidetti Gianni F., 2015, Advances in Biological Regulation, V59, P36, DOI 10.1016/j.jbior.2015.06.001; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hocking JC, 2012, MECH DEVELOP, V129, P125, DOI 10.1016/j.mod.2012.05.003; Huang HM, 2004, BIOCHEM BIOPH RES CO, V320, P1247, DOI 10.1016/j.bbrc.2004.06.083; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ida C, 2009, BIOSCI BIOTECH BIOCH, V73, P79, DOI 10.1271/bbb.80483; Jang SH, 2011, J VET SCI, V12, P35, DOI 10.4142/jvs.2011.12.1.35; Jang SH, 2011, EUR J PHARMACOL, V651, P26, DOI 10.1016/j.ejphar.2010.10.066; Jang SH, 2009, BIOCHEM BIOPH RES CO, V384, P180, DOI 10.1016/j.bbrc.2009.04.108; JARVINEN M, 1993, CELL BIOL INT, V17, P399, DOI 10.1006/cbir.1993.1078; Kim SJ, 2012, CELL DEATH DIFFER, V19, P333, DOI 10.1038/cdd.2011.102; KOEFFLER HP, 1980, BLOOD, V56, P344; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; LANGDON SP, 1988, LEUKEMIA RES, V12, P211, DOI 10.1016/0145-2126(88)90138-5; Leung YM, 2012, PHARMACOL THERAPEUT, V133, P151, DOI 10.1016/j.pharmthera.2011.10.005; Limb JK, 2009, CELL MOL LIFE SCI, V66, P1962, DOI 10.1007/s00018-009-8775-5; Liu K, 2010, BLOOD CELL MOL DIS, V45, P269, DOI 10.1016/j.bcmd.2010.09.004; Liu QH, 2002, J EXP MED, V196, P897, DOI 10.1084/jem.20020381; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; O'Grady SM, 2005, INT J BIOCHEM CELL B, V37, P1578, DOI 10.1016/j.biocel.2005.04.002; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI 10.1517/14728222.12.7.837 ; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Pettiford SM, 2003, LEUKEMIA, V17, P366, DOI 10.1038/sj.leu.2402767; Pillozzi S, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/217910; Rae JL, 2000, EXP EYE RES, V70, P339, DOI 10.1006/exer.1999.0796; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Tong HX, 2010, J PHYSIOL-LONDON, V588, P1451, DOI 10.1113/jphysiol.2009.186676; VEGA-SAENZ DE MIERA E, 1992, BIOCHEM BIOPH RES CO, V186, P1681; VOLPI N, 1994, EXP CELL RES, V215, P119, DOI 10.1006/excr.1994.1323; Wang HZ, 2002, CANCER RES, V62, P4843; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yi ZC, 2004, ACTA PHARMACOL SIN, V25, P231; You MH, 2013, ACTA PHARMACOL SIN, V34, P129, DOI 10.1038/aps.2012.142; Zeller KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064897; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72	53	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148633	10.1371/journal.pone.0148633	http://dx.doi.org/10.1371/journal.pone.0148633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849432	Green Published, gold			2022-12-26	WOS:000369554000142
J	Wang, L; Wang, YC; Cao, HL; Hao, XY; Zeng, JM; Yang, YJ; Wang, XC				Wang, Lu; Wang, Yuchun; Cao, Hongli; Hao, Xinyuan; Zeng, Jianming; Yang, Yajun; Wang, Xinchao			Transcriptome Analysis of an Anthracnose-Resistant Tea Plant Cultivar Reveals Genes Associated with Resistance to Colletotrichum camelliae	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; CINNAMOYL-COA REDUCTASE; NBS-LRR PROTEINS; ELSINOE-AMPELINA; WINTER DORMANCY; EXPRESSION; SINENSIS; ARABIDOPSIS; METABOLISM; IDENTIFICATION	Tea plant breeding is a topic of great economic importance. However, disease remains a major cause of yield and quality losses. In this study, an anthracnose-resistant cultivar, ZC108, was developed. An infection assay revealed different responses to Colletotrichum sp. infection between ZC108 and its parent cultivar LJ43. ZC108 had greater resistance than LJ43 to Colletotrichum camelliae. Additionally, ZC108 exhibited earlier sprouting in the spring, as well as different leaf shape and plant architecture. Microarray data revealed that the genes that are differentially expressed between LJ43 and ZC108 mapped to secondary metabolism-related pathways, including phenylpropanoid biosynthesis, phenylalanine metabolism, and flavonoid biosynthesis pathways. In addition, genes involved in plant hormone biosynthesis and signaling as well as plant-pathogen interaction pathways were also changed. Quantitative real-time PCR was used to examine the expression of 27 selected genes in infected and uninfected tea plant leaves. Genes encoding a MADS-box transcription factor, NBS-LRR disease-resistance protein, and phenylpropanoid metabolism pathway components (CAD, CCR, POD, beta-glucosidase, ALDH and PAL) were among those differentially expressed in ZC108.	[Wang, Lu; Wang, Yuchun; Cao, Hongli; Hao, Xinyuan; Zeng, Jianming; Yang, Yajun; Wang, Xinchao] Chinese Acad Agr Sci, Natl Ctr Tea Plant Improvement, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Lu; Hao, Xinyuan; Zeng, Jianming; Yang, Yajun; Wang, Xinchao] Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China; [Wang, Yuchun] Northwest Agr & Forestry Univ, Coll Hort, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Yang, YJ; Wang, XC (corresponding author), Chinese Acad Agr Sci, Natl Ctr Tea Plant Improvement, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China.; Yang, YJ; Wang, XC (corresponding author), Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China.	yjyang@tricaas.com; wangxinchao@caas.cn	Hao, Xinyuan/AAF-6386-2021; Wang, Xinchao/I-5745-2019; Wang, Lu/AGT-2034-2022	Hao, Xinyuan/0000-0001-8300-7491; Wang, Xinchao/0000-0002-5224-6286; Yang, Yajun/0000-0003-0552-5730	Earmarked Fund for China Agriculture Research System [CARS-23]; Major Project for New Agricultural Varieties Breeding of Zhejiang Province [2012C2905-3]; Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology (CAAS-ASTIP-TRICAAS)	Earmarked Fund for China Agriculture Research System; Major Project for New Agricultural Varieties Breeding of Zhejiang Province; Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology (CAAS-ASTIP-TRICAAS)	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-23), the Major Project for New Agricultural Varieties Breeding of Zhejiang Province (2012C2905-3) and the Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology (CAAS-ASTIP-2014-TRICAAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Araujo L, 2015, PLANT DIS, V99, P447, DOI 10.1094/PDIS-08-14-0788-RE; Arvind Gulati, 1993, Indian Phytopathology, V46, P155; Baxter HL, 2013, BIOFUELS-UK, V4, P635, DOI [10.4155/BFS.13.56, 10.4155/bfs.13.56]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen Jin, 2005, Genetic Resources and Crop Evolution, V52, P41, DOI 10.1007/s10722-005-0285-1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Dauwe R, 2007, PLANT J, V52, P263, DOI 10.1111/j.1365-313X.2007.03233.x; Deng WW, 2013, J PLANT PHYSIOL, V170, P272, DOI 10.1016/j.jplph.2012.10.010; Derikvand MM, 2008, PLANTA, V227, P943, DOI 10.1007/s00425-007-0669-x; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Finlayson SA, 2010, PLANT PHYSIOL, V152, P1914, DOI 10.1104/pp.109.148833; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Gao M, 2012, PLANT PHYSIOL BIOCH, V58, P253, DOI 10.1016/j.plaphy.2012.07.009; Hao XY, 2014, INT J MOL SCI, V15, P22155, DOI 10.3390/ijms151222155; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kavousi HR., 2009, PLANT PATHOLOGY J, V8, P127, DOI [10.3923/ppj.2009.127.132, DOI 10.3923/PPJ.2009.127.132]; Kim DS, 2014, J EXP BOT, V65, P2295, DOI 10.1093/jxb/eru109; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Lauvergeat V, 2001, PHYTOCHEMISTRY, V57, P1187, DOI 10.1016/S0031-9422(01)00053-X; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louime C, 2011, INT J MOL SCI, V12, P3473, DOI 10.3390/ijms12063473; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Nagar PK, 2000, ACTA PHYSIOL PLANT, V22, P439, DOI 10.1007/s11738-000-0086-2; Nagar PK, 2006, ACTA PHYSIOL PLANT, V28, P165, DOI 10.1007/s11738-006-0043-9; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Pallas JA, 1996, PLANT J, V10, P281, DOI 10.1046/j.1365-313X.1996.10020281.x; Payyavula RS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-39; Pedras MSC, 2012, MOL PLANT PATHOL, V13, P483, DOI 10.1111/j.1364-3703.2011.00765.x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Powell L. E., 1987, Plant hormones and their role in plant growth and development., P539; Prashant S, 2011, PLANT CELL REP, V30, P2215, DOI 10.1007/s00299-011-1127-6; Prom L. K., 2015, American Journal of Experimental Agriculture, V6, P242, DOI 10.9734/AJEA/2015/14589; Saravanakumar D, 2007, CROP PROT, V26, P556, DOI 10.1016/j.cropro.2006.05.007; Sirisha VL, 2012, PLANT GROWTH REGUL, V66, P239, DOI 10.1007/s10725-011-9647-1; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Tan LQ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0914-6; Teichmann T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00233; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Vasanthaiah HKN, 2010, PLANT GROWTH REGUL, V61, P127, DOI 10.1007/s10725-010-9458-9; Wachira F, 2001, J HORTIC SCI BIOTECH, V76, P557; Wang HA, 2010, J PHOTOCH PHOTOBIO B, V99, P150, DOI 10.1016/j.jphotobiol.2010.03.011; Wang L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0352-x; Wang L, 2014, SCI HORTIC-AMSTERDAM, V174, P133, DOI 10.1016/j.scienta.2014.05.024; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wen YQ, 2012, PLANTA, V236, P525, DOI 10.1007/s00425-012-1624-z; Xu W, 2015, RADIAT RES, V183, P511, DOI 10.1667/RR13909.1; Yang Y., 2003, CHINA TEA, V25, P12; Yoshida K, 2006, JARQ-JPN AGR RES Q, V40, P379, DOI 10.6090/jarq.40.379	62	36	40	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148535	10.1371/journal.pone.0148535	http://dx.doi.org/10.1371/journal.pone.0148535			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849553	gold, Green Submitted, Green Published			2022-12-26	WOS:000369554000119
J	Mendez-Gonzalez, MP; Kucheryavykh, YV; Zayas-Santiago, A; Velez-Carrasco, W; Maldonado-Martinez, G; Cubano, LA; Nichols, CG; Skatchkov, SN; Eaton, MJ				Mendez-Gonzalez, Miguel P.; Kucheryavykh, Yuriy V.; Zayas-Santiago, Astrid; Velez-Carrasco, Wanda; Maldonado-Martinez, Geronimo; Cubano, Luis A.; Nichols, Colin G.; Skatchkov, Serguei N.; Eaton, Misty J.			Novel KCNJ10 Gene Variations Compromise Function of Inwardly Rectifying Potassium Channel 4.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; GLUTAMATE UPTAKE; KIR4.1 CHANNELS; PH SENSITIVITY; SEIZURE SUSCEPTIBILITY; SENSORINEURAL DEAFNESS; MOLECULAR-MECHANISMS; CORTICAL ASTROCYTES; EXPRESSION; SUBUNIT	The KCNJ10 gene encoding Kir4.1 contains numerous SNPs whose molecular effects remain unknown. We investigated the functional consequences of uncharacterized SNPs (Q212R, L166Q, and G83V) on homomeric (Kir4.1) and heteromeric (Kir4.1-Kir5.1) channel function. We compared these with previously characterized EAST/SeSAME mutants (G77R and A167V) in kidney-derived tsA201 cells and in glial cell-derived C6 glioma cells. The membrane potentials of tsA201 cells expressing G77R and G83V were significantly depolarized as compared with WTKir4.1, whereas cells expressing Q212R, L166Q, and A167V were less affected. Furthermore, macroscopic currents from cells expressing WTKir4.1 and Q212R channels did not differ, whereas currents from cells expressing L166Q, G83V, G77R, and A167V were reduced. Unexpectedly, L166Q current responses were rescued when co-expressed with Kir5.1. In addition, we observed notable differences in channel activity between C6 glioma cells and tsA201 cells expressing L166Q and A167V, suggesting that there are underlying differences between cell lines in terms of Kir4.1 protein synthesis, stability, or expression at the surface. Finally, we determined spermine (SPM) sensitivity of these uncharacterized SNPs and found that Q212R-containing channels displayed reduced block by 1 mu M SPM. At 100 mu M SPM, the block was equal to or greater than WT, suggesting that the greater driving force of SPM allowed achievement of steady state. In contrast, L166Q-Kir5.1 channels achieved a higher block than WT, suggesting a more stable interaction of SPM in the deep pore cavity. Overall, our data suggest that G83V, L166Q, and Q212R residues play a pivotal role in controlling Kir4.1 channel function.	[Mendez-Gonzalez, Miguel P.; Kucheryavykh, Yuriy V.; Velez-Carrasco, Wanda; Skatchkov, Serguei N.; Eaton, Misty J.] Univ Cent Caribe, Dept Biochem, POB 60327, Bayamon, PR 00960 USA; [Zayas-Santiago, Astrid] Univ Cent Caribe, Dept Pathol & Lab Med, Bayamon, PR 00960 USA; [Zayas-Santiago, Astrid; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Physiol, POB 60327, Bayamon, PR 00960 USA; [Maldonado-Martinez, Geronimo] Univ Cent Caribe, Dept Data Management & Stat Res Support Unit, Bayamon, PR 00960 USA; [Cubano, Luis A.] Univ Cent Caribe, Dept Anat & Cell Biol, Bayamon, PR 00960 USA; [Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mendez-Gonzalez, MP; Skatchkov, SN (corresponding author), Univ Cent Caribe, Dept Biochem, POB 60327, Bayamon, PR 00960 USA.; Skatchkov, SN (corresponding author), Univ Cent Caribe, Dept Physiol, POB 60327, Bayamon, PR 00960 USA.	miguel.mendez3@upr.edu; sergueis50@yahoo.com	Maldonado-Martínez, Gerónimo/AAB-9049-2019	Maldonado-Martínez, Gerónimo/0000-0002-6859-0866; Zayas-Santiago, Astrid/0000-0003-4028-0564	National Institutes of Health [SC1GM088019, R01NS065201, G12MD007583, R25GM110513]; Department of Education [P031M105050]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM110513, SC1GM088019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education(US Department of Education); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants SC1GM088019, R01NS065201, G12MD007583, and R25GM110513 and Department of Education Title V Promoting Postbaccalaureate Opportunities for Hispanic Americans Grant P031M105050. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Casamassima M, 2003, J BIOL CHEM, V278, P43533, DOI 10.1074/jbc.M306596200; Chen J, 2014, NEUROSCIENCE, V265, P137, DOI 10.1016/j.neuroscience.2014.01.036; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Heuser K, 2012, J NEUROPATH EXP NEUR, V71, P814, DOI 10.1097/NEN.0b013e318267b5af; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Higashi K, 2001, AM J PHYSIOL-CELL PH, V281, pC922, DOI 10.1152/ajpcell.2001.281.3.C922; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Ishii M, 1997, J NEUROSCI, V17, P7725; Ishii M, 2003, AM J PHYSIOL-CELL PH, V285, pC260, DOI 10.1152/ajpcell.00560.2002; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Konstas AA, 2003, AM J PHYSIOL-CELL PH, V284, pC910, DOI 10.1152/ajpcell.00479.2002; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Kucheryavykh YV, 2007, CHANNELS, V1, P172, DOI 10.4161/chan.4389; Kucheryavykh YV, 2008, GLIA, V56, P775, DOI 10.1002/glia.20652; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kurata HT, 2010, J GEN PHYSIOL, V135, P495, DOI 10.1085/jgp.200910253; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Li LY, 2001, GLIA, V33, P57, DOI 10.1002/1098-1136(20010101)33:1<57::AID-GLIA1006>3.0.CO;2-0; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Olsen ML, 2015, J NEUROSCI, V35, P13827, DOI 10.1523/JNEUROSCI.2603-15.2015; Olsen ML, 2006, GLIA, V53, P516, DOI 10.1002/glia.20312; Olsen ML, 2004, GLIA, V46, P63, DOI 10.1002/glia.10346; Parrock S, 2013, NEPHRON PHYSIOL, V123, P7, DOI 10.1159/000356353; Pattnaik BR, 2012, MOL GENET METAB, V105, P64, DOI 10.1016/j.ymgme.2011.10.004; Paulais M, 2011, P NATL ACAD SCI USA, V108, P10361, DOI 10.1073/pnas.1101400108; Pearson WL, 1999, J PHYSIOL-LONDON, V514, P639, DOI 10.1111/j.1469-7793.1999.639ad.x; Pessia M, 2001, J PHYSIOL-LONDON, V532, P359, DOI 10.1111/j.1469-7793.2001.0359f.x; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Phani NM, 2014, GENE, V536, P247, DOI 10.1016/j.gene.2013.12.026; Poopalasundaram S, 2000, GLIA, V30, P362, DOI 10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Skatchkov SN, 2014, PSYCHIAT CLIN N AM, V37, P653, DOI 10.1016/j.psc.2014.08.008; Skatchkov SN, 1999, GLIA, V27, P171, DOI 10.1002/(SICI)1098-1136(199908)27:2<171::AID-GLIA7>3.3.CO;2-6; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; Wu J, 2004, J MEMBRANE BIOL, V197, P179, DOI 10.1007/s00232-004-0652-4; Xu HX, 2000, J PHYSIOL-LONDON, V528, P267, DOI 10.1111/j.1469-7793.2000.00267.x; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Yang ZJ, 2000, J GEN PHYSIOL, V116, P33, DOI 10.1085/jgp.116.1.33; Yang ZJ, 1999, J PHYSIOL-LONDON, V520, P921, DOI 10.1111/j.1469-7793.1999.00921.x	54	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7716	7726		10.1074/jbc.M115.679910	http://dx.doi.org/10.1074/jbc.M115.679910			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26867573	Green Published, hybrid			2022-12-26	WOS:000383447600041
J	Noy, T; Vergnolle, O; Hartman, TE; Rhee, KY; Jacobs, WR; Berney, M; Blanchard, JS				Noy, Tahel; Vergnolle, Olivia; Hartman, Travis E.; Rhee, Kyu Y.; Jacobs, William R., Jr.; Berney, Michael; Blanchard, John S.			Central Role of Pyruvate Kinase in Carbon Co-catabolism of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; bacterial metabolism; fatty acid metabolism; microbial pathogenesis; Mycobacterium tuberculosis; pyruvate kinase; tricarboxylic acid cycle (TCA cycle) (Krebs cycle)	ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; METABOLISM; GROWTH; DEHYDROGENASE; METHYLGLYOXAL; BACTERIA; PHOSPHOENOLPYRUVATE; PHOSPHORYLATION; ACETYLATION	Mycobacterium tuberculosis (Mtb) displays a high degree of metabolic plasticity to adapt to challenging host environments. Genetic evidence suggests that Mtb relies mainly on fatty acid catabolism in the host. However, Mtb also maintains a functional glycolytic pathway and its role in the cellular metabolism of Mtb has yet to be understood. Pyruvate kinase catalyzes the last and rate-limiting step in glycolysis and the Mtb genome harbors one putative pyruvate kinase (pykA, Rv1617). Here we show that pykA encodes an active pyruvate kinase that is allosterically activated by glucose 6-phosphate (Glc-6-P) and adenosine monophosphate (AMP). Deletion of pykA prevents Mtb growth in the presence of fermentable carbon sources and has a cidal effect in the presence of glucose that correlates with elevated levels of the toxic catabolite methylglyoxal. Growth attenuation was also observed in media containing a combination of short chain fatty acids and glucose and surprisingly, in media containing odd and even chain fatty acids alone. Untargeted high sensitivity metabolomics revealed that inactivation of pyruvate kinase leads to accumulation of phosphoenolpyruvate (P-enolpyruvate), citrate, and aconitate, which was consistent with allosteric inhibition of isocitrate dehydrogenase by P-enolpyruvate. This metabolic block could be relieved by addition of the -ketoglutarate precursor glutamate. Taken together, our study identifies an essential role of pyruvate kinase in preventing metabolic block during carbon co-catabolism in Mtb.	[Noy, Tahel; Vergnolle, Olivia; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, New York, NY 10461 USA; [Jacobs, William R., Jr.; Berney, Michael] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA; [Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, New York, NY 10461 USA; [Hartman, Travis E.; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Yeshiva University; Yeshiva University; Howard Hughes Medical Institute; Yeshiva University; Cornell University	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, New York, NY 10461 USA.; Berney, M (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA.	michael.berney@einstein.yu.edu; john.blanchard@einstein.yu.edu	Berney, Michael/GQZ-2111-2022	Berney, Michael/0000-0002-4833-0573; Hartman, Travis/0000-0002-3926-6928; Jacobs, William/0000-0003-3321-3080	National Institutes of Health [AI060899, AI26170, AI119573]; Burroughs Wellcome Career Award in the Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026170, R21AI119573, R01AI026170, R22AI026170, R01AI060899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI060899 (to J. S. B.), AI26170 (to W. R. J.), AI119573 (to M. B.), and a Burroughs Wellcome Career Award in the Biomedical Sciences (to K. Y. R.).	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Berney M, 2015, P NATL ACAD SCI USA, V112, P10008, DOI 10.1073/pnas.1513033112; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brzostek A, 2005, MICROBIOL-SGM, V151, P2393, DOI 10.1099/mic.0.27953-0; Chavadi S, 2009, J BACTERIOL, V191, P7545, DOI 10.1128/JB.00619-09; Cheng JH, 2013, J SEP SCI, V36, P1418, DOI 10.1002/jssc.201201158; CORTASSA S, 1995, BIOTECHNOL BIOENG, V47, P193, DOI 10.1002/bit.260470211; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Ferguson GP, 1999, TRENDS MICROBIOL, V7, P242, DOI 10.1016/S0966-842X(99)01510-3; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kayne FJ, 1973, ENZYMES, V8, P353, DOI 10.1016/S1874-6047(08)60071-2; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Koul A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4369; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Kremling A, 2008, BIOINFORMATICS, V24, P704, DOI 10.1093/bioinformatics/btn010; Maksymiuk C, 2015, P NATL ACAD SCI USA, V112, pE5834, DOI 10.1073/pnas.1510932112; Marrero J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003116; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Nandakumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5306; Ogawa T, 2007, J BACTERIOL, V189, P1176, DOI 10.1128/JB.01628-06; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Ponce E, 1999, J BIOSCI BIOENG, V87, P775, DOI 10.1016/S1389-1723(99)80152-2; Randell E. W., 2005, Journal of Pharmacological and Toxicological Methods, V51, P153, DOI 10.1016/j.vascn.2004.08.005; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Siddiquee KA, 2004, FEMS MICROBIOL LETT, V235, P25, DOI 10.1016/j.femsle.2004.04.004; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Trujillo C, 2014, MBIO, V5, DOI 10.1128/mBio.00085-14; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Veith N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003159; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WILSON AJ, 1986, CAN J MICROBIOL, V32, P969, DOI 10.1139/m86-180; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu T, 2001, BIOTECHNOL PROGR, V17, P624, DOI 10.1021/bp0100575; Zoraghi R, 2011, ANTIMICROB AGENTS CH, V55, P2042, DOI 10.1128/AAC.01250-10; Zoraghi R, 2010, BIOCHEMISTRY-US, V49, P7733, DOI 10.1021/bi100780t	57	24	26	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7060	7069		10.1074/jbc.M115.707430	http://dx.doi.org/10.1074/jbc.M115.707430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26858255	Green Published, hybrid			2022-12-26	WOS:000373299700040
J	Domiciano, IG; Domit, C; Broadhurst, MK; Koch, MS; Bracarense, APFRL				Domiciano, Isabela G.; Domit, Camila; Broadhurst, Matt K.; Koch, Mariana S.; Bracarense, Ana Paula F. R. L.			Assessing Disease and Mortality among Small Cetaceans Stranded at a World Heritage Site in Southern Brazil	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; DOLPHINS DELPHINUS-DELPHIS; SOTALIA-GUIANENSIS; MARINE MAMMALS; HEAVY-METAL; MORBILLIVIRUS; CONSERVATION; PATHOLOGY; BYCATCH; LESIONS	Cetaceans are considered environmental sentinels and their health often reflects either anthropogenic or natural spatio-temporal disturbances. This study investigated the pathological findings and mortality of small cetaceans with the aim of detecting hazards and monitoring health trends in a high-biodiversity area. Between 2007 and 2012, 218 stranded cetaceans were recorded on the Parana coast, southern Brazil. Fifty-seven (26.1%) of these animals, including 50 Sotalia guianensis, 2 Pontoporia blainvillei, 2 Stenella frontalis, 1 Stenella longirostris, 1 Tursiops truncatus and 1 Globicephala melas were necropsied and samples were collected for histopathology. Causes of death were determined in 46 of the 57 (80.7%) animals and most (30 or 65.2%) were ascribed to anthropogenic activities, including fisheries bycatch (28/30) and trauma (2/30). The remaining 16 fatalities were considered natural, and attributed to pneumonia (10/16), emaciation (3/16), septicemia (1/16), neonatal pathology (1/16) and choking via food obstruction (1/16). Irrespective of the cause, bronchointerstitial pneumonia, associated with parasitism, lymphadenitis and membranous glomerulonephritis were common findings among all fatalities. These results suggest, that while anthropogenic activities are a leading cause of cetacean strandings in Parana, underlying pre-existing diseases may contribute towards deaths. Although the studied area is considered a biosphere reserve by UNESCO, complex anthropogenic and natural interactions might be occurring, increasing cetacean susceptibility to hazards. This study may help facilitate developing an effective conservation plan for coastal cetaceans focusing on reducing fisheries interactions, habitat degradation and pollution as mechanisms for ultimately increasing species resilience.	[Domiciano, Isabela G.; Koch, Mariana S.; Bracarense, Ana Paula F. R. L.] Univ Estadual Londrina, Dept Vet Prevent Med, Lab Anim Pathol, Londrina, Parana, Brazil; [Domiciano, Isabela G.; Domit, Camila; Koch, Mariana S.] Univ Fed Parana, Ctr Estudos Mar, Lab Ecol & Conservat, Pontal Do Parana, Parana, Brazil; [Broadhurst, Matt K.] NSW Dept Primary Ind, Fisheries Conservat Technol Unit, Coffs Harbour, Australia; [Broadhurst, Matt K.] Univ Queensland, Sch Biol Sci, Marine & Estuarine Ecol Unit, Brisbane, Qld, Australia	Universidade Estadual de Londrina; Universidade Federal do Parana; NSW Department of Primary Industries; University of Queensland	Bracarense, APFRL (corresponding author), Univ Estadual Londrina, Dept Vet Prevent Med, Lab Anim Pathol, Londrina, Parana, Brazil.	ana.bracarense@pq.cnpq.br	Domit, Camila/J-8038-2016; Broadhurst, Matt/I-6783-2015	Domit, Camila/0000-0001-6158-6963; Broadhurst, Matt/0000-0003-0184-7249; Koch, Mariana/0000-0002-1838-5987	CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [551399]	CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was partially financed by CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant 551399).	Altrao CS, 2013, 22 ENC AN IN CIENT; Andriguetto-Filho J.M., 2006, PESCA MARINHA ESTUAR, P117; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; Beineke A, 2010, VET IMMUNOL IMMUNOP, V133, P81, DOI 10.1016/j.vetimm.2009.06.019; Bloch Dorete, 1993, Reports of the International Whaling Commission Special Issue, V14, P163; Bogomolni AL, 2010, DIS AQUAT ORGAN, V88, P143, DOI 10.3354/dao02146; Bossart GD, 2011, VET PATHOL, V48, P676, DOI 10.1177/0300985810388525; Burri P.H., 1999, LUNG DEV, P122; Carvalho VL, 2010, VET PARASITOL, V173, P116, DOI 10.1016/j.vetpar.2010.06.023; Chaves P.T.C., 2003, ATLANTICA, V25, P53; Crespo Enrique A., 2010, Latin American Journal of Aquatic Mammals, V8, P47; Dailey MD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P357; Di Beneditto A. P. M., 2003, LAT AM J AQUAT MAMM, V2, P79, DOI DOI 10.5597/LAJAM00035; Di Guardo G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00211; Diaz-Delgado J, 2012, J VET MED SCI, V74, P1063, DOI 10.1292/jvms.11-0573; Domiciano IG, 2012, CLIN VET, V99, P100; Fauquier DA, 2009, DIS AQUAT ORGAN, V88, P85, DOI 10.3354/dao02095; Flores PAC, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1188; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gonzales-Vieira O, 2015, J COMP PATHOL; Groch KR, 2014, EMERG INFECT DIS, V20, P511, DOI 10.3201/eid2003.131557; Guimaraes JP, 2015, J PARASITOL, V101, P248, DOI 10.1645/14-513.1; Gulland FMD, 2007, ECOHEALTH, V4, P135, DOI 10.1007/s10393-007-0097-1; Headley SA, 2009, J VET DIAGN INVEST, V21, P588, DOI 10.1177/104063870902100502; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jepson PD, 2000, VET REC, V146, P721, DOI 10.1136/vr.146.25.721; Kuwamura M, 2007, J VET MED SCI, V69, P531, DOI 10.1292/jvms.69.531; Lane EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107038; Lavery TJ, 2009, MAR ENVIRON RES, V67, P1, DOI 10.1016/j.marenvres.2008.09.005; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lopez A., 2007, PATHOLOGIC BASIS VET, P463; Mannocci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032615; Marigo J, 2010, J WILDLIFE DIS, V46, P599, DOI 10.7589/0090-3558-46.2.599; Martineau D, 2007, INT J COMP PHYSL, V20, P194; Martins CC, 2012, SCI TOTAL ENVIRON, V417, P158, DOI 10.1016/j.scitotenv.2011.11.086; Mcfee WE, 2009, J WILDLIFE DIS, V45, P575; Mizerkowski BD, 2012, OCEAN DYNAM, V62, P1409, DOI 10.1007/s10236-012-0569-x; Moore MJ, 2013, DIS AQUAT ORGAN, V103, P229, DOI 10.3354/dao02566; Motta MRA, 2006, THESIS U ESTADUAL CE; Moura JF, 2014, REV ENVIRON CONTAM T, V228, P1, DOI [10.1007/978-3-319-01619-1_1, DOI 10.1007/978-3-319-01619-1_1]; Ninomiya H, 2005, J VET MED SCI, V67, P473, DOI 10.1292/jvms.67.473; Noernberg M. A., 2008, Brazilian Journal of Aquatic Science & Technology, V12, P49; O'Shea TJ, 2008, J MAMMAL, V89, P529, DOI 10.1644/07-MAMM-S-416R.1; Osinga N, 2008, EUR J WILDLIFE RES, V54, P667, DOI 10.1007/s10344-008-0193-8; Parsons E.C.M., 2013, INTRO MARINE MAMMAL; Pellisso SC, 2008, VET IMMUNOL IMMUNOP, V121, P189, DOI 10.1016/j.vetimm.2007.09.009; Peltier H, 2014, ECOL INDIC, V39, P203, DOI 10.1016/j.ecolind.2013.12.019; Perrin W. F., 1984, REPORT INT WHALING C, P181; Perrin William F., 2002, Mammalian Species, V702, P1, DOI 10.1644/1545-1410(2002)702<0001:SF>2.0.CO;2; Perrin William F., 1998, Mammalian Species, V599, P1; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Reeves R. R., 2013, ENDANGER SPECIES RES, V20, P71; Robert MC, 2012, RELATORIO TECNICO CO; Rosa C, 2008, SCI TOTAL ENVIRON, V399, P165, DOI 10.1016/j.scitotenv.2008.01.062; Rosas FCW, 2002, MAMMALIA, V66, P231, DOI 10.1515/mamm.2002.66.2.231; Rosas FCW, 2002, J MAMMAL, V83, P507; Rosas Fernando C. Weber, 2002, Latin American Journal of Aquatic Mammals, V1, P161; Ruoppolo V, THESIS U SAO PAULO; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Secchi Eduardo R., 2003, Journal of Cetacean Research and Management, V5, P61; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Simmonds MP, 2009, J MAR BIOL ASSOC UK, V89, P203, DOI 10.1017/S0025315408003196; Van Bressem MF, 2014, VIRUSES-BASEL, V6, P5145, DOI 10.3390/v6125145; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Wright A.J., 2007, INTERJ COMP PSYCHO, V20, P274, DOI DOI 10.5070/P4202009994	66	22	22	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149295	10.1371/journal.pone.0149295	http://dx.doi.org/10.1371/journal.pone.0149295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871703	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100143
J	Meekrathok, P; Suginta, W				Meekrathok, Piyanat; Suginta, Wipa			Probing the Catalytic Mechanism of Vibrio harveyi GH20 beta-N-Acetylglucosaminidase by Chemical Rescue	PLOS ONE			English	Article							LYTIC POLYSACCHARIDE MONOOXYGENASE; SUBSTRATE-ASSISTED CATALYSIS; TAY-SACHS-DISEASE; CHITIN UTILIZATION; MARINE-BACTERIA; GLYCOSIDE HYDROLASES; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; HEXOSAMINIDASE-B; SANDHOFF-DISEASE	Background Vibrio harveyi GH20 beta-N-acetylglucosaminidase (VhGlcNAcase) is a chitinolytic enzyme responsible for the successive degradation of chitin fragments to GlcNAc monomers, activating the onset of the chitin catabolic cascade in marine Vibrios. Methods Two invariant acidic pairs (Asp303-Asp304 and Asp437-Glu438) of VhGlcNAcase were mutated using a site-directed mutagenesis strategy. The effects of these mutations were examined and the catalytic roles of these active-site residues were elucidated using a chemical rescue approach. Enhancement of the enzymic activity of the VhGlcNAcase mutants was evaluated by a colorimetric assay using pNP-GlcNAc as substrate. Results Substitution of Asp303, Asp304, Asp437 or Glu438 with Ala/Asn/Gln produced a dramatic loss of the GlcNAcase activity. However, the activity of the inactive D437A mutant was recovered in the presence of sodium formate. Our kinetic data suggest that formate ion plays a nucleophilic role by mimicking the beta-COO-side chain of Asp437, thereby stabilizing the reaction intermediate during both the glycosylation and the deglycosylation steps. Conclusions Chemical rescue of the inactive D437A mutant of VhGlcNAcase by an added nucleophile helped to identify Asp437 as the catalytic nucleophile/base, and hence its acidic partner Glu438 as the catalytic proton donor/acceptor. General Significance Identification of the catalytic nucleophile of VhGlcNAcases supports the proposal of a substrate-assisted mechanism of GH20 GlcNAcases, requiring the catalytic pair Asp437-Glu438 for catalysis. The results suggest the mechanistic basis of the participation of beta-Nacetylglucosaminidase in the chitin catabolic pathway of marine Vibrios.	[Meekrathok, Piyanat; Suginta, Wipa] Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Meekrathok, Piyanat; Suginta, Wipa] Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand; [Suginta, Wipa] Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology	Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand.; Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand.; Suginta, W (corresponding author), Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th		Meekrathok, Piyanat/0000-0003-3566-1231	Suranaree University of Technology (SUT); Office of the Higher Education Commission under the NRU project of Thailand; Thailand Research Fund (TRF); SUT [BRG578001, PHD/0084/2550]	Suranaree University of Technology (SUT); Office of the Higher Education Commission under the NRU project of Thailand; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); SUT	This work was financially supported by Suranaree University of Technology (SUT) and the Office of the Higher Education Commission under the NRU project of Thailand. PM received a Ph.D. Scholarship through the Royal Golden Jubilee Ph.D. Program from the Thailand Research Fund (TRF) and SUT (Grant no. PHD/0084/2550). WS was funded by TRF and SUT through the Basic Research Grant (Grant no. BRG578001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1991, J BIOL CHEM, V266, P24268; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; Cobucci-Ponzano B, 2003, BIOCHEMISTRY-US, V42, P9525, DOI 10.1021/bi035036t; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Hamre AG, 2015, CARBOHYD RES, V407, P166, DOI 10.1016/j.carres.2015.02.010; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; JEUNIAUX C, 1991, BIOCHEM SYST ECOL, V19, P347, DOI 10.1016/0305-1978(91)90051-Z; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; MACLEOD AM, 1994, BIOCHEMISTRY-US, V33, P6371, DOI 10.1021/bi00186a042; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 1998, J BIOL CHEM, V273, P19618, DOI 10.1074/jbc.273.31.19618; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Paal K, 2004, BIOCHEM J, V378, P141, DOI 10.1042/BJ20031028; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; Sirimontree P, 2016, J BIOCHEM, V159, P191, DOI 10.1093/jb/mvv087; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suginta W, 2005, FEBS J, V272, P3376, DOI 10.1111/j.1742-4658.2005.04753.x; Suginta W, 2004, ARCH BIOCHEM BIOPHYS, V424, P171, DOI 10.1016/j.abb.2004.01.017; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Vallmitjana M, 2001, BIOCHEMISTRY-US, V40, P5975, DOI 10.1021/bi002947j; Viladot JL, 1998, BIOCHEMISTRY-US, V37, P11332, DOI 10.1021/bi980586q; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; YU C, 1991, J BIOL CHEM, V266, P24260; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5; Zobell CE, 1938, J BACTERIOL, V35, P275, DOI 10.1128/JB.35.3.275-287.1938	45	18	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149228	10.1371/journal.pone.0149228	http://dx.doi.org/10.1371/journal.pone.0149228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870945	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100131
J	Lehtihet, M; Bonde, Y; Beckman, L; Berinder, K; Hoybye, C; Rudling, M; Sloan, JH; Konrad, RJ; Angelin, B				Lehtihet, Mikael; Bonde, Ylva; Beckman, Lena; Berinder, Katarina; Hoybye, Charlotte; Rudling, Mats; Sloan, John H.; Konrad, Robert J.; Angelin, Bo			Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; C-REACTIVE PROTEIN; IRON-METABOLISM; GROWTH-HORMONE; REPLACEMENT THERAPY; RESPONSE ELEMENT; TESTOSTERONE; FERROPORTIN; SERUM; LIVER	Objective Hepcidin reduces iron absorption by binding to the intestinal iron transporter ferroportin, thereby causing its degradation. Although short-term administration of testosterone or growth hormone (GH) has been reported to decrease circulating hepcidin levels, little is known about how hepcidin is influenced in human endocrine conditions associated with anemia. Research design and methods We used a sensitive and specific dual-monoclonal antibody sandwich immunoassay to measure hepcidin-25 in patients (a) during initiation of in vitro fertilization when endogenous estrogens were elevated vs. suppressed, (b) with GH deficiency before and after 12 months substitution treatment, (c) with hyperthyroidism before and after normalization, and (d) with hyperprolactinemia before and after six months of treatment with a dopamine agonist. Results In response to a marked stimulation of endogenous estrogen production, median hepcidin levels decreased from 4.85 to 1.43 ng/mL (p < 0.01). Hyperthyroidism, hyperprolactinemia, or GH substitution to GH-deficient patients did not influence serum hepcidin-25 levels. Conclusions In humans, gonadotropin-stimulated endogenous estrogen markedly decreases circulating hepcidin-25 levels. No clear and stable correlation between iron biomarkers and hepcidin-25 was seen before or after treatment of hyperthyroidism, hyperprolactinemia or growth hormone deficiency.	[Lehtihet, Mikael; Bonde, Ylva; Beckman, Lena; Berinder, Katarina; Hoybye, Charlotte; Rudling, Mats; Angelin, Bo] Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Dept Med, S-14186 Huddinge, Sweden; [Lehtihet, Mikael; Bonde, Ylva; Beckman, Lena; Berinder, Katarina; Hoybye, Charlotte; Rudling, Mats; Angelin, Bo] Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Dept Mol Med & Surg, S-14186 Huddinge, Sweden; [Bonde, Ylva; Beckman, Lena; Rudling, Mats; Angelin, Bo] Karolinska Inst, Karolinska Univ Hosp, Mol Nutr Unit, Ctr Innovat Med,Dept Biosci & Nutr, S-14186 Huddinge, Sweden; [Sloan, John H.; Konrad, Robert J.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Eli Lilly	Lehtihet, M (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Dept Med, S-14186 Huddinge, Sweden.; Lehtihet, M (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Dept Mol Med & Surg, S-14186 Huddinge, Sweden.	Mikael.lehtihet@ki.se	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899; Berinder, Katarina/0000-0003-2488-0375	Lilly Research Laboratories, Eli Lilly Co	Lilly Research Laboratories, Eli Lilly Co	The authors received no specific funding for this work. Lilly Research Laboratories, Eli Lilly & Co, provided support in the form of salaries for authors JHS and RJK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Atanasiu V, 2007, EUR J HAEMATOL, V78, P1, DOI 10.1111/j.1600-0609.2006.00772.x; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; BANG P, 1991, ACTA ENDOCRINOL-COP, V124, P620, DOI 10.1530/acta.0.1240620; Beggs LA, 2014, AM J PHYSIOL-ENDOC M, V307, pE456, DOI 10.1152/ajpendo.00184.2014; Berinder K, 2011, PITUITARY, V14, P199, DOI 10.1007/s11102-010-0277-9; Bonde Y, 2014, J LIPID RES, V55, P2408, DOI 10.1194/jlr.M051664; Butterfield AM, 2010, CLIN CHEM, V56, P1725, DOI 10.1373/clinchem.2010.151522; Centanni M, 1999, ARCH INTERN MED, V159, P1726, DOI 10.1001/archinte.159.15.1726; Ellegala DB, 2003, J NEUROSURG, V98, P974, DOI 10.3171/jns.2003.98.5.0974; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Gianoukakis AG, 2009, CLIN ENDOCRINOL, V70, P781, DOI 10.1111/j.1365-2265.2008.03382.x; GOLDE DW, 1977, SCIENCE, V196, P1112, DOI 10.1126/science.870971; Goyal J, 2013, AM J HEMATOL, V88, P976, DOI 10.1002/ajh.23519; Guo W, 2013, AGING CELL, V12, P280, DOI 10.1111/acel.12052; Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Latour C, 2014, HEPATOLOGY, V59, P683, DOI 10.1002/hep.26648; Lundberg J, 2013, J INTERN MED, V274, P227, DOI 10.1111/joim.12112; MILMAN N, 1992, ANN HEMATOL, V65, P96, DOI 10.1007/BF01698138; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Nishioka H, 2005, J ENDOCRINOL INVEST, V28, P528, DOI 10.1007/BF03347241; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Persson L, 2012, ARTERIOSCL THROM VAS, V32, P810, DOI 10.1161/ATVBAHA.111.242461; Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Qian Y, 2015, CELL SIGNAL, V27, P934, DOI 10.1016/j.cellsig.2015.01.017; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Raso GM, 2009, BIOCHEM PHARMACOL, V78, P1001, DOI 10.1016/j.bcp.2009.05.034; RICOUX R, 1994, ANN BIOL CLIN-PARIS, V52, P125; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Schumann K, 2007, J TRACE ELEM MED BIO, V21, P147, DOI 10.1016/j.jtemb.2007.06.002; Shifren JL, 2008, J CLIN ENDOCR METAB, V93, P1702, DOI 10.1210/jc.2007-2193; Smitz J, 2007, HUM REPROD, V22, P676, DOI 10.1093/humrep/del445; TenHave SMTH, 1997, CLIN ENDOCRINOL, V47, P565, DOI 10.1046/j.1365-2265.1997.3241124.x; Troutt JS, 2012, CLIN CHEM, V58, P1225, DOI 10.1373/clinchem.2012.186866; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045	39	43	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148802	10.1371/journal.pone.0148802	http://dx.doi.org/10.1371/journal.pone.0148802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866603	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700040
J	Moya-Alvarez, V; Mireku, MO; Ayotte, P; Cot, M; Bodeau-Livinec, F				Moya-Alvarez, Violeta; Mireku, Michael Osei; Ayotte, Pierre; Cot, Michel; Bodeau-Livinec, Florence			Elevated Blood Lead Levels Are Associated with Reduced Risk of Malaria in Beninese Infants	PLOS ONE			English	Article							IRON-DEFICIENCY; FALCIPARUM-MALARIA; CHILDREN; COUNTRIES; TOXICITY	Introduction Elevated blood lead levels (BLL) and malaria carry an important burden of disease in West Africa. Both diseases might cause anemia and they might entail long-term consequences for the development and the health status of the child. Albeit the significant impact of malaria on lead levels described in Nigeria, no evaluation of the effect of elevated BLL on malaria risk has been investigated so far. Materials and Methods Between 2010 and 2012, blood lead levels of 203 Beninese infants from Allada, a semi-rural area 50km North from Cotonou, were assessed at 12 months of age. To assess lead levels, blood samples were analyzed by mass spectrometry. In parallel, clinical, microbiological and hematological data were collected. More precisely, hemoglobin, serum ferritin, CRP, vitamin B12, folate levels, and Plasmodium falciparum parasitemia were assessed and stool samples were also analyzed. Results At 12 months, the mean BLL of infants was 7.41 mu g/dL (CI: 65.2; 83), and 128 infants (63%) had elevated blood lead levels, defined by the CDC as BLL>5 mu g/dL. Lead poisoning, defined as BLL>10 mu g/dL, was found in 39 infants (19%). Twenty-five infants (12.5%) had a positive blood smear at 12 months and 144 infants were anemic (71%, hemoglobin<110 g/L). Elevated blood lead levels were significantly associated with reduced risk of a positive blood smear (AOR = 0.38, P-value = 0.048) and P. falciparum parasite density (beta-estimate = -1.42, P-value = 0.03) in logistic and negative binomial regression multivariate models, respectively, adjusted on clinical and environmental indicators. Conclusion Our study shows for the first time that BLL are negatively associated with malarial risk considering other risk factors. Malaria is one of the main causes of morbidity and mortality in infants under 5 years worldwide, and lead poisoning is the 6th most important contributor to the global burden of diseases measured in disability adjusted life years (DALYs) according to the Institute of Health Metrics. In conclusion, due to the high prevalence of elevated BLL, health interventions should look forward to minimize the exposure to lead to better protect the population in West Africa.	[Moya-Alvarez, Violeta; Mireku, Michael Osei; Cot, Michel] IRD, Mere & Enfant Face Infect Trop UMR MERIT 216, Paris, France; [Moya-Alvarez, Violeta; Mireku, Michael Osei] Univ Paris 06, Ecole Doctorale Pierre Louis Sante Publ, Paris, France; [Moya-Alvarez, Violeta] Ecole Hautes Etud Sante Publ, Rennes, France; [Mireku, Michael Osei; Bodeau-Livinec, Florence] Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Rennes, France; [Ayotte, Pierre] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Ayotte, Pierre] CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [Ayotte, Pierre] INSPQ, Direct Sante Environm & Toxicol, Quebec City, PQ, Canada; [Cot, Michel] Univ Paris 05, PRES Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Paris, France; [Bodeau-Livinec, Florence] Paris Descartes Univ, Ctr Epidemiol & Stat, DHU Risks Pregnancy,Sorbonne Paris Cite, Inserm UMR Obstet Perinatal & Pediat Epidemiol Re, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Laval University; Laval University; Institut national de sante publique du Quebec (INSPQ); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Moya-Alvarez, V (corresponding author), IRD, Mere & Enfant Face Infect Trop UMR MERIT 216, Paris, France.; Moya-Alvarez, V (corresponding author), Univ Paris 06, Ecole Doctorale Pierre Louis Sante Publ, Paris, France.; Moya-Alvarez, V (corresponding author), Ecole Hautes Etud Sante Publ, Rennes, France.	vmoyaalvarez@gmail.com	Bodeau-Livinec, Florence/U-9053-2017; Cot, Michel/E-7633-2011; Moya-Alvarez, Violeta/AAK-2238-2020; Mireku, Michael/O-1714-2018	Bodeau-Livinec, Florence/0000-0002-4266-6287; Cot, Michel/0000-0003-3014-4294; Moya-Alvarez, Violeta/0000-0001-7901-2263; Mireku, Michael/0000-0002-2157-8456	Ecole des Hautes Etudes en Sante Publique-Direction Generale de l'Armement grant; Univeriste Pierre et Marie Curie grant; NIH; Bill and Melinda Gates foundation	Ecole des Hautes Etudes en Sante Publique-Direction Generale de l'Armement grant; Univeriste Pierre et Marie Curie grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation)	VMA received the Ecole des Hautes Etudes en Sante Publique-Direction Generale de l'Armement grant for her doctoral fellowship. MOM received the Univeriste Pierre et Marie Curie grant for his doctoral fellowship. The NIH and the Bill and Melinda Gates foundation contributed to the funding of the study.	Baghurst PA, 1992, N ENGL J MED, V1279-1284; Batista-Foguet JM, 2004, SOC INDIC RES, V67, P315, DOI 10.1023/B:SOCI.0000032341.14612.b8; Bayoumi RAL, 1997, MED HYPOTHESES, V48, P11, DOI 10.1016/S0306-9877(97)90017-7; BELLINGER DC, 1992, PEDIATRICS, V90, P855; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; CDC, CDC RESP ADV COMM CH; Clune AL, 2011, J HLTH POLLUTION, P1; CORTINOVIS I, 1993, SOC SCI MED, V36, P1087, DOI 10.1016/0277-9536(93)90127-P; Dapul Heda, 2014, Adv Pediatr, V61, P313, DOI 10.1016/j.yapd.2014.04.004; GRAZIANO JH, 1991, ARCH ENVIRON HEALTH, V46, P347, DOI 10.1080/00039896.1991.9934401; Heo Y, 1996, TOXICOL APPL PHARM, V138, P149, DOI 10.1006/taap.1996.0108; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kwong WT, 2004, SCI TOTAL ENVIRON, V330, P21, DOI 10.1016/j.scitotenv.2004.03.017; LUBRAN MM, 1980, ANN CLIN LAB SCI, V10, P402; Lynes MA, 2006, TOXICOL APPL PHARM, V210, P9, DOI 10.1016/j.taap.2005.04.021; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Mendelsohn AL, 1998, PEDIATRICS, P101; Mireku MO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003463; Moya-alvarez V, 2015, OPEN FORUM INFECT DI, P1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngueta G, 2013, TROP MED INT HEALTH, V18, P1283, DOI 10.1111/tmi.12179; Nriagu J, 2008, INT J HYG ENVIR HEAL, V211, P591, DOI 10.1016/j.ijheh.2008.05.001; Okebe JU, 2011, COCHRANE DATABASE SY; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Pruss-Ustun A, 2002, PREVENTING DIS HLTH; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wright NJ, 2005, ARCH DIS CHILD, V90, P262, DOI 10.1136/adc.2003.043562; Wright RO, 2003, J PEDIATR-US, V142, P9, DOI 10.1067/mpd.2003.mpd0344	30	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149049	10.1371/journal.pone.0149049	http://dx.doi.org/10.1371/journal.pone.0149049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866471	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000370050700057
J	Nakagawa, Y; Muneta, T; Otabe, K; Ozeki, N; Mizuno, M; Udo, M; Saito, R; Yanagisawa, K; Ichinose, S; Koga, H; Tsuji, K; Sekiya, I				Nakagawa, Yusuke; Muneta, Takeshi; Otabe, Koji; Ozeki, Nobutake; Mizuno, Mitsuru; Udo, Mio; Saito, Ryusuke; Yanagisawa, Katsuaki; Ichinose, Shizuko; Koga, Hideyuki; Tsuji, Kunikazu; Sekiya, Ichiro			Cartilage Derived from Bone Marrow Mesenchymal Stem Cells Expresses Lubricin In Vitro and In Vivo	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; AUTOLOGOUS CHONDROCYTE IMPLANTATION; SUPERFICIAL ZONE PROTEIN; ARTICULAR-CARTILAGE; ADIPOSE-TISSUE; FRICTIONAL-PROPERTIES; RECOMBINANT LUBRICIN; SYNOVIAL-FLUID; RAT MODEL; OSTEOARTHRITIS	Objective Lubricin expression in the superficial cartilage will be a crucial factor in the success of cartilage regeneration. Mesenchymal stem cells (MSCs) are an attractive cell source and the use of aggregates of MSCs has some advantages in terms of chondrogenic potential and efficiency of cell adhesion. Lubricin expression in transplanted MSCs has not been fully elucidated so far. Our goals were to determine (1) whether cartilage pellets of human MSCs expressed lubricin in vitro chondrogenesis, (2) whether aggregates of human MSCs promoted lubricin expression, and (3) whether aggregates of MSCs expressed lubricin in the superficial cartilage after transplantation into osteochondral defects in rats. Methods For in vitro analysis, human bone marrow (BM) MSCs were differentiated into cartilage by pellet culture, and also aggregated using the hanging drop technique. For an animal study, aggregates of BM MSCs derived from GFP transgenic rats were transplanted to the osteochondral defect in the trochlear groove of wild type rat knee joints. Lubricin expression was mainly evaluated in differentiated and regenerated cartilages. Results In in vitro analysis, lubricin was detected in the superficial zone of the pellets and conditioned medium. mRNA expression of Proteoglycan4 (Prg4), which encodes lubricin, in pellets was significantly higher than that of undifferentiated MSCs. Aggregates showed different morphological features between the superficial and deep zone, and the Prg4 mRNA expression increased after aggregate formation. Lubricin was also found in the aggregate. In a rat study, articular cartilage regeneration was significantly better in the MSC group than in the control group as shown by macroscopical and histological analysis. The transmission electron microscope showed that morphology of the superficial cartilage in the MSC group was closer to that of the intact cartilage than in the control group. GFP positive cells remained in the repaired tissue and expressed lubricin in the superficial cartilage. Conclusion Cartilage derived from MSCs expressed lubricin protein both in vitro and in vivo. Aggregation promoted lubricin expression of MSCs in vitro and transplantation of aggregates of MSCs regenerated cartilage including the superficial zone in a rat osteochondral defect model. Our results indicate that aggregated MSCs could be clinically relevant for therapeutic approaches to articular cartilage regeneration with an appropriate superficial zone in the future.	[Nakagawa, Yusuke; Muneta, Takeshi; Udo, Mio; Saito, Ryusuke; Yanagisawa, Katsuaki; Koga, Hideyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Joint Surg & Sports Med, Tokyo, Japan; [Nakagawa, Yusuke; Otabe, Koji; Ozeki, Nobutake; Mizuno, Mitsuru; Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Tokyo, Japan; [Tsuji, Kunikazu] Tokyo Med & Dent Univ, Dept Cartilage Regenerat, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sekiya, I (corresponding author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan.	sekiya.arm@tmd.ac.jp	Tsuji, Kunikazu/HDM-9242-2022; Nakagawa, Yusuke/H-7320-2019; Koga, Hideyuki/B-2448-2019; Mitsuru, Mizuno/K-3962-2017	Tsuji, Kunikazu/0000-0002-1013-8359; Koga, Hideyuki/0000-0003-4574-1796; Mitsuru, Mizuno/0000-0002-4410-3621; Muneta, Takeshi/0000-0003-1018-2939	Highway Program for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development	Highway Program for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Highway Program for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development (to IS).	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; Andrades JA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3793; Bao JP, 2011, MOL BIOL REP, V38, P2879, DOI 10.1007/s11033-010-9949-9; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chevalier X, 2010, CURR DRUG TARGETS, V11, P546, DOI 10.2174/138945010791011866; Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436; Cui Z, 2015, BONE, V74, P37, DOI 10.1016/j.bone.2014.12.065; Drewniak EI, 2012, ARTHRITIS RHEUM-US, V64, P465, DOI 10.1002/art.33337; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104; Gleghorn JP, 2007, EUR CELLS MATER, V14, P20, DOI 10.22203/eCM.v014a02; Guzman-Morales J, 2014, OSTEOARTHR CARTILAGE, V22, P323, DOI 10.1016/j.joca.2013.12.011; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Hughes L C, 2005, Eur Cell Mater, V9, P68; Ichinose S, 2010, LAB INVEST, V90, P210, DOI 10.1038/labinvest.2009.125; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Katagiri H, 2013, BIOCHEM BIOPH RES CO, V435, P603, DOI 10.1016/j.bbrc.2013.05.026; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Lee SY, 2010, TISSUE ENG PT A, V16, P317, DOI [10.1089/ten.tea.2009.0104, 10.1089/ten.TEA.2009.0104]; Mandelbaum B, 2005, ORTHOPEDICS, V28, pS207; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Musumeci G, 2015, SCAND J MED SCI SPOR, V25, pe222, DOI 10.1111/sms.12290; Musumeci G, 2015, HISTOL HISTOPATHOL, V30, P1, DOI 10.14670/HH-30.1; Musumeci G, 2014, ACTA HISTOCHEM, V116, P1407, DOI 10.1016/j.acthis.2014.09.008; Musumeci G, 2014, HISTOL HISTOPATHOL, V29, P707, DOI 10.14670/HH-29.707; Musumeci G, 2013, J NUTR BIOCHEM, V24, P2064, DOI 10.1016/j.jnutbio.2013.07.007; Musumeci G, 2013, J BONE MINER METAB, V31, P274, DOI 10.1007/s00774-012-0414-9; Musumeci G, 2011, EXP BIOL MED, V236, P1333, DOI 10.1258/ebm.2011.011183; Nakagawa Y, 2015, OSTEOARTHR CARTILAGE, V23, P1007, DOI 10.1016/j.joca.2015.02.008; Nakagawa Y, 2016, J MAGN RESON IMAGING, V43, P434, DOI 10.1002/jmri.24988; Niikura T, 2007, ARTHRITIS RHEUM, V56, P2312, DOI 10.1002/art.22659; Ogawa H, 2014, GENE DEV, V28, P127, DOI 10.1101/gad.231969.113; Otabe K, 2015, J ORTHOP RES, V33, P1, DOI 10.1002/jor.22750; Pedersen DR, 2013, ORTHOP RES REV, V5, P13, DOI 10.2147/ORR.S38400; Rees SG, 2002, MATRIX BIOL, V21, P593, DOI 10.1016/S0945-053X(02)00056-2; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Ruan MZC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005409; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schubert T, 2009, INT J MOL MED, V23, P455, DOI 10.3892/ijmm_00000151; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; Sekiya I, 2015, CLIN ORTHOP RELAT R, V473, P2316, DOI 10.1007/s11999-015-4324-8; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; Su JL, 2001, HYBRIDOMA, V20, P149, DOI 10.1089/027245701750293475; Sun YL, 2006, CONNECT TISSUE RES, V47, P215, DOI 10.1080/03008200600846754; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Teeple E, 2008, J ORTHOP RES, V26, P231, DOI 10.1002/jor.20492; Teeple E, 2011, AM J SPORT MED, V39, P164, DOI 10.1177/0363546510378088; Tins BJ, 2005, RADIOLOGY, V234, P501, DOI 10.1148/radiol.2342031970; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Young AA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1898	59	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148777	10.1371/journal.pone.0148777	http://dx.doi.org/10.1371/journal.pone.0148777			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867127	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700036
J	Carlson, N; Hommel, K; Olesen, JB; Soja, AM; Vilsboll, T; Kamper, AL; Torp-Pedersen, C; Gislason, G				Carlson, Nicholas; Hommel, Kristine; Olesen, Jonas Bjerring; Soja, Anne-Merete; Vilsboll, Tina; Kamper, Anne-Lise; Torp-Pedersen, Christian; Gislason, Gunnar			Dialysis-Requiring Acute Kidney Injury in Denmark 2000-2012: Time Trends of Incidence and Prevalence of Risk Factors-A Nationwide Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; MORTALITY; POPULATION; OUTCOMES; REGISTRY; DISEASE; VALIDATION; MORBIDITY; VALIDITY	Introduction Dialysis-requiring acute kidney injury is a severe illness associated with poor prognosis. However, information pertaining to incidence rates and prevalence of risk factors remains limited in spite of increasing focus. We evaluate time trends of incidence rates and changing patterns in prevalence of comorbidities, concurrent medication, and other risk factors in nationwide retrospective cohort study. Materials and Methods All patients with dialysis-requiring acute kidney injury were identified between January 1st 2000 and December 31st 2012. By cross-referencing data from national administrative registries, the association of changing patterns in dialysis treatment, comorbidity, concurrent medication and demographics with incidence of dialysis-requiring acute kidney injury was evaluated. Results A total of 18,561 adult patients with dialysis-requiring AKI were identified between 2000 and 2012. Crude incidence rate of dialysis-requiring AKI increased from 143 per million (95% confidence interval, 137-144) in 2000 to 366 per million (357-375) in 2006, and remained stable hereafter. Notably, incidence of continuous veno-venous hemodialysis (CRRT) and use of acute renal replacement therapy in elderly >75 years increased substantially from 23 per million (20-26) and 328 per million (300-355) in 2000, to 213 per million (206-220) and 1124 per million (1076-1172) in 2012, respectively. Simultaneously, patient characteristics and demographics shifted towards increased age and comorbidity. Conclusions Although growth in crude incidence rate of dialysis-requiring AKI stabilized in 2006, continuous growth in use of CRRT, and acute renal replacement therapy of elderly patients >75 years, was observed. Our results indicate an underlying shift in clinical paradigm, as opposed to unadulterated growth in incidence of dialysis-requiring AKI.	[Carlson, Nicholas; Olesen, Jonas Bjerring; Gislason, Gunnar] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Gentofte, Denmark; [Carlson, Nicholas; Hommel, Kristine] Univ Copenhagen, Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark; [Soja, Anne-Merete] Univ Copenhagen, Hvidovre Hosp, Dept Cardiol, DK-2650 Hvidovre, Denmark; [Vilsboll, Tina] Univ Copenhagen, Gentofte Hosp, Ctr Diabet Res, Gentofte, Denmark; [Kamper, Anne-Lise] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Aalborg University	Carlson, N (corresponding author), Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Gentofte, Denmark.; Carlson, N (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark.	Nicholas.carlson@regionh.dk	Gislason, Gunnar/B-7561-2009; Vilsboll, Tina/I-6562-2016; Carlson, Nicholas/M-2666-2016	Gislason, Gunnar/0000-0002-0548-402X; Kamper, Anne-Lise/0000-0001-7523-6569; Carlson, Nicholas/0000-0002-4374-470X	Danish Heart Foundation; Danish Kidney Foundation; Department of Cardiology at Copenhagen University Hospital Gentofte; Department of Nephrology at Copenhagen University Hospital Herlev; Helen and Ejnar Bjoernows Foundation; Danish Society of Nephrology; Health Foundation; Novo Nordisk Foundation; Bristol-Myers Squibb; Boehringer Ingelheim; Lundbeck Foundation; Capital Region of Denmark; Novo Nordisk Fonden [NNF16OC0020224, NNF12OC1015904, NNF15OC0016230, NNF12OC1015957] Funding Source: researchfish	Danish Heart Foundation; Danish Kidney Foundation; Department of Cardiology at Copenhagen University Hospital Gentofte; Department of Nephrology at Copenhagen University Hospital Herlev; Helen and Ejnar Bjoernows Foundation; Danish Society of Nephrology; Health Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Lundbeck Foundation(Lundbeckfonden); Capital Region of Denmark; Novo Nordisk Fonden(Novo Nordisk Foundation)	NC: Grants received from The Danish Heart Foundation, The Danish Kidney Foundation, The Department of Cardiology at Copenhagen University Hospital Gentofte and the Department of Nephrology at Copenhagen University Hospital Herlev, Helen and Ejnar Bjoernows Foundation, The Danish Society of Nephrology and the Health Foundation. GG: Supported by an unrestricted clinical research scholarship from the Novo Nordisk Foundation. JO: Has received speaker fees and funding for research from Bristol-Myers Squibb and Boehringer Ingelheim, the Lundbeck Foundation, and The Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and no funding was specifically designated for this work.	Afshinnia F, 2009, RENAL FAILURE, V31, P647, DOI 10.3109/08860220903151401; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Blichert-Hansen Linea, 2013, Clin Epidemiol, V5, P9, DOI 10.2147/CLEP.S37763; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Fagugli RM, 2014, J NEPHROL; Gammelager H, 2013, CRIT CARE, V17, DOI 10.1186/cc12824; Grams ME, 2014, CLIN J AM SOC NEPHRO, V9, P682, DOI 10.2215/CJN.07650713; Hamel MB, 2005, J AM GERIATR SOC, V53, P424, DOI 10.1111/j.1532-5415.2005.53159.x; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu RK, 2013, CLIN J AM SOC NEPHRO, V8, P1476, DOI 10.2215/CJN.12611212; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; JURGENSEN HJ, 1986, METHOD INFORM MED, V25, P158; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Kearns B, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-49; Khera S, 2013, AM J CARDIOL, V112, P1279, DOI 10.1016/j.amjcard.2013.06.008; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kolhe NV, 2015, KIDNEY INT, V88, P1161, DOI 10.1038/ki.2015.234; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lenihan CR, 2013, ANN THORAC SURG, V95, P20, DOI 10.1016/j.athoracsur.2012.05.131; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Matuszkiewicz-Rowinska J, 2015, KIDNEY INT, V87, P1264, DOI 10.1038/ki.2015.61; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Rodrigues FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069998; Sakhuja A, 2015, AM J RESP CRIT CARE, V192, P951, DOI 10.1164/rccm.201502-0329OC; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Thakar CV, 2013, INT J NEPHROL, V2013, DOI [10.1155/2013/827459, DOI 10.1155/2013/827459]; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Toft P, 2000, Ugeskr Laeger, V162, P2868; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wald R, 2015, AM J KIDNEY DIS, V65, P870, DOI 10.1053/j.ajkd.2014.10.017; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wonnacott A, 2014, CLIN J AM SOC NEPHRO; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668	45	19	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148809	10.1371/journal.pone.0148809	http://dx.doi.org/10.1371/journal.pone.0148809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863015	Green Published, gold			2022-12-26	WOS:000370046600108
J	Cassel, R; Ducreux, S; Alam, MR; Dingreville, F; Berle, C; Burda-Jacob, K; Chauvin, A; Chikh, K; Paita, L; Al-Mawla, R; Da Silva, CC; Rieusset, J; Thivolet, C; Van Coppenolle, F; Madec, AM				Cassel, R.; Ducreux, S.; Alam, M. R.; Dingreville, F.; Berle, C.; Burda-Jacob, K.; Chauvin, A.; Chikh, K.; Paita, L.; Al-Mawla, R.; Da Silva, C. Crola; Rieusset, J.; Thivolet, C.; Van Coppenolle, F.; Madec, A. M.			Protection of Human Pancreatic Islets from Lipotoxicity by Modulation of the Translocon	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; BETA-CELL DYSFUNCTION; SATURATED FATTY-ACID; INSULIN-RESISTANCE; CALCIUM LEAK; ER STRESS; KAPPA-B; MECHANISMS; PALMITATE	Type 2 diabetes is characterized by peripheral insulin resistance and pancreatic beta cell dysfunction. Elevated free fatty acids (FFAs) may impair beta cell function and mass (lipotoxicity). Altered calcium homeostasis may be involved in defective insulin release. The endoplasmic reticulum (ER) is the major intracellular calcium store. Lipotoxicity induces ER stress and in parallel an ER calcium depletion through unknown ER calcium leak channels. The main purposes of this study is first to identify one of these channels and secondly, to check the opportunity to restore beta cells function (i.e., insulin secretion) after pharmacological inhibition of ER calcium store depletion. We investigated the functionality of translocon, an ER calcium leak channel and its involvement on FFAs-induced alterations in MIN6B1 cells and in human pancreatic islets. We evidenced that translocon acts as a functional ER calcium leak channel in human beta cells using anisomycin and puromycin (antibiotics), respectively blocker and opener of this channel. Puromycin induced a significant ER calcium release, inhibited by anisomycin pretreatment. Palmitate treatment was used as FFA model to induce a mild lipotoxic effect: ER calcium content was reduced, ER stress but not apoptosis were induced and glucose induced insulin secretion was decreased in our beta cells. Interestingly, translocon inhibition by chronic anisomycin treatment prevented dysfunctions induced by palmitate, avoiding reticular calcium depletion, ER stress and restoring insulin secretion. Our results provide for the first time compelling evidence that translocon actively participates to the palmitate-induced ER calcium leak and insulin secretion decrease in beta cells. Its inhibition reduces these lipotoxic effects. Taken together, our data indicate that TLC may be a new potential target for the treatment of type 2 diabetes.	[Cassel, R.; Dingreville, F.; Berle, C.; Burda-Jacob, K.; Chauvin, A.; Chikh, K.; Rieusset, J.; Thivolet, C.; Madec, A. M.] Univ Lyon 1, Fac Med Charles Merieux Lyon Sud, CarMeN Lab, INSA Lyon,INRA,Inserm,UMR U1060,U1235, F-69003 Lyon, France; [Ducreux, S.; Alam, M. R.; Paita, L.; Al-Mawla, R.; Da Silva, C. Crola; Van Coppenolle, F.] Univ Lyon 1, Fac Med Rockefeller, CarMeN Lab, INSA Lyon,INRA,Inserm,UMR U1060,U1235, F-69003 Lyon, France; [Thivolet, C.] Hop Lyon Sud, Hosp Civils Lyon, Serv Endocrinol Diabetol & Nutr, F-69310 Pierre Benite, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Madec, AM (corresponding author), Univ Lyon 1, Fac Med Charles Merieux Lyon Sud, CarMeN Lab, INSA Lyon,INRA,Inserm,UMR U1060,U1235, F-69003 Lyon, France.	anne-marie.coquelet-madec@univ-lyon1.fr	Rieusset, Jennifer/F-1595-2018; Carmen, Team2/Y-7383-2019; Carmen, Team1/Y-7382-2019; DUCREUX, SYLVIE/D-6257-2013; Alam, Muhammad Rizwan/AAE-2266-2019; Carmen, Team3/Y-7384-2019	Rieusset, Jennifer/0000-0002-1587-2253; Carmen, Team2/0000-0001-9867-5724; Carmen, Team1/0000-0003-4234-1746; DUCREUX, SYLVIE/0000-0003-3207-9537; Alam, Muhammad Rizwan/0000-0002-1578-5723; Carmen, Team3/0000-0002-3614-0924; BERGER, Marie-Agnes/0000-0003-4189-6029; Lab, Carmen/0000-0002-5935-3236; CHIKH, Karim/0000-0002-1217-4193	INSERM (Institut national de la sante et la recherche Medical) (FR); Universite Claude bernard Lyon1 (FR); JDRF award (ECIT Islet for Basic Research program) from the Geneva University Hospital [31-2008-413]	INSERM (Institut national de la sante et la recherche Medical) (FR); Universite Claude bernard Lyon1 (FR); JDRF award (ECIT Islet for Basic Research program) from the Geneva University Hospital	This work was supported by INSERM (Institut national de la sante et la recherche Medical) (FR) and Universite Claude bernard Lyon1 (FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Human islets were provided through the JDRF award 31-2008-413 (ECIT Islet for Basic Research program; T. Berney, D. Bosco) from the Geneva University Hospital. We thank the genomic platform (E. Meugnier, E. Loizon, S. Pesanti) from INSERM UMR-1060 CARMEN and A. Durand and C. Durand (INSERM UMR-1060) for technical assistance in cell culture. We thank Prof Dr. Roger Tsien (UCSD, San Diego, USA) for ER Ca2+ sensors. MIN6B1 cell line was provided by Dr. Jun-ichi Miyazaki, OUMS, Osaka, Japan [55].	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; [Anonymous], 2014, LANCET DIABETES ENDO; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Charles MA, 1997, DIABETOLOGIA, V40, P1101, DOI 10.1007/s001250050793; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Dey D, 2007, MOL CELL BIOCHEM, V300, P149, DOI 10.1007/s11010-006-9378-1; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Erdmann F, 2010, BIOCHEM BIOPH RES CO, V396, P714, DOI 10.1016/j.bbrc.2010.04.168; Flourakis M, 2006, FASEB J, V20, P1215, DOI 10.1096/fj.05-5254fje; Fonseca SG, 2001, TRENDS ENDOCRIN MET, V22, P266; Giaccia A, 2010, AM J PHYSIOL-ENDOC M, V200, pE255; Gilon P, 2014, CELL CALCIUM, V14, P136; Giunti R, 2007, ARCH BIOCHEM BIOPHYS, V462, P115, DOI 10.1016/j.abb.2007.03.039; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Hara T, 2014, ENDOCRINOLOGY, V155, P758, DOI 10.1210/en.2013-1519; Hommelberg PPH, 2009, AM J PHYSIOL-ENDOC M, V296, pE114, DOI 10.1152/ajpendo.00436.2007; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kaufman RJ, ANN REV BIOCH, V20, P767; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lloyd DJ, 2010, DIABETES, V59, P460, DOI 10.2337/db08-1362; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Madec AM, 2013, FASEB J, V27, P5122, DOI 10.1096/fj.13-234104; Martino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036188; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Paredes RM, 2013, CELL CALCIUM, V53, P286, DOI 10.1016/j.ceca.2013.01.002; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Swanton E, 2003, MOL MEMBR BIOL, V20, P99, DOI 10.1080/0968768031000069241; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433	54	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148686	10.1371/journal.pone.0148686	http://dx.doi.org/10.1371/journal.pone.0148686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862742	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600097
J	Motta, C; Palermo, E; Studer, V; Germanotta, M; Germani, G; Centonze, D; Cappa, P; Rossi, S; Rossi, S				Motta, Caterina; Palermo, Eduardo; Studer, Valeria; Germanotta, Marco; Germani, Giorgio; Centonze, Diego; Cappa, Paolo; Rossi, Silvia; Rossi, Stefano			Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis	PLOS ONE			English	Article							SCALE; IMPAIRMENT; IMPACT; MS	Background The available clinical outcome measures of disability in multiple sclerosis are not adequately responsive or sensitive. Objective To investigate the feasibility of inertial sensor-based gait analysis in multiple sclerosis. Methods A cross-sectional study of 80 multiple sclerosis patients and 50 healthy controls was performed. Lower-limb kinematics was evaluated by using a commercially available magnetic inertial measurement unit system. Mean and standard deviation of range of motion (mROM, sROM) for each joint of lower limbs were calculated in one minute walking test. A motor performance index (E) defined as the sum of sROMs was proposed. Results We established two novel observer-independent measures of disability. Hip mROM was extremely sensitive in measuring lower limb motor impairment, being correlated with muscle strength and also altered in patients without clinically detectable disability. On the other hand, E index discriminated patients according to disability, being altered only in patients with moderate and severe disability, regardless of walking speed. It was strongly correlated with fatigue and patient-perceived health status. Conclusions Inertial sensor-based gait analysis is feasible and can detect clinical and subclinical disability in multiple sclerosis.	[Motta, Caterina; Studer, Valeria; Germani, Giorgio; Centonze, Diego; Rossi, Silvia] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy; [Motta, Caterina; Centonze, Diego; Rossi, Silvia] IRCCS Ist Neurol Mediterraneo INM Neuromed, Pozzilli, Italy; [Palermo, Eduardo; Cappa, Paolo] Univ Roma La Sapienza, Dept Mech & Aerosp Engn, Rome, Italy; [Studer, Valeria; Germani, Giorgio] Fdn Santa Lucia, CERC, Rome, Italy; [Germanotta, Marco] Don Carlo Gnocchi Onlus Fdn, Milan, Italy; [Rossi, Silvia] IRCCS Fdn Carlo Besta Neurol Inst, Neuroimmunol & Neuromuscolar Dis Unit, Milan, Italy; [Rossi, Stefano] Univ Tuscia, Dept Econ & Management Ind Engn, Viterbo, Italy	University of Rome Tor Vergata; IRCCS Neuromed; Sapienza University Rome; IRCCS Santa Lucia; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Istituto Neurologico Besta; Tuscia University	Rossi, S (corresponding author), Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy.; Rossi, S (corresponding author), IRCCS Ist Neurol Mediterraneo INM Neuromed, Pozzilli, Italy.; Rossi, S (corresponding author), IRCCS Fdn Carlo Besta Neurol Inst, Neuroimmunol & Neuromuscolar Dis Unit, Milan, Italy.	silvia.rossi@istituto-besta.it	Centonze, Diego/J-7767-2016; Palermo, Eduardo/AAX-8426-2021; Rossi, Stefano/AAB-9111-2020; Germanotta, Marco/J-3893-2018; Motta, Caterina/L-1513-2018	Centonze, Diego/0000-0002-8390-8545; Palermo, Eduardo/0000-0002-3213-8261; Germanotta, Marco/0000-0002-0747-831X; studer, valeria/0000-0003-2529-7640; ROSSI, Stefano/0000-0003-0006-7013	Italian Institute of Technology (IIT)	Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT)	Part of this work was supported by a grant from the Italian Institute of Technology (IIT) - Project Seed ("ITINERE-Interactive Technology: an Instrumented Novel Exoskeleton for Rehabilitation" 2009).	Aminian K, 2004, COMPUT ANIMAT VIRT W, V15, P79, DOI 10.1002/cav.2; Behrens J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-89; Burschka JM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-161; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; McKenna SP, 2010, VALUE HEALTH, V13, P946, DOI 10.1111/j.1524-4733.2010.00767.x; Palermo E, 2014, PHYSIOL MEAS, V35, P399, DOI 10.1088/0967-3334/35/3/399; Palermo E, 2014, MEASUREMENT, V52, P145, DOI 10.1016/j.measurement.2014.03.004; Pearson OR, 2004, QJM-INT J MED, V97, P463, DOI 10.1093/qjmed/hch084; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Remelius JG, 2012, ARCH PHYS MED REHAB, V93, P1637, DOI 10.1016/j.apmr.2012.02.019; Rossi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073139; Sehle A, 2014, J NEUROL, V261, P1752, DOI 10.1007/s00415-014-7415-7; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Sosnoff JJ, 2011, GAIT POSTURE, V34, P145, DOI 10.1016/j.gaitpost.2011.03.020; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Tellez N, 2005, MULT SCLER J, V11, P198, DOI 10.1191/1352458505ms1148oa	22	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148997	10.1371/journal.pone.0148997	http://dx.doi.org/10.1371/journal.pone.0148997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863109	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600136
J	Park, J; Khloya, P; Seo, Y; Kumar, S; Lee, HK; Jeon, DK; Jo, S; Sharma, PK; Namkung, W				Park, Jinhong; Khloya, Poonam; Seo, Yohan; Kumar, Satish; Lee, Ho K.; Jeon, Dong-Kyu; Jo, Sungwoo; Sharma, Pawan K.; Namkung, Wan			Potentiation of Delta F508-and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CHLORIDE CHANNEL ACTIVATORS; SMALL-MOLECULE CORRECTORS; CYSTIC-FIBROSIS; IN-VITRO; CFTR POTENTIATOR; MUTATION; PROTEIN; CELLS; INHIBITORS	The most common mutation of CFTR, affecting approximately 90% of CF patients, is a deletion of phenylalanine at position 508 (F508del, Delta F508). Misfolding of Delta F508-CFTR impairs both its trafficking to the plasma membrane and its chloride channel activity. To identify small molecules that can restore channel activity of Delta F508-CFTR, we synthesized and evaluated eighteen novel hydroxypyrazoline analogues as CFTR potentiators. To elucidate potentiation activities of hydroxypyrazolines for Delta F508-CFTR, CFTR activity was measured using a halide-sensitive YFP assay, Ussing chamber assay and patch-clamp technique. Compounds 7p, 7q and 7r exhibited excellent potentiation with EC50 value < 10 mu M. Among the compounds, 7q (a novel CFTR potentiator, CP7q) showed the highest potentiation activity with EC50 values of 0.88 +/- 0.11 and 4.45 +/- 0.31 mu M for wild-type and Delta F508-CFTR, respectively. In addition, CP7q significantly potentiated chloride conductance of G551D-CFTR, a CFTR gating mutant; its maximal potentiation activity was 1.9 fold higher than the well-known CFTR potentiator genistein. Combination treatment with CP7q and VX-809, a corrector of Delta F508-CFTR, significantly enhanced functional rescue of Delta F508-CFTR compared with VX-809 alone. CP7q did not alter the cytosolic cAMP level and showed no cytotoxicity at the concentration showing maximum efficacy. The hydroxypyrazolines may be potential development candidates for drug therapy of cystic fibrosis.	[Park, Jinhong; Seo, Yohan; Jeon, Dong-Kyu; Jo, Sungwoo; Namkung, Wan] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon 406840, South Korea; [Park, Jinhong; Seo, Yohan; Lee, Ho K.; Namkung, Wan] Yonsei Univ, WCU Program Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea; [Khloya, Poonam; Kumar, Satish; Sharma, Pawan K.] Kurukshetra Univ, Dept Chem, Kurukshetra 136119, Haryana, India	Yonsei University; Yonsei University; Kurukshetra University	Namkung, W (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon 406840, South Korea.; Namkung, W (corresponding author), Yonsei Univ, WCU Program Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea.; Sharma, PK (corresponding author), Kurukshetra Univ, Dept Chem, Kurukshetra 136119, Haryana, India.	pksharma@kuk.ac.in; wnamkung@yonsei.ac.kr	서, 요한/AAZ-6433-2020; Sharma, Pawan K./AAQ-8877-2020	Sharma, Pawan K./0000-0001-6613-1634	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1040142]; Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [HI08C2149]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A1040142) and a grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (HI08C2149).	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Becq F, 2006, CURR PHARM DESIGN, V12, P471, DOI 10.2174/138161206775474459; Boinot C, 2014, J PHARMACOL EXP THER, V350, P624, DOI 10.1124/jpet.114.214890; Boumendjel A, 2008, J MED CHEM, V51, P2307, DOI 10.1021/jm0708331; Carlile GW, 2015, J CYST FIBROS, V14, P16, DOI 10.1016/j.jcf.2014.06.001; Chandak N, 2013, EUR J MED CHEM, V59, P203, DOI 10.1016/j.ejmech.2012.11.015; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davis PB, 2012, NAT REV DRUG DISCOV, V11, P349, DOI 10.1038/nrd3723; Favia M, 2014, AM J PHYSIOL-LUNG C, V307, pL48, DOI 10.1152/ajplung.00305.2013; French PJ, 1997, AM J PHYSIOL-CELL PH, V273, pC747, DOI 10.1152/ajpcell.1997.273.2.C747; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Huang CS, 1998, J NAT PROD, V61, P1283, DOI 10.1021/np980026s; Illek B, 1998, AM J PHYSIOL-LUNG C, V275, pL902, DOI 10.1152/ajplung.1998.275.5.L902; Illek B, 2000, AM J PHYSIOL-CELL PH, V279, pC1838, DOI 10.1152/ajpcell.2000.279.6.C1838; Khloya P, 2014, EUR J MED CHEM, V76, P284, DOI 10.1016/j.ejmech.2014.02.023; Knapp JM, 2012, J MED CHEM, V55, P1242, DOI 10.1021/jm201372q; Kumar S, 2012, BIOORGAN MED CHEM, V20, P4237, DOI 10.1016/j.bmc.2012.05.074; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Moran O, 2005, CELL MOL LIFE SCI, V62, P446, DOI 10.1007/s00018-004-4422-3; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Phuan PW, 2014, MOL PHARMACOL, V86, P42, DOI 10.1124/mol.114.092478; Pyle LC, 2011, AM J PHYSIOL-LUNG C, V301, pL587, DOI 10.1152/ajplung.00465.2010; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Robert R, 2008, MOL PHARMACOL, V73, P478, DOI 10.1124/mol.107.040725; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sharma PK, 2012, MED CHEM RES, V21, P2945, DOI 10.1007/s00044-011-9823-x; SOLIMAN R, 1979, J MED CHEM, V22, P321, DOI 10.1021/jm00189a022; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Weinreich F, 1997, PFLUG ARCH EUR J PHY, V434, P484, DOI 10.1007/s004240050424; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Wine JJ, 1995, CURR BIOL, V5, P1357, DOI 10.1016/S0960-9822(95)00269-7; Ye L, 2010, J MED CHEM, V53, P3772, DOI 10.1021/jm100235h; Yoon JH, 2000, ANN OTO RHINOL LARYN, V109, P594, DOI 10.1177/000348940010900612; Yu GJ, 2008, J MED CHEM, V51, P6044, DOI 10.1021/jm800533c; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149131	10.1371/journal.pone.0149131	http://dx.doi.org/10.1371/journal.pone.0149131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863533	Green Submitted, gold, Green Published			2022-12-26	WOS:000370046600158
J	Tung, H; Wei, SC; Lo, HR; Chao, YC				Tung, Hsuan; Wei, Sung-Chan; Lo, Huei-Ru; Chao, Yu-Chan			Baculovirus IE2 Stimulates the Expression of Heat Shock Proteins in Insect and Mammalian Cells to Facilitate Its Proper Functioning	PLOS ONE			English	Article							GENE-TRANSFER; DNA-REPLICATION; PROMOTER; HSP90; IDENTIFICATION; ACTIVATION; INDUCTION; APOPTOSIS; VECTOR; SITES	Baculoviruses have gained popularity as pest control agents and for protein production in insect systems. These viruses are also becoming popular for gene expression, tissue engineering and gene therapy in mammalian systems. Baculovirus infection triggers a heat shock response, and this response is crucial for its successful infection of host insect cells. However, the viral protein(s) or factor(s) that trigger this response are not yet clear. Previously, we revealed that IE2-an early gene product of the baculovirus-could form unique nuclear bodies for the strong trans-activation of various promoters in mammalian cells. Here, we purified IE2 nuclear bodies from Vero E6 cells and investigated the associated proteins by using mass spectrometry. Heat shock proteins (HSPs) were found to be one of the major IE2-associated proteins. Our experiments show that HSPs are greatly induced by IE2 and are crucial for the trans-activation function of IE2. Interestingly, blocking both heat shock protein expression and the proteasome pathway preserved the IE2 protein and its nuclear body structure, and revived its function. These observations reveal that HSPs do not function directly to assist the formation of the nuclear body structure, but may rather protect IE2 from proteasome degradation. Aside from functional studies in mammalian cells, we also show that HSPs were stimulated and required to determine IE2 protein levels, in insect cells infected with baculovirus. Upon inhibiting the expression of heat shock proteins, baculovirus IE2 was substantially suppressed, resulting in a significantly suppressed viral titer. Thus, we demonstrate a unique feature in that IE2 can function in both insect and non-host mammalian cells to stimulate HSPs, which may be associated with IE2 stabilization and lead to the protection of the its strong gene activation function in mammalian cells. On the other hand, during viral infection in insect cells, IE2 could also strongly stimulate HSPs and ultimately affect viral replication.	[Tung, Hsuan; Chao, Yu-Chan] Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci, Taipei 115, Taiwan; [Tung, Hsuan; Chao, Yu-Chan] Natl Chung Hsing Univ, Taichung 40227, Taiwan; [Tung, Hsuan; Wei, Sung-Chan; Lo, Huei-Ru; Chao, Yu-Chan] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Tung, Hsuan] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Wei, Sung-Chan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chao, Yu-Chan] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; National Defense Medical Center; National Chung Hsing University	Chao, YC (corresponding author), Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci, Taipei 115, Taiwan.; Chao, YC (corresponding author), Natl Chung Hsing Univ, Taichung 40227, Taiwan.; Chao, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.; Chao, YC (corresponding author), Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan.	mbycchao@gate.sinica.edu.tw	Chao, Yu-Chan/ABF-6571-2021	Chao, Yu-Chan/0000-0002-9528-8806	MOST from the Ministry of Science and Technology [104-2321-B-001-040, 103-2325-B-001-030-CC2, 103-2811-B-001-141, 104-2811-B-001-112]; Academia Sinica, Taiwan [022361]	MOST from the Ministry of Science and Technology; Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This research was funded by grants MOST 104-2321-B-001-040, 103-2325-B-001-030-CC2, 103-2811-B-001-141, and 104-2811-B-001-112 from the Ministry of Science and Technology, and by grant 022361 from Academia Sinica, Taiwan.	Airenne KJ, 2013, MOL THER, V21, P739, DOI 10.1038/mt.2012.286; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Barford D, 2013, CURR OPIN STRUC BIOL, V23, P357, DOI 10.1016/j.sbi.2013.03.009; Bastian TW, 2010, J VIROL, V84, P2384, DOI 10.1128/JVI.01686-09; Boyce FM, 1996, P NATL ACAD SCI USA, V93, P2348, DOI 10.1073/pnas.93.6.2348; Breitenbach JE, 2013, ARCH VIROL, V158, P1517, DOI 10.1007/s00705-013-1640-8; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Burch AD, 2004, J VIROL, V78, P7175, DOI 10.1128/JVI.78.13.7175-7185.2004; CARSON DD, 1988, VIROLOGY, V162, P444, DOI 10.1016/0042-6822(88)90485-0; Cox MMJ, 2011, J INVERTEBR PATHOL, V107, pS31, DOI 10.1016/j.jip.2011.05.003; Crouch EA, 2005, ARCH VIROL, V150, P1563, DOI 10.1007/s00705-005-0527-8; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; Elia G, 1999, EUR J BIOCHEM, V264, P736, DOI 10.1046/j.1432-1327.1999.00610.x; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Imai N, 2000, ACTA VIROL, V44, P199; Imai N, 2005, J GEN VIROL, V86, P637, DOI 10.1099/vir.0.80523-0; Katsuma S, 2011, J GEN VIROL, V92, P699, DOI 10.1099/vir.0.027573-0; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001491; Lin CY, 2010, CURR GENE THER, V10, P242, DOI 10.2174/156652310791321242; Liu CYY, 2010, CURR GENE THER, V10, P232; Liu CYY, 2009, J VIROL, V83, P3604, DOI 10.1128/JVI.01778-08; Livingston CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000619; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Lyupina YV, 2011, VIROLOGY, V421, P34, DOI 10.1016/j.virol.2011.09.010; Lyupina YV, 2010, VIROLOGY, V406, P336, DOI 10.1016/j.virol.2010.07.039; Mainz D, 2002, J VIROL, V76, P5198, DOI 10.1128/JVI.76.10.5198-5207.2002; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Manwell LA, 2007, COMP BIOCHEM PHYS A, V148, P521, DOI 10.1016/j.cbpa.2007.06.422; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Mena JA, 2011, EXPERT REV VACCINES, V10, P1063, DOI [10.1586/ERV.11.24, 10.1586/erv.11.24]; Monteiro F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00391; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; OReilly DR, 1994, BACULOVIRUS EXPRESSI, Vxiii; PASSARELLI AL, 1993, J VIROL, V67, P2149, DOI 10.1128/JVI.67.4.2149-2158.1993; RODEMS SM, 1995, J VIROL, V69, P5368, DOI 10.1128/JVI.69.9.5368-5375.1995; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Sahin E, 2011, INT J HYPERTHER, V27, P63, DOI 10.3109/02656736.2010.528139; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Schultz KLW, 2009, J VIROL, V83, P262, DOI 10.1128/JVI.01827-08; Shippam-Brett CE, 2001, VIRUS RES, V75, P13, DOI 10.1016/S0168-1702(00)00253-7; Stewart TM, 2005, J VIROL, V79, P4619, DOI 10.1128/JVI.79.8.4619-4629.2005; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Svensson RU, 2007, CANCER RES, V67, P10445, DOI 10.1158/0008-5472.CAN-07-1955; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001; Wang X, 2010, BIOSYSTEMS, V100, P31, DOI 10.1016/j.biosystems.2009.12.005; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wu CP, 2008, VIRUS RES, V138, P7, DOI 10.1016/j.virusres.2008.07.026; Wu YL, 2008, VIRUS RES, V135, P247, DOI 10.1016/j.virusres.2008.04.001; Wu YL, 2011, J VIROL, V85, P6856, DOI 10.1128/JVI.01843-10; Xiao A, 2010, ARCH VIROL, V155, P1021, DOI 10.1007/s00705-010-0691-3; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Yokota S, 2000, CANCER RES, V60, P2942; YOO SH, 1994, VIROLOGY, V202, P746, DOI 10.1006/viro.1994.1396; YOO SH, 1994, VIROLOGY, V202, P164, DOI 10.1006/viro.1994.1332; Zhang L, 2011, CELL CYCLE, V10, P3515, DOI 10.4161/cc.10.20.17789	63	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148578	10.1371/journal.pone.0148578	http://dx.doi.org/10.1371/journal.pone.0148578			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863132	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600082
J	Ntiri, ES; Calatayud, PA; Van den Berg, J; Schulthess, F; Le Ru, BP				Ntiri, Eric Siaw; Calatayud, Paul-Andre; Van den Berg, Johnnie; Schulthess, Fritz; Le Ru, Bruno Pierre			Influence of Temperature on Intra- and Interspecific Resource Utilization within a Community of Lepidopteran Maize Stemborers	PLOS ONE			English	Article							ELDANA-SACCHARINA LEPIDOPTERA; PARTELLUS SWINHOE LEPIDOPTERA; BUSSEOLA-FUSCA LEPIDOPTERA; STEM-BORERS; CHILO-PARTELLUS; CLIMATE-CHANGE; HOST PLANTS; DEPENDENT COMPETITION; PHYTOPHAGOUS INSECTS; SPECIES INTERACTIONS	Competition or facilitation characterises intra-and interspecific interactions within communities of species that utilize the same resources. Temperature is an important factor influencing those interactions and eventual outcomes. The noctuid stemborers, Busseola fusca and Sesamia calamistis and the crambid Chilo partellus attack maize in sub-Saharan Africa. They often occur as a community of interacting species in the same field and plant at all elevations. The influence of temperature on the intra-and interspecific interactions among larvae of these species, was studied using potted maize plants exposed to varying temperatures in a greenhouse and artificial stems kept at different constant temperatures (15 degrees C, 20 degrees C, 25 degrees C and 30 degrees C) in an incubator. The experiments involved single-and multispecies infestation treatments. Survival and relative growth rates of each species were assessed. Both intra-and interspecific competitions were observed among all three species. Interspecific competition was stronger between the noctuids and the crambid than between the two noctuids. Temperature affected both survival and relative growth rates of the three species. Particularly at high temperatures, C. partellus was superior in interspecific interactions shown by higher larval survival and relative growth rates. In contrast, low temperatures favoured survival of B. fusca and S. calamistis but affected the relative growth rates of all three species. Survival and relative growth rates of B. fusca and S. calamistis in interspecific interactions did not differ significantly across temperatures. Temperature increase caused by future climate change is likely to confer an advantage on C. partellus over the noctuids in the utilization of resources (crops).	[Ntiri, Eric Siaw; Calatayud, Paul-Andre; Le Ru, Bruno Pierre] Int Ctr Insect Physiol & Ecol, POB 30772, Nairobi, Kenya; [Ntiri, Eric Siaw; Van den Berg, Johnnie] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Calatayud, Paul-Andre; Le Ru, Bruno Pierre] CNRS, UMR 247, IRD, Lab Evolut Genomes Comportement & Ecol Diversite, Gif Sur Yvette, France; [Calatayud, Paul-Andre; Le Ru, Bruno Pierre] Univ Paris 11, Orsay, France; [Schulthess, Fritz] 4 Postfach 508, Chur, Switzerland	International Centre of Insect Physiology & Ecology (ICIPE); North West University - South Africa; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Ntiri, ES (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772, Nairobi, Kenya.; Ntiri, ES (corresponding author), North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa.	ensiaw@gmail.com	Paul-André, Calatayud/K-3282-2019; Van den Berg, Johnnie/M-7256-2013; Calatayud, Paul-andre/AAG-8117-2020; Le Ru, bruno/K-3480-2016; Ntiri, Eric Siaw/AFO-6189-2022; LE RU, BRUNO/C-5862-2011	Van den Berg, Johnnie/0000-0002-6831-3180; Calatayud, Paul-andre/0000-0002-9482-4646; Le Ru, bruno/0000-0002-4208-3727; Ntiri, Eric Siaw/0000-0002-8598-1201; 	Swedish International Development Cooperation Agency through the CAPACITY BUILDING FOR SCIENCE EDUCATION AND RESEARCH COOPERATION IN AFRICA (CB-SERCA) PROJECT of the CB & ID Programme of icipe [75000529]; Ministry of Foreign Affairs of Finland through the Climate Change Impacts of Ecosystem Services and Food Security in Eastern Africa (CHIESA) project	Swedish International Development Cooperation Agency through the CAPACITY BUILDING FOR SCIENCE EDUCATION AND RESEARCH COOPERATION IN AFRICA (CB-SERCA) PROJECT of the CB & ID Programme of icipe; Ministry of Foreign Affairs of Finland through the Climate Change Impacts of Ecosystem Services and Food Security in Eastern Africa (CHIESA) project	This work was supported by the Swedish International Development Cooperation Agency [Contribution no. 75000529] through the CAPACITY BUILDING FOR SCIENCE EDUCATION AND RESEARCH COOPERATION IN AFRICA (CB-SERCA) PROJECT of the CB & ID Programme of icipe. It was also supported by the Ministry of Foreign Affairs of Finland sponsorship through the Climate Change Impacts of Ecosystem Services and Food Security in Eastern Africa (CHIESA) project.	Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; Agrawal AA, 2005, ENTOMOL EXP APPL, V115, P97, DOI 10.1111/j.1570-7458.2005.00294.x; Alexandrou MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1745; Applebaum SW, 1999, ANNU REV ENTOMOL, V44, P317, DOI 10.1146/annurev.ento.44.1.317; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BERGER A, 1989, ENTOMOL EXP APPL, V50, P125, DOI 10.1007/BF00365396; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Bezemer TM, 1998, OECOLOGIA, V116, P128, DOI 10.1007/s004420050571; Breeuwer A, 2008, OECOLOGIA, V156, P155, DOI 10.1007/s00442-008-0963-8; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; CAMMELL ME, 1992, ADV ECOL RES, V22, P117, DOI 10.1016/S0065-2504(08)60135-X; Carmona-Catot G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054734; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Craig TP, 2000, ECOL ENTOMOL, V25, P7, DOI 10.1046/j.1365-2311.2000.00226.x; Damos Petros, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/123405; Dangles O, 2008, ECOL APPL, V18, P1795, DOI 10.1890/07-1638.1; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gounou S, 2004, AFR ENTOMOL, V12, P171; Guofa Zhou, 2001, Insect Science and its Application, V21, P395; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; INBAR M, 1995, ECOLOGY, V76, P1506, DOI 10.2307/1938152; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Jiang L, 2004, J ANIM ECOL, V73, P569, DOI 10.1111/j.0021-8790.2004.00830.x; Jiang NQ, 2006, ANN SOC ENTOMOL FR, V42, P381, DOI 10.1080/00379271.2006.10697470; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; KARBAN R, 1986, ECOLOGY, V67, P1063, DOI 10.2307/1939829; KAUFMANN T, 1983, J GEORGIA ENTOMOL SO, V18, P259; Kfir R, 1997, ANN ENTOMOL SOC AM, V90, P619, DOI 10.1093/aesa/90.5.619; Kfir R, 2002, ANNU REV ENTOMOL, V47, P701, DOI 10.1146/annurev.ento.47.091201.145254; Khadioli N, 2014, ANN APPL BIOL, V165, P373, DOI 10.1111/aab.12157; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Krueger W., 2008, South African Journal of Plant and Soil, V25, P144; Kutywayo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073432; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Laws AN, 2010, ENVIRON ENTOMOL, V39, P312, DOI 10.1603/EN09294; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Masters GJ, 1998, ECOL ENTOMOL, V23, P45, DOI 10.1046/j.1365-2311.1998.00109.x; Matama-Kauma T., 2001, Insect Science and its Application, V21, P317; Moya-Larano J, 2007, BIOLOGY LETT, V3, P475, DOI 10.1098/rsbl.2007.0300; Ndemah R, 2003, ENVIRON ENTOMOL, V32, P51, DOI 10.1603/0046-225X-32.1.51; Nooten SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085987; Ofomata VC, 2000, ANN ENTOMOL SOC AM, V93, P492, DOI 10.1603/0013-8746(2000)093[0492:CSOTFE]2.0.CO;2; Ofomata VC, 1999, ENTOMOL EXP APPL, V93, P141, DOI 10.1023/A:1003844318375; Ojeda-Avila T, 2003, J INSECT PHYSIOL, V49, P293, DOI 10.1016/S0022-1910(03)00003-9; Ong'amo GO, 2006, ANN SOC ENTOMOL FR, V42, P363, DOI 10.1080/00379271.2006.10697468; Ong'amo GO, 2006, ANN SOC ENTOMOL FR, V42, P171, DOI 10.1080/00379271.2006.10700620; ONYANGO FO, 1994, ENTOMOL EXP APPL, V73, P139, DOI 10.1007/BF02383419; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pascual S, 2004, B ENTOMOL RES, V94, P369, DOI 10.1079/BER2003307; R Development Team, 2014, R LANG ENV STAT COMP; Ranum P, 2014, ANN NY ACAD SCI, V1312, P105, DOI 10.1111/nyas.12396; Rebe M, 2004, AFR ENTOMOL, V12, P187; Rensburg J. B. J. van, 1987, South African Journal of Plant and Soil, V4, P183; Rwomushana I, 2009, ENTOMOL EXP APPL, V133, P27, DOI 10.1111/j.1570-7458.2009.00897.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Scherber C, 2013, ECOL EVOL, V3, P1449, DOI 10.1002/ece3.564; Schoonhoven L. M., 2005, Insect-plant biology; Seshu Reddy K. V., 1998, P25; SHANOWER TG, 1993, B ENTOMOL RES, V83, P237, DOI 10.1017/S0007485300034726; Shiojiri K, 2002, ECOL LETT, V5, P186, DOI 10.1046/j.1461-0248.2002.00292.x; Speight M.R., 2008, ECOLOGY INSECTS CONC, V2nd ed.; Sporleder M, 2004, ENVIRON ENTOMOL, V33, P477, DOI 10.1603/0046-225X-33.3.477; STILING PD, 1983, ECOLOGY, V64, P770, DOI 10.2307/1937200; Stokes K, 2015, ENTOMOL EXP APPL, V154, P23, DOI 10.1111/eea.12251; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tadele Tefera, 2004, Tropical Science, V44, P128, DOI 10.1002/ts.153; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Taniguchi Y, 2000, ECOLOGY, V81, P2027, DOI 10.2307/177290; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; VANDENBERG J, 1991, B ENTOMOL RES, V81, P137, DOI 10.1017/S0007485300051191; Venail PA, 2014, J ECOL, V102, P1288, DOI 10.1111/1365-2745.12271; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Wang HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098761; WILSON DS, 1984, ECOL ENTOMOL, V9, P205, DOI 10.1111/j.1365-2311.1984.tb00716.x; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]; Zilli A, 2005, NOCTUIDAE EUROPAEAE, V8	86	25	26	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148735	10.1371/journal.pone.0148735	http://dx.doi.org/10.1371/journal.pone.0148735			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859748	gold, Green Published			2022-12-26	WOS:000370038400071
J	Phang, CW; Karsani, SA; Sethi, G; Abd Malek, SN				Phang, Chung-Weng; Karsani, Saiful Anuar; Sethi, Gautam; Abd Malek, Sri Nurestri			Flavokawain C Inhibits Cell Cycle and Promotes Apoptosis, Associated with Endoplasmic Reticulum Stress and Regulation of MAPKs and Akt Signaling Pathways in HCT 116 Human Colon Carcinoma Cells	PLOS ONE			English	Article							ANTIOXIDATIVE ACTIVITY; PIPER-METHYSTICUM; MAMMALIAN-CELLS; CASPASE CASCADE; CANCER-THERAPY; TUMOR-GROWTH; DEATH; MITOCHONDRIA; ACTIVATION; PROTEIN	Flavokawain C (FKC) is a naturally occurring chalcone which can be found in Kava (Piper methysticum Forst) root. The present study evaluated the effect of FKC on the growth of various human cancer cell lines and the underlying associated mechanisms. FKC showed higher cytotoxic activity against HCT 116 cells in a time- and dose-dependent manner in comparison to other cell lines (MCF-7, HT-29, A549 and CaSki), with minimal toxicity on normal human colon cells. The apoptosis-inducing capability of FKC on HCT 116 cells was evidenced by cell shrinkage, chromatin condensation, DNA fragmentation and increased phosphatidylserine externalization. FKC was found to disrupt mitochondrial membrane potential, resulting in the release of Smac/DIABLO, AIF and cytochrome c into the cytoplasm. Our results also revealed that FKC induced intrinsic and extrinsic apoptosis via upregulation of the levels of pro-apoptotic proteins (Bak) and death receptors (DR5), while downregulation of the levels of anti-apoptotic proteins (XIAP, cIAP-1, c-FlipL, Bcl-xL and survivin), resulting in the activation of caspase-3, -8 and -9 and cleavage of poly(ADPribose) polymerase (PARP). FKC was also found to cause endoplasmic reticulum (ER) stress, as suggested by the elevation of GADD153 protein after FKC treatment. After the cells were exposed to FKC (60 mu M) over 18hrs, there was a substantial increase in the phosphorylation of ERK 1/2. The expression of phosphorylated Akt was also reduced. FKC also caused cell cycle arrest in the S phase in HCT 116 cells in a time- and dose-dependent manner and with accumulation of cells in the sub-G1 phase. This was accompanied by the downregulation of cyclin-dependent kinases (CDK2 and CDK4), consistent with the upregulation of CDK inhibitors (p21(Cip1) and p27(Kip1)), and hypophosphorylation of Rb.	[Phang, Chung-Weng; Karsani, Saiful Anuar; Abd Malek, Sri Nurestri] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore	Universiti Malaya; National University of Singapore	Abd Malek, SN (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	srimalek@um.edu.my	Phang, Chung Weng/AAK-6217-2020; Malek, Sri Nurestri/W-8556-2019; Malek, Sri Nurestri Abd/B-9834-2010; SA, karsani/B-9667-2010; Sethi, Gautam/F-2372-2011	Malek, Sri Nurestri/0000-0001-6278-8559; Malek, Sri Nurestri Abd/0000-0001-6278-8559; SA, karsani/0000-0003-1617-9554; Sethi, Gautam/0000-0002-8677-8475	High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MoE/SC/02]	High Impact Research MoE Grant from the Ministry of Education Malaysia	This research is supported by High Impact Research MoE Grant UM.C/625/1/HIR/MoE/SC/02 from the Ministry of Education Malaysia. This grant was awarded to SNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu N, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-102; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Aizat AAA, 2011, ASIAN PAC J CANCER P, V12, P2909; Berthelet Jean, 2013, Cells, V2, P163, DOI 10.3390/cells2010163; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chen SP, 2006, VIROLOGY, V347, P379, DOI 10.1016/j.virol.2005.11.052; Cote CS, 2004, BIOCHEM BIOPH RES CO, V322, P147, DOI 10.1016/j.bbrc.2004.07.093; Darzynkiewicz Z, 2008, METHODS, V44, P250, DOI 10.1016/j.ymeth.2007.11.008; Dharmaratne HRW, 2002, PHYTOCHEMISTRY, V59, P429; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Guicciardi ME, 2011, EXP CELL RES, V317, P107, DOI 10.1016/j.yexcr.2010.10.005; Han CR, 2012, BIOORG MED CHEM LETT, V22, P945, DOI 10.1016/j.bmcl.2011.12.023; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Ho YF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/857257; Houghton P, 2007, METHODS, V42, P377, DOI 10.1016/j.ymeth.2007.01.003; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Itoh N, 2002, CANCER, V94, P3127, DOI 10.1002/cncr.10591; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jin HR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.169; Johnson ME, 2004, VET PATHOL, V41, P599, DOI 10.1354/vp.41-6-599; Johnson TL, 2010, EVID-BASED COMPL ALT, V7, P351, DOI 10.1093/ecam/nen011; Karmakar S, 2007, APOPTOSIS, V12, P671, DOI 10.1007/s10495-006-0024-x; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Klamt F, 2005, J BIOL CHEM, V280, P21346, DOI 10.1074/jbc.M501170200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Kuo YF, 2010, FREE RADICAL BIO MED, V49, P214, DOI 10.1016/j.freeradbiomed.2010.04.005; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Lenferink AEG, 2001, CANCER RES, V61, P6583; Li N, 2008, J AGR FOOD CHEM, V56, P3876, DOI 10.1021/jf073520n; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin FM, 2008, CANCER RES, V68, P6634, DOI 10.1158/0008-5472.CAN-08-0635; Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017; Majors BS, 2007, METAB ENG, V9, P317, DOI 10.1016/j.ymben.2007.05.003; Malek NA, 2011, MOLECULES, V16, P583, DOI 10.3390/molecules16010583; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Ng SC, 2013, BRIT MED BULL, V105, P29, DOI 10.1093/bmb/lds040; Novak B, 2003, BIOCHEM SOC T, V31, P1526; Parrish AB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008672; Puteh SEW, 2013, ASIA-PAC PSYCHIAT, V5, P110, DOI 10.1111/appy.12055; Rahman SNSA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/257108; Selimovic D, 2011, CARCINOGENESIS, V32, P1268, DOI 10.1093/carcin/bgr112; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tamm I, 2001, LANCET ONCOL, V2, P33, DOI 10.1016/S1470-2045(00)00193-5; Tzifi Flora, 2012, Adv Hematol, V2012, P524308, DOI 10.1155/2012/524308; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vogel S, 2008, BIOORGAN MED CHEM, V16, P4286, DOI 10.1016/j.bmc.2008.02.079; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Weiss J, 2005, DRUG METAB DISPOS, V33, P1580, DOI 10.1124/dmd.105.005892; Whitton PA, 2003, PHYTOCHEMISTRY, V64, P673, DOI 10.1016/S0031-9422(03)00381-9; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Xu Y, 2014, MOL CLIN ONCOL, V2, P3, DOI 10.3892/mco.2013.202; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zeestraten Eliane C M, 2013, Biomark Cancer, V5, P13, DOI 10.4137/BIC.S11475; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zi XL, 2005, CANCER RES, V65, P3479, DOI 10.1158/0008-5472.CAN-04-3803	65	30	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148775	10.1371/journal.pone.0148775	http://dx.doi.org/10.1371/journal.pone.0148775			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859847	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400081
J	Nawaz, MS; Giarda, E; Bedogni, F; La Montanara, P; Ricciardi, S; Ciceri, D; Alberio, T; Landsberger, N; Rusconi, L; Kilstrup-Nielsen, C				Nawaz, Mohammad Sarfaraz; Giarda, Elisa; Bedogni, Francesco; La Montanara, Paolo; Ricciardi, Sara; Ciceri, Dalila; Alberio, Tiziana; Landsberger, Nicoletta; Rusconi, Laura; Kilstrup-Nielsen, Charlotte			CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization	PLOS ONE			English	Article							AXON OUTGROWTH; RETT-SYNDROME; KINASE; POLARITY; SIGNAL; GENE	In the last years, the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene has been associated with epileptic encephalopathies characterized by the early onset of intractable epilepsy, severe developmental delay, autistic features, and often the development of Rett syndrome-like features. Still, the role of CDKL5 in neuronal functions is not fully understood. By way of a yeast two hybrid screening we identified the interaction of CDKL5 with shootin1, a brain specific protein acting as a determinant of axon formation during neuronal polarization. We found evidence that CDKL5 is involved, at least in part, in regulating neuronal polarization through its interaction with shootin1. Indeed, the two proteins interact in vivo and both are localized in the distal tip of outgrowing axons. By using primary hippocampal neurons as model system we find that adequate CDKL5 levels are required for axon specification. In fact, a significant number of neurons overexpressing CDKL5 is characterized by supernumerary axons, while the silencing of CDKL5 disrupts neuronal polarization. Interestingly, shootin1 phosphorylation is reduced in neurons silenced for CDKL5 suggesting that the kinase affects, directly or indirectly, the post-translational modification of shootin1. Finally, we find that the capacity of CDKL5 to generate surplus axons is attenuated in neurons with reduced shootin1 levels, in agreement with the notion that two proteins act in a common pathway. Altogether, these results point to a role of CDKL5 in the early steps of neuronal differentiation that can be explained, at least in part, by its association with shootin1.	[Nawaz, Mohammad Sarfaraz; Giarda, Elisa; La Montanara, Paolo; Ciceri, Dalila; Rusconi, Laura; Kilstrup-Nielsen, Charlotte] Univ Insubria, Dept Biotechnol & Life Sci, Ctr Neurosci, Lab Genet & Epigenet Control Gene Express, I-21052 Busto Arsizio, Italy; [Bedogni, Francesco; Landsberger, Nicoletta] San Raffaele Sci Insitute, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy; [Ricciardi, Sara] Fdn Ist Nazl Genet Mol INGM, Mol Histol & Cell Growth Unit, I-20122 Milan, Italy; [Alberio, Tiziana] Univ Insubria, Dept Sci & High Technol, Ctr Neurosci, Lab Biochem & Funct Prote, I-21052 Busto Arsizio, Italy; [Landsberger, Nicoletta] Univ Milan, Dept Med Biotechnol & Translat Medicin, I-20090 Segrate, Italy	University of Insubria; University of Insubria; University of Milan	Rusconi, L; Kilstrup-Nielsen, C (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Ctr Neurosci, Lab Genet & Epigenet Control Gene Express, I-21052 Busto Arsizio, Italy.	laura.rusconi@uninsubria.it; c.kilstrup-nielsen@uninsubria.it	Ciceri, Dalila/K-9766-2017; Ricciardi, Sara/I-6308-2018; Alberio, Tiziana/I-5398-2018	Ricciardi, Sara/0000-0001-8124-432X; Alberio, Tiziana/0000-0002-6065-6699; Landsberger, Nicoletta/0000-0003-0820-3155; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; bedogni, francesco/0000-0002-6651-0041; Ciceri, Dalila/0000-0003-4688-406X; La Montanara, Paolo/0000-0002-5146-9269	Telethon Foundation [GGP10032]; Ministero della Salute Foundation; Cariplo Foundation [2010-0724]; EU Initial Training Network program [238242]; Jerome Lejeune Foundation; Italian parents' association L'Albero di Greta; Italian parents' association ProRett Ricerca	Telethon Foundation(Fondazione Telethon); Ministero della Salute Foundation; Cariplo Foundation(Fondazione Cariplo); EU Initial Training Network program; Jerome Lejeune Foundation; Italian parents' association L'Albero di Greta; Italian parents' association ProRett Ricerca	This work was supported by Telethon (GGP10032), Ministero della Salute (Ricerca finalizzata 2008 - Bando Malattie Rare) and Cariplo (2010-0724) Foundations (to NL) and by the EU Initial Training Network program (no. 238242 "DisChrom") and the Jerome Lejeune Foundation (to CKN), and the Italian parents' associations L'Albero di Greta and ProRett Ricerca.	Amendola E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091613; Baj G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00018; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Cheng PL, 2012, ANNU REV NEUROSCI, V35, P181, DOI 10.1146/annurev-neuro-061010-113618; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Fehr S, 2013, EUR J HUM GENET, V21, P266, DOI 10.1038/ejhg.2012.156; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fuchs C, 2014, NEUROBIOL DIS, V70, P53, DOI 10.1016/j.nbd.2014.06.006; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Kilstrup-Nielsen C, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/728267; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Rusconi L, 2011, J BIOL CHEM, V286, P36550, DOI 10.1074/jbc.M111.235630; Sapir T, 2013, J NEUROSCI, V33, P11932, DOI 10.1523/JNEUROSCI.5425-12.2013; Shimada T, 2008, J CELL BIOL, V181, P817, DOI 10.1083/jcb.200712138; Szafranski P, 2014, EUR J HUM GENET, P217; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Toriyama M, 2013, CURR BIOL, V23, P529, DOI 10.1016/j.cub.2013.02.017; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Williamson SL, 2012, HUM GENET, V131, P187, DOI 10.1007/s00439-011-1058-x; Zhu YC, 2013, P NATL ACAD SCI USA, V110, P9118, DOI 10.1073/pnas.1300003110	29	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148634	10.1371/journal.pone.0148634	http://dx.doi.org/10.1371/journal.pone.0148634			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849555	Green Published, Green Accepted, gold			2022-12-26	WOS:000369554000143
J	Rapp, AE; Bindl, R; Recknagel, S; Erbacher, A; Muller, I; Schrezenmeier, H; Ehrnthaller, C; Gebhard, F; Ignatius, A				Rapp, Anna E.; Bindl, Ronny; Recknagel, Stefan; Erbacher, Annika; Mueller, Ingo; Schrezenmeier, Hubert; Ehrnthaller, Christian; Gebhard, Florian; Ignatius, Anita			Fracture Healing Is Delayed in Immunodeficient NOD/scid-IL2R gamma(null)(c) Mice	PLOS ONE			English	Article							CELL-DEVELOPMENT; GAMMA-CHAIN; BONE; INFLAMMATION; OSTEOIMMUNOLOGY; INTERLEUKIN-15; MACROPHAGES; CYTOKINES; HEMATOMA; CALLUS	Following bone fracture, the repair process starts with an inflammatory reaction at the fracture site. Fracture healing is disturbed when the initial inflammation is increased or prolonged, whereby, a balanced inflammatory response is anticipated to be crucial for fracture healing, because it may induce down-stream responses leading to tissue repair. However, the impact of the immune response on fracture healing remains poorly understood. Here, we investigated bone healing in NOD/scid-IL2R gamma(null)(c) mice, which exhibit severe defects in innate and adaptive immunity, by biomechanical testing, histomorphometry and micro-computed tomography. We demonstrated that NOD/scid-IL2R gamma(null)(c) mice exhibited normal skeletal anatomy and a mild bone phenotype with a slightly reduced bone mass in the trabecular compartment in comparison to immunocompetent Balb/c mice. Fracture healing was impaired in immunodeficient NOD/scid-IL2R gamma(null)(c) mice. Callus bone content was unaffected during the early healing stage, whereas it was significantly reduced during the later healing period. Concomitantly, the amount of cartilage was significantly increased, indicating delayed endochondral ossification, most likely due to the decreased osteoclast activity observed in cells isolated from NOD/scid-IL2R gamma(null)(c) mice. Our results suggest that-under aseptic, uncomplicated conditions-the immediate immune response after fracture is nonessential for the initiation of bone formation. However, an intact immune system in general is important for successful bone healing, because endochondral ossification is delayed in immunodeficient NOD/scid-IL2R gamma(null)(c) mice.	[Rapp, Anna E.; Bindl, Ronny; Recknagel, Stefan; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany; [Erbacher, Annika] Univ Childrens Hosp Tubingen, Dept Gen Paediat Haematol & Oncol, Tubingen, Germany; [Mueller, Ingo] Univ Med Ctr Hamburg Eppendorf, Bone Marrow Transplantat Unit, Clin Paediat Haematol & Oncol, Hamburg, Germany; [Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immunogenet, Ulm, Germany; [Schrezenmeier, Hubert] Univ Hosp Ulm, Ulm, Germany; [Schrezenmeier, Hubert] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany; [Ehrnthaller, Christian; Gebhard, Florian] Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, D-89069 Ulm, Germany	Ulm University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Ulm University; Ulm University	Rapp, AE (corresponding author), Univ Ulm, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany.	anna.rapp@uni-ulm.de	Müller, Ingo/AAW-9025-2021; Ignatius, Anita/M-6012-2013; Rapp, Anna/L-8807-2016	Müller, Ingo/0000-0002-7477-6632; Ignatius, Anita/0000-0002-4782-1979; Rapp, Anna/0000-0001-5122-765X; Erbacher, Annika/0000-0002-6367-3769	European Commission [241879]; German Research Foundation (DFG) in the framework of the Collaborative Research Center 1149 (CRC1149)	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation (DFG) in the framework of the Collaborative Research Center 1149 (CRC1149)(German Research Foundation (DFG))	This study was funded by the 7th Framework Programme (FP7) of the European Commission through the REBORNE Project, grant no. 241879 and the German Research Foundation (DFG) in the framework of the Collaborative Research Center 1149 (CRC1149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bhandari M, 2003, J ORTHOP TRAUMA, V17, P353, DOI 10.1097/00005131-200305000-00006; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bozlar M, 2005, SAUDI MED J, V26, P1250; Bunn R. J., 2005, BONE JOINT J, V87, P265; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Chan JK, 2015, EMBO MOL MED, V7, P547, DOI 10.15252/emmm.201404487; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Danks L, 2013, J BIOCHEM, V154, P29, DOI 10.1093/jb/mvt049; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Djaafar S, 2010, ARTHRITIS RHEUM-US, V62, P3300, DOI 10.1002/art.27645; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Heilmann A, 2013, J ORTHOP RES, V31, P1845, DOI 10.1002/jor.22426; Hernandez RK, 2012, ACTA ORTHOP, V83, P653, DOI 10.3109/17453674.2012.747054; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252; Konnecke I, 2014, BONE, V64, P155, DOI 10.1016/j.bone.2014.03.052; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495; Lee Y, 2011, BIOMOL THER, V19, P141, DOI 10.4062/biomolther.2011.19.2.141; Li X, 2001, BONE, V29, P134, DOI 10.1016/S8756-3282(01)00497-5; Manigrasso MB, 2008, CALCIFIED TISSUE INT, V82, P465, DOI 10.1007/s00223-008-9144-3; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Marusic A, 2000, LAB INVEST, V80, P1761, DOI 10.1038/labinvest.3780186; Mori G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/720504; Nakashima T, 2009, J CLIN IMMUNOL, V29, P555, DOI 10.1007/s10875-009-9316-6; Niikura T, 2014, J ORTHOP SCI, V19, P120, DOI 10.1007/s00776-013-0472-4; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pacifici R, 2010, BONE, V47, P461, DOI 10.1016/j.bone.2010.04.611; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017; Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schmidt-Bleek K, 2015, TISSUE ENG PART B-RE, V21, P354, DOI [10.1089/ten.teb.2014.0677, 10.1089/ten.TEB.2014.0677]; Schmidt-Bleek K, 2009, J ORTHOP RES, V27, P1147, DOI 10.1002/jor.20901; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Takayanagi H, 2010, ANN NY ACAD SCI, V1192, P117, DOI 10.1111/j.1749-6632.2009.05303.x; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107	45	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147465	10.1371/journal.pone.0147465	http://dx.doi.org/10.1371/journal.pone.0147465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849055	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000018
J	Sonoda, R; Tanaka, K; Kikuchi, T; Onishi, Y; Takao, T; Tahara, T; Yoshida, Y; Suzawa, N; Kawazu, S; Iwamoto, Y; Kushiyama, A				Sonoda, Remi; Tanaka, Kentaro; Kikuchi, Takako; Onishi, Yukiko; Takao, Toshiko; Tahara, Tazu; Yoshida, Yoko; Suzawa, Naoki; Kawazu, Shoji; Iwamoto, Yasuhiko; Kushiyama, Akifumi			C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; BODY-MASS INDEX; GLYCEMIC CONTROL; INTRAVENOUS GLUCAGON; INSULIN-SECRETION; JAPANESE PATIENTS; AFTER-DISCHARGE; RISK-FACTORS; ASSOCIATION; MANAGEMENT	In this study, we investigate how measures of insulin secretion and other clinical information affect long-term glycemic control in patients with type 2 diabetes mellitus. Between October 2012 and June 2014, we monitored 202 diabetes patients who were admitted to the hospital of Asahi Life Foundation for glycemic control, as well as for training and education in diabetes management. We measured glycated hemoglobin (HbA1c) six months after discharge to assess disease management. In univariate analysis, fasting plasma C-peptide immunoreactivity (F-CPR) and pooled urine CPR (U-CPR) were significantly associated with HbA1c, in contrast to.CPR and C-peptide index (CPI). This association was strongly independent of most other patient variables. In exploratory factor analysis, five underlying factors, namely insulin resistance, aging, sex differences, insulin secretion, and glycemic control, represented patient characteristics. In particular, insulin secretion and resistance strongly influenced F-CPR, while insulin secretion affected U-CPR. In conclusion, the data indicate that among patients with type 2 diabetes mellitus, F-CPR and U-CPR may predict improved glycemic control six months after hospitalization.	[Sonoda, Remi; Tanaka, Kentaro; Kikuchi, Takako; Onishi, Yukiko; Takao, Toshiko; Tahara, Tazu; Yoshida, Yoko; Suzawa, Naoki; Kawazu, Shoji; Iwamoto, Yasuhiko; Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chuo Ku, Tokyo, Japan	Asahi Life Foundation	Kushiyama, A (corresponding author), Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chuo Ku, Tokyo, Japan.	kusiyaa-tky@umin.ac.jp	Onishi, Yukiko/AAU-9057-2021; Kushiyama, Akifumi/W-5988-2019; Kushiyama, Akifumi/A-6386-2011	Onishi, Yukiko/0000-0003-1180-5982; Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487				Aarts EO, 2013, OBES SURG, V23, P867, DOI 10.1007/s11695-013-0872-8; Ayyagari P, 2011, INT J HEALTH CARE FI, V11, P35, DOI 10.1007/s10754-010-9087-x; Chan WB, 2000, QJM-MON J ASSOC PHYS, V93, P183, DOI 10.1093/qjmed/93.3.183; Chen PC, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0160-4; Dungan Kathleen M, 2012, J Diabetes Sci Technol, V6, P1045; FABER O K, 1986, Diabetes Metabolism Reviews, V2, P331; FRIER BM, 1977, DIABETES, V26, P369; Funakoshi S, 2011, J DIABETES INVEST, V2, P429, DOI 10.1111/j.2040-1124.2011.00126.x; Funakoshi S, 2011, J DIABETES INVEST, V2, P297, DOI 10.1111/j.2040-1124.2010.00096.x; Funakoshi S, 2008, DIABETES RES CLIN PR, V82, P353, DOI 10.1016/j.diabres.2008.09.010; Gomez-Huelgas R, 2014, ACTA DIABETOL, V51, P377, DOI 10.1007/s00592-013-0520-8; Goto A, 2010, ENDOCR J, V57, P237, DOI 10.1507/endocrj.K09E-279; Haneda Masakazu, 2013, Nihon Naika Gakkai Zasshi, V102, P2291; Healy SJ, 2013, DIABETES CARE, V36, P2960, DOI 10.2337/dc13-0108; HENDRIKSEN C, 1977, DIABETOLOGIA, V13, P615, DOI 10.1007/BF01236316; Incalzi Raffaele Antonelli, 2002, BMC Geriatr, V2, P4, DOI 10.1186/1471-2318-2-4; Koproski J, 1997, DIABETES CARE, V20, P1553, DOI 10.2337/diacare.20.10.1553; MADSBAD S, 1981, ACTA MED SCAND, V210, P153; Moss SE, 1999, ARCH INTERN MED, V159, P2053, DOI 10.1001/archinte.159.17.2053; Murai K, 2014, DRUGS R&D, V14, P301, DOI 10.1007/s40268-014-0072-6; Murea M, 2012, AM J NEPHROL, V36, P488, DOI 10.1159/000343920; Saisho Y, 2013, ENDOCR J, V60, P517; Scheen AJ, 1996, DIABETES METAB, V22, P397; Shim WS, 2006, EUR J ENDOCRINOL, V155, P615, DOI 10.1530/eje.1.02249; SMITH DM, 1987, J GEN INTERN MED, V2, P168, DOI 10.1007/BF02596146; Taverna MJ, 2001, DIABETIC MED, V18, P584, DOI 10.1046/j.1464-5491.2001.00534.x; The Japan Diabetes Society, 2013, EV BAS PRACT GUID TR; TURNER RC, 1995, DIABETES, V44, P1249; Usui R, 2015, J DIABETES COMPLICAT, V29, P1203, DOI 10.1016/j.jdiacomp.2015.07.020; Wei NJ, 2012, ENDOCR PRACT, V18, P456, DOI 10.4158/EP11309.OR; Wexler DJ, 2012, DIABETES RES CLIN PR, V98, P249, DOI 10.1016/j.diabres.2012.09.016; Yamada Y, 2006, DIABETES RES CLIN PR, V74, P222, DOI 10.1016/j.diabres.2006.03.030	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147303	10.1371/journal.pone.0147303	http://dx.doi.org/10.1371/journal.pone.0147303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849676	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000013
J	Su, HY; Waldron, RT; Gong, R; Ramanujan, VK; Pandol, SJ; Lugea, A				Su, Hsin-Yuan; Waldron, Richard T.; Gong, Raymond; Ramanujan, V. Krishnan; Pandol, Stephen J.; Lugea, Aurelia			The Unfolded Protein Response Plays a Predominant Homeostatic Role in Response to Mitochondrial Stress in Pancreatic Stellate Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ROTTLERIN INDUCES AUTOPHAGY; DELTA-INDEPENDENT PATHWAY; BREAST-CANCER CELLS; SIGNALING PATHWAY; ER-STRESS; GENE-EXPRESSION; STEM-CELLS; APOPTOSIS; DEATH	Activated pancreatic stellate cells (PaSC) are key participants in the stroma of pancreatic cancer, secreting extracellular matrix proteins and inflammatory mediators. Tumors are poorly vascularized, creating metabolic stress conditions in cancer and stromal cells that necessitate adaptive homeostatic cellular programs. Activation of autophagy and the endoplasmic reticulum unfolded protein response (UPR) have been described in hepatic stellate cells, but the role of these processes in PaSC responses to metabolic stress is unknown. We reported that the PI3K/mTOR pathway, which AMPK can regulate through multiple inputs, modulates PaSC activation and fibrogenic potential. Here, using primary and immortalized mouse PaSC, we assess the relative contributions of AMPK/mTOR signaling, autophagy and the UPR to cell fate responses during metabolic stress induced by mitochondrial dysfunction. The mitochondrial uncoupler rottlerin at low doses (0.5-2.5 mu M) was added to cells cultured in 10% FBS complete media. Mitochondria rapidly depolarized, followed by altered mitochondrial dynamics and decreased cellular ATP levels. This mitochondrial dysfunction elicited rapid, sustained AMPK activation, mTOR pathway inhibition, and blockade of autophagic flux. Rottlerin treatment also induced rapid, sustained PERK/CHOP UPR signaling. Subsequently, high doses (> 5 mu M) induced loss of cell viability and cell death. Interestingly, AMPK knock-down using siRNA did not prevent rottlerin-induced mTOR inhibition, autophagy, or CHOP upregulation, suggesting that AMPK is dispensable for these responses. Moreover, CHOP genetic deletion, but not AMPK knock-down, prevented rottlerin-induced apoptosis and supported cell survival, suggesting that UPR signaling is a major modulator of cell fate in PaSC during metabolic stress. Further, short-term rottlerin treatment reduced both PaSC fibrogenic potential and IL-6 mRNA expression. In contrast, expression levels of the angiogenic factors HGF and VEGF alpha were unaffected, and the immune modulator IL-4 was markedly upregulated. These data imply that metabolic stress-induced PaSC reprogramming differentially modulates neighboring cells in the tumor microenvironment.	[Su, Hsin-Yuan; Waldron, Richard T.; Gong, Raymond; Pandol, Stephen J.; Lugea, Aurelia] Cedars Sinai Med Ctr, Dept Med, Pancreat Res Grp, Los Angeles, CA 90048 USA; [Waldron, Richard T.; Ramanujan, V. Krishnan; Pandol, Stephen J.; Lugea, Aurelia] UCLA VA Greater Los Angeles Hlth Sci Ctr, Dept Med, David Geffen Sch Med, Los Angeles, CA USA; [Ramanujan, V. Krishnan] Cedars Sinai Med Ctr, Metab Photon Lab, Dept Surg, Los Angeles, CA 90048 USA; [Ramanujan, V. Krishnan] Cedars Sinai Med Ctr, Metab Photon Lab, Dept Biomed Sci, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Lugea, A (corresponding author), Cedars Sinai Med Ctr, Dept Med, Pancreat Res Grp, Los Angeles, CA 90048 USA.; Lugea, A (corresponding author), UCLA VA Greater Los Angeles Hlth Sci Ctr, Dept Med, David Geffen Sch Med, Los Angeles, CA USA.	Aurelia.Lugea@cshs.org	Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002	National Institutes of Health [R01 AA019954, P01CA163200, P01DK098108, P50 AA011999]; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK098108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019954, P50AA011999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support was provided by the National Institutes of Health R01 AA019954 (to AL), P01CA163200 (to SP), P01DK098108 (to SP and AL), P50 AA011999 (to SP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; B'chir W, 2014, CELL SIGNAL, V26, P1385, DOI 10.1016/j.cellsig.2014.03.009; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Gholamin S, 2014, CURR DRUG TARGETS, V15, P1302, DOI 10.2174/1389450115666141107105456; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; He K, 2015, ONCOGENE; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kojima K, 2008, BIOCHEM BIOPH RES CO, V376, P434, DOI 10.1016/j.bbrc.2008.09.007; Kumar D, 2014, CANCER LETT, V343, P179, DOI 10.1016/j.canlet.2013.10.003; Kumar D, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-171; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Lim JH, 2008, APOPTOSIS, V13, P1378, DOI 10.1007/s10495-008-0264-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lu QY, 2013, J CHROMATOGR SEP TEC, V4, P1; Lu WY, 2014, CELL SIGNAL, V26, P1303, DOI 10.1016/j.cellsig.2014.02.018; Lugea A, 2006, GASTROENTEROLOGY, V131, P885, DOI 10.1053/j.gastro.2006.06.023; MAIOLI E, 2012, THESCIENTIFICWORLDJO, V2012, DOI DOI 10.1100/2012/350826; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miller BW, 2012, MOL CELL BIOCHEM, V367, P31, DOI 10.1007/s11010-012-1316-9; Ming M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114573; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohno I, 2010, AM J PHYSIOL-GASTR L, V298, pG63, DOI 10.1152/ajpgi.00257.2009; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pandol S, 2012, J GASTROEN HEPATOL, V27, P127, DOI 10.1111/j.1440-1746.2011.07013.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patel MB, 2014, CARCINOGENESIS, V35, P1891, DOI 10.1093/carcin/bgu122; Paulo JA, 2011, J PROTEOME RES, V10, P4835, DOI 10.1021/pr2006318; De Obanos MP, 2006, J CELL PHYSIOL, V209, P580, DOI 10.1002/jcp.20790; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Song KS, 2008, AUTOPHAGY, V4, P650, DOI 10.4161/auto.6057; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Suhane S, 2011, BIOCHEM BIOPH RES CO, V414, P73, DOI 10.1016/j.bbrc.2011.09.024; Valencia T, 2014, CANCER CELL, V26, P121, DOI 10.1016/j.ccr.2014.05.004; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Wu YS, 2015, NAT CELL BIOL, V17, P715, DOI 10.1038/ncb3172; Xue J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8158; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	61	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148999	10.1371/journal.pone.0148999	http://dx.doi.org/10.1371/journal.pone.0148999			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849807	Green Published, gold			2022-12-26	WOS:000369554000193
J	Erguler, K; Smith-Unna, SE; Waldock, J; Proestos, Y; Christophides, GK; Lelieveld, J; Parham, PE				Erguler, Kamil; Smith-Unna, Stephanie E.; Waldock, Joanna; Proestos, Yiannis; Christophides, George K.; Lelieveld, Jos; Parham, Paul E.			Large-Scale Modelling of the Environmentally-Driven Population Dynamics of Temperate Aedes albopictus (Skuse)	PLOS ONE			English	Article							BLOOD-FEEDING BEHAVIOR; ANOPHELES-GAMBIAE; AEGYPTI DIPTERA; CHIKUNGUNYA-DISEASE; EMILIA-ROMAGNA; CULICIDAE; VECTOR; SURVIVAL; COMPETITION; DENGUE	The Asian tiger mosquito, Aedes albopictus, is a highly invasive vector species. It is a proven vector of dengue and chikungunya viruses, with the potential to host a further 24 arboviruses. It has recently expanded its geographical range, threatening many countries in the Middle East, Mediterranean, Europe and North America. Here, we investigate the theoretical limitations of its range expansion by developing an environmentally-driven mathematical model of its population dynamics. We focus on the temperate strain of Ae. albopictus and compile a comprehensive literature-based database of physiological parameters. As a novel approach, we link its population dynamics to globally-available environmental datasets by performing inference on all parameters. We adopt a Bayesian approach using experimental data as prior knowledge and the surveillance dataset of Emilia-Romagna, Italy, as evidence. The model accounts for temperature, precipitation, human population density and photoperiod as the main environmental drivers, and, in addition, incorporates the mechanism of diapause and a simple breeding site model. The model demonstrates high predictive skill over the reference region and beyond, confirming most of the current reports of vector presence in Europe. One of the main hypotheses derived from the model is the survival of Ae. albopictus populations through harsh winter conditions. The model, constrained by the environmental datasets, requires that either diapausing eggs or adult vectors have increased cold resistance. The model also suggests that temperature and photoperiod control diapause initiation and termination differentially. We demonstrate that it is possible to account for unobserved properties and constraints, such as differences between laboratory and field conditions, to derive reliable inferences on the environmental dependence of Ae. albopictus populations.	[Erguler, Kamil; Waldock, Joanna; Lelieveld, Jos] Cyprus Inst, Energy Environm & Water Res Ctr, 2121 Aglantzia, Nicosia, Cyprus; [Smith-Unna, Stephanie E.] Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England; [Smith-Unna, Stephanie E.] Univ Cambridge, Sainsbury Lab, Bateman St, Cambridge CB2 1LR, England; [Waldock, Joanna; Christophides, George K.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Proestos, Yiannis; Christophides, George K.] Cyprus Inst, Computat Based Sci & Technol Res Ctr, 2121 Aglantzia, Nicosia, Cyprus; [Lelieveld, Jos] Max Planck Inst Chem, Dept Atmospher Chem, D-55128 Mainz, Germany; [Parham, Paul E.] Univ Liverpool, Fac Hlth & Life Sci, Dept Publ Hlth & Policy, Liverpool L69 3GL, Merseyside, England; [Parham, Paul E.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Grantham Inst Climate Change, Dept Infect Dis Epidemiol, St Marys Campus, London W2 1PG, England	University of Cambridge; University of Cambridge; Imperial College London; Max Planck Society; University of Liverpool; Imperial College London	Erguler, K (corresponding author), Cyprus Inst, Energy Environm & Water Res Ctr, 2121 Aglantzia, Nicosia, Cyprus.; Parham, PE (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Dept Publ Hlth & Policy, Liverpool L69 3GL, Merseyside, England.; Parham, PE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Grantham Inst Climate Change, Dept Infect Dis Epidemiol, St Marys Campus, London W2 1PG, England.	k.erguler@cyi.ac.cy; paul.parham@liverpool.ac.uk	Lelieveld, Jos/A-1986-2013; Erguler, Kamil/ABD-4636-2020; Erguler, Kamil/Y-5990-2019	Lelieveld, Jos/0000-0001-6307-3846; Erguler, Kamil/0000-0002-2674-592X; Waldock, Joanna/0000-0002-3622-5899; Christophides, George/0000-0002-3323-1687; Proestos, Yiannis/0000-0001-5991-0322	European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation [EIA/EIA/0311(BIE)/13]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC [226144]; Imperial College London through the Wellcome Trust Institutional Strategic Support Fund for a Sabbatical at the Cyprus Institute	European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Imperial College London through the Wellcome Trust Institutional Strategic Support Fund for a Sabbatical at the Cyprus Institute	This work was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Project Upsilon Gamma EIA/Delta Upsilon Gamma EIA/0311(BIE)/13). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/20072013)/ERC grant agreement number 226144. PEP would like to thank the University of Liverpool for financial support throughout this research. GKC would like to acknowledge funding by Imperial College London through the Wellcome Trust Institutional Strategic Support Fund for a Sabbatical at the Cyprus Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340; Aguiar e Oliveira Junior H., 2012, STOCHASTIC GLOBAL OP, P33, DOI [10.1007/978-3-642-27479-4_4, DOI 10.1007/978-3-642-27479-4_4]; Albieri A, 2010, B INSECTOL, V63, P209; Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646; Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; [Anonymous], GRIDD POP WORLD FUT; Bellini R, COMMUNICATION; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Braks MAH, 2006, MED VET ENTOMOL, V20, P53, DOI 10.1111/j.1365-2915.2006.00612.x; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; Calado Daniéla C., 2002, Rev. Bras. entomol., V46, P93, DOI 10.1590/S0085-56262002000100011; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Christiansen-Jucht C, 2015, INT J ENV RES PUB HE, V12, P5975, DOI 10.3390/ijerph120605975; de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008; Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6; Erguler K, 2018, HOPPMCMC ADAPTIVE BA; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036; Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018; Estrada-Franco J. G., 1995, Technical Paper - Pan American Health Organization; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Fontenille D, 2007, ECOL CONT VECTOR-BOR, V1, P169; Gavotte L, 2009, J MED ENTOMOL, V46, P451, DOI 10.1603/033.046.0306; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hall F.G., 2003, INT SATELLITE LAND S; HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; HIEN D S, 1975, Acta Parasitologica Polonica, V23, P537; HOBBS JH, 1991, J AM MOSQUITO CONTR, V7, P488; Huang J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-87; Imai C, 1976, JAPANESE J SANITARY; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lacour G, 2012, P 18 EUR SOC VECT EC; Lacour G, 2014, J INSECT PHYSIOL, V71, P87, DOI 10.1016/j.jinsphys.2014.10.008; Lounibos L. P., 2001, Biological Invasions, V3, P151, DOI 10.1023/A:1014519919099; Lunde TM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-28; Lunde TM, 2013, PARASITE VECTOR, V6, P1, DOI 10.1186/1756-3305-6-20; Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033; MORI A, 1981, Tropical Medicine, V23, P79; Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008; Moulay D, 2013, J THEOR BIOL, V318, P129, DOI 10.1016/j.jtbi.2012.11.008; Moulay D, 2012, MATH BIOSCI ENG, V9, P369, DOI 10.3934/mbe.2012.9.369; Muturi EJ, 2011, J MED ENTOMOL, V48, P243, DOI 10.1603/ME10017; NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314; Neto PL, 2004, NEOTROP ENTOMOL, V33, P29, DOI 10.1590/S1519-566X2004000100006; O'Donnell D, 2010, INFECT GENET EVOL, V10, P669, DOI 10.1016/j.meegid.2010.03.011; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005; Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099; Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554; Reynolds JA, 2012, J INSECT PHYSIOL, V58, P966, DOI 10.1016/j.jinsphys.2012.04.013; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2; Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; SOTA T, 1992, OECOLOGIA, V90, P353, DOI 10.1007/BF00317691; Stephenson TS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009127; Tandon Neelam, 2000, Dengue Bulletin, V24, P117; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Tsuda Y, 1994, TROPICAL MED, V36; Udaka M., 1959, Kontyu Tokyo, V27, P202; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100; Wang R. l., 1966, Acta Entomologica Sinica, V15, P75; Wang RI., 1966, ACTA ENTOMOL SINICA; Watson R, 2007, BRIT MED J, V335, P532, DOI 10.1136/bmj.39332.708738.DB; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830	81	29	29	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149282	10.1371/journal.pone.0149282	http://dx.doi.org/10.1371/journal.pone.0149282			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871447	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100141
J	Renz, C; Oeljeklaus, S; Grinhagens, S; Warscheid, B; Johnsson, N; Gronemeyer, T				Renz, Christian; Oeljeklaus, Silke; Grinhagens, Soeren; Warscheid, Bettina; Johnsson, Nils; Gronemeyer, Thomas			Identification of Cell Cycle Dependent Interaction Partners of the Septins by Quantitative Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; HIGHER-ORDER STRUCTURES; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; AXIAL LANDMARK; AMINO-ACIDS; PHOSPHORYLATION; PROTEOMICS; KINASE	The septins are a conserved family of GTP-binding proteins that, in the baker's yeast, assemble into a highly ordered array of filaments at the mother bud neck. These filaments undergo significant structural rearrangements during the cell cycle. We aimed at identifying key components that are involved in or regulate the transitions of the septins. By combining cell synchronization and quantitative affinity-purification mass-spectrometry, we performed a screen for specific interaction partners of the septins at three distinct stages of the cell cycle. A total of 83 interaction partners of the septins were assigned. Surprisingly, we detected DNA-interacting/nuclear proteins and proteins involved in ribosome biogenesis and protein synthesis predominantly present in alpha-factor arrested that do not display an assembled septin structure. Furthermore, two distinct sets of regulatory proteins that are specific for cells at S-phase with a stable septin collar or at mitosis with split septin rings were identified. Complementary methods like SPLIFF and immunoprecipitation allowed us to more exactly define the spatial and temporal characteristics of selected hits of the AP-MS screen.	[Renz, Christian; Grinhagens, Soeren; Johnsson, Nils; Gronemeyer, Thomas] Univ Ulm, Dept Mol Genet & Cell Biol, D-89069 Ulm, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Dept Biochem & Funct Prote, Inst Biol 2, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	Ulm University; University of Freiburg	Gronemeyer, T (corresponding author), Univ Ulm, Dept Mol Genet & Cell Biol, D-89069 Ulm, Germany.	thomas.gronemeyer@uni-ulm.de		Renz, Christian/0000-0003-3164-3597; Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft; Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]; Bundesministerium fur Bildung und Forschung (BMBF Initiative SysTec) [0315690B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; Bundesministerium fur Bildung und Forschung (BMBF Initiative SysTec)(Federal Ministry of Education & Research (BMBF))	Research in the BW laboratory is supported by the Deutsche Forschungsgemeinschaft and the Excellence Initiative of the German Federal & State Governments (EXC 294 BIOSS Centre for Biological Signalling Studies). CR was supported by a grant of the Bundesministerium fur Bildung und Forschung (BMBF Initiative SysTec 0315690B) to NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; DeMay BS, 2011, J CELL BIOL, V193, P1065, DOI 10.1083/jcb.201012143; Dunkler A, 2015, METHODS MOL BIOL, V1346, P151, DOI 10.1007/978-1-4939-2987-0_11; Pablo-Hernando ME, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-55; Finnigan GC, 2015, GENETICS, V200, P841, DOI 10.1534/genetics.115.176495; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Hanrahan J, 2003, MOL CELL, V12, P663, DOI 10.1016/j.molcel.2003.08.006; Hernandez-Rodriguez Y, 2012, CURR OPIN MICROBIOL, V15, P660, DOI 10.1016/j.mib.2012.09.007; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; Jimenez J, 1998, J CELL BIOL, V143, P1617, DOI 10.1083/jcb.143.6.1617; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Kang PJ, 2013, J CELL SCI, V126, P1218, DOI 10.1242/jcs.118521; Kang PJ, 2012, J CELL SCI, V125, P3840, DOI 10.1242/jcs.103697; Khan A, 2015, ANNU REV MICROBIOL, V69, P487, DOI 10.1146/annurev-micro-091014-104250; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Merlini L, 2015, MOL BIOL CELL, V26, P3245, DOI 10.1091/mbc.E15-06-0366; Mitchell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025336; Moreno D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.3; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Muller J, 2008, CHEMBIOCHEM, V9, P2029, DOI 10.1002/cbic.200800190; Nakahira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013799; Oeljeklaus S, 2012, J PROTEOME RES, V11, P2567, DOI 10.1021/pr3000333; Oeljeklaus S, 2009, FEBS LETT, V583, P1674, DOI 10.1016/j.febslet.2009.04.018; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Ong K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6698; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Qiu WJ, 2008, GENETICS, V180, P1445, DOI 10.1534/genetics.108.091900; Renz C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-60; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Schneider C, 2013, J CELL SCI, V126, P3390, DOI 10.1242/jcs.125302; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Tang CSL, 2002, CELL CYCLE, V1, P42, DOI 10.4161/cc.1.1.99; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wloka C, 2011, BIOL CHEM, V392, P813, DOI 10.1515/BC.2011.083; Zongzhi Huang, 2014, REPRESENTATION PRACT, V1, P1	53	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148340	10.1371/journal.pone.0148340	http://dx.doi.org/10.1371/journal.pone.0148340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871441	Green Submitted, gold, Green Published			2022-12-26	WOS:000370054100024
J	Dixon, BREA; Radin, JN; Piazuelo, MB; Contreras, DC; Algood, HMS				Dixon, Beverly R. E. A.; Radin, Jana N.; Piazuelo, M. Blanca; Contreras, Diana C.; Algood, Holly M. Scott			IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; HOST-DEFENSE; INFLAMMATORY RESPONSES; GASTRIC-MUCOSA; TH17 CELLS; IN-VITRO; INFECTION; INTERLEUKIN-22; SUBFAMILY; CYTOKINES	Helicobacter pylori colonization of the human stomach can lead to adverse clinical outcomes including gastritis, peptic ulcers, or gastric cancer. Current data suggest that in addition to bacterial virulence factors, the magnitude and types of immune responses influence the outcome of colonization. Specifically, CD4(+) T cell responses impact the pathology elicited in response to H. pylori. Because gastritis is believed to be the initiating host response to more detrimental pathological outcomes, there has been a significant interest in pro-inflammatory T cell cytokines, including the cytokines produced by T helper 17 cells. Th17 cells produce IL-17A, IL-17F, IL-21 and IL-22. While these cytokines have been linked to inflammation, IL-17A and IL-22 are also associated with anti-microbial responses and control of bacterial colonization. The goal of this research was to determine the role of IL-22 in activation of antimicrobial responses in models of H. pylori infection using human gastric epithelial cell lines and the mouse model of H. pylori infection. Our data indicate that IL-17A and IL-22 work synergistically to induce antimicrobials and chemokines such as IL-8, components of calprotectin (CP), lipocalin (LCN) and some beta-defensins in both human and primary mouse gastric epithelial cells (GEC) and gastroids. Moreover, IL-22 and IL-17A-activated GECs were capable of inhibiting growth of H. pylori in vitro. While antimicrobials were activated by IL-17A and IL-22 in vitro, using a mouse model of H. pylori infection, the data herein indicate that IL-22 deficiency alone does not render mice more susceptible to infection, change their antimicrobial gene transcription, or significantly change their inflammatory response.	[Algood, Holly M. Scott] Vet Affairs Tennessee Valley Healthcare Serv, Nashville, TN USA; [Dixon, Beverly R. E. A.; Radin, Jana N.; Piazuelo, M. Blanca; Algood, Holly M. Scott] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Contreras, Diana C.; Algood, Holly M. Scott] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Radin, Jana N.] Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign	Algood, HMS (corresponding author), Vet Affairs Tennessee Valley Healthcare Serv, Nashville, TN USA.; Algood, HMS (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN USA.; Algood, HMS (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.	holly.m.algood@vanderbilt.edu	Dixon, Beverly R.E.A./AAD-5714-2020	Dixon, Beverly R.E.A./0000-0001-9207-3386; Contreras Healey, Diana C/0000-0001-6981-8386	Office of Medical Research, Department of Veterans Affairs [IBX000915A]; National Institutes of Health [P30DK058404]; NIH [P30DK058404]; NATIONAL CANCER INSTITUTE [P01CA028842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000915] Funding Source: NIH RePORTER	Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work has been funded primarily by a Merit Review Grant IBX000915A (to HMSA) from the Office of Medical Research, Department of Veterans Affairs. Core Services including use of the Cell Imaging Shared Resource were performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health grant P30DK058404 Core Scholarship (Richard Peek). The contents of this paper do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express sincere gratitude to Tudor Ilca and Vicki Cope for worthy contributions to this work; and Lydia Wroblewski for her valuable time spent in training laboratory personnel in generating murine gastroids. We also acknowledge Core Services performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by NIH grant P30DK058404.	Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Algood HMS, 2009, J IMMUNOL, V183, P5837, DOI 10.4049/jimmunol.0901206; Allen AJ, 2011, VET IMMUNOL IMMUNOP, V141, P258, DOI 10.1016/j.vetimm.2011.03.014; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Behrends J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057379; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Busman-Sahay KO, 2015, J LEUKOCYTE BIOL, V97, P499, DOI 10.1189/jlb.3RU0814-386R; Carbo A, 2012, PNAS; Carbo A, 2014, MBIO, V5, DOI 10.1128/mBio.01243-14; Carrion M, 2013, RHEUMATOLOGY, V52, P2177, DOI 10.1093/rheumatology/ket315; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Chen JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097350; Conti P, 2003, IMMUNOL LETT, V88, P171, DOI 10.1016/S0165-2478(03)00087-7; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cover TL, 2013, GUT MICROBES, V4, P482, DOI 10.4161/gmic.26262; De Falco M, 2015, J CELL PHYSIOL, V230, P1702, DOI 10.1002/jcp.24933; Eidenschenk C, 2014, CURR TOP MICROBIOL, V380, P213, DOI 10.1007/978-3-662-43492-5_10; Ferreira RM, 2014, BEST PRACT RES CL GA, V28, P1003, DOI 10.1016/j.bpg.2014.09.004; Gaddy JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004450; Gaddy JA, 2013, INFECT IMMUN, V81, P2258, DOI 10.1128/IAI.01271-12; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Graham AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017171; Haeberle HA, 1997, INFECT IMMUN, V65, P4229, DOI 10.1128/IAI.65.10.4229-4235.1997; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Horvath DJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00056; Itoh T, 2003, HELICOBACTER, V8, P268, DOI 10.1046/j.1523-5378.2003.00154.x; Ji YH, 2014, INT J CLIN EXP PATHO, V7, P3694; Jia L, 2014, ADV EXP MED BIOL, V841, P209, DOI 10.1007/978-94-017-9487-9_8; Kanda N, 2009, EUR J IMMUNOL, V39, P996, DOI 10.1002/eji.200838852; KARTTUNEN R, 1995, GUT, V36, P341, DOI 10.1136/gut.36.3.341; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li LJ, 2014, WORLD J GASTROENTERO, V20, P18177, DOI 10.3748/wjg.v20.i48.18177; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liao F, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.70; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Liu JZ, 2009, CYTOKINE, V48, P156, DOI 10.1016/j.cyto.2009.07.005; Liu T, 2012, J CLIN IMMUNOL, V32, P1332, DOI 10.1007/s10875-012-9718-8; Luzza F, 2001, DIGEST LIVER DIS, V33, P14, DOI 10.1016/S1590-8658(01)80130-4; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Mizuno T, 2005, WORLD J GASTROENTERO, V11, P6305, DOI 10.3748/wjg.v11.i40.6305; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; Noto JM, 2015, J INFECT DIS, V211, P1790, DOI 10.1093/infdis/jiu805; Noto JM, 2013, J CLIN INVEST, V123, P479, DOI 10.1172/JCI64373; Noto Jennifer M, 2012, Methods Mol Biol, V921, P7; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Otani K, 2009, BIOCHEM BIOPH RES CO, V382, P252, DOI 10.1016/j.bbrc.2009.02.107; Rahman MT, 2014, RHEUMATOLOGY, V53, P270, DOI 10.1093/rheumatology/ket375; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sugimoto M, 2009, CANCER SCI, V100, P2152, DOI 10.1111/j.1349-7006.2009.01291.x; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wozniak KL, 2014, MICROBIOL-SGM, V160, P1440, DOI 10.1099/mic.0.073445-0; Wroblewski LE, 2015, GUT, V64, P720, DOI 10.1136/gutjnl-2014-307650; Xiang XG, 2012, IMMUNOL CELL BIOL, V90, P611, DOI 10.1038/icb.2011.79; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhuang Y, 2015, GUT, V64, P1368, DOI 10.1136/gutjnl-2014-307020; Zhuang Y, 2012, CANCER IMMUNOL IMMUN, V61, P1965, DOI 10.1007/s00262-012-1241-5; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	74	46	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148514	10.1371/journal.pone.0148514	http://dx.doi.org/10.1371/journal.pone.0148514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867135	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700018
J	Huang, WF; Zhang, HX; Hao, YM; Xu, XB; Zhai, Y; Wang, SX; Li, Y; Ma, FC; Li, YF; Wang, ZF; Zhang, Y; Zhang, XM; Liang, RX; Wei, ZL; Cui, Y; Li, YQ; Yu, XS; Ji, HZ; He, FC; Xie, WM; Zhou, GQ				Huang, Wenfeng; Zhang, Hongxing; Hao, Yumin; Xu, Xiaobing; Zhai, Yun; Wang, Shaoxia; Li, Yang; Ma, Fuchao; Li, Yuanfeng; Wang, Zhifu; Zhang, Yang; Zhang, Xiumei; Liang, Renxiang; Wei, Zhongliang; Cui, Ying; Li, Yongqiang; Yu, Xinsen; Ji, Hongzan; He, Fuchu; Xie, Weimin; Zhou, Gangqiao			A Non-Synonymous Single Nucleotide Polymorphism in the HJURP Gene Associated with Susceptibility to Hepatocellular Carcinoma among Chinese	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CENP-A; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL INSTABILITY; REPAIR GENES; DNA-DAMAGE; CANCER; ANEUPLOIDY; CARCINOGENESIS; ACTIVATION	Objective HJURP (Holliday Junction-Recognizing Protein) plays dual roles in DNA repair and in accurate chromosome segregation during mitosis. We examined whether the single nucleotide polymorphisms (SNPs) of HJURP were associated with the risk of occurrence of hepatocellular carcinoma (HCC) among chronic hepatitis B virus (HBV) carriers from well-known high-risk regions for HCC in China. Methods Twenty-four haplotype-tagging SNPs across HJURP were selected from HapMap data using the Haploview software. We genotyped these 24 SNPs using the using Sequenom's iPLEX assay in the Fusui population, consisting of 348 patients with HCC and 359 cancer-free controls, and further investigated the significantly associated SNP using the TaqMan assay in the Haimen population, consisting of 100 cases and 103 controls. The genetic associations with the risk of HCC were analyzed by logistic regression. Results We observed an increased occurrence of HCC consistently associated with A/C or C/C genotypes of the non-synonymous SNP rs3771333 compared with the A/A genotype in both the Fusui and Haimen populations, with a pooled odds ratio 1.82 (95% confidence interval, 1.33-2.49; P = 1.9 x 10(-4)). Case-only analysis further indicated that carriers of the at-risk C allele were younger than those carrying the A/A genotype (P = 0.0016). In addition, the expression levels of HJURP in C allele carriers were lower than that in A/A genotype carriers (P = 0.0078 and 0.0010, for mRNA and protein levels, respectively). Conclusion Our findings suggest that rs3771333 in HJURP may play a role in mediating the susceptibility to HCC among Chinese.	[Huang, Wenfeng; Zhang, Hongxing; Hao, Yumin; Zhai, Yun; Li, Yuanfeng; Wang, Zhifu; Zhang, Yang; Zhang, Xiumei; He, Fuchu; Zhou, Gangqiao] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China; [Huang, Wenfeng; Zhang, Hongxing; Hao, Yumin; Zhai, Yun; Li, Yuanfeng; Wang, Zhifu; Zhang, Yang; Zhang, Xiumei; He, Fuchu; Zhou, Gangqiao] Natl Engn Res Ctr Prot Drugs, Beijing, Peoples R China; [Huang, Wenfeng; Zhang, Hongxing; Hao, Yumin; Zhai, Yun; Li, Yuanfeng; Wang, Zhifu; Zhang, Yang; Zhang, Xiumei; He, Fuchu; Zhou, Gangqiao] Natl Ctr Prot Sci Beijing, Beijing, Peoples R China; [Huang, Wenfeng; Cui, Ying; Li, Yongqiang; Xie, Weimin] Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Guangxi, Peoples R China; [Huang, Wenfeng] Guangxi Med Univ, Affiliated Hosp 3, Nanning, Guangxi, Peoples R China; [Xu, Xiaobing; Ji, Hongzan] Second Mil Med Univ, Dept Gastroenterol & Hepatol, Jinling Hosp, Clin Sch Nanjing, Nanjing, Jiangsu, Peoples R China; [Wang, Shaoxia; Li, Yang] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing, Peoples R China; [Ma, Fuchao] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Liang, Renxiang; Wei, Zhongliang] Liver Canc Inst Fusui Cty, Shanghai, Guangxi, Peoples R China; [Yu, Xinsen] Dis Prevent & Control Ctr Haimen Cty, Haimen, Jiangsu, Peoples R China	Academy of Military Medical Sciences - China; Guangxi Medical University; Guangxi Medical University; Naval Medical University; Academy of Military Medical Sciences - China; Guangxi Medical University	Xie, WM; Zhou, GQ (corresponding author), Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China.; Zhou, GQ (corresponding author), Natl Engn Res Ctr Prot Drugs, Beijing, Peoples R China.; Zhou, GQ (corresponding author), Natl Ctr Prot Sci Beijing, Beijing, Peoples R China.; Xie, WM (corresponding author), Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Guangxi, Peoples R China.	xieweimin3358@163.com; zhougq114@126.com		Li, Yuanfeng/0000-0001-8227-7019; Huang, Wenfeng/0000-0002-3194-4368	National Natural Science Foundation of China [81125017, 81222027, 81060169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81125017, 81222027 and 81060169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1989, J CLIN EPIDEMIOL, V42, P659, DOI 10.1016/0895-4356(89)90009-7; Barash H, 2010, P NATL ACAD SCI USA, V107, P2207, DOI 10.1073/pnas.0908867107; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; Chung K-T, 2010, WOMEN PIONEERS MED R, Vvii; Coates P, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2567; Dandri M, 2002, HEPATOLOGY, V35, P217, DOI 10.1053/jhep.2002.30203; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; Li R, 2011, CARCINOGENESIS, V32, P530, DOI 10.1093/carcin/bgr018; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Loomba R, 2013, CLIN GASTROENTEROL H, V11, P1636, DOI 10.1016/j.cgh.2013.04.043; Martin-Lluesma S, 2008, HEPATOLOGY, V48, P1467, DOI 10.1002/hep.22542; Mellone BG, 2009, CELL, V137, P409, DOI 10.1016/j.cell.2009.04.035; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; SHEN FM, 1991, AM J HUM GENET, V49, P88; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Subramanian L, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140043; Teoh NC, 2008, HEPATOLOGY, V47, P2078, DOI 10.1002/hep.22194; Tong WM, 2002, CANCER RES, V62, P6990; Vineis P, 2009, JNCI-J NATL CANCER I, V101, P24, DOI 10.1093/jnci/djn437; Wang JY, 2014, J BIOL CHEM, V289, P8326, DOI 10.1074/jbc.M113.529958; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wilkens L, 2004, P NATL ACAD SCI USA, V101, P1309, DOI 10.1073/pnas.0305817101; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; YU MW, 1994, CRIT REV ONCOL HEMAT, V17, P71, DOI 10.1016/1040-8428(94)90020-5; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148618	10.1371/journal.pone.0148618	http://dx.doi.org/10.1371/journal.pone.0148618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863619	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600087
J	Mukaihara, K; Suehara, Y; Kohsaka, S; Akaike, K; Tanabe, Y; Kubota, D; Ishii, M; Fujimura, T; Kazuno, S; Okubo, T; Takagi, T; Yao, T; Kaneko, K; Saito, T				Mukaihara, Kenta; Suehara, Yoshiyuki; Kohsaka, Shinji; Akaike, Keisuke; Tanabe, Yu; Kubota, Daisuke; Ishii, Midori; Fujimura, Tsutomu; Kazuno, Saiko; Okubo, Taketo; Takagi, Tatsuya; Yao, Takashi; Kaneko, Kazuo; Saito, Tsuyoshi			Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-II; NF-KAPPA-B; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE; RECEPTOR ACTIVATOR; CREATINE-KINASE; STROMAL CELLS; RANK LIGAND; RESORPTION; CANCER	Giant cell tumors of bone (GCTB) are locally aggressive osteolytic bone tumors. Recently, some clinical trials have shown that denosumab is a novel and effective therapeutic option for aggressive and recurrent GCTB. This study was performed to investigate the molecular mechanism underlying the therapeutic effect of denosumab. Comparative proteomic analyses were performed using GCTB samples which were taken before and after denosumab treatment. Each expression profile was analyzed using the software program to further understand the affected biological network. One of identified proteins was further evaluated by gelatin zymography and an immunohistochemical analysis. We identified 13 consistently upregulated proteins and 19 consistently downregulated proteins in the pre- and post-denosumab samples. Using these profiles, the software program identified molecular interactions between the differentially expressed proteins that were indirectly involved in the RANK/RANKL pathway and in several non-canonical subpathways including the Matrix metalloproteinase pathway. The data analysis also suggested that the identified proteins play a critical functional role in the osteolytic process of GCTB. Among the most downregulated proteins, the activity of MMP-9 was significantly decreased in the denosumab-treated samples, although the residual stromal cells were found to express MMP-9 by an immunohistochemical analysis. The expression level of MMP-9 in the primary GCTB samples was not correlated with any clinicopathological factors, including patient outcomes. Although the replacement of tumors by fibro-osseous tissue or the diminishment of osteoclast-like giant cells have been shown as therapeutic effects of denosumab, the residual tumor after denosumab treatment, which is composed of only stromal cells, might be capable of causing bone destruction; thus the therapeutic application of denosumab would be still necessary for these lesions. We believe that the protein expression patterns and the results of the network analysis will provide a better understanding of the effects of denosumab administration in patients with GCTB.	[Mukaihara, Kenta; Suehara, Yoshiyuki; Akaike, Keisuke; Tanabe, Yu; Kubota, Daisuke; Ishii, Midori; Okubo, Taketo; Takagi, Tatsuya; Kaneko, Kazuo] Juntendo Univ, Sch Med, Dept Orthoped Surg, Tokyo 113, Japan; [Kohsaka, Shinji] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Fujimura, Tsutomu; Kazuno, Saiko] Juntendo Univ, Sch Med, Lab Biochem Anal, Cent Lab Med Sci, Tokyo 113, Japan; [Yao, Takashi; Saito, Tsuyoshi] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 113, Japan	Juntendo University; Memorial Sloan Kettering Cancer Center; Juntendo University; Juntendo University	Suehara, Y (corresponding author), Juntendo Univ, Sch Med, Dept Orthoped Surg, Tokyo 113, Japan.	ysuehara@juntendo.ac.jp		Fujimura, Tsutomu/0000-0003-1744-7725	Ministry of Education, Science, Sports and Culture, Tokyo, Japan [26670286, 15H04964]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26893267, 26670286] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for General Scientific Research 412 from the Ministry of Education, Science, Sports and Culture (no. 26670286 to 413 Tsuyoshi Saito and no. 15H04964 to Yoshiyuki Suehara), Tokyo, Japan.	Akaike K, 2014, SKELETAL RADIOL, V43, P1767, DOI 10.1007/s00256-014-1961-z; Atkins GJ, 2006, J BONE MINER RES, V21, P1339, DOI 10.1359/JBMR.060604; Balke M, 2010, LANCET ONCOL, V11, P218, DOI 10.1016/S1470-2045(10)70027-9; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chen JF, 2010, J BIOL CHEM, V285, P36315, DOI 10.1074/jbc.M110.157743; Conti A, 2011, AM J PATHOL, V178, P88, DOI 10.1016/j.ajpath.2010.11.035; Dalberg K, 2000, WORLD J SURG, V24, P334, DOI 10.1007/s002689910053; Datta A, 2010, J PROTEOME RES, V9, P472, DOI 10.1021/pr900829h; Dufresne Armelle, 2012, Bonekey Rep, V1, P149, DOI 10.1038/bonekey.2012.149; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Fujisaki K, 2007, LIFE SCI, V80, P1311, DOI 10.1016/j.lfs.2006.12.037; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Halleen JM, 2006, CLIN LAB, V52, P499; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5; Kobayashi D, 2009, MOL CELL PROTEOMICS, V8, P2350, DOI 10.1074/mcp.M900179-MCP200; Lau CPY, 2013, CONNECT TISSUE RES, V54, P439, DOI 10.3109/03008207.2013.848202; Lee CH, 2008, MODERN PATHOL, V21, P531, DOI 10.1038/modpathol.3801023; Lieveld M, 2014, VIRCHOWS ARCH, V465, P703, DOI 10.1007/s00428-014-1666-7; Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Masui F, 1998, PATHOL INT, V48, P355; Mendenhall WM, 2006, AM J CLIN ONCOL-CANC, V29, P96, DOI 10.1097/01.coc.0000195089.11620.b7; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Nikitovic D, 2008, IUBMB LIFE, V60, P818, DOI 10.1002/iub.131; Rabinovich Alexander, 2009, Open Bone J, V1, P46; Rao VH, 1997, CLIN EXP METASTAS, V15, P400, DOI 10.1023/A:1018450204980; Roux S, 2002, AM J CLIN PATHOL, V117, P210; Shingleton WD, 1996, BIOCHEM CELL BIOL, V74, P759, DOI 10.1139/o96-083; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Steensma MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069101; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Tanabe N, 2005, LIFE SCI, V77, P615, DOI 10.1016/j.lfs.2004.10.079; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Ueda Y, 1996, AM J PATHOL, V148, P611; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Werner M, 2006, INT ORTHOP, V30, P484, DOI 10.1007/s00264-006-0215-7; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	44	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148401	10.1371/journal.pone.0148401	http://dx.doi.org/10.1371/journal.pone.0148401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863138	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600064
J	Reddy, DS; Bhatnagar-Mathur, P; Reddy, PS; Cindhuri, KS; Ganesh, AS; Sharma, KK				Reddy, Dumbala Srinivas; Bhatnagar-Mathur, Pooja; Reddy, Palakolanu Sudhakar; Cindhuri, Katamreddy Sri; Ganesh, Adusumalli Sivaji; Sharma, Kiran Kumar			Identification and Validation of Reference Genes and Their Impact on Normalized Gene Expression Studies across Cultivated and Wild Cicer Species	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; INTERNAL REFERENCE GENES; SUPERIOR REFERENCE GENES; DRAFT GENOME SEQUENCE; RT-PCR; QRT-PCR; HOUSEKEEPING GENES; BRASSICA-NAPUS; TRANSCRIPT NORMALIZATION	Quantitative Real-Time PCR (qPCR) is a preferred and reliable method for accurate quantification of gene expression to understand precise gene functions. A total of 25 candidate reference genes including traditional and new generation reference genes were selected and evaluated in a diverse set of chickpea samples. The samples used in this study included nine chickpea genotypes (Cicer spp.) comprising of cultivated and wild species, six abiotic stress treatments (drought, salinity, high vapor pressure deficit, abscisic acid, cold and heat shock), and five diverse tissues (leaf, root, flower, seedlings and seed). The geNorm, NormFinder and RefFinder algorithms used to identify stably expressed genes in four sample sets revealed stable expression of UCP and G6PD genes across genotypes, while TIP41 and CAC were highly stable under abiotic stress conditions. While PP2A and ABCT genes were ranked as best for different tissues, ABCT, UCP and CAC were most stable across all samples. This study demonstrated the usefulness of new generation reference genes for more accurate qPCR based gene expression quantification in cultivated as well as wild chickpea species. Validation of the best reference genes was carried out by studying their impact on normalization of aquaporin genes PIP1;4 and TIP3;1, in three contrasting chickpea genotypes under high vapor pressure deficit (VPD) treatment. The chickpea TIP3;1 gene got significantly up regulated under high VPD conditions with higher relative expression in the drought susceptible genotype, confirming the suitability of the selected reference genes for expression analysis. This is the first comprehensive study on the stability of the new generation reference genes for qPCR studies in chickpea across species, different tissues and abiotic stresses.	[Reddy, Dumbala Srinivas; Bhatnagar-Mathur, Pooja; Reddy, Palakolanu Sudhakar; Cindhuri, Katamreddy Sri; Ganesh, Adusumalli Sivaji; Sharma, Kiran Kumar] Int Crops Res Inst Semi Arid Trop, Genet Transformat Lab, Patancheru 502324, Telangana, India	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Bhatnagar-Mathur, P (corresponding author), Int Crops Res Inst Semi Arid Trop, Genet Transformat Lab, Patancheru 502324, Telangana, India.	p.bhatnagar@cgiar.org	Sharma, Kiran/GZL-1834-2022		CGIAR	CGIAR(CGIAR)	This work has received funding from the CGIAR research program on grain legumes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Berr A, 2010, PLANT CELL, V22, P3232, DOI 10.1105/tpc.110.079962; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Li JD, 2014, PLANT MOL BIOL REP, V32, P1002, DOI 10.1007/s11105-014-0701-9; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Nakayama TJ, 2014, GENET MOL RES, V13, P860, DOI 10.4238/2014.February.13.4; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Olsvik Pal A, 2008, BMC Res Notes, V1, P47, DOI 10.1186/1756-0500-1-47; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ray Debashree L, 2014, BMC Res Notes, V7, P304, DOI 10.1186/1756-0500-7-304; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Reddy PS., 2015, PLANT GENE, V1, P35, DOI [DOI 10.1016/J.PLGENE.2015.02.001, 10.1016/j.plgene.2015.02.001]; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Saha GC, 2013, PLANT MOL BIOL REP, V31, P1109, DOI 10.1007/s11105-013-0579-y; Silberberg G, 2009, ANAL BIOCHEM, V391, P91, DOI 10.1016/j.ab.2009.05.026; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stajner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068228; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vadez V, 2001, J EXP BOT, V52, P153, DOI 10.1093/jexbot/52.354.153; Vadez V., 2015, PLANT GENE, V1, P18, DOI DOI 10.1016/J.PLGENE.2014.12.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wang HB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08094; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Yuan XY, 2014, APPL BIOCHEM BIOTECH, V173, P1431, DOI 10.1007/s12010-014-0951-x; Zaman-Allah M, 2011, FUNCT PLANT BIOL, V38, P270, DOI 10.1071/FP10244; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	64	34	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148451	10.1371/journal.pone.0148451	http://dx.doi.org/10.1371/journal.pone.0148451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863232	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600074
J	Zhao, JS; Niu, HL; Li, AY; Nie, L				Zhao, Jingshan; Niu, Honglin; Li, Aiying; Nie, Lei			Acetylbritannilactone Modulates Vascular Endothelial Growth Factor Signaling and Regulates Angiogenesis in Endothelial Cells	PLOS ONE			English	Article							FACTOR RECEPTOR FLK1; TUMOR ANGIOGENESIS; VEGF; MICE; NEUROPILIN-1; TRAFFICKING; EXPRESSION; SURVIVAL; CANCER; GENE	The present study was conducted to determine the effects of 1-O-acetylbritannilactone (ABL), a compound extracted from Inula britannica L., on vascular endothelial growth factor (VEGF) signaling and angiogenesis in endothelial cells (ECs). We showed that ABL promotes VEGF-induced cell proliferation, growth, migration, and tube formation in cultured human ECs. Furthermore, the modulatory effect of ABL on VEGF-induced Akt, MAPK p42/44, and p38 phosphorylation, as well as on upstream VEGFR-2 phosphorylation, were associated with VEGF-dependent Matrigel angiogenesis in vivo. In addition, animals treated with ABL (26 mg/kg/day) recovered blood flow significantly earlier than control animals, suggesting that ABL affects ischemia-mediated angiogenesis and arteriogenesis in vivo. Finally, we demonstrated that ABL strongly reduced the levels of VEGFR-2 on the cell surface, enhanced VEGFR-2 endocytosis, which consistent with inhibited VE-cadherin, a negative regulator of VEGF signaling associated with VEGFR-2 complex formation, but did not alter VE-cadherin or VEGFR-2 expression in ECs. Our results suggest that ABL may serve as a novel therapeutic intervention for various cardiovascular diseases, including chronic ischemia, by regulating VEGF signaling and modulating angiogenesis.	[Zhao, Jingshan; Li, Aiying] Hebei Univ Chinese Med, Dept Biochem & Mol Biol, Coll Basic Med, Shijiazhuang 050200, Peoples R China; [Niu, Honglin] Hebei Med Univ, Hosp 3, Dept Nephrol, Shijiazhuang 050051, Peoples R China; [Niu, Honglin] Key Lab Kidney Dis Hebei Prov, Shijiazhuang 050071, Peoples R China; [Nie, Lei] Hebei Med Univ, Minist Educ, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang 050017, Peoples R China; [Nie, Lei] Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Peoples R China; [Nie, Lei] Hebei Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China	Hebei University of Chinese Medicine; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Nie, L (corresponding author), Hebei Med Univ, Minist Educ, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang 050017, Peoples R China.; Nie, L (corresponding author), Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Peoples R China.; Nie, L (corresponding author), Hebei Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China.	nieleinl@yahoo.com		Li, Aiying/0000-0001-7779-1814	National Natural Science Foundation of China [31271466, 31571176]; Hebei Province Science and Technique Supporting Project [13277739D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Science and Technique Supporting Project	This project was supported by the National Natural Science Foundation of China (No. 31271466 and 31571176) and Hebei Province Science and Technique Supporting Project (No. 13277739D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker CM, 2002, CANCER BIOL THER, V1, P548, DOI 10.4161/cbt.1.5.176; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Decaussin M, 1999, J PATHOL, V188, P369; Fang XM, 2011, ONCOL REP, V26, P1181, DOI 10.3892/or.2011.1411; He ZF, 2015, BIOCHEM BIOPH RES CO, V464, P422, DOI 10.1016/j.bbrc.2015.06.126; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Li YW, 2002, J EXP MED, V195, P1575, DOI 10.1084/jem.20020072; Liu B, 2008, J PHARMACOL EXP THER, V324, P292, DOI 10.1124/jpet.107.127407; Liu B, 2011, INT J CARDIOL, V149, P30, DOI 10.1016/j.ijcard.2009.11.036; Liu YP, 2007, EUR J PHARMACOL, V577, P28, DOI 10.1016/j.ejphar.2007.08.030; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Nie L, 2013, J CLIN INVEST, V123, P5082, DOI 10.1172/JCI67752; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Niu HL, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-135; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Rivera CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024887; Salikhova A, 2008, CIRC RES, V103, pE71, DOI 10.1161/CIRCRESAHA.108.183327; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168	25	0	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148968	10.1371/journal.pone.0148968	http://dx.doi.org/10.1371/journal.pone.0148968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863518	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600131
J	Ban, JJ; Yang, S; Im, W; Kim, M				Ban, Jae-Jun; Yang, Seungwon; Im, Wooseok; Kim, Manho			Neurogenic Effects of Cell-Free Extracts of Adipose Stem Cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MAMMALIAN NEURAL STEM; STROMAL CELLS; REGENERATIVE MEDICINE; SUBVENTRICULAR ZONE; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; IN-VIVO; TISSUE; GROWTH	Stem-cell-based therapies are regarded as promising treatments for neurological disorders, and adipose-derived stem cells (ASCs) are a feasible source of clinical application of stem cell. Recent studies have shown that stem cells have a therapeutic potential for use in the treatment of various illnesses through paracrine action. To examine the effects of cell components of ASCs on neural stem cells (NSCs), we treated cell-free extracts of ASCs (CFE-ASCs) containing various components with brain-derived NSCs. To elucidate the effects of CFE-ASCs in NSC proliferation, we treated mouse subventricular zone-derived cultured NSCs with various doses of CFE-ASCs. As a result, CFE-ASCs were found to induce the proliferation of NSCs under conditions of growth factor deprivation in a dose-dependent manner (p<0.01). CFE-ASCs increase the expression of neuron and astrocyte differentiation markers including Tuj-1 (p<0.05) and glial fibrillary acidic protein (p<0.01) without altering the cell's fate in differentiating NSCs. In addition, treatment with CFE-ASCs induces an increase in neurite numbers (p<0.01) and lengths of NSCs (p<0.05). Furthermore, CFE-ASCs rescue the hydrogen peroxide-induced reduction of NSCs' viability (p<0.05) and neurite branching (p<0.01). Findings from our study indicate that CFE-ASCs support the survival, proliferation and differentiation of NSCs accompanied with neurite outgrowth, suggesting that CFE-ASCs can modulate neurogenesis in the central nervous system.	[Ban, Jae-Jun; Im, Wooseok; Kim, Manho] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Yang, Seungwon] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kim, Manho] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; University of Chicago; Seoul National University (SNU)	Im, W; Kim, M (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.; Kim, M (corresponding author), Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea.	imwooseok@gmail.com; kimmanho@snu.ac.kr	Yang, Seungwon/AAM-7585-2021		National Research Foundation of Korea (NRF) [2014R1A2A1A11051520]; Korea Health 21 R & D Project by the Ministry of Health & Welfare, Republic of Korea [HI14C2348]; National Research Foundation of Korea [2015R1D1A1A01060056]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Health 21 R & D Project by the Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) (2014R1A2A1A11051520), Korea Health 21 R & D Project (HI14C2348) by the Ministry of Health & Welfare, Republic of Korea, and National Research Foundation of Korea (2015R1D1A1A01060056).	Atsma DE, 2007, CURR OPIN LIPIDOL, V18, P645, DOI 10.1097/MOL.0b013e3282f0dd1f; Banks WA, 2001, CURR PHARM DESIGN, V7, P125, DOI 10.2174/1381612013398310; Brown Larry R, 2005, Expert Opin Drug Deliv, V2, P29, DOI 10.1517/17425247.2.1.29; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Choi YS, 2012, BIOMATERIALS, V33, P6943, DOI 10.1016/j.biomaterials.2012.06.057; Deleyrolle Loic P., 2009, V549, P91, DOI 10.1007/978-1-60327-931-4_7; Deshpande RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137918; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fraser JK, 2006, NAT CLIN PRACT CA S1, V3, P33, DOI DOI 10.1038/ncpcardio0444; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hrvoj-Mihic B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00707; Huri PY, 2014, CELL MOL BIOENG, V7, P497, DOI 10.1007/s12195-014-0362-7; Im W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059438; Jacqueline GA, 2006, NEURAL STEM CELL CUL; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kim WS, 2009, J DERMATOL SCI, V53, P96, DOI 10.1016/j.jdermsci.2008.08.007; Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; McGinn MJ, 2012, J NEUROSCI RES, V90, P1159, DOI 10.1002/jnr.23012; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Pan WH, 2000, NEUROENDOCRINOLOGY, V72, P171, DOI 10.1159/000054584; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; Skaper SD, 2005, ANN NY ACAD SCI, V1053, P376, DOI 10.1196/annals.1344.032; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	41	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148691	10.1371/journal.pone.0148691	http://dx.doi.org/10.1371/journal.pone.0148691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859291	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400066
J	Gohari, IM; Kropinski, AM; Weese, SJ; Parreira, VR; Whitehead, AE; Boerlin, P; Prescott, JF				Gohari, Iman Mehdizadeh; Kropinski, Andrew M.; Weese, Scott J.; Parreira, Valeria R.; Whitehead, Ashley E.; Boerlin, Patrick; Prescott, John F.			Plasmid Characterization and Chromosome Analysis of Two netF plus Clostridium perfringens Isolates Associated with Foal and Canine Necrotizing Enteritis	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE PLASMID; GENOME SEQUENCE; ENCODING PLASMIDS; TOXIN PLASMIDS; ENTEROTOXIN; PCW3; GENE; IDENTIFICATION; ORGANIZATION; CONJUGATION	The recent discovery of a novel beta-pore-forming toxin, NetF, which is strongly associated with canine and foal necrotizing enteritis should improve our understanding of the role of type A Clostridium perfringens associated disease in these animals. The current study presents the complete genome sequence of two netF-positive strains, JFP55 and JFP838, which were recovered from cases of foal necrotizing enteritis and canine hemorrhagic gastroenteritis, respectively. Genome sequencing was done using Single Molecule, Real-Time (SMRT) technology-PacBio and Illumina Hiseq2000. The JFP55 and JFP838 genomes include a single 3.34 Mb and 3.53 Mb chromosome, respectively, and both genomes include five circular plasmids. Plasmid annotation revealed that three plasmids were shared by the two newly sequenced genomes, including a NetF/NetE toxins-encoding tcp-conjugative plasmid, a CPE/CPB2 toxins-encoding tcp-conjugative plasmid and a putative bacteriocin-encoding plasmid. The putative beta-pore-forming toxin genes, netF, netE and netG, were located in unique pathogenicity loci on tcp-conjugative plasmids. The C. perfringens JFP55 chromosome carries 2,825 protein-coding genes whereas the chromosome of JFP838 contains 3,014 protein-encoding genes. Comparison of these two chromosomes with three available reference C. perfringens chromosome sequences identified 48 (similar to 247 kb) and 81 (similar to 430 kb) regions unique to JFP55 and JFP838, respectively. Some of these divergent genomic regions in both chromosomes are phage-and plasmid-related segments. Sixteen of these unique chromosomal regions (similar to 69 kb) were shared between the two isolates. Five of these shared regions formed a mosaic of plasmid-integrated segments, suggesting that these elements were acquired early in a clonal lineage of netF-positive C. perfringens strains. These results provide significant insight into the basis of canine and foal necrotizing enteritis and are the first to demonstrate that netF resides on a large and unique plasmid-encoded locus.	[Gohari, Iman Mehdizadeh; Kropinski, Andrew M.; Weese, Scott J.; Parreira, Valeria R.; Boerlin, Patrick; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Whitehead, Ashley E.] Univ Calgary, Dept Vet Clin & Diagnost Sci, Calgary, AB CSB 101E, Canada	University of Guelph; University of Calgary	Prescott, JF (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	prescott@uoguelph.ca		Whitehead, Ashley/0000-0002-3165-6809	Natural Sciences and Engineering Discovery Grant	Natural Sciences and Engineering Discovery Grant	Funding was provided from Natural Sciences and Engineering Discovery Grant.	ABRAHAM LJ, 1985, PLASMID, V14, P37, DOI 10.1016/0147-619X(85)90030-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Bannam TL, 2011, MBIO, V2, DOI 10.1128/mBio.00190-11; Bantwal R, 2012, PLASMID, V67, P139, DOI 10.1016/j.plasmid.2011.12.016; Barbara AJ, 2008, VET MICROBIOL, V126, P377, DOI 10.1016/j.vetmic.2007.07.019; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Brynestad S, 2001, INFECT IMMUN, V69, P3483, DOI 10.1128/IAI.69.5.3483-3487.2001; Chalmers G, 2008, J CLIN MICROBIOL, V46, P3957, DOI 10.1128/JCM.01548-08; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gohari IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122684; Govind R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002727; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hassan KA, 2015, RES MICROBIOL, V166, P255, DOI 10.1016/j.resmic.2014.10.003; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hosomi K, 2014, MOL GENET GENOMICS, V289, P1267, DOI 10.1007/s00438-014-0887-4; Hughes ML, 2007, J BACTERIOL, V189, P7531, DOI 10.1128/JB.00767-07; Iacobino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071324; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; Li JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010932; Lindstrom M, 2011, FOOD MICROBIOL, V28, P192, DOI 10.1016/j.fm.2010.03.020; McClane B.A., 2006, PROKARYOTES, V3rd ed., P688; McClane BA, 1996, TOXICON, V34, P1335, DOI 10.1016/S0041-0101(96)00101-8; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2002, INFECT IMMUN, V70, P4261, DOI 10.1128/IAI.70.8.4261-4272.2002; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; Nowell VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032271; Ohtani K, 2010, ANAEROBE, V16, P258, DOI 10.1016/j.anaerobe.2009.10.003; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parreira VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049753; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Porter CJ, 2012, MOL MICROBIOL, V83, P275, DOI 10.1111/j.1365-2958.2011.07930.x; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; ROOD JI, 1978, PLASMID, V1, P563, DOI 10.1016/0147-619X(78)90013-6; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Sparks SG, 2001, J CLIN MICROBIOL, V39, P883, DOI 10.1128/JCM.39.3.883-888.2001; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976; Uzal F A, 2010, Open Toxinology J, V2, P24; Uzal FA, 2014, FUTURE MICROBIOL, V9, P361, DOI 10.2217/fmb.13.168; Yonogi S, 2014, INFECT IMMUN, V82, P2390, DOI 10.1128/IAI.01759-14; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	56	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148344	10.1371/journal.pone.0148344	http://dx.doi.org/10.1371/journal.pone.0148344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859667	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400034
J	Hertzog, LR; Meyer, ST; Weisser, WW; Ebeling, A				Hertzog, Lionel R.; Meyer, Sebastian T.; Weisser, Wolfgang W.; Ebeling, Anne			Experimental Manipulation of Grassland Plant Diversity Induces Complex Shifts in Aboveground Arthropod Diversity	PLOS ONE			English	Article							BOTTOM-UP; SPECIES-DIVERSITY; TOP-DOWN; MULTITROPHIC INTERACTIONS; BIODIVERSITY; COMMUNITIES; RICHNESS; HERBIVORY; EXTRAPOLATION; RAREFACTION	Changes in producer diversity cause multiple changes in consumer communities through various mechanisms. However, past analyses investigating the relationship between plant diversity and arthropod consumers focused only on few aspects of arthropod diversity, e.g. species richness and abundance. Yet, shifts in understudied facets of arthropod diversity like relative abundances or species dominance may have strong effects on arthropod-mediated ecosystem functions. Here we analyze the relationship between plant species richness and arthropod diversity using four complementary diversity indices, namely: abundance, species richness, evenness (equitability of the abundance distribution) and dominance (relative abundance of the dominant species). Along an experimental gradient of plant species richness (1, 2, 4, 8, 16 and 60 plant species), we sampled herbivorous and carnivorous arthropods using pitfall traps and suction sampling during a whole vegetation period. We tested whether plant species richness affects consumer diversity directly (i), or indirectly through increased productivity (ii). Further, we tested the impact of plant community composition on arthropod diversity by testing for the effects of plant functional groups (iii). Abundance and species richness of both herbivores and carnivores increased with increasing plant species richness, but the underlying mechanisms differed between the two trophic groups. While higher species richness in herbivores was caused by an increase in resource diversity, carnivore richness was driven by plant productivity. Evenness of herbivore communities did not change along the gradient in plant species richness, whereas evenness of carnivores declined. The abundance of dominant herbivore species showed no response to changes in plant species richness, but the dominant carnivores were more abundant in species-rich plant communities. The functional composition of plant communities had small impacts on herbivore communities, whereas carnivore communities were affected by forbs of small stature, grasses and legumes. Contrasting patterns in the abundance of dominant species imply different levels of resource specialization for dominant herbivores (narrow food spectrum) and carnivores (broad food spectrum). That in turn could heavily affect ecosystem functions mediated by herbivorous and carnivorous arthropods, such as herbivory or biological pest control.	[Hertzog, Lionel R.; Meyer, Sebastian T.; Weisser, Wolfgang W.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Ctr Food & Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Ebeling, Anne] Univ Jena, Inst Ecol, Jena, Germany	Technical University of Munich; Friedrich Schiller University of Jena	Ebeling, A (corresponding author), Univ Jena, Inst Ecol, Jena, Germany.	anne.ebeling@uni-jena.de	Meyer, Sebastian Tobias/AAH-3856-2021; Weisser, Wolfgang W/B-9718-2014	Meyer, Sebastian Tobias/0000-0003-0833-1472; Weisser, Wolfgang W/0000-0002-2757-8959; Hertzog, Lionel/0000-0003-0869-9672	German Science Foundation (Deutsche Forschungsgemeinschaft) [WWW: FOR 1451, WE 401 1381/15-2, WE 1381/17-2]; Deutsche Forschungsgemeinschaft [WE 1381/17-2, FOR 1451, WE 1381/15-2]	German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the German Science Foundation (Deutsche Forschungsgemeinschaft), grant numbers WWW: FOR 1451, WE 401 1381/15-2, WE 1381/17-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the Deutsche Forschungsgemeinschaft (FOR 1451, WE 1381/15-2, WE 1381/17-2). We thank the gardener team and the technical assistants in particular Gerlinde Kratzsch for maintaining the field site. Further, we acknowledge numerous student assistants, who helped weeding the experimental plots. Ilka Wolf, Silke Schroeck and Sylvia Creutzburg are greatly acknowledged for helping in data collection, and Alexandra Weigelt and Enrica de Luca for providing biomass data.	Abbas M, 2014, BASIC APPL ECOL, V15, P169, DOI 10.1016/j.baae.2014.02.001; [Anonymous], 2014, R LANG ENV STAT COMP; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Boyer AG, 2003, OECOLOGIA, V136, P309, DOI 10.1007/s00442-003-1272-x; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; BRUST GE, 1986, AGR ECOSYST ENVIRON, V18, P145, DOI 10.1016/0167-8809(86)90137-4; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chalcraft DR, 2009, BIODIVERS CONSERV, V18, P91, DOI 10.1007/s10531-008-9457-6; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Ebeling A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106529; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; FAHNESTOCK JT, 1993, INT J PLANT SCI, V154, P432, DOI 10.1086/297126; Gagic V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2620; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; HSIEH T.C., 2014, INEXT INTERPOLATION; Joern A, 2013, ANNU REV ENTOMOL, V58, P19, DOI 10.1146/annurev-ento-120811-153540; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; MacArthur R. H., 1984, GEOGRAPHICAL ECOLOGY; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; MATSON PA, 1992, ECOLOGY, V73, P723, DOI 10.2307/1940151; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Milcu A, 2013, ECOLOGY, V94, P1878, DOI 10.1890/12-1936.1; Nitschke N, 2014, OIKOS; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Rzanny M, 2013, OIKOS, V122, P967, DOI 10.1111/j.1600-0706.2012.00114.x; Rzanny M, 2012, J ANIM ECOL, V81, P614, DOI 10.1111/j.1365-2656.2012.01951.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; WILLIAMS SL, 1993, ECOLOGY, V74, P904, DOI 10.2307/1940815; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	44	31	31	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148768	10.1371/journal.pone.0148768	http://dx.doi.org/10.1371/journal.pone.0148768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859496	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400077
J	Correa-Martin, L; Parraga, E; Sanchez-Margallo, FM; Latorre, R; Lopez-Albors, O; Wise, R; Malbrain, MLNG; Castellanos, G				Correa-Martin, L.; Parraga, E.; Sanchez-Margallo, F. M.; Latorre, R.; Lopez-Albors, O.; Wise, R.; Malbrain, M. L. N. G.; Castellanos, G.			Mechanical Intestinal Obstruction in a Porcine Model: Effects of Intra-Abdominal Hypertension. A Preliminary Study	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; PULSE PRESSURE VARIATION; STROKE VOLUME VARIATION; CRITICALLY-ILL PATIENTS; BOWEL OBSTRUCTION; BLOOD-FLOW; RAT MODEL; INTERNATIONAL-CONFERENCE; DISTRESS SYNDROME; TRANSLOCATION	Introduction Mechanical intestinal obstruction is a disorder associated with intra-abdominal hypertension and abdominal compartment syndrome. As the large intestine intraluminal and intra-abdominal pressures are increased, so the patient's risk for intestinal ischaemia. Previous studies have focused on hypoperfusion and bacterial translocation without considering the concomitant effect of intra-abdominal hypertension. The objective of this study was to design and evaluate a mechanical intestinal obstruction model in pigs similar to the human pathophysiology. Materials and Methods Fifteen pigs were divided into three groups: a control group (n = 5) and two groups of 5 pigs with intra-abdominal hypertension induced by mechanical intestinal obstruction. The intra-abdominal pressures of 20 mmHg were maintained for 2 and 5 hours respectively. Hemodynamic, respiratory and gastric intramucosal pH values, as well as blood tests were recorded every 30 min. Results Significant differences between the control and mechanical intestinal obstruction groups were noted. The mean arterial pressure, cardiac index, dynamic pulmonary compliance and abdominal perfusion pressure decreased. The systemic vascular resistance index, central venous pressure, pulse pressure variation, airway resistance and lactate increased within 2 hours from starting intra-abdominal hypertension (p<0.05). In addition, we observed increased values for the peak and plateau airway pressures, and low values of gastric intramucosal pH in the mechanical intestinal obstruction groups that were significant after 3 hours. Conclusion The mechanical intestinal obstruction model appears to adequately simulate the pathophysiology of intestinal obstruction that occurs in humans. Monitoring abdominal perfusion pressure, dynamic pulmonary compliance, gastric intramucosal pH and lactate values may provide insight in predicting the effects on endorgan function in patients with mechanical intestinal obstruction.	[Correa-Martin, L.; Sanchez-Margallo, F. M.] Jesus Uson Minimally Invas Surg Ctr, Laparoscopy Dept, Caceres, Spain; [Parraga, E.; Latorre, R.; Lopez-Albors, O.] Univ Murcia, Fac Vet, Dept Anat & Comparat Pathol, Murcia, Spain; [Wise, R.] Edendale Hosp, Crit Care Unit, Pietermaritzburg, South Africa; [Wise, R.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Perioperat Res Grp, Dept Anaesthet & Crit Care, Durban, South Africa; [Malbrain, M. L. N. G.] Ziekenhuis Netwerk Antwerpen, Med & Surg ICU & High Care Burn Unit, Antwerp, Belgium; [Castellanos, G.] Virgen Arrixaca Gen Univ Hosp, Dept Gen Surg, Murcia, Spain	University of Murcia; University of Kwazulu Natal; Hospital Clinico Universitario Virgen de la Arrixaca	Correa-Martin, L (corresponding author), Jesus Uson Minimally Invas Surg Ctr, Laparoscopy Dept, Caceres, Spain.	lcorrea@ccmijesususon.com	Latorre, Rafael/L-1184-2014; Sánchez Margallo, Francisco Miguel Miguel/I-5605-2019; Malbrain, Manu LNG/B-3680-2017; Albors, Octavio Lopez/D-8612-2015; PARRAGA, EDUARDO/ABB-9054-2021	Latorre, Rafael/0000-0002-3609-2790; Sánchez Margallo, Francisco Miguel Miguel/0000-0003-2138-988X; Malbrain, Manu LNG/0000-0002-1816-5255; Albors, Octavio Lopez/0000-0002-1410-1668; Correa Martin, Laura/0000-0003-4470-7924	Extremadura Regional Government through the Plan Regional de Investigacion de Extremadura [PRI09A161]	Extremadura Regional Government through the Plan Regional de Investigacion de Extremadura	This work was supported by one grant from Extremadura Regional Government through the Plan Regional de Investigacion de Extremadura (PRI09A161 to Minimally Invasive Surgery Center Jesus Uson). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameloot K, 2012, SURG CLIN N AM, V92, P207, DOI 10.1016/j.suc.2012.01.009; [Anonymous], GUID EUTH AN; Baigorri-Gonzalez F, 2005, OXIGENACION TISULAR, V29; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Cheatham ML, 2007, ACTA CLIN BELG, V62, P98, DOI 10.1179/acb.2007.62.s1.013; Cheatham ML, 2007, INTENS CARE MED, V33, P951, DOI 10.1007/s00134-007-0592-4; Cheatham ML, 2000, J TRAUMA, V49, P621, DOI 10.1097/00005373-200010000-00008; Correa-Martin L, 2013, ACTAS UROL ESP, V37, P273, DOI 10.1016/j.acuro.2012.06.001; Correa-Martin L, 2014, GASTROENT HEPAT-BARC, V37, P51, DOI 10.1016/j.gastrohep.2013.08.002; Correa-Martin L, 2013, J SURG RES, V184, P1028, DOI 10.1016/j.jss.2013.04.041; de Laet I E, 2007, Med Intensiva, V31, P88; de Tomas J TF, 2001, CIR ESPAN, P129; Deenichin GP, 2008, SURG TODAY, V38, P5, DOI 10.1007/s00595-007-3573-x; Diaz F DA, 2012, CONSECUENCIAS HEMODI, V83, P454; DIEBEL L, 1992, AM SURGEON, V58, P573; DIEBEL LN, 1992, J TRAUMA, V33, P279, DOI 10.1097/00005373-199208000-00019; Duperret S, 2007, INTENS CARE MED, V33, P163, DOI 10.1007/s00134-006-0412-2; El-Awady SI, 2009, ACTA CIR BRAS, V24, P98, DOI 10.1590/S0102-86502009000200005; Fauci B, 2008, MED INTERNA; Giardino R., 1993, Bollettino Societa Italiana Biologia Sperimentale, V69, P625; Gudmundsson FF, 2001, SURG ENDOSC, V15, P854, DOI 10.1007/s004640090090; Holodinsky JK, 2013, CRIT CARE, V17, DOI 10.1186/cc13075; Jacques D, 2011, CRIT CARE, V15, DOI 10.1186/cc9980; Kaussen T, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S17; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Kucuk HF, 2010, ULUS TRAVMA ACIL CER, V16, P349; Laurell H, 2006, ANTICANCER RES, V26, P3675; Lee RK, 2012, CRIT CARE NURSE, V32, P19, DOI 10.4037/ccn2012662; Leite R, 2010, ACTA CIR BRAS, V25, P2, DOI 10.1590/S0102-86502010000100003; Lopez-Kostner F, 1997, SURG CLIN N AM, V77, P1265, DOI 10.1016/S0039-6109(05)70617-4; Madl C, 2003, BEST PRACT RES CL GA, V17, P445, DOI 10.1016/S1521-6918(03)00022-2; Makinen MT, 2001, CAN J ANAESTH, V48, P121; Malbrain M, 2009, F1000 MED REP, V1; Malbrain MLNG, 2008, MINERVA ANESTESIOL, V74, P657; Malbrain MLNG, 2014, MINERVA ANESTESIOL, V80, P293; Malbrain MLNG, 2006, INTENS CARE MED, V32, P1722, DOI 10.1007/s00134-006-0349-5; Malbrain MLNG, 2009, CLIN CHEST MED, V30, P45, DOI 10.1016/j.ccm.2008.09.003; Malbrain MLNG, 2009, CRIT CARE MED, V37, P781, DOI 10.1097/CCM.0b013e318194c397; Malbrain ML, 2002, ABDOMINAL PERFUSION; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Malbrain MLNG, 2004, INTENS CARE MED, V30, P357, DOI 10.1007/s00134-003-2107-2; Markogiannakis H, 2007, WORLD J GASTROENTERO, V13, P432, DOI 10.3748/wjg.v13.i3.432; Vivas AM, 2008, ENFERM INTENSIV, V19, P132, DOI 10.1016/S1130-2399(08)72755-X; Otto J, 2010, SHOCK, V33, P639, DOI 10.1097/SHK.0b013e3181cb8be0; PATTILLO JC, 2004, REV CHIL MED INTENSI, V19, P7; Pelosi P, 2007, ACTA CLIN BELG, V62, P78, DOI 10.1179/acb.2007.62.s1.011; Piacentini E, 2010, ENFERM INFEC MICR CL, V28, P2, DOI 10.1016/S0213-005X(10)70024-0; Pittner A, 2002, ANESTH ANALG, V94, P1510, DOI 10.1097/00000539-200206000-00025; Renner J, 2009, CRIT CARE MED, V37, P650, DOI 10.1097/CCM.0b013e3181959864; Sanchez-Miralles A, 2013, MED INTENSIVA, V37, P99, DOI 10.1016/j.medin.2011.11.019; Schachtrupp A, 2007, ACTA CLIN BELG, V62, P225, DOI 10.1179/acb.2007.62.s1.031; Schachtrupp A, 2002, J SURG RES, V106, P37, DOI 10.1006/jsre.2002.6421; Sugrue M, 1996, WORLD J SURG, V20, P988, DOI 10.1007/s002689900149; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Swindle MM, 1998, SACAND J LAB ANIM SC, V25; Toens C, 2002, SHOCK, V18, P316, DOI 10.1097/00024382-200210000-00005; van Noord D, 2011, DIGEST DIS SCI, V56, P506, DOI 10.1007/s10620-010-1303-5; Walters Eric M, 2013, Mo Med, V110, P212; Wu CC, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-39; Yuan ML, 2013, WORLD J GASTROENTERO, V19, P692, DOI 10.3748/wjg.v19.i5.692; Zanoni FL, 2009, CLINICS, V64, P911, DOI 10.1590/S1807-59322009000900013	63	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148058	10.1371/journal.pone.0148058	http://dx.doi.org/10.1371/journal.pone.0148058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849559	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000035
J	Davillas, A; Benzeval, M; Kumari, M				Davillas, Apostolos; Benzeval, Michaela; Kumari, Meena			Association of Adiposity and Mental Health Functioning across the Lifespan: Findings from Understanding Society (The UK Household Longitudinal Study)	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; GENERAL-POPULATION; JOLLY FAT; OBESITY; DEPRESSION; OVERWEIGHT; METAANALYSIS; ADULTS; DISORDERS	Background Evidence on the adiposity-mental health associations is mixed, with studies finding positive, negative or no associations, and less is known about how these associations may vary by age. Objective To examine the association of adiposity -body mass index (BMI), waist circumference (WC) and percentage body fat (BF%)-with mental health functioning across the adult lifespan. Methods Data from 11,257 participants (aged 18+) of Understanding Society: the UK Household Longitudinal Study (waves 2 and 3, 5/2010-7/2013) were employed. Regressions of mental health functioning, assessed by the Mental Component Summary (MCS-12) and the General Health Questionnaire (GHQ-12), on adiposity measures (continuous or dichotomous indicators) were estimated adjusted for covariates. Polynomial age-adiposity interactions were estimated. Results Higher adiposity was associated with poorer mental health functioning. This emerged in the 30s, increased up to mid-40s (all central adiposity and obesity-BF% measures) or early 50s (all BMI measures) and then decreased with age. Underlying physical health generally accounted for these associations except for central adiposity, where associations remained statistically significant from the mid-30s to50s. Cardiovascular, followed by arthritis and endocrine, conditions played the greatest role in attenuating the associations under investigation. Conclusions We found strong age-specific patterns in the adiposity-mental health functioning association that varied across adiposity measures. Underlying physical health had the dominant role in attenuating these associations. Policy makers and health professionals should target increased adiposity, mainly central adiposity, as it is a risk factor for poor mental health functioning in those aged between mid-30s to 50 years.	[Davillas, Apostolos; Benzeval, Michaela; Kumari, Meena] Univ Essex, ISER, Colchester CO4 3SQ, Essex, England; [Benzeval, Michaela] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Kumari, Meena] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Essex; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; University College London	Kumari, M (corresponding author), Univ Essex, ISER, Colchester CO4 3SQ, Essex, England.; Kumari, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	mkumari@essex.ac.uk	Benzeval, Michaela/J-3163-2015	Benzeval, Michaela/0000-0002-0372-2098; Kumari, Meena/0000-0001-9716-1035; Davillas, Apostolos/0000-0002-6607-274X	Economic and Social Research Council; University of Essex; ESRC [ES/L009153/1, ES/N00812X/1, ES/K005146/1] Funding Source: UKRI; Economic and Social Research Council [ES/K005146/1, ES/L009153/1, ES/N00812X/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Essex; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	MB is funded by Economic and Social Research Council and the University of Essex, MK and AD are funded by the University of Essex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; Atlantis E, 2008, INT J OBESITY, V32, P715, DOI 10.1038/sj.ijo.0803762; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Bowling A., 1991, MEASURING HLTH REV Q; Cash TF., 2004, BODY IMAGE, V1, P363, DOI [10.1016/j.bodyim.2004.10.001, DOI 10.1016/J.B0DYIM.2004.10.001, DOI 10.1016/J.BODYIM.2004.10.001]; Clarke LH, 2011, CAN J AGING, V30, P495, DOI 10.1017/S0714980811000274; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; Dalal DK, 2012, ORGAN RES METHODS, V15, P339, DOI 10.1177/1094428111430540; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Epel ES, 2000, PSYCHOSOM MED, V62, P623, DOI 10.1097/00006842-200009000-00005; Faith MS, 2002, J PSYCHOSOM RES, V53, P935, DOI 10.1016/S0022-3999(02)00308-2; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Han TS, 1998, AM J PUBLIC HEALTH, V88, P1814, DOI 10.2105/AJPH.88.12.1814; He Y, 2008, PSYCHOL MED, V38, P1639, DOI 10.1017/S0033291707002474; Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122; Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7; Knies G., 2014, UNDERSTANDING SOC UK; Larsson U, 2002, INT J OBESITY, V26, P417, DOI 10.1038/sj.ijo.0801919; Linke SE, 2009, ARCH GEN PSYCHIAT, V66, P499, DOI 10.1001/archgenpsychiatry.2009.27; Lynn P., 2012, UNDERSTANDING SOC WO; Magallares A, 2014, APPL RES QUAL LIFE, V9, P295, DOI 10.1007/s11482-013-9226-x; Marijnissen RM, 2011, J AM GERIATR SOC, V59, P67, DOI 10.1111/j.1532-5415.2010.03228.x; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; McFall S., 2014, UNDERSTANDING SOC UK; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Oswald A., 2007, ECON J, DOI DOI 10.1111/J.1468-0297.2007.02077_1.X; Palinkas LA, 1996, J PSYCHOSOM RES, V40, P59, DOI 10.1016/0022-3999(95)00542-0; Panel NOEIE, 1998, CLIN GUIDELINES IDEN; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Propper C, 2005, SOC SCI MED, V61, P2065, DOI 10.1016/j.socscimed.2005.04.013; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Rivenes AC, 2009, J PSYCHOSOM RES, V66, P269, DOI 10.1016/j.jpsychores.2008.07.012; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; ROSS CE, 1994, J HEALTH SOC BEHAV, V35, P63, DOI 10.2307/2137335; Stata Corp, 2013, STAT STAT SOFTW REL; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; Ul-Haq Z, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-153; Ul-Haq Z, 2014, J EPIDEMIOL COMMUN H, V68, P340, DOI 10.1136/jech-2013-203077; Ul-Haq Z, 2013, OBESITY, V21, pE322, DOI 10.1002/oby.20107; University of Essex. Institute for Social and Economic Research and National Centre for Social Research. Understanding Society, 2014, UND SOC WAV 2 3 NURS; University of Essex. Institute for Social and Economic Research and National Centre for Social Research. Understanding Society, 2009, UND SOC WAV 1 5, P1; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2003, INV MENT HLTH; Xu QY, 2011, OBES RES CLIN PRACT, V5, pE267, DOI 10.1016/j.orcp.2011.04.007	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148561	10.1371/journal.pone.0148561	http://dx.doi.org/10.1371/journal.pone.0148561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849046	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000369554000126
J	Shen, LY; Chen, L; Zhang, SH; Du, JJ; Bai, L; Zhang, Y; Jiang, YZ; Li, XW; Wang, JY; Zhu, L				Shen, Linyuan; Chen, Lei; Zhang, Shunhua; Du, Jingjing; Bai, Lin; Zhang, Yi; Jiang, Yanzhi; Li, Xuewei; Wang, Jinyong; Zhu, Li			MicroRNA-27b Regulates Mitochondria Biogenesis in Myocytes	PLOS ONE			English	Article							MUSCLE FIBER-TYPE; SKELETAL-MUSCLE; OVEREXPRESSION; PGC-1-ALPHA; ACTIVATION; MEF2C; RNA	MicroRNAs (miRNAs) are small, non-coding RNAs that affect the post-transcriptional regulation of various biological pathways. To date, it is not fully understood how miRNAs regulate mitochondrial biogenesis. This study aimed at the identification of the role of miRNA-27b in mitochondria biogenesis. The mitochondria content in C2C12 cells was significantly increased during myogenic differentiation and accompanied by a marked decrease of miRNA-27b expression. Furthermore, the expression of the predicted target gene of miRNA-27b, forkhead box j3 (Foxj3), was also increased during myogenic differentiation. Luciferase activity assays confirmed that miRNA-27b directly targets the 3'-untranslated region (3'-UTR) of Foxj3. Overexpression of miRNA-27b provoked a decrease of mitochondria content and diminished expression of related mitochondrial genes and Foxj3 both at mRNA and protein levels. The expression levels of downstream genes of Foxj3, such as Mef2c, PGC1 alpha, NRF1 and mtTFA, were also decreased in C2C12 cells upon overexpression of miRNA-27b. These results suggested that miRNA-27b may affect mitochondria biogenesis by down-regulation of Foxj3 during myocyte differentiation.	[Shen, Linyuan; Zhang, Shunhua; Du, Jingjing; Bai, Lin; Li, Xuewei; Zhu, Li] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Sichuan, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China; [Zhang, Yi] Xichang Coll, Dept Anim Sci, Xichang 615000, Sichuan, Peoples R China; [Jiang, Yanzhi] Sichuan Agr Univ, Dept Biol, Coll Life & Sci, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University; Xichang College; Sichuan Agricultural University	Zhu, L (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Sichuan, Peoples R China.; Wang, JY (corresponding author), Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China.	kingyou@vip.sina.com; zhuli7508@163.com	Du, Jingjing/X-4006-2019	Shen, Linyuan/0000-0001-6072-3268	Sichuan Sci & Tech Support Program [2013NZ0041, 2013NZ0056]; earmarked fund for China Agriculture Research System [CARS-36-05B]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]	Sichuan Sci & Tech Support Program; earmarked fund for China Agriculture Research System; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The study was supported by the Sichuan Sci & Tech Support Program (No. 2013NZ0041 and 2013NZ0056), the earmarked fund for China Agriculture Research System (No. CARS-36-05B), and Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2010, DEV BIOL, V337, P396, DOI 10.1016/j.ydbio.2009.11.015; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Chinchilla A, 2010, CARDIOVASC RES; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Gao YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082782, 10.1371/journal.pone.0075065]; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hou Ning, 2012, Yichuan, V34, P326, DOI 10.3724/SP.J.1005.2012.00326; Kang T, 2013, J BIOL CHEM, V288, P34394, DOI 10.1074/jbc.M113.514372; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu YK, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; May-Panloup P, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-65; Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, pE818, DOI 10.1152/ajpendo.00322.2004; Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5; Ngamsiri P, 2014, MITOCHONDRION, V14, P54, DOI 10.1016/j.mito.2013.11.003; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shum AMY, 2012, AGING-US, V4, P133, DOI 10.18632/aging.100436; Sierra V, 2013, RECENT PATENTS ENDOC, V7, P120, DOI 10.2174/1872214811307020005; Singh K, 2013, FEBS J, V280, P3991, DOI 10.1111/febs.12188; Tak H, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.73; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1770; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	34	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148532	10.1371/journal.pone.0148532	http://dx.doi.org/10.1371/journal.pone.0148532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849429	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000118
J	Pandey, S; Modak, A; Phale, PS; Bhaumik, P				Pandey, Suman; Modak, Arnab; Phale, Prashant S.; Bhaumik, Prasenjit			High Resolution Structures of Periplasmic Glucose-binding Protein of Pseudomonas putida CSV86 Reveal Structural Basis of Its Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; glucose transport; protein structure; Pseudomonas; structure-function; substrate specificity; sugar transport; periplasmic glucose-binding protein; x-ray crystallography; sugar binding pocket	CRYSTAL-STRUCTURES; MALTOSE-BINDING; PREFERENTIAL UTILIZATION; CONFORMATIONAL-CHANGES; AROMATIC-COMPOUNDS; ACTIVE-TRANSPORT; RECEPTOR; MECHANISM; CHEMOTAXIS; STABILITY	Periplasmic substrate-binding proteins (SBPs) bind to the specific ligand with high affinity and mediate their transport into the cytoplasm via the cognate inner membrane ATP-binding cassette proteins. Because of low sequence identities, understanding the structural basis of substrate recognition by SBPs has remained very challenging. There are several structures available for the ligand-bound sugar SBPs, but very few unliganded structures are reported. No structural data are available for sugar SBPs from Pseudomonas sp. to date. This study reports the first high resolution crystal structures of periplasmic glucose-binding protein from Pseudomonas putida CSV86 (ppGBP) in unliganded form (2.5 ) and complexed with glucose (1.25 ) and galactose (1.8 ). Asymmetric domain closure of ppGBP was observed upon substrate binding. The ppGBP was found to have an affinity of approximate to 0.3 m for glucose. The structural analysis showed that the sugars are bound to the protein mainly by hydrogen bonds, and the loss of two strong hydrogen bonds between ppGBP and galactose compared with glucose may be responsible for lowering its affinity toward galactose. The higher stability of ppGBP-glucose complex was also indicated by an 8 degrees C increase in the melting temperature compared with unliganded form and ppGBP-galactose complex. ppGBP binds to monosaccharide, but the structural features revealed it to have an oligosaccharide-binding protein fold, indicating that during evolution the sugar binding pocket may have undergone structural modulation to accommodate monosaccharide only.	[Pandey, Suman; Modak, Arnab; Phale, Prashant S.; Bhaumik, Prasenjit] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Modak, Arnab] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Connecticut	Phale, PS; Bhaumik, P (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	pphale@iitb.ac.in; pbhaumik@iitb.ac.in		modak, arnab/0000-0001-7262-0143	Department of Biotechnology, Ministry of Science and Technology, India; Council of Scientific and Industrial Research, India; Department of Science and Technology, Ministry of Science and Technology, India	Department of Biotechnology, Ministry of Science and Technology, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Ministry of Science and Technology, India(Department of Science & Technology (India))	This work was supported in part by a Ramalingaswami re-entry fellowship and research grant (to P. B.) from the Department of Biotechnology, Ministry of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Ph.D. fellowship from the Council of Scientific and Industrial Research, India.; Supported by a research grant from the Department of Science and Technology, Ministry of Science and Technology, India.	Adewoye LO, 2000, GENE, V253, P323, DOI 10.1016/S0378-1119(00)00285-7; Basu A, 2006, APPL ENVIRON MICROB, V72, P2226, DOI 10.1128/AEM.72.3.2226-2230.2006; Basu A, 2007, J BACTERIOL, V189, P7556, DOI 10.1128/JB.01235-07; Benson DE, 2002, BIOCHEMISTRY-US, V41, P3262, DOI 10.1021/bi011359i; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Borrok MJ, 2007, PROTEIN SCI, V16, P1032, DOI 10.1110/ps.062707807; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhuri BN, 1999, J MOL BIOL, V286, P1519, DOI 10.1006/jmbi.1999.2571; Chekan JR, 2014, J BIOL CHEM, V289, P34965, DOI 10.1074/jbc.M114.579904; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; Cuneo MJ, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-50; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ejby M, 2013, MOL MICROBIOL, V90, P1100, DOI 10.1111/mmi.12419; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOCCO MM, 1994, J BIOL CHEM, V269, P8931; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Guo ML, 2003, J BIOL CHEM, V278, P2490, DOI 10.1074/jbc.M208776200; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heddle J, 2003, J BIOL CHEM, V278, P50322, DOI 10.1074/jbc.M307941200; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsieh HV, 2004, BIOSENS BIOELECTRON, V19, P653, DOI 10.1016/S0956-5663(03)00271-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Licht A, 2011, J MOL BIOL, V406, P92, DOI 10.1016/j.jmb.2010.11.048; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; MAO B, 1982, J BIOL CHEM, V257, P1131; Matsumoto N, 2009, FEBS J, V276, P3008, DOI 10.1111/j.1742-4658.2009.07020.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER DM, 1980, J BIOL CHEM, V255, P2465; Modak A., 2014, THESIS INDIAN I TECH; Modak A, 2014, FEBS J, V281, P365, DOI 10.1111/febs.12607; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Paliwal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084000; Pandey S., 2015, ADV BIOSCI BIOTECHNO, V6, P164, DOI [10.4236/abb.2015.63016, DOI 10.4236/ABB.2015.63016]; Phale P. S., 2013, GENOME ANNOUNC, V1; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schafer K, 2004, J MOL BIOL, V335, P261, DOI 10.1016/j.jmb.2003.10.042; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Shrivastava R, 2011, MICROBIOL-SGM, V157, P1531, DOI 10.1099/mic.0.047191-0; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; Taylor D, 2014, BIOINFORMATICS, V30, P3189, DOI 10.1093/bioinformatics/btu506; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vahedi-Faridi A, 2010, J MOL BIOL, V397, P709, DOI 10.1016/j.jmb.2010.01.054; Wilkinson T., 2003, ABC PROTEINS BACTERI, P187; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	64	17	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7844	7857		10.1074/jbc.M115.697268	http://dx.doi.org/10.1074/jbc.M115.697268			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26861882	Green Published, hybrid			2022-12-26	WOS:000374056700008
J	Forsberg, Z; Nelson, CE; Dalhus, B; Mekasha, S; Loose, JSM; Crouch, LI; Rohr, AK; Gardner, JG; Eijsink, VGH; Vaaje-Kolstad, G				Forsberg, Zarah; Nelson, Cassandra E.; Dalhus, Bjorn; Mekasha, Sophanit; Loose, Jennifer S. M.; Crouch, Lucy I.; Rohr, Asmund K.; Gardner, Jeffrey G.; Eijsink, Vincent G. H.; Vaaje-Kolstad, Gustav			Structural and Functional Analysis of a Lytic Polysaccharide Monooxygenase Important for Efficient Utilization of Chitin in Cellvibrio japonicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; CELL WALL DEGRADATION; CELLULOSE DEGRADATION; SERRATIA-MARCESCENS; SUBSTRATE-SPECIFICITY; OXIDATIVE CLEAVAGE; PROTEIN CBP21; ALPHA-CHITIN; REFINEMENT; DISCOVERY	Cellvibrio japonicus is a Gram-negative soil bacterium that is primarily known for its ability to degrade plant cell wall polysaccharides through utilization of an extensive repertoire of carbohydrate-active enzymes. Several putative chitin-degrading enzymes are also found among these carbohydrate-active enzymes, such as chitinases, chitobiases, and lytic polysaccharide monooxygenases (LPMOs). In this study, we have characterized the chitin-active LPMO, CjLPMO10A, a tri-modular enzyme containing a catalytic family AA10 LPMO module, a family 5 chitin-binding module, and a C-terminal unclassified module of unknown function. Characterization of the latter module revealed tight and specific binding to chitin, thereby unraveling a new family of chitin-binding modules (classified as CBM73). X-ray crystallographic elucidation of the CjLPMO10A catalytic module revealed that the active site of the enzyme combines structural features previously only observed in either cellulose or chitin-active LPMO10s. Analysis of the copper-binding site by EPR showed a signal signature more similar to those observed for cellulose-cleaving LPMOs. The full-length LPMO shows no activity toward cellulose but is able to bind and cleave both alpha- and beta-chitin. Removal of the chitin-binding modules reduced LPMO activity toward alpha-chitin compared with the full-length enzyme. Interestingly, the full-length enzyme and the individual catalytic LPMO module boosted the activity of an endochitinase equally well, also yielding similar amounts of oxidized products. Finally, gene deletion studies show that CjLPMO10A is needed by C. japonicus to obtain efficient growth on both purified chitin and crab shell particles.	[Forsberg, Zarah; Mekasha, Sophanit; Loose, Jennifer S. M.; Rohr, Asmund K.; Eijsink, Vincent G. H.; Vaaje-Kolstad, Gustav] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Nelson, Cassandra E.; Gardner, Jeffrey G.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; [Dalhus, Bjorn] Univ Oslo, Inst Clin Med, Dept Med Biochem, POB 4950, N-0424 Oslo, Norway; [Dalhus, Bjorn] Oslo Univ Hosp, Rikshosp, Clin Diagnost & Intervent, Dept Microbiol, POB 4950, N-0424 Oslo, Norway; [Crouch, Lucy I.] Newcastle Univ, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Norwegian University of Life Sciences; University System of Maryland; University of Maryland Baltimore County; University of Oslo; University of Oslo; National Hospital Norway; Newcastle University - UK	Vaaje-Kolstad, G (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	gustav.vaaje-kolstad@nmbu.no	Nelson, Cassandra/U-7963-2017; Forsberg, Zarah/AAM-2395-2020; Dalhus, Bjørn/AAK-2895-2020; Kjendseth, Åsmund Røhr/O-2543-2016; Mekasha, Sophanit/AAH-6400-2021	Nelson, Cassandra/0000-0002-7284-5198; Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Forsberg, Zarah/0000-0002-8236-7986	Research Council of Norway [216625/F50]; European Synchrotron Radiation Facility [MX-1468]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); European Synchrotron Radiation Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Beri for providing the C. sapidus shells and for technical assistance. We are grateful for synchrotron travel support from The Research Council of Norway Grant 216625/F50. We also thank the European Synchrotron Radiation Facility staff for help and beamtime at beamline ID30A Project MX-1468.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adav SS, 2010, J PROTEOME RES, V9, P3016, DOI 10.1021/pr901174z; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Book AJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu E, 2015, P NATL ACAD SCI USA, V112, P3973, DOI 10.1073/pnas.1418798112; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Gardner JG, 2014, MOL MICROBIOL, V94, P1121, DOI 10.1111/mmi.12821; Gardner JG, 2012, METHOD ENZYMOL, V510, P331, DOI 10.1016/B978-0-12-415931-0.00018-5; Gardner JG, 2010, APPL ENVIRON MICROB, V76, P5079, DOI 10.1128/AEM.00454-10; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; Gudmundsson M, 2014, J BIOL CHEM, V289, P18782, DOI 10.1074/jbc.M114.563494; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Heuts DPHM, 2008, BIOCHEM J, V413, P175, DOI 10.1042/BJ20071591; Hilden L, 2003, BIOTECHNOL LETT, V25, P553, DOI 10.1023/A:1022846304826; Hori C, 2011, FEMS MICROBIOL LETT, V321, P14, DOI 10.1111/j.1574-6968.2011.02307.x; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa YS, 2013, J AGR FOOD CHEM, V61, P11061, DOI 10.1021/jf402743e; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Phillips CM, 2011, J PROTEOME RES, V10, P4177, DOI 10.1021/pr200329b; Rytioja J, 2014, FUNGAL GENET BIOL, V72, P91, DOI 10.1016/j.fgb.2013.12.008; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHNELLMANN J, 1994, MOL MICROBIOL, V13, P807, DOI 10.1111/j.1365-2958.1994.tb00473.x; Selig MJ, 2015, CELLULOSE, V22, P2263, DOI 10.1007/s10570-015-0635-x; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yakovlev I, 2012, APPL MICROBIOL BIOT, V95, P979, DOI 10.1007/s00253-012-4206-x	72	78	79	3	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7300	7312		10.1074/jbc.M115.700161	http://dx.doi.org/10.1074/jbc.M115.700161			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858252	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000383447600008
J	Rabhi, S; Rabhi, I; Trentin, B; Piquemal, D; Regnault, B; Goyard, S; Lang, T; Descoteaux, A; Enninga, J; Guizani-Tabbane, L				Rabhi, Sameh; Rabhi, Imen; Trentin, Bernadette; Piquemal, David; Regnault, Beatrice; Goyard, Sophie; Lang, Thierry; Descoteaux, Albert; Enninga, Jost; Guizani-Tabbane, Lamia			Lipid Droplet Formation, Their Localization and Dynamics during Leishmania major Macrophage Infection	PLOS ONE			English	Article							MYCOBACTERIUM-LEPRAE; INTRACELLULAR DOMAINS; INFLAMMATORY RESPONSE; EICOSANOID FORMATION; IN-VIVO; HOST; BODIES; CHOLESTEROL; CELLS; AMAZONENSIS	Leishmania, the causative agent of vector-borne diseases, known as leishmaniases, is an obligate intracellular parasite within mammalian hosts. The outcome of infection depends largely on the activation status of macrophages, the first line of mammalian defense and the major target cells for parasite replication. Understanding the strategies developed by the parasite to circumvent macrophage defense mechanisms and to survive within those cells help defining novel therapeutic approaches for leishmaniasis. We previously showed the formation of lipid droplets (LDs) in L. major infected macrophages. Here, we provide novel insights on the origin of the formed LDs by determining their cellular distribution and to what extent these high-energy sources are directed to the proximity of Leishmania parasites. We show that the ability of L. major to trigger macrophage LD accumulation is independent of parasite viability and uptake and can also be observed in non-infected cells through paracrine stimuli suggesting that LD formation is from cellular origin. The accumulation of LDs is demonstrated using confocal microscopy and live-cell imagin in parasite-free cytoplasmic region of the host cell, but also promptly recruited to the proximity of Leishmania parasites. Indeed LDs are observed inside parasitophorous vacuole and in parasite cytoplasm suggesting that Leishmania parasites besides producing their own LDs, may take advantage of these high energy sources. Otherwise, these LDs may help cells defending against parasitic infection. These metabolic changes, rising as common features during the last years, occur in host cells infected by a large number of pathogens and seem to play an important role in pathogenesis. Understanding how Leishmania parasites and different pathogens exploit this LD accumulation will help us define the common mechanism used by these different pathogens to manipulate and/or take advantage of this high-energy source.	[Rabhi, Sameh; Rabhi, Imen; Guizani-Tabbane, Lamia] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Parasitol Med Biotechnol & Biomol, 13,Pl Pasteur BP 74, Tunis 1002, Tunisia; [Rabhi, Sameh] Univ Carthage, Ave Republ BP 77, Carthage 1054, Tunisia; [Rabhi, Imen] Univ Manouba, Biotechnol & Biogeo Resources Valorizat Lab LR11E, Sidi Thabet 2020, Ariana, Tunisia; [Rabhi, Imen] Univ Manouba, Higher Inst Biotechnol, Sidi Thabet 2020, Ariana, Tunisia; [Trentin, Bernadette; Piquemal, David] Acobiom Cap Delta Biopole Euromed II, 1682 Rue Valsiere, F-34184 Montpellier 4, France; [Regnault, Beatrice] Inst Pasteur Paris, Genopole, DNA Chip Platform, 25-28 Rue Dr Roux, F-75015 Paris, France; [Goyard, Sophie; Lang, Thierry] Inst Pasteur, Dept Infect & Epidemiol, Lab Proc Infect Trypanosomatides, 26 Rue Dr Roux, F-75724 Paris 15, France; [Descoteaux, Albert] INRS Inst Armand Frappier, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada; [Descoteaux, Albert] Ctr Host Parasite Interact, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada; [Enninga, Jost] Inst Pasteur, Dynam Host Pathogen Interact Unit, 25 Rue Dr Roux, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; Universite de la Manouba; Universite de la Manouba; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Quebec; Institut national de la recherche scientifique (INRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Guizani-Tabbane, L (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Parasitol Med Biotechnol & Biomol, 13,Pl Pasteur BP 74, Tunis 1002, Tunisia.	lamia.guizani@pasteur.rns.tn	Descoteaux, Albert/ABE-6326-2021	REGNAULT, Beatrice/0000-0002-3914-1914; Goyard, Sophie/0000-0002-8937-2796; Lang, Thierry/0000-0001-5032-8360; RABHI, Imen/0000-0002-9403-576X; Piquemal, David/0000-0002-5870-4276	European community grant [37231]; L'Oreal-UNESCO Pan Arab Regional Fellowship For Women in Science; ERC [261166]; Canadian Institutes of Health Research [MOP-12933]; Institut Pasteur International Network (RIIP-Calmette)	European community grant(European Commission); L'Oreal-UNESCO Pan Arab Regional Fellowship For Women in Science(L'Oreal Group); ERC(European Research Council (ERC)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institut Pasteur International Network (RIIP-Calmette)	L. G. T. was supported by funds from European community grant (Proposal number: 37231), I. R. was supported by a L'Oreal-UNESCO Pan Arab Regional Fellowship For Women in Science, J. E. was supported by an ERC starting grant (Rupteffects, number 261166), and is a member of the LabEx consortia IBEID and Milieu Interieur at the Institut Pasteur and A. D. was supported by the Canadian Institutes of Health Research (MOP-12933). S. R. was supported with a Traineeship grants to facilitate mobility within the Institut Pasteur International Network (RIIP-Calmette) for a 3 months traineeship in the lab of A. D. and with a 6 months fellowship, from L'Oreal-UNESCO Pan Arab Regional Fellowship For Women in Science that I. R. was granted, for a traineeship spent in the Lab of Dr Jost Enninga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Araujo-Santos T, 2014, J INFECT DIS, V210, P1951, DOI 10.1093/infdis/jiu299; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bashmakov Yuriy K, 2010, Comp Hepatol, V9, P3, DOI 10.1186/1476-5926-9-3; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Charron AJ, 2002, J CELL SCI, V115, P3049; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Das P, 2014, INDIAN J BIOCHEM BIO, V51, P542; De Cicco NNT, 2012, EXP PARASITOL, V130, P330, DOI 10.1016/j.exppara.2012.02.014; de Mattos KA, 2012, MEM I OSWALDO CRUZ, V107, P156, DOI 10.1590/S0074-02762012000900023; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Feingold KR, 2012, J LIPID RES, V53, P2487, DOI 10.1194/jlr.E033407; Feingold KR, 2010, J LIPID RES, V51, P682, DOI 10.1194/jlr.E005454; Franca-Costa J, 2015, J INFECT DIS, V211, P426, DOI 10.1093/infdis/jiu455; Ghosh J, 2012, J LIPID RES, V53, P2560, DOI 10.1194/jlr.M026914; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lecoeur H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002276; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Matheoud D, 2013, CELL HOST MICROBE, V14, P15, DOI 10.1016/j.chom.2013.06.003; Matte C, 2001, PARASITE IMMUNOL, V23, P177, DOI 10.1046/j.1365-3024.2001.00372.x; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Mellouk N, 2014, CELL HOST MICROBE, V16, P517, DOI 10.1016/j.chom.2014.09.005; Melo RCN, 2006, INFLAMM RES, V55, P342, DOI 10.1007/s00011-006-5205-0; Melo RCN, 2003, TISSUE CELL, V35, P59, DOI 10.1016/S0040-8166(02)00105-2; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Melo RCN, 2011, J HISTOCHEM CYTOCHEM, V59, P540, DOI 10.1369/0022155411404073; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Osorio y Fortea Jose, 2009, BMC Genomics, V10, P119, DOI 10.1186/1471-2164-10-119; Passero LFD, 2008, PARASITOL RES, V102, P1025, DOI 10.1007/s00436-007-0871-6; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Polando R, 2013, J LEUKOCYTE BIOL, V93, P921, DOI 10.1189/jlb.0212086; Portugal LR, 2008, MICROBES INFECT, V10, P276, DOI 10.1016/j.micinf.2007.12.001; Pulido-Mendez M, J SUBMICROSC CYTOL P, V38, P143; Rabhi I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001763; Rank RG, 2011, INFECT IMMUN, V79, P3291, DOI 10.1128/IAI.00200-11; Rodriguez-Acosta A, 1998, J SUBMICR CYTOL PATH, V30, P299; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Vinet AF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000628; WHO, 2015, LEISHM; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139	57	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148640	10.1371/journal.pone.0148640	http://dx.doi.org/10.1371/journal.pone.0148640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871576	Green Published, gold			2022-12-26	WOS:000370054100043
J	Cilano, K; Mazanek, Z; Khan, M; Metcalfe, S; Zhang, XN				Cilano, Kevin; Mazanek, Zachary; Khan, Mahmuda; Metcalfe, Sarah; Zhang, Xiao-Ning			A New Mutation, hap1-2, Reveals a C Terminal Domain Function in AtMago Protein and Its Biological Effects in Male Gametophyte Development in Arabidopsis thaliana	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; MAGO-NASHI; SWISS-MODEL; CRYSTAL-STRUCTURE; DROSOPHILA; GENE; NUCLEOLUS; UPF3	The exon-exon junction complex (EJC) is a conserved eukaryotic multiprotein complex that examines the quality of and determines the availability of messenger RNAs (mRNAs) post-transcriptionally. Four proteins, MAGO, Y14, eIF4AIII and BTZ, function as core components of the EJC. The mechanisms of their interactions and the biological indications of these interactions are still poorly understood in plants. A new mutation, hap1-2. leads to premature pollen death and a reduced seed production in Arabidopsis. This mutation introduces a viable truncated transcript AtMago Delta C. This truncation abolishes the interaction between AtMago and AtY14 in vitro, but not the interaction between AtMago and AteIF4AIII. In addition to a strong nuclear presence of AtMago, both AtMago and AtMago Delta C exhibit processing-body (P-body) localization. This indicates that AtMago Delta C may replace AtMago in the EJC when aberrant transcripts are to be degraded. When introducing an NMD mutation, upf3-1, into the existing HAP1/hap1-2 mutant, plants showed a severely reduced fertility. However, the change of splicing pattern of a subset of SR protein transcripts is mostly correlated with the sr45-1 and upf3-1 mutations, not the hap1-2 mutation. These results imply that the C terminal domain (CTD) of AtMago is required for the AtMago-AtY14 heterodimerization during EJC assembly, UPF3-mediated NMD pathway and the AtMago-AtY14 heterodimerization work synergistically to regulate male gametophyte development in plants.	[Cilano, Kevin; Khan, Mahmuda; Zhang, Xiao-Ning] St Bonaventure Univ, Dept Biol, St Bonaventure, NY 14778 USA; [Mazanek, Zachary; Metcalfe, Sarah; Zhang, Xiao-Ning] St Bonaventure Univ, Biochem Program, St Bonaventure, NY 14778 USA; [Cilano, Kevin] St Francis Inn Minist, Philadelphia, PA USA; [Mazanek, Zachary] Johns Hopkins Univ, Dept Chem, Baltimore, MD USA; [Khan, Mahmuda] George Washington Univ, Sch Med, Washington, DC USA	Johns Hopkins University; George Washington University	Zhang, XN (corresponding author), St Bonaventure Univ, Dept Biol, St Bonaventure, NY 14778 USA.; Zhang, XN (corresponding author), St Bonaventure Univ, Biochem Program, St Bonaventure, NY 14778 USA.	xzhang@sbu.edu	Zhang, Xiao-Ning/J-1737-2019	Zhang, Xiao-Ning/0000-0001-8650-1356; Metcalfe, Sarah/0000-0002-6926-443X	National Science Foundation [NSF0950158]; Direct For Biological Sciences [1146300, 1147144] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work received financial support from The National Science Foundation, Grant number: NSF0950158. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000471; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Boothby TC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-45; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Buchwald G, 2010, P NATL ACAD SCI USA, V107, P10050, DOI 10.1073/pnas.1000993107; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; EYAL Y, 1995, PLANT CELL, V7, P373, DOI 10.1105/tpc.7.3.373; Fang YD, 2005, MOL BIOL CELL, V16, P5710, DOI 10.1091/mbc.E05-08-0706; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gong PC, 2014, PLANT J, V80, P905, DOI 10.1111/tpj.12672; Gong PC, 2014, PLANT PHYSIOL, V165, P1047, DOI 10.1104/pp.114.237958; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kawano T, 2004, MECH DEVELOP, V121, P27, DOI 10.1016/j.mod.2003.11.003; Kerenyi Z, 2008, EMBO J, V27, P1585, DOI 10.1038/emboj.2008.88; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim SH, 2009, PLANT CELL, V21, P2045, DOI 10.1105/tpc.109.067736; Koroleva OA, 2009, PLANT CELL, V21, P1592, DOI 10.1105/tpc.108.060434; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Park NI, 2007, PLANTA, V225, P625, DOI 10.1007/s00425-006-0385-y; Park NI, 2009, PLANT SCI, V176, P461, DOI 10.1016/j.plantsci.2008.12.016; Parma DH, 2007, DEV BIOL, V308, P507, DOI 10.1016/j.ydbio.2007.06.007; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; Singh KK, 2013, RNA BIOL, V10, P1291, DOI 10.4161/rna.25827; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Zhang XN, 2009, PLANT PHYSIOL, V150, P1450, DOI 10.1104/pp.109.138180	46	22	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148200	10.1371/journal.pone.0148200	http://dx.doi.org/10.1371/journal.pone.0148200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867216	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700010
J	Arnold, M; Liesirova, K; Broeg-Morvay, A; Meisterernst, J; Schlager, M; Mono, ML; El-Koussy, M; Kagi, G; Jung, S; Sarikaya, H				Arnold, Marcel; Liesirova, Kai; Broeg-Morvay, Anne; Meisterernst, Julia; Schlager, Markus; Mono, Marie-Luise; El-Koussy, Marwan; Kaegi, Georg; Jung, Simon; Sarikaya, Hakan			Dysphagia in Acute Stroke: Incidence, Burden and Impact on Clinical Outcome	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; OROPHARYNGEAL DYSPHAGIA; RESPIRATORY-INFECTIONS; NOSOCOMIAL INFECTIONS; ASPIRATION PNEUMONIA; SWALLOWING DISORDERS; POSTSTROKE DYSPHAGIA; CIRCULATION STROKES	Background Reported frequency of post-stroke dysphagia in the literature is highly variable. In view of progress in stroke management, we aimed to assess the current burden of dysphagia in acute ischemic stroke. Methods We studied 570 consecutive patients treated in a tertiary stroke center. Dysphagia was evaluated by using the Gugging Swallowing Screen (GUSS). We investigated the relationship of dysphagia with pneumonia, length of hospital stay and discharge destination and compared rates of favourable clinical outcome and mortality at 3 months between dysphagic patients and those without dysphagia. Results Dysphagia was diagnosed in 118 of 570 (20.7%) patients and persisted in 60 (50.9%) at hospital discharge. Thirty-six (30.5%) patients needed nasogastric tube because of severe dysphagia. Stroke severity rather than infarct location was associated with dysphagia. Dysphagic patients suffered more frequently from pneumonia (23.1% vs. 1.1%, p<0.001), stayed longer at monitored stroke unit beds (4.4 +/- 2.8 vs. 2.7 +/- 2.4 days; p<0.001) and were less often discharged to home (19.5% vs. 63.7%, p = 0.001) as compared to those without dysphagia. At 3 months, dysphagic patients less often had a favourable outcome (35.7% vs. 69.7%; p<0.001), less often lived at home (38.8% vs. 76.5%; p<0.001), and more often had died (13.6% vs. 1.6%; p<0.001). Multivariate analyses identified dysphagia to be an independent predictor of discharge destination and institutionalization at 3 months, while severe dysphagia requiring tube placement was strongly associated with mortality. Conclusion Dysphagia still affects a substantial portion of stroke patients and may have a large impact on clinical outcome, mortality and institutionalization.	[Arnold, Marcel; Liesirova, Kai; Broeg-Morvay, Anne; Meisterernst, Julia; Schlager, Markus; Mono, Marie-Luise; Jung, Simon; Sarikaya, Hakan] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [El-Koussy, Marwan] Univ Hosp Bern, Dept Neuroradiol, CH-3010 Bern, Switzerland; [Kaegi, Georg] Kantonsspital, Dept Neurol & Neurophysiol, St Gallen, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen	Arnold, M (corresponding author), Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland.	marcel.arnold@insel.ch			Nestec S.A.	Nestec S.A.	This study was supported by Nestec S.A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman KW, 2010, ARCH OTOLARYNGOL, V136, P784, DOI 10.1001/archoto.2010.129; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Bonilha HS, 2014, DYSPHAGIA, V29, P545, DOI 10.1007/s00455-014-9543-8; Broadley S, 2003, J CLIN NEUROSCI, V10, P300, DOI 10.1016/S0967-5868(03)00022-5; Brogan E, 2014, DYSPHAGIA, V29, P340, DOI 10.1007/s00455-013-9514-5; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Daniels SK, 2012, STROKE, V43, P892, DOI 10.1161/STROKEAHA.111.640946; De Marchis GM, 2011, J NEUROL NEUROSUR PS, V82, P33, DOI 10.1136/jnnp.2010.211151; Doggett DL, 2001, DYSPHAGIA, V16, P279, DOI 10.1007/s00455-001-0087-3; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Ellis C, 2012, STROKE, V43, P1429, DOI 10.1161/STROKEAHA.111.647339; Falsetti P, 2009, J STROKE CEREBROVASC, V18, P329, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.009; Fang MC, 2014, AM J MED, V127, P608, DOI 10.1016/j.amjmed.2014.03.017; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Fourrier F, 2000, INTENS CARE MED, V26, P1239, DOI 10.1007/s001340000585; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goldhill DR, 2007, AM J CRIT CARE, V16, P50; Gonzalez-Fernandez Marlis, 2013, Curr Phys Med Rehabil Rep, V1, P187; Hamdy S, 1997, LANCET, V350, P686, DOI 10.1016/S0140-6736(97)02068-0; Heckert KD, 2009, STROKE, V40, P1381, DOI 10.1161/STROKEAHA.108.533489; KIDD D, 1995, QJM-MON J ASSOC PHYS, V88, P409; Langdon PC, 2009, NEUROEPIDEMIOLOGY, V32, P107, DOI 10.1159/000177036; Langdon PC, 2007, J CLIN NEUROSCI, V14, P630, DOI 10.1016/j.jocn.2006.04.009; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Langmore SE, 2002, DYSPHAGIA, V17, P298, DOI 10.1007/s00455-002-0072-5; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; Lee S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000269; Li L, 2015, EUR J PHYS REHAB MED, V51, P71; Mann G, 2000, CEREBROVASC DIS, V10, P380, DOI 10.1159/000016094; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Meng NH, 2000, AM J PHYS MED REHAB, V79, P170, DOI 10.1097/00002060-200003000-00010; Metheny NA, 2002, AM J CRIT CARE, V11, P150, DOI 10.4037/ajcc2002.11.2.150; Milins B, 2003, GERONTOLOGY, V49, P173, DOI 10.1159/000069171; Momosaki R, 2014, NEUROMODULATION, V17, P637, DOI 10.1111/ner.12137; Nilsson H, 1998, DYSPHAGIA, V13, P32, DOI 10.1007/PL00009547; Okubo PCMI, 2012, CEREBROVASC DIS, V33, P501, DOI 10.1159/000336240; Paciaroni M, 2004, EUR NEUROL, V51, P162, DOI 10.1159/000077663; Sarikaya H, 2011, STROKE, V42, P2498, DOI 10.1161/STROKEAHA.110.607614; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Smithard DG, 2007, AGE AGEING, V36, P90, DOI 10.1093/ageing/afl149; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Trapl M, 2007, STROKE, V38, P2948, DOI 10.1161/STROKEAHA.107.483933; Upadya A, 2004, J CRIT CARE, V19, P16, DOI 10.1016/j.jcrc.2004.02.004; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VEIS SL, 1985, ARCH PHYS MED REHAB, V66, P372; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002; Yeh SJ, 2011, J NEUROL SCI, V306, P38, DOI 10.1016/j.jns.2011.04.001	52	169	181	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148424	10.1371/journal.pone.0148424	http://dx.doi.org/10.1371/journal.pone.0148424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863627	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600069
J	Jeffries, MD; Gannon, TW; Brosnan, JT; Ahmed, KA; Breeden, GK				Jeffries, Matthew D.; Gannon, Travis W.; Brosnan, James T.; Ahmed, Khalied A.; Breeden, Gregory K.			Factors Influencing Dislodgeable 2, 4-D Plant Residues from Hybrid Bermudagrass (Cynodon dactylon L. x C. transvaalensis) Athletic Fields	PLOS ONE			English	Article							LEAF WETNESS DURATION; CREEPING BENTGRASS; ANNUAL BLUEGRASS; 2,4-D; ABSORPTION; EXPOSURE; ACID; TRANSLOCATION; CHLORPYRIFOS; METABOLISM	Research to date has confirmed 2,4-D residues may dislodge from turfgrass; however, experiments have not been conducted on hybrid bermudagrass (Cynodon dactylon L. x C. transvaalensis), the most common athletic field turfgrass in subtropical climates. More specifically, previous research has not investigated the effect of post-application irrigation on dislodgeable 2,4-D residues from hybrid bermudagrass and across turfgrass species, research has been nondescript regarding sample time within a d (TWD) or conducted in the afternoon when the turfgrass canopy is dry, possibly underestimating potential for dislodgement. The effect of irrigation and TWD on 2,4-D dislodgeability was investigated. Dislodgeable 2,4-D amine was reduced > 300% following irrigation. From 2 to 7 d after treatment (DAT), <= 0.5% of applied 2,4-D was dislodged from irrigated turfgrass, while <= 2.3% of applied 2,4-D was dislodged when not irrigated. 2,4-D dislodgeability decreased as TWD increased. Dislodgeable 2,4-D residues declined to < 0.1% of the applied at 1 DAT-13: 00, and increased to 1 to 3% of the applied 2 DAT-5: 00, suggesting 2,4-D re-suspended on treated turfgrass vegetation overnight. In conclusion, irrigating treated turfgrass reduced dislodgeable 2,4-D. 2,4-D dislodgeability increased as TWD decreased, which was attributed to non-precipitation climatic conditions favoring turfgrass canopy wetness. This research will improve turfgrass management practices and research designed to minimize human 2,4-D exposure.	[Jeffries, Matthew D.; Gannon, Travis W.; Ahmed, Khalied A.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Brosnan, James T.; Breeden, Gregory K.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA	University of North Carolina; North Carolina State University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Jeffries, MD (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.	mdjeffri@ncsu.edu		Gannon, Travis/0000-0001-7140-8896				[Anonymous], 2009, 2007 CENS AGR US SUM; [Anonymous], 2007, 2 4 D CHEM SUMM; [Anonymous], 2001, REV REP ACT SUBST 2; [Anonymous], 2020, ASOPOS 20 ASSESSMENT; BAIER W., 1966, AGR METEOROL, V3, P103, DOI 10.1016/0002-1571(66)90008-2; Bus JS, 2007, CROP PROT, V26, P266, DOI 10.1016/j.cropro.2005.06.010; CARROLL MJ, 1993, WEED TECHNOL, V7, P437, DOI 10.1017/S0890037X00027858; Christians N, 2011, FUNDAMENTALS TURFGRA, P59; Cisar J. L., 2001, International Turfgrass Society Research Journal, V9, P12; COUPLAND D, 1981, WEED SCI, V29, P556, DOI 10.1017/S0043174500063724; DeBoer DW, 2001, APPL ENG AGRIC, V17, P11; Department of Health and Human Service: Centers for Disease Control & Prevention, 2005, NCEH PUB; Garabrant DH, 2002, CRIT REV TOXICOL, V32, P233, DOI 10.1080/20024091064237; Giesler LJ, 1996, AGR FOREST METEOROL, V81, P145, DOI 10.1016/0168-1923(95)02302-X; GOH KS, 1986, B ENVIRON CONTAM TOX, V37, P27, DOI 10.1007/BF01607724; HARRIS SA, 1992, J ENVIRON SCI HEAL B, V27, P9, DOI 10.1080/03601239209372764; HILL RH, 1989, ARCH ENVIRON CON TOX, V18, P469, DOI 10.1007/BF01055011; Hoffmann EJ, 2012, J ECON ENTOMOL, V105, P67, DOI 10.1603/EC11251; Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607; HUGHES RN, 1994, AGR FOREST METEOROL, V67, P173, DOI 10.1016/0168-1923(94)90002-7; Hurto KA, 2009, PESTICIDES URBAN ENV, P86; Junge A, 2004, AM J SPORT MED, V32, p23S, DOI 10.1177/0363546503261246; Kennepohl E, 2001, HDB PESTICIDE TOXICO, V2, P1623; Kincaid DC, 1996, T ASAE, V39, P839, DOI 10.13031/2013.27568; Kohler EA, 2002, WEED SCI, V50, P576, DOI 10.1614/0043-1745(2002)050[0576:SOUATA]2.0.CO;2; Krolski M.E., 2010, ACS S SERIES, P43; Kruit RJW, 2008, ATMOS ENVIRON, V42, P5304, DOI 10.1016/j.atmosenv.2008.02.061; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Loughner DL, 2010, APPL TURFGRASS SCI; Lutgens FK, 2007, ATMOSPHERE INTRO MET, P110; Magri A, 2009, J ENVIRON QUAL, V38, P4, DOI 10.2134/jeq2007.0620; McCullough PE, 2009, WEED SCI, V57, P470, DOI 10.1614/WS-09-025.1; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Moody RP, 1997, TOXICOL IN VITRO, V11, P251, DOI 10.1016/S0887-2333(97)00013-1; Morgan MK, 2008, J EXPO SCI ENV EPID, V18, P486, DOI 10.1038/sj.jes.7500641; MUNRO IC, 1992, J AM COLL TOXICOL, V11, P559, DOI 10.3109/10915819209141893; Nishioka MG, 2001, ENVIRON HEALTH PERSP, V109, P1185, DOI 10.2307/3454867; Nishioka MG, 2002, B ENVIRON CONTAM TOX, V68, P64, DOI 10.1007/s00128-001-0220-x; Petrovic AM, 1994, HDB INTEGRATED PEST, P30; Puhalla J, 1999, SPORTS FIELDS MANUAL, P119; SEARS MK, 1987, PESTIC SCI, V20, P223, DOI 10.1002/ps.2780200307; Sentelhas PC, 2007, INT J BIOMETEOROL, V51, P265, DOI 10.1007/s00484-006-0070-7; Shaner DL, 2014, HERBICIDE HDB, P16; Shin EH, 2011, BIOMED CHROMATOGR, V25, P124, DOI 10.1002/bmc.1513; Snyder GH, 1998, ASSESSMENT RISKS ASS, P647; Steel RGD, 1997, PRINCIPLES PROCEDURE, V3, P352; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; THOMPSON DG, 1984, PESTIC SCI, V15, P353, DOI 10.1002/ps.2780150405; U.S. EPA, 2005, MEM 24 D HES REV HUM; United States Census Bureau, 2012, PART SEL SPORTS ACT; US EPA (US Environmental Protection Agency), 2012, STAND OP PROC RES PE; Weisenberger D, 2012, 2011 ANN REPORT PURD, P22; Wilson TB, 1999, AGR FOREST METEOROL, V93, P111, DOI 10.1016/S0168-1923(98)00116-6; Yu JL, 2013, WEED SCI, V61, P217, DOI 10.1614/WS-D-12-00136.1	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148992	10.1371/journal.pone.0148992	http://dx.doi.org/10.1371/journal.pone.0148992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863005	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600135
J	Ribeiro, JC; Simoes, J; Silva, F; Silva, ED; Hummel, C; Hummel, T; Paiva, A				Ribeiro, Joao Carlos; Simoes, Joao; Silva, Filipe; Silva, Eduardo D.; Hummel, Cornelia; Hummel, Thomas; Paiva, Antonio			Cultural Adaptation of the Portuguese Version of the "Sniffin' Sticks" Smell Test: Reliability, Validity, and Normative Data	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; OLFACTORY FUNCTION-TEST; OF-PENNSYLVANIA SMELL; ODOR IDENTIFICATION; PARKINSONS-DISEASE; DISCRIMINATION; DYSFUNCTION; THRESHOLDS; UNIVERSITY; POPULATION	The cross-cultural adaptation and validation of the Sniffin` Sticks test for the Portuguese population is described. Over 270 people participated in four experiments. In Experiment 1, 67 participants rated the familiarity of presented odors and seven descriptors of the original test were adapted to a Portuguese context. In Experiment 2, the Portuguese version of Sniffin` Sticks test was administered to 203 healthy participants. Older age, male gender and active smoking status were confirmed as confounding factors. The third experiment showed the validity of the Portuguese version of Sniffin` Sticks test in discriminating healthy controls from patients with olfactory dysfunction. In Experiment 4, the test-retest reliability for both the composite score (r(71) = 0.86) and the identification test (r(71) = 0.62) was established (p< 0.001). Normative data for the Portuguese version of Sniffin` Sticks test is provided, showing good validity and reliability and effectively distinguishing patients from healthy controls with high sensitivity and specificity. The Portuguese version of Sniffin` Sticks test identification test is a clinically suitable screening tool in routine outpatient Portuguese settings.	[Ribeiro, Joao Carlos; Simoes, Joao; Paiva, Antonio] Coimbra Univ Hosp CHUC, Dept Otorhinolaryngol, Coimbra, Portugal; [Ribeiro, Joao Carlos; Simoes, Joao; Silva, Eduardo D.; Paiva, Antonio] Univ Coimbra, Fac Med, Coimbra, Portugal; [Ribeiro, Joao Carlos; Silva, Filipe; Silva, Eduardo D.] Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal; [Hummel, Cornelia; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Dresden, Germany	Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra; Technische Universitat Dresden	Ribeiro, JC (corresponding author), Coimbra Univ Hosp CHUC, Dept Otorhinolaryngol, Coimbra, Portugal.; Ribeiro, JC (corresponding author), Univ Coimbra, Fac Med, Coimbra, Portugal.; Ribeiro, JC (corresponding author), Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal.	jcarlosribeiro@uc.pt	Ribeiro, Joao Carlos/AAW-4573-2020; Simões, João/AAK-6207-2020; Simões, João/O-1483-2016	Ribeiro, Joao Carlos/0000-0002-1039-6358; Simões, João/0000-0002-3276-0448; Simões, João/0000-0002-3276-0448	Fundacao para a Ciencia e Tecnologia [71016_2010]; Else Kroner-Fresenius Stiftung [2015_A71];  [E-Rare4/0001/2012E];  [UID/04539/2013]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Else Kroner-Fresenius Stiftung; ; 	This work was supported by E-Rare4/0001/2012E (EDS); Fundacao para a Ciencia e Tecnologia Post Doctoral Grant 71016_2010 (FS); UID/04539/2013 (EDS); Else Kroner-Fresenius Stiftung (http://www.ekfs.de/; grant number 2015_A71) (TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesveldt S, 2008, RHINOLOGY, V46, P131; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; Catana IV, 2013, CLUJUL MEDICAL, V86, pS56; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; DOTY RL, 1989, PERCEPT PSYCHOPHYS, V45, P381, DOI 10.3758/BF03210709; Eibenstein A, 2005, Acta Otorhinolaryngol Ital, V25, P18; Fjaeldstad A, 2015, CLIN OTOLARYNGOLOGY; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Haehner A, 2009, CHEM SENSES, V34, P705, DOI 10.1093/chemse/bjp057; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2013, OTOLARYNGOLOGIA POLS, V68, P308; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Konstantinidis I, 2008, RHINOLOGY, V46, P292; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Lotsch J, 2008, CHEM SENSES, V33, P17, DOI 10.1093/chemse/bjm058; Lotsch J, 2004, CHEM SENSES, V29, P311, DOI 10.1093/chemse/bjh034; Mackay-Sim A, 2004, J CLIN NEUROSCI, V11, P874, DOI 10.1016/j.jocn.2003.12.001; Neumann C, 2012, CLIN OTOLARYNGOL, V37, P23, DOI 10.1111/j.1749-4486.2012.02431.x; Oniz A, 2013, J NEUROL SCI-TURK, V30, P270; Running CA, 2015, ATTEN PERCEPT PSYCHO, V77, P692, DOI 10.3758/s13414-014-0798-9; Shu CH, 2007, AM J RHINOL, V21, P570, DOI 10.2500/ajr.2007.21.3075; Silveira-Moriyama L, 2009, MOVEMENT DISORD, V24, P1229, DOI 10.1002/mds.22545; Silveira-Moriyama L, 2008, MOVEMENT DISORD, V23, P2328, DOI 10.1002/mds.22241; Sorokowska A, 2015, ATTEN PERCEPT PSYCHO, V77, P731, DOI 10.3758/s13414-014-0811-3; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Yuan BC, 2010, J CHIN MED ASSOC, V73, P483, DOI 10.1016/S1726-4901(10)70103-9	32	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148937	10.1371/journal.pone.0148937	http://dx.doi.org/10.1371/journal.pone.0148937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863023	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600126
J	Saar-Ashkenazy, R; Veksler, R; Guez, J; Jacob, Y; Shelef, I; Shalev, H; Friedman, A; Cohen, JE				Saar-Ashkenazy, Rotem; Veksler, Ronel; Guez, Jonathan; Jacob, Yael; Shelef, Ilan; Shalev, Hadar; Friedman, Alon; Cohen, Jonathan E.			Breakdown of Inter-Hemispheric Connectivity Is Associated with Posttraumatic Symptomatology and Memory Impairment	PLOS ONE			English	Article							ANISOTROPIC WATER DIFFUSION; ADMINISTERED PTSD SCALE; WHITE-MATTER INTEGRITY; HUMAN CORPUS-CALLOSUM; STRESS-DISORDER; ANTERIOR CINGULATE; NERVOUS-SYSTEM; BRAIN; SURVIVORS; TRAUMA	Altered brain anatomy in specific gray-matter regions has been shown in patients with post-traumatic stress disorder (PTSD). Recently, white-matter tracts have become a focus of research in PTSD. The corpus callosum (CC) is the principal white-matter fiber bundle, crucial in relaying sensory, motor and cognitive information between hemispheres. Alterations in CC fibers have been reported in PTSD and might be assumed to underlie substantial behavioral and cognitive sequelae; however most diffusion tensor imaging (DTI) studies in adult-onset PTSD failed to address the clinical correlates between imaging and PTSD symptoms severity, behavioral manifestation and cognitive functions. In the current study we examined (a) to what extent microstructural integrity of the CC is associated with memory performance and (b) whether imaging and cognitive parameters are associated with PTSD symptom severity. DTI data were obtained and fractional anisotropy (FA) values were computed for 16 patients and 14 controls. PTSD symptom severity was assessed by employing the clinician administered PTSD scale (CAPS) and memory was tested using a task probing item and associative memory for words and pictures. Significant correlations were found between PTSD symptoms severity, memory accuracy and reaction-time to CC FA values in the PTSD group. This study demonstrates meaningful clinical and cognitive correlates of microstructural connectivity. These results have implications for diagnostic tools and future studies aimed at identifying individuals at risk for PTSD.	[Saar-Ashkenazy, Rotem; Friedman, Alon] Ben Gurion Univ Negev, Dept Brain & Cognit Neurosci, Zlotowski Ctr Neurosci Ben Gurion, IL-84105 Beer Sheva, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Dept Psychol, Ashqelon, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Sch Social Work, Ashqelon, Israel; [Veksler, Ronel; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, IL-84105 Beer Sheva, Israel; [Guez, Jonathan] Achva Acad Coll, Dept Psychol, Beer Tuvia Reg Council, Tel Aviv, Israel; [Guez, Jonathan] Beer Sheva Mental Hlth Ctr, Beer Sheva, Israel; [Jacob, Yael] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Jacob, Yael] Tel Aviv Univ, Funct Brain Imaging Unit, Wohl Inst Adv Imaging, IL-69978 Tel Aviv, Israel; [Shelef, Ilan] Soroka Univ, Med Ctr, Dept Radiol, Beer Sheva, Israel; [Shalev, Hadar] Soroka Univ, Med Ctr, Dept Psychiat, Beer Sheva, Israel; [Friedman, Alon] Dalhousie Univ, Dept Med Neurosci, Fac Med, Halifax, NS, Canada; [Cohen, Jonathan E.] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel	Ben Gurion University; Ben Gurion University; Tel Aviv University; Tel Aviv University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Dalhousie University; Hebrew University of Jerusalem; Hadassah University Medical Center	Cohen, JE (corresponding author), Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel.	cohenjon@hadassah.org.il	Guez, Jonathan/M-1620-2019	Guez, Jonathan/0000-0002-4964-7206; Cohen, Jonathan/0000-0001-8120-3827; shelef, ilan/0000-0002-8398-6455	Deutsche Forschungsgemeinschaft (DFG) [KI 537/29-2]; Israeli Ministry of Health [87365411]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Israeli Ministry of Health	This work was supported by Deutsche Forschungsgemeinschaft (DFG): KI 537/29-2, Israeli Ministry of Health: 87365411.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bester M, 2013, J NEUROL SCI, V330, P61, DOI 10.1016/j.jns.2013.04.005; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Borgaro SR, 2003, BRAIN INJURY, V17, P545, DOI 10.1080/0269905031000070206; Bremner JD, 1995, PSYCHIAT RES, V59, P97; Bustamante V, 2001, J TRAUMA STRESS, V14, P791, DOI 10.1023/A:1013050423901; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Frederiksen KS, 2013, DAN MED J, V60; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Golier JA, 2002, AM J PSYCHIAT, V159, P1682, DOI 10.1176/appi.ajp.159.10.1682; Guez J, 2013, PSYCHIAT RES, V209, P479, DOI 10.1016/j.psychres.2012.12.013; Guez J, 2011, J TRAUMA STRESS, V24, P260, DOI 10.1002/jts.20635; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jenkins MA, 1998, AM J PSYCHIAT, V155, P278; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Keedwell PA, 2012, BIOL PSYCHIAT, V72, P296, DOI 10.1016/j.biopsych.2012.01.022; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Kitayama N, 2007, J NERV MENT DIS, V195, P1027, DOI 10.1097/NMD.0b013e31815c044f; Kleim B, 2008, J CONSULT CLIN PSYCH, V76, P231, DOI 10.1037/0022-006X.76.2.231; Kochunov P, 2010, NEUROIMAGE, V53, P1109, DOI 10.1016/j.neuroimage.2010.01.078; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lu SJ, 2013, AUST NZ J PSYCHIAT, V47, P1183, DOI 10.1177/0004867413508454; McNally RJ, 1998, CLIN PSYCHOL REV, V18, P971, DOI 10.1016/S0272-7358(98)00036-1; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Navas-Sanchez FJ, 2013, HUMAN BRAIN MAPPING, V3, P22355; NELSON DL, 1976, J EXP PSYCHOL-HUM L, V2, P523, DOI 10.1037/0278-7393.2.5.523; Papadaki EZ, 2014, EUR J NEUROL, V21, P499, DOI 10.1111/ene.12338; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Rubinstein O, 2005, NORMS FOR WORDS IN H; Saar-Ashkenazy R, 2015, PSYCHIAT RES-NEUROIM, V233, P165, DOI 10.1016/j.pscychresns.2015.05.015; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Spielberger CD, 1983, MANUAL FOR THE STATE; Tavanti M, 2012, NEUROL SCI, V33, P59, DOI 10.1007/s10072-011-0659-4; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Treit S, 2013, NEUROSCIENCE, V16, P019; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Villarreal G, 2004, PSYCHIAT RES-NEUROIM, V131, P227, DOI 10.1016/j.pscychresns.2004.05.002; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	56	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0144766	10.1371/journal.pone.0144766	http://dx.doi.org/10.1371/journal.pone.0144766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863536	gold, Green Submitted, Green Published			2022-12-26	WOS:000370046600005
J	Mizuno, S; Ogishima, S; Kitatani, K; Kikuchi, M; Tanaka, H; Yaegashi, N; Nakaya, J				Mizuno, Satoshi; Ogishima, Soichi; Kitatani, Kazuyuki; Kikuchi, Masataka; Tanaka, Hiroshi; Yaegashi, Nobuo; Nakaya, Jun			Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SIGNALING PATHWAYS; INFLAMMATION; MAP; SPHINGOLIPIDS; ACCUMULATION; GANGLIOSIDES; METABOLISM; TARGET; BRAINS	Alzheimer's disease (AD) is the most common cause of senile dementia. Many inflammatory factors such as amyloid-beta and pro-inflammatory cytokines are known to contribute to the inflammatory response in the AD brain. Sphingolipids are widely known to have roles in the pathogenesis of inflammatory diseases, where the precise roles for sphingolipids in inflammation-associated pathogenesis of AD are not well understood. Here we performed a network analysis to clarify the importance of sphingolipids and to model relationships among inflammatory factors and sphingolipids in AD. In this study, we have updated sphingolipid signaling and metabolic cascades in a map of AD signaling networks that we named "AlzPathway," a comprehensive knowledge repository of signaling pathways in AD. Our network analysis of the updated AlzPathway indicates that the pathways related to ceramide are one of the primary pathways and that ceramide is one of the important players in the pathogenesis of AD. The results of our analysis suggest the following two prospects about inflammation in AD: (1) ceramide could play important roles in both inflammatory and anti-inflammatory pathways of AD, and (2) several factors such as Sphingomyelinase and Siglec-11 may be associated with ceramide related inflammation and anti-inflammation pathways in AD. In this study, network analysis of comprehensive knowledge repository reveals a dual role for ceramide in AD. This result provides a clue to clarify sphingolipids related inflammatory and anti-inflammatory pathways in AD.	[Mizuno, Satoshi; Nakaya, Jun] Tohoku Univ, Grad Sch Med, Dept Clin Informat, Sendai, Miyagi 980, Japan; [Mizuno, Satoshi; Ogishima, Soichi; Tanaka, Hiroshi] Tohoku Univ, Tohoku Med Megabank Org, Dept Clin Record Informat, Sendai, Miyagi 980, Japan; [Kitatani, Kazuyuki; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Gynecol & Obstet, Sendai, Miyagi 980, Japan; [Kikuchi, Masataka] Osaka Univ, Grad Sch Med, Dept Genome Informat, Suita, Osaka, Japan	Tohoku University; Tohoku University; Tohoku University; Osaka University	Mizuno, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Clin Informat, Sendai, Miyagi 980, Japan.; Mizuno, S; Ogishima, S (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Dept Clin Record Informat, Sendai, Miyagi 980, Japan.	samizuno@med.tohoku.ac.jp; ogishima@sysmedbio.org	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25330333]; Grants-in-Aid for Scientific Research [26240044] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grant number : 25330333, URL : https://kaken.nii.ac.jp/d/p/25330333.en.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Caberlotto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078919; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Calzone L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.7; Car H, 2012, POSTEP HIG MED DOSW, V66, P295, DOI 10.5604/17322693.999024; Colell A, 2009, J BIOENERG BIOMEMBR, V41, P417, DOI 10.1007/s10863-009-9242-6; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Fernandes A, 2014, CELL MOL LIFE SCI, V71, P3969, DOI 10.1007/s00018-014-1670-8; Filippov V, 2012, J ALZHEIMERS DIS, V29, P537, DOI 10.3233/JAD-2011-111202; Fujita KA, 2014, MOL NEUROBIOL, V49, P88, DOI 10.1007/s12035-013-8489-4; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Hartmann T, 2006, NEURODEGENER DIS, V3, P305, DOI 10.1159/000095271; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Horres CR, 2012, NEUROCHEM RES, V37, P1137, DOI 10.1007/s11064-011-0692-y; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kwak JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096456; Lukiw WJ, 2010, MOL NEUROBIOL, V42, P10, DOI 10.1007/s12035-010-8126-4; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Malhotra A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13634; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P1935, DOI 10.1016/j.bbamem.2007.02.009; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Mielke MM, 2012, CLIN LIPIDOL, V7, P525, DOI 10.2217/CLP.12.59; Mielke MM, 2010, NEUROMOL MED, V12, P331, DOI 10.1007/s12017-010-8121-y; Mizuno S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-52; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ogishima S, 2013, CLIN PHARMACOL THER, V93, P399, DOI 10.1038/clpt.2013.37; Patil S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-137; Pernber Z, 2012, DEMENT GERIATR COGN, V33, P174, DOI 10.1159/000338181; Potapov Anatolij P, 2005, Genome Inform, V16, P270; Rubio-Perez Jose Miguel, 2012, ScientificWorldJournal, V2012, P756357, DOI 10.1100/2012/756357; Salminen A, 2009, J MOL MED, V87, P697, DOI 10.1007/s00109-009-0472-1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soreghan M, 2003, ADV DRUG DELIVER REV, V55, P1515, DOI 10.1016/j.addr.2003.07.007; Taki T, 2012, BIOL PHARM BULL, V35, P1642, DOI 10.1248/bpb.b12-00400; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Terrill-Usery SE, 2014, BBA-MOL BASIS DIS, V1842, P2276, DOI 10.1016/j.bbadis.2014.08.001; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Van Dooren T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/167024; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Voronkov M, 2011, FUTURE MED CHEM, V3, P821, DOI [10.4155/FMC.11.47, 10.4155/fmc.11.47]; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Wu CK, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S3-S2; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Yuyama K, 2014, BBA-MOL CELL BIOL L, V1841, P793, DOI 10.1016/j.bbalip.2013.08.002	54	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148431	10.1371/journal.pone.0148431	http://dx.doi.org/10.1371/journal.pone.0148431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849355	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000093
J	Litvinov, RI; Farrell, DH; Weisel, JW; Bennett, JS				Litvinov, Rustem I.; Farrell, David H.; Weisel, John W.; Bennett, Joel S.			The Platelet Integrin IIb3 Differentially Interacts with Fibrin Versus Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; fibrin; fibrinogen; integrin; platelet	GLYCOPROTEIN-IIB; GAMMA-CHAIN; BINDING-SITE; STIMULATED PLATELETS; RECOGNITION SITE; CLOT RETRACTION; FLOWING BLOOD; ALPHA-CHAIN; RECEPTOR; IIIA	Fibrinogen binding to the integrin IIb3 mediates platelet aggregation and spreading on fibrinogen-coated surfaces. However, in vivo IIb3 activation and fibrinogen conversion to fibrin occur simultaneously, although the relative contributions of fibrinogen versus fibrin to IIb3-mediated platelet functions are unknown. Here, we compared the interaction of IIb3 with fibrin and fibrinogen to explore their differential effects. A microscopic bead coated with fibrinogen or monomeric fibrin produced by treating the immobilized fibrinogen with thrombin was captured by a laser beam and repeatedly brought into contact with surface-attached purified IIb3. When IIb3-ligand complexes were detected, the rupture forces were measured and displayed as force histograms. Monomeric fibrin displayed a higher probability of interacting with IIb3 and a greater binding strength. IIb3-fibrin interactions were also less sensitive to inhibition by abciximab and eptifibatide. Both fibrinogen- and fibrin-IIb3 interactions were partially inhibited by RGD peptides, suggesting the existence of common RGD-containing binding motifs. This assumption was supported using the fibrin variants D97E or D574E with mutated RGD motifs. Fibrin made from a fibrinogen / variant lacking the C IIb3-binding motif was more reactive with IIb3 than the parent fibrinogen. These results demonstrate that fibrin is more reactive with IIb3 than fibrinogen. Fibrin is also less sensitive to IIb3 inhibitors, suggesting that fibrin and fibrinogen have distinct binding requirements. In particular, the maintenance of IIb3 binding activity in the absence of the C-dodecapeptide and the -chain RGD sequences suggests that the IIb3-binding sites in fibrin are not confined to its known -chain and RGD motifs.	[Litvinov, Rustem I.; Weisel, John W.; Bennett, Joel S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Farrell, David H.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	University of Pennsylvania; Pennsylvania Medicine; Oregon Health & Science University	Bennett, JS (corresponding author), Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, 421 Curie Blvd,814 BRB 2-3, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu	Pieper, Maja/AAN-8539-2020; Litvinov, Rustem/E-5291-2011	Litvinov, Rustem/0000-0003-0643-1496	National Institutes of Health [PO1 HL40387, RO1 HL090774, UO1 HL116330]; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090774, P01HL040387, U01HL116330, P01HL120846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants PO1 HL40387, RO1 HL090774, and UO1 HL116330 and a grant from the American Society of Hematology. The authors, except for DHF, declare they have no conflicts of interest with the contents of this article. D. H. F. and Oregon Health and Science University have a significant interest in Gamma Therapeutics, a company that may have a commercial interest in the results of this research and technology. This potential individual and institutional conflict of interest has been reviewed and managed by Oregon Health and Science University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; BENNETT JS, 1988, J BIOL CHEM, V263, P12948; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Carr ME, 2003, CELL BIOCHEM BIOPHYS, V38, P55, DOI 10.1385/CBB:38:1:55; Cho J, 2005, J BIOL CHEM, V280, P35490, DOI 10.1074/jbc.M506289200; COHEN I, 1982, J CELL BIOL, V93, P775, DOI 10.1083/jcb.93.3.775; Collet JP, 2002, CIRC RES, V90, P428, DOI 10.1161/hh0402.105095; Dai A, 2015, J BIOL CHEM, V290, P27168, DOI 10.1074/jbc.M115.682377; de Willige SU, 2009, BLOOD, V114, P3994, DOI 10.1182/blood-2009-05-217968; Falati Shahrokh, 2004, Methods Mol Biol, V272, P187; Farrell DH, 2004, CURR OPIN HEMATOL, V11, P151, DOI 10.1097/01.moh.0000131440.02397.a4; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; FARRELL DH, 1994, J BIOL CHEM, V269, P226; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; GARTNER TK, 1988, THROMB RES, V49, P43; HAMAGUCHI M, 1993, BLOOD, V81, P2348; Hantgan RR, 2010, BIOCHEMISTRY-US, V49, P9217, DOI 10.1021/bi1009858; HANTGAN RR, 1985, BLOOD, V65, P1299, DOI 10.1182/blood.V65.6.1299.bloodjournal6561299; HANTGAN RR, 1988, BIOCHIM BIOPHYS ACTA, V968, P24, DOI 10.1016/0167-4889(88)90040-7; Hantgan RR, 1998, THROMB RES, V89, P271, DOI 10.1016/S0049-3848(98)00021-8; Holmback K, 1996, EMBO J, V15, P5760, DOI 10.1002/j.1460-2075.1996.tb00962.x; Jirouskova M, 1997, THROMB HAEMOSTASIS, V78, P1125; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; KLOCZEWIAK M, 1983, THROMB RES, V29, P249, DOI 10.1016/0049-3848(83)90147-0; Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Litvinov RI, 2012, J BIOL CHEM, V287, P35275, DOI 10.1074/jbc.M112.404848; Litvinov RI, 2011, BIOPHYS J, V100, P165, DOI 10.1016/j.bpj.2010.11.019; MARTINEZSALES V, 1995, HAEMOSTASIS, V25, P158; Podolnikova NP, 2009, BIOCHEMISTRY-US, V48, P617, DOI 10.1021/bi801751s; Podolnikova NP, 2005, BIOCHEMISTRY-US, V44, P16920, DOI 10.1021/bi051581d; Podolnikova NP, 2003, J BIOL CHEM, V278, P32251, DOI 10.1074/jbc.M300410200; Remijn JA, 2003, J THROMB HAEMOST, V1, P2245, DOI 10.1046/j.1538-7836.2003.00399.x; Remijn JA, 2002, BRIT J HAEMATOL, V117, P650, DOI 10.1046/j.1365-2141.2002.03467.x; Rooney MM, 1998, BLOOD, V92, P2374, DOI 10.1182/blood.V92.7.2374.2374_2374_2381; Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Sun JEP, 2012, INTEGR BIOL-UK, V4, P84, DOI 10.1039/c1ib00085c; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; ZAMARRON C, 1991, J BIOL CHEM, V266, P16193	43	40	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7858	7867		10.1074/jbc.M115.706861	http://dx.doi.org/10.1074/jbc.M115.706861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26867579	Green Published, hybrid			2022-12-26	WOS:000374056700009
J	Spoerry, C; Seele, J; Valentin-Weigand, P; Baums, CG; von Pawel-Rammingen, U				Spoerry, Christian; Seele, Jana; Valentin-Weigand, Peter; Baums, Christoph G.; von Pawel-Rammingen, Ulrich			Identification and Characterization of IgdE, a Novel IgG-degrading Protease of Streptococcus suis with Unique Specificity for Porcine IgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; cysteine protease; immunoglobulin G (IgG); proteolytic enzyme; Streptococcus; substrate specificity	CYSTEINE PROTEINASE; STRICT SPECIFICITY; SIGNAL PEPTIDES; HUMAN PATHOGEN; VIRULENCE; IMMUNOGLOBULINS; CLEAVAGE; IDES; ENDOPEPTIDASE; SEROTYPE-2	Streptococcus suis is a major endemic pathogen of pigs causing meningitis, arthritis, and other diseases. Zoonotic S. suis infections are emerging in humans causing similar pathologies as well as severe conditions such as toxic shock-like syndrome. Recently, we discovered an IdeS family protease of S. suis that exclusively cleaves porcine IgM and represents the first virulence factor described, linking S. suis to pigs as their natural host. Here we report the identification and characterization of a novel, unrelated protease of S. suis that exclusively targets porcine IgG. This enzyme, designated IgdE for immunoglobulin G-degrading enzyme of S. suis, is a cysteine protease distinct from previous characterized streptococcal immunoglobulin degrading proteases of the IdeS family and mediates efficient cleavage of the hinge region of porcine IgG with a high degree of specificity. The findings that all S. suis strains investigated possess the IgG proteolytic activity and that piglet serum samples contain specific antibodies against IgdE strongly indicate that the protease is expressed in vivo during infection and represents a novel and putative important bacterial virulence/colonization determinant, and a thus potential therapeutic target.	[Spoerry, Christian; von Pawel-Rammingen, Ulrich] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Spoerry, Christian; von Pawel-Rammingen, Ulrich] Umea Univ, Umea Ctr Microbial Res, S-90187 Umea, Sweden; [Seele, Jana; Valentin-Weigand, Peter; Baums, Christoph G.] Univ Vet Med Hannover, Ctr Infect Med, Inst Microbiol, D-30173 Hannover, Germany; [Baums, Christoph G.] Univ Leipzig, Coll Vet Med, Ctr Infect Dis, Inst Bacteriol & Mycol, D-04103 Leipzig, Germany	Umea University; Umea University; University of Veterinary Medicine Hannover, Foundation; Leipzig University	von Pawel-Rammingen, U (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.; von Pawel-Rammingen, U (corresponding author), Umea Univ, Umea Ctr Microbial Res, S-90187 Umea, Sweden.	ulrich.von-pawel@molbiol.umu.se		Spoerry, Christian/0000-0001-5763-6542	Carl Tryggers foundation; Insamlingstiftelsen at Umea University; Stiftelsen J.C. Kempes Stipendiefond at Umea University; German Research Foundation [SFB587, BA 4730/1-1]; German Federal Ministry for Research and Education (BMBF) within the Helmholtz-CAS-Joint Research Group ZooStrep [HCJRG-116]	Carl Tryggers foundation; Insamlingstiftelsen at Umea University; Stiftelsen J.C. Kempes Stipendiefond at Umea University; German Research Foundation(German Research Foundation (DFG)); German Federal Ministry for Research and Education (BMBF) within the Helmholtz-CAS-Joint Research Group ZooStrep(Federal Ministry of Education & Research (BMBF))	This work was supported in part by Carl Tryggers foundation, Insamlingstiftelsen at Umea University, and the Stiftelsen J.C. Kempes Stipendiefond at Umea University. The materials from piglets investigated in this work were obtained within a study financed by the German Research Foundation under Grants SFB587 and BA 4730/1-1. A patent application for IgdE has been filed. C. S. and U. v. P. R. are listed as inventors in this application.; Supported by the German Federal Ministry for Research and Education (BMBF) within the Helmholtz-CAS-Joint Research Group ZooStrep (HCJRG-116).	Aarestrup F, 2012, NATURE, V486, P465, DOI 10.1038/486465a; ABRAHAMSON M, 1987, J BIOL CHEM, V262, P9688; Allgaier A, 2001, J CLIN MICROBIOL, V39, P445, DOI 10.1128/JCM.39.2.445-453.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baums CG, 2007, APPL ENVIRON MICROB, V73, P711, DOI 10.1128/AEM.01800-06; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BJORCK L, 1989, NATURE, V337, P385, DOI 10.1038/337385a0; Butler JE, 2009, IMMUNOGENETICS, V61, P209, DOI 10.1007/s00251-008-0336-9; Butler JE, 2009, DEV COMP IMMUNOL, V33, P321, DOI 10.1016/j.dci.2008.06.015; Butler JE, 2006, J IMMUNOL, V177, P5480, DOI 10.4049/jimmunol.177.8.5480; DREW MD, 1988, CAN J ANIM SCI, V68, P1277, DOI 10.4141/cjas88-143; Dunn BM., 1989, PROTEOLYTIC ENZYMES, P57; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; GREEN GDJ, 1981, J BIOL CHEM, V256, P1923; Haas B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130528; HIGGINS R, 2005, DIS SWINE; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KLOBASA F, 1981, RES VET SCI, V31, P195, DOI 10.1016/S0034-5288(18)32494-9; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Palmieri C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00235; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROKESOVA L, 1992, IMMUNOL LETT, V31, P259, DOI 10.1016/0165-2478(92)90124-7; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Seele J, 2015, VET RES, V46, DOI 10.1186/s13567-015-0171-6; Seele J, 2013, J BACTERIOL, V195, P930, DOI 10.1128/JB.01875-12; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HJ, 1996, ACTA RADIOL, V37, P2; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Unterweger C, 2014, BERL MUNCH TIERARZTL, V127, P194, DOI 10.2376/0005-9366-127-194; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; Vincents B, 2011, FASEB J, V25, P3741, DOI 10.1096/fj.11-187799; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; WALLENFELS K, 1968, EUR J BIOCHEM, V3, P267, DOI 10.1111/j.1432-1033.1968.tb19526.x; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wisselink HJ, 2002, J CLIN MICROBIOL, V40, P2922, DOI 10.1128/JCM.40.8.2922-2929.2002; Zhang AD, 2010, VET MICROBIOL, V140, P171, DOI 10.1016/j.vetmic.2009.06.034	43	18	19	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7915	7925		10.1074/jbc.M115.711440	http://dx.doi.org/10.1074/jbc.M115.711440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26861873	hybrid, Green Published			2022-12-26	WOS:000374056700014
J	Bachstetter, AD; Zhou, ZQ; Rowe, RK; Xing, B; Goulding, DS; Conley, AN; Sompol, P; Meier, S; Abisambra, JF; Lifshitz, J; Watterson, DM; Van Eldik, LJ				Bachstetter, Adam D.; Zhou, Zhengqiu; Rowe, Rachel K.; Xing, Bin; Goulding, Danielle S.; Conley, Alyssa N.; Sompol, Pradoldej; Meier, Shelby; Abisambra, Jose F.; Lifshitz, Jonathan; Watterson, D. Martin; Van Eldik, Linda J.			MW151 Inhibited IL-1 beta Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses	PLOS ONE			English	Article							ATTENUATES SYNAPTIC DYSFUNCTION; CYTOKINE UP-REGULATION; PROINFLAMMATORY CYTOKINE; ALZHEIMERS-DISEASE; MOUSE MODEL; GLIAL ACTIVATION; P38-ALPHA MAPK; INFLAMMATION; NEUROINFLAMMATION; PROGRESSION	A prevailing neuroinflammation hypothesis is that increased production of proinflammatory cytokines contributes to progressive neuropathology, secondary to the primary damage caused by a traumatic brain injury (TBI). In support of the hypothesis, post-injury interventions that inhibit the proinflammatory cytokine surge can attenuate the progressive pathology. However, other post-injury neuroinflammatory responses are key to endogenous recovery responses. Therefore, it is critical that pharmacological attenuation of detrimental or dysregulated neuroinflammatory processes avoid pan-suppression of inflammation. MW151 is a CNS-penetrant, small molecule experimental therapeutic that restores injuryor disease-induced overproduction of proinflammatory cytokines towards homeostasis without immunosuppression. Post-injury administration of MW151 in a closed head injury model of mild TBI suppressed acute cytokine up-regulation and downstream cognitive impairment. Here, we report results from a diffuse brain injury model in mice using midline fluid percussion. Low dose (0.5-5.0 mg/kg) administration of MW151 suppresses interleukin-1 beta (IL-1 beta) levels in the cortex while sparing reactive microglia and astrocyte responses. To probe molecular mechanisms, we used live cell imaging of the BV-2 microglia cell line to demonstrate that MW151 does not affect proliferation, migration, or phagocytosis of the cells. Our results provide insight into the roles of glial responses to brain injury and indicate the feasibility of using appropriate dosing for selective therapeutic modulation of injurious IL-1 beta increases while sparing other glial responses to injury.	[Bachstetter, Adam D.; Zhou, Zhengqiu; Xing, Bin; Goulding, Danielle S.; Conley, Alyssa N.; Sompol, Pradoldej; Meier, Shelby; Abisambra, Jose F.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Bachstetter, Adam D.; Rowe, Rachel K.; Lifshitz, Jonathan; Van Eldik, Linda J.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Bachstetter, Adam D.; Rowe, Rachel K.; Lifshitz, Jonathan; Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Abisambra, Jose F.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Watterson, D. Martin] Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Veteran Affairs Healthcare Syst, Phoenix, AZ USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Northwestern University; Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona	Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Van Eldik, LJ (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA.; Van Eldik, LJ (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA.	linda.vaneldik@uky.edu	Abisambra, Joe/AAP-3269-2020; Abisambra, Jose/V-6860-2019	Abisambra, Jose/0000-0001-6341-679X; Bachstetter, Adam/0000-0003-4646-6757; Watterson, Daniel/0000-0001-7605-5866; Rowe, Rachel/0000-0002-9034-3159; Meier, Shelby/0000-0003-1946-9004	NIH/NIA [K99 AG044445, U01 AG050636]; Kentucky Spinal Cord and Head Injury Research Trust [12-20A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG044445, U01AG050636, U01AG043415] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by NIH/NIA (K99 AG044445 to ADB, and U01 AG050636 to LVE and DMW), and the Kentucky Spinal Cord and Head Injury Research Trust (12-20A to LVE).	Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Craft JM, 2006, GLIA, V53, P484, DOI 10.1002/glia.20306; Craft JM, 2004, NEUROBIOL AGING, V25, P1283, DOI 10.1016/j.neurobiolaging.2004.01.006; Craft JM, 2004, J MOL NEUROSCI, V24, P115, DOI 10.1385/JMN:24:1:115; Eakin K, 2015, FRONTIERS NEUROENGIN; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Jenrow KA, 2013, RADIAT RES, V179, P549, DOI 10.1667/RR3026.1; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karpus WJ, 2008, J NEUROIMMUNOL, V203, P73, DOI 10.1016/j.jneuroim.2008.06.039; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Macauley SL, 2014, J NEUROSCI, V34, P13077, DOI 10.1523/JNEUROSCI.2518-14.2014; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ranaivo HR, 2006, J NEUROSCI, V26, P662, DOI 10.1523/JNEUROSCI.4652-05.2006; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Roy SM, 2015, ACS CHEM NEUROSCI, V6, P666, DOI 10.1021/acschemneuro.5b00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shineman DW, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt90; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Watterson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066226; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	39	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149451	10.1371/journal.pone.0149451	http://dx.doi.org/10.1371/journal.pone.0149451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871438	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100159
J	Steiner, M; Hawranek, T; Schneider, M; Ferreira, F; Horejs-Hoeck, J; Harrer, A; Himly, M				Steiner, Markus; Hawranek, Thomas; Schneider, Michael; Ferreira, Fatima; Horejs-Hoeck, Jutta; Harrer, Andrea; Himly, Martin			Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels	PLOS ONE			English	Article							PERIPHERAL-BLOOD; INFLAMMATION; AGGREGATION; ACTIVATION; RESPONSES; TLR4	Human blood basophils have recently gained interest in addition to their function as allergic effector cells. Previous work suggests the involvement of innate immune mechanisms in the development and exacerbation of allergic responses, which might be mediated by basophils. We assayed the expression levels of Toll-like receptor (TLR) 1, 2, 4 and 6 on purified basophils from birch pollen-, house dust mite-, and non-allergic individuals. Additionally, we compared cytokine and chemokine secretion upon TLR stimulation in these basophil donor groups. Expression of TLR4 on the basophils of the allergic donor groups was decreased and CXCL8 secretion was elevated upon stimulation of TLR1/2 and TLR2/6 compared to the non-allergic donors. Decreased TLR expression and elevated CXCL8 secretion may represent possible mechanisms for aggravation of allergic symptoms in case of parasitic infection.	[Steiner, Markus; Ferreira, Fatima; Horejs-Hoeck, Jutta; Harrer, Andrea; Himly, Martin] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Steiner, Markus] Paracelsus Med Univ, Lab Immunol & Mol Canc Res, Salzburg, Austria; [Hawranek, Thomas] Paracelsus Med Univ, Dept Dermatol, Salzburg, Austria; [Schneider, Michael] Buhlmann Labs AG, Schonenbuch, Switzerland; [Harrer, Andrea] Paracelsus Med Univ, Dept Neurol, Salzburg, Austria	Salzburg University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Himly, M (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	martin.himly@sbg.ac.at	Horejs-Hoeck, Jutta/AAF-1735-2019; Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Horejs-Hoeck, Jutta/E-5010-2011; Himly, Martin/D-1568-2015	Horejs-Hoeck, Jutta/0000-0002-0984-204X; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Steiner, Markus/0000-0003-4424-6347; Himly, Martin/0000-0001-5416-085X; Harrer, Andrea/0000-0001-7717-6125	Austrian Science Fund (FWF) [P18820-B13]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grant P18820-B13 of the Austrian Science Fund (FWF). Buehlmann Laboratories AG did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries (Michael Schneider) and/or research materials (stimulation buffer for basophils).; We thank Sven Mostboeck for his advice concerning statistical data analysis. This work was supported by grant P18820-B13 of the Austrian Science Fund (FWF).	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Baranek T, 2007, J IMMUNOL, V179, P6184, DOI 10.4049/jimmunol.179.9.6184; Bieneman AP, 2005, J ALLERGY CLIN IMMUN, V115, P295, DOI 10.1016/j.jaci.2004.10.018; Boumiza R, 2003, CLIN EXP ALLERGY, V33, P259, DOI 10.1046/j.1365-2222.2003.01594.x; Gibbs BF, 2005, CLIN EXP MED, V5, P43, DOI 10.1007/s10238-005-0064-5; Gilmartin L, 2008, INT ARCH ALLERGY IMM, V145, P182, DOI 10.1159/000109287; Gyimesi E, 2013, INFLAMM RES, V62, P213, DOI 10.1007/s00011-012-0569-9; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Jeon JH, 2015, MOL IMMUNOL, V65, P168, DOI 10.1016/j.molimm.2015.01.022; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Komiya A, 2006, INT ARCH ALLERGY IMM, V140, P23, DOI 10.1159/000092707; Kucuksezer UC, 2013, J ALLERGY CLIN IMMUN, V131, P875, DOI 10.1016/j.jaci.2012.10.051; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Suurmond J, 2014, EUR J IMMUNOL, V44, P386, DOI 10.1002/eji.201343617; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; Watanabe T, 2013, J GASTROENTEROL, V48, P247, DOI 10.1007/s00535-012-0626-8; Yi MH, 2015, CYTOKINE, V75, P356, DOI 10.1016/j.cyto.2015.07.011; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884	20	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149275	10.1371/journal.pone.0149275	http://dx.doi.org/10.1371/journal.pone.0149275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870962	Green Published, gold			2022-12-26	WOS:000370054100140
J	Oyallon, J; Vanzo, N; Krzemien, J; Morin-Poulard, I; Vincent, A; Crozatier, M				Oyallon, Justine; Vanzo, Nathalie; Krzemien, Joanna; Morin-Poulard, Ismael; Vincent, Alain; Crozatier, Michele			Two Independent Functions of Collier/Early B Cell Factor in the Control of Drosophila Blood Cell Homeostasis	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR MAINTENANCE; LYMPH-GLAND; IMMUNE-RESPONSE; SIGNALING CENTER; STEM-CELL; DUAL ROLE; NICHE; DIFFERENTIATION; MODEL; PROTEIN	Blood cell production in the Drosophila hematopoietic organ, the lymph gland, is controlled by intrinsic factors and extrinsic signals. Initial analysis of Collier/Early B Cell Factor function in the lymph gland revealed the role of the Posterior Signaling Center (PSC) in mounting a dedicated cellular immune response to wasp parasitism. Further, premature blood cell differentiation when PSC specification or signaling was impaired, led to assigning the PSC a role equivalent to the vertebrate hematopoietic niche. We report here that Collier is expressed in a core population of lymph gland progenitors and cell autonomously maintains this population. The PSC contributes to lymph gland homeostasis by regulating blood cell differentiation, rather than by maintaining core progenitors. In addition to PSC signaling, switching off Collier expression in progenitors is required for efficient immune response to parasitism. Our data show that two independent sites of Collier/Early B Cell Factor expression, hematopoietic progenitors and the PSC, achieve control of hematopoiesis.	[Oyallon, Justine; Vanzo, Nathalie; Krzemien, Joanna; Morin-Poulard, Ismael; Vincent, Alain; Crozatier, Michele] Univ Toulouse 3, Ctr Biol Dev, Ctr Biol Integrat, CNRS, 118 Route Narbonne, F-31062 Toulouse 09, France; [Oyallon, Justine] Univ Nacl Autonoma Mexico, Lab Citogenet & Mutagenesis Ambientales, Ctr Ciencias Atmosfera, Ciudad Univ Coyoacan, Mexico City 04510, DF, Mexico; [Krzemien, Joanna] Univ St Andrews, St Andrews KY16 9RJ, Fife, Scotland; [Morin-Poulard, Ismael] Hubrecht Inst, Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universidad Nacional Autonoma de Mexico; University of St Andrews; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Vincent, A; Crozatier, M (corresponding author), Univ Toulouse 3, Ctr Biol Dev, Ctr Biol Integrat, CNRS, 118 Route Narbonne, F-31062 Toulouse 09, France.	alain.vincent@univ-tlse3.fr; michele.crozatier-borde@univ-tlse3.fr	Vincent, Alain/AAE-4712-2019	Morin-Poulard, Ismael/0000-0002-8234-0716	CNRS, University Toulouse III, Ministere de la Recherche [ANR-11-BSV2-0008]; ARC (Association pour la Recherche sur le Cancer); FRM (Fondation pour la Recherche Medicale) [DEQ20090515429]	CNRS, University Toulouse III, Ministere de la Recherche; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale)	This work was financially supported by the CNRS, University Toulouse III, Ministere de la Recherche (ANR-11-BSV2-0008), ARC (Association pour la Recherche sur le Cancer), and FRM (Fondation pour la Recherche Medicale, grant number DEQ20090515429).; We thank E. Agius, L. Bataille, M. Boube, M. Meister, C. Monod and M. Suzanne for critical reading of the manuscript and members of the Vincent/Crozatier's Lab for discussion. We also thank C. Monod for skilled assistance during this work. We thank I. Ando and T. Trenczek for antibodies and T. Williams for vectors. We thank L. Waltzer and M. Haenlin for personal communication concerning increased progenitor differentiation upon col knock-down in the medullary zone (tep4-Gal4 > icol). We are grateful to the Toulouse RIO imaging platform. O. Bohner, J. Favier, and V. Nicolas for fly culture. This work was financially supported by the CNRS, University Toulouse III, Ministere de la Recherche (ANR-11-BSV2-0008), ARC (Association pour la Recherche sur le Cancer) and FRM (Fondation pour la Recherche Medicale, grant number DEQ20090515429).	Benmimoun B, 2015, P NATL ACAD SCI USA, V112, P9052, DOI 10.1073/pnas.1423967112; Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 2007, CELL CYCLE, V6, P1443; Crozatier M, 2011, DIS MODEL MECH, V4, P439, DOI 10.1242/dmm.007351; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; Dragojlovic-Munther M, 2013, DEV BIOL, V384, P313, DOI 10.1016/j.ydbio.2013.04.004; Dragojlovic-Munther M, 2012, DEVELOPMENT, V139, P3752, DOI 10.1242/dev.074203; Ferguson GB, 2014, CURR BIOL, V24, P2665, DOI 10.1016/j.cub.2014.09.081; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Gao HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107768; Gao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074684; Gao HJ, 2011, GENESIS, V49, P105, DOI 10.1002/dvg.20711; Ghosh S, 2015, DEV CELL, V33, P478, DOI 10.1016/j.devcel.2015.03.014; Gold KS, 2014, EXP HEMATOL, V42, P717, DOI 10.1016/j.exphem.2014.06.002; Grigorian M, 2011, DEV GENES EVOL, V221, P121, DOI 10.1007/s00427-011-0364-6; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Khadilkar RJ, 2014, P NATL ACAD SCI USA, V111, P4898, DOI 10.1073/pnas.1303559111; Kieslinger M, 2010, CELL STEM CELL, V7, P496, DOI 10.1016/j.stem.2010.07.015; Krzemien J, 2008, THESIS U TOULOUSE 3; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, INT J DEV BIOL, V54, P1117, DOI 10.1387/ijdb.093053jk; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Lam V, 2014, BIOCHEM BIOPH RES CO, V453, P467, DOI 10.1016/j.bbrc.2014.09.109; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Rivas ML, 2008, EMBO REP, V9, P1114, DOI 10.1038/embor.2008.170; Makki R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000441; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Minakhina S, 2011, DEV BIOL, V352, P308, DOI 10.1016/j.ydbio.2011.01.035; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mondal BC, 2014, ELIFE, V3, DOI 10.7554/eLife.03626; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pennetier D, 2012, P NATL ACAD SCI USA, V109, P3389, DOI 10.1073/pnas.1109407109; Russo J, 1996, PARASITOLOGY, V112, P135, DOI 10.1017/S0031182000065173; Shim J, 2013, CELL, V155, P1141, DOI 10.1016/j.cell.2013.10.032; Shim J, 2013, DEVELOPMENT, V140, P4647, DOI 10.1242/dev.079087; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Tokusumi T, 2015, DEVELOPMENT, V142, P2261, DOI 10.1242/dev.121798; Tokusumi T, 2011, DEVELOPMENT, V138, P3879, DOI 10.1242/dev.069336; Tokusumi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041604; Tokusumi Y, 2010, DEVELOPMENT, V137, P3561, DOI 10.1242/dev.053728	54	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148978	10.1371/journal.pone.0148978	http://dx.doi.org/10.1371/journal.pone.0148978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866694	Green Submitted, Green Published, gold			2022-12-26	WOS:000370050700050
J	Kalia, P; Brooks, RA; Kinrade, SD; Morgan, DJ; Brown, AP; Rushton, N; Jugdaohsingh, R				Kalia, Priya; Brooks, Roger A.; Kinrade, Stephen D.; Morgan, David J.; Brown, Andrew P.; Rushton, Neil; Jugdaohsingh, Ravin			Adsorption of Amorphous Silica Nanoparticles onto Hydroxyapatite Surfaces Differentially Alters Surfaces Properties and Adhesion of Human Osteoblast Cells	PLOS ONE			English	Article							SUBSTITUTED HYDROXYAPATITE; IN-VITRO; GROWTH; RATS; VIVO	Silicon (Si) is suggested to be an important/essential nutrient for bone and connective tissue health. Silicon-substituted hydroxyapatite (Si-HA) has silicate ions incorporated into its lattice structure and was developed to improve attachment to bone and increase new bone formation. Here we investigated the direct adsorption of silicate species onto an HA coated surface as a cost effective method of incorporating silicon on to HA surfaces for improved implant osseointegration, and determined changes in surface characteristics and osteoblast cell adhesion. Plasma-sprayed HA-coated stainless steel discs were incubated in silica dispersions of different concentrations (0-42 mM Si), at neutral pH for 12 h. Adsorbed Si was confirmed by XPS analysis and quantified by ICP-OES analysis following release from the HA surface. Changes in surface characteristics were determined by AFM and measurement of surface wettability. Osteoblast cell adhesion was determined by vinculin plaque staining. Maximum Si adsorption to the HA coated disc occurred after incubation in the 6 mM silica dispersion and decreased progressively with higher silica concentrations, while no adsorption was observed with dispersions below 6 mM Si. Comparison of the Si dispersions that produced the highest and lowest Si adsorption to the HA surface, by TEM-based analysis, revealed an abundance of small amorphous nanosilica species (NSP) of similar to 1.5 nm in diameter in the 6 mM Si dispersion, with much fewer and larger NSP in the 42 mM Si dispersions. 29Si-NMR confirmed that the NSPs in the 6 mM silica dispersion were polymeric and similar in composition to the larger NSPs in the 42 mM Si dispersion, suggesting that the latter were aggregates of the former. Amorphous NSP adsorbed from the 6 mM dispersion on to a HA-coated disc surface increased the surface's water contact angle by 53 degrees, whereas that adsorbed from the 42 mM dispersion decreased the contact angle by 18 degrees, indicating increased and decreased hydrophobicity, respectively. AFM showed an increase in surface roughness of the 6 mM Si treated surface, which correlated well with an increase in number of vinculin plaques. These findings suggest that NSP of the right size (relative to charge) adsorb readily to the HA surface, changing the surface characteristics and, thus, improving osteoblast cell adhesion. This treatment provides a simple way to modify plasma-coated HA surfaces that may enable improved osseointegration of bone implants.	[Kalia, Priya; Brooks, Roger A.; Rushton, Neil] Univ Cambridge, Div Trauma & Orthopaed Surg, Cambridge, England; [Kinrade, Stephen D.] Lakehead Univ, Dept Chem, Thunder Bay, ON P7B 5E1, Canada; [Morgan, David J.] Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Cardiff CF10 3AX, S Glam, Wales; [Brown, Andrew P.] Univ Leeds, Sch Chem & Proc Engn, Leeds, W Yorkshire, England; [Jugdaohsingh, Ravin] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, Cambs, England; [Kalia, Priya] Instinctif Partners, Div Life Sci, London, England	University of Cambridge; Lakehead University; Cardiff University; University of Leeds; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Kalia, P (corresponding author), Univ Cambridge, Div Trauma & Orthopaed Surg, Cambridge, England.; Kalia, P (corresponding author), Instinctif Partners, Div Life Sci, London, England.	priyakalia@gmail.com	Morgan, David John/F-6285-2010; , Roger/N-7021-2019	Morgan, David John/0000-0002-6571-5731; Brown, Andy/0000-0001-9692-2154	National Institute of Health Research (NIHR); Medical Research Council [MC_US_A090_0008/U1059]; Engineering and Physical Sciences Research Council (UK) [EP/F019823/1, EP/K023853/1]; Orthopaedic Research UK; EPSRC [EP/E059678/1, EP/F019823/1, EP/P00122X/1, EP/K023853/1] Funding Source: UKRI; MRC [MC_U105960399] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K023853/1, EP/F019823/1, EP/P00122X/1, EP/E059678/1] Funding Source: researchfish; Medical Research Council [MC_U105960399] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Orthopaedic Research UK; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the National Institute of Health Research (NIHR) and the Medical Research Council, grant number MC_US_A090_0008/Unit Programme number U1059, www.mrc.ac.uk, to RJ; Engineering and Physical Sciences Research Council (UK), grant number EP/F019823/1 (https://www.epsrc.ac.uk) to PK, DJM; Engineering and Physical Sciences Research Council (UK), grant number EP/K023853/1 (https://www.epsrc.ac.uk) "Leeds EPSRC Nanoscience and Nanotechnology Research Equipment Facility (LENNF)" to APB and PK. Orthopaedic Research UK Grant "Drug Delivery of Silicon from the Furlong HA-C Hip" (www.oruk.org) to PK, RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366; Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806; Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899; CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619; Coathup MJ, 2011, J BONE JOINT SURG AM, V93A, P2219, DOI [10.2106/JBJS.I.01623, 10.2106/JBJS.J.01623]; Gomes PS, 2010, J BIOMED MATER RES B, V94B, P337, DOI 10.1002/jbm.b.31656; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99; Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225; Jugdaohsingh R, 2008, BONE, V43, P596, DOI 10.1016/j.bone.2008.04.014; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076; Porter AE, 2004, J BIOMED MATER RES A, V69A, P670, DOI 10.1002/jbm.a.30035; Rai A, 2010, LANGMUIR, V26, P4152, DOI 10.1021/la903366a; Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X; RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113; SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0; Tang Q, 2010, J MATER SCI-MATER M, V21, P173, DOI 10.1007/s10856-009-3841-y; Wiens M, 2009, BIOMATERIALS, V30, P1648, DOI 10.1016/j.biomaterials.2008.12.021; Zamir E, 1999, J CELL SCI, V112, P1655; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262	22	11	11	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0144780	10.1371/journal.pone.0144780	http://dx.doi.org/10.1371/journal.pone.0144780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863624	Green Published, Green Accepted, gold			2022-12-26	WOS:000370046600006
J	Marsh, A; Casey-Green, K; Probert, F; Withall, D; Mitchell, DA; Dilly, SJ; James, S; Dimitri, W; Ladwa, SR; Taylor, PC; Singer, DRJ				Marsh, Andrew; Casey-Green, Katherine; Probert, Fay; Withall, David; Mitchell, Daniel A.; Dilly, Suzanne J.; James, Sean; Dimitri, Wade; Ladwa, Sweta R.; Taylor, Paul C.; Singer, Donald R. J.			Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein	PLOS ONE			English	Article							PHAGE DISPLAY TECHNOLOGY; ENHANCED ATP RELEASE; PANNEXIN CHANNELS; NATURAL-PRODUCTS; CONNEXIN EXPRESSION; MOUSE; IDENTIFICATION; HEMICHANNELS; SEQUENCE; RNA	Finding pleiomorphic targets for drugs allows new indications or warnings for treatment to be identified. As test of concept, we applied a new chemical genomics approach to uncover additional targets for the widely prescribed lipid-lowering pro-drug simvastatin. We used mRNA extracted from internal mammary artery from patients undergoing coronary artery surgery to prepare a viral cardiovascular protein library, using T7 bacteriophage. We then studied interactions of clones of the bacteriophage, each expressing a different cardiovascular polypeptide, with surface-bound simvastatin in 96-well plates. To maximise likelihood of identifying meaningful interactions between simvastatin and vascular peptides, we used a validated photo-immobilisation method to apply a series of different chemical linkers to bind simvastatin so as to present multiple orientations of its constituent components to potential targets. Three rounds of biopanning identified consistent interaction with the clone expressing part of the gene GJC3, which maps to Homo sapiens chromosome 7, and codes for gap junction gamma-3 protein, also known as connexin 30.2/31.3 (mouse connexin Cx29). Further analysis indicated the binding site to be for the N-terminal domain putatively 'regulating' connexin hemichannel and gap junction pores. Using immunohistochemistry we found connexin 30.2/31.3 to be present in samples of artery similar to those used to prepare the bacteriophage library. Surface plasmon resonance revealed that a 25 amino acid synthetic peptide representing the discovered N-terminus did not interact with simvastatin lactone, but did bind to the hydrolysed HMG CoA inhibitor, simvastatin acid. This interaction was also seen for fluvastatin. The gap junction blockers carbenoxolone and flufenamic acid also interacted with the same peptide providing insight into potential site of binding. These findings raise key questions about the functional significance of GJC3 transcripts in the vasculature and other tissues, and this connexin's role in therapeutic and adverse effects of statins in a range of disease states.	[Dilly, Suzanne J.; Ladwa, Sweta R.] Tangent Reprofiling Ltd, Cent Point, SEEK, 45 Beech St, London EC2Y 8AD, England; [James, Sean; Dimitri, Wade; Singer, Donald R. J.] Univ Hosp Coventry & Warwickshire, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England; [Marsh, Andrew; Casey-Green, Katherine; Probert, Fay; Withall, David; Taylor, Paul C.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Singer, Donald R. J.] 11 Chandos St, London W1G 9EB, England; [Singer, Donald R. J.] Univ Warwick, Warwick Med Sch, Clin Sci Res Labs, Div Metab & Vasc Hlth, Coventry CV2 2DX, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Singer, DRJ (corresponding author), Univ Hosp Coventry & Warwickshire, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England.; Marsh, A (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.; Singer, DRJ (corresponding author), 11 Chandos St, London W1G 9EB, England.; Singer, DRJ (corresponding author), Univ Warwick, Warwick Med Sch, Clin Sci Res Labs, Div Metab & Vasc Hlth, Coventry CV2 2DX, W Midlands, England.	a.marsh@warwick.ac.uk; fpm.chandos@gmail.com	Marsh, Andrew/F-4478-2011; Mitchell, Daniel/A-6580-2009	Marsh, Andrew/0000-0001-8845-3562; Probert, Fay/0000-0002-8580-2023; Mitchell, Daniel/0000-0003-0936-6212	Engineering and Physical Sciences Research Council, United Kingdom (EPSRC); Tangent Reprofiling Ltd; University of Warwick; Advantage West Midlands (AWM); European Regional Development Fund (ERDF); Biotechnology and Biological Sciences Research Council [BB/C524338/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council, United Kingdom (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Tangent Reprofiling Ltd; University of Warwick; Advantage West Midlands (AWM); European Regional Development Fund (ERDF)(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Engineering and Physical Sciences Research Council, United Kingdom (EPSRC), and Tangent Reprofiling Ltd, for funding this study. Katherine Casey-Green received an EPSRC Small and Medium-sized Enterprise Collaborative Award in Science and Engineering (CASE) Studentship with Tangent Reprofiling Limited. Andrew Marsh and Paul Taylor received EPSRC Impact Funding from the University of Warwick, which employed Fay Probert and David Withall. EPSRC played no part in the design of the research or preparation of the manuscript. There are no patents, products in development or marketed products arising from this research to declare. The SPR equipment used in this research was obtained through Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials Project 2), with Support from Advantage West Midlands (AWM) and partly funded by the European Regional Development Fund (ERDF). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abascal F, 2013, BBA-BIOMEMBRANES, V1828, P4, DOI 10.1016/j.bbamem.2012.02.007; Ahn M, 2008, J NEUROSCI RES, V86, P992, DOI 10.1002/jnr.21561; Altevogt BM, 2002, J NEUROSCI, V22, P6458; Altevogt BM, 2000, MOL BIOL CELL, V11, p330A; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2015, GJC3 TISSUE EXPRESSI; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bedner P, 2012, BBA-BIOMEMBRANES, V1818, P1971, DOI 10.1016/j.bbamem.2011.10.016; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berger SI, 2011, WIRES SYST BIOL MED, V3, P129, DOI 10.1002/wsbm.114; Beyer EC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00067; Beyer EC, 2012, BBA-BIOMEMBRANES, V1818, P1823, DOI 10.1016/j.bbamem.2011.10.011; Billaud M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005824; Billaud M, 2014, PHARMACOL REV, V66, P513, DOI 10.1124/pr.112.007351; Bjaelde RG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00238; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Bukauskas FF, 2006, P NATL ACAD SCI USA, V103, P9726, DOI 10.1073/pnas.0603372103; Bulusu KC, 2014, NUCLEIC ACIDS RES, V42, pD1040, DOI 10.1093/nar/gkt1182; Burnham MP, 2014, BRIT J PHARMACOL, V171, P4808, DOI 10.1111/bph.12554; Casey-Green K, 2011, THESIS; Cavaletti G, 2011, LANCET ONCOL, V12, P1151, DOI 10.1016/S1470-2045(11)70131-0; Chadjichristos CE, 2006, CIRCULATION, V113, P2835, DOI 10.1161/CIRCULATIONAHA.106.627703; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cruciani V, 2006, CELL MOL LIFE SCI, V63, P1125, DOI 10.1007/s00018-005-5571-8; D'hondt C, 2013, BIOCHEM BIOPH RES CO, V432, P707, DOI 10.1016/j.bbrc.2013.01.066; Dahl G, 2014, FEBS LETT, V588, P1396, DOI 10.1016/j.febslet.2014.03.007; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Derda R, 2010, ANGEW CHEM INT EDIT, V49, P5301, DOI 10.1002/anie.201001143; Dilly SJ, 2007, CHEM COMMUN, P2808, DOI 10.1039/b704271j; Dilly SJ, 2006, LANGMUIR, V22, P8144, DOI 10.1021/la060743j; Dilly SJ, 2011, MOL BIOSYST, V7, P116, DOI 10.1039/c0mb00118j; Duffy HS, 2001, CELL COMMUN ADHES, V8, P225, DOI 10.3109/15419060109080728; Eiberger J, 2001, CELL COMMUN ADHES, V8, P163, DOI 10.3109/15419060109080717; Favis R, 2011, PHARMACOGENET GENOM, V21, P121, DOI 10.1097/FPC.0b013e3283436b45; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gnanasekar M, 2009, ANTIMICROB AGENTS CH, V53, P1054, DOI 10.1128/AAC.01222-08; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Harris AL D., 2009, CONNEXINS A GUIDE; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jayasinghe S, 2001, J MOL BIOL, V312, P927, DOI 10.1006/jmbi.2001.5008; Kalmatsky BD, 2012, ARCH BIOCHEM BIOPHYS, V526, P1, DOI 10.1016/j.abb.2012.05.027; Kang M, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0058-6; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164; Knezl V, 2008, NEUROENDOCRINOL LETT, V29, P798; Koh KK, 2011, ATHEROSCLEROSIS, V215, P1, DOI 10.1016/j.atherosclerosis.2010.10.036; Kramer RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng058; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Kwak BR, 2002, ARTERIOSCL THROM VAS, V22, P225, DOI 10.1161/hq0102.104125; Kyle JW, 2009, J BIOL CHEM, V284, P20418, DOI 10.1074/jbc.M109.016907; Ladwa SR, 2008, CHEMMEDCHEM, V3, P742, DOI 10.1002/cmdc.200700317; Leslie BJ, 2008, CHEM SOC REV, V37, P1347, DOI 10.1039/b702942j; Lewandowski Rebecca, 2009, P129, DOI 10.1007/978-1-59745-489-6_5; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li J, 2007, GLIA, V55, P93, DOI 10.1002/glia.20427; Li X, 2004, NEUROSCIENCE, V126, P611, DOI 10.1016/j.neuroscience.2004.03.063; Liang WG, 2011, CELL BIOCHEM BIOPHYS, V61, P189, DOI 10.1007/s12013-011-9188-2; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; MA PTS, 1986, P NATL ACAD SCI USA, V83, P8370, DOI 10.1073/pnas.83.21.8370; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martinez AD, 2011, BIOCHEM J, V436, P35, DOI 10.1042/BJ20110008; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; Moreno AP, 2007, PROG BIOPHYS MOL BIO, V94, P107, DOI 10.1016/j.pbiomolbio.2007.03.004; Nagy JI, 2003, J COMP NEUROL, V464, P356, DOI 10.1002/cne.10797; Nakagawa S, 2010, CURR OPIN STRUC BIOL, V20, P423, DOI 10.1016/j.sbi.2010.05.003; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oh S, 2004, BIOPHYS J, V87, P912, DOI 10.1529/biophysj.103.038448; Oshima A, 2011, J MOL BIOL, V405, P724, DOI 10.1016/j.jmb.2010.10.032; Peddibhotla S, 2007, J AM CHEM SOC, V129, P12222, DOI 10.1021/ja0733686; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P505, DOI 10.1124/dmd.30.5.505; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; R Core Team, 2012, R LANG ENV STAT COMP; Riedmaier S, 2010, CLIN PHARMACOL THER, V87, P65, DOI 10.1038/clpt.2009.181; Robles O, 2014, NAT PROD REP, V31, P318, DOI 10.1039/c3np70087a; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Saba TG, 2005, HUM GENET, V116, P167, DOI 10.1007/s00439-004-1193-8; Sargiannidou I, 2008, NEUROBIOL DIS, V30, P221, DOI 10.1016/j.nbd.2008.01.009; Sche PP, 1999, CHEM BIOL, V6, P707, DOI 10.1016/S1074-5521(00)80018-6; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shen J, 2010, J CARDIOVASC PHARM T, V15, P296, DOI 10.1177/1074248410373750; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Skottheim IB, 2008, EUR J PHARM SCI, V33, P317, DOI 10.1016/j.ejps.2007.12.009; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Sohl G, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00083; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sohl G, 2003, CELL COMMUN ADHES, V10, P27, DOI 10.1080/15419060390220468; Sohl G, 2001, BIOL CHEM, V382, P973, DOI 10.1515/BC.2001.122; Sonntag S, 2009, EUR J CELL BIOL, V88, P65, DOI 10.1016/j.ejcb.2008.08.004; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Su C-C, 2012, CELL BIOCH BIOPHYS, P1; Takakusagi Y, 2010, EXPERT OPIN DRUG DIS, V5, P361, DOI 10.1517/17460441003653155; Taylor PC, 2013, CHEM COMMUN, V49, P9588, DOI 10.1039/c3cc44647f; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; Tribulova N, 2008, PHYSIOL RES, V57, pS1, DOI 10.33549/physiolres.931546; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Verselis VK, 2013, NEUROPHARMACOLOGY, V75, P517, DOI 10.1016/j.neuropharm.2013.03.020; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Wang LH, 2005, INT J CARDIOL, V100, P467, DOI 10.1016/j.ijcard.2004.12.005; Wang WH, 2010, AUDIOL NEURO-OTOL, V15, P81, DOI 10.1159/000231633; Wang WH, 2001, MOL VIS, V7, P89; Wang X, 2012, BBA-BIOMEMBRANES, V1818, P1148, DOI 10.1016/j.bbamem.2011.12.027; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yang JJ, 2005, BIOCHEM BIOPH RES CO, V338, P723, DOI 10.1016/j.bbrc.2005.09.193; Zhou CY, 2010, ORG LETT, V12, P2104, DOI 10.1021/ol100587j; Zhou QH, 2013, J AM CHEM SOC, V135, P12994, DOI 10.1021/ja407739y; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	123	2	2	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148266	10.1371/journal.pone.0148266	http://dx.doi.org/10.1371/journal.pone.0148266			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863535	Green Published, gold			2022-12-26	WOS:000370046600050
J	Connor, DO; Zantow, J; Hust, M; Bier, FF; von Nickisch-Rosenegk, M				Connor, Daniel O.; Zantow, Jonas; Hust, Michael; Bier, Frank F.; von Nickisch-Rosenegk, Markus			Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; VACCINE ANTIGENS; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; ANTIMICROBIAL RESISTANCE; RECOMBINANT ANTIBODIES; SALMONELLA-TYPHIMURIUM; UNTREATABLE GONORRHEA; MULTIDRUG-RESISTANT; ESCHERICHIA-COLI	Neisseria gonorrhoeae is one of the most prevalent sexually transmitted diseases worldwide with more than 100 million new infections per year. A lack of intense research over the last decades and increasing resistances to the recommended antibiotics call for a better understanding of gonococcal infection, fast diagnostics and therapeutic measures against N. gonorrhoeae. Therefore, the aim of this work was to identify novel immunogenic proteins as a first step to advance those unresolved problems. For the identification of immunogenic proteins, pHORF oligopeptide phage display libraries of the entire N. gonorrhoeae genome were constructed. Several immunogenic oligopeptides were identified using polyclonal rabbit antibodies against N. gonorrhoeae. Corresponding full-length proteins of the identified oligopeptides were expressed and their immunogenic character was verified by ELISA. The immunogenic character of six proteins was identified for the first time. Additional 13 proteins were verified as immunogenic proteins in N. gonorrhoeae.	[Connor, Daniel O.; von Nickisch-Rosenegk, Markus] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc IZI BB, Dept Bioanalyt & Biosensor, Potsdam, Germany; [Zantow, Jonas; Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Bier, Frank F.] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Bier, Frank F.] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc IZI BB, Dept Biosyst Integrat & Automat, Potsdam, Germany	Fraunhofer Gesellschaft; Braunschweig University of Technology; University of Potsdam; Fraunhofer Gesellschaft	Connor, DO (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc IZI BB, Dept Bioanalyt & Biosensor, Potsdam, Germany.	Daniel.Connor@izi-bb.fraunhofer.de	Bier, Frank/AAN-2532-2020	Bier, Frank/0000-0003-0375-9832; Hust, Michael/0000-0003-3418-6045	German Federal Ministry of Education and Research [03IS2201A]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 03IS2201A of the German Federal Ministry of Education and Research (www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlaAldeen DAA, 1996, J MED MICROBIOL, V45, P419, DOI 10.1099/00222615-45-6-419; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bae JE, 2002, VET MICROBIOL, V88, P189, DOI 10.1016/S0378-1135(02)00101-3; Barbee LA, 2013, INFECT DIS CLIN N AM, V27, P723, DOI 10.1016/j.idc.2013.08.001; Becker M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0167-3; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bennett JE, 2015, MANDELL DOUGLAS BENN; Beranova-Giorgianni S, 2003, TRAC-TREND ANAL CHEM, V22, P273, DOI 10.1016/S0165-9936(03)00508-9; BLACK JR, 1985, J INFECT DIS, V151, P650, DOI 10.1093/infdis/151.4.650; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; CANNON JG, 1989, CLIN MICROBIOL REV, V2, pS1, DOI 10.1128/CMR.2.Suppl.S1-S4.1989; Christodoulides M, 2014, EXPERT REV PROTEOMIC, V11, P573, DOI 10.1586/14789450.2014.938640; Cole MJ, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.45.20955; Danckert L, 2014, MICROCHIM ACTA, V181, P1707, DOI 10.1007/s00604-014-1197-6; Dennehy R, 2012, CURR PROTEIN PEPT SC, V13, P807, DOI 10.2174/138920312804871184; Dietrich M, 2009, FEBS J, V276, P5507, DOI 10.1111/j.1742-4658.2009.07234.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; Dorman CJ, 2003, CURR OPIN GENET DEV, V13, P179, DOI 10.1016/S0959-437X(03)00025-X; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Gil J, 2009, HUM VACCINES, V5, P347, DOI 10.4161/hv.5.5.7367; Grifantini R, 2002, ANN NY ACAD SCI, V975, P202, DOI 10.1111/j.1749-6632.2002.tb05953.x; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hoppe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065837; Hsu CA, 2008, PROTEOMICS, V8, P2115, DOI 10.1002/pmic.200700574; Hubalek M, 2003, J CHROMATOGR B, V787, P149, DOI 10.1016/S1570-0232(02)00730-4; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2006, BIOTECHNIQUES, V41, P335, DOI 10.2144/000112225; Jacobsson Karin, 2003, Biological Procedures Online, V5, P123, DOI 10.1251/bpo54; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; JOHN J, 1978, BRIT J VENER DIS, V54, P322; Kelly DF, 2005, ADV EXP MED BIOL, V568, P217; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kovach AR, 2014, RNA, V20, P1548, DOI 10.1261/rna.044032.113; Kugler J, 2008, APPL MICROBIOL BIOT, V80, P447, DOI 10.1007/s00253-008-1576-1; Kugler J, 2013, VIRUSES-BASEL, V5, P2531, DOI 10.3390/v5102531; Kurz S, 2003, VACCINE, V21, P768, DOI 10.1016/S0264-410X(02)00596-0; Kwiatek A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00712; LaFrentz BR, 2011, J FISH DIS, V34, P823, DOI 10.1111/j.1365-2761.2011.01297.x; Mendum TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005940; Meyer T, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-29; MILLER HI, 1981, P NATL ACAD SCI-BIOL, V78, P6754, DOI 10.1073/pnas.78.11.6754; MULKS MH, 1978, NEW ENGL J MED, V299, P973, DOI 10.1056/NEJM197811022991802; Naseem S, 2010, VET MICROBIOL, V142, P285, DOI 10.1016/j.vetmic.2009.09.071; Nowalk AJ, 2006, INFECT IMMUN, V74, P3864, DOI 10.1128/IAI.00189-06; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; PANNEKOEK Y, 1995, MOL MICROBIOL, V15, P277, DOI 10.1111/j.1365-2958.1995.tb02242.x; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Pawlik MC, 2012, J BACTERIOL, V194, P6594, DOI 10.1128/JB.01091-12; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piekarowicz A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-66; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Qamra R, 2005, TUBERCULOSIS, V85, P385, DOI 10.1016/j.tube.2005.08.014; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Rotman E, 2014, ANNU REV GENET, V48, P405, DOI 10.1146/annurev-genet-120213-092007; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook J., 2001, MOL CLONING LAB MANU; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Spence JM, 2002, MICROB PATHOGENESIS, V32, P117, DOI 10.1006/mpat.2001.0484; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; SVENSSON L, 1980, AM J OBSTET GYNECOL, V138, P1017, DOI 10.1016/0002-9378(80)91099-6; SWANSON J, 1982, INFECT IMMUN, V38, P668, DOI 10.1128/IAI.38.2.668-672.1982; Tapsall John W, 2009, Expert Rev Anti Infect Ther, V7, P821, DOI 10.1586/eri.09.63; Tsolakos N, 2014, J PROTEOMICS, V101, P63, DOI 10.1016/j.jprot.2014.02.013; Tureci O, 1997, MOL MED TODAY, V3, P342, DOI 10.1016/S1357-4310(97)01081-2; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]; Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010, ORAL CEPHALOSPORINS; Urquhart BL, 1998, BIOCHEM BIOPH RES CO, V253, P70, DOI 10.1006/bbrc.1998.9709; Vaughan TE, 2006, VACCINE, V24, P5277, DOI 10.1016/j.vaccine.2006.03.013; WALLIN J, 1975, BRIT J VENER DIS, V51, P41; Weng JW, 2009, BIOPHYS J, V96, P1918, DOI 10.1016/j.bpj.2008.11.035; WHO, 2012, WHO GLOB ACT PLAN CO; Williams JN, 2007, INFECT IMMUN, V75, P1364, DOI 10.1128/IAI.01424-06; Williams JN, 2014, VACCINE, V32, P1280, DOI 10.1016/j.vaccine.2013.12.070; Williams JN, 2009, INFECT IMMUN, V77, P5080, DOI 10.1128/IAI.00701-09; Workowski KA, 2008, ANN INTERN MED, V148, P606, DOI 10.7326/0003-4819-148-8-200804150-00005; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu H, 2006, P NATL ACAD SCI USA, V103, P4011, DOI 10.1073/pnas.0510921103	96	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148986	10.1371/journal.pone.0148986	http://dx.doi.org/10.1371/journal.pone.0148986			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859666	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400115
J	Kavlashvili, T; Jia, YC; Dai, DH; Meng, XB; Thiel, KW; Leslie, KK; Yang, SJ				Kavlashvili, Tamar; Jia, Yichen; Dai, Donghai; Meng, Xiangbing; Thiel, Kristina W.; Leslie, Kimberly K.; Yang, Shujie			Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION; ESTROGEN; RESPONSIVENESS; MECHANISMS; INHIBITORS; PROMOTERS; CARCINOMA; CELLS; WOMEN	Endometrial cancer, the most common gynecologic malignancy, is a hormonally-regulated disease. Response to progestin therapy positively correlates with hormone receptor expression, in particular progesterone receptor (PR). However, many advanced tumors lose PR expression. We recently reported that the efficacy of progestin therapy can be significantly enhanced by combining progestin with epigenetic modulators, which we term "molecularly enhanced progestin therapy." What remained unclear was the mechanism of action and if estrogen receptor alpha (ER alpha), the principle inducer of PR, is necessary to restore functional expression of PR via molecularly enhanced progestin therapy. Therefore, we modeled advanced endometrial tumors that have lost both ER alpha and PR expression by generating ER alpha-null endometrial cancer cell lines. CRISPR-Cas9 technology was used to delete ER alpha at the genomic level. Our data demonstrate that treatment with a histone deacetylase inhibitor (HDACi) was sufficient to restore functional PR expression, even in cells devoid of ER alpha. Our studies also revealed that HDACi treatment results in marked downregulation of the oncogene Myc. We established that PR is a negative transcriptional regulator of Myc in endometrial cancer in the presence or absence of ER alpha, which is in contrast to studies in breast cancer cells. First, estrogen stimulation augmented PR expression and decreased Myc in endometrial cancer cell lines. Second, progesterone increased PR activity yet blunted Myc mRNA and protein expression. Finally, overexpression of PR by adenoviral transduction in ER alpha-null endometrial cancer cells significantly decreased expression of Myc and Myc-regulated genes. Analysis of the Cancer Genome Atlas (TCGA) database of endometrial tumors identified an inverse correlation between PR and Myc mRNA levels, with a corresponding inverse correlation between PR and Myc downstream transcriptional targets SRD5A1, CDK2 and CCNB1. Together, these data reveal a previously unanticipated inverse relationship between the tumor suppressor PR and the oncogene Myc in endometrial cancer.	[Kavlashvili, Tamar; Jia, Yichen; Dai, Donghai; Meng, Xiangbing; Thiel, Kristina W.; Leslie, Kimberly K.; Yang, Shujie] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Meng, Xiangbing; Leslie, Kimberly K.; Yang, Shujie] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Jia, Yichen] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	University of Iowa; University of Iowa; University of Washington; University of Washington Seattle	Yang, SJ (corresponding author), Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.; Yang, SJ (corresponding author), Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.	Shujie-yang@uiowa.edu		Dai, Donghai/0000-0002-9670-7822; Leslie, Kimberly/0000-0002-2704-8990; meng, xiangbing/0000-0002-9612-6438; Jia, Yichen/0000-0002-9127-5610; Thiel, Kristina/0000-0001-8295-864X; Yang, Shujie/0000-0003-1753-3068	American Cancer Society Institutional Research Grant; NIH [R01CA99908, R01CA184101]; Department of Obstetrics and Gynecology Research Development Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063117] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA099908, P30CA086862, R01CA184101] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology Research Development Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society Institutional Research Grant (SY), and the NIH R01CA99908 and R01CA184101 (KKL), the Department of Obstetrics and Gynecology Research Development Fund (KKL). The funders did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANC FACTS FIG; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Diep CH, 2015, J MOL ENDOCRINOL, V54, pR31, DOI 10.1530/JME-14-0252; DUBIK D, 1987, CANCER RES, V47, P6517; Gabay M, 2014, COLD SPRING HARB PER, V4; Giulianelli S, 2012, CANCER RES, V72, P2416, DOI 10.1158/0008-5472.CAN-11-3290; Hunter DJ, 2010, CANCER EPIDEM BIOMAR, V19, P2496, DOI 10.1158/1055-9965.EPI-10-0747; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Lee JH, 2012, ADV CANCER RES, V116, P39, DOI 10.1016/B978-0-12-394387-3.00002-1; Leslie KK, 2005, GYNECOL ONCOL, V96, P32, DOI 10.1016/j.ygyno.2004.09.057; Li CI, 2012, CANCER RES, V72, P2028, DOI 10.1158/0008-5472.CAN-11-4064; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McEwan MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049160; McKeown MR, 2014, COLD SPRING HARB PER, V4; Moore MR, 1997, J STEROID BIOCHEM, V62, P243, DOI 10.1016/S0960-0760(97)00036-8; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Prystowsky MB, 2009, J PATHOL, V218, P467, DOI 10.1002/path.2554; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh M, 2007, GYNECOL ONCOL, V106, P325, DOI 10.1016/j.ygyno.2007.03.042; Tansey WP, 2014, N J SCI, V2014, P27; Wargon V, 2015, INT J CANCER, V136, P2680, DOI 10.1002/ijc.29304; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Yang S, 2013, CURR PHARM DES; Yang SJ, 2014, ONCOTARGET, V5, P9783, DOI 10.18632/oncotarget.2392; Yang SJ, 2011, DISCOV MED, V12, P205; Yang S, 2011, TRENDS ENDOCRIN MET, V22, P145, DOI 10.1016/j.tem.2011.01.005	27	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148912	10.1371/journal.pone.0148912	http://dx.doi.org/10.1371/journal.pone.0148912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859414	gold, Green Published			2022-12-26	WOS:000370038400103
J	Val, S; Burgett, K; Brown, KJ; Preciado, D				Val, Stephanie; Burgett, Katelyn; Brown, Kristy J.; Preciado, Diego			SuperSILAC Quantitative Proteome Profiling of Murine Middle Ear Epithelial Cell Remodeling with NTHi	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; EXPRESSION; METAPLASIA; EFFUSION; PHOSPHORYLATION; PROLIFERATION; MANAGEMENT; INDUCTION; DIAGNOSIS; PATHOLOGY	Background Chronic Otitis Media with effusion (COME) develops after sustained inflammation and is characterized by secretory middle ear epithelial metaplasia and effusion, most frequently mucoid. Non-typeable Haemophilus influenzae (NTHi), the most common acute Otitis Media (OM) pathogen, is postulated to promote middle ear epithelial remodeling in the progression of OM from acute to chronic. The goals of this study were to examine histopathological and quantitative proteomic epithelial effects of NTHi challenge in a murine middle ear epithelial cell line. Methods NTHi lysates were generated and used to stimulate murine epithelial cells (mMEEC) cultured at air-liquid interface over 48 hours-1 week. Conditional quantitative Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) of cell lysates was performed to interrogate the global protein production in the cells, using the SuperSILAC technique. Histology of the epithelium over time was done to measure bacterial dependent remodeling. Results Mass spectrometry analysis identified 2,565 proteins across samples, of which 74 exhibited differential enrichment or depletion in cell lysates (+/-2.0 fold-change; p value<0.05). The key molecular functions regulated by NTHi lysates exposure were related to cell proliferation, death, migration, adhesion and inflammation. Finally, chronic exposure induced significant epithelial thickening of cells grown at air liquid interface. Conclusions NTHi lysates drive pathways responsible of cell remodeling in murine middle ear epithelium which likely contributes to observed epithelial hyperplasia in vitro. Further elucidation of these mediators will be critical in understanding the progression of OM from acute to chronic at the molecular level.	[Val, Stephanie; Burgett, Katelyn; Preciado, Diego] Childrens Natl Hlth Syst, Sheikh Zayed Ctr Pediat Surg Innovat, Washington, DC USA; [Brown, Kristy J.] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA; [Preciado, Diego] Childrens Natl Hlth Syst, Div Pediat Otolaryngol, Washington, DC USA	Children's National Health System; Children's National Health System; Children's National Health System	Preciado, D (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Ctr Pediat Surg Innovat, Washington, DC USA.; Preciado, D (corresponding author), Childrens Natl Hlth Syst, Div Pediat Otolaryngol, Washington, DC USA.	dpreciad@cnmc.org			NIDCD [R01DC012377]; National Institute of Health (NIH) [P30HD040677]; NIH [2R24HD050846-06, NICHD 5P30HD040677, UL1TR000075]; CRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, R24HD050846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012377] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01DC012377 from the NIDCD. Microscopic analysis was carried out at the Children's Research Institute (CRI) Light Microscopy and Image Analysis Core supported by CRI and National Institute of Health (NIH) grant P30HD040677. This work was partially supported by NIH core grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research), NICHD 5P30HD040677 (Intellectual and Developmental Disabilities Research Center) and UL1TR000075 (NIH National Center for Advancing Translational Sciences). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Bluestone C.D, 1996, PEDIAT OTOLARYNGOLOG; Brown KJ, 1834, BIOCHIM BIOPHYS ACTA, P2454; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Caye-Thomasen P, 2002, INT J PEDIATR OTORHI, V63, P99, DOI 10.1016/S0165-5876(01)00641-3; Cherry Donald K, 2002, Adv Data, P1; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; He JS, 2014, J BREAST CANCER, V17, P200, DOI 10.4048/jbc.2014.17.3.200; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Klein JO, 2002, PEDIATR ANN, V31, P777, DOI 10.3928/0090-4481-20021201-06; Koch PJ, 2004, J INVEST DERMATOL, V123, pX, DOI 10.1111/j.0022-202X.2004.23495.x; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; LEUBE RE, 1991, VIRCHOWS ARCH B, V61, P227; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Maeda K, 2004, LARYNGOSCOPE, V114, P1967, DOI 10.1097/01.mlg.0000147930.29261.51; Mazzalupo S, 2003, DEV DYNAM, V226, P356, DOI 10.1002/dvdy.10245; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; MOLL R, 1989, VIRCHOWS ARCH B, V58, P129, DOI 10.1007/BF02890064; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Ninkina NN, 1999, EXP CELL RES, V246, P308, DOI 10.1006/excr.1998.4292; Paramio JM, 1999, EUR J CELL BIOL, V78, P33, DOI 10.1016/S0171-9335(99)80005-3; Preciado D PM, 2015, INT J PEDIA IN PRESS; Preciado D, 2008, LARYNGOSCOPE, V118, P464, DOI 10.1097/MLG.0b013e31815aedc7; Preciado D, 2013, LARYNGOSCOPE, V123, pE66, DOI 10.1002/lary.24097; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Rosenfeld RM, 2001, OTOLARYNG HEAD NECK, V125, P440, DOI 10.1067/mhn.2001.119326; Ruhrberg C, 1997, CURR OPIN GENET DEV, V7, P392, DOI 10.1016/S0959-437X(97)80154-2; RYAN AF, 1993, ACTA OTO-LARYNGOL, V113, P68, DOI 10.3109/00016489309135769; Ryan AF, 2005, ANN OTO RHINOL LARYN, V114, P42, DOI 10.1177/00034894051140S106; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; Storck Sebastien, 2007, Subcell Biochem, V41, P125; STOSIEK P, 1992, VIRCHOWS ARCH A, V421, P133, DOI 10.1007/BF01607046; TOS M, 1977, ANN OTO RHINOL LARYN, V86, P209, DOI 10.1177/000348947708600212; Tsuboi Y, 2002, ACTA OTO-LARYNGOL, V122, P153, DOI 10.1080/00016480252814153; Tsuchiya K, 2005, ACTA OTO-LARYNGOL, V125, P823, DOI 10.1080/00016480510031533; Val S, 2015, J INVEST MED, V63, P258, DOI 10.1097/JIM.0000000000000127; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Wu XF, 2011, AM J RESP CELL MOL, V45, P525, DOI 10.1165/rcmb.2010-0133OC; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148612	10.1371/journal.pone.0148612	http://dx.doi.org/10.1371/journal.pone.0148612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859300	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400057
J	Moorhouse, AJ; Rennison, C; Raza, M; Lilic, D; Gow, NAR				Moorhouse, Alexander J.; Rennison, Claire; Raza, Muhammad; Lilic, Desa; Gow, Neil A. R.			Clonal Strain Persistence of Candida albicans Isolates from Chronic Mucocutaneous Candidiasis Patients	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; POPULATION-STRUCTURE; AZOLE RESISTANCE; IL-17 IMMUNITY; SUSCEPTIBILITY; RECOMBINATION; MECHANISMS; REVEALS; RELATEDNESS; FLUCONAZOLE	Chronic mucocutaneous candidiasis (CMC) is a primary immunodeficiency disorder characterised by susceptibility to chronic Candida and fungal dermatophyte infections of the skin, nails and mucous membranes. Molecular epidemiology studies of CMC infection are limited in number and scope and it is not clear whether single or multiple strains inducing CMC persist stably or are exchanged and replaced. We subjected 42 C. albicans individual single colony isolates from 6 unrelated CMC patients to multilocus sequence typing (MLST). Multiple colonies were typed from swabs taken from multiple body sites across multiple time points over a 17-month period. Among isolates from each individual patient, our data show clonal and persistent diploid sequence types (DSTs) that were stable over time, identical between multiple infection sites and exhibit azole resistant phenotypes. No shared origin or common source of infection was identified among isolates from these patients. Additionally, we performed C. albicans MLST SNP genotype frequency analysis to identify signatures of past loss of heterozygosity (LOH) events among persistent and azole resistant isolates retrieved from patients with autoimmune disorders including CMC.	[Moorhouse, Alexander J.; Gow, Neil A. R.] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland; [Rennison, Claire; Raza, Muhammad; Lilic, Desa] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Aberdeen; Newcastle University - UK	Gow, NAR (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland.	n.gow@abdn.ac.uk	GOW, Neil/AAS-5323-2021	GOW, Neil/0000-0002-2776-5850; Moorhouse, Alexander/0000-0002-1626-6087	MRC; Wellcome Trust [086827, 075470, 097377, 101873]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was supported by the MRC for a PhD studentship for AM and the Wellcome Trust for funding (086827, 075470, 097377 & 101873).	Badoc C, 2002, FEMS MICROBIOL LETT, V209, P249, DOI 10.1111/j.1574-6968.2002.tb11139.x; Balloux F, 2003, GENETICS, V164, P1635; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Magri MMC, 2013, J CLIN MICROBIOL, V51, P268, DOI 10.1128/JCM.02366-12; Chen KW, 2009, INFECT GENET EVOL, V9, P912, DOI 10.1016/j.meegid.2009.06.011; Chen KW, 2005, J MED MICROBIOL, V54, P249, DOI 10.1099/jmm.0.45829-0; CLSI, 2008, M27A3 CLSI; Coleman D, 1997, Oral Dis, V3 Suppl 1, pS96; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Da Matta DA, 2010, J CLIN MICROBIOL, V48, P3062, DOI 10.1128/JCM.00262-10; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; Dodgson AR, 2005, FUNGAL GENET BIOL, V42, P233, DOI 10.1016/j.fgb.2004.11.010; Dodgson AR, 2003, J CLIN MICROBIOL, V41, P5709, DOI 10.1128/JCM.41.12.5709-5717.2003; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2011, EUKARYOT CELL, V10, P54, DOI 10.1128/EC.00281-10; Farrer RA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003703; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Forche A, 1999, FUNGAL GENET BIOL, V28, P107, DOI 10.1006/fgbi.1999.1164; Ford CB, 2015, ELIFE, V4, DOI 10.7554/eLife.00662; Gammelsrud KW, 2012, MED MYCOL, V50, P619, DOI 10.3109/13693786.2012.675088; Ge SH, 2012, FUNGAL GENET BIOL, V49, P86, DOI 10.1016/j.fgb.2011.10.006; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Hickman MA, 2015, GENETICS, V200, P781, DOI 10.1534/genetics.115.178020; Hickman MA, 2013, NATURE, V494, P55, DOI 10.1038/nature11865; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Jacobsen MD, 2008, MED MYCOL, V46, P647, DOI 10.1080/13693780801986631; Jacobsen MD, 2008, FEMS YEAST RES, V8, P1334, DOI 10.1111/j.1567-1364.2008.00438.x; Jacobsen MD, 2007, J CLIN MICROBIOL, V45, P317, DOI 10.1128/JCM.01549-06; Jarmula A, 2011, POSTEP HIG MED DOSW, V65, P216, DOI 10.5604/17322693.937011; Jeffares DC, 2015, NAT GENET, V47, P235, DOI 10.1038/ng.3215; L'Ollivier C, 2012, INFECT GENET EVOL, V12, P1949, DOI 10.1016/j.meegid.2012.07.025; Laverdiere M, 2006, J ANTIMICROB CHEMOTH, V57, P705, DOI 10.1093/jac/dkl022; Lilic D, 2012, CURR OPIN MICROBIOL, V15, P420, DOI 10.1016/j.mib.2012.06.003; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Lott TJ, 2012, MED MYCOL, V50, P136, DOI 10.3109/13693786.2011.592153; Lott TJ, 2010, EUKARYOT CELL, V9, P619, DOI 10.1128/EC.00002-10; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Marco F, 1999, J CLIN MICROBIOL, V37, P2817, DOI 10.1128/JCM.37.9.2817-2828.1999; McManus BA, 2008, J CLIN MICROBIOL, V46, P652, DOI 10.1128/JCM.01574-07; McManus BA, 2014, INFECT GENET EVOL, V21, P166, DOI 10.1016/j.meegid.2013.11.008; McManus BA, 2012, J CLIN MICROBIOL, V50, P3335, DOI 10.1128/JCM.01532-12; McManus BA, 2011, J CLIN MICROBIOL, V49, P1879, DOI 10.1128/JCM.00026-11; Noel T, 2012, J MYCOL MED, V22, P173, DOI 10.1016/j.mycmed.2012.04.004; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Odds FC, 2009, FEMS YEAST RES, V9, P1091, DOI 10.1111/j.1567-1364.2009.00577.x; Puel A, 2012, CURR OPIN ALLERGY CL, V12, P616, DOI 10.1097/ACI.0b013e328358cc0b; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Pujol C, 1997, J CLIN MICROBIOL, V35, P2348, DOI 10.1128/JCM.35.9.2348-2358.1997; REAGAN DR, 1995, DIAGN MICR INFEC DIS, V21, P191, DOI 10.1016/0732-8893(95)00048-F; REDDING S, 1994, CLIN INFECT DIS, V18, P240, DOI 10.1093/clinids/18.2.240; Sampaio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010155; SCHMID J, 1990, J CLIN MICROBIOL, V28, P1236, DOI 10.1128/JCM.28.6.1236-1243.1990; Shin JH, 2007, J CLIN MICROBIOL, V45, P2385, DOI 10.1128/JCM.00381-07; Siikala E, 2010, J ANTIMICROB CHEMOTH, V65, P2505, DOI 10.1093/jac/dkq354; Smeekens SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029248; Soll DR, 2003, FEMS IMMUNOL MED MIC, V39, P1, DOI 10.1016/S0928-8244(03)00242-6; Takezaki S, 2012, J IMMUNOL, V189, P1521, DOI 10.4049/jimmunol.1200926; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047767	67	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0145888	10.1371/journal.pone.0145888	http://dx.doi.org/10.1371/journal.pone.0145888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849050	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000006
J	Viiard, E; Bessmeltseva, M; Simm, J; Talve, T; Aaspollu, A; Paalme, T; Sarand, I				Viiard, Ene; Bessmeltseva, Marianna; Simm, Jaak; Talve, Tiina; Aaspollu, Anu; Paalme, Toomas; Sarand, Inga			Diversity and Stability of Lactic Acid Bacteria in Rye Sourdoughs of Four Bakeries with Different Propagation Parameters	PLOS ONE			English	Article							FERMENTATION PROCESSES; POPULATION-DYNAMICS; SP-NOV.; LACTOBACILLUS; GROWTH; AMPLIFICATION; BIODIVERSITY; MICROFLORA; COMPLEX; YEASTS	We identified the lactic acid bacteria within rye sourdoughs and starters from four bakeries with different propagation parameters and tracked their dynamics for between 5-28 months after renewal. Evaluation of bacterial communities was performed using plating, denaturing gradient gel electrophoresis, and pyrosequencing of 16S rRNA gene amplicons. Lactobacillus amylovorus and Lactobacillus frumenti or Lactobacillus helveticus, Lactobacillus pontis and Lactobacillus panis prevailed in sourdoughs propagated at higher temperature, while ambient temperature combined with a short fermentation cycle selected for Lactobacillus sanfranciscensis, Lactobacillus pontis, and Lactobacillus zymae or Lactobacillus helveticus, Lactobacillus pontis and Lactobacillus zymae. The ratio of species in bakeries employing room-temperature propagation displayed a seasonal dependence. Introduction of different and controlled propagation parameters at one bakery (higher fermentation temperature, reduced inoculum size, and extended fermentation time) resulted in stabilization of the microbial community with an increased proportion of L. helveticus and L. pontis. Despite these new propagation parameters no new species were detected.	[Viiard, Ene; Bessmeltseva, Marianna; Talve, Tiina; Paalme, Toomas; Sarand, Inga] Competence Ctr Food & Fermentat Technol, Tallinn, Estonia; [Viiard, Ene; Bessmeltseva, Marianna; Paalme, Toomas; Sarand, Inga] Tallinn Univ Technol, Food Proc Dept, EE-19086 Tallinn, Estonia; [Simm, Jaak; Aaspollu, Anu] Tallinn Univ Technol, Ctr Biol Integrated Syst, EE-19086 Tallinn, Estonia; [Sarand, Inga] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	Tallinn University of Technology; Tallinn University of Technology; Tallinn University of Technology	Viiard, E (corresponding author), Competence Ctr Food & Fermentat Technol, Tallinn, Estonia.; Viiard, E (corresponding author), Tallinn Univ Technol, Food Proc Dept, EE-19086 Tallinn, Estonia.	ene@tftak.eu	Talve, Tiina/AAZ-3494-2020; Sarand, Inga/AAK-1871-2020	Talve, Tiina/0000-0002-8659-5759; Sarand, Inga/0000-0002-9517-8965	European Regional Development Fund [EU29994]; Estonian Research Council [ETF9417]; Ministry of Education and Research [IUT19-27]; European Social Fund Doctoral Studies and Internationalization Programme DoRa; graduate school "Functional materials and technologies" - European Social Fund in Estonia [1.2.0401.09-0079]	European Regional Development Fund(European Commission); Estonian Research Council(Estonian Research Council); Ministry of Education and Research; European Social Fund Doctoral Studies and Internationalization Programme DoRa; graduate school "Functional materials and technologies" - European Social Fund in Estonia	Financial support was provided by the European Regional Development Fund (http://www.struktuurifondid.ee/euroopa-regionaalarengu-fond/) project EU29994 (EV, MB, TT, IS) together with funds from Estonian Research Council (http://www.etag.ee/rahastamine/etf-grandid/) research grant ETF9417 (IS), Ministry of Education and Research (http://www.etag.ee/rahastamine/institutsionaalne-uurimistoetus/) research grant IUT19-27 (TP, IS) and the European Social Fund Doctoral Studies and Internationalization Programme DoRa (http://adm.archimedes.ee/stipendiumid/programm-dora/) administered by SA Archimedes (EV, MB). This work has been partially supported by graduate school "Functional materials and technologies" receiving funding from the European Social Fund (http://www.struktuurifondid.ee/euroopa-sotsiaalfond-2/) under project 1.2.0401.09-0079 in Estonia (EV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F., 2009, J COMPUT SCI SYST BI, V2, P74, DOI DOI 10.4172/JCSB.1000019; Bocker G., 1995, GETR MEHL BROT, V49, P370; De Vuyst L, 2005, TRENDS FOOD SCI TECH, V16, P43, DOI 10.1016/j.tifs.2004.02.012; De Vuyst L, 2014, FOOD MICROBIOL, V37, P11, DOI 10.1016/j.fm.2013.06.002; De Vuyst L, 2004, INT J FOOD MICROBIOL, V90, P93, DOI 10.1016/S0168-1605(03)00298-8; De Vuyst L, 2002, APPL ENVIRON MICROB, V68, P6059, DOI 10.1128/AEM.68.12.6059-6069.2002; Ehrmann MA, 2007, INT J SYST EVOL MICR, V57, P745, DOI 10.1099/ijs.0.64700-0; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gafan GP, 2005, FEMS MICROBIOL LETT, V253, P303, DOI 10.1016/j.femsle.2005.09.048; Ganzle MG, 1998, APPL ENVIRON MICROB, V64, P2616; GOBBETTI M, 1994, WORLD J MICROB BIOT, V10, P275, DOI 10.1007/BF00414862; Hammes W.P., 1998, MICROBIOLOGY FERMENT, V1, P199, DOI [10.1007/978-1-4613-0309-1_8, DOI 10.1007/978-1-4613-0309-1_8]; Hansen AS, 2004, HDB FOOD BEVERAGE FE, P840; KLINE L, 1971, APPL MICROBIOL, V21, P459, DOI 10.1128/AEM.21.3.459-465.1971; Kurtzman CP, 2005, J CLIN MICROBIOL, V43, P101, DOI 10.1128/JCM.43.1.101-111.2005; Leroy F, 2006, INT J FOOD MICROBIOL, V112, P102, DOI 10.1016/j.ijfoodmicro.2006.05.016; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P7453, DOI 10.1128/AEM.69.12.7453-7461.2003; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P475, DOI 10.1128/AEM.69.1.475-482.2003; Mihhalevski A, 2011, J APPL MICROBIOL, V110, P529, DOI 10.1111/j.1365-2672.2010.04904.x; Minervini F, 2014, INT J FOOD MICROBIOL, V171, P136, DOI 10.1016/j.ijfoodmicro.2013.11.021; Minervini F, 2012, APPL ENVIRON MICROB, V78, P5328, DOI 10.1128/AEM.00572-12; Muller MRA, 2001, FOOD MICROBIOL, V18, P217, DOI 10.1006/fmic.2000.0394; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rosenquist H, 2000, FOOD MICROBIOL, V17, P241, DOI 10.1006/fmic.1999.0313; Scheirlinck I, 2009, J APPL MICROBIOL, V106, P1081, DOI 10.1111/j.1365-2672.2008.04094.x; Scheirlinck I, 2007, APPL ENVIRON MICROB, V73, P6262, DOI 10.1128/aem.00894-07; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siragusa S, 2009, APPL ENVIRON MICROB, V75, P1099, DOI 10.1128/AEM.01524-08; Stolz Peter, 1996, Advances in Food Sciences, V18, P234; Valjakka TT, 2003, HDB DOUGH FERMENTATI, P269; Vancanneyt M, 2005, INT J SYST EVOL MICR, V55, P615, DOI 10.1099/ijs.0.63274-0; Vera A, 2009, FOOD MICROBIOL, V26, P728, DOI 10.1016/j.fm.2009.07.010; Viiard E, 2013, J APPL MICROBIOL, V114, P404, DOI 10.1111/jam.12045; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	38	24	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148325	10.1371/journal.pone.0148325	http://dx.doi.org/10.1371/journal.pone.0148325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849134	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000067
J	Carballal, S; Cuevasanta, E; Yadav, PK; Gherasim, C; Ballou, DP; Alvarez, B; Banerjee, R				Carballal, Sebastian; Cuevasanta, Ernesto; Yadav, Pramod K.; Gherasim, Carmen; Ballou, David P.; Alvarez, Beatriz; Banerjee, Ruma			Kinetics of Nitrite Reduction and Peroxynitrite Formation by Ferrous Heme in Human Cystathionine -Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; kinetics; nitric oxide; oxygen radicals; superoxide ion; hemeprotein; nitrite; oxygen; peroxynitrite	RENAL ISCHEMIA-REPERFUSION; BETA-SYNTHASE; ANAEROBIC CONDITIONS; HYDROGEN-SULFIDE; OXIDATIVE STRESS; CHEMICAL BIOLOGY; REDOX REGULATION; LIGAND SWITCH; HUMAN ENZYME; OXIDE	Cystathionine -synthase (CBS) is a pyridoxal phosphate-dependent enzyme that catalyzes the condensation of homocysteine with serine or with cysteine to form cystathionine and either water or hydrogen sulfide, respectively. Human CBS possesses a noncatalytic heme cofactor with cysteine and histidine as ligands, which in its oxidized state is relatively unreactive. Ferric CBS (Fe(III)-CBS) can be reduced by strong chemical and biochemical reductants to Fe(II)-CBS, which can bind carbon monoxide (CO) or nitric oxide (NO center dot), leading to inactive enzyme. Alternatively, Fe(II)-CBS can be reoxidized by O-2 to Fe(III)-CBS, forming superoxide radical anion (O-2(-center dot)). In this study, we describe the kinetics of nitrite (NO2-) reduction by Fe(II)-CBS to form Fe(II)NO center dot-CBS. The second order rate constant for the reaction of Fe(II)-CBS with nitrite was obtained at low dithionite concentrations. Reoxidation of Fe(II)NO center dot-CBS by O-2 showed complex kinetic behavior and led to peroxynitrite (ONOO-) formation, which was detected using the fluorescent probe, coumarin boronic acid. Thus, in addition to being a potential source of superoxide radical, CBS constitutes a previously unrecognized source of NO center dot and peroxynitrite.	[Carballal, Sebastian] Univ Republica, Fac Med, Dept Bioquim, Avda Gral Flores 2125, Montevideo 11800, Uruguay; [Carballal, Sebastian; Cuevasanta, Ernesto; Alvarez, Beatriz] Univ Republica, Fac Ciencias, Ctr Free Rad & Biomed Res, Montevideo 11800, Uruguay; [Cuevasanta, Ernesto; Alvarez, Beatriz] Univ Republica, Fac Ciencias, Lab Enzimol, Montevideo 11800, Uruguay; [Yadav, Pramod K.; Gherasim, Carmen; Ballou, David P.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Michigan System; University of Michigan	Carballal, S (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Avda Gral Flores 2125, Montevideo 11800, Uruguay.; Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	scarballal@fmed.edu.uy; rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684; Alvarez, Beatriz/0000-0001-6911-3132	Universidad de la Republica (Comision Sectorial de Investigacion Cientifica (CSIC)); Comision Academica de Posgrado (CAP); L'Oreal-Unesco, Uruguay; PROLAB Grant from the American Society for Biochemistry and Molecular Biology; National Institutes of Health [HL58984]; American Heart Association [14POST18760003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	Universidad de la Republica (Comision Sectorial de Investigacion Cientifica (CSIC)); Comision Academica de Posgrado (CAP); L'Oreal-Unesco, Uruguay; PROLAB Grant from the American Society for Biochemistry and Molecular Biology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants and fellowships from Universidad de la Republica (Comision Sectorial de Investigacion Cientifica (CSIC) (to B. A. and E. C.) and Comision Academica de Posgrado (CAP) (to E. C.)), L'Oreal-Unesco, Uruguay (to B. A.), a PROLAB Grant from the American Society for Biochemistry and Molecular Biology (to S. C.), National Institutes of Health Grant HL58984 (to R. B.), and American Heart Association Postdoctoral Fellowship 14POST18760003 (to P. K. Y). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 1996, J NEUROSCI, V16, P1066; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Carballal S, 2008, BIOCHEMISTRY-US, V47, P3194, DOI 10.1021/bi700912k; Carballal S, 2016, BIOCHEMISTRY-US, V55, P238, DOI 10.1021/acs.biochem.5b01326; Carballal S, 2014, BBA-GEN SUBJECTS, V1840, P768, DOI 10.1016/j.bbagen.2013.07.005; Carballal S, 2013, BIOCHEMISTRY-US, V52, P4553, DOI 10.1021/bi4004556; Celano L, 2009, ARCH BIOCHEM BIOPHYS, V491, P96, DOI 10.1016/j.abb.2009.08.022; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; CREUTZ C, 1974, INORG CHEM, V13, P2041, DOI 10.1021/ic50138a054; Cuevasanta E., 2013, BIOINORG REACT MECH, V9, P27; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Evande R, 2004, ARCH BIOCHEM BIOPHYS, V427, P188, DOI 10.1016/j.abb.2004.04.027; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gherasim C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085544; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Hannibal L, 2011, J BIOL CHEM, V286, P39224, DOI 10.1074/jbc.M111.286351; Herold S, 2005, BIOCHEMISTRY-US, V44, P6223, DOI 10.1021/bi0475929; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; Ingi T, 1996, J NEUROSCI, V16, P5621; Kabil O, 2001, J BIOL CHEM, V276, P19350, DOI 10.1074/jbc.M100029200; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; KLUG D, 1972, J BIOL CHEM, V247, P4839; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; LAMBETH DO, 1973, J BIOL CHEM, V248, P6095; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Michalski R, 2014, J BIOL CHEM, V289, P22536, DOI 10.1074/jbc.M114.553727; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Moller JKS, 2004, CHEM-EUR J, V10, P2291, DOI 10.1002/chem.200305368; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Prathapasinghe GA, 2007, AM J PHYSIOL-RENAL, V292, pF1354, DOI 10.1152/ajprenal.00301.2006; Puranik M, 2006, J BIOL CHEM, V281, P13433, DOI 10.1074/jbc.M600246200; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; SCHELLENBERG KA, 1958, J BIOL CHEM, V231, P547; SCHWARTZ SE, 1981, ATMOS ENVIRON, V15, P1129, DOI 10.1016/0004-6981(81)90303-6; SEBASTIO G, 1995, AM J HUM GENET, V56, P1324; Sen S, 2007, BIOCHEMISTRY-US, V46, P4110, DOI 10.1021/bi602617f; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Smith AT, 2012, BIOCHEMISTRY-US, V51, P6360, DOI 10.1021/bi300421z; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P253, DOI 10.1016/S0162-0134(01)00336-1; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Tejero J, 2015, BIOCHEMISTRY-US, V54, P722, DOI 10.1021/bi501196k; Tejero J, 2009, FEBS J, V276, P4505, DOI 10.1111/j.1742-4658.2009.07157.x; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Vadon-Le Goff S., 2001, BIOCHEM BIOPH RES CO, V283, P487; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Vicente JB, 2016, J BIOL CHEM, V291, P572, DOI 10.1074/jbc.M115.681221; Vicente JB, 2014, J BIOL CHEM, V289, P8579, DOI 10.1074/jbc.M113.507533; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w; Yadav PK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414706; Zeida A, 2013, ARCH BIOCHEM BIOPHYS, V539, P81, DOI 10.1016/j.abb.2013.08.016; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	77	24	24	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8004	8013		10.1074/jbc.M116.718734	http://dx.doi.org/10.1074/jbc.M116.718734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26867575	hybrid, Green Published			2022-12-26	WOS:000374056700021
J	Liu, YJ; Liu, C; Chang, ZN; Wadas, B; Brower, CS; Song, ZH; Xu, ZL; Shang, YL; Liu, WX; Wang, LN; Dong, W; Varshavsky, A; Hu, RG; Li, W				Liu, Yu-Jiao; Liu, Chao; Chang, ZeNan; Wadas, Brandon; Brower, Christopher S.; Song, Zhen-Hua; Xu, Zhi-Liang; Shang, Yong-Liang; Liu, Wei-Xiao; Wang, Li-Na; Dong, Wen; Varshavsky, Alexander; Hu, Rong-Gui; Li, Wei			Degradation of the Separase-cleaved Rec8, a Meiotic Cohesin Subunit, by the N-end Rule Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; UBIQUITIN LIGASE; CHROMOSOME SEGREGATION; TERMINAL ACETYLATION; PROTEIN-FRAGMENTS; KLEISIN SUBUNIT; SUBSTRATE RECOGNITION; CELLULAR-PROTEINS; STRUCTURAL BASIS; UBR1	The Ate1 arginyltransferase (R-transferase) is a component of the N-end rule pathway, which recognizes proteins containing N-terminal degradation signals called N-degrons, polyubiquitylates these proteins, and thereby causes their degradation by the proteasome. Ate1 arginylates N-terminal Asp, Glu, or (oxidized) Cys. The resulting N-terminal Arg is recognized by ubiquitin ligases of the N-end rule pathway. In the yeast Saccharomyces cerevisiae, the separase-mediated cleavage of the Scc1/Rad21/Mcd1 cohesin subunit generates a C-terminal fragment that bears N-terminal Arg and is destroyed by the N-end rule pathway without a requirement for arginylation. In contrast, the separase-mediated cleavage of Rec8, the mammalian meiotic cohesin subunit, yields a fragment bearing N-terminal Glu, a substrate of the Ate1 R-transferase. Here we constructed and used a germ cell-confined Ate1(-/-) mouse strain to analyze the separase-generated C-terminal fragment of Rec8. We show that this fragment is a short-lived N-end rule substrate, that its degradation requires N-terminal arginylation, and that male Ate1(-/-) mice are nearly infertile, due to massive apoptotic death of Ate1(-/-) spermatocytes during the metaphase of meiosis I. These effects of Ate1 ablation are inferred to be caused, at least in part, by the failure to destroy the C-terminal fragment of Rec8 in the absence of N-terminal arginylation.	[Liu, Yu-Jiao; Liu, Chao; Song, Zhen-Hua; Xu, Zhi-Liang; Shang, Yong-Liang; Liu, Wei-Xiao; Wang, Li-Na; Li, Wei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Liu, Chao; Song, Zhen-Hua; Xu, Zhi-Liang; Shang, Yong-Liang; Wang, Li-Na] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Chang, ZeNan; Wadas, Brandon; Brower, Christopher S.; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Brower, Christopher S.] Texas Womans Univ, Dept Biol, Denton, TX 76204 USA; [Liu, Yu-Jiao; Dong, Wen] Ocean Univ China, Coll Marine Life, Qingdao 266003, Peoples R China; [Hu, Rong-Gui] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; California Institute of Technology; Texas Womans University; Ocean University of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, W (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Dong, W (corresponding author), Ocean Univ China, Coll Marine Life, Qingdao 266003, Peoples R China.; Hu, RG (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	wdong@ouc.edu.cn; avarsh@caltech.edu; coryhu@sibs.ac.cn; leways@ioz.ac.cn	liu, chao/GQZ-6687-2022; Dong, Wen/AAP-4488-2020	Wadas, Brandon/0000-0003-2796-2384; Dong, Wen/0000-0001-5036-8311	National Natural Science Foundation of China [31171374, 31471277]; Major Basic Research Program [2012CB944404]; National Institutes of Health [R01-DK039520, R01-GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grants 31171374 and 31471277 and Major Basic Research Program Grant 2012CB944404 (to W. L.) and by National Institutes of Health Grants R01-DK039520 and R01-GM031530 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Brower CS, 2014, P NATL ACAD SCI USA, V111, pE4936, DOI 10.1073/pnas.1419587111; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Camdere G, 2015, ELIFE, V4, DOI 10.7554/eLife.11315; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; CHAPMAN DL, 1994, DEV BIOL, V165, P500, DOI 10.1006/dbio.1994.1270; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372; de Boer E, 2007, J CELL SCI, V120, P731, DOI 10.1242/jcs.003186; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hirano T, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015792; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kouznetsova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028255; Kudo NR, 2009, J CELL SCI, V122, P2686, DOI 10.1242/jcs.035287; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Marston AL, 2014, GENETICS, V196, P31, DOI 10.1534/genetics.112.145144; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; McAleenan A, 2013, NATURE, V493, P250, DOI 10.1038/nature11630; McNicoll F, 2013, CURR TOP DEV BIOL, V102, P1, DOI 10.1016/B978-0-12-416024-8.00001-5; Miller MP, 2013, CURR OPIN CELL BIOL, V25, P687, DOI 10.1016/j.ceb.2013.07.009; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Murayama Y, 2015, CELL, V163, P1628, DOI 10.1016/j.cell.2015.11.030; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; Ohkura H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015859; Panigrahi AK, 2011, MOL CELL BIOL, V31, P4335, DOI 10.1128/MCB.06075-11; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Piatkov KI, 2015, MICROB CELL, V2, P376, DOI 10.15698/mic2015.10.231; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, MOL CELL, V48, P926, DOI 10.1016/j.molcel.2012.10.012; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Rankin S, 2015, FEBS J, V282, P2413, DOI 10.1111/febs.13301; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Rossitto M, 2015, SEMIN CELL DEV BIOL, V45, P84, DOI 10.1016/j.semcdb.2015.09.014; Rudra S, 2013, J CELL SCI, V126, P31, DOI 10.1242/jcs.116566; Saha S, 2011, DEV BIOL, V358, P1, DOI 10.1016/j.ydbio.2011.06.043; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Singh VP, 2015, CURR OPIN CELL BIOL, V37, P9, DOI 10.1016/j.ceb.2015.08.003; Song ZH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.559; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tachibana-Konwalski K, 2013, CURR BIOL, V23, P2534, DOI 10.1016/j.cub.2013.10.052; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2012, PROTEIN SCI, V21, P1634, DOI 10.1002/pro.2148; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wang HN, 2014, CELL RES, V24, P852, DOI 10.1038/cr.2014.70; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Winters T, 2014, EMBO J, V33, P1256, DOI 10.1002/embj.201387330; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681; Zhang NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069458; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	98	18	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7426	7438		10.1074/jbc.M116.714964	http://dx.doi.org/10.1074/jbc.M116.714964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26858254	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000383447600019
J	Sarkar, M; Liu, Y; Qi, JP; Peng, HY; Morimoto, J; Rader, C; Chiorazzi, N; Kodadek, T				Sarkar, Mohosin; Liu, Yun; Qi, Junpeng; Peng, Haiyong; Morimoto, Jumpei; Rader, Christoph; Chiorazzi, Nicholas; Kodadek, Thomas			Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINATORIAL LIBRARIES; PEPTIDE; IMMUNOGLOBULIN; DISCOVERY; ANTIBODY; DYNAMICS; LIGANDS	Chronic lymphocytic leukemia (CLL) is a disease in which a single B-cell clone proliferates relentlessly in peripheral lymphoid organs, bone marrow, and blood. DNA sequencing experiments have shown that about 30% of CLL patients have stereotyped antigen-specific B-cell receptors (BCRs) with a high level of sequence homology in the variable domains of the heavy and light chains. These include many of the most aggressive cases that have IGHV-unmutated BCRs whose sequences have not diverged significantly from the germ line. This suggests a personalized therapy strategy in which a toxin or immune effector function is delivered selectively to the pathogenic B-cells but not to healthy B-cells. To execute this strategy, serum-stable, drug-like compounds able to target the antigen-binding sites of most or all patients in a stereotyped subset are required. We demonstrate here the feasibility of this approach with the discovery of selective, high affinity ligands for CLL BCRs of the aggressive, stereotyped subset 7P that cross-react with the BCRs of several CLL patients in subset 7p, but not with BCRs from patients outside this subset.	[Sarkar, Mohosin; Morimoto, Jumpei; Kodadek, Thomas] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Qi, Junpeng; Peng, Haiyong; Rader, Christoph; Kodadek, Thomas] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Liu, Yun; Chiorazzi, Nicholas] Feinstein Inst Med Res, Hofstra North Shore LIJ Sch Med, Karches Ctr Chron Lymphocyt Leukemia Res, Manhasset, NY 11030 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Hofstra University; Northwell Health	Kodadek, T (corresponding author), Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA.; Kodadek, T (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	kodadek@scripps.edu	Qi, Junpeng/AAH-5525-2020; Peng, Haiyong/S-8045-2016; Qi, Junpeng/G-6949-2019; Morimoto, Jumpei/D-9024-2017	Morimoto, Jumpei/0000-0002-8393-9616; Rader, Christoph/0000-0001-9955-3454; Kodadek, Thomas/0000-0003-1930-4795	National Institutes of Health [1 DP3 DK094309, CA081554]; NHLBI, Stanford Proteomics Center [NO1-HV-00242]; NATIONAL CANCER INSTITUTE [R01CA181258, R01CA081554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, Stanford Proteomics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1 DP3 DK094309 (to T. K.) and CA081554 (to N. C.), and a contract from the NHLBI, Stanford Proteomics Center, NO1-HV-00242 (to T. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary R, 2015, BIOCHEMISTRY-US, V54, P2085, DOI 10.1021/bi501417q; Adhikary R, 2012, J BIOL CHEM, V287, P27139, DOI 10.1074/jbc.M112.372698; Agathangelidis A, 2014, LEUKEMIA LYMPHOMA, V55, P2252, DOI 10.3109/10428194.2013.879715; Agathangelidis A, 2012, BLOOD, V119, P4467, DOI 10.1182/blood-2011-11-393694; Aquino C, 2012, NAT CHEM, V4, P99, DOI [10.1038/NCHEM.1200, 10.1038/nchem.1200]; Buhl L, 2002, BRIT J HAEMATOL, V116, P549, DOI 10.1046/j.0007-1048.2001.03311.x; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Catera R, 2008, MOL MED, V14, P665, DOI 10.2119/2008-00102.Catera; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Doran TM, 2014, ACS COMB SCI, V16, P259, DOI 10.1021/co500030f; Esencay M, 2015, NAT REV DRUG DISCOV, V14, P381, DOI 10.1038/nrd4625; Gao Y, 2015, ACS COMB SCI, V17, P49, DOI 10.1021/co500154e; Gao Y, 2014, JOVE-J VIS EXP, DOI 10.3791/51299; Gao Y, 2013, CHEM BIOL, V20, P360, DOI 10.1016/j.chembiol.2013.01.013; Jaglowski SM, 2010, BLOOD, V116, P3705, DOI 10.1182/blood-2010-04-001230; Lian WL, 2013, J AM CHEM SOC, V135, P11990, DOI 10.1021/ja405106u; Liu Y, 2013, MOL MED, V19, P245, DOI 10.2119/molmed.2013.00082; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Morimoto J, 2014, BIOCONJUGATE CHEM, V25, P1479, DOI 10.1021/bc500226j; Olivos HJ, 2002, ORG LETT, V4, P4057, DOI 10.1021/ol0267578; Sarkar M, 2014, CHEM BIOL, V21, P1670, DOI 10.1016/j.chembiol.2014.10.010; Sarkar M, 2013, J AM SOC MASS SPECTR, V24, P1026, DOI 10.1007/s13361-013-0633-x; Seiler T, 2009, BLOOD, V114, P3615, DOI 10.1182/blood-2009-01-197822; Seo JW, 2010, ORG LETT, V12, P492, DOI 10.1021/ol902660p; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103; Yang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021018	28	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7558	7570		10.1074/jbc.M115.701656	http://dx.doi.org/10.1074/jbc.M115.701656			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26851280	Green Published, hybrid			2022-12-26	WOS:000383447600029
J	Yun, T; Yu, KW; Yang, SS; Cui, YF; Wang, ZX; Ren, HY; Chen, S; Li, L; Liu, XY; Fang, M; Jiang, XJ				Yun, Tao; Yu, Kaiwen; Yang, ShuangShuang; Cui, Yifan; Wang, Zixi; Ren, Huiyu; Chen, She; Li, Lin; Liu, Xiaoyun; Fang, Min; Jiang, Xuejun			Acetylation of p53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; CYTOCHROME-C; TRANSCRIPTIONAL TARGET; CELL-DEATH; CANCER-CELLS; BINDING; ACTIVATION; INDUCTION; RELEASE; PROCASPASE-9	The p53 tumor suppressor controls cell growth, metabolism, and death by regulating the transcription of various target genes. The target-specific transcriptional activity of p53 is highly regulated. Here we demonstrate that acetylation of p53 at Lys-120 up-regulates its transcriptional activity toward Apaf-1, a core component in the mitochondrial apoptotic pathway, and thus sensitizes caspase activation and apoptosis. We found that histone deacetylase (HDAC) inhibitors, including butyrate, augment Lys-120 acetylation of p53 and thus Apaf-1 expression by inhibiting HDAC1. In p53-null cells, transfection of wild-type but not K120R mutant p53 can restore the p53-dependent sensitivity to butyrate. Strikingly, transfection of acetylation-mimicking K120Q mutant p53 is sufficient to up-regulates Apaf-1 in a manner independent of butyrate treatment. Therefore, HDAC inhibitors can induce p53 acetylation at lysine 120, which in turn enhances mitochondrion-mediated apoptosis through transcriptional up-regulation of Apaf-1.	[Yun, Tao; Cui, Yifan; Wang, Zixi; Ren, Huiyu; Fang, Min] Peking Univ, Peking Tsinghua Ctr Life Sci, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yun, Tao] Peking Univ, Acad Adv Interdisciplinary Studies, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yun, Tao; Cui, Yifan; Wang, Zixi; Ren, Huiyu; Fang, Min] Peking Univ, Sch Life Sci, Div Cell Biol, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yu, Kaiwen; Liu, Xiaoyun] Peking Univ, Coll Chem & Mol Engn, Inst Analyt Chem, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yu, Kaiwen; Liu, Xiaoyun] Peking Univ, Coll Chem & Mol Engn, Synthet & Funct Biomol Ctr, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Yang, ShuangShuang] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Yiheyuan Ave 5, Beijing 100875, Peoples R China; [Chen, She; Li, Lin] Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China; [Yun, Tao; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; National Institute of Biological Sciences, Beijing; Memorial Sloan Kettering Cancer Center	Fang, M (corresponding author), Peking Univ, Sch Life Sci, Div Cell Biol, Yiheyuan Ave 5, Beijing 100875, Peoples R China.; Liu, XY (corresponding author), Peking Univ, Coll Chem & Mol Engn, Inst Analyt Chem, Yiheyuan Ave 5, Beijing 100875, Peoples R China.; Liu, XY (corresponding author), Peking Univ, Coll Chem & Mol Engn, Synthet & Funct Biomol Ctr, Yiheyuan Ave 5, Beijing 100875, Peoples R China.; Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	xiaoyun.liu@pku.edu.cn; min.fang@pku.edu.cn; jiangx@mskcc.org		Wang, Zixi/0000-0002-9354-1206; Yu, Kaiwen/0000-0002-6050-8477	National Basic Program of China 973 Program [2013CB910104]; National Science Foundation of China [31271524]; Peking University; National Institutes of Health [R01CA166413, R01GM113013]; Memorial Sloan Kettering Cancer Center [P30 CA008748]; NATIONAL CANCER INSTITUTE [R01CA166413, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113013] Funding Source: NIH RePORTER	National Basic Program of China 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Program of China 973 Program Grant (2013CB910104), National Science Foundation of China Grant 31271524, a startup fund from Peking University, National Institutes of Health Grants R01CA166413 and R01GM113013, and Memorial Sloan Kettering Cancer Center Support Grant/Core Grant P30 CA008748. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Cianfrocca R, 2008, CELL DEATH DIFFER, V15, P354, DOI 10.1038/sj.cdd.4402264; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kraker AJ, 2003, MOL CANCER THER, V2, P401; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lobera M, 2013, NAT CHEM BIOL, V9, P319, DOI [10.1038/nchembio.1223, 10.1038/NCHEMBIO.1223]; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Marek L, 2013, J MED CHEM, V56, P427, DOI 10.1021/jm301254q; Medina V, 1997, CANCER RES, V57, P3697; Mellert HS, 2011, J BIOL CHEM, V286, P4264, DOI 10.1074/jbc.M110.184663; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Robles AI, 2001, CANCER RES, V61, P6660; Sen N, 2013, MOL CELL, V52, P406, DOI 10.1016/j.molcel.2013.09.003; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thompson H. J., 1992, CANCER EPIDEM BIOMAR, V1, P697; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang XD, 2001, GENE DEV, V15, P2922; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang J, 2014, CELL MOL LIFE SCI, V71, P3885, DOI 10.1007/s00018-014-1656-6; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	41	28	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7386	7395		10.1074/jbc.M115.706341	http://dx.doi.org/10.1074/jbc.M115.706341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26851285	hybrid, Green Published			2022-12-26	WOS:000383447600015
J	Lin, CM; Tseng, YC; Hsu, HL; Chen, CJ; Chen, DYT; Yan, FX; Chiu, WT				Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta			Arterial Spin Labeling Perfusion Study in the Patients with Subacute Mild Traumatic Brain Injury	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; SEVERE HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; ISCHEMIA; FLOW; MRI; 3T; CT	Background This study uses a MRI technique, three-dimension pulse continuous arterial spin labeling (3D-PCASL), to measure the patient's cerebral blood flow (CBF) at the subacute stage of mild traumatic brain injury (MTBI) in order to analyze the relationship between cerebral blood flow and neurocognitive deficits. Objective To provide the relationship between cortical CBF and neuropsychological dysfunction for the subacute MTBI patients. Methods After MTBI, perfusion MR imaging technique (3D-PCASL) measures the CBF of MTBI patients (n = 23) within 1 month and that of normal controls (n = 22) to determine the quantity and location of perfusion defect. The correlation between CBF abnormalities and cognitive deficits was elucidated by combining the results of the neuropsychological tests of the patients. Result We observed a substantial reduction in CBF in the bilateral frontal and left occipital cortex as compared with the normal persons. In addition, there were correlation between post concussive symptoms (including dizziness and simulator sickness) and CBF in the hypoperfused areas. The more severe symptom was correlated with higher CBF in bilateral frontal and left occipital lobes. Conclusion First, this study determined that despite no significant abnormality detected on conventional CT and MRI studies, hypoperfusion was observed in MTBI group using 3D-PCASL technique in subacute stage, which suggested that this approach may increase sensitivity to MTBI. Second, the correlation between CBF and the severity of post concussive symptoms suggested that changes in cerebral hemodynamicsmay play a role in pathophysiology underlies the symptoms.	[Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Dept Diagnost Radiol, New Taipei, Taiwan; [Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian] Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, New Taipei, Taiwan; [Chen, Chi-Jen] Minist Hlth & Welf, Chia Yi Hosp, Chiayi, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Hsu, HL (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Diagnost Radiol, New Taipei, Taiwan.; Hsu, HL (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan.; Hsu, HL (corresponding author), Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, New Taipei, Taiwan.	anne.hlh@gmail.com						Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Audenaert K., 2003, MED SCI MONITOR, V9, P112; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Chang TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076072; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Davis P, 2012, EXPERT PANEL ON NEUR, V14; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2009, J MAGN RESON IMAGING, V29, P1425, DOI 10.1002/jmri.21794; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; Piker EG, 2008, J AM ACAD AUDIOL, V19, P337, DOI 10.3766/jaaa.19.4.6; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1998, NEUROSURGERY, V42, P1276, DOI 10.1097/00006123-199806000-00042; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wong AM, 2014, J MAGN RESON IMAGING, V39, P427, DOI 10.1002/jmri.24178	32	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149109	10.1371/journal.pone.0149109	http://dx.doi.org/10.1371/journal.pone.0149109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871696	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100107
J	Tang, YL; Fu, XQ; Shen, Q; Tang, KX				Tang, Yueli; Fu, Xueqing; Shen, Qian; Tang, Kexuan			Roles of MPBQ-MT in Promoting a/gamma-Tocopherol Production and Photosynthesis under High Light in Lettuce	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; VITAMIN-E; SINGLET OXYGEN; ASCORBATE-PEROXIDASE-2 EXPRESSION; HOMOGENTISATE PHYTYLTRANSFERASE; PROTEIN-PHOSPHORYLATION; ANTIOXIDANT PROPERTIES; ARABIDOPSIS LEAVES; HYDROGEN-PEROXIDE; ALPHA-TOCOPHEROL	2-methyl-6-phytyl-1, 4-benzoquinol methyltransferase (MPBQ-MT) is a vital enzyme catalyzing a key methylation step in both a/gamma-tocopherol and plastoquinone biosynthetic pathway. In this study, the gene encoding MPBQ-MT was isolated from lettuce (Lactuca sativa) by rapid amplification of cDNA ends (RACE), named LsMT. Overexpression of LsMT in lettuce brought about a significant increase of a-and.-tocopherol contents with a reduction of phylloquinone (vitamin K1) content, suggesting a competition for a common substrate phytyl diphosphate (PDP) between the two biosynthetic pathways. Besides, overexpression of LsMT significantly increased plastoquinone (PQ) level. The increase of tocopherol and plastoquinone levels by LsMT overexpression conduced to the improvement of plants' tolerance and photosynthesis under high light stress, by directing excessive light energy toward photosynthetic production rather than toward generation of more photooxidative damage. These findings suggest that the role and function of MPBQ-MT can be further explored for enhancing vitamin E value, strengthening photosynthesis and phototolerance under high light in plants.	[Tang, Yueli; Fu, Xueqing; Shen, Qian; Tang, Kexuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Tang, KX (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, Shanghai 200030, Peoples R China.	kxtang@sjtu.edu.cn.com	Tang, Kexuan/E-3555-2013; SHEN, QIAN/O-6347-2015	Tang, Kexuan/0000-0002-8748-9624; SHEN, QIAN/0000-0002-4621-4659	China Ministry of Science & Technology (China national High-Tech "863" Program [2011AA100605]; China Ministry of Agriculture (China Transgenic Research Program [2013ZX08002-001]; Shanghai Education Committee	China Ministry of Science & Technology (China national High-Tech "863" Program; China Ministry of Agriculture (China Transgenic Research Program; Shanghai Education Committee	Support was provided by the China Ministry of Science & Technology (China national High-Tech "863" Program (grant no. 2011AA100605)); China Ministry of Agriculture (China Transgenic Research Program (grant No. 2013ZX08002-001)). The Shanghai Education Committee funded Shanghai Leading Academic Discipline Project (Horticulture).	Allen JF, 2000, PHILOS T R SOC B, V355, P1351, DOI 10.1098/rstb.2000.0697; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Chang CCC, 2004, PLANT J, V38, P499, DOI 10.1111/j.1365-313X.2004.02066.x; Chen SY, 2006, TRANSGENIC RES, V15, P655, DOI 10.1007/s11248-006-9012-8; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; Cruz JA, 2005, J EXP BOT, V56, P395, DOI 10.1093/jxb/eri022; DellaPenna D, 2005, J PLANT PHYSIOL, V162, P729, DOI 10.1016/j.jplph.2005.04.004; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Fryer MJ, 2003, PLANT J, V33, P691, DOI 10.1046/j.1365-313X.2003.01656.x; Hasunuma T, 2008, J BIOSCI BIOENG, V105, P518, DOI 10.1263/jbb.105.518; Horvath G, 2006, PHYTOCHEMISTRY, V67, P1185, DOI 10.1016/j.phytochem.2006.04.004; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; HUGHES DE, 1983, J PHARM SCI-US, V72, P126, DOI 10.1002/jps.2600720208; Ivanov B, 2007, FEBS LETT, V581, P1342, DOI 10.1016/j.febslet.2007.02.044; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; KRUK J, 1994, FREE RADICAL RES, V21, P409, DOI 10.3109/10715769409056593; Kruk J, 1997, CHEM PHYS LIPIDS, V87, P73, DOI 10.1016/S0009-3084(97)00027-3; Kruk J, 2003, BIOCHEMISTRY-US, V42, P8501, DOI 10.1021/bi034036q; Kruk J, 2008, BBA-BIOENERGETICS, V1777, P154, DOI 10.1016/j.bbabio.2007.10.008; Ksas B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10919; Laurent MS, 2010, PLANT PHYSIOL BIOCH, V48, P301; Li Y, 2011, BIOL PLANTARUM, V55, P453, DOI 10.1007/s10535-011-0110-y; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Martinis J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-23; Morales M, 2014, PLANTA, V240, P437, DOI 10.1007/s00425-014-2104-4; Munekage YN, 2008, PLANT CELL PHYSIOL, V49, P1688, DOI 10.1093/pcp/pcn140; Munne-Bosch S, 2002, CRIT REV PLANT SCI, V21, P31, DOI 10.1016/S0735-2689(02)80037-5; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Pinto-Marijuan M, 2014, J EXP BOT, V65, P3845, DOI 10.1093/jxb/eru086; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; Scheibe R, 2005, J EXP BOT, V56, P1481, DOI 10.1093/jxb/eri181; Schneider C, 2005, MOL NUTR FOOD RES, V49, P7, DOI 10.1002/mnfr.200400049; Singh DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047547; Slesak I, 2003, PLANT CELL PHYSIOL, V44, P573, DOI 10.1093/pcp/pcg073; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Van Eenennaam AL, 2003, PLANT CELL, V15, P3007, DOI 10.1105/tpc.015875; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Wolf G, 2005, J NUTR, V135, P363, DOI 10.1093/jn/135.3.363; Yang DH, 2001, PHOTOSYNTH RES, V68, P163, DOI 10.1023/A:1011849919438; Zer H, 2003, TRENDS BIOCHEM SCI, V28, P467, DOI 10.1016/S0968-0004(03)00173-7	48	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148490	10.1371/journal.pone.0148490	http://dx.doi.org/10.1371/journal.pone.0148490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867015	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700017
J	Tsujimoto, M; Kuroyanagi, G; Matsushima-Nishiwaki, R; Kito, Y; Enomoto, Y; Iida, H; Ogura, S; Otsuka, T; Tokuda, H; Kozawa, O; Iwama, T				Tsujimoto, Masanori; Kuroyanagi, Gen; Matsushima-Nishiwaki, Rie; Kito, Yuko; Enomoto, Yukiko; Iida, Hiroki; Ogura, Shinji; Otsuka, Takanobu; Tokuda, Haruhiko; Kozawa, Osamu; Iwama, Toru			Factor Xa Inhibitor Suppresses the Release of Phosphorylated HSP27 from Collagen-Stimulated Human Platelets: Inhibition of HSP27 Phosphorylation via p44/p42 MAP Kinase	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; ATRIAL-FIBRILLATION; STROKE PREVENTION; PDGF-AB; RIVAROXABAN; AGGREGATION; ACTIVATION; MECHANISMS; DISEASE	Selective inhibitors of factor Xa (FXa) are widely recognized as useful therapeutic tools for stroke prevention in non-valvular atrial fibrillation or venous thrombosis. Thrombin, which is rapidly generated from pro-thrombin through the activation of factor X to FXa, acts as a potent activator of human platelets. Thus, the reduction of thrombin generation by FXa inhibitor eventually causes a suppressive effect on platelet aggregation. However, little is known whether FXa inhibitors directly affect the function of human platelets. We have previously reported that collagen induces the phosphorylation of heat shock protein 27 (HSP27), a low-molecular weight heat shock protein via Rac-dependent activation of p44/p42 mitogen-activated protein (MAP) kinase in human platelets, eventually resulting in the release of HSP27. In the present study, we investigated the direct effect of FXa inhibitor on the collagen-induced human platelet activation. Rivaroxaban as well as edoxaban significantly reduced the collagen-induced phosphorylation of both HSP27 and p44/p42 MAP kinase without affecting the platelet aggregation. Rivaroxaban significantly inhibited the release of phosphorylated HSP27 from collagen-stimulated platelets but not the secretion of platelet derived growth factor-AB. In patients administrated with rivaroxaban, the collagen-induced levels of phosphorylated HSP27 were markedly diminished after 2 days of administration, which failed to affect the platelet aggregation. These results strongly suggest that FXa inhibitor reduces the collagen-stimulated release of phosphorylated HSP27 from human platelets due to the inhibition of HSP27 phosphorylation via p44/p42 MAP kinase.	[Tsujimoto, Masanori; Enomoto, Yukiko; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan; [Tsujimoto, Masanori; Kuroyanagi, Gen; Matsushima-Nishiwaki, Rie; Tokuda, Haruhiko; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Kuroyanagi, Gen; Otsuka, Takanobu] Nagoya City Univ, Dept Orthoped Surg, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kito, Yuko; Iida, Hiroki] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi, Japan	Gifu University; Gifu University; Gifu University; Nagoya City University; Gifu University; National Center for Geriatrics & Gerontology	Kozawa, O (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan.	okozawa@gifu-u.ac.jp		Iwama, Toru/0000-0002-9426-284X; Ogura, Shinji/0000-0001-7686-6001	Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan [25-4]; Bayer Yakuhin, Ltd.	Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan; Bayer Yakuhin, Ltd.	This investigation was supported in part by the Research Funding for Longevity Sciences (25-4) from National Center for Geriatrics and Gerontology (NCGG), Japan, and research funding from Bayer Yakuhin, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Ahrens I, 2014, SEMIN HEMATOL, V51, P147, DOI 10.1053/j.seminhematol.2014.03.004; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Black SA, 2015, THROMB HAEM IN PRESS, V114; Borensztajn K, 2011, EXPERT OPIN THER TAR, V15, P341, DOI 10.1517/14728222.2011.553608; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Butt E, 2001, J BIOL CHEM, V276, P7108, DOI 10.1074/jbc.M009234200; Chen CH, 2015, INT J CARDIOL, V191, P244, DOI 10.1016/j.ijcard.2015.03.369; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Doi T, 2010, INT J MOL MED, V26, P387, DOI 10.3892/ijmm_00000477; Eller T, 2014, CLIN CHEM LAB MED, V52, P835, DOI 10.1515/cclm-2013-0936; Eriksson BI, 2011, ANNU REV MED, V62, P41, DOI 10.1146/annurev-med-062209-095159; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gong IY, 2013, CAN J CARDIOL, V29, pS24, DOI 10.1016/j.cjca.2013.04.002; Hanai Y, 2009, LIFE SCI, V85, P386, DOI 10.1016/j.lfs.2009.07.003; Jin CH, 2014, MOL MED, V20, P280, DOI 10.2119/molmed.2014.00058; Kageyama Y, 2013, INT J MOL MED, V32, P813, DOI 10.3892/ijmm.2013.1455; Kato H, 2010, THROMB RES, V126, P39, DOI 10.1016/j.thromres.2009.12.003; Kato K, 1996, J NEUROCHEM, V66, P946; Kubitza D, 2007, BRIT J CLIN PHARMACO, V63, P469, DOI 10.1111/j.1365-2125.2006.02776.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Merendino AM, 2002, CELL STRESS CHAPERON, V7, P269, DOI 10.1379/1466-1268(2002)007<0269:HSPPHB>2.0.CO;2; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perzborn E, 2015, J CARDIOVAS IN PRESS; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Spronk HMH, 2014, CARDIOVASC RES, V101, P344, DOI 10.1093/cvr/cvt343; Tokuda H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128977; Wong PC, 2010, THROMB HAEMOSTASIS, V104, P302, DOI 10.1160/TH10-02-0097; ZHU Y, 1994, BLOOD, V84, P3715, DOI 10.1182/blood.V84.11.3715.bloodjournal84113715	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149077	10.1371/journal.pone.0149077	http://dx.doi.org/10.1371/journal.pone.0149077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867010	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700062
J	Angelini, E; Camerini, G; Diop, M; Roche, P; Rodi, T; Schippa, C; Thomas, T				Angelini, Eric; Camerini, Gerard; Diop, Malick; Roche, Patrice; Rodi, Thomas; Schippa, Christine; Thomas, Thierry			Respiratory Health - Exposure Measurements and Modeling in the Fragrance and Flavour Industry	PLOS ONE			English	Article							MICROWAVE-POPCORN PLANT; BRONCHIOLITIS OBLITERANS; LUNG-DISEASE; DIACETYL; WORKERS	Although the flavor and fragrance industry is about 150 years old, the use of synthetic materials started more than 100 years ago, and the awareness of the respiratory hazard presented by some flavoring substances emerged only recently. In 2001, the US National Institute of Occupational Safety and Health (NIOSH) identified for the first time inhalation exposure to flavoring substances in the workplace as a possible occupational hazard. As a consequence, manufacturers must comply with a variety of workplace safety requirements, and management has to ensure the improvement of health and safety of the employees exposed to hazardous volatile organic compounds. In this sensitive context, MANE opened its facilities to an intensive measuring campaign with the objective to better estimate the real level of hazardous respiratory exposure of workers. In this study, exposure to 27 hazardous volatile substances were measured during several types of handling operations (weighing-mixing, packaging, reconditioning-transferring), 430 measurement results were generated, and were exploited to propose an improved model derived from the well-known ECETOC-TRA model. The quantification of volatile substances in the working atmosphere involved three main steps: adsorption of the chemicals on a solid support, thermal desorption, followed by analysis by gas chromatography-mass spectrometry. Our approach was to examine experimental measures done in various manufacturing workplaces and to define correction factors to reflect more accurately working conditions and habits. Four correction factors were adjusted in the ECETOC-TRA to integrate important exposure variation factors: exposure duration, percentage of the substance in the composition, presence of collective protective equipment and wearing of personal protective equipment. Verification of the validity of the model is based on the comparison of the values obtained after adaptation of the ECETOC-TRA model, according to various exposure scenarios, with the experimental values measured under real conditions. After examination of the predicted results, 98% of the values obtained with the proposed new model were above the experimental values measured in real conditions. This must be compared with the results of the classical ECETOC-TRA system, which generates only 37% of overestimated values. As the values generated by the new model intended to help decision-makers of the industry to implement adapted protective action and information, and considering the high variability of the working environments, it was of the utmost importance to us not to underestimate the exposure level. The proposed correction factors have been designed to achieve this goal. We wish to propose the present method as an improved monitoring tool to improve respiratory health and safety in the flavor and fragrance manufacturing facilities.	[Angelini, Eric; Camerini, Gerard; Diop, Malick; Roche, Patrice; Rodi, Thomas; Schippa, Christine; Thomas, Thierry] V Mane Fils Sa, Le Barp, France		Schippa, C (corresponding author), V Mane Fils Sa, Le Barp, France.	christine.schippa@mane.com			V. MANE FILS SA	V. MANE FILS SA	This study was funded by V. MANE FILS SA. The authors are paid employees of V. MANE FILS SA, and they participated in study design, data collection, decision to publish and preparation of the manuscript.	[Anonymous], 2013, EFSA J, V11, P3474; [Anonymous], 2013, X43298 NF AFNOR; [Anonymous], 2008, EUSES 2 1 1 US MAN; [Anonymous], 2013, 13137 NF EN ISO AFNO; [Anonymous], 2014, X43267 NF AFNOR; [Anonymous], 2003, PV2118 OSHA; [Anonymous], 2010, 1076 NF EN AFNOR; [Anonymous], 2011, ISO 16000 6 INDOOR A; Boylstein Randy, 2006, J Occup Environ Hyg, V3, P530, DOI 10.1080/15459620600909708; Cox-Ganser J, 2011, J OCCUP ENVIRON HYG, V8, P59, DOI 10.1080/15459624.2011.540168; Delmaar C., 2006, CONSEXPO CONSUMER EX; ECETOC, 2012, 114 ECETOC; Fedan JS, 2006, TOXICOL APPL PHARM, V215, P17, DOI 10.1016/j.taap.2006.02.001; Kanwal R, 2006, J OCCUP ENVIRON MED, V48, P149, DOI 10.1097/01.jom.0000194152.48728.fb; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Kullman G, 2005, J OCCUP ENVIRON HYG, V2, P169, DOI 10.1080/15459620590923091; Kullman G, 2007, 200603033043 HETA NI; Martyny JW, 2008, J OCCUP ENVIRON HYG, V5, P679, DOI 10.1080/15459620802368463; NIOSH, 2003, 2557 NIOSH; Pierce JS, 2015, TOXICOL REP, V2, P1200, DOI 10.1016/j.toxrep.2015.08.006; RIFM, 2012, RIFM LAUNCH 2 BOX IN; SafeWorkAustralia, 2012, AUSTR WORKPLACE BARO; Sahakian N, 2009, ADV FOOD NUTR RES, V55, P163, DOI 10.1016/S1043-4526(08)00403-8; Singal M, 2008, HOUSEHOLD PERSONAL C, V3, P40; Tielemans E, 2008, ANN OCCUP HYG, V52, P577, DOI 10.1093/annhyg/men059; Urban AM, 2015, SOC TOX 54 ANN M TOX; Van Rooy GBGJ, 2005, RESP EFFECTS WORKERS	27	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148769	10.1371/journal.pone.0148769	http://dx.doi.org/10.1371/journal.pone.0148769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863607	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600105
J	Nakajima, W; Jitsuki, S; Sano, A; Takahashi, T				Nakajima, Waki; Jitsuki, Susumu; Sano, Akane; Takahashi, Takuya			Sustained Enhancement of Lateral Inhibitory Circuit Maintains Cross Modal Cortical Reorganization	PLOS ONE			English	Article							AMPA-RECEPTOR TRAFFICKING; PRIMARY SENSORY CORTICES; RAT BARREL CORTEX; SYNAPTIC PLASTICITY; INTRACORTICAL CIRCUITS; SOCIAL-ISOLATION; IN-VIVO; EXPERIENCE; SUBUNIT; HIPPOCAMPUS	Deprivation of one modality can lead to the improvement of other intact modalities. We have previously reported that visual deprivation drives AMPA receptors into synapses from layer4 to 2/3 in the barrel cortex and sharpens functional whisker-barrel map at layer2/3 2 days after the beginning of visual deprivation. Enhanced excitatory synaptic transmission at layer4-2/3 synapses is transient and returns to the base line level a week after the beginning of visual deprivation. Here we found that sharpened whisker-barrel function is maintained at least for a week in visually deprived animals. While increased AMPA receptor-mediated synaptic transmission at layer4-2/3 synapses dropped to the base line a week after the beginning of visual deprivation, lateral inhibitory synaptic transmission onto the neighboring barrel was kept strengthened for a week of visually deprived animals. Thus, transient strengthening of excitatory synapses at layer4-2/3 in the barrel cortex could trigger the enhancement of inhibitory inputs to neighboring barrel, and sustained lateral inhibition can maintain the sharpening of whisker-barrel map in visually deprived animals.	[Nakajima, Waki; Jitsuki, Susumu; Sano, Akane; Takahashi, Takuya] Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 232, Japan	Yokohama City University	Takahashi, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 232, Japan.	takahast@yokohama-cu.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT of Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (TT), "Development of biomarker candidates for social behavior" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (TT), and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/Minds) carried out under the Strategic Research Program for Brain Sciences by the MEXT of Japan (TT), Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization" from the MEXT of Japan (SJ), Grant-in-Aid for Young Scientists (B) of the MEXT of Japan (SJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Griebel G, 2013, NEUROPHARMACOLOGY, V70, P19, DOI 10.1016/j.neuropharm.2012.12.008; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lee HK, 2015, CURR OPIN NEUROBIOL, V35, P119, DOI 10.1016/j.conb.2015.08.002; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Meng XY, 2015, CELL REP, V12, P955, DOI 10.1016/j.celrep.2015.07.018; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Miyazaki T, 2013, EUR J NEUROSCI, V37, P1602, DOI 10.1111/ejn.12188; Miyazaki T, 2012, J CLIN INVEST, V122, P2690, DOI 10.1172/JCI63060; Miyazaki T, 2012, BRAIN RES, V1435, P1, DOI 10.1016/j.brainres.2011.11.033; Morishita W, 1997, J PHYSIOL-LONDON, V505, P307, DOI 10.1111/j.1469-7793.1997.307bb.x; Nemeth K, 2014, J PHARMACEUT BIOMED, V88, P579, DOI 10.1016/j.jpba.2013.10.017; Petrus E, 2015, J NEUROSCI, V35, P8790, DOI 10.1523/JNEUROSCI.4975-14.2015; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Tada H, 2013, NEUROSCIENCE, V248, P664, DOI 10.1016/j.neuroscience.2013.06.040; Tada H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131359; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Teegarden BR, 2008, CURR TOP MED CHEM, V8, P969, DOI 10.2174/156802608784936700; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zhang Y, 2015, NAT NEUROSCI, V18, P402, DOI 10.1038/nn.3936	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149068	10.1371/journal.pone.0149068	http://dx.doi.org/10.1371/journal.pone.0149068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863615	gold, Green Submitted, Green Published			2022-12-26	WOS:000370046600150
J	Figueroa-Montiel, A; Ramos, MA; Mares, RE; Duenas, S; Pimienta, G; Ortiz, E; Possani, LD; Licea-Navarro, AF				Figueroa-Montiel, Andrea; Ramos, Marco A.; Mares, Rosa E.; Duenas, Salvador; Pimienta, Genaro; Ortiz, Ernesto; Possani, Lourival D.; Licea-Navarro, Alexei F.			In Silico Identification of Protein Disulfide Isomerase Gene Families in the De Novo Assembled Transcriptomes of Four Different Species of the Genus Conus	PLOS ONE			English	Article							RNA-SEQ DATA; DIVERSITY; REVEALS; CONOTOXINS; PLATFORM; BINDING; DOMAIN; LENGTH	Small peptides isolated from the venom of the marine snails belonging to the genus Conus have been largely studied because of their therapeutic value. These peptides can be classified in two groups. The largest one is composed by peptides rich in disulfide bonds, and referred to as conotoxins. Despite the importance of conotoxins given their pharmacology value, little is known about the protein disulfide isomerase (PDI) enzymes that are required to catalyze their correct folding. To discover the PDIs that may participate in the folding and structural maturation of conotoxins, the transcriptomes of the venom duct of four different species of Conus from the peninsula of Baja California (Mexico) were assembled. Complementary DNA (cDNA) libraries were constructed for each species and sequenced using a Genome Analyzer Illumina platform. The raw RNA-seq data was converted into transcript sequences using Trinity, a de novo assembler that allows the grouping of reads into contigs without a reference genome. An N50 value of 605 was established as a reference for future assemblies of Conus transcriptomes using this software. Transdecoder was used to extract likely coding sequences from Trinity transcripts, and PDI-specific sequence motif "APWCGHCK" was used to capture potential PDIs. An in silico analysis was performed to characterize the group of PDI protein sequences encoded by the duct-transcriptome of each species. The computational approach entailed a structural homology characterization, based on the presence of functional Thioredoxin-like domains. Four different PDI families were characterized, which are constituted by a total of 41 different gene sequences. The sequences had an average of 65% identity with other PDIs. Using MODELLER 9.14, the homology-based three-dimensional structure prediction of a subset of the sequences reported, showed the expected thioredoxin fold which was confirmed by a "simulated annealing" method.	[Figueroa-Montiel, Andrea; Duenas, Salvador; Pimienta, Genaro; Licea-Navarro, Alexei F.] Ctr Invest & Estudios Super Ensenada CICESE, Dept Innovac Biomed, Ensenada, Baja California, Mexico; [Ramos, Marco A.; Mares, Rosa E.] Univ Autonoma Baja California, Fac Ciencias Quim & Ingn, Tijuana, Baja California, Mexico; [Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico	Universidad Autonoma de Baja California; Universidad Nacional Autonoma de Mexico	Licea-Navarro, AF (corresponding author), Ctr Invest & Estudios Super Ensenada CICESE, Dept Innovac Biomed, Ensenada, Baja California, Mexico.	alicea@cicese.mx	Navaro, Alexei Fedorovish Licea/B-4106-2016; Ramos-Ibarra, Marco A./D-5438-2012; Mares, Rosa E/D-2451-2016; Ortiz, Ernesto/E-4592-2013	Navaro, Alexei Fedorovish Licea/0000-0003-4022-7405; Ramos-Ibarra, Marco A./0000-0002-8950-2079; Mares, Rosa E/0000-0001-6102-6966; Ortiz, Ernesto/0000-0002-8713-0224; Duenas, Salvador/0000-0002-0818-820X	Centro de Investigacion Cientifica y Educacion Superior de Ensenada	Centro de Investigacion Cientifica y Educacion Superior de Ensenada	This work was supported by Centro de Investigacion Cientifica y Educacion Superior de Ensenada, Internal Project for AFLN.	Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Biggs JS, 2010, MOL PHYLOGENET EVOL, V56, P1, DOI 10.1016/j.ympev.2010.03.029; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; d'Aloisio E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-101; Darby NJ, 1999, FEBS LETT, V448, P167, DOI 10.1016/S0014-5793(99)00374-9; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Elliger CA, 2011, TOXICON, V57, P311, DOI 10.1016/j.toxicon.2010.12.008; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; Gowd KH, 2007, MOL BIOSYST, V3, P554, DOI 10.1039/b705382g; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Interests CF, 2011, INT GEN VIEW, V29, P24, DOI [10.1038/nbt0111-24, DOI 10.1038/NBT0111-24]; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Knodler LA, 1999, J BIOL CHEM, V274, P29805, DOI 10.1074/jbc.274.42.29805; Langmead B, 2012, NATURE METHODS, V29, P997, DOI [10.1016/j.biotechadv.2011.08.021.Secreted, DOI 10.1016/J.BIOTECHADV.2011.08.021.SECRETED]; Lavergne V, 2015, P NATL ACAD SCI USA, V112, pE3782, DOI 10.1073/pnas.1501334112; Lucero HA, 1999, J BIOL CHEM, V274, P3243, DOI 10.1074/jbc.274.5.3243; Neves J, 2013, MAR DRUGS, V11, P2203, DOI 10.3390/md11062203; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Ramos MA, 2005, MOL BIOCHEM PARASIT, V143, P236, DOI 10.1016/j.molbiopara.2005.04.013; Rendon-anaya M, 2013, TOXINOLOGY, P1, DOI [10.1007/978-94-007-6647-1, DOI 10.1007/978-94-007-6647-1]; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; Safavi-Hemami H, 2012, J BIOL CHEM, V287, P34288, DOI 10.1074/jbc.M112.366781; Safavi-Hemami H, 2011, J PROTEOME RES, V10, P3904, DOI 10.1021/pr1012976; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; Wang XJ, 2013, BIOINFORMATICS, V29, P3235, DOI 10.1093/bioinformatics/btt543; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119	34	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148390	10.1371/journal.pone.0148390	http://dx.doi.org/10.1371/journal.pone.0148390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859138	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400038
J	Omori, K; Hattori, N; Senoo, T; Takayama, Y; Masuda, T; Nakashima, T; Iwamoto, H; Fujitaka, K; Hamada, H; Kohno, N				Omori, Keitaro; Hattori, Noboru; Senoo, Tadashi; Takayama, Yusuke; Masuda, Takeshi; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Hamada, Hironobu; Kohno, Nobuoki			Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-beta-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; LUNG COLLAGEN; CELLS; MICE; VITRONECTIN; INTEGRINS; BINDING	Transforming growth factor-beta (TGF-beta) is central during the pathogenesis of pulmonary fibrosis, in which the plasminogen activator inhibitor-1 (PAI-1) also has an established role. TGF-beta is also known to be the strongest inducer of PAI-1. To investigate the link between PAI-1 and TGF-beta in fibrotic processes, we evaluated the effect of SK-216, a PAI-1-specific inhibitor, in TGF-beta-dependent epithelial-mesenchymal transition (EMT) and fibroblast to myofibroblast differentiation. In human alveolar epithelial A549 cells, treatment with TGF-beta induced EMT, whereas co-treatment with SK-216 attenuated the occurrence of EMT. The inhibition of TGF-beta-induced EMT by SK-216 was also confirmed in the experiment using murine epithelial LA-4 cells. Blocking EMT by SK-216 inhibited TGF-beta-induced endogenous production of PAI-1 and TGF-beta in A549 cells as well. These effects of SK-216 were not likely mediated by suppressing either Smad or ERK pathways. Using human lung fibroblast MRC-5 cells, we demonstrated that SK-216 inhibited TGF-beta-dependent differentiation of fibroblasts to myofibroblasts. We also observed this inhibition by SK-216 in human primary lung fibroblasts. Following these in vitro results, we tested oral administration of SK-216 into mice injected intratracheally with bleomycin. We found that SK-216 reduced the degree of bleomycin-induced pulmonary fibrosis in mice. Although the precise mechanisms underlying the link between TGF-beta and PAI-1 regarding fibrotic process were not determined, PAI-1 seems to act as a potent downstream effector on the pro-fibrotic property of TGF-beta. In addition, inhibition of PAI-1 activity by a PAI-1 inhibitor exerts an antifibrotic effect even in vivo. These data suggest that targeting PAI-1 as a downstream effector of TGF-beta could be a promising therapeutic strategy for pulmonary fibrosis.	[Omori, Keitaro; Hattori, Noboru; Senoo, Tadashi; Takayama, Yusuke; Masuda, Takeshi; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Kohno, Nobuoki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan; [Hamada, Hironobu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University	Hattori, N (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan.	nhattori@hiroshima-u.ac.jp	Hamada, Hironobu/A-6489-2018; Hiyama, Eiso/A-2013-2019; Nakashima, Taku/D-1517-2011	Hamada, Hironobu/0000-0002-7979-0708; Hiyama, Eiso/0000-0001-9179-5037; Nakashima, Taku/0000-0002-0035-674X; Iwamoto, Hiroshi/0000-0003-4922-5334	Ministry of Education, Culture, Sports, Science and Technology of Japan [22390165]; ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/a_menu/shinkou/hojyo/03041519.htm no. 22390165 to NH) and a grant to the Diffuse Lung Diseases Research Group from the ministry of Health, Labour and Welfare, Japan. These funders had a role in study design, data collection and analysis.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; ALBO D, 1994, BIOCHEM BIOPH RES CO, V203, P857, DOI 10.1006/bbrc.1994.2262; Courey AJ, 2011, BLOOD, V118, P2313, DOI 10.1182/blood-2010-12-324574; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Huang WT, 2012, AM J RESP CELL MOL, V46, P87, DOI 10.1165/rcmb.2011-0139OC; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kim JY, 2007, LASER SURG MED, P1; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; KUHN C, 1991, AM J PATHOL, V138, P1257; Loskutoff DJ, 1999, APMIS, P107; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; OLMAN MA, 1995, J CLIN INVEST, V96, P1621, DOI 10.1172/JCI118201; Piek E, 1999, J CELL SCI, V112, P4557; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Scaffidi AK, 2001, J CELL SCI, V114, P3507; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Vial D, 2008, J CELL SCI, V121, P1661, DOI 10.1242/jcs.020149; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; ZHANG K, 1994, AM J PATHOL, V145, P114; Zhang YP, 2013, THROMB RES, V131, P64, DOI 10.1016/j.thromres.2012.09.003	35	50	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148969	10.1371/journal.pone.0148969	http://dx.doi.org/10.1371/journal.pone.0148969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859294	gold, Green Submitted, Green Published			2022-12-26	WOS:000370038400111
J	Kikuchi, M; Koyasu, S; Shinohara, S; Imai, Y; Hino, M; Naito, Y				Kikuchi, Masahiro; Koyasu, Sho; Shinohara, Shogo; Imai, Yukihiro; Hino, Megumu; Naito, Yasushi			Preoperative Diagnostic Strategy for Parotid Gland Tumors Using Diffusion-Weighted MRI and Technetium-99m Pertechnetate Scintigraphy: A Prospective Study	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BILATERAL WARTHIN TUMOR; ECHO-PLANAR; SALIVARY-GLANDS; FROZEN-SECTION; LESIONS; BIOPSY; HEAD; NECK; COEFFICIENT	Objective Fine needle aspiration cytology (FNAC) for diagnosis of a parotid gland tumor is widely used but its sensitivity is low and non-diagnostic rate is relatively high. In contrast, core needle biopsy (CNB) has a higher sensitivity and lower rate of sampling errors but has a higher risk of injury to adjacent organs such as facial nerve than FNAC. Screening of patients with parotid gland tumors to identify cases of pleomorphic adenoma (PA) and Warthin tumor (WT) may allow CNB to be confined to patients without PA and WT. We established an algorithm for preoperative diagnosis and management of parotid gland tumor using diffusion-weighted MRI and Tc-99m pertechnetate scintigraphy. This algorithm was developed with the goal of maximal reduction of the number of patients in whom CNB is required. The purpose of the study is to validate our algorithm prospectively. Methods A prospective study was conducted in 71 cases who were newly diagnosed with parotid gland tumor and 53 cases were enrolled in the study. In the algorithm, PA (high apparent diffusion coefficient (ADC) (mean)>= 1.5x10(-3) mm(2)/s) and non-PA (low ADC(mean)< 1.5x10(-3) mm(2)/s) cases are first distinguished based on the ADC(mean) on diffusion-weighed MRI. Second, among suspected non-PA cases, WT and non-WT are distinguished using technetium-99m pertechnetate scintigraphy. CNB is then performed only in probable non-PA and non-WT cases. Results CNB was only required in 40% (21/53) of all cases, we made a preoperative histopathological diagnosis with an accuracy of 87% (46/53) and we correctly diagnosed whether a tumor was benign or malignant with an accuracy of 96% (51/53). Preoperative surgical planning had to be changed during surgery in only one case (2%) Conclusions Our algorithm is valuable in terms of clinical practice with highly potential for preoperative diagnosis and with less risk of CNB procedure.	[Kikuchi, Masahiro; Shinohara, Shogo; Naito, Yasushi] Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan; [Koyasu, Sho; Hino, Megumu] Kobe City Med Ctr Gen Hosp, Dept Radiol, Kobe, Hyogo, Japan; [Imai, Yukihiro] Kobe City Med Ctr Gen Hosp, Dept Clin Pathol, Kobe, Hyogo, Japan; [Koyasu, Sho] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Japan	Kobe City Medical Center General Hospital; Kobe City Medical Center General Hospital; Kobe City Medical Center General Hospital; Kyoto University	Kikuchi, M (corresponding author), Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan.	kikuchan0414@gmail.com	Kikuchi, Masahiro/AAQ-5569-2020; Koyasu, Sho/I-5747-2019; Shinohara, Shogo/H-8976-2019	Kikuchi, Masahiro/0000-0002-0711-468X; Shinohara, Shogo/0000-0002-1794-2091; Koyasu, Sho/0000-0002-6690-7460	Kasahara Fund for Promotion of Cancer Research	Kasahara Fund for Promotion of Cancer Research	This study was supported by the Kasahara Fund for Promotion of Cancer Research and MK. received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celebi I, 2013, CLIN IMAG, V37, P232, DOI 10.1016/j.clinimag.2012.04.025; CHAPNIK JS, 1983, LARYNGOSCOPE, V93, P695; Cho HW, 2011, AM J ROENTGENOL, V196, P1160, DOI 10.2214/AJR.10.4256; Chuang CC, 2012, J NEUROSURG, V117, P63, DOI 10.3171/2012.7.GKS121003; Douville NJ, 2013, HEAD NECK-J SCI SPEC, V35, P1657, DOI 10.1002/hed.23193; Eida S, 2007, AM J NEURORADIOL, V28, P116; Habermann CR, 2009, AM J NEURORADIOL, V30, P591, DOI 10.3174/ajnr.A1412; Haldar S, 2015, INT J ORAL MAX SURG, V44, P151, DOI 10.1016/j.ijom.2014.09.025; Heaton CM, 2013, LARYNGOSCOPE, V123, P3056, DOI 10.1002/lary.24247; IBI A, 1981, J ORAL SURG, V39, P362; Ichihara T, 2014, ACTA OTO-LARYNGOL, V134, P1185, DOI 10.3109/00016489.2014.914246; Ikeda M, 2004, AM J NEURORADIOL, V25, P1256; Juan CJ, 2009, RADIOLOGY, V253, P144, DOI 10.1148/radiol.2531082228; Kikuchi Masahiro, 2010, Nihon Jibiinkoka Gakkai Kaiho, V113, P441; Klussmann JP, 2006, ACTA OTO-LARYNGOL, V126, P1213, DOI 10.1080/00016480600740605; Koyasu S, 2014, EUR RADIOL, V24, P3088, DOI 10.1007/s00330-014-3369-5; Maeda M, 2008, J NEURORADIOLOGY, V35, P71, DOI 10.1016/j.neurad.2008.01.080; Miyake H, 2001, EUR RADIOL, V11, P2472, DOI 10.1007/s003300100839; Motoori K, 2005, J COMPUT ASSIST TOMO, V29, P506, DOI 10.1097/01.rct.0000164672.34261.33; Pfeiffer J, 2012, INT J ORAL MAX SURG, V41, P437, DOI 10.1016/j.ijom.2011.12.005; Sasaki M, 2011, AM J NEURORADIOL, V32, P1100, DOI 10.3174/ajnr.A2434; Schmidt RL, 2011, AM J CLIN PATHOL, V136, P45, DOI 10.1309/AJCPOIE0CZNAT6SQ; Seethala RR, 2005, HEAD NECK-J SCI SPEC, V27, P217, DOI 10.1002/hed.20142; Srinivasan A, 2008, AM J NEURORADIOL, V29, P40, DOI 10.3174/ajnr.A0743; Suh SI, 2005, J COMPUT ASSIST TOMO, V29, P121, DOI 10.1097/01.rct.0000150141.14113.ab; Vories AA, 1997, SOUTHERN MED J, V90, P416, DOI 10.1097/00007611-199704000-00011; WEINSTEIN GS, 1994, J NUCL MED, V35, P179; Witt BL, 2014, LARYNGOSCOPE, V124, P695, DOI 10.1002/lary.24339; Wu EH, 2013, KOREAN J RADIOL, V14, P299, DOI 10.3348/kjr.2013.14.2.299; Yabuuchi H, 2008, RADIOLOGY, V249, P909, DOI 10.1148/radiol.2493072045; Yerli H, 2007, ACTA RADIOL, V48, P980, DOI 10.1080/02841850701501717; Yoshino N, 2001, RADIOLOGY, V221, P837, DOI 10.1148/radiol.2213010131; Zaghi S, 2014, AM J OTOLARYNG, V35, P713, DOI 10.1016/j.amjoto.2014.07.013; Zbaren P, 2004, CANCER-AM CANCER SOC, V100, P1876, DOI 10.1002/cncr.20186	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148973	10.1371/journal.pone.0148973	http://dx.doi.org/10.1371/journal.pone.0148973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849569	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000191
J	Nakatsukasa, K; Kamura, T				Nakatsukasa, Kunio; Kamura, Takumi			Subcellular Fractionation Analysis of the Extraction of Ubiquitinated Polytopic Membrane Substrate during ER-Associated Degradation	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; STEROL-INDUCED DISLOCATION; MAMMALIAN 20S PROTEASOMES; COENZYME-A REDUCTASE; HMG-COA REDUCTASE; ENDOPLASMIC-RETICULUM; MISFOLDED PROTEINS; SACCHAROMYCES-CEREVISIAE; LIGASE	During ER-associated degradation (ERAD), misfolded polytopic membrane proteins are ubiquitinated and retrotranslocated to the cytosol for proteasomal degradation. However, our understanding as to how polytopic membrane proteins are extracted from the ER to the cytosol remains largely unclear. To better define the localization and physical properties of ubiquitinated polytopic membrane substrates in vivo, we performed subcellular fractionation analysis of Ste6*, a twelve transmembrane protein that is ubiquitinated primarily by Doa10 E3 ligase in yeast. Consistent with previous in vitro studies, ubiquitinated Ste6* was extracted from P20 (20,000 g pellet) fraction to S20 (20,000 g supernatant) fraction in a Cdc48/p97-dependent manner. Similarly, Ubx2p, which recruits Cdc48/p97 to the ER, facilitated the extraction of Ste6*. By contrast, lipid droplet formation, which was suggested to be dispensable for the degradation of Hrd1-substrates in yeast, was not required for the degradation of Ste6*. Intriguingly, we found that ubiquitinated Ste6* in the S20 fraction could be enriched by further centrifugation at 100,000 g. Although it is currently uncertain whether ubiquitinated Ste6* in P100 fraction is completely free from any lipids, membrane flotation analysis suggested the existence of two distinct populations of ubiquitinated Ste6* with different states of membrane association. Together, these results imply that ubiquitinated Ste6* may be sequestered into a putative quality control sub-structure by Cdc48/p97. Fractionation assays developed in the present study provide a means to further dissect the ill-defined post-ubiquitination step during ERAD of polytopic membrane substrates.	[Nakatsukasa, Kunio; Kamura, Takumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Nakatsukasa, K; Kamura, T (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	z47875a@cc.nagoya-u.ac.jp; z47617a@nucc.cc.nagoya-u.ac.jp			JSPS KAKENHI [15K18503, 15K14474]; MEXT KAKENHI [24112006]; Grants-in-Aid for Scientific Research [24112006] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by JSPS KAKENHI Grant Number 15K18503 to K. N. and 15K14474 to T. K. and MEXT KAKENHI Grant Number 24112006 to T. K. https://www.jsps.go.jp/english/index.html.	Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Elsabrouty R, 2013, MOL BIOL CELL, V24, P3300, DOI 10.1091/mbc.E13-03-0157; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nakatsukasa K, 2015, CRIT REV BIOCHEM MOL, V50, P489, DOI 10.3109/10409238.2015.1081869; Nakatsukasa K, 2015, MOL CELL, V59, P22, DOI 10.1016/j.molcel.2015.04.013; Nakatsukasa K, 2013, MOL BIOL CELL, V24, P1765, DOI 10.1091/mbc.E12-12-0907; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; Olzmann JA, 2011, J BIOL CHEM, V286, P27872, DOI 10.1074/jbc.C111.266452; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Palmer EA, 2003, J CELL SCI, V116, P2361, DOI 10.1242/jcs.00439; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Rieder S E, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0307s07; Rodrigo-Brenni MC, 2012, DEV CELL, V23, P896, DOI 10.1016/j.devcel.2012.10.012; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Stolz A, 2013, P NATL ACAD SCI USA, V110, P15271, DOI 10.1073/pnas.1304928110; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wunderley L, 2014, J CELL SCI, V127, P4728, DOI 10.1242/jcs.155648; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	80	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148327	10.1371/journal.pone.0148327	http://dx.doi.org/10.1371/journal.pone.0148327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849222	Green Published, gold			2022-12-26	WOS:000369554000068
J	Troelstra, SA; Bosdriesz, JR; De Boer, MR; Kunst, AE				Troelstra, Sigrid A.; Bosdriesz, Jizzo R.; De Boer, Michiel R.; Kunst, Anton E.			Effect of Tobacco Control Policies on Information Seeking for Smoking Cessation in the Netherlands: A Google Trends Study	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; FREE LEGISLATION; IMPACT; CONSUMPTION; PREVALENCE; LAW	Background The impact of tobacco control policies on measures of smoking cessation behaviour has often been studied, yet there is little information on their precise magnitude and duration. This study aims to measure the magnitude and timing of the impact of Dutch tobacco control policies on the rate of searching for information on smoking cessation, using Google Trends search query data. Methods An interrupted time series analysis was used to examine the effect of two types of policies (smoke-free legislation and reimbursement of smoking cessation support (SCS)) on Google searches for 'quit smoking'. Google Trends data were seasonally adjusted and analysed using autoregressive integrated moving average (ARIMA) modelling. Multiple effect periods were modelled as dummy variables and analysed simultaneously to examine the magnitude and duration of the effect of each intervention. The same analysis was repeated with Belgian search query data as a control group, since Belgium is the country most comparable to the Netherlands in terms of geography, language, history and culture. Results A significant increase in relative search volume (RSV) was found from one to four weeks (21-41%) after the introduction of the smoking ban in restaurants and bars in the Netherlands in 2008. The introduction of SCS reimbursement in 2011 was associated with a significant increase of RSV (16-22%) in the Netherlands after 3 to 52 weeks. The reintroduction of SCS in 2013 was associated with a significant increase of RSV (9-21%) in the Netherlands from 3 to 32 weeks after the intervention. No effects were found in the Belgian control group for the smoking ban and the reintroduction of SCS in 2013, but there was a significant increase in RSV shortly before and after the introduction of SCS in 2011. Conclusions These findings suggest that these tobacco control policies have short-term or medium-term effects on the rate of searching for information on smoking cessation, and therefore potentially on smoking cessation rates.	[Troelstra, Sigrid A.; Bosdriesz, Jizzo R.; Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [De Boer, Michiel R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam	Troelstra, SA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	sigrid_troelstra@hotmail.com	Bosdriesz, Jizzo/Q-6250-2016; Troelstra, Sigrid/C-1288-2018	Bosdriesz, Jizzo/0000-0002-1038-7814; Troelstra, Sigrid/0000-0003-1738-4752; de Boer, Michiel/0000-0001-9240-0199; Kunst, Anton/0000-0002-3313-5273	European Commission, Directorate-General for Research and Innovation [278273]	European Commission, Directorate-General for Research and Innovation	This work was supported by the European Commission, Directorate-General for Research and Innovation, under the FP7-Health-2011 program, with grant agreement number 278273; http://ec.europa.eu/research/fp7/index_en.cfm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AB, 2007, TOB CONTROL, V16, P101, DOI 10.1136/tc.2006.017426; Ayers JW, 2014, NICOTINE TOB RES, V16, P576, DOI 10.1093/ntr/ntt186; Ayers JW, 2012, J AFFECT DISORDERS, V142, P323, DOI 10.1016/j.jad.2012.05.005; Ayers JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016777; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Blanke DD, 2004, TOOLS ADV TOBACCO CO; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Cavazos-Rehg PA, 2015, TOB CONTROL, V24, P249, DOI 10.1136/tobaccocontrol-2013-051276; Chandran A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087482; Cook T.C., 1979, QUASIEXPERIMENTATION; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Edwards R, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.020347; European Union, 2015, EUR DAT; Google Support, 2014, TRENDS HELP; Hackshaw L, 2010, TOB CONTROL, V19, P160, DOI 10.1136/tc.2009.032656; Hanbury A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-130; HU TW, 1995, AM J PUBLIC HEALTH, V85, P1218, DOI 10.2105/AJPH.85.9.1218; IBM Corp, 2012, SPSS; Jo CL, 2015, TOB CONTROL, V24, P395, DOI 10.1136/tobaccocontrol-2013-051261; Joossens L, 2007, PROGR TOBACCO CONTRO; Joossens L, 2014, TOBACCO CONTROL SCAL; McAfee TA, 2008, AM J PREV MED, V35, P103, DOI 10.1016/j.amepre.2008.04.017; Ministry of Health WaS, 1990, TOB ACT; Nagelhout GE, 2015, TOB CONTROL, V24, P455, DOI 10.1136/tobaccocontrol-2013-051430; Nagelhout GE, 2013, HEALTH EDUC RES, V28, P83, DOI 10.1093/her/cys101; Nagelhout GE, 2012, NICOTINE TOB RES, V14, P1474, DOI 10.1093/ntr/nts081; Nagelhout GE, 2012, EUR J PUBLIC HEALTH, V22, P4, DOI 10.1093/eurpub/ckr203; Nagelhout GE, 2012, ADDICTION, V107, P407, DOI 10.1111/j.1360-0443.2011.03642.x; Nagelhout GE, 2011, ADDICTION, V106, P816, DOI 10.1111/j.1360-0443.2010.03247.x; Nelson BK, 1998, ACAD EMERG MED, V5, P739, DOI 10.1111/j.1553-2712.1998.tb02493.x; PEKURINEN M, 1987, SOC SCI MED, V25, P875, DOI 10.1016/0277-9536(87)90256-5; PEW Research Center's Internet & American Life Project, 2014, INT US DEM; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Shadish WR, 2009, ANNU REV PSYCHOL, V60, P607, DOI 10.1146/annurev.psych.60.110707.163544; STIVORO, 2013, KERNC ROK NED 2012 O; Szatkowski L, 2011, ADDICTION, V106, P1827, DOI 10.1111/j.1360-0443.2011.03494.x; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; Thyrian JR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-2; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Wakefield MA, 2014, B WORLD HEALTH ORGAN, V92, P413, DOI 10.2471/BLT.13.118448; Warner KE, 2010, NICOTINE TOB RES, V12, P876, DOI 10.1093/ntr/ntq125; Willems RA, 2012, EVALUATIE ECHT STOPP; Wilson N, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-75; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Zhang F, 2011, J CLIN EPIDEMIOL, V64, P1252, DOI 10.1016/j.jclinepi.2011.02.007; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]	47	20	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148489	10.1371/journal.pone.0148489	http://dx.doi.org/10.1371/journal.pone.0148489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849567	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000107
J	Hu, JX; Stern, M; Gimenez, LE; Wanka, L; Zhu, L; Rossi, M; Meister, J; Inoue, A; Beck-Sickinger, AG; Gurevich, VV; Wess, J				Hu, Jianxin; Stern, Matthew; Gimenez, Luis E.; Wanka, Lizzy; Zhu, Lu; Rossi, Mario; Meister, Jaroslawna; Inoue, Asuka; Beck-Sickinger, Annette G.; Gurevich, Vsevolod V.; Wess, Juergen			A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of G(q/11)-dependent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-helix receptor; arrestin; cell signaling; G protein; G protein-coupled receptor (GPCR); DREADD; biased signaling	IN-VIVO; FUNCTIONAL SELECTIVITY; NONVISUAL ARRESTINS; LIPID-METABOLISM; STRUCTURAL BASIS; INSULIN-RELEASE; ACTIVATION; DESENSITIZATION; RESIDUES; AGONISM	Designer receptors exclusively activated by a designer drug (DREADDs) are clozapine-N-oxide-sensitive designer G protein-coupled receptors (GPCRs) that have emerged as powerful novel chemogenetic tools to study the physiological relevance of GPCR signaling pathways in specific cell types or tissues. Like endogenous GPCRs, clozapine-N-oxide-activated DREADDs do not only activate heterotrimeric G proteins but can also trigger -arrestin-dependent (G protein-independent) signaling. To dissect the relative physiological relevance of G protein-mediated versus -arrestin-mediated signaling in different cell types or physiological processes, the availability of G protein- and -arrestin-biased DREADDs would be highly desirable. In this study, we report the development of a mutationally modified version of a non-biased DREADD derived from the M-3 muscarinic receptor that can activate G(q/11) with high efficacy but lacks the ability to interact with -arrestins. We also demonstrate that this novel DREADD is active in vivo and that cell type-selective expression of this new designer receptor can provide novel insights into the physiological roles of G protein (G(q/11))-dependent versus -arrestin-dependent signaling in hepatocytes. Thus, this novel G(q/11)-biased DREADD represents a powerful new tool to study the physiological relevance of G(q/11)-dependent signaling in distinct tissues and cell types, in the absence of -arrestin-mediated cellular effects. Such studies should guide the development of novel classes of functionally biased ligands that show high efficacy in various pathophysiological conditions but display a reduced incidence of side effects.	[Hu, Jianxin; Stern, Matthew; Zhu, Lu; Rossi, Mario; Meister, Jaroslawna; Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bldg 8A,Room B1A-05,8 Ctr Dr MSC 0810, Bethesda, MD 20892 USA; [Gimenez, Luis E.; Gurevich, Vsevolod V.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Wanka, Lizzy; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; Leipzig University; Tohoku University; Japan Science & Technology Agency (JST)	Wess, J (corresponding author), NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bldg 8A,Room B1A-05,8 Ctr Dr MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov	Zhu, Lu/N-1073-2017; Gurevich, Vsevolod/A-3236-2008	Zhu, Lu/0000-0003-2716-4649; Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135; Rossi, Mario/0000-0001-7004-0225	National Institutes of Health Intramural Research Program; NIDDK; United States Department of Health and Human Services; Deutsche Forschungsgemeinschaft [DCRC1052-A3]; National Institutes of Health [GM077561, GM109955]; PRESTO, Japan Science and Technology Agency; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM109955] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Health and Human Services; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Intramural Research Program, NIDDK, United States Department of Health and Human Services (to J. H., M. S., L. Z., M. R., J. M., and J. W.), Deutsche Forschungsgemeinschaft Grant DCRC1052-A3 (to L. W.), National Institutes of Health RO1 Grants GM077561 and GM109955 (to V. V. G.), and PRESTO, Japan Science and Technology Agency (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Curto E, 2011, MOL PHARMACOL, V80, P1033, DOI 10.1124/mol.111.074674; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Estall JL, 2006, CURR PHARM DESIGN, V12, P1731, DOI 10.2174/138161206776873671; EXTON J H, 1987, Diabetes Metabolism Reviews, V3, P163; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Gurevich Vsevolod V, 2014, Curr Protoc Pharmacol, V67, DOI 10.1002/0471141755.ph0210s67; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Li JH, 2013, ENDOCRINOLOGY, V154, P3539, DOI 10.1210/en.2012-2127; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Nakajima K, 2012, MOL PHARMACOL, V82, P575, DOI 10.1124/mol.112.080358; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rossi M, 2015, P NATL ACAD SCI USA, V112, pE6818, DOI 10.1073/pnas.1519430112; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Shonberg J, 2014, MED RES REV, V34, P1286, DOI 10.1002/med.21318; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Wess J, 2013, TRENDS PHARMACOL SCI, V34, P385, DOI 10.1016/j.tips.2013.04.006; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; White KL, 2015, J PHARMACOL EXP THER, V352, P98, DOI 10.1124/jpet.114.216820; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Zhou L, 2014, CURR OPIN CELL BIOL, V27, P102, DOI 10.1016/j.ceb.2013.11.010	50	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7809	7820		10.1074/jbc.M115.702282	http://dx.doi.org/10.1074/jbc.M115.702282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26851281	Green Published, hybrid			2022-12-26	WOS:000374056700005
J	Tahimic, CGT; Long, RK; Kubota, T; Sun, MY; Elalieh, H; Fong, C; Menendez, AT; Wang, YM; Vilardaga, JP; Bikle, DD				Tahimic, Candice G. T.; Long, Roger K.; Kubota, Takuo; Sun, Maggie Yige; Elalieh, Hashem; Fong, Chak; Menendez, Alicia T.; Wang, Yongmei; Vilardaga, Jean-Pierre; Bikle, Daniel D.			Regulation of Ligand and Shear Stress-induced Insulin-like Growth Factor 1 (IGF1) Signaling by the Integrin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin-like growth factor (IGF); integrin; mechanotransduction; osteoblast; shear stress; IGF1 receptor; IGF1 signaling	FOCAL ADHESION KINASE; FACTOR-I RECEPTOR; BONE-FORMATION; BED REST; CELLS; OSTEOBLAST; ACTIVATION; OSTEOCYTES; RESISTANCE; MECHANOTRANSDUCTION	Mechanical loading of the skeleton, as achieved during daily movement and exercise, preserves bone mass and stimulates bone formation, whereas skeletal unloading from prolonged immobilization leads to bone loss. A functional interplay between the insulin-like growth factor 1 receptor (IGF1R), a major player in skeletal development, and integrins, mechanosensors, is thought to regulate the anabolic response of osteogenic cells to mechanical load. The mechanistic basis for this cross-talk is unclear. Here we report that integrin signaling regulates activation of IGF1R and downstream targets in response to both IGF1 and a mechanical stimulus. In addition, integrins potentiate responsiveness of IGF1R to IGF1 and mechanical forces. We demonstrate that integrin-associated kinases, Rous sarcoma oncogene (SRC) and focal adhesion kinase (FAK), display distinct actions on IGF1 signaling; FAK regulates IGF1R activation and its downstream effectors, AKT and ERK, whereas SRC controls signaling downstream of IGF1R. These findings linked to our observation that IGF1 assembles the formation of a heterocomplex between IGF1R and integrin 3 subunit indicate that the regulation of IGF1 signaling by integrins proceeds by direct receptor-receptor interaction as a possible means to translate biomechanical forces into osteoanabolic signals.	[Tahimic, Candice G. T.; Sun, Maggie Yige; Elalieh, Hashem; Fong, Chak; Menendez, Alicia T.; Wang, Yongmei; Bikle, Daniel D.] Vet Affairs Med Ctr, Endocrine Res Unit, San Francisco, CA 94121 USA; [Tahimic, Candice G. T.; Sun, Maggie Yige; Elalieh, Hashem; Fong, Chak; Menendez, Alicia T.; Wang, Yongmei; Bikle, Daniel D.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Long, Roger K.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Kubota, Takuo] Osaka Univ, Dept Pediat, Osaka 5650871, Japan; [Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15213 USA; [Tahimic, Candice G. T.] NASA, Space Biosci Div, Ames Res Ctr, Moffett Field, CA 94035 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Osaka University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Bikle, DD (corresponding author), 1700 Owens St,MB360, San Francisco, CA 94158 USA.	Daniel.Bikle@ucsf.edu		Vilardaga, Jean-Pierre/0000-0002-1217-1435; Tahimic, Candice/0000-0001-5862-2652	National Institutes of Health (NIAMS) [RO1 AR055924]; National Institutes of Health (NIDKK) [R01 DK087688, R01DK102495]; National Space Biomedical Research Institute [NASA NCC 9-58]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055924, P30AR066262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087688, R01DK102495] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health (NIDKK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants (RO1 AR055924; NIAMS, to D. D. B.) and R01 DK087688 and R01DK102495; NIDKK, to J. P.-V.).; Supported by postdoctoral fellowship awards from the National Space Biomedical Research Institute (NASA NCC 9-58).	Andersson S, 2009, BIOCHEM BIOPH RES CO, V387, P36, DOI 10.1016/j.bbrc.2009.06.088; ARNAUD SB, 1992, AVIAT SPACE ENVIR MD, V63, P14; Basso N, 2002, BONE, V30, P347, DOI 10.1016/S8756-3282(01)00678-0; BIKLE DD, 1994, J BONE MINER RES, V9, P1789; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Govoni Kristen E, 2012, Curr Mol Pharmacol, V5, P143; Haapasalo H, 2000, BONE, V27, P351, DOI 10.1016/S8756-3282(00)00331-8; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; HUGHES DE, 1993, J BONE MINER RES, V8, P527; HULTENBY K, 1993, EUR J CELL BIOL, V62, P86; Kaneko K, 2014, BIOCHEM BIOPH RES CO, V447, P352, DOI 10.1016/j.bbrc.2014.04.006; KANNUS P, 1994, BONE, V15, P279, DOI 10.1016/8756-3282(94)90289-5; Kapur S, 2005, J BIOL CHEM, V280, P20163, DOI 10.1074/jbc.M501460200; KATO H, 1993, J BIOL CHEM, V268, P2655; Kubota T, 2013, ACTA ASTRONAUT, V92, P73, DOI 10.1016/j.actaastro.2012.08.007; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Le Roith Derek, 2003, Exp Diabesity Res, V4, P205, DOI 10.1155/EDR.2003.205; Liu WG, 2008, CARCINOGENESIS, V29, P1096, DOI 10.1093/carcin/bgn026; Long RK, 2011, J BONE MINER RES, V26, P2948, DOI 10.1002/jbmr.511; McGarry JG, 2004, FASEB J, V18, P482, DOI 10.1096/fj.04-2210fje; Nauman EA, 1999, ANN BIOMED ENG, V27, P194, DOI 10.1114/1.173; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Rittweger J, 2005, BONE, V36, P1019, DOI 10.1016/j.bone.2004.11.014; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311; Sakai K, 1998, CALCIFIED TISSUE INT, V63, P515, DOI 10.1007/s002239900567; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Sakata T, 2003, BONE, V32, P669, DOI 10.1016/S8756-3282(03)00088-7; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Vilardaga JP, 2013, METHOD ENZYMOL, V522, P337, DOI 10.1016/B978-0-12-407865-9.00016-9; Wang YM, 2006, J ENDOCRINOL, V189, P279, DOI 10.1677/joe.1.06351; Westbroek I, 2000, BIOCHEM BIOPH RES CO, V268, P414, DOI 10.1006/bbrc.2000.2154; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	41	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8140	8149		10.1074/jbc.M115.693598	http://dx.doi.org/10.1074/jbc.M115.693598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26865633	hybrid, Green Published			2022-12-26	WOS:000374056700031
J	Wang, XJ; Tang, T; Farid, M; Quek, R; Tao, M; Lim, ST; Wee, HL; Chan, A				Wang, Xiao Jun; Tang, Tiffany; Farid, Mohamad; Quek, Richard; Tao, Miriam; Lim, Soon Thye; Wee, Hwee Lin; Chan, Alexandre			Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy	PLOS ONE			English	Article							ELDERLY-PATIENTS; SECONDARY PROPHYLAXIS; AGGRESSIVE LYMPHOMA; UNITED-STATES; SOLID TUMOR; FILGRASTIM; CANCER; RISK	Objective This study aims to compare the cost-effectiveness of various strategies of myeloid growth factor prophylaxis for reducing the risk of febrile neutropenia (FN) in patients with non-Hodgkin lymphoma in Singapore who are undergoing R-CHOP chemotherapy with curative intent. Methods A Markov model was created to compare seven prophylaxis strategies: 1) primary prophylaxis (PP) with nivestim (biosimilar filgrastim) throughout all cycles of chemotherapy; 2) PP with nivestim during the first two cycles of chemotherapy; 3) secondary prophylaxis (SP) with nivestim; 4) PP with pegfilgrastim throughout all cycles of chemotherapy; 5) PP with pegfilgrastim during the first two cycles of chemotherapy; 6) SP with pegfilgrastim; and 7) no prophylaxis (NP). The perspective of a hospital was taken and cost-effectiveness was expressed as the cost per episode of FN avoided over six cycles of chemotherapy. A probabilistic sensitivity analysis was conducted. Results Strategies 3, 6, and 7 were dominated in the base case analysis by strategy 5. The costs associated with strategies 2, 5, 1, and 4 were US$3,813, US$4,056, US$4,545, and US $5,331, respectively. The incremental cost-effectiveness ratios for strategy 5 vs. strategy 2, strategy 1 vs. strategy 5, and strategy 4 vs. strategy 1 were US$13,532, US$22,565, and US$30,452, respectively, per episode of FN avoided. Strategy 2 has the highest probability to be cost-effective (ranged from 48% to 60%) when the willingness to pay (WTP) threshold is lower than US$10,000 per FN episode prevented. Conclusion In Singapore, routine PP with granulocyte colony-stimulating factor (nivestim or pegfilgrastim) is cost-effective for reducing the risk of FN in patients receiving R-CHOP.	[Wang, Xiao Jun; Wee, Hwee Lin; Chan, Alexandre] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Wang, Xiao Jun; Chan, Alexandre] Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore; [Tang, Tiffany; Farid, Mohamad; Quek, Richard; Tao, Miriam; Lim, Soon Thye] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS)	Chan, A (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.; Chan, A (corresponding author), Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore.	phaac@nus.edu.sg	Wee, Hwee Lin/D-4126-2012; Chan, Alexandre/D-5035-2016	Wee, Hwee Lin/0000-0002-7150-1801; Chan, Alexandre/0000-0003-4391-4219				Aapro Matti, 2012, J Oncol Pharm Pract, V18, P171, DOI 10.1177/1078155211407367; Aarts MJ, 2013, J CLIN ONCOL, V31, P4283, DOI 10.1200/JCO.2012.48.3644; Chan A, 2014, SUPPORT CARE CANCER, V22, P1105, DOI 10.1007/s00520-013-2067-1; Chan A, 2011, ASIA-PAC J CLIN ONCO, V7, P75, DOI 10.1111/j.1743-7563.2010.01355.x; Chan KKW, 2012, J CLIN ONCOL, V30, P1064, DOI 10.1200/JCO.2011.36.8647; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Department of Statistics Singapore, CONS PRIC IND; Gascon P, 2013, SUPPORT CARE CANCER, V21, P2925, DOI 10.1007/s00520-013-1911-7; Henry D, 2014, SEMIN ONCOL, V41, pS13, DOI 10.1053/j.seminoncol.2014.03.009; Hill Gregory, 2014, J Med Econ, V17, P32, DOI 10.3111/13696998.2013.844160; Kamioner D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-547; Lathia N, 2013, JNCI-J NATL CANCER I, V105, P1078, DOI 10.1093/jnci/djt182; Lyman G, 2009, CURR MED RES OPIN, V25, P401, DOI 10.1185/03007990802636817 ; Lyman GH, 2003, LEUKEMIA LYMPHOMA, V44, P2069, DOI 10.1080/1042819031000119262; Michels SL, 2012, PHARMACOECONOMICS, V30, P809, DOI 10.2165/11592980-000000000-00000; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; NCCN.org, CLIN PRACT GUID ONC; Osby E, 2003, BLOOD, V101, P3840, DOI 10.1182/blood-2002-10-3238; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Szende A, 2007, EQ 5D VALUE SETS INV, P63; The World Bank, PPP CONV FACT GDP; Waller CF, 2010, ONKOLOGIE, V33, P504, DOI 10.1159/000319693; Wang XJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-434; Wang XJ, 2015, PSYCHOMETRIC PROPERT; Wong M, 2012, ANN ACAD MED SINGAP, V41, P287	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148901	10.1371/journal.pone.0148901	http://dx.doi.org/10.1371/journal.pone.0148901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871584	gold, Green Published			2022-12-26	WOS:000370054100070
J	Higami, Y; Ogawa, E; Ryujin, Y; Goto, K; Seto, R; Wada, H; Tho, NV; Lan, LTT; Pare, PD; Nakano, Y				Higami, Yuichi; Ogawa, Emiko; Ryujin, Yasushi; Goto, Kenichi; Seto, Ruriko; Wada, Hiroshi; Nguyen Van Tho; Le Thi Tuyet Lan; Pare, Peter D.; Nakano, Yasutaka			Increased Epicardial Adipose Tissue Is Associated with the Airway Dominant Phenotype of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							VISCERAL ABDOMINAL FAT; PERICARDIAL FAT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; RHEUMATOID-ARTHRITIS; MORTALITY; COPD; CALCIFICATION; ACCUMULATION; DIMENSIONS	Background Epicardial adipose tissue (EAT) has been shown to be a non-invasive marker that predicts the progression of cardiovascular disease (CVD). It has been reported that the EAT volume is increased in patients with chronic obstructive pulmonary disease (COPD). However, little is known about which phenotypes of COPD are associated with increased EAT. Methods One hundred and eighty smokers who were referred to the clinic were consecutively enrolled. A chest CT was used for the quantification of the emphysematous lesions, airway lesions, and EAT. These lesions were assessed as the percentage of low attenuation volume (LAV%), the square root of airway wall area of a hypothetical airway with an internal perimeter of 10 mm (root Aaw at Pi10) and the EAT area, respectively. The same measurements were made on 225 Vietnamese COPD patients to replicate the results. Results Twenty-six of the referred patients did not have COPD, while 105 were diagnosed as having COPD based on a FEV1/FVC<0.70. The EAT area was significantly associated with age, BMI, FEV1 (% predicted), FEV1/FVC, self-reported hypertension, self-reported CVD, statin use, LAV%, and root Aaw at Pi10 in COPD patients. The multiple regression analyses showed that only BMI, self-reported CVD and root Aaw at Pi10 were independently associated with the EAT area (R-2 = 0.51, p<0.0001). These results were replicated in the Vietnamese population. Conclusions The EAT area is independently associated with airway wall thickness. Because EAT is also an independent predictor of CVD risk, these data suggest a mechanistic link between the airway predominant form of COPD and CVD.	[Higami, Yuichi; Ogawa, Emiko; Ryujin, Yasushi; Goto, Kenichi; Seto, Ruriko; Wada, Hiroshi; Nguyen Van Tho; Nakano, Yasutaka] Shiga Univ Med Sci, Dept Internal Med, Div Resp Med, Otsu, Shiga, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan; [Nguyen Van Tho; Le Thi Tuyet Lan] Univ Med Ctr, Resp Care Ctr, Ho Chi Minh City, Vietnam; [Pare, Peter D.] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada	Shiga University of Medical Science; Shiga University of Medical Science; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Ogawa, E (corresponding author), Shiga Univ Med Sci, Dept Internal Med, Div Resp Med, Otsu, Shiga, Japan.; Ogawa, E (corresponding author), Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan.	eogawa@belle.shiga-med.ac.jp	Pare, Peter D/C-7425-2011	Nguyen, Tho/0000-0002-0198-6284				Abbara S, 2006, EUR J RADIOL, V57, P417, DOI 10.1016/j.ejrad.2005.12.030; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; [Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Balci A, 2010, DERMATOLOGY, V220, P32, DOI 10.1159/000254482; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli B, 2011, AM J RESP CRIT CARE, V183, P317, DOI 10.1164/rccm.201004-0665OC; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Furutate R, 2011, INT J CHRONIC OBSTR, V6, P423, DOI 10.2147/COPD.S22885; Giles JT, 2010, ARTHRITIS RHEUM-US, V62, P3173, DOI 10.1002/art.27629; Kaplan O, 2015, EUR REV MED PHARMACO, V19, P2461; Kishida K, 2012, ANN MED, V44, P233, DOI 10.3109/07853890.2011.564202; Kranenburg AR, 2006, AM J CLIN PATHOL, V126, P725, DOI 10.1309/JC477FAEL1YKV54W; Lee HM, 2012, CHEST, V142, P1118, DOI 10.1378/chest.11-2421; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; Tho NV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098335; Ogawa E, 2009, THORAX, V64, P20, DOI 10.1136/thx.2008.097543; Oyama N, 2011, JPN J RADIOL, V29, P104, DOI 10.1007/s11604-010-0524-z; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Tatsumi K, 2004, RESPIROLOGY, V9, P331, DOI 10.1111/j.1440-1843.2004.00611.x; Tho NV, 2015, ANN AM THORAC SOC, DOI [10.1513/AnnalsATS.201411-501OC, DOI 10.1513/ANNALSATS.201411-5010C]; van den Borst B, 2012, AM J CLIN NUTR, V96, P516, DOI 10.3945/ajcn.112.040774; Williams MC, 2014, THORAX, V69, P718, DOI 10.1136/thoraxjnl-2012-203151; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Zagaceta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065593	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148794	10.1371/journal.pone.0148794	http://dx.doi.org/10.1371/journal.pone.0148794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866482	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700039
J	Lehners, N; Tabatabai, J; Prifert, C; Wedde, M; Puthenparambil, J; Weissbrich, B; Biere, B; Schweiger, B; Egerer, G; Schnitzler, P				Lehners, Nicola; Tabatabai, Julia; Prifert, Christiane; Wedde, Marianne; Puthenparambil, Joe; Weissbrich, Benedikt; Biere, Barbara; Schweiger, Brunhilde; Egerer, Gerlinde; Schnitzler, Paul			Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; RISK-FACTORS; G-PROTEIN; MOLECULAR CHARACTERIZATION; ANTIVIRAL THERAPY; VIRAL-INFECTIONS; GROUP-A; OUTBREAK; RECIPIENTS; PNEUMONIA	Respiratory viruses are a cause of upper respiratory tract infections (URTI), but can be associated with severe lower respiratory tract infections (LRTI) in immunocompromised patients. The objective of this study was to investigate the genetic variability of influenza virus, parainfluenza virus and respiratory syncytial virus (RSV) and the duration of viral shedding in hematological patients. Nasopharyngeal swabs from hematological patients were screened for influenza, parainfluenza and RSV on admission as well as on development of respiratory symptoms. Consecutive swabs were collected until viral clearance. Out of 672 tested patients, a total of 111 patients (17%) were infected with one of the investigated viral agents: 40 with influenza, 13 with parainfluenza and 64 with RSV; six patients had influenza/RSV or parainfluenza/RSV co-infections. The majority of infected patients (n = 75/111) underwent stem cell transplantation (42 autologous, 48 allogeneic, 15 autologous and allogeneic). LRTI was observed in 48 patients, of whom 15 patients developed severe LRTI, and 13 patients with respiratory tract infection died. Phylogenetic analysis revealed a variety of influenza A (H1N1) pdm09, A(H3N2), influenza B, parainfluenza 3 and RSV A, B viruses. RSV A was detected in 54 patients, RSV B in ten patients. The newly emerging RSV A genotype ON1 predominated in the study cohort and was found in 48 (75%) of 64 RSV-infected patients. Furthermore, two distinct clusters were detected for RSV A genotype ON1, identical RSV G gene sequences in these patients are consistent with nosocomial transmission. Long-term viral shedding for more than 30 days was significantly associated with prior allogeneic transplantation (p = 0.01) and was most pronounced in patients with RSV infection (n = 16) with a median duration of viral shedding for 80 days (range 35-334 days). Long-term shedding of respiratory viruses might be a catalyzer of nosocomial transmission and must be considered for efficient infection control in immunocompromised patients.	[Lehners, Nicola; Puthenparambil, Joe; Egerer, Gerlinde] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Tabatabai, Julia; Schnitzler, Paul] Heidelberg Univ, Dept Infect Dis, Virol, Heidelberg, Germany; [Prifert, Christiane; Weissbrich, Benedikt] Univ Wurzburg, Inst Virol & Immunobiol, D-97070 Wurzburg, Germany; [Wedde, Marianne; Biere, Barbara; Schweiger, Brunhilde] Robert Koch Inst, Natl Reference Ctr Influenza, Berlin, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg; Robert Koch Institute	Schnitzler, P (corresponding author), Heidelberg Univ, Dept Infect Dis, Virol, Heidelberg, Germany.	Paul_Schnitzler@med.uni-heidelberg.de	Tabatabai, Julia/AFQ-1931-2022		Robert Koch Institute from Federal Ministry of Health [FKZ 1369-393]	Robert Koch Institute from Federal Ministry of Health	This study was supported by the Robert Koch Institute from funds of the Federal Ministry of Health (FKZ 1369-393).	Abdallah A, 2003, BONE MARROW TRANSPL, V32, P195, DOI 10.1038/sj.bmt.1704116; Avetisyan G, 2009, TRANSPLANTATION, V88, P1222, DOI 10.1097/TP.0b013e3181bb477e; Buda S, 2013, INFLUENZA WEEKLY REP; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; DeVincenzo JP, 2012, ANTIVIR THER, V17, P213, DOI 10.3851/IMP2064; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Englund JA, 2013, VACCINE, V31, P5706, DOI 10.1016/j.vaccine.2013.09.046; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; European Centre for Disease Prevention and Control, 2013, INFL VIR CHAR SUMM E; Falcone V, 2013, ARCH VIROL, V158, P1297, DOI 10.1007/s00705-013-1610-1; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; GARCIA O, 1994, J VIROL, V68, P5448; Geis S, 2013, J CLIN MICROBIOL, V51, P155, DOI 10.1128/JCM.02151-12; Grund S, 2010, ARCH VIROL, V155, P1797, DOI 10.1007/s00705-010-0771-4; Hayden Frederick G., 1997, American Journal of Medicine, V102, P55, DOI 10.1016/S0002-9343(97)80013-7; Hirsch H, 2012, 4 EUR C INF LEUK JUA; Jalal H, 2007, J CLIN MICROBIOL, V45, P1690, DOI 10.1128/JCM.01912-06; Karron RA, 2013, CURR TOP MICROBIOL, V372, P259, DOI 10.1007/978-3-642-38919-1_13; Khanna N, 2008, CLIN INFECT DIS, V46, P402, DOI 10.1086/525263; Lavergne V, 2011, BONE MARROW TRANSPL, V46, P137, DOI 10.1038/bmt.2010.67; Lehners N, 2013, BONE MARROW TRANSPL, V48, P1548, DOI 10.1038/bmt.2013.94; Lehners N, 2013, EMERG INFECT DIS, V19, P748, DOI [10.3201/eid1905.120034, 10.3201/eid1905.130034]; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Ljungman P, 2009, BONE MARROW TRANSPL, V44, P521, DOI 10.1038/bmt.2009.263; Luchsinger V, 2012, CLIN INFECT DIS, V54, P905, DOI 10.1093/cid/cir955; Mayer JL, 2014, ROFO-FORTSCHR RONTG, V186, P686, DOI 10.1055/s-0033-1356353; Mazzulli T, 1999, J INFECT DIS, V180, P1686, DOI 10.1086/315085; McCarthy AJ, 1999, BONE MARROW TRANSPL, V24, P1315, DOI 10.1038/sj.bmt.1702078; Milano F, 2010, BLOOD, V115, P2088, DOI 10.1182/blood-2009-09-244152; Nichols WG, 2004, CLIN INFECT DIS, V39, P1300, DOI 10.1086/425004; Nichols WG, 2001, BLOOD, V98, P573, DOI 10.1182/blood.V98.3.573; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Pollara CP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-127; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Renaud C, 2013, BIOL BLOOD MARROW TR, V19, P1220, DOI 10.1016/j.bbmt.2013.05.005; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor GS, 2001, J CLIN MICROBIOL, V39, P801, DOI 10.1128/JCM.39.2.801-803.2001; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Torres HA, 2007, HAEMATOLOGICA, V92, P1216, DOI 10.3324/haematol.11300; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Whimbey E, 1996, CLIN INFECT DIS, V22, P778, DOI 10.1093/clinids/22.5.778	48	66	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148258	10.1371/journal.pone.0148258	http://dx.doi.org/10.1371/journal.pone.0148258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866481	Green Published, gold			2022-12-26	WOS:000370050700012
J	Mladenoff, DJ; Sahajpal, R; Johnson, CP; Rothstein, DE				Mladenoff, David J.; Sahajpal, Ritvik; Johnson, Christopher P.; Rothstein, David E.			Recent Land Use Change to Agriculture in the US Lake States: Impacts on Cellulosic Biomass Potential and Natural Lands	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; MARGINAL LAND; BIOENERGY PRODUCTION; CLIMATE-CHANGE; FOREST COVER; BIOFUELS; WILLOW; GRASSLANDS; ETHANOL; ENERGY	Perennial cellulosic feedstocks may have potential to reduce life-cycle greenhouse gas (GHG) emissions by offsetting fossil fuels. However, this potential depends on meeting a number of important criteria involving land cover change, including avoiding displacement of agricultural production, not reducing uncultivated natural lands that provide biodiversity habitat and other valued ecosystem services, and avoiding the carbon debt (the amount of time needed to repay the initial carbon loss) that accompanies displacing natural lands. It is unclear whether recent agricultural expansion in the United States competes with lands potentially suited for bioenergy feedstocks. Here, we evaluate how recent land cover change (2008-2013) has affected the availability of lands potentially suited for bioenergy feedstock production in the U.S. Lake States (Minnesota, Wisconsin, Michigan) and its impact on other natural ecosystems. The region is potentially well suited for a diversity of bioenergy production systems, both grasses and woody biomass, due to the widespread forest economy in the north and agricultural economy in the south. Based on remotely-sensed data, our results show that between 2008 and 2013, 836,000 ha of non-agricultural open lands were already converted to agricultural uses in the Lake States, a loss of nearly 37%. The greatest relative changes occurred in the southern half that includes some of the most diverse cultivable lands in the country. We use transition diagrams to reveal gross changes that can be obscured if only net change is considered. Our results indicate that expansion of row crops (corn, soybean) was responsible for the majority of open land loss. Even if recently lost open lands were brought into perennial feedstock production, there would a substantial carbon debt. This reduction in open land availability for biomass production is closing the window of opportunity to establish a sustainable cellulosic feedstock economy in the Lake States as mandated by current Federal policy, incurring a substantial GHG debt, and displacing a range of other natural ecosystems and their services.	[Mladenoff, David J.; Sahajpal, Ritvik; Johnson, Christopher P.] Univ Wisconsin, Dept Forest & Wildlife Ecol, 1630 Linden Dr, Madison, WI 53706 USA; [Rothstein, David E.] Michigan State Univ, Dept Forestry, 126 Nat Resource Bldg, E Lansing, MI 48824 USA; [Sahajpal, Ritvik] Univ Maryland, Dept Geog Sci, 2181 Samuel J Lefrak Hall, College Pk, MD 20742 USA	University of Wisconsin System; University of Wisconsin Madison; Michigan State University; University System of Maryland; University of Maryland College Park	Mladenoff, DJ (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, 1630 Linden Dr, Madison, WI 53706 USA.	david.mladenoff@wisc.edu	Sahajpal, Ritvik/N-4565-2013	Sahajpal, Ritvik/0000-0002-6418-289X	US Department of Agriculture, Agriculture and Food Research Initiative, Sustainable Bioenergy Program [2010-03866]	US Department of Agriculture, Agriculture and Food Research Initiative, Sustainable Bioenergy Program	Funding from US Department of Agriculture, Agriculture and Food Research Initiative, Sustainable Bioenergy Program (2010-03866) to DER and DJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding from US Department of Agriculture, Agriculture and Food Research Initiative, Sustainable Bioenergy Program (2010-03866).	Amichev BY, 2012, GCB BIOENERGY, V4, P70, DOI 10.1111/j.1757-1707.2011.01110.x; Aust C, 2014, GCB BIOENERGY, V6, P521, DOI 10.1111/gcbb.12083; Baum S, 2012, GCB BIOENERGY, V4, P728, DOI 10.1111/j.1757-1707.2012.01162.x; Becker DR, 2009, ENERG POLICY, V37, P5687, DOI 10.1016/j.enpol.2009.08.033; Boryan C, 2011, GEOCARTO INT, V2011, P1, DOI DOI 10.1080/10106049.2011.562309; Brown TR, 2013, BIOFUEL BIOPROD BIOR, V7, P235, DOI 10.1002/bbb.1387; Campbell SP, 2012, BIOMASS BIOENERG, V47, P342, DOI 10.1016/j.biombioe.2012.09.026; Cunningham MA, 2006, LANDSCAPE URBAN PLAN, V78, P217, DOI 10.1016/j.landurbplan.2005.08.002; Dauber J., 2012, BIORISK, P5, DOI [10.3897/biorisk.7.3036, DOI 10.3897/biorisk.7.3036]; Davis SC, 2012, FRONT ECOL ENVIRON, V10, P69, DOI 10.1890/110003; Desiree JI, 2014, GCB BIOENERGY, V6, P183, DOI 10.1111/gcbb.12067; Djomo SN, 2011, GCB BIOENERGY, V3, P181, DOI 10.1111/j.1757-1707.2010.01073.x; Dominguez-Faus R, 2013, ENVIRON SCI TECHNOL, V47, P6030, DOI 10.1021/es400435n; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Emili LA, 2014, LAND-BASEL, V3, P658, DOI 10.3390/land3030658; EPA, 2010, FED REGISTER, V75; Faber S., 2012, PLOWED CROP SUBSIDIE; Fargione JE, 2010, ANNU REV ECOL EVOL S, V41, P351, DOI 10.1146/annurev-ecolsys-102209-144720; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Fassnacht KS, 2006, FOREST ECOL MANAG, V222, P167, DOI 10.1016/j.foreco.2005.09.026; Fatal Y. S., 2014, Journal of Agricultural and Applied Economics, V46, P157; Feng HL, 2010, AM J AGR ECON, V92, P789, DOI 10.1093/ajae/aaq023; Foley JA, 2004, GEOPHYS MONOGR SER, V153, P249, DOI 10.1029/153GM19; GAP, 2013, US GEOL SURV GAP AN; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; Gibson W.P., 2002, P 13 AMS C APPL CLIM, P181; Gopalakrishnan G, 2011, J ENVIRON QUAL, V40, P1593, DOI 10.2134/jeq2010.0539; Grace PR, 2011, AGR SYST, V104, P292, DOI 10.1016/j.agsy.2010.09.001; Han WG, 2012, COMPUT ELECTRON AGR, V84, P111, DOI 10.1016/j.compag.2012.03.005; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hertel TW, 2010, BIOSCIENCE, V60, P223, DOI 10.1525/bio.2010.60.3.8; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Jager HI, 2010, GCB BIOENERGY, V2, P248, DOI 10.1111/j.1757-1707.2010.01059.x; Johnston CA, 2014, LANDSCAPE ECOL, V29, P81, DOI 10.1007/s10980-013-9947-0; Johnston CA, 2013, WETLANDS, V33, P175, DOI 10.1007/s13157-012-0365-x; Kang S, 2013, LAND USE POLICY, V30, P106, DOI 10.1016/j.landusepol.2012.03.002; Kloiber SM, 2013, STATUS AND TRENDS OF; Langpap C, 2011, ENVIRON RESOUR ECON, V49, P147, DOI 10.1007/s10640-010-9428-8; Lark TJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044003; Liu T.-Y., 2012, P 18 IEEE INT S AS C, P1; Lubowski R., 2006, ENV EFFECTS AGR LAND; Luman D., 2008, ASSESSMENT POTENTIAL; McNab WH, 2005, DESCRIPTION ECOLOGIC; Mehaffey M, 2012, ECOL APPL, V22, P8, DOI 10.1890/10-1573.1; Mooney D., 2013, Staff Paper - Agricultural and Applied Economics, University of Wisconsin-Madison; NASS, 2013, USDA NAT AGR STAT SE; Palmer MM, 2014, GCB BIOENERGY, V6, P450, DOI 10.1111/gcbb.12069; Plevin RJ, 2010, ENVIRON SCI TECHNOL, V44, P8015, DOI 10.1021/es101946t; Rhemtulla JM, 2007, LANDSCAPE ECOL, V22, P57, DOI 10.1007/s10980-007-9117-3; Rowe RL, 2013, GCB BIOENERGY, V5, P257, DOI 10.1111/gcbb.12040; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Searchinger TD, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024007; Sexton JO, 2015, REMOTE SENS ENVIRON, V156, P418, DOI 10.1016/j.rse.2014.08.038; Stubbs M, 2013, CONSERVATION RESERVE, P7; Theobald DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094628; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Wickham JD, 2013, REMOTE SENS ENVIRON, V130, P294, DOI 10.1016/j.rse.2012.12.001; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Xue C, GLOBAL CHAGNE BIOL B; Zalesny RS, 2012, FOREST ECOL MANAG, V284, P45, DOI 10.1016/j.foreco.2012.07.022	63	15	15	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148566	10.1371/journal.pone.0148566	http://dx.doi.org/10.1371/journal.pone.0148566			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866474	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700021
J	Nolin, F; Michel, J; Wortham, L; Tchelidze, P; Banchet, V; Lalun, N; Terryn, C; Ploton, D				Nolin, Frederique; Michel, Jean; Wortham, Laurence; Tchelidze, Pavel; Banchet, Vincent; Lalun, Nathalie; Terryn, Christine; Ploton, Dominique			Stage-Specific Changes in the Water, Na+, Cl- and K+ Contents of Organelles during Apoptosis, Demonstrated by a Targeted Cryo Correlative Analytical Approach	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; CYTOCHROME-C; OXIDATIVE STRESS; NANO ANALYSIS; ACTIVATION; DEATH; MITOCHONDRIA; IONS; CONDENSATION; DECREASE	Many studies have demonstrated changes in the levels of several ions during apoptosis, but a few recent studies have reported conflicting results concerning the changes in water content in apoptotic cells. We used a correlative light and cryo-scanning transmission electron microscopy method to quantify water and ion/element contents simultaneously at a nanoscale resolution in the various compartments of cells, from the onset to the end of apoptosis. We used stably transfected HeLa cells producing H2B-GFP to identify the stages of apoptosis in cells and for a targeted elemental analysis within condensed chromatin, nucleoplasm, mitochondria and the cytosol. We found that the compartments of apoptotic cells contained, on average, 10% more water than control cells. During mitochondrial outer membrane permeabilization, we observed a strong increase in the Na+ and Cl- contents of the mitochondria and a strong decrease in mitochondrial K+ content. During the first step in apoptotic volume decrease (AVD), Na+ and Cl- levels decreased in all cell compartments, but remained higher than those in control cells. Conversely, during the second step of AVD, Na+ and Cl- levels increased considerably in the nucleus and mitochondria. During these two steps of AVD, K+ content decreased steadily in all cell compartments. We also determined in vivo ion status during caspase-3 activity and chromatin condensation. Finally, we found that actinomycin D-tolerant cells had water and K+ contents similar to those of cells entering apoptosis but lower Na+ and Cl- contents than both cells entering apoptosis and control cells.	[Nolin, Frederique; Michel, Jean; Wortham, Laurence; Banchet, Vincent] Univ Reims, Lab Rech Nanosci, EA 4682, Reims, France; [Tchelidze, Pavel; Lalun, Nathalie; Ploton, Dominique] Univ Reims, CNRS, UMR 7369, Reims, France; [Terryn, Christine] Univ Reims, PICT, Reims, France	Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Ploton, D (corresponding author), Univ Reims, CNRS, UMR 7369, Reims, France.	dominique.ploton@univ-reims.fr	Ploton, Dominique DP/W-7169-2018	Ploton, Dominique DP/0000-0002-4541-3146	INSERM; Region Champagne Ardenne	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Champagne Ardenne(Region Grand-Est)	This work was supported by INSERM (www.inserm.fr) (Physicancer program: Noci-cytox); and Region Champagne Ardenne (www.cr-champagne-ardenne.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Arrebola F, 2006, AM J PHYSIOL-CELL PH, V290, pC638, DOI 10.1152/ajpcell.00364.2005; Bellissent-Funel MC, 2011, WATER: THE FORGOTTEN BIOLOGICAL MOLECULE, P23; Benitez-Rangel E, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.93; Benninger R.K.P., 2013, CURR PROTOC CELL BIO, P1; Borjesson SI, 2011, J BIOL CHEM, V286, P39823, DOI 10.1074/jbc.M111.262725; Bortner CD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0104; Bortner CD, 2011, CELL PHYSIOL BIOCHEM, V28, P1079, DOI 10.1159/000335864; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chaplin M, 2011, WATER: THE FORGOTTEN BIOLOGICAL MOLECULE, P3; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dedkova EN, 2012, J MOL CELL CARDIOL, V52, P48, DOI 10.1016/j.yjmcc.2011.08.030; Fernandez-Segura E, 2008, METHOD CELL BIOL, V88, P19, DOI 10.1016/S0091-679X(08)00402-0; Flusberg DA, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/035002; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Goldman A, 2011, PLOS ONE, V6, pe2385; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hansen JC., 2000, ANNU REV BIOPH BIOM, V31, P361; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kasim NR, 2013, APOPTOSIS, V18, P521, DOI 10.1007/s10495-013-0804-z; Kim NH, 2006, J BIOCHEM MOL BIOL, V39, P452; Ko SK, 2014, NAT CHEM, V6, P885, DOI [10.1038/NCHEM.2021, 10.1038/nchem.2021]; Martinez-Fabregas J, 2014, MOL CELL PROTEOMICS, V13, P1439, DOI 10.1074/mcp.M113.034322; Mentre P, 2012, J BIOL PHYS, V38, P13, DOI 10.1007/s10867-011-9225-9; Mitra K, 2010, CURR PROTOC CELL BIO; Model MA, 2014, AM J PHYSIOL-CELL PH, V306, pC417, DOI 10.1152/ajpcell.00328.2013; Nolin F, 2015, METHODS MOL BIOL, V1228, P145, DOI 10.1007/978-1-4939-1680-1_12; Nolin F, 2013, CELL MOL LIFE SCI, V70, P2383, DOI 10.1007/s00018-013-1267-7; Nolin F, 2012, J STRUCT BIOL, V180, P352, DOI 10.1016/j.jsb.2012.08.011; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Orlov SN, 2013, J PHYSIOL-LONDON, V591, P6123, DOI 10.1113/jphysiol.2013.258624; Platonova A, 2012, APOPTOSIS, V17, P429, DOI 10.1007/s10495-011-0694-x; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tomaskova Z, 2010, FEBS LETT, V584, P2085, DOI 10.1016/j.febslet.2010.01.035; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; WARLEY A, 1983, J CELL SCI, V60, P217; Wu CC, 2013, ANTIOXID REDOX SIGN, V19, P546, DOI 10.1089/ars.2012.4905; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Yang KT, 2004, FASEB J, V18, P1442, DOI 10.1096/fj.03-1038fje	51	11	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148727	10.1371/journal.pone.0148727	http://dx.doi.org/10.1371/journal.pone.0148727			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866363	Green Submitted, Green Published, gold			2022-12-26	WOS:000370050700029
J	Ventura, E; Cordazzo, C; Quarto, R; Zardi, L; Rosano, C				Ventura, Elisa; Cordazzo, Cinzia; Quarto, Rodolfo; Zardi, Luciano; Rosano, Camillo			C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8	PLOS ONE			English	Article							ISOFORM; MARKER	Background Fibronectin (FN) is a large multidomain molecule that is involved in many cellular processes. Different FN isoforms arise from alternative splicing of the pre-mRNA including, most notably, the FN isoform that contains the "extra-domain-B" (ED-B). The FN isoform containing ED-B (known as B-FN) is undetectable in healthy adult tissues but is present in large amounts in neoplastic and foetal tissues as well as on the blood vessels during angiogenesis. Thus, antibodies specific for B-FN can be useful for detecting and targeting neoplastic tissues in vivo. We previously characterised C6, a new monoclonal antibody specific for human B-FN and we suggested that it reacts with the B-C loop of the type III repeat 8 which is masked in FN isoforms lacking ED-B and that the insertion of ED-B in FN molecules unmasked it. Here we have now consolidated and refined the characterization of this B-FN specific antibody demonstrating that the epitope recognized by C6 also includes loop E-F of ED-B. Methodology We built the three dimensional model of the variable regions of the mAb C6 and of the FN fragment EDB-III8 and performed protein: protein docking simulation using the web server ClusPro2.0. To confirm the data obtained by protein: protein docking we generated mutant fragments of the recombinant FN fragment EDB-III8 and tested their reactivity with C6. Conclusion The monoclonal antibody C6 reacts with an epitope formed by the B-C loop of domain III8 and the E-F loop of ED-B. Both loops are required for an immunological reaction, thus this monoclonal is strictly specific for B-FN but the part of the epitope on III8 confers the human specificity.	[Ventura, Elisa] G Gaslini Inst Children, Lab Oncol, Genoa, Italy; [Cordazzo, Cinzia; Zardi, Luciano] Sirius Biotech, Adv Biotechnol Ctr, Genoa, Italy; [Quarto, Rodolfo] Univ Genoa, Lab Stem Cells, Genoa, Italy; [Quarto, Rodolfo] IRCCS AOU San Martino IST, Lab Regenerat Med, Genoa, Italy; [Rosano, Camillo] IRCCS AOU San Martino IST, Lab Biopolymers & Prote, Genoa, Italy; [Ventura, Elisa] Univ Zurich Hosp, Dept Neurol, Lab Mol Neurooncol, CH-8091 Zurich, Switzerland; [Ventura, Elisa] Univ Zurich, Zurich, Switzerland	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Zurich; University Zurich Hospital; University of Zurich	Zardi, L (corresponding author), Sirius Biotech, Adv Biotechnol Ctr, Genoa, Italy.	luciano.zardi@sirius-biotech.com	Quarto, Rodolfo/AAB-2182-2019; Rosano, Camillo/D-5386-2011; Rosano, Camillo/AAA-9954-2021	Rosano, Camillo/0000-0003-2949-9215; Rosano, Camillo/0000-0003-2949-9215; Ventura, Elisa/0000-0002-5999-7613; Quarto, Rodolfo/0000-0002-1146-894X	Sirius-biotech	Sirius-biotech	This study was partially supported by Sirius-biotech. The funder provided support in the form of salaries for authors (L.Z. and partially to C.C.) and for research materials but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the author contribution sections.	Balza E, 2009, INT J CANCER, V125, P751, DOI 10.1002/ijc.24473; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; Berndorff D, 2006, J NUCL MED, V47, P1707; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Chen SL, 2012, INVEST OPHTH VIS SCI, V53, P8333, DOI 10.1167/iovs.12-9766; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; KACZMAREK J, 1994, INT J CANCER, V59, P11, DOI 10.1002/ijc.2910590104; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Kraft S, 2015, J MOL MED BERL, P65; Mariani G, 1997, CANCER, V80, P2378, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2378::AID-CNCR7>3.0.CO;2-7; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Schiefner A, 2012, J BIOL CHEM, V287, P17578, DOI 10.1074/jbc.M111.303131; Ventura E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009145; Yamada K.M., 1996, MOL CELLULAR BIOL WO, P51; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	22	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148103	10.1371/journal.pone.0148103	http://dx.doi.org/10.1371/journal.pone.0148103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867013	Green Submitted, Green Published, gold			2022-12-26	WOS:000370050700008
J	Ducasse, D; Jaussent, I; Olie, E; Guillaume, S; Lopez-Castroman, J; Courtet, P				Ducasse, Deborah; Jaussent, Isabelle; Olie, Emilie; Guillaume, Sebastien; Lopez-Castroman, Jorge; Courtet, Philippe			Personality Traits of Suicidality Are Associated with Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Suicidal Women Sample	PLOS ONE			English	Article							ANGER-EXPRESSION; MENSTRUAL-CYCLE; CEREBROSPINAL-FLUID; GABA CONCENTRATIONS; LUTEAL-PHASE; PAIN; SEROTONIN; BEHAVIOR; MOOD; ALLOPREGNANOLONE	Objective Both Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD) might increase the risk of suicidal behavior. The aim of this study was to assess the relationship between personality dimensions specifically involved in suicidal vulnerability and PMS/PMDD. Method We collected data from 232 women consecutively hospitalized after a suicide attempt. We examined the relationship between impulsivity, aggressiveness/hostility, hopelessness, trait anger, affect intensity, emotional lability, and PMS/PMDD. Notably, we created an algorithm from the shortened Premenstrual Assessment form in order to assess PMDD status. Results The proportions of PMS and PMDD among female suicide attempters were 50% and 23% respectively. Women with PMS or PMDD were more likely to endorse most of these personality traits to than those without even after controlling for potential confounders. We found an impulsive-aggressive pattern of personality in women with PMS or PMDD, independently from the time of the menstrual cycle. Interestingly, trait anger remained associated with both PMS and PMDD independently of every other personality traits. The higher the anger level, the higher the risk was to suffer from both PMS and PMDD. Conclusions This study demonstrates a strong, independent association between PMS/PMDD and trait anger among a representative sample of female suicide attempters. It is of major interest for clinicians in view of addressing a substantial public health problem among women of reproductive age.	[Ducasse, Deborah; Olie, Emilie; Guillaume, Sebastien; Lopez-Castroman, Jorge; Courtet, Philippe] CHU Montpellier, Lapeyronie Hosp, Dept Psychiat Emergency & Acute Care, Montpellier, France; [Ducasse, Deborah; Jaussent, Isabelle; Olie, Emilie; Guillaume, Sebastien; Lopez-Castroman, Jorge; Courtet, Philippe] Univ Montpellier I, INSERM, U1061, Montpellier, France; [Ducasse, Deborah; Olie, Emilie; Guillaume, Sebastien; Lopez-Castroman, Jorge; Courtet, Philippe] Fondamental Fdn, Creteil, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Ducasse, D (corresponding author), CHU Montpellier, Lapeyronie Hosp, Dept Psychiat Emergency & Acute Care, Montpellier, France.; Ducasse, D (corresponding author), Univ Montpellier I, INSERM, U1061, Montpellier, France.; Ducasse, D (corresponding author), Fondamental Fdn, Creteil, France.	d-ducasse@chu-montpellier.fr	Castroman, Lopez/A-6192-2014	Castroman, Lopez/0000-0003-0618-0690; Jaussent, Isabelle/0000-0002-8205-7590; ducasse, deborah/0000-0003-3874-5748	Programme Hospitalier de Recherche Clinique (CHU of Montpellier - PHRC UF) [7653]	Programme Hospitalier de Recherche Clinique (CHU of Montpellier - PHRC UF)	This study was financially supported by Programme Hospitalier de Recherche Clinique (CHU of Montpellier - PHRC UF 7653). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol ES, 2013, COMPR PSYCHIAT, V54, P850, DOI 10.1016/j.comppsych.2013.03.013; American College of Obstetricians and Gynecologists (ACOG), 2000, ACOG PRACTICE BULLET, V15; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193; Bailey JW, 1999, J WOMEN HEALTH GEN-B, V8, P1181, DOI 10.1089/jwh.1.1999.8.1181; Baron KG, 2007, J BEHAV MED, V30, P1, DOI 10.1007/s10865-006-9086-z; Bartley EJ, 2015, CLIN J PAIN, V31, P304, DOI 10.1097/AJP.0000000000000112; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Berlin RE, 2001, J CLIN PSYCHIAT, V62, P337, DOI 10.4088/JCP.v62n0505; Bhagwagar Z, 2004, AM J PSYCHIAT, V161, P368, DOI 10.1176/appi.ajp.161.2.368; Borteyrou X, 2008, ENCEPHALE, V34, P249, DOI 10.1016/j.encep.2007.06.001; BOUVARD M, 1992, Encephale, V18, P237; Bruehl S, 2012, PAIN, V153, P2352, DOI 10.1016/j.pain.2012.08.001; Bruehl S, 2011, PSYCHOSOM MED, V73, P612, DOI 10.1097/PSY.0b013e318227cb88; Burns JW, 2005, J BEHAV MED, V28, P555, DOI 10.1007/s10865-005-9020-9; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Cirillo PC, 2012, REV BRAS PSIQUIATR, V34, P467, DOI 10.1016/j.rbp.2012.04.010; Coccaro EF, 2010, J NEURAL TRANSM, V117, P241, DOI 10.1007/s00702-009-0359-x; Courtet P, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.6; Courtet P., 2013, SUICIDE ENV SOCIAL; Critchlow DG, 2001, J CLIN PSYCHIAT, V62, P688, DOI 10.4088/JCP.v62n0905; Dennerstein Lorraine, 2012, Menopause Int, V18, P48, DOI 10.1258/mi.2012.012013; Ducasse D, 2014, PSYCHOTHERA IN PRESS; Duke AA, 2013, PSYCHOL BULL, V139, P1148, DOI 10.1037/a0031544; Ende G, 2015, NEUROPSYCHOPHARMACOL; Endicott J, 1999, J WOMEN HEALTH GEN-B, V8, P663, DOI 10.1089/jwh.1.1999.8.663; Epperson CN, 2012, AM J PSYCHIAT, V169, P465, DOI 10.1176/appi.ajp.2012.11081302; Freeman Ellen W., 2003, Prim Care Companion J Clin Psychiatry, V5, P30; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; Glick Amy R, 2015, Int J Adolesc Med Health, V27, P143, DOI 10.1515/ijamh-2015-5005; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P1, DOI 10.1016/S0306-4530(03)00098-2; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P55, DOI 10.1016/S0306-4530(03)00097-0; HALBREICH U, 1981, MED HYPOTHESES, V7, P1045, DOI 10.1016/0306-9877(81)90100-6; Halbreich U, 2010, J AFFECT DISORDERS, V122, P10, DOI 10.1016/j.jad.2009.05.018; Hantsoo L, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0628-3; Hartlage SA, 2002, PSYCHOL REP, V90, P189, DOI 10.2466/PR0.90.1.189-202; HARVEY PD, 1989, J CLIN PSYCHOL, V45, P786, DOI 10.1002/1097-4679(198909)45:5<786::AID-JCLP2270450515>3.0.CO;2-P; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Haywood A, 2002, J PSYCHOSOM RES, V52, P223, DOI 10.1016/S0022-3999(02)00297-0; Heinemann LAJ, 2012, HEALTH CARE WOMEN IN, V33, P109, DOI 10.1080/07399332.2011.610530; Holmes EA, 2007, J BEHAV THER EXP PSY, V38, P423, DOI 10.1016/j.jbtep.2007.10.004; Hong JP, 2012, SOC PSYCH PSYCH EPID, V47, P1937, DOI 10.1007/s00127-012-0509-6; Horesh N, 1997, PSYCHOTHER PSYCHOSOM, V66, P92, DOI 10.1159/000289115; Jandl M, 2010, J AFFECT DISORDERS, V123, P138, DOI 10.1016/j.jad.2009.09.011; Keilp JG, 2006, PSYCHOL MED, V36, P1779, DOI 10.1017/S0033291706008725; KERNS RD, 1994, J BEHAV MED, V17, P57, DOI 10.1007/BF01856882; Kim D R, 2004, Arch Womens Ment Health, V7, P37, DOI 10.1007/s00737-003-0027-3; KOSTEN TA, 1992, AM J PSYCHIAT, V149, P1225; KUCZMIERCZYK AR, 1986, PERCEPT MOTOR SKILL, V63, P387, DOI 10.2466/pms.1986.63.2.387; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Larsen RJ, 1996, J PERS, V64, P185, DOI 10.1111/j.1467-6494.1996.tb00819.x; Lee L. K., 2006, SMJ Singapore Medical Journal, V47, P869; LESTER D, 1995, PHARMACOPSYCHIATRY, V28, P45, DOI 10.1055/s-2007-979587; Liu B, 2015, PSYCHIAT RES-NEUROIM, V231, P64, DOI 10.1016/j.pscychresns.2014.10.020; Luoma JB, 2012, COGN BEHAV PRACT, V19, P265; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Marjoribanks J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001396.pub3; McGirr A, 2007, J CLIN PSYCHIAT, V68, P721, DOI 10.4088/JCP.v68n0509; Moberg T, 2011, J AFFECT DISORDERS, V132, P173, DOI 10.1016/j.jad.2011.01.018; N-Wihlback AC, 2006, PSYCHOPHARMACOLOGY, V186, P388, DOI 10.1007/s00213-005-0185-2; Oquendo MA, 2004, AM J PSYCHIAT, V161, P1433, DOI 10.1176/appi.ajp.161.8.1433; Oquendo MA, 2014, AM J PSYCHIAT, V171, P1259, DOI 10.1176/appi.ajp.2014.14020194; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pearlstein T, 2005, J AFFECT DISORDERS, V85, P275, DOI 10.1016/j.jad.2004.10.004; Perroud N, 2013, J AFFECT DISORDERS, V146, P246, DOI 10.1016/j.jad.2012.09.012; Perroud N, 2011, J AFFECT DISORDERS, V134, P112, DOI 10.1016/j.jad.2011.05.048; Pettit JW, 2009, DEPRESS ANXIETY, V26, P758, DOI 10.1002/da.20512; Pilver CE, 2013, SOC PSYCH PSYCH EPID, V48, P437, DOI 10.1007/s00127-012-0548-z; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Quartana PJ, 2007, EMOTION, V7, P400, DOI 10.1037/1528-3542.7.2.400; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Rapkin A, 2003, PSYCHONEUROENDOCRINO, V28, P39, DOI 10.1016/S0306-4530(03)00096-9; RAPKIN AJ, 1987, OBSTET GYNECOL, V70, P533; RAPKIN AJ, 1992, CLIN OBSTET GYNECOL, V35, P629, DOI 10.1097/00003081-199209000-00022; Rapkin AJ, 1997, OBSTET GYNECOL, V90, P709, DOI 10.1016/S0029-7844(97)00417-1; Rapkin Andrea J, 2012, Menopause Int, V18, P52, DOI 10.1258/mi.2012.012014; Rapkin Andrea J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P157, DOI 10.1586/erp.09.14; Rhudy JL, 2014, PAIN, V155, P2144, DOI 10.1016/j.pain.2014.08.011; Robins CJ, 2012, J CLIN PSYCHOL, V68, P117, DOI 10.1002/jclp.20857; Rodrigues D, 2013, PAIN THER, V2, P113, DOI 10.1007/s40122-013-0017-8; ROSEN LN, 1988, ACTA PSYCHIAT SCAND, V77, P446, DOI 10.1111/j.1600-0447.1988.tb05149.x; Roy A, 2014, ARCH SUICIDE RES, V18, P28, DOI 10.1080/13811118.2013.801816; Sanacora G, 2002, AM J PSYCHIAT, V159, P663, DOI 10.1176/appi.ajp.159.4.663; Sassoon SA, 2011, ARCH WOMEN MENT HLTH, V14, P257, DOI 10.1007/s00737-011-0212-8; Saunders KEA, 2006, PSYCHOL MED, V36, P901, DOI 10.1017/S0033291706007392; Schimmack U, 2004, PERS SOC PSYCHOL B, V30, P1062, DOI 10.1177/0146167204264292; Schiola A, 2011, VALUE HEALTH, V14, pS93, DOI 10.1016/j.jval.2011.05.008; SCHMIDT PJ, 1994, J CLIN ENDOCR METAB, V79, P1256, DOI 10.1210/jc.79.5.1256; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shelef L, 2015, EUR PSYCHIAT, V30, P765, DOI 10.1016/j.eurpsy.2014.12.004; Smith MJ, 2003, BIOL PSYCHIAT, V54, P757, DOI 10.1016/S0006-3223(02)01924-8; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Steiner M, 2000, INT CLIN PSYCHOPHARM, V15, pS5; Steiner M, 2000, J PSYCHIATR NEUROSCI, V25, P459; Straneva PA, 2002, HEALTH PSYCHOL, V21, P358, DOI 10.1037//0278-6133.21.4.358; TAYLOR DL, 1984, NEUROPSYCHOBIOLOGY, V12, P16, DOI 10.1159/000118103; Turecki G, 2005, J PSYCHIATR NEUROSCI, V30, P398; Uchino BN, 2004, J SOC CLIN PSYCHOL, V23, P123, DOI 10.1521/jscp.23.2.123.31014; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; Vowles KE, 2011, BEHAV RES THER, V49, P748, DOI 10.1016/j.brat.2011.08.002; Wang H, 2010, LANCET, V380, p2071 , DOI DOI 10.1016/S0140-6736(12)61719-X; WEGNER DM, 1994, J PERS, V62, P615, DOI 10.1111/j.1467-6494.1994.tb00311.x; Williams WR, 2007, MED SCI MONITOR, V13, pCR118; Yonkers Kimberly Ann, 2008, Lancet, V371, P1200, DOI 10.1016/S0140-6736(08)60527-9	108	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148653	10.1371/journal.pone.0148653	http://dx.doi.org/10.1371/journal.pone.0148653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863007	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600090
J	Garcia-Gonzalez, R; Aldezabal, A; Laskurain, NA; Margalida, A; Novoa, C				Garcia-Gonzalez, Ricardo; Aldezabal, Arantza; Laskurain, Nere Amaia; Margalida, Antoni; Novoa, Claude			Factors Affecting Diet Variation in the Pyrenean Rock Ptarmigan (Lagopus muta pyrenaica): Conservation Implications	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; WILLOW PTARMIGAN; BARNACLE GEESE; GROUSE; SNOW; NUTRITION; ALPINE; TETRIX; HISPANIENSIS; LIMITATIONS	The Pyrenean rock ptarmigan (Lagopus muta pyrenaica) lives at one of the southernmost limits of the ptarmigan range. Their small population sizes and the impacts of global changes are limiting factors in the conservation of this threatened subspecies. An effective conservation policy requires precise basic knowledge of a species' food and habitat requirements, information that is practically non-existent for this Pyrenean population. Here, we describe the diet of a ptarmigan population in the Eastern Pyrenees, the environmental factors influencing its variability and the relationship between diet floristic composition and quality. Diet composition was determined by microhistological analysis of faeces and diet quality was estimated from free-urate faecal N content. Our results show that grouse diet is based mainly on arctic-alpine shrubs of the Ericaceae family, as well as dwarf willows (Salix spp.) and Dryas octopetala. The most frequently consumed plant species was Rhododendron ferrugineum, but its abundance in the diet was negatively related to the diet nitrogen content. Conversely, the abundance of Salix spp., grass leaves and arthropods increased the nitrogen content of the diet. Seasonality associated with snow-melting contributed the most to variability in the Pyrenean ptarmigan diet, differentiating winter from spring/summer diets. The latter was characterised by a high consumption of dwarf willows, flowers, arthropods and tender forb leaves. Geographic area and sex-age class influenced diet variability to a lesser extent. Current temperature increases in the Pyrenees due to global warming may reduce the persistence and surface area of snow-packs where preferred plants for rock ptarmigan usually grow, thus reducing food availability. The high consumption of Rh. ferrugineum characterised the diet of the Pyrenean population. Given the toxicity of this plant for most herbivores, its potential negative effect on Pyrenean ptarmigan populations should be evaluated.	[Garcia-Gonzalez, Ricardo] CSIC, Inst Pirenaico Ecol, Jaca, Spain; [Aldezabal, Arantza; Laskurain, Nere Amaia] Univ Basque Country, Plant Biol & Ecol Dept, Bilbao, Spain; [Margalida, Antoni] Univ Lleida, Dept Anim Prod, Div Wildlife, Fac Life Sci & Engn, Lleida, Spain; [Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Novoa, Claude] Off Natl Chasse & Faune Sauvage, Prades, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of Basque Country; Universitat de Lleida; University of Bern	Margalida, A (corresponding author), Univ Lleida, Dept Anim Prod, Div Wildlife, Fac Life Sci & Engn, Lleida, Spain.; Margalida, A (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland.	amargalida@prodan.udl.cat	Margalida, Antoni/A-2723-2011; Margalida, Antoni/AAG-5337-2020; Aldezabal, Arantza/V-7930-2017; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Aldezabal, Arantza/0000-0001-7917-7690; Margalida, Antoni/0000-0002-7383-671X; Laskurain, Nere Amaia/0000-0002-9521-8584; Garcia-Gonzalez, Ricardo/0000-0001-5625-8690; Margalida, Antoni/0000-0002-3904-6212	RTA (Agricultural Technologies and Resources) [2005-00160-C02-02]; MAM Spanish projects [2484/2002]; LEDDRA Desertification process and land degradation (SICA-EU) [FW7 ENV.2009.2.1.3.2]; Ministry of Economy and Competitiveness [RYC-2012-11867]	RTA (Agricultural Technologies and Resources); MAM Spanish projects; LEDDRA Desertification process and land degradation (SICA-EU); Ministry of Economy and Competitiveness	This work was carried out with a cooperation agreement between the Office National de la Chasse et de la Faune Sauvage (France) and the Consejo Superior de Investigaciones Cientificas (Spain). Additional funds were provided by RTA (Agricultural Technologies and Resources) 2005-00160-C02-02, MAM 2484/2002 Spanish projects and LEDDRA FW7 ENV.2009.2.1.3.2 Desertification process and land degradation (SICA-EU). AM was supported by a Ramon y Cajal research contract from the Ministry of Economy and Competitiveness (RYC-2012-11867).	Allen T, 2005, ANIM BEHAV, V70, P305, DOI 10.1016/j.anbehav.2004.10.022; Ameztegui A, 2010, GLOBAL ECOL BIOGEOGR, V19, P632, DOI 10.1111/j.1466-8238.2010.00550.x; ANDREEV AV, 1988, CAN J ZOOL, V66, P1382, DOI 10.1139/z88-203; [Anonymous], 1965, ANATOMY DICOTYLEDONS; ANTOR RJ, 1995, J AVIAN BIOL, V26, P81, DOI 10.2307/3677216; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Atlas Flora Pyrenaea, 2015, POCTEFA CTP UE PROJ; Atta-ur-Rahman, 2003, STUDIES NATURAL PROD; Bech N, 2013, HEREDITY, V111, P402, DOI 10.1038/hdy.2013.62; Bech N, 2009, ANIM CONSERV, V12, P138, DOI 10.1111/j.1469-1795.2008.00233.x; BERNARDLAURENT A, 1983, REV ECOL-TERRE VIE, V37, P241; Bolos O, 1990, FLORA MANUAL PAISOS; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bossert A., 1980, Ornithologische Beobachter, V77, P121; BOUDAREL P, 1991, ACTA BIOL MONTANA, V10, P11; Braun-Blanquet J., 1948, VEGETATION ALPINE PY; BRITTAS R, 1988, ORNIS SCAND, V19, P49, DOI 10.2307/3676527; Carey Cynthia, 1996, P324; Chapuis JL, 1986, REGIME ALIMENTAIRE G; Charrier O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092976; Davies S, 2014, HORM BEHAV, V66, P41, DOI 10.1016/j.yhbeh.2014.04.003; DELBARRIO G, 1990, MT RES DEV, V10, P227, DOI 10.2307/3673602; Elson LT, 2007, NORTHEAST NAT, V14, P89, DOI 10.1656/1092-6194(2007)14[89:WFHOLL]2.0.CO;2; Filacorda S, 1997, WILDLIFE BIOL, V3, P187, DOI 10.2981/wlb.1997.023; Forbey JS, 2013, WILDLIFE BIOL, V19, P374, DOI 10.2981/13-014; Frutos P, 2002, ANIM FEED SCI TECH, V95, P215, DOI 10.1016/S0377-8401(01)00323-6; Ganan N, 2002, REU TECHNICAL SERIES, V66, P86; Garcia-Gonzalez R, 2006, PIRINEOS, V161, P85; Garcia-Gonzalez R., 1992, PLANT AN INT WORKSH, P6; Garcia-Gonzalez R, 1987, ACTA BIOL MONTANA, V7, P35; GarciaGonzalez R, 1996, FOREST ECOL MANAG, V88, P15, DOI 10.1016/S0378-1127(96)03805-4; Garin I, 2008, REV ECOLOGIE TERRE V, V63, P85; Gelting P., 1937, SUDIES FOOD E GREENL; GONZALEZ G, 1989, REV ECOL-TERRE VIE, V44, P347; Imperio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081598; [IUCN WPA], 2009, 41 WPAIUCN IUCNSSC R; Jensen GH, 2014, POLAR BIOL, V37, P1, DOI 10.1007/s00300-013-1404-7; JONES PJ, 1976, IBIS, V118, P547, DOI 10.1111/j.1474-919X.1976.tb03516.x; Legendre P., 2012, NUMERICAL ECOLOGY; Lopez-Moreno JI, 2008, GLOBAL PLANET CHANGE, V61, P300, DOI 10.1016/j.gloplacha.2007.10.004; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Martinez C., 1985, Donana Acta Vertebrata, V12, P174; MOODY S, 1978, AM NAT, V112, P965, DOI 10.1086/283339; MOSS R, 1972, BRIT J NUTR, V27, P285, DOI 10.1079/BJN19720093; MOSS R, 1972, J ANIM ECOL, V41, P411, DOI 10.2307/3477; Moss R, 1997, P NUTR SOC, V56, P1137, DOI 10.1079/PNS19970116; Moss R., 1968, Symposia of the Zoological Society of London, VNo. 21, P207; MOSS R, 1984, IBIS, V126, P212, DOI 10.1111/j.1474-919X.1984.tb08000.x; MOSS R, 1990, ORNIS SCAND, V21, P115, DOI 10.2307/3676806; Nelli L, 2013, WILDLIFE BIOL, V19, P382, DOI 10.2981/13-009; Novoa C, 1999, REV ECOL-TERRE VIE, V54, P149; Novoa C, J ORNITHOLO IN PRESS; Novoa C, 2008, IBIS, V150, P270, DOI 10.1111/j.1474-919X.2007.00771.x; Pasche F, 2004, BIOL CONSERV, V118, P101, DOI 10.1016/j.biocon.2003.07.012; Petraitis PS, 1996, FUNCT ECOL, V10, P421, DOI 10.2307/2389934; PROP J, 1992, FUNCT ECOL, V6, P180, DOI 10.2307/2389753; PROP J, 1993, ORNIS SCAND, V24, P110, DOI 10.2307/3676360; PULLIAINEN E, 1991, HOLARCTIC ECOL, V14, P156; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Schweiger AK, 2012, EUR J WILDLIFE RES, V58, P35, DOI 10.1007/s10344-011-0537-7; Sedinger JS, 1997, CONDOR, V99, P314, DOI 10.2307/1369937; Skrede I, 2006, MOL ECOL, V15, P1827, DOI 10.1111/j.1365-294X.2006.02908.x; SPIDSO TK, 1980, ORNIS SCAND, V11, P99, DOI 10.2307/3675914; Storch I, 2000, WILDLIFE BIOL, V6, P195, DOI 10.2981/wlb.2000.016; SUTLUPMAR N, 1993, ARCH TOXICOL, V67, P148, DOI 10.1007/BF01973687; Tape KD, 2010, ECOSCIENCE, V17, P186, DOI 10.2980/17-2-3323; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERPSTRA K, 1974, Zeitschrift fuer Tierphysiologie Tierernaehrung und Futtermittelkunde, V32, P306; UNANDER S, 1985, Polar Research, V3, P239, DOI 10.1111/j.1751-8369.1985.tb00510.x; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; WEEDEN RB, 1969, AUK, V86, P271, DOI 10.2307/4083500; [No title captured]	74	3	3	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148614	10.1371/journal.pone.0148614	http://dx.doi.org/10.1371/journal.pone.0148614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863532	Green Published, gold			2022-12-26	WOS:000370046600086
J	Mathupala, SP; Kiousis, S; Szerlip, NJ				Mathupala, Saroj P.; Kiousis, Sam; Szerlip, Nicholas J.			A Lab Assembled Microcontroller-Based Sensor Module for Continuous Oxygen Measurement in Portable Hypoxia Chambers	PLOS ONE			English	Article							TUMOR HYPOXIA; BRAIN-TUMORS; CANCER	Background Hypoxia-based cell culture experiments are routine and essential components of in vitro cancer research. Most laboratories use low-cost portable modular chambers to achieve hypoxic conditions for cell cultures, where the sealed chambers are purged with a gas mixture of preset O-2 concentration. Studies are conducted under the assumption that hypoxia remains unaltered throughout the 48 to 72 hour duration of such experiments. Since these chambers lack any sensor or detection system to monitor gas-phase O-2, the cell-based data tend to be non-uniform due to the ad hoc nature of the experimental setup. Methodology With the availability of low-cost open-source microcontroller-based electronic project kits, it is now possible for researchers to program these with easy-to-use software, link them to sensors, and place them in basic scientific apparatus to monitor and record experimental parameters. We report here the design and construction of a small-footprint kit for continuous measurement and recording of O-2 concentration in modular hypoxia chambers. The low-cost assembly (US$135) consists of an Arduino-based microcontroller, data-logging freeware, and a factory pre-calibrated miniature O-2 sensor. A small, intuitive software program was written by the authors to control the data input and output. The basic nature of the kit will enable any student in biology with minimal experience in hobby-electronics to assemble the system and edit the program parameters to suit individual experimental conditions. Results/Conclusions We show the kit's utility and stability of data output via a series of hypoxia experiments. The studies also demonstrated the critical need to monitor and adjust gas-phase O-2 concentration during hypoxia-based experiments to prevent experimental errors or failure due to partial loss of hypoxia. Thus, incorporating the sensor-microcontroller module to a portable hypoxia chamber provides a researcher a capability that was previously available only to labs with access to sophisticated (and expensive) cell culture incubators.	[Mathupala, Saroj P.; Kiousis, Sam] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA; [Mathupala, Saroj P.; Kiousis, Sam] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA; [Szerlip, Nicholas J.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Michigan System; University of Michigan	Mathupala, SP (corresponding author), Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA.; Mathupala, SP (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA.	smathupala@med.wayne.edu			National Cancer Institute (USA) [CA116257]; Elsa U. Pardee Foundation (MI, USA) [410320]; Marvin E. Klein, MD, Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA116257] Funding Source: NIH RePORTER	National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa U. Pardee Foundation (MI, USA); Marvin E. Klein, MD, Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by CA116257, National Cancer Institute (USA) [www.cancer.gov]; 410320, Elsa U. Pardee Foundation (MI, USA) [www.pardeefoundation.org]; and Marvin E. Klein, MD, Charitable Trust.	Bates MK, 2012, CULTURING CELLS HYPO; Colen CB, 2011, METABOLIC TARGETING, DOI [10.1593/neo.11134, DOI 10.1593/NEO.11134]; Evans SM, 2004, CANCER RES, V64, P1886, DOI 10.1158/0008-5472.CAN-03-2424; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Li M, ARDUINO RES BIOTECH; LUBBERS DW, 1995, ACTA ANAESTH SCAND, V39, P37; Margolis M, 2012, ARDUINO COOKBOOK, Vxx; Mathupala SP, 2007, J BIOENERG BIOMEMBR, V39, P73, DOI 10.1007/s10863-006-9062-x; Monk S, 2013, PRACTICAL ELECT INVE, Vxxv; Monk S, 2012, PROGRAMMING ARDUINO, Vxiv; OPITZ N, 1987, INT ANESTHESIOL CLIN, V25, P177; Rau M, 2014, TRUE HYPOXIA REPLICA; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu DL, 2011, JOVE-J VIS EXP, DOI 10.3791/2899	18	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148923	10.1371/journal.pone.0148923	http://dx.doi.org/10.1371/journal.pone.0148923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862760	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600124
J	Kim, SY; Jeong, BH; Park, HY; Jeon, K; Han, SJ; Shin, SJ; Koh, WJ				Kim, Su-Young; Jeong, Byeong-Ho; Park, Hye Yun; Jeon, Kyeongman; Han, Seung Jung; Shin, Sung Jae; Koh, Won-Jung			Association of ISMav6 with the Pattern of Antibiotic Resistance in Korean Mycobacterium avium Clinical Isolates but No Relevance between Their Genotypes and Clinical Features	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; NONTUBERCULOUS MYCOBACTERIA; INSERTION-SEQUENCE; SUBSP HOMINISSUIS; GENETIC DIVERSITY; LUNG-DISEASE; IDENTIFICATION; IS1245; STRAINS; DIFFERENTIATION	The aim of this study was to genetically characterize clinical isolates from patients diagnosed with Mycobacterium avium lung disease and to investigate the clinical significance. Multi-locus sequencing analysis (MLSA) and pattern of insertion sequence analysis of M. avium isolates from 92 Korean patients revealed that all isolates were M. avium subspecies hominissuis. In hsp65 sequevar analysis, codes 2, 15, and 16 were most frequently found (88/92) with similar proportions among cases additionally two isolates belonging to code N2 and an unreported code were identified, respectively. In insertion element analysis, all isolates were IS1311 positive and IS900 negative. Four of the M. avium subsp. hominissuis isolates did not harbor IS1245 and 1 of the M. avium isolates intriguingly harbored DT1, which is thought to be a M. intracellulare-specific element. M. avium subsp. hominissuis harboring ISMav6 is prevalent in Korea. No significant association between clinical manifestation and treatment response has been found in patients with the hsp65 code type and ISMav6, indicating that no specific strain/genotype among M. avium subsp. hominissuis organisms was a major source of M. avium lung disease. Interestingly, the presence of ISMav6 was correlated with greater resistance to moxifloxacin. Conclusively, the genotype of Korean M. avium subsp. hominissuis isolates is not a disease determinant responsible for lung disease and specific virulent factors of M. avium subsp. hominissuis need to be investigated further.	[Kim, Su-Young; Jeong, Byeong-Ho; Park, Hye Yun; Jeon, Kyeongman; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Han, Seung Jung; Shin, Sung Jae] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol,Inst Immunol & Immunol Dis, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.; Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol,Inst Immunol & Immunol Dis, Seoul, South Korea.	sjshin@yuhs.ac; wjkoh@skku.edu	Koh, Won Jung/C-9595-2011; park, hy/O-5934-2014; Kim, Su-Young/GVT-4242-2022; Jeon, Kyeongman/F-5963-2019; Koh, Won-Jung/D-9586-2018	Kim, Su-Young/0000-0002-6369-3399; Jeon, Kyeongman/0000-0002-4822-1772; Koh, Won-Jung/0000-0002-4756-3527; Jeong, Byeong-Ho/0000-0002-3124-1718; Shin, Sung Jae/0000-0003-0854-4582	Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HR14C0006, HI15C2778]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2015R1A2A1A01003959]	Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by a grant of the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HR14C0006 and HI15C2778, http://www.htdream.kr/, SJS and WJK) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2015R1A2A1A01003959, http://www.nrf.re.kr/, WJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Bartos M, 2006, J MICROBIOL METH, V64, P333, DOI 10.1016/j.mimet.2005.05.009; Ben Salah I, 2008, MICROBIOL-SGM, V154, P3715, DOI 10.1099/mic.0.2008/020164-0; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Brode SK, 2014, INT J TUBERC LUNG D, V18, P1370, DOI 10.5588/ijtld.14.0120; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2 CLSI; Dai JL, 2011, J CLIN MICROBIOL, V49, P144, DOI 10.1128/JCM.00957-10; Despierres L, 2012, EUR J CLIN MICROBIOL, V31, P1373, DOI 10.1007/s10096-011-1452-2; Dvorska L, 2002, J CLIN MICROBIOL, V40, P3712, DOI 10.1128/JCM.40.10.3712-3719.2002; Englund S, 1999, DIAGN MICR INFEC DIS, V33, P163, DOI 10.1016/S0732-8893(98)00098-4; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; GUERRERO C, 1995, J CLIN MICROBIOL, V33, P304, DOI 10.1128/JCM.33.2.304-307.1995; Harmsen D, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-26; Hashemi-Shahraki A, 2013, INFECT GENET EVOL, V20, P312, DOI 10.1016/j.meegid.2013.08.027; Ichikawa K, 2009, J MED MICROBIOL, V58, P945, DOI 10.1099/jmm.0.008623-0; Iwamoto T, 2012, INFECT GENET EVOL, V12, P846, DOI 10.1016/j.meegid.2011.06.018; Jang MA, 2014, J CLIN MICROBIOL, V52, P1207, DOI 10.1128/JCM.03053-13; Jeong BH, 2015, AM J RESP CRIT CARE, V191, P96, DOI 10.1164/rccm.201408-1545OC; Johansen TB, 2005, J CLIN MICROBIOL, V43, P2500, DOI 10.1128/JCM.43.5.2500-2502.2005; Kikuchi T, 2009, THORAX, V64, P901, DOI 10.1136/thx.2009.114603; Kim SY, 2012, INT J TUBERC LUNG D, V16, P1393, DOI 10.5588/ijtld.12.0147; Koh WJ, 2013, TUBERC RESPIR DIS, V75, P199, DOI 10.4046/trd.2013.75.5.199; Koh WJ, 2012, CHEST, V142, P1482, DOI 10.1378/chest.12-0494; Kolb J, 2014, INT J MED MICROBIOL, V304, P941, DOI 10.1016/j.ijmm.2014.06.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Oliveira RS, 2003, J CLIN MICROBIOL, V41, P44, DOI 10.1128/JCM.41.1.44-49.2003; Rabello MCDS, 2010, J CLIN MICROBIOL, V48, P2257, DOI 10.1128/JCM.02256-09; Rindi L, 2014, INFECT GENET EVOL, V21, P375, DOI 10.1016/j.meegid.2013.12.007; ROIZ MP, 1995, J CLIN MICROBIOL, V33, P1389, DOI 10.1128/JCM.33.5.1389-1391.1995; Schweickert B, 2008, EMERG INFECT DIS, V14, P1443, DOI 10.3201/eid1409.071032; Shin SJ, 2013, CLIN INFECT DIS, V57, P32, DOI 10.1093/cid/cit172; Shin SJ, 2010, J CLIN MICROBIOL, V48, P4057, DOI 10.1128/JCM.00904-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatano Y, 2012, EUR J CLIN MICROBIOL, V31, P445, DOI 10.1007/s10096-011-1326-7; THOREL MF, 1990, INT J SYST BACTERIOL, V40, P254, DOI 10.1099/00207713-40-3-254; Tran QT, 2014, J CLIN MICROBIOL, V52, P1201, DOI 10.1128/JCM.03399-13; Turenne CY, 2006, J CLIN MICROBIOL, V44, P433, DOI 10.1128/JCM.44.2.433-440.2006; Wallace RJ, 2013, J CLIN MICROBIOL, V51, P1747, DOI 10.1128/JCM.00186-13	40	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148917	10.1371/journal.pone.0148917	http://dx.doi.org/10.1371/journal.pone.0148917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859598	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400105
J	Ying, ZK; Chen, MJ; Xie, XY; Wang, XK; Kherada, N; Desikan, R; Mihai, G; Burns, P; Sun, QH; Rajagopalan, S				Ying, Zhekang; Chen, Minjie; Xie, Xiaoyun; Wang, Xiaoke; Kherada, Nisharahmed; Desikan, Rajagopal; Mihai, Georgeta; Burns, Patrick; Sun, Qinghua; Rajagopalan, Sanjay			Lipoicmethylenedioxyphenol Reduces Experimental Atherosclerosis through Activation of Nrf2 Signaling	PLOS ONE			English	Article							ALPHA-LIPOIC ACID; DEFICIENT MICE; IN-VIVO; ANTIOXIDANT; EXPRESSION; MECHANISMS; CHOLESTEROL; FACTOR-2; MIGRATION; PROTECTS	Objective Oxidative stress is implicated in the pathogenesis of atherosclerosis, and Nrf2 is the transcriptional factor central in cellular antioxidant responses. In the present study, we investigate the effect of a dihydrolipoic acid derivative lipoicmethylenedioxyphenol (LMDP) on the progression of atherosclerosis and test whether its effect on atherosclerosis is mediated by Nrf2. Methods and Results Both magnetic resonance imaging (MRI) scanning and en face analysis reveal that 14 weeks of treatment with LMDP markedly reduced atherosclerotic burden in a rabbit balloon vascular injury model. Myograph analyses show decreased aortic contractile response to phenylephrine and increased aortic response to acetylcholine and insulin in LMDP-treated animals, suggesting that LMDP inhibits atherosclerosis through improving vascular function. A role of Nrf2 signaling in mediating the amelioration of vascular function by LMDP was supported by increased Nrf2 translocation into nuclear and increased expression of Nrf2 target genes. Furthermore, chemotaxis analysis with Boydem chamber shows that leukocytes isolated from LMDP-treated rabbits had reduced chemotaxis, and knock-down of Nrf2 significantly reduced the effect of LMDP on the chemotaxis of mouse macrophages. Conclusion Our results support that LMDP has an anti-atherosclerotic effect likely through activation of Nrf2 signaling and subsequent inhibition of macrophage chemotaxis.	[Ying, Zhekang; Chen, Minjie] Tongji Univ, Sch Med, East Hosp, Dept Cardiol, Shanghai 200120, Peoples R China; [Ying, Zhekang; Chen, Minjie; Wang, Xiaoke; Rajagopalan, Sanjay] Univ Maryland, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21201 USA; [Xie, Xiaoyun; Kherada, Nisharahmed; Desikan, Rajagopal; Mihai, Georgeta; Burns, Patrick] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Xie, Xiaoyun] Tongji Univ, Sch Med, Tongji Hosp, Div Geriatr Med, Shanghai 200092, Peoples R China; [Desikan, Rajagopal] InVasc Therapeut, Tucker, GA USA; [Desikan, Rajagopal] VIT Univ, Sch Adv Sci, Dept Chem & Pharmaceut Chem, Vellore 632014, Tamil Nadu, India	Tongji University; University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University; Tongji University; Vellore Institute of Technology	Ying, ZK (corresponding author), Tongji Univ, Sch Med, East Hosp, Dept Cardiol, Shanghai 200120, Peoples R China.; Ying, ZK (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21201 USA.	yingzhekang@hotmail.com	Burns, Patrick/C-5943-2013	Burns, Patrick/0000-0001-5229-3886	National Natural Science Foundation of China [81270342, 81500216]; American Heart Association [11POST7640030, 13SDG17070131]; National Institutes of Health [R01ES024516, R01ES013406, R01ES015146]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024516, R01ES015146, R01ES013406] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/ No. 81270342 to ZY and 81500216 to MC), the American Heart Association (http://www.heart.org 11POST7640030, 13SDG17070131 to ZY) and the National Institutes of Health (https://grants.nih.gov/grants/oer.htm R01ES024516 to ZY and R01ES013406 and R01ES015146 to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LMMP was synthesized by Dr. Rajagopal Desikan, which is protected by a patent (Patent number: 8198317) that belongs to the Ohio State University Research Foundation and Invasc Therapeutic. This work was supported by the National Natural Science Foundation of China (Grant No. 81270342 to Z.Y. and 81500216 to M.C.), the American Heart Association (11POST7640030, 13SDG17070131 to Z.Y.) and the National Institutes of Health (R01ES024516 to Z.Y. and R01ES013406 and R01ES015146 to S.R.).	Amom Z, 2008, J CLIN BIOCHEM NUTR, V43, P88, DOI 10.3164/jcbn.2008051; Barajas B, 2011, ARTERIOSCL THROM VAS, V31, P58, DOI 10.1161/ATVBAHA.110.210906; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Collins AR, 2012, ARTERIOSCLER THROMB; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Ding Y, 2014, INT J CARDIOL, V175, P508, DOI 10.1016/j.ijcard.2014.06.045; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P1641, DOI 10.1517/13543784.13.12.1641; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Fayad ZA, 2000, CIRCULATION, V101, P2503, DOI 10.1161/01.CIR.101.21.2503; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Kim HS, 2012, P NATL ACAD SCI USA, V109, pE2803, DOI 10.1073/pnas.1212596109; Levonen AL, 2007, ARTERIOSCL THROM VAS, V27, P741, DOI 10.1161/01.ATV.0000258868.80079.4d; Lii CK, 2010, J NUTR, V140, P885, DOI 10.3945/jn.110.121418; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; Park SJ, 2012, INT J MOL SCI, V13, P7915, DOI 10.3390/ijms13077915; Sawada H, 2012, ATHEROSCLEROSIS, V225, P83, DOI 10.1016/j.atherosclerosis.2012.08.023; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Shay KP, 2012, BBA-MOL CELL RES, V1823, P1102, DOI 10.1016/j.bbamcr.2012.04.002; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sussan TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003791; Tinkel J, 2012, CARDIOL REV, V20, P77, DOI 10.1097/CRD.0b013e31823dbbad; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Ying ZK, 2012, J LIPID RES, V53, P879, DOI 10.1194/jlr.M022806; Ying ZK, 2011, ARTERIOSCL THROM VAS, V31, P536, DOI 10.1161/ATVBAHA.110.219287; Ying ZK, 2010, LIFE SCI, V86, P95, DOI 10.1016/j.lfs.2009.11.009; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375; Zhang WJ, 2008, CIRCULATION, V117, P421, DOI 10.1161/CIRCULATIONAHA.107.725275; Zulkhairi A, 2008, BIOMED PHARMACOTHER, V62, P716, DOI 10.1016/j.biopha.2006.12.003	31	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148305	10.1371/journal.pone.0148305	http://dx.doi.org/10.1371/journal.pone.0148305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859892	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400028
J	Gao, LL; Turner, MK; Chao, SM; Kolmer, J; Anderson, JA				Gao, Liangliang; Turner, M. Kathryn; Chao, Shiaoman; Kolmer, James; Anderson, James A.			Genome Wide Association Study of Seedling and Adult Plant Leaf Rust Resistance in Elite Spring Wheat Breeding Lines	PLOS ONE			English	Article							SELECTION; SOFTWARE; PROGRAM; TRAITS; NUMBER; UG99; QTL	Leaf rust is an important disease, threatening wheat production annually. Identification of resistance genes or QTLs for effective field resistance could greatly enhance our ability to breed durably resistant varieties. We applied a genome wide association study (GWAS) approach to identify resistance genes or QTLs in 338 spring wheat breeding lines from public and private sectors that were predominately developed in the Americas. A total of 46 QTLs were identified for field and seedling traits and approximately 20-30 confer field resistance in varying degrees. The 10 QTLs accounting for the most variation in field resistance explained 26-30% of the total variation (depending on traits: percent severity, coefficient of infection or response type). Similarly, the 10 QTLs accounting for most of the variation in seedling resistance to different races explained 24-34% of the variation, after correcting for population structure. Two potentially novel QTLs (QLr. umn-1AL, QLr. umn-4AS) were identified. Identification of novel genes or QTLs and validation of previously identified genes or QTLs for seedling and especially adult plant resistance will enhance understanding of leaf rust resistance and assist breeding for resistant wheat varieties. We also developed computer programs to automate field and seedling rust phenotype data conversions. This is the first GWAS study of leaf rust resistance in elite wheat breeding lines genotyped with high density 90K SNP arrays.	[Gao, Liangliang; Turner, M. Kathryn; Anderson, James A.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Kolmer, James] USDA ARS Cereal Dis Lab, St Paul, MN 55108 USA; [Kolmer, James] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Chao, Shiaoman] USDA ARS Biosci Res Lab, Fargo, ND 58102 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Anderson, JA (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA.; Kolmer, J (corresponding author), USDA ARS Cereal Dis Lab, St Paul, MN 55108 USA.; Kolmer, J (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.	Jim.Kolmer@ars.usda.gov; ander319@umn.edu	Anderson, James/AAI-2477-2021	Anderson, James/0000-0003-4655-6517; Gao, Liangliang/0000-0002-3864-0631	United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) [2011-68002-30029]; ARS [ARS-0424595] Funding Source: Federal RePORTER	United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study is part of the Triticeae Coordinated Agriculture Project (TCAP, www.triticeaecap.org), funded by the United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) grant no. 2011-68002-30029.	[Anonymous], 2014, R LANG ENV STAT COMP; Babiker EM, 2015, THEOR APPL GENET, V128, P605, DOI 10.1007/s00122-015-2456-6; Bajgain P, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0628-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernardo R., 2010, BREEDING QUANTITATIV, V2; Bernardo R, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.11.0028; Bipinraj A, 2011, J APPL GENET, V52, P171, DOI 10.1007/s13353-010-0026-9; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chapman JA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0582-8; Chu CG, 2009, THEOR APPL GENET, V119, P263, DOI 10.1007/s00122-009-1035-0; Darino MA, 2015, EUPHYTICA, V206, P135, DOI 10.1007/s10681-015-1486-0; Draz I. S., 2015, Annals of Agricultural Science (Cairo), V60, P29; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eu-ahsunthornwattana J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004445; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gao LL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0404-4; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Guttieri MJ, 2015, CROP SCI; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Huerta-Espino J, 2011, EUPHYTICA, V179, P143, DOI 10.1007/s10681-011-0361-x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Kertho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129580; Kolmer JA, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0274-9; Kolmer JA, 2011, PLANT DIS, V95, P1032, DOI 10.1094/PDIS-04-11-0275; Kolmer JA, 2003, CROP SCI, V43, P1266, DOI 10.2135/cropsci2003.1266; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2006, THEOR APPL GENET, V114, P21, DOI 10.1007/s00122-006-0406-z; Letta T, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.08.0026; Li ZF, 2014, CROP SCI, V54, P1907, DOI 10.2135/cropsci2014.02.0162; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037146; Liu ZL, 2013, CROP SCI, V53, P1566, DOI 10.2135/cropsci2012.09.0532; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; Maccaferri M, 2010, MOL BREEDING, V26, P189, DOI 10.1007/s11032-009-9353-0; Marais GF, 2008, PLANT BREEDING, V127, P340, DOI 10.1111/j.1439-0523.2008.01513.x; Marroni F, 2011, TREE GENET GENOMES, V7, P1011, DOI 10.1007/s11295-011-0391-5; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McIntosh R., 2013, CATALOGUE GENE SYMBO; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Singh D, 2009, EUPHYTICA, V169, P253, DOI 10.1007/s10681-009-9959-7; Stakman E.C., 1962, E617 USDAARS; Stubbs R., 1986, CEREAL DIS METHODOLO; Thavamanikumar S, 2015, G3-GENES GENOM GENET, V5, P1991, DOI 10.1534/g3.115.019745; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu LX, 2011, THEOR APPL GENET, V123, P1257, DOI 10.1007/s00122-011-1664-y; Zegeye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105593; Zhang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103747; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	63	99	100	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148671	10.1371/journal.pone.0148671	http://dx.doi.org/10.1371/journal.pone.0148671			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849364	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000153
J	Hansen, MJ; Schaerf, TM; Krause, J; Ward, AJW				Hansen, M. J.; Schaerf, T. M.; Krause, J.; Ward, A. J. W.			Crimson Spotted Rainbowfish (Melanotaenia duboulayi) Change Their Spatial Position according to Nutritional Requirement	PLOS ONE			English	Article							ROACH RUTILUS-RUTILUS; STICKLEBACKS GASTEROSTEUS-ACULEATUS; BROWN CAPUCHIN MONKEYS; DECISION-MAKING; FORAGING BEHAVIOR; ANIMAL GROUPS; SELFISH HERD; FISH SHOALS; PREDATOR AVOIDANCE; INDIVIDUALS LEAD	Decision making in moving animal groups has been shown to be disproportionately influenced by individuals at the front of groups. Therefore, an explanation of state-dependent positioning of individuals within animal groups may provide a mechanism for group movement decisions. Nutritional state is dynamic and can differ between members of the same group. It is also known to drive animal movement decisions. Therefore, we assayed 6 groups of 8 rainbowfish foraging in a flow tank. Half of the fish had been starved for 24h and half had been fed 1h prior to experimental start. Groups were assayed again one week later but individuals were allocated to the opposite nutritional treatment. During the assay the positions of individually identified fish were recorded as were the number of food items they each ate and the position within the group they acquired them from. Food-deprived fish were more often found towards the front of the shoal; the mean weighted positional score of food-deprived fish was significantly larger than that of well-fed fish. Individuals were not consistent in their position within a shoal between treatments. There was a significant positive correlation between mean weighted positional score and number of food items acquired which displays an obvious benefit to front positions. These results suggest that positional preferences are based on nutritional state and provide a mechanism for state-dependent influence on group decision-making as well as increasing our understanding of what factors are important for group functioning.	[Hansen, M. J.; Schaerf, T. M.; Ward, A. J. W.] Univ Sydney, Anim Behav Lab, Sch Biol Sci, Sydney, NSW 2006, Australia; [Schaerf, T. M.] Univ New England, Sch Sci & Technol, Armidale, NSW 2351, Australia; [Krause, J.] Liebniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, D-12587 Berlin, Germany; [Krause, J.] Humbolt Univ Berlin, Fac Life Sci, Thaer Inst, Berlin, Germany	University of Sydney; University of New England; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Hansen, MJ (corresponding author), Univ Sydney, Anim Behav Lab, Sch Biol Sci, Sydney, NSW 2006, Australia.	matthew.hansen@sydney.edu.au	Krause, Jens/J-4381-2013; Schaerf, Timothy/M-7821-2015	Krause, Jens/0000-0002-1289-2857; Ward, Ashley/0000-0003-0842-533X; Schaerf, Timothy/0000-0001-6642-8374	Australian Research Council [DP130101670]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council via DP130101670.	Beauchamp G, 2014, CAN J ZOOL, V92, P785, DOI 10.1139/cjz-2014-0037; Beauchamp G, 2007, ANIM BEHAV, V73, P445, DOI 10.1016/j.anbehav.2006.09.004; Beecham JA, 1999, J THEOR BIOL, V198, P533, DOI 10.1006/jtbi.1999.0930; Beekman M, 2006, ANIM BEHAV, V71, P161, DOI 10.1016/j.anbehav.2005.04.009; Bibost AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080907; BILL RG, 1976, SCIENCE, V193, P1146, DOI 10.1126/science.193.4258.1146; BLACK JM, 1992, ANIM BEHAV, V44, P41, DOI 10.1016/S0003-3472(05)80752-3; Brown C, 2000, THESIS U QUEENSLAND; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; BUMANN D, 1993, BEHAVIOUR, V125, P189, DOI 10.1163/156853993X00236; Burns ALJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036567; Colleter M, 2011, ANIM BEHAV, V81, P1231, DOI 10.1016/j.anbehav.2011.03.011; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dambach M, 1999, J INSECT PHYSIOL, V45, P423, DOI 10.1016/S0022-1910(98)00141-3; DeBlois EM, 1996, OECOLOGIA, V108, P192, DOI 10.1007/BF00333231; Diwold K, 2011, SWARM INTELL-US, V5, P121, DOI 10.1007/s11721-011-0054-z; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hansen MJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1713, DOI 10.1007/s00265-015-1983-0; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Hirsch BT, 2007, Q REV BIOL, V82, P9, DOI 10.1086/511657; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; JANSON CH, 1990, ANIM BEHAV, V40, P910, DOI 10.1016/S0003-3472(05)80993-5; JANSON CH, 1990, ANIM BEHAV, V40, P922, DOI 10.1016/S0003-3472(05)80994-7; Janson S, 2005, ANIM BEHAV, V70, P349, DOI 10.1016/j.anbehav.2004.10.018; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Keenleyside M. H. A., 1955, Behaviour, V8, P183, DOI 10.1163/156853955X00229; Kenny D. A., 1987, STAT SOCIAL BEHAV SC; Killen S. S., 2011, P ROYAL SOC B; King AJ, 2009, COMMUN INTEGR BIOL, V2, P146; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; Klok CJ, 1999, FUNCT ECOL, V13, P417, DOI 10.1046/j.1365-2435.1999.00324.x; KRAUSE J, 1994, BIOL REV, V69, P187, DOI 10.1111/j.1469-185X.1994.tb01505.x; Krause J, 1998, J FISH BIOL, V52, P494, DOI 10.1006/jfbi.1997.0595; Krause J, 1998, BEHAVIOUR, V135, P1031, DOI 10.1163/156853998792913519; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; KRAUSE J, 1993, ANIM BEHAV, V45, P1019, DOI 10.1006/anbe.1993.1119; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; KRAUSE J, 1993, J FISH BIOL, V43, P309, DOI 10.1111/j.1095-8649.1993.tb01194.x; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Krause J, 2002, LIVING GROUPS; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; MAJOR PF, 1978, ANIM BEHAV, V26, P760, DOI 10.1016/0003-3472(78)90142-2; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Marras S, 2015, BEHAV ECOL SOCIOBIOL, V69, P219, DOI 10.1007/s00265-014-1834-4; McClure M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1573, DOI 10.1007/s00265-011-1167-5; McGuigan K, 2003, EVOLUTION, V57, P104; MORGAN MJ, 1988, ANIM BEHAV, V36, P1317, DOI 10.1016/S0003-3472(88)80200-8; Morrell LJ, 2008, BEHAV ECOL, V19, P909, DOI 10.1093/beheco/arn050; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; OCONNELL CP, 1972, J FISH RES BOARD CAN, V29, P285, DOI 10.1139/f72-047; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; Priyadarshana T, 2006, HYDROBIOLOGIA, V568, P341, DOI 10.1007/s10750-006-0201-5; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; RAYOR LS, 1990, BEHAV ECOL SOCIOBIOL, V27, P77, DOI 10.1007/BF00168449; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; ROBINSON CJ, 1989, J FISH BIOL, V35, P459, DOI 10.1111/j.1095-8649.1989.tb02997.x; ROBINSON CJ, 1989, J FISH BIOL, V34, P631, DOI 10.1111/j.1095-8649.1989.tb03341.x; ROMEY WL, 1995, BEHAV ECOL SOCIOBIOL, V37, P195, DOI 10.1007/s002650050181; Rowcliffe JM, 2004, J ANIM ECOL, V73, P97, DOI 10.1111/j.1365-2656.2004.00783.x; RYER CH, 1995, ANIM BEHAV, V49, P411, DOI 10.1006/anbe.1995.0054; RYER CH, 1992, ANIM BEHAV, V44, P69, DOI 10.1016/S0003-3472(05)80756-0; Schultz KM, 2008, J EXP BIOL, V211, P3287, DOI 10.1242/jeb.018994; Stankowich T, 2003, ANIM BEHAV, V66, P589, DOI 10.1006/anbe.2003.2232; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2013, BEHAV ECOL SOCIOBIOL, V67, P457, DOI 10.1007/s00265-012-1466-5; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Swaney W, 2001, ANIM BEHAV, V62, P591, DOI 10.1006/anbe.2001.1788; Teichroeb JA, 2015, INT J PRIMATOL, V36, P154, DOI 10.1007/s10764-015-9818-4; The MathWorks Inc, 2014, MATLAB STAT TOOLB RE; Voelkl B, 2015, P NATL ACAD SCI USA, V112, P2115, DOI 10.1073/pnas.1413589112; Ward A., 2016, SOCIALITY BEHAV GROU; Ward AJW, 2005, ENVIRON BIOL FISH, V72, P155, DOI 10.1007/s10641-004-9078-1; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2002, J ANIM ECOL, V71, P10, DOI 10.1046/j.0021-8790.2001.00571.x	83	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148334	10.1371/journal.pone.0148334	http://dx.doi.org/10.1371/journal.pone.0148334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849566	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000071
J	Iwakura, H; Dote, K; Bando, M; Koyama, H; Hosoda, K; Kangawa, K; Nakao, K				Iwakura, Hiroshi; Dote, Katsuko; Bando, Mika; Koyama, Hiroyuki; Hosoda, Kiminori; Kangawa, Kenji; Nakao, Kazuwa			Establishment of Leptin-Responsive Cell Lines from Adult Mouse Hypothalamus	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GENE-EXPRESSION; IN-VITRO; C-FOS; RESISTANCE; MICE; INSULIN; RECEPTOR; PROTEIN; NEURONS	Leptin resistance is considered to be the primary cause of obesity. However, the cause of leptin resistance remains incompletely understood, and there is currently no cure for the leptin-resistant state. In order to identify novel drug-target molecules that could overcome leptin resistance, it would be useful to develop in vitro assay systems for evaluating leptin resistance. In this study, we established immortalized adult mouse hypothalamus-derived cell lines, termed adult mouse hypothalamus (AMH) cells, by developing transgenic mice in which SV40 Tag was overexpressed in chromogranin A-positive cells in a tamoxifen-dependent manner. In order to obtain leptin-responsive clones, we selected clones based on the phosphorylation levels of STAT3 induced by leptin. The selected clones were fairly responsive to leptin in terms of STAT3, ERK, and Akt phosphorylation and induction of c-Fos mRNA induction. Pretreatment with leptin, insulin, and palmitate attenuated the c-Fos mRNA response to leptin, suggesting that certain aspects of leptin resistance might be reconstituted in this cellular model. These cell lines are useful tools for understanding the molecular nature of the signal disturbance in the leptin-resistant state and for identifying potential target molecules for drugs that relieve leptin resistance, although they have drawbacks including de-differentiated nature and lack of long-time stability.	[Iwakura, Hiroshi; Dote, Katsuko; Bando, Mika; Koyama, Hiroyuki; Hosoda, Kiminori; Kangawa, Kenji; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Koyama, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan; [Hosoda, Kiminori] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Osaka, Japan	Kyoto University; Kyoto University; Kyoto University; National Cerebral & Cardiovascular Center - Japan	Iwakura, H (corresponding author), Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan.	hiwaku@kuhp.kyoto-u.ac.jp		Iwakura, Hiroshi/0000-0001-8033-0736	Takeda Pharmaceutical Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan	Takeda Pharmaceutical Co. Ltd.(Takeda Pharmaceutical Company Ltd); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Takeda Pharmaceutical Co. Ltd. and funds from the Ministry of Education, Culture, Sports, Science and Technology of Japan. HI received above funding. [http://www.takeda.com/; http://www.mext.go.jp/english/] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Brown R, 2009, J NEUROIMMUNOL, V209, P96, DOI 10.1016/j.jneuroim.2009.02.001; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chiappini F, 2014, J CLIN INVEST, V124, P3781, DOI 10.1172/JCI68585; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cui H, 2005, J NEUROSCI, V25, P9497, DOI 10.1523/JNEUROSCI.2269-05.2005; Cui H, 2006, FASEB J, V20, P2654, DOI 10.1096/fj.06-5989fje; Dhillon SS, 2011, ENDOCRINOLOGY, V152, P4138, DOI 10.1210/en.2011-0178; Dhillon SS, 2011, REGUL PEPTIDES, V167, P192, DOI 10.1016/j.regpep.2011.01.005; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman J, 2014, J ENDOCRINOL, V223, pT1, DOI 10.1530/JOE-14-0405; George M, 2014, J CARDIOVASC PHARM T, V19, P65, DOI 10.1177/1074248413501017; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Iwakura H, 2002, J CLIN ENDOCR METAB, V87, P4885, DOI 10.1210/jc.2002-020882; Iwakura H, 2011, ENDOCRINOLOGY, V152, P2619, DOI 10.1210/en.2010-1455; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; Iwakura H, 2009, AM J PHYSIOL-ENDOC M, V297, pE802, DOI 10.1152/ajpendo.00205.2009; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MIYAZAKI J, 1989, GENE, V79, P269; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Nazarians-Armavil A, 2013, MOL ENDOCRINOL, V27, P990, DOI 10.1210/me.2012-1338; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Velloso LA, 2015, ENDOCR REV, V36, P245, DOI 10.1210/er.2014-1100; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148639	10.1371/journal.pone.0148639	http://dx.doi.org/10.1371/journal.pone.0148639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849804	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000145
J	Reagan, AJ; Dubief, Y; Dodds, PS; Danforth, CM				Reagan, Andrew J.; Dubief, Yves; Dodds, Peter Sheridan; Danforth, Christopher M.			Predicting Flow Reversals in a Computational Fluid Dynamics Simulated Thermosyphon Using Data Assimilation	PLOS ONE			English	Article							NATURAL CIRCULATION; CONVECTION LOOP; KALMAN FILTER; CHAOTIC FLOW; MODEL	A thermal convection loop is a annular chamber filled with water, heated on the bottom half and cooled on the top half. With sufficiently large forcing of heat, the direction of fluid flow in the loop oscillates chaotically, dynamics analogous to the Earth's weather. As is the case for state-of-the-art weather models, we only observe the statistics over a small region of state space, making prediction difficult. To overcome this challenge, data assimilation (DA) methods, and specifically ensemble methods, use the computational model itself to estimate the uncertainty of the model to optimally combine these observations into an initial condition for predicting the future state. Here, we build and verify four distinct DA methods, and then, we perform a twin model experiment with the computational fluid dynamics simulation of the loop using the Ensemble Transform Kalman Filter (ETKF) to assimilate observations and predict flow reversals. We show that using adaptively shaped localized covariance outperforms static localized covariance with the ETKF, and allows for the use of less observations in predicting flow reversals. We also show that a Dynamic Mode Decomposition (DMD) of the temperature and velocity fields recovers the low dimensional system underlying reversals, finding specific modes which together are predictive of reversal direction.	[Reagan, Andrew J.; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Dept Math & Stat, Vermont Complex Syst Ctr, Computat Story Lab, Burlington, VT 05405 USA; [Reagan, Andrew J.; Dubief, Yves; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05405 USA; [Dubief, Yves] Univ Vermont, Sch Engn, Vermont Complex Syst Ctr, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Reagan, AJ (corresponding author), Univ Vermont, Dept Math & Stat, Vermont Complex Syst Ctr, Computat Story Lab, Burlington, VT 05405 USA.; Reagan, AJ (corresponding author), Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05405 USA.	andrew.reagan@uvm.edu			Vermont Space Grant Consortium; NASA EPSCoR; NSF-DMS [0940271]; Mathematics & Climate Research Network; Vermont Advanced Computing Center	Vermont Space Grant Consortium; NASA EPSCoR(National Aeronautics & Space Administration (NASA)); NSF-DMS(National Science Foundation (NSF)); Mathematics & Climate Research Network; Vermont Advanced Computing Center	This work was made possible by funding from the Vermont Space Grant Consortium, NASA EPSCoR, NSF-DMS Grant No. 0940271, the Mathematics & Climate Research Network and the Vermont Advanced Computing Center.	[Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Bauer P, 2015, NATURE, V525, P47, DOI 10.1038/nature14956; Bishop CH, 2001, MON WEATHER REV, V129, P420, DOI 10.1175/1520-0493(2001)129<0420:ASWTET>2.0.CO;2; Bishop CH, 2011, MON WEATHER REV, V139, P1241, DOI 10.1175/2010MWR3403.1; Burroughs EA, 2005, J FLUID MECH, V543, P203, DOI 10.1017/S0022112005006361; CREVELING HF, 1975, J FLUID MECH, V67, P65, DOI 10.1017/S0022112075000171; Danforth CM, 2008, J ATMOS SCI, V65, P1467, DOI 10.1175/2007JAS2419.1; Danforth CM, 2007, MON WEATHER REV, V135, P281, DOI 10.1175/MWR3289.1; Desrayaud G, 2006, INT J HEAT FLUID FL, V27, P154, DOI 10.1016/j.ijheatfluidflow.2005.04.002; EHRHARD P, 1990, J FLUID MECH, V217, P487, DOI 10.1017/S0022112090000817; Glenn D, 2013, THESIS U VERMONT; GORMAN M, 1986, PHYSICA D, V19, P255, DOI 10.1016/0167-2789(86)90022-9; GORMAN M, 1984, PHYS REV LETT, V52, P2241, DOI 10.1103/PhysRevLett.52.2241; Harris KD, 2011, ARXIV11085685; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hunt BR, 2007, PHYSICA D, V230, P112, DOI 10.1016/j.physd.2006.11.008; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; Jasak H., 2007, INT WORKSH COUPL MET, V1000, P1; Jiang YY, 2003, J HEAT TRANS-T ASME, V125, P612, DOI 10.1115/1.1571846; Kalnay E., 2003, ATMOSPHERIC MODELING, DOI DOI 10.1017/CBO9780511802270; Kalnay E, 2007, TELLUS A, V59, P758, DOI 10.1111/J.1600-0870.2007.00261.X; KELLER JB, 1966, J FLUID MECH, V26, P599, DOI 10.1017/S0022112066001423; Li H, 2009, MON WEATHER REV, V137, P3407, DOI 10.1175/2009MWR2766.1; LORENC AC, 1986, Q J ROY METEOR SOC, V112, P1177, DOI 10.1002/qj.49711247414; Louisos WF, 2013, INT J HEAT MASS TRAN, V61, P565, DOI 10.1016/j.ijheatmasstransfer.2013.02.015; Ott E, 2004, TELLUS A, V56, P415, DOI 10.1111/j.1600-0870.2004.00076.x; Ridouane E, 2010, INT J HEAT MASS TRAN, V53, P76, DOI 10.1016/j.ijheatmasstransfer.2009.10.003; Savely R, 1972, TECHNICAL REPORT; Sornette D, 2006, INT J FORECASTING, V22, P153, DOI 10.1016/j.ijforecast.2005.02.004; Tu J.H., 2013, PREPRINTARXIV; Welander P., 1995, INT GEOPHYS SERIES, P59; Yang SC, 2006, J ATMOS SCI, V63, P2340, DOI 10.1175/JAS3739.1; Yuen PK, 1999, PHYS FLUIDS, V11, P1435, DOI 10.1063/1.870007	34	2	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148134	10.1371/journal.pone.0148134	http://dx.doi.org/10.1371/journal.pone.0148134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849061	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000042
J	Xing, MM; Lv, HH; Ma, J; Xu, DH; Li, HL; Yang, LM; Kang, JG; Wang, XW; Fang, ZY				Xing, Miaomiao; Lv, Honghao; Ma, Jian; Xu, Donghui; Li, Hailong; Yang, Limei; Kang, Jungen; Wang, Xiaowu; Fang, Zhiyuan			Transcriptome Profiling of Resistance to Fusarium oxysporum f. sp conglutinans in Cabbage (Brassica oleracea) Roots	PLOS ONE			English	Article							RNA-SEQ DATA; SALICYLIC-ACID; WILT RESISTANCE; ESSENTIAL COMPONENT; ARABIDOPSIS; GENE; PROTEINS; DEFENSE; IDENTIFICATION; EXPRESSION	Fusarium wilt caused by Fusarium oxysporum f. sp. conglutinans (FOC) is a destructive disease of Brassica crops, which results in severe yield losses. There is little information available about the mechanism of disease resistance. To obtain an overview of the transcriptome profiles in roots of R4P1, a Brassica oleracea variety that is highly resistant to fusarium wilt, we compared the transcriptomes of samples inoculated with FOC and samples inoculated with distilled water. RNA-seq analysis generated more than 136 million 100-bp clean reads, which were assembled into 62,506 unigenes (mean size = 741 bp). Among them, 49,959 (79.92%) genes were identified based on sequence similarity searches, including SwissProt (29,050, 46.47%), Gene Ontology (GO) (33,767, 54.02%), Clusters of Orthologous Groups (KOG) (14,721, 23.55%) and Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG) (12,974, 20.76%) searches; digital gene expression analysis revealed 885 differentially expressed genes (DEGs) between infected and control samples at 4, 12, 24 and 48 hours after inoculation. The DEGs were assigned to 31 KEGG pathways. Early defense systems, including the MAPK signaling pathway, calcium signaling and salicylic acid-mediated hypersensitive response (SA-mediated HR) were activated after pathogen infection. SA-dependent systemic acquired resistance (SAR), ethylene (ET)- and jasmonic (JA)-mediated pathways and the lignin biosynthesis pathway play important roles in plant resistance. We also analyzed the expression of defense-related genes, such as genes encoding pathogenesis-related (PR) proteins, UDP-glycosyltransferase (UDPG), pleiotropic drug resistance, ATP-binding cassette transporters (PDR-ABC transporters), myrosinase, transcription factors and kinases, which were differentially expressed. The results of this study may contribute to efforts to identify and clone candidate genes associated with disease resistance and to uncover the molecular mechanism underlying FOC resistance in cabbage.	[Xing, Miaomiao; Ma, Jian; Li, Hailong; Kang, Jungen] Beijing Acad Agr & Forestry Sci, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Vegetable Res Ctr, Minist Agr, 50 Zhanghua St, Beijing 100097, Peoples R China; [Lv, Honghao; Xu, Donghui; Yang, Limei; Wang, Xiaowu; Fang, Zhiyuan] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr, 12 Zhongguancun Nandajie St, Beijing 100081, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Kang, JG (corresponding author), Beijing Acad Agr & Forestry Sci, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Vegetable Res Ctr, Minist Agr, 50 Zhanghua St, Beijing 100097, Peoples R China.; Wang, XW (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr, 12 Zhongguancun Nandajie St, Beijing 100081, Peoples R China.	kangjungen@nercv.org; wangxiaowu@caas.cn	Wang, Xiaowu/L-2579-2019; Lv, Honghao/AFS-6332-2022	fang, zhi yuan/0000-0003-1664-759X; Lv, Honghao/0000-0003-2635-3042	National Natural Science Foundation of China [31171958]; National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period [2012BAD02B01, 2014BAD01B08]; Beijing Science and Technology Commission Project [Z141105002314020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period; Beijing Science and Technology Commission Project	This work was financially supported by grants from the National Natural Science Foundation of China (31171958), the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (2012BAD02B01, 2014BAD01B08), and the Beijing Science and Technology Commission Project (Z141105002314020).	Agarwal P, 2014, MOL BIOL REP, V41, P599, DOI 10.1007/s11033-013-2897-4; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bernardi R, 2000, FEBS LETT, V467, P296, DOI 10.1016/S0014-5793(00)01179-0; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Blanco F, 2005, PLANT MOL BIOL, V59, P927, DOI 10.1007/s11103-005-2227-x; Capella AN, 2001, PLANTA, V213, P691, DOI 10.1007/s004250100548; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Derckel JP, 1998, PHYSIOL PLANTARUM, V104, P56, DOI 10.1034/j.1399-3054.1998.1040108.x; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jiang Ming, 2011, Scientia Agricultura Sinica, V44, P3053; Kang J, 2010, SCREENING CABBAGE GE, P15; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Leister RT, 2005, PLANT CELL, V17, P1268, DOI 10.1105/tpc.104.029637; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Chun-Yu, 2012, BMC Genomics, V13, P374, DOI 10.1186/1471-2164-13-374; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Liu J, 2009, PLANT SIGNAL BEHAV, V4, P1107, DOI 10.4161/psb.4.12.9944; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lu GY, 2011, EUR J PLANT PATHOL, V131, P585, DOI 10.1007/s10658-011-9833-z; LuHongHao, 2011, Acta Horticulturae Sinica, V38, P875; Lv HH, 2013, MOL BREEDING, V32, P961, DOI 10.1007/s11032-013-9925-x; Lv HH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1094; Lyons R, 2015, PLOS ONE, V10, P1; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; MCGREGOR DI, 1988, CAN J PLANT SCI, V68, P367, DOI 10.4141/cjps88-048; Metraux JP, 2002, EUPHYTICA, V124, P237, DOI 10.1023/A:1015690702313; Migocka M, 2012, PLANT GROWTH REGUL, V67, P171, DOI 10.1007/s10725-012-9674-6; MITHEN RF, 1992, PLANT BREEDING, V108, P60, DOI 10.1111/j.1439-0523.1992.tb00100.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagano AJ, 2008, PLANT CELL PHYSIOL, V49, P969, DOI 10.1093/pcp/pcn075; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Nomura Y., 1976, Journal of the Central Agricultural Experiment Station, P141; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Pu ZJ, 2012, MOL BREEDING, V30, P809, DOI 10.1007/s11032-011-9665-8; Rahmanpour S, 2010, EUR J PLANT PATHOL, V128, P429, DOI 10.1007/s10658-010-9685-y; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Sarwar M, 1998, PLANT SOIL, V201, P103, DOI 10.1023/A:1004381129991; Shang Y, 2009, CHINESE SCI BULL, V54, P3249, DOI 10.1007/s11434-009-0553-0; Shimizu M, 2015, THEOR APPL GENET, V128, P119, DOI 10.1007/s00122-014-2416-6; Singh I, 2012, J BIOSCIENCES, V37, P563, DOI 10.1007/s12038-012-9208-4; Smith E., 1899, SCI AM SUPPL, V48, P19981, DOI DOI 10.1038/SCIENTIFICAMERICAN11181899-19981SUPP; Snyder WC, 1940, AM J BOT, V27, P64, DOI 10.2307/2436688; Song JT, 2006, MOL CELLS, V22, P233; Tian RP, 2009, CHINESE AGR SCI B, V5, P39; Trewavas A, 1999, PLANT PHYSIOL, V120, P1, DOI 10.1104/pp.120.1.1; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vidhyasekaran P., 2015, PLANT HORMONE SIGNAL, P27; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036; 李明远, 2003, [植物保护, Plant Protection], V29, P44	68	30	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148048	10.1371/journal.pone.0148048	http://dx.doi.org/10.1371/journal.pone.0148048			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849436	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000034
J	Hong, K; Xu, G; Grayson, TB; Shalev, A				Hong, Kyunghee; Xu, Guanlan; Grayson, Truman B.; Shalev, Anath			Cytokines Regulate beta-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); cytokine; microRNA (miRNA); pancreatic islet; type 1 diabetes; TXNIP	NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; CARBOHYDRATE RESPONSE ELEMENT; NITRIC-OXIDE; INDUCED APOPTOSIS; OXIDATIVE STRESS; DEATH; GLUCOSE; EXPRESSION; INTERLEUKIN-1-BETA	Thioredoxin-interacting protein (TXNIP) is a key regulator of diabetic beta-cell apoptosis and dysfunction, and TXNIP inhibition prevents diabetes in mouse models of type 1 and type 2 diabetes. Although we have previously shown that TXNIP is strongly induced by glucose, any regulation by the proinflammatory cytokines tumor necrosis factor alpha (TNF alpha), interleukin-1 beta (IL-1 beta), and interferon gamma (IFN gamma) has remained largely unexplored. Moreover, even though this three-cytokine mixture is widely used to mimic type 1 diabetes in vitro, the mechanisms involved are not fully understood. Interestingly, we have now found that this cytokine mixture increases beta-cell TXNIP expression; however, although TNF alpha had no effect, IL-1 beta surprisingly down-regulated TXNIP transcription, whereas IFN gamma increased TXNIP levels in INS-1 beta-cells and primary islets. Human TXNIP promoter analyses and chromatin immunoprecipitation studies revealed that the IL-1 beta effect was mediated by inhibition of carbohydrate response element binding protein activity. In contrast, IFN gamma increased pro-apoptotic TXNIP post-transcriptionally via induction of endoplasmic reticulum stress, activation of inositol-requiring enzyme 1 alpha (IRE1 alpha), and suppression of miR-17, a microRNA that targets and down-regulates TXNIP. In fact, miR-17 knockdown was able to mimic the IFN gamma effects on TXNIP, whereas miR-17 overexpression blunted the cytokine effect. Thus, our results demonstrate for the first time that the proinflammatory cytokines TNF alpha, IL-1 beta, and IFN gamma each have distinct and in part opposing effects on beta-cell TXNIP expression. These findings thereby provide new mechanistic insight into the regulation of TXNIP and beta-cell biology and reveal novel links between proinflammatory cytokines, carbohydrate response element binding protein-mediated transcription, and microRNA signaling.	Univ Alabama Birmingham, Comprehens Diabet Ctr, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shalev, A (corresponding author), Univ Alabama Birmingham, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA.	shalev@uab.edu			National Institutes of Health [R01DK-078752, UC4DK104204]; JDRF [3-SRA-2014-302-M-R]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104204, P30DK079626, R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK-078752 and UC4DK104204. This work was also supported by JDRF Grant 3-SRA-2014-302-M-R. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Allagnat F, 2012, CELL DEATH DIFFER, V19, P1836, DOI 10.1038/cdd.2012.67; Arous C, 2015, J BIOL CHEM, V290, P6653, DOI 10.1074/jbc.M114.611111; Barbu A, 2002, MOL CELL ENDOCRINOL, V190, P75, DOI 10.1016/S0303-7207(02)00009-6; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; da Silva XG, 2006, J LIPID RES, V47, P2482, DOI DOI 10.1194/JLR.M600289-JLR200; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; DEBRAYSACHS M, 1991, J AUTOIMMUN, V4, P237, DOI 10.1016/0896-8411(91)90021-4; Delaney CA, 1997, ENDOCRINOLOGY, V138, P2610, DOI 10.1210/en.138.6.2610; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kanari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059026; Kwon G, 1999, J BIOL CHEM, V274, P18702, DOI 10.1074/jbc.274.26.18702; Laffranchi R, 1997, EXP CELL RES, V237, P217, DOI 10.1006/excr.1997.3791; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Loweth AC, 1998, DIABETES, V47, P727, DOI 10.2337/diabetes.47.5.727; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Masson E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1251, DOI 10.1152/ajpendo.90619.2008; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Pirot P, 2006, DIABETOLOGIA, V49, P1229, DOI 10.1007/s00125-006-0214-7; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rabinovitch A, 2003, REV ENDOCR METAB DIS, V4, P291, DOI 10.1023/A:1025160614313; Shaked M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028804; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Stephens LA, 1999, ENDOCRINOLOGY, V140, P3219, DOI 10.1210/en.140.7.3219; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Wali JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113128; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Xiang RL, 2015, BIOMED ENVIRON SCI, V28, P169, DOI 10.3967/bes2015.023; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhuo DX, 2010, J BIOL CHEM, V285, P31491, DOI 10.1074/jbc.M109.068387	54	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8428	8439		10.1074/jbc.M115.698365	http://dx.doi.org/10.1074/jbc.M115.698365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26858253	Green Published, hybrid			2022-12-26	WOS:000374773200010
J	Ballke, C; Gran, E; Baekkevold, ES; Jahnsen, FL				Ballke, Christina; Gran, Einar; Baekkevold, Espen S.; Jahnsen, Frode L.			Characterization of Regulatory T-Cell Markers in CD4+T Cells of the Upper Airway Mucosa	PLOS ONE			English	Article							ALLERGIC RHINITIS; IN-VIVO; HOMEOSTASIS; HELIOS; CTLA-4	CD4+ T regulatory cells (Tregs) comprise a heterogeneous population of cells the regulate immune responses and prevent autoimmunity. Most reports on human Tregs are derived from studies of peripheral blood, although Tregs mainly exert their functions in the periphery. Here we performed a detailed analysis of Tregs in the human upper airway mucosa under non-inflammatory conditions, and found that 10% of all CD4+ T cells expressed the transcription factor FOXP3 and the memory marker CD45RO, as well as high levels of CTLA-4. The majority of FOXP3+CD4+ T cells co-expressed the transcription factor Helios and produced very little cytokines, compatible with being thymus-derived Tregs. FOXP3 +Helios-CD4+ T cells were more heterogeneous. A mean of 24% produced the immunomodulatory cytokine IL-10, whereas a large fraction also produced IL-2, IFN-mu or IL-17. A significant population (6%) of FOXP3-negative T cells also produced IL-10, usually in combination with IFN-mu. Together, we found that CD4+ T cells in the upper airways differed functionally from their counterparts in peripheral blood, including higher expression of IL-10. Moreover, our findings suggest that several subsets of CD4+ T cells with functionally distinct regulatory properties reside in the upper airway mucosa which should be taken into account when targeting Tregs for therapy.	[Ballke, Christina; Baekkevold, Espen S.; Jahnsen, Frode L.] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Ballke, Christina; Baekkevold, Espen S.; Jahnsen, Frode L.] Univ Oslo, Oslo, Norway; [Gran, Einar] Lovisenberg Diakonale Hosp, Dept Otorhinolaryngol, Oslo, Norway	University of Oslo; University of Oslo	Baekkevold, ES; Jahnsen, FL (corresponding author), Oslo Univ Hosp, Dept Pathol, Oslo, Norway.; Baekkevold, ES; Jahnsen, FL (corresponding author), Univ Oslo, Oslo, Norway.	esbaekke@rr-research.no; fjahnsen@rr-research.no			Research Council of Norway through its Centers of Excellence funding scheme [179573]; South Eastern Norway Regional Health Authority [1012105]	Research Council of Norway through its Centers of Excellence funding scheme; South Eastern Norway Regional Health Authority	This work was partly supported by the Research Council of Norway through its Centers of Excellence funding scheme, project number 179573, and grants from the South Eastern Norway Regional Health Authority, project number 1012105.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Chen JZ, 2009, J LEUKOCYTE BIOL, V86, P1305, DOI 10.1189/jlb.0609406; Cosmi L, 2006, CLIN EXP ALLERGY, V36, P261, DOI 10.1111/j.1365-2222.2006.02429.x; Danilova E, 2015, MUCOSAL IMMUNOL, V8, P107, DOI 10.1038/mi.2014.46; Do JS, 2016, MUCOSAL IMMUNOL, V9, P137, DOI 10.1038/mi.2015.45; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kim YC, 2012, BLOOD, V119, P2810, DOI 10.1182/blood-2011-09-377895; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Lord JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136485; Mercer F, 2014, J IMMUNOL, V193, P1047, DOI 10.4049/jimmunol.1302936; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Skrindo I, 2015, CLIN EXP ALLERGY, V45, P1296, DOI 10.1111/cea.12543; Skrindo I, 2011, CLIN EXP ALLERGY, V41, P954, DOI 10.1111/j.1365-2222.2011.03710.x; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	36	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148826	10.1371/journal.pone.0148826	http://dx.doi.org/10.1371/journal.pone.0148826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866695	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700041
J	Kimura, Y; Soma, T; Kasahara, N; Delobel, D; Hanami, T; Tanaka, Y; de Hoon, MJL; Hayashizaki, Y; Usui, K; Harbers, M				Kimura, Yasumasa; Soma, Takahiro; Kasahara, Naoko; Delobel, Diane; Hanami, Takeshi; Tanaka, Yuki; de Hoon, Michiel J. L.; Hayashizaki, Yoshihide; Usui, Kengo; Harbers, Matthias			Edesign: Primer and Enhanced Internal Probe Design Tool for Quantitative PCR Experiments and Genotyping Assays	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; THIAZOLE ORANGE; DNA; FLUORESCENCE; THERMODYNAMICS; MUTATIONS	Analytical PCR experiments preferably use internal probes for monitoring the amplification reaction and specific detection of the amplicon. Such internal probes have to be designed in close context with the amplification primers, and may require additional considerations for the detection of genetic variations. Here we describe Edesign, a new online and standalone tool for designing sets of PCR primers together with an internal probe for conducting quantitative real-time PCR (qPCR) and genotypic experiments. Edesign can be used for selecting standard DNA oligonucleotides like for instance TaqMan probes, but has been further extended with new functions and enhanced design features for Eprobes. Eprobes, with their single thiazole orange-labelled nucleotide, allow for highly sensitive genotypic assays because of their higher DNA binding affinity as compared to standard DNA oligonucleotides. Using new thermodynamic parameters, Edesign considers unique features of Eprobes during primer and probe design for establishing qPCR experiments and genotyping by melting curve analysis. Additional functions in Edesign allow probe design for effective discrimination between wild-type sequences and genetic variations either using standard DNA oligonucleotides or Eprobes. Edesign can be freely accessed online at http://www.dnaform.com/edesign2/, and the source code is available for download.	[Kimura, Yasumasa] KK DNAFORM, Tsurumi Ku, 75-1 Ono Cho, Yokohama, Kanagawa 2300046, Japan; [Kimura, Yasumasa; Soma, Takahiro; Delobel, Diane; Hanami, Takeshi; Tanaka, Yuki; de Hoon, Michiel J. L.; Usui, Kengo; Harbers, Matthias] RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Kasahara, Naoko] RIKEN Om Sci Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Hayashizaki, Yoshihide; Usui, Kengo] RIKEN Prevent Med & Diag Innovat Program, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Kimura, Yasumasa] Univ Tokyo, Inst Med Sci, Div Syst Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Kasahara, Naoko] Tohoku Univ, Tohoku Med Megabank Org, Dept Bioclin Informat, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan	RIKEN; RIKEN; RIKEN; University of Tokyo; Tohoku University	Kimura, Y (corresponding author), KK DNAFORM, Tsurumi Ku, 75-1 Ono Cho, Yokohama, Kanagawa 2300046, Japan.; Kimura, Y; Harbers, M (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Kimura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Syst Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	y.kimura.sc@gmail.com; matthias.harbers@riken.jp	TANAKA, Yuki/AAE-4497-2019; Delobel, Diane/C-4152-2017; Hanami, Takeshi/C-3653-2017; Hayashizaki, Yoshihide/N-6590-2015	Delobel, Diane/0000-0002-1644-1228; Hanami, Takeshi/0000-0003-1868-1409; Harbers, Matthias/0000-0002-5613-7220; de Hoon, Michiel/0000-0003-0489-2352	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program; K.K. DNAFORM	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program; K.K. DNAFORM	This work was supported by (1) research grants for RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to YH, (2) a research grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program to YH, and (3) a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Partial funding was also provided by K.K. DNAFORM. The funder provided support in the form of salaries for authors [YK, MH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alvarez-Fernandez R, 2013, METHOD ENZYMOL, V529, P1, DOI 10.1016/B978-0-12-418687-3.00001-X; Atsumi J, 2015, ONCOL REP, V33, P2719, DOI 10.3892/or.2015.3883; Caplin BE, 1999, BIOCHEMICA, P2; Davis AR, 2010, BIOCHEMISTRY-US, V49, P8669, DOI 10.1021/bi100146z; Didenko VV, 2001, BIOTECHNIQUES, V31, P1106, DOI 10.2144/01315rv02; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Ikeda S, 2008, BIOCONJUGATE CHEM, V19, P1719, DOI 10.1021/bc800201m; Ikeda S, 2008, CHEM-ASIAN J, V3, P958, DOI 10.1002/asia.200800014; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kimura Y, 2012, BIOCHEMISTRY-US, V51, P6056, DOI 10.1021/bi300293d; LEE LG, 1986, CYTOMETRY, V7, P508, DOI 10.1002/cyto.990070603; Liu YP, 2014, SCI REP-UK, V4, DOI 10.1038/srep07521; Mann T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp443; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McTigue PM, 2004, BIOCHEMISTRY-US, V43, P5388, DOI 10.1021/bi035976d; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Naiser T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-509; Okamoto A, 2011, CHEM SOC REV, V40, P5815, DOI 10.1039/c1cs15025a; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rozen S, 2000, Methods Mol Biol, V132, P365; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SantaLucia John Jr., 2007, V402, P3; SPIELMANN HP, 1995, BIOCHEMISTRY-US, V34, P8542, DOI 10.1021/bi00027a004; Sugizaki K, 2010, BIOCONJUGATE CHEM, V21, P2276, DOI 10.1021/bc1002949; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	34	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146950	10.1371/journal.pone.0146950	http://dx.doi.org/10.1371/journal.pone.0146950			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863543	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600014
J	Koo, HJ; Lee, M; Kim, J; Woo, CW; Jeong, SY; Choi, EK; Kim, N; Lee, JS				Koo, Hyun Jung; Lee, Myoungsun; Kim, Jin; Woo, Chul Woong; Jeong, Seong-Yun; Choi, Eun Kyung; Kim, Namkug; Lee, Jin Seong			Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging	PLOS ONE			English	Article							IONIZING-RADIATION; GROWTH-FACTOR; TUMOR MICROCIRCULATION; ANTIANGIOGENIC THERAPY; RECTAL-CARCINOMA; CANCER; PERFUSION; INHIBITION; CHEMOTHERAPY; ANGIOSTATIN	Purpose We assessed the effects of anti-angiogenic therapy (AAT) on radiation therapy (RT), evaluating the tumor growth and perfusion patterns on dynamic contrast enhanced MR (DCE-MR) images. Methods Thirteen nude mice with heterotopic xenograft cancer of human lung cancer cell line were used. To observe the interval change of the tumor size and demonstrate the time-signal intensity enhancement curve of the tumor, the mice were subdivided into four groups: control (n = 2), AAT (n = 2), RT (n = 5), and combined therapy (AART, n = 4). DCE-MR images were taken four weeks after treatment. Perfusion parameters were obtained based on the Brix model. To compare the interval size changes in the RT group with those in the AART group, repeated measures ANOVA was used. Perfusion parameters in both the RT and AART groups were compared using a Mann-Whitney U test. Results Tumor growth was more suppressed in AART group than in the other groups. Control group showed the rapid wash-in and wash-out pattern on DCE-MR images. In contrast to RT group with delayed and prolonged enhancement, both AAT and AART groups showed the rapid wash-in and plateau pattern. The signal intensity in the plateau/time to peak enhancement (P<0.016) and the maximum enhancement ratio (P<0.016) of AART group were higher than those of RT group. Conclusions AART showed synergistic effects in anticancer treatment. The pattern of the time-intensity curve on the DCE-MR images in each group implies that AAT might help maintain the perfusion in the cancer of AART group.	[Koo, Hyun Jung; Lee, Myoungsun; Kim, Jin; Kim, Namkug; Lee, Jin Seong] Univ Ulsan, Res Inst Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea; [Koo, Hyun Jung; Lee, Myoungsun; Kim, Jin; Kim, Namkug; Lee, Jin Seong] Univ Ulsan, Dept Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea; [Lee, Myoungsun; Kim, Jin; Woo, Chul Woong; Jeong, Seong-Yun] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Choi, Eun Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea	University of Ulsan; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Lee, JS (corresponding author), Univ Ulsan, Res Inst Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea.; Lee, JS (corresponding author), Univ Ulsan, Dept Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea.	jslee@amc.seoul.kr	Kim, Namkug/E-3843-2012	Kim, Namkug/0000-0002-3438-2217; Koo, Hyun Jung/0000-0001-5640-3835	Korean Health Technology R&D Project of the Ministry of Health & Welfare of the Republic of Korea [HI10C2014]	Korean Health Technology R&D Project of the Ministry of Health & Welfare of the Republic of Korea	This study was supported by a grant (HI10C2014) of the Korean Health Technology R&D Project of the Ministry of Health & Welfare of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisik MF, 2010, RADIOLOGY, V256, P441, DOI 10.1148/radiol.10091733; Barentsz JO, 1998, RADIOLOGY, V207, P791, DOI 10.1148/radiology.207.3.9609906; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; BUCKLEY DL, 1994, MAGNET RESON MED, V32, P646, DOI 10.1002/mrm.1910320514; de Vries A, 2000, RADIOLOGY, V217, P385, DOI 10.1148/radiology.217.2.r00nv02385; Deplanque G, 2000, EUR J CANCER, V36, P1713, DOI 10.1016/S0959-8049(00)00149-0; DeVries AF, 2001, CANCER RES, V61, P2513; Galbraith SM, 2003, J CLIN ONCOL, V21, P2831, DOI 10.1200/JCO.2003.05.187; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Gorski DH, 1999, CANCER RES, V59, P3374; Gorski DH, 1998, CANCER RES, V58, P5686; Griffin RJ, 2002, CANCER RES, V62, P1702; Juan CJ, 2009, EUR RADIOL, V19, P94, DOI 10.1007/s00330-008-1104-9; Knopp M V, 1994, Magn Reson Imaging Clin N Am, V2, P633; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Lee CG, 2000, CANCER RES, V60, P5565; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Mauceri HJ, 1996, CANCER RES, V56, P4311; Maxwell RJ, 2002, NMR BIOMED, V15, P89, DOI 10.1002/nbm.754; Mayr NA, 2000, J MAGN RESON IMAGING, V12, P1027, DOI 10.1002/1522-2586(200012)12:6<1027::AID-JMRI31>3.0.CO;2-5; Morgan B, 2003, J CLIN ONCOL, V21, P3955, DOI 10.1200/JCO.2003.08.092; Nielsen DL, 2012, EXPERT OPIN BIOL TH, V12, P795, DOI 10.1517/14712598.2012.679655; Padhani AR, 2005, ABDOM IMAGING, V30, P324, DOI 10.1007/s00261-004-0265-5; Reddick WE, 1999, JMRI-J MAGN RESON IM, V10, P277, DOI 10.1002/(SICI)1522-2586(199909)10:3<277::AID-JMRI8>3.0.CO;2-S; Rodjan F, 2012, AM J NEURORADIOL, V7, P7; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Teicher BA, 1998, ANTICANCER RES, V18, P2567; Thukral A, 2007, RADIOLOGY, V244, P727, DOI 10.1148/radiol.2443060926; Timke C, 2008, CLIN CANCER RES, V14, P2210, DOI 10.1158/1078-0432.CCR-07-1893; VANDERWOUDE HJ, 1995, AM J ROENTGENOL, V165, P593, DOI 10.2214/ajr.165.3.7645476; Wachsberger P, 2003, CLIN CANCER RES, V9, P1957; Wang J, 2004, AM J ROENTGENOL, V183, P713, DOI 10.2214/ajr.183.3.1830713; Yoo DS, 2012, CLIN CANCER RES, V18, P1404, DOI 10.1158/1078-0432.CCR-11-1982	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148784	10.1371/journal.pone.0148784	http://dx.doi.org/10.1371/journal.pone.0148784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862906	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600107
J	Martinez, C; Chavarria, C; Sharpe, DMT; De Leon, LF				Martinez, Celestino; Chavarria, Carmen; Sharpe, Diana M. T.; De Leon, Luis Fernando			Low Predictability of Colour Polymorphism in Introduced Guppy (Poecilia reticulata) Populations in Panama	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; MALE PREDATION RISK; FEMALE MATE CHOICE; TRINIDADIAN GUPPIES; SEXUAL SELECTION; MATING PREFERENCES; RAPID EVOLUTION; PHENOTYPIC VARIATION; GEOGRAPHIC-VARIATION; ADAPTIVE EVOLUTION	Colour polymorphism is a recurrent feature of natural populations, and its maintenance has been studied in a range of taxa in their native ranges. However, less is known about whether (and how) colour polymorphism is maintained when populations are removed from their native environments, as in the case of introduced species. We here address this issue by analyzing variation in colour patterns in recently-discovered introduced populations of the guppy (Poecilia reticulata) in Panama. Specifically, we use classic colour analysis to estimate variation in the number and the relative area of different colour spots across low predation sites in the introduced Panamanian range of the species. We then compare this variation to that found in the native range of the species under low-and high predation regimes. We found aspects of the colour pattern that were both consistent and inconsistent with the classical paradigm of colour evolution in guppies. On one hand, the same colours that dominated in native populations (orange, iridescent and black) were also the most dominant in the introduced populations in Panama. On the other, there were no clear differences between either introduced-low and native low-and high predation populations. Our results are therefore only partially consistent with the traditional role of female preference in the absence of predators, and suggest that additional factors could influence colour patterns when populations are removed from their native environments. Future research on the interaction between female preference and environmental variability (e.g. multifarious selection), could help understand adaptive variation in this widely-introduced species, and the contexts under which variation in adaptive traits parallels (or not) variation in the native range.	[Martinez, Celestino; Chavarria, Carmen; De Leon, Luis Fernando] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama; [Sharpe, Diana M. T.] McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada	Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); McGill University	De Leon, LF (corresponding author), Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama.	luis.deleonreyna@gmail.com	De León, Luis/H-1112-2011	De León, Luis/0000-0001-9317-420X	Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama) [ITE12-002]; Sistema Nacional de Investigacion (SNI); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FRQNT, Canada)	Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama); Sistema Nacional de Investigacion (SNI); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FRQNT, Canada)	Funding was provided by the Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama), in the form of a Grant No. ITE12-002 to LFD. LFD and DMTS were supported by the Sistema Nacional de Investigacion (SNI). DMTS was also supported by a post-doctoral fellowship from The Fonds Quebecois de la Recherche sur la Nature et les Technologies (FRQNT, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey RM, 1963, POECILIID FISHES CYP, V126, P1; Blows MW, 2003, EVOLUTION, V57, P1622, DOI 10.1111/j.0014-3820.2003.tb00369.x; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; BREDEN F, 1987, NATURE, V329, P831, DOI 10.1038/329831a0; BROOKS R, 1995, ANIM BEHAV, V50, P301, DOI 10.1006/anbe.1995.0246; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Brooks R, 1999, AM NAT, V154, P37, DOI 10.1086/303219; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; Deacon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024416; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Easty LK, 2011, ANIM BEHAV, V82, P1085, DOI 10.1016/j.anbehav.2011.08.001; Egea-Serrano A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3266; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; FARR JA, 1977, EVOLUTION, V31, P162, DOI 10.1111/j.1558-5646.1977.tb00993.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Godin JGJ, 2005, ANIM BEHAV, V69, P999, DOI 10.1016/j.anbehav.2004.07.016; Godin JGJ, 2003, BEHAV ECOL, V14, P194, DOI 10.1093/beheco/14.2.194; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Gonzalez L, 2004, THESIS U PANAMA; Gordon SP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1244; Gotanda KM, 2013, OECOLOGIA, V172, P155, DOI 10.1007/s00442-012-2485-7; Gotanda KM, 2014, USING ADAPTIVE TRAIT, P108; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Gray SM, 2011, CAN J FISH AQUAT SCI, V68, P330, DOI 10.1139/F10-151; Grether GF, 2004, P ROY SOC B-BIOL SCI, V271, P45, DOI 10.1098/rspb.2003.2526; Grether GF, 2001, ECOLOGY, V82, P1546, DOI 10.1890/0012-9658(2001)082[1546:RFCCRA]2.0.CO;2; Hall M, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-1; Haskins C. P., 1961, POLYMORPHISM POPULAT; Hedrick PW, 2001, MOL ECOL, V10, P851, DOI 10.1046/j.1365-294X.2001.01243.x; Hendry AP, 2013, EVOL ECOL RES, V15, P111; Hildebrand S. F., 1938, Field Museum Publications Chicago Zoological Series, V22, P219; HOAGLAND KE, 1977, BIOL BULL, V152, P360, DOI 10.2307/1540424; Hoopes M.F., 2009, INVASION ECOLOGY, Vsecond; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; HOUDE AE, 1990, SCIENCE, V248, P1405, DOI 10.1126/science.248.4961.1405; Houde AE, 1997, ANIM BEHAV, V53, P343, DOI 10.1006/anbe.1996.0399; Hudon J, 2003, PHYSIOL BIOCHEM ZOOL, V76, P776, DOI 10.1086/378138; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Hugall AF, 2012, NATURE, V485, P631, DOI 10.1038/nature11050; Hughes KA, 2013, NATURE, V503, P108, DOI 10.1038/nature12717; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Karim N, 2007, J EVOLUTION BIOL, V20, P1339, DOI 10.1111/j.1420-9101.2007.01350.x; Kelehear C, 2012, ECOL LETT, V15, P329, DOI 10.1111/j.1461-0248.2012.01742.x; Kemp DJ, 2009, P ROY SOC B-BIOL SCI, V276, P4335, DOI 10.1098/rspb.2009.1226; Kemp DJ, 2008, BIOL J LINN SOC, V95, P734, DOI 10.1111/j.1095-8312.2008.01112.x; Kettlewell B, 1973, EVOLUTION MELANISM S; Kiritome A, 2012, ICHTHYOL RES, V59, P304, DOI 10.1007/s10228-012-0287-x; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kodric-Brown A, 2001, BEHAV ECOL SOCIOBIOL, V50, P346, DOI 10.1007/s002650100374; Kolbe JJ, 2012, SCIENCE, V335, P1086, DOI 10.1126/science.1209566; Kordric-Brown A, 1985, BEHAV ECOL SOCIOBIOL, V25, P393; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lindholm A, 2002, AM NAT, V160, pS214, DOI 10.1086/342898; Lindholm AK, 2014, J EVOLUTION BIOL, V27, P437, DOI 10.1111/jeb.12313; Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Loftin H., 1965, THESIS FLORIDA STATE; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Millar NP, 2012, ENVIRON BIOL FISH, V94, P513, DOI 10.1007/s10641-011-9801-7; Millar NP, 2006, OIKOS, V113, P1; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MULLER F, 1879, P ENTOMOL SOC LOND, pR20; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1111/j.0014-3820.2002.tb01388.x; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Poulton EB, 1890, THE COLOURS OF ANIMA, DOI [10.5962/bhl.title.11353, DOI 10.5962/BHL.TITLE.11353]; Price AC, 2008, ZEBRAFISH, V5, P297, DOI 10.1089/zeb.2008.0551; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; ROBISSON P, 1993, ETHOLOGY, V94, P279; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Ruell EW, 2013, P R SOC B, V280, P2012, DOI DOI 10.1098/RSPB.2012.2019; Schwartz AK, 2010, FUNCT ECOL, V24, P354, DOI 10.1111/j.1365-2435.2009.01652.x; STONER G, 1988, BEHAV ECOL SOCIOBIOL, V22, P285, DOI 10.1007/BF00299844; Team R. D. C, 2011, R LANG ENV STAT COMP; Templeton CN, 2004, BEHAV ECOL, V15, P673, DOI 10.1093/beheco/arh065; Torres-Dowdall J, 2012, EVOLUTION, V66, P3432, DOI 10.1111/j.1558-5646.2012.01694.x; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Vega AJ, 2006, TECNOCIENCIA, V8, P87; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; WINGE O, 1947, HEREDITY, V1, P65, DOI 10.1038/hdy.1947.4; Winge O, 1922, J GENET, V12, P145, DOI 10.1007/BF02983078; ZARET TM, 1971, ECOLOGY, V52, P336, DOI 10.2307/1934593	89	3	3	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148040	10.1371/journal.pone.0148040	http://dx.doi.org/10.1371/journal.pone.0148040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863538	Green Submitted, gold, Green Published			2022-12-26	WOS:000370046600041
J	Prothmann, M; von Knobelsdorff-Brenkenhoff, F; Topper, A; Dieringer, MA; Shahid, E; Graessl, A; Rieger, J; Lysiak, D; Thalhammer, C; Huelnhagen, T; Kellman, P; Niendorf, T; Schulz-Menger, J				Prothmann, Marcel; von Knobelsdorff-Brenkenhoff, Florian; Toepper, Agnieszka; Dieringer, Matthias A.; Shahid, Etham; Graessl, Andreas; Rieger, Jan; Lysiak, Darius; Thalhammer, C.; Huelnhagen, Till; Kellman, Peter; Niendorf, Thoralf; Schulz-Menger, Jeanette			High Spatial Resolution Cardiovascular Magnetic Resonance at 7.0 Tesla in Patients with Hypertrophic Cardiomyopathy - First Experiences: Lesson Learned from 7.0 Tesla	PLOS ONE			English	Article							MYOCARDIAL CRYPTS; TASK-FORCE; PREVALENCE; DIAGNOSIS; FIBROSIS; DISEASE; DESIGN	Background Cardiovascular Magnetic Resonance (CMR) provides valuable information in patients with hypertrophic cardiomyopathy (HCM) based on myocardial tissue differentiation and the detection of small morphological details. CMR at 7.0T improves spatial resolution versus today's clinical protocols. This capability is as yet untapped in HCM patients. We aimed to examine the feasibility of CMR at 7.0T in HCM patients and to demonstrate its capability for the visualization of subtle morphological details. Methods We screened 131 patients with HCM. 13 patients (9 males, 56 +/- 31 years) and 13 healthy age-and gender-matched subjects (9 males, 55 +/- 31years) underwent CMR at 7.0T and 3.0T (Siemens, Erlangen, Germany). For the assessment of cardiac function and morphology, 2D CINE imaging was performed (voxel size at 7.0T: (1.4x1.4x2.5) mm(3) and (1.4x1.4x4.0) mm(3); at 3.0T: (1.8x1.8x6.0) mm(3)). Late gadolinium enhancement (LGE) was performed at 3.0T for detection of fibrosis. Results All scans were successful and evaluable. At 3.0T, quantification of the left ventricle (LV) showed similar results in short axis view vs. the biplane approach (LVEDV, LVESV, LVMASS, LVEF) (p = 0.286; p = 0.534; p = 0.155; p = 0.131). The LV-parameters obtained at 7.0T where in accordance with the 3.0T data (p(LVEDV) = 0.110; p(LVESV) = 0.091; p(LVMASS) = 0.131; p(LVEF) = 0.182). LGE was detectable in 12/13 (92%) of the HCM patients. High spatial resolution CINE imaging at 7.0T revealed hyperintense regions, identifying myocardial crypts in 7/13 (54%) of the HCM patients. All crypts were located in the LGE-positive regions. The crypts were not detectable at 3.0T using a clinical protocol. Conclusions CMR at 7.0T is feasible in patients with HCM. High spatial resolution gradient echo 2D CINE imaging at 7.0T allowed the detection of subtle morphological details in regions of extended hypertrophy and LGE.	[Prothmann, Marcel; von Knobelsdorff-Brenkenhoff, Florian; Toepper, Agnieszka; Dieringer, Matthias A.; Shahid, Etham; Graessl, Andreas; Lysiak, Darius; Thalhammer, C.; Huelnhagen, Till; Niendorf, Thoralf; Schulz-Menger, Jeanette] Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany; [Prothmann, Marcel; von Knobelsdorff-Brenkenhoff, Florian; Toepper, Agnieszka; Dieringer, Matthias A.; Shahid, Etham; Schulz-Menger, Jeanette] Expt & Clin Res Ctr, Working Grp Cardiovasc Magnet Resonance, Berlin, Germany; [Prothmann, Marcel; von Knobelsdorff-Brenkenhoff, Florian; Toepper, Agnieszka; Dieringer, Matthias A.; Shahid, Etham; Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany; [Rieger, Jan; Lysiak, Darius; Niendorf, Thoralf] MRI TOOLS GmbH, Berlin, Germany; [Kellman, Peter] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Niendorf, Thoralf; Schulz-Menger, Jeanette] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helios Kliniken; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); German Centre for Cardiovascular Research	Schulz-Menger, J (corresponding author), Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany.; Schulz-Menger, J (corresponding author), Expt & Clin Res Ctr, Working Grp Cardiovasc Magnet Resonance, Berlin, Germany.; Schulz-Menger, J (corresponding author), HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany.; Schulz-Menger, J (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	Jeanette.Schulz-Menger@charite.de		Schulz-Menger, Jeanette/0000-0003-3100-1092; Huelnhagen, Till/0000-0002-6755-2171	Charite	Charite	The study was supported by university funds (Charite) hold by Prof. Dr. med. Jeanette Schulz Menger. Thoralf Niendorf is founder and CEO of MRI. TOOLS GmbH, Berlin, Germany. Jan Rieger is founder and CTO of MRI. TOOLS GmbH, Berlin, Germany. Darius Lysiak is currently employee of MRI. TOOLS GmbH, Berlin, Germany. MRI. TOOLS GmbH provided support in the form of salaries for authors Jan Rieger and Darius Lysiak, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Brouwer WP, 2012, EUR HEART J-CARD IMG, V13, P292, DOI 10.1093/ehjci/jes005; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Child N, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0066-0; Commission IE, 2013, 60601233 IEC; Deva DP, 2013, RADIOLOGY, V269, P68, DOI 10.1148/radiol.13122344; Elliott PM, 2014, EUR HEART J; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Graessl A, 2014, MAGN RESON MED, V72, P276, DOI 10.1002/mrm.24903; Hezel F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052324; Kellman P, 2009, MAGN RESON MED, V61, P215, DOI 10.1002/mrm.21657; Klix S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117095; Kramer CM, 2015, AM HEART J, V170, P223, DOI 10.1016/j.ahj.2015.05.013; KURIBAYASHI T, 1992, AM J CARDIOL, V70, P1333, DOI 10.1016/0002-9149(92)90771-P; Mainero C, 2009, NEUROLOGY, V73, P941, DOI 10.1212/WNL.0b013e3181b64bf7; Maron MS, 2012, CIRC-CARDIOVASC IMAG, V5, P441, DOI 10.1161/CIRCIMAGING.112.972760; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Petryka J, 2014, CIRC-CARDIOVASC IMAG, V7, P259, DOI 10.1161/CIRCIMAGING.113.001241; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Rudolph A, 2009, J AM COLL CARDIOL, V53, P284, DOI 10.1016/j.jacc.2008.08.064; Santoro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049963; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Sinnecker T, 2012, ARCH NEUROL-CHICAGO, V69, P739, DOI 10.1001/archneurol.2011.2450; Thalhammer C, 2012, J MAGN RESON IMAGING, V36, P847, DOI 10.1002/jmri.23724; van Elderen SGC, 2009, MAGN RESON MED, V62, P1379, DOI 10.1002/mrm.22168; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-23; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-53; von Knobelsdorff-Brenkenhoff F, 2010, EUR RADIOL, V20, P2844, DOI 10.1007/s00330-010-1888-2; Winter L, 2015, MAGN RESON MED, V74, P999, DOI 10.1002/mrm.25483	31	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148066	10.1371/journal.pone.0148066	http://dx.doi.org/10.1371/journal.pone.0148066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863618	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000370046600042
J	Gong, HX; Zhang, KB; Wu, LM; Baigorri, BF; Yin, Y; Geng, XC; Xu, JR; Zhu, J				Gong, Hong-xia; Zhang, Ke-bei; Wu, Lian-ming; Baigorri, Brian F.; Yin, Yan; Geng, Xiao-chuan; Xu, Jian-Rong; Zhu, Jiong			Dual Energy Spectral CT Imaging for Colorectal Cancer Grading: A Preliminary Study	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; COMPUTED-TOMOGRAPHY; LIVER METASTASES; BREAST-LESIONS; COLON-CANCER; CARCINOMA; INVOLVEMENT; RECURRENCE; STRATEGIES; ONCOLOGY	Objectives To assess the diagnostic value of dual energy spectral CT imaging for colorectal cancer grading using the quantitative iodine density measurements in both arterial phase (AP) and venous phase (VP). Methods 81 colorectal cancer patients were divided into two groups based on their pathological findings: a low grade group including well (n = 13) and moderately differentiated cancer (n = 24), and a high grade group including poorly differentiated (n = 42) and signet ring cell cancer (n = 2). Iodine density (ID) in the lesions was derived from the iodine-based material decomposition (MD) image and normalized to that in the psoas muscle to obtain normalized iodine density (NID). The difference in ID and NID between AP and VP was calculated. Results The ID and NID values of the low grade cancer group were, 14.65 +/- 3.38mg/mL and 1.70 +/- 0.33 in AP, and 21.90 +/- 3.11mg/mL and 2.05 +/- 0.32 in VP, respectively. The ID and NID values for the high grade cancer group were 20.63 +/- 3.72mg/mL and 2.95 +/- 0.72 in AP, and 26.27 +/- 3.10mg/mL and 3.51 +/- 1.12 in VP, respectively. There was significant difference for ID and NID between the low grade and high grade cancer groups in both AP and VP (all p< 0.001). ROC analysis indicated that NID of 1.92 in AP provided 70.3% sensitivity and 97.7% specificity in differentiating low grade cancer from high grade cancer. Conclusions The quantitative measurement of iodine density in AP and VP can provide useful information to differentiate low grade colorectal cancer from high grade colorectal cancer with NID in AP providing the greatest diagnostic value.	[Gong, Hong-xia; Zhang, Ke-bei; Wu, Lian-ming; Yin, Yan; Geng, Xiao-chuan; Xu, Jian-Rong; Zhu, Jiong] Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Renji Hosp, Shanghai 200127, Peoples R China; [Baigorri, Brian F.] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27516 USA	Shanghai Jiao Tong University; University of North Carolina; University of North Carolina Chapel Hill	Xu, JR; Zhu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Renji Hosp, Shanghai 200127, Peoples R China.	xujianr@yeah.net; jiongzhurenji@126.com			National Basic Research Program of China [2012CB932600]; Shanghai Leading Academic Discipline Project [S30203]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This study was supported by the National Basic Research Program of China (no. 2012CB932600) and Shanghai Leading Academic Discipline Project (no. S30203).; Thanks for Dr. Li Jianying's technical support in understanding spectral CT imaging and in editing the manuscript. This study was supported by the National Basic Research Program of China (no. 2012CB932600) and Shanghai Leading Academic Discipline Project (no. S30203).	Ahsan H, 1998, ANN INTERN MED, V128, P900, DOI 10.7326/0003-4819-128-11-199806010-00006; Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; BOSSI P, 1995, CANCER RES, V55, P5049; Choi HJ, 1998, ONCOLOGY-BASEL, V55, P575, DOI 10.1159/000011915; Diculescu Mircea, 2002, Rom J Gastroenterol, V11, P183; Elmas N, 2002, EUR J RADIOL, V42, P206, DOI 10.1016/S0720-048X(02)00036-0; Engel CJ, 1996, AM J SURG PATHOL, V20, P1260, DOI 10.1097/00000478-199610000-00012; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Furman-Haran E, 2005, CANCER-AM CANCER SOC, V104, P708, DOI 10.1002/cncr.21225; Geyer LL, 2012, EUR J RADIOL, V81, P3711, DOI 10.1016/j.ejrad.2011.02.043; Gollub MJ, 2007, RADIOL CLIN N AM, V45, P85, DOI 10.1016/j.rcl.2006.10.003; Hamilton SR, 2000, WHO CLASSIFICATION T; Hayashi M, 1999, AM J ROENTGENOL, V172, P969, DOI 10.2214/ajr.172.4.10587130; Hugh TJ, 1997, SURG ONCOL, V6, P19, DOI 10.1016/S0960-7404(97)00002-9; Iyer RB, 2002, AM J ROENTGENOL, V179, P3, DOI 10.2214/ajr.179.1.1790003; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Lennon AM, 2003, AM J CLIN PATHOL, V119, P108, DOI 10.1309/J6BDTWM2M792TN2V; Li M, 2012, INVEST RADIOL, V47, P58, DOI 10.1097/RLI.0b013e318229fef3; Maruyama M, 2014, ACTA RADIOL; Paparo F, 2013, EUR J RADIOL, V82, pE1, DOI 10.1016/j.ejrad.2012.08.021; Poston GJ, 2004, SURG ONCOL, V13, P125, DOI 10.1016/j.suronc.2004.08.001; SACLARIDES TJ, 1994, DIS COLON RECTUM, V37, P921, DOI 10.1007/BF02052599; Smith NJ, 2007, BRIT J CANCER, V96, P1030, DOI 10.1038/sj.bjc.6603646; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; Soyer P, 2012, ABDOM IMAGING, V37, P1092, DOI 10.1007/s00261-012-9844-z; Teifke A, 2006, RADIOLOGY, V239, P351, DOI 10.1148/radiol.2392050205; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Wang Zhong-qiu, 2003, Zhonghua Yi Xue Za Zhi, V83, P1882; Zerhouni EA, 1996, RADIOLOGY, V200, P443, DOI 10.1148/radiology.200.2.8685340	29	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147756	10.1371/journal.pone.0147756	http://dx.doi.org/10.1371/journal.pone.0147756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859405	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400013
J	Mortensen, JL; Reed, JM				Mortensen, Jennifer L.; Reed, J. Michael			Population Viability and Vital Rate Sensitivity of an Endangered Avian Cooperative Breeder, the White-Breasted Thrasher (Ramphocinclus brachyurus)	PLOS ONE			English	Article							RED-COCKADED WOODPECKERS; LIFE-HISTORY TRAITS; SIMULATION-MODEL; DYNAMICS; SURVIVAL; DISPERSAL; CONSEQUENCES; PREDICTIONS; DEMOGRAPHY; LANDSCAPE	Social behaviors can significantly affect population viability, and some behaviors might reduce extinction risk. We used population viability analysis to evaluate effects of past and proposed habitat loss on the White-breasted Thrasher (Ramphocinclus brachyurus), a cooperatively breeding songbird with a global population size of <2000 individuals. We used an individual-based approach to build the first demographic population projection model for this endangered species, parameterizing the model with data from eight years of field study before and after habitat loss within the stronghold of the species' distribution. The recent habitat loss resulted in an approximately 18% predicted decline in population size; this estimate was mirrored by a separate assessment using occupancy data. When mortality rates remained close to the pre-habitat loss estimate, quasi-extinction probability was low under extant habitat area, but increased with habitat loss expected after current plans for resort construction are completed. Post-habitat loss mortality rate estimates were too high for projected populations to persist. Vital rate sensitivity analyses indicated that population growth rate and population persistence were most sensitive to juvenile mortality. However, observed values for adult mortality were closest to the threshold value above which populations would crash. Adult mortality, already relatively low, may have the least capacity to change compared to other vital rates, whereas juvenile mortality may have the most capacity for improvement. Results suggest that improving mortality estimates and determining the cause(s) of juvenile mortality should be research priorities. Despite predictions that aspects of cooperative systems may result in variation in reproduction or juvenile mortality being the most sensitive vital rates, adult mortality was the most sensitive in half of the demographic models of other avian cooperative breeders. Interestingly, vital rate sensitivity differed by model type. However, studies that explicitly modeled the species' cooperative breeding system found reproduction to be the most sensitive rate.	[Mortensen, Jennifer L.; Reed, J. Michael] Tufts Univ, Dept Biol, Medford, MA USA	Tufts University	Mortensen, JL (corresponding author), Tufts Univ, Dept Biol, Medford, MA USA.	mortejen@gmail.com		Mortensen, Jennifer/0000-0001-9162-7033	P.E.O. Scholar Award; Tufts University Faculty Research Award	P.E.O. Scholar Award; Tufts University Faculty Research Award	This research was partially supported by a P.E.O. Scholar Award to JLM (http://www.peointernational.org/about-peo-scholar-awards-psa). Publication costs were supported by a Tufts University Faculty Research Award to JMR (http://ase.tufts.edu/faculty/awards/frac/Application.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2001, SCI TOTAL ENVIRON, V274, P283, DOI 10.1016/S0048-9697(01)00750-1; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Andrews AJ, 2007, SPATIAL TEMPORAL VAR; Colomer MA, 2011, ECOL MODEL, V222, P33, DOI 10.1016/j.ecolmodel.2010.09.012; [Anonymous], 2014, R LANG ENV STAT COMP; Anthony D, 2008, IMPORTANT BIRD AREAS; ASKINS RA, 1991, BIOTROPICA, V23, P481, DOI 10.2307/2388270; Beauchamp G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0844; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Beissinger SR, 2014, PEERJ, V2, DOI 10.7717/peerj.549; BirdLife International, 2008, STAT WORLDS BIRDS IN; BirdLife International, 2015, SPEC FACTSH RAMPH BR; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Breininger DR, 1999, WILDLIFE SOC B, V27, P810; Brook Barry W., 1997, Pacific Conservation Biology, V3, P125; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Brown J.L., 1987, HELPING COMMUNAL BRE; CASWELL H, 1978, THEOR POPUL BIOL, V14, P215, DOI 10.1016/0040-5809(78)90025-4; Caswell H, 1989, MATRIX POPULATION MO; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Clark ME, 2007, ECOL MODEL, V209, P110, DOI 10.1016/j.ecolmodel.2007.06.008; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cooper CB, 2002, ECOL APPL, V12, P1576, DOI 10.1890/1051-0761(2002)012[1576:LPADSS]2.0.CO;2; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Coutts SR, 2014, POPUL ECOL, V56, P7, DOI 10.1007/s10144-013-0422-1; Cross PC, 2001, CONSERV BIOL, V15, P1335, DOI 10.1046/j.1523-1739.2001.00031.x; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; Duca C, 2009, BIOL CONSERV, V142, P563, DOI 10.1016/j.biocon.2008.11.010; Ernest P, 2005, PRASLIN BAY RESORT S; Faaborg J, 1995, AUK, V112, P503, DOI 10.2307/4088741; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Fefferman NH, 2006, J WILDLIFE MANAGE, V70, P649, DOI 10.2193/0022-541X(2006)70[649:AVRSAF]2.0.CO;2; Felix ML, 2014, GOJ BLAN PLAN ACTION; Ferrer M, 2013, BIOL CONSERV, V159, P32, DOI 10.1016/j.biocon.2012.10.011; Fox J., 2019, R COMPANION APPL REG, V.; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Gonzalez-Suarez M, 2008, CONSERV BIOL, V22, P1608, DOI 10.1111/j.1523-1739.2008.00995.x; Goutte A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3313; Graveson R, 2003, 3 FCG INT LTD; Grimm V, 2005, CONSERV BIOL, V19, P578, DOI 10.1111/j.1523-1739.2005.000163.x; Hambler C, 2011, BIOL CONSERV, V144, P713, DOI 10.1016/j.biocon.2010.09.004; He FL, 2012, ECOLOGY, V93, P974, DOI 10.1890/11-1786.1; Henle K, 2004, BIODIVERS CONSERV, V13, P9, DOI 10.1023/B:BIOC.0000004312.41575.83; HEPPELL SS, 1994, J WILDLIFE MANAGE, V58, P479, DOI 10.2307/3809319; Johnston JP, 1997, AM NAT, V150, P771, DOI 10.1086/286093; Kesler DC, 2007, BIOL CONSERV, V136, P520, DOI 10.1016/j.biocon.2006.12.023; Lacy R.C., 2014, VORTEX STOCHASTIC SI; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lacy RC, 2012, VORTEX STOCHASTIC SI; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; Letcher BH, 1998, BIOL CONSERV, V86, P1, DOI 10.1016/S0006-3207(98)00019-6; Lopez-Lopez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037862; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MAGUIRE LA, 1995, J WILDLIFE MANAGE, V59, P533, DOI 10.2307/3802460; MCCARTHY MA, 1995, BIOL CONSERV, V73, P93, DOI 10.1016/0006-3207(95)00046-7; McCarthy MA, 1996, ECOL MODEL, V85, P151, DOI 10.1016/0304-3800(94)00191-X; McCarthy MA, 2003, CONSERV BIOL, V17, P982, DOI 10.1046/j.1523-1739.2003.01570.x; Miller PS., 2005, VORTEX STOCHASTIC SI; Morris W. F., 2002, QUANTITATIVE CONSERV; Mortensen J, 2009, SHORT TERM BEHAV DEM; O'Grady JJ, 2008, ANIM CONSERV, V11, P442, DOI 10.1111/j.1469-1795.2008.00201.x; Oborny B, 2005, OIKOS, V109, P291; Pe'er G, 2013, CONSERV BIOL, V27, P644, DOI 10.1111/cobi.12076; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Reed JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1648; Reed JM, 2014, CONSERV BIOL, V28, P867, DOI 10.1111/cobi.12274; Reed JM, 2005, ECOL MODEL, V183, P411, DOI 10.1016/j.ecolmodel.2004.02.025; Reed JM, 1999, CONSERV BIOL, V13, P232, DOI 10.1046/j.1523-1739.1999.013002232.x; Reed JM, 1996, AUK, V113, P608, DOI 10.2307/4088981; Reed JM, 1998, BIOL CONSERV, V84, P35, DOI 10.1016/S0006-3207(97)00077-3; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Riehl C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2245; Root KV, 1998, ECOL APPL, V8, P854, DOI 10.1890/1051-0761(1998)008[0854:ETEOHQ]2.0.CO;2; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; SAETHER BE, 1988, NATURE, V331, P616, DOI 10.1038/331616a0; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Salguero-Gomez R, 2010, AM NAT, V176, P710, DOI 10.1086/657044; Schiegg K, 2002, J ANIM ECOL, V71, P710, DOI 10.1046/j.1365-2656.2002.00637.x; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Stacey P.B., 1990, COOPERATIVE BREEDING; STACEY PB, 1992, ECOL APPL, V2, P18, DOI 10.2307/1941886; Stahl JT, 2006, ECOL MODEL, V198, P23, DOI 10.1016/j.ecolmodel.2006.04.001; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; TEAR TH, 1993, SCIENCE, V262, P976, DOI 10.1126/science.262.5136.976; Temple H, 2005, ECOLOGY COOPERATIVE; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; Temple HJ, 2009, IBIS, V151, P99, DOI 10.1111/j.1474-919X.2008.00867.x; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; WAIDE RB, 1991, BIOTROPICA, V23, P475, DOI 10.2307/2388269; Walters JR, 2002, ECOL APPL, V12, P249, DOI 10.1890/1051-0761(2002)012[0249:PVAFRC]2.0.CO;2; WAUER RH, 1992, WILSON BULL, V104, P656; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White RL, 2012, BIRD CONSERV INT, V22, P468, DOI 10.1017/S0959270912000184; Wiley James W., 1993, Bird Conservation International, V3, P319; Wittmer HU, 2010, BIOL CONSERV, V143, P86, DOI 10.1016/j.biocon.2009.09.007; Woolfenden G.E., 1984, FLORIDA SCRUB JAY DE; Young RP, 2010, BIRD CONSERV INT, V20, P354, DOI 10.1017/S0959270910000080; Zeigler SL, 2014, ECOL APPL, V24, P2144, DOI 10.1890/13-1275.1	103	15	15	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148928	10.1371/journal.pone.0148928	http://dx.doi.org/10.1371/journal.pone.0148928			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859690	Green Submitted, gold, Green Published			2022-12-26	WOS:000370038400106
J	Rivera, AL; Estanol, B; Senties-Madrid, H; Fossion, R; Toledo-Roy, JC; Mendoza-Temis, J; Morales, IO; Landa, E; Robles-Cabrera, A; Moreno, R; Frank, A				Leonor Rivera, Ana; Estanol, Bruno; Senties-Madrid, Horacio; Fossion, Ruben; Toledo-Roy, Juan C.; Mendoza-Temis, Joel; Morales, Irving O.; Landa, Emmanuel; Robles-Cabrera, Adriana; Moreno, Rene; Frank, Alejandro			Heart Rate and Systolic Blood Pressure Variability in the Time Domain in Patients with Recent and Long-Standing Diabetes Mellitus	PLOS ONE			English	Article							AUTONOMIC NEUROPATHY; BARORECEPTOR REFLEX; NEONATAL SEPSIS; MORTALITY; TESTS; VARIABLES; CAPACITY; DYNAMICS; BEAT; AGE	Diabetes Mellitus (DM) affects the cardiovascular response of patients. To study this effect, interbeat intervals (IBI) and beat-to-beat systolic blood pressure (SBP) variability of patients during supine, standing and controlled breathing tests were analyzed in the time domain. Simultaneous noninvasive measurements of IBI and SBP for 30 recently diagnosed and 15 long-standing DM patients were compared with the results for 30 rigorously screened healthy subjects (control). A statistically significant distinction between control and diabetic subjects was provided by the standard deviation and the higher moments of the distributions (skewness, and kurtosis) with respect to the median. To compare IBI and SBP for different populations, we define a parameter, a, that combines the variability of the heart rate and the blood pressure, as the ratio of the radius of the moments for IBI and the same radius for SBP. As diabetes evolves, a decreases, standard deviation of the IBI detrended signal diminishes (heart rate signal becomes more "rigid"), skewness with respect to the median approaches zero (signal fluctuations gain symmetry), and kurtosis increases (fluctuations concentrate around the median). Diabetes produces not only a rigid heart rate, but also increases symmetry and has leptokurtic distributions. SBP time series exhibit the most variable behavior for recently diagnosed DM with platykurtic distributions. Under controlled breathing, SBP has symmetric distributions for DM patients, while control subjects have non-zero skewness. This may be due to a progressive decrease of parasympathetic and sympathetic activity to the heart and blood vessels as diabetes evolves.	[Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Toledo-Roy, Juan C.; Mendoza-Temis, Joel; Morales, Irving O.; Landa, Emmanuel; Frank, Alejandro] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [Leonor Rivera, Ana; Fossion, Ruben; Toledo-Roy, Juan C.; Mendoza-Temis, Joel; Morales, Irving O.; Landa, Emmanuel; Frank, Alejandro] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Leonor Rivera, Ana] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro, Mexico; [Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Toledo-Roy, Juan C.; Mendoza-Temis, Joel; Morales, Irving O.; Landa, Emmanuel; Frank, Alejandro] Lab Nacl Ciencias Complejidad, Mexico City, DF, Mexico; [Estanol, Bruno; Senties-Madrid, Horacio; Robles-Cabrera, Adriana; Moreno, Rene] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Lab Neurofisiol, Dept Neurol & Psiquiatria, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico.; Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico.; Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro, Mexico.; Rivera, AL (corresponding author), Lab Nacl Ciencias Complejidad, Mexico City, DF, Mexico.	ana.rivera@nucleares.unam.mx	Toledo-Roy, Juan Claudio/N-6666-2019; Rivera, Ana Leonor/L-4433-2019; Fossion, Ruben/X-1682-2019; Rivera, Ana Leonor/B-5062-2010; Nucleares, Instituto/AAK-6270-2020; Toledo-Roy, Juan/G-6071-2019	Toledo-Roy, Juan Claudio/0000-0002-0267-3378; Rivera, Ana Leonor/0000-0002-0296-7966; Fossion, Ruben/0000-0001-8456-2075; Rivera, Ana Leonor/0000-0002-0296-7966; Toledo-Roy, Juan/0000-0002-0267-3378	UNAM; CONACYT [0133524, 0232647]	UNAM(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Finantial funding for this work was supplied by UNAM (http://www.nucleares.unam.mx/) and CONACYT (http://www.conacyt.gob.mx/) under grants 0133524 and 0232647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S., 2011, CURR NEUROBIOL, V2, P101; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1995, DIABETES CARE S1, V18, P59, DOI [10.2337/diacare.18.1.S59, DOI 10.2337/DIACARE.18.1.S59]; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Camm AJ, 1996, EUR HEART J, V17, P354; COWLEY AW, 1973, CIRC RES, V32, P564, DOI 10.1161/01.RES.32.5.564; Estañol Bruno, 2011, Arch. Cardiol. Méx., V81, P330; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Floras JS, 2013, CAN J CARDIOL, V29, P557, DOI 10.1016/j.cjca.2013.02.012; Fossion R, 2013, [Frontiers in Biology, 生物学前沿], V8, P247; FREEMAN R, 1991, ARCH NEUROL-CHICAGO, V48, P185, DOI 10.1001/archneur.1991.00530140079020; GOLDSTEIN IB, 1988, DIABETES CARE, V11, P774, DOI 10.2337/diacare.11.10.774; Griffin MP, 2001, PEDIATRICS, V107, P97, DOI 10.1542/peds.107.1.97; Haagglund H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00356; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Kilpatrick ES, 2010, DIABETES CARE, V33, P2442, DOI 10.2337/dc10-1000; KITNEY R I, 1982, Automedica (London), V4, P155; Kovatchev BP, 2003, PEDIATR RES, V54, P892, DOI 10.1203/01.PDR.0000088074.97781.4F; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; MALPAS SC, 1990, DIABETES, V39, P1177, DOI 10.2337/diabetes.39.10.1177; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; Parati G, 2013, DIABETES CARE, V36, pS312, DOI 10.2337/dcS13-2043; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Robles-Cabrera A, 2014, REV NEUROLOGIA, V59, P508, DOI 10.33588/rn.5911.2014314; Rosengard-Barlund M, 2011, DIABETOLOGIA, V54, P1862, DOI 10.1007/s00125-011-2164-y; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Schmitt DT, 2007, AM J PHYSIOL-REG I, V293, pR1923, DOI 10.1152/ajpregu.00372.2007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sharma VK, 2015, J CLIN DIAGN RES, V9, pCC08, DOI 10.7860/JCDR/2015/15373.6662; SMITH SA, 1982, BRIT MED J, V285, P1599, DOI 10.1136/bmj.285.6355.1599; Sucharita S, 2011, Indian J Endocrinol Metab, V15, P198, DOI 10.4103/2230-8210.83406; Sucharita S, 2002, PHYSIOL MEAS, V23, P347, DOI 10.1088/0967-3334/23/2/310; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Van Den Akker T. J., 1983, Automedica, V4, P201; Weston PJ, 1996, CLIN SCI, V91, P59, DOI 10.1042/cs0910059; Ziegler D, 2008, DIABETES CARE, V31, P556, DOI 10.2337/dc07-1615	42	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148378	10.1371/journal.pone.0148378	http://dx.doi.org/10.1371/journal.pone.0148378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849653	Green Submitted, gold, Green Published			2022-12-26	WOS:000369554000084
J	Tyler, AD; Christianson, S; Knox, NC; Mabon, P; Wolfe, J; Van Domselaar, G; Graham, MR; Sharma, MK				Tyler, Andrea D.; Christianson, Sara; Knox, Natalie C.; Mabon, Philip; Wolfe, Joyce; Van Domselaar, Gary; Graham, Morag R.; Sharma, Meenu K.			Comparison of Sample Preparation Methods Used for the Next-Generation Sequencing of Mycobacterium tuberculosis	PLOS ONE			English	Article							LIBRARY PREPARATION; GENOME ASSEMBLIES; BACTERIAL GENOME; DNA EXTRACTION; BIAS; CONSTRUCTION; ACCURATE	The advent and widespread application of next-generation sequencing (NGS) technologies to the study of microbial genomes has led to a substantial increase in the number of studies in which whole genome sequencing (WGS) is applied to the analysis of microbial genomic epidemiology. However, microorganisms such as Mycobacterium tuberculosis (MTB) present unique problems for sequencing and downstream analysis based on their unique physiology and the composition of their genomes. In this study, we compare the quality of sequence data generated using the Nextera and TruSeq isolate preparation kits for library construction prior to Illumina sequencing-by-synthesis. Our results confirm that MTB NGS data quality is highly dependent on the purity of the DNA sample submitted for sequencing and its guanine-cytosine content (or GC-content). Our data additionally demonstrate that the choice of library preparation method plays an important role in mitigating downstream sequencing quality issues. Importantly for MTB, the Illumina TruSeq library preparation kit produces more uniform data quality than the Nextera XT method, regardless of the quality of the input DNA. Furthermore, specific genomic sequence motifs are commonly missed by the Nextera XT method, as are regions of especially high GC-content relative to the rest of the MTB genome. As coverage bias is highly undesirable, this study illustrates the importance of appropriate protocol selection when performing NGS studies in order to ensure that sound inferences can be made regarding mycobacterial genomes.	[Tyler, Andrea D.; Christianson, Sara; Wolfe, Joyce; Sharma, Meenu K.] Publ Hlth Agcy Canada, Natl Reference Ctr Mycobacteriol, Natl Microbiol Lab, Winnipeg, MB, Canada; [Knox, Natalie C.; Mabon, Philip; Van Domselaar, Gary; Graham, Morag R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Sci Technol Cores & Serv Div, Winnipeg, MB, Canada; [Van Domselaar, Gary; Graham, Morag R.; Sharma, Meenu K.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Van Domselaar, Gary] Univ Manitoba, Dept Comp Sci, Winnipeg, MB R3T 2N2, Canada	Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba; University of Manitoba	Tyler, AD (corresponding author), Publ Hlth Agcy Canada, Natl Reference Ctr Mycobacteriol, Natl Microbiol Lab, Winnipeg, MB, Canada.	andrea.d.tyler@phac-aspc.gc.ca; meenu.sharma@phac-aspc.gc.ca	Sharma, Meenu/AAE-2536-2022; Sharma, Meenu/GWM-5030-2022	Sharma, Meenu/0000-0002-6020-9995; Knox, Natalie/0000-0001-6133-7799	Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada; Public Health Agency of Canada	Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada; Public Health Agency of Canada	This study was funded through an intramural grant from the Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada and the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Andrews S, FASTQC QUALITY CONTR; [Anonymous], 2013, PROKKA PROKARYOTIC G; [Anonymous], 2014, SMALT; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; De Almeida Isabela Neves, 2013, BMC Res Notes, V6, P561, DOI 10.1186/1756-0500-6-561; Espitia C, 1999, MICROBIOL-UK, V145, P3487, DOI 10.1099/00221287-145-12-3487; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Illumina inc, 2015, NEXT XT DNA LIBR PER, P48; Illumina inc, 2012, TRUSEQ DNA SAMPL PRE, P148; Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Kerpedjiev P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-100; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lan JH, 2015, HUM IMMUNOL, V76, P166, DOI 10.1016/j.humimm.2014.12.016; Liao YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08747; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Merker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082551; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Ng PC, 2010, METHODS MOL BIOL, V628, P215, DOI 10.1007/978-1-60327-367-1_12; Nguyen D, 2003, AM J RESP CRIT CARE, V168, P1353, DOI 10.1164/rccm.200307-910OC; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Petkau A., 2015, PIPELINE IDENTIFYING; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Pightling AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104579; POULET S, 1995, ARCH MICROBIOL, V163, P87, DOI 10.1007/s002030050176; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Scott D, 2015, CURR MICROBIOL, V70, P338, DOI 10.1007/s00284-014-0721-6; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Thermo Fisher Scientific, 2008, 260 280 260 230 RATI, P2; Timms VJ, 2015, J MICROBIOL METH, V112, P99, DOI 10.1016/j.mimet.2015.03.016; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3	46	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148676	10.1371/journal.pone.0148676	http://dx.doi.org/10.1371/journal.pone.0148676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849565	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000155
J	Zhao, WS; Sun, MY; Sun, LF; Liu, Y; Yang, Y; Huang, LD; Fan, YZ; Cheng, XY; Cao, P; Hu, YM; Li, LY; Tian, Y; Wang, R; Yu, Y				Zhao, Wen-Shan; Sun, Meng-Yang; Sun, Liang-Fei; Liu, Yan; Yang, Yang; Huang, Li-Dong; Fan, Ying-Zhe; Cheng, Xiao-Yang; Cao, Peng; Hu, You-Min; Li, Lingyong; Tian, Yun; Wang, Rui; Yu, Ye			A Highly Conserved Salt Bridge Stabilizes the Kinked Conformation of 2,3-Sheet Essential for Channel Function of P2X4 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; conformational change; ion channel; protein expression; protein stability; P2X receptors; salt bridge	ATP-BINDING SITES; ION-CHANNEL; EXTRACELLULAR LOOP; PROTEIN STABILITY; AGONIST BINDING; LEFT-FLIPPER; SURFACE; ANTAGONIST; ACTIVATION; INVOLVEMENT	Significant progress has been made in understanding the roles of crucial residues/motifs in the channel function of P2X receptors during the pre-structure era. The recent structural determination of P2X receptors allows us to reevaluate the role of those residues/motifs. Residues Arg-309 and Asp-85 (rat P2X4 numbering) are highly conserved throughout the P2X family and were involved in loss-of-function polymorphism in human P2X receptors. Previous studies proposed that they participated in direct ATP binding. However, the crystal structure of P2X demonstrated that those two residues form an intersubunit salt bridge located far away from the ATP-binding site. Therefore, it is necessary to reevaluate the role of this salt bridge in P2X receptors. Here, we suggest the crucial role of this structural element both in protein stability and in channel gating rather than direct ATP interaction and channel assembly. Combining mutagenesis, charge swap, and disulfide cross-linking, we revealed the stringent requirement of this salt bridge in normal P2X4 channel function. This salt bridge may contribute to stabilizing the bending conformation of the 2,3-sheet that is structurally coupled with this salt bridge and the 2-helix. Strongly kinked 2,3 is essential for domain-domain interactions between head domain, dorsal fin domain, right flipper domain, and loop 7,8 in P2X4 receptors. Disulfide cross-linking with directions opposing or along the bending angle of the 2,3-sheet toward the 2-helix led to loss-of-function and gain-of-function of P2X4 receptors, respectively. Further insertion of amino acids with bulky side chains into the linker between the 2,3-sheet or the conformational change of the 2-helix, interfering with the kinked conformation of 2,3, led to loss-of-function of P2X4 receptors. All these findings provided new insights in understanding the contribution of the salt bridge between Asp-85 and Arg-309 and its structurally coupled 2,3-sheet to the function of P2X receptors.	[Zhao, Wen-Shan; Sun, Meng-Yang; Wang, Rui] Lanzhou Univ, Sch Basic Med Sci, Sch Life Sci, Lanzhou 730000, Peoples R China; [Zhao, Wen-Shan; Sun, Meng-Yang; Wang, Rui] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Zhao, Wen-Shan; Sun, Meng-Yang; Sun, Liang-Fei; Liu, Yan; Yang, Yang; Huang, Li-Dong; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China; [Zhao, Wen-Shan; Sun, Meng-Yang; Sun, Liang-Fei; Liu, Yan; Yang, Yang; Huang, Li-Dong; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China; [Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Fan, Ying-Zhe] Shanghai Univ Chinese Tradit Med, Putuo Dist Ctr Hosp, Shanghai 200062, Peoples R China; [Li, Lingyong] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Cao, Peng] Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Nanjing 210023, Jiangsu, Peoples R China; [Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing 210028, Jiangsu, Peoples R China	Lanzhou University; Lanzhou University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Hunan Agricultural University; Shanghai University of Traditional Chinese Medicine; University of Texas System; UTMD Anderson Cancer Center; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Wang, R (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Sch Life Sci, Lanzhou 730000, Peoples R China.; Wang, R (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.	wangrui@lzu.edu.cn; yuye@shsmu.edu.cn	Cheng, Xiaoyang/N-9970-2019; Cheng, Xiaoyang/M-1257-2017	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; , Peng/0000-0002-2044-3074; Zhao, Wenshan/0000-0002-8018-5978; Yu, Ye/0000-0002-4054-8543	National Excellent Young Scientist Foundation of China [31222018]; National Program on Key Basic Research Project of China [2014CB910302]; National Natural Science Foundation of China [31570832, 31170787, 31400707, 81473377, 81302694]; Key National S&T Program "Major New Drug Development" Grant [2012ZX09504001-003]; "Shanghai Jiao Tong University-SMC Mutual Funds" for Excellent Young Scholar; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine [13XJ10042]; Shanghai Jiao Tong University School of Medicine-Key Incubation Project; National Key Laboratory of Receptors [SIMM1601KF-02]	National Excellent Young Scientist Foundation of China; National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S&T Program "Major New Drug Development" Grant; "Shanghai Jiao Tong University-SMC Mutual Funds" for Excellent Young Scholar; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine-Key Incubation Project; National Key Laboratory of Receptors	This work was supported by National Excellent Young Scientist Foundation of China Grant 31222018, National Program on Key Basic Research Project of China Grant 2014CB910302, National Natural Science Foundation of China Grants 31570832, 31170787, 31400707, 81473377 and 81302694, Key National S&T Program "Major New Drug Development" Grant 2012ZX09504001-003, "Shanghai Jiao Tong University-SMC Mutual Funds" for Excellent Young Scholar, Science and Technology Fund of Shanghai Jiao Tong University School of Medicine Grant 13XJ10042, Shanghai Jiao Tong University School of Medicine-Key Incubation Project, and the Opening Project of National Key Laboratory of Receptors Grant SIMM1601KF-02. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Ennion S, 2000, J BIOL CHEM, V275, P35656; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Habermacher C, 2016, ELIFE, V5, DOI 10.7554/eLife.11050; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hausmann R, 2013, MOL PHARMACOL, V83, P73, DOI 10.1124/mol.112.081489; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Jiang RT, 2010, J BIOL CHEM, V285, P15805, DOI 10.1074/jbc.M110.101980; Jie YL, 2014, NEUROSCI LETT, V582, P1, DOI 10.1016/j.neulet.2014.08.038; Kasuya G, 2016, CELL REP, V14, P932, DOI 10.1016/j.celrep.2015.12.087; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Kowalski M, 2014, BRIT J PHARMACOL, V171, P5093, DOI 10.1111/bph.12830; Laha KT, 2011, MOL PHARMACOL, V79, P662, DOI 10.1124/mol.110.068619; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Lorinczi E, 2012, P NATL ACAD SCI USA, V109, P11396, DOI 10.1073/pnas.1118759109; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Roberts JA, 2009, J NEUROCHEM, V109, P1042, DOI 10.1111/j.1471-4159.2009.06035.x; Sackin H, 2009, BIOPHYS J, V97, P1058, DOI 10.1016/j.bpj.2009.05.056; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Turner RD, 2015, LANCET, V386, P244, DOI 10.1016/S0140-6736(15)61274-0; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wang J, 2016, ACTA PHARMACOL SIN, V37, P44, DOI 10.1038/aps.2015.127; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	52	16	16	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7990	8003		10.1074/jbc.M115.711127	http://dx.doi.org/10.1074/jbc.M115.711127			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26865631	Green Published, hybrid			2022-12-26	WOS:000374056700020
J	Niu, YY; Yang, Y; Liu, Y; Huang, LD; Yang, XN; Fan, YZ; Cheng, XY; Cao, P; Hu, YM; Li, LY; Lu, XY; Tian, Y; Yu, Y				Niu, You-Ya; Yang, Yang; Liu, Yan; Huang, Li-Dong; Yang, Xiao-Na; Fan, Ying-Zhe; Cheng, Xiao-Yang; Cao, Peng; Hu, You-Min; Li, Lingyong; Lu, Xiang-Yang; Tian, Yun; Yu, Ye			Exploration of the Peptide Recognition of an Amiloride-sensitive FMRFamide Peptide-gated Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; EPITHELIAL NA+ CHANNEL; EXTRACELLULAR DOMAIN; HOMOLOGY MODEL; POSITION 552; ACID; ACTIVATION; MODULATION; NEURONS; SITE	FMRFamide (Phe-Met-Arg-Phe-NH2)-activated sodium channel (FaNaC) is an amiloride-sensitive sodium channel activated by endogenous tetrapeptide in invertebrates, and belongs to the epithelial sodium channel/degenerin (ENaC/DEG) superfamily. The ENaC/DEG superfamily differs markedly in its means of activation, such as spontaneously opening or gating by mechanical stimuli or tissue acidosis. Recently, it has been observed that a number of ENaC/DEG channels can be activated by small molecules or peptides, indicating that the ligand-gating may be an important feature of this superfamily. The peptide ligand control of the channel gating might be an ancient ligand-gating feature in this superfamily. Therefore, studying the peptide recognition of FaNaC channels would advance our understanding of the ligand-gating properties of this superfamily of ion channels. Here we demonstrate that Tyr-131, Asn-134, Asp-154, and Ile-160, located in the putative upper finger domain of Helix aspersa FaNaC (HaFaNaC) channels, are key residues for peptide recognition of this ion channel. Two HaFaNaC specific-insertion motifs among the ENaC/DEG superfamily, residing at the putative alpha 4-alpha 5 linker of the upper thumb domain and the alpha 6-alpha 7 linker of the upper knuckle domain, are also essential for the peptide recognition of HaFaNaC channels. Chemical modifications and double mutant cycle analysis further indicated that those two specific inserts and key residues in the upper finger domain together participate in peptide recognition of HaFaNaC channels. This ligand recognition site is distinct from that of acid-sensing ion channels (ASICs) by a longer distance between the recognition site and the channel gate, carrying useful information about the ligand gating and the evolution of the trimeric ENaC/DEG superfamily of ion channels.	[Niu, You-Ya; Yang, Xiao-Na; Lu, Xiang-Yang; Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Niu, You-Ya; Yang, Yang; Liu, Yan; Huang, Li-Dong; Yang, Xiao-Na; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China; [Niu, You-Ya; Yang, Yang; Liu, Yan; Huang, Li-Dong; Yang, Xiao-Na; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200025, Peoples R China; [Niu, You-Ya; Yang, Yang; Liu, Yan; Huang, Li-Dong; Yang, Xiao-Na; Cheng, Xiao-Yang; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200025, Peoples R China; [Fan, Ying-Zhe] Shanghai Univ Chinese Tradit Med, Putuo Dist Ctr Hosp, Shanghai 200062, Peoples R China; [Li, Lingyong] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Cao, Peng] Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Nanjing 210023, Jiangsu, Peoples R China; [Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing 210028, Jiangsu, Peoples R China	Hunan Agricultural University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; University of Texas System; UTMD Anderson Cancer Center; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Tian, Y; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200025, Peoples R China.	tianyun79616@163.com; yuye@shsmu.edu.cn	Cheng, Xiaoyang/N-9970-2019; Cheng, Xiaoyang/M-1257-2017	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; , Peng/0000-0002-2044-3074; Yu, Ye/0000-0002-4054-8543	National Excellent Young Scientist Foundation of China [31222018]; National Program on Key Basic Research Project of China [2014CB910302]; National Natural Science Foundation of China [31170787, 31570832, 31400707, 81302694, 81473377]; National Key Laboratory of Receptors [SIMM1601KF-02]; Shanghai Jiao Tong University-SMC Mutual Funds for Excellent Young Scholar [2013SMC-A-7]; Shanghai Jiao Tong University School of Medicine-Key Incubation Project [12x190030017]; Key National SAMP;T Program "Major New Drug Development" Grant [2012ZX09504001-003]; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine [13XJ10042]	National Excellent Young Scientist Foundation of China; National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Laboratory of Receptors; Shanghai Jiao Tong University-SMC Mutual Funds for Excellent Young Scholar; Shanghai Jiao Tong University School of Medicine-Key Incubation Project; Key National SAMP;T Program "Major New Drug Development" Grant; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine	This study was supported by grants from the National Excellent Young Scientist Foundation of China (no. 31222018), National Program on Key Basic Research Project of China (2014CB910302), National Natural Science Foundation of China (nos. 31170787, 31570832, 31400707, 81302694, and 81473377), the Opening Project of National Key Laboratory of Receptors (SIMM1601KF-02), Shanghai Jiao Tong University-SMC Mutual Funds for Excellent Young Scholar (2013SMC-A-7), Shanghai Jiao Tong University School of Medicine-Key Incubation Project (12x190030017), Key National S&T Program "Major New Drug Development" Grant (no. 2012ZX09504001-003), and Science and Technology Fund of Shanghai Jiao Tong University School of Medicine (13XJ10042). The authors declare that they have no conflicts of interest with the contents of this article.	Almaca J, 2013, CELL, V154, P1390, DOI 10.1016/j.cell.2013.08.045; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; BELKIN KJ, 1993, J NEUROSCI, V13, P5139, DOI 10.1523/JNEUROSCI.13-12-05139.1993; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Cottrell GA, 2005, PFLUG ARCH EUR J PHY, V450, P168, DOI 10.1007/s00424-005-1385-7; Cottrell GA, 1997, J EXP BIOL, V200, P2377; Cottrell GA, 2001, FEBS LETT, V489, P71, DOI 10.1016/S0014-5793(01)02081-6; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Furukawa Y, 2006, PFLUG ARCH EUR J PHY, V451, P646, DOI 10.1007/s00424-005-1498-z; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Green KA, 2002, PFLUG ARCH EUR J PHY, V443, P813, DOI 10.1007/s00424-001-0750-4; Grunder S, 2015, J EXP BIOL, V218, P551, DOI 10.1242/jeb.111666; Hong K, 2000, J NEUROSCI, V20, P2575; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kodani Y, 2014, J PHYSIOL SCI, V64, P141, DOI 10.1007/s12576-013-0303-6; Kodani Y, 2010, ZOOL SCI, V27, P440, DOI 10.2108/zsj.27.440; Kota P, 2014, J BIOL CHEM, V289, P23029, DOI 10.1074/jbc.M114.570952; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Mercado J, 2008, J BIOL CHEM, V283, P15250, DOI 10.1074/jbc.M708638200; Ostrovskaya O, 2004, J NEUROCHEM, V91, P252, DOI 10.1111/j.1471-4159.2004.02688.x; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Perry SJ, 2001, J NEUROSCI, V21, P5559, DOI 10.1523/JNEUROSCI.21-15-05559.2001; Pietra F, 2011, CHEM BIODIVERS, V8, P816, DOI 10.1002/cbdv.201100060; RUBEN P, 1986, J NEUROSCI, V6, P252; Shi SJ, 2012, J BIOL CHEM, V287, P15439, DOI 10.1074/jbc.M112.346551; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Smith RN, 2014, CHANNELS, V8, P49, DOI 10.4161/chan.26978; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wiemuth D, 2013, CHANNELS, V7, P38, DOI 10.4161/chan.22406; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	54	5	6	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7571	7582		10.1074/jbc.M115.710251	http://dx.doi.org/10.1074/jbc.M115.710251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26867576	Green Published, hybrid			2022-12-26	WOS:000383447600030
J	He, GJ; Li, J; Yang, L; Hou, CH; Ni, TJ; Yang, ZJ; Qian, XL; Li, CZ				He, Guangjie; Li, Jing; Yang, Lu; Hou, Chunhua; Ni, Tianjun; Yang, Zhijun; Qian, Xinlai; Li, Changzheng			The Synthesis of a Coumarin Carbohydrazide Dinuclear Copper Complex Based Fluorescence Probe and Its Detection of Thiols	PLOS ONE			English	Article							SELECTIVE DETECTION; LIVING CELLS; INTRACELLULAR THIOLS; OXIDATIVE STRESS; CYSTEINE; GLUTATHIONE; HOMOCYSTEINE; BIOTHIOLS; CHEMOSENSORS; NAPHTHALIMIDE	Small-molecule thiols, such as cysteine (CYS) and glutathione (GSH), are essential for maintaining the cellular redox environment and play important roles in regulating various cellular physiological functions. A fluorescence probe (compound 1-Cu2+) for thiols based on coumarin carbohydrazide dinuclear copper complex was developed. Compound 1 was synthesized from the reaction of 7-(diethylamino)-2-oxo-2H-chromene-3-carbohydrazide with 4-tert-butyl-2,6-diformylphenol. Accordingly, the copper complex (compound 1-Cu2+) was prepared by mixing compound 1 with 2 equivalents copper ions. Compound 1 had strong fluorescence while compound 1-Cu2+ hardly possessed fluorescence owing to the quenching nature of paramagnetism Cu2+ to the fluorescence molecule excited state. However, the fluorescence intensity of compound 1-Cu2+ was increased dramatically after the addition of thiol-containing amino acids, but not the other non-sulfhydryl amino acids. UV-vis absorption and fluorescence spectra indicated that compound 1-Cu2+ had good selectivity and sensitivity for thiols such as glutathione in CH3CN:H2O (3:2, v/v) PBS solution. The fluorescence imaging experiments implied that compound 1-Cu2+ has potential application in thiol-containing amino acids detection in living cells.	[He, Guangjie; Li, Jing] Xinxiang Med Univ, Dept Forens Med, Jinsui Rd 601, Xinxiang 453003, Peoples R China; [Yang, Lu; Ni, Tianjun; Yang, Zhijun; Qian, Xinlai; Li, Changzheng] Xinxiang Med Univ, Sch Basic Med Sci, Jinsui Rd 601, Xinxiang 453003, Peoples R China; [Hou, Chunhua] Xinxiang Med Univ, Coll Pharm, Jinsui Rd 601, Xinxiang 453003, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University	He, GJ (corresponding author), Xinxiang Med Univ, Dept Forens Med, Jinsui Rd 601, Xinxiang 453003, Peoples R China.; Li, CZ (corresponding author), Xinxiang Med Univ, Sch Basic Med Sci, Jinsui Rd 601, Xinxiang 453003, Peoples R China.	guangjiehe@163.com; changzhenl@yahoo.com			National Natural Science Foundation [21371148, 81401470, 21571153]; National Natural Science Foundation of China; Key Scientific and Technological Project of Henan Province [122102310196]; Science and Technology Department of Henan Province; Education Project of Henan Province [12A150019]; Education Department of Henan Provincial	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technological Project of Henan Province; Science and Technology Department of Henan Province; Education Project of Henan Province; Education Department of Henan Provincial	This work was financially supported by the following: (1) National Natural Science Foundation (No.21371148), National Natural Science Foundation of China and G. He received the funding, http://www.nsfc.gov.cn/. (2) National Natural Science Foundation (No.81401470), National Natural Science Foundation of China and T. Ni received the funding, http://www.nsfc.gov.cn/. (3) Key Scientific and Technological Project of Henan Province (No.122102310196), the Science and Technology Department of Henan Province and G. He received the funding, http://www.henan.gov.cn/zwgk/system/2006/09/15/010007049. shtml. (4) The financial support from Education Project of Henan Province (No. 12A150019), the Education Department of Henan Provincial and G. He received the funding, http://www.haedu.gov.cn/.; This work was financially supported by the National Natural Science Foundation (No. 21371148, 81401470 and 21571153), the financial support from Key Scientific and Technological Project of Henan Province (No. 122102310196) and the financial support from Education Project of Henan Province (No. 12A150019).	Chen X, 2010, CHEM SOC REV, V39, P2120, DOI 10.1039/b925092a; Dai ZC, 2013, ANAL CHEM, V85, P11658, DOI 10.1021/ac403370g; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Han QX, 2014, ORG BIOMOL CHEM, V12, P5023, DOI 10.1039/c4ob00463a; He GJ, 2008, INORG CHEM, V47, P5169, DOI 10.1021/ic702494s; He GJ, 2010, TETRAHEDRON, V66, P9762, DOI 10.1016/j.tet.2010.09.043; Hong R, 2006, J AM CHEM SOC, V128, P1078, DOI 10.1021/ja056726i; Hong V, 2009, J AM CHEM SOC, V131, P9986, DOI 10.1021/ja809345d; Jung HS, 2013, CHEM SOC REV, V42, P6019, DOI 10.1039/c3cs60024f; Jung HS, 2011, CHEM COMMUN, V47, P5142, DOI 10.1039/c1cc10672d; Kong FP, 2013, CHEM COMMUN, V49, P9176, DOI 10.1039/c3cc45519j; Lee JH, 2015, J INCL PHENOM MACRO, V82, P117, DOI 10.1007/s10847-015-0486-y; Lee MH, 2013, CHEM REV, V113, P5071, DOI 10.1021/cr300358b; Lee MH, 2012, J AM CHEM SOC, V134, P1316, DOI 10.1021/ja210065g; Li HL, 2009, CHEM COMMUN, P5904, DOI 10.1039/b907511a; Li J, 2014, ANAL CHEM, V86, P3037, DOI 10.1021/ac403885n; Lim CS, 2011, J AM CHEM SOC, V133, P11132, DOI 10.1021/ja205081s; Lim SY, 2014, J AM CHEM SOC, V136, P7018, DOI 10.1021/ja500962u; Lindoy LF, 1998, SYNTHESIS-STUTTGART, P1029; Liu J, 2014, J AM CHEM SOC, V136, P574, DOI 10.1021/ja409578w; Liu SR, 2014, ANAL CHIM ACTA, V849, P64, DOI 10.1016/j.aca.2014.08.024; Long LL, 2013, ORG BIOMOL CHEM, V11, P8214, DOI 10.1039/c3ob41741g; Lou ZR, 2013, CHEM COMMUN, V49, P391, DOI 10.1039/c2cc36839k; Ma YM, 2004, J MED CHEM, V47, P6349, DOI 10.1021/jm049751s; Maeda H, 2005, ANGEW CHEM INT EDIT, V44, P2922, DOI 10.1002/anie.200500114; Malwal SR, 2014, CHEM COMMUN, V50, P11533, DOI 10.1039/c4cc05462h; Niu LY, 2015, CHEM SOC REV, V44, P6143, DOI 10.1039/c5cs00152h; Niu LY, 2012, J AM CHEM SOC, V134, P18928, DOI 10.1021/ja309079f; Peng HJ, 2012, SENSORS-BASEL, V12, P15907, DOI 10.3390/s121115907; Reddy GU, 2014, CHEM COMMUN, V50, P9899, DOI 10.1039/c4cc04214j; Reiss A, 2014, BIOINORG CHEM APPL, V2014, DOI 10.1155/2014/926287; Sarkar D, 2014, J LUMIN, V146, P480, DOI 10.1016/j.jlumin.2013.09.080; Shi YG, 2013, BIOORG MED CHEM LETT, V23, P2538, DOI 10.1016/j.bmcl.2013.03.004; Sobhakumari A, 2013, TOXICOL APPL PHARM, V272, P736, DOI 10.1016/j.taap.2013.07.013; Su DD, 2014, BIOMATERIALS, V35, P6078, DOI 10.1016/j.biomaterials.2014.04.035; Takechi H, 2000, CHEM PHARM BULL, V48, P1702; Tang B, 2007, J AM CHEM SOC, V129, P11666, DOI 10.1021/ja072572q; Tian MG, 2014, ORG BIOMOL CHEM, V12, P6128, DOI 10.1039/c4ob00382a; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tu FQ, 2014, ELECTROPHORESIS, V35, P1188, DOI 10.1002/elps.201300452; Wang FY, 2014, CHEM-EUR J, V20, P11471, DOI 10.1002/chem.201403450; Wang P, 2012, ORG LETT, V14, P520, DOI 10.1021/ol203123t; Wei MJ, 2013, CHEM COMMUN, V49, P4640, DOI 10.1039/c3cc39045d; Xu C, 2015, BIOSENS BIOELECTRON, V72, P275, DOI 10.1016/j.bios.2015.05.030; Yi L, 2009, ANGEW CHEM INT EDIT, V48, P4034, DOI 10.1002/anie.200805693; Yu CW, 2014, SENSORS-BASEL, V14, P21375, DOI 10.3390/s141121375; Zhang HT, 2015, CHEM COMMUN, V51, P2029, DOI 10.1039/c4cc08156k; Zhang HT, 2012, CHEM COMMUN, V48, P10672, DOI 10.1039/c2cc35513b; Zhang Q, 2014, CHEM COMMUN, V50, P14002, DOI 10.1039/c4cc04978k; Zhao LZ, 2014, ACS APPL MATER INTER, V6, P11190, DOI 10.1021/am501249p; Zhao X., 2010, FAGUANG XUEBAO, V31, P433; Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931; Zong J, 2014, BIOSENS BIOELECTRON, V51, P330, DOI 10.1016/j.bios.2013.07.042	53	15	15	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148026	10.1371/journal.pone.0148026	http://dx.doi.org/10.1371/journal.pone.0148026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871436	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100015
J	Montero, R; Yubero, D; Villarroya, J; Henares, D; Jou, C; Rodriguez, MA; Ramos, F; Nascimento, A; Ortez, CI; Campistol, J; Perez-Duenas, B; O'Callaghan, M; Pineda, M; Garcia-Cazorla, A; Oferil, JC; Montoya, J; Ruiz-Pesini, E; Emperador, S; Meznaric, M; Campderros, L; Kalko, SG; Villarroya, F; Artuch, R; Jimenez-Mallebrera, C				Montero, Raquel; Yubero, Delia; Villarroya, Joan; Henares, Desiree; Jou, Cristina; Angeles Rodriguez, Maria; Ramos, Federico; Nascimento, Andres; Ignacio Ortez, Carlos; Campistol, Jaume; Perez-Duenas, Belen; O'Callaghan, Mar; Pineda, Mercedes; Garcia-Cazorla, Angeles; Colomer Oferil, Jaume; Montoya, Julio; Ruiz-Pesini, Eduardo; Emperador, Sonia; Meznaric, Marija; Campderros, Laura; Kalko, Susana G.; Villarroya, Francesc; Artuch, Rafael; Jimenez-Mallebrera, Cecilia			GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; INHIBITORY CYTOKINE-1; DISORDERS; BIOMARKER; DEFICIENCY; EXPRESSION; MUTATIONS; INDUCTION; CRITERIA; THERAPY	Background We previously described increased levels of growth and differentiation factor 15 (GDF-15) in skeletal muscle and serum of patients with mitochondrial diseases. Here we evaluated GDF-15 as a biomarker for mitochondrial diseases affecting children and compared it to fibroblast-growth factor 21 (FGF-21). To investigate the mechanism of GDF-15 induction in these pathologies we measured its expression and secretion in response to mitochondrial dysfunction. Methods We analysed 59 serum samples from 48 children with mitochondrial disease, 19 samples from children with other neuromuscular diseases and 33 samples from aged-matched healthy children. GDF-15 and FGF-21 circulating levels were determined by ELISA. Results Our results showed that in children with mitochondrial diseases GDF-15 levels were on average increased by 11-fold (mean 4046pg/ml, 1492 SEM) relative to healthy (350, 21) and myopathic (350, 32) controls. The area under the curve for the receiver-operating-characteristic curve for GDF-15 was 0.82 indicating that it has a good discriminatory power. The overall sensitivity and specificity of GDF-15 for a cut-off value of 550pg/mL was 67.8% (54.4%-79.4%) and 92.3%(81.5%-97.9%), respectively. We found that elevated levels of GDF-15 and or FGF-21 correctly identified a larger proportion of patients than elevated levels of GDF-15 or FGF-21 alone. GDF-15, as well as FGF-21, mRNA expression and protein secretion, were significantly induced after treatment of myotubes with oligomycin and that levels of expression of both factors significantly correlated. Conclusions Our data indicate that GDF-15 is a valuable serum quantitative biomarker for the diagnosis of mitochondrial diseases in children and that measurement of both GDF-15 and FGF-21 improves the disease detection ability of either factor separately. Finally, we demonstrate for the first time that GDF-15 is produced by skeletal muscle cells in response to mitochondrial dysfunction and that its levels correlate in vitro with FGF-21 levels.	[Montero, Raquel; Yubero, Delia; Artuch, Rafael] Hosp St Joan de Deu, Dept Clin Biochem, Barcelona, Spain; [Montero, Raquel; Yubero, Delia; Jou, Cristina; Nascimento, Andres; Campistol, Jaume; Perez-Duenas, Belen; Pineda, Mercedes; Garcia-Cazorla, Angeles; Montoya, Julio; Ruiz-Pesini, Eduardo; Emperador, Sonia; Artuch, Rafael; Jimenez-Mallebrera, Cecilia] Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain; [Montero, Raquel; Yubero, Delia; Jou, Cristina; Nascimento, Andres; Campistol, Jaume; Perez-Duenas, Belen; Pineda, Mercedes; Garcia-Cazorla, Angeles; Montoya, Julio; Ruiz-Pesini, Eduardo; Emperador, Sonia; Artuch, Rafael; Jimenez-Mallebrera, Cecilia] Inst Salud Carlos III, Madrid, Spain; [Montero, Raquel; Yubero, Delia; Villarroya, Joan; Jou, Cristina; Angeles Rodriguez, Maria; Nascimento, Andres; Ignacio Ortez, Carlos; Campistol, Jaume; Perez-Duenas, Belen; O'Callaghan, Mar; Pineda, Mercedes; Garcia-Cazorla, Angeles; Campderros, Laura; Villarroya, Francesc; Artuch, Rafael; Jimenez-Mallebrera, Cecilia] Inst Pediat Res St Joan de Deu, Barcelona, Spain; [Villarroya, Joan; Campderros, Laura; Villarroya, Francesc] IBUB, Biochem & Mol Biol Dept, Ctr Biomed Res Obes & Nutr CIBEROBN, Madrid, Spain; [Henares, Desiree; Angeles Rodriguez, Maria; Nascimento, Andres; Ignacio Ortez, Carlos; Colomer Oferil, Jaume; Jimenez-Mallebrera, Cecilia] Hosp St Joan de Deu, Fdn Sant Joan de Deu, Neuromuscular Unit, Neuropaediat Dept, Barcelona, Spain; [Jou, Cristina] Hosp St Joan de Deu, Dept Pathol, Barcelona, Spain; [Ramos, Federico; Campistol, Jaume; Perez-Duenas, Belen; O'Callaghan, Mar; Garcia-Cazorla, Angeles] Hosp St Joan de Deu, Neuropaediat Dept, Barcelona, Spain; [Montoya, Julio; Ruiz-Pesini, Eduardo; Emperador, Sonia] Univ Zaragoza, Biochem & Mol Biol Dept, Zaragoza, Spain; [Ruiz-Pesini, Eduardo] Univ Zaragoza, Fdn ARAID, Zaragoza, Spain; [Meznaric, Marija] Univ Ljubljana, Fac Med, Inst Anat, Ljubljana, Slovenia; [Kalko, Susana G.] Hosp Clin Barcelona, Bioinformat Core Facil, IDIBAPS, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; University of Barcelona; University of Barcelona; University of Zaragoza; University of Zaragoza; University of Ljubljana; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Jimenez-Mallebrera, C (corresponding author), Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.; Jimenez-Mallebrera, C (corresponding author), Inst Salud Carlos III, Madrid, Spain.; Jimenez-Mallebrera, C (corresponding author), Inst Pediat Res St Joan de Deu, Barcelona, Spain.; Jimenez-Mallebrera, C (corresponding author), Hosp St Joan de Deu, Fdn Sant Joan de Deu, Neuromuscular Unit, Neuropaediat Dept, Barcelona, Spain.	cjimenezm@hsjdbcn.org	Marija, Meznaric/A-5112-2016; Jiménez-Mallebrera, Cecilia/F-5030-2016; Perez-Duenas, Belen/AAG-9054-2019; Villarroya, Joan/W-4066-2018; Campderros, Laura/AAM-4550-2021; Villarroya, Francesc/K-4357-2014; Henares Bonilla, Desiree/K-2543-2017	Marija, Meznaric/0000-0002-5907-6929; Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; Villarroya, Joan/0000-0002-7859-1109; Campderros, Laura/0000-0003-4377-034X; Kalko, Susana/0000-0002-6701-0233; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Artuch, Rafael/0000-0002-3422-9685; PEREZ DUENAS, BELEN/0000-0002-4979-2788; Henares Bonilla, Desiree/0000-0003-2631-2718; Villarroya, Francesc/0000-0003-1266-9142; Yubero, Delia/0000-0001-7742-0589	Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria [PI10/00177, PI13/00837, PI14/00028, PI14/00005]; European Regional Development Fund (FEDER); Hospital Sant Joan de Deu; Instituto de Salud Carlos III grant [CP09/00011]; Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon [B33]; Ministerio de Economia y Competitividad, MINECO [SAF2014-55725-R]; Generalitat de Catalunya [2014SGR-141]; Plan Nacional de I+D+I	Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria; European Regional Development Fund (FEDER)(European Commission); Hospital Sant Joan de Deu; Instituto de Salud Carlos III grant(Instituto de Salud Carlos III); Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon(Gobierno de Aragon); Ministerio de Economia y Competitividad, MINECO(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Plan Nacional de I+D+I	This work was funded by the "Plan Nacional de I+D+I and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria", projects PI10/00177 (CJM), PI13/00837 (MAR, CJ, AN, JC, CJM), PI14/00028 (RA), PI14/00005 (SE, JM) and the European Regional Development Fund (FEDER). MAR is sponsored by the Hospital Sant Joan de Deu Reserch Grants. CJM is funded by the Instituto de Salud Carlos III grant CP09/00011. JM is funded by Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon (Grupos Consolidados B33). JV, LC and FV are funded by grants from the "Ministerio de Economia y Competitividad, MINECO" (SAF2014-55725-R) and "Generalitat de Catalunya" (2014SGR-141).	Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Bottner M, 1999, CELL TISSUE RES, V297, P103, DOI 10.1007/s004410051337; Brito S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00102; Chi CS, 2015, PEDIATR NEONATOL, V56, P7, DOI 10.1016/j.pedneo.2014.03.009; de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331; DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126; Dominguez-Rodriguez A, 2011, AM J CARDIOL, V108, P955, DOI 10.1016/j.amjcard.2011.05.028; Dostalova I, 2009, EUR J ENDOCRINOL, V161, P397, DOI 10.1530/EJE-09-0417; Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Kahli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105759; Koene S, 2015, JIMD REP, DOI [10.1007/89042015436, DOI 10.1007/89042015436]; Lajer M, 2010, DIABETES CARE, V33, P1567, DOI 10.2337/dc09-2174; Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040; Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54; O'Callaghan MM, 2015, MITOCHONDRION, V22, P17, DOI 10.1016/j.mito.2015.03.001; Park SH, 2012, J BIOL CHEM, V287, P19841, DOI 10.1074/jbc.M111.330639; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y; Roth P, 2010, CLIN CANCER RES, V16, P3851, DOI 10.1158/1078-0432.CCR-10-0705; Strelau J, 2000, ADV RES NEURODEGENER, V8, P273; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001; Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100; Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506; Yubero D, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0284-5; Zimmers TA, 2006, J SURG RES, V130, P45, DOI 10.1016/j.jss.2005.07.036; Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70	31	88	91	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148709	10.1371/journal.pone.0148709	http://dx.doi.org/10.1371/journal.pone.0148709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867126	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700027
J	O'Brien, KM; Nonnenmann, MW				O'Brien, Kate M.; Nonnenmann, Matthew W.			Airborne Influenza A Is Detected in the Personal Breathing Zone of Swine Veterinarians	PLOS ONE			English	Article							IN-VITRO; ALVEOLAR MACROPHAGES; GENETIC REASSORTMENT; VIRUS; DUST; TRANSMISSION; PIGS; EXPOSURE; INHALATION; PREVENTION	The 2009 H1N1 pandemic emphasized a need to evaluate zoonotic transmission of influenza A in swine production. Airborne influenza A virus has been detected in swine facilities during an outbreak. However, the personal exposure of veterinarians treating infected swine has not been characterized. Two personal bioaerosol samplers, the NIOSH bioaerosol sampler and the personal high-flow inhalable sampler head (PHISH), were placed in the breathing zone of veterinarians treating swine infected with either H1N1 or H3N2 influenza A. A greater number of viral particles were recovered from the NIOSH bioaerosol sampler (2094 RNA copies/m(3)) compared to the PHISH sampler (545 RNA copies/m(3)). In addition, the majority of viral particles were detected by the NIOSH bioaerosol sampler in the > 4 mu m size fraction. These results suggest that airborne influenza A virus is present in the breathing zone of veterinarians treating swine, and the aerosol route of zoonotic transmission of influenza virus should be further evaluated among agricultural workers.	[O'Brien, Kate M.; Nonnenmann, Matthew W.] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA USA	University of Iowa	Nonnenmann, MW (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA USA.	matthew-nonnenmann@uiowa.edu	Nonnenmann, Matthew/K-6245-2019	Nonnenmann, Matthew/0000-0001-8920-1877	University of Iowa College of Public Health New Investigator Award-MWN	University of Iowa College of Public Health New Investigator Award-MWN	The research was funded by the University of Iowa College of Public Health New Investigator Award-MWN. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135675; Anthony TR, 2010, ANN OCCUP HYG, V54, P427, DOI 10.1093/annhyg/meq029; Blachere FM, 2007, INFLUENZA OTHER RESP, V1, P113, DOI 10.1111/j.1750-2659.2007.00020.x; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Chen PS, 2010, ENVIRON HEALTH PERSP, V118, P1211, DOI 10.1289/ehp.0901782; Choi MJ, 2015, CLIN INFECT DIS, V61, P1355, DOI 10.1093/cid/civ618; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Corzo CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071444; Corzo CA, 2013, VET J, V196, P171, DOI 10.1016/j.tvjl.2012.09.024; Ellenbecker MJ, 1996, AM J IND MED, V29, P303, DOI 10.1002/(SICI)1097-0274(199604)29:4<303::AID-AJIM5>3.0.CO;2-P; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Knetter SM, 2014, VET IMMUNOL IMMUNOP, V157, P20, DOI 10.1016/j.vetimm.2013.10.019; Koehler KA, 2012, ANN OCCUP HYG, V56, P194, DOI 10.1093/annhyg/mer077; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Palmberg L, 1998, THORAX, V53, P260, DOI 10.1136/thx.53.4.260; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; Poole JA, 2008, J ALLERGY CLIN IMMUN, V122, P375, DOI 10.1016/j.jaci.2008.05.023; Rabinowitz P, 2013, J AGROMEDICINE, V18, P304, DOI 10.1080/1059924X.2013.826603; Roelofs CF, 2003, AIHA J, V64, P62, DOI 10.1080/15428110308984788; Schofield L, 2005, AVIAN INFLUENZA AERO; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shu B, 2011, J CLIN MICROBIOL, V49, P2614, DOI 10.1128/JCM.02636-10; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Steel J, 2014, CURR TOP MICROBIOL, V385, P377, DOI 10.1007/82_2014_395; Tao H, 2015, J VIROL, V89, P8453, DOI 10.1128/JVI.01162-15; Urbain B, 1999, AM J VET RES, V60, P1055; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Wang Z, 1997, EUR RESPIR J, V10, P381, DOI 10.1183/09031936.97.10020381; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	37	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149083	10.1371/journal.pone.0149083	http://dx.doi.org/10.1371/journal.pone.0149083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867129	Green Published, gold			2022-12-26	WOS:000370050700063
J	Geng, HY; Wu, F; Kong, LT; Tang, YQ; Zhou, Q; Chang, M; Zhou, YF; Jiang, XW; Li, SB; Wang, F				Geng, Haiyang; Wu, Feng; Kong, Lingtao; Tang, Yanqing; Zhou, Qian; Chang, Miao; Zhou, Yifang; Jiang, Xiaowei; Li, Songbai; Wang, Fei			Disrupted Structural and Functional Connectivity in Prefrontal-Hippocampus Circuitry in First-Episode Medication-Nave Adolescent Depression	PLOS ONE			English	Article							WHITE-MATTER MICROSTRUCTURE; MAJOR DEPRESSION; FORNIX INTEGRITY; NAIVE PATIENTS; DEFAULT MODE; BRAIN; DISORDER; ABNORMALITIES; VOLUME; ACTIVATION	Background Evidence implicates abnormalities in prefrontal-hippocampus neural circuitry in major depressive disorder (MDD). This study investigates the potential disruptions in prefrontal-hippocampus structural and functional connectivity, as well as their relationship in first-episode medication-naive adolescents with MDD in order to investigate the early stage of the illness without confounds of illness course and medication exposure. Methods Diffusion tensor imaging and resting-state functional magnetic resonance imaging (rs-fMRI) data were acquired from 26 first-episode medication-naive MDD adolescents and 31 healthy controls (HC). Fractional anisotropy (FA) values of the fornix and the prefrontal-hippocampus functional connectivity was compared between MDD and HC groups. The correlation between the FA value of fornix and the strength of the functional connectivity in the prefrontal cortex (PFC) region showing significant differences between the two groups was identified. Results Compared with the HC group, adolescent MDD group had significant lower FA values in the fornix, as well as decreased functional connectivity in four PFC regions. Significant negative correlations were observed between fornix FA values and functional connectivity from hippocampus to PFC within the HC group. There was no significant correlation between the fornix FA and the strength of functional connectivity within the adolescent MDD group. Conclusions First-episode medication-naIve adolescent MDD showed decreased structural and functional connectivity as well as deficits of the association between structural and functional connectivity shown in HC in the PFC-hippocampus neural circuitry. These findings suggest that abnormal PFC-hippocampus neural circuitry may present in the early onset of MDD and play an important role in the neuropathophysiology of MDD.	[Geng, Haiyang; Chang, Miao; Jiang, Xiaowei; Li, Songbai; Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang 110001, Peoples R China; [Wu, Feng; Kong, Lingtao; Tang, Yanqing; Zhou, Qian; Chang, Miao; Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang 110001, Liaoning, Peoples R China; [Tang, Yanqing; Zhou, Yifang] China Med Univ, Affiliated Hosp 1, Dept Gerontol, Shenyang 110001, Liaoning, Peoples R China; [Wang, Fei] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA	China Medical University; China Medical University; China Medical University; Yale University	Li, SB; Wang, F (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang 110001, Peoples R China.; Wang, F (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang 110001, Liaoning, Peoples R China.; Wang, F (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA.	songbaili001@163.com; fei.wang@mail.cmu.edu.cn			National Natural Science Foundation of China [81101012, 81301166, 81071099, 81271499]; Liaoning Doctor Scientific Foundation [20111099]; Liaoning Pandeng Scholar; National Institution of Health [K01MH086621]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH086621] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Doctor Scientific Foundation; Liaoning Pandeng Scholar; National Institution of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Natural Science Foundation of China (81101012 to F. Wu, 81301166 to LK, 81071099 and 81271499 to YT), the Liaoning Doctor Scientific Foundation (20111099 to F. Wu), the Liaoning Pandeng Scholar (to F. Wang), the National Institution of Health (K01MH086621 to F. Wang), the National Alliance for Research on Schizophrenia and Depression (F. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajani M, 2014, PSYCHOL MED, V44, P2287, DOI 10.1017/S0033291713003000; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Barnea-Goraly N, 2009, BIOL PSYCHIAT, V66, P238, DOI 10.1016/j.biopsych.2009.02.025; Bessette KL, 2014, BRAIN IMAGING BEHAV, V8, P531, DOI 10.1007/s11682-013-9274-8; Birmaher B, 2007, J AM ACAD CHILD PSY, V46, P1503, DOI 10.1097/chi.0b013e318145ae1c; Birmaher B, 2009, BIPOLAR DISORD, V11, P52, DOI 10.1111/j.1399-5618.2008.00659.x; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Bracht T, 2015, J AFFECT DISORDERS, V187, P45, DOI 10.1016/j.jad.2015.06.041; Cao XH, 2012, J AFFECT DISORDERS, V141, P194, DOI 10.1016/j.jad.2012.03.002; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Cullen KR, 2010, J AM ACAD CHILD PSY, V49, P173, DOI 10.1016/j.jaac.2009.11.005; Davidson CA, 2012, SCHIZOPHR RES, V134, P165, DOI 10.1016/j.schres.2011.11.012; de Kwaasteniet B, 2013, BIOL PSYCHIAT, V74, P40, DOI 10.1016/j.biopsych.2012.12.024; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2013, NEURON, V77, P999, DOI 10.1016/j.neuron.2013.02.034; Elliott R, 1998, PSYCHOL MED, V28, P559, DOI 10.1017/S0033291798006709; Fairhall SL, 2010, BIOL PSYCHOL, V85, P499, DOI 10.1016/j.biopsycho.2010.09.002; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Forbes EE, 2006, J CHILD PSYCHOL PSYC, V47, P1031, DOI 10.1111/j.1469-7610.2006.01673.x; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Frodl T, 2011, J CLIN PSYCHIAT, V72, P448, DOI 10.4088/JCP.09m05393blu; Fu CHY, 2007, AM J PSYCHIAT, V164, P599, DOI 10.1176/appi.ajp.164.4.599; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gong QY, 2015, BIOL PSYCHIAT, V77, P223, DOI 10.1016/j.biopsych.2014.08.009; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Jin CW, 2011, NEUROSCI LETT, V503, P105, DOI 10.1016/j.neulet.2011.08.017; Kelley R, 2013, PSYCHIAT RES-NEUROIM, V211, P119, DOI 10.1016/j.pscychresns.2012.06.008; Kerestes R, 2012, PSYCHIAT RES-NEUROIM, V202, P30, DOI 10.1016/j.pscychresns.2011.11.004; Kong LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079055; Kong LT, 2013, J PSYCHIATR RES, V47, P733, DOI 10.1016/j.jpsychires.2013.02.003; Kuroki N, 2006, BIOL PSYCHIAT, V60, P22, DOI 10.1016/j.biopsych.2005.09.021; Lee BT, 2008, PROG NEURO-PSYCHOPH, V32, P778, DOI 10.1016/j.pnpbp.2007.12.009; Li WJ, 2014, J NEUROL SCI, V338, P46, DOI 10.1016/j.jns.2013.12.016; Liu H, 2014, SCHIZOPHRENIA BULL, V40, P469, DOI 10.1093/schbul/sbt044; Liu H, 2011, J MAGN RESON IMAGING, V34, P1430, DOI 10.1002/jmri.22784; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; MacMaster FP, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-2; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Milne AMB, 2012, J PSYCHIATR NEUROSCI, V37, P28, DOI 10.1503/jpn.110004; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nardi B, 2013, EUR REV MED PHARMACO, V17, P1546; Peng DH, 2014, J AFFECT DISORDERS, V168, P21, DOI 10.1016/j.jad.2014.05.061; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; Renouf AG, 1997, J AM ACAD CHILD PSY, V36, P998, DOI 10.1097/00004583-199707000-00023; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Shad MU, 2012, J CHILD ADOL PSYCHOP, V22, P190, DOI 10.1089/cap.2011.0005; Sheline YI, 2011, BIOL PSYCHIAT, V70, P308, DOI 10.1016/j.biopsych.2011.06.006; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Steffens DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022697; Tang Y, 2013, PSYCHOL MED, V43, P1921, DOI 10.1017/S0033291712002759; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang LH, 2008, PSYCHIAT RES-NEUROIM, V163, P143, DOI 10.1016/j.pscychresns.2007.10.004; Wang YF, 2014, NEUROENDOCRINOL LETT, V35, P697; Wang Z, 2015, NEUROSCI BULL, V31, P13, DOI 10.1007/s12264-014-1489-1; Wang ZJ, 2015, NEUROSCIENTIST, V21, P290, DOI 10.1177/1073858414537560; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; Xu K, 2013, J PSYCHIATR NEUROSCI, V38, P43, DOI 10.1503/jpn.110132; Ye M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133775; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zou K, 2010, BIOL PSYCHIAT, V67, P186, DOI 10.1016/j.biopsych.2009.09.014	65	22	24	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148345	10.1371/journal.pone.0148345	http://dx.doi.org/10.1371/journal.pone.0148345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863301	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600057
J	Alcaraz, LD; Martinez-Sanchez, S; Torres, I; Ibarra-Laclette, E; Herrera-Estrella, L				David Alcaraz, Luis; Martinez-Sanchez, Shamayim; Torres, Ignacio; Ibarra-Laclette, Enrique; Herrera-Estrella, Luis			The Metagenome of Utricularia gibba's Traps: Into the Microbial Input to a Carnivorous Plant	PLOS ONE			English	Article							ESCHERICHIA-COLI; BLADDERWORT UTRICULARIA; PSEUDOMONAS-AERUGINOSA; RHIZOSPHERE MICROBIOME; COMPLETE GENOME; BACTERIAL; SEQUENCES; PROTEIN; DNA; 2-OXOGLUTARATE	The genome and transcriptome sequences of the aquatic, rootless, and carnivorous plant Utricularia gibba L. (Lentibulariaceae), were recently determined. Traps are necessary for U. gibba because they help the plant to survive in nutrient-deprived environments. The U. gibba's traps (Ugt) are specialized structures that have been proposed to selectively filter microbial inhabitants. To determine whether the traps indeed have a microbiome that differs, in composition or abundance, from the microbiome in the surrounding environment, we used whole-genome shotgun (WGS) metagenomics to describe both the taxonomic and functional diversity of the Ugt microbiome. We collected U. gibba plants from their natural habitat and directly sequenced the metagenome of the Ugt microbiome and its surrounding water. The total predicted number of species in the Ugt was more than 1,100. Using pangenome fragment recruitment analysis, we were able to identify to the species level of some key Ugt players, such as Pseudomonas monteilii. Functional analysis of the Ugt metagenome suggests that the trap microbiome plays an important role in nutrient scavenging and assimilation while complementing the hydrolytic functions of the plant.	[David Alcaraz, Luis; Martinez-Sanchez, Shamayim] Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Lab Nacl Ciencias Sostenibilidad, Inst Ecol, AP 70-275, Mexico City 04510, DF, Mexico; [Torres, Ignacio] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Antigua Carretera Patzcuaro 8701, Morelia 58190, Michoacan, Mexico; [Ibarra-Laclette, Enrique] Inst Ecol AC, Red Estudios Mol Avanzados, Carretera Antigua Coatepec 351, El Haya Xalapa 91070, Veracruz, Mexico; [Ibarra-Laclette, Enrique; Herrera-Estrella, Luis] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad LANGEBIO, Km 9-6 Carretera Irapuato Leon, Guanajuato 36821, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto de Ecologia - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Alcaraz, LD (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Lab Nacl Ciencias Sostenibilidad, Inst Ecol, AP 70-275, Mexico City 04510, DF, Mexico.	lalcaraz@iecologia.unam.mx	Alcaraz, Luis David/D-1352-2011; Herrera-Estrella, Luis/AAL-2472-2020; Herrera-Estrella, Luis/ABC-7431-2020	Alcaraz, Luis David/0000-0003-3284-0605; Herrera-Estrella, Luis/0000-0001-7936-3856; 	HHMI grant [55007646];  [DGAPA-PAPIIT-UNAM IA200514];  [CONACyT CB0237387]	HHMI grant(Howard Hughes Medical Institute); ; 	This work was supported by the HHMI grant 55007646 to LHE. LDA and SMS were supported by grants DGAPA-PAPIIT-UNAM IA200514, and CONACyT CB0237387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the HHMI grant 55007646 to LHE. LDA and SMS were supported by grants DGAPA-PAPIIT-UNAM IA200514, and CONACyT CB0237387. We thank the valuable comments and suggestions of three anonymous reviewers.	Adamczack J, 2014, J BIOL CHEM, V289, P30753, DOI 10.1074/jbc.M114.603886; Allali N, 2002, J BACTERIOL, V184, P3224, DOI 10.1128/JB.184.12.3224-3231.2002; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Cao HX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00526; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dorador C, 2013, FUND APPL LIMNOL, V182, P135, DOI 10.1127/1863-9135/2013/0393; Dueholm MS, 2014, BACTERIA USED BIOAUG, V2, P2010, DOI [10.1128/genomeA.00524-14, DOI 10.1128/GENOMEA.00524-14]; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Elomari M, 1997, ISOLATED CLIN SPECIM, V60, P846; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Frisli T, 2013, J APPL MICROBIOL, V114, P141, DOI 10.1111/jam.12035; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Ghai R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00490; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Gliessmon SR, 1988, AGROECOLOGY ECOLOGIC; Gotelli N, 2013, ENCY BIODIVERSITY, V5; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Hardoim PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030438; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; HINTON DM, 1995, MYCOPATHOLOGIA, V129, P117, DOI 10.1007/BF01103471; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Horne I, 2002, CLONING EXPRESSION P, P2687; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Izumi A, 2012, PROTEINS, V80, P2799, DOI 10.1002/prot.24177; Juang TCC, 2011, BOT STUD, V52, P47; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Laalami S, 2014, CELL MOL LIFE SCI, V71, P1799, DOI 10.1007/s00018-013-1472-4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Liu Y, 2014, MAR GENOM, V15, P1, DOI 10.1016/j.margen.2014.04.005; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Madhaiyan M, 2013, GENOME ANNOUNC, V1, P3, DOI [10.1128/genomeA.00023-13.7, DOI 10.1128/GENOMEA.00023-13.7]; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miao JF, 2013, INT IMMUNOPHARMACOL, V16, P429, DOI 10.1016/j.intimp.2013.05.007; Moore A., 2009, ABSTRACTS PROGRAMS G, P41; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nagashima S, 2012, J BACTERIOL, V194, P3541, DOI 10.1128/JB.00511-12; Nakatsu CH, 2006, INT J SYST EVOL MICR, V56, P983, DOI 10.1099/ijs.0.63524-0; Nawrocki E.P., 2009, STRUCTURAL RNA HOMOL, DOI 10.7936/K78050MP; Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Paulson JN, 2011, GENOME BIOL, V12, P12, DOI 10.1186/1465-6906-12-S1-P17; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Perez-Gutierrez RA, 2013, ISME J, V7, P487, DOI 10.1038/ismej.2012.119; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Quadt-Hallman A, 1997, BACTERIAL ENDOPHYTES, V582, P577; Richards JH, 2001, AM J BOT, V88, P170, DOI 10.2307/2657137; Santiago-Rodriguez TM, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-435; Schleifer KH., 2009, BERGEYS MANUAL SYSTE, P19, DOI [DOI 10.1007/978-0-387-68489-5_3, 10.1007/978-0-387-68489-5_3]; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Sirova D, 2003, NEW PHYTOL, V159, P669, DOI 10.1046/j.1469-8137.2003.00834.x; Sirova D, 2014, ANN BOT-LONDON, V114, P125, DOI 10.1093/aob/mcu067; Sirova D, 2010, J EXP BOT, V61, P99, DOI 10.1093/jxb/erp286; Sirova D, 2009, AQUAT BOT, V90, P129, DOI 10.1016/j.aquabot.2008.07.007; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Vos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030600; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei CY, 2014, BIOL FERT SOILS, V50, P657, DOI 10.1007/s00374-013-0878-3; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Ziegler K, 2001, FEMS MICROBIOL LETT, V196, P13, DOI 10.1111/j.1574-6968.2001.tb10533.x	82	12	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148979	10.1371/journal.pone.0148979	http://dx.doi.org/10.1371/journal.pone.0148979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859489	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400113
J	Dubberke, ER; Olsen, MA; Stwalley, D; Kelly, CP; Gerding, DN; Young-Xu, Y; Mahe, C				Dubberke, Erik R.; Olsen, Margaret A.; Stwalley, Dustin; Kelly, Ciaran P.; Gerding, Dale N.; Young-Xu, Yinong; Mahe, Cedric			Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; UNITED-STATES; DISEASE; EPIDEMIOLOGY; HOSPITALS; NOROVIRUS; OUTBREAK; BURDEN	Background Population attributable risk percent (PAR%) is an epidemiological tool that provides an estimate of the percent reduction in total disease burden if that disease could be entirely eliminated among a subpopulation. As such, PAR% is used to efficiently target prevention interventions. Due to significant limitations in current Clostridium difficile Infection (CDI) prevention practices and the development of new approaches to prevent CDI, such as vaccination, we determined the PAR% for CDI in various subpopulations in the Medicare 5% random sample. Methods This was a retrospective cohort study using the 2009 Medicare 5% random sample. Comorbidities, infections, and healthcare exposures during the 12 months prior to CDI were identified. CDI incidence and PAR% were calculated for each condition/exposure. Easy to identify subpopulations that could be targeted from prevention interventions were identified based on PAR%. Findings There were 1,465,927 Medicare beneficiaries with 9,401 CDI cases for an incidence of 677/100,000 persons. Subpopulations representing less than 15% of the entire population and with a PAR% >= 30% were identified. These included deficiency anemia (PAR%=37.9%), congestive heart failure (PAR%=30.2%), fluid and electrolyte disorders (PAR%=29.6%), urinary tract infections (PAR%=40.5%), pneumonia (PAR%=35.2%), emergent hospitalization (PAR%=48.5%) and invasive procedures (PAR%=38.9%). Stratification by age and hospital exposures indicates hospital exposures are more strongly associated with CDI than age. Significance Small and identifiable subpopulations that account for relatively large proportions of CDI cases in the elderly were identified. These data can be used to target specific subpopulations for CDI prevention interventions.	[Dubberke, Erik R.; Olsen, Margaret A.; Stwalley, Dustin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Olsen, Margaret A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Kelly, Ciaran P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Gerding, Dale N.] Edward Hines Jr Vet Affairs Hosp, Hines, IL USA; [Gerding, Dale N.] Loyola Univ, Chicago Stritch Sch Med, Maywood, IL 60153 USA; [Young-Xu, Yinong] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Mahe, Cedric] Sanofi Pasteur, Lyon, France	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; Dartmouth College; Sanofi-Aventis; Sanofi France	Dubberke, ER (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	edubberk@dom.wustl.edu			Sanofi-Pasteur; Washington University Center for Administrative Data Research (CADR); Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1 TR000448]; Agency for Healthcare Research and Quality (AHRQ) [R24 HS19455]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R24HS019455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER	Sanofi-Pasteur; Washington University Center for Administrative Data Research (CADR); Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The funding for this study was provided by Sanofi-Pasteur. The sponsor participated in study design, interpretation of data, and preparation and review of the manuscript. Support was also provided by the Washington University Center for Administrative Data Research (CADR). CADR Research is supported in part by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) and Grant Number R24 HS19455 through the Agency for Healthcare Research and Quality (AHRQ). The funder provided support in the form of salaries for author CM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P157; Bateman BT, 2013, J THORAC CARDIOV SUR, V146, P472, DOI 10.1016/j.jtcvs.2013.02.075; Bignardi GE, 2007, J HOSP INFECT, V67, P198, DOI 10.1016/j.jhin.2007.07.001; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cunha BA, 2008, J HOSP INFECT, V70, P98, DOI 10.1016/j.jhin.2008.06.001; Dubberke ER, 2008, EMERG INFECT DIS, V14, P1031, DOI 10.3201/eid1407.070867; Dubberke ER, 2007, CLIN INFECT DIS, V45, P1543, DOI 10.1086/523582; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Dubberke ER, 2011, INFECT CONT HOSP EP, V32, P360, DOI 10.1086/658944; Ghose C, 2015, INFECT DIS CLIN N AM, V29, P145, DOI 10.1016/j.idc.2014.11.013; Goto M, 2014, CLIN INFECT DIS, V58, P688, DOI 10.1093/cid/cit737; Kuntz JL, 2012, EMERG INFECT DIS, V18, P960, DOI 10.3201/eid1806.111528; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P1202, DOI 10.2105/AJPH.85.9.1202; Poole C, 2015, ANN EPIDEMIOL, V25, P147, DOI 10.1016/j.annepidem.2014.11.015; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447; Zilberberg MD, 2011, INFECT CONT HOSP EP, V32, P649, DOI 10.1086/660360	27	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0146822	10.1371/journal.pone.0146822	http://dx.doi.org/10.1371/journal.pone.0146822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859403	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400004
J	Xu, LH; Zhang, TH; Zheng, LN; Li, HJ; Tang, YY; Luo, XG; Sheng, JH; Wang, JJ				Xu, LiHua; Zhang, TianHong; Zheng, LiNa; Li, HuiJun; Tang, YingYing; Luo, XingGuang; Sheng, JianHua; Wang, JiJun			Psychometric Properties of Prodromal Questionnaire-Brief Version among Chinese Help-Seeking Individuals	PLOS ONE			English	Article							CLINICAL HIGH-RISK; ULTRA-HIGH RISK; INTERRATER RELIABILITY; YOUNG-PEOPLE; PSYCHOSIS; SCHIZOPHRENIA; VALIDITY; PQ; EXPERIENCES; VALIDATION	Prodromal Questionnaire (PQ) and Structured Interview for Prodromal Syndromes (SIPS) have been used as a two-stage process for identifying subjects at clinical high risk (CHR) of psychosis. The Prodromal Questionnaire-Brief version (PQ-B) contains 21 items derived from the PQ. The present study aimed to examine the psychometric properties of PQ-B in a Chinese help-seeking outpatient sample and to explore which items can better predict CHR diagnosis by SIPS and future transition to psychosis. In our preliminary epidemiological study, 1461 patients from a pool of 2101 individuals (15-45 years of age) completed the two-stage process. In the present study, 239 (20%) people were randomly selected among the sample who met the initial PQ-B screening criteria but had no positive diagnosis on SIPS, as well as 72 individuals with negative results on both PQ-B and SIPS, 89 prodromal and 105 psychotic subjects, yielding a total of 505 participants. The internal consistency coefficient for the PQ-B was good, with a Cronbach's alpha of 0.897. The concordant validity of PQ-B with SIPS dichotomized diagnosis of prodrome/psychosis versus no psychosis was 0.54. To ensure 80% or a higher sensitivity and a certain specificity, 7 and 24 were respectively set as the cutoff points for the PQ-B total score and distress score for Chinese help-seeking outpatients. A logistic regression model based on six PQ-B items could allow predicting the psychotic diagnosis on SIPS, with an accuracy of 65.8%. Prodromal individuals who scored higher on the 12th item of PQ-B (Do you worry at times that something may be wrong with your mind?) were less likely to convert to psychosis. PQ-B is a useful instrument for screening CHR subjects, but the cutoff score may be higher than that recommended by the author scores for help-seeking individuals in outpatient clinics. Some specific PQ-B items may have significant predictive power on dichotomized SIPS diagnoses and deserve special attention from researchers in future studies.	[Xu, LiHua; Zhang, TianHong; Tang, YingYing; Sheng, JianHua; Wang, JiJun] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai Key Lab Psychot Disorders, BioX Inst,Minist Educ,Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Zheng, LiNa] Liaocheng Peoples Hosp, Dept Psychiat, Liaocheng, Shandong, Peoples R China; [Li, HuiJun] Florida A&M Univ, Dept Psychol, Tallahassee, FL USA; [Li, HuiJun] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Luo, XingGuang] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Luo, XingGuang] VA Connecticut Healthcare Syst, West Haven Campus, West Haven, CT USA; [Luo, XingGuang] Beijing Huilongguan Hosp, Biol Psychiat Res Ctr, Beijing, Peoples R China	Shanghai Jiao Tong University; State University System of Florida; Florida A&M University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Zhang, TH; Sheng, JH; Wang, JJ (corresponding author), Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai Key Lab Psychot Disorders, BioX Inst,Minist Educ,Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	zhang_tianhong@126.com; sjh-lyl@263.net; jijunwang27@163.com	Xu, Lihua/ABF-4012-2021	Zhang, TianHong/0000-0002-5379-7119	National Natural Science Foundation of China [81201043, 81171267, 81171280, 81372122, 81261120410, 81361120403]; Shanghai Science and Technology Committee [14411961400, 15411967200]; National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health) [2011-873]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]; Shanghai health system advanced appropriate technology [2013SY003]; Shanghai Municipal Natural Science Foundation [12ZR1448400]; Shanghai Jiao Tong University Foundation [14JCRY04, YG2014MS40]; National Key Clinical Disciplines at Shanghai Mental Health Center (OMAMH) [2011-873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health); Shanghai Key Laboratory of Psychotic Disorders; Shanghai health system advanced appropriate technology; Shanghai Municipal Natural Science Foundation; Shanghai Jiao Tong University Foundation; National Key Clinical Disciplines at Shanghai Mental Health Center (OMAMH)	1. National Natural Science Foundation of China (81201043, 81171267, 81171280, 81372122, 81261120410,81361120403) (www.nsfc.gov.cn) (the study design, data collection and analysis) 2. Shanghai Science and Technology Committee (14411961400, 15411967200) (www.stcsm.gov.cn) (the study design, data collection and analysis) 3. National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health, 2011-873; OMAMH, 2011-873) (www.smhc.org.cn) (data collection and analysis) 4. Shanghai Key Laboratory of Psychotic Disorders (13dz2260500) (www.smhc.org.cn) (data collection and analysis) 5. Shanghai health system advanced appropriate technology (2013SY003) (www.wsjsw.gov.cn/wsj/) (data collection and analysis) 6. Shanghai Municipal Natural Science Foundation (12ZR1448400) (www.stcsm.gov.cn) (preparation of the manuscript) 7. Shanghai Jiao Tong University Foundation (14JCRY04, YG2014MS40) (www.sjtu.edu.cn) (revised the manuscript)	Association AP, DIAGN STAT MAN MENT; Beck A.T., 1967, DEPRESSION CLIN EXPT; Bortolon C, 2015, COMPR PSYCHIAT, V57, P97, DOI 10.1016/j.comppsych.2014.10.011; Cassano P, 2012, PSYCHIAT SERV, V63, P482, DOI 10.1176/appi.ps.201100271; Chen FZ, 2016, EARLY INTERV PSYCHIA, V10, P308, DOI 10.1111/eip.12173; Chiu SC, 2010, J FORMOS MED ASSOC, V109, P647, DOI 10.1016/S0929-6646(10)60105-2; Fusar-Poli P, 2014, PSYCHOL MED, V44, P17, DOI 10.1017/S0033291713000184; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Guloksuz S, 2015, PSYCHOL MED, V45, P2389, DOI 10.1017/S0033291715000380; Hafner H, 1998, SOC PSYCH PSYCH EPID, V33, P380, DOI 10.1007/s001270050069; HOLLON SD, 1980, COGNITIVE THER RES, V4, P383, DOI 10.1007/BF01178214; Ising HK, 2012, SCHIZOPHRENIA BULL, V38, P1288, DOI 10.1093/schbul/sbs068; Jarrett M, 2012, SCHIZOPHR RES, V136, P1, DOI 10.1016/j.schres.2012.01.025; Kammermann J, 2009, FORTSCHR NEUROL PSYC, V77, P278, DOI 10.1055/s-0028-1109227; Kline E, 2012, SCHIZOPHR RES, V141, P72, DOI 10.1016/j.schres.2012.07.022; Loewy RL, 2012, EARLY INTERV PSYCHIA, V6, P69, DOI 10.1111/j.1751-7893.2011.00286.x; Loewy RL, 2011, SCHIZOPHR RES, V129, P42, DOI 10.1016/j.schres.2011.03.029; Loewy RL, 2005, SCHIZOPHR RES, V77, P141, DOI 10.1016/j.schres.2005.03.007; Markarian Y, 2010, CLIN PSYCHOL REV, V30, P78, DOI 10.1016/j.cpr.2009.09.005; Miller T, 2004, SCHIZOPHRENIA RES; Miller TJ, 1999, PSYCHIAT QUART, V70, P273, DOI 10.1023/A:1022034115078; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Miller TJ, 2002, AM J PSYCHIAT, V159, P863, DOI 10.1176/appi.ajp.159.5.863; Muller M, 2010, SCHIZOPHR RES, V123, P217, DOI 10.1016/j.schres.2010.08.018; O'Brien MP, 2014, J CONSULT CLIN PSYCH, V82, P90, DOI 10.1037/a0034667; Okewole AO, 2015, SCHIZOPHR RES, V164, P281, DOI 10.1016/j.schres.2015.01.006; Piskulic D, 2015, PSYCHIAT RES, V225, P93, DOI 10.1016/j.psychres.2014.10.021; Solis M, 2014, NATURE, V508, pS12, DOI 10.1038/508S12a; Therman S, 2014, INT J METH PSYCH RES, V23, P62, DOI 10.1002/mpr.1427; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283; Zhang TH, 2014, SCHIZOPHR RES, V152, P391, DOI 10.1016/j.schres.2013.11.039; [郑丽娜 Zheng Lina], 2012, [中国心理卫生杂志, Chinese Mental Health Journal], V26, P571	34	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148935	10.1371/journal.pone.0148935	http://dx.doi.org/10.1371/journal.pone.0148935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859774	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400107
J	Garcia-Gonzalez, R; Aldezabal, A; Laskurain, NA; Margalida, A; Novoa, C				Garcia-Gonzalez, Ricardo; Aldezabal, Arantza; Amaia Laskurain, Nere; Margalida, Antoni; Novoa, Claude			Influence of Snowmelt Timing on the Diet Quality of Pyrenean Rock Ptarmigan (Lagopus muta pyrenaica): Implications for Reproductive Success	PLOS ONE			English	Article							CLIMATE-CHANGE; CHEMICAL-COMPOSITION; BREEDING SUCCESS; PLANT PHENOLOGY; LARGE-SCALE; GROUSE; ALPINE; WEATHER; BIRDS; CONSEQUENCES	The Pyrenean rock ptarmigan (Lagopus muta pyrenaica) is the southernmost subspecies of the species in Europe and is considered threatened as a consequence of changes in landscape, human pressure, climate change, and low genetic diversity. Previous studies have shown a relationship between the date of snowmelt and reproductive success in the Pyrenean ptarmigan. It is well established that birds laying early in the breeding season have higher reproductive success, but the specific mechanism for this relationship is debated. We present an explicative model of the relationship between snowmelt date and breeding success mediated by food quality for grouse in alpine environments. From microhistological analyses of 121 faecal samples collected during three years in the Canigou Massif (Eastern Pyrenees), and the assessment of the chemical composition of the main dietary components, we estimated the potential quality of individual diets. Potential dietary quality was correlated with free-urate faecal N, a proxy of the digestible protein content ingested by ptarmigan, and both were correlated with phenological stage of consumed plants, which in turn depends on snowmelt date. Our findings suggest that the average snowmelt date is subject to a strong interannual variability influencing laying date. In years of early snowmelt, hens benefit from a longer period of high quality food resources potentially leading to a higher breeding success. On the contrary, in years of late snowmelt, hens begin their breeding period in poorer nutrient condition because the peaks of protein content of their main food items are delayed with respect to laying date, hence reducing breeding performance. We discuss the possible mismatch between breeding and snowmelt timing.	[Garcia-Gonzalez, Ricardo] CSIC, Inst Pirenaico Ecol, Jaca, Spain; [Aldezabal, Arantza; Amaia Laskurain, Nere] Univ Basque Country, Plant Biol & Ecol Dept, Bilbao, Spain; [Margalida, Antoni] Univ Lleida, Fac Life Sci & Engn, Div Wildlife, Dept Anim Prod, Lleida, Spain; [Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Novoa, Claude] Off Natl Chasse & Faune Sauvage, Prades, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of Basque Country; Universitat de Lleida; University of Bern	Margalida, A (corresponding author), Univ Lleida, Fac Life Sci & Engn, Div Wildlife, Dept Anim Prod, Lleida, Spain.; Margalida, A (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland.	amargalida@prodan.udl.cat	Aldezabal, Arantza/V-7930-2017; Margalida, Antoni/AAG-5337-2020; Margalida, Antoni/A-2723-2011; Margalida, Antoni/A-2723-2011	Aldezabal, Arantza/0000-0001-7917-7690; Margalida, Antoni/0000-0002-0576-3993; Laskurain, Nere Amaia/0000-0002-9521-8584; Garcia-Gonzalez, Ricardo/0000-0001-5625-8690; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212	Office National de la Chasse et de la Faune Sauvage (France); Consejo Superior de Investigaciones Cientificas (Spain); RTA (Agricultural Technologies and Resources) [2005-00160-C02-02, MAM 2484/2002]; LEDDRA project Desertification process and land degradation (SICA-EU) [FW7 ENV.2009.2.1.3.2]; Ministry of Economy and Competitiveness [RYC-2012-11867]	Office National de la Chasse et de la Faune Sauvage (France); Consejo Superior de Investigaciones Cientificas (Spain); RTA (Agricultural Technologies and Resources); LEDDRA project Desertification process and land degradation (SICA-EU); Ministry of Economy and Competitiveness	This study was conducted under the framework of a contract between the Office National de la Chasse et de la Faune Sauvage (France) and Consejo Superior de Investigaciones Cientificas (Spain). Additional funds were provided by RTA (Agricultural Technologies and Resources) 2005-00160-C02-02 and MAM 2484/2002 Spanish projects. LEDDRA project FW7 ENV.2009.2.1.3.2 Desertification process and land degradation (SICA-EU) also provided supplementary funds for publication process. AM was supported by a Ramon y Cajal research contract from the Ministry of Economy and Competitiveness (RYC-2012-11867).	Afonso I, 2006, LAGOPODO ALPINO LAGO, P11; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; ANDREEV AV, 1988, CAN J ZOOL, V66, P1382, DOI 10.1139/z88-203; [Anonymous], 1982, FOURRAGES; [Anonymous], 1965, ANATOMY DICOTYLEDONS; Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; BARNETT JK, 1994, J RANGE MANAGE, V47, P114, DOI 10.2307/4002817; Bech N, 2013, HEREDITY, V111, P402, DOI 10.1038/hdy.2013.62; Bech N, 2009, ANIM CONSERV, V12, P138, DOI 10.1111/j.1469-1795.2008.00233.x; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Blanco-Fontao B, 2009, J ORNITHOL, V151, P901; Bolos O.de., 1990, FLORA MANUAL DELS PA; Bossert A., 1980, Ornithologische Beobachter, V77, P121; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; BOUDAREL P, 1991, ACTA BIOL MONTANA, V10, P11; BRITTAS R, 1988, ORNIS SCAND, V19, P49, DOI 10.2307/3676527; Carey Cynthia, 1996, P324; Cattadori IM, 2000, WILDLIFE BIOL, V6, P213, DOI 10.2981/wlb.2000.018; Chapin F. S. III, 1975, Arctic and Alpine Research, V7, P209, DOI 10.2307/1549997; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; CLARKE JA, 1992, CONDOR, V94, P622, DOI 10.2307/1369247; Coppack T, 2004, ADV ECOL RES, V35, P131, DOI 10.1016/S0065-2504(04)35007-5; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Davies S, 2014, HORM BEHAV, V66, P41, DOI 10.1016/j.yhbeh.2014.04.003; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; DELBARRIO G, 1990, MT RES DEV, V10, P227, DOI 10.2307/3673602; DRENT RH, 1980, ARDEA, V68, P225; Dunn P, 2004, ADV ECOL RES, V35, P69, DOI 10.1016/S0065-2504(04)35004-X; ERIKSTAD KE, 1983, ORNIS SCAND, V14, P249, DOI 10.2307/3676311; Figueroa I, 2009, ETHOL ECOL EVOL, V21, P251, DOI 10.1080/08927014.2009.9522480; Filacorda S, 1997, WILDLIFE BIOL, V3, P187, DOI 10.2981/wlb.1997.023; Fisher R.A., 1963, STAT TABLES BIOL AGR, V6th; Garcia-Gonzalez R, PLOS ONE IN PRESS; Garcia-Gonzalez R., 2013, PASTOS NUEVOS RETOS, P41; Garcia-Gonzalez R, 1987, ACTA BIOL MONTANA, V7, P35; GASAWAY WC, 1976, COMP BIOCHEM PHYS A, V53, P109, DOI 10.1016/S0300-9629(76)80021-7; GONZALEZ G, 1989, REV ECOL-TERRE VIE, V44, P347; Grabowski MM, 2013, POLAR BIOL, V36, P1097, DOI 10.1007/s00300-013-1332-6; Haferkamp MR, 2005, RANGELAND ECOL MANAG, V58, P155, DOI 10.2111/04-01.1; HANNON SJ, 1988, AUK, V105, P330, DOI 10.2307/4087498; Huntley B., 2007, CLIMATIC ATLAS EUROP; Imperio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081598; Isern-Vallverdu J, 1990, B SAN VEG PLAGAS, V20, P311; Jensen GH, 2014, POLAR BIOL, V37, P1, DOI 10.1007/s00300-013-1404-7; JONES PJ, 1976, IBIS, V118, P547, DOI 10.1111/j.1474-919X.1976.tb03516.x; KADMON R, 1993, ECOLOGY, V74, P816, DOI 10.2307/1940808; Korner C, 1999, ALPINE PLANT LIFE FU; LAINE KM, 1987, OIKOS, V50, P389, DOI 10.2307/3565500; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Liebezeit JR, 2014, POLAR BIOL, V37, P1309, DOI 10.1007/s00300-014-1522-x; Lopez-Moreno JI, 2008, GLOBAL PLANET CHANGE, V61, P300, DOI 10.1016/j.gloplacha.2007.10.004; Lopez-Moreno JI, 2005, ARCT ANTARCT ALP RES, V37, P253, DOI 10.1657/1523-0430(2005)037[0253:RVOSDI]2.0.CO;2; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Marinas A, 2006, PIRINEOS, V161, P85, DOI DOI 10.3989/pirineos.2006.v161.4; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Martinez C., 1985, Donana Acta Vertebrata, V12, P174; Molau U, 2005, AM J BOT, V92, P422, DOI 10.3732/ajb.92.3.422; Moller AP, 2008, OECOLOGIA, V155, P845, DOI 10.1007/s00442-007-0944-3; MORTON ML, 1978, CONDOR, V80, P285, DOI 10.2307/1368037; MOSS R, 1972, BRIT J NUTR, V27, P285, DOI 10.1079/BJN19720093; MOSS R, 1972, J ANIM ECOL, V41, P411, DOI 10.2307/3477; Moss R., 1968, Symposia of the Zoological Society of London, VNo. 21, P207; MOSS R, 1984, IBIS, V126, P212, DOI 10.1111/j.1474-919X.1984.tb08000.x; MOSS R, 1990, ORNIS SCAND, V21, P115, DOI 10.2307/3676806; Newton I, 1989, LIFETIME REPROD BIRD; Nielsen JT, 2003, IBIS, V145, P1; Novoa C, 1999, REV ECOL-TERRE VIE, V54, P149; Novoa C, 2008, IBIS, V150, P270, DOI 10.1111/j.1474-919X.2007.00771.x; Oberbauer SF, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0481; OWEN M, 1975, J WILDLIFE MANAGE, V39, P271, DOI 10.2307/3799903; Pendlebury CJ, 2004, J EXP BIOL, V207, P2065, DOI 10.1242/jeb.00999; Penteriani V, 2003, IBIS, V145, pE77, DOI 10.1046/j.1474-919X.2003.00159.x; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Price MV, 1998, ECOLOGY, V79, P1261, DOI 10.1890/0012-9658(1998)079[1261:EOEWOP]2.0.CO;2; PROP J, 1991, OECOLOGIA, V87, P19, DOI 10.1007/BF00323775; PROP J, 1993, ORNIS SCAND, V24, P110, DOI 10.2307/3676360; PULLIAINEN E, 1991, HOLARCTIC ECOL, V14, P156; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Revermann R, 2012, J ORNITHOL, V153, P891, DOI 10.1007/s10336-012-0819-1; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Sanz JJ, 2003, GLOBAL CHANGE BIOL, V9, P461, DOI 10.1046/j.1365-2486.2003.00575.x; Sawa Y, 2011, BIRD STUDY, V58, P200, DOI 10.1080/00063657.2011.559532; Scherini GC, 2003, ARDEA, V91, P11; Sedinger JS, 1997, CONDOR, V99, P314, DOI 10.2307/1369937; SMYTH KE, 1984, CAN J ZOOL, V62, P2250, DOI 10.1139/z84-327; Storch I, 2000, WILDLIFE BIOL, V6, P195, DOI 10.2981/wlb.2000.016; TERPSTRA K, 1974, Zeitschrift fuer Tierphysiologie Tierernaehrung und Futtermittelkunde, V32, P306; Theurillat JP, 2000, PHYTOCOENOLOGIA, V30, P439; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; van Rees H, 1984, RANGELAND J, V6, P86; Visser ME, 2009, P ROY SOC B-BIOL SCI, V276, P2323, DOI 10.1098/rspb.2009.0213; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Wilson S, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-9; Wilson S, 2010, J AVIAN BIOL, V41, P319, DOI 10.1111/j.1600-048X.2009.04945.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; [No title captured]	98	10	11	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148632	10.1371/journal.pone.0148632	http://dx.doi.org/10.1371/journal.pone.0148632			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849356	Green Published, gold			2022-12-26	WOS:000369554000141
J	Fernandez-Reiriz, MJ; Irisarri, J; Labarta, U				Jose Fernandez-Reiriz, Mara; Irisarri, Jade; Labarta, Uxio			Flexibility of Physiological Traits Underlying Inter-Individual Growth Differences in Intertidal and Subtidal Mussels Mytilusgalloprovincialis	PLOS ONE			English	Article							MYTILUS-GALLOPROVINCIALIS LMK; CLAM RUDITAPES-PHILIPPINARUM; ROCKY SHORE ORIGIN; CRASSOSTREA-GIGAS; FEEDING-BEHAVIOR; ENVIRONMENTAL PARAMETERS; CLEARANCE RATE; FOOD REGIMES; SEED ORIGIN; EDULIS	Mussel seed (Mytilusgalloprovincialis) gathered from the intertidal and subtidal environments of a Galician embayment (NW, Spain) were maintained in the laboratory during five months to select fast (F) and slow (S) growing mussels. The physiological basis underlying inter-individual growth variations were compared for F and S mussels from both origins. Fast growing seemed to be a consequence of greater energy intake (20% higher clearance and ingestion rate) and higher food absorption rate coupled with low metabolic costs. The enhanced energy absorption (around 65% higher) resulted in 3 times higher Scope for Growth in F mussels (20.5 +/- 4.9 J h(-1)) than S individuals (7.3 +/- 1.1 J h(-1)). The higher clearance rate of F mussels appears to be linked with larger gill filtration surface compared to S mussels. Intertidal mussels showed higher food acquisition and absorption per mg of organic weight (i.e. mass-specific standardization) than subtidal mussels under the optimal feeding conditions of the laboratory. However, the enhanced feeding and digestive rates were not enough to compensate for the initial differences in tissue weight between mussels of similar shell length collected from the intertidal and subtidal environments. At the end of the experiment, subtidal individuals had higher gill efficiency, which probably lead to higher total feeding and absorption rates relative to intertidal individuals.	[Jose Fernandez-Reiriz, Mara; Irisarri, Jade; Labarta, Uxio] CSIC, Inst Invest Marinas, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Fernandez-Reiriz, MJ (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	mjreiriz@iim.csic.es	Labarta, Uxio/D-5644-2012		project Physiology and Genetic of Growth in Commercial Bivalves 'FIGEBIV' [AGL2013-49144-C3-2-R]; JAE-Predoc CSIC-FSE	project Physiology and Genetic of Growth in Commercial Bivalves 'FIGEBIV'; JAE-Predoc CSIC-FSE	This work was funded by the project Physiology and Genetic of Growth in Commercial Bivalves 'FIGEBIV' (AGL2013-49144-C3-2-R). JI was funded by JAE-Predoc CSIC-FSE 2012-2015.	Alfaro AC, 2008, MAR BIOL RES, V4, P376, DOI 10.1080/17451000802022879; [Anonymous], 1983, SHELL FORMATION MO 1; Babarro JMF, 2000, J MAR BIOL ASSOC UK, V80, P865, DOI 10.1017/S0025315400002848; Babarro JMF, 2000, J SHELLFISH RES, V19, P187; Babarro JMF, 2000, J SHELLFISH RES, V19, P195; Bayne B. L., 1985, EFFECTS STRESS POLLU; Bayne BL, 2004, INTEGR COMP BIOL, V44, P425, DOI 10.1093/icb/44.6.425; Bayne BL, 1999, PHYSIOL BIOCHEM ZOOL, V72, P705, DOI 10.1086/316714; Camacho AP, 1995, AQUACULTURE, V138, P349, DOI 10.1016/0044-8486(95)01139-0; CONOVER RJ, 1966, LIMNOL OCEANOGR, V11, P338, DOI 10.4319/lo.1966.11.3.0338; de Sousa JT, 2011, J EXP MAR BIOL ECOL, V406, P46, DOI 10.1016/j.jembe.2011.06.001; Fernandez-Reiriz MJ, 2001, J COMP PHYSIOL B, V171, P449; Filgueira R, 2006, LIMNOL OCEANOGR-METH, V4, P284, DOI 10.4319/lom.2006.4.284; Filgueira R, 2008, REV BIOL MAR OCEANOG, V43, P391; FISCHER H, 1983, MAR ECOL PROG SER, V12, P59, DOI 10.3354/meps012059; Freites L, 2003, CIENC MAR, V29, P603, DOI 10.7773/cm.v29i42.196; Freites L, 2002, COMP BIOCHEM PHYS B, V132, P453, DOI 10.1016/S1096-4959(02)00057-X; Freites L, 2002, AQUACULTURE, V207, P97, DOI 10.1016/S0044-8486(01)00752-9; HAWKINS AJS, 1990, MAR BIOL, V105, P197, DOI 10.1007/BF01344287; Iglesias JIP, 1996, J SHELLFISH RES, V15, P673; IVLEV VS, 1966, J FISH RES BOARD CAN, V23, P1727, DOI 10.1139/f66-160; Fernandez-Reiriz MJ, 2012, MAR ECOL PROG SER, V454, P65, DOI 10.3354/meps09660; Fernandez-Reiriz MJ, 2015, AQUACULTURE, V446, P42, DOI 10.1016/j.aquaculture.2015.04.025; Labarta U, 1997, MAR ECOL PROG SER, V152, P167, DOI 10.3354/meps152167; Leitao A, 2001, AQUACULTURE, V193, P39, DOI 10.1016/S0044-8486(00)00488-9; MALLET AL, 1987, J EXP MAR BIOL ECOL, V108, P217, DOI 10.1016/0022-0981(87)90086-4; Navarro JM, 2003, J EXP MAR BIOL ECOL, V287, P13, DOI 10.1016/S0022-0981(02)00501-4; Perez-Camacho A, 2014, ECOL INDIC, V45, P538, DOI 10.1016/j.ecolind.2014.05.015; Perez-Camacho A, 2013, AQUACULTURE, V406, P172, DOI 10.1016/j.aquaculture.2013.05.019; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Tamayo D, 2015, J EXP MAR BIOL ECOL, V471, P92, DOI 10.1016/j.jembe.2015.05.017; Tamayo D, 2014, MAR BIOL, V161, P1627, DOI 10.1007/s00227-014-2447-1; Tamayo D, 2013, J COMP PHYSIOL B, V183, P893, DOI 10.1007/s00360-013-0764-1; Tamayo D, 2011, AQUACULTURE, V321, P113, DOI 10.1016/j.aquaculture.2011.08.024; TEDENGREN M, 1990, MAR ECOL PROG SER, V59, P221, DOI 10.3354/meps059221; Widdows J., 1985, P161; Winberg G.G., 1960, FISH RES BOARD CAN, V194, P185; Wolowicz M, 1999, HALIOTIS, V28, P1; WORRALL CM, 1983, MAR ECOL PROG SER, V12, P267, DOI 10.3354/meps012267	39	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148245	10.1371/journal.pone.0148245	http://dx.doi.org/10.1371/journal.pone.0148245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849372	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000057
J	Motloch, LJ; Larbig, R; Gebing, T; Reda, S; Schwaiger, A; Leitner, J; Wolny, M; Eckardt, L; Hoppe, UC				Motloch, Lukas Jaroslaw; Larbig, Robert; Gebing, Tina; Reda, Sara; Schwaiger, Astrid; Leitner, Johannes; Wolny, Martin; Eckardt, Lars; Hoppe, Uta C.			By Regulating Mitochondrial Ca2+-Uptake UCP2 Modulates Intracellular Ca2+	PLOS ONE			English	Article							SINGLE-CHANNEL PROPERTIES; SENSITIVE K+ CHANNELS; UNCOUPLING PROTEIN-2; OXIDATIVE-PHOSPHORYLATION; CALCIUM UNIPORTER; INWARD CURRENT; RETICULUM; HEART; MCU; MEMBRANE	Introduction The possible role of UCP2 in modulating mitochondrial Ca2+-uptake (mCa(2+)-uptake) via the mitochondrial calcium uniporter (MCU) is highly controversial. Methods Thus, we analyzed mCa(2+)-uptake in isolated cardiac mitochondria, MCU single-channel activity in cardiac mitoplasts, dual Ca2+-transients from mitochondrial ((Ca2+)m) and intracellular compartment ((Ca2+)c) in the whole-cell configuration in cardiomyocytes of wildtype (WT) and UCP2(-/-) mice. Results Isolated mitochondria showed a Ru360 sensitive mCa(2+)-uptake, which was significantly decreased in UCP2(-/-) (229.4 +/- 30.8 FU vs. 146.3 +/- 23.4 FU, P<0.05). Single-channel registrations confirmed a Ru360 sensitive voltage-gated Ca2+-channel in mitoplasts, i.e. mCa1, showing a reduced single-channel activity in UCP2(-/-) (Po, total: 0.34 +/- 0.05% vs. 0.07 +/- 0.01%, P<0.05). In UCP2(-/-) cardiomyocytes (Ca2+)m was decreased (0.050 +/- 0.009 FU vs. 0.021 +/- 0.005 FU, P<0.05) while (Ca2+)c was unchanged (0.032 +/- 0.002 FU vs. 0.028 +/- 0.004 FU, P>0.05) and transsarcolemmal Ca2+-influx was inhibited suggesting a possible compensatory mechanism. Additionally, we observed an inhibitory effect of ATP on mCa(2+)-uptake in WT mitoplasts and (Ca2+)m of cardiomyocytes leading to an increase of (Ca2+)c while no ATP dependent effect was observed in UCP2(-/-). Conclusion Our results indicate regulatory effects of UCP2 on mCa(2+)-uptake. Furthermore, we propose, that previously described inhibitory effects on MCU by ATP may be mediated via UCP2 resulting in changes of excitation contraction coupling.	[Motloch, Lukas Jaroslaw; Larbig, Robert; Gebing, Tina; Reda, Sara; Schwaiger, Astrid; Leitner, Johannes; Wolny, Martin; Hoppe, Uta C.] Paracelsus Med Univ, Dept Internal Med 2, Salzburg, Austria; [Larbig, Robert; Eckardt, Lars] Univ Hosp Muenster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany	Paracelsus Private Medical University; University of Munster	Motloch, LJ (corresponding author), Paracelsus Med Univ, Dept Internal Med 2, Salzburg, Austria.	lukas.motloch@pmu.ac.at		Motloch, Lukas Jaroslaw/0000-0002-5829-6743	Marga and Walter Boll-Stiftung; Paracelsus Medical University, Salzburg [R-12/04038-LAR]	Marga and Walter Boll-Stiftung; Paracelsus Medical University, Salzburg	This work was supported by grants from the Marga and Walter Boll-Stiftung (UCH) and the Paracelsus Medical University, Salzburg (R-12/04038-LAR; LJM and RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja M, 2014, EMBO REP, V15, P205, DOI 10.1002/embr.201438446; Altschafl BA, 2007, BBA-BIOMEMBRANES, V1768, P1784, DOI 10.1016/j.bbamem.2007.04.011; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P., 2007, V45, P481; Bondarenko AI, 2015, PFLUG ARCH EUR J PHY, V467, P2509, DOI 10.1007/s00424-015-1727-z; Bondarenko AI, 2014, PFLUG ARCH EUR J PHY, V466, P1411, DOI 10.1007/s00424-013-1383-0; Bondarenko AI, 2013, PFLUG ARCH EUR J PHY, V465, P997, DOI 10.1007/s00424-013-1224-1; Bratic A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002324; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Er F, 2004, CIRCULATION, V110, P3100, DOI 10.1161/01.CIR.0000146900.84943.E0; Fieni F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2325; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gassanov N, 2006, CELL CALCIUM, V39, P175, DOI 10.1016/j.ceca.2005.10.008; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Holmuhamedov EL, 1998, AM J PHYSIOL-HEART C, V275, pH1567, DOI 10.1152/ajpheart.1998.275.5.H1567; HOLMUHAMEDOV EL, 1986, EUR J BIOCHEM, V158, P543, DOI 10.1111/j.1432-1033.1986.tb09788.x; Hoppe UC, 1998, CARDIOVASC RES, V38, P788, DOI 10.1016/S0008-6363(98)00047-9; Hoppe UC, 2010, FEBS LETT, V584, P1975, DOI 10.1016/j.febslet.2010.04.017; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kohlhaas M, 2010, CIRCULATION, V121, P1606, DOI 10.1161/CIRCULATIONAHA.109.914911; Korge P, 2001, AM J PHYSIOL-HEART C, V280, pH2203, DOI 10.1152/ajpheart.2001.280.5.H2203; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Lange PS, 2003, CARDIOVASC RES, V59, P321, DOI 10.1016/S0008-6363(03)00434-6; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Litsky ML, 1997, BIOCHEMISTRY-US, V36, P7071, DOI 10.1021/bi970180y; Lu XY, 2013, CIRC RES, V112, P424, DOI 10.1161/CIRCRESAHA.111.300501; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Pott C, 2005, CIRC RES, V97, P1288, DOI 10.1161/01.RES.0000196563.84231.21; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Tian XY, 2012, CIRC RES, V110, P1211, DOI [10.1161/CIRCRESAHA.111.262170, 10.1161/circresaha.111.262170]; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2013, J BIOL CHEM, V288, P15367, DOI 10.1074/jbc.M113.462259; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Wu ZF, 2009, ANTIOXID REDOX SIGN, V11, P1805, DOI [10.1089/ars.2009.2427, 10.1089/ARS.2009.2427]; Zazueta C, 1999, J BIOENERG BIOMEMBR, V31, P551, DOI 10.1023/A:1005464927366; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	62	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148359	10.1371/journal.pone.0148359	http://dx.doi.org/10.1371/journal.pone.0148359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849136	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000079
J	Nelp, MT; Song, Y; Wysocki, VH; Bandarian, V				Nelp, Micah T.; Song, Yang; Wysocki, Vicki H.; Bandarian, Vahe			A Protein-derived Oxygen Is the Source of the Amide Oxygen of Nitrile Hydratases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; enzyme catalysis; enzyme mechanism; metalloenzyme; post-translational modification (PTM); nitrile hydratase; protein chemical modification	SURFACE-INDUCED DISSOCIATION; NONHEME IRON; CATALYTIC MECHANISM; ACID LIGAND; CRYSTALLOGRAPHY; INTERMEDIATE; NUCLEOPHILE; SUBSTRATE; SUBUNIT; COMPLEX	Nitrile hydratase metalloenzymes are unique and important biocatalysts that are used industrially to produce high value amides from their corresponding nitriles. After more than three decades since their discovery, the mechanism of this class of enzymes is becoming clear with evidence from multiple recent studies that the cysteine-derived sulfenato ligand of the active site metal serves as the nucleophile that initially attacks the nitrile. Herein we describe the first direct evidence from solution phase catalysis that the source of the product carboxamido oxygen is the protein. Using O-18-labeled water under single turnover conditions and native high resolution protein mass spectrometry, we show that the incorporation of labeled oxygen into both product and protein is turnover-dependent and that only a single oxygen is exchanged into the protein even under multiple turnover conditions, lending significant support to proposals that the post-translationally modified sulfenato group serves as the nucleophile to initiate hydration of nitriles.	[Nelp, Micah T.; Bandarian, Vahe] Univ Utah, Dept Chem, 315 South 1400 East,TBBC 3627, Salt Lake City, UT 84112 USA; [Song, Yang; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University	Bandarian, V (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East,TBBC 3627, Salt Lake City, UT 84112 USA.	vahe@chem.utah.edu		Wysocki, Vicki/0000-0003-0495-2538	NIGMS of the National Institutes of Health [R01GM72623, R01GM113658]; Career Award in Biomedical Sciences from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113658, R01GM072623] Funding Source: NIH RePORTER	NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Career Award in Biomedical Sciences from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS of the National Institutes of Health Grants R01GM72623(to V. B.) and R01GM113658(to V. H. W.), and a Career Award in Biomedical Sciences from the Burroughs Wellcome Fund (to V. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADZAMLI IK, 1979, INORG CHEM, V18, P303, DOI 10.1021/ic50192a019; Arakawa T, 2009, J AM CHEM SOC, V131, P14838, DOI 10.1021/ja903979s; Blackwell AE, 2011, ANAL CHEM, V83, P2862, DOI 10.1021/ac200452b; Hashimoto K, 2008, J BIOL CHEM, V283, P36617, DOI 10.1074/jbc.M806577200; Heinrich L, 2001, EUR J INORG CHEM, P2203; Hopmann KH, 2014, INORG CHEM, V53, P2760, DOI 10.1021/ic500091k; JIN HY, 1993, J AM CHEM SOC, V115, P5290, DOI 10.1021/ja00065a048; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Kovacs JA, 2004, CHEM REV, V104, P825, DOI 10.1021/cr020619e; Light KM, 2015, CHEM SCI, V6, P6280, DOI 10.1039/c5sc02012c; Lydon J. D., 1981, INORG CHEM, V21, P3180; Martinez S, 2014, J AM CHEM SOC, V136, P1186, DOI 10.1021/ja410462j; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200; Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; NAGASAWA T, 1987, EUR J BIOCHEM, V162, P691, DOI 10.1111/j.1432-1033.1987.tb10692.x; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Nelp MT, 2014, BIOCHEMISTRY-US, V53, P3990, DOI 10.1021/bi500260j; Pereira RA, 1998, EXTREMOPHILES, V2, P347, DOI 10.1007/s007920050078; Piersma SR, 2000, J INORG BIOCHEM, V80, P283, DOI 10.1016/S0162-0134(00)00076-3; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Song Y, 2015, ACS CENTRAL SCI, V1, P477, DOI 10.1021/acscentsci.5b00251; SUGIURA Y, 1987, J AM CHEM SOC, V109, P5848, DOI 10.1021/ja00253a046; Takarada H, 2006, BIOSCI BIOTECH BIOCH, V70, P881, DOI 10.1271/bbb.70.881; Tsujimura M, 2003, J AM CHEM SOC, V125, P11532, DOI 10.1021/ja035018z; Yamanaka Y, 2015, ANGEW CHEM INT EDIT, V54, P10763, DOI 10.1002/anie.201502731	28	6	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7822	7829		10.1074/jbc.M115.704791	http://dx.doi.org/10.1074/jbc.M115.704791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26865634	Green Published, hybrid			2022-12-26	WOS:000374056700006
J	Abboud, J; Nougarou, F; Descarreaux, M				Abboud, Jacques; Nougarou, Francois; Descarreaux, Martin			Muscle Activity Adaptations to Spinal Tissue Creep in the Presence of Muscle Fatigue	PLOS ONE			English	Article							LOW-BACK-PAIN; TRUNK MOTOR VARIABILITY; SURFACE EMG SIGNAL; LUMBAR SPINE; FLEXION-RELAXATION; STABILIZING SYSTEM; PROLONGED FLEXION; SPECTRAL-ANALYSIS; PASSIVE STRETCH; STATIC FLEXION	Aim The aim of this study was to identify adaptations in muscle activity distribution to spinal tissue creep in presence of muscle fatigue. Methods Twenty-three healthy participants performed a fatigue task before and after 30 minutes of passive spinal tissue deformation in flexion. Right and left erector spinae activity was recorded using large-arrays surface electromyography (EMG). To characterize muscle activity distribution, dispersion was used. During the fatigue task, EMG amplitude root mean square (RMS), median frequency and dispersion in x-and y-axis were compared before and after spinal creep. Results Important fatigue-related changes in EMG median frequency were observed during muscle fatigue. Median frequency values showed a significant main creep effect, with lower median frequency values on the left side under the creep condition (p <= 0.0001). A significant main creep effect on RMS values was also observed as RMS values were higher after creep deformation on the right side (p = 0.014); a similar tendency, although not significant, was observed on the left side (p = 0.06). A significant creep effects for x-axis dispersion values was observed, with higher dispersion values following the deformation protocol on the left side (p <= 0.001). Regarding y-axis dispersion values, a significant creep x fatigue interaction effect was observed on the left side (p = 0.016); a similar tendency, although not significant, was observed on the right side (p = 0.08). Conclusion Combined muscle fatigue and creep deformation of spinal tissues led to changes in muscle activity amplitude, frequency domain and distribution.	[Abboud, Jacques] Univ Quebec Trois Rivieres, Dept Anat, Quebec City, PQ, Canada; [Nougarou, Francois] Univ Quebec Trois Rivieres, Dept Genie Elect, Quebec City, PQ, Canada; [Descarreaux, Martin] Univ Quebec Trois Rivieres, Dept Sci Activite Phys, Quebec City, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres	Abboud, J (corresponding author), Univ Quebec Trois Rivieres, Dept Anat, Quebec City, PQ, Canada.	jacques.abboud@uqtr.ca		Descarreaux, Martin/0000-0002-3545-5860	Universite du Quebec a Trois-Rivieres Excellence Fund; Natural Sciences and Engineering Research Council of Canada	Universite du Quebec a Trois-Rivieres Excellence Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Universite du Quebec a Trois-Rivieres Excellence Fund and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud J, 2015, J MANIP PHYSIOL THER, V38, P359, DOI 10.1016/j.jmpt.2015.06.007; Abboud J, 2014, EUR J APPL PHYSIOL, V114, P2645, DOI 10.1007/s00421-014-2985-8; Arjmand N, 2006, J BIOMECH, V39, P510, DOI 10.1016/j.jbiomech.2004.11.030; Avela J, 2004, J APPL PHYSIOL, V96, P2325, DOI 10.1152/japplphysiol.01010.2003; Bonato P, 2002, IEEE T NEUR SYS REH, V10, P38, DOI 10.1109/TNSRE.2002.1021585; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Callaghan JP, 1998, PHYS THER, V78, P8, DOI 10.1093/ptj/78.1.8; CHAFFIN DB, 1973, AM IND HYG ASSOC J, V34, P513, DOI 10.1080/0002889738506892; Champagne A, 2009, J MANIP PHYSIOL THER, V32, P521, DOI 10.1016/j.jmpt.2009.08.008; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; CRISCO JJ, 1992, CLIN BIOMECH, V7, P19, DOI 10.1016/0268-0033(92)90003-M; DE LUCA CJ, 1993, MUSCLE NERVE, V16, P210, DOI 10.1002/mus.880160216; Dickey JP, 2003, CLIN BIOMECH, V18, P783, DOI 10.1016/S0268-0033(03)00166-9; Dupeyron A, 2010, J ELECTROMYOGR KINES, V20, P426, DOI 10.1016/j.jelekin.2009.05.004; Falla D, 2014, PAIN, V155, P944, DOI 10.1016/j.pain.2014.01.027; Farina D, 2000, J ELECTROMYOGR KINES, V10, P337, DOI 10.1016/S1050-6411(00)00025-0; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Fowles JR, 2000, J APPL PHYSIOL, V89, P1179, DOI 10.1152/jappl.2000.89.3.1179; Fuller JR, 2011, EXP BRAIN RES, V211, P133, DOI 10.1007/s00221-011-2661-8; Gerhardt JJ, 2002, AMERICAN MEDICAL A T; Gonzalez-Izal M, 2012, J ELECTROMYOGR KINES, V22, P501, DOI 10.1016/j.jelekin.2012.02.019; Granata KP, 2005, CLIN BIOMECH, V20, P16, DOI 10.1016/j.clinbiomech.2004.09.001; Granata KP, 2000, SPINE, V25, P1398, DOI 10.1097/00007632-200006010-00012; Granata KR, 2004, HUM FACTORS, V46, P81, DOI 10.1518/hfes.46.1.81.30391; Guo HR, 2002, OCCUP ENVIRON MED, V59, P680, DOI 10.1136/oem.59.10.680; Hansen L, 2006, SPINE, V31, P1888, DOI 10.1097/01.brs.0000229232.66090.58; Herrmann CM, 2006, J ELECTROMYOGR KINES, V16, P637, DOI 10.1016/j.jelekin.2005.11.004; Hodges PW, 1999, ARCH PHYS MED REHAB, V80, P1005, DOI 10.1016/S0003-9993(99)90052-7; Hollman JH, 2013, GAIT POSTURE, V38, P161, DOI 10.1016/j.gaitpost.2012.10.028; Howarth SJ, 2013, J ELECTROMYOGR KINES, V23, P794, DOI 10.1016/j.jelekin.2013.04.002; Lariviere C, 2003, EUR J APPL PHYSIOL, V89, P171, DOI 10.1007/s00421-002-0769-z; Lehman Gregory J, 2005, Chiropr Osteopat, V13, P23, DOI 10.1186/1746-1340-13-23; Mannion AF, 1997, J REHABIL RES DEV, V34, P427; MARRAS WS, 1993, SPINE, V18, P617, DOI 10.1097/00007632-199304000-00015; MCGILL SM, 1992, CLIN BIOMECH, V7, P43, DOI 10.1016/0268-0033(92)90007-Q; MCLAIN RF, 1994, SPINE, V19, P495, DOI 10.1097/00007632-199403000-00001; Ng JKF, 2001, SPINE, V26, P53, DOI 10.1097/00007632-200101010-00011; O'Sullivan PB, 2002, SPINE, V27, P1238, DOI 10.1097/00007632-200206010-00019; Olson MW, 2014, HUM MOVEMENT SCI, V34, P12, DOI 10.1016/j.humov.2014.03.004; Olson MW, 2004, CLIN BIOMECH, V19, P769, DOI 10.1016/j.clinbiomech.2004.05.007; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Rogers EL, 2006, SPINE, V31, P839, DOI 10.1097/01.brs.0000206361.53451.c7; Sanchez-Zuriaga D, 2010, SPINE, V35, P517, DOI 10.1097/BRS.0b013e3181b967ea; Shin G, 2007, CLIN BIOMECH, V22, P965, DOI 10.1016/j.clinbiomech.2007.06.003; Shin G, 2009, SPINE, V34, P1873, DOI 10.1097/BRS.0b013e3181aa6a55; Solomonow M, 1999, SPINE, V24, P2426, DOI 10.1097/00007632-199912010-00003; Solomonow M, 1998, SPINE, V23, P2552, DOI 10.1097/00007632-199812010-00010; Solomonow M, 2012, J ELECTROMYOGR KINES, V22, P155, DOI 10.1016/j.jelekin.2011.11.008; THOMPSON WR, 2010, ACSMS GUIDELINES FOR; Toosizadeh N, 2013, ERGONOMICS, V56, P954, DOI 10.1080/00140139.2013.785601; Trajano GS, 2014, J APPL PHYSIOL, V117, P1486, DOI 10.1152/japplphysiol.00809.2014; Tucker K, 2009, J ELECTROMYOGR KINES, V19, P373, DOI 10.1016/j.jelekin.2007.10.003; VANDIEEN JH, 1993, ERGONOMICS, V36, P407, DOI 10.1080/00140139308967898; Vydevska-Chichova M, 2007, J ELECTROMYOGR KINES, V17, P131, DOI 10.1016/j.jelekin.2006.01.004; Zwarts MJ, 2003, MUSCLE NERVE, V28, P1, DOI 10.1002/mus.10358	55	15	15	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149076	10.1371/journal.pone.0149076	http://dx.doi.org/10.1371/journal.pone.0149076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866911	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700061
J	Gregorini, M; Corradetti, V; Rocca, C; Pattonieri, EF; Valsania, T; Milanesi, S; Serpieri, N; Bedino, G; Esposito, P; Libetta, C; Avanzini, MA; Mantelli, M; Ingo, D; Peressini, S; Albertini, R; Dal Canton, A; Rampino, T				Gregorini, Marilena; Corradetti, Valeria; Rocca, Chiara; Pattonieri, Eleonora Francesca; Valsania, Teresa; Milanesi, Samantha; Serpieri, Nicoletta; Bedino, Giulia; Esposito, Pasquale; Libetta, Carmelo; Avanzini, Maria Antonietta; Mantelli, Melissa; Ingo, Daniela; Peressini, Sabrina; Albertini, Riccardo; Dal Canton, Antonio; Rampino, Teresa			Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR	PLOS ONE			English	Article							EXPERIMENTAL KIDNEY-TRANSPLANTATION; STEM-CELLS; MESSENGER-RNA; TUBULOINTERSTITIAL FIBROSIS; THERAPEUTIC APPLICATIONS; GLOMERULAR HEMODYNAMICS; INFLAMMATORY RESPONSE; INTERSTITIAL FIBROSIS; NEPHROPATHY; RECEPTOR	We studied Mesenchymal Stromal Cells (MSC) effects in experimental Unilateral Ureteral Obstruction (UUO), a fibrogenic renal disease. Rats were divided in 5 groups: sham, UUO, MSC treated-UUO, ACEi treated-UUO, MSC+ACEi treated-UUO. Data were collected at 1, 7, 21 days. UUO induced monocyte renal infiltration, tubular cell apoptosis, tubular atrophy, interstitial fibrosis and overexpression of TGF beta, Renin mRNA (RENmRNA), increase of Renin, Angiotensin II (AII) and aldosterone serum levels. Both lisinopril (ACEi) and MSC treatment prevented monocyte infiltration, reduced tubular cell apoptosis, renal fibrosis and TGF beta expression. Combined therapy provided a further suppression of monocyte infiltration and tubular injury. Lisinopril alone caused a rebound activation of Renin-Angiotensin System (RAS), while MSC suppressed RENmRNA and Renin synthesis and induced a decrease of AII and aldosterone serum levels. Furthermore, in in-vitro and in-vivo experiments, MSC inhibit Human antigen R (HuR) trascription, an enhancer of RENmRNA stability by IL10 release. In conclusion, we demonstrate that in UUO MSC prevent fibrosis, by decreasing HuR-dependent RENmRNA stability. Our findings give a clue to understand the molecular mechanism through which MSC may prevent fibrosis in a wide and heterogeneous number of diseases that share RAS activation as common upstream pathogenic mechanism.	[Gregorini, Marilena; Corradetti, Valeria; Rocca, Chiara; Pattonieri, Eleonora Francesca; Valsania, Teresa; Milanesi, Samantha; Serpieri, Nicoletta; Bedino, Giulia; Esposito, Pasquale; Libetta, Carmelo; Dal Canton, Antonio; Rampino, Teresa] Fdn IRCCS Policlin San Matteo, Nephrol Unit, Dialysis, Transplantat, Pavia, Italy; [Gregorini, Marilena; Corradetti, Valeria; Rocca, Chiara; Pattonieri, Eleonora Francesca; Valsania, Teresa; Milanesi, Samantha; Serpieri, Nicoletta; Bedino, Giulia; Esposito, Pasquale; Libetta, Carmelo; Dal Canton, Antonio; Rampino, Teresa] Univ Pavia, Via Palestro 3, I-27100 Pavia, Italy; [Avanzini, Maria Antonietta; Mantelli, Melissa; Ingo, Daniela] Fdn IRCCS Policlin S Matteo, Lab Transplant Immunol Cell Factory, Pavia, Italy; [Peressini, Sabrina; Albertini, Riccardo] Fdn IRCCS Policlin San Matteo, Clin Chem Lab, Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Corradetti, V (corresponding author), Fdn IRCCS Policlin San Matteo, Nephrol Unit, Dialysis, Transplantat, Pavia, Italy.	valeria.corradetti@gmail.com	Pasquale, Esposito/I-8338-2012; Rampino, Teresa/AFI-8315-2022; Rampino, Teresa/AAF-3988-2022; CORRADETTI, VALERIA/P-7882-2015; Milanesi, Samantha/AAB-9539-2020; Avanzini, Maria Antonietta/K-7839-2016; albertini, riccardo/AAB-7779-2019	Pasquale, Esposito/0000-0002-0834-5586; Rampino, Teresa/0000-0002-5311-9174; Rampino, Teresa/0000-0002-5311-9174; CORRADETTI, VALERIA/0000-0003-4143-5345; Milanesi, Samantha/0000-0001-8055-1686; Avanzini, Maria Antonietta/0000-0002-6056-9018; GREGORINI, MARILENA/0000-0003-1440-6872; PATTONIERI, ELEONORA FRANCESCA/0000-0001-7870-2094; Mantelli, Melissa/0000-0001-9945-1861	Italian Society of Nephrology	Italian Society of Nephrology	Giulia Bedino received a grant from Italian Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Experiments have been supported by a grant of Italian Society of Nephrology.	Adams DJ, 2003, J BIOL CHEM, V278, P44894, DOI 10.1074/jbc.M307782200; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asanuma H, 2011, J SURG RES, V168, pE51, DOI 10.1016/j.jss.2010.06.022; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cantaluppi V, 2013, AM J KIDNEY DIS, V61, P300, DOI 10.1053/j.ajkd.2012.05.027; CANTON AD, 1977, KIDNEY INT, V12, P403, DOI 10.1038/ki.1977.131; Chaabane W, 2013, AM J PHYSIOL-RENAL, V304, pF432, DOI 10.1152/ajprenal.00425.2012; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Ciccocioppo R, 2014, CYTOTHERAPY, V16, P1080, DOI 10.1016/j.jcyt.2014.03.002; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; DALCANTON A, 1979, KIDNEY INT, V15, P457, DOI 10.1038/ki.1979.61; DALCANTON A, 1980, KIDNEY INT, V17, P491; De Martino M, 2010, TRANSPL P, V42, P1331, DOI 10.1016/j.transproceed.2010.03.079; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Grande MT, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-19; Gregorini M, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0044-1; Gregorini M, 2013, MAYO CLIN PROC, V88, P1174, DOI 10.1016/j.mayocp.2013.06.021; Greish Sahar, 2012, World J Stem Cells, V4, P101, DOI 10.4252/wjsc.v4.i10.101; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ishidoya S, 1996, KIDNEY INT, V49, P1110, DOI 10.1038/ki.1996.161; ISHIDOYA S, 1995, KIDNEY INT, V47, P1285, DOI 10.1038/ki.1995.183; Iwai N, 1996, HYPERTENSION, V27, P399, DOI 10.1161/01.HYP.27.3.399; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Krishnamurthy P, 2010, FASEB J, V24, P2484, DOI 10.1096/fj.09-149815; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Liu X, 2011, J PEDIATR SURG, V46, P537, DOI 10.1016/j.jpedsurg.2010.09.040; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Ma XL, 2013, CELL TRANSPLANT, V22, P2279, DOI 10.3727/096368912X658692; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Morris BJ, 2004, ACTA PHYSIOL SCAND, V181, P369, DOI 10.1111/j.1365-201X.2004.01307.x; Morrissey JJ, 1997, KIDNEY INT, V52, P926, DOI 10.1038/ki.1997.414; Morrissey JJ, 1999, AM J PHYSIOL-RENAL, V276, pF39, DOI 10.1152/ajprenal.1999.276.1.F39; Morrissey JJ, 1996, KIDNEY INT, V49, pS83; Muller DN, 2006, CLIN J AM SOC NEPHRO, V1, P221, DOI 10.2215/CJN.01201005; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Rampino Teresa, 2011, G Ital Nefrol, V28, P132; Rampino T, 2011, CLIN SCI, V120, P25, DOI 10.1042/CS20100147; Reinders MEJ, 2013, CYTOTHERAPY, V15, P663, DOI 10.1016/j.jcyt.2013.01.010; Reinders MEJ, 2010, NEPHROL DIAL TRANSPL, V25, P17, DOI 10.1093/ndt/gfp552; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; SHARMA AK, 1993, KIDNEY INT, V44, P774, DOI 10.1038/ki.1993.312; Sugiyama H, 2005, NEPHROL DIAL TRANSPL, V20, P2670, DOI 10.1093/ndt/gfi045; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067475; Truong LD, 2011, CONTRIB NEPHROL, V169, P311, DOI 10.1159/000314578; Ueno T, 2013, KIDNEY INT, V84, P297, DOI 10.1038/ki.2013.81; Vernon MA, 2010, SEMIN NEPHROL, V30, P302, DOI 10.1016/j.semnephrol.2010.03.004; Vidotti DB, 2004, AM J PHYSIOL-RENAL, V286, pF1039, DOI 10.1152/ajprenal.00371.2003; Visavadiya NP, 2011, NEPHRON EXP NEPHROL, V117, pE62, DOI [10.1159/000320593, 10.1159/000320594]; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; Yi T, 2012, ARCH PHARM RES, V35, P213, DOI 10.1007/s12272-012-0202-z; Zonta S, 2010, TRANSPL P, V42, P1336, DOI 10.1016/j.transproceed.2010.03.081	63	24	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148542	10.1371/journal.pone.0148542	http://dx.doi.org/10.1371/journal.pone.0148542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866372	Green Published, gold, Green Submitted			2022-12-26	WOS:000370050700020
J	Baiamonte, M; Parker, MO; Vinson, GP; Brennan, CH				Baiamonte, Matteo; Parker, Matthew O.; Vinson, Gavin P.; Brennan, Caroline H.			Sustained Effects of Developmental Exposure to Ethanol on Zebrafish Anxiety-Like Behaviour	PLOS ONE			English	Article							PRENATAL ALCOHOL EXPOSURE; CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL RESPONSES; ELEVATED PLUS-MAZE; SPECTRUM DISORDERS; SEX-DIFFERENCES; BETA-ENDORPHIN; STRESS; MECHANISMS; FEMALES	In zebrafish developmentally exposed to ambient ethanol (20mM-50mM) 1-9 days post fertilization (dpf), the cortisol response to stress has been shown to be significantly attenuated in larvae, juveniles and 6 month old adults. These data are somewhat at variance with similar studies in mammals, which often show heightened stress responses. To test whether these cortisol data correlate with behavioural changes in treated animals, anxiety-like behaviour of zebrafish larvae (9dpf and 10dpf) and juveniles (23dpf) was tested in locomotor assays designed to this end. In open field tests treated animals were more exploratory, spending significantly less time at the periphery of the arena. Behavioural effects of developmental exposure to ethanol were sustained in 6-month-old adults, as judged by assessment of thigmotaxis, novel tank diving and scototaxis. Like larvae and juveniles, developmentally treated adults were generally more exploratory, and spent less time at the periphery of the arena in thigmotaxis tests, less time at the bottom of the tank in the novel tank diving tests, and less time in the dark area in scototaxis tests. The conclusion that ethanol- exposed animals showed less anxiety-like behaviour was validated by comparison with the effects of diazepam treatment, which in thigmotaxis and novel tank diving tests had similar effects to ethanol pretreatment. There is thus a possible link between the hypophysealpituitary- interrenal axis and the behavioural actions of developmental ethanol exposure. The mechanisms require further elucidation.	[Baiamonte, Matteo; Vinson, Gavin P.; Brennan, Caroline H.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Parker, Matthew O.] Univ Portsmouth, Sch Hlth Sci & Social Work, Portsmouth, Hants, England	University of London; Queen Mary University London; University of Portsmouth	Brennan, CH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	c.h.brennan@qmul.ac.uk	Parker, Matthew/J-6815-2019	Parker, Matthew/0000-0002-7172-5231	National Centre for the replacement, refinement and reduction of animals in research, UK [G1000053]; Biotechnology and Biological Science Research Council, UK; Royal Society, UK; Biotechnology and Biological Sciences Research Council [976807] Funding Source: researchfish; National Centre for the Replacement [G1000053/1] Funding Source: researchfish	National Centre for the replacement, refinement and reduction of animals in research, UK; Biotechnology and Biological Science Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society, UK(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement	This work was supported by https://www.nc3rs.org.uk, G1000053, National Centre for the replacement, refinement and reduction of animals in research, UK, to CHB and MOP; http://www.bbsrc.ac.uk, Biotechnology and Biological Science Research Council, UK, to MB; and https://royalsociety.org, Royal Society, UK, to CHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinoff B, 2003, ALCOHOL CLIN EXP RES, V27, P1420, DOI 10.1097/01.ALC.0000087581.13912.64; Baiamonte M, 2015, PLOS ONE; Bailey JM, 2015, NEUROTOXICOL TERATOL, V48, P1, DOI 10.1016/j.ntt.2015.01.005; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Boyd KN, 2010, J NEUROCHEM, V115, P142, DOI 10.1111/j.1471-4159.2010.06904.x; Boyd KN, 2010, J NEUROCHEM, V112, P784, DOI 10.1111/j.1471-4159.2009.06509.x; Brennan CH, 2010, ZEBRAFISH MODELS NEU; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Carneiro LMV, 2005, NEUROTOXICOL TERATOL, V27, P585, DOI 10.1016/j.ntt.2005.06.006; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; COLANGELO W, 1982, PROG NEUROBIOL, V19, P271, DOI 10.1016/0301-0082(82)90009-0; Collier AD, 2014, PROG NEURO-PSYCHOPH, V55, P16, DOI 10.1016/j.pnpbp.2014.05.014; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; de Abreu MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103232; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; ELLIS FW, 1966, J PHARMACOL EXP THER, V153, P121; Evrard Sergio Gustavo, 2010, Vertex, V21, P260; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Gabriel KI, 2006, PSYCHONEUROENDOCRINO, V31, P1046, DOI 10.1016/j.psyneuen.2006.06.003; Gangisetty O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113228; Glavas MM, 2007, ALCOHOL CLIN EXP RES, V31, P1598, DOI 10.1111/j.1530-0277.2007.00460.x; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Haley DW, 2006, ALCOHOL CLIN EXP RES, V30, P2055, DOI 10.1111/j.1530-0277.2006.00251.x; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Hellemans KGC, 2010, ALCOHOL CLIN EXP RES, V34, P633, DOI 10.1111/j.1530-0277.2009.01132.x; Hellemans KGC, 2008, ANN NY ACAD SCI, V1144, P154, DOI 10.1196/annals.1418.016; JONES KL, 1973, LANCET, V2, P999; Keedwell PA, 2001, ADDICT BIOL, V6, P247, DOI 10.1080/13556210120056580; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Kim CK, 1999, ALCOHOL CLIN EXP RES, V23, P301, DOI 10.1097/00000374-199902000-00016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Marchesi C, 1997, PSYCHIAT RES, V72, P187, DOI 10.1016/S0165-1781(97)00101-7; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Mead EA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00154; O'Connor MJ, 2009, DEV DISABIL RES REV, V15, P225, DOI 10.1002/ddrr.74; Osborn JA, 1996, PSYCHONEUROENDOCRINO, V21, P127, DOI 10.1016/0306-4530(95)00037-2; Osborn JA, 1998, ALCOHOL CLIN EXP RES, V22, P685, DOI 10.1097/00000374-199805000-00021; Paintner A, 2012, J CHILD NEUROL, V27, P258, DOI 10.1177/0883073811428376; Parker MO, 2014, PROG NEURO-PSYCHOPH, V55, P94, DOI 10.1016/j.pnpbp.2014.03.011; Parker MO, 2015, AQUAT TOXICOL; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; Richendrfer H, 2012, BEHAV BRAIN RES, V228, P99, DOI 10.1016/j.bbr.2011.11.041; Rose AK, 2010, ALCOHOL CLIN EXP RES, V34, P2011, DOI 10.1111/j.1530-0277.2010.01298.x; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Schambra UB, 2015, NEUROTOXICOL TERATOL, V51, P1, DOI 10.1016/j.ntt.2015.07.003; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Slone JL, 2002, NEUROTOXICOL TERATOL, V24, P173, DOI 10.1016/S0892-0362(01)00186-6; Stewart A, 2011, PROG NEURO-PSYCHOPH, V35, P1421, DOI 10.1016/j.pnpbp.2010.11.035; Taylor A N, 1988, Adv Exp Med Biol, V245, P311; TAYLOR AN, 1981, ALCOHOL CLIN EXP RES, V5, P237, DOI 10.1111/j.1530-0277.1981.tb04895.x; TAYLOR AN, 1982, PHARMACOL BIOCHEM BE, V16, P585; TAYLOR AN, 1986, ALCOHOL, V3, P255, DOI 10.1016/0741-8329(86)90034-0; Tran S, 2014, PROG NEURO-PSYCHOPH, V55, P87, DOI 10.1016/j.pnpbp.2014.02.008; Uban KA, 2013, PSYCHONEUROENDOCRINO, V38, P1953, DOI 10.1016/j.psyneuen.2013.02.017; Vinson GP, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0028; Vinson GP, 2009, MOL CELL ENDOCRINOL, V300, P2, DOI 10.1016/j.mce.2008.09.008; WEINBERG J, 1992, ALCOHOL, V9, P219, DOI 10.1016/0741-8329(92)90057-H; WEINBERG J, 1988, ALCOHOL CLIN EXP RES, V12, P647, DOI 10.1111/j.1530-0277.1988.tb00258.x; Weinberg J, 2008, J NEUROENDOCRINOL, V20, P470, DOI 10.1111/j.1365-2826.2008.01669.x; Weinberg J, 1996, ALCOHOL CLIN EXP RES, V20, P122, DOI 10.1111/j.1530-0277.1996.tb01054.x	64	35	35	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148425	10.1371/journal.pone.0148425	http://dx.doi.org/10.1371/journal.pone.0148425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862749	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600070
J	Hegde, S; Kesterson, RA; Srivastava, OP				Hegde, Shylaja; Kesterson, Robert A.; Srivastava, Om P.			CRY beta A3/A1-Crystallin Knockout Develops Nuclear Cataract and Causes Impaired Lysosomal Cargo Clearance and Calpain Activation	PLOS ONE			English	Article							GAMMA-CRYSTALLIN; EYE LENS; ORGANELLE DEGRADATION; DOMINANT CATARACT; EPITHELIAL-CELLS; BETA-CRYSTALLIN; CALCIUM-BINDING; AUTOPHAGY; MUTATION; PROTEIN	beta A3/A1-crystallin is an abundant structural protein of the lens that is very critical for lens function. Many different genetic mutations have been shown to associate with different types of cataracts in humans and in animal models. beta A3/A1-crystallin has four Greek key-motifs that organize into two crystallin domains. It shown to bind calcium with moderate affinity and has putative calcium-binding site. Other than in the lens, beta A3/A1 is also expressed in retinal astrocytes, retinal pigment epithelial (RPE) cells, and retinal ganglion cells. The function of beta A3/A1-crystallin in the retinal cell types is well studied; however, a clear understanding of the function of this protein in the lens has not yet been established. In the current study, we generated the beta A3/A1-crystallin knockout (KO) mouse and explored the function of beta A3/A1-crystallin in lens development. Our results showed that beta A3-KO mice develop congenital nuclear cataract and exhibit persistent fetal vasculature condition. At the cellular level KO lenses show defective lysosomal clearance and accumulation of nuclei, mitochondria, and autophagic cargo in the outer cortical region of the lens. In addition, the calcium level and the expression and activity of calpain-3 were increased in KO lenses. Taken together, these results suggest the lack of beta A3-crystallin function in lenses, alters calcium homeostasis which in turn causes lysosomal defects and calpain activation. These defects are responsible for the development of nuclear cataract in KO lenses.	[Hegde, Shylaja; Srivastava, Om P.] Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, Birmingham, AL 35294 USA; [Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Srivastava, OP (corresponding author), Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, Birmingham, AL 35294 USA.	srivasta@uab.edu			NIH [EY-06400, P30EY003039, P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, P60 DK079626]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006400, P30EY003039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038, P60DK079626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by NIH grants EY-06400 (OS) and P30EY003039 [http://www.nih.gov/grants-funding]. For assistance in creating the mouse model, we thank the UAB Transgenic & Genetically Engineered Models Core; [supported by awards NIH P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, and P60 DK079626 (RAK)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bai F, 2003, J BIOL CHEM, V278, P36876, DOI 10.1074/jbc.M304010200; Bateman JB, 2000, INVEST OPHTH VIS SCI, V41, P3278; BERBERS GAM, 1984, EUR J BIOCHEM, V139, P467, DOI 10.1111/j.1432-1033.1984.tb08029.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; CLAYTON RM, 1986, CURR TOP DEV BIOL, V20, P137, DOI 10.1016/S0070-2153(08)60660-2; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Dirks RPH, 1998, EXP EYE RES, V66, P267, DOI 10.1006/exer.1997.0439; Ferrini W, 2004, INVEST OPHTH VIS SCI, V45, P1436, DOI 10.1167/iovs.03-0760; Gehlbach P, 2006, NEUROSCIENCE, V137, P447, DOI 10.1016/j.neuroscience.2005.08.084; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Graw J, 1999, GENOMICS, V62, P67, DOI 10.1006/geno.1999.5974; Gupta R, 2010, MOL VIS, V16, P2242; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Jobby MK, 2007, FEBS J, V274, P4135, DOI 10.1111/j.1742-4658.2007.05941.x; Kannabiran C, 1998, Mol Vis, V4, P21; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; NIXON RA, 1986, J NEUROSCI, V6, P1264; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Parthasarathy G, 2011, J MOL HISTOL, V42, P59, DOI 10.1007/s10735-010-9307-1; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Qi YH, 2004, HUM GENET, V114, P192, DOI 10.1007/s00439-003-1049-7; Reddy MA, 2004, HUM MOL GENET, V13, P945, DOI 10.1093/hmg/ddh110; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; Srivastava OP, 1999, BBA-PROTEIN STRUCT M, V1434, P331, DOI 10.1016/S0167-4838(99)00183-1; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Valapala M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2624; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Wenk M, 1999, J MOL BIOL, V286, P1533, DOI 10.1006/jmbi.1999.2582; Werten PJL, 1999, MOL BIOL REP, V26, P201, DOI 10.1023/A:1007046926233; Xi JH, 2003, MOL VIS, V9, P410; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang C, 2005, DEV DYNAM, V234, P36, DOI 10.1002/dvdy.20494; Zhang C, 2011, EUR J CELL BIOL, V90, P440, DOI 10.1016/j.ejcb.2011.01.003; Zou J, 2015, NEUROLOGY S, V84	49	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149027	10.1371/journal.pone.0149027	http://dx.doi.org/10.1371/journal.pone.0149027			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863613	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600141
J	Kirmeier, T; Gopalakrishnan, R; Gormanns, V; Werner, AM; Cuboni, S; Rudolf, GC; Hofner, G; Wanner, KT; Sieber, SA; Schmidt, U; Holsboer, F; Rein, T; Hausch, F				Kirmeier, Thomas; Gopalakrishnan, Ranganath; Gormanns, Vanessa; Werner, Anna M.; Cuboni, Serena; Rudolf, Georg C.; Hoefner, Georg; Wanner, Klaus T.; Sieber, Stephan A.; Schmidt, Ulrike; Holsboer, Florian; Rein, Theo; Hausch, Felix			Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores	PLOS ONE			English	Article							IMIPRAMINE BINDING-SITES; RAT-BRAIN; DOPAMINE TRANSPORTER; 5-HYDROXYTRYPTAMINE UPTAKE; SEROTONIN TRANSPORTER; TRICYCLIC ANTIDEPRESSANTS; DRUG DISCOVERY; H-3 IMIPRAMINE; COCAINE; IDENTIFICATION	The aim of this study was to design, synthesize and validate a multifunctional antidepressant probe that is modified at two distinct positions. The purpose of these modifications was to allow covalent linkage of the probe to interaction partners, and decoration of probe-target complexes with fluorescent reporter molecules. The strategy for the design of such a probe (i.e., azidobupramine) was guided by the need for the introduction of additional functional groups, conveying the required properties while keeping the additional moieties as small as possible. This should minimize the risk of changing antidepressant-like properties of the new probe azidobupramine. To control for this, we evaluated the binding parameters of azidobupramine to known target sites such as the transporters for serotonin (SERT), norepinephrine (NET), and dopamine (DAT). The binding affinities of azidobupramine to SERT, NET, and DAT were in the range of structurally related and clinically active antidepressants. Furthermore, we successfully visualized azidobupramine-SERT complexes not only in SERT-enriched protein material but also in living cells stably overexpressing SERT. To our knowledge, azidobupramine is the first structural analogue of a tricyclic antidepressant that can be covalently linked to target structures and further attached to reporter molecules while preserving antidepressant-like properties and avoiding radioactive isotopes.	[Kirmeier, Thomas; Holsboer, Florian] Max Planck Inst Psychiat, Clin Dept, Munich, Germany; [Gopalakrishnan, Ranganath; Gormanns, Vanessa; Werner, Anna M.; Cuboni, Serena; Schmidt, Ulrike; Rein, Theo; Hausch, Felix] Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany; [Rudolf, Georg C.; Sieber, Stephan A.] Tech Univ Munich, IAS, CIPSM, Dept Chem, Garching, Germany; [Hoefner, Georg; Wanner, Klaus T.] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, Munich, Germany; [Kirmeier, Thomas; Holsboer, Florian] HMNC GmbH, Munich, Germany; [Gopalakrishnan, Ranganath] Max Planck Inst Mol Physiol, Dept Biol Chem, AstraZeneca MPI Satellite Unit, Rheinlanddamm 201, D-44139 Dortmund, Germany; [Werner, Anna M.] Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Cuboni, Serena] Prosteros Biostruct GmbH, Planegg Martinsried, Germany; [Rudolf, Georg C.] BASF Chem India Pvt Ltd, TTC Area, Turbhe, Navi Mumbai, India	Max Planck Society; Max Planck Society; Technical University of Munich; University of Munich; Max Planck Society; Bernhard Nocht Institut fur Tropenmedizin; BASF	Rein, T; Hausch, F (corresponding author), Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany.	theorein@mpipsykl.mpg.de; hausch@mpipsykl.mpg.de		Wanner, Klaus/0000-0003-4399-1425; Rein, Theo/0000-0003-2850-4289				Arnold Thomas, 2008, Curr Protoc Protein Sci, VChapter 4, DOI 10.1002/0471140864.ps0408s53; Basile A, 2001, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0706S01/ABSTRACT; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Bianchi MT, 2008, MED HYPOTHESES, V70, P951, DOI 10.1016/j.mehy.2007.09.012; Bianchi MT, 2010, MED HYPOTHESES, V74, P297, DOI 10.1016/j.mehy.2009.09.003; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BOPP B, 1974, LIFE SCI, V14, P415, DOI 10.1016/0024-3205(74)90356-7; Callingham BA, 1967, EXCERPTA MEDICA  122, V122, P35; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cisar JS, 2012, J AM CHEM SOC, V134, P10385, DOI 10.1021/ja304213w; Cuboni S, 2014, ANGEW CHEM INT EDIT, V53, P5008, DOI 10.1002/anie.201310567; DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364; Grimm SH, 2015, CHEMMEDCHEM, V10, P1027, DOI 10.1002/cmdc.201500084; Gurevich EV, 1996, NEUROPSYCHOPHARMACOL, V14, P309, DOI 10.1016/0893-133X(95)00139-5; Hopkins AL, 2009, NATURE, V462, P167, DOI 10.1038/462167a; HORMAZABAL L, 1985, PSYCHOPHARMACOLOGY, V86, P205, DOI 10.1007/BF00431710; HORN AS, 1974, BRIT J PHARMACOL, V51, P399, DOI 10.1111/j.1476-5381.1974.tb10675.x; Hrdina PD, 1986, RECEPTOR BINDING, P455; Kelly JP, 1999, EUR NEUROPSYCHOPHARM, V9, P101, DOI 10.1016/S0924-977X(98)00010-8; Kubinyi H, 2002, J BRAZIL CHEM SOC, V13, P717, DOI 10.1590/S0103-50532002000600002; Lapinsky DJ, 2012, BIOORGAN MED CHEM, V20, P6237, DOI 10.1016/j.bmc.2012.09.010; Lapinsky DJ, 2011, BIOORGAN MED CHEM, V19, P504, DOI 10.1016/j.bmc.2010.11.002; Leslie BJ, 2008, CHEM SOC REV, V37, P1347, DOI 10.1039/b702942j; Lo G, 2014, BIOCONJUGATE CHEM, V25, P1172, DOI 10.1021/bc500195w; MAXWELL RA, 1969, J PHARMACOL EXP THER, V166, P320; Moellering RE, 2012, CHEM BIOL, V19, P11, DOI 10.1016/j.chembiol.2012.01.001; NAKAKI T, 1985, J NEUROCHEM, V45, P920, DOI 10.1111/j.1471-4159.1985.tb04081.x; Newman AH, 2006, J MED CHEM, V49, P6621, DOI 10.1021/jm0603973; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Parnas ML, 2008, MOL PHARMACOL, V73, P1141, DOI 10.1124/mol.107.043679; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Raghavan AS, 2009, DRUG DISCOV TODAY, V14, P178, DOI 10.1016/j.drudis.2008.09.014; ROTMAN A, 1982, BIOCHIM BIOPHYS ACTA, V714, P173, DOI 10.1016/0304-4165(82)90141-6; Sanchez C, 1999, CELL MOL NEUROBIOL, V19, P467, DOI 10.1023/A:1006986824213; SEGAWA T, 1977, J PHARM PHARMACOL, V29, P139, DOI 10.1111/j.2042-7158.1977.tb11270.x; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; STOCKERT M, 1986, J RECEPTOR RES, V6, P283, DOI 10.3109/10799898609074815; Sumranjit J, 2013, MOLECULES, V18, P10425, DOI 10.3390/molecules180910425; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; TODRICK A, 1969, J PHARM PHARMACOL, V21, P751, DOI 10.1111/j.2042-7158.1969.tb08164.x; USDIN TB, 1991, P NATL ACAD SCI USA, V88, P11168, DOI 10.1073/pnas.88.24.11168; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; WENNOGLE LP, 1985, EMBO J, V4, P971, DOI 10.1002/j.1460-2075.1985.tb03726.x; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107	48	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148608	10.1371/journal.pone.0148608	http://dx.doi.org/10.1371/journal.pone.0148608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863431	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600085
J	Maharani, A; Tampubolon, G				Maharani, Asri; Tampubolon, Gindo			National Economic Development Status May Affect the Association between Central Adiposity and Cognition in Older Adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; RISK-FACTORS; OBESITY; PERFORMANCE; OVERWEIGHT; POPULATION; PREVENTION; LIFE	Background Obesity is becoming a global problem, rather than one found only in developed countries. Although recent studies have suggested a detrimental effect of obesity on cognition, studies of the relationship between obesity and cognition among older adults have been limited to developed countries. We aimed to examine the associations between central obesity, as measured by waist circumference, and cognition level in adults aged 50 years and older in England and Indonesia. Methods We used linear regression models to analyse these associations and multiple imputation to manage missing data. The 2006 English Longitudinal Study of Ageing Wave 3 is the source of data from England, while data from Indonesia is sourced from the 2007 Indonesian Family Life Survey Wave 4. Findings Centrally obese respondents had lower cognition levels than non-centrally obese respondents in England. In contrast, central adiposity had a statistically significant positive association with cognition in Indonesia. Higher levels of education and higher economic status were associated with higher cognitive ability, while age was associated with lower cognition in both countries. Elevated C-reactive protein (CRP) concentrations and smoking behaviour, both linked to higher risk of obesity, were negatively associated with cognitive ability among older adults in England, but they had no statistically significant association with cognition among Indonesians. Interpretation The contradictory findings on obesity and cognition in England and Indonesia not only create a puzzle, but they may also have different policy implications in these countries. Reducing the prevalence of obesity may be the main focus in England and other developed countries to maintain older adults' cognition. However, Indonesia and other developing countries should place more emphasis on education, in addition to continued efforts to tackle the double burden of malnutrition, in order to prevent cognitive impairment among older adults.	[Maharani, Asri] Brawijaya Univ, Fac Med, Malang, Indonesia; [Maharani, Asri; Tampubolon, Gindo] Univ Manchester, Cathie Marsh Inst Social Res, Humanities Bridgeford St Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England	Brawijaya University; University of Manchester	Maharani, A (corresponding author), Brawijaya Univ, Fac Med, Malang, Indonesia.; Maharani, A (corresponding author), Univ Manchester, Cathie Marsh Inst Social Res, Humanities Bridgeford St Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	asri.maharani@postgrad.manchester.ac.uk	; Maharani, Asri/U-7663-2017	Tampubolon, Gindo/0000-0002-9081-2349; Maharani, Asri/0000-0002-5931-8692	Medical Research Council; Economic Research Council through the Lifelong Health and Wellbeing programme [G1001375/1]; MRC [G1001375] Funding Source: UKRI; Medical Research Council [G1001375] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic Research Council through the Lifelong Health and Wellbeing programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Gindo Tampubolon was supported by the Medical Research Council and Economic Research Council through the Lifelong Health and Wellbeing programme (grant reference: G1001375/1).	Asparouhov T., 2010, SIMPLE 2 ORDER CHI S, P1; Berg E. van den, 2007, Neurology, V69, P979, DOI 10.1212/01.wnl.0000271381.30143.75; Bettcher BM, 2012, BRAIN BEHAV IMMUN, V26, P103, DOI 10.1016/j.bbi.2011.07.240; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Corsi DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025120; Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Dobbelsteyn CJ, 2001, INT J OBESITY, V25, P652, DOI 10.1038/sj.ijo.0801582; Elias Merrill F, 2005, Neurobiol Aging, V26 Suppl 1, P11, DOI 10.1016/j.neurobiolaging.2005.08.019; Fergenbaum JH, 2009, OBESITY, V17, P1957, DOI 10.1038/oby.2009.161; Fiocco AJ, 2010, ARCH NEUROL-CHICAGO, V67, P876, DOI 10.1001/archneurol.2010.130; Gunstad J, 2006, J CLIN NEUROSCI, V13, P540, DOI 10.1016/j.jocn.2005.08.010; Guxens M, 2008, AM J EPIDEMIOL, V1, P1; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Kiliaan AJ, 2014, LANCET NEUROL, V13, P913, DOI 10.1016/S1474-4422(14)70085-7; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Kuo HK, 2006, J AM GERIATR SOC, V54, P97, DOI 10.1111/j.1532-5415.2005.00522.x; Marmot M., 2015, ENGLISH LONGITUDINAL, DOI [10.5255/UKDA-SN-5050-10., DOI 10.5255/UKDA-SN-5050-10, http://dx.doi.org/10.5255/UKDA-SN-5050-10]; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nilsson LG, 2009, SCAND J PSYCHOL, V50, P660, DOI 10.1111/j.1467-9450.2009.00777.x; Nyberg L, 1996, J GERONTOL B-PSYCHOL, V51, pP234, DOI 10.1093/geronb/51B.4.P234; Nyberg L, 1997, EXP AGING RES, V23, P137, DOI 10.1080/03610739708254029; Osika W, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a699; Paccaud F, 2000, J CLIN EPIDEMIOL, V53, P393, DOI 10.1016/S0895-4356(99)00184-5; Riggs N, 2010, CHILD NEUROPSYCHOL, V16, P279, DOI 10.1080/09297041003601488; Schneeweis N, 2014, DEMOGRAPHY, V51, P619, DOI 10.1007/s13524-014-0281-1; Skirbekk V, 2013, INTELLIGENCE, V41, P169, DOI 10.1016/j.intell.2013.02.001; Skirbekk V, 2012, P NATL ACAD SCI USA, V109, P770, DOI 10.1073/pnas.1112173109; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Sobal J., 2001, SOCIAL CULTURAL INFL; Strauss J., 2009, WR6751NIANICHD RAND; Sweat V, 2008, INFLAMMATION, V31, P198, DOI 10.1007/s10753-008-9065-3; Tampubolon G, 2015, ALZHEIMERS DEMENT, P1; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; West NA, 2009, J GERONTOL A-BIOL, V64, P103, DOI 10.1093/gerona/gln006; WHO, 2008, WAIST CIRCUMFERENCE; World Bank, 2013, DOUBL BURD MALN IND; Yaffe K, 2013, CHRONIC MED DIS COGN	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148406	10.1371/journal.pone.0148406	http://dx.doi.org/10.1371/journal.pone.0148406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863443	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600067
J	West, JD; Carrier, EJ; Bloodworth, NC; Schroer, AK; Chen, P; Ryzhova, LM; Gladson, S; Shay, S; Hutcheson, JD; Merryman, WD				West, James D.; Carrier, Erica J.; Bloodworth, Nathaniel C.; Schroer, Alison K.; Chen, Peter; Ryzhova, Larisa M.; Gladson, Santhi; Shay, Sheila; Hutcheson, Joshua D.; Merryman, W. David			Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension	PLOS ONE			English	Article							5-HYDROXYTRYPTAMINE TRANSPORTER GENE; SMOOTH-MUSCLE; 5-HT2B RECEPTORS; TRANSGENIC MOUSE; KNOCKOUT MICE; CROSS-TALK; CELLS; SRC; CONTRACTION; DISEASE	Serotonergic anorexigens are the primary pharmacologic risk factor associated with pulmonary arterial hypertension (PAH), and the resulting PAH is clinically indistinguishable from the heritable form of disease, associated with BMPR2 mutations. Both BMPR2 mutation and agonists to the serotonin receptor HTR2B have been shown to cause activation of SRC tyrosine kinase; conversely, antagonists to HTR2B inhibit SRC trafficking and downstream function. To test the hypothesis that a HTR2B antagonist can prevent BMRP2 mutation induced PAH by restricting aberrant SRC trafficking and downstream activity, we exposed BMPR2 mutant mice, which spontaneously develop PAH, to a HTR2B antagonist, SB204741, to block the SRC activation caused by BMPR2 mutation. SB204741 prevented the development of PAH in BMPR2 mutant mice, reduced recruitment of inflammatory cells to their lungs, and reduced muscularization of their blood vessels. By atomic force microscopy, we determined that BMPR2 mutant mice normally had a doubling of vessel stiffness, which was substantially normalized by HTR2B inhibition. SB204741 reduced SRC phosphorylation and downstream activity in BMPR2 mutant mice. Gene expression arrays indicate that the primary changes were in cytoskeletal and muscle contractility genes. These results were confirmed by gel contraction assays showing that HTR2B inhibition nearly normalizes the 400% increase in gel contraction normally seen in BMPR2 mutant smooth muscle cells. Heritable PAH results from increased SRC activation, cellular contraction, and vascular resistance, but antagonism of HTR2B prevents SRC phosphorylation, downstream activity, and PAH in BMPR2 mutant mice.	[West, James D.; Carrier, Erica J.; Chen, Peter; Gladson, Santhi; Shay, Sheila] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Bloodworth, Nathaniel C.; Schroer, Alison K.; Ryzhova, Larisa M.; Hutcheson, Joshua D.; Merryman, W. David] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	West, JD (corresponding author), Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA.; Merryman, WD (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA.	j.west@vanderbilt.edu; david.merryman@vanderbilt.edu	Merryman, W. David/AAY-4781-2021; West, James/E-2960-2010	Hutcheson, Joshua/0000-0002-8383-4435; West, James/0000-0002-6004-0202	NIH [R01 HL095797, P01 HL108800, R01 HL115103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115103, F30HL126280, P01HL108800, R01HL095797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following NIH grants: R01 HL095797 and P01 HL108800 (to JDW) and R01 HL115103 (to WDM). NCB was supported as an AHA Pre-Doctoral Fellow (15PRE23260021); AKS was supported as an NSF Graduate Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Adnot S, 2013, HANDB EXP PHARMACOL, V218, P365, DOI 10.1007/978-3-642-38664-0_15; Austin ED, 2009, SEMIN RESP CRIT CARE, V30, P386, DOI 10.1055/s-0029-1233308; Bloodworth NC, 2015, HYPERTENSION, V65, P483, DOI 10.1161/HYPERTENSIONAHA.114.04652; Chen WC, 2013, JOVE-J VIS EXP, DOI 10.3791/50023; Crona Daniel, 2009, BMC Pulm Med, V9, P19, DOI 10.1186/1471-2466-9-19; de Raaf MA, 2015, AM J PHYSIOL-LUNG C, V309, pL1164, DOI 10.1152/ajplung.00127.2015; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; Eddahibi S, 2001, J PHARMACOL EXP THER, V297, P148; FORBES IT, 1995, J MED CHEM, V38, P855, DOI 10.1021/jm00006a001; GURTNER HP, 1985, COR VASA, V27, P160; Hemnes AR, 2014, AM J RESP CRIT CARE, V189, P325, DOI 10.1164/rccm.201306-1086OC; Hu J, 2015, AM J CARDIOVASC DRUG; Hutcheson JD, 2012, J MOL CELL CARDIOL, V53, P707, DOI 10.1016/j.yjmcc.2012.08.012; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Johnson JA, 2011, AM J PHYSL LUNG CELL; Keegan A, 2001, CIRC RES, V89, P1231, DOI 10.1161/hh2401.100426; Lane Kirk L, 2011, Pulm Circ, V1, P72; Launay JM, 2012, BLOOD, V119, P1772, DOI 10.1182/blood-2011-06-358374; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machiyama H, 2014, J CELL SCI, V127, P3440, DOI 10.1242/jcs.143438; MacLean MR, 2010, ADV EXP MED BIOL, V661, P309, DOI 10.1007/978-1-60761-500-2_20; MacLean MR, 2004, CIRCULATION, V109, P2150, DOI 10.1161/01.CIR.0000127375.56172.92; Merryman WD, 2007, TISSUE ENG, V13, P2281, DOI 10.1089/ten.2006.0324; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P2591, DOI 10.1073/pnas.050282397; Parekh A, 2011, BIOPHYS J, V100, P573, DOI 10.1016/j.bpj.2010.12.3733; Paulin R, 2011, AM J PHYSIOL-HEART C, V301, pH1798, DOI 10.1152/ajpheart.00654.2011; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Prewitt AR, 2015, J BIOL CHEM, V290, P960, DOI 10.1074/jbc.M114.591057; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2000, CIRCULATION, V102, P2836; Sewell-Loftin MK, 2014, BIOMATERIALS, V35, P2809, DOI 10.1016/j.biomaterials.2013.12.051; Sewell-Loftin MK, 2012, J HEART VALVE DIS, V21, P513; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Talati M, 2014, DISEASES, V2, P20; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; Yao Q, 2014, J BIOL CHEM, V289, P12666, DOI 10.1074/jbc.M113.546481	48	59	63	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148657	10.1371/journal.pone.0148657	http://dx.doi.org/10.1371/journal.pone.0148657			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863209	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600092
J	Kieslich, CA; Tamamis, P; Guzman, YA; Onel, M; Floudas, CA				Kieslich, Chris A.; Tamamis, Phanourios; Guzman, Yannis A.; Onel, Melis; Floudas, Christodoulos A.			Highly Accurate Structure-Based Prediction of HIV-1 Coreceptor Usage Suggests Intermolecular Interactions Driving Tropism	PLOS ONE			English	Article							V3 LOOP; GP120; CHEMOKINE; ENTRY; RECEPTOR; CXCR4; CCR5; COFACTOR; PROTEASE	HIV-1 entry into host cells is mediated by interactions between the V3-loop of viral glycoprotein gp120 and chemokine receptor CCR5 or CXCR4, collectively known as HIV-1 coreceptors. Accurate genotypic prediction of coreceptor usage is of significant clinical interest and determination of the factors driving tropism has been the focus of extensive study. We have developed a method based on nonlinear support vector machines to elucidate the interacting residue pairs driving coreceptor usage and provide highly accurate coreceptor usage predictions. Our models utilize centroid-centroid interaction energies from computationally derived structures of the V3-loop: coreceptor complexes as primary features, while additional features based on established rules regarding V3-loop sequences are also investigated. We tested our method on 2455 V3-loop sequences of various lengths and subtypes, and produce a median area under the receiver operator curve of 0.977 based on 500 runs of 10-fold cross validation. Our study is the first to elucidate a small set of specific interacting residue pairs between the V3-loop and coreceptors capable of predicting coreceptor usage with high accuracy across major HIV-1 subtypes. The developed method has been implemented as a web tool named CRUSH, CoReceptor USage prediction for HIV-1, which is available at http://ares.tamu.edu/CRUSH/.	[Kieslich, Chris A.; Tamamis, Phanourios; Guzman, Yannis A.; Onel, Melis; Floudas, Christodoulos A.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX USA; [Kieslich, Chris A.; Tamamis, Phanourios; Guzman, Yannis A.; Onel, Melis; Floudas, Christodoulos A.] Texas A&M Univ, Texas A&M Energy Inst, College Stn, TX USA; [Guzman, Yannis A.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Princeton University	Floudas, CA (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX USA.; Floudas, CA (corresponding author), Texas A&M Univ, Texas A&M Energy Inst, College Stn, TX USA.	floudas@tamu.edu		Tamamis, Phanourios/0000-0002-3342-2651; Kieslich, Chris/0000-0002-1845-6589	Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research.	Aiamkitsumrit B, 2014, CURR HIV RES, V12, P132, DOI 10.2174/1570162X12666140526121746; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Altmann A, 2007, ANTIVIR THER, V12, P169; Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Bartlett AD, 2014, AIDS, V28, P1611, DOI 10.1097/QAD.0000000000000288; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Borchers HW, 2014, PRACMA PRACTICAL NUM; Bozek K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002977; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Cashin K, 2013, RETROVIROLOGY, V10, P1; Cashin K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08543; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Gorham RD, 2011, ANN BIOMED ENG, V39, P1252, DOI 10.1007/s10439-010-0226-9; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Heider D, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-14; Hou TJ, 2009, PROTEINS, V74, P837, DOI 10.1002/prot.22192; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kieslich CA, 2013, AIDS RES HUM RETROV, V29, P1386, DOI [10.1089/aid.2012.0173, 10.1089/AID.2012.0173]; Levy Y, 2003, J PHYS CHEM B, V107, P3068, DOI 10.1021/jp0219956; Lise S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-365; Meyer D, 2014, E1071 MISC FUNCTIONS; Montagna C, 2014, AIDS RES HUM RETROV, V30, P1203, DOI 10.1089/aid.2014.0006; Olejnik M, 2014, BIOINFORMATICS, V30, P3272, DOI 10.1093/bioinformatics/btu535; Pfeifer N, 2012, BIOINFORMATICS, V28, pI589, DOI 10.1093/bioinformatics/bts373; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; R Core Team, 2021, R LANGUAGE ENV STAT; Rajgaria R, 2008, PROTEINS, V70, P950, DOI 10.1002/prot.21561; Sander O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/journal.pcbi.0030058; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Tamamis P, 2014, BMC BIOPHYS, V7, DOI 10.1186/2046-1682-7-5; Tamamis P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095767; Tamamis P, 2013, BIOPHYS J, V105, P1502, DOI 10.1016/j.bpj.2013.07.049; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Younai FS, 2013, INT J ORAL SCI, V5, P191, DOI 10.1038/ijos.2013.76	48	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148974	10.1371/journal.pone.0148974	http://dx.doi.org/10.1371/journal.pone.0148974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859389	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400112
J	Zheng, WS; Men, HW; Li, J; Xing, Y; Wu, B; Wang, ZL; Li, JJ; Teng, DH; Shi, Y; Li, J; Jiang, P; Cai, JZ				Zheng, Weisheng; Men, Hewei; Li, Jing; Xing, Yu; Wu, Bin; Wang, Zhenglu; Li, Junjie; Teng, Dahong; Shi, Yuan; Li, Jiang; Jiang, Pu; Cai, Jinzhen			Global MicroRNA Expression Profiling of Mouse Livers following Ischemia-Reperfusion Injury at Different Stages	PLOS ONE			English	Article							HEPATIC ISCHEMIA/REPERFUSION INJURY; TRANSPLANTATION; IDENTIFICATION; TRANSLATION; SIGNATURE; MECHANISM; BEDSIDE; BENCH; STEM	Hepatic ischemia-reperfusion injury is a dynamic process consisting of two stages: ischemia and reperfusion, and triggers a cascade of physiological and biochemical events. Given the important role of microRNAs in regulating gene expression, we analyzed gene expression changes in mouse livers at sham control, ischemia stage, and reperfusion stage. We generated global expression profiles of microRNA and mRNA genes in mouse livers subjected to ischemia-reperfusion injury at the three stages, respectively. Comparison analysis showed that reperfusion injury had a distinct expression profile whereas the ischemia sample and the sham control were clustered together. Consistently, there are 69 differentially expressed microRNAs between the reperfusion sample and the sham control whereas 28 differentially expressed microRNAs between the ischemia sample and the sham control. We further identified two modes of microRNA expression changes in ischemia-reperfusion injury. Functional analysis of both the differentially expressed microRNAs in the two modes and their target mRNAs revealed that ischemia injury impaired mitochondrial function, nutrient consumption, and metabolism process. In contrast, reperfusion injury led to severe tissue inflammation that is predominantly an innate-immune response in the ischemia-reperfusion process. Our staged analysis of gene expression profiles provides new insights into regulatory mechanisms of microRNAs in mouse hepatic IR injury.	[Zheng, Weisheng; Men, Hewei; Xing, Yu; Wu, Bin; Wang, Zhenglu; Li, Junjie; Teng, Dahong; Shi, Yuan; Li, Jiang; Cai, Jinzhen] Tianjin First Cent Hosp, Dept Transplant Surg, Tianjin, Peoples R China; [Zheng, Weisheng] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Li, Jing] Tianjin First Cent Hosp, Dept Gastroenterol, Tianjin, Peoples R China; [Jiang, Pu] Chongqing Med Univ, Dept Forens Med, Coll Basic Med, Chongqing, Peoples R China; [Li, Jing] Tianjin Med Univ, Tianjin, Peoples R China	Tianjin Medical University; Tongji University; Tianjin Medical University; Chongqing Medical University; Tianjin Medical University	Cai, JZ (corresponding author), Tianjin First Cent Hosp, Dept Transplant Surg, Tianjin, Peoples R China.; Jiang, P (corresponding author), Chongqing Med Univ, Dept Forens Med, Coll Basic Med, Chongqing, Peoples R China.	jiangpu_e@163.com; caijinzhen@sina.com	Linong, Ji/AAB-6543-2020		National Natural Science Foundation of China [81170443, 81400680]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (81170443, 81400680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahde R, 2010, BRIT J SURG, V97, P1461, DOI 10.1002/bjs.7176; Banga NR, 2005, BRIT J SURG, V92, P528, DOI 10.1002/bjs.5004; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borozan I, 2006, AM J TRANSPLANT, V6, P806, DOI 10.1111/j.1600-6143.2006.01254.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen Q, 2013, TRANSPL P, V45, P492, DOI 10.1016/j.transproceed.2012.10.045; Defamie V, 2008, AM J TRANSPLANT, V8, P1221, DOI 10.1111/j.1600-6143.2008.02249.x; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gao SM, 2010, BIOCHEM BIOPH RES CO, V403, P203, DOI 10.1016/j.bbrc.2010.10.137; Gehrau RC, 2013, TRANSPLANTATION, V96, P926, DOI 10.1097/TP.0b013e3182a20398; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Jiang W, 2011, TRANSPL P, V43, P1462, DOI 10.1016/j.transproceed.2011.01.191; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Navarro-Sabate A, 2006, LIVER TRANSPLANT, V12, P1615, DOI 10.1002/lt.20863; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Vascotto C, 2006, PROTEOMICS, V6, P3455, DOI 10.1002/pmic.200500770; Wu He-Shui, 2004, Hepatobiliary Pancreat Dis Int, V3, P250; Xu CF, 2009, OMICS, V13, P513, DOI 10.1089/omi.2009.0035; Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	29	9	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148677	10.1371/journal.pone.0148677	http://dx.doi.org/10.1371/journal.pone.0148677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859886	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400064
J	Bao, Y; Song, WM; Pan, J; Jiang, CM; Srivastava, R; Li, B; Zhu, LY; Su, HY; Gao, XS; Liu, H; Yu, X; Yang, L; Cheng, XH; Zhang, HX				Bao, Yan; Song, Wei-Meng; Pan, Jing; Jiang, Chun-Mei; Srivastava, Renu; Li, Bei; Zhu, Lu-Ying; Su, Hong-Yan; Gao, Xiao-Shu; Liu, Hua; Yu, Xiang; Yang, Lei; Cheng, Xian-Hao; Zhang, Hong-Xia			Overexpression of the NDR1/HIN1-Like Gene NHL6 Modifies Seed Germination in Response to Abscisic Acid and Abiotic Stresses in Arabidopsis	PLOS ONE			English	Article							MOSAIC-VIRUS INFECTION; TUBBY-LIKE PROTEINS; HYPERSENSITIVE RESPONSE; SIGNAL-TRANSDUCTION; MEMBRANE-PROTEIN; LEAF SENESCENCE; THALIANA NHL10; EXPRESSION; TOLERANCE; NDR1	NHL (NDR1/HIN1-like) genes play crucial roles in pathogen induced plant responses to biotic stress. Here, we report the possible function of NHL6 in plant response to abscisic acid (ABA) and abiotic stress. NHL6 was highly expressed in non-germinated seeds, and its expression was strongly induced by ABA and multiple abiotic stress signals. Loss-of-function of NHL6 decreased sensitivity to ABA in the early developmental stages including seed germination and post-germination seedling growth of the nhl6 mutants. However, overexpression of NHL6 increased sensitivity to ABA, salt and osmotic stress of the transgenic plants. Further studies indicated that the increased sensitivity in the 35S:: NHL6 overexpressing plants could be a result of both ABA hypersensitivity and increased endogenous ABA accumulation under the stress conditions. It was also seen that the ABA-responsive element binding factors AREB1, AREB2 and ABF3 could regulate NHL6 expression at transcriptional level. Our results indicate that NHL6 plays an important role in the abiotic stresses-induced ABA signaling and biosynthesis, particularly during seed germination and early seedling development in Arabidopsis.	[Bao, Yan; Zhu, Lu-Ying; Su, Hong-Yan; Cheng, Xian-Hao; Zhang, Hong-Xia] Ludong Univ, Coll Agr, 186 Hongqizhong Rd, Yantai 264025, Peoples R China; [Bao, Yan; Song, Wei-Meng; Pan, Jing; Jiang, Chun-Mei; Li, Bei; Gao, Xiao-Shu; Liu, Hua; Yu, Xiang; Zhang, Hong-Xia] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China; [Bao, Yan; Srivastava, Renu] Iowa State Univ, Inst Plant Sci, Ames, IA 50011 USA; [Bao, Yan; Srivastava, Renu] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Yang, Lei] Nanjing Univ, Coll Life Sci, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China	Ludong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Iowa State University; Iowa State University; Nanjing University	Cheng, XH; Zhang, HX (corresponding author), Ludong Univ, Coll Agr, 186 Hongqizhong Rd, Yantai 264025, Peoples R China.; Zhang, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	chengxianhao@sohu.com; hxzhang@sippe.ac.cn	Yu, Xiang/H-9666-2019; Bao, Yan/AAQ-3173-2020; LIU, HUA/M-7659-2019	Yu, Xiang/0000-0002-5730-8802; Bao, Yan/0000-0002-9870-5943; yang, lei/0000-0003-2009-7316	National Natural Science Foundation of China [31171169, 31371228, 31370670, 31400226, 31470661]; National Mega Project of GMO Crops [2013ZX08001-003, 2013ZX08004002-006, 2014ZX0800942B]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08030108]; Natural Science Foundation of Shandong Province of China [ZR2014CM004]; Natural Science Foundation of Jiangsu Province of China [BK2012306]; Shanghai Key Laboratory of Bio-Energy Crops	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project of GMO Crops; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Shanghai Key Laboratory of Bio-Energy Crops	This work has been jointly supported by the following grants: the National Natural Science Foundation of China (31171169, 31371228, 31370670, 31400226, 31470661); the National Mega Project of GMO Crops (2013ZX08001-003, 2013ZX08004002-006, 2014ZX0800942B); the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA08030108); the Natural Science Foundation of Shandong Province of China (ZR2014CM004); the Natural Science Foundation of Jiangsu Province of China (BK2012306); and Shanghai Key Laboratory of Bio-Energy Crops.	Antoni R, 2013, PLANT PHYSIOL, V161, P931, DOI 10.1104/pp.112.208678; Bao Y, 2014, PLANT MOL BIOL, V86, P471, DOI 10.1007/s11103-014-0241-6; Bao Y, 2014, NEW PHYTOL, V202, P174, DOI 10.1111/nph.12644; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Cacas JL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-144; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coppinger P, 2004, PLANT J, V40, P225, DOI 10.1111/j.1365-313X.2004.02203.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dormann P, 2000, PLANT PHYSIOL BIOCH, V38, P789, DOI 10.1016/S0981-9428(00)01186-4; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Gopalan S, 1996, PLANT CELL, V8, P1095, DOI 10.1105/tpc.8.7.1095; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; JEFFERSON RA, 1987, EMBO J, V6, P3901; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2002, NUCLEIC ACIDS RES, V40, pD302, DOI DOI 10.1093/NAR/GKR931; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu H, 2010, PLANT CELL ENVIRON, V33, P1989, DOI 10.1111/j.1365-3040.2010.02200.x; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pontier D, 1999, PLANT MOL BIOL, V39, P1243, DOI 10.1023/A:1006133311402; Reitz MU, 2012, PLANT PHYSIOL, V160, P349, DOI 10.1104/pp.112.201319; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Varet A, 2002, MOL PLANT MICROBE IN, V15, P608, DOI 10.1094/MPMI.2002.15.6.608; Vilaine F, 2013, PLANT CELL, V25, P1689, DOI 10.1105/tpc.113.111849; Yang L, 2008, PLANT MOL BIOL, V66, P329, DOI 10.1007/s11103-007-9267-3; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zheng MS, 2005, PLANT SCI, V168, P415, DOI 10.1016/j.plantsci.2004.09.016; Zheng MS, 2004, PLANTA, V218, P740, DOI 10.1007/s00425-003-1169-2; Zhu JQ, 2009, PHYSIOL PLANTARUM, V136, P407, DOI 10.1111/j.1399-3054.2009.01235.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	46	24	27	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148572	10.1371/journal.pone.0148572	http://dx.doi.org/10.1371/journal.pone.0148572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849212	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000128
J	Clooney, AG; Fouhy, F; Sleator, RD; Driscoll, AO; Stanton, C; Cotter, PD; Claesson, MJ				Clooney, Adam G.; Fouhy, Fiona; Sleator, Roy D.; Driscoll, Aisling O'; Stanton, Catherine; Cotter, Paul D.; Claesson, Marcus J.			Comparing Apples and Oranges?: Next Generation Sequencing and Its Impact on Microbiome Analysis	PLOS ONE			English	Article							ION TORRENT; ILLUMINA; PLATFORMS; BACTERIAL; IDENTIFICATION; TECHNOLOGIES; EXTRACTION; ASSEMBLER; CELL; DNA	Rapid advancements in sequencing technologies along with falling costs present widespread opportunities for microbiome studies across a vast and diverse array of environments. These impressive technological developments have been accompanied by a considerable growth in the number of methodological variables, including sampling, storage, DNA extraction, primer pairs, sequencing technology, chemistry version, read length, insert size, and analysis pipelines, amongst others. This increase in variability threatens to compromise both the reproducibility and the comparability of studies conducted. Here we perform the first reported study comparing both amplicon and shotgun sequencing for the three leading next-generation sequencing technologies. These were applied to six human stool samples using Illumina HiSeq, MiSeq and Ion PGM shotgun sequencing, as well as amplicon sequencing across two variable 16S rRNA gene regions. Notably, we found that the factor responsible for the greatest variance in microbiota composition was the chosen methodology rather than the natural inter-individual variance, which is commonly one of the most significant drivers in microbiome studies. Amplicon sequencing suffered from this to a large extent, and this issue was particularly apparent when the 16S rRNA V1-V2 region amplicons were sequenced with MiSeq. Somewhat surprisingly, the choice of taxonomic binning software for shotgun sequences proved to be of crucial importance with even greater discriminatory power than sequencing technology and choice of amplicon. Optimal N50 assembly values for the HiSeq was obtained for 10 million reads per sample, whereas the applied MiSeq and PGM sequencing depths proved less sufficient for shotgun sequencing of stool samples. The latter technologies, on the other hand, provide a better basis for functional gene categorisation, possibly due to their longer read lengths. Hence, in addition to highlighting methodological biases, this study demonstrates the risks associated with comparing data generated using different strategies. We also recommend that laboratories with particular interests in certain microbes should optimise their protocols to accurately detect these taxa using different techniques.	[Clooney, Adam G.; Claesson, Marcus J.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Fouhy, Fiona; Stanton, Catherine; Cotter, Paul D.] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Clooney, Adam G.; Sleator, Roy D.] Cork Inst Technol, Dept Biol Sci, Cork, Ireland; [Driscoll, Aisling O'] Cork Inst Technol, Dept Comp, Cork, Ireland; [Clooney, Adam G.; Fouhy, Fiona; Sleator, Roy D.; Driscoll, Aisling O'; Stanton, Catherine; Cotter, Paul D.; Claesson, Marcus J.] Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland	University College Cork; Teagasc; Cork Institute of Technology; Cork Institute of Technology; University College Cork	Claesson, MJ (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.; Cotter, PD (corresponding author), TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland.; Cotter, PD; Claesson, MJ (corresponding author), Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.	paul.cotter@teagasc.ie; m.claesson@ucc.ie	Cotter, Paul/AAX-5449-2021; Claesson, Marcus/AAE-4145-2019; Stanton, Catherine/A-9549-2015; Cotter, Paul/B-7781-2008	Cotter, Paul/0000-0002-5465-9068; Claesson, Marcus/0000-0002-5712-0623; Stanton, Catherine/0000-0002-6724-7011; Cotter, Paul/0000-0002-5465-9068; Fouhy, Fiona/0000-0002-8285-7694; Clooney, Adam/0000-0003-4881-9544	Science Foundation Ireland (SFI) [SFI/12/RC/2273, 11/PI/1137]; FP7 [603038]	Science Foundation Ireland (SFI)(Science Foundation Ireland); FP7	This publication has emanated from research supported in part by a research grant from Science Foundation Ireland (SFI) under Grant Number SFI/12/RC/2273 and 11/PI/1137 and by FP7 funded CFMATTERS (Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified, Grant Agreement no. 603038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0747-1; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Beck J, 2014, NEUROBIOL AGING, V35, P261, DOI 10.1016/j.neurobiolaging.2013.07.017; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brozynska M, 2014, DIRECT CHLOROPLAST S; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Freitas TAK, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv180; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lonardi S, 2015, BIOINFORMATICS, V31, P2972, DOI 10.1093/bioinformatics/btv311; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sinclair L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116955; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van der Veen BE, 2014, GENOMICS, V104, P459, DOI 10.1016/j.ygeno.2014.10.008; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wang J, 2014, SCI WORLD J, DOI 10.1155/2014/931515; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	38	154	158	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148028	10.1371/journal.pone.0148028	http://dx.doi.org/10.1371/journal.pone.0148028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849217	gold, Green Submitted, Green Published			2022-12-26	WOS:000369554000032
J	Koppram, R; Mapelli, V; Albers, E; Olsson, L				Koppram, Rakesh; Mapelli, Valeria; Albers, Eva; Olsson, Lisbeth			The Presence of Pretreated Lignocellulosic Solids from Birch during Saccharomyces cerevisiae Fermentations Leads to Increased Tolerance to Inhibitors - A Proteomic Study of the Effects	PLOS ONE			English	Article							ACETIC-ACID; XYLOSE; YEAST; EXPRESSION; CELLULASE; STRAIN; INVOLVEMENT; PATHWAY; ETHANOL; BIOMASS	The fermentation performance of Saccharomyces cerevisiae in the cellulose to ethanol conversion process is largely influenced by the components of pretreated biomass. The insoluble solids in pretreated biomass predominantly constitute cellulose, lignin, and -to a lesser extent-hemicellulose. It is important to understand the effects of water-insoluble solids (WIS) on yeast cell physiology and metabolism for the overall process optimization. In the presence of synthetic lignocellulosic inhibitors, we observed a reduced lag phase and enhanced volumetric ethanol productivity by S. cerevisiae CEN. PK 113-7D when the minimal medium was supplemented with WIS of pretreated birch or spruce and glucose as the carbon source. To investigate the underlying molecular reasons for the effects of WIS, we studied the response of WIS at the proteome level in yeast cells in the presence of acetic acid as an inhibitor. Comparisons were made with cells grown in the presence of acetic acid but without WIS in the medium. Altogether, 729 proteins were detected and quantified, of which 246 proteins were significantly up-regulated and 274 proteins were significantly down-regulated with a fold change >= 1.2 in the presence of WIS compared to absence of WIS. The cells in the presence of WIS up-regulated several proteins related to cell wall, glycolysis, electron transport chain, oxidative stress response, oxygen and radical detoxification and unfolded protein response; and down-regulated most proteins related to biosynthetic pathways including amino acid, purine, isoprenoid biosynthesis, aminoacyl-tRNA synthetases and pentose phosphate pathway. Overall, the identified differentially regulated proteins may indicate that the likelihood of increased ATP generation in the presence of WIS was used to defend against acetic acid stress at the expense of reduced biomass formation. Although, comparative proteomics of cells with and without WIS in the acetic acid containing medium revealed numerous changes, a direct effect of WIS on cellular physiology remains to be investigated.	[Koppram, Rakesh; Mapelli, Valeria; Albers, Eva; Olsson, Lisbeth] Chalmers Univ Technol, Dept Chem & Biol Engn, Ind Biotechnol, S-41296 Gothenburg, Sweden; [Koppram, Rakesh] Austrian Ctr Ind Biotechnol, Vienna, Austria	Chalmers University of Technology; Austrian Centre of Industrial Biotechnology	Olsson, L (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, Ind Biotechnol, S-41296 Gothenburg, Sweden.	lisbeth.olsson@chalmers.se	Mapelli, Valeria/E-4434-2014	Mapelli, Valeria/0000-0001-8724-3221; /0000-0002-0827-5442; Albers, Eva/0000-0002-1921-3415	Nordic Energy Top-level Research Initiative [TFI PK-bio 02]	Nordic Energy Top-level Research Initiative	This work was supported by Nordic Energy Top-level Research Initiative, TFI PK-bio 02, "HG Biofuels". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida B, 2009, PROTEOMICS, V9, P720, DOI 10.1002/pmic.200700816; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Ask M, 2013, BIOTECHNOLOGY BIOFUE, V6; Ask M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-87; Balat M, 2011, ENERG CONVERS MANAGE, V52, P858, DOI 10.1016/j.enconman.2010.08.013; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998; Carmelo V, 1996, ARCH MICROBIOL, V166, P315, DOI 10.1007/s002030050389; Casey E, 2010, FEMS YEAST RES, V10, P385, DOI 10.1111/j.1567-1364.2010.00623.x; Ding MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043474; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eliasson A, 2000, APPL ENVIRON MICROB, V66, P3381, DOI 10.1128/AEM.66.8.3381-3386.2000; Ferreira T, 2001, J BIOL CHEM, V276, P29613, DOI 10.1074/jbc.R100022200; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huttlin EL, 2007, J PROTEOME RES, V6, P392, DOI 10.1021/pr0603194; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Jeppsson M, 2003, FEMS YEAST RES, V3, P167, DOI 10.1016/S1567-1356(02)00186-1; Jorgensen H, 2007, BIOTECHNOL BIOENG, V96, P862, DOI 10.1002/bit.21115; Kawahata M, 2006, FEMS YEAST RES, V6, P924, DOI 10.1111/j.1567-1364.2006.00089.x; Koppram R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-32; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Lindberg L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073936; Mira NP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-79; Nissen TL, 2000, YEAST, V16, P463, DOI 10.1002/(SICI)1097-0061(20000330)16:5<463::AID-YEA535>3.0.CO;2-3; Pampulha ME, 2000, FEMS MICROBIOL LETT, V184, P69, DOI 10.1016/S0378-1097(00)00022-7; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Wang RF, 2014, BIORESOURCE TECHNOL, V172, P303, DOI 10.1016/j.biortech.2014.09.028; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wisselink HW, 2007, APPL ENVIRON MICROB, V73, P4881, DOI 10.1128/AEM.00177-07; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200; Zhou H, 2012, METAB ENG, V14, P611, DOI 10.1016/j.ymben.2012.07.011	35	6	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148635	10.1371/journal.pone.0148635	http://dx.doi.org/10.1371/journal.pone.0148635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849651	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000144
J	Sullivan, LL; Danielson, BJ; Harpole, WS				Sullivan, Lauren L.; Danielson, Brent J.; Harpole, W. Stanley			Mammalian Herbivores Alter the Population Growth and Spatial Establishment of an Early-Establishing Grassland Species	PLOS ONE			English	Article							DISTANCE SEED DISPERSAL; CHAMAECRISTA-FASCICULATA; INSECT HERBIVORY; PLANT; COMPETITION; CONSEQUENCES; DETERMINANTS; DIVERSITY; SELECTION; PATTERNS	Plant-herbivore interactions influence the establishment context of plant species, as herbivores alter the community context in which individual species establish, and the spatial relationship between individuals and their source population as plants invade. This relationship can be described using an establishment kernel, which takes into account movement through seed dispersal, and subsequent establishment of adults. Mammalian herbivores are hypothesized to influence plant population growth and establishment through a combination of consumption of seeds and seedlings, and movement of seeds. While the movement abilities of plants are well known, we have very few empirical mechanistic tests of how biotic factors like mammalian herbivores influence this spread potential. As herbivores of all sizes are abundant on the landscape, we asked the question, how do mammalian herbivores influence the population growth, spatial establishment, and the community establishment context of an early-recruiting native prairie legume, Chamaecrista fasciculata? We planted C. fasciculata in source populations within a four-acre tallgrass prairie restoration in plots with and without herbivores, and monitored its establishment with respect to distance from the source populations. We found that herbivores decreased population growth, and decreased the mean and range establishment distance. Additionally, C. fasciculata established more often without herbivores, and when surrounded by weedy, annual species. Our results provide insight into how the interactions between plants and herbivores can alter the spatial dynamics of developing plant communities, which is vital for colonization and range spread with fragmentation and climate change. Mammalian herbivores have the potential to both slow rates of establishment, but also determine the types of plant communities that surround invading species. Therefore, it is essential to consider the herbivore community when attempting to restore functioning plant communities.	[Sullivan, Lauren L.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Sullivan, Lauren L.; Danielson, Brent J.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Harpole, W. Stanley] UFZ Helmholtz Ctr Environm Res, Dept Physiol Divers, Permoserstr 15, D-04318 Leipzig, Germany; [Harpole, W. Stanley] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Harpole, W. Stanley] Univ Halle Wittenberg, Inst Biol, Kirchtor 1, D-06108 Halle, Saale, Germany	University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg	Sullivan, LL (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.; Sullivan, LL (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	lsulliva@umn.edu	Harpole, William S/C-2814-2013	Harpole, William S/0000-0002-3404-9174	Iowa Living Roadway Trust Fund [90-00-LRTF-211, 90-00-LRTF-307]; Audubon Toyota TogetherGreen Fellowship; National Science Foundation GRFP; Iowa State University, Department of Ecology Evolution and Organismal Biology	Iowa Living Roadway Trust Fund; Audubon Toyota TogetherGreen Fellowship; National Science Foundation GRFP(National Science Foundation (NSF)); Iowa State University, Department of Ecology Evolution and Organismal Biology	Funding for this work was provided by the Iowa Living Roadway Trust Fund << http://www.iowadot.gov/lrtf/>> project numbers: 90-00-LRTF-211 and 90-00-LRTF-307, the Audubon Toyota TogetherGreen Fellowship << http://www.togethergreen.org/>>, the National Science Foundation GRFP << https://www.nsfgrfp.org/>>, and the Iowa State University, Department of Ecology Evolution and Organismal Biology << http://www.eeob.iastate.edu/>>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Baer SG, 2002, ECOL APPL, V12, P1688, DOI 10.1890/1051-0761(2002)012[1688:CIESAF]2.0.CO;2; Bolker B., 2014, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; BROWN VK, 1989, OIKOS, V54, P67, DOI 10.2307/3565898; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Chang G, 2009, BEHAV PROCESS, V82, P7, DOI 10.1016/j.beproc.2009.03.002; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; CONNELL J H, 1971, P298; Craven S.R., 1994, DAMAGE PREVENTION CO; Durham CA, 2004, J AGR RESOUR ECON, V29, P112; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Eskelinen A, 2008, J ECOL, V96, P155, DOI 10.1111/j.1365-2745.2007.01322.x; FENSTER CB, 1991, AM J BOT, V78, P13, DOI 10.2307/2445224; FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x; Harper J. L., 1974, Annual Review of Ecology and Systematics, V5, P419, DOI 10.1146/annurev.es.05.110174.002223; Higgins SI, 2008, J ECOL, V96, P679, DOI 10.1111/j.1365-2745.2008.01391.x; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Honek A, 2011, BASIC APPL ECOL, V12, P89, DOI 10.1016/j.baae.2010.11.003; Howe HF, 2002, ECOL LETT, V5, P30, DOI 10.1046/j.1461-0248.2002.00276.x; Hulme PE, 1996, J ECOL, V84, P609, DOI 10.2307/2261482; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Klein EK, 2013, METHODS ECOL EVOL, V4, P1059, DOI 10.1111/2041-210X.12110; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; LEE TD, 1982, ECOLOGY, V63, P1363, DOI 10.2307/1938864; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; LOUDA SM, 1982, ECOL MONOGR, V52, P25, DOI 10.2307/2937343; Marazzi B., 2010, PREP FLORA N AM N ME; Maron JL, 1998, ECOLOGY, V79, P1281, DOI 10.1890/0012-9658(1998)079[1281:IHAABI]2.0.CO;2; Martin LM, 2005, J APPL ECOL, V42, P327, DOI 10.1111/j.1365-2664.2005.01019.x; MCCANNY SJ, 1985, OIKOS, V45, P148, DOI 10.2307/3565232; MURDOCH WW, 1966, AM NAT, V100, P219, DOI 10.1086/282415; Nathan R, 2004, J ECOL, V92, P733, DOI 10.1111/j.0022-0477.2004.00914.x; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Orrock JL, 2008, ECOLOGY, V89, P1168, DOI 10.1890/07-0223.1; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Plummer M, 2014, RJAGS BAYESIAN GRAPH; Rios RS, 2008, OECOLOGIA, V156, P577, DOI 10.1007/s00442-008-1024-z; Rutter MT, 2004, EVOLUTION, V58, P2657, DOI 10.1111/j.0014-3820.2004.tb01619.x; Salmon T., 2010, VOLES MEADOW MICE; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Teller BJ, 2014, ECOLOGY, V95, P2694, DOI 10.1890/14-0474.1; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; VANDERWALL SB, 1993, OECOLOGIA, V96, P246, DOI 10.1007/BF00317738; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8	55	4	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147715	10.1371/journal.pone.0147715	http://dx.doi.org/10.1371/journal.pone.0147715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849564	gold, Green Published			2022-12-26	WOS:000369554000023
J	Talbert, EE; Smuder, AJ; Kwon, OS; Sollanek, KJ; Wiggs, MP; Powers, SK				Talbert, Erin E.; Smuder, Ashley J.; Kwon, Oh Sung; Sollanek, Kurt J.; Wiggs, Michael P.; Powers, Scott K.			Blockage of the Ryanodine Receptor via Azumolene Does Not Prevent Mechanical Ventilation-Induced Diaphragm Atrophy	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNELS; SKELETAL-MUSCLE; SOLEUS MUSCLE; CONTRACTILE PROPERTIES; DISUSE ATROPHY; DYSFUNCTION; CA2+; WEAKNESS; RATS; MITOCHONDRIA	Mechanical ventilation (MV) is a life-saving intervention for patients in respiratory failure. However, prolonged MV causes the rapid development of diaphragm muscle atrophy, and diaphragmatic weakness may contribute to difficult weaning from MV. Therefore, developing a therapeutic countermeasure to protect against MV-induced diaphragmatic atrophy is important. MV-induced diaphragm atrophy is due, at least in part, to increased production of reactive oxygen species (ROS) from diaphragm mitochondria and the activation of key muscle proteases (i.e., calpain and caspase-3). In this regard, leakage of calcium through the ryanodine receptor (RyR1) in diaphragm muscle fibers during MV could result in increased mitochondrial ROS emission, protease activation, and diaphragm atrophy. Therefore, these experiments tested the hypothesis that a pharmacological blockade of the RyR1 in diaphragm fibers with azumolene (AZ) would prevent MV-induced increases in mitochondrial ROS production, protease activation, and diaphragmatic atrophy. Adult female Sprague-Dawley rats underwent 12 hours of full-support MV while receiving either AZ or vehicle. At the end of the experiment, mitochondrial ROS emission, protease activation, and fiber cross-sectional area were determined in diaphragm muscle fibers. Decreases in muscle force production following MV indicate that the diaphragm took up a sufficient quantity of AZ to block calcium release through the RyR1. However, our findings reveal that AZ treatment did not prevent the MV-induced increase in mitochondrial ROS emission or protease activation in the diaphragm. Importantly, AZ treatment did not prevent MV-induced diaphragm fiber atrophy. Thus, pharmacological inhibition of the RyR1 in diaphragm muscle fibers is not sufficient to prevent MV-induced diaphragm atrophy.	[Talbert, Erin E.; Smuder, Ashley J.; Kwon, Oh Sung; Sollanek, Kurt J.; Wiggs, Michael P.; Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Kwon, Oh Sung] George E Wahlen Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA; [Kwon, Oh Sung] Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Sollanek, Kurt J.] Sonoma State Univ, Dept Kinesiol, Rohnert Pk, CA 94928 USA; [Wiggs, Michael P.] Univ Texas Tyler, Dept Hlth & Kinesiol, Tyler, TX 75799 USA	State University System of Florida; University of Florida; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; California State University System; Sonoma State University; University of Texas System; University of Texas at Tyler	Talbert, EE (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.; Talbert, EE (corresponding author), Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA.	erin.talbert@osumc.edu	Kwon, Oh Sung/AAL-4116-2021; Talbert, Erin/AAM-5535-2020	Talbert, Erin/0000-0003-4587-0950	American Heart Association [11PRE6520001]; National Institutes of Health [R01 HL087839, R21 AR064956]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064956] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These experiments were supported by American Heart Association (www.heart.org) Predoctoral Fellowship 11PRE6520001 to EETand National Institutes of Health (www.nih.gov) R01 HL087839 and R21 AR064956 to SKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Andersson DC, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-9; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fischer DR, 2001, SHOCK, V15, P200, DOI 10.1097/00024382-200115030-00007; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Ingalls CP, 1999, J APPL PHYSIOL, V87, P386, DOI 10.1152/jappl.1999.87.1.386; Kachaeva EV, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/493618; Kandarian SC, 2002, EXERC SPORT SCI REV, V30, P111, DOI 10.1097/00003677-200207000-00004; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; LEBOURDELLES G, 1994, AM J RESP CRIT CARE, V149, P1539, DOI 10.1164/ajrccm.149.6.8004310; Lee I, 2002, MOL CELL BIOCHEM, V234, P63, DOI 10.1023/A:1015921513720; LESLIE GC, 1989, BRIT J PHARMACOL, V97, P1151, DOI 10.1111/j.1476-5381.1989.tb12573.x; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; Min K, 2015, J PHYSIOL-LONDON, V593, P2017, DOI 10.1113/jphysiol.2014.286518; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Nelson WB, 2012, CRIT CARE MED; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Picard M, 2012, AM J RESPIR CRIT CAR; Powers SK, 2013, AM J PHYSIOL-REG I, V305, pR464, DOI 10.1152/ajpregu.00231.2013; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Schaffer S. W., 2007, MITOCHONDRIA DYNAMIC; SEGAL SS, 1986, AM J PHYSIOL, V250, pC474, DOI 10.1152/ajpcell.1986.250.3.C474; Shanely RA, 2002, AM J RESP CRIT CARE, V166, P1369, DOI 10.1164/rccm.200202-088OC; Smuder AJ, 2012, CRIT CARE MED, V40, P927, DOI 10.1097/CCM.0b013e3182374a84; Smuder AJ, 2012, J APPL PHYSIOL, V112, P501, DOI 10.1152/japplphysiol.01086.2011; Sudo RT, 2008, BASIC CLIN PHARMACOL, V102, P308, DOI 10.1111/j.1742-7843.2007.00156.x; Trouillet JL, 2009, J THORAC CARDIOV SUR, V138, P948, DOI 10.1016/j.jtcvs.2009.05.034; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046	42	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148161	10.1371/journal.pone.0148161	http://dx.doi.org/10.1371/journal.pone.0148161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849371	gold, Green Published			2022-12-26	WOS:000369554000045
J	Ulusoy, M; Sipahi, R				Ulusoy, Melda; Sipahi, Rifat			Experimental Evaluation of a Braille-Reading-Inspired Finger Motion Adaptive Algorithm	PLOS ONE			English	Article							DISPLAYS	Braille reading is a complex process involving intricate finger-motion patterns and finger-rubbing actions across Braille letters for the stimulation of appropriate nerves. Although Braille reading is performed by smoothly moving the finger from left-to-right, research shows that even fluent reading requires right-to-left movements of the finger, known as "reversal". Reversals are crucial as they not only enhance stimulation of nerves for correctly reading the letters, but they also show one to re-read the letters that were missed in the first pass. Moreover, it is known that reversals can be performed as often as in every sentence and can start at any location in a sentence. Here, we report experimental results on the feasibility of an algorithm that can render a machine to automatically adapt to reversal gestures of one's finger. Through Braille-reading-analogous tasks, the algorithm is tested with thirty sighted subjects that volunteered in the study. We find that the finger motion adaptive algorithm (FMAA) is useful in achieving cooperation between human finger and the machine. In the presence of FMAA, subjects' performance metrics associated with the tasks have significantly improved as supported by statistical analysis. In light of these encouraging results, preliminary experiments are carried out with five blind subjects with the aim to put the algorithm to test. Results obtained from carefully designed experiments showed that subjects' Braille reading accuracy in the presence of FMAA was more favorable then when FMAA was turned off. Utilization of FMAA in future generation Braille reading devices thus holds strong promise.	[Ulusoy, Melda; Sipahi, Rifat] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA	Northeastern University	Sipahi, R (corresponding author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.	rifat@coe.neu.edu		Sipahi, Rifat/0000-0001-9307-5324	NSF (US) [0921360]; National Science Foundation [0921360]	NSF (US)(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The theme of this paper was inspired by the authors' previous (now expired) grant under NSF (US) (http://www.nsf.gov/awardsearch/showAward?AWD_ID=0921360). The work was performed after grant expiration.; This study was inspired from authors previous research supported by National Science Foundation Award no. 0921360. Authors gratefully acknowledge all volunteers that participated in the study, and are gratefully with National Braille Press (88 St. Stephen Street, Boston 02115) for their welcoming of collaborations. Some parts of this study are under intellectual property protection at Northeastern University University (INV-16001 Provisional. Inventors: Rifat Sipahi & Melda Ulusoy). Authors have no further declarations.	American Foundation of the Blind. Estimated Number of Adult Braille Readers in the United States, 1996, J VISUAL IMPAIRMENT, V90, P287; [Anonymous], PSYCHONOMIC B REV, V22; Antle AN, P 5 INT C TANG EMB E; Aranyanak I, 2013, BEHAV RES METHODS, V45, P216, DOI 10.3758/s13428-012-0235-8; BALINT L, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN AND CYBERNETICS, VOLS 1-5, P292, DOI 10.1109/ICSMC.1995.537774; Bar-Cohen Y, 2009, SPIE NEWSROOM, V11; Bertelson P, 1995, LANGUAGE TOUCH CASE, P91; Cassidy J, 2014, BBC NEWS; Cho HC, 2006, 2006 SICE-ICASE INTERNATIONAL JOINT CONFERENCE, VOLS 1-13, P1909; Davies M., 2008, CORPUS CONT AM ENGLI; Drewes H, P 4 INT C MOB TECHN; Erin J, 2004, J VISUAL IMPAIRMENT, V98; Eui Chul L, KSII T INTERNET INFO, V7, P834; Fricke J., 1994, Computers for Handicapped Persons. 4th International Conference, ICCHP '94 Proceedings, P461; Fricke J., 1997, IEE C DEV TACT DISPL; Hable R, 2013, INT C MOB BUS ICMB, P18; Hughes B, 2014, SCI STUD READ, V18, P94, DOI 10.1080/10888438.2013.802203; Hughes B, 2011, HUM MOVEMENT SCI, V30, P711, DOI 10.1016/j.humov.2010.05.005; Kane Shaun K, 2008, P 10 INT ACM SIGACCE, P73, DOI DOI 10.1145/1414471.1414487; Kato Y, 2007, IEEE T ELECTRON DEV, V54, P202, DOI 10.1109/TED.2006.888678; Kawaguchi Yoshihisa, 2010, Proceedings of the SICE 2010 - 49th Annual Conference of the Society of Instrument and Control Engineers of Japan, P379; Kwon HJ, 2009, SENSOR ACTUAT A-PHYS, V154, P238, DOI 10.1016/j.sna.2008.10.002; Laver K, 2012, PRESENCE-TELEOP VIRT, V21, P183, DOI 10.1162/PRES_a_00098; Lee EC, 2009, OPT ENG, V48, DOI 10.1117/1.3158992; Legge GE., 1999, VIS IMPAIR RES, V1, P131, DOI [10.1076/vimr.1.3.131.4438, DOI 10.1076/VIMR.1.3.131.4438]; Leung R, 2007, ICMI'07: PROCEEDINGS OF THE NINTH INTERNATIONAL CONFERENCE ON MULTIMODAL INTERFACES, P374; Levesque V., 2005, ACM T APPL PERCEPTIO, V2, P132, DOI [10.1145/1060581.1060587, DOI 10.1145/1060581.1060587]; Levesque V, 2007, WORLD HAPTICS 2007: SECOND JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P115; Linjama J, P 3 NORD C HUM COMP; Matsushima F, 2014, COMMUN COMPUT PHYS, V435, P361, DOI DOI 10.1007/978-3-319-07854-0; Matysek M., 2009, P SOC PHOTO-OPT INS, V7287, DOI DOI 10.1117/12.819217; Nicol Heather N, 2013, ASSETS 13, P1, DOI 10.1017/S0032247412000666; NORCIO AF, 1989, IEEE T SYST MAN CYB, V19, P399, DOI 10.1109/21.31042; Quenqua Douglas, 2014, NY TIMES; Ramstein C., 1996, ASSETS '96. The Second Annual ACM Conference on Assistive Technologies, P37, DOI 10.1145/228347.228355; Ren KL, 2008, SENSOR ACTUAT A-PHYS, V143, P335, DOI 10.1016/j.sna.2007.10.083; Roberts J W, 2004, US Patent, Patent No. [6,776,619B1, 6776619, 6,776,619]; Roberts John, 2000, SID S, V31, P1130, DOI DOI 10.1889/1.1832864; Runyan NH, 2011, P SOC PHOTO-OPT INS; Russomanno A, 2015, IEEE T HAPTICS, P1; Schiff W., 1982, TACTUAL PERCEPTION S, P7; Syed F, 2015, NEW ENGL J MED, V372, P1377, DOI 10.1056/NEJMc1414481; TEIGEN KH, 1994, THEOR PSYCHOL, V4, P525, DOI 10.1177/0959354394044004; Ulusoy M, 2015, FINGER MOTION ADAPTI; Ulusoy M, 2015, THESIS NE U; Ulusoy M, 2014, IEEE HAPTICS SYM, P431, DOI 10.1109/HAPTICS.2014.6775494; Vidal-Verdu F, 2007, IEEE T NEUR SYS REH, V15, P119, DOI 10.1109/TNSRE.2007.891375	47	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148356	10.1371/journal.pone.0148356	http://dx.doi.org/10.1371/journal.pone.0148356			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849058	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000078
J	Potenza, L; Vallerini, D; Barozzi, P; Riva, G; Gilioli, A; Forghieri, F; Candoni, A; Cesaro, S; Quadrelli, C; Maertens, J; Rossi, G; Morselli, M; Codeluppi, M; Mussini, C; Colaci, E; Messerotti, A; Paolini, A; Maccaferri, M; Fantuzzi, V; Del Giovane, C; Stefani, A; Morandi, U; Maffei, R; Marasca, R; Narni, F; Fanin, R; Comoli, P; Romani, L; Beauvais, A; Viale, PL; Latge, JP; Lewis, RE; Luppi, M				Potenza, Leonardo; Vallerini, Daniela; Barozzi, Patrizia; Riva, Giovanni; Gilioli, Andrea; Forghieri, Fabio; Candoni, Anna; Cesaro, Simone; Quadrelli, Chiara; Maertens, Johan; Rossi, Giulio; Morselli, Monica; Codeluppi, Mauro; Mussini, Cristina; Colaci, Elisabetta; Messerotti, Andrea; Paolini, Ambra; Maccaferri, Monica; Fantuzzi, Valeria; Del Giovane, Cinzia; Stefani, Alessandro; Morandi, Uliano; Maffei, Rossana; Marasca, Roberto; Narni, Franco; Fanin, Renato; Comoli, Patrizia; Romani, Luigina; Beauvais, Anne; Viale, Pier Luigi; Latge, Jean Paul; Lewis, Russell E.; Luppi, Mario			Mucorales-Specific T Cells in Patients with Hematologic Malignancies	PLOS ONE			English	Article							INVASIVE FUNGAL-INFECTIONS; MUCORMYCOSIS; ZYGOMYCOSIS; DIAGNOSIS; PULMONARY; ASPERGILLOSIS; EPIDEMIOLOGY; IMMUNITY; MANAGEMENT; DISEASES	Background Invasive mucormycosis (IM) is an emerging life-threatening fungal infection. It is difficult to obtain a definite diagnosis and to initiate timely intervention. Mucorales-specific T cells occur during the course of IM and are involved in the clearance of the infection. We have evaluated the feasibility of detecting Mucorales-specific T cells in hematological patients at risk for IM, and have correlated the detection of such cells with the clinical conditions of the patients. Methods and Findings By using an enzyme linked immunospot assay, the presence of Mucorales-specific T cells in peripheral blood (PB) samples has been investigated at three time points during high-dose chemotherapy for hematologic malignancies. Mucorales-specific T cells producing interferon-., interleukin-10 and interleukin-4 were analysed in order to detect a correlation between the immune response and the clinical picture. Twenty-one (10.3%) of 204 patients, accounting for 32 (5.3%) of 598 PB samples, tested positive for Mucorales-specific T cells. Two groups could be identified. Group 1, including 15 patients without signs or symptoms of invasive fungal diseases (IFD), showed a predominance of Mucorales-specific T cells producing interferon-gamma. Group 2 included 6 patients with a clinical picture consistent with invasive fungal disease (IFD): 2 cases of proven IM and 4 cases of possible IFD. The proven patients had significantly higher number of Mucorales-specific T cells producing interleukin-10 and interleukin-4 and higher rates of positive samples by using derived diagnostic cut-offs when compared with the 15 patients without IFD. Conclusions Mucorales-specific T cells can be detected and monitored in patients with hematologic malignancies at risk for IM. Mucorales-specific T cells polarized to the production of T helper type 2 cytokines are associated with proven IM and may be evaluated as a surrogate diagnostic marker for IM.	[Potenza, Leonardo; Vallerini, Daniela; Barozzi, Patrizia; Riva, Giovanni; Gilioli, Andrea; Forghieri, Fabio; Quadrelli, Chiara; Morselli, Monica; Colaci, Elisabetta; Messerotti, Andrea; Paolini, Ambra; Maccaferri, Monica; Fantuzzi, Valeria; Maffei, Rossana; Marasca, Roberto; Narni, Franco; Luppi, Mario] Univ Modena & Reggio Emilia, Sect Hematol, Dept Surg & Med Sci, Azienda Osped Univ Policlin, Modena, Italy; [Candoni, Anna; Fanin, Renato] Azienda Osped Univ Santa Maria della Misericordia, Hematol & Bone Marrow Transplantat, Udine, Italy; [Cesaro, Simone] Policlin GB Rossi, Pediat Hematol Oncol, Verona, Italy; [Maertens, Johan] Univ Ziekenhuizen Leuven, Dept Hematol, Campus Gasthuisberg, Leuven, Belgium; [Rossi, Giulio] Azienda Osped Univ Policlin, Dept Pathol, Modena, Italy; [Codeluppi, Mauro; Mussini, Cristina] Azienda Osped Univ Policlin, Clin Infect Dis, Integrated Dept Med Emergency Med & Med Specialti, Modena, Italy; [Del Giovane, Cinzia] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin, Sect Stat, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Stefani, Alessandro; Morandi, Uliano] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin, Div Thorac Surg, Dept Surg & Med Sci, Modena, Italy; [Comoli, Patrizia] IRCCS Policlin S Matteo, Pediat Hematol Oncol & Transplantat, Pavia, Italy; [Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Beauvais, Anne; Latge, Jean Paul] Inst Pasteur, Unite Aspergillus, Paris, France; [Viale, Pier Luigi; Lewis, Russell E.] Univ Bologna, Clin Infect Dis, Dept Internal Med Geriatr & Nephrol Dis, S Orsola Malpighi Hosp, Bologna, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Hospital Santa Maria della Misericordia; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; KU Leuven; University Hospital Leuven; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; IRCCS Fondazione San Matteo; University of Perugia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Potenza, L; Luppi, M (corresponding author), Univ Modena & Reggio Emilia, Sect Hematol, Dept Surg & Med Sci, Azienda Osped Univ Policlin, Modena, Italy.	leonardo.potenza@unimore.it; mario.luppi@unimore.it	Maffei, Rossana/O-4836-2016; Luppi, Mario/J-3668-2016; Lewis, Russell E/A-4616-2015; Beauvais, Anne/A-6358-2012; Barozzi, Patrizia/Q-2638-2016; Cesaro, Simone/I-3272-2019; Rossi, Giulio/K-6217-2016; Candoni, Anna/AAU-6289-2020; Maccaferri, Monica/J-1737-2018; Potenza, Leonardo/P-9579-2016; Romani, Luigina/O-9987-2018; Rossi, Antonio/K-7054-2016; Candoni, Anna/ABE-1708-2021; Comoli, Patrizia/K-2732-2018; Paolini, Ambra/J-8237-2018; Mussini, Cristina/K-8672-2016; Stefani, Alessandro/I-8199-2014; Marasca, Roberto/I-8072-2013; Cesaro, Simone/F-8118-2019; Morandi, Uliano/C-9451-2017	Maffei, Rossana/0000-0002-3518-2006; Luppi, Mario/0000-0002-0373-1154; Lewis, Russell E/0000-0002-2002-4339; Barozzi, Patrizia/0000-0002-8936-1114; Cesaro, Simone/0000-0002-8698-9547; Rossi, Giulio/0000-0001-8855-1218; Candoni, Anna/0000-0003-4436-1310; Maccaferri, Monica/0000-0003-2818-6516; Potenza, Leonardo/0000-0002-2738-6105; Rossi, Antonio/0000-0003-3295-0345; Comoli, Patrizia/0000-0001-5964-0553; Paolini, Ambra/0000-0002-0786-1802; Mussini, Cristina/0000-0002-6615-4198; Stefani, Alessandro/0000-0003-4547-6232; Marasca, Roberto/0000-0002-6431-6878; Cesaro, Simone/0000-0002-8698-9547; Morandi, Uliano/0000-0002-4039-7626; NARNI, Franco/0000-0003-3994-9101; Del Giovane, Cinzia/0000-0002-5028-932X; Romani, Luigina/0000-0002-1356-525X; Maccaferri, Monica/0000-0002-1413-825X	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy [AIRC IG-14797]; Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS (LP and FF); Societa' Italiana di Ematologia Sperimentale (SIES); Gilead Sciences	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS (LP and FF); Societa' Italiana di Ematologia Sperimentale (SIES); Gilead Sciences(Gilead Sciences)	This work was supported by the Associazione Italiana per la Ricerca sul Cancro [grant number AIRC IG-14797], Milan, Italy (ML); the Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS (LP and FF); Gilead Fellowship Program 2012-2014 (ML); the Societa' Italiana di Ematologia Sperimentale (SIES, "Piero Martino'' awarded to LP); and research funds by Gilead Sciences to ML. The funders had no role in study design, data collection; This work was supported by the Associazione Italiana per la Ricerca sul Cancro [grant number AIRC IG-14797], Milan, Italy (ML); the Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti"-Modena-ONLUS (LP and FF); Gilead Fellowship Program 2012-2014 (ML); the Societa' Italiana di Ematologia Sperimentale (SIES, "Piero Martino" award to LP) and research funds by Gilead Sciences to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.and analysis, decision to publish, or preparation of the manuscript.	Bacher P, 2015, AM J RESP CRIT CARE, V191, P348, DOI 10.1164/rccm.201407-1235LE; Bitar D, 2009, EMERG INFECT DIS, V15, P1395, DOI 10.3201/eid1509.090334; Bozza S, 2009, J IMMUNOL, V183, P2407, DOI 10.4049/jimmunol.0900961; Chamilos G, 2005, CLIN INFECT DIS, V41, P60, DOI 10.1086/430710; Chamilos G, 2008, CLIN INFECT DIS, V47, P503, DOI 10.1086/590004; Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986; Cornely OA, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12371; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Kontoyiannis DP, 2006, INFECT DIS CLIN N AM, V20, P581, DOI 10.1016/j.idc.2006.06.003; Kontoyiannis DP, 2012, CLIN INFECT DIS, V54, pS79, DOI 10.1093/cid/cir886; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Kontoyiannis DP, 2005, J INFECT DIS, V191, P1350, DOI 10.1086/428780; Lass-Florl C, 2007, CLIN INFECT DIS, V45, pE101, DOI 10.1086/521245; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; Lewis RE, 2013, FUTURE MICROBIOL, V8, P1163, DOI 10.2217/fmb.13.78; Pagano L, 2013, HAEMATOLOGICA, V98, DOI 10.3324/haematol.2012.083063; Pagano L, 2009, BRIT J HAEMATOL, V146, P597, DOI 10.1111/j.1365-2141.2009.07738.x; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Petrikkos G, 2012, CLIN INFECT DIS, V54, pS23, DOI 10.1093/cid/cir866; Potenza L, 2007, LEUKEMIA, V21, P578, DOI 10.1038/sj.leu.2404504; Potenza L, 2008, CLIN VACCINE IMMUNOL, V15, P1625, DOI 10.1128/CVI.00198-08; Potenza L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074326; Potenza L, 2011, BLOOD, V118, P5416, DOI 10.1182/blood-2011-07-366526; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Skiada A, 2013, HAEMATOLOGICA, V98, P492, DOI 10.3324/haematol.2012.065110; Spellberg B, 2010, CLIN INFECT DIS, V48, P1743; Sun HY, 2011, LANCET INFECT DIS, V11, P301, DOI 10.1016/S1473-3099(10)70316-9; Walsh TJ, 2012, CLIN INFECT DIS, V54, pS55, DOI 10.1093/cid/cir868	31	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149108	10.1371/journal.pone.0149108	http://dx.doi.org/10.1371/journal.pone.0149108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871570	Green Published, gold			2022-12-26	WOS:000370054100106
J	Blazquez, R; Sachez-Margallo, FM; Crisostomo, V; Baez, C; Maestre, J; Alvarez, V; Casado, JG				Blazquez, Rebeca; Miguel Sachez-Margallo, Francisco; Crisostomo, Veronica; Baez, Claudia; Maestre, Juan; Alvarez, Veronica; Casado, Javier G.			Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; MESENCHYMAL STEM-CELLS; INTERFERON-ALPHA THERAPY; ISCHEMIC CARDIOMYOPATHY; INFLAMMATORY CYTOKINES; MYOCARDIAL-INFARCTION; ALKALINE-PHOSPHATASE; PERICARDIAL FLUID; DIFFERENT FORMS; HEART-FAILURE	Introduction The intrapericardial delivery has been defined as an efficient method for pharmacological agent delivery. Here we hypothesize that intrapericardial administration of cardiosphere-derived cells (CDCs) may have an immunomodulatory effect providing an optimal microenvironment for promoting cardiac repair. To our knowledge, this is the first report studying the effects of CDCs for myocardial repair using the intrapericardial delivery route. Material and Methods CDCs lines were isolated, expanded and characterized by flow cytometry and PCR. Their differentiation ability was determined using specific culture media and differential staining. 300,000 CDCs/kg were injected into the pericardial space of a swine myocardial infarcted model. Magnetic resonance imaging, biochemical analysis of pericardial fluid and plasma, cytokine measurements and flow cytometry analysis were performed. Results Our results showed that, phenotype and differentiation behavior of porcine CDCs were equivalent to previously described CDCs. Moreover, the intrapericardial administration of CDCs fulfilled the safety aspects as non-adverse effects were reported. Finally, the phenotypes of resident lymphocytes and TH1 cytokines in the pericardial fluid were significantly altered after CDCs administration. Conclusions The pericardial fluid could be considered as a safe and optimal vehicle for CDCs administration. The observed changes in the studied immunological parameters could exert a modulation in the inflammatory environment of infarcted hearts, indirectly benefiting the endogenous cardiac repair.	[Blazquez, Rebeca; Miguel Sachez-Margallo, Francisco; Alvarez, Veronica; Casado, Javier G.] Jesus Uson Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain; [Crisostomo, Veronica; Baez, Claudia; Maestre, Juan] Jesus Uson Minimally Invas Surg Ctr, Endoluminal Therapy & Diag, Caceres, Spain		Casado, JG (corresponding author), Jesus Uson Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain.	jgarcia@ccmijesususon.com	Pérez, Verónica Álvarez/AAP-1021-2020; Blázquez, Rebeca/Q-2588-2019; García, Javier/AAH-1330-2020; G Casado, Javier/ABE-9043-2021; Sánchez Margallo, Francisco Miguel Miguel/I-5605-2019; Garcia, Javier/X-4319-2018; Blazquez, Rebeca/D-9523-2017; Blazquez Duran, Rebeca/A-9008-2015	Pérez, Verónica Álvarez/0000-0002-7319-6089; Blázquez, Rebeca/0000-0002-1149-8305; Sánchez Margallo, Francisco Miguel Miguel/0000-0003-2138-988X; Blazquez, Rebeca/0000-0002-1149-8305; Blazquez Duran, Rebeca/0000-0002-1149-8305; Baez Diaz, Claudia/0000-0001-9031-2929; G Casado, Javier/0000-0001-6797-7287; Crisostomo, Veronica/0000-0003-1740-7029	GobEx (Ayuda a grupos catalogados de la Junta de Extremadura) [GR15175]; Junta de Extremadura (FEDER/FSE) [TA13042, IB13123]; Redes tematicas de investigacion cooperativa en salud [RD12/0042/0025]; UEX; Junta de Extremadura; MICINN; FEDER; FSE	GobEx (Ayuda a grupos catalogados de la Junta de Extremadura); Junta de Extremadura (FEDER/FSE); Redes tematicas de investigacion cooperativa en salud; UEX; Junta de Extremadura; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); FEDER(European Commission); FSE(European Social Fund (ESF))	This work was supported in part by one grant from GobEx (Ayuda a grupos catalogados de la Junta de Extremadura, GR15175), two grants from Junta de Extremadura to JGC (TA13042 and IB13123 co-financed by FEDER/FSE) and two grants from Redes tematicas de investigacion cooperativa en salud (RD12/0042/0025 to FMSM and CB).; Technical and human support provided by Facility of Bioscience Applied Techniques of SAIUEx (financed by UEX, Junta de Extremadura, MICINN, FEDER and FSE).	Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Bjorkstrom NK, 2008, J IMMUNOL, V181, P4219, DOI 10.4049/jimmunol.181.6.4219; Blazquez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122377; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Boonen A, 1999, CLIN RHEUMATOL, V18, P177, DOI 10.1007/s100670050081; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Burr SP, 2013, IMMUNOL CELL BIOL, V91, P12, DOI 10.1038/icb.2012.60; Caliskan M, 2007, J HYPERTENS, V25, P2497, DOI 10.1097/HJH.0b013e3282f05bf1; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; Denyer MS, 2006, VET IMMUNOL IMMUNOP, V110, P279, DOI 10.1016/j.vetimm.2005.10.005; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Ege T, 2003, CYTOKINE, V23, P47, DOI 10.1016/S1043-4666(03)00180-7; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fukushima S, 2013, FUTUR CARDIOL, V9, P215, DOI [10.2217/FCA.12.85, 10.2217/fca.12.85]; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Gressens B, 2004, ACTA GASTRO-ENT BELG, V67, P301; Hoogduijn MJ, 2011, HUM GENE THER, V22, P1587, DOI 10.1089/hum.2011.039; Huang NF, 2009, REGEN MED, V4, P527, DOI 10.2217/RME.09.32; Ishigami S, 2015, CIRC RES, V116, P653, DOI 10.1161/CIRCRESAHA.116.304671; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jiang SY, 2013, EXP CLIN CARDIOL, V18, P53; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kanazawa H, 2015, CIRC-HEART FAIL, V8, P322, DOI 10.1161/CIRCHEARTFAILURE.114.001484; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kwon Yoo-Wook, 2010, Int J Stem Cells, V3, P8; Ladage D, 2011, GENE THER, V18, P979, DOI 10.1038/gt.2011.52; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Mazo M, 2011, J CARDIOVASC TRANSL, V4, P145, DOI 10.1007/s12265-010-9246-y; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; Pankuweit S, 2000, HERZ, V25, P748, DOI 10.1007/PL00001993; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poelzl G, 2009, CIRC-HEART FAIL, V2, P294, DOI 10.1161/CIRCHEARTFAILURE.108.826735; Popescu C, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-30; RIEMANN D, 1994, INT ARCH ALLERGY IMM, V104, P48, DOI 10.1159/000236708; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sheng CC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/547902; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Smith Rachel Ruckdeschel, 2013, Biomatter, V3, DOI 10.4161/biom.24490; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113009; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; van Ramshorst J, 2011, J CARDIOVASC TRANSL, V4, P182, DOI 10.1007/s12265-010-9249-8; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63; Yang Y, 2012, NMR BIOMED, V25, P227, DOI 10.1002/nbm.1735	55	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149001	10.1371/journal.pone.0149001	http://dx.doi.org/10.1371/journal.pone.0149001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866919	Green Published, Green Submitted, gold			2022-12-26	WOS:000370050700052
J	Koga, H; Fujitani, H; Morino, Y; Miyamoto, N; Tsuchimoto, J; Shibata, TF; Nozawa, M; Shigenobu, S; Ogura, A; Tachibana, K; Kiyomoto, M; Amemiya, S; Wada, H				Koga, Hiroyuki; Fujitani, Haruka; Morino, Yoshiaki; Miyamoto, Norio; Tsuchimoto, Jun; Shibata, Tomoko F.; Nozawa, Masafumi; Shigenobu, Shuji; Ogura, Atsushi; Tachibana, Kazunori; Kiyomoto, Masato; Amemiya, Shonan; Wada, Hiroshi			Experimental Approach Reveals the Role of alx1 in the Evolution of the Echinoderm Larval Skeleton	PLOS ONE			English	Article							GENE REGULATORY NETWORK; SEA-URCHIN EMBRYO; PHYLOGENETIC ANALYSES; HOMEOBOX GENE; EXPRESSION; INSIGHTS; RNA; SKELETOGENESIS; PLASTICITY; TISSUES	Over the course of evolution, the acquisition of novel structures has ultimately led to wide variation in morphology among extant multicellular organisms. Thus, the origins of genetic systems for new morphological structures are a subject of great interest in evolutionary biology. The larval skeleton is a novel structure acquired in some echinoderm lineages via the activation of the adult skeletogenic machinery. Previously, VEGF signaling was suggested to have played an important role in the acquisition of the larval skeleton. In the present study, we compared expression patterns of Alx genes among echinoderm classes to further explore the factors involved in the acquisition of a larval skeleton. We found that the alx1 gene, originally described as crucial for sea urchin skeletogenesis, may have also played an essential role in the evolution of the larval skeleton. Unlike those echinoderms that have a larval skeleton, we found that alx1 of starfish was barely expressed in early larvae that have no skeleton. When alx1 overexpression was induced via injection of alx1 mRNA into starfish eggs, the expression patterns of certain genes, including those possibly involved in skeletogenesis, were altered. This suggested that a portion of the skeletogenic program was induced solely by alx1. However, we observed no obvious external phenotype or skeleton. We concluded that alx1 was necessary but not sufficient for the acquisition of the larval skeleton, which, in fact, requires several genetic events. Based on these results, we discuss how the larval expression of alx1 contributed to the acquisition of the larval skeleton in the putative ancestral lineage of echinoderms.	[Koga, Hiroyuki; Fujitani, Haruka; Morino, Yoshiaki; Miyamoto, Norio; Wada, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Miyamoto, Norio] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan; [Tsuchimoto, Jun] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan; [Tsuchimoto, Jun] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan; [Shibata, Tomoko F.; Shigenobu, Shuji] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Nozawa, Masafumi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Nozawa, Masafumi] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka, Japan; [Shigenobu, Shuji] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan; [Ogura, Atsushi] Nagahama Inst Biosci & Technol, Nagahama, Japan; [Tachibana, Kazunori] Tokyo Inst Technol, Grad Sch Biosci, Yokohama, Kanagawa 227, Japan; [Kiyomoto, Masato; Amemiya, Shonan] Ochanomizu Univ, Marine & Coastal Res Ctr, Tateyama, Toyama, Japan; [Amemiya, Shonan] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Amemiya, Shonan] Keio Univ, Res & Educ Ctr Nat Sci, Yokohama, Kanagawa 223, Japan; [Koga, Hiroyuki] Univ Tokyo, Grad Sch Sci, Tokyo 113, Japan; [Shibata, Tomoko F.] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan	University of Tsukuba; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kanazawa University; Aichi Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; Tokyo Institute of Technology; Ochanomizu University; University of Tokyo; Keio University; University of Tokyo; Tohoku University	Koga, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	hiro1224koga@gmail.com	Nozawa, Masafumi/S-9054-2019; Koga, Hiroyuki/AAG-1165-2019; Shigenobu, Shuji/B-6239-2011	Koga, Hiroyuki/0000-0001-7060-9565; Shigenobu, Shuji/0000-0003-4640-2323; Morino, Yoshiaki/0000-0001-5437-9464; Miyamoto, Norio/0000-0002-3051-3945	 [11J00274];  [23128502]	; 	This work was supported by Grant-in-Aid for JSPS Fellows 11J00274 to HK, and Grant-in-Aid for Scientific Research on Innovative Areas 23128502 to HW.	Adomako-Ankomah A, 2013, DEVELOPMENT, V140, P4214, DOI 10.1242/dev.100479; Amemiya S, 2015, ACTA ZOOL-STOCKHOLM, V96, P37, DOI 10.1111/azo.12049; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cheers MS, 2005, DEV BIOL, V283, P384, DOI 10.1016/j.ydbio.2005.02.037; Cheng XR, 2014, DEV BIOL, V391, P147, DOI 10.1016/j.ydbio.2014.04.015; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Clausen S, 2005, NATURE, V438, P351, DOI 10.1038/nature04109; Costa C, 2012, DEV GENES EVOL, V222, P245, DOI 10.1007/s00427-012-0405-9; Davidson EH, 2006, REG GEN GEN REG; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Duloquin L, 2007, DEVELOPMENT, V134, P2293, DOI 10.1242/dev.005108; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; ETTENSOHN CA, 1988, DEV BIOL, V125, P396, DOI 10.1016/0012-1606(88)90220-5; Ettensohn CA, 2007, DEVELOPMENT, V134, P3077, DOI 10.1242/dev.009092; Ettensohn CA, 2013, GENESIS, V51, P383, DOI 10.1002/dvg.22380; Ettensohn CA, 2009, DEVELOPMENT, V136, P11, DOI 10.1242/dev.023564; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; Garfield D, 2012, EVOL DEV, V14, P152, DOI 10.1111/j.1525-142X.2012.00532.x; Garfield DA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001696; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hinman VF, 2014, GENESIS, V52, P193, DOI 10.1002/dvg.22757; Hyman LH, 1955, INVERTEBRATES ECHINO, VIV; Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0; KILLIAN CE, 1989, DEV BIOL, V133, P148, DOI 10.1016/0012-1606(89)90306-0; Killian CE, 2010, GENE EXPR PATTERNS, V10, P135, DOI 10.1016/j.gep.2010.01.002; Kitajima T, 1996, DEV GROWTH DIFFER, V38, P687; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Koga H, 2014, GENESIS, V52, P186, DOI 10.1002/dvg.22758; Koga H, 2010, DEV GENES EVOL, V220, P107, DOI 10.1007/s00427-010-0333-5; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; McCauley BS, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-17; McCauley BS, 2010, DEV BIOL, V340, P200, DOI 10.1016/j.ydbio.2009.11.020; McGonnell IM, 2011, EVOL DEV, V13, P343, DOI 10.1111/j.1525-142X.2011.00489.x; Miyamoto N, 2010, EVOL DEV, V12, P416, DOI 10.1111/j.1525-142X.2010.00428.x; Morino Y, 2012, EVOL DEV, V14, P428, DOI 10.1111/j.1525-142X.2012.00563.x; Nakano H, 2003, NATURE, V421, P158, DOI 10.1038/nature01236; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pespeni MH, 2013, EVOLUTION, V67, P1901, DOI 10.1111/evo.12036; Rafiq K, 2014, DEVELOPMENT, V141, P950, DOI 10.1242/dev.105585; Rafiq K, 2012, DEVELOPMENT, V139, P579, DOI 10.1242/dev.073049; RICHARDSON W, 1989, DEV BIOL, V132, P266, DOI 10.1016/0012-1606(89)90222-4; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Rottinger E, 2004, DEVELOPMENT, V131, P1075, DOI 10.1242/dev.01000; Sharma T, 2010, DEVELOPMENT, V137, P1149, DOI 10.1242/dev.048652; SHIMIZUNISHIKAWA K, 1990, DEV GROWTH DIFFER, V32, P629; Shoguchi E, 2000, DEV GROWTH DIFFER, V42, P61; Smith AB, 2005, GEOL J, V40, P255, DOI 10.1002/gj.1018; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Sun ZL, 2014, GENE EXPR PATTERNS, V16, P93, DOI 10.1016/j.gep.2014.10.002; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A., 2005, ROBUSTNESS EVOLVABIL; YAMASHITA M, 1985, BIOL BULL, V169, P131, DOI 10.2307/1541393	64	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149067	10.1371/journal.pone.0149067	http://dx.doi.org/10.1371/journal.pone.0149067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866800	Green Published, gold			2022-12-26	WOS:000370050700060
J	Mollet, IG; Patel, D; Govani, FS; Giess, A; Paschalaki, K; Periyasamy, M; Lidington, EC; Mason, JC; Jones, MD; Game, L; Ali, S; Shovlin, CL				Mollet, Ines G.; Patel, Dilipkumar; Govani, Fatima S.; Giess, Adam; Paschalaki, Koralia; Periyasamy, Manikandan; Lidington, Elaine C.; Mason, Justin C.; Jones, Michael D.; Game, Laurence; Ali, Simak; Shovlin, Claire L.			Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes	PLOS ONE			English	Article							TRANSFERRIN-BOUND IRON; HEREDITARY HEMORRHAGIC TELANGIECTASIA; PERIPHERAL ARTERIAL-DISEASE; HEMODIALYSIS-PATIENTS; BETA-THALASSEMIA; FERROUS SULFATE; P53; ACTIVATION; STORES; REDUCTION	Background Spontaneous reports from patients able to report vascular sequelae in real time, and recognition that serum non transferrin bound iron may reach or exceed 10 mu mol/L in the blood stream after iron tablets or infusions, led us to hypothesize that conventional iron treatments may provoke acute vascular injury. This prompted us to examine whether a phenotype could be observed in normal human endothelial cells treated with low dose iron. Methodology Confluent primary human endothelial cells (EC) were treated with filter-sterilized iron (II) citrate or fresh media for RNA sequencing and validation studies. RNA transcript profiles were evaluated using directional RNA sequencing with no pre-specification of target sequences. Alignments were counted for exons and junctions of the gene strand only, blinded to treatment types. Principal Findings Rapid changes in RNA transcript profiles were observed in endothelial cells treated with 10 mu mol/L iron (II) citrate, compared to media-treated cells. Clustering for Gene Ontology (GO) performed on all differentially expressed genes revealed significant differences in biological process terms between iron and media-treated EC, whereas 10 sets of an equivalent number of randomly selected genes from the respective EC gene datasets showed no significant differences in any GO terms. After 1 hour, differentially expressed genes clustered to vesicle mediated transport, protein catabolism, and cell cycle (Benjamini p = 0.0016, 0.0024 and 0.0032 respectively), and by 6 hours, to cellular response to DNA damage stimulus most significantly through DNA repair genes FANCG, BLM, and H2AFX. Comet assays demonstrated that 10 mu M iron treatment elicited DNA damage within 1 hour. This was accompanied by a brisk DNA damage response pulse, as ascertained by the development of DNA damage response (DDR) foci, and p53 stabilization. Significance These data suggest that low dose iron treatments are sufficient to modify the vascular endothelium, and induce a DNA damage response.	[Mollet, Ines G.; Patel, Dilipkumar; Govani, Fatima S.; Paschalaki, Koralia; Lidington, Elaine C.; Mason, Justin C.; Shovlin, Claire L.] Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci, London, England; [Giess, Adam; Jones, Michael D.; Game, Laurence] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England; [Periyasamy, Manikandan; Ali, Simak] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Govani, Fatima S.; Giess, Adam] Univ Oxford, Nuffield Dept Med, Oxford, England	Imperial College London; Imperial College London; Imperial College London; University of Oxford	Shovlin, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci, London, England.	c.shovlin@imperial.ac.uk	Periyasamy, Manikandan/AAL-6211-2020; Mollet, Ines Guerra/H-8526-2019; periyasamy, manikandan/AAB-7924-2020; Ali, Simak/N-4740-2019; Paschalaki, Koralia/B-4465-2018	Mollet, Ines Guerra/0000-0002-1422-1336; Ali, Simak/0000-0002-1320-0816; Shovlin, Claire/0000-0001-9007-5775; Coombes, Raoul Charles/0000-0002-4811-1100; Paschalaki, Koralia/0000-0002-4114-6140; Periyasamy, Manikandan/0000-0001-7626-2531; Giess, Adam/0000-0003-1683-2146; Mason, Justin/0000-0001-7783-1660	Averil Macdonald Memorial Trust; National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre; British Heart Foundation [PG/09/041/27515]; Cancer Research UK [18784] Funding Source: researchfish	Averil Macdonald Memorial Trust; National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)	This work received funding from the Averil Macdonald Memorial Trust, the National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre; the British Heart Foundation (PG/09/041/27515); and other donations from families and friends of HHT patients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja HS, 2003, J BIOL REG HOMEOS AG, V17, P29; Akhlaghpoor S, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-62; Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; Breuer W, 2000, TRANSFUS SCI, V23, P185, DOI 10.1016/S0955-3886(00)00087-4; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan S, 2014, ACTA HAEMATOL-BASEL, V132, P200, DOI 10.1159/000356808; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; DePalma RG, 2010, J VASC SURG, V51, P1498, DOI 10.1016/j.jvs.2009.12.068; Dresow B, 2008, BIOMETALS, V21, P273, DOI 10.1007/s10534-007-9116-5; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Finnamore H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076516; Gaenzer H, 2002, J AM COLL CARDIOL, V40, P2189, DOI 10.1016/S0735-1097(02)02611-6; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Govani FS, 2013, MOL SYNDROMOL, V4, P184, DOI 10.1159/000350208; Houschyar KS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-54; Hutchinson C, 2004, EUR J CLIN INVEST, V34, P782, DOI 10.1111/j.1365-2362.2004.01416.x; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kartikasari AER, 2006, FASEB J, V20, P353, DOI 10.1096/fj.05-4700fje; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114; Mollet IG, 2010, NUCLEIC ACIDS RES, V38, P4740, DOI 10.1093/nar/gkq197; Munoz-Bravo C, 2013, NUTRIENTS, V5, P2384, DOI 10.3390/nu5072384; Musallam KM, 2013, CURR OPIN HEMATOL, V20, P187, DOI 10.1097/MOH.0b013e32835f5a5c; Nelson M, 2004, J HUM NUTR DIET, V17, P43, DOI 10.1046/j.1365-277X.2003.00497.x; Nikolova T, 2014, TOXICOL SCI, V140, P103, DOI 10.1093/toxsci/kfu066; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roeckel N, 2009, CANCER RES, V69, P292, DOI 10.1158/0008-5472.CAN-08-3314; Rudini N, 2008, EMBO J, V27, P993, DOI 10.1038/emboj.2008.46; Scheiber-Mojdehkar B, 2004, J AM SOC NEPHROL, V15, P1648, DOI 10.1097/01.ASN.0000130149.18412.56; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schumann K, 2012, FOOD NUTR BULL, V33, P128, DOI 10.1177/156482651203300206; Scientific Advisory Committee on Nutrition, SACN IR HLTH REP; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shovlin CL, 2015, ANGIOGENESIS, V18, P566; Shovlin CL, 2014, AM J RESP CRIT CARE, V190, P1217, DOI 10.1164/rccm.201407-1254CI; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Shovlin Claire L, 2010, PLoS One, V5, pe9154, DOI 10.1371/journal.pone.0009154; SULLIVAN JL, 1981, LANCET, V1, P1293; Tian XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038164; Van Campenhout A, 2008, BIOMETALS, V21, P159, DOI 10.1007/s10534-007-9104-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wen YY, 2010, CANCER SCI, V101, P73, DOI 10.1111/j.1349-7006.2009.01339.x; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zacharski LR, 2007, JAMA-J AM MED ASSOC, V297, P603, DOI 10.1001/jama.297.6.603; Zacharski LR, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.013; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650	59	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0147990	10.1371/journal.pone.0147990	http://dx.doi.org/10.1371/journal.pone.0147990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866805	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700006
J	Alors, D; Lumbsch, HT; Divakar, PK; Leavitt, SD; Crespo, A				Alors, David; Lumbsch, H. Thorsten; Divakar, Pradeep K.; Leavitt, Steven D.; Crespo, Ana			An Integrative Approach for Understanding Diversity in the Punctelia rudecta Species Complex (Parmeliaceae, Ascomycota)	PLOS ONE			English	Article							LICHEN FAMILY PARMELIACEAE; PHYLOGENETIC INFERENCE; ADJACENT TERRITORIES; MOLECULAR PHYLOGENY; PARMELIOID LICHENS; CETRARIA-ACULEATA; GENERIC CONCEPTS; DELIMITATION; DNA; CHARACTERS	High levels of cryptic diversity have been documented in lichenized fungi, especially in Parmeliaceae, and integrating various lines of evidence, including coalescent-based species delimitation approaches, help establish more robust species circumscriptions. In this study, we used an integrative taxonomic approach to delimit species in the lichen-forming fungal genus Punctelia (Parmeliaceae), with a particular focus on the cosmopolitan species P. rudecta. Nuclear, mitochondrial ribosomal DNA and protein-coding DNA sequences were analyzed in phylogenetic and coalescence-based frameworks. Additionally, morphological, ecological and geographical features of the sampled specimens were evaluated. Five major strongly supported monophyletic clades were recognized in the genus Punctelia, and each clade could be characterized by distinct patterns in medullary chemistry. Punctelia rudecta as currently circumscribed was shown to be polyphyletic. A variety of empirical species delimitation methods provide evidence for a minimum of four geographically isolated species within the nominal taxon Punctelia rudecta, including a newly described saxicolous species, P. guanchica, and three corticolous species. In order to facilitate reliable sample identification for biodiversity, conservation, and air quality bio-monitoring research, these three species have been epitypified, in addition to the description of a new species.	[Alors, David; Divakar, Pradeep K.; Crespo, Ana] Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Plaza Ramon y Cajal S-N, Madrid, Spain; [Lumbsch, H. Thorsten; Leavitt, Steven D.] Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA	Complutense University of Madrid; Field Museum of Natural History (Chicago)	Alors, D (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Plaza Ramon y Cajal S-N, Madrid, Spain.	d.alors@gmail.com	Crespo, Ana/N-6236-2014; ALors, David/L-1618-2017; Divakar, Pradeep K/E-5603-2014; Leavitt, Steven D./AAC-6462-2021	Crespo, Ana/0000-0002-5271-0157; ALors, David/0000-0001-7288-9521; Divakar, Pradeep K/0000-0002-0300-0124; Leavitt, Steven D./0000-0002-5034-9724; Lumbsch, Thorsten/0000-0003-1512-835X	Spanish Ministerio de Ciencia e Innovacion [CGL2013-42498-P]; Universidad Complutense-Banco Santander [GR3/14]; National Science Foundation [DEB-0949147]; Ministerio de CIencia e Innovacion [BES-2011-046091]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad Complutense-Banco Santander; National Science Foundation(National Science Foundation (NSF)); Ministerio de CIencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (CGL2013-42498-P), the Universidad Complutense-Banco Santander (GR3/14), and the National Science Foundation ("Hidden diversity in parmelioid lichens", DEB-0949147). And David Alors is developing his work thanks to a Grant by the Ministerio de CIencia e Innovacion BES-2011-046091	de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Arup U, 2013, NORD J BOT, V31, P16, DOI 10.1111/j.1756-1051.2013.00062.x; Blanco O, 2006, MOL PHYLOGENET EVOL, V39, P52, DOI 10.1016/j.ympev.2005.12.015; Canez LS, 2009, ESTUDOS TAXONOMICOS; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Crespo A, 2004, LICHENOLOGIST, V36, P299, DOI 10.1017/S0024282904014434; Crespo A, 2001, TAXON, V50, P807, DOI 10.2307/1223708; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2011, LICHENOLOGIST, V43, P511, DOI 10.1017/S0024282911000570; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Del-Prado R, 2013, TAXON, V62, P928, DOI 10.12705/625.22; Divakar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083115; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ELIX JA, 1988, MYCOTAXON, V31, P491; Elix JA, 2009, SYST BIODIVERS, V7, P479, DOI 10.1017/S1477200009990223; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Fernandez-Mendoza F, 2013, MOL ECOL, V22, P1961, DOI 10.1111/mec.12210; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; HALE MASON E., 1965, SVENSK BOT TTOSKR, V59, P37; Hawksworth DL, 2008, LICHENOLOGIST, V40, P1, DOI 10.1017/S0024282908007329; Hawksworth DL, 2011, LICHENOLOGIST, V43, P639, DOI 10.1017/S0024282911000454; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Kalb K, 2007, BIBLIOTHECA LICHENOL, V95, P297; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kraichak E, 2015, SCI REPORTS IN PRESS; KROG H, 1982, Nordic Journal of Botany, V2, P287, DOI 10.1111/j.1756-1051.1982.tb01191.x; KROG H, 1977, NORW J BOT, V24, P167; Leavitt S.D., 2015, RECENT ADV LICHENOLO, P11, DOI 10.1007/978-81-322-2235-4_2; Leavitt SD, 2013, J BIOGEOGR, V40, P1792, DOI 10.1111/jbi.12118; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Leavitt SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-176; Lendemer JC, 2010, LICHENOLOGIST, V42, P405, DOI 10.1017/S0024282910000101; Lindblom L, 2008, LICHENOLOGIST, V40, P399, DOI 10.1017/S0024282908007937; Lumbsch HT, 2008, AUST SYST BOT, V21, P217, DOI 10.1071/SB07049; Lumbsch HT, 2006, BIOL J LINN SOC, V89, P615, DOI 10.1111/j.1095-8312.2006.00696.x; Lumbsch HT, 2014, SYST BIODIVERS, V12, P271, DOI 10.1080/14772000.2014.905506; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch H. Thorsten, 2002, P281; Lumbsch HT, 2008, BMC EVOLUTIONARY BIO, V8; Maddison WP, 2011, MESQUITE MODULAR SYS; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moncada B, 2014, BRYOLOGIST, V117, P119, DOI 10.1639/0007-2745-117.2.119; Myllys L, 2011, LICHENOLOGIST, V43, P617, DOI 10.1017/S0024282911000132; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Perez-Ortega S, 2012, ANN BOT-LONDON, V109, P1133, DOI 10.1093/aob/mcs042; Platt JL, 2000, MYCOLOGIA, V92, P475, DOI 10.2307/3761506; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A., 2009, FIGTREE 1 2 2; Rambaut A, 2009, TREE ANNOTATOR; RDT, 2008, R LANG ENV STAT COMP; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmitt I, 2004, MOL PHYLOGENET EVOL, V33, P43, DOI 10.1016/j.ympev.2004.04.014; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Serusiaux E, 2011, J BIOGEOGR, V38, P1138, DOI 10.1111/j.1365-2699.2010.02469.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Tan G, 2015, SYST BIOL, P1; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zoller S, 1999, LICHENOLOGIST, V31, P511	86	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146537	10.1371/journal.pone.0146537	http://dx.doi.org/10.1371/journal.pone.0146537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863231	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600011
J	Bailleul, AM; Scannella, JB; Horner, JR; Evans, DC				Bailleul, Alida M.; Scannella, John B.; Horner, John R.; Evans, David C.			Fusion Patterns in the Skulls of Modern Archosaurs Reveal That Sutures Are Ambiguous Maturity Indicators for the Dinosauria	PLOS ONE			English	Article							BITE-FORCE PERFORMANCE; CRANIOFACIAL ONTOGENY; CRANIAL SUTURES; TYRANNOSAURIDAE DINOSAURIA; AMERICAN ALLIGATORS; GROWTH; CLOSURE; ORNITHISCHIA; BONE; CERATOPSIDAE	The sutures of the skulls of vertebrates are generally open early in life and slowly close as maturity is attained. The assumption that all vertebrates follow this pattern of progressive sutural closure has been used to assess maturity in the fossil remains of non-avian dinosaurs. Here, we test this assumption in two members of the Extant Phylogenetic Bracket of the Dinosauria, the emu, Dromaius novaehollandiae and the American alligator, Alligator mississippiensis, by investigating the sequence and timing of sutural fusion in their skulls. As expected, almost all the sutures in the emu skull progressively close (i.e., they get narrower) and then obliterate during ontogeny. However, in the American alligator, only two sutures out of 36 obliterate completely and they do so during embryonic development. Surprisingly, as maturity progresses, many sutures of alligators become wider in large individuals compared to younger, smaller individuals. Histological and histomorphometric analyses on two sutures and one synchondrosis in an ontogenetic series of American alligator confirmed our morphological observations. This pattern of sutural widening might reflect feeding biomechanics and dietary changes through ontogeny. Our findings show that progressive sutural closure is not always observed in extant archosaurs, and therefore suggest that cranial sutural fusion is an ambiguous proxy for assessing maturity in non-avian dinosaurs.	[Bailleul, Alida M.; Scannella, John B.; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Bailleul, Alida M.; Scannella, John B.; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Evans, David C.] Univ Toronto, Royal Ontario Museum, Toronto, ON, Canada; [Evans, David C.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Bailleul, Alida M.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Royal Ontario Museum; University of Toronto; University of Toronto; University of Missouri System; University of Missouri Columbia	Bailleul, AM (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.; Bailleul, AM (corresponding author), Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA.; Bailleul, AM (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA.	bailleula@missouri.edu			M.A Fritz Travel grant; Evolving Earth Foundation; Jurassic Foundation; Geological Society of America; Sigma Xi; Paleontology Department at the MOR	M.A Fritz Travel grant; Evolving Earth Foundation; Jurassic Foundation; Geological Society of America; Sigma Xi; Paleontology Department at the MOR	Travel costs for AMB to the ROM were funded by the M.A Fritz Travel grant. This research was supported by grants from the Evolving Earth Foundation (http://www.evolvingearth.org/evolvingearthgrants/grantsmain.htm), the Jurassic Foundation, the Geological Society of America, and Sigma Xi (https://www.sigmaxi.org/programs/grants-in-aid) to AMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank D. Collins at Montana Emu Ranch for providing emu heads; M. Holland and P. Bannon for preparing emu skulls; K. Seymour at the Royal Ontario Museum (ROM) for his assistance; G. Hurlburt for providing information about the types of skeletonization for the ROM alligator specimens; C. Woodruff at the Museum of the Rockies for his help in skeletonization protocols; N. Atwood for figure compilation and discussions; R. Elsey for her insights and for providing alligator specimens; T. Carr for conversations regarding ontograms, and C. Holliday and K. Middleton for discussions. For various help with histology and specimen preparation, we thank B. Harmon, D. Laudier, E-T Lamm, H. Flora and J. Gardner. We greatly thank J. Cray (Editor) and A. Tavares and S. Herring (reviewers) for their helpful comments and for improving the quality of this manuscript. We also thank the Paleontology Department at the MOR and Gerry Orhstrom for support. Travel costs for AMB to the ROM were funded by the M. A Fritz Travel grant. This research was supported by grants from the Evolving Earth Foundation, the Jurassic Foundation, the Geological Society of America and Sigma Xi to AMB.	Barmann EV, 2012, J MAMM EVOL, V19, P43, DOI 10.1007/s10914-011-9176-8; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; BIEWENER AA, 1983, J EXP BIOL, V105, P147; Brochu C. A., 1992, ONTOGENY POSTCRANIUM; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; CHABRECK RH, 1979, HERPETOLOGICA, V35, P51; Chinsamy-Turan A, 2001, ENCY LIFE SCI, P1; Chopra SRK, 1957, CRANIAL SUTURE CLOSU, P67; COHEN MM, 1993, AM J MED GENET, V47, P581, DOI 10.1002/ajmg.1320470507; Cole A, 2003, PALAEONTOLOGICAL ASS, V52, P29; Coombs W.P. Jr, 1990, P456; Curtis N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0442; Davies SJJF., 2002, RATITES TINAMOUS TIN; DELANY MF, 1986, J WILDLIFE MANAGE, V50, P348, DOI 10.2307/3801926; DELANY MF, 1990, J HERPETOL, V24, P418, DOI 10.2307/1565063; DODSON P, 1975, J ZOOL, V175, P315; Dwight T., 1890, BOSTON MED SURG J, V122, P389, DOI DOI 10.1056/NEJM189004241221701; Erickson GM, 2004, J ZOOL, V262, P21, DOI 10.1017/S0952836903004400; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Evans DC, 2005, LIFE O PAST, P349; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frederickson JA, 2014, PEERJ, V2, DOI 10.7717/peerj.252; Gamer M, 2012, IRR VARIOUS COEFFICI; Goonewardene LA, 2003, J APPL POULTRY RES, V12, P27, DOI 10.1093/japr/12.1.27; Goswami A, 2013, J EVOLUTION BIOL, V26, P1294, DOI 10.1111/jeb.12127; Grzimek B., 2003, GRZIMEKS ANIMAL LIFE, V8; HERRING SW, 1972, ACTA ANAT, V83, P222; Herring SW, 2000, CRANIOSYNOSTOSIS, P3; Hershkovitz I, 1997, AM J PHYS ANTHROPOL, V103, P393, DOI 10.1002/(SICI)1096-8644(199707)103:3<393::AID-AJPA8>3.0.CO;2-R; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, J ANATOMY; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; JASLOW CR, 1995, J ZOOL, V235, P193; JASLOW CR, 1989, ZOOL J LINN SOC-LOND, V95, P273, DOI 10.1111/j.1096-3642.1989.tb02312.x; Joanen T., 1987, WILDLIFE MANAGEMENT, P329; JOLLIE MALCOLM T., 1957, J MORPH, V100, P389, DOI 10.1002/jmor.1051000302; Knaup Britta, 2004, J Orofac Orthop, V65, P467, DOI 10.1007/s00056-004-0415-y; KOKICH V G, 1986, P81; Kopher RA, 2003, J BONE MINER RES, V18, P521, DOI 10.1359/jbmr.2003.18.3.521; Krogman WM, 1930, AM J ANAT, V46, P315, DOI 10.1002/aja.1000460206; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Landon DB, 1998, J WILDLIFE MANAGE, V62, P674, DOI 10.2307/3802343; Lee YN, 1996, J VERTEBR PALEONTOL, V16, P232, DOI 10.1080/02724634.1996.10011311; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Maddison WP, 2011, MESQUITE MODULAR SYS; Maisano JA, 2002, J VERTEBR PALEONTOL, V22, P268, DOI 10.1671/0272-4634(2002)022[0268:TFOSEA]2.0.CO;2; Mao JJ, 2002, J DENT RES, V81, P810, DOI 10.1177/154405910208101203; Mao JJ, 2005, CURR OPIN ORTHOP, V16, P331; Marieb EN, 2014, ESSENTIALS HUMAN ANA; Marshall C. L., 2000, EMBRYONIC GROWTH PAT; Mehrara BJ, 1999, PLAST RECONSTR SURG, V104, P1003, DOI 10.1097/00006534-199909040-00016; Minnaar M., 1992, EMU FARMERS HDB; Peptan AI, 2008, BONE, V42, P432, DOI 10.1016/j.bone.2007.05.014; PERSSON M, 1979, ARCH ORAL BIOL, V24, P283, DOI 10.1016/0003-9969(79)90090-6; PERSSON M, 1977, AM J ORTHOD DENTOFAC, V72, P42, DOI 10.1016/0002-9416(77)90123-3; PERSSON M, 1978, J ANAT, V125, P313; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; Rauhut OWM, 2004, CAN J EARTH SCI, V41, P1109, DOI 10.1139/E04-053; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sahni D, 2005, FORENSIC SCI INT, V148, P199, DOI 10.1016/j.forsciint.2004.06.002; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Schroeder Michael A., 2005, P303; Schweikher FP, 1930, AM J ANAT, V45, P443, DOI 10.1002/aja.1000450305; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; Sun ZY, 2004, ANAT REC PART A, V276A, P150, DOI 10.1002/ar.a.20002; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Todd TW, 1925, AM J PHYS ANTHROPOL, V8, P23, DOI 10.1002/ajpa.1330080103; Vij K, 2006, BONE, V38, P722, DOI 10.1016/j.bone.2005.10.028; Wilson LAB, 2009, J ANAT, V214, P339, DOI 10.1111/j.1469-7580.2008.01031.x; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Woodward A, 1992, EXPT ALLIGATOR HARVE; Woodward AR, 1995, J HERPETOL, V29, P507, DOI 10.2307/1564733; Woodward HN, 2015, PALEOBIOLOGY, V41, P503, DOI 10.1017/pab.2015.19; Woodward HN, 2011, J HERPETOL, V45, P339; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007	85	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147687	10.1371/journal.pone.0147687	http://dx.doi.org/10.1371/journal.pone.0147687			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862766	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600034
J	Hernandez, J; Moore, C; Si, XM; Richer, S; Jackson, J; Wang, W				Hernandez, Jerome; Moore, Cecil; Si, Xuemei; Richer, Stuart; Jackson, Janet; Wang, Wei			Aging Dogs Manifest Myopia as Measured by Autorefractor	PLOS ONE			English	Article							OPTICAL DEFOCUS; SURESIGHT	Objective Dogs, like humans, experience eye changes with aging: hardening and clouding of the lens and accumulated oxidative damage from UV sunlight. It has been debated whether such changes could be affecting the visual function of dogs. The objective of this study was to determine if autorefractometry could be used to measure visual function in dogs. Animals and Methods Nine Beagle dogs (ages 1 to 14 years) were examined by a veterinary ophthalmologist and their eyes determined to be free of cataracts. Spherical equivalent refractive error was measured by handheld autorefractor (Welch Allyn SureSight) under both indirect and direct lighting conditions with five measurements per condition, per eye. Measures were repeated on three different days for each dog within six weeks. Nonparametric statistics were used to detect differences among lighting conditions and test days, and between eyes. Spearmen correlation assessed the visual measurement outcomes' association with age. Results There was no difference for day-to-day or between-eye measurements. Significantly, the Beagles showed a myopic shift with aging (average spherical equivalent ranged from plano to -3.00 diopters), suggesting that dogs become more near-sighted as they age (r = -0.48 and -0.73 under direct and indirect lights; p<0.05 both). Younger dogs were able to make larger accommodation changes from indirect light to direct light conditions, indicating a more flexible lens (r = -0.50, p<0.05). Conclusions Although designed for humans, the hand-held autorefractor technique is applicable to dogs and sensitive to light conditions. The age-associated myopic shift could be expected to compromise dogs' visual functions.	[Hernandez, Jerome] Nestle Purina Res, St Joseph, MO USA; [Moore, Cecil] Univ Missouri, Dept Vet Med & Surg, Columbia, MO USA; [Si, Xuemei; Jackson, Janet; Wang, Wei] Nestle Res Ctr, St Louis, MO USA; [Richer, Stuart] Captain James A Lovell Fed Hlth Care Facil, Ophthalmol, N Chicago, IL USA	University of Missouri System; University of Missouri Columbia; Nestle SA	Wang, W (corresponding author), Nestle Res Ctr, St Louis, MO USA.	wei.wang@rd.nestle.com			Nestle	Nestle(Nestle SA)	This study was supported by Nestle. The funder played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Berliner ML, 1966, BIOMICROSCOPY EYE, P1147; Chylack L.T.KPM, 2000, PRINCIPLES PRACTICE, P227; DAVIDSON MG, 2007, VET OPHTHALMOLOGY, P859; Groth AD, 2013, VET OPHTHALMOL, V16, P319, DOI 10.1111/j.1463-5224.2012.01075.x; Kubai MA, 2008, AM J VET RES, V69, P946, DOI 10.2460/ajvr.69.7.946; MURPHY CJ, 1992, INVEST OPHTH VIS SCI, V33, P2459; Murphy CJ, 1997, AM J VET RES, V58, P414; Mutti DO, 1999, INVEST OPHTH VIS SCI, V40, P1577; Ofri R, 2012, AM J VET RES, V73, P546, DOI 10.2460/ajvr.73.4.546; Steele G, 2003, OPTOMETRY VISION SCI, V80, P573, DOI 10.1097/00006324-200308000-00010; Tobias G, 1998, AM J VET RES, V59, P945; Williams LA, 2011, OPTOMETRY VISION SCI, V88, P269, DOI 10.1097/OPX.0b013e3182058ff0; Ying GS, 2011, INVEST OPHTH VIS SCI, V52, P9658, DOI 10.1167/iovs.11-8559	13	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148436	10.1371/journal.pone.0148436	http://dx.doi.org/10.1371/journal.pone.0148436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862919	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600071
J	Westerman, E; Monteiro, A				Westerman, Erica; Monteiro, Antonia			Rearing Temperature Influences Adult Response to Changes in Mating Status	PLOS ONE			English	Article							BICYCLUS-ANYNANA BUTTERFLIES; MATE CHOICE; SOCIAL EXPERIENCES; WING PATTERNS; PHENOTYPIC PLASTICITY; BRAIN-DEVELOPMENT; CLIMATE-CHANGE; FEMALE; INSECTS; EJACULATE	Rearing environment can have an impact on adult behavior, but it is less clear how rearing environment influences adult behavior plasticity. Here we explore the effect of rearing temperature on adult mating behavior plasticity in the butterfly Bicyclus anynana, a species that has evolved two seasonal forms in response to seasonal changes in temperature. These seasonal forms differ in both morphology and behavior. Females are the choosy sex in cohorts reared at warm temperatures (WS butterflies), and males are the choosy sex in cohorts reared at cooler temperatures (DS butterflies). Rearing temperature also influences mating benefits and costs. In DS butterflies, mated females live longer than virgin females, and mated males live shorter than virgin males. No such benefits or costs to mating are present in WS butterflies. Given that choosiness and mating costs are rearing temperature dependent in B. anynana, we hypothesized that temperature may also impact male and female incentives to remate in the event that benefits and costs of second matings are similar to those of first matings. We first examined whether lifespan was affected by number of matings. We found that two matings did not significantly increase lifespan for either WS or DS butterflies relative to single matings. However, both sexes of WS but not DS butterflies experienced decreased longevity when mated to a non-virgin relative to a virgin. We next observed pairs of WS and DS butterflies and documented changes in mating behavior in response to changes in the mating status of their partner. WS but not DS butterflies changed their mating behavior in response to the mating status of their partner. These results suggest that rearing temperature influences adult mating behavior plasticity in B. anynana. This developmentally controlled behavioral plasticity may be adaptive, as lifespan depends on the partner's mating status in one seasonal form, but not in the other.	[Westerman, Erica; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Westerman, Erica] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Monteiro, Antonia] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Monteiro, Antonia] Yale NUS Coll, Singapore, Singapore	Yale University; University of Chicago; National University of Singapore; Yale NUS College	Westerman, E (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.; Westerman, E (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	ewesterman@uchicago.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X	National Science Foundation [IOS-110382]; Yale University	National Science Foundation(National Science Foundation (NSF)); Yale University	This research was funded by a National Science Foundation (www.nsf.gov) IOS-110382 Doctoral Dissertation Improvement Grant to EW and AM, and Yale University (www.yale.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Bailey NW, 2008, P ROY SOC B-BIOL SCI, V275, P2645, DOI 10.1098/rspb.2008.0859; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Bissoondath CJ, 1996, FUNCT ECOL, V10, P457, DOI 10.2307/2389938; Boggs Carol L., 1995, P215; BRAKEFIELD PM, 1993, ACTA BIOTHEOR, V41, P447, DOI 10.1007/BF00709376; BRAKEFIELD PM, 1995, J EVOLUTION BIOL, V8, P559, DOI 10.1046/j.1420-9101.1995.8050559.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; Bro-Jorgensen J, 2010, BIOL REV, DOI [10.1111/j.1469-185X.2010.00149, DOI 10.1111/J.1469-185X.2010.00149]; Champagne FA, 2005, CURR OPIN NEUROBIOL, V15, P704, DOI 10.1016/j.conb.2005.10.001; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Cook PA, 1996, P ROY SOC B-BIOL SCI, V263, P1047, DOI 10.1098/rspb.1996.0154; de Jong MA, 2013, MOL ECOL, V22, P341, DOI 10.1111/mec.12114; de Jong MA, 2010, CLIM RES, V43, P91, DOI 10.3354/cr00881; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Doi H, 2008, BIOL LETTERS, V4, P388, DOI 10.1098/rsbl.2008.0234; Engqvist L, 2001, P ROY SOC B-BIOL SCI, V268, P729, DOI 10.1098/rspb.2000.1423; Etges WJ, 2007, EVOLUTION, V61, P1106, DOI 10.1111/j.1558-5646.2007.00104.x; ETGES WJ, 1992, EVOLUTION, V46, P1945, DOI [10.2307/2410042, 10.1111/j.1558-5646.1992.tb01180.x]; Everett A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-232; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Fedorka KM, 2002, ANIM BEHAV, V64, P361, DOI 10.1006/anbe.2002.3052; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fowler-Finn KD, 2012, EVOLUTION, V66, P459, DOI 10.1111/j.1558-5646.2011.01446.x; Friberg U, 2006, ANIM BEHAV, V72, P1259, DOI 10.1016/j.anbehav.2006.03.021; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Hardling R, 2008, AM NAT, V172, P259, DOI 10.1086/589452; Heinze S, 2012, J COMP NEUROL, V520, P1599, DOI 10.1002/cne.23054; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Jia ZY, 2000, ECOL ENTOMOL, V25, P115, DOI 10.1046/j.1365-2311.2000.00239.x; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Karlsson B, 1998, ECOLOGY, V79, P2931, DOI 10.1890/0012-9658(1998)079[2931:NGRBAR]2.0.CO;2; Kemp DJ, 2004, OIKOS, V105, P65, DOI 10.1111/j.0030-1299.2004.12874.x; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; Kozak GM, 2009, EVOLUTION, V63, P353, DOI 10.1111/j.1558-5646.2008.00564.x; Laviola G, 1998, NEUROSCI BIOBEHAV R, V23, P197, DOI 10.1016/S0149-7634(98)00021-9; Leech DI, 2007, IBIS, V149, P128, DOI 10.1111/j.1474-919X.2007.00729.x; Macias-Munoz A, 2015, MOLECULAR BIOLOGY AN, DOI [10.1093/molbev/msv197, DOI 10.1093/M0LBEV/MSV197]; Migaud M, 2015, FRONT NEUROENDOCRIN, V37, P146, DOI 10.1016/j.yfrne.2014.11.004; Monteiro A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064061, DOI 10.1371/J0URNAL.P0NE.0064061]; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Musolin DL, 2012, ENTOMOL REV, V92, P715, DOI DOI 10.1134/S0013873812070019; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Nylin S, 2013, PHYSIOL ENTOMOL, V38, P96, DOI 10.1111/phen.12014; Papadopoulos NT, 2009, PHYSIOL ENTOMOL, V34, P238, DOI 10.1111/j.1365-3032.2009.00680.x; Pfennig KS, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0599; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Prudic KL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1531; Prudic KL, 2011, SCIENCE, V331, P73, DOI 10.1126/science.1197114; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Rypstra AL, 2003, ETHOLOGY, V109, P315, DOI 10.1046/j.1439-0310.2003.00874.x; Sandvik M, 2000, P ROY SOC B-BIOL SCI, V267, P2151, DOI 10.1098/rspb.2000.1262; SHAPIRO A.M., 1976, EVOL BIOL, V9, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; Sherry DF, 2015, FRONT NEUROENDOCRIN, V37, P158, DOI 10.1016/j.yfrne.2014.11.008; Sherry DF, 2010, PHILOS T R SOC B, V365, P933, DOI 10.1098/rstb.2009.0220; SIMMONS LW, 1994, J EVOLUTION BIOL, V7, P189, DOI 10.1046/j.1420-9101.1994.7020189.x; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; Snell-Rood EC, 2011, BEHAV ECOL, V22, P291, DOI 10.1093/beheco/arq169; South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991; Thomas ML, 2011, BIOL REV, V86, P1, DOI 10.1111/j.1469-185X.2010.00130.x; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Verzijden MN, 2012, TRENDS ECOL EVOL, V27, P511, DOI 10.1016/j.tree.2012.05.007; Wainwright PE, 2006, AM J CLIN NUTR, V84, P961, DOI 10.1093/ajcn/84.5.961; Wedell N, 2004, ANIM BEHAV, V67, P1059, DOI 10.1016/j.anbehav.2003.10.007; Wedell N, 1999, P ROY SOC B-BIOL SCI, V266, P1033, DOI 10.1098/rspb.1999.0740; Westerman EL, 2014, J INSECT BEHAV, V27, P478, DOI 10.1007/s10905-014-9441-9; Westerman EL, 2014, EVOLUTION, V68, P1661, DOI 10.1111/evo.12381; Westerman EL, 2013, ANIM BEHAV, V86, P1139, DOI 10.1016/j.anbehav.2013.09.002; Westerman EL, 2012, P NATL ACAD SCI USA, V109, P10948, DOI 10.1073/pnas.1118378109; WIKLUND C, 1982, ANIM BEHAV, V30, P790, DOI 10.1016/S0003-3472(82)80151-6; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14	78	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146546	10.1371/journal.pone.0146546	http://dx.doi.org/10.1371/journal.pone.0146546			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863319	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600012
J	Zhang, HN; Liu, YH; Guan, SY; Qu, D; Wang, L; Wang, XS; Li, XB; Zhou, SM; Zhou, Y; Wang, N; Meng, JR; Ma, X				Zhang, Huinan; Liu, Yunhan; Guan, Shaoyu; Qu, Di; Wang, Ling; Wang, Xinshang; Li, Xubo; Zhou, Shimeng; Zhou, Ying; Wang, Ning; Meng, Jingru; Ma, Xue			An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FOCAL CEREBRAL-ISCHEMIA; EXENDIN-4; RATS; ACTIVATION; EXPRESSION; MICE; ANTAGONIST; INFARCTION; APOPTOSIS	Diabetes is a major risk factor for the development of stroke. Glucagon-like peptide-1 receptor (GLP-1R) agonists have been in clinical use for the treatment of diabetes and also been reported to be neuroprotective in ischemic stroke. The quinoxaline 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline (DMB) is an agonist and allosteric modulator of the GLP-1R with the potential to increase the affinity of GLP-1 for its receptor. The aim of this study was to evaluate the neuroprotective effects of DMB on transient focal cerebral ischemia. In cultured cortical neurons, DMB activated the GLP-1R, leading to increased intracellular cAMP levels with an EC50 value about 100 fold that of exendin-4. Pretreatment of neurons with DMB protected against necrotic and apoptotic cell death was induced by oxygen-glucose deprivation (OGD). The neuroprotective effects of DMB were blocked by GLP1R knockdown with shRNA but not by GLP-1R antagonism. In C57BL/6 mice, DMB was orally administered 30 min prior to middle cerebral artery occlusion (MCAO) surgery. DMB markedly reduced the cerebral infarct size and neurological deficits caused by MCAO and reperfusion. The neuroprotective effects were mediated by activation of the GLP-1R through the cAMP-PKA-CREB signaling pathway. DMB exhibited anti-apoptotic effects by modulating Bcl-2 family members. These results provide evidence that DMB, a small molecular GLP-1R agonist, attenuates transient focal cerebral ischemia injury and inhibits neuronal apoptosis induced by MCAO. Taken together, these data suggest that DMB is a potential neuroprotective agent against cerebral ischemia.	[Zhang, Huinan; Guan, Shaoyu; Qu, Di; Wang, Xinshang; Li, Xubo; Zhou, Shimeng; Zhou, Ying; Wang, Ning; Meng, Jingru; Ma, Xue] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Liu, Yunhan] Fourth Mil Med Univ, Sch Nurse, Xian 710032, Peoples R China; [Wang, Ling] Fourth Mil Med Univ, Dept Hlth Stat, Fac Preventat Med, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Meng, JR; Ma, X (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China.	mjrfmmu@hotmail.com; maxuel@fmmu.edu.cn			National Natural Science Foundation of China [81571278, 81471093, 81402931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Nos. 81571278 (Xue Ma), 81471093 (Jingru Meng) and 81402931 (Ying Zhou).	Ashabi G, 2014, METAB BRAIN DIS, V29, P47, DOI 10.1007/s11011-013-9475-2; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Briyal S, 2012, BRAIN RES, V1427, P23, DOI 10.1016/j.brainres.2011.10.026; Camos S, 2010, MOLECULES, V15, P9104, DOI 10.3390/molecules15129104; Chen T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05531; Darsalia V, 2015, J CEREBR BLOOD F MET, V35, P718, DOI 10.1038/jcbfm.2015.17; Darsalia V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103114; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; Ding L, 2012, ACTA PHARMACOL SIN, V33, P75, DOI 10.1038/aps.2011.149; Dong YF, 2013, CNS NEUROSCI THER, V19, P617, DOI 10.1111/cns.12117; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; GOKE R, 1993, J BIOL CHEM, V268, P19650; Green CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044284; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holscher C, 2012, CNS DRUGS, V26, P871, DOI 10.2165/11635890-000000000-00000; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; MacManus JP, 2000, J NEUROTRAUM, V17, P899, DOI 10.1089/neu.2000.17.899; Manandhar B, 2015, J MED CHEM, V58, P1020, DOI 10.1021/jm500810s; Meloni BP, 2001, NEUROSCIENCE, V108, P17, DOI 10.1016/S0306-4522(01)00396-7; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Pyke C, 2013, ENDOCRINOLOGY, V154, P4, DOI 10.1210/en.2012-2124; Sairanen T, 2006, BRAIN, V129, P189, DOI 10.1093/brain/awh645; Sanderson TH, 2009, NEUROL RES, V31, P947, DOI 10.1179/174313209X382449; Sato K, 2013, INT J MOL SCI, V14, P21513, DOI 10.3390/ijms141121513; Tanne D, 2008, ADV CARDIOL, V45, P107, DOI 10.1159/000115190; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Tzefos M, 2012, ANN PHARMACOTHER, V46, P68, DOI 10.1345/aph.1Q379; Wu F, 2013, MOL CELL NEUROSCI, V52, P9, DOI 10.1016/j.mcn.2012.10.001; Wu ZH, 2014, THERANOSTICS, V4, P770, DOI 10.7150/thno.7759; Zhang HN, 2015, EUR J PHARM SCI, V70, P82, DOI 10.1016/j.ejps.2015.01.010; Zhang ZY, 2014, FREE RADICAL BIO MED, V68, P8, DOI 10.1016/j.freeradbiomed.2013.11.007	44	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148827	10.1371/journal.pone.0148827	http://dx.doi.org/10.1371/journal.pone.0148827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863436	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600112
J	Engelmann, F; Rivera, A; Park, B; Messerle-Forbes, M; Jensen, JT; Messaoudi, I				Engelmann, Flora; Rivera, Andrea; Park, Byung; Messerle-Forbes, Marci; Jensen, Jeffrey T.; Messaoudi, Ilhem			Impact of Estrogen Therapy on Lymphocyte Homeostasis and the Response to Seasonal Influenza Vaccine in Post-Menopausal Women	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; SYSTEMIC ANTIBODY-RESPONSES; BLOOD MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; T-CELLS; TNF-ALPHA; IMMUNE-RESPONSES; IFN-GAMMA; RECEPTOR; INTERLEUKIN-6	It is widely recognized that changes in levels of ovarian steroids modulate severity of autoimmune disease and immune function in young adult women. These observations suggest that the loss of ovarian steroids associated with menopause could affect the age-related decline in immune function, known as immune senescence. Therefore, in this study, we determined the impact of menopause and estrogen therapy (ET) on lymphocyte subset frequency as well as the immune response to seasonal influenza vaccine in three different groups: 1) young adult women (regular menstrual cycles, not on hormonal contraception); 2) post-menopausal (at least 2 years) women who are not receiving any form of hormone therapy (HT) and 3) post-menopausal hysterectomized women receiving ET. Although the numbers of circulating CD4 and CD20 B cells were reduced in the post-menopausal group receiving ET, we also detected a better preservation of naive B cells, decreased CD4 T cell inflammatory cytokine production, and slightly lower circulating levels of the pro-inflammatory cytokine IL-6. Following vaccination, young adult women generated more robust antibody and T cell responses than both post-menopausal groups. Despite similar vaccine responses between the two post-menopausal groups, we observed a direct correlation between plasma 17 beta estradiol (E2) levels and fold increase in IgG titers within the ET group. These findings suggest that ET affects immune homeostasis and that higher plasma E2 levels may enhance humoral responses in post-menopausal women.	[Engelmann, Flora; Rivera, Andrea; Messaoudi, Ilhem] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Park, Byung] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Div Biostat, Portland, OR 97201 USA; [Messerle-Forbes, Marci; Jensen, Jeffrey T.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Jensen, Jeffrey T.; Messaoudi, Ilhem] Oregon Natl Primate Res Ctr, Div Reprod Sci, Beaverton, OR USA; [Messaoudi, Ilhem] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA	University of California System; University of California Riverside; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center	Messaoudi, I (corresponding author), Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA.; Messaoudi, I (corresponding author), Oregon Natl Primate Res Ctr, Div Reprod Sci, Beaverton, OR USA.; Messaoudi, I (corresponding author), Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA.	messaoud@ucr.edu	Jensen, Jeffrey T/C-7421-2014	Jensen, Jeffrey T/0000-0002-4733-1224	Center for Gender Differences at OHSU; Leadership in Aging Research Fellowship from the Brookdale Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD085809] Funding Source: NIH RePORTER	Center for Gender Differences at OHSU; Leadership in Aging Research Fellowship from the Brookdale Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the Center for Gender Differences at OHSU, and a Leadership in Aging Research Fellowship from the Brookdale Foundation.	Agematsu K, 2000, HISTOL HISTOPATHOL, V15, P573, DOI 10.14670/HH-15.573; Al-Harthi L, 2001, AIDS, V15, P1535, DOI 10.1097/00002030-200108170-00011; Al-Harthi L, 2000, J INTERF CYTOK RES, V20, P719, DOI 10.1089/10799900050116426; Angstwurm MWA, 1997, CYTOKINE, V9, P370, DOI 10.1006/cyto.1996.0178; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Baeza I, 2010, J NEUROIMMUNOL, V219, P90, DOI 10.1016/j.jneuroim.2009.12.008; Baeza I, 2011, BIOGERONTOLOGY, V12, P227, DOI 10.1007/s10522-010-9317-0; Bluming AZ, 2009, CANCER J, V15, P93, DOI 10.1097/PPO.0b013e31819e332a; Brooks-Asplund EM, 2002, CYTOKINE, V19, P193, DOI 10.1006/cyto.2002.1963; Butts CL, 2007, INT IMMUNOL, V19, P287, DOI 10.1093/intimm/dxl145; Calder AE, 2011, NEUROIMMUNOMODULAT, V18, P281, DOI 10.1159/000329496; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; CARLSTEN H, 1992, CELL IMMUNOL, V144, P190, DOI 10.1016/0008-8749(92)90236-I; Carroll ML, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-184; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; Deguchi K, 2001, MENOPAUSE, V8, P266, DOI 10.1097/00042192-200107000-00008; Delpy L, 2005, J IMMUNOL, V175, P5050, DOI 10.4049/jimmunol.175.8.5050; Effros Rita B, 2005, Discov Med, V5, P293; Engelmann F, 2010, AGE DORDR; Evans MJ, 1997, CLIN IMMUNOL IMMUNOP, V82, P258, DOI 10.1006/clin.1996.4300; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franklin RD, 1999, J REPROD IMMUNOL, V42, P93, DOI 10.1016/S0165-0378(98)00086-2; Gameiro Catia, 2010, Front Biosci (Elite Ed), V2, P1299; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; GIGLIO T, 1994, LIFE SCI, V54, P1305, DOI 10.1016/0024-3205(94)00508-7; Giuliani N, 2001, EXP GERONTOL, V36, P547, DOI 10.1016/S0531-5565(00)00220-5; Hsu HC, 2006, MECH AGEING DEV, V127, P231, DOI 10.1016/j.mad.2005.10.001; Hughes GC, 2008, J IMMUNOL, V180, P2029, DOI 10.4049/jimmunol.180.4.2029; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Kanda N, 1999, J ALLERGY CLIN IMMUN, V103, P282, DOI 10.1016/S0091-6749(99)70503-8; Karpuzoglu E, 2009, CLIN REV ALLERG IMMU, V40, P16; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Khan D, 2010, EUR J IMMUNOL, V40, P2549, DOI 10.1002/eji.201040303; Kim WU, 2010, CLIN EXP IMMUNOL, V161, P453, DOI 10.1111/j.1365-2249.2010.04194.x; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Kovats S, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P53, DOI 10.1007/978-3-642-02155-8_3; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kumru S, 2004, J REPROD IMMUNOL, V63, P31, DOI 10.1016/j.jri.2004.02.001; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; McNerlan SE, 2002, EXP GERONTOL, V37, P227, DOI 10.1016/S0531-5565(01)00188-7; Nguyen DC, 2011, VACCINE, V29, P2515, DOI 10.1016/j.vaccine.2011.01.080; PAAVONEN T, 1981, J EXP MED, V154, P1935, DOI 10.1084/jem.154.6.1935; Pennock JW, 2009, VACCINE, V27, P5830, DOI 10.1016/j.vaccine.2009.07.052; Polanczyk MJ, 2006, J NEUROSCI RES, V84, P370, DOI 10.1002/jnr.20881; Porter VR, 2001, EXP GERONTOL, V36, P311, DOI 10.1016/S0531-5565(00)00195-9; Rider V, 2001, J RHEUMATOL, V28, P2644; Salem Mohamed Labib, 2004, Current Drug Targets - Inflammation and Allergy, V3, P97, DOI 10.2174/1568010043483944; Sandmand M, 2003, GERONTOLOGY, V49, P155, DOI 10.1159/000069174; Saucedo R, 2002, GYNECOL OBSTET INVES, V53, P114, DOI 10.1159/000053005; Stopinska-Gluszak U, 2006, J REPROD IMMUNOL, V69, P65, DOI 10.1016/j.jri.2005.07.006; Suenaga R, 1998, J RHEUMATOL, V25, P1305; Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003; Verthelyi D, 2000, IMMUNOLOGY, V100, P384, DOI 10.1046/j.1365-2567.2000.00047.x; Verthelyi DI, 1998, CELL IMMUNOL, V189, P125, DOI 10.1006/cimm.1998.1372; Vural P, 2006, PHARMACOL RES, V53, P367, DOI 10.1016/j.phrs.2006.01.005; Vural P, 2006, PHARMACOL RES, V54, P298, DOI 10.1016/j.phrs.2006.06.006; Wagner Wolfgang M, 2004, Biogerontology, V5, P63, DOI 10.1023/B:BGEN.0000017832.57617.66; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; WEISS NS, 1980, NEW ENGL J MED, V303, P1195, DOI 10.1056/NEJM198011203032102; Yasui T, 2007, MATURITAS, V56, P396, DOI 10.1016/j.maturitas.2006.11.002; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8	68	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149045	10.1371/journal.pone.0149045	http://dx.doi.org/10.1371/journal.pone.0149045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859566	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400123
J	Graves, N; Page, K; Martin, E; Brain, D; Hall, L; Campbell, M; Fulop, N; Jimmeison, N; White, K; Paterson, D; Barnett, AG				Graves, Nicholas; Page, Katie; Martin, Elizabeth; Brain, David; Hall, Lisa; Campbell, Megan; Fulop, Naomi; Jimmeison, Nerina; White, Katherine; Paterson, David; Barnett, Adrian G.			Cost-Effectiveness of a National Initiative to Improve Hand Hygiene Compliance Using the Outcome of Healthcare Associated Staphylococcus aureus Bacteraemia	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; LENGTH-OF-STAY; DECISION-MAKING; SAVE-LIVES; INDICATOR; ECONOMICS; EFFICACY; PROGRAM; RATES	Background The objective is to estimate the incremental cost-effectiveness of the Australian National Hand Hygiene Inititiave implemented between 2009 and 2012 using healthcare associated Staphylococcus aureus bacteraemia as the outcome. Baseline comparators are the eight existing state and territory hand hygiene programmes. The setting is the Australian public healthcare system and 1,294,656 admissions from the 50 largest Australian hospitals are included. Methods The design is a cost-effectiveness modelling study using a before and after quasi-experimental design. The primary outcome is cost per life year saved from reduced cases of healthcare associated Staphylococcus aureus bacteraemia, with cost estimated by the annual on-going maintenance costs less the costs saved from fewer infections. Data were harvested from existing sources or were collected prospectively and the time horizon for the model was 12 months, 2011-2012. Findings No useable pre-implementation Staphylococcus aureus bacteraemia data were made available from the 11 study hospitals in Victoria or the single hospital in Northern Territory leaving 38 hospitals among six states and territories available for cost-effectiveness analyses. Total annual costs increased by $2,851,475 for a return of 96 years of life giving an incremental cost-effectiveness ratio (ICER) of $29,700 per life year gained. Probabilistic sensitivity analysis revealed a 100% chance the initiative was cost effective in the Australian Capital Territory and Queensland, with ICERs of $1,030 and $8,988 respectively. There was an 81% chance it was cost effective in New South Wales with an ICER of $33,353, a 26% chance for South Australia with an ICER of $64,729 and a 1% chance for Tasmania and Western Australia. The 12 hospitals in Victoria and the Northern Territory incur annual on-going maintenance costs of $1.51M; no information was available to describe cost savings or health benefits. Conclusions The Australian National Hand Hygiene Initiative was cost-effective against an Australian threshold of $42,000 per life year gained. The return on investment varied among the states and territories of Australia.	[Graves, Nicholas; Page, Katie; Martin, Elizabeth; Brain, David; Hall, Lisa; Campbell, Megan; White, Katherine; Barnett, Adrian G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Fulop, Naomi] UCL, Dept Appl Hlth Res, London, England; [Jimmeison, Nerina] Queensland Univ Technol, Sch Management, Brisbane, Qld 4001, Australia; [Jimmeison, Nerina] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of London; University College London; Queensland University of Technology (QUT); University of Queensland	Graves, N (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	n.graves@qut.edu.au	Page, Katie/H-4283-2019; Barnett, Adrian/I-9850-2012; Martin, Elizabeth/O-3573-2019; Hall, Lisa/H-6322-2012	Page, Katie/0000-0001-9183-9175; Barnett, Adrian/0000-0001-6339-0374; Martin, Elizabeth/0000-0003-0252-8303; Fulop, Naomi/0000-0001-5306-6140; Graves, Nicholas/0000-0002-5559-3267; Paterson, David/0000-0003-2079-4437; Campbell, Megan/0000-0002-6056-6140; Brain, David/0000-0002-6612-348X; Jimmieson, Nerina/0000-0003-4901-7949; White, Katherine/0000-0002-0345-4724	National Health and Medical Research Council [553081]; Australian Commission on Safety and Quality in Health Care; Hand Hygiene Australia; Centre for Healthcare Related Infection Surveillance and Prevention, Communicable Diseases Branch, Queensland Health	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Commission on Safety and Quality in Health Care; Hand Hygiene Australia; Centre for Healthcare Related Infection Surveillance and Prevention, Communicable Diseases Branch, Queensland Health	Financial support for this study was provided by a National Health and Medical Research Council Partnership grant (number 553081) with financial and in-kind support from Australian Commission on Safety and Quality in Health Care, Hand Hygiene Australia, and jurisdictional health departments. Representatives of the Australian Commission on Safety and Quality in Health Care attended research governance meetings to provide feedback on the progress of the project, but the design and conduct is the sole responsibility of the investigators awarded the grant. The funders had no veto on study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Centre for Healthcare Related Infection Surveillance and Prevention, Communicable Diseases Branch, Queensland Health, supports the salaries of NG & DP. We are grateful to all the infection control practitioners who took their time to answer the costing survey and provide other information about the implementation of the National Hand Hygiene Initiative. All authors have no relationships with companies that might have an interest in the submitted work; their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and they have no non-financial interests that may be relevant to the submitted work.	ACSQHC, 2012, SURV HEALTHC ASS INF; Allegranzi B, GLOBAL IMPLEMENTATIO, P1474; Australian Comission on Safety and Quality in Health Care, 2013, IMPL GUID SURV STAPH; Australian Institute of Health and Welfare, 2013, HLTH SERV SER, V50; Australian Institute of Health and Welfare, 2010, AUSTR HLTH SER, V12; Australian Institute of Health and Welfare, 2013, HLTH SERV SER, V53; Australian Institute of Health and Welfare (AIHW), 2012, LIF EXP; Azim S, 2014, MED J AUSTRALIA, V200, P534, DOI 10.5694/mja13.11203; Barnett A. G., 2014, Healthcare Infection, V19, P128, DOI 10.1071/HI14033; Barnett AG, 2014, INFECT CONT HOSP EP, V35, P1029, DOI 10.1086/677160; Barnett AG, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003587; Barnett AG, 2011, VALUE HEALTH, V14, P381, DOI 10.1016/j.jval.2010.09.008; Beyersmann J, 2006, INFECT CONT HOSP EP, V27, P493, DOI 10.1086/503375; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Collignon PJ, 2006, MED J AUSTRALIA, V184, P404, DOI 10.5694/j.1326-5377.2006.tb00291.x; Collignon Pj, STAPHYLOCOCCUS AUREU; Dick AW, DECADE INVESTMENT IN, P1527; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; George B HA, 2001, PHARMACOECONOMICS; Gould DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005186.pub3; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Graves N, 2007, INFECT CONT HOSP EP, V28, P178, DOI 10.1086/510787; Graves N, 2013, INFECT CONT HOSP EP, V34, P424, DOI 10.1086/669862; Graves N, 2010, CLIN INFECT DIS, V50, P1017, DOI 10.1086/651110; Grayson ML, 2008, MED J AUSTRALIA, V188, P633, DOI 10.5694/j.1326-5377.2008.tb01820.x; Grayson ML, 2009, MED J AUSTRALIA, V191, P420, DOI 10.5694/j.1326-5377.2009.tb02873.x; Hand Hygiene Australia, 2014, NAT DAT; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Huis A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-92; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Lawes T, 2015, LANCET INFECT DIS, V15, P1438, DOI 10.1016/S1473-3099(15)00315-1; Lawes T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006596; Lawes TG, 2012, CLIN INFECT DIS, V55, P1027, DOI 10.1093/cid/cis602; Luangasanatip N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3728; McLaws ML, 2009, MED J AUSTRALIA, V191, pS26; Naikoba S, 2001, EFFECTIVENESS INTERV; National Institute for Health and Clinical Excellence, GUID METH TECHN APPR; Page K, 2014, J HOSP INFECT, V88, P141, DOI 10.1016/j.jhin.2014.06.005; Page K, 2013, J HOSP INFECT, V84, P200, DOI 10.1016/j.jhin.2013.03.006; Page K, J HOSP INFE IN PRESS; Pantle AC, 2009, MED J AUSTRALIA, V191, pS8; Perencevich EN, 2007, INFECT CONT HOSP EP, V28, P1121, DOI 10.1086/521852; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Playford EG, 2012, MED J AUSTRALIA, V197, P29, DOI 10.5694/mja12.10677; Rechner IJ, 2005, ANAESTH INTENS CARE, V33, P477, DOI 10.1177/0310057X0503300409; Reichardt C, 2013, J HOSP INFECT, V83, pS11, DOI 10.1016/S0195-6701(13)60004-3; Russo PL, 2015, AM J INFECT CONTROL, V43, P773, DOI 10.1016/j.ajic.2015.02.029; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Schweizer ML, SEARCHING OPTIMAL HA, P1537; Srigley JA, 2014, BMJ QUAL SAF, V23, P974, DOI 10.1136/bmjqs-2014-003080; Stewardson AJ, 2014, INFECT CONT HOSP EP, V35, P1294, DOI 10.1086/678063; Stone SP, EVALUATION NATL CLEA, P1756; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304	58	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148190	10.1371/journal.pone.0148190	http://dx.doi.org/10.1371/journal.pone.0148190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859688	Green Published, gold			2022-12-26	WOS:000370038400025
J	Hatai, H; Lepelley, A; Zeng, WY; Hayden, MS; Ghosh, S				Hatai, Hirotsugu; Lepelley, Alice; Zeng, Wangyong; Hayden, Matthew S.; Ghosh, Sankar			Toll-Like Receptor 11 (TLR11) Interacts with Flagellin and Profilin through Disparate Mechanisms	PLOS ONE			English	Article							TOXOPLASMA-GONDII PROFILIN; DOUBLE-STRANDED-RNA; PROTEOLYTIC CLEAVAGE; CPG-DNA; RECOGNITION; ACTIVATION; INFECTION; FRAGMENT; BACTERIA; IMMUNITY	Toll-like receptors (TLRs) are innate immune receptors that sense a variety of pathogen-associated molecular patterns (PAMPs) by interacting with them and subsequently initiating signal transduction cascades that elicit immune responses. TLR11 has been shown to interact with two known protein PAMPs: Salmonella and E. coli flagellin FliC and Toxoplasma gondii profilin-like protein. Given the highly divergent biology of these pathogens recognized by TLR11, it is unclear whether common mechanisms are used to recognize these distinct protein PAMPs. Here we show that TLR11 interacts with these two PAMPs using different receptor domains. Furthermore, TLR11 binding to flagellin and profilin exhibits differential dependency on pH and receptor ectodomain cleavage.	[Hatai, Hirotsugu; Lepelley, Alice; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA; [Hatai, Hirotsugu] Univ Tokyo, Grad Sch Med, Dept Pathol Immunol & Microbiol, Bunkyo Ku, Tokyo, Japan; [Zeng, Wangyong; Hayden, Matthew S.] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY USA	Columbia University; University of Tokyo; Columbia University	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA.	sg2715@columbia.edu	Lepelley, Alice/P-1197-2018	Lepelley, Alice/0000-0001-8656-7291; Hayden, Matthew/0000-0003-1670-6430; Hatai, Hitoshi/0000-0002-9063-7616	Japan Society for the Promotion of Science [243602]; NIH [R37-AI33443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Japan Society for the Promotion of Science (Grant-in-Aid for JSPS Fellows; 243602 to HH), NIH grant R37-AI33443 and institutional support from Columbia University to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KL, 2014, IMMUNOL REV, V260, P206, DOI 10.1111/imr.12180; Cai ZY, 2009, J BIOL CHEM, V284, P33088, DOI 10.1074/jbc.M109.050757; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Huh JW, 2014, P NATL ACAD SCI USA, V111, P7072, DOI 10.1073/pnas.1322838111; Kanno A, 2013, INT IMMUNOL, V25, P413, DOI 10.1093/intimm/dxt007; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Kucera K, 2010, J MOL BIOL, V403, P616, DOI 10.1016/j.jmb.2010.09.022; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Murakami Y, 2014, J IMMUNOL, V193, P5208, DOI 10.4049/jimmunol.1400386; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Raetz M, 2013, J IMMUNOL, V191, P4818, DOI 10.4049/jimmunol.1301301; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi ZC, 2012, J BIOL CHEM, V287, P43417, DOI 10.1074/jbc.M112.411009; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Toscano F, 2013, J IMMUNOL, V190, P764, DOI 10.4049/jimmunol.1202173; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	31	35	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148987	10.1371/journal.pone.0148987	http://dx.doi.org/10.1371/journal.pone.0148987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859749	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400116
J	Onogi, A; Ideta, O; Yoshioka, T; Ebana, K; Yamasaki, M; Iwata, H				Onogi, Akio; Ideta, Osamu; Yoshioka, Takuma; Ebana, Kaworu; Yamasaki, Masanori; Iwata, Hiroyoshi			Uncovering a Nuisance Influence of a Phenological Trait of Plants Using a Nonlinear Structural Equation: Application to Days to Heading and Culm Length in Asian Cultivated Rice (Oryza Sativa L.)	PLOS ONE			English	Article							SOMATIC-CELL SCORE; FLOWERING TIME; MILK-YIELD; INFERRING RELATIONSHIPS; NATURAL VARIATION; DATE; HEIGHT; MODELS; LOCI; GENE	Phenological traits of plants, such as flowering time, are linked to growth phase transition. Thus, phenological traits often influence other traits through the modification of the duration of growth period. This influence is a nuisance in plant breeding because it hampers genetic evaluation of the influenced traits. Genetic effects on the influenced traits have two components, one that directly affects the traits and one that indirectly affects the traits via the phenological trait. These cannot be distinguished by phenotypic evaluation and ordinary linear regression models. Consequently, if a phenological trait is modified by introgression or editing of the responsible genes, the phenotypes of the influenced traits can change unexpectedly. To uncover the influence of the phenological trait and evaluate the direct genetic effects on the influenced traits, we developed a nonlinear structural equation (NSE) incorporating a nonlinear influence of the phenological trait. We applied the NSE to real data for cultivated rice (Oryza sativa L.): days to heading (DH) as a phenological trait and culm length (CL) as the influenced trait. This showed that CL of the cultivars that showed extremely early heading was shortened by the strong influence of DH. In a simulation study, it was shown that the NSE was able to infer the nonlinear influence and direct genetic effects with reasonable accuracy. However, the NSE failed to infer the linear influence in this study. When no influence was simulated, an ordinary bi-trait linear model (OLM) tended to infer the genetic effects more accurately. In such cases, however, by comparing the NSE and OLM using an information criterion, we could assess whether the nonlinear assumption of the NSE was appropriate for the data analyzed. This study demonstrates the usefulness of the NSE in revealing the phenotypic influence of phenological traits.	[Onogi, Akio; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan; [Ideta, Osamu] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima, Japan; [Yoshioka, Takuma; Yamasaki, Masanori] Kobe Univ, Food Resources Educ & Res Ctr, Grad Sch Agr Sci, Kasai, Hyogo, Japan; [Ebana, Kaworu] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; Kobe University; National Institute of Agrobiological Sciences - Japan	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp	Yamasaki, Masanori/C-5193-2018	Yamasaki, Masanori/0000-0001-7759-3965	JSPS KAKENHI [25252002, 14J10661, 15H04436]; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [NVR-0002]; Grants-in-Aid for Scientific Research [15H04436] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Numbers 25252002, 14J10661 and 15H04436, and by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, NVR-0002).	Bauer DJ, 2005, STRUCT EQU MODELING, V12, P513, DOI 10.1207/s15328007sem1204_1; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Bollen KA, 1989, STRUCTURAL EQUATIONS; de los Campos G, 2006, J DAIRY SCI, V89, P4445, DOI 10.3168/jds.S0022-0302(06)72493-6; Dhungana P, 2007, CROP SCI, V47, P477, DOI 10.2135/cropsci2006.06.0425; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Endo-Higashi N, 2011, PLANT CELL PHYSIOL, V52, P1083, DOI 10.1093/pcp/pcr059; Ergon A, 2006, THEOR APPL GENET, V112, P232, DOI 10.1007/s00122-005-0115-z; Gelman A., 2014, BAYESIAN DATA ANAL, VThird; Gianola D, 2004, GENETICS, V167, P1407, DOI 10.1534/genetics.103.025734; Godoy AS, 1999, EUPHYTICA, V105, P155, DOI 10.1023/A:1003490016166; Guo RX, 2012, BIOMETRICS, V68, P567, DOI 10.1111/j.1541-0420.2012.01751.x; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hori K, 2013, PLANT J, V76, P36, DOI 10.1111/tpj.12268; Hori K, 2012, BREEDING SCI, V62, P223, DOI 10.1270/jsbbs.62.223; Hori K, 2009, BREEDING SCI, V59, P285, DOI 10.1270/jsbbs.59.285; KENNY DA, 1984, PSYCHOL BULL, V96, P201, DOI 10.1037/0033-2909.96.1.201; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kumudini S, 2001, CROP SCI, V41, P391, DOI 10.2135/cropsci2001.412391x; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; LI ZK, 1995, THEOR APPL GENET, V91, P374, DOI 10.1007/BF00220902; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Sabadin PK, 2012, THEOR APPL GENET, V124, P1389, DOI 10.1007/s00122-012-1795-9; SAKAI KAN-ICHI, 1964, RADIAT BOT, V4, P141, DOI 10.1016/S0033-7560(64)80065-X; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; SCHAPAUGH WT, 1980, CROP SCI, V20, P529, DOI 10.2135/cropsci1980.0011183X002000040028x; Song XY, 2010, J COMPUT GRAPH STAT, V19, P590, DOI 10.1198/jcgs.2010.09094; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Weng XY, 2014, PLANT PHYSIOL, V164, P735, DOI 10.1104/pp.113.231308; Wu XL, 2007, J DAIRY SCI, V90, P3508, DOI 10.3168/jds.2006-762; Wu XL, 2008, GENET SEL EVOL, V40, P333, DOI 10.1051/gse:2008009; Wu XL, 2010, J ANIM BREED GENET, V127, P3, DOI 10.1111/j.1439-0388.2009.00835.x; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Zou GH, 2012, J EXP BOT, V63, P5451, DOI 10.1093/jxb/ers205	39	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148609	10.1371/journal.pone.0148609	http://dx.doi.org/10.1371/journal.pone.0148609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859143	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400056
J	Patil, NK; Luan, LM; Bohannon, JK; Guo, Y; Hernandez, A; Fensterheim, B; Sherwood, ER				Patil, Naeem K.; Luan, Liming; Bohannon, Julia K.; Guo, Yin; Hernandez, Antonio; Fensterheim, Benjamin; Sherwood, Edward R.			IL-15 Superagonist Expands mCD8(+)T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection	PLOS ONE			English	Article							TYROSINE KINASE-3 LIGAND; DENDRITIC CELLS; TRANS-PRESENTATION; ORGAN DYSFUNCTION; INDUCED APOPTOSIS; IN-VIVO; SEPSIS; INTERLEUKIN-15; RECEPTOR; SURVIVAL	Background Severely burned patients are highly susceptible to opportunistic infections and sepsis, owing to the loss of the protective skin barrier and immunological dysfunction. Interleukin-15 (IL-15) belongs to the IL-2 family of common gamma chain cytokines and stimulates the proliferation and activation of T (specifically memory CD8), NK and NKT cells. It has been shown to preserve T cell function and improve survival during cecal ligation and puncture (CLP)-induced sepsis in mice. However, the therapeutic efficacy of IL-15 or IL-15 superagonist (SA) during infection after burn injury has not been evaluated. Moreover, very few, if any, studies have examined, in detail, the effect of burn injury and infection on the adaptive immune system. Thus, we examined the effect of burn and sepsis on adaptive immune cell populations and the effect of IL-15 SA treatment on the host response to infection. Methods Mice were subjected to a 35% total body surface area burn, followed by wound infection with Pseudomonas aeruginosa. In some experiments, IL-15 SA was administered after burn injury, but before infection. Leukocytes in spleen, liver and peritoneal cavity were characterized using flow cytometry. Bacterial clearance, organ injury and survival were also assessed. Results Burn wound infection led to a significant decline in total white blood cell and lymphocyte counts and induced organ injury and sepsis. Burn injury caused decline in CD4(+) and CD8(+) T cells in the spleen, which was worsened by infection. IL-15 treatment inhibited this decline and significantly increased cell numbers and activation, as determined by CD69 expression, of CD4(+), CD8(+), B, NK and NKT cells in the spleen and liver after burn injury. However, IL-15 SA treatment failed to prevent burn wound sepsis- induced loss of CD4(+), CD8(+), B, NK and NKT cells and failed to improve bacterial clearance and survival. Conclusion Cutaneous burn injury and infection cause significant adaptive immune dysfunction. IL-15 SA does not augment host resistance to burn wound sepsis in mice despite inducing proliferation and activation of lymphocyte subsets.	[Patil, Naeem K.; Luan, Liming; Bohannon, Julia K.; Hernandez, Antonio; Sherwood, Edward R.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Guo, Yin; Fensterheim, Benjamin; Sherwood, Edward R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Sherwood, ER (corresponding author), Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA.; Sherwood, ER (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.	edward.r.sherwood@vanderbilt.edu	Patil, Naeem/O-9252-2016; Guo, Yin/W-6588-2018	Patil, Naeem/0000-0002-5323-0729	National Institute of Health [GM66885, NIH R01 GM66885]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM066885] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health RO1 grant-GM66885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institute of Health grant NIH R01 GM66885. The authors thank Dr. Kelli Boyd of the Translational Pathology Shared Resource at Vanderbilt University for assistance with running CBC analyses and serum ALT, AST and BUN	Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Abu-Sittah G S, 2012, Ann Burns Fire Disasters, V25, P26; Ahmad A, 2005, CURR HIV RES, V3, P261, DOI 10.2174/1570162054368093; Ahmad R, 2007, J MOL BIOL, V367, P25, DOI 10.1016/j.jmb.2006.12.060; Aluarado R, 2009, BURNS, V35, P4, DOI 10.1016/j.burns.2008.03.008; Anguille S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-109; Blaser BW, 2006, BLOOD, V108, P2463, DOI 10.1182/blood-2006-04-019059; Bohannon JK, 2015, J LEUKOC BIOL; Bohannon J, 2008, J IMMUNOL, V180, P3038, DOI 10.4049/jimmunol.180.5.3038; Bohannon J, 2010, J IMMUNOL, V185, P2847, DOI 10.4049/jimmunol.0903619; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; Chalekson CP, 2002, PLAST RECONSTR SURG, V109, P1338, DOI 10.1097/00006534-200204010-00020; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Cui GW, 2014, P NATL ACAD SCI USA, V111, P1915, DOI 10.1073/pnas.1318281111; Doherty TM, 1996, J IMMUNOL, V156, P735; Eckmann L, 2001, MICROBES INFECT, V3, P1191, DOI 10.1016/S1286-4579(01)01479-4; Fitzwater J, 2003, J TRAUMA, V54, P959, DOI 10.1097/01.TA.0000029382.26295.AB; Fukuzuka K, 2000, J TRAUMA, V49, P710, DOI 10.1097/00005373-200010000-00020; Fukuzuka K, 2000, AM J PHYSIOL-REG I, V278, pR1005, DOI 10.1152/ajpregu.2000.278.4.R1005; Gamelli RL, 1998, J TRAUMA, V44, P469, DOI 10.1097/00005373-199803000-00008; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Guo Y, 2015, J IMMUNOL, V195, P2353, DOI 10.4049/jimmunol.1500300; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Hiromatsu T, 2003, J INFECT DIS, V187, P1442, DOI 10.1086/374643; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Howard TS, 2013, J BURN CARE RES, V34, P413, DOI 10.1097/BCR.0b013e3182685e11; Inoue S, 2010, J IMMUNOL, V184, P1401, DOI 10.4049/jimmunol.0902307; Jeschke MG, 2015, EBIOMEDICINE, V2, P1536, DOI 10.1016/j.ebiom.2015.07.040; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Khawam K, 2009, CANCER RES, V69, P1561, DOI 10.1158/0008-5472.CAN-08-3198; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Latenser BA, 2009, CRIT CARE MED, V37, P2819, DOI 10.1097/CCM.0b013e3181b3a08f; Lodolce J, 2002, MOL IMMUNOL, V39, P537, DOI 10.1016/S0161-5890(02)00211-0; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Ma LL, 2002, J IMMUNOL, V169, P5787, DOI 10.4049/jimmunol.169.10.5787; Maeurer MJ, 2000, INFECT IMMUN, V68, P2962, DOI 10.1128/IAI.68.5.2962-2970.2000; Mann EA, 2012, SHOCK, V37, P4, DOI 10.1097/SHK.0b013e318237d6bf; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; Mercer-Jones MA, 1999, INFLAMMATION, V23, P305; Patil NK, 2014, AM J PHYSIOL-RENAL, V306, pF734, DOI 10.1152/ajprenal.00643.2013; Peck-Palmer OM, 2009, SHOCK, V31, P359, DOI 10.1097/SHK.0b013e31818ba2a2; Pelletier M, 2002, FEBS LETT, V532, P164, DOI 10.1016/S0014-5793(02)03668-2; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Shelley O, 2003, SHOCK, V20, P123, DOI 10.1097/01.shk.0000079426.52617.00; Shen HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050238; Shindo Y, 2015, SHOCK, V43, P334, DOI 10.1097/SHK.0000000000000317; Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018; Stanojcic M, 2015, ANN SURG; Steel JC, 2012, TRENDS PHARMACOL SCI, V33, P35, DOI 10.1016/j.tips.2011.09.004; Tagaya Y, 1996, EMBO J, V15, P4928, DOI 10.1002/j.1460-2075.1996.tb00873.x; Toliver-Kinsky TE, 2005, J IMMUNOL, V174, P404, DOI 10.4049/jimmunol.174.1.404; Toliver-Kinsky TE, 2003, INFECT IMMUN, V71, P3058, DOI 10.1128/IAI.71.6.3058-3067.2003; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Valvis SM, 2015, J INVEST DERMATOL, V135, P2119, DOI 10.1038/jid.2015.123; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Wang Z, 2015, J PHARMACOL EXP THER, V352, P61, DOI 10.1124/jpet.114.219394; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Wysocka M, 2005, J IMMUNOL, V174, P7398, DOI 10.4049/jimmunol.174.11.7398	65	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148452	10.1371/journal.pone.0148452	http://dx.doi.org/10.1371/journal.pone.0148452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859674	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400043
J	Peng, Q; Wu, B; Jiang, ML; Jin, J; Hou, ZP; Zheng, J; Zhang, JY; Duan, WZ				Peng, Qi; Wu, Bin; Jiang, Mali; Jin, Jing; Hou, Zhipeng; Zheng, Jennifer; Zhang, Jiangyang; Duan, Wenzhen			Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MUTANT HUNTINGTIN; MESSENGER-RNA; TRANSGENIC MICE; NUCLEAR-LOCALIZATION; ENERGY-METABOLISM; STRIATAL NEURONS; GENE-EXPRESSION; LEVELS DECREASE; PROTEIN LENGTH	Huntington's disease (HD) is caused by an expansion of the trinucleotide poly (CAG) tract located in exon 1 of the huntingtin (Htt) gene leading to progressive neurodegeneration in selected brain regions, and associated functional impairments in motor, cognitive, and psychiatric domains. Since the discovery of the gene mutation that causes the disease, mouse models have been developed by different strategies. Recently, a new model, the zQ175 knock-in (KI) line, was developed in an attempt to have the Htt gene in a context and causing a phenotype that more closely mimics HD in humans. The behavioral phenotype was characterized across the independent laboratories and important features reminiscent of human HD are observed in zQ175 mice. In the current study, we characterized the zQ175 model housed in an academic laboratory under reversed dark-light cycle, including motor function, in vivo longitudinal structural MRI imaging for brain volume, MRS for striatal metabolites, neuropathology, as well as a panel of key disease marker proteins in the striatum at different ages. Our results suggest that homozygous zQ175 mice exhibited significant brain atrophy before the motor deficits and brain metabolite changes. Altered striatal medium spiny neuronal marker, postsynaptic marker protein and complement component C1qC also characterized zQ175 mice. Our results confirmed that the zQ175 KI model is valuable in understanding of HD-like pathophysiology and evaluation of potential therapeutics. Our data also provide suggestions to select appropriate outcome measurements in preclinical studies using the zQ175 mice.	[Peng, Qi; Wu, Bin; Jiang, Mali; Jin, Jing; Zheng, Jennifer; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA; [Wu, Bin] China Med Univ, Dept Gen Practice, Hosp 1, Shenyang 110001, Liaoning Provin, Peoples R China; [Hou, Zhipeng; Zhang, Jiangyang] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD USA	Johns Hopkins University; China Medical University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Duan, WZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA.; Duan, WZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Duan, WZ (corresponding author), Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD USA.	wduan2@jhmi.edu		Zhang, Jiangyang/0000-0003-0740-2662; Zhang, Jiangyang/0000-0003-4146-8163	Cure Huntington's Disease Initiative (CHDI) Inc Foundation [A5972, A7887]; National Institute of Health [R01NS082338]; CHDI foundation [A7887, A-5972]; NINDS [NS082338]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070909, R01NS082338] Funding Source: NIH RePORTER	Cure Huntington's Disease Initiative (CHDI) Inc Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Cure Huntington's Disease Initiative (CHDI) Inc Foundation (A5972, A7887) and National Institute of Health R01NS082338 to W.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank David Howland, Larry Park at CHDI Foundation for their excellent advice. This research is supported by CHDI foundation (A-5972 and A7887 to WD) and NINDS (NS082338 to WD)	ALBIN RL, 1991, ANN NEUROL, V30, P542, DOI 10.1002/ana.410300406; Augood SJ, 1997, ANN NEUROL, V42, P215, DOI 10.1002/ana.410420213; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Denovan-Wright EM, 2000, NEUROSCIENCE, V98, P705, DOI 10.1016/S0306-4522(00)00157-3; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; GRAMSBERGEN JB, 1986, ARCH NEUROL-CHICAGO, V43, P1276, DOI 10.1001/archneur.1986.00520120056016; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hu H, 2004, EUR J NEUROSCI, V20, P3351, DOI 10.1111/j.1460-9568.2004.03796.x; Jenkins BG, 2005, J NEUROCHEM, V95, P553, DOI 10.1111/j.1471-4159.2005.03411.x; Jin J, 2015, HUM MOL GENET, V24, P2508, DOI 10.1093/hmg/ddv016; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Kuo YT, 2005, J MAGN RESON IMAGING, V21, P334, DOI 10.1002/jmri.20285; Lee CYD, 2013, FEBS J, V280, P4382, DOI 10.1111/febs.12418; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Lerch JP, 2008, NEUROIMAGE, V39, P32, DOI 10.1016/j.neuroimage.2007.08.033; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; McCaw EA, 2004, EUR J BIOCHEM, V271, P4909, DOI 10.1111/j.1432-1033.2004.04460.x; Menalled L, 2000, EXP NEUROL, V162, P328, DOI 10.1006/exnr.1999.7327; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Reynolds NC, 2005, BRAIN RES, V1031, P82, DOI 10.1016/j.brainres.2004.10.030; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Rosas HD, 2001, NEUROLOGY, V57, P1025, DOI 10.1212/WNL.57.6.1025; Rosas HD, 2014, NEUROLOGY, V82, P850, DOI 10.1212/WNL.0000000000000187; Saleh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004962; Sanchez-Pernaute R, 1999, NEUROLOGY, V53, P806, DOI 10.1212/WNL.53.4.806; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Sturrock A, 2010, NEUROLOGY, V75, P1702, DOI 10.1212/WNL.0b013e3181fc27e4; Tkac I, 2012, J CEREBR BLOOD F MET, V32, P1977, DOI 10.1038/jcbfm.2012.104; Unschuld PG, 2012, MOVEMENT DISORD, V27, P895, DOI 10.1002/mds.25010; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032; van den Bogaard SJA, 2011, J NEUROL, V258, P2230, DOI 10.1007/s00415-011-6099-5; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Zacharoff L, 2012, J CEREBR BLOOD F MET, V32, P502, DOI 10.1038/jcbfm.2011.157	45	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148839	10.1371/journal.pone.0148839	http://dx.doi.org/10.1371/journal.pone.0148839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859386	Green Published, gold, Green Submitted			2022-12-26	WOS:000370038400094
J	Chang, YT; Wu, CC; Tang, TY; Lu, CT; Lai, CS; Shen, CH				Chang, Yi-Ting; Wu, Chih-Chen; Tang, Tsung-Yung; Lu, Chun-Te; Lai, Chih-Sheng; Shen, Ching-Hui			Differences between Total Intravenous Anesthesia and Inhalation Anesthesia in Free Flap Surgery of Head and Neck Cancer	PLOS ONE			English	Article							PROPOFOL; RECONSTRUCTION; COMPLICATIONS; PREDICTORS; SEVOFLURANE; INJURY	Background Many studies have evaluated risk factors associated with complications after free flap surgery, but these studies did not evaluate the impact of anesthesia management. The goal of the current study was to evaluate the differences between patients who received inhalation and total intravenous anesthesia (TIVA) in free flap surgery. Methods One hundred and fifty-six patients who underwent free flap surgery for head and neck cancer were retrospectively divided into the TIVA (96 patients) and the inhalation group (87 patients). Perioperative hemodynamic data and postoperative medical complications were determined by documented medical records. Results Ninety-six patients in the TIVA group were compared with 87 patients who received inhalation anesthesia. There were no differences in gender, age, classification of physical status based on American Society for Anesthesiologists (ASA) score, and cormobidities between the two groups. Patients in the TIVA group required less perioperative crystalloid (4172.46 +/- 1534.95 vs. 5183.91 +/- 1416.40 ml, p < 0.0001) and colloid (572.46 +/- 335.14 vs. 994.25 +/- 434.65 ml, p < 0.0001) to maintain hemodynamic stability. Although the mean anesthesia duration was shorter in the TIVA group (11.02 +/- 2.84 vs. 11.70 +/- 1.96 hours, p = 0.017), the blood loss was similar between groups (p = 0.71). There was no difference in surgical complication rate, but patients in the TIVA group developed fewer pulmonary complications (18 vs. 47, p = 0.0008). After multivariate regression, patients in the TIVA group had a significantly reduced risk of pulmonary complication compared with the inhalation group (Odds ratio 0.41, 95% CI 0.18-0.92). Conclusions Total intravenous anesthesia was associated with significantly fewer pulmonary complications in patients who received free flap reconstruction.	[Chang, Yi-Ting; Wu, Chih-Chen; Tang, Tsung-Yung; Shen, Ching-Hui] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Lu, Chun-Te; Lai, Chih-Sheng] Taichung Vet Gen Hosp, Dept Surg, Div Plast & Reconstruct Surg, Taichung, Taiwan; [Shen, Ching-Hui] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Shen, CH (corresponding author), Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan.; Shen, CH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	forscipaper@gmail.com		Chang, Yi-Ting/0000-0003-3421-742X				Booi DI, 2011, EUR J PLAST SURG, V34, P81, DOI 10.1007/s00238-010-0466-9; BrooksBrunn JA, 1997, CHEST, V111, P564, DOI 10.1378/chest.111.3.564; Clark JR, 2007, HEAD NECK-J SCI SPEC, V29, P1090, DOI 10.1002/hed.20639; Cole CD, 2007, NEUROSURGERY, V61, P369, DOI 10.1227/01.neu.0000303996.74526.30; Deryck YLJM, 2010, ACTA ANAESTH SCAND, V54, P979, DOI 10.1111/j.1399-6576.2010.02267.x; Gooneratne H, 2013, Acta Anaesthesiol Scand, V57, P1293, DOI 10.1111/aas.12180; Gupta A, 2004, ANESTH ANALG, V98, P632, DOI 10.1213/01.ANE.0000103187.70627.57; Hagau N, 2009, MICROSURG, V29, P161, DOI 10.1002/micr.20584; Haughey BH, 2001, OTOLARYNG HEAD NECK, V125, P10, DOI 10.1067/mhn.2001.116788; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; le Nobel GJ, 2012, LARYNGOSCOPE, V122, P1014, DOI 10.1002/lary.22454; Ng JM, 2011, CURR OPIN ANESTHESIO, V24, P37, DOI 10.1097/ACO.0b013e32834141f7; Patel RS, 2010, HEAD NECK-J SCI SPEC, V32, P1345, DOI 10.1002/hed.21331; Sudheer PS, 2006, ANAESTHESIA, V61, P138, DOI 10.1111/j.1365-2044.2005.04464.x; Votta-Velis EG, 2007, ANESTH ANALG, V105, P1363, DOI 10.1213/01.ane.0000281144.06703.0d; Wei LG, 2013, J ANESTH, V27, P366, DOI 10.1007/s00540-012-1539-7; Zhong T, 2011, PLAST RECONSTR SURG, V128, P1153, DOI 10.1097/PRS.0b013e318221da56	18	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147713	10.1371/journal.pone.0147713	http://dx.doi.org/10.1371/journal.pone.0147713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849439	gold, Green Submitted, Green Published			2022-12-26	WOS:000369554000022
J	Myers, CA; Slack, T; Martin, CK; Broyles, ST; Heymsfield, SB				Myers, Candice A.; Slack, Tim; Martin, Corby K.; Broyles, Stephanie T.; Heymsfield, Steven B.			Change in Obesity Prevalence across the United States Is Influenced by Recreational and Healthcare Contexts, Food Environments, and Hispanic Populations	PLOS ONE			English	Article							BODY-MASS INDEX; GEOGRAPHIC-DISTRIBUTION; US; COUNTY; DISPARITIES; ADULTS	Objective To examine change in county-level adult obesity prevalence between 2004 and 2009 and identify associated community characteristics. Methods Change in county-level adult (>= 20 years) obesity prevalence was calculated for a 5-year period (2004-2009). Community measures of economic, healthcare, recreational, food environment, population structure, and education contexts were also calculated. Regression analysis was used to assess community characteristics associated (p<0.01) with change in adult obesity prevalence. Results Mean +/- SD change in obesity prevalence was 5.1 +/- 2.4%. Obesity prevalence decreased in 1.4% (n = 44) and increased in 98% (n = 3,060) of counties from 2004-2009. Results showed that both baseline levels and increases in physically inactive adults were associated with greater increases in obesity prevalence, while baseline levels of and increases in physician density and grocery store/supercenter density were related to smaller increases in obesity rates. Baseline levels of the Hispanic population share were negatively linked to changing obesity levels, while places with greater Hispanic population growth saw greater increases in obesity. Conclusions Most counties in the U.S. experienced increases in adult obesity prevalence from 2004 to 2009. Findings suggest that community-based interventions targeting adult obesity need to incorporate a range of community factors, such as levels of physical inactivity, access to physicians, availability of food outlets, and ethnic/racial population composition.	[Myers, Candice A.; Martin, Corby K.; Broyles, Stephanie T.; Heymsfield, Steven B.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Slack, Tim] Louisiana State Univ, Dept Sociol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University	Myers, CA (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	candice.myers@pbrc.edu	Heymsfield, Steven B/N-1968-2017; Myers, Candice/N-1979-2017; Broyles, Stephanie/C-8647-2011; Martin, Corby K./N-1976-2017	Heymsfield, Steven B/0000-0003-1127-9425; Myers, Candice/0000-0003-1923-3448; Broyles, Stephanie/0000-0003-3168-0056; Martin, Corby K./0000-0002-8125-4015	American Heart Association [11GRNT7750027]; NORC Center Grant - NIDDK [2P30DK072476]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; National Heart Lung and Blood Institute of the National Institutes of Health [1 F32 HL123242]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL123242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NORC Center Grant - NIDDK; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was partially supported by 1) 11GRNT7750027 from the American Heart Association, 2) NORC Center Grant #2P30DK072476 entitled "Nutritional Programming: Environmental and Molecular Interactions" sponsored by NIDDK, 3) 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center, and 4) 1 F32 HL123242 from the National Heart Lung and Blood Institute of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott G, 2014, OBESITY, V22, P2413, DOI 10.1002/oby.20853; Ahern M, 2011, J RURAL HEALTH, V27, P367, DOI 10.1111/j.1748-0361.2011.00378.x; An R, 2014, ISRN OBESITY, V2014, P6; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2005, EXPLORING SPATIAL DA; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x; Cadwell BL., 2005, J DATA SCI, V8, P173; Center for Disease Control and Prevention, 2009, CTR DIS CONTR PREV D; Chi G, 2008, POPUL RES POLICY REV, V27, P17, DOI 10.1007/s11113-007-9051-8; Crimmins EM, 2007, AM J PUBLIC HEALTH, V97, P1305, DOI 10.2105/AJPH.2006.091892; Drewnowski A, 2014, INT J OBESITY, V38, P833, DOI 10.1038/ijo.2013.179; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; Ennis S. R., 2011, HISPANIC POPULATION; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford PB, 2008, NUTR REV, V66, P216, DOI 10.1111/j.1753-4887.2008.00026.x; Gregg EW, 2010, JAMA-J AM MED ASSOC, V303, P933; Gutierrez-Fisac JL, 1999, INT J OBESITY, V23, P342, DOI 10.1038/sj.ijo.0800823; Hillemeier MM, 2003, HEALTH SERV RES, V38, P1645, DOI 10.1111/j.1475-6773.2003.00198.x; Jenkins JC, 2001, AM SOCIOL REV, V66, P718, DOI 10.2307/3088955; Kutner M. H., 2004, APPL LINEAR REGRESSI; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Le A, 2014, OBESITY, V22, P300, DOI 10.1002/oby.20451; Michimi A, 2010, AM J PREV MED, V39, pE1, DOI 10.1016/j.amepre.2010.04.008; Moreno JP, 2015, J RACIAL ETHN HEALTH, P1; Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004; Myers CA, 2015, OBESITY, V23, P481, DOI 10.1002/oby.20963; Pouliou T, 2009, PREV MED, V48, P362, DOI 10.1016/j.ypmed.2009.01.017; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Saib MS, 2014, INT J ENV RES PUB HE, V11, P3765, DOI 10.3390/ijerph110403765; Shrestha SS, 2012, OPEN DIABETES J, V5, P29, DOI DOI 10.2174/1876524601205010029; Singleton CR, AM J PREVENTIVE MED; Slack T, 2014, OBESITY, V22, P868, DOI 10.1002/oby.20502; Slack T, 2012, SOC SCI RES, V41, P263, DOI 10.1016/j.ssresearch.2011.10.001; Sturm R, 2014, CA-CANCER J CLIN, V64, P337, DOI 10.3322/caac.21237; US Bureau of the Census, POP EST; Vanhulst J., 2015, POPULATION RES POLIC, P1; Voss PR, 2006, POPUL RES POLICY REV, V25, P369, DOI 10.1007/s11113-006-9007-4	38	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148394	10.1371/journal.pone.0148394	http://dx.doi.org/10.1371/journal.pone.0148394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849803	gold, Green Published			2022-12-26	WOS:000369554000085
J	Puntambekar, SS; Nyayanit, D; Saxena, P; Gadgil, CJ				Puntambekar, Shraddha S.; Nyayanit, Dimpal; Saxena, Priyanka; Gadgil, Chetan J.			Identification of Unintuitive Features of Sumoylation through Mathematical Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO PATHWAY; UBIQUITIN; CONJUGATION; REGULATOR; ENZYMES; ROLES; UBC9; E1	Sumoylation is a multistep, multienzymatic post-translational modification in which a small ubiquitin-like modifier protein (SUMO) is attached to the target. We present the first mathematical model for sumoylation including enzyme mechanism details such as autosumoylation of E2 and multifunctional nature of SENP. Simulations and analysis reveal three nonobvious properties for the long term response, modeled as an open system: (i) the steady state sumoylation level is robust to variation in several enzyme properties; (ii) even when autosumoylation of E2 results in equal or higher activity, the target sumoylation levels are lower; and (iii) there is an optimal SENP concentration at which steady state target sumoylation level is maximum. These results are qualitatively different for a short term response modeled as a closed system, where e.g. sumoylation always decreases with increasing SENP levels. Simulations with multiple targets suggest that the available SUMO is limiting, indicating a possible explanation for the experimentally observed low fractional sumoylation. We predict qualitative differences in system responses at short post-translational and longer transcriptional time scales. We thus use this mechanism-based model to explain system properties and generate testable hypotheses for existence and mechanism of unexpected responses.	[Puntambekar, Shraddha S.; Nyayanit, Dimpal; Gadgil, Chetan J.] CSIR Natl Chem Lab, Chem Engn & Proc Dev Div, Pune 411008, Maharashtra, India; [Puntambekar, Shraddha S.; Nyayanit, Dimpal; Saxena, Priyanka; Gadgil, Chetan J.] Acad Sci & Innovat Res AcSIR, CSIR NCL Campus, Pune 411008, Maharashtra, India; [Saxena, Priyanka; Gadgil, Chetan J.] CSIR Inst Genom & Integrat Biol, New Delhi 110020, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Gadgil, CJ (corresponding author), CSIR Natl Chem Lab, Chem Engn & Proc Dev Div, Pune 411008, Maharashtra, India.	cj.gadgil@ncl.res.in			Department of Biotechnology-Bioinformatics National Certification (DBT-BINC) fellowship; University Grants Commission fellowship; Council of Scientific and Industrial Research fellowship; NCL-IGIB Joint Research Initiative project [BSC0124]	Department of Biotechnology-Bioinformatics National Certification (DBT-BINC) fellowship; University Grants Commission fellowship(University Grants Commission, India); Council of Scientific and Industrial Research fellowship(Council of Scientific & Industrial Research (CSIR) - India); NCL-IGIB Joint Research Initiative project	This work was supported by a Department of Biotechnology-Bioinformatics National Certification (DBT-BINC) fellowship (to S. S. P.), a University Grants Commission fellowship (to D. N.), a Council of Scientific and Industrial Research fellowship (to P. S.), and funds from the BSC0124 NCL-IGIB Joint Research Initiative project. The authors declare that they have no conflicts of interest with the contents of this article.	Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bawa-Khalfe T, 2010, SUBCELL BIOCHEM, V54, P170, DOI 10.1007/978-1-4419-6676-6_14; Bhaskar V, 2002, MOL CELL BIOL, V22, P492, DOI 10.1128/MCB.22.2.492-504.2002; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Lee D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05573; Liu JL, 2005, BIOPHYS J, V88, P3212, DOI 10.1529/biophysj.104.056085; Lopez-Canovas F. J., 2010, J BIOMED SCI ENG, V3, P274; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Reverter David, 2009, V497, P225, DOI 10.1007/978-1-59745-566-4_15; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Truong K, 2011, BIOCHEMISTRY-US, V50, P5757, DOI 10.1021/bi2001856; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Wang JH, 2010, J BIOL CHEM, V285, P23732, DOI 10.1074/jbc.M110.114660; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Wang YE, 2012, BIOL CELL, V104, P121, DOI 10.1111/boc.201100105; Watts FZ, 2013, CHROMOSOMA, V122, P451, DOI 10.1007/s00412-013-0422-0; Xu LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034616; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	26	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9458	9468		10.1074/jbc.M115.676122	http://dx.doi.org/10.1074/jbc.M115.676122			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26861881	Green Published, hybrid			2022-12-26	WOS:000375602300007
J	Pintscher, S; Kuleta, P; Cieluch, E; Borek, A; Sarewicz, M; Osyczka, A				Pintscher, Sebastian; Kuleta, Patryk; Cieluch, Ewelina; Borek, Arkadiusz; Sarewicz, Marcin; Osyczka, Artur			Tuning of Hemes b Equilibrium Redox Potential Is Not Required for Cross-Membrane Electron Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome; electron transfer; oxidation-reduction (redox); photosynthesis; respiratory chain; heme iron ligation	CYTOCHROME B(6)F COMPLEX; BACILLUS-SUBTILIS SUCCINATE; PROTON MOTIVE FORCE; RHODOBACTER-CAPSULATUS; BC(1) COMPLEX; AXIAL LIGATION; WOLINELLA-SUCCINOGENES; PARAMAGNETIC-RESONANCE; MENAQUINONE REDUCTASE; STRUCTURAL-ANALYSIS	In biological energy conversion, cross-membrane electron transfer often involves an assembly of two hemes b. The hemes display a large difference in redox midpoint potentials (E(m_)b), which in several proteins is assumed to facilitate cross-membrane electron transfer and overcome a barrier of membrane potential. Here we challenge this assumption reporting on heme b ligand mutants of cytochrome bc(1) in which, for the first time in transmembrane cytochrome, one natural histidine has been replaced by lysine without loss of the native low spin type of heme iron. With these mutants we show that E(m_)b can be markedly increased, and the redox potential of one of the hemes can stay above the level of quinone pool, or E(m_)b can be markedly decreased to the point that two hemes are almost isopotential, yet the enzyme retains catalytically competent electron transfer between quinone binding sites and remains functional in vivo. This reveals that cytochrome bc(1) can accommodate large changes in E(m_)b without hampering catalysis, as long as these changes do not impose overly endergonic steps on downhill electron transfer from substrate to product. We propose that hemes b in this cytochrome and in other membranous cytochromes b act as electronic connectors for the catalytic sites with no fine tuning in E(m_)b required for efficient cross-membrane electron transfer. We link this concept with a natural flexibility in occurrence of several thermodynamic configurations of the direction of electron flow and the direction of the gradient of potential in relation to the vector of the electric membrane potential.	[Pintscher, Sebastian; Kuleta, Patryk; Cieluch, Ewelina; Borek, Arkadiusz; Sarewicz, Marcin; Osyczka, Artur] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Mol Biophys, 7 Gronostajowa St, PL-30387 Krakow, Poland	Jagiellonian University	Osyczka, A (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Mol Biophys, 7 Gronostajowa St, PL-30387 Krakow, Poland.	artur.osyczka@uj.edu.pl		Sarewicz, Marcin/0000-0001-6813-5997	Wellcome Trust; Ministry of Science and Higher Education	Wellcome Trust(Wellcome Trust); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by The Wellcome Trust International Senior Research Fellowship (to A. O.). The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. The authors declare that they have no conflicts of interest with the contents of this article.	Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Battistuzzi G, 2002, J AM CHEM SOC, V124, P5315, DOI 10.1021/ja017479v; Berczi A, 2010, EUR BIOPHYS J BIOPHY, V39, P1129, DOI 10.1007/s00249-009-0564-4; Berry EA, 2008, J BIOL INORG CHEM, V13, P481, DOI 10.1007/s00775-008-0372-9; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Bewley KD, 2013, BBA-BIOENERGETICS, V1827, P938, DOI 10.1016/j.bbabio.2013.03.010; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; CHEESMAN MR, 1990, NATURE, V346, P771, DOI 10.1038/346771a0; Cieluch E, 2010, BBA-BIOENERGETICS, V1797, P296, DOI 10.1016/j.bbabio.2009.11.003; Czapla M, 2012, BIOCHEMISTRY-US, V51, P829, DOI 10.1021/bi2016316; Czapla M, 2012, PROTEIN ENG DES SEL, V25, P15, DOI 10.1093/protein/gzr055; Desmet F, 2011, FEBS LETT, V585, P545, DOI 10.1016/j.febslet.2011.01.006; Dutton P L, 1978, Methods Enzymol, V54, P411; Ekiert R, 2014, BIOCHEM BIOPH RES CO, V451, P270, DOI 10.1016/j.bbrc.2014.07.117; Farid TA, 2013, NAT CHEM BIOL, V9, P826, DOI [10.1038/NCHEMBIO.1362, 10.1038/nchembio.1362]; Finnegan MG, 1996, BBA-BIOENERGETICS, V1274, P9, DOI 10.1016/0005-2728(95)00155-7; Frielingsdorf S, 2011, BIOCHEMISTRY-US, V50, P10836, DOI 10.1021/bi201594m; Fufezan C, 2008, PROTEINS, V73, P690, DOI 10.1002/prot.22097; Garcia LM, 2008, CAN J MICROBIOL, V54, P456, DOI [10.1139/W08-037, 10.1139/w08-037]; GARTNER P, 1991, EUR J BIOCHEM, V200, P215, DOI 10.1111/j.1432-1033.1991.tb21070.x; Gross R, 2004, J BIOL CHEM, V279, P274, DOI 10.1074/jbc.M310610200; Haas AH, 2004, BIOPHYS J, V87, P4298, DOI 10.1529/biophysj.104.042945; HAGERHALL C, 1995, BIOCHEMISTRY-US, V34, P11080; Hasan SS, 2013, BBA-BIOENERGETICS, V1827, P1295, DOI 10.1016/j.bbabio.2013.03.002; Jensen LMR, 2012, J BIOL INORG CHEM, V17, P1241, DOI 10.1007/s00775-012-0939-3; Jensen LMR, 2010, SCIENCE, V327, P1392, DOI 10.1126/science.1182492; Jormakka M, 2003, FEBS LETT, V545, P25, DOI 10.1016/S0014-5793(03)00389-2; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Kamensky Y, 2007, BIOCHEMISTRY-US, V46, P8647, DOI 10.1021/bi700054g; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Koch H.G., 2007, CURR CHEM BIOL, V1, P59; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; KROGER A, 1979, EUR J BIOCHEM, V94, P465, DOI 10.1111/j.1432-1033.1979.tb12914.x; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lanciano P, 2013, BIOCHEMISTRY-US, V52, P7196, DOI 10.1021/bi400561e; Lanciano P, 2011, BIOCHEMISTRY-US, V50, P1651, DOI 10.1021/bi101736v; Lu PL, 2014, P NATL ACAD SCI USA, V111, P1813, DOI 10.1073/pnas.1323931111; Mao JJ, 2003, BIOCHEMISTRY-US, V42, P9829, DOI 10.1021/bi027288k; MATHEWS FS, 1979, J BIOL CHEM, V254, P1699; Matsson M, 2000, BIOCHEMISTRY-US, V39, P8617, DOI 10.1021/bi000271m; Mileni M, 2006, BIOCHEM J, V395, P191, DOI 10.1042/BJ20051675; NICHOLLS DG, 2013, BIOENERGETICS; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Osyczka A, 2001, BIOCHEMISTRY-US, V40, P14547, DOI 10.1021/bi011630w; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; ROBERTSON DE, 1993, BIOCHEMISTRY-US, V32, P1310, DOI 10.1021/bi00056a016; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Rothery RA, 2001, J MOL MICROB BIOTECH, V3, P273; Rotsaert FAJ, 2003, J BIOL CHEM, V278, P33224, DOI 10.1074/jbc.M302653200; Rotsaert FAJ, 2008, BBA-BIOENERGETICS, V1777, P239, DOI 10.1016/j.bbabio.2007.08.005; Sarewicz M, 2015, PHYSIOL REV, V95, P219, DOI 10.1152/physrev.00006.2014; Sarewicz M, 2013, BIOCHEMISTRY-US, V52, P6388, DOI 10.1021/bi400624m; Shinkarev VP, 2001, BIOCHEMISTRY-US, V40, P12584, DOI 10.1021/bi011334j; Stoffels L, 2012, J BACTERIOL, V194, P475, DOI 10.1128/JB.06014-11; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Suga M, 2013, FEBS LETT, V587, P3267, DOI 10.1016/j.febslet.2013.08.023; Swierczek M, 2010, SCIENCE, V329, P451, DOI 10.1126/science.1190899; TAKAMIYA KI, 1979, BIOCHIM BIOPHYS ACTA, V546, P1, DOI 10.1016/0005-2728(79)90166-X; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; Volkmer T, 2006, BBA-BIOMEMBRANES, V1758, P1815, DOI 10.1016/j.bbamem.2006.05.009; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; YUN CH, 1991, BIOCHEMISTRY-US, V30, P6747, DOI 10.1021/bi00241a017; Zhang HB, 2008, J BIOENERG BIOMEMBR, V40, P493, DOI 10.1007/s10863-008-9174-6; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	71	12	12	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6872	6881		10.1074/jbc.M115.712307	http://dx.doi.org/10.1074/jbc.M115.712307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26858251	Green Published, hybrid			2022-12-26	WOS:000373299700025
J	Antharam, VC; McEwen, DC; Garrett, TJ; Dossey, AT; Li, EC; Kozlov, AN; Mesbah, Z; Wang, GP				Antharam, Vijay C.; McEwen, Daniel C.; Garrett, Timothy J.; Dossey, Aaron T.; Li, Eric C.; Kozlov, Andrew N.; Mesbah, Zhubene; Wang, Gary P.			An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection	PLOS ONE			English	Article							INTESTINAL MICROFLORA; SUGAR-CHOLESTANOLS; BILE-SALTS; CONVERSION; BACTERIA; RISK; BIOHYDROGENATION; TRANSPLANTATION; COPROSTEROL; PATTERNS	Clostridium difficile infection (CDI) is characterized by dysbiosis of the intestinal microbiota and a profound derangement in the fecal metabolome. However, the contribution of specific gut microbes to fecal metabolites in C. difficile-associated gut microbiome remains poorly understood. Using gas-chromatography mass spectrometry (GC-MS) and 16S rRNA deep sequencing, we analyzed the metabolome and microbiome of fecal samples obtained longitudinally from subjects with Clostridium difficile infection (n = 7) and healthy controls (n = 6). From 155 fecal metabolites, we identified two sterol metabolites at > 95% match to cholesterol and coprostanol that significantly discriminated C. difficile-associated gut microbiome from healthy microbiota. By correlating the levels of cholesterol and coprostanol in fecal extracts with 2,395 bacterial operational taxonomic units (OTUs) determined by 16S rRNA sequencing, we identified 63 OTUs associated with high levels of coprostanol and 2 OTUs correlated with low coprostanol levels. Using indicator species analysis (ISA), 31 of the 63 coprostanol-associated bacteria correlated with health, and two Veillonella species were associated with low coprostanol levels that correlated strongly with CDI. These 65 bacterial taxa could be clustered into 12 sub-communities, with each community containing a consortium of organisms that co-occurred with one another. Our studies identified 63 human gut microbes associated with cholesterol-reducing activities. Given the importance of gut bacteria in reducing and eliminating cholesterol from the GI tract, these results support the recent finding that gut microbiome may play an important role in host lipid metabolism.	[Antharam, Vijay C.; Li, Eric C.; Kozlov, Andrew N.; Mesbah, Zhubene; Wang, Gary P.] Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA; [McEwen, Daniel C.] Minnesota State Univ Moorhead, Dept Biosci, Moorhead, MN USA; [Garrett, Timothy J.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Dossey, Aaron T.] All Things Bugs LLC, Athens, GA USA; [Wang, Gary P.] North Florida South Georgia Vet Hlth Syst, Med Serv, Gainesville, FL USA	State University System of Florida; University of Florida; Minnesota State Colleges & Universities; Minnesota State University Moorhead; State University System of Florida; University of Florida	Antharam, VC (corresponding author), Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA.	vantharam@methodist.edu	Garrett, Timothy/T-9833-2019	Garrett, Timothy/0000-0003-1623-009X; Dossey, Aaron T/0000-0002-6652-964X; Kozlov, Andrew/0000-0002-3181-6470	National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Award [UL1RR029890, UL1 TR000064]; National Institutes of Health, National Institute of Allergy and Infectious Diseases [KO8 AI077713]; Merck Investigator-Initiated grant [IISP 38992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR001427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI077713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097209] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Award; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck Investigator-Initiated grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Award **UL1RR029890 and **UL1 TR000064**. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases KO8 AI077713 awarded to GPW (http://www.niaid.nih.gov/Pages/default.aspx), and Merck Investigator-Initiated grant IISP 38992 awarded to GPW (http://engagezone.merck.com/clostridium.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2008, GUT, V57, P205, DOI 10.1136/gut.2007.128231; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Bakken JS, 2009, ANAEROBE, V15, P285, DOI 10.1016/j.anaerobe.2009.09.007; Bauer MP, 2009, CURR OPIN INFECT DIS, V22, P517, DOI 10.1097/QCO.0b013e32833229ce; Benno Peter, 2005, Microbial Ecology in Health and Disease, V17, P200, DOI 10.1080/08910600500519854; Borody TJ, 2000, AM J GASTROENTEROL, V95, P3028; BORRIELLO SP, 1986, J MED MICROBIOL, V21, P299, DOI 10.1099/00222615-21-4-299; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; CHANG TW, 1980, J INFECT DIS, V142, P113, DOI 10.1093/infdis/142.1.113; Curry S, 2010, CLIN LAB MED, V30, P329, DOI 10.1016/j.cll.2010.04.001; Dam H, 1934, BIOCHEM J, V28, P820, DOI 10.1042/bj0280820; Dam H, 1934, BIOCHEM J, V28, P815, DOI 10.1042/bj0280815; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; EYSSEN H, 1974, AM J CLIN NUTR, V27, P1329, DOI 10.1093/ajcn/27.11.1329; EYSSEN HJ, 1973, EUR J BIOCHEM, V36, P411, DOI 10.1111/j.1432-1033.1973.tb02926.x; Faried A, 2007, CANCER SCI, V98, P1358, DOI 10.1111/j.1349-7006.2007.00563.x; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Gerard P, 2004, FEMS MICROBIOL ECOL, V47, P337, DOI 10.1016/S0168-6496(03)00285-X; Gerard P, 2007, APPL ENVIRON MICROB, V73, P5742, DOI 10.1128/AEM.02806-06; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Gylling H, 1996, J HEPATOL, V24, P444, DOI 10.1016/S0168-8278(96)80165-6; Hahismoto S, 2008, GLYCOCONJUGATE J, V25, P531, DOI 10.1007/s10719-008-9108-x; Hayatsu M, 2008, SOIL SCI PLANT NUTR, V54, P33, DOI 10.1111/j.1747-0765.2007.00195.x; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kerzmann A, 2006, ACS CHEM BIOL, V1, P141, DOI 10.1021/cb600133b; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; LICHTENSTEIN AH, 1990, ANN MED, V22, P49, DOI 10.3109/07853899009147241; LIPKIN M, 1981, J CLIN INVEST, V67, P304, DOI 10.1172/JCI110027; Lye HS, 2010, J DAIRY SCI, V93, P1383, DOI 10.3168/jds.2009-2574; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MIDTVEDT AC, 1993, J PEDIATR GASTR NUTR, V17, P161, DOI 10.1097/00005176-199308000-00006; MIDTVEDT AC, 1988, J PEDIATR GASTR NUTR, V7, P559, DOI 10.1097/00005176-198807000-00014; MIDTVEDT T, 1990, APMIS, V98, P839, DOI 10.1111/j.1699-0463.1990.tb05004.x; Motzkus-Feagans CA, 2012, GUT, V61, P1538, DOI 10.1136/gutjnl-2011-301378; Naggie S, 2011, AM J MED, V124, P276, DOI 10.1016/j.amjmed.2010.10.013; Navder K P, 1992, Indian J Med Sci, V46, P275; Pereira DIA, 2002, APPL ENVIRON MICROB, V68, P4689, DOI 10.1128/AEM.68.9.4689-4693.2002; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; SADZIKOWSKI MR, 1977, APPL ENVIRON MICROB, V34, P355, DOI 10.1128/AEM.34.4.355-362.1977; SALYERS AA, 1977, S AFR MED J, V51, P823; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; SEKIMOTO H, 1983, JPN J MED, V22, P14; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Veiga P, 2005, FEMS MICROBIOL LETT, V242, P81, DOI 10.1016/j.femsle.2004.10.042; WAINFAN E, 1954, J BIOL CHEM, V207, P843; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; WILKINS TD, 1974, CANCER RES, V34, P2250; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	56	67	70	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148824	10.1371/journal.pone.0148824	http://dx.doi.org/10.1371/journal.pone.0148824			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871580	Green Submitted, gold, Green Published			2022-12-26	WOS:000370054100061
J	Kuljis, DA; Gad, L; Loh, DH; Kaswan, ZM; Hitchcock, ON; Ghiani, CA; Colwell, CS				Kuljis, Dika A.; Gad, Laura; Loh, Dawn H.; Kaswan, Zoe MacDowell; Hitchcock, Olivia N.; Ghiani, Cristina A.; Colwell, Christopher S.			Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; WHEEL-RUNNING ACTIVITY; SLEEP-WAKE CYCLE; SUPRACHIASMATIC NUCLEUS; FUNCTIONAL DECLINE; GENDER-DIFFERENCES; HUMAN-BRAIN; AGE; RHYTHMS; DEPRESSION	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that affects men and women in equal numbers, but some epidemiological studies indicate there may be sex differences in disease progression. One of the early symptoms of HD is disruptions in the circadian timing system, but it is currently unknown whether sex is a factor in these alterations. Since sex differences in HD could provide important insights to understand cellular and molecular mechanism(s) and designing early intervention strategies, we used the bacterial artificial chromosome transgenic mouse model of HD (BACHD) to examine whether sex differences in circadian behavioral rhythms are detectable in an animal model of the disease. Similar to BACHD males, BACHD females display circadian disruptions at both 3 and 6 months of age; however, deficits to BACHD female mouse activity levels, rhythm precision, and behavioral fragmentation are either delayed or less severe relative to males. These sex differences are associated with a smaller suprachiasmatic nucleus (SCN) in BACHD male mice at age of symptom onset (3 months), but are not associated with sex-specific differences in SCN daytime electrical activity deficits, or peptide expression (arginine vasopressin, vasoactive intestinal peptide) within the SCN. Notably, BACHD females exhibited delayed motor coordination deficits, as measured using rotarod and challenge beam. These findings suggest a sex specific factor plays a role both in non-motor and motor symptom progression for the BACHD mouse.	[Kuljis, Dika A.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Gad, Laura; Loh, Dawn H.; Kaswan, Zoe MacDowell; Hitchcock, Olivia N.; Ghiani, Cristina A.; Colwell, Christopher S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Ghiani, Cristina A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Colwell, CS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	CColwell@mednet.ucla.edu	Ghiani, Cristina/Q-9385-2019; Colwell, Chris/AAM-6111-2020	Ghiani, Cristina/0000-0002-9867-6185; Colwell, Christopher/0000-0002-1059-184X	CHDI Foundation "Circadian Disruption in Mouse Models of Huntington's Disease" [A-7293]; NIH [T32 HD 07228-26]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER	CHDI Foundation "Circadian Disruption in Mouse Models of Huntington's Disease"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by CHDI Foundation "Circadian Disruption in Mouse Models of Huntington's Disease" A-7293 http://chdifoundation. org/CC; NIH Training Grant T32 HD 07228-26 DK. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, BEHAV BRAIN RES, V238, P243, DOI 10.1016/j.bbr.2012.10.039; Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Adan A, 2002, CHRONOBIOL INT, V19, P709, DOI 10.1081/CBI-120005390; Aziz NA, 2010, PARKINSONISM RELAT D, V16, P345, DOI 10.1016/j.parkreldis.2010.02.009; Aziz NA, 2009, J NEUROL, V256, P1961, DOI 10.1007/s00415-009-5196-1; Aziz NA, 2009, J CLIN ENDOCR METAB, V94, P1223, DOI 10.1210/jc.2008-2543; Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Blattner MS, 2013, J BIOL RHYTHM, V28, P291, DOI 10.1177/0748730413497190; Butler MP, 2012, ENDOCRINOLOGY, V153, P2344, DOI 10.1210/en.2011-1842; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; Cohen S, 2009, ARCH INTERN MED, V169, P62, DOI 10.1001/archinternmed.2008.505; DAVIS FC, 1983, AM J PHYSIOL, V244, pR93, DOI 10.1152/ajpregu.1983.244.1.R93; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ehlen JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062205; Epping EA, 2013, J PSYCHIATR RES, V47, P1423, DOI 10.1016/j.jpsychires.2013.05.026; Fahrenkrug J, 2007, J MOL NEUROSCI, V31, P139, DOI 10.1385/JMN/31:02:139; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Foroud T, 1999, J NEUROL NEUROSUR PS, V66, P52, DOI 10.1136/jnnp.66.1.52; Goodman Anna O G, 2010, PLoS Curr, V2, pRRN1189, DOI 10.1371/currents.RRN1189; Goodman AOG, 2011, CURR NEUROL NEUROSCI, V11, P211, DOI 10.1007/s11910-010-0163-x; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hatori M, 2014, ELIFE, V3, DOI 10.7554/eLife.03357; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; HEUSER IJE, 1991, BIOL PSYCHIAT, V30, P943, DOI 10.1016/0006-3223(91)90007-9; HOFMAN MA, 1988, J ANAT, V160, P127; Iwahana E, 2008, HORM BEHAV, V53, P422, DOI 10.1016/j.yhbeh.2007.11.014; Kalliolia E, 2014, MOVEMENT DISORD, V29, P1511, DOI 10.1002/mds.26003; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Kopp C, 2006, BEHAV BRAIN RES, V167, P165, DOI 10.1016/j.bbr.2005.09.001; Krishnan V, 2006, CURR OPIN PULM MED, V12, P383, DOI 10.1097/01.mcp.0000245705.69440.6a; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Kuljis DA, 2013, ENDOCRINOLOGY, V154, P1501, DOI 10.1210/en.2012-1921; Laermans J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110176; Lee TM, 2004, ANN NY ACAD SCI, P262; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Li Q, 2015, NEUROBIOL DIS, V77, P155, DOI 10.1016/j.nbd.2015.03.009; Loh DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069993; Marder K, 2000, NEUROLOGY, V54, P452, DOI 10.1212/WNL.54.2.452; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; MATTSSON B, 1974, ACTA PSYCHIAT SCAND, P221; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; MOE KE, 1991, J AM GERIATR SOC, V39, P383, DOI 10.1111/j.1532-5415.1991.tb02904.x; Moldofsky H, 2001, SLEEP MED REV, V5, P387, DOI 10.1053/smrv.2001.0179; Morton AJ, 2013, EXP NEUROL, V243, P34, DOI 10.1016/j.expneurol.2012.10.014; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Paul KN, 2008, J WOMENS HEALTH, V17, P1201, DOI 10.1089/jwh.2008.0841; Paul KN, 2006, SLEEP, V29, P1211, DOI 10.1093/sleep/29.9.1211; Paulsen Jane S, 2005, Adv Neurol, V96, P209; Paulsen JS, 2013, J NEUROL NEUROSUR PS, V84, P1233, DOI 10.1136/jnnp-2013-305114; Paulsen JS, 2006, BIOL PSYCHIAT, V59, P57, DOI 10.1016/j.biopsych.2005.06.003; Paulsen JS, 2005, J NEUROPSYCH CLIN N, V17, P496, DOI 10.1176/appi.neuropsych.17.4.496; Paulsen JS, 2011, HUNTINGTON DIS, V82, P201; Peavy GM, 2010, MOVEMENT DISORD, V25, P1163, DOI 10.1002/mds.22953; Pekmezovic T, 2007, EUR J EPIDEMIOL, V22, P523, DOI 10.1007/s10654-007-9157-7; Petit D, 2004, J PSYCHOSOM RES, V56, P487, DOI 10.1016/j.jpsychores.2004.02.001; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; ROOS RAC, 1991, J MED GENET, V28, P515, DOI 10.1136/jmg.28.8.515; ROPER TJ, 1976, PHYSIOL BEHAV, V17, P549, DOI 10.1016/0031-9384(76)90121-9; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; SHERMAN BM, 1976, J CLIN ENDOCR METAB, V42, P629, DOI 10.1210/jcem-42-4-629; Shirbin CA, 2013, PSYCHONEUROENDOCRINO, V38, P2439, DOI 10.1016/j.psyneuen.2012.10.020; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; TAKAHASHI JS, 1980, AM J PHYSIOL, V239, pR497, DOI 10.1152/ajpregu.1980.239.5.R497; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; van der Vinne V, 2015, J BIOL RHYTHM, V30, P53, DOI 10.1177/0748730414564786; van Duijn E, 2010, BRAIN RES BULL, V83, P232, DOI 10.1016/j.brainresbull.2010.08.006; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; van Wamelen DJ, 2013, SLEEP, V36, P117, DOI 10.5665/sleep.2314; Vonsattel J, 1985, J NEUROPATHOL EXP NE, P559; WEVER RA, 1984, EXPERIENTIA, V40, P1226, DOI 10.1007/BF01946652; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wirz-Justice A, 2006, INT CLIN PSYCHOPHARM, V21, pS11, DOI 10.1097/01.yic.0000195660.37267.cf; WOLLNIK F, 1988, PHYSIOL BEHAV, V43, P389, DOI 10.1016/0031-9384(88)90204-1; Yan L, 2007, COLD SH Q B, V72, P527, DOI 10.1101/sqb.2007.72.037; ZHOU JN, 1995, NEUROBIOL AGING, V16, P571, DOI 10.1016/0197-4580(95)00043-E; Zielonka D, 2013, PARKINSONISM RELAT D, V19, P192, DOI 10.1016/j.parkreldis.2012.09.012; ZUCKER I, 1973, PHYSIOL BEHAV, V11, P239, DOI 10.1016/0031-9384(73)90356-9	88	21	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147583	10.1371/journal.pone.0147583	http://dx.doi.org/10.1371/journal.pone.0147583			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871695	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100008
J	Qin, YS; Liu, L; He, YN; Wang, C; Liang, MY; Chen, XL; Hao, HS; Qin, T; Zhao, XM; Wang, D				Qin, YuSheng; Liu, Ling; He, YaNan; Wang, Chen; Liang, MingYuan; Chen, XiaoLi; Hao, HaiSheng; Qin, Tong; Zhao, XueMing; Wang, Dong			Testicular Busulfan Injection in Mice to Prepare Recipients for Spermatogonial Stem Cell Transplantation Is Safe and Non-Toxic	PLOS ONE			English	Article							MOUSE TESTES; GERM-CELLS; MALE-INFERTILITY; SPERMATOGENESIS; RECOVERY; SPERM; RESTORATION	Current methods of administering busulfan to remove the endogenous germ cells cause hematopoietic toxicity, require special instruments and a narrow transplantation time. We use a direct testicular injection of busulfan method for preparing recipients for SSC transplantation. Male ICR mice (recipients) were divided into four groups, and two experimental groups were treated with a bilateral testicular injection of 4 or 6 mg/kg/side busulfan (n = 60 per concentration group). Mice received an intraperitoneal injection (i.p.) of 40 mg/kg busulfan (n = 60, positive control) and bilateral testicular injections of 50% DMSO (n = 60, negative control). Donor SSCs from RFP-transgenic C57BL/6J mice were introduced into the seminiferous tubules of each recipient testis via efferent duct injection on day 16-17 after busulfan treatment. Recipient mice mated with mature female ICR mice and the number of progeny was recorded. The index detected at day 14, 21, 28, 35 and 70 after busulfan treatment. Blood analysis shows that the toxicity of busulfan treated groups was much lower than i.p. injection groups. Fertility was restored in mice treated with busulfan and donor-derived offspring were obtained after SSC transplantation. Our study indicated that intratesticular injection busulfan for the preparation of recipients in mice is safe and feasible.	[Qin, YuSheng; Liu, Ling; He, YaNan; Chen, XiaoLi; Hao, HaiSheng; Qin, Tong; Zhao, XueMing; Wang, Dong] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Utilizat, Beijing 100193, Peoples R China; [Liang, MingYuan] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun 130118, Peoples R China; [Wang, Chen] Guangxi Univ, Nanning 530004, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Jilin Agricultural University; Guangxi University	Wang, D (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Utilizat, Beijing 100193, Peoples R China.	dwangcn2002@vip.sina.com			National Science and Technology Support Program of China [2011BAD19B02]; Agricultural Science and Technology Innovation Program (ASTIP) [cxgc-ias-06]; Beijing Innovation Team of Technology System in Dairy Industry	National Science and Technology Support Program of China; Agricultural Science and Technology Innovation Program (ASTIP); Beijing Innovation Team of Technology System in Dairy Industry	This work was supported by grants from the National Science and Technology Support Program of China (No. 2011BAD19B02), the Agricultural Science and Technology Innovation Program (ASTIP) (cxgc-ias-06) and the Beijing Innovation Team of Technology System in Dairy Industry.	Abuelhija M, 2012, TOXICOL SCI, V126, P545, DOI 10.1093/toxsci/kfs021; Adly MA, 2010, PATHOL ONCOL RES, V16, P427, DOI 10.1007/s12253-009-9232-3; Benoff S, 2000, HUM REPROD UPDATE, V6, P107, DOI 10.1093/humupd/6.2.107; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Hermann BP, 2012, CELL STEM CELL, V11, P715, DOI 10.1016/j.stem.2012.07.017; Herrid M, 2013, ANIM BIOTECHNOL, V24, P293, DOI 10.1080/10495398.2013.785431; Hill JR, 2006, REPROD FERT DEVELOP, V18, P13, DOI 10.1071/RD05123; Hoff J, 2000, LAB ANIMAL, V29, P47; Honaramooz A, 2005, J ANDROL, V26, P698, DOI 10.2164/jandrol.05032; Jahnukainen K, 2011, HUM REPROD, V26, P1945, DOI 10.1093/humrep/der160; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Knoch J, 2012, EUR J DERMATOL, V22, P443, DOI 10.1684/ejd.2012.1654; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Ma WZ, 2011, BIOL REPROD, V85, P670, DOI 10.1095/biolreprod.110.089623; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Moisan AE, 2003, REPRODUCTION, V126, P205, DOI 10.1530/rep.0.1260205; Molyneux G, 2008, INT J EXP PATHOL, V89, P159, DOI 10.1111/j.1365-2613.2008.00580.x; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nozawa M, 2014, MOL BIOL EVOL, V31, P614, DOI 10.1093/molbev/mst239; Oatley JM, 2002, J ANIM SCI, V80, P1925; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Omran HM, 2013, MOL MED REP, V7, P1631, DOI 10.3892/mmr.2013.1390; Qin YS, 2016, REPROD FERT DEVELOP, V28, P1916, DOI 10.1071/RD14290; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Trefil P, 2010, THERIOGENOLOGY, V74, P1670, DOI 10.1016/j.theriogenology.2010.07.002; Wakeley KE, 2000, CURR OPIN OBSTET GYN, V12, P43, DOI 10.1097/00001703-200002000-00008; Wang DZ, 2010, ASIAN J ANDROL, V12, P263, DOI 10.1038/aja.2009.67; Yamashita KM, 2011, J THROMB HAEMOST, V9, P2057, DOI 10.1111/j.1538-7836.2011.04449.x; Zhang Wei, 2009, Zhonghua Nan Ke Xue, V15, P703; Zhang Z, 2006, J ANDROL, V27, P365, DOI 10.2164/jandrol.05179; Zohni K, 2012, HUM REPROD, V27, P44, DOI 10.1093/humrep/der357; Zorrilla Michelle, 2013, Curr Genet Med Rep, V1, DOI 10.1007/s40142-013-0027-1	38	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148388	10.1371/journal.pone.0148388	http://dx.doi.org/10.1371/journal.pone.0148388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871566	gold, Green Submitted, Green Published			2022-12-26	WOS:000370054100025
J	Espana-Agusti, J; Zou, XG; Wong, K; Fu, BY; Yang, FT; Tuveson, DA; Adams, DJ; Matakidou, A				Espana-Agusti, Judit; Zou, Xiangang; Wong, Kim; Fu, Beiyuan; Yang, Fengtang; Tuveson, David A.; Adams, David J.; Matakidou, Athena			Generation and Characterisation of a Pax8-CreER(T2) Transgenic Line and a Slc22a6-CreER(T2) Knock-In Line for Inducible and Specific Genetic Manipulation of Renal Tubular Epithelial Cells	PLOS ONE			English	Article							LINDAU TUMOR-SUPPRESSOR; MOUSE PROXIMAL TUBULE; CRE/LOX RECOMBINATION; CRE RECOMBINASE; CYST FORMATION; KIDNEY; MICE; EXPRESSION; INACTIVATION; DNA	Genetically relevant mouse models need to recapitulate the hallmarks of human disease by permitting spatiotemporal gene targeting. This is especially important for replicating the biology of complex diseases like cancer, where genetic events occur in a sporadic fashion within developed somatic tissues. Though a number of renal tubule targeting mouse lines have been developed their utility for the study of renal disease is limited by lack of inducibility and specificity. In this study we describe the generation and characterisation of two novel mouse lines directing CreER(T2) expression to renal tubular epithelia. The Pax8-CreER(T2) transgenic line uses the mouse Pax8 promoter to direct expression of CreERT2 to all renal tubular compartments (proximal and distal tubules as well as collecting ducts) whilst the Slc22a6-CreER(T2) knock-in line utilises the endogenous mouse Slc22a6 locus to specifically target the epithelium of proximal renal tubules. Both lines show high organ and tissue specificity with no extrarenal activity detected. To establish the utility of these lines for the study of renal cancer biology, Pax8-CreER(T2) and Slc22a6-CreER(T2) mice were crossed to conditional Vhl knockout mice to induce long-term renal tubule specific Vhl deletion. These models exhibited renal specific activation of the hypoxia inducible factor pathway (a VHL target). Our results establish Pax8-CreER(T2) and Slc22a6-CreER(T2) mice as valuable tools for the investigation and modelling of complex renal biology and disease.	[Espana-Agusti, Judit; Tuveson, David A.; Matakidou, Athena] Univ Cambridge, CRUK Cambridge Inst, Dept Oncol, Cambridge, England; [Zou, Xiangang] Univ Cambridge, Transgen Facil, CRUK Cambridge Inst, Cambridge, England; [Wong, Kim; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Wellcome Genome Campus, Cambridge, England; [Fu, Beiyuan; Yang, Fengtang] Wellcome Trust Sanger Inst, Cytogenet Facil, Wellcome Genome Campus, Cambridge, England; [Tuveson, David A.] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY USA	CRUK Cambridge Institute; University of Cambridge; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Cold Spring Harbor Laboratory	Matakidou, A (corresponding author), Univ Cambridge, CRUK Cambridge Inst, Dept Oncol, Cambridge, England.	Athena.Matakidou@cruk.cam.ac.uk	Yang, Fan/GYU-4249-2022	Yang, Fengtang/0000-0002-3573-2354; Adams, David/0000-0001-9490-0306; Wong, Kim/0000-0002-0984-1477	Cancer Research UK Clinician Scientist Fellowship award [C37839/A12177]; Wellcome Trust Sanger Institute [WT098051]; Cancer Research UK [12177, 13031] Funding Source: researchfish	Cancer Research UK Clinician Scientist Fellowship award; Wellcome Trust Sanger Institute(Wellcome Trust); Cancer Research UK(Cancer Research UK)	This work was supported by a Cancer Research UK Clinician Scientist Fellowship award (C37839/A12177; http://www.cancerresearchuk.org) to AM. DA, BF, FY are funded by the Wellcome Trust Sanger Institute (grant number WT098051; http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Dworniczak B, 2007, NEPHRON EXP NEPHROL, V106, pE11, DOI 10.1159/000100554; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Ge YQ, 2008, AM J PHYSIOL-RENAL, V295, pF1635, DOI 10.1152/ajprenal.90279.2008; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hwang JS, 2010, HISTOL HISTOPATHOL, V25, P33, DOI 10.14670/HH-25.33; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lantinga-van Leeuwen IS, 2007, HUM MOL GENET, V16, P3188, DOI 10.1093/hmg/ddm299; Lee CM, 2009, ONCOGENE, V28, P1694, DOI 10.1038/onc.2009.12; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Mathia S, 2013, ACTA PHYSIOL, V207, P565, DOI 10.1111/apha.12058; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; Rubera I, 2004, J AM SOC NEPHROL, V15, P2050, DOI 10.1097/01.ASN.0000133023.89251.01; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tannenbaum M, 1971, Pathol Annu, V6, P249; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Wang SS, 2014, P NATL ACAD SCI US	31	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148055	10.1371/journal.pone.0148055	http://dx.doi.org/10.1371/journal.pone.0148055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866916	Green Published, gold, Green Accepted			2022-12-26	WOS:000370050700007
J	Langenhof, MR; Apperloo, R; Komdeur, J				Langenhof, M. Rohaa; Apperloo, Rienk; Komdeur, Jan			Small Variations in Early-Life Environment Can Affect Coping Behaviour in Response to Foraging Challenge in the Three-Spined Stickleback	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; CLIMATE-CHANGE; GASTEROSTEUS-ACULEATUS; PERSONALITY-TRAITS; SOCIAL-ENVIRONMENT; INFORMATION USE; POPULATIONS; INDIVIDUALS; EXPLORATION; STRESSORS	Context An increasing concern in the face of human expansion throughout natural habitats is whether animal populations can respond adaptively when confronted with challenges like environmental change and novelty. Behavioural flexibility is an important factor in estimating the adaptive potential of both individuals and populations, and predicting the degree to which they can cope with change. Study Design This study on the three-spined stickleback (Gasterosteus aculeatus) is an empiric illustration of the degree of behavioural variation that can emerge between semi-natural systems within only a single generation. Wild-caught adult sticklebacks (P, N = 400) were randomly distributed in equal densities over 20 standardized semi-natural environments (ponds), and one year later offspring (F1, N = 652) were presented with repeated behavioural assays. Individuals were challenged to reach a food source through a novel transparent obstacle, during which exploration, activity, foraging, sociability and wall-biting behaviours were recorded through video observation. We found that coping responses of individuals from the first generation to this unfamiliar foraging challenge were related to even relatively small, naturally diversified variation in developmental environment. All measured behaviours were correlated with each other. Especially exploration, sociability and wall-biting were found to differ significantly between ponds. These differences could not be explained by stickleback density or the turbidity of the water. Findings Our findings show that a) differences in early-life environment appear to affect stickleback feeding behaviour later in life; b) this is the case even when the environmental differences are only small, within natural parameters and diversified gradually; and c) effects are present despite semi-natural conditions that fluctuate during the year. Therefore, in behaviourally plastic animals like the stickleback, the adaptive response to human-induced habitat disturbance may occur rapidly (within one generation) and vary strongly based on the system's (starting) conditions. This has important implications for the variability in animal behaviour, which may be much larger than expected from studying laboratory systems, as well as for the validity of predictions of population responses to change.	[Langenhof, M. Rohaa; Apperloo, Rienk; Komdeur, Jan] Univ Groningen, Groningen Inst Evolutionary Life Sci, Behav & Physiol Ecol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands	University of Groningen	Langenhof, MR (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Behav & Physiol Ecol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	m.b.w.langenhof@gmail.com	Komdeur, Jan/X-1261-2019	Komdeur, Jan/0000-0002-9241-0124; Langenhof, M. Rohaa/0000-0003-3434-4357	Ubbo Emmius scholarschip; Schure-Beijerink-Popping Fonds	Ubbo Emmius scholarschip; Schure-Beijerink-Popping Fonds	An Ubbo Emmius scholarschip was awarded to MRL to carry out PhD research on personality development. A E2000 grant from the Schure-Beijerink-Popping Fonds was awarded to MRL to cover expenses of a field expedition to gather, transport and house the animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2009, MOL ECOL, V18, P3885, DOI 10.1111/j.1365-294X.2009.04319.x; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; Bell AM, 2011, J EVOLUTION BIOL, V24, P943, DOI 10.1111/j.1420-9101.2011.02247.x; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2010, J COMP PHYSIOL B, V180, P211, DOI 10.1007/s00360-009-0395-8; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Bjaerke O, 2010, ECOL FRESHW FISH, V19, P249, DOI 10.1111/j.1600-0633.2010.00409.x; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Bradbury RB, 2001, TRENDS ECOL EVOL, V16, P440, DOI 10.1016/S0169-5347(01)02189-9; Bradshaw WE, 2010, ANNU REV PHYSIOL, V72, P147, DOI 10.1146/annurev-physiol-021909-135837; Calsbeek R, 2009, J EVOLUTION BIOL, V22, P97, DOI 10.1111/j.1420-9101.2008.01625.x; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Day T, 1996, OECOLOGIA, V108, P380, DOI 10.1007/BF00334665; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2012, J ANIM ECOL, V81, P116, DOI 10.1111/j.1365-2656.2011.01877.x; Fletcher RJ, 2010, CONDOR, V112, P225, DOI 10.1525/cond.2010.090236; Garduno-Paz MV, 2010, BIOL J LINN SOC, V100, P407, DOI 10.1111/j.1095-8312.2010.01423.x; Gonda A, 2009, P ROY SOC B-BIOL SCI, V276, P2085, DOI 10.1098/rspb.2009.0026; Gracceva G, 2011, DEV PSYCHOBIOL, V53, P614, DOI 10.1002/dev.20586; Grether GF, 2005, AM NAT, V166, pE115, DOI 10.1086/432023; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Harcourt JL, 2010, ETHOLOGY, V116, P440, DOI 10.1111/j.1439-0310.2010.01757.x; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; Herczeg G, 2009, ANIM BEHAV, V77, P575, DOI 10.1016/j.anbehav.2008.10.023; Heuschele J, 2009, BEHAV ECOL, V20, P1223, DOI 10.1093/beheco/arp123; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Huntingford FA, 2009, J FISH BIOL, V75, P1943, DOI 10.1111/j.1095-8649.2009.02420.x; Jenssen BM, 2006, ENVIRON HEALTH PERSP, V114, P76, DOI 10.1289/ehp.8057; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kraak SBM, 1999, BEHAV ECOL, V10, P696, DOI 10.1093/beheco/10.6.696; Laland KN, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1019; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Langenhof MBW, 2013, SUSTAINABILITY-BASEL, V5, P1764, DOI 10.3390/su5051764; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Minderman J, 2009, BEHAV ECOL, V20, P830, DOI 10.1093/beheco/arp067; Naguib M, 2011, DEV PSYCHOBIOL, V53, P592, DOI 10.1002/dev.20533; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Ostlund-Nilsson S, 2006, BIOL 3 SPINED STICKL; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Richter S, 2012, OECOLOGIA, V169, P269, DOI 10.1007/s00442-011-2191-x; Scheiber IBR, 2009, HORM BEHAV, V55, P133, DOI 10.1016/j.yhbeh.2008.09.006; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Storey KB, 2012, CABI CLIM CHANGE SER, V3, P1; Sweeney K, 2013, ETHOLOGY, V119, P436, DOI 10.1111/eth.12081; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Vlieger L, 2009, J FISH BIOL, V75, P2163, DOI 10.1111/j.1095-8649.2009.02403.x; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	52	2	2	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147000	10.1371/journal.pone.0147000	http://dx.doi.org/10.1371/journal.pone.0147000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862908	Green Submitted, Green Published, gold			2022-12-26	WOS:000370046600017
J	Rosslau, K; Herholz, SC; Knief, A; Ortmann, M; Deuster, D; Schmidt, CM; Zehnhoff-Dinnesen, A; Pantev, C; Dobel, C				Rosslau, Ken; Herholz, Sibylle C.; Knief, Arne; Ortmann, Magdalene; Deuster, Dirk; Schmidt, Claus-Michael; Zehnhoff-Dinnesen, Antoinetteam; Pantev, Christo; Dobel, Christian			Song Perception by Professional Singers and Actors: An MEG Study	PLOS ONE			English	Article							AUDITORY-CORTEX; MUSICAL SYNTAX; LANGUAGE; BRAIN; SPEECH; MUSICIANS; IMAGERY; ERP; SEMANTICS; ATTENTION	The cortical correlates of speech and music perception are essentially overlapping, and the specific effects of different types of training on these networks remain unknown. We compared two groups of vocally trained professionals for music and speech, singers and actors, using recited and sung rhyme sequences from German art songs with semantic and/or prosodic/melodic violations (i.e. violations of pitch) of the last word, in order to measure the evoked activation in a magnetoencephalographic (MEG) experiment. MEG data confirmed the existence of intertwined networks for the sung and spoken modality in an early time window after word violation. In essence for this early response, higher activity was measured after melodic/prosodic than semantic violations in predominantly right temporal areas. For singers as well as for actors, modality-specific effects were evident in predominantly left-temporal lateralized activity after semantic expectancy violations in the spoken modality, and right-dominant temporal activity in response to melodic violations in the sung modality. As an indication of a special group-dependent audiation process, higher neuronal activity for singers appeared in a late time window in right temporal and left parietal areas, both after the recited and the sung sequences.	[Rosslau, Ken; Knief, Arne; Deuster, Dirk; Schmidt, Claus-Michael; Zehnhoff-Dinnesen, Antoinetteam] Univ Hosp Muenster, Dept Phoniatr & Pedaudiol, Munster, Germany; [Herholz, Sibylle C.; Ortmann, Magdalene; Pantev, Christo; Dobel, Christian] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Herholz, Sibylle C.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Ortmann, Magdalene] Univ Hosp Cologne, Jean Uhrmacher Inst Clin ENT Res, Cologne, Germany; [Dobel, Christian] Univ Jena, Dept Otorhinolaryngol, Jena, Germany	University of Munster; University of Munster; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne; Friedrich Schiller University of Jena	Rosslau, K (corresponding author), Univ Hosp Muenster, Dept Phoniatr & Pedaudiol, Munster, Germany.	ken.rosslau@uni-muenster.de			Medical Faculty of the Westfalische-Wilhelms-University of Muenster; Deutsche Forschungsgemeinschaft [DO 711/7-1, HE6067/3-1, PA 392/12-2]; Open Access Publication Fund of University of Muenster	Medical Faculty of the Westfalische-Wilhelms-University of Muenster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of University of Muenster	Ken Rosslau is supported by the Deanery of the Medical Faculty of the Westfalische-Wilhelms-University of Muenster; Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. Christian Dobel received support from Deutsche Forschungsgemeinschaft DO 711/7-1. Sibylle C. Herholz received support from Deutsche Forschungsgemeinschaft HE6067/3-1. Christo Pantev received support from Deutsche Forschungsgemeinschaft PA 392/12-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besson M, 2001, ANN NY ACAD SCI, V930, P232, DOI 10.1111/j.1749-6632.2001.tb05736.x; BESSON M, 1987, PSYCHOPHYSIOLOGY, V24, P14, DOI 10.1111/j.1469-8986.1987.tb01853.x; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; Brodsky W, 2008, J EXP PSYCHOL HUMAN, V34, P427, DOI 10.1037/0096-1523.34.2.427; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; Dick F, 2010, CEREB CORTEX; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Gaab N, 2003, ANN NY ACAD SCI, V999, P385, DOI 10.1196/annals.1284.048; Geukes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084029; Gordon EE, 1993, LEARING SEQUENCES MU; Gordon RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009889; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Herholz SC, 2012, J COGNITIVE NEUROSCI, V24, P1382, DOI 10.1162/jocn_a_00216; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hirschfeld G, 2011, BRAIN LANG, V116, P91, DOI 10.1016/j.bandl.2010.07.002; Hubbard TL, 2010, PSYCHOL BULL, V136, P302, DOI 10.1037/a0018436; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Keuper K, 2012, HUM BRAIN MAPP; Kleber B, 2007, NEUROIMAGE, V36, P889, DOI 10.1016/j.neuroimage.2007.02.053; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2001, ANN NY ACAD SCI, V930, P420, DOI 10.1111/j.1749-6632.2001.tb05758.x; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Kolinsky R, 2009, COGNITION, V112, P1, DOI 10.1016/j.cognition.2009.02.014; Kreitewolf J, 2014, NEUROIMAGE, V102, P332, DOI 10.1016/j.neuroimage.2014.07.038; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Mueller W, 1827, WINTERREISE, P1; Mueller W, 1823, DIE SCHONE MULLERIN, V1, p[4, 6824]; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Peretz I, 2009, ANN NY ACAD SCI, V1169, P256, DOI 10.1111/j.1749-6632.2009.04557.x; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Sammler D, 2009, ANN NY ACAD SCI, V1169, P494, DOI 10.1111/j.1749-6632.2009.04792.x; Sammler D, 2013, NEUROIMAGE, V64, P134, DOI 10.1016/j.neuroimage.2012.09.035; SAMSON S, 1994, NEUROPSYCHOLOGIA, V32, P231, DOI 10.1016/0028-3932(94)90008-6; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Schon D, 2008, COGNITION, V106, P975, DOI 10.1016/j.cognition.2007.03.005; Schon D, 2005, ANN NY ACAD SCI, V1060, P71, DOI 10.1196/annals.1360.006; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Schulze K, 2010, HUM BRAIN MAPP; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; Wolters CH, 2004, P ANN INT IEEE EMBS, V26, P3569; Zarate JM, 2008, NEUROIMAGE, V40, P1871, DOI 10.1016/j.neuroimage.2008.01.026; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zatorre Robert J, 2009, Ann N Y Acad Sci, V1169, P1, DOI 10.1111/j.1749-6632.2009.04794.x; Zatorre RJ, 2010, J COGNITIVE NEUROSCI, V22, P775, DOI 10.1162/jocn.2009.21239	61	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147986	10.1371/journal.pone.0147986	http://dx.doi.org/10.1371/journal.pone.0147986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863437	Green Published, gold			2022-12-26	WOS:000370046600040
J	Zhao, Y; Li, MY; Zhao, J; Knorz, MC; Sun, L; Tian, M; Zhou, XT				Zhao, Yu; Li, Meiyan; Zhao, Jing; Knorz, Michael C.; Sun, Ling; Tian, Mi; Zhou, Xingtao			Posterior Corneal Elevation after Small Incision Lenticule Extraction for Moderate and High Myopia	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; REFRACTIVE SURGERY; ORBSCAN-II; PHOTOREFRACTIVE KERATECTOMY; LASIK EYES; POST-LASIK; PENTACAM; SURFACE; THICKNESS; SMILE	Purpose To investigate the changes of posterior corneal elevation after small incision lenticule extraction (SMILE) for moderate and high myopia. Methods In this prospective study, fifty consecutive eyes of thirty patients (10 male, 20 female) who underwent SMILE for myopia and myopic astigmatism were included. Eyes were divided in two groups based on the preoperative spherical equivalent refraction: high myopia group (32 eyes, range -6.25D to -10.00D) and moderate myopia group (18 eyes, range -3.00D to -6.00D). Posterior corneal surfaces were measured by a Scheimpflug camera (Pentacam, Oculus Germany) preoperatively and 1 month, 3 months, 6 months and 12 months post-operatively. Posterior central elevation (PCE) and posterior mean elevation (PME) at 17 predetermined points in the central-4mm area above the best-fit sphere were analyzed. Results No significant difference in the amount of posterior corneal elevation changes in the high myopia group was noted over time (P = 0.23 and P = 0.94 for PCE and PME, respectively). Similarly, the changes in the moderate myopia group before and after SMILE were not significant either (P = 0.34 and P = 0.40 for PCE and PME). A statistically significant correlation was found between the residual bed thickness and the shift of the PCE in the high myopia group at 12 months postoperatively (r = 0.53, P = 0.01). Conclusions The results of this study suggest that the posterior corneal surface remain stable within one year after SMILE for both moderate and high myopia. The changes of PCE correlate to the residual bed thickness for high myopia. Long-term changes of posterior corneal surface need further investigation.	[Zhao, Yu; Li, Meiyan; Zhao, Jing; Sun, Ling; Tian, Mi; Zhou, Xingtao] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China; [Knorz, Michael C.] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany	Fudan University; Ruprecht Karls University Heidelberg	Zhou, XT (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China.	xingtaozhou@163.com	zhou, xt/GWZ-9212-2022		Key Project of Science and Technology of Shanghai [11JC1402000]; National Natural Science Foundation of China [81570879]; Outstanding Academic Leaders Program of Shanghai [XBR2013098]	Key Project of Science and Technology of Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Academic Leaders Program of Shanghai	The work was supported by The Key Project of Science and Technology of Shanghai (Grant No. 11JC1402000), by the National Natural Science Foundation of China (Grant No. 81570879), and by the Outstanding Academic Leaders Program of Shanghai (Grant No. XBR2013098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek TM, 2001, OPHTHALMOLOGY, V108, P317, DOI 10.1016/S0161-6420(00)00502-9; Belin Michael W., 1993, CLAO (Contact Lens Association of Ophthalmologists) Journal, V19, P64; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Chakrabarti HS, 2001, J CATARACT REFR SURG, V27, P1823, DOI 10.1016/S0886-3350(01)01089-6; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; Ciolino JB, 2007, J CATARACT REFR SURG, V33, P1366, DOI 10.1016/j.jcrs.2007.04.016; Ciolino JB, 2006, J CATARACT REFR SURG, V32, P1426, DOI 10.1016/j.jcrs.2006.03.037; Dong ZX, 2014, BRIT J OPHTHALMOL, V98, P263, DOI 10.1136/bjophthalmol-2013-303415; Grewal DS, 2011, J REFRACT SURG, V27, P261, DOI 10.3928/1081597X-20100618-01; Ha BJ, 2009, J REFRACT SURG, V25, P290, DOI 10.3928/1081597X-20090301-09; Hashemi H, 2007, J CATARACT REFR SURG, V33, P841, DOI 10.1016/j.jcrs.2007.01.019; Khairat YM, 2013, CLIN OPHTHALMOL, V7, P1771, DOI 10.2147/OPTH.S48077; Kim H, 2006, OPHTHALMOLOGICA, V220, P37, DOI 10.1159/000089273; Kunert KS, 2015, KLIN MONATSBL AUGENH, V232, P67, DOI 10.1055/s-0034-1383053; Mihaltz K, 2009, CORNEA, V28, P976, DOI 10.1097/ICO.0b013e31819e34de; Modis L, 2001, CORNEA, V20, P711, DOI 10.1097/00003226-200110000-00008; Nilforoushan MR, 2008, J CATARACT REFR SURG, V34, P623, DOI 10.1016/j.jcrs.2007.11.054; Nishimura R, 2007, OPHTHALMOLOGY, V114, P1104, DOI 10.1016/j.ophtha.2006.09.014; Pallikaris IG, 2001, J CATARACT REFR SURG, V27, P1796, DOI 10.1016/S0886-3350(01)01090-2; Reinstein DZ, 2013, J REFRACT SURG, V29, P454, DOI 10.3928/1081597X-20130617-03; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Roy AS, 2014, J CATARACT REFR SURG, V40, P971, DOI 10.1016/j.jcrs.2013.08.065; Seiler T, 1998, J CATARACT REFR SURG, V24, P1007, DOI 10.1016/S0886-3350(98)80057-6; Sekundo W, 2014, GRAEF ARCH CLIN EXP, V252, P837, DOI 10.1007/s00417-014-2608-4; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Twa MD, 2005, J CATARACT REFR SURG, V31, P61, DOI 10.1016/j.jcrs.2004.09.032; Wang Z, 1999, OPHTHALMOLOGY, V106, P406, DOI 10.1016/S0161-6420(99)90083-0; Wu D, 2014, J CATARACT REFR SURG, V40, P954, DOI 10.1016/j.jcrs.2013.07.056; Yao PJ, 2013, J REFRACT SURG, V29, P669, DOI 10.3928/1081597X-20130806-01; Zhang L, 2010, INVEST OPHTH VIS SCI, V51, P3468, DOI 10.1167/iovs.09-4811	30	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148370	10.1371/journal.pone.0148370	http://dx.doi.org/10.1371/journal.pone.0148370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863612	gold, Green Published, Green Submitted			2022-12-26	WOS:000370046600060
J	Qiu, XS; Fu, Q; Meng, CC; Yu, SQ; Zhan, Y; Dong, LN; Song, CP; Sun, YJ; Tan, L; Hu, SL; Wang, XQ; Liu, XW; Peng, DX; Liu, XF; Ding, C				Qiu, Xusheng; Fu, Qiang; Meng, Chunchun; Yu, Shengqing; Zhan, Yuan; Dong, Luna; Song, Cuiping; Sun, Yingjie; Tan, Lei; Hu, Shunlin; Wang, Xiaoquan; Liu, Xiaowen; Peng, Daxin; Liu, Xiufan; Ding, Chan			Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TRANSCRIPTIVE COMPLEX; ALPHA-INTERFERON; PREVENTING STAT1; VIRULENT-STRAIN; EXPRESSION; CDNA; GENERATION; CHICKEN; GAMMA	Newcastle disease virus (NDV) V protein is considered as an effector for IFN antagonism, however, the mechanism remains unknown. In this study, the expression of STAT1 and phospho-STAT1 in cells infected with NDV or transfected with V protein-expressing plasmids were analyzed. Our results showed that NDV V protein targets phospho-STAT1 reduction in the cells depends on the stimulation of IFN-alpha. In addition, a V-deficient genotype VII recombinant NDV strain rZJ1-VS was constructed using reverse genetic technique to confirm the results. The rZJ1-VS lost the ability to reduce phospho-STAT1 and induced higher expression of IFN-responsive genes in infected cells. Furthermore, treatment with an ubiquitin E1 inhibitor PYR-41 demonstrated that phospho-STAT1 reduction was caused by degradation, but not de-phosphorylation. We conclude that NDV V protein targets phospho-STAT1 degradation to block IFN-alpha signaling, which adds novel knowledge to the strategies used by paramyxoviruses to evade IFN.	[Qiu, Xusheng; Fu, Qiang; Meng, Chunchun; Yu, Shengqing; Zhan, Yuan; Dong, Luna; Song, Cuiping; Sun, Yingjie; Tan, Lei; Ding, Chan] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Fu, Qiang; Hu, Shunlin; Wang, Xiaoquan; Liu, Xiaowen; Peng, Daxin; Liu, Xiufan] Yangzhou Univ, Key Lab Anim Infect Dis, Yangzhou 225009, Jiangsu, Peoples R China; [Peng, Daxin; Liu, Xiufan; Ding, Chan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Yangzhou University	Ding, C (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.; Liu, XF (corresponding author), Yangzhou Univ, Key Lab Anim Infect Dis, Yangzhou 225009, Jiangsu, Peoples R China.; Liu, XF; Ding, C (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	xfliu@yzu.edu.cn; shoveldeen@shvri.ac.cn	Peng, Daxin/AAJ-3476-2021		Chinese National High-tech R&D Program (863 Program) [2011AA10A209]; National Natural Science Foundation of China [31101822]; Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]	Chinese National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Special Fund for Agro-scientific Research in the Public Interest	This work was funded by (1) the Chinese National High-tech R&D Program (863 Program, 2011AA10A209), http://program.most.gov.cn/, the funder played a role in study design and data collection and analysis. (2) National Natural Science Foundation of China (31101822), http://www.nsfc.gov.cn/, the funder played a role in study design and data collection and analysis. (3) Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033), http://www.moa.gov.cn/, the funder played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamares JG, 2010, VIRUS RES, V147, P153, DOI 10.1016/j.virusres.2009.10.020; Alexander D.J., 1998, LAB MANUAL ISOLATION, P156; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; HAMAGUCHI M, 1985, VIROLOGY, V147, P295, DOI 10.1016/0042-6822(85)90132-1; HAMAGUCHI M, 1983, VIROLOGY, V128, P105, DOI 10.1016/0042-6822(83)90322-7; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Horvath CM, 2004, CYTOKINE GROWTH F R, V15, P117, DOI 10.1016/j.cytogfr.2004.02.003; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Jang J, 2010, APPL MICROBIOL BIOT, V85, P1509, DOI 10.1007/s00253-009-2189-z; Johnson KN, 2000, J VIROL, V74, P5123, DOI 10.1128/JVI.74.11.5123-5132.2000; Jun-Qing W, 2013, CHIN J ANIM INFECT D, V21, P1; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Kato A, 2003, BMC IMMUNOL, V4, P8; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim SH, 2012, J VIROL, V86, P11394, DOI 10.1128/JVI.01922-12; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Kumar R, 2013, INDIAN J VIROL, V24, P278, DOI 10.1007/s13337-013-0148-x; Lee CK, 1997, J BIOL CHEM, V272, P21872, DOI 10.1074/jbc.272.35.21872; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Liu HL, 2008, RES VET SCI, V85, P612, DOI 10.1016/j.rvsc.2008.02.013; Liu YL, 2007, ARCH VIROL, V152, P1241, DOI 10.1007/s00705-007-0961-x; Locke DP, 2000, VIRUS RES, V69, P55, DOI 10.1016/S0168-1702(00)00175-1; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Mebatsion T, 2001, J VIROL, V75, P420, DOI 10.1128/JVI.75.1.420-428.2001; OIE B. S. C., 2014, MAN DIAGN TESTS VACC, P5; Onomoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019799; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Saif YM, 2008, NEWCASTLE DIS OTHER; SAMSON ACR, 1991, J GEN VIROL, V72, P1709, DOI 10.1099/0022-1317-72-7-1709; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; Stepnowski P, 2004, HUM EXP TOXICOL, V23, P513, DOI 10.1191/0960327104ht480oa; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Sun YJ, 2013, MOL IMMUNOL, V53, P321, DOI 10.1016/j.molimm.2012.08.022; Susta L, 2013, MICROB PATHOGENESIS, V61-62, P73, DOI 10.1016/j.micpath.2013.05.009; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yeow WS, 1997, INT J BIOCHEM CELL B, V29, P513, DOI 10.1016/S1357-2725(96)00105-7; Yokosawa N, 2002, J VIROL, V76, P12683, DOI 10.1128/JVI.76.24.12683-12690.2002; Yu Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-120; Yusoff K, 2001, AVIAN PATHOL, V30, P439, DOI 10.1080/03079450120078626; Zou J, 2005, VIRUS GENES, V30, P13, DOI 10.1007/s11262-004-4577-x	58	34	39	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148560	10.1371/journal.pone.0148560	http://dx.doi.org/10.1371/journal.pone.0148560			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859759	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400053
J	Rommel, A; Varnaccia, G; Lahmann, N; Kottner, J; Kroll, LE				Rommel, Alexander; Varnaccia, Gianni; Lahmann, Nils; Kottner, Jan; Kroll, Lars Eric			Occupational Injuries in Germany: Population-Wide National Survey Data Emphasize the Importance of Work-Related Factors	PLOS ONE			English	Article							HEALTH INTERVIEW SURVEY; UNINTENTIONAL INJURIES; JOB DEMANDS; LIFE-STYLE; RISK; WORKPLACE; AGE; CONSTRUCTION; ACCIDENTS; SMOKING	Unintentional injuries cause much of the global mortality burden, with the workplace being a common accident setting. Even in high-income economies, occupational injury figures remain remarkably high. Because risk factors for occupational injuries are prone to confounding, the present research takes a comprehensive approach. To better understand the occurrence of occupational injuries, sociodemographic factors and work-and health-related factors are tested simultaneously. Thus, the present analysis aims to develop a comprehensive epidemiological model that facilitates the explanation of varying injury rates in the workplace. The representative phone survey German Health Update 2010 provides information on medically treated occupational injuries sustained in the year prior to the interview. Data were collected on sociodemographics, occupation, working conditions, health-related behaviors, and chronic diseases. For the economically active population (18-70 years, n = 14,041), the 12-month prevalence of occupational injuries was calculated with a 95% confidence interval (CI). Blockwise multiple logistic regression was applied to successively include different groups of variables. Overall, 2.8% (95% CI 2.4-3.2) of the gainfully employed population report at least one occupational injury (women: 0.9%; 95% CI 0.7-1.2; men: 4.3%; 95% CI 3.7-5.0). In the fully adjusted model, male gender (OR 3.16) and age 18-29 (OR 1.54), as well as agricultural (OR 5.40), technical (OR 3.41), skilled service (OR 4.24) or manual (OR 5.12), and unskilled service (OR 3.13) or manual (OR 4.97) occupations are associated with higher chances of occupational injuries. The same holds for frequent stressors such as heavy carrying (OR 1.78), working in awkward postures (OR 1.46), environmental stress (OR 1.48), and working under pressure (OR 1.41). Among health-related variables, physical inactivity (OR 1.47) and obesity (OR 1.73) present a significantly higher chance of occupational injuries. While the odds for most work-related factors were as expected, the associations for health-related factors such as smoking, drinking, and chronic diseases were rather weak. In part, this may be due to context-specific factors such as safety and workplace regulations in high-income countries like Germany. This assumption could guide further research, taking a multi-level approach to international comparisons.	[Rommel, Alexander; Varnaccia, Gianni; Kroll, Lars Eric] Robert Koch Inst, Epidemiol & Hlth Monitoring, Gen Pape Str 62-66, D-12101 Berlin, Germany; [Lahmann, Nils] Charite, Inst Hlth Sci Educ & Nursing, Augustenburger Pl 1, D-13353 Berlin, Germany; [Kottner, Jan] Charite, Clin Res Ctr Hair & Skin Sci, Charitepl 1, D-10117 Berlin, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rommel, A (corresponding author), Robert Koch Inst, Epidemiol & Hlth Monitoring, Gen Pape Str 62-66, D-12101 Berlin, Germany.	RommelA@rki.de	; Kottner, Jan/N-2365-2013	Lahmann, Nils/0000-0002-6934-5387; Kottner, Jan/0000-0003-0750-3818	German Federal Ministry of Health; Robert Koch Institute; RKI; German Federal Ministry of Health; Robert Koch Institute; RKI	German Federal Ministry of Health; Robert Koch Institute; RKI; German Federal Ministry of Health; Robert Koch Institute; RKI	The health survey German Health Update 2010 is part of the Federal Health Monitoring (FHM) in Germany. The FHM is done by the Robert Koch Institute (RKI) on behalf of the Federal Ministry of Health. The ministry finances the RKI and gives substantial funds for the FHM. Three of the authors (AR LEK GV) are employees of the RKI. No one of the authors received specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The study was funded by the German Federal Ministry of Health and the Robert Koch Institute.	[Anonymous], 2014, SICH GES BEI ARB 201; [Anonymous], 2012, DAT FAKT ERG STUD GE; Aust F., 2009, UMFRAGEFORSCHUNG, P195, DOI 10.1007/978-3-531-91852-5_10; Badura B, 2013, FEHLZEITEN REPORT 20; Bhattacherjee A, 2003, J OCCUP HEALTH, V45, P382, DOI 10.1539/joh.45.382; Bhattacherjee A, 2013, INT J OCCUP MED ENV, V26, P910, DOI 10.2478/s13382-013-0165-4; BLOSSFELD HP, 1987, AM J SOCIOL, V93, P89, DOI 10.1086/228707; Bundesanstalt fur Arbeitsschutz und Arbeitsmedizin, 2011, SICH GES BEI ARB 201; Bureau of Labor Statistics, 2014, EMPL REP WORKPL INJ; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CELLIER JM, 1995, PERCEPT MOTOR SKILL, V80, P931, DOI 10.2466/pms.1995.80.3.931; Centers for Disease Control and Prevention, 2009, BEH RISK FACT SURV S; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Chau N, 2004, INT ARCH OCC ENV HEA, V77, P60, DOI 10.1007/s00420-003-0460-7; Chau N, 2009, OCCUP MED-OXFORD, V59, P114, DOI 10.1093/occmed/kqp002; Dembe AE, 2004, J OCCUP ENVIRON HYG, V1, P542, DOI 10.1080/15459620490478376; Dong XW, 2005, SCAND J WORK ENV HEA, V31, P329, DOI 10.5271/sjweh.915; Eurostat, 2014, NONF ACC WORK EC ACT; Gabler S, 2002, INT J PUBLIC OPIN R, V14, P339, DOI 10.1093/ijpor/14.3.339; Hamalainen P, 2009, J SAFETY RES, V40, P125, DOI 10.1016/j.jsr.2008.12.010; Hanecke K, 1998, SCAND J WORK ENV HEA, V24, P43; Holbrook A, 2008, ADV TELEPHONE SURVEY; ICECI Coordination and Maintenance Group, 2004, INT CLASS EXT CAUS I; International Labour Organization, 2014, CREAT SAF HLTH WORKP; Khanzode VV, 2012, SAFETY SCI, V50, P1355, DOI 10.1016/j.ssci.2011.12.015; Khlat M, 2008, PUBLIC HEALTH, V122, P771, DOI 10.1016/j.puhe.2007.09.012; Kouvonen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077178; Kroll L, 2011, GBE KOMPAKT, V2; Kroll LE, 2011, METHODS DATA ANAL, V5, P63; Kubo J, 2014, OCCUP ENVIRON MED, V71, P159, DOI 10.1136/oemed-2013-101653; Lange C, 2015, INT J EPIDEMIOL, V44, P442, DOI 10.1093/ije/dyv067; Li F, 2013, ACCIDENT ANAL PREV, V51, P243, DOI 10.1016/j.aap.2012.11.029; Lin TC, 2013, SCAND J WORK ENV HEA, V39, P268, DOI 10.5271/sjweh.3347; Lombardi DA, 2012, CHRONOBIOL INT, V29, P556, DOI 10.3109/07420528.2012.675253; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu ML, 2014, INT J BEHAV MED, V21, P42, DOI 10.1007/s12529-013-9325-y; Musa AI, 2013, THEOR ISS ERGON SCI, V14, P99, DOI 10.1080/1463922X.2011.611271; Nakata A, 2006, SOC SCI MED, V63, P2452, DOI 10.1016/j.socscimed.2006.06.009; Nakata A, 2006, AM J IND MED, V49, P658, DOI 10.1002/ajim.20338; Oh JH, 2003, SOC SCI MED, V57, P2173, DOI 10.1016/S0277-9536(03)00073-X; Palmer KT, 2008, OCCUP ENVIRON MED, V65, P757, DOI 10.1136/oem.2007.037440; Pollack KM, 2007, INJURY PREV, V13, P297, DOI 10.1136/ip.2006.014787; Ramchand R, 2009, EFFECTS SUBSTANCES U; Rasmussen K, 2011, AM J IND MED, V54, P143, DOI 10.1002/ajim.20911; Rinnert K, 2009, DIABETOLOGE, V5, P531, DOI 10.1007/s11428-009-0440-y; RYAN J, 1992, AM J PUBLIC HEALTH, V82, P29, DOI 10.2105/AJPH.82.1.29; SACKS JJ, 1994, PREV MED, V23, P515, DOI 10.1006/pmed.1994.1070; Smith P, 2012, J OCCUP ENVIRON MED, V54, P841, DOI 10.1097/JOM.0b013e31824e11f7; Sprince NL, 2008, J OCCUP ENVIRON MED, V50, P804, DOI 10.1097/JOM.0b013e318168efcf; Uehli K, 2014, SLEEP MED REV, V18, P61, DOI 10.1016/j.smrv.2013.01.004; Varnaccia G, 2014, BUNDESGESUNDHEITSBLA, V57, P604, DOI 10.1007/s00103-014-1961-0; Veazie MA, 2000, ALCOHOL CLIN EXP RES, V24, P1811, DOI 10.1097/00000374-200012000-00010; VEAZIE MA, 1994, ANNU REV PUBL HEALTH, V15, P203, DOI 10.1146/annurev.pu.15.050194.001223; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; Wen CP, 2005, TOB CONTROL, V14, pI28, DOI 10.1136/tc.2003.005629; Wilkins Kathryn, 2007, Health Rep, V18, P25; Williamson A, 2011, ACCIDENT ANAL PREV, V43, P498, DOI 10.1016/j.aap.2009.11.011; Zheng L, 2010, AM J IND MED, V53, P588, DOI 10.1002/ajim.20833	59	24	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148798	10.1371/journal.pone.0148798	http://dx.doi.org/10.1371/journal.pone.0148798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859560	Green Submitted, gold, Green Published			2022-12-26	WOS:000370038400087
J	Blanchard, S; Saillet, S; Ivanov, A; Benquet, P; Benar, CG; Pelegrini-Issac, M; Benali, H; Wendling, F				Blanchard, Solenna; Saillet, Sandrine; Ivanov, Anton; Benquet, Pascal; Benar, Christian-George; Pelegrini-Issac, Melanie; Benali, Habib; Wendling, Fabrice			A New Computational Model for Neuro-Glio-Vascular Coupling: Astrocyte Activation Can Explain Cerebral Blood Flow Nonlinear Response to Interictal Events	PLOS ONE			English	Article							BRAIN ELECTRICAL-ACTIVITY; ARTERIOLAR SMOOTH-MUSCLE; MATHEMATICAL-MODEL; GABA RELEASE; GLUTAMATE TRANSPORTER; BIOPHYSICAL MODEL; PREFRONTAL CORTEX; ENERGY-METABOLISM; SYNAPTIC ACTIVITY; IN-VIVO	Developing a clear understanding of the relationship between cerebral blood flow (CBF) response and neuronal activity is of significant importance because CBF increase is essential to the health of neurons, for instance through oxygen supply. This relationship can be investigated by analyzing multimodal (fMRI, PET, laser Doppler...) recordings. However, the important number of intermediate (non-observable) variables involved in the underlying neurovascular coupling makes the discovery of mechanisms all the more difficult from the sole multimodal data. We present a new computational model developed at the population scale (voxel) with physiologically relevant but simple equations to facilitate the interpretation of regional multimodal recordings. This model links neuronal activity to regional CBF dynamics through neuro-glio-vascular coupling. This coupling involves a population of glial cells called astrocytes via their role in neurotransmitter (glutamate and GABA) recycling and their impact on neighboring vessels. In epilepsy, neuronal networks generate epileptiform discharges, leading to variations in astrocytic and CBF dynamics. In this study, we took advantage of these large variations in neuronal activity magnitude to test the capacity of our model to reproduce experimental data. We compared simulations from our model with isolated epileptiform events, which were obtained in vivo by simultaneous local field potential and laser Doppler recordings in rats after local bicuculline injection. We showed a predominant neuronal contribution for low level discharges and a significant astrocytic contribution for higher level discharges. Besides, neuronal contribution to CBF was linear while astrocytic contribution was nonlinear. Results thus indicate that the relationship between neuronal activity and CBF magnitudes can be nonlinear for isolated events and that this nonlinearity is due to astrocytic activity, highlighting the importance of astrocytes in the interpretation of regional recordings.	[Blanchard, Solenna; Benquet, Pascal; Wendling, Fabrice] Univ Rennes 1, INSERM U1099, Lab Traitement Signal & Image, Rennes, France; [Saillet, Sandrine; Ivanov, Anton; Benar, Christian-George] Aix Marseille Univ, INSERM UMRS 1106, Inst Neurosci Syst, Marseille, France; [Pelegrini-Issac, Melanie; Benali, Habib] Sorbonne Univ, Univ Paris 06, CNRS, INSERM,Lab Imagerie Biomed, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Blanchard, S (corresponding author), Univ Rennes 1, INSERM U1099, Lab Traitement Signal & Image, Rennes, France.	solenna.blanchard@univ-rennes1.fr	Benquet, Pascal/ABC-6954-2020; Wendling, Fabrice/F-8924-2013; WENDLING, Fabrice/P-9574-2019	WENDLING, Fabrice/0000-0003-2428-9665; Pelegrini-Issac, Melanie/0000-0003-3260-5795; Blanchard, Solenna/0000-0003-0732-1926; Ivanov, Anton/0000-0002-8650-6322; Saillet, Sandrine/0000-0002-3747-3261; Benquet, Pascal/0000-0003-0217-5886	Agence Nationale de la Recherche [ANR 2010 BLAN 030901]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by a grant from the Agence Nationale de la Recherche ANR 2010 BLAN 030901 named MULTIMODEL project: http://www.agence-nationale-recherche.fr/?Project=ANR-10-BLAN-0309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; Anderson CM, 2000, GLIA, V32, P1; Aradi I, 2002, J PHYSIOL-LONDON, V538, P227, DOI 10.1113/jphysiol.2001.013054; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Aubert A, 2005, J CEREBR BLOOD F MET, V25, P1476, DOI 10.1038/sj.jcbfm.9600144; Aubert A, 2002, NEUROIMAGE, V17, P1162, DOI 10.1006/nimg.2002.1224; Aubert A, 2001, ACTA BIOTHEOR, V49, P301, DOI 10.1023/A:1014286728421; Auger C, 1998, J NEUROSCI, V18, P4532; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Banaji M, 2005, MATH BIOSCI, V194, P125, DOI 10.1016/j.mbs.2004.10.005; Banaji M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000212; Bennett MR, 2008, J THEOR BIOL, V252, P123, DOI 10.1016/j.jtbi.2008.01.022; Bennett MR, 2008, J THEOR BIOL, V250, P172, DOI 10.1016/j.jtbi.2007.08.024; Bojak I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041902; Buxton RB, 2012, NEUROIMAGE, V62, P953, DOI 10.1016/j.neuroimage.2012.01.012; Calvetti D, 2011, J THEOR BIOL, V274, P12, DOI 10.1016/j.jtbi.2010.12.007; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Chander BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048802; Cloutier M, 2009, J COMPUT NEUROSCI, V27, P391, DOI 10.1007/s10827-009-0152-8; Dubeau S, 2011, NEUROIMAGE, V57, P1480, DOI 10.1016/j.neuroimage.2011.04.030; Dvorzhak A, 2010, J PHYSIOL-LONDON, V588, P2351, DOI 10.1113/jphysiol.2010.187054; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Gaohua Lu, 2009, Theor Biol Med Model, V6, P26, DOI 10.1186/1742-4682-6-26; GARLIN AB, 1995, J NEUROCHEM, V64, P2572; Giove F, 2009, BIOPHYSICS BIOENGINE, V2, P1; Grimbert F, 2006, NEURAL COMPUT, V18, P3052, DOI 10.1162/neco.2006.18.12.3052; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hascup ER, 2010, J NEUROCHEM, V115, P1608, DOI 10.1111/j.1471-4159.2010.07066.x; Hascup KN, 2008, J PHARMACOL EXP THER, V324, P725, DOI 10.1124/jpet.107.131698; Heja L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007153; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Huneau C, 2013, EPILEPSIA, V54, P2219, DOI 10.1111/epi.12406; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; JANSEN BH, 1993, BIOL CYBERN, V68, P275, DOI 10.1007/BF00224863; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Jolivet R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004036; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kinney GA, 2002, J NEUROPHYSIOL, V88, P2899, DOI 10.1152/jn.00037.2002; Kowianski P, 2013, NEUROSCI RES, V75, P171, DOI 10.1016/j.neures.2013.01.014; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lee CCJ, 2009, J COMPUT NEUROSCI, V26, P459, DOI 10.1007/s10827-008-0122-6; Lee M, 2011, GLIA, V59, P1600, DOI 10.1002/glia.21202; Leybaert L, 2005, J CEREBR BLOOD F MET, V25, P2, DOI 10.1038/sj.jcbfm.9600001; LIU QR, 1993, J BIOL CHEM, V268, P2106; Lopes da Silva F, 2002, ENCY HUMAN BRAIN, P147; Losi G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00132; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Molaee-Ardekani B, 2010, NEUROIMAGE, V52, P1109, DOI 10.1016/j.neuroimage.2009.12.049; Mysona B, 2009, CELL TISSUE RES, V335, P477, DOI 10.1007/s00441-008-0742-1; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Occhipinti R, 2007, ANN BIOMED ENG, V35, P886, DOI 10.1007/s10439-007-9270-5; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Postnov DE, 2007, BIOSYSTEMS, V89, P84, DOI 10.1016/j.biosystems.2006.04.012; Reato D, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00081; Riera JJ, 2008, NEUROIMAGE, V40, P1436, DOI 10.1016/j.neuroimage.2007.12.051; Rowley NM, 2012, NEUROCHEM INT, V61, P546, DOI 10.1016/j.neuint.2012.02.013; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Sotero RC, 2008, NEUROIMAGE, V39, P290, DOI 10.1016/j.neuroimage.2007.08.001; Sotero RC, 2007, NEUROIMAGE, V35, P149, DOI 10.1016/j.neuroimage.2006.10.027; Suzuki K, 2001, J CELL SCI, V114, P3717; Tan J, 1999, J PHARMACOL EXP THER, V289, P1600; Uludag K, 2014, NEUROIMAGE; Vanzetta I, 2010, J NEUROPHYSIOL, V103, P3139, DOI 10.1152/jn.01048.2009; Vazquez AL, 2006, NEUROIMAGE, V32, P1642, DOI 10.1016/j.neuroimage.2006.04.195; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343; Wendling F, 2002, EUR J NEUROSCI, V15, P1499, DOI 10.1046/j.1460-9568.2002.01985.x; Wendling F, 2000, BIOL CYBERN, V83, P367, DOI 10.1007/s004220000160; White HS, 2002, J PHARMACOL EXP THER, V302, P636, DOI 10.1124/jpet.102.034819; Wolf F, 2008, SCIENCE, V320, P1597, DOI 10.1126/science.1160122; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200	77	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147292	10.1371/journal.pone.0147292	http://dx.doi.org/10.1371/journal.pone.0147292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849643	gold, Green Published			2022-12-26	WOS:000369554000012
J	Kim, DW; Kim, DK; Jo, A; Jin, HR; Eun, KM; Mo, JH; Cho, SH				Kim, Dae Woo; Kim, Dong-Kyu; Jo, Ara; Jin, Hong Ryul; Eun, Kyoung Mi; Mo, Ji-Hun; Cho, Seong H.			Age-Related Decline of Neutrophilic Inflammation Is Associated with Better Postoperative Prognosis in Non-eosinophilic Nasal Polyps	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; CHRONIC RHINOSINUSITIS; EXPRESSION; FEATURES; PROFILE	Background Innate and adaptive immune responses change with increasing age and affect the course of diseases. Previous study investigated immunologic alteration in Western nasal polyps (NP) which is mostly eosinophilic. However, there are no reports regarding age-related immune changes of non-eosinophilic NP (NE-NP) which is a predominant subtype in Asian population. Methods A total of 153 subjects, including 20 with control, 63 with chronic rhinosinusitis (CRS) without NP (CRSsNP), and 70 with CRS with NP were enrolled. Age-related changes in computed tomography (CT), cytokines and clinical information were investigated. Tissue samples were analyzed for protein levels of IL-5, IL-17A, IL-23, interferon (IFN)-gamma, CCL-11, and CXCL-8, using Luminex immunoassay and for mRNA expression levels of interleukin (IL)-5, IL-17A, IL-23p19, IFN-gamma, CCL-11, CXCL-1, CXCL-2, CXCL-8, and CXCR2 by quantitative RT-PCR. Immunohistochemistry (IHC) was performed for the number of inflammatory cells. Results We observed that Lund-Mackay CT scores decreased with age in NE-NP. The number of human neutrophil elastase-positive cells and myeloperoxidase gene expression decreased in older patients with NE-NP, but not in control subjects, CRSsNP, and E-NP. Neutrophil-associated cytokines including IL-17A and IL-23, were negatively correlated with age in NENP at the protein and mRNA levels. Additionally, the expression of CXCR2, a receptor for CXCL-1 and CXCL-2, was decreased with age in NE-NP. However, there were no age-related changes in blood neutrophil count, and neutrophil-recruiting chemokines such as CXCL-1, CXCL-2, and CXCL-8. Elderly NE-NP patients showed better endoscopic scores at 12 months after surgery compared with the non-elderly. Conclusion Age-related decline in neutrophil inflammation may favorably affect postoperative results in elderly patients with NE-NP.	[Kim, Dae Woo; Jin, Hong Ryul; Eun, Kyoung Mi] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Dae Woo; Jo, Ara; Cho, Seong H.] Univ S Florida, Coll Med, Dept Internal Med, Div Allergy Immunol, Tampa, FL 33612 USA; [Kim, Dong-Kyu] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon, South Korea; [Kim, Dong-Kyu] Hallym Univ, Coll Med, Nanobio Regenerat Med Inst, Chunchon, South Korea; [Mo, Ji-Hun] Dankook Univ, Coll Med, Dept Otorhinolaryngol, Cheonan, South Korea	Seoul National University (SNU); Seoul National University Hospital; State University System of Florida; University of South Florida; Hallym University; Hallym University; Dankook University	Cho, SH (corresponding author), Univ S Florida, Coll Med, Dept Internal Med, Div Allergy Immunol, Tampa, FL 33612 USA.	scho2@health.usf.edu	; Mo, Ji-Hun/E-5586-2011	Jo, Ara/0000-0002-2781-8529; Kim, Dong-Kyu/0000-0003-4917-0177; Mo, Ji-Hun/0000-0003-1331-364X	Ministry of Science, ICT and Future Planning [NRF-2014R1A1A1005598]; NIH [1K23AI110731]; American Heart Association [11SDG7590063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI110731] Funding Source: NIH RePORTER	Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dae Woo Kim has received the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2014R1A1A1005598). Seong H Cho has received grant support from NIH 1K23AI110731 and American Heart Association 11SDG7590063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Cao PP, 2014, CLIN EXP ALLERGY, V44, P690, DOI 10.1111/cea.12304; Cho SH, 2015, AM J RESP CELL MOL, V53, P601, DOI 10.1165/rcmb.2015-0207RC; Cho SH, 2012, J ALLERGY CLIN IMMUN, V129, P858, DOI 10.1016/j.jaci.2011.12.002; Dalboni TM, 2013, CYTOKINE, V61, P716, DOI 10.1016/j.cyto.2013.01.016; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Fulop T, 1997, MECH AGEING DEV, V96, P15, DOI 10.1016/S0047-6374(96)01881-7; Hanania NA, 2011, J ALLERGY CLIN IMMUN, V128, pS4, DOI 10.1016/j.jaci.2011.06.048; Hellquist HB, 1996, ALLERGY ASTHMA PROC, V17, P237, DOI 10.2500/108854196778662264; Kim DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139945; Kim DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111352; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Krings JG, 2014, LARYNGOSCOPE, V124, P838, DOI 10.1002/lary.24401; Lee JY, 2007, LARYNGOSCOPE, V117, P1084, DOI 10.1097/MLG.0b013e318058197a; Lund V J, 1995, Ann Otol Rhinol Laryngol Suppl, V167, P17; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Mahdavinia M, 2015, J ALLERGY CLIN IMMUN, V135, P576, DOI 10.1016/j.jaci.2014.08.031; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Payne SC, 2011, LARYNGOSCOPE, V121, P2262, DOI 10.1002/lary.21969; Pothoven KL, 2015, J ALLERGY CLIN IMMUN, V136, P737, DOI 10.1016/j.jaci.2015.01.043; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Shin JM, 2015, INT FORUM ALLERGY RH, V5, P541, DOI 10.1002/alr.21506; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Yu ZJ, 2015, INT FORUM ALLERGY RH, V5, P734, DOI 10.1002/alr.21530	26	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148442	10.1371/journal.pone.0148442	http://dx.doi.org/10.1371/journal.pone.0148442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849431	gold, Green Submitted, Green Published			2022-12-26	WOS:000369554000094
J	Picot, M; Billard, JM; Dombret, C; Albac, C; Karameh, N; Daumas, S; Hardin-Pouzet, H; Mhaouty-Kodja, S				Picot, Marie; Billard, Jean-Marie; Dombret, Carlos; Albac, Christelle; Karameh, Nida; Daumas, Stephanie; Hardin-Pouzet, Helene; Mhaouty-Kodja, Sakina			Neural Androgen Receptor Deletion Impairs the Temporal Processing of Objects and Hippocampal CA1-Dependent Mechanisms	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FREE TESTOSTERONE; COGNITIVE PERFORMANCE; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; PREFRONTAL CORTEX; GONADAL-HORMONES; DENDRITIC THORNS; NMDA RECEPTORS; SPATIAL MEMORY	We studied the role of testosterone, mediated by the androgen receptor (AR), in modulating temporal order memory for visual objects. For this purpose, we used male mice lacking AR specifically in the nervous system. Control and mutant males were gonadectomized at adulthood and supplemented with equivalent amounts of testosterone in order to normalize their hormonal levels. We found that neural AR deletion selectively impaired the processing of temporal information for visual objects, without affecting classical object recognition or anxiety-like behavior and circulating corticosterone levels, which remained similar to those in control males. Thus, mutant males were unable to discriminate between the most recently seen object and previously seen objects, whereas their control littermates showed more interest in exploring previously seen objects. Because the hippocampal CA1 area has been associated with temporal memory for visual objects, we investigated whether neural AR deletion altered the functionality of this region. Electrophysiological analysis showed that neural AR deletion affected basal glutamate synaptic transmission and decreased the magnitude of N-methyl-D-aspartate receptor (NMDAR) activation and high-frequency stimulation-induced long-term potentiation. The impairment of NMDAR function was not due to changes in protein levels of receptor. These results provide the first evidence for the modulation of temporal processing of information for visual objects by androgens, via AR activation, possibly through regulation of NMDAR signaling in the CA1 area in male mice.	[Picot, Marie; Dombret, Carlos; Albac, Christelle; Karameh, Nida; Daumas, Stephanie; Hardin-Pouzet, Helene; Mhaouty-Kodja, Sakina] Univ Paris 06, INSERM, Neurosci Paris Seine, Unite Mixte Rech UMR S1130, Paris, France; [Picot, Marie; Dombret, Carlos; Albac, Christelle; Karameh, Nida; Daumas, Stephanie; Hardin-Pouzet, Helene; Mhaouty-Kodja, Sakina] Univ Paris 06, CNRS, UMR 8246, Paris, France; [Picot, Marie; Dombret, Carlos; Albac, Christelle; Karameh, Nida; Daumas, Stephanie; Hardin-Pouzet, Helene; Mhaouty-Kodja, Sakina] Univ Paris 06, Sorbonne Univ, UM CR18, Paris, France; [Billard, Jean-Marie] Univ Paris 05, Ctr Psychiat & Neurosci, Sorbonne Paris Cite, UMR 894, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Mhaouty-Kodja, S (corresponding author), Univ Paris 06, INSERM, Neurosci Paris Seine, Unite Mixte Rech UMR S1130, Paris, France.; Mhaouty-Kodja, S (corresponding author), Univ Paris 06, CNRS, UMR 8246, Paris, France.; Mhaouty-Kodja, S (corresponding author), Univ Paris 06, Sorbonne Univ, UM CR18, Paris, France.	sakina.mhaouty-kodja@upmc.fr	Billard, Jean-Marie/ABD-4987-2020	Hardin-Pouzet, Helene/0000-0001-9401-2456; Mhaouty-Kodja, Sakina/0000-0001-9743-5243; Daumas, Stephanie/0000-0001-7048-7617; PICOT, Marie/0000-0002-5331-9723	Interdisciplinary Programme "Longevite et Vieillissement" of the Centre National de la Recherche Scientifique	Interdisciplinary Programme "Longevite et Vieillissement" of the Centre National de la Recherche Scientifique	This work was supported by a grant from the Interdisciplinary Programme "Longevite et Vieillissement" of the Centre National de la Recherche Scientifique.	Alexander GM, 1998, HORM BEHAV, V33, P85, DOI 10.1006/hbeh.1998.1439; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Ceccarelli I, 2001, BEHAV BRAIN RES, V123, P65, DOI 10.1016/S0166-4328(01)00195-4; Cherrier MM, 2002, J CLIN ENDOCR METAB, V87, P3090, DOI 10.1210/jc.87.7.3090; Cho J, 2015, SCIENCE, V350, P82, DOI 10.1126/science.aac7368; Day M, 2005, BEHAV BRAIN RES, V164, P128, DOI 10.1016/j.bbr.2005.05.011; Downes JJ, 2002, NEUROPSYCHOLOGIA, V40, P853, DOI 10.1016/S0028-3932(01)00172-5; Driscoll I, 2007, CURR ALZHEIMER RES, V4, P33, DOI 10.2174/156720507779939878; Edinger KL, 2004, BEHAV NEUROSCI, V118, P1352, DOI 10.1037/0735-7044.118.6.1352; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Frye CA, 2004, PSYCHONEUROENDOCRINO, V29, P1019, DOI 10.1016/j.psyneuen.2003.10.004; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Gibbs RB, 2008, ENDOCRINOLOGY, V149, P3176, DOI 10.1210/en.2007-1645; GOLDSTEIN JL, 1972, J CLIN INVEST, V51, P1647, DOI 10.1172/JCI106966; Golomb JD, 2008, MEM COGNITION, V36, P947, DOI 10.3758/MC.36.5.947; Gonzalez-Burgos I, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/309494; Hajszan T, 2007, ENDOCRINOLOGY, V148, P1963, DOI 10.1210/en.2006-1626; Handa RJ, 2008, HORM BEHAV, V53, P741, DOI 10.1016/j.yhbeh.2007.09.012; Hannesson DK, 2004, J NEUROSCI, V24, P4596, DOI 10.1523/JNEUROSCI.5517-03.2004; Harley CW, 2000, HIPPOCAMPUS, V10, P693; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hatanaka Y, 2009, BIOCHEM BIOPH RES CO, V381, P728, DOI 10.1016/j.bbrc.2009.02.130; Hauser E, 2009, BEHAV NEUROSCI, V123, P1339, DOI 10.1037/a0017681; Hoge J, 2007, NEUROBIOL LEARN MEM, V88, P225, DOI 10.1016/j.nlm.2007.04.013; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Howell S, 2001, HORM RES, V56, P86, DOI 10.1159/000048142; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Isgor C, 2003, J NEUROBIOL, V55, P179, DOI 10.1002/neu.10200; Janowsky JS, 2006, TRENDS COGN SCI, V10, P77, DOI 10.1016/j.tics.2005.12.010; Junjaud G, 2006, J NEUROCHEM, V98, P1159, DOI 10.1111/j.1471-4159.2006.03944.x; KERR JE, 1995, ENDOCRINOLOGY, V136, P3213, DOI 10.1210/en.136.8.3213; Kesner RP, 2010, BEHAV BRAIN RES, V215, P299, DOI 10.1016/j.bbr.2009.12.029; Kesner RP, 2010, NEUROBIOL LEARN MEM, V93, P111, DOI 10.1016/j.nlm.2009.08.010; Kimoto T, 2010, ENDOCRINOLOGY, V151, P5795, DOI 10.1210/en.2010-0581; Kollen M, 2010, NEUROBIOL AGING, V31, P129, DOI 10.1016/j.neurobiolaging.2008.03.010; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Leranth C, 2003, J NEUROSCI, V23, P1588; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Ooishi Y, 2012, J STEROID BIOCHEM, V131, P37, DOI 10.1016/j.jsbmb.2011.10.004; Packard MG, 1996, BEHAV NEUROSCI, V110, P626; Pause BM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00033; Pettorossi VE, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.185; Picot M, 2014, ENDOCRINOLOGY, V155, P502, DOI 10.1210/en.2013-1639; Potier B, 2000, EXP GERONTOL, V35, P1185, DOI 10.1016/S0531-5565(00)00122-4; Pouliot WA, 1996, SYNAPSE, V23, P10, DOI 10.1002/(SICI)1098-2396(199605)23:1<10::AID-SYN2>3.3.CO;2-Z; Raskin K, 2012, ENDOCRINOLOGY, V153, P3376, DOI 10.1210/en.2012-1001; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Rossbach UL, 2010, MOL CELL ENDOCRINOL, V314, P143, DOI 10.1016/j.mce.2009.07.027; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Skucas VA, 2013, J NEUROSCI, V33, P2338, DOI 10.1523/JNEUROSCI.3857-12.2013; Tanaka M, 2013, NEUROPHARMACOLOGY, V75, P262, DOI 10.1016/j.neuropharm.2013.07.029; Thilers PP, 2006, PSYCHONEUROENDOCRINO, V31, P565, DOI 10.1016/j.psyneuen.2005.12.005; Tsurugizawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1345, DOI 10.1016/j.bbrc.2005.09.188; Winkler JM, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-51; Zuloaga DG, 2008, HORM BEHAV, V54, P758, DOI 10.1016/j.yhbeh.2008.08.004	61	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148328	10.1371/journal.pone.0148328	http://dx.doi.org/10.1371/journal.pone.0148328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849367	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000069
J	Yano, S; Takehara, K; Miwa, S; Kishimoto, H; Hiroshima, Y; Murakami, T; Urata, Y; Kagawa, S; Bouvet, M; Fujiwara, T; Hoffman, RM				Yano, Shuya; Takehara, Kiyoto; Miwa, Shinji; Kishimoto, Hiroyuki; Hiroshima, Yukihiko; Murakami, Takashi; Urata, Yasuo; Kagawa, Shunsuke; Bouvet, Michael; Fujiwara, Toshiyoshi; Hoffman, Robert M.			Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model	PLOS ONE			English	Article							PATIENT; CELLS; PROTEIN; TUMORS	Fluorescence-guided surgery (FGS) of cancer is an area of intense development. In the present report, we demonstrate that the telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 could label colon-cancer liver metastasis in situ in an orthotopic mouse model enabling successful FGS. OBP-401-GFP-labeled liver metastasis resulted in complete resection with FGS, in contrast, conventional bright-light surgery (BLS) did not result in complete resection of the metastasis. OBP-401-FGS reduced the recurrence rate and prolonged over-all survival compared with BLS. In conclusion, adenovirus OBP-401 is a powerful tool to label liver metastasis in situ with GFP which enables its complete resection, not possible with conventional BLS.	[Yano, Shuya; Takehara, Kiyoto; Miwa, Shinji; Hiroshima, Yukihiko; Murakami, Takashi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Yano, Shuya; Takehara, Kiyoto; Miwa, Shinji; Hiroshima, Yukihiko; Murakami, Takashi; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Yano, Shuya; Takehara, Kiyoto; Kishimoto, Hiroyuki; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med, Dept Surg Gastroenterol, Okayama 7008530, Japan; [Urata, Yasuo] Oncolys BioPharm Inc, Tokyo, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Okayama University; Oncolys BioPharma	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA USA.; Hoffman, RM (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	all@anticancer.com	Yano, Shuya/AAL-8028-2020; Kagawa, Shunsuke/B-2189-2011; Miwa, Shinji/AAI-9309-2020	Miwa, Shinji/0000-0002-5962-8287; Kagawa, Shunsuke/0000-0002-3610-8211; Murakami, Takashi/0000-0002-9429-5705	National Cancer Institute [CA132971, CA142669]; Ministry of Education, Science and culture, Japan; Ministry of Health and Welfare, Japan; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Education, Science and culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grant numbers CA132971 and CA142669 to MB and by grants-in-Aid from the Ministry of Education, Science and culture, Japan and grants from the Ministry of Health and Welfare, Japan to TF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, MOL CANCER THER, V8, P3001, DOI 10.1158/1535-7163.MCT-09-0556; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Lintoiu-Ursut B, 2015, J Med Life, V8 Spec Issue, P12; Maawy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097965; Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Momiyama M, 2012, J SURG RES, V178, P280, DOI 10.1016/j.jss.2012.03.020; Murakami T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138752; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Yano S, 2015, CANCER GENE THER, V22, P344, DOI 10.1038/cgt.2015.26; Yano S, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2015-000096; Yano S, 2015, MOL THER, V23, P1182, DOI 10.1038/mt.2015.63; Yano S, 2015, ONCOTARGET, V6, P13133, DOI 10.18632/oncotarget.3811; Yano S, 2013, CLIN CANCER RES, V19, P6495, DOI 10.1158/1078-0432.CCR-13-0742	21	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148760	10.1371/journal.pone.0148760	http://dx.doi.org/10.1371/journal.pone.0148760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849435	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000166
J	Moles, A; Butterworth, JA; Sanchez, A; Hunter, JE; Leslie, J; Sellier, H; Tiniakos, D; Cockell, SJ; Mann, DA; Oakley, F; Perkins, ND				Moles, A.; Butterworth, J. A.; Sanchez, A.; Hunter, J. E.; Leslie, J.; Sellier, H.; Tiniakos, D.; Cockell, S. J.; Mann, D. A.; Oakley, F.; Perkins, N. D.			A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-kappa B-dependent liver regeneration and cancer	ONCOGENE			English	Article							ARF TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CELL-FUNCTION; P65; PHOSPHORYLATION; TRANSACTIVATION; INFLAMMATION; REPRESSION; DISEASE	Post-translational modifications of nuclear factor (NF)-kappa B subunits provide a mechanism to differentially regulate their activity in response to the many stimuli that induce this pathway. However, the physiological significance of these modifications is largely unknown, and it remains unclear if these have a critical role in the normal and pathological functions of NF-kappa B in vivo. Among these, phosphorylation of the RelA(p65) Thr505 residue has been described as an important regulator of NF-kappa B activity in cell lines, but its physiological significance was not known. Therefore, to learn more about the role of this pathway in vivo, we generated a knockin mouse with a RelA T505A mutation. Unlike RelA knockout mice, the RelA T505A mice develop normally but exhibit aberrant hepatocyte proliferation following liver partial hepatectomy or damage resulting from carbon tetrachloride (CCl4) treatment. Consistent with these effects, RelA T505A mice exhibit earlier onset of cancer in the N-nitrosodiethylamine model of hepatocellular carcinoma. These data reveal a critical pathway controlling NF-kappa B function in the liver that acts to suppress the tumour-promoting activities of RelA.	[Moles, A.; Leslie, J.; Tiniakos, D.; Mann, D. A.; Oakley, F.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Butterworth, J. A.; Sanchez, A.; Hunter, J. E.; Sellier, H.; Perkins, N. D.] Newcastle Univ, Fac Med Sci, Inst Cell & Mol Biosci ICaMB, Newcastle Upon Tyne, Tyne & Wear, England; [Cockell, S. J.] Newcastle Univ, Fac Med Sci, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Oakley, F; Perkins, ND (corresponding author), Newcastle Univ, Sch Med, Fac Med Sci, Inst Cell & Mol Biosci ICaMB, Catherine Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	fiona.oakley@ncl.ac.uk; neil.perkins@ncl.ac.uk	Moles, Ana/A-5889-2017; Tiniakos, Dina G/AAA-5708-2020; Sanchez, Ana M/K-4970-2016	Moles, Ana/0000-0002-3915-0060; Sanchez, Ana M/0000-0003-4293-4648; Mann, Derek/0000-0003-0950-243X; Oakley, Fiona/0000-0001-8692-1836; Cockell, Simon/0000-0002-6831-9806	Newcastle University; Wellcome Trust [094409]; Leukaemia Lymphoma Research Grant [11022]; Cancer Research UK Programme Grant [C1443/A12750]; Medical Research Council (MRC) [G0900535]; Welcome Trust Equipment Grant [087961]; MRC [G0900535, MR/K001949/1] Funding Source: UKRI; Cancer Research UK [22095, 12750] Funding Source: researchfish; Medical Research Council [MR/K001949/1, 1367534, G0900535] Funding Source: researchfish; National Centre for the Replacement [NC/K000748/1] Funding Source: researchfish	Newcastle University; Wellcome Trust(Wellcome TrustEuropean Commission); Leukaemia Lymphoma Research Grant; Cancer Research UK Programme Grant(Cancer Research UK); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welcome Trust Equipment Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	We would like to thank Adam Moore for technical assistance. We are also grateful to Sonia Rocha, Kirsteen Campbell, Niall Kenneth and all members of the NDP laboratory for helpful advice. AM is a Newcastle University Fellow funded by Newcastle University. JB and HS are funded by the Wellcome Trust Grant 094409, JEH is funded by Leukaemia Lymphoma Research Grant 11022, AS was funded by Cancer Research UK Programme Grant C1443/A12750. FO receives funding from Medical Research Council (MRC) Grant G0900535. The IVIS Spectrum system was funded by Welcome Trust Equipment Grant 087961.	Alexander J, 2013, J GASTROEN HEPATOL, V28, P848, DOI 10.1111/jgh.12116; Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hunter JE, 2015, ONCOGENE; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Mari M, 2008, GASTROENTEROLOGY, V134, P1507, DOI 10.1053/j.gastro.2008.01.073; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Msaki A, 2011, MOL BIOL CELL, V22, P3032, DOI 10.1091/mbc.E11-04-0280; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2009, BIOL CHEM, V390, P965, DOI 10.1515/BC.2009.111; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Ringelhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046469; Robinson SM, 2010, CLIN SCI, V118, P691, DOI 10.1042/CS20090549; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wilson CL, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms7818, 10.1038/ncomms9901]; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127	39	24	27	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4623	4632		10.1038/onc.2015.526	http://dx.doi.org/10.1038/onc.2015.526			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26853469	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000382336300008
J	Lee, JM; Lee, SH; Wang, JH; Oh, SJ; Kim, B; Jung, S; Shim, SH; Lin, PW; Lee, SB; Cho, MY; Koh, YJ; Kim, SY; Ahn, S; Lee, J; Kim, KM; Cheong, KH; Choi, J; Kim, KA				Lee, J. M.; Lee, S. H.; Wang, J-H; Oh, S. J.; Kim, B.; Jung, S.; Shim, S-h; Lin, P. W.; Lee, S. B.; Cho, M-Y; Koh, Y. J.; Kim, S. Y.; Ahn, S.; Lee, J.; Kim, K-m; Cheong, K. H.; Choi, J.; Kim, K-A			Novel strategy for a bispecific antibody: induction of dual target internalization and degradation	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; C-MET ANTIBODY; TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; RNA INTERFERENCE; IN-VIVO; THERAPY; MECHANISM; CETUXIMAB	Activation of the extensive cross-talk among the receptor tyrosine kinases (RTKs), particularly ErbB family-Met cross-talk, has emerged as a likely source of drug resistance. Notwithstanding brilliant successes were attained while using small-molecule inhibitors or antibody therapeutics against specific RTKs in multiple cancers over recent decades, a high recurrence rate remains unsolved in patients treated with these targeted inhibitors. It is well aligned with multifaceted properties of cancer and cross-talk and convergence of signaling pathways of RTKs. Thereby many therapeutic interventions have been actively developed to overcome inherent or acquired resistance. To date, no bispecific antibody (BsAb) showed complete depletion of dual RTKs from the plasma membrane and efficient dual degradation. In this manuscript, we report the first findings of a target-specific dual internalization and degradation of membrane RTKs induced by designed BsAbs based on the internalizing monoclonal antibodies and the therapeutic values of these BsAbs. Leveraging the anti-Met mAb able to internalize and degrade by a unique mechanism, we generated the BsAbs for Met/epidermal growth factor receptor (EGFR) and Met/HER2 to induce an efficient EGFR or HER2 internalization and degradation in the presence of Met that is frequently overexpressed in the invasive tumors and involved in the resistance against EGFR-or HER2-targeted therapies. We found that Met/EGFR BsAb ME22S induces dissociation of the Met-EGFR complex from Hsp90, followed by significant degradation of Met and EGFR. By employing patient-derived tumor models we demonstrate therapeutic potential of the BsAb-mediated dual degradation in various cancers.	[Lee, J. M.; Oh, S. J.; Kim, B.; Jung, S.; Kim, K-A] Samsung Bioepis Co Ltd, Open Innovat Team, 107 Chomdandaero, Inchon 406840, South Korea; [Lee, S. H.; Shim, S-h; Choi, J.] SAIT, Samsung Biomed Res Inst, Gyeonggi Do, South Korea; [Wang, J-H] Samsung Bioepis Co Ltd, Qual Evaluat Team, Bioassay Grp, Inchon, South Korea; [Lin, P. W.; Lee, S. B.] Samsung Bioepis Co Ltd, Cell Engn Team, Inchon, South Korea; [Cho, M-Y; Koh, Y. J.; Cheong, K. H.] SAIT, Gyeonggi Do, South Korea; [Kim, S. Y.; Lee, J.; Kim, K-m] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Ahn, S.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, KA (corresponding author), Samsung Bioepis Co Ltd, Open Innovat Team, 107 Chomdandaero, Inchon 406840, South Korea.	ka10.kim@samsung.com	Lee, Jee Yun/C-9646-2011; Lee, Ji Min/ABE-7494-2021	Lee, Ji Min/0000-0003-2978-2440				Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Annamalai B, 2009, MOL CANCER RES, V7, P1021, DOI 10.1158/1541-7786.MCR-08-0582; Castoldi R, 2013, ONCOGENE, V32, P5593, DOI 10.1038/onc.2013.245; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Doebele RC, 2010, LUNG CANCER, V69, P1, DOI 10.1016/j.lungcan.2009.12.009; Doody JF, 2007, MOL CANCER THER, V6, P2642, DOI 10.1158/1535-7163.MCT-06-0506; Duan Y, 2012, MOL IMMUNOL, V51, P188, DOI 10.1016/j.molimm.2012.03.015; Dulak AM, 2011, ONCOGENE, V30, P3625, DOI 10.1038/onc.2011.84; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Goffin JR, 2013, CLIN THER, V35, P1282, DOI 10.1016/j.clinthera.2013.08.007; Greenall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034658; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Ha SY, 2015, INT J CANCER, V136, P1629, DOI 10.1002/ijc.29159; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Karamouzis MV, 2009, LANCET ONCOL, V10, P709, DOI 10.1016/S1470-2045(09)70137-8; Kim B, 2015, ONCOGENE, V34, P1083, DOI 10.1038/onc.2014.51; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111693; Krishnamoorthy GP, 2013, J BIOL CHEM, V288, P17481, DOI 10.1074/jbc.M112.439422; Lee JM, 2014, ONCOGENE, V33, P34, DOI 10.1038/onc.2012.551; Lee JY, 2015, ONCOTARGET, V6, P25619, DOI 10.18632/oncotarget.4627; Lin L., 2012, CHEMOTHER RES PRACT, V2012, DOI DOI 10.1155/2012/817297; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-0568; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Modjtahedi H, 1996, BRIT J CANCER, V73, P228, DOI 10.1038/bjc.1996.40; Oh YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04980; Oh YM, 2012, MOL CELLS, V34, P523, DOI 10.1007/s10059-012-0194-z; Pai SI, 2006, GENE THER, V13, P464, DOI 10.1038/sj.gt.3302694; REITER Y, 1994, BIOCHEMISTRY-US, V33, P5451, DOI 10.1021/bi00184a014; Reungwetwattana Thanyanan, 2013, J Carcinog, V12, P22, DOI 10.4103/1477-3163.123972; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Sgambato A, 2012, CURR PHARM DESIGN, V18, P6155, DOI 10.2174/138161212803582478; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Stevenson M, 2004, NEW ENGL J MED, V351, P1772, DOI 10.1056/NEJMra045004; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Troiani T, 2013, CLIN CANCER RES, V19, P6751, DOI 10.1158/1078-0432.CCR-13-0423; Weatherill EE, 2012, PROTEIN ENG DES SEL, V25, P321, DOI 10.1093/protein/gzs021; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Yang HY, 2009, MOL CELLS, V27, P225, DOI 10.1007/s10059-009-0028-9; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	48	15	15	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4437	4446		10.1038/onc.2015.514	http://dx.doi.org/10.1038/onc.2015.514			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26853467				2022-12-26	WOS:000382153100002
J	Harada, Y; Huang, CC; Yamaki, S; Dohmae, N; Suzuki, T				Harada, Yoichiro; Huang, Chengcheng; Yamaki, Satoshi; Dohmae, Naoshi; Suzuki, Tadashi			Non-lysosomal Degradation of Singly Phosphorylated Oligosaccharides Initiated by the Action of a Cytosolic Endo--N-acetylglucosaminidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; endoplasmic reticulum (ER); glycobiology; N-linked glycosylation; oligosaccharide; dolichol-linked oligosaccharides; endo--N-acetylglucosaminidase; non-lysosomal glycan degradation; phosphorylated oligosaccharides	POLYMANNOSE-TYPE OLIGOSACCHARIDES; DOLICHOL-LINKED OLIGOSACCHARIDES; GLUCOSE STARVATION; SACCHAROMYCES-CEREVISIAE; GLYCOSYLATION; IDENTIFICATION; GENE; ER; FIBROBLASTS; GENERATION	Phosphorylated oligosaccharides (POSs) are produced by the degradation of dolichol-linked oligosaccharides (DLOs) by an unclarified mechanism in mammalian cells. Although POSs are exclusively found in the cytosol, their intracellular fates remain unclear. Our findings indicate that POSs are catabolized via a non-lysosomal glycan degradation pathway that involves a cytosolic endo--N-acetylglucosaminidase (ENGase). Quantitative and structural analyses of POSs revealed that ablation of the ENGase results in the significant accumulation of POSs with a hexasaccharide structure composed of Man1,2Man1,3(Man1,6)Man1,4GlcNAc1,4GlcNAc. In vitro ENGase assays revealed that the presence of an 1,2-linked mannose residue facilitates the hydrolysis of POSs by the ENGase. Liquid chromatography-mass spectrometric analyses and fluorescent labeling experiments show that such POSs contain one phosphate group at the reducing end. These results indicate that ENGase efficiently hydrolyzes POSs that are larger than Man(4)GlcNAc(2)-P, generating GlcNAc-1-P and neutral Gn1-type free oligosaccharides. These results provide insight into important aspects of the generation and degradation of POSs.	[Harada, Yoichiro; Huang, Chengcheng; Suzuki, Tadashi] RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Glycometabolome Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Yamaki, Satoshi] Shimadzu Co Ltd, Analyt & Measuring Instruments Div, Global Applicat Dev Ctr, Hadano, Kanagawa 2591304, Japan; [Dohmae, Naoshi] RIKEN Global Res Cluster, Collaborat Promot Unit, Wako, Saitama 3510198, Japan; [Harada, Yoichiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Sakuragaoka, Kagoshima 8908544, Japan	RIKEN; Shimadzu Corporation; RIKEN; Kagoshima University	Suzuki, T (corresponding author), RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Glycometabolome Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Dohmae, Naoshi/C-2040-2011; Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014; huang, chengcheng/GRX-5340-2022	Dohmae, Naoshi/0000-0002-5242-9410; Suzuki, Tadashi/0000-0003-1030-7631; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24770134, 26650040, 25291030]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 24770134 and 26650040 (to Y. H.) and 25291030 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Albrecht S, 2014, BRIT J NUTR, V111, P1313, DOI 10.1017/S0007114513003772; BAUMANN H, 1983, J BIOL CHEM, V258, P3942; BELARD M, 1988, BIOCHEM J, V255, P235; CACAN R, 1980, EUR J BIOCHEM, V106, P473, DOI 10.1111/j.1432-1033.1980.tb04594.x; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; Doerrler WT, 1999, P NATL ACAD SCI USA, V96, P13050, DOI 10.1073/pnas.96.23.13050; Dwivedi R, 2013, BIOPOLYMERS, V99, P772, DOI 10.1002/bip.22296; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; GERSHMAN H, 1981, J BIOL CHEM, V256, P7774; Haga Y, 2009, GLYCOBIOLOGY, V19, P987, DOI 10.1093/glycob/cwp075; Harada Y, 2015, GLYCOBIOLOGY, V25, P1196, DOI 10.1093/glycob/cwv055; Harada Y, 2015, CELL MOL LIFE SCI, V72, P2509, DOI 10.1007/s00018-015-1881-7; Harada Y, 2013, P NATL ACAD SCI USA, V110, P19366, DOI 10.1073/pnas.1312187110; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; HASE S, 1979, J BIOCHEM-TOKYO, V85, P989, DOI 10.1093/oxfordjournals.jbchem.a132431; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hirayama H, 2015, SEMIN CELL DEV BIOL, V41, P110, DOI 10.1016/j.semcdb.2014.11.009; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Huang CC, 2015, P NATL ACAD SCI USA, V112, P1398, DOI 10.1073/pnas.1414593112; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 1997, J BIOCHEM, V122, P1167, DOI 10.1093/oxfordjournals.jbchem.a021877; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Peric D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011675; REARICK JI, 1981, J BIOL CHEM, V256, P6255; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Rose MD., 1990, METHODS YEAST GENETI; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Seino J, 2013, J BIOL CHEM, V288, P26898, DOI 10.1074/jbc.M113.464503; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2015, J BIOCHEM, V157, P23, DOI 10.1093/jb/mvu068; Suzuki T, 2014, BIOCHEM BIOPH RES CO, V453, P213, DOI 10.1016/j.bbrc.2014.05.075; TURCO SJ, 1982, J BIOL CHEM, V257, P8674; Vleugels W, 2011, BIOCHIMIE, V93, P823, DOI 10.1016/j.biochi.2011.01.016	41	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8048	8058		10.1074/jbc.M115.685313	http://dx.doi.org/10.1074/jbc.M115.685313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26858256	hybrid, Green Published			2022-12-26	WOS:000374056700024
J	Lombard, R; Doz, E; Carreras, F; Epardaud, M; Le Vern, Y; Buzoni-Gatel, D; Winter, N				Lombard, Robin; Doz, Emilie; Carreras, Florence; Epardaud, Mathieu; Le Vern, Yves; Buzoni-Gatel, Dominique; Winter, Nathalie			IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune Response	PLOS ONE			English	Article							PULMONARY HOST-DEFENSE; CD4 T-CELLS; TUBERCULOSIS INFECTION; VACCINATION; RECEPTOR; BCG; INTERLEUKIN-17; GRANULOMA; FAMILY; INFLAMMATION	During chronic infection with Mycobacterium tuberculosis (Mtb), bacilli multiplication is constrained within lung granulomas until excessive inflammation destroys the lung. Neutrophils are recruited early and participate in granuloma formation, but excessive neutrophilia exacerbates the tuberculosis disease. Neutrophils thus appear as potential targets for therapeutic interventions, especially in patients for whom no antibiotic treatment is possible. Signals that regulate neutrophil recruitment to the lung during mycobacterial infection need to be better understood. We demonstrated here, in the mouse model, that neutrophils were recruited to the lung in two waves after intranasal infection with virulent Mtb or the live attenuated vaccine strain Bacillus Calmette Guerin (BCG). A first wave of neutrophils was swiftly recruited, followed by a subsequent adaptive wave that reached the lung together with IFN-gamma and IL-17A-producing T cells. Interestingly, the second neutrophil wave did not participate to mycobacteria control in the lung and established contacts with T cells. The adaptive wave was critically dependent on the expression of IL-17RA, the receptor for IL-17A, expressed in non-hematopoietic cells. In absence of this receptor, curtailed CXCL-1 and 5 production in the lung restrained neutrophil recruitment. CXCL-1 and 5 instillation reconstituted lung neutrophil recruitment in BCG-infected IL17RA-/- mice.	[Lombard, Robin; Doz, Emilie; Carreras, Florence; Epardaud, Mathieu; Le Vern, Yves; Buzoni-Gatel, Dominique; Winter, Nathalie] Univ Tours, INRA, UMR 1282, Infectiol & Sante Publ, Nouzilly, France	INRAE; Universite de Tours	Winter, N (corresponding author), Univ Tours, INRA, UMR 1282, Infectiol & Sante Publ, Nouzilly, France.	nathalie.winter@tours.inra.fr	Winter, Nathalie/U-2690-2018	Winter, Nathalie/0000-0003-0994-7834; Doz-Deblauwe, Emilie/0000-0002-3126-4004	gence Nationale pour la Recherche (FR) Grant [ANR-008-MIEN-00117MycImPact]; Region Centre (FR) [2013-00085470]	gence Nationale pour la Recherche (FR) Grant; Region Centre (FR)(Region Centre-Val de Loire)	This work was supported by the Agence Nationale pour la Recherche (FR) Grant No ANR-008-MIEN-00117MycImPact to NW, the Region Centre (FR) 2013-00085470 to NW and the Region Centre (FR) fellowship to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; APPELBERG R, 1992, IMMUNOLOGY, V75, P414; APPELBERG R, 1989, CLIN EXP IMMUNOL, V78, P478; APPLEBERG R, 1991, Clinical and Experimental Immunology, V83, P231; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Aujla SJ, 2007, EXP LUNG RES, V33, P507, DOI 10.1080/01902140701756604; Basile JI, 2011, J INFECT DIS, V204, P1054, DOI 10.1093/infdis/jir460; Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR; BLOCH H, 1955, AM REV TUBERC PULM, V71, P228; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Chen SC, 2001, J IMMUNOL, V166, P3362, DOI 10.4049/jimmunol.166.5.3362; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Doz E, 2013, J IMMUNOL, V191, P3818, DOI 10.4049/jimmunol.1300527; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fine PEM, 2001, SCAND J INFECT DIS, V33, P243, DOI 10.1080/003655401300077144; Freches D, 2013, IMMUNOLOGY, V140, P220, DOI 10.1111/imm.12130; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gheorghiu M, 1988, J BIOL STAND, V16, P168; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Lopez A, 1984, BRIT J HAEMATOL, V184, P489; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Martino A, 2011, NEUTROPHILS IN INFECTIOUS DISEASES, P42; Martino A, 2010, J IMMUNOL, V184, P2038, DOI 10.4049/jimmunol.0903348; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nouailles G, 2014, J CLIN INVEST, V124, P1268, DOI 10.1172/JCI72030; ORME IM, 1988, INFECT IMMUN, V56, P3310, DOI 10.1128/IAI.56.12.3310-3312.1988; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	45	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149455	10.1371/journal.pone.0149455	http://dx.doi.org/10.1371/journal.pone.0149455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871571	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100160
J	Schmitt, M; Boras, S; Tjoa, A; Watanabe, T; Jansen, S				Schmitt, Marco; Boras, Sven; Tjoa, Aiyen; Watanabe, Toshihiro; Jansen, Steven			Aluminium Accumulation and Intra-Tree Distribution Patterns in Three Arbor aluminosa (Symplocos) Species from Central Sulawesi	PLOS ONE			English	Article							MELASTOMA-MALABATHRICUM; INTERNAL DETOXIFICATION; ACID SOILS; PLANTS; RESISTANCE; TOXICITY; GROWTH; ROOT; AL; HYPERACCUMULATION	Accumulation of Aluminium (Al) at concentrations far above 1,000 mg kg(-1) in aboveground plant tissues of Arbor aluminosa (Symplocos) species is the main reason why traditional Indonesian weavers rely on their leaves and bark as a mordant for dyeing textile. Recently, Symplocos species have become a flagship species for the conservation efforts of weaving communities due to their traditionally non-sustainable sampling and increasing demand for Symplocos plant material. Here we investigated Symplocos odoratissima, S. ophirensis and S. ambangensis at three montane rainforest sites in Central Sulawesi to measure Al levels in different tissues and organs. The highest Al concentrations were found in old leaves (24,180 +/- 7,236 mg.kg(-1) dry weight, mean +/- SD), while young leaves had significantly lower Al levels (20,708 +/- 7,025 mg.kg(-1)). Al accumulation was also lower in bark and wood tissue of the trunk (17,231 +/- 8,356 mg.kg(-1) and 5,181 +/- 2,032 mg.kg(-1), respectively). Two Al excluding species (Syzigium sp. and Lithocarpus sp.) contained only high Al levels in their roots. Moreover, no difference was found in soil pH (4.7 +/- 0.61) and nutrient (K, Ca, Fe, Mg) availability at different soil levels and within or outside the crown of Symplocos trees, except for the upper soil layer. Furthermore, a positive and significant correlation between Al and Ca concentrations was found at the whole plant level for Symplocos, and at the leaf level for S. ophirensis and S. ambangensis, suggesting a potential role of Ca in Al uptake and/or detoxification within the plant. Our results provide evidence for strong Al accumulation in Symplocos species and illustrate that both Al accumulation and exclusion represent two co-occurring strategies of montane rainforest plants for dealing with Al toxicity. Indonesian weavers should be encouraged to harvest old leaves, which have the most efficient mordant capacity due to high Al concentrations.	[Schmitt, Marco; Boras, Sven; Jansen, Steven] Univ Ulm, Inst Systemat Bot & Ecol, D-89069 Ulm, Germany; [Tjoa, Aiyen] Tadulako Univ, Fac Agr, Palu, Indonesia; [Watanabe, Toshihiro] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan	Ulm University; Universitas Tadulako; Hokkaido University	Jansen, S (corresponding author), Univ Ulm, Inst Systemat Bot & Ecol, D-89069 Ulm, Germany.	steven.jansen@uni-ulm.de	Watanabe, Toshihiro/AAT-6071-2021; Jansen, Steven/A-9868-2012	Watanabe, Toshihiro/0000-0003-4466-811X; Jansen, Steven/0000-0002-4476-5334	Ministry for Science, Research and the Arts of Baden-Wurttemberg; Grants-in-Aid for Scientific Research [15K14673, 15H04465] Funding Source: KAKEN	Ministry for Science, Research and the Arts of Baden-Wurttemberg; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank the Ministry for Science, Research and the Arts of Baden-Wurttemberg for financial support to SJ (Zukunftsoffensive IV Juniorprofessoren-Programm; https://mwk.badenwuerttemberg.de/de/startseite/).	Akashi N, 1999, FOREST ECOL MANAG, V113, P75, DOI 10.1016/S0378-1127(98)00415-0; Baker AJM, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P85; BAKER AJM, 1981, J PLANT NUTR, V3, P643, DOI 10.1080/01904168109362867; Barberon M, 2014, PLANT PHYSIOL, V166, P528, DOI 10.1104/pp.114.246124; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Boyd RS, 2007, PLANT SOIL, V293, P153, DOI 10.1007/s11104-007-9240-6; Brunner I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00172; Burkill IH, 2002, DICT EC PRODUCTS MAL, VI; Burkill IH, 2002, DICT EC PRODUCTS MAL, VII; CHENERY E. M., 1948, Kew Bulletin, P173, DOI 10.2307/4119757; Chenery EM., 1949, KEW B, V4, P463, DOI DOI 10.2307/4109057; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Culmsee H, 2009, BLUMEA, V54, P119, DOI 10.3767/000651909X475473; Culmsee H, 2011, BIODIVERS CONSERV, V20, P1103, DOI 10.1007/s10531-011-0019-y; Cunningham AB, 2011, ECON BOT, V65, P241, DOI 10.1007/s12231-011-9161-4; Driessen F, 1902, REV GEN MAT COLOR, V6, P252; Freeman JL, 2009, AM J BOT, V96, P1075, DOI 10.3732/ajb.0800287; Fung KF, 2008, J SCI FOOD AGR, V88, P1582, DOI 10.1002/jsfa.3254; Grevenstuk T, 2013, METALLOMICS, V5, P1584, DOI 10.1039/c3mt00232b; HARIDASAN M, 1988, FOREST ECOL MANAG, V24, P15, DOI 10.1016/0378-1127(88)90021-7; HARIDASAN M, 1987, CAPACIDAD BIOPRODUCT, P309; Haridasan Mundayatan, 2008, Braz. J. Plant Physiol., V20, P183, DOI 10.1590/S1677-04202008000300003; HUANG JWW, 1992, PLANTA, V188, P414, DOI 10.1007/BF00192809; HUTCHINSON GE, 1945, SOIL SCI, V60, P29, DOI 10.1097/00010694-194507000-00004; Hutchinson GE, 1943, Q REV BIOL, V18, P1, DOI 10.1086/394666; Hutchinson GE, 1943, T CONN ACAD ARTS SCI, V35, P73; Jansen S, 2004, PLANT BIOLOGY, V6, P498, DOI 10.1055/s-2004-820980; Jansen S, 2002, ANN BOT-LONDON, V90, P53, DOI 10.1093/aob/mcf142; Jansen S, 2002, BOT REV, V68, P235, DOI 10.1663/0006-8101(2002)068[0235:AHIAAR]2.0.CO;2; KINRAIDE TB, 1991, PLANT SOIL, V134, P167, DOI 10.1007/BF00010729; Kinraide TB, 1997, J EXP BOT, V48, P1115, DOI 10.1093/jxb/48.5.1115; KIRKBY EA, 1984, PLANT CELL ENVIRON, V7, P397, DOI 10.1111/j.1365-3040.1984.tb01429.x; Klug B, 2010, NEW PHYTOL, V187, P380, DOI 10.1111/j.1469-8137.2010.03288.x; Kochian LV, 2015, ANNU REV PLANT BIOL, V66, P571, DOI 10.1146/annurev-arplant-043014-114822; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kochian LV, 2002, PLANT SOIL, V247, P109, DOI 10.1023/A:1021141212073; Lemmens RHMJ, 1992, DYE TANNIN PRODUCING; Ma JF, 1997, NATURE, V390, P569, DOI 10.1038/37518; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; Ma JF, 1997, PLANT PHYSIOL, V113, P1033, DOI 10.1104/pp.113.4.1033; Ma JF, 2000, PLANTA, V211, P355, DOI 10.1007/s004250000292; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Maejima E, 2014, BOTANY, V92, P327, DOI 10.1139/cjb-2013-0298; MARSCHNER H, 1987, J PLANT NUTR, V10, P1175, DOI 10.1080/01904168709363645; Martens SN, 2002, AM J BOT, V89, P998, DOI 10.3732/ajb.89.6.998; Masunaga T, 1998, SOIL SCI PLANT NUTR, V44, P315, DOI 10.1080/00380768.1998.10414454; MATSUMOTO H, 1976, PLANT CELL PHYSIOL, V17, P627; Mazen AMA, 2004, RUSS J PLANT PHYSL+, V51, P281, DOI 10.1023/B:RUPP.0000019226.03536.21; Medeiros R. A. de, 1985, Plant and Soil, V88, P433, DOI 10.1007/BF02197499; MEDINA E, 1990, J BIOGEOGR, V17, P403, DOI 10.2307/2845370; Meharg AA, 2003, NEW PHYTOL, V157, P25, DOI 10.1046/j.1469-8137.2003.00541.x; Meharg AA, 2002, NEW PHYTOL, V156, P1, DOI 10.1046/j.1469-8137.2002.00513.x; Metali F, 2015, NEW PHYTOL, V205, P280, DOI 10.1111/nph.12987; Metali F, 2012, NEW PHYTOL, V193, P637, DOI 10.1111/j.1469-8137.2011.03965.x; Mundim FM, 2009, ENTOMOL EXP APPL, V130, P47, DOI 10.1111/j.1570-7458.2008.00789.x; Nguyen NT, 2003, TREE PHYSIOL, V23, P1041, DOI 10.1093/treephys/23.15.1041; Pogue AL, 2014, FRONT NEUROL, V5, DOI [10.3389/fneur.2014.00262, 10.3389/fneur.2014.00043]; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; Radlkofer L, 1904, BER DEUT BOT GES, V22, P216; Reeves RD, 2000, PHYTOREMEDIATION OF TOXIC METALS, P193; Rehmus A, 2014, PLANT SOIL, V382, P301, DOI 10.1007/s11104-014-2110-0; Rengel Z, 2015, J SOIL SCI PLANT NUT, V15, P397; Serrano HC, 2015, J PLANT ECOL, V8, P41, DOI 10.1093/jpe/rtu007; Tolra R, 2011, J PLANT RES, V124, P165, DOI 10.1007/s10265-010-0344-3; Von Faber F.C, 1925, FLORA, V118, P89; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Watanabe T, 1998, PLANT SOIL, V201, P165, DOI 10.1023/A:1004341415878; Watanabe T, 2005, CAN J BOT, V83, P1518, DOI 10.1139/b05-111; Watanabe T, 2005, NEW PHYTOL, V165, P773, DOI 10.1111/j.1469-8137.2004.01261.x; Watanabe T, 2001, PLANT SOIL, V237, P63, DOI 10.1023/A:1013395814958; Watanabe T, 1997, SOIL SCI PLANT NUTR, V43, P827, DOI 10.1080/00380768.1997.10414649; Watanabe T, 2007, NEW PHYTOL, V174, P516, DOI 10.1111/j.1469-8137.2007.02078.x; Watanabe T, 2006, PLANT CELL ENVIRON, V29, P2124, DOI 10.1111/j.1365-3040.2006.001586.x; WEBB L. J., 1954, AUSTRALIAN JOUR BOT, V2, P176, DOI 10.1071/BT9540176; Wehnert A., 1906, ANATOMISCH SYSTEMATI; YOSHII Y., 1932, SCI REPT TOHOKU IMP UNIV [SER 4], V7, P65; Zeng QL, 2013, TREE PHYSIOL, V33, P96, DOI 10.1093/treephys/tps117	79	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149078	10.1371/journal.pone.0149078	http://dx.doi.org/10.1371/journal.pone.0149078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871698	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100098
J	Kim, S; Kim, Y; Park, SM				Kim, Sujin; Kim, Yongjoo; Park, Sang Min			Body Mass Index and Decline of Cognitive Function	PLOS ONE			English	Article							LATE-LIFE; DEPRESSIVE SYMPTOMS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; INCIDENT DEMENTIA; KEY ROLE; RISK; OBESITY; METAANALYSIS; OVERWEIGHT	Background The association between body mass index (BMI) and cognitive function is a public health issue. This study investigated the relationship between obesity and cognitive impairment which was assessed by the Korean version of the Mini-mental state examination (K-MMSE) among mid- and old-aged people in South Korea. Methods A cohort of 5,125 adults, age 45 or older with normal cognitive function (K-MMSE >= 24) at baseline (2006), was derived from the Korean Longitudinal Study of Aging (KLoSA) 2006 similar to 2012. The association between baseline BMI and risk of cognitive impairment was assessed using multiple logistic regression models. We also assessed baseline BMI and change of cognitive function over the 6-year follow-up using multiple linear regressions. Results During the follow-up, 358 cases of severe cognitive impairment were identified. Those with baseline BMI >= 25 kg/m(2) than normal-weight (18.5 >= BMI<23 kg/m(2)) were marginally less likely to experience the development of severe cognitive impairment (adjusted odds ratio [aOR] = 0.73, 95% CI = 0.52 to 1.03; P-trend = 0.03). This relationship was stronger among female (aOR = 0.63, 95% CI = 0.40 to 1.00; P-trend = 0.01) and participants with low-normal K-MMSE score (MMSE: 24-26) at baseline (aOR = 0.59, 95% CI = 0.35 to 0.98; P-trend<0.01). In addition, a slower decline of cognitive function was observed in obese individuals than those with normal weight, especially among women and those with low-normal K-MMSE score at baseline. Conclusion In this nationally representative study, we found that obesity was associated with lower risk of cognitive decline among mid- and old-age population.	[Kim, Sujin; Park, Sang Min] Harvard Univ, TH Chan Sch Publ Hlth, Takemi Program Int Hlth, Boston, MA 02115 USA; [Kim, Yongjoo] Harvard Univ, TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Seoul National University (SNU); Seoul National University (SNU)	Park, SM (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Takemi Program Int Hlth, Boston, MA 02115 USA.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.	smpark.snuh@gmail.com	Kim, Yongjoo/N-9751-2019; Park, Sang Min/V-9194-2019	Kim, Yongjoo/0000-0002-0768-9256; Kim, Sujin/0000-0002-4251-6318				Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Aslan AKD, 2015, AGE AGEING, V44, P59, DOI 10.1093/ageing/afu108; Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Brayne C, 2005, NEUROBIOL AGING, V26, pS6, DOI 10.1016/j.neurobiolaging.2005.09.030; Bryant AN, 2014, AM J GERIAT PSYCHIAT, V22, P653, DOI 10.1016/j.jagp.2013.08.006; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chen HL, 2009, AM J EPIDEMIOL, V169, P1064, DOI 10.1093/aje/kwp033; Coin A, 2012, J NUTR HEALTH AGING, V16, P553, DOI 10.1007/s12603-012-0052-x; Dahl AK, 2013, INT J OBESITY, V37, P296, DOI 10.1038/ijo.2012.37; Dahl AK, 2013, EPIDEMIOL REV, V35, P22, DOI 10.1093/epirev/mxs002; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Douketis JD, 2005, CAN MED ASSOC J, V172, P995, DOI 10.1503/cmaj.045170; Emmerzaal TL, 2015, J ALZHEIMERS DIS, V43, P739, DOI 10.3233/JAD-141086; Euser SM, 2009, SERUM URIC ACID AND; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Folstein MF, 2005, HYPERTENSION, V46, P654; Han Changsu, 2009, Arch Gerontol Geriatr, V49, pe133, DOI 10.1016/j.archger.2008.11.005; Hughes TF, 2009, NEUROLOGY, V72, P1741, DOI 10.1212/WNL.0b013e3181a60a58; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kohler S, 2010, J AM GERIATR SOC, V58, P873, DOI 10.1111/j.1532-5415.2010.02807.x; Korea Labor Institutue, 2007, US GUID 2007 KLOSA; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Luchsinger JA, ADIPOSITY ALZHEIMERE; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Nourhashash, 2002, CMAJ, V50, P1796; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Prickett C, 2015, OBES RES CLIN PRACT, V9, P93, DOI 10.1016/j.orcp.2014.05.001; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P431, DOI 10.1016/S2213-8587(15)00033-9; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Schuurman AG, 2002, NEUROLOGY, V58, P1501, DOI 10.1212/WNL.58.10.1501; Sergi G, 2005, J GERONTOL A-BIOL, V60, P866, DOI 10.1093/gerona/60.7.866; Shen CC, 2013, NEUROLOGY, V81, P1538, DOI 10.1212/WNL.0b013e3182a956ad; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Suemoto CK, 2015, INT J OBESITY, V39, P1383, DOI 10.1038/ijo.2015.83; Suk SH, 2003, STROKE, V34, P1586, DOI 10.1161/01.STR.0000075294.98582.2F; Thomas F, 2005, HYPERTENSION, V46, P654, DOI 10.1161/01.HYP.0000184282.51550.00; Tolppanen AM, 2014, J ALZHEIMERS DIS, V38, P201, DOI 10.3233/JAD-130698; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Xiang XL, 2015, ARCH GERONTOL GERIAT, V60, P394, DOI 10.1016/j.archger.2015.02.008; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Yaffe K, 1999, ARCH GEN PSYCHIAT, V56, P425, DOI 10.1001/archpsyc.56.5.425; Yoon K, 2014, ARCH GERONTOL GERIAT, V59, P584, DOI 10.1016/j.archger.2014.08.008	52	51	53	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148908	10.1371/journal.pone.0148908	http://dx.doi.org/10.1371/journal.pone.0148908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867138	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700045
J	Sun, JR; Zhang, XC; Cao, YN; Zhao, QL; Bao, ED; Lv, YJ				Sun, Jiarui; Zhang, Xinchen; Cao, Yinan; Zhao, Qiling; Bao, Endong; Lv, Yingjun			Ovarian Toxicity in Female Rats after Oral Administration of Melamine or Melamine and Cyanuric Acid	PLOS ONE			English	Article							DOSE-RESPONSE ASSESSMENT; REPRODUCTIVE TOXICITY; OXIDATIVE STRESS; COMBINED-EXPOSURE; NRK-52E CELLS; F344 RATS; MICE; APOPTOSIS; NEPHROTOXICITY; PATHWAY	Although the toxicity of melamine to the kidneys and testes is well known, few studies have investigated the effects of melamine on female reproductive organs. Therefore, this study explores the effects of oral administration melamine or melamine and cyanuric acid for 28 days on the ovaries of female rats. Rats that were exposed to the mixture exhibited reduced ovarian and uterine weights, a shorter estrous cycle, and reduced serum estrogen and progesterone levels compared to rats that were exposed to melamine and control rats. Furthermore, morphological analysis revealed pathological changes in the ovaries of rats exposed to melamine or the mixture, such as more atretic follicles and necrosis of oocytes and granulosa cells. TUNEL staining revealed that the exposed groups had a higher proportion of TUNEL-positive granulosa cells than the control group, and the mRNA expressions of SOD1, GPX1, GPX2, P450scc, 17 beta-HSD I, and 17 beta-HSD II were reduced in the exposure groups compared with the control group. These results indicated that exposure to melamine alone or to the melamine-cyanuric acid mixture could damage the ovaries in rats.	[Sun, Jiarui; Zhang, Xinchen; Cao, Yinan; Zhao, Qiling; Bao, Endong; Lv, Yingjun] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Lv, YJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	lyj@njau.edu.cn			Natural Science Foundation of China [31101786]; National Key Basic Research Program of China (973 Program) [2014CB138502]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Natural Science Foundation of China, http://www.nsfc.gov.cn/, number: 31101786, receiver: YL; National Key Basic Research Program of China (973 Program), http://www.973.gov.cn/, number: 2014CB138502, receiver: EB; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), http:// jsycw.ec.js.edu.cn/, number: none, receiver: YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Natural Science Foundation of China (31101786), the National Key Basic Research Program of China (973 Program) (2014CB138502) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	ALLEN LM, 1982, DRUG METAB REV, V13, P499, DOI 10.3109/03602538209029992; Berisha B, 2002, ENDOCRINE, V17, P207, DOI 10.1385/ENDO:17:3:207; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Brown CA, 2007, J VET DIAGN INVEST, V19, P525, DOI 10.1177/104063870701900510; Chan JYW, 2011, FOOD CHEM TOXICOL, V49, P1544, DOI 10.1016/j.fct.2011.03.046; Chang LL, 2014, REPROD TOXICOL, V46, P1, DOI 10.1016/j.reprotox.2014.02.008; Chio L, 2010, TOXICOL ENV HLTH A, V73, P1407, DOI [10.1080/15287394.2010.511540, DOI 10.1080/15287394.2010.511540]; da Costa GG, 2012, TOXICOL APPL PHARM, V262, P99, DOI 10.1016/j.taap.2012.04.031; Dai XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142564; Dobson RLM, 2008, TOXICOL SCI, V106, P251, DOI 10.1093/toxsci/kfn160; Dorne JL, 2013, TOXICOL APPL PHARM, V270, P218, DOI 10.1016/j.taap.2012.01.012; Duan X, 2015, HUM REPROD, V30, P1643, DOI 10.1093/humrep/dev091; Dufour Alfred P., 2006, Journal of Water and Health, V4, P425; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Ferre C, 2013, EXP TOXICOL PATHOL, V65, P397, DOI 10.1016/j.etp.2011.12.004; Fu Y, 2014, LIFE SCI, V100, P61, DOI 10.1016/j.lfs.2014.01.081; Guo CZ, 2012, CELL BIOL INT, V36, P383, DOI 10.1042/CBI20110504; Guo CZ, 2012, CELL BIOL INT, V36, P183, DOI 10.1042/CBI20110036; HAMMOND BG, 1986, ENVIRON HEALTH PERSP, V69, P287, DOI 10.2307/3430400; Jacob CC, 2011, TOXICOL SCI, V119, P391, DOI 10.1093/toxsci/kfq333; Ji AL, 2014, WORLD J PEDIATR, V10, P7, DOI 10.1007/s12519-014-0447-3; Kim GH, 2014, J TOXICOL ENV HEAL A, V77, P22; Kim SH, 2011, J APPL TOXICOL, V31, P506, DOI 10.1002/jat.1703; Lv YJ, 2013, REGUL TOXICOL PHARM, V65, P183, DOI 10.1016/j.yrtph.2012.11.011; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Reimschuessel R, 2010, FOOD CHEM TOXICOL, V48, P2898, DOI 10.1016/j.fct.2010.07.024; Reimschuessel R, 2010, J MED TOXICOL, V6, P468, DOI 10.1007/s13181-010-0107-5; Skinner CG, 2010, J MED TOXICOL, V6, P50, DOI 10.1007/s13181-010-0038-1; Son JY, 2014, TOX RESEARCH, V30, P99, DOI 10.5487/TR.2014.30.2.099; Stine CB, 2014, FOOD CHEM TOXICOL, V68, P142, DOI 10.1016/j.fct.2014.02.029; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Takahashi N, 2012, REPROD TOXICOL, V33, P27, DOI 10.1016/j.reprotox.2011.10.010; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Walters KA, 2015, REPRODUCTION, V149, pR193, DOI 10.1530/REP-14-0517; Yin RH, 2013, RES VET SCI, V94, P618, DOI 10.1016/j.rvsc.2012.11.010	36	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149063	10.1371/journal.pone.0149063	http://dx.doi.org/10.1371/journal.pone.0149063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866683	gold, Green Submitted, Green Published			2022-12-26	WOS:000370050700059
J	Zungsontiporn, N; Tello, RR; Zhang, GX; Mitchell, BI; Budoff, M; Kallianpur, KJ; Nakamoto, BK; Keating, SM; Norris, PJ; Ndhlovu, LC; Souza, SA; Shikuma, CM; Chow, DC				Zungsontiporn, Nath; Tello, Raquel R.; Zhang, Guangxiang; Mitchell, Brooks I.; Budoff, Matthew; Kallianpur, Kalpana J.; Nakamoto, Beau K.; Keating, Sheila M.; Norris, Philip J.; Ndhlovu, Lishomwa C.; Souza, Scott A.; Shikuma, Cecilia M.; Chow, Dominic C.			Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTION; SUBCLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; DISEASE EVENTS; RISK-FACTORS; MARKERS; INFLAMMATION; IMMUNODEFICIENCY; HETEROGENEITY; ASSOCIATIONS	Background Persistent inflammation and immune activation has been hypothesized to contribute to increased prevalence of subclinical atherosclerosis and cardiovascular disease (CVD) risk in patients with chronic HIV infection. In this study, we examined the correlation of peripheral monocyte subsets and soluble biomarkers of inflammation to coronary artery calcium (CAC) progression, as measured by cardiac computed tomography scan. Methods We conducted a longitudinal analysis utilizing baseline data of 78 participants with HIV infection on stable antiretroviral therapy (ART) in the Hawaii Aging with HIV-Cardiovascular study who had available baseline monocyte subset analysis as well as CAC measurement at baseline and at 2-year follow up. Monocyte phenotypes were assessed from cryopreserved blood by flow cytometry and plasma was assayed for soluble biomarkers using antibody-coated beads in a high sensitivity Milliplex Luminex platform. Change in CAC over 2 years was analyzed as the primary outcome variable. Results Of all monocyte subsets and biomarkers tested, higher non-classical monocyte percentage (rho = 0.259, p = 0.022), interleukin (IL)-6 (rho = 0.311, p = 0.012), and monocyte chemoattractant protein (MCP)-1 (rho = 0.524, p = <0.001) were significantly correlated to higher 2-year CAC progression in unadjusted Spearman's correlation. Non-classical monocyte percentage (rho = 0.247, p = 0.039), and MCP-1 (rho = 0.487, p = <0.001), remained significantly correlated to 2-year CAC progression, while IL-6 was not (rho = 0.209, p = 0.120) after adjustment for age, hypertension, diabetes mellitus, total/HDL cholesterol ratio, smoking history, and BMI. Conclusion The percentage of non-classical monocytes and plasma MCP-1 levels were independently associated with CAC progression and may be related to the progression of atherosclerosis and increased CVD risk associated with chronic HIV infection on stable ART.	[Zungsontiporn, Nath; Tello, Raquel R.; Mitchell, Brooks I.; Kallianpur, Kalpana J.; Nakamoto, Beau K.; Ndhlovu, Lishomwa C.; Souza, Scott A.; Shikuma, Cecilia M.; Chow, Dominic C.] Univ Hawaii, John A Burns Sch Med, Dept Med, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Zhang, Guangxiang; Mitchell, Brooks I.; Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Nakamoto, Beau K.] Straub Hosp, Honolulu, HI USA; [Keating, Sheila M.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Budoff, Matthew] Harbor UCLA, Los Angeles Biomed Res Inst, Los Angeles, CA USA	University of Hawaii System; University of Hawaii System; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Chow, DC (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Med, Hawaii Ctr AIDS, Honolulu, HI 96822 USA.	dominicc@hawaii.edu	n, l/AAX-3992-2020; Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946; Keating, Sheila/0000-0002-8324-3694; Chow, Dominic/0000-0001-7395-038X; Ndhlovu, Lishomwa/0000-0001-5427-4187	National Institutes of Health [R01HL095135, K23HL088981, U54MD007584]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL088981, R01HL095135] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	R01HL095135 and K23HL088981 and U54MD007584 are funded by the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baker JV, 2014, AIDS, V28, P831, DOI 10.1097/QAD.0000000000000145; Barbour JD, 2014, ATHEROSCLEROSIS, V232, P52, DOI 10.1016/j.atherosclerosis.2013.10.021; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Floris-Moore M, 2009, AIDS, V23, P941, DOI 10.1097/QAD.0b013e328329c76b; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Libby P, 2013, SEMIN IMMUNOPATHOL, V35, P553, DOI 10.1007/s00281-013-0387-3; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Maniar A, 2013, EUR J PREV CARDIOL, V20, P720, DOI 10.1177/2047487312447843; McKibben RA, 2015, J INFECT DIS, V211, P1219, DOI 10.1093/infdis/jiu594; Parra S, 2010, HIV MED, V11, P225, DOI 10.1111/j.1468-1293.2009.00766.x; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Shikuma CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090330; Shikuma CM, 2014, AIDS RES HUM RETROV, V30, P142, DOI [10.1089/aid.2013.0183, 10.1089/AID.2013.0183]; Shikuma CM, 2012, AIDS RES HUM RETROV, V28, P793, DOI [10.1089/aid.2011.0086, 10.1089/AID.2011.0086]; Tallone T, 2011, J CARDIOVASC TRANSL, V4, P211, DOI 10.1007/s12265-011-9256-4; Thomas G, 2015, NONCLASSICAL PATROLL; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; Westhorpe CLV, 2014, IMMUNOL CELL BIOL, V92, P133, DOI 10.1038/icb.2013.84; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Zawada AM, 2012, IMMUNOBIOLOGY, V217, P1273, DOI 10.1016/j.imbio.2012.07.001; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zungsontiporn N, 2015, HIV CLIN TRIALS, V10, P1	40	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149143	10.1371/journal.pone.0149143	http://dx.doi.org/10.1371/journal.pone.0149143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867220	gold, Green Published, Green Submitted			2022-12-26	WOS:000370050700073
J	Dik, JWH; Dinkelacker, AG; Vemer, P; Lo-Ten-Foe, JR; Lokate, M; Sinha, B; Friedrich, AW; Postma, MJ				Dik, Jan-Willem H.; Dinkelacker, Ariane G.; Vemer, Pepijn; Lo-Ten-Foe, Jerome R.; Lokate, Mariette; Sinha, Bhanu; Friedrich, Alex W.; Postma, Maarten J.			Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital	PLOS ONE			English	Article							NOROVIRUS INFECTION; MANAGEMENT; STANDARDS; IMPACT	Objectives Nosocomial outbreaks, especially with (multi-)resistant microorganisms, are a major problem for health care institutions. They can cause morbidity and mortality for patients and controlling these costs substantial amounts of funds and resources. However, how much is unclear. This study sets out to provide a comparable overview of the costs of multiple outbreaks in a single academic hospital in the Netherlands. Methods Based on interviews with the involved staff, multiple databases and stored records from the Infection Prevention Division all actions undertaken, extra staff employment, use of resources, bed-occupancy rates, and other miscellaneous cost drivers during different outbreaks were scored and quantified into Euros. This led to total costs per outbreak and an estimated average cost per positive patient per outbreak day. Results Seven outbreaks that occurred between 2012 and 2014 in the hospital were evaluated. Total costs for the hospital ranged between (sic)10,778 and (sic)356,754. Costs per positive patient per outbreak day, ranged between (sic)10 and (sic)1,369 (95% CI: (sic)49-(sic)1,042), with a mean of (sic)546 and a median of (sic)519. Majority of the costs (50%) were made because of closed beds. Conclusions This analysis is the first to give a comparable overview of various outbreaks, caused by different microorganisms, in the same hospital and all analyzed with the same method. It shows a large variation within the average costs due to different factors (e.g. closure of wards, type of ward). All outbreaks however cost considerable amounts of efforts and money (up to (sic)356,754), including missed revenue and control measures.	[Dik, Jan-Willem H.; Dinkelacker, Ariane G.; Lo-Ten-Foe, Jerome R.; Lokate, Mariette; Sinha, Bhanu; Friedrich, Alex W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Dinkelacker, Ariane G.] Univ Tubingen Hosp, Dept Med Microbiol, Tubingen, Germany; [Vemer, Pepijn; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Vemer, Pepijn; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & HealthcaRE SHARE, NL-9713 AV Groningen, Netherlands; [Vemer, Pepijn; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands	University of Groningen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Groningen; University of Groningen; University of Groningen	Friedrich, AW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	alex.friedrich@umcg.nl	Friedrich, Alex/ABG-9823-2020	Dik, Jan-Willem/0000-0003-3258-8817; Postma, Maarten/0000-0002-6306-3653; Sinha, Bhanu/0000-0003-1634-0010	European Union; German state of North Rhine-Westphalia; German state of Lower Saxony; Dutch province Overijssel via the EurSafety Health-net project [Interreg IVa III-1-01=073]; Dutch province Gelderland via the EurSafety Health-net project [Interreg IVa III-1-01=073]; Dutch province Limburg via the EurSafety Health-net project [Interreg IVa III-1-01=073]	European Union(European Commission); German state of North Rhine-Westphalia; German state of Lower Saxony; Dutch province Overijssel via the EurSafety Health-net project; Dutch province Gelderland via the EurSafety Health-net project; Dutch province Limburg via the EurSafety Health-net project	This work was partly supported by the European Union, the German states of North Rhine-Westphalia and Lower Saxony and the Dutch provinces Overijssel, Gelderland and Limburg via the EurSafety Health-net project [Interreg IVa III-1-01=073]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorholt I, 2004, EUR J CLIN MICROBIOL, V23, P688, DOI 10.1007/s10096-004-1198-1; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Bou R, 2009, J HOSP INFECT, V71, P138, DOI 10.1016/j.jhin.2008.07.018; Christiansen KJ, 2004, INFECT CONT HOSP EP, V25, P384, DOI 10.1086/502410; Fretz R, 2009, WIEN KLIN WOCHENSCHR, V121, P137, DOI 10.1007/s00508-008-1135-x; Gandra S, 2014, CLIN MICROBIOL INFEC, V20, P973, DOI 10.1111/1469-0691.12798; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Jiang YS, 2016, SURG INFECT, V17, P58, DOI 10.1089/sur.2015.036; Johnston CP, 2007, CLIN INFECT DIS, V45, P534, DOI 10.1086/520666; Navas E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2289-x; Perencevich EN, 2007, INFECT CONT HOSP EP, V28, P1121, DOI 10.1086/521852; Piednoir E, 2011, CRIT CARE MED, V39, P2672, DOI 10.1097/CCM.0b013e31822827e0; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Sadique Z, 2016, J INFECT DIS, V213, pS19, DOI 10.1093/infdis/jiv410; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246; van den Brink R, 2013, END ANTIBIOTICS; WHO, 2014, EV THREAT ANT RES OP; Zingg W, 2005, INFECT CONT HOSP EP, V26, P263, DOI 10.1086/502537	19	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149226	10.1371/journal.pone.0149226	http://dx.doi.org/10.1371/journal.pone.0149226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863145	Green Published, gold, Green Submitted			2022-12-26	WOS:000370046600163
J	Jeong, D; Han, C; Kang, I; Park, HT; Kim, J; Ryu, H; Gho, YS; Park, J				Jeong, Dayeong; Han, Chungmin; Kang, Inhye; Park, Hyun Taek; Kim, Jiyoon; Ryu, Hayoung; Gho, Yong Song; Park, Jaesung			Effect of Concentrated Fibroblast-Conditioned Media on In Vitro Maintenance of Rat Primary Hepatocyte	PLOS ONE			English	Article							CELL-CELL INTERACTIONS; NONPARENCHYMAL CELLS; LIVER; CULTURE; COCULTURES; SURFACES; ENZYMES	The effects of concentrated fibroblast-conditioned media were tested to determine whether hepatocyte function can be maintained without direct contact between hepatocytes and fibroblasts. Primary rat hepatocytes cultured with a concentrated conditioned media of NIH-3T3 J2 cell line (final concentration of 55 mg/ml) showed significantly improved survival and functions (albumin and urea) compared to those of control groups. They also showed higher expression levels of mRNA, albumin and tyrosine aminotransferase compared to hepatocyte monoculture. The results suggest that culture with concentrated fibroblast-conditioned media could be an easy method for in vitro maintenance of primary hepatocytes. They also could be contribute to understand and analyze co-culture condition of hepatocyte with stroma cells.	[Jeong, Dayeong; Kim, Jiyoon; Park, Jaesung] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea; [Han, Chungmin; Kang, Inhye; Park, Jaesung] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeong Buk, South Korea; [Park, Hyun Taek; Gho, Yong Song] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, Gyeong Buk, South Korea; [Park, Hyun Taek; Gho, Yong Song] Pohang Univ Sci & Technol POSTECH, Div Mol & Life Sci, Pohang, Gyeong Buk, South Korea; [Ryu, Hayoung] Chadwick Int Sch, Songdo, Incheon, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Park, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea.; Park, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeong Buk, South Korea.	jpark@postech.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2011-0030075, 2011-0028845]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2011-0030075, and 2011-0028845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikgoz A, 2013, BIOMOLECULES, V3, P242, DOI 10.3390/biom3010242; Auth M K, 1998, Transpl Int, V11 Suppl 1, pS439, DOI 10.1007/s001470050516; Beigel J, 2008, TOXICOL IN VITRO, V22, P171, DOI 10.1016/j.tiv.2007.06.019; Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695; Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bierwolf J, 2011, BIOTECHNOL BIOENG, V108, P141, DOI 10.1002/bit.22924; Brieva TA, 2001, BIOTECHNOL BIOENG, V76, P295, DOI 10.1002/bit.10041; Cho CH, 2008, BIOTECHNOL BIOENG, V101, P345, DOI 10.1002/bit.21911; Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225; CORLU A, 1991, J CELL BIOL, V115, P505, DOI 10.1083/jcb.115.2.505; De Smet K, 2001, BIOCHEM PHARMACOL, V61, P1293, DOI 10.1016/S0006-2952(01)00612-8; DONATO MT, 1990, IN VITRO CELL DEV B, V26, P1057; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; Evenou F, 2011, BIOTECHNOL PROGR, V27, P1146, DOI 10.1002/btpr.626; Hansen LK, 1999, J CELL SCI, V112, P2971; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Jindal R, 2009, FASEB J, V23, P2288, DOI 10.1096/fj.08-114934; Kang YH, 2004, EXP CELL RES, V293, P239, DOI 10.1016/j.yexcr.2003.10.011; Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351; KOIDE N, 1990, EXP CELL RES, V186, P227, DOI 10.1016/0014-4827(90)90300-Y; LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Leite SB, 2011, TOXICOL IN VITRO, V25, P825, DOI 10.1016/j.tiv.2011.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MORIN O, 1986, J CELL PHYSIOL, V129, P103, DOI 10.1002/jcp.1041290115; Morin O, 1988, Revis Biol Celular, V15, P1; SATO Y, 1994, HEPATOLOGY, V19, P1023, DOI 10.1002/hep.1840190430; Tisaoussis J, 2001, LIVER TRANSPLANT, V7, P2, DOI 10.1053/jlts.2001.20845; Uyama N, 2002, J HEPATOL, V36, P590, DOI 10.1016/S0168-8278(02)00023-5; Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751	34	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148846	10.1371/journal.pone.0148846	http://dx.doi.org/10.1371/journal.pone.0148846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863621	Green Published, gold			2022-12-26	WOS:000370046600114
J	Lopes, C; Aubert, S; Bourgois-Rocha, F; Barnat, M; Rego, AC; Deglon, N; Perrier, AL; Humbert, S				Lopes, Carla; Aubert, Sophie; Bourgois-Rocha, Fany; Barnat, Monia; Rego, Ana Cristina; Deglon, Nicole; Perrier, Anselme L.; Humbert, Sandrine			Dominant-Negative Effects of Adult-Onset Huntingtin Mutations Alter the Division of Human Embryonic Stem Cells-Derived Neural Cells	PLOS ONE			English	Article							MITOTIC SPINDLE ORIENTATION; MUTANT HUNTINGTIN; CAG REPEAT; DISEASE; DIFFERENTIATION; LINES; PROGENITORS; DERIVATION; EXPANSION; TRANSPORT	Mutations of the huntingtin protein (HTT) gene underlie both adult-onset and juvenile forms of Huntington's disease (HD). HTT modulates mitotic spindle orientation and cell fate in mouse cortical progenitors from the ventricular zone. Using human embryonic stem cells (hESC) characterized as carrying mutations associated with adult-onset disease during pre-implantation genetic diagnosis, we investigated the influence of human HTT and of an adult-onset HD mutation on mitotic spindle orientation in human neural stem cells (NSCs) derived from hESCs. The RNAi-mediated silencing of both HTT alleles in neural stem cells derived from hESCs disrupted spindle orientation and led to the mislocalization of dynein, the p150(Glued) subunit of dynactin and the large nuclear mitotic apparatus (NuMA) protein. We also investigated the effect of the adult-onset HD mutation on the role of HTT during spindle orientation in NSCs derived from HD-hESCs. By combining SNP-targeting allele-specific silencing and gain-of-function approaches, we showed that a 46-glutamine expansion in human HTT was sufficient for a dominant-negative effect on spindle orientation and changes in the distribution within the spindle pole and the cell cortex of dynein, p150(Glued) and NuMA in neural cells. Thus, neural derivatives of disease-specific human pluripotent stem cells constitute a relevant biological resource for exploring the impact of adult-onset HD mutations of the HTT gene on the division of neural progenitors, with potential applications in HD drug discovery targeting HTT-dynein-p150(Glued) complex interactions.	[Lopes, Carla; Barnat, Monia; Humbert, Sandrine] Grenoble Inst Neurosci, Grenoble, France; [Lopes, Carla; Barnat, Monia; Humbert, Sandrine] INSERM, U836, Grenoble, France; [Lopes, Carla; Barnat, Monia; Humbert, Sandrine] Grenoble Alpes Univ, Grenoble, France; [Lopes, Carla; Rego, Ana Cristina] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Lopes, Carla] Univ Coimbra IIIUC, Inst Interdisciplinary Res, Coimbra, Portugal; [Aubert, Sophie] AFM, I STEM, CECS, Corbeil Essonnes, France; [Bourgois-Rocha, Fany; Perrier, Anselme L.] AFM, I STEM, INSERM, U861, Corbeil Essonnes, France; [Bourgois-Rocha, Fany; Perrier, Anselme L.] AFM, I STEM, UEVE U861, Evry, France; [Rego, Ana Cristina] Univ Coimbra, Fac Med, Coimbra, Portugal; [Deglon, Nicole] Lausanne Univ Hosp CHUV, DNC, LNCM, Lausanne, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universidade de Coimbra; Universidade de Coimbra; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universidade de Coimbra; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Humbert, S (corresponding author), Grenoble Inst Neurosci, Grenoble, France.; Perrier, AL; Humbert, S (corresponding author), INSERM, U836, Grenoble, France.; Perrier, AL (corresponding author), AFM, I STEM, INSERM, U861, Corbeil Essonnes, France.; Perrier, AL (corresponding author), AFM, I STEM, UEVE U861, Evry, France.	aperrier@istem.fr; sandrine.humbert@ujf-grenoble.fr	Perrier, Anselme L/B-2272-2019; BARNAT, Monia/AAK-6305-2021; Rego, Ana Cristina C/L-4272-2014; Rego, Ana Cristina/AAH-2606-2020; Deglon, Nicole/A-2265-2012; Lopes, Carla/V-6557-2018; Humbert, Sandrine/S-2981-2016	Perrier, Anselme L/0000-0001-7915-1968; Rego, Ana Cristina C/0000-0003-0700-3776; Deglon, Nicole/0000-0003-4475-9476; Lopes, Carla/0000-0002-2543-8821; Humbert, Sandrine/0000-0002-9501-2658	Agence Nationale pour la Recherche - Maladies Rares [ANR-12-SVSE4 HUGE]; DIM-STEM POLE Region Ile de France fellowship; Fondation pour la Recherche Medicale [FRM DEQ20120323715]; INSERM; Canceropole Ile de France [INCA-6517-2013]; laboratoire d'Excellence Revive [ANR-10-LABX-73]; NeurATRIS: A Translational Research Infrastructure for Biotherapies in Neurosciences [Investissement d'Avenir - ANR-11-INBS-0011]; INGESTEM: the National Infrastructure Engineering for Pluripotent and differentiated Stem cells [ANR-11-INBS-0009]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/51192/2010]; Association Francaise contre les Myopathies (AFM-Telethon)	Agence Nationale pour la Recherche - Maladies Rares(French National Research Agency (ANR)); DIM-STEM POLE Region Ile de France fellowship(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Canceropole Ile de France(Region Ile-de-France); laboratoire d'Excellence Revive; NeurATRIS: A Translational Research Infrastructure for Biotherapies in Neurosciences; INGESTEM: the National Infrastructure Engineering for Pluripotent and differentiated Stem cells; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Association Francaise contre les Myopathies (AFM-Telethon)	This work was supported by Agence Nationale pour la Recherche - Maladies Rares, http://www.agence-nationale-recherche.fr/ (ANR-12-SVSE4 HUGE, S.H.); DIM-STEM POLE Region Ile de France fellowship, http://www.dim-biotherapies.com/ (F.B-R.); Fondation pour la Recherche Medicale, http://www.frm.org/ (FRM DEQ20120323715, equipe labellisee, S.H.); INSERM, http://www.inserm.fr/ (S.H. & A.L.P.); Canceropole Ile de France, http://www.canceropole-idf.fr/ (INCA-6517-2013); the laboratoire d'Excellence Revive, http://www.gouvernement.fr/investissements-d-avenir-cgi/(Investissement d'Avenir; ANR-10-LABX-73, A.L.P.), NeurATRIS: A Translational Research Infrastructure for Biotherapies in Neurosciences, http://www.gouvernement.fr/investissements-d-avenir-cgi/ (Investissement d'Avenir - ANR-11-INBS-0011, A.L.P.); INGESTEM: the National Infrastructure Engineering for Pluripotent and differentiated Stem cells, http://www.gouvernement.fr/investissements-d-avenir-cgi/(Investissement d'Avenir - ANR-11-INBS-0009, A.L.P.). C. Lopes was supported by a PhD fellowship from 'Fundacao para a Ciencia e a Tecnologia', http://www.fct.pt/ (SFRH/BD/51192/2010). I-Stem is part of the Biotherapies Institute for Rare Diseases (BIRD) supported by the Association Francaise contre les Myopathies (AFM-Telethon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; Drouet V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099341; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Elias S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002142; Elias S, 2014, STEM CELL REP, V2, P491, DOI 10.1016/j.stemcr.2014.02.011; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Group T. H. D. C. R., 1993, CELL, V72, P971, DOI [10.1016/0092-8674(93)90585-E8458085, DOI 10.1016/0092-8674(93)90585-E8458085]; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Killoran A, 2013, NEUROLOGY, V80, P2022, DOI 10.1212/WNL.0b013e318294b304; Lee JK, 2012, NEUROLOGY, V79, P668, DOI 10.1212/WNL.0b013e3182648b65; Mattis VB, 2015, HUM MOL GENET, V24, P3257, DOI 10.1093/hmg/ddv080; Molina-Calavita M, 2014, J NEUROSCI, V34, P10034, DOI 10.1523/JNEUROSCI.0715-14.2014; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nicoleau C, 2013, STEM CELLS, V31, P1763, DOI 10.1002/stem.1462; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Ooi J, 2014, MOL NEUROBIOL; Pardo R, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-17; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Shitamukai A, 2012, DEV GROWTH DIFFER, V54, P277, DOI 10.1111/j.1440-169X.2012.01345.x; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Sousa CM, 2013, J HUNTINGTONS DIS, V2, P395, DOI 10.3233/JHD-130082; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	36	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148680	10.1371/journal.pone.0148680	http://dx.doi.org/10.1371/journal.pone.0148680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863614	Green Published, Green Submitted, gold			2022-12-26	WOS:000370046600096
J	Boulding, T; Wu, F; McCuaig, R; Dunn, J; Sutton, CR; Hardy, K; Tu, WJ; Bullman, A; Yip, D; Dahlstrom, JE; Rao, S				Boulding, Tara; Wu, Fan; McCuaig, Robert; Dunn, Jennifer; Sutton, Christopher R.; Hardy, Kristine; Tu, Wenjuan; Bullman, Amanda; Yip, Desmond; Dahlstrom, Jane E.; Rao, Sudha			Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; DUAL-SPECIFICITY PHOSPHATASES; GENE-EXPRESSION; C-THETA; PKC-THETA; PHOSPHORYLATION; CHROMATIN; P300; JNK; IDENTIFICATION	Dual-specificity phosphatases (DUSPs) dephosphorylate threonine/serine and tyrosine residues on their substrates. Here we show that DUSP1, DUSP4, and DUSP6 are involved in epithelial-to-mesenchymal transition (EMT) and breast cancer stem cell (CSC) regulation. DUSP1, DUSP4, and DUSP6 are induced during EMT in a PKC pathway signal-mediated EMT model. We show for the first time that the key chromatin-associated kinase PKC-theta directly regulates a subset of DUSP family members. DUSP1, DUSP4, and DUSP6 globally but differentially co-exist with enhancer and permissive active histone post-translational modifications, suggesting that they play distinct roles in gene regulation in EMT/CSCs. We show that nuclear DUSP4 associates with the key acetyltransferase p300 in the context of the chromatin template and dynamically regulates the interplay between two key phosphorylation marks: the 1834 (active) and 89 (inhibitory) residues central to p300's acetyltransferase activity. Furthermore, knockdown with small-interfering RNAs (siRNAs) shows that DUSP4 is required for maintaining H3K27ac, a mark mediated by p300. DUSP1, DUSP4, and DUSP6 knockdown with siRNAs shows that they participate in the formation of CD44(hi)/CD24(lo)/EpCAM(+) breast CSCs: DUSP1 knockdown reduces CSC formation, while DUSP4 and DUSP6 knockdown enhance CSC formation. Moreover, DUSP6 is overexpressed in patient-derived HER2(+) breast carcinomas compared to benign mammary tissue. Taken together, these findings illustrate novel pleiotropic roles for DUSP family members in EMT and CSC regulation in breast cancer.	[Boulding, Tara; Wu, Fan; McCuaig, Robert; Dunn, Jennifer; Sutton, Christopher R.; Hardy, Kristine; Tu, Wenjuan; Rao, Sudha] Univ Canberra, Fac ESTeM, Hlth Res Inst, Bruce, ACT 2617, Australia; [Bullman, Amanda; Dahlstrom, Jane E.] Canberra Hosp, ACT Pathol, Anat Pathol, Garran, ACT 2605, Australia; [Bullman, Amanda; Yip, Desmond; Dahlstrom, Jane E.] Australian Natl Univ, ANU Med Sch, Acton, ACT 2601, Australia; [Yip, Desmond] Canberra Hosp, Dept Med Oncol, Garran, ACT 2605, Australia	University of Canberra; Australian National University; Canberra Hospital; Australian National University; Australian National University; Canberra Hospital	Rao, S (corresponding author), Univ Canberra, Fac ESTeM, Hlth Res Inst, Bruce, ACT 2617, Australia.	Sudha.Rao@canberra.edu.au	Dunn, Jennifer/ABA-7400-2021; WU, FAN/P-3132-2015; Rao, Sudha/AAW-5192-2020; Yip, Desmond/G-2043-2014; Dahlstrom, Jane/E-4683-2018	WU, FAN/0000-0001-7763-8852; Rao, Sudha/0000-0001-9547-947X; Yip, Desmond/0000-0002-2806-2401; Hardy, Kristine/0000-0003-1660-4477; McCuaig, Robert D./0000-0003-0124-4173; Dahlstrom, Jane/0000-0001-5608-693X	National Health and Medical Research Council (NHMRC) [APP1068065]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by National Health and Medical Research Council (NHMRC) APP1068065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2008, J MICROSC-OXFORD, V230, P121, DOI 10.1111/j.1365-2818.2008.01967.x; Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; Avraham A, 1998, EUR J IMMUNOL, V28, P2320, DOI 10.1002/(SICI)1521-4141(199808)28:08<2320::AID-IMMU2320>3.0.CO;2-K; Folgueira MAAK, 2009, ONCOL REP, V22, P805, DOI 10.3892/or_00000503; Baglia ML, 2014, BREAST CANCER RES TR, V148, P211, DOI 10.1007/s10549-014-3127-z; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Candas D, 2014, CANCER RES, V74, P7498, DOI 10.1158/0008-5472.CAN-14-0844; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Castelli M, 2004, J BIOL CHEM, V279, P44731, DOI 10.1074/jbc.M407669200; Chang JT, 2013, CANCER LETT, V341, P16, DOI 10.1016/j.canlet.2013.03.004; Crowell S, 2014, J BIOL CHEM, V289, P28753, DOI 10.1074/jbc.M114.591925; Cui YK, 2006, CANCER RES, V66, P5950, DOI 10.1158/0008-5472.CAN-05-3243; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dinic J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10082; He H, 2010, PROSTATE, V70, P1119, DOI 10.1002/pros.21146; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamdje AHN, 2014, WORLD J CLIN CASES, V2, P769, DOI 10.12998/wjcc.v2.i12.769; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kim H, 2015, J BREAST CANCER, V18, P1, DOI [10.4048/jbc.2015.18.11, 10.4048/jbc.2015.18.1.1]; Kinney CM, 2009, AM J PHYSIOL-CELL PH, V296, pC242, DOI 10.1152/ajpcell.00492.2008; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Landry RP, 2012, J PAIN, V13, P836, DOI 10.1016/j.jpain.2012.05.013; Lazo JS, 2002, MOL PHARMACOL, V61, P720, DOI 10.1124/mol.61.4.720; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu Y, 2013, EXP CELL RES, V319, P3140, DOI 10.1016/j.yexcr.2013.08.023; Loda M, 1996, AM J PATHOL, V149, P1553; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Lucci MA, 2010, CELL ONCOL, V32, P361, DOI 10.3233/CLO-2010-0520; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manzano RG, 2014, INT J ONCOL, V45, P2250, DOI 10.3892/ijo.2014.2648; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Nunes-Xavier C, 2011, ANTI-CANCER AGENT ME, V11, P109, DOI 10.2174/187152011794941190; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Rojo F, 2009, CLIN CANCER RES, V15, P3530, DOI 10.1158/1078-0432.CCR-08-2070; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Sutcliffe EL, 2011, MOL CELL, V41, P704, DOI 10.1016/j.molcel.2011.02.030; Sutcliffe EL, 2009, MOL CELL BIOL, V29, P1972, DOI 10.1128/MCB.01590-08; Szerlong HJ, 2010, J BIOL CHEM, V285, P31954, DOI 10.1074/jbc.M110.148718; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Vogt A, 2008, MOL CANCER THER, V7, P330, DOI 10.1158/1535-7163.MCT-07-2165; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Ward Y, 2001, MOL CELL BIOL, V21, P5958, DOI 10.1128/MCB.21.17.5958-5969.2001; Watson MB, 2007, ACTA ONCOL, V46, P651, DOI 10.1080/02841860601156157; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zafar A, 2015, GENOM DATA, V3, P28, DOI 10.1016/j.gdata.2014.11.002; Zafar A, 2014, MOL CELL BIOL, V34, P2961, DOI 10.1128/MCB.01693-13; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	61	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148065	10.1371/journal.pone.0148065	http://dx.doi.org/10.1371/journal.pone.0148065			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859151	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400020
J	Clauss, S; Wakili, R; Hildebrand, B; Kaab, S; Hoster, E; Klier, I; Martens, E; Hanley, A; Hanssen, H; Halle, M; Nickel, T				Clauss, Sebastian; Wakili, Reza; Hildebrand, Bianca; Kaeaeb, Stefan; Hoster, Eva; Klier, Ina; Martens, Eimo; Hanley, Alan; Hanssen, Henner; Halle, Martin; Nickel, Thomas			MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study - A Sub-Study of the Munich Marathon Study)	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNA; CIRCULATING MICRORNAS; DIASTOLIC DYSFUNCTION; POTENTIAL BIOMARKER; ENDURANCE EXERCISE; TISSUE DOPPLER; HEART-FAILURE; FOLLOW-UP; FIBRILLATION; RISK	Introduction Physical activity is beneficial for individual health, but endurance sport is associated with the development of arrhythmias like atrial fibrillation. The underlying mechanisms leading to this increased risk are still not fully understood. MicroRNAs are important mediators of proarrhyth-mogenic remodeling and have potential value as biomarkers in cardiovascular diseases. Therefore, the objective of our study was to determine the value of circulating microRNAs as potential biomarkers for atrial remodeling in marathon runners (miRathon study). Methods 30 marathon runners were recruited into our study and were divided into two age-matched groups depending on the training status: elite (ER, >= 55 km/week, n = 15) and non-elite runners (NER, <= 40 km/week, n = 15). All runners participated in a 10 week training program before the marathon. MiRNA plasma levels were measured at 4 time points: at baseline (V1), after a 10 week training period (V2), immediately after the marathon (V3) and 24h later (V4). Additionally, we obtained clinical data including serum chemistry and echocardiography at each time point. Results MiRNA plasma levels were similar in both groups over time with more pronounced changes in ER. After the marathon miR-30a plasma levels increased significantly in both groups. MiR-1 and miR-133a plasma levels also increased but showed significant changes in ER only. 24h after the marathon plasma levels returned to baseline. MiR-26a decreased significantly after the marathon in elite runners only and miR-29b showed a non-significant decrease over time in both groups. In ER miRNA plasma levels showed a significant correlation with LA diameter, in NER miRNA plasma levels did not correlate with echocardiographic parameters. Conclusion MiRNAs were differentially expressed in the plasma of marathon runners with more pronounced changes in ER. Plasma levels in ER correlate with left atrial diameter suggesting that circulating miRNAs could potentially serve as biomarkers of atrial remodeling in athletes.	[Clauss, Sebastian; Wakili, Reza; Hildebrand, Bianca; Kaeaeb, Stefan; Klier, Ina; Martens, Eimo; Nickel, Thomas] Univ Munich, Med Klin & Poliklin 1, Campus Grosshadern, Munich, Germany; [Clauss, Sebastian; Wakili, Reza; Kaeaeb, Stefan; Halle, Martin] DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich Heart Alliance, Munich, Germany; [Clauss, Sebastian; Hanley, Alan] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Hoster, Eva] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Hanssen, Henner; Halle, Martin] Tech Univ Munich, Klinikum Rechts Isar MRI, Dept Prevent & Sports Med, D-80290 Munich, Germany; [Hanssen, Henner] Univ Basel, Inst Exercise & Hlth Sci, Sports Med, Basel, Switzerland	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Harvard University; Massachusetts General Hospital; University of Munich; Technical University of Munich; University of Basel	Clauss, S (corresponding author), Univ Munich, Med Klin & Poliklin 1, Campus Grosshadern, Munich, Germany.; Clauss, S (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich Heart Alliance, Munich, Germany.; Clauss, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA.	sebastian.clauss@med.uni-muenchen.de	Hoster, Eva/M-2795-2019; Martens, Eimo/AAX-3975-2021; Clauss, Sebastian/HDL-7189-2022	Hoster, Eva/0000-0002-0749-1389; Martens, Eimo/0000-0002-5801-0901; Clauss, Sebastian/0000-0002-5675-6128; Halle, Martin/0000-0003-3065-530X; Hanssen, Henner/0000-0001-5501-4205	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [PIOF-GA-2012-328352]; German Centre for Cardiovascular Research (DZHK); Heinrich and Lotte Muehlfenzl Foundation	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; German Centre for Cardiovascular Research (DZHK); Heinrich and Lotte Muehlfenzl Foundation	This study was supported by Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-328352), SC; German Centre for Cardiovascular Research (DZHK), SC, RW, SK, MH; and Heinrich and Lotte Muehlfenzl Foundation, TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Clauss was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-328352). Dres. Clauss, Kaab, Wakili, Halle were supported by the German Centre for Cardiovascular Research (DZHK). Dr. Nickel was supported by the Heinrich and Lotte Muehlfenzl Foundation, which provides educational grants for young scientists.	Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Ashor AW, 2015, SPORTS MED, V45, P279, DOI 10.1007/s40279-014-0272-9; Baggish AL, 2014, J APPL PHYSIOL, V116, P522, DOI 10.1152/japplphysiol.01141.2013; Baldesberger S, 2008, EUR HEART J, V29, P71, DOI 10.1093/eurheartj/ehm555; Banzet S, 2013, J APPL PHYSIOL, V115, P1237, DOI 10.1152/japplphysiol.00075.2013; Baumgart BR, 2016, TOXICOL APPL PHARM, V312, P26, DOI 10.1016/j.taap.2015.10.007; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Biffi M, 2002, HEART, V87, P443, DOI 10.1136/heart.87.5.443; Blume GG, 2011, EUR J ECHOCARDIOGR, V12, P421, DOI 10.1093/ejechocard/jeq175; Chen Y, 2014, J MOL CELL CARDIOL, V77, P113, DOI 10.1016/j.yjmcc.2014.10.001; Choi JI, 2008, CIRC J, V72, P2051, DOI 10.1253/circj.CJ-08-0428; Clauss SS, 2015, ARRHYTHMIA ELECTROPH, V4, P10; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Doss JF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2156-2; Drighil A, 2008, EUR J ECHOCARDIOGR, V9, P530, DOI 10.1093/ejechocard/jen125; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eijsvogels TMH, 2016, PHYSIOL REV, V96, P99, DOI 10.1152/physrev.00029.2014; Elosua R, 2006, INT J CARDIOL, V108, P332, DOI 10.1016/j.ijcard.2005.05.020; Fagard R, 2003, HEART, V89, P1455, DOI 10.1136/heart.89.12.1455; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Girmatsion Z, 2009, HEART RHYTHM, V6, P1802, DOI 10.1016/j.hrthm.2009.08.035; Guasch E, 2013, J AM COLL CARDIOL, V62, P68, DOI 10.1016/j.jacc.2013.01.091; Hanssen H, 2011, ATHEROSCLEROSIS, V216, P433, DOI 10.1016/j.atherosclerosis.2011.02.009; Hanssen H, 2011, CLIN SCI, V120, P143, DOI 10.1042/CS20100206; Khan H, 2015, HEART RHYTHM, V12, P1424, DOI 10.1016/j.hrthm.2015.03.024; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; MANIER G, 1991, EUR HEART J, V12, P1183, DOI 10.1093/eurheartj/12.11.1183; Mattioli AV, 1996, CARDIOLOGY, V87, P205, DOI 10.1159/000177088; Melduni RM, 2012, J ATR FIBRILLATION, V5, P87; Melduni RM, 2008, J AM SOC ECHOCARDIOG, V21, P848, DOI 10.1016/j.echo.2007.12.001; Melduni RM, 2011, J AM COLL CARDIOL, V58, P953, DOI 10.1016/j.jacc.2011.05.021; Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Neilan TG, 2006, EUR HEART J, V27, P1079, DOI 10.1093/eurheartj/ehi813; Nickel T, 2012, ATHEROSCLEROSIS, V220, P219, DOI 10.1016/j.atherosclerosis.2011.09.036; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Ono S, 2015, J CLIN MED, V4, P1890, DOI 10.3390/jcm4101890; Padrao AI, 2016, PROTEOMICS, V16, P816, DOI 10.1002/pmic.201500382; Park CS, 2012, EUR HEART J-CARD IMG, V13, P938, DOI 10.1093/ehjci/jes069; Patil Harshal R, 2012, Mo Med, V109, P312; Pelliccia A, 2005, J AM COLL CARDIOL, V46, P690, DOI 10.1016/j.jacc.2005.04.052; Pena LL, 2003, CIRCULATION, V107, P1210, DOI 10.1161/01.CIR.0000055013.92097.40; Psaty BM, 1997, CIRCULATION, V96, P2455; Rosenberg MA, 2012, EUR HEART J, V33, P904, DOI 10.1093/eurheartj/ehr378; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Sinner MF, 2011, CARDIOGENETICS, V1, P35, DOI 10.4081/cardiogenetics.2011.sl.e7; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Tiberio P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731479; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Uhlemann M, 2014, EUR J PREV CARDIOL, V21, P484, DOI 10.1177/2047487312467902; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasan RS, 2003, AM J CARDIOL, V91, P1079, DOI 10.1016/S0002-9149(03)00152-8; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Verma A, 2006, J CARDIOVASC ELECTR, V17, P741, DOI 10.1111/j.1540-8167.2006.00488.x; Wakili R, 2012, HERZ, V37, P166, DOI 10.1007/s00059-012-3594-0; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yuda S, 1998, J AM COLL CARDIOL, V31, P1097, DOI 10.1016/S0735-1097(98)00058-8; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	66	63	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148599	10.1371/journal.pone.0148599	http://dx.doi.org/10.1371/journal.pone.0148599			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859843	Green Published, Green Submitted, gold			2022-12-26	WOS:000370038400054
J	Hayat, T; Qayyum, S; Imtiaz, M; Alsaedi, A				Hayat, Tasawar; Qayyum, Sumaira; Imtiaz, Maria; Alsaedi, Ahmed			Impact of Cattaneo-Christov Heat Flux in Jeffrey Fluid Flow with Homogeneous-Heterogeneous Reactions	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MODEL	Two-dimensional stretched flow of Jeffrey fluid in view of Cattaneo-Christov heat flux is addressed. Effects of homogeneous-heterogeneous reactions are also considered. Suitable transformations are used to form ordinary differential equations. Convergent series solutions are computed. Impact of significant parameters on the velocity, temperature, concentration and skin friction coefficient is addressed. Analysis of thermal relaxation is made. The obtained results show that ratio of relaxation to retardation times and Deborah number have inverse relation for velocity profile. Temperature distribution has decreasing behavior for Prandtl number and thermal relaxation time. Also concentration decreases for larger values of strength of homogeneous reaction parameter while it increases for strength of heterogeneous reaction parameter.	[Hayat, Tasawar; Qayyum, Sumaira; Imtiaz, Maria] Quaid I Azam Univ 45320, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Imtiaz, M (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad, Pakistan.	mi_qau@gmail.com	Hayat, Tasawar/Y-2524-2019; Imtiaz, Maria/AAE-2547-2021; Alsaedi, Ahmed/A-2094-2013; Qayyum, Sumaira/AAA-7476-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasbandy Saeid, 2014, Mathematical and Computational Applications, V19, P124; Abbasi FM, 2015, AIP ADV, V5, DOI 10.1063/1.4914549; Bachok N, 2011, COMMUN NONLINEAR SCI, V16, P4296, DOI 10.1016/j.cnsns.2011.01.008; Cao BY, 2007, J APPL PHYS, V102, DOI 10.1063/1.2775215; Cattaneo C., 1948, ATTI SEMIN MAT FIS, V3, P83, DOI DOI 10.1007/978-3-642-11051-1_5; CHAUDHARY MA, 1995, FLUID DYN RES, V16, P311, DOI 10.1016/0169-5983(95)00015-6; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Ciarletta M, 2010, MECH RES COMMUN, V37, P445, DOI 10.1016/j.mechrescom.2010.06.002; Das K., 2012, INDIAN J MATH, V54, P19; Dong Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3634113; Farooq M, 2015, J MECH, V33, P1; Farooq U, 2015, COMPUT FLUIDS, V111, P69, DOI 10.1016/j.compfluid.2015.01.005; Fourier J.-B.J., 1822, THEORIE ANAL CHALEUR; Hamad M. A. A., 2013, J FLUIDS, V2013, P8; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4908602; Hayat T, 2012, NUCL ENG DES, V243, P15, DOI 10.1016/j.nucengdes.2011.11.005; Hayat T, 2015, THERM SCI, DOI [10.2298/TSCI140922067H, DOI 10.2298/TSCI140922067H]; Hayat T, 2016, J AEROSPACE ENG, V29, DOI 10.1061/(ASCE)AS.1943-5525.0000568; Hayat T, 2015, J MAGN MAGN MATER, V395, P294, DOI 10.1016/j.jmmm.2015.07.092; Hayat T, 2015, Z NATURFORSCH A, V70, P333, DOI 10.1515/zna-2014-0280; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Khan WA, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4007138; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Rashidi MM, 2014, ADV MECH ENG, DOI 10.1155/2014/735939; Reddy GB, 2015, AIN SHAMS ENG J, V6, P355, DOI 10.1016/j.asej.2014.09.004; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014; Tibullo V, 2011, MECH RES COMMUN, V38, P77, DOI 10.1016/j.mechrescom.2010.10.008; [特里帕蒂D Tripathi D], 2011, [应用数学和力学, Applied Mathematics and Mechanics], V32, P1148; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Zhang MK, 2014, INT J THERM SCI, V84, P9, DOI 10.1016/j.ijthermalsci.2014.04.014	33	82	82	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148662	10.1371/journal.pone.0148662	http://dx.doi.org/10.1371/journal.pone.0148662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859675	Green Submitted, Green Published, gold			2022-12-26	WOS:000370038400061
J	Wood, CE; Chang, EI; Richards, EM; Rabaglino, MB; Keller-Wood, M				Wood, Charles E.; Chang, Eileen I.; Richards, Elaine M.; Belen Rabaglino, Maria; Keller-Wood, Maureen			Transcriptomics Modeling of the Late-Gestation Fetal Pituitary Response to Transient Hypoxia	PLOS ONE			English	Article							HEMODYNAMIC-RESPONSES; ANTERIOR-PITUITARY; CYTOSCAPE PLUGIN; BLOOD-FLOW; SHEEP; HYPOXEMIA; EXPRESSION; ESTRADIOL; HORMONE; NEWBORN	Background The late-gestation fetal sheep responds to hypoxia with physiological, neuroendocrine, and cellular responses that aid in fetal survival. The response of the fetus to hypoxia represents a coordinated effort to maximize oxygen transfer from the mother and minimize wasteful oxygen consumption by the fetus. While there have been many studies aimed at investigating the coordinated physiological and endocrine responses to hypoxia, and while immunohistochemical or in situ hybridization studies have revealed pathways supporting the endocrine function of the pituitary, there is little known about the coordinated cellular response of the pituitary to the hypoxia. Results Thirty min hypoxia (from 17.0 +/- 1.7 to 8.0 +/- 0.8 mm Hg, followed by 30 min normoxia) upregulated 595 and downregulated 790 genes in fetal pituitary (123-132 days' gestation; term = 147 days). Network inference of up-and down-regulated genes revealed a high degree of functional relatedness amongst the gene sets. Gene ontology analysis revealed upregulation of cellular metabolic processes (e.g., RNA synthesis, response to estrogens) and downregulation of protein phosphorylation, protein metabolism, and mitosis. Genes found to be at the center of the network of upregulated genes included genes important for purine binding and signaling. At the center of the downregulated network were genes involved in mRNA processing, DNA repair, sumoylation, and vesicular trafficking. Transcription factor analysis revealed that both up-and down-regulated gene sets are enriched for control by several transcription factors (e.g., SP1, MAZ, LEF1, NRF1, ELK1, NFAT, E12, PAX4) but not for HIF-1, which is known to be an important controller of genomic responses to hypoxia. Conclusions The multiple analytical approaches used in this study suggests that the acute response to 30 min of transient hypoxia in the late-gestation fetus results in reduced cellular metabolism and a pattern of gene expression that is consistent with cellular oxygen and ATP starvation. In this early time point, we see a vigorous gene response. But, like the hypothalamus, the transcriptomic response is not consistent with mediation by HIF-1. If HIF-1 is a significant controller of gene expression in the fetal pituitary after hypoxia, it must be at a later time.	[Wood, Charles E.; Chang, Eileen I.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Richards, Elaine M.; Keller-Wood, Maureen] Univ Florida, Coll Pharm, Dept Pharmacodynam, Gainesville, FL 32610 USA; [Belen Rabaglino, Maria] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Belen Rabaglino, Maria] Consejo Nacl Invest Cient & Tecn, CEPROCOR, Cordoba, Argentina	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Wood, CE (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA.	woodc@ufl.edu		Chang, Eileen/0000-0002-3444-7260; Rabaglino, Maria/0000-0002-0099-045X; Keller-Wood, Maureen/0000-0002-1443-9212	National Institute of Child Health and Human Development [HD057561, HD033053]; National Institute of Diabetes, Digestive, and Kidney Diseases [T32DK076541]; NIH [HD057561, HD033053, T32DK076541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033053, R01HD057561] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK076541] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institute of Child Health and Human Development HD057561 and HD033053 to CEW, and from the National Institute of Diabetes, Digestive, and Kidney Diseases T32DK076541 to EIC (trainee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants HD057561 and HD033053 to CEW, and T32DK076541 to EIC (trainee) and CEW (PI). We thank Ms. Xiaoying (Lisa) Fang, and Ms. Kristina Steinfeldt, and for their expert technical assistance. Also, we thank the Genomics Division of the University of Florida's Interdisciplinary Center for Biotech Research for the use of the Agilent Bioanalyzer and Agilent scanner.	ANTOLOVICH GC, 1989, ENDOCRINOLOGY, V124, P1333, DOI 10.1210/endo-124-3-1333; Barcroft SJ, 1947, RES PRENATAL LIFE 1; BARD H, 1976, PEDIATR RES, V10, P823, DOI 10.1203/00006450-197610000-00002; BODDY K, 1974, ENDOCRINOLOGY, V94, P588, DOI 10.1210/endo-94-2-588; Butler TG, 1999, J PHYSIOL-LONDON, V516, P907, DOI 10.1111/j.1469-7793.1999.0907u.x; Chang EI, 2015, NEONATOLOGY, V107, P249, DOI 10.1159/000369374; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Fletcher AJW, 2006, AM J PHYSIOL-HEART C, V291, pH3023, DOI 10.1152/ajpheart.00504.2006; Gardner DS, 2004, J PHYSIOL-LONDON, V557, P1021, DOI 10.1113/jphysiol.2004.061796; Hasegawa T, 2013, HUM PATHOL, V44, P1271, DOI 10.1016/j.humpath.2012.10.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingerman E, 2013, J CELL BIOL, V200, P619, DOI 10.1083/jcb.201211069; ITSKOVITZ J, 1991, PEDIATR RES, V30, P381, DOI 10.1203/00006450-199110000-00016; IWAMOTO HS, 1979, CIRC RES, V44, P430, DOI 10.1161/01.RES.44.3.430; JONES CT, 1977, J ENDOCRINOL, V72, P279, DOI 10.1677/joe.0.0720279; Koltsova SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110597; LIGGINS GC, 1968, J ENDOCRINOL, V40, P371, DOI 10.1677/joe.0.0400371; LIGGINS GC, 1967, AM J OBSTET GYNECOL, V98, P1080, DOI 10.1016/0002-9378(67)90031-2; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MCMILLEN IC, 1995, J ENDOCRINOL, V144, P569, DOI 10.1677/joe.0.1440569; MESCHIA G, 1965, Q J EXP PHYSIOL CMS, V50, P466, DOI 10.1113/expphysiol.1965.sp001812; MESCHIA G, 1961, Q J EXP PHYSIOL CMS, V46, P95, DOI 10.1113/expphysiol.1961.sp001520; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; PAGE RB, 1982, AM J PHYSIOL, V243, pE427, DOI 10.1152/ajpendo.1982.243.6.E427; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Rabaglino MB, 2012, PHYSIOL GENOMICS, V44, P669, DOI 10.1152/physiolgenomics.00127.2011; Rayl EA, 1996, J BIOL CHEM, V271, P2225, DOI 10.1074/jbc.271.4.2225; Reimsnider SK, 2004, J ENDOCRINOL, V180, P303, DOI 10.1677/joe.0.1800303; Richardson B, 1996, PEDIATR RES, V40, P337, DOI 10.1203/00006450-199608000-00024; ROBINSON J S, 1979, Journal of Developmental Physiology (Eynsham), V1, P379; ROSENBERG AA, 1982, AM J PHYSIOL, V242, pH862, DOI 10.1152/ajpheart.1982.242.5.H862; Rurak D, 2013, AM J PHYSIOL-REG I, V304, pR908, DOI 10.1152/ajpregu.00430.2012; RURAK DW, 1978, J PHYSIOL-LONDON, V277, P341, DOI 10.1113/jphysiol.1978.sp012275; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schaub CE, 2009, NEONATOLOGY, V96, P115, DOI 10.1159/000208793; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHELDON RE, 1979, AM J OBSTET GYNECOL, V135, P1071, DOI 10.1016/0002-9378(79)90739-7; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toubas PL, 1973, CIRCULATION       S4, V38, P47; VEDECKIS WV, 1989, CANCER RES, V49, pS2295; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood CE, 2003, J PHYSIOL-LONDON, V549, P573, DOI 10.1113/jphysiol.2002.038398; Wood CE, 1999, AM J PHYSIOL-REG I, V277, pR1541, DOI 10.1152/ajpregu.1999.277.6.R1541; WOOD CE, 1983, ENDOCRINOLOGY, V112, P1930, DOI 10.1210/endo-112-6-1930; WOOD CE, 1982, AM J PHYSIOL, V243, pE278, DOI 10.1152/ajpendo.1982.243.4.E278; Wood CE, 2014, PHYSIOL GENOMICS, V46, P523, DOI 10.1152/physiolgenomics.00186.2013; Wood CE, 2013, PHYSIOL GENOMICS, V45, P521, DOI 10.1152/physiolgenomics.00005.2013; Wood CE, 2011, NEONATOLOGY, V100, P155, DOI 10.1159/000324431; World Medical A. & American Physiological, 2002, AM J PHYSIOL-REG I, V283, pR281; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang XF, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-186, 10.1186/1471-2105-15-335]	56	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148465	10.1371/journal.pone.0148465	http://dx.doi.org/10.1371/journal.pone.0148465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859870	Green Published, gold			2022-12-26	WOS:000370038400045
J	Zeng, MQ; Wang, L; Chen, CF; Zeng, FC; Huang, L; Xue, RZ; Chen, JJ; Gao, BM; Tang, ZY				Zeng, Mingqiang; Wang, Ling; Chen, Caifang; Zeng, Fanchang; Huang, Liang; Xue, Ruizhi; Chen, Junjie; Gao, Benmin; Tang, Zhengyan			Factors Associated with Knowledge of and Willingness for Adult Male Circumcision in Changsha, China	PLOS ONE			English	Article							HIV PREVENTION; ACCEPTABILITY; MEN; RISK; INFECTIONS; HIV/AIDS	Background Male circumcision (MC) has been shown to reduce the risk of male genital diseases. MC is not commonly practiced among Chinese males and little is known about the factors associated with their knowledge of and willingness for MC. This study was to explore the knowledge regarding the foreskin among Chinese males and to identify factors associated with their willingness to undergo circumcision. Methods A total of 237 patients with redundant prepuce/phimosis were interviewed through face-to-face interviews. The items on the questionnaire included: demographics, an objective scale assessing knowledge about the foreskin, willingness to have MC, the attitudes of sexual partners and doctors toward redundant prepuce/phimosis, and the approaches that patients used to acquire knowledge regarding the prepuce. Univariate analysis and multiple logistic regression analysis were performed to identify factors that are associated with willingness to be circumcised (WTC). Results A total of 212 patients completed the interview. Multivariable logistic regression showed that three factors were significantly associated with WTC: being married (OR = 0.43), perceiving redundant prepuce/phimosis as a disease (OR = 1.93), and if a patient's partner supported MC (OR = 1.39). 58% (n = 122) had received information about the foreskin from another party: 18% (n = 37) from school, 8% (n = 17) from family, 17% (n = 36) from friends, 27% (n = 57) from health care providers. About 4% (n = 8) believed that their partners disliked their redundant prepuce/phimosis. 20% (n = 42) had received doctors' advice to undergo circumcision. Conclusion Knowledge about the foreskin was low among Chinese males. Our study elucidates the factors associated with WTC and suggests that more education of the population about the foreskin can help improve the recognition of a correctible abnormality and help patients assess the potential role of MC in their health.	[Zeng, Mingqiang; Zeng, Fanchang; Huang, Liang; Xue, Ruizhi; Chen, Junjie; Gao, Benmin; Tang, Zhengyan] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Wang, Ling] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Chen, Caifang] Cent S Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Hunan, Peoples R China	Central South University; University System of Ohio; Ohio State University; Central South University	Tang, ZY (corresponding author), Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China.	xytzyan@163.com	Wang, Ling/AAN-3433-2021					Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Ben Kun-Long, 2009, Zhonghua Nan Ke Xue, V15, P395; Blank S, 2012, PEDIATRICS, V130, pE756, DOI 10.1542/peds.2012-1990; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; Cox G, 2012, SURG GUIDE CIRCUMCIS, P243, DOI [10.1007/978-1-4471-2858-8_21, DOI 10.1007/978-1-4471-2858-8_21]; Diseker RA, 2000, SEX TRANSM INFECT, V76, P474, DOI 10.1136/sti.76.6.474; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gust DA, 2011, SEX TRANSM DIS, V38, P536, DOI 10.1097/OLQ.0b013e318207f5b0; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Mavhu W, 2011, TROP MED INT HEALTH, V16, P589, DOI 10.1111/j.1365-3156.2011.02744.x; Morris B. J., 2012, Open Journal of Preventive Medicine, V2, P79, DOI 10.4236/ojpm.2012.21012; Morris BJ, 2013, J SEX MED, V10, P2644, DOI 10.1111/jsm.12293; Morris BJ, 2013, J UROLOGY, V189, P2118, DOI 10.1016/j.juro.2012.11.114; Nelson CP, 2005, J UROLOGY, V173, P978, DOI 10.1097/01.ju.0000145758.80937.7d; Tieu HV, 2010, SEX TRANSM DIS, V37, P352, DOI 10.1097/OLQ.0b013e3181c9963a; Tobian AAR, 2011, LANCET, V378, P314, DOI 10.1016/S0140-6736(11)61162-8; Tobian AAR, 2010, ARCH PEDIAT ADOL MED, V164, P78, DOI 10.1001/archpediatrics.2009.232; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; World Health Organization, 2007, WORLD BANK INF PACK; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198	25	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148832	10.1371/journal.pone.0148832	http://dx.doi.org/10.1371/journal.pone.0148832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859292	gold, Green Published, Green Submitted			2022-12-26	WOS:000370038400093
J	Balcazar-Lopez, E; Mendez-Lorenzo, LH; Batista-Garcia, RA; Esquivel-Naranjo, U; Ayala, M; Kumar, VV; Savary, O; Cabana, H; Herrera-Estrella, A; Folch-Mallol, JL				Balcazar-Lopez, Edgar; Helena Mendez-Lorenzo, Luz; Alberto Batista-Garcia, Ramon; Esquivel-Naranjo, Ulises; Ayala, Marcela; Kumar, Vaidyanathan Vinoth; Savary, Olivier; Cabana, Hubert; Herrera-Estrella, Alfredo; Luis Folch-Mallol, Jorge			Xenobiotic Compounds Degradation by Heterologous Expression of a Trametes sanguineus Laccase in Trichoderma atroviride	PLOS ONE			English	Article							FUNGAL LACCASES; REESEI; GENE	Fungal laccases are enzymes that have been studied because of their ability to decolorize and detoxify effluents; they are also used in paper bleaching, synthesis of polymers, bioremediation, etc. In this work we were able to express a laccase from Trametes (Pycnoporus) sanguineus in the filamentous fungus Trichoderma atroviride. For this purpose, a transformation vector was designed to integrate the gene of interest in an intergenic locus near the blu17 terminator region. Although monosporic selection was still necessary, stable integration at the desired locus was achieved. The native signal peptide from T. sanguineus laccase was successful to secrete the recombinant protein into the culture medium. The purified, heterologously expressed laccase maintained similar properties to those observed in the native enzyme (Km and kcat and kcat/km values for ABTS, thermostability, substrate range, pH optimum, etc). To determine the bioremediation potential of this modified strain, the laccase-overexpressing Trichoderma strain was used to remove xenobiotic compounds. Phenolic compounds present in industrial wastewater and bisphenol A (an endocrine disruptor) from the culture medium were more efficiently removed by this modified strain than with the wild type. In addition, the heterologously expressed laccase was able to decolorize different dyes as well as remove benzo[a] pyrene and phenanthrene in vitro, showing its potential for xenobiotic compound degradation.	[Balcazar-Lopez, Edgar; Helena Mendez-Lorenzo, Luz; Alberto Batista-Garcia, Ramon] Univ Autonoma Estado Morelos, Fac Ciencias, Av Univ 1001, Cuernavaca, Mor, Mexico; [Balcazar-Lopez, Edgar; Helena Mendez-Lorenzo, Luz; Alberto Batista-Garcia, Ramon; Luis Folch-Mallol, Jorge] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Av Univ 1001, Cuernavaca, Morelos, Mexico; [Esquivel-Naranjo, Ulises] Univ Autonoma Queretaro, Fac Ciencias Nat, Unidad Microbiol Basica & Aplicada, Anillo Vial Fray Junipero Serra Km 8 S-N, Santiago De Qro 76000, Mexico; [Ayala, Marcela] Univ Nacl Autonoma Mexico, Inst Biotecnol, Av Univ 2001, Cuernavaca, Morelos, Mexico; [Kumar, Vaidyanathan Vinoth; Savary, Olivier; Cabana, Hubert] Univ Sherbrooke, Dept Civil Engn, 2500 Blvd Univ, Sherbrooke, PQ J1K 2R1, Canada; [Kumar, Vaidyanathan Vinoth] SRM Univ, Dept Biotechnol, Sch Bioengn, Bioproc Lab, Kattankulathur 603203, Tamil Nadu, India; [Herrera-Estrella, Alfredo] Lab Nacl Genom Biodiversidad, Cinvestav Campus Guanajuato,Km 9-6 Libramiento No, Irapuato 36821, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; Universidad Autonoma de Queretaro; Universidad Nacional Autonoma de Mexico; University of Sherbrooke; SRM Institute of Science & Technology Chennai; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Folch-Mallol, JL (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Av Univ 1001, Cuernavaca, Morelos, Mexico.	jordi@uaem.mx	Vaidyanathan, Vinoth kumar/B-2606-2011; Herrera-Estrella, Alfredo/F-3185-2011; Ayala, Marcela/A-4876-2008; Herrera-Estrella, Alfredo/J-8210-2019; Esquivel, Edgardo/GLR-3607-2022	Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Balcazar, Edgar/0000-0003-0616-309X; Batista-Garcia, Ramon Alberto/0000-0002-1032-0767; Cabana, Hubert/0000-0003-3417-6816; Ayala, Marcela/0000-0002-1234-4287; ESQUIVEL-NARANJO, EDGARDO ULISES/0000-0002-1934-7042; Folch-Mallol, Jorge/0000-0002-1860-8175	Consejo Nacional de Ciencia y Tecnologia from the Mexican government [CB-153789-Q]; Consejo Nacional de Ciencia y Tecnologia; Consejo Nacional de Ciencia y Tecnologia-Secretaria de Energia project [150001]; BBVA-Bancomer; Natural Sciences and Engineering Research Council of Canada	Consejo Nacional de Ciencia y Tecnologia from the Mexican government; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia-Secretaria de Energia project; BBVA-Bancomer(BBVA Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was partially funded by a grant of Consejo Nacional de Ciencia y Tecnologia (http://www.conacyt.gob.mx/) CB-153789-Q from the Mexican government. EB-L and RAB-G had a scholarship from Consejo Nacional de Ciencia y Tecnologia. LHM-L had a scholarship from Consejo Nacional de Ciencia y Tecnologia-Secretaria de Energia project 150001. EB-L had a mobility grant from BBVA-Bancomer-2011. The work was also partially funded by a grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala M, 2011, J BIOL INORG CHEM, V16, P63, DOI 10.1007/s00775-010-0702-6; Ba S, 2013, CRIT REV BIOTECHNOL, V33, P404, DOI 10.3109/07388551.2012.725390; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; BOYD AC, 1995, GENE, V153, P57, DOI 10.1016/0378-1119(94)00788-T; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Camarero S, 2012, APPL ENVIRON MICROB, V78, P1370, DOI 10.1128/AEM.07530-11; Carlile MJD, 2001, FUNGI, V1; d'Acunzo F, 2006, NEW J CHEM, V30, P583, DOI 10.1039/b516719a; Dantan-Gonzalez E, 2008, INT MICROBIOL, V11, P163, DOI 10.2436/20.1501.01.56; Del Carratore R, 2011, BIOTECHNOL LETT, V33, P1201, DOI 10.1007/s10529-011-0557-0; E.P.A, 2010, BISPH ACT PLAN 2010; Esquivel-Naranjo EU, 2007, MICROBIOL-SGM, V153, P3909, DOI 10.1099/mic.0.2007/007302-0; Hamzah A, 2012, SAINS MALAYS, V41, P71; Han MJ, 2004, J MICROBIOL, V42, P94; HERRERAESTRELLA A, 1990, MOL MICROBIOL, V4, P839, DOI 10.1111/j.1365-2958.1990.tb00654.x; Hoshida H, 2005, BIOSCI BIOTECH BIOCH, V69, P1090, DOI 10.1271/bbb.69.1090; Jolivalt C, 2005, APPL MICROBIOL BIOT, V66, P450, DOI 10.1007/s00253-004-1717-0; KARHUNEN T, 1993, MOL GEN GENET, V241, P515, DOI 10.1007/BF00279893; Kovacs K, 2009, BIORESOURCE TECHNOL, V100, P1350, DOI 10.1016/j.biortech.2008.08.006; Krastanov A. I., 2007, Bulgarian Journal of Agricultural Science, V13, P349; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; Lee H, 2010, FOLIA MICROBIOL, V55, P447, DOI 10.1007/s12223-010-0075-9; Lee H, 2014, J MICROBIOL METH, V97, P56, DOI 10.1016/j.mimet.2013.12.007; Lomascolo A, 2011, APPL MICROBIOL BIOT, V92, P1129, DOI 10.1007/s00253-011-3596-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majeau JA, 2010, BIORESOURCE TECHNOL, V101, P2331, DOI 10.1016/j.biortech.2009.10.087; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Nishibori N, 2013, J BIOSCI BIOENG, V115, P394, DOI 10.1016/j.jbiosc.2012.10.025; Ortega SN, 2011, BIODEGRADATION, V22, P43, DOI 10.1007/s10532-010-9374-8; Pardo I, 2012, BIOTECHNOL BIOENG, V109, P2978, DOI 10.1002/bit.24588; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rodriguez E, 1999, CURR MICROBIOL, V38, P27, DOI 10.1007/PL00006767; Sack U, 1997, APPL ENVIRON MICROB, V63, P3919, DOI 10.1128/AEM.63.10.3919-3925.1997; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Scott RD, 1931, IND ENG CHEM, V3, P0067, DOI 10.1021/ac50073a034; Torres-Duarte C, 2012, APPL BIOCHEM BIOTECH, V168, P864, DOI 10.1007/s12010-012-9825-2; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Cazares-Garcia SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055295; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Zeilinger S, 2004, CURR GENET, V45, P54, DOI 10.1007/s00294-003-0454-8; Zhang JW, 2012, J BIOSCI BIOENG, V113, P697, DOI 10.1016/j.jbiosc.2012.01.016	44	33	34	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147997	10.1371/journal.pone.0147997	http://dx.doi.org/10.1371/journal.pone.0147997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849129	gold, Green Submitted, Green Published			2022-12-26	WOS:000369554000031
J	Lu, M; An, HM; Li, LL				Lu, Min; An, Huaming; Li, Liangliang			Genome Survey Sequencing for the Characterization of the Genetic Background of Rosa roxburghii Tratt and Leaf Ascorbate Metabolism Genes	PLOS ONE			English	Article							MICROSATELLITE MARKERS; VITAMIN-C; ACID; IDENTIFICATION; EVOLUTION; PLANTS; SIZE; CLASSIFICATION; INSIGHTS; PATHWAY	Rosa roxburghii Tratt is an important commercial horticultural crop in China that is recognized for its nutritional and medicinal values. In spite of the economic significance, genomic information on this rose species is currently unavailable. In the present research, a genome survey of R. roxburghii was carried out using next-generation sequencing (NGS) technologies. Total 30.29 Gb sequence data was obtained by HiSeq 2500 sequencing and an estimated genome size of R. roxburghii was 480.97 Mb, in which the guanine plus cytosine (GC) content was calculated to be 38.63%. All of these reads were technically assembled and a total of 627,554 contigs with a N50 length of 1.484 kb and furthermore 335,902 scaffolds with a total length of 409.36 Mb were obtained. Transposable elements (TE) sequence of 90.84 Mb which comprised 29.20% of the genome, and 167,859 simple sequence repeats (SSRs) were identified from the scaffolds. Among these, the mono-(66.30%), di-(25.67%), and tri-(6.64%) nucleotide repeats contributed to nearly 99% of the SSRs, and sequence motifs AG/CT (28.81%) and GAA/TTC (14.76%) were the most abundant among the dinucleotide and trinucleotide repeat motifs, respectively. Genome analysis predicted a total of 22,721 genes which have an average length of 2311.52 bp, an average exon length of 228.15 bp, and average intron length of 401.18 bp. Eleven genes putatively involved in ascorbate metabolism were identified and its expression in R. roxburghii leaves was validated by quantitative real-time PCR (qRT-PCR). This is the first report of genome-wide characterization of this rose species.	[Lu, Min; An, Huaming; Li, Liangliang] Guizhou Univ, Coll Agr, Guiyang 550003, Guizhou, Peoples R China; [An, Huaming; Li, Liangliang] Guizhou Engn Res Ctr Fruit Crops, Guiyang, Guizhou, Peoples R China	Guizhou University	An, HM (corresponding author), Guizhou Univ, Coll Agr, Guiyang 550003, Guizhou, Peoples R China.; An, HM (corresponding author), Guizhou Engn Res Ctr Fruit Crops, Guiyang, Guizhou, Peoples R China.	anhuaming@hotmail.com			National Natural Science Foundation of China [31360475]; special project of major science and technology in Guizhou Province, P.R. China [20136006-1]; natural science foundation in Guizhou Province, P.R. China [20122169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special project of major science and technology in Guizhou Province, P.R. China; natural science foundation in Guizhou Province, P.R. China	This work was supported by grants from the National Natural Science Foundation of China (31360475, AHM), http://www.nsfc.gov.cn; the special project of major science and technology in Guizhou Province, P.R. China (20136006-1, AHM), http://kjt.gzst.gov.cn; and the natural science foundation in Guizhou Province, P.R. China (20122169, LM), http://www.nsfc.gov.cn. The funders provided support in the form of salaries for authors [AMH and LM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; An HM, 2007, J HORTIC SCI BIOTECH, V82, P627, DOI 10.1080/14620316.2007.11512283; An HuaMing, 2005, Acta Horticulturae Sinica, V32, P994; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bennetzen JL, 2000, PLANT CELL, V12, P1021, DOI 10.1105/tpc.12.7.1021; Bryc K, 2013, GENETICS, V195, P553, DOI 10.1534/genetics.113.154500; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Conklin PL, 2004, PLANT CELL ENVIRON, V27, P959, DOI 10.1111/j.1365-3040.2004.01203.x; Cruz-Rus E, 2011, J EXP BOT, V62, P4191, DOI 10.1093/jxb/err122; Darlington C. D., 1955, CHROMOSOME ATLAS FLO; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Fan WeiGuo, 2011, Acta Horticulturae Sinica, V38, P1609; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; He Z., 1984, ACTA HORTICULTURAE S, V11, P271; Hirakawa H, 2015, DNA RES, V22, P171, DOI 10.1093/dnares/dsv002; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jiao Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-201; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kraaijeveld K, 2010, EVOL BIOL, V37, P227, DOI 10.1007/s11692-010-9093-4; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Yingrui, 2010, Human Genomics, V4, P271; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Liu QL, 2005, J MOUNTAIN AGR BIOL, V24, P522; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Ravishankar KV, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0289-2; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shi XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1954; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smulders MJM, 2012, WILD CROP RELATIVES, P277; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; The Potato Genome Sequencing Consortium, 2011, NATURE, V475, P1; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561; Wen XP, 2004, J HORTIC SCI BIOTECH, V79, P189, DOI 10.1080/14620316.2004.11511747; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yan XQ, 2015, GENE, V561, P54, DOI 10.1016/j.gene.2015.02.054; Yokoya K, 2000, ANN BOT-LONDON, V85, P557, DOI 10.1006/anbo.1999.1102; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069909; ZHU WF, 1984, J GUIZHOU AGR COLL, V3, P1	63	45	57	12	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147530	10.1371/journal.pone.0147530	http://dx.doi.org/10.1371/journal.pone.0147530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849133	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000019
J	Warda, AK; Tempelaars, MH; Boekhorst, J; Abee, T; Groot, MNN				Warda, Alicja K.; Tempelaars, Marcel H.; Boekhorst, Jos; Abee, Tjakko; Groot, Masja N. Nierop			Identification of CdnL, a Putative Transcriptional Regulator Involved in Repair and Outgrowth of Heat-Damaged Bacillus cereus Spores	PLOS ONE			English	Article							LOW-GC-CONTENT; GENE-EXPRESSION; RECOVERY MEDIUM; DNA-DAMAGE; SUBTILIS; CARD; GERMINATION; RESISTANCE; INJURY; INACTIVATION	Spores are widely present in the environment and are common contaminants in the food chain, creating a challenge for food industry. Nowadays, heat treatments conventionally applied in food processing may become milder to comply with consumer desire for products with higher sensory and nutritional values. Consequently subpopulations of spores may emerge that are sublethally damaged rather than inactivated. Such spores may germinate, repair damage, and eventually grow out leading to uncontrolled spoilage and safety issues. To gain insight into both the behaviour of damaged Bacillus cereus spores, and the process of damage repair, we assessed the germination and outgrowth performance using OD595 measurements and microscopy combined with genome-wide transcription analysis of untreated and heat-treated spores. The first two methods showed delayed germination and outgrowth of heat-damaged B. cereus ATCC14579 spores. A subset of genes uniquely expressed in heat-treated spores was identified with putative roles in the outgrowth of damaged spores, including cdnL (BC4714) encoding the putative transcriptional regulator CdnL. Next, a B. cereus ATCC14579 cdnL (BC4714) deletion mutant was constructed and assessment of outgrowth from heat-treated spores under food relevant conditions showed increased damage compared to wild type spores. The approach used in this study allows for identification of candidate genes involved in spore damage repair. Further identification of cellular parameters and characterisation of the molecular processes contributing to spore damage repair may provide leads for better control of spore outgrowth in foods.	[Warda, Alicja K.; Boekhorst, Jos; Abee, Tjakko; Groot, Masja N. Nierop] TI Food & Nutr, Wageningen, Netherlands; [Warda, Alicja K.; Tempelaars, Marcel H.; Abee, Tjakko] Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Warda, Alicja K.; Groot, Masja N. Nierop] Wageningen UR Food & Biobased Res, Wageningen, Netherlands; [Boekhorst, Jos] NIZO Food Res BV, Ede, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; NIZO Food Research	Abee, T (corresponding author), TI Food & Nutr, Wageningen, Netherlands.; Abee, T (corresponding author), Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands.	tjakko.abee@wur.nl	warda, Alicja/ABF-2403-2020; Tempelaars, Marcel/C-5077-2008	warda, Alicja/0000-0001-8317-6455; Boekhorst, Jos/0000-0002-4807-7838; Tempelaars, Marcel/0000-0003-0635-5606	TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition; TIFN	TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition; TIFN	The project is funded by TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition. The public partners are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The private partners have contributed to the project through regular discussion. The TIFN provided support in the form of salaries for authors [AKW, MHT, JB, TA, MNNG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. NIZO food research (http://www.nizo.com) is a contract research organization. NIZO was paid by TIFN to provide input on experimental design, bioinformatics analysis and data interpretation (i.e. the salary of Jos Boekhorst was indirectly paid by TIFN). NIZO has no financial interest in any specific outcome of the study.	Abee T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S9; Aguirre JS, 2015, INT J FOOD MICROBIOL, V202, P20, DOI 10.1016/j.ijfoodmicro.2015.02.020; Aguirre JS, 2012, INT J FOOD MICROBIOL, V153, P444, DOI 10.1016/j.ijfoodmicro.2011.12.012; Andersson A, 1995, INT J FOOD MICROBIOL, V28, P145, DOI 10.1016/0168-1605(95)00053-4; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BARACH JT, 1975, APPL MICROBIOL, V30, P873, DOI 10.1128/AEM.30.5.873-875.1975; Barraza-Salas M, 2010, FEMS MICROBIOL LETT, V302, P159, DOI 10.1111/j.1574-6968.2009.01845.x; Bassi D, 2013, FOOD MICROBIOL, V33, P11, DOI 10.1016/j.fm.2012.08.004; Bernal-Bernal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121322; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Cazemier AE, 2001, J APPL MICROBIOL, V90, P761, DOI 10.1046/j.1365-2672.2001.01302.x; Coleman WH, 2009, J APPL MICROBIOL, V106, P1600, DOI 10.1111/j.1365-2672.2008.04127.x; Coleman WH, 2007, J BACTERIOL, V189, P8458, DOI 10.1128/JB.01242-07; Cortezzo DE, 2004, J APPL MICROBIOL, V97, P838, DOI 10.1111/j.1365-2672.2004.02370.x; Dembek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064011; Dierick K, 2005, J CLIN MICROBIOL, V43, P4277, DOI 10.1128/JCM.43.8.4277-4279.2005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; Ellermeier CD, 2006, CELL, V124, P549, DOI 10.1016/j.cell.2005.11.041; Faille C, 1997, J FOOD PROTECT, V60, P544, DOI 10.4315/0362-028X-60.5.544; FEEHERRY F, 1987, APPL ENVIRON MICROB, V53, P365, DOI 10.1128/AEM.53.2.365-370.1987; Gaillard S, 2005, INT J FOOD MICROBIOL, V105, P53, DOI 10.1016/j.ijfoodmicro.2005.04.009; Garcia D, 2010, INT J FOOD MICROBIOL, V140, P146, DOI 10.1016/j.ijfoodmicro.2010.04.005; Garcia-Moreno D, 2010, NUCLEIC ACIDS RES, V38, P4586, DOI 10.1093/nar/gkq214; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Granum P.E., 2005, FOODBORNE PATHOGENS; Hornstra LM, 2005, APPL ENVIRON MICROB, V71, P774, DOI 10.1128/AEM.71.2.774-781.2005; Kaur G, 2014, PROTEINS, V82, P879, DOI 10.1002/prot.24419; Keijser BJF, 2007, J BACTERIOL, V189, P3624, DOI 10.1128/JB.01736-06; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; Mols M, 2011, INT J FOOD MICROBIOL, V151, P119, DOI 10.1016/j.ijfoodmicro.2011.08.004; Ramirez-Guadiana FH, 2012, J BACTERIOL, V194, P6096, DOI 10.1128/JB.01340-12; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Segev E, 2013, J BACTERIOL, V195, P1875, DOI 10.1128/JB.00093-13; Segev E, 2012, CELL, V148, P139, DOI 10.1016/j.cell.2011.11.059; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P., 2014, MICROBIOL SPECTR, P201, DOI [DOI 10.1128/MICROBIOLSPEC.TBS-0003-2012, DOI 10.1128/microbiolspec.TBS-0003-2012]; Sinai L, 2015, MOL CELL, V57, P695, DOI 10.1016/j.molcel.2014.12.019; Smelt JPPM, 2008, INT J FOOD MICROBIOL, V128, P34, DOI 10.1016/j.ijfoodmicro.2008.08.023; Srivastava DB, 2013, P NATL ACAD SCI USA, V110, P12619, DOI 10.1073/pnas.1308270110; Stallings CL, 2011, TRANSCR-AUSTIN, V2, P15, DOI 10.4161/trns.2.1.13628; Stringer SC, 2011, FOOD MICROBIOL, V28, P228, DOI 10.1016/j.fm.2010.03.003; Tabit FT, 2010, INT J FOOD MICROBIOL, V140, P207, DOI 10.1016/j.ijfoodmicro.2010.03.033; Ter Beek A, 2011, FOOD MICROBIOL, V28, P678, DOI 10.1016/j.fm.2010.07.003; van Melis CCJ, 2011, FOOD MICROBIOL, V28, P275, DOI 10.1016/j.fm.2010.04.005; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warda AK, 2015, INT J FOOD MICROBIOL, V201, P27, DOI 10.1016/j.ijfoodmicro.2015.02.010; Yang XF, 2008, INFECT IMMUN, V76, P4439, DOI 10.1128/IAI.00740-08	52	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148670	10.1371/journal.pone.0148670	http://dx.doi.org/10.1371/journal.pone.0148670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849219	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000152
J	Zou, Z; Yang, LF; Wang, DH; Huang, QX; Mo, YY; Xie, GS				Zou, Zhi; Yang, Lifu; Wang, Danhua; Huang, Qixing; Mo, Yeyong; Xie, Guishui			Gene Structures, Evolution and Transcriptional Profiling of the WRKY Gene Family in Castor Bean (Ricinus communis L.)	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; ABSCISIC-ACID; EXPRESSION PROFILES; NEGATIVE REGULATORS; ARABIDOPSIS WRKY33; BINDING PROTEINS; WIDE ANALYSIS; RESISTANCE; SENESCENCE; SUPERFAMILY	WRKY proteins comprise one of the largest transcription factor families in plants and form key regulators of many plant processes. This study presents the characterization of 58 WRKY genes from the castor bean (Ricinus communis L., Euphorbiaceae) genome. Compared with the automatic genome annotation, one more WRKY-encoding locus was identified and 20 out of the 57 predicted gene models were manually corrected. All RcWRKY genes were shown to contain at least one intron in their coding sequences. According to the structural features of the present WRKY domains, the identified RcWRKY genes were assigned to three previously defined groups (I-III). Although castor bean underwent no recent whole-genome duplication event like physic nut (Jatropha curcas L., Euphorbiaceae), comparative genomics analysis indicated that one gene loss, one intron loss and one recent proximal duplication occurred in the RcWRKY gene family. The expression of all 58 RcWRKY genes was supported by ESTs and/or RNA sequencing reads derived from roots, leaves, flowers, seeds and endosperms. Further global expression profiles with RNA sequencing data revealed diverse expression patterns among various tissues. Results obtained from this study not only provide valuable information for future functional analysis and utilization of the castor bean WRKY genes, but also provide a useful reference to investigate the gene family expansion and evolution in Euphorbiaceus plants.	[Zou, Zhi; Yang, Lifu; Wang, Danhua; Mo, Yeyong; Xie, Guishui] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Danzhou Invest & Expt Stn Trop Crops, Danzhou, Hainan, Peoples R China; [Huang, Qixing] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Zou, Z; Xie, GS (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Danzhou Invest & Expt Stn Trop Crops, Danzhou, Hainan, Peoples R China.	zouzhi2008@126.com; xie23300459@163.com	Zou, Zhi/F-1266-2018	Zou, Zhi/0000-0003-2881-1932	National Natural Science Foundation of China [31371556]; Fundamental Research Funds for Rubber Research Institute, CATAS [1630022015004]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-34-GW5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Rubber Research Institute, CATAS; Earmarked Fund for Modern Agro-industry Technology Research System	The Funding should be the National Natural Science Foundation of China (31371556), the Fundamental Research Funds for Rubber Research Institute, CATAS (1630022015004) and the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-34-GW5).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brown AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030100; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chandrasekaran U, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-33; Chandrasekaran U, 2014, PLANT GROWTH REGUL, V72, P203, DOI 10.1007/s10725-013-9846-z; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen XT, 2013, PLANT CELL REP, V32, P1589, DOI 10.1007/s00299-013-1469-3; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Hsu FC, 2013, PLANT CELL, V25, P2699, DOI 10.1105/tpc.113.114447; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang XS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2233-6; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li HL, 2012, GENE, V503, P248, DOI 10.1016/j.gene.2012.04.069; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Li ZH, 2012, J INTEGR PLANT BIOL, V54, P526, DOI 10.1111/j.1744-7909.2012.01136.x; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu R, 2013, J EXP BOT, V64, P5443, DOI 10.1093/jxb/ert307; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muthamilarasan M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00910; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Rivarola M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021743; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Schon M, 2013, MOL PLANT MICROBE IN, V26, P758, DOI 10.1094/MPMI-11-12-0265-R; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Van Aken O, 2013, PLANT PHYSIOL, V162, P254, DOI 10.1104/pp.113.215996; Wu PZ, 2015, PLANT J, V81, P810, DOI 10.1111/tpj.12761; Xiong WD, 2013, GENE, V524, P124, DOI 10.1016/j.gene.2013.04.047; Xu W, 2014, NUCLEIC ACIDS RES, V42, P6987, DOI 10.1093/nar/gku375; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; Yamasaki K, 2012, J BIOL CHEM, V287, P7683, DOI 10.1074/jbc.M111.279844; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhou X, 2011, MOL CELLS, V31, P303, DOI 10.1007/s10059-011-0047-1; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; [邹智 Zou Zhi], 2013, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V35, P36	69	28	30	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148243	10.1371/journal.pone.0148243	http://dx.doi.org/10.1371/journal.pone.0148243			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849139	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000055
J	Perez-Cembranos, A; Leon, A; Perez-Mellado, V				Perez-Cembranos, Ana; Leon, Alicia; Perez-Mellado, Valentin			Omnivory of an Insular Lizard: Sources of Variation in the Diet of Podarcis lilfordi (Squamata, Lacertidae)	PLOS ONE			English	Article							PLANT CONSUMPTION; FEEDING ECOLOGY; DRY-WEIGHT; EVOLUTION; SELECTION; ENERGETICS; DIVERSITY; BIOMASS; LENGTH	Through 17 years and from a sample of 7,790 faecal pellets and 26,346 prey items, we studied the diet of the Balearic lizard Podarcis lilfordi in Aire Island (Menorca, Balearic Islands, Spain). We analysed the diet in terms of prey frequencies, as well as by their volume and biomass contributions. The diet of the Balearic lizard was extremely variable through the years, months and areas under study. The dominance of small clumped prey, particularly ants, was confirmed. However, the main contribution by volume corresponded to beetles, with a relevant role for Diplopoda and terrestrial Isopoda during some months and at particular areas of the island. Several prey items were probably captured at the base of shrubs, under stones or inside rock crevices. Therefore, our estimations of electivity would only be reliable for epigeal and flying prey. The capacity of the Balearic lizard to include marine subsidies in its diet, such as coastal crustaceans, is noteworthy. Also, its consumption of carrion from carcasses of gulls and rabbits and leftovers from human visitors is remarkable. Juvenile conspecifics can also be a sporadic food resource, especially during the second half of summer, whereas the consumption of vegetal matter is constant for each whole year. The shifts of vegetal exploitation among areas of the island and months take place according to availability of different plant species at each area or during a given period. Thus, lizards are able to conduct a thorough monitoring of plant phenology, exploiting a large variety of plant species. Omnivory does not imply the indiscriminate inclusion of any edible food in its diet. Rather, the inclusion of several food items means the adoption of a wide range of foraging behaviours adapted to the exploitation of each food resource.	[Perez-Cembranos, Ana; Leon, Alicia; Perez-Mellado, Valentin] Univ Salamanca, Dept Anim Biol, E-37008 Salamanca, Spain	University of Salamanca	Perez-Mellado, V (corresponding author), Univ Salamanca, Dept Anim Biol, E-37008 Salamanca, Spain.	valentin@usal.es	Carvalheiro, Roberto/I-2239-2013; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Adriana S/E-4342-2016; Pérez-Cembranos, Ana/H-8542-2015; de Rezende Neves, Haroldo Henrique/F-9521-2012; León, Alicia/ABF-2086-2021; Carvalheiro, Roberto/AAG-2222-2020; MILANESI, Marco/P-7473-2015; Contreras-Castillo, Carmen Josefina/C-4696-2012; AJMONE MARSAN, Paolo/M-2466-2018	Carvalheiro, Roberto/0000-0002-4506-0555; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carmo, Adriana S/0000-0002-2712-4789; Pérez-Cembranos, Ana/0000-0002-8296-2283; León, Alicia/0000-0001-5919-1858; Carvalheiro, Roberto/0000-0002-4506-0555; MILANESI, Marco/0000-0001-6244-7455; Contreras Castillo, Carmen Josefina/0000-0002-0554-4694; Solkner, Johann/0000-0002-1517-5829; AJMONE MARSAN, Paolo/0000-0003-3165-4579	Ministerio de Economia y Competitividad [CGL2012-39850-CO2-02]; FEDER funds from the European Union	Ministerio de Economia y Competitividad(Spanish Government); FEDER funds from the European Union(European Commission)	The study was funded by the research project CGL2012-39850-CO2-02 from the Spanish Ministry of Science and Innovation (currently: Ministerio de Economia y Competitividad) co-funded by FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angelici FM, 1997, ITAL J ZOOL, V64, P267, DOI 10.1080/11250009709356207; BAUMGARTNER LUTHER L., 1939, JOUR WILDLIFE MANAGEMENT, V3, P266, DOI 10.2307/3796113; BEST TL, 1984, J HERPETOL, V18, P291, DOI 10.2307/1564083; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075962; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; BROWN RP, 1992, OECOLOGIA, V91, P500, DOI 10.1007/BF00650322; BROWN RP, 1994, FUNCT ECOL, V8, P427, DOI 10.2307/2390065; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; CALVER MC, 1982, AUST WILDLIFE RES, V9, P293; Canyelles X, 2003, INSECTES ILLES BALEA; Capizzi Dario, 1999, Herpetozoa, V11, P117; Castilla AM, 1996, COPEIA, P991, DOI 10.2307/1447663; CASTILLA AM, 1991, J HERPETOL, V25, P30, DOI 10.2307/1564791; Civantos E, 2013, AFR J HERPETOL, V62, P78, DOI 10.1080/21564574.2013.799101; COLLINS PT, 1992, AM MIDL NAT, V128, P404, DOI 10.2307/2426474; Cooper WE, 2002, J ZOOL, V257, P487, DOI 10.1017/S0952836902001085; Cronquist A., 1988, EVOLUTION CLASSIFICA; Diaz J.A., 1990, Donana Acta Vertebrata, V17, P67; Fialho RF, 2000, J HERPETOL, V34, P325, DOI 10.2307/1565437; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; Gillon Y, 1967, SECONDARY PRODUCTIVI, V2, P519; Hawlena D, 2009, OECOLOGIA, V161, P411, DOI 10.1007/s00442-009-1375-0; Herrel A, 2004, J EVOLUTION BIOL, V17, P974, DOI 10.1111/j.1420-9101.2004.00758.x; Herrel A, 2008, P NATL ACAD SCI USA, V105, P4792, DOI 10.1073/pnas.0711998105; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hodar JA, 1996, ACTA OECOL, V17, P421; Hodar JA, 1997, MISC ZOOL, V20, P1; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Johnson MK, 1983, SAE831684 TECH PAP S, P1; Luiselli L, 2006, J TROP ECOL, V22, P91, DOI 10.1017/S0266467405002877; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Magnusson WE, 2003, COPEIA, P13, DOI 10.1643/0045-8511(2003)003[0013:UOGFTE]2.0.CO;2; Magurran A.E., 2004, MEASURING BIOL DIVER; Maragou P., 1996, Herpetozoa, V9, P105; MARTIN J, 1993, OIKOS, V66, P318, DOI 10.2307/3544820; Mateo JA, ZOOL ANZ IN PRESS; Monti DM, 2013, BIOL J LINN SOC, V108, P144, DOI 10.1111/j.1095-8312.2012.02019.x; Moore P.D., 1991, BLACKWELL SCI PUBLI; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ortmann Sylvia, 2006, P397; Ouboter MP, 1981, AMPHIB REPTIL, V2, P243; Pafilis P, 2009, NATURWISSENSCHAFTEN, V96, P1107, DOI 10.1007/s00114-009-0564-3; Pallmann P, 2012, MOL ECOL RESOUR, V12, P1068, DOI 10.1111/1755-0998.12004; Perera A, 2004, REV MENORCA, V86, P159; Perez-Cembranos A, 2015, SALAMANDRA, V51, P63; Perez-Cembranos A, 2015, ANIM COGN, V18, P629, DOI 10.1007/s10071-014-0831-3; Perez-Mellado V, HERPETOFAUNAS MEDITE; Perez-Mellado V., 1989, REV MENORCA, V80, P455; Perez-Mellado V., 1998, FAUNA IBERICA, P272; Perez-Mellado V., 2009, QUADERNS NATURA BALE; Perez-Mellado V., 2007, MAINLAND INSULAR LAC, P133; Perez-Mellado V, 2008, AMPHIBIA-REPTILIA, V29, P49, DOI 10.1163/156853808783431587; Perez-Mellado V, 2011, AMPHIBIA-REPTILIA, V32, P1, DOI 10.1163/017353710X530212; Perez-Mellado Valentin, 1993, Bonner Zoologische Beitraege, V44, P193; Pianka ER, 2003, WINDOWS EVOLUTION DI; POLIS GA, 1985, J HERPETOL, V19, P99, DOI 10.2307/1564425; Provenza Frederick D., 1993, P78; Punt W, 1980, NW EUROPEAN FLORA 2; Quayle A., 1983, British Journal of Herpetology, V6, P309; R Core Team, 2021, R LANGUAGE ENV STAT; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Roman P, 1971, TEJIDOS VEGETALES; SADEK RA, 1981, ZOOL J LINN SOC-LOND, V73, P313, DOI 10.1111/j.1096-3642.1981.tb01599.x; SAGE RD, 1982, AM MIDL NAT, V108, P407, DOI 10.2307/2425505; Sagonas K, 2014, BIOL J LINN SOC, V112, P469, DOI 10.1111/bij.12290; SALVADOR A., 1986, HDB REPTILIEN AMPHIB, P83; Scherer R., 2014, SIMBOOT SIMULTANEOUS; Stephens D.W., 1986, pi; Teerink B. J., 2003, HAIR W EUROPEAN MAMM; Valdes B., 1987, ATLAS POLINICO ANDAL; Van Damme R, 1999, J HERPETOL, V33, P663; VANDERPLOEG HA, 1979, ECOL MODEL, V7, P135, DOI 10.1016/0304-3800(79)90004-8; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	77	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148947	10.1371/journal.pone.0148947	http://dx.doi.org/10.1371/journal.pone.0148947			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871439	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100078
J	Pereira, AGT; Utsunomiya, YT; Milanesi, M; Torrecilha, RBP; Carmo, AS; Neves, HHR; Carvalheiro, R; Ajmone-Marsan, P; Sonstegard, TS; Solkner, J; Contreras-Castillo, CJ; Garcia, JF				Pereira, Anirene G. T.; Utsunomiya, Yuri T.; Milanesi, Marco; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Neves, Haroldo H. R.; Carvalheiro, Roberto; Ajmone-Marsan, Paolo; Sonstegard, Tad S.; Solkner, Johann; Contreras-Castillo, Carmen J.; Garcia, Jose F.			Pleiotropic Genes Affecting Carcass Traits in Bos indicus (Nellore) Cattle Are Modulators of Growth	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-I CONCENTRATION; LINEAR MIXED MODELS; VISUAL SCORES; EXPRESSION; VARIANTS; ANGUS; PROOPIOMELANOCORTIN; MYOSTATIN; THICKNESS	Two complementary methods, namely Multi-Trait Meta-Analysis and Versatile Gene-Based Test for Genome-wide Association Studies (VEGAS), were used to identify putative pleiotropic genes affecting carcass traits in Bos indicus (Nellore) cattle. The genotypic data comprised over 777,000 single-nucleotide polymorphism markers scored in 995 bulls, and the phenotypic data included deregressed breeding values (dEBV) for weight measurements at birth, weaning and yearling, as well visual scores taken at weaning and yearling for carcass finishing precocity, conformation and muscling. Both analyses pointed to the pleomorphic adenoma gene 1 (PLAG1) as a major pleiotropic gene. VEGAS analysis revealed 224 additional candidates. From these, 57 participated, together with PLAG1, in a network involved in the modulation of the function and expression of IGF1 (insulin like growth factor 1), IGF2 (insulin like growth factor 2), GH1 (growth hormone 1), IGF1R (insulin like growth factor 1 receptor) and GHR (growth hormone receptor), suggesting that those pleiotropic genes operate as satellite regulators of the growth pathway.	[Pereira, Anirene G. T.; Contreras-Castillo, Carmen J.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Agroind Alimentos & Nutr, Piracicaba, Brazil; [Utsunomiya, Yuri T.; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Garcia, Jose F.] UNESP Univ Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Milanesi, Marco; Garcia, Jose F.] UNESP Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Fac Med Vet & Aracatuba, Aracatuba, SP, Brazil; [Pereira, Anirene G. T.; Utsunomiya, Yuri T.; Milanesi, Marco; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Garcia, Jose F.] IAEA, Collaborating Ctr Anim Genom & Bioinformat, Aracatuba, SP, Brazil; [Neves, Haroldo H. R.] GenSys Consultores Assoc, Porto Alegre, RS, Brazil; [Carvalheiro, Roberto] UNESP Univ Estadual Paulista, Dept Zootecnia, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Piacenza, Italy; [Sonstegard, Tad S.] Recombinetics Inc, St Paul, MN USA; [Solkner, Johann] BOKU Univ Nat Resources & Life Sci, Dept Sustainable Agr Syst, Div Livestock Sci, Vienna, Austria	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Catholic University of the Sacred Heart; University of Natural Resources & Life Sciences, Vienna	Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.; Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Fac Med Vet & Aracatuba, Aracatuba, SP, Brazil.; Garcia, JF (corresponding author), IAEA, Collaborating Ctr Anim Genom & Bioinformat, Aracatuba, SP, Brazil.	jfgarcia@fmva.unesp.br	Carvalheiro, Roberto/I-2239-2013; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Adriana S/E-4342-2016; Pérez-Cembranos, Ana/H-8542-2015; de Rezende Neves, Haroldo Henrique/F-9521-2012; León, Alicia/ABF-2086-2021; Carvalheiro, Roberto/AAG-2222-2020; MILANESI, Marco/P-7473-2015; Contreras-Castillo, Carmen Josefina/C-4696-2012; AJMONE MARSAN, Paolo/M-2466-2018	Carvalheiro, Roberto/0000-0002-4506-0555; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carmo, Adriana S/0000-0002-2712-4789; Pérez-Cembranos, Ana/0000-0002-8296-2283; León, Alicia/0000-0001-5919-1858; Carvalheiro, Roberto/0000-0002-4506-0555; MILANESI, Marco/0000-0001-6244-7455; Contreras Castillo, Carmen Josefina/0000-0002-0554-4694; Solkner, Johann/0000-0002-1517-5829; AJMONE MARSAN, Paolo/0000-0003-3165-4579	National Counsel of Technological and Scientific Development (CNPq) [560922/2010-8, 483590/2010-0]; Sao Paulo Research Foundation (FAPESP) [2014/01095-8, 2013/02552-0]; Gensys Consultores Associados; Recombinetics, Inc	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Gensys Consultores Associados; Recombinetics, Inc	This research was supported by: National Counsel of Technological and Scientific Development (CNPq-http://www.cnpq.br/) (process 560922/2010-8 and 483590/2010-0); and Sao Paulo Research Foundation (FAPESP-http://www.fapesp.br/) (process 2014/01095-8 and 2013/02552-0). Gensys Consultores Associados and Recombinetics, Inc provided support in the form of salaries for authors HHRN and TSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adoligbe C, 2012, MOL BIOL REP, V39, P4067, DOI 10.1007/s11033-011-1188-1; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Boligon AA, 2011, LIVEST SCI, V135, P238, DOI 10.1016/j.livsci.2010.07.011; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cancian PH, 2014, SCI AGR, V71, P17, DOI 10.1590/S0103-90162014000100002; Cao JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13950; Capomaccio S, 2015, BIOINFORMATICS, V31, P2380, DOI 10.1093/bioinformatics/btv144; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen L, 2005, FRONT BIOSCI-LANDMRK, V10, P1961, DOI 10.2741/1671; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Davis ME, 2003, J ANIM SCI, V81, P2164; Davis ME, 1997, J ANIM SCI, V75, P317; DeAtley KL, 2011, J ANIM SCI, V89, P2031, DOI 10.2527/jas.2010-3293; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fortes M, 2013, EVIDENCE PLEIOTROPIS; Fortes M, 2012, BIOL; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Fortes MRS, 2012, ANIM PROD SCI, V52, P143, DOI 10.1071/AN11165; Garrick DJ, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-17; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Hartati H, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0229-5; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Keady SM, 2013, J ANIM SCI, V91, P654, DOI 10.2527/jas.2012-5850; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Littlejohn M, 2012, GENETIC VARIATION PL; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Neves HHR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-17; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rimbault M, 2013, GENOME RES, V23, P1985, DOI 10.1101/gr.157339.113; Ronnegrard L, 2010, HGLM PACKAGE FITTING, V2; ROSIE R, 1992, J NEUROENDOCRINOL, V4, P625, DOI 10.1111/j.1365-2826.1992.tb00212.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor JA, 2007, BIOL REPROD, V76, P524, DOI 10.1095/biolreprod.106.055533; Taylor JF, 2014, AQUACULTURE, V420, pS8, DOI 10.1016/j.aquaculture.2013.02.017; Utsunomiya YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088561; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; Velazquez MA, 2008, DOMEST ANIM ENDOCRIN, V35, P325, DOI 10.1016/j.domaniend.2008.07.002; Versteyhe Soetkin, 2013, Front Endocrinol (Lausanne), V4, P98, DOI 10.3389/fendo.2013.00098; Voz ML, 2000, CANCER RES, V60, P106; Xu Z Y, 2010, Animal, V4, P1541, DOI 10.1017/S1751731110000649; Xue M, 2011, INDIAN J ANIMAL SCI; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	55	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158165	10.1371/journal.pone.0158165	http://dx.doi.org/10.1371/journal.pone.0158165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	26871439	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300019
